<?xml version="1.0"?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35197628</article-id>
      <article-id pub-id-type="pmc">8891020</article-id>
      <article-id pub-id-type="publisher-id">4436</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-04436-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Brown</surname>
            <given-names>Anna-Leigh</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Wilkins</surname>
            <given-names>Oscar G.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Keuss</surname>
            <given-names>Matthew J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8499-7455</contrib-id>
          <name>
            <surname>Hill</surname>
            <given-names>Sarah E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zanovello</surname>
            <given-names>Matteo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Weaverly Colleen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bampton</surname>
            <given-names>Alexander</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Flora C. Y.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Masino</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qi</surname>
            <given-names>Yue A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bryce-Smith</surname>
            <given-names>Sam</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gatt</surname>
            <given-names>Ariana</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hallegger</surname>
            <given-names>Martina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fagegaltier</surname>
            <given-names>Delphine</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phatnani</surname>
            <given-names>Hemali</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author" id="IAu1">
          <collab>NYGC ALS Consortium<contrib-group><contrib contrib-type="author"><name><surname>Phatnani</surname><given-names>Hemali</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Kwan</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Sareen</surname><given-names>Dhruv</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Broach</surname><given-names>James R.</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Simmons</surname><given-names>Zachary</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Arcila-Londono</surname><given-names>Ximena</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Edward B.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Van Deerlin</surname><given-names>Vivianna M.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Shneider</surname><given-names>Neil A.</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Fraenkel</surname><given-names>Ernest</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Ostrow</surname><given-names>Lyle W.</given-names></name><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name><surname>Baas</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="Aff30">30</xref><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Zaitlen</surname><given-names>Noah</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Berry</surname><given-names>James D.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Malaspina</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="Aff35">35</xref><xref ref-type="aff" rid="Aff36">36</xref><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Fratta</surname><given-names>Pietro</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cox</surname><given-names>Gregory A.</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>Leslie M.</given-names></name><xref ref-type="aff" rid="Aff39">39</xref><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name><surname>Finkbeiner</surname><given-names>Steve</given-names></name><xref ref-type="aff" rid="Aff41">41</xref></contrib><contrib contrib-type="author"><name><surname>Dardiotis</surname><given-names>Efthimios</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Timothy M.</given-names></name><xref ref-type="aff" rid="Aff43">43</xref></contrib><contrib contrib-type="author"><name><surname>Chandran</surname><given-names>Siddharthan</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Pal</surname><given-names>Suvankar</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Hornstein</surname><given-names>Eran</given-names></name><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name><surname>MacGowan</surname><given-names>Daniel J.</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><name><surname>Heiman-Patterson</surname><given-names>Terry</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name><surname>Hammell</surname><given-names>Molly G.</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name><surname>Patsopoulos</surname><given-names>Nikolaos. A.</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name><surname>Butovsky</surname><given-names>Oleg</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name><surname>Dubnau</surname><given-names>Joshua</given-names></name><xref ref-type="aff" rid="Aff50">50</xref></contrib><contrib contrib-type="author"><name><surname>Nath</surname><given-names>Avindra</given-names></name><xref ref-type="aff" rid="Aff51">51</xref></contrib><contrib contrib-type="author"><name><surname>Bowser</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="Aff52">52</xref><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name><surname>Harms</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name><surname>Aronica</surname><given-names>Eleonora</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name><surname>Poss</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="Aff56">56</xref></contrib><contrib contrib-type="author"><name><surname>Phillips-Cremins</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="Aff57">57</xref></contrib><contrib contrib-type="author"><name><surname>Crary</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff58">58</xref></contrib><contrib contrib-type="author"><name><surname>Atassi</surname><given-names>Nazem</given-names></name><xref ref-type="aff" rid="Aff59">59</xref></contrib><contrib contrib-type="author"><name><surname>Lange</surname><given-names>Dale J.</given-names></name><xref ref-type="aff" rid="Aff60">60</xref><xref ref-type="aff" rid="Aff61">61</xref></contrib><contrib contrib-type="author"><name><surname>Adams</surname><given-names>Darius J.</given-names></name><xref ref-type="aff" rid="Aff62">62</xref><xref ref-type="aff" rid="Aff63">63</xref></contrib><contrib contrib-type="author"><name><surname>Stefanis</surname><given-names>Leonidas</given-names></name><xref ref-type="aff" rid="Aff64">64</xref><xref ref-type="aff" rid="Aff65">65</xref></contrib><contrib contrib-type="author"><name><surname>Gotkine</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="Aff66">66</xref></contrib><contrib contrib-type="author"><name><surname>Baloh</surname><given-names>Robert H.</given-names></name><xref ref-type="aff" rid="Aff67">67</xref><xref ref-type="aff" rid="Aff68">68</xref></contrib><contrib contrib-type="author"><name><surname>Babu</surname><given-names>Suma</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Raj</surname><given-names>Towfique</given-names></name><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Paganoni</surname><given-names>Sabrina</given-names></name><xref ref-type="aff" rid="Aff69">69</xref></contrib><contrib contrib-type="author"><name><surname>Shalem</surname><given-names>Ophir</given-names></name><xref ref-type="aff" rid="Aff70">70</xref><xref ref-type="aff" rid="Aff71">71</xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Colin</given-names></name><xref ref-type="aff" rid="Aff72">72</xref><xref ref-type="aff" rid="Aff73">73</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="Aff74">74</xref></contrib><contrib contrib-type="author"><name><surname>Harris</surname><given-names>Brent</given-names></name><xref ref-type="aff" rid="Aff75">75</xref></contrib><contrib contrib-type="author"><name><surname>Broce</surname><given-names>Iris</given-names></name><xref ref-type="aff" rid="Aff76">76</xref></contrib><contrib contrib-type="author"><name><surname>Drory</surname><given-names>Vivian</given-names></name><xref ref-type="aff" rid="Aff77">77</xref></contrib><contrib contrib-type="author"><name><surname>Ravits</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff78">78</xref></contrib><contrib contrib-type="author"><name><surname>McMillan</surname><given-names>Corey</given-names></name><xref ref-type="aff" rid="Aff79">79</xref></contrib><contrib contrib-type="author"><name><surname>Menon</surname><given-names>Vilas</given-names></name><xref ref-type="aff" rid="Aff80">80</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Lani</given-names></name><xref ref-type="aff" rid="Aff81">81</xref></contrib><contrib contrib-type="author"><name><surname>Altschuler</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="Aff81">81</xref></contrib><contrib contrib-type="author"><name><surname>Lerner</surname><given-names>Yossef</given-names></name><xref ref-type="aff" rid="Aff82">82</xref></contrib><contrib contrib-type="author"><name><surname>Sattler</surname><given-names>Rita</given-names></name><xref ref-type="aff" rid="Aff83">83</xref></contrib><contrib contrib-type="author"><name><surname>Van Keuren-Jensen</surname><given-names>Kendall</given-names></name><xref ref-type="aff" rid="Aff84">84</xref></contrib><contrib contrib-type="author"><name><surname>Rozenblatt-Rosen</surname><given-names>Orit</given-names></name><xref ref-type="aff" rid="Aff85">85</xref></contrib><contrib contrib-type="author"><name><surname>Lindblad-Toh</surname><given-names>Kerstin</given-names></name><xref ref-type="aff" rid="Aff85">85</xref></contrib><contrib contrib-type="author"><name><surname>Nicholson</surname><given-names>Katharine</given-names></name><xref ref-type="aff" rid="Aff86">86</xref></contrib><contrib contrib-type="author"><name><surname>Gregersen</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff87">87</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jeong-Ho</given-names></name><xref ref-type="aff" rid="Aff88">88</xref></contrib><contrib contrib-type="author"><name><surname>Kokos</surname><given-names>Sulev</given-names></name><xref ref-type="aff" rid="Aff89">89</xref></contrib><contrib contrib-type="author"><name><surname>Muljo</surname><given-names>Stephen</given-names></name><xref ref-type="aff" rid="Aff90">90</xref></contrib></contrib-group></collab>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9609-7975</contrib-id>
          <name>
            <surname>Newcombe</surname>
            <given-names>Jia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gustavsson</surname>
            <given-names>Emil K.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seddighi</surname>
            <given-names>Sahba</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reyes</surname>
            <given-names>Joel F.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coon</surname>
            <given-names>Steven L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ramos</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4319-8745</contrib-id>
          <name>
            <surname>Schiavo</surname>
            <given-names>Giampietro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fisher</surname>
            <given-names>Elizabeth M. C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9355-5704</contrib-id>
          <name>
            <surname>Raj</surname>
            <given-names>Towfique</given-names>
          </name>
          <xref ref-type="aff" rid="Aff13">13</xref>
          <xref ref-type="aff" rid="Aff14">14</xref>
          <xref ref-type="aff" rid="Aff15">15</xref>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2758-1741</contrib-id>
          <name>
            <surname>Secrier</surname>
            <given-names>Maria</given-names>
          </name>
          <xref ref-type="aff" rid="Aff17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lashley</surname>
            <given-names>Tammaryn</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2452-4277</contrib-id>
          <name>
            <surname>Ule</surname>
            <given-names>Jernej</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1356-9074</contrib-id>
          <name>
            <surname>Buratti</surname>
            <given-names>Emanuele</given-names>
          </name>
          <xref ref-type="aff" rid="Aff19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Humphrey</surname>
            <given-names>Jack</given-names>
          </name>
          <xref ref-type="aff" rid="Aff13">13</xref>
          <xref ref-type="aff" rid="Aff14">14</xref>
          <xref ref-type="aff" rid="Aff15">15</xref>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Ward</surname>
            <given-names>Michael E.</given-names>
          </name>
          <address>
            <email>wardme@nih.gov</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8762-8188</contrib-id>
          <name>
            <surname>Fratta</surname>
            <given-names>Pietro</given-names>
          </name>
          <address>
            <email>p.fratta@ucl.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, </institution><institution>UCL Queen Square Institute of Neurology, UCL, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.451388.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1795 1830</institution-id><institution>The Francis Crick Institute, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.416870.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2177 357X</institution-id><institution>National Institute of Neurological Disorders and Stroke, NIH, </institution></institution-wrap>Bethesda, MD USA </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Queen Square Brain Bank, UCL Queen Square Institute of Neurology, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution>Center for Alzheimer&#x2019;s and Related Dementias, </institution><institution>National Institutes of Health, </institution></institution-wrap>Bethesda, MD USA </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.429884.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1791 0895</institution-id><institution>Center for Genomics of Neurodegenerative Disease, </institution><institution>New York Genome Center (NYGC), </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>NeuroResource, Department of Neuroinflammation, </institution><institution>UCL Queen Square Institute of Neurology, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Medical Scientist Training Program, </institution><institution>Johns Hopkins University School of Medicine, </institution></institution-wrap>Baltimore, MD USA </aff>
        <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.420089.7</institution-id><institution-id institution-id-type="ISNI">0000 0000 9635 8082</institution-id><institution>Molecular Genomics Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, </institution></institution-wrap>Bethesda, MD USA </aff>
        <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>UK Dementia Research Institute, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Nash Family Department of Neuroscience and Friedman Brain Institute, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Ronald M. Loeb Center for Alzheimer&#x2019;s Disease, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Estelle and Daniel Maggin Department of Neurology, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>Department of Genetics, Evolution and Environment, UCL Genetics Institute, </institution><institution>University College London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.454324.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0661 0844</institution-id><institution>Department of Molecular Biology and Nanobiotechnology, </institution><institution>National Institute of Chemistry, </institution></institution-wrap>Ljubljana, Slovenia </aff>
        <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.425196.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 4810</institution-id><institution>Molecular Pathology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), </institution></institution-wrap>Trieste, Italy </aff>
        <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.264727.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2248 3398</institution-id><institution>Department of Neurology, </institution><institution>Lewis Katz School of Medicine, Temple University, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>Cedars-Sinai Department of Biomedical Sciences, Board of Governors Regenerative Medicine Institute and Brain Program, Cedars-Sinai Medical Center, </institution><institution>University of California, </institution></institution-wrap>Los Angeles, CA USA </aff>
        <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution>Department of Medicine, </institution><institution>University of California, </institution></institution-wrap>Los Angeles, CA USA </aff>
        <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.29857.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4281</institution-id><institution>Department of Biochemistry and Molecular Biology, Penn State Institute for Personalized Medicine, </institution><institution>The Pennsylvania State University, </institution></institution-wrap>Hershey, PA USA </aff>
        <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.29857.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4281</institution-id><institution>Department of Neurology, </institution><institution>The Pennsylvania State University, </institution></institution-wrap>Hershey, PA USA </aff>
        <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.239864.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 8523 7701</institution-id><institution>Department of Neurology, </institution><institution>Henry Ford Health System, </institution></institution-wrap>Detroit, MI USA </aff>
        <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Pathology and Laboratory Medicine, Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Neurology, Center for Motor Neuron Biology and Disease, Institute for Genomic Medicine, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution>Department of Biological Engineering, </institution><institution>Massachusetts Institute of Technology, </institution></institution-wrap>Cambridge, MA USA </aff>
        <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Neurology, </institution><institution>Johns Hopkins School of Medicine, </institution></institution-wrap>Baltimore, MD USA </aff>
        <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.5650.6</institution-id><institution-id institution-id-type="ISNI">0000000404654431</institution-id><institution>Department of Neurogenetics, </institution><institution>Academic Medical Centre, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
        <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Leiden University Medical Center, </institution></institution-wrap>Leiden, The Netherlands </aff>
        <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Department of Medicine, </institution><institution>Lung Biology Center, University of California, </institution></institution-wrap>San Francisco, CA USA </aff>
        <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>ALS Multidisciplinary Clinic, Neuromuscular Division, Department of Neurology, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Neurological Clinical Research Institute, Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution>Centre for Neuroscience and Trauma, Blizard Institute, Barts, </institution><institution>Queen Mary University of London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution>The London School of Medicine and Dentistry, </institution><institution>Queen Mary University of London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.439462.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0399 6800</institution-id><institution>Department of Neurology, </institution><institution>Basildon University Hospital, </institution></institution-wrap>Basildon, UK </aff>
        <aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.249880.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0374 0039</institution-id><institution>The Jackson Laboratory, </institution></institution-wrap>Bar Harbor, ME USA </aff>
        <aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.266093.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7243</institution-id><institution>Department of Psychiatry and Human Behavior, Department of Biological Chemistry, School of Medicine, </institution><institution>University of California, </institution></institution-wrap>Irvine, CA USA </aff>
        <aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.266093.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7243</institution-id><institution>Department of Neurobiology and Behavior, School of Biological Sciences, </institution><institution>University of California, </institution></institution-wrap>Irvine, CA USA </aff>
        <aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.249878.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0572 7110</institution-id><institution>Taube/Koret Center for Neurodegenerative Disease Research, Roddenberry Center for Stem Cell Biology and Medicine, </institution><institution>Gladstone Institute, </institution></institution-wrap>San Francisco, CA USA </aff>
        <aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.410558.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0035 6670</institution-id><institution>Department of Neurology and Sensory Organs, </institution><institution>University of Thessaly, </institution></institution-wrap>Thessaly, Greece </aff>
        <aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>Department of Neurology, </institution><institution>Washington University in St Louis, </institution></institution-wrap>St Louis, MO USA </aff>
        <aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>Centre for Clinical Brain Sciences, </institution><institution>Anne Rowling Regenerative Neurology Clinic, Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, </institution></institution-wrap>Edinburgh, UK </aff>
        <aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.13992.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0604 7563</institution-id><institution>Department of Molecular Genetics, </institution><institution>Weizmann Institute of Science, </institution></institution-wrap>Rehovot, Israel </aff>
        <aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Neurology, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.264727.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2248 3398</institution-id><institution>Center for Neurodegenerative Disorders, Department of Neurology, </institution><institution>the Lewis Katz School of Medicine, Temple University, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.225279.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0387 3667</institution-id><institution>Cold Spring Harbor Laboratory, </institution></institution-wrap>Cold Spring Harbor, NY USA </aff>
        <aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Ann Romney Center for Neurologic Diseases, Brigham and Women&#x2019;s Hospital, Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.36425.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2216 9681</institution-id><institution>Department of Anesthesiology, </institution><institution>Stony Brook University, </institution></institution-wrap>Stony Brook, NY USA </aff>
        <aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.416870.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2177 357X</institution-id><institution>Section of Infections of the Nervous System, </institution><institution>National Institute of Neurological Disorders and Stroke, NIH, </institution></institution-wrap>Bethesda, MD USA </aff>
        <aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.427785.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0664 3531</institution-id><institution>Department of Neurology, Barrow Neurological Institute, St Joseph&#x2019;s Hospital, </institution></institution-wrap>Phoenix, AZ USA </aff>
        <aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.240866.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2110 9177</institution-id><institution>Medical Center, Department of Neurobiology, Barrow Neurological Institute, </institution><institution>St Joseph&#x2019;s Hospital and Medical Center, </institution></institution-wrap>Phoenix, AZ USA </aff>
        <aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Neurology, Division of Neuromuscular Medicine, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="GRID">grid.7177.6</institution-id><institution-id institution-id-type="ISNI">0000000084992262</institution-id><institution>Department of Neuropathology, Academic Medical Center, </institution><institution>University of Amsterdam, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
        <aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="GRID">grid.29857.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4281</institution-id><institution>Department of Biology and Veterinary and Biomedical Sciences, </institution><institution>The Pennsylvania State University, </institution></institution-wrap>University Park, PA USA </aff>
        <aff id="Aff57"><label>57</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>New York Stem Cell Foundation, Department of Bioengineering, School of Engineering and Applied Sciences, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Pathology, Fishberg Department of Neuroscience, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Neurology, </institution><institution>Harvard Medical School, Neurological Clinical Research Institute, Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="GRID">grid.239915.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 8823</institution-id><institution>Department of Neurology, </institution><institution>Hospital for Special Surgery, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff61"><label>61</label><institution-wrap><institution-id institution-id-type="GRID">grid.413734.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8499 1112</institution-id><institution>Weill Cornell Medical Center, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff62"><label>62</label><institution-wrap><institution-id institution-id-type="GRID">grid.416113.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 9759 4781</institution-id><institution>Medical Genetics, </institution><institution>Atlantic Health System, Morristown Medical Center, </institution></institution-wrap>Morristown, NJ USA </aff>
        <aff id="Aff63"><label>63</label><institution-wrap><institution-id institution-id-type="GRID">grid.417328.b</institution-id><institution-id institution-id-type="ISNI">0000 0000 8945 8587</institution-id><institution>Overlook Medical Center, </institution></institution-wrap>Summit, NJ USA </aff>
        <aff id="Aff64"><label>64</label><institution-wrap><institution-id institution-id-type="GRID">grid.417975.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 8857</institution-id><institution>Center of Clinical Research, Experimental Surgery and Translational Research, </institution><institution>Biomedical Research Foundation of the Academy of Athens (BRFAA), </institution></institution-wrap>Athens, Greece </aff>
        <aff id="Aff65"><label>65</label><institution-wrap><institution-id institution-id-type="GRID">grid.5216.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 0800</institution-id><institution>1st Department of Neurology, Eginition Hospital, </institution><institution>Medical School, National and Kapodistrian University of Athens, </institution></institution-wrap>Athens, Greece </aff>
        <aff id="Aff66"><label>66</label><institution-wrap><institution-id institution-id-type="GRID">grid.9619.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0538</institution-id><institution>Neuromuscular/EMG service and ALS/Motor Neuron Disease Clinic, </institution><institution>Hebrew University-Hadassah Medical Center, </institution></institution-wrap>Jerusalem, Israel </aff>
        <aff id="Aff67"><label>67</label>Board of Governors Regenerative Medicine Institute, Los Angeles, CA USA </aff>
        <aff id="Aff68"><label>68</label><institution-wrap><institution-id institution-id-type="GRID">grid.50956.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2152 9905</institution-id><institution>Department of Neurology, </institution><institution>Cedars-Sinai Medical Center, </institution></institution-wrap>Los Angeles, CA USA </aff>
        <aff id="Aff69"><label>69</label><institution-wrap><institution-id institution-id-type="GRID">grid.416228.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0451 8771</institution-id><institution>Harvard Medical School, Department of Physical Medicine and Rehabilitation, </institution><institution>Spaulding Rehabilitation Hospital, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff70"><label>70</label><institution-wrap><institution-id institution-id-type="GRID">grid.239552.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0680 8770</institution-id><institution>Center for Cellular and Molecular Therapeutics, </institution><institution>Children&#x2019;s Hospital of Philadelphia, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff71"><label>71</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Genetics, Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff72"><label>72</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>Centre for Clinical Brain Sciences, </institution><institution>University of Edinburgh, </institution></institution-wrap>Edinburgh, UK </aff>
        <aff id="Aff73"><label>73</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>Euan MacDonald Centre for Motor Neurone Disease Research, </institution><institution>University of Edinburgh, </institution></institution-wrap>Edinburgh, UK </aff>
        <aff id="Aff74"><label>74</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Genetics and Genomic Sciences, </institution><institution>Icahn Institute of Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff75"><label>75</label><institution-wrap><institution-id institution-id-type="GRID">grid.411667.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2186 0438</institution-id><institution>Department of Neuropathology, Georgetown Brain Bank, </institution><institution>Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, </institution></institution-wrap>Washington, DC USA </aff>
        <aff id="Aff76"><label>76</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Neuroradiology Section, Department of Radiology and Biomedical Imaging, </institution><institution>University of California, San Francisco, </institution></institution-wrap>San Francisco, CA USA </aff>
        <aff id="Aff77"><label>77</label><institution-wrap><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution>Neuromuscular Diseases Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, </institution><institution>Tel-Aviv University, </institution></institution-wrap>Tel-Aviv, Israel </aff>
        <aff id="Aff78"><label>78</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Neuroscience, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA USA </aff>
        <aff id="Aff79"><label>79</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Neurology, </institution><institution>University of Pennsylvania Perelman School of Medicine, </institution></institution-wrap>Philadelphia, PA USA </aff>
        <aff id="Aff80"><label>80</label><institution-wrap><institution-id institution-id-type="GRID">grid.239585.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 2675</institution-id><institution>Department of Neurology, </institution><institution>Columbia University Medical Center, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff81"><label>81</label><institution-wrap><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution>Department of Pharmaceutical Chemistry, </institution><institution>University of California San Francisco, </institution></institution-wrap>San Francisco, CA USA </aff>
        <aff id="Aff82"><label>82</label><institution-wrap><institution-id institution-id-type="GRID">grid.9619.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0538</institution-id><institution>Hadassah Hebrew University, </institution></institution-wrap>Jerusalem, Israel </aff>
        <aff id="Aff83"><label>83</label><institution-wrap><institution-id institution-id-type="GRID">grid.427785.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0664 3531</institution-id><institution>Department of Translational Neuroscience, </institution><institution>Barrow Neurological Institute, </institution></institution-wrap>Phoenix, AZ USA </aff>
        <aff id="Aff84"><label>84</label><institution-wrap><institution-id institution-id-type="GRID">grid.250942.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3225</institution-id><institution>The Translational Genomics Research Institute (TGen), </institution></institution-wrap>Phoenix, AZ USA </aff>
        <aff id="Aff85"><label>85</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0546 1623</institution-id><institution>Broad Institute, </institution></institution-wrap>Cambridge, MA USA </aff>
        <aff id="Aff86"><label>86</label><institution-wrap><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff87"><label>87</label><institution-wrap><institution-id institution-id-type="GRID">grid.416477.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2168 3646</institution-id><institution>Institute of Molecular Medicine, Feinstein Institutes for Medical Research, </institution><institution>Northwell Health, </institution></institution-wrap>Manhasset, NY USA </aff>
        <aff id="Aff88"><label>88</label><institution-wrap><institution-id institution-id-type="GRID">grid.37172.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 2292 0500</institution-id><institution>Korea Advanced Institute of Science and Technology (KAIST), </institution></institution-wrap>Daejeon, South Korea </aff>
        <aff id="Aff89"><label>89</label><institution-wrap><institution-id institution-id-type="GRID">grid.482226.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0437 5686</institution-id><institution>Perron Institute for Neurological and Translational Science, </institution></institution-wrap>Nedlands, Western Australia Australia </aff>
        <aff id="Aff90"><label>90</label><institution-wrap><institution-id institution-id-type="GRID">grid.419681.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2164 9667</institution-id><institution>Integrative Immunobiology Section, National Institute of Allergy and Infectious Disease, NIH, </institution></institution-wrap>Bethesda, MD USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>2</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>23</day>
        <month>2</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>603</volume>
      <issue>7899</issue>
      <fpage>131</fpage>
      <lpage>137</lpage>
      <history>
        <date date-type="received">
          <day>2</day>
          <month>4</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>1</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Variants of <italic>UNC13A</italic>, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref></sup>, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-43<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in <italic>UNC13A</italic>, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic <italic>UNC13A</italic> polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These&#xA0;polymorphisms&#xA0;potentiate cryptic exon inclusion,&#xA0;both in cultured cells and in&#xA0;brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which <italic>UNC13A</italic> variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Risk variants for ALS&#xA0;and FTD&#xA0;in the&#xA0;synaptic gene <italic>UNC13A</italic> increase the expression of an <italic>UNC13A</italic> cryptic exon in neurons with TDP-43 depletion.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Amyotrophic lateral sclerosis</kwd>
        <kwd>Neurodegeneration</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating adult-onset neurodegenerative disorders with shared genetic causes and common pathological aggregates<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Genome-wide association studies (GWAS) have repeatedly demonstrated a shared risk locus for ALS and FTD in the crucial synaptic gene <italic>UNC13A</italic>, although the mechanism underlying this association has remained unknown<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref></sup>.</p>
      <p id="Par4">ALS and FTD are pathologically defined by cytoplasmic aggregation and nuclear depletion of TAR DNA-binding protein 43 (TDP-43) in more than 97% of ALS cases and 45% of FTD cases<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup> (frontotemporal lobar degeneration (FTLD) due to TDP-43 proteinopathy (FTLD-TDP)). TDP-43 is an RNA-binding protein (RBP) that resides primarily in the nucleus and has key regulatory roles in RNA metabolism, including as a splicing repressor. Upon loss of nuclear TDP-43&#x2014;an early pathological feature in TDP-43-associated ALS (ALS-TDP) and FTLD-TDP&#x2014;non-conserved intronic sequences are de-repressed and erroneously included in mature RNAs. These events are referred to as cryptic exons (CEs) and often lead to premature stop codons and transcript degradation,&#xA0;or premature polyadenylation<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. One such&#xA0;CE occurs&#xA0;in the stathmin 2 (<italic>STMN2</italic>) transcript<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. This <italic>STMN2</italic> CE is selectively expressed in affected tissue, and its level correlates with TDP-43 phosphorylation, enabling it to serve as a functional readout for TDP-43 proteinopathy<sup><xref ref-type="bibr" rid="CR8">8</xref>&#x2013;<xref ref-type="bibr" rid="CR10">10</xref></sup>.&#xA0;However, a link between&#xA0;CEs and disease risk has not yet been established.&#xA0;</p>
      <p id="Par5">Here we report the presence of a CE in <italic>UNC13A</italic>, which is present at high levels in neurons from patients with ALS and FTLD-TDP. This CE&#xA0;promotes nonsense-mediated decay (NMD) and <italic>UNC13A</italic> transcript and protein loss. Notably, intronic&#xA0;risk-associated single nucleotide polymorphisms (SNPs) for ALS and FTD in <italic>UNC13A</italic> promote increased inclusion of this CE. Collectively, our findings reveal the molecular mechanism behind one of the top GWAS hits for ALS and FTD and provide a promising new therapeutic target for TDP-43 proteinopathies.</p>
    </sec>
    <sec id="Sec2">
      <title><italic>UNC13A</italic> cryptic exon production on TDP-43 knockdown</title>
      <p id="Par6">To identify novel CEs promoted by TDP-43 depletion, we performed RNA sequencing (RNA-seq) on human induced pluripotent stem (iPS) cell-derived cortical-like i<sup>3</sup>Neurons, in which we reduced TDP-43 expression using CRISPR inhibition<sup><xref ref-type="bibr" rid="CR11">11</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref></sup> (CRISPRi). Differential splicing and expression analyses identified 179 CEs, including several that have been reported previously, in genes including <italic>AGRN</italic>, <italic>RAP1GAP</italic>, <italic>PFKP</italic> and <italic>STMN2</italic><sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup> (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>, Supplementary Data&#xA0;<xref rid="MOESM11" ref-type="media">1, 2</xref>). We examined splicing, expression, ALS GWAS<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> risk genes and diagnostic panel genes for ALS and FTD<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Of the 179 CE-harbouring genes, only the synaptic gene <italic>UNC13A</italic> was also an ALS&#x2013;FTD risk gene (Fig. <xref rid="Fig1" ref-type="fig">1b, c</xref>, Supplementary Table <xref rid="MOESM4" ref-type="media">1</xref>). <italic>UNC13A</italic> polymorphisms modify both disease risk and progression in ALS and FTLD-TDP<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR17">17</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref></sup>, suggesting a potential functional relationship between TDP-43, <italic>UNC13A</italic> and disease risk. Inspection of <italic>UNC13A</italic> splicing revealed the presence of a CE, occurring in two forms distinguishable by their size, between exons 20 and 21 after TDP-43 knockdown (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>), and increased intron retention between exons 31 and 32 (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1a</xref>). One ALS-TDP and FTLD-TDP risk SNP&#x2014;<italic>rs12973192</italic><sup><xref ref-type="bibr" rid="CR15">15</xref></sup>&#x2014;lies 16&#xA0;bp inside the CE (hereafter referred to as the CE SNP). Another SNP&#x2014;<italic>rs12608932</italic><sup><xref ref-type="bibr" rid="CR1">1</xref></sup><italic>&#x2014;</italic>is located 534 bp downstream of the donor splice site of the CE within the same intron (hereafter referred to as the intronic SNP) (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). There are five polymorphisms associated with ALS risk in <italic>UNC13A</italic><sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. All are in high linkage disequilibrium with both the CE and intronic SNPs in European populations, with an allele frequency of 0.3423 and 0.3651, respectively<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). The proximity of the disease-associated SNPs to the <italic>UNC13A</italic> CE suggests that the SNPs may influence <italic>UNC13A</italic> splicing. Of note, we also observed robust mis-splicing in <italic>UNC13B</italic>, which encodes another member of the UNC13 synaptic protein family (Fig. <xref rid="Fig1" ref-type="fig">1e, f</xref>). TDP-43 knockdown led to the inclusion of an annotated frame-shift-inducing exon between exons 10 and 11 in <italic>UNC13B</italic>, hereafter referred to as the <italic>UNC13B</italic> frameshift exon (FSE), and increased intron retention between exon 21 and 22 (Fig. <xref rid="Fig1" ref-type="fig">1e, f</xref>, Extended Data Fig. <xref rid="Fig5" ref-type="fig">1b</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>TDP-43 depletion in neurons leads to altered splicing in synaptic genes <italic>UNC13A</italic> and <italic>UNC13B</italic>.</title><p><bold>a</bold>, Differential splicing analysis by MAJIQ<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> in control (<italic>n</italic>&#x2009;=&#x2009;4) and CRISPRi TDP-43 depleted (KD) (<italic>n</italic>&#x2009;=&#x2009;3) iPS cell-derived cortical-like i<sup>3</sup>Neurons. Each point denotes a splice junction. <bold>b</bold>, Representative sashimi plots showing cryptic exon (CE) inclusion between exons 20 and 21 of <italic>UNC13A</italic> upon TDP-43 knockdown. <bold>c</bold>, <bold>f</bold>, Schematics showing intron retention (IR) (orange; bottom), TDP-43 binding region<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>(green), and two ALS- and FTLD-associated SNPs (red) in UNC13A (<bold>c</bold>) and UNC13B (<bold>f</bold>). <bold>d</bold>, LocusZoom plot of the <italic>UNC13A</italic> locus in the most recent ALS GWAS<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>; the dashed line indicates the risk threshold used in that study. Lead SNP <italic>rs12973192</italic> is plotted as a purple diamond, other SNPs are coloured by linkage disequilibrium (LD) with <italic>rs12973192</italic> in European individuals from 1000 Genomes. Ref. var., reference variant. <bold>e</bold>, Representative sashimi plot of <italic>UNC13B</italic> showing inclusion of the FSE upon TDP-43 knockdown. <bold>g</bold>, BaseScope detection of <italic>UNC13A</italic> CE (white puncta) in control (top) and TDP-43-knockdown (bottom) i<sup>3</sup>Neurons co-stained for TDP-43 (green), neuronal processes (stained for TUBB3, pink) and nuclei (blue). Scale bar, 5&#xA0;&#x3BC;m.&#xA0;<bold>h</bold>, Quantification of RT&#x2013;PCR products using iPS cell-derived neurons made from an independent iPS cell line, NCRM5, with a non-targeting control short guide RNA (sgRNA) (sgTARDBP&#x2212;), an intermediate TDP-43 knockdown (sgTARDBP+) or stronger TDP-43 knockdown (sgTARDBP++). Data are mean&#x2009;&#xB1;&#x2009;s.e.m. sgControl, <italic>n</italic>&#x2009;=&#x2009;6; sgTARDBP+, <italic>n</italic>&#x2009;=&#x2009;5; sgTARDBP++, <italic>n</italic>&#x2009;=&#x2009;6; one-way ANOVA with multiple comparisons. *<italic>P</italic>&#xA0;&lt;&#xA0;0.05, **<italic>P</italic>&#xA0;&lt;&#xA0;0.01, ***<italic>P</italic>&#xA0;&lt;&#xA0;0.001, ****<italic>P</italic>&#xA0;&lt;&#xA0;0.0001. <bold>i</bold>, Schematic of nanopore long reads quantified in <bold>j</bold>, Extended Data Figs. <xref rid="Fig6" ref-type="fig">2d, e,</xref>&#xA0;<xref rid="Fig7" ref-type="fig">5e, f</xref>. <bold>j</bold>, Percentage of targeted <italic>UNC13A</italic> long reads with TDP-43-regulated splice events that contain CE, intron retention or both in TDP-43-knockdown SH-SY5Y cells.</p><p><xref rid="MOESM15" ref-type="media">Source data</xref></p></caption><graphic xlink:href="41586_2022_4436_Fig1_HTML" id="d32e2600"/></fig></p>
      <p id="Par7">We validated the <italic>UNC13A</italic> CE in i<sup>3</sup>Neurons by in situ hybridization, which showed a primarily nuclear localization and occurred predominantly in TDP-43-knockdown neurons (Fig. <xref rid="Fig1" ref-type="fig">1g</xref>, Extended Data Fig. <xref rid="Fig5" ref-type="fig">1c</xref>). To confirm the CE was not restricted to neurons derived from a single iPS cell line, we performed TDP-43 knockdown in independent i<sup>3</sup>Neurons using two different guides leading to different levels of TDP-43 knockdown (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1d, e</xref>). CE expression was restricted to cells with TDP-43 knockdown in both lines, and correlated with the level of TDP-43 knockdown (Fig. <xref rid="Fig1" ref-type="fig">1h</xref>, Extended Data Fig. <xref rid="Fig5" ref-type="fig">1f, g</xref>). We also detected these splicing changes in RNA-seq data we generated from TDP-43 depleted SH-SY5Y and SK-N-DZ neuronal lines, and publicly available RNA-seq from iPS cell-derived motor neurons<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> and SK-N-DZ datasets<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1h&#x2013;k</xref>, Supplementary Table <xref rid="MOESM5" ref-type="media">2</xref>). We note that the expression of these events was lowest in the SH-SY5Y experiment, which also showed the weakest TDP-43 knockdown (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1l</xref>). Using stronger TDP-43 knockdown, we validated the <italic>UNC13A</italic> CE by PCR with reverse transcription (RT&#x2013;PCR) and Sanger sequencing in SH-SY5Y and SK-N-DZ cell lines (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2a</xref>).</p>
      <p id="Par8">In support of a direct role for TDP-43 regulation of <italic>UNC13A</italic> and <italic>UNC13B</italic>, we found multiple TDP-43-binding peaks<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> both downstream and within the body of the <italic>UNC13A</italic> CE (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>) and intron retention (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1a</xref>). Additionally, TDP-43-binding peaks<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> were present near both splice events in <italic>UNC13B</italic> (Fig. <xref rid="Fig1" ref-type="fig">1f</xref>, Extended Data Fig. <xref rid="Fig5" ref-type="fig">1b</xref>). Additional iCLIP of endogenous TDP-43 in SH-SY5Y cells confirmed enhanced binding near the <italic>UNC13A</italic> CE and intron retention and <italic>UNC13B</italic> FSE and intron retention (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2 b, c</xref>). We next tested whether the <italic>UNC13A</italic> intron retention and CE events co-occured in transcripts. Using targeted long-read sequencing, we determined that although co-regulated, <italic>UNC13A</italic> CE and intron retention occurred largely independently from each other (Fig. <xref rid="Fig1" ref-type="fig">1l, j</xref>; Extended Data Fig. <xref rid="Fig6" ref-type="fig">2d,e</xref>).</p>
    </sec>
    <sec id="Sec3">
      <title><italic>UNC13A</italic> is downregulated on TDP-43 knockdown</title>
      <p id="Par9">Next, we examined whether incorrect splicing of <italic>UNC13A</italic> and <italic>UNC13B</italic> affected transcript levels in neurons and neuron-like cells. TDP-43 knockdown significantly reduced <italic>UNC13A</italic> RNA abundance in the three experiments with the highest levels of cryptic splicing (false discovery rate (FDR)&#x2009;&lt;&#x2009;0.0001; Extended Data Figs. <xref rid="Fig5" ref-type="fig">1h</xref>, <xref rid="Fig7" ref-type="fig">3a</xref>). Similarly, <italic>UNC13B</italic> RNA was significantly downregulated in four datasets (FDR&#x2009;&lt;&#x2009;0.0001) (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3b</xref>). We confirmed these results by quantitative PCR (qPCR) in i<sup>3</sup>Neurons, and SH-SY5Y and SK-N-DZ cell lines (Extended Data Figs. <xref rid="Fig5" ref-type="fig">1d, e,</xref>&#xA0;<xref rid="Fig7" ref-type="fig">3c, d</xref>). The number of ribosome footprints aligning to <italic>UNC13A</italic> and <italic>UNC13B</italic> was also reduced after TDP-43 knockdown (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3e</xref>, <xref rid="MOESM13" ref-type="media">Supplementary Data 3</xref>; FDR&#x2009;&lt;&#x2009;0.05). Notably, TDP-43 knockdown decreased expression of UNC13A and UNC13B at the protein level in a dose-dependent manner, as assessed by quantitative proteomics (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title><italic>UNC13A</italic> and <italic>UNC13B</italic> are downregulated after TDP-43 knockdown owing to the production of NMD-sensitive transcripts.</title><p><bold>a</bold>, Ribosome profiling of TDP-43-knockdown i<sup>3</sup>Neurons shows a reduction in ribosome occupancy of <italic>STMN2</italic>, <italic>UNC13A</italic> and <italic>UNC13B</italic> transcripts. <bold>b</bold>, Mass spectrometry-based proteomic analysis shows dose-dependent reduction in protein abundance of UNC13A and TDP-43 upon TDP-43 knockdown in i<sup>3</sup>Neurons. <italic>n</italic>&#x2009;=&#x2009;6 biological replicates. Two-sample <italic>t</italic>-test. <bold>c</bold>, Protein and RNA quantification of TDP-43, UNC13A and UNC13B in SH-SY5Y with varying levels of doxycycline-inducible TDP-43 knockdown. <italic>n</italic>&#x2009;=&#x2009;3 biological replicates. <bold>d</bold>, Transcript expression upon treatment with CHX suggests that <italic>UNC13A</italic> and <italic>UNC13B</italic>, but not <italic>STMN2</italic>, are sensitive to NMD. <italic>HNRNPL</italic> is used as a positive control. <italic>n</italic>&#x2009;=&#x2009;7 biological replicates (<italic>UNC13A</italic>, <italic>HNRNPL</italic> and <italic>STMN2</italic>) and 8 biological replicates (<italic>UNC13B</italic>). One-sample <italic>t</italic>-test. Data are mean&#x2009;&#xB1;&#x2009;s.e.m. (<bold>b</bold>&#x2013;<bold>d</bold>).</p><p><xref rid="MOESM16" ref-type="media">Source data</xref></p></caption><graphic xlink:href="41586_2022_4436_Fig2_HTML" id="d32e2858"/></fig></p>
      <p id="Par10">To assess the relation between TDP-43 reduction and UNC13 splicing, RNA and protein levels, we assayed SH-SY5Y cells with increasing amounts of TDP-43 knockdown. We found that changes in UNC13A paralleled those of TDP-43, whereas UNC13B levels were less affected (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3f</xref>, <xref rid="MOESM1" ref-type="media">Supplementary Fig. 1</xref>). <italic>UNC13A</italic> CE inclusion and intron retention increased on TDP-43 knockdown, with the CE being detected only after more than 50% TDP-43 loss, whereas <italic>UNC13B</italic> FSE and intron retention were not robustly detected until more than 90% of TDP-43 expression was lost (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3g</xref>).</p>
      <p id="Par11">To assess whether the amount of <italic>UNC13A</italic> CE expression was underestimated owing to efficient transcript degradation, we investigated whether it promoted NMD, as predicted by the presence of a premature termination codon. Knockdown of the key NMD factor <italic>UPF1</italic> or cycloheximide (CHX) treatment&#x2014;which stalls translation and impairs NMD&#x2014;increased the amount of <italic>UNC13A</italic> CE and <italic>UNC13B</italic> FSE, which also leads to a PTC at the beginning of exon 11, confirming that both <italic>UNC13A</italic> and <italic>UNC13B</italic> were targeted by NMD (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3h, i</xref>). Conversely, CHX treatment and <italic>UPF1</italic> knockdown did not alter levels of the aberrant <italic>STMN2</italic> transcript, which was not predicted to undergo NMD (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3h</xref>). Of note, CHX treatment of SH-SY5Y cells with the least TDP-43 knockdown (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>) enabled detection of the <italic>UNC13A</italic> CE, supporting the notion that its occurrence may be underestimated owing to efficient degradation (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3j,&#xA0;k</xref>).</p>
      <p id="Par12">Together, these data suggest that TDP-43 has an essential role in ensuring the correct pre-mRNA splicing of <italic>UNC13A</italic> and <italic>UNC13B</italic>, thereby maintaining normal expression of these key presynaptic proteins.</p>
    </sec>
    <sec id="Sec4">
      <title><italic>UNC13A</italic> cryptic exon in patient neurons</title>
      <p id="Par13">To test whether the <italic>UNC13A</italic> CE could be detected in tissues from patients affected by TDP-43 pathology, we first analysed RNA-seq data from neuronal nuclei sorted from frontal cortices of patients with ALS&#x2013;FTLD<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. We compared the levels of <italic>UNC13A</italic> CE to the levels of a CE in <italic>STMN2</italic> known to be regulated by TDP-43. Both <italic>STMN2</italic> and <italic>UNC13A</italic> CEs were found exclusively in TDP-43-depleted nuclei. Although the lack of NMD activity in the nucleus means that the nuclear splicing ratio may not reflect that of the whole cell, in some cases, the <italic>UNC13A</italic> CE percent spliced in (PSI (<italic>&#x3A8;</italic>)) reached 100% (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). This suggests that there is a substantial loss of UNC13A expression in the subpopulation of neurons with TDP-43 pathology in human patients with ALS&#x2013;FTLD.<fig id="Fig3"><label>Fig. 3</label><caption><title><italic>UNC13A</italic> CE is highly expressed in tissues from patients with ALS or FTLD and correlates with known markers of TDP-43 loss of function.</title><p><bold>a</bold>, <italic>UNC13A</italic> and <italic>STMN2</italic> CE expression from a published dataset of frontal cortex neuronal nuclei from patients with ALS or FTLD sorted according to TDP-43 expression<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. <bold>b</bold>, <italic>UNC13A</italic> CE expression in bulk RNA-seq from the NYGC ALS Consortium data normalized by library size across disease and tissue samples. ALS cases are stratified by mutation status, FTLD cases are stratified by pathological subtype. <bold>c</bold>, CE expression throughout ALS-TDP and FTLD-TDP cases across tissue, number of tissue samples in brackets. <bold>d</bold>, BaseScope detection of <italic>UNC13A</italic> CE (red foci) in FTLD-TDP (9 individuals) but not control (5 individuals) or non-TDP FTLD (FTLD-TAU) (4 individuals) frontal cortex samples and quantification of background-corrected foci frequency between groups. Scale bar, 10&#x2009;&#x3BC;m. Data are mean&#x2009;&#xB1;&#x2009;s.e.m. (<bold>b</bold>&#x2013;<bold>d</bold>); Wilcoxon test.</p><p><xref rid="MOESM17" ref-type="media">Source data</xref></p></caption><graphic xlink:href="41586_2022_4436_Fig3_HTML" id="d32e3025"/></fig></p>
      <p id="Par14">Next, we quantified <italic>UNC13A</italic> CE inclusion in bulk RNA-seq data from the New York Genome Center (NYGC) ALS Consortium, which contains 1,349 brain and spinal cord tissues from a total of 377 individuals, including those with ALS or FTLD and controls. The <italic>UNC13A</italic> CE was detected exclusively in tissues from individuals with FTLD-TDP and ALS-TDP (89% and 38% of individuals, respectively), and not in individuals with non-TDP ALS (caused by <italic>SOD1</italic> and <italic>FUS</italic> mutations), FTLD associated with TAU (FTLD-TAU), FTLD associated with FUS (FTLD-FUS) or controls. There were no systematic differences across tissues between controls and non-TDP ALS or FTLD and ALS-TDP or FTLD-TDP in confounding factors such as library depth, RNA integrity number or cellular composition, which could explain the <italic>UNC13A</italic> CE specificity (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4a&#x2013;d</xref>). The lower detection rate in ALS compared with FTLD is possibly owing to the lower expression of <italic>UNC13A</italic> in the spinal cord (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4a</xref>), although differences in NMD efficiency between cortical and spinal regions could also affect detection rate<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. <italic>UNC13A</italic> CE was more likely to be detected in bulk samples that had been sequenced with 125-bp rather than 100-bp paired-end reads, but other technical factors did not systematically affect detection (Extended Data Fig. <xref rid="Fig9" ref-type="fig">5a&#x2013;d</xref>).</p>
      <p id="Par15"><italic>UNC13A</italic> CE expression mirrored the known tissue distribution of TDP-43 aggregation and nuclear clearance<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>: it was specific to ALS-TDP spinal cord and motor cortex, as well as FTLD-TDP frontal and temporal cortices, but was absent from the cerebellum in both disease and control states (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). Furthermore, although the <italic>UNC13A</italic> CE induces NMD (unlike the <italic>STMN2</italic> CE) it was detected at similar levels to the <italic>STMN2</italic> CE in cortical regions, whereas <italic>STMN2</italic> CE was more abundant in the spinal cord (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). Targeted long-read sequencing of <italic>UNC13A</italic> in FTLD frontal cortex revealed that the CE and intron retention events can co-occur but, as in SH-SY5Y cells, they are mostly detected independently (Extended Data Fig. <xref rid="Fig9" ref-type="fig">5e, f</xref>). Thus, pathological <italic>UNC13A</italic> CEs occur in vivo and are specific to neurodegenerative disease subtypes in which mislocalization and nuclear depletion of TDP-43 occurs.</p>
      <p id="Par16">We next assessed expression of the <italic>UNC13B</italic> FSE across the NYGC dataset. We detected no increase in the <italic>UNC13B</italic> FSE in pathological ALS-TDP or FTLD-TDP tissues. However, the presence throughout control and ALS or FTD brains of a shorter isoform of the CE that included the FSE, which was absent in our in vitro experiments, may mask underlying changes (Extended Data Fig. <xref rid="Fig10" ref-type="fig">6a&#x2013;c</xref>).</p>
      <p id="Par17">We also evaluated both <italic>UNC13A</italic> and <italic>UNC13B</italic> intron retention events from bulk RNA-seq. Unlike the CE, both intron retention events were also detected in control brains, making it difficult to determine whether TDP-43 pathology increased intron retention (Extended Data Fig. <xref rid="Fig11" ref-type="fig">7a, b</xref>).</p>
      <p id="Par18">We next investigated whether <italic>UNC13A</italic> CEs could be visualized by in situ hybridization in brains from patients with FTLD, using the same probe used for iPS cell-derived neurons. We detected red foci in cortical neurons at a significantly higher frequency in FTLD-TDP relative to both neurologically normal controls (Kruskal&#x2013;Wallis test, <italic>P</italic>&#x2009;=&#x2009;0.021) and non-TDP FTLD (FTLD-TAU) (<italic>P</italic>&#x2009;=&#x2009;0.010) (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>).</p>
      <p id="Par19">To assess whether <italic>UNC13A</italic> CE levels in bulk tissue were related to the level of TDP-43 proteinopathy, we used the <italic>STMN2</italic> CE PSI as a proxy. The PSI of <italic>STMN2</italic> CE correlates with the cryptic PSI of other well-known TDP-43 induced CEs, such as those in <italic>RAP1GAP</italic> and <italic>PFKP</italic><sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup> (Extended Data Fig. <xref rid="Fig11" ref-type="fig">7c,d</xref>) and correlates with the amount of phosphorylated TDP-43 in patient samples<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. As expected, across the NYGC ALS Consortium samples we observed a significant positive correlation between the level of <italic>STMN2</italic> CE PSI and <italic>UNC13A</italic> CE PSI across the NYGC ALS Consortium samples (rho&#x2009;=&#x2009;0.56, <italic>P</italic>&#x2009;=&#x2009;2.9&#xA0;&#xD7;&#xA0;10<sup>&#x2212;7</sup>, <italic>n</italic>&#x2009;=&#x2009;72 cortical samples) (Extended Data Fig. <xref rid="Fig11" ref-type="fig">7e</xref>).</p>
      <p id="Par20">Collectively, our analysis reveals a strong relationship between TDP-43 pathology and the level of <italic>UNC13A</italic> CE, supporting a model with direct regulation of <italic>UNC13A</italic> mRNA splicing by TDP-43.</p>
    </sec>
    <sec id="Sec5">
      <title><italic>UNC13A</italic> risk SNPs exacerbate cryptic splicing</title>
      <p id="Par21">To test whether the ALS&#x2013;FTD risk SNPs in <italic>UNC13A</italic> promote cryptic splicing, thereby explaining their link to disease, we assessed <italic>UNC13A</italic> CE levels across different genotypes. We found significantly increased <italic>UNC13A</italic> CE in cases homozygous for CE rs12973192 (G) and intronic rs12608932 (C) SNPs (<italic>P</italic>&#x2009;=&#x2009;0.028, Wilcoxon test) (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8a</xref>, Supplementary Table <xref rid="MOESM7" ref-type="media">4</xref>). To ensure that this was not owing to more severe TDP-43 loss of function in these samples, we normalized <italic>UNC13A</italic> CE by the level of <italic>STMN2</italic> cryptic splicing, a well-established product of TDP-43 loss of function. Again, we found significantly increased <italic>UNC13A</italic> CE in cases with homozygous risk variants (<italic>P</italic>&#x2009;&lt;&#x2009;0.001, Wilcoxon test) (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>, Extended Data Fig. <xref rid="Fig12" ref-type="fig">8b</xref>). Next, we performed targeted RNA-seq on <italic>UNC13A</italic> CE from temporal cortices of ten&#xA0;FTLD-TDP patients who were heterozygous in the risk allele and four controls (<xref rid="MOESM8" ref-type="media">Supplementary Table 5</xref>). There was no detection of the CE in the control samples, and in the patient samples&#xA0;we detected significant biases towards reads containing the risk allele (<italic>P</italic>&#x2009;&lt;&#x2009;0.05, single-tailed binomial test) in six samples, with a seventh sample approaching significance (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>), suggesting that the two ALS- and FTLD-linked variants promote cryptic splicing in vivo.<fig id="Fig4"><label>Fig. 4</label><caption><title><italic>UNC13A</italic> ALS and FTD risk variants enhance <italic>UNC13A</italic> CE splicing in patients and in vitro by altering TDP-43 pre-mRNA binding.</title><p><bold>a</bold>, Ratio of <italic>UNC13A</italic> and <italic>STMN2</italic> CE <italic>&#x3A8;</italic> in ALS-TDP and FTLD-TDP cortex, split by genotype for <italic>UNC13A</italic> risk alleles. In box plots, the centre line shows the median, box edges delineate 25th and 75th percentiles and Tukey whiskers are plotted. <bold>b</bold>, Unique cDNAs from targeted RNA-seq in ten patients with FTLD-TDP who are heterozygous for the risk SNP within the <italic>UNC13A</italic> cryptic exon. Single-tailed binomial tests. Patients 1, 5 and 7 carry the C9orf72 hexanucleotide repeat. <bold>c</bold>, Schematic of <italic>UNC13A</italic> minigenes containing exon 20, intron 20 and exon 21 and combinations of <italic>UNC13A</italic> alleles. <bold>d</bold>, <bold>e</bold>, Representative image (<bold>d</bold>) and quantification (<bold>e</bold>) of RT&#x2013;PCR products from <italic>UNC13A</italic> minigenes in SH-SY5Y cells with or without TDP-43 knockdown. Data are mean&#x2009;&#xB1;&#x2009;s.e.m. Each variant was compared with the healthy minigene with which it was co-transfected and results were compared with an unpaired <italic>t</italic>-test (<italic>n</italic>&#x2009;=&#x2009;3 biological replicates). <bold>f</bold>, TDP-43 iCLIP of SH-SY5Y cells containing 2R and 2H minigenes. Top, average crosslink density. Middle, average density change 2R for &#x2212; 2H (20-nt rolling window, units are crosslinks per 1,000). Bottom, predicted TDP-43 binding footprints (UGNNUG motif). <bold>g</bold>, Average change in E-value (measure of binding enrichment) across proteins for heptamers containing risk or healthy CE SNP alleles. TDP-43 is indicated in red. <bold>h</bold>, Binding affinities between TDP-43 and 14-nt RNA containing the CE (<italic>n</italic>&#x2009;=&#x2009;4) or intronic (<italic>n</italic>&#x2009;=&#x2009;3) healthy or risk sequences measured by isothermal titration calorimetry. Data are mean &#x2009;&#xB1;&#x2009;s.d.; two-sample <italic>t</italic>-test. <bold>i</bold>, <bold>j</bold>, Representative image (<bold>i</bold>) and quantification (<bold>j</bold>) of RT&#x2013;PCR products from <italic>UNC13A</italic> minigenes with mutated UGNNUG TDP-43 binding motifs as shown in <bold>f</bold>. Data are mean&#x2009;&#xB1;&#x2009;s.e.m.; <italic>n</italic>&#x2009;=&#x2009;3 biological replicates; statistical analysis as in (<bold>d</bold>, <bold>e</bold>).</p><p><xref rid="MOESM18" ref-type="media">Source data</xref></p></caption><graphic xlink:href="41586_2022_4436_Fig4_HTML" id="d32e3371"/></fig></p>
      <p id="Par22">To directly assess whether the risk SNPs increase CE inclusion, we performed minigene experiments. Using two minigenes containing <italic>UNC13A</italic> exon 20, intron 20 and exon 21, with and without the two ALS- and FTLD-linked variants, we determined that the risk variants enhanced CE upon TDP-43 loss (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8c</xref>). To examine whether the CE SNP, intronic SNP or short tandem repeat expansion rs56041637<italic>&#x2014;</italic>which is in linkage disequilibrium with the two SNPs<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>&#x2014;are responsible for promoting the CE inclusion, we generated minigenes featuring different combinations of these genomic variants (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). Using quantitative analysis of RT&#x2013;PCR products, we found that both the CE SNP and, to a lesser extent, the intronic SNP independently promoted CE inclusion, with the highest overall levels detected for the 2R minigene (Fig. <xref rid="Fig4" ref-type="fig">4d, e</xref>, Extended Data Fig. <xref rid="Fig12" ref-type="fig">8d</xref>).</p>
      <p id="Par23">TDP-43 can both inhibit and promote splicing by binding to pre-mRNA. We performed TDP-43 iCLIP in HEK 293T cells expressing either the 2R or the 2H minigene to fine map TDP-43 binding to <italic>UNC13A</italic> intron 20 and investigate whether the risk SNPs have an effect on this interaction. In agreement with our iCLIP data of endogenous <italic>UNC13A</italic> in SH-SY5Y cells (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2b</xref>), we observed an enrichment of crosslinks within the approximately 800-nucleotide UG-rich region containing both SNPs in intron 20 (Fig. <xref rid="Fig4" ref-type="fig">4f</xref>). When comparing 2R with 2H, the largest fractional changes were near each SNP (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8e</xref>). We detected a 21% decrease in total TDP-43 crosslinks centred around the CE SNP and a 73% increase upstream of the intronic SNP (Fig. <xref rid="Fig4" ref-type="fig">4f</xref>, Extended Data Fig. <xref rid="Fig12" ref-type="fig">8f</xref>; 50-nucleotide windows). These data suggest these two disease-risk SNPs distort the pattern of TDP-43&#x2013;RNA interactions, decreasing TDP-43 binding near the CE donor splice site.</p>
      <p id="Par24">To explore whether these two SNPs directly influence TDP-43 binding, we analysed a dataset of in vitro RNA heptamer&#x2013;RBP binding enrichments. We examined the effect of the SNPs on relative RBP enrichment<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> by comparing healthy versus risk SNP-containing heptamers. When investigating which RBPs were most affected in their RNA binding enrichment by the CE risk SNP, TDP-43 had the third largest decrease of any RBP, with only two non-mammalian RBPs showing a larger decrease (Fig. <xref rid="Fig4" ref-type="fig">4g</xref>, Extended Data Fig. <xref rid="Fig12" ref-type="fig">8g</xref>). The intronic SNP did not strongly affect TDP-43 binding, although data was only available for 2 out of 7 possible heptamers (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8h, i</xref>). To verify that the CE SNP directly inhibited TDP-43 binding, we performed isothermal titration calorimetry using recombinant TDP-43 and short RNAs. We observed nanomolar binding affinity in all cases, with an increased dissociation constant (<italic>K</italic><sub>d</sub>) (lower binding affinity) for the CE SNP region (<italic>P</italic>&#x2009;=&#x2009;0.023, two-sample <italic>t</italic>-test) and a trend of decreasing <italic>K</italic><sub>d</sub> for the intronic SNP region (<italic>P</italic>&#x2009;=&#x2009;0.052) when the risk variants were present (Fig. <xref rid="Fig4" ref-type="fig">4h</xref>, Extended Data Fig. <xref rid="Fig13" ref-type="fig">9a&#x2013;d</xref>, <xref rid="MOESM14" ref-type="media">Supplementary Data 4</xref>). Last, to test whether TDP-43 binding to the CE SNP region is critical for CE repression, we mutated the UGNNUG TDP-43-binding motif in this region, leading to significantly increased CE inclusion (Fig. <xref rid="Fig4" ref-type="fig">4i, j</xref>, Extended Data Fig. <xref rid="Fig13" ref-type="fig">9e</xref>). Together these data suggest that the risk SNPs modulate TDP-43 binding, in part via direct changes in binding affinity, exacerbating <italic>UNC13A</italic> CE inclusion.</p>
    </sec>
    <sec id="Sec6" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par25">Our results support a model in which <italic>UNC13A</italic> SNPs and TDP-43 loss synergistically drive cryptic exon inclusion in <italic>UNC13A</italic> transcripts, thereby reducing expression of a synaptic gene that is critical for normal neuronal function.</p>
      <p id="Par26">In this model, when nuclear TDP-43 levels are normal in healthy individuals, TDP-43 binds efficiently to <italic>UNC13A</italic> pre-mRNA, even in the presence of risk SNPs, thus preventing CE splicing. Conversely, severe nuclear depletion of TDP-43 in end-stage disease induces CE inclusion in all cases. However, in the setting of partial TDP-43 loss that occurs early in degenerating neurons, risk-associated intronic and CE risk SNPs alter TDP-43 binding to <italic>UNC13A</italic> pre-mRNA, exacerbating CE inclusion in these transcripts. The ensuing loss of UNC13A protein&#x2014;which is critical for normal synaptic activity&#x2014;at earlier disease stages may explain the associated risk effect of these SNPs. Notably, we found that both risk alleles for these SNPs independently and additively promoted cryptic splicing in vitro. Further, when the two variants are not co-inherited, as seen in individuals from east Asia with ALS, an attenuated effect is observed<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. A similar phenomenon, in which SNP pairs both contribute to risk, has been widely studied at the APOE locus in Alzheimer&#x2019;s disease<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Clarification of single versus additive effects of co-inherited SNPs regarding effects on CE inclusion, as well as contributions of other RBPs, will require future investigation.</p>
      <p id="Par27">UNC13 family proteins are highly conserved across metazoans and are essential for calcium-triggered synaptic vesicle release<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. In mice, single knockout of <italic>Unc13a</italic> blocks action potential-induced neurotransmitter release from the majority of glutamatergic hippocampal synapses<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Double knockout of <italic>Unc13a</italic> and <italic>Unc13b</italic> inhibits both excitatory and inhibitory synaptic transmission in hippocampal neurons and greatly impairs transmission at neuromuscular junctions<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. In TDP-43-depleted neuronal nuclei derived from patients with ALS or FTLD, which reflect transcript expression before NMD, the <italic>UNC13A</italic> CE is present in up to 100% of transcripts, suggesting that expression of functional <italic>UNC13A</italic> is markedly reduced, which could affect normal synaptic transmission.</p>
      <p id="Par28">TDP-43 loss induces hundreds of splicing changes, several of which have also been detected in brains of patients with ALS or FTLD. However, it has remained unclear whether these events&#x2014;even those that occur in essential neuronal genes&#x2014;contribute to disease pathogenesis. The fact that genetic variation modulating <italic>UNC13A</italic> CE levels influences the rate of ALS progression strongly supports the role of <italic>UNC13A</italic> downregulation as an important effector of neurotoxicity mediated by TDP-43 loss. The <italic>UNC13A</italic> CE is thus a promising target for therapies that modulate splicing, potentially applicable to 97% of ALS cases and approximately half of FTD cases. These findings are also of interest to other neurodegenerative diseases&#x2014;such as Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease and chronic traumatic encephalopathy&#x2014;in which TDP-43 depletion occurs in a substantial fraction of cases.</p>
    </sec>
    <sec id="Sec7" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec8">
        <title>Human iPS cell culture</title>
        <p id="Par29">All policies of the NIH Intramural research program were followed for the procurement and use of iPS cells. For most studies, the iPS cells used were from the WTC11 line, derived from a healthy 30-year-old male, and obtained from the Coriell cell repository. Infomed consent was obtained from the donor. We confirmed the WTC11 line contained no ALS&#x2013;FTD mutations in the ALS and FTD risk genes in Supplementary Table <xref rid="MOESM4" ref-type="media">1</xref>. For key experiments, an independent line was used, NCRM5. NCRM5 was derived from umbilical cord blood from NIH Center for Regenerative Medicine (CRM), Bethesda, MD, USA. Informed consent was obtained from the donor. All culture procedures were conducted as previously<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. In brief, iPS cells were grown on tissue culture dishes coated with human embryonic stem cell-qualified Matrigel (Corning, catalogue no. 354277). They were maintained in Essential 8 Medium (E8; Thermo Fisher Scientific, catalogue (cat.) no. A1517001) supplemented with 10&#x2009;&#x3BC;M ROCK inhibitor (RI; Y-27632; Selleckchem, cat. no. S1049) in a 37&#x2009;&#xB0;C, 5% CO<sub>2</sub> incubator. Medium was replaced every 1&#x2013;2 days as needed. Cells were passaged with accutase (Life Technologies, cat. no. A1110501), 5&#x2013;10&#x2009;min treatment at 37&#x2009;&#xB0;C. Accutase was removed and cells were washed with PBS before re-plating. Following dissociation, cells were plated in E8 media supplemented with 10&#x2009;&#x3BC;M RI to promote survival. RI was removed once cells grew into colonies of 5&#x2013;10 cells.</p>
        <p id="Par30">The following cell line and DNA samples were obtained from the NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical Research: GM25256.</p>
      </sec>
      <sec id="Sec9">
        <title>Data</title>
        <p id="Par31">Publicly available data were obtained from the Gene Expression Omnibus (GEO): iPS cell MNs<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, GSE121569; SK-N-DZ<sup>b</sup>, GSE97262; FACS-sorted frontal cortex neuronal nuclei, GSE126543; Riboseq, E-MTAB-10235; targeted RNA-seq, E-MTAB-10237; minigene TDP-43 iCLIP, E-MTAB-10297; SH-SY5Y TDP-43 iCLIP, E-MTAB-11243; and <italic>UNC13A</italic>-targeted nanopore, E-MTAB-11244.</p>
      </sec>
      <sec id="Sec10">
        <title>CRISPRi knockdown in human iPS cells</title>
        <p id="Par32">The human iPS cells used in this study were previously engineered<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup> to express mouse or human neurogenin-2 (NGN2) under a doxycycline-inducible promoter, as well as an enzymatically dead Cas9 (+/&#x2212; CAG-dCas9-BFP-KRAB)<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. For WTC11 these were integrated at the AAVS1 safe harbour and the CLYBL promoter safe harbour respectively, while for NCRM5, these were both integrated at the CLYBL promoter safe harbour.</p>
        <p id="Par33">To achieve knockdown, sgRNAs targeting either <italic>TARDBP</italic>/TDP-43, <italic>UPF1</italic> or a non-targeting control guide were delivered to iPS cells by lentiviral transduction. To make the virus, Lenti-X human embryonic kidney (HEK) cells were transfected with the sgRNA plasmids using Lipofectamine 3000 (Life Technologies, cat. no. L3000150), then cultured for 2&#x2013;3 days in the following media: DMEM, high glucose GlutaMAX Supplement media (Life Technologies, cat. no. 10566024) with 10% FBS (Sigma, cat. no. TMS-013-B), supplemented with viral boost reagent (ALSTEM, cat. no. VB100). Virus was then concentrated from the media 1:10 in PBS using Lenti-X concentrator (Takara Bio, cat. no. 631231), aliquoted and stored at &#x2212;80&#x2009;&#xB0;C for future use.</p>
        <p id="Par34">The sgRNAs were cloned into either pU6-sgRNA EF1Alpha-puro-T2A-BFP vector<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup> (gift from J. Weissman; Addgene 60955) or a modified version containing a human U6 promoter, a blasticidin (Bsd) resistance gene, and eGFP. sgRNA sequences were as follows: non-targeting control:GTCCACCCTTATCTAGGCTA, <italic>UPF1</italic>: GGCCAGACGCAGACGCCCCC, and <italic>TARDBP</italic>: GGGAAGTCAGCCGTGAGACC (strong guide), and GCGGCCTAGCGGGTGAGTCG (weaker guide). The stronger <italic>TARDBP</italic> guide was used in all cases unless otherwise stated.</p>
        <p id="Par35">Virus was delivered to iPS cells in suspension following an accutase split. Cells were plated and cultured overnight. The following morning, cells were washed with PBS and media was changed to E8 or E8+RI depending on cell density. Two days after lentiviral delivery, cells were selected overnight with either puromycin (10&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup>) or blasticidin (50&#x2013;100&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup>). iPS cells were then expanded 1&#x2013;2 days before initiating neuronal differentiation. Knockdown efficiency was tested at iPS cell and neuronal stages using immunofluorescence, qPCR and observed in RNA-seq data.</p>
      </sec>
      <sec id="Sec11">
        <title>iPS cell-derived i<sup>3</sup>Neuron differentiation and culture</title>
        <p id="Par36">To initiate neuronal differentiation, 20&#x2013;25 million iPS cells per 15&#x2009;cm plate were individualized using accutase on day 0 and re-plated onto Matrigel-coated tissue culture dishes in N2 differentiation media containing: knockout DMEM/F12 media (Life Technologies Corporation, cat. no. 12660012) with N2 supplement (Life Technologies Corporation, cat. no. 17502048), 1&#xD7; GlutaMAX (Thermofisher Scientific, cat. no. 35050061), 1&#xD7; MEM nonessential amino acids (NEAA) (Thermofisher Scientific, cat. no. 11140050), 10&#x2009;&#x3BC;M ROCK inhibitor (Y-27632; Selleckchem, cat. no. S1049) and 2&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup> doxycycline (Clontech, cat. no. 631311). Media was changed daily during this stage.</p>
        <p id="Par37">On day 3 pre-neuron cells were replated onto dishes coated with freshly made poly-<sc>l</sc>-ornithine (PLO; 0.1&#x2009;mg&#xA0;ml<sup>&#x2212;1</sup>; Sigma, cat. no. P3655-10MG), either 96-well plates (50,000 per well), 6-well dishes (2 million per well), or 15&#x2009;cm dishes (45&#x2009;million per plate), in i<sup>3</sup>Neuron Culture Media: BrainPhys media (Stemcell Technologies, cat. no. 05790) supplemented with 1&#xD7; B27 Plus Supplement (ThermoFisher Scientific, cat. no. A3582801), 10&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup> BDNF (PeproTech, cat. no. 450-02), 10&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup> NT-3 (PeproTech, cat. no. 450-03), 1&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup> mouse laminin (Sigma, cat. no. L2020-1MG), and 2&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup> doxycycline (Clontech, cat. no. 631311). i<sup>3</sup>Neurons were then fed three times a week by half media changes. i<sup>3</sup>Neuron were then collected on day 7 or 17 after the addition of doxycycline or 4 or 14 days after re-plating.</p>
      </sec>
      <sec id="Sec12">
        <title>Generation of stable TDP-43-knockdown cell line</title>
        <p id="Par38">SH-SY5Y and SK-N-DZ cells were transduced with SmartVector lentivirus (V3IHSHEG_6494503) containing a doxycycline-inducible shRNA cassette for TDP-43. Transduced cells were selected with puromycin (1&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup>) for one week. For doxycycline dose&#x2013;response experiments, the pool of TDP-43-knockdown SH-SY5Y cells were plated as single cells and expanded to obtain a clonal population.</p>
      </sec>
      <sec id="Sec13">
        <title>Depletion of TDP-43 from immortalized human cell lines</title>
        <p id="Par39">SH-SY5Y cells for RT&#x2013;qPCR validations and western blots were grown in DMEM/F12 containing Glutamax (Thermo) supplemented with 10% FBS (Thermo). For induction of shRNA against TDP-43 cells were treated with 5&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2013;1</sup> doxycyline hyclate (Sigma D9891). After 3&#x2009;days medium was replaced with Neurobasal (Thermo) supplemented with B27 (Thermo) to induce differentiation. After a further 7&#x2009;days, cells were collected for protein or RNA. For doxycycline dose response experiments, doxycycline was used at concentrations of 12.5&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup>, 18.75&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup>, 21&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup>, 25&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup>, and 75&#x2009;ng&#xA0;ml<sup>&#x2212;1</sup>. SH-SY5Y and SK-N-DZ cells for RNA-seq experiments were treated with siRNA, as previously described<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p>
      </sec>
      <sec id="Sec14">
        <title>RNA sequencing, differential gene expression and splicing analysis</title>
        <p id="Par40">For RNA-seq experiments of i<sup>3</sup>Neurons, the i<sup>3</sup>Neurons were grown on 96-well dishes. For collection on day 17, media was completely removed, and wells were treated with tri-reagent (100&#x2009;&#x3BC;l per well) (Zymo research corporation, cat. no. R2050-1-200). Then 5 wells were pooled together for each biological replicate: control (<italic>n</italic>&#x2009;=&#x2009;4); TDP-43 knockdown (<italic>n</italic>&#x2009;=&#x2009;3). To isolate RNA, we used a Direct-zol RNA miniprep kit (Zymo Research Corporation, cat. no. R2052), following manufacturer&#x2019;s instructions including the optional DNAse step. Note: one knockdown replicate did not pass RNA quality controls and so was not submitted for sequencing, resulting in a total of <italic>n</italic>&#x2009;=&#x2009;3 samples for this condition. Sequencing libraries were prepared with polyA enrichment using a TruSeq Stranded mRNA Prep Kit (Illumina) and sequenced (2&#xA0;&#xD7;&#xA0;75 bp) on an Illumina HiSeq 2500 machine.</p>
        <p id="Par41">Samples were quality trimmed using Fastp with the parameter &#x201C;qualified_quality_phred: 10&#x201D;, and aligned to the GRCh38 genome build using STAR (v2.7.0f)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> with gene models from GENCODE v31<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Gene expression was quantified using FeatureCounts<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> using gene models from GENCODE v31. Any gene which did not have an expression of at least 0.5 counts per million (CPM) in more than 2 samples was removed. For differential gene expression analysis, all samples were run in the same manner using the standard DESeq2<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> workflow without additional covariates, except for the Klim MNs dataset<sup>9</sup>, where we included the day of differentiation. The DESeq2 median of ratios, which controls for both sequencing depth and RNA composition, was used to normalize gene counts. Differential expression was defined at a Benjamini&#x2013;Hochberg false discovery rate&#x2009;&lt;&#x2009;0.1. Salmon (v1.5.1)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> using an index built from GENCODE v34<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> was used to assess the isoform expression of <italic>UNC13B</italic>. Our alignment pipeline is implemented in Snakemake version 5.5.4<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> and available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/rna_seq_snakemake">https://github.com/frattalab/rna_seq_snakemake</ext-link>.</p>
        <p id="Par42">STAR aligned BAMs were used as input to MAJIQ (v2.1)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> for differential splicing analysis using the GRCh38 reference genome. A threshold of 10% &#x394;<italic>&#x3A8;</italic> was used for calling the probability of significant change between groups. The results of the deltaPSI module were then parsed using custom R scripts to obtain <italic>&#x3A8;</italic> and probability of change for each junction. Cryptic splicing was defined as junctions with <italic>&#x3A8;</italic>&#x2009;&lt;&#x2009;5% in control samples, &#x394;<italic>&#x3A8;</italic>&#x2009;&gt;&#x2009;10%, and the junction was unannotated in GENCODE v31. Our splicing pipeline is implemented in Snakemake version 5.5.4 and available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/splicing">https://github.com/frattalab/splicing</ext-link>.</p>
        <p id="Par43">Counts for specific junctions were tallied by parsing the STAR splice junction output tables using bedtools<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. Splice junction parsing pipeline is implemented in Snakemake version 5.5.4 and available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/bedops_parse_star_junctions">https://github.com/frattalab/bedops_parse_star_junctions</ext-link>. <italic>&#x3A8;</italic> was evaluated using coordinates in Supplementary Table 6:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\psi =\frac{{\rm{I}}{\rm{n}}{\rm{c}}{\rm{l}}{\rm{u}}{\rm{s}}{\rm{i}}{\rm{o}}{\rm{n}}\,{\rm{r}}{\rm{e}}{\rm{a}}{\rm{d}}{\rm{s}}}{{\rm{I}}{\rm{n}}{\rm{c}}{\rm{l}}{\rm{u}}{\rm{s}}{\rm{i}}{\rm{o}}{\rm{n}}\,{\rm{r}}{\rm{e}}{\rm{a}}{\rm{d}}{\rm{s}}+{\rm{e}}{\rm{x}}{\rm{c}}{\rm{l}}{\rm{u}}{\rm{s}}{\rm{i}}{\rm{o}}{\rm{n}}\,{\rm{r}}{\rm{e}}{\rm{a}}{\rm{d}}{\rm{s}}}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi>&#x3C8;</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thinmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thinmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow><mml:mspace width="thinmathspace"/><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41586_2022_4436_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par44">Intron retention was assessed using IRFinder<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> with gene models from GENCODE v31.</p>
      </sec>
      <sec id="Sec15">
        <title>Analysis of published iCLIP data</title>
        <p id="Par45">Cross-linked read files from TDP-43 iCLIP experiments in SH-SY5Y and human neuronal stem cells<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> were processed using iCount v2.0.1.dev implemented in Snakemake version 5.5.4, available at <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/pipeline_iclip">https://github.com/frattalab/pipeline_iclip</ext-link>. Sites of cross-linked reads from all replicates were merged into a single file using iCount group command. Significant positions of cross-link read density with respect to the same gene (GENCODE v34 annotations) were then identified using the iCount peaks command with default parameters.</p>
      </sec>
      <sec id="Sec16">
        <title>Western blot</title>
        <p id="Par46">SH-SY5Y cells were lysed directly in the sample loading buffer (Thermo NP0008). Lysates were heated at 95&#x2009;&#xB0;C for 5&#x2009;min with 100&#x2009;mM DTT. If required lysates were passed through a QIAshredder (Qiagen) to shear DNA. Lysates were resolved on 4&#x2013;12% Bis-Tris Gels (Thermo) or homemade 6% Bis-Tris gels and transferred to 0.45&#x2009;&#x3BC;m PVDF (Millipore) membranes. After blocking with 5% milk, blots were probed with antibodies (Rb anti-UNC13A (Synaptic Systems 126 103) 1:2,000; Rb anti-UNC13B (abcam ab97924) 1:1,000; Rat anti-Tubulin (abcam ab6161 clone YOL1/34) 1:5,000, Mouse anti-TDP-43 (abcam ab104223 clone 3H8) 1:5,000) for 2&#x2009;h at room temperature. After washing, blots were probed with HRP conjugated secondary antibodies (Goat anti-Rabbit HRP (Bio-Rad 1706515) 1:10,000; Goat anti-Mouse HRP (Bio-Rad 1706516) 1:10,000; Rabbit anti-Rat HRP (Dako P0450) 1:10,000) and developed with Chemiluminescent substrate (Merck Millipore WBKLS0500) on a ChemiDoc Imaging System (Bio-Rad). Band intensity was measured with ImageJ (NIH version 2.0.0-rc-69).</p>
      </sec>
      <sec id="Sec17">
        <title>RT&#x2013;qPCR</title>
        <p id="Par47">RNA was extracted from SH-SY5Y and SK-N-DZ cells with a RNeasy kit (Qiagen) or from i<sup><italic>3</italic></sup>Neurons on day 7&#xA0;after the initiation of differentiation using a Direct-zol RNA miniprep kit (Zymo Research R2052) following the manufacturer&#x2019;s protocol including the on-column DNA digestion step. RNA concentrations were measured by Nanodrop and 500&#x2013;1,000&#x2009;ng of RNA was used for reverse transcription. First strand cDNA synthesis was performed with SSIV (Thermo 18090050), RevertAid (Thermo K1622) or High-Capacity cDNA Reverse Transcription Kit (Thermo 4368814) using random hexamer primers and following the manufacturer&#x2019;s protocol including all optional steps. Gene expression analysis was performed by qPCR using Taqman Multiplex Universal Master Mix (Thermo 4461882) or Taqman Universal PCR Master Mix (Thermo 4304437) and TaqMan assays (UNC13A-Fam Hs00392638_m1, UNC13B-Fam Hs01066405_m1, TDP-43-Vic Hs00606522_m1, GAPDH-Jun assay 4485713, TDP-43-FAM Hs00606522_m1, UPF1-FAM Hs00161289_m1, HPRT1-FAM Hs02800695_m1) on a QuantStudio 5 or a QuantStudio 6 Flex Real-Time PCR system (Applied Biosystems) and quantified using the &#x394;&#x394;<italic>C</italic><sub>t</sub> method<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>.</p>
      </sec>
      <sec id="Sec18">
        <title>RT&#x2013;PCR</title>
        <p id="Par48">RNA extraction and cDNA synthesis was performed as described under &#x2018;RT&#x2013;qPCR&#x2019;. <italic>UNC13A</italic> CE was amplified with a forward primer in exon 20 (5&#x2032;-CAAGCGAACTGACAAATCTGCCGTGTCG-3&#x2032;) and reverse primer in exon 21 (5&#x2032;-GGCATCGTCACCCTTGGCATCTGG-3&#x2032;). <italic>UNC13A</italic> intron retention was amplified with a forward primer in exon 30 (5&#x2032;-ATGCCCTATTCTCCTGCTCC-3&#x2032;) and a reverse primer that spans the exon 32&#x2013;33 junction (5&#x2032;-CATCCAGCTCCTTTCCTCCC-3&#x2032;). <italic>UNC13B</italic> FSE was amplified with forward primer (5&#x2032;-TCCGAGCAGTTACCAAGGTT-3&#x2032;) and reverse primer (5&#x2032;-GCTGTCAATGCCATAGAGCC-3&#x2032;). <italic>UNC13B</italic> intron retention was amplified with a forward primer that spans the exon 19&#x2013;20 junction (5&#x2032;-CAGGCCATGACGCACTTTG-3&#x2032;) and a reverse primer in exon 22 (5&#x2032;-GATTTTAAGTCCTGAAGCCGTTC-3&#x2032;). For Sanger sequencing, <italic>UNC13A</italic> CE was amplified with exon 19 forward primer (5&#x2032;-GACATCAAATCCCGCGTGAA-3&#x2032;) and exon 22 reverse primer (5&#x2032;-CATTGATGTTGGCGAGCAGG-3&#x2032;). Amplicons were resolved by agarose gel and the bands corresponding to the short and long form of the cryptic exon were excised and purified (NEB T1030L). The <italic>UNC13A</italic> exon 22 reverse primer (5&#x2032;-ATACTTGGAGGAGAGGCAGG-3&#x2032;) was used for sequencing reactions. PCR products were resolved on a TapeStation 4200 (Agilent) and bands were quantified with TapeStation Systems Software v3.2 (Agilent).</p>
      </sec>
      <sec id="Sec19">
        <title>Nonsense-mediated decay inhibition</title>
        <p id="Par49">For the SH-SY5Y experiment, 10 days after&#xA0;the induction of shRNA against TDP-43 with 1&#x2009;&#xB5;g&#xA0;ml<sup>&#x2212;1</sup> doxycyline hyclate (Sigma D9891-1G), cells were treated either with 100&#x2009;&#x3BC;M CHX or DMSO<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> for 6&#x2009;h before collecting the RNA with a RNeasy Minikit (Qiagen). Reverse transcription was performed using RevertAid cDNA synthesis kit (Thermo), and transcript levels were quantified by qPCR (QuantStudio 5 Real-Time PCR system, Applied Biosystems) using the &#x394;&#x394;<italic>C</italic><sub>t</sub> method<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Using RefFinder (<ext-link ext-link-type="uri" xlink:href="https://www.heartcure.com.au/reffinder/">https://www.heartcure.com.au/reffinder/</ext-link>), we identified <italic>GAPDH</italic> as the most stable endogenous control across our conditions of interest; the forward GAPDH primer used was 5&#x2032;-CACCAGGGCTGCTTTTAACT-3&#x2032;, and the reverse primer was 5&#x2032;-GACAAGCTTCCCGTTCTCAG-3&#x2032;. Since it has been shown to undergo NMD<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, <italic>HNRNPL</italic> NMD transcript was used as a positive control. The UNC13B experiment was subsequently performed, following the same method.</p>
        <p id="Par50">For the TDP-43-UPF1 double siRNA knockdown, SH-SY5Y cells were transfected with 40&#x2009;pM TDP-43 siRNA and either 40&#x2009;pM control or 40&#x2009;pM UPF1 siRNAs, and collected after 96&#x2009;h. Similarly to our experiment with CHX, we used a qPCR approach with GAPDH as endogenous control and <italic>HNRNPL</italic> as positive control. To assess TDP-43 and UPF1 levels, we used the following primers: TDP-43 forward, 5&#x2032;-GATGGTGTGACTGCAAACTTC-3&#x2032;; TDP-43 reverse, 5&#x2032;-CAGCTCATCCTCAGTCATGTC-3&#x2032;; <italic>UPF1</italic> forward, 5&#x2032;-TCGAGGAAGATGAAGAAGACAC-3&#x2032;, and UPF1 reverse, 5&#x2032;-TCCGTTGCAGAACCACTTC-3&#x2032;.</p>
        <p id="Par51">For both experiments in SH-SY5Y cells, <italic>UNC13A</italic> CE was amplified with a forward primer in exon 20 (5&#x2032;-CAAGCGAACTGACAAATCTGCCGTGTCG-3&#x2032;) and reverse primer within the CE (5&#x2032;-CCTGGAAAGAACTCTTATCCCCAGGAACTAGTTTGTTG-3&#x2032;); UNC13B FSE was amplified with a forward primer in exon 10 (5&#x2032;-TCCGAGCAGTTACCAAGGTT-3&#x2032;) and reverse primer within the FSE (5&#x2032;-GAAAAGCGAGGAGCCCTTCAG-3&#x2032;); <italic>STMN2</italic> CE was amplified with a forward primer in exon 1 (5&#x2032;-GCTCTCTCCGCTGCTGTAG-3&#x2032;) and reverse primer within the cryptic exon (5&#x2032;-CTGTCTCTCTCTCTCGCACA-3&#x2032;); <italic>HNRNPL</italic> NMD transcript was amplified with a forward primer in the NMD-inducing exon (5&#x2032;-GGTCGCAGTGTATGTTTGATG-3&#x2032;) and reverse primer in exon 7 (5&#x2032;-GGCGTTTGTTGGGGTTGCT-3&#x2032;).</p>
        <p id="Par52">For i<sup><italic>3</italic></sup>Neuron experiments, iPS cells were infected sequentially, first with either control or a TDP-43 targeting sgRNA in the human pU6-sgRNA EF1A-Bsd-T2A-eGFP backbone, and then second with either a control or UPF1-targeting sgRNA in the bovine pU6-sgRNA EF1A-puro-T2A-BFP backbone for a total of 4 groups: control/control, control/UPF1, TDP43/control, TDP43/UPF1. Two days following each infection, iPS cells were selected with either blasticidin (first infection) or puromycin and blasticidin (second infection) (see &#x2018;CRISPRi knockdown in human iPS cells&#x2019; for further details). iPS cells were then differentiated and neurons were collected in tri-reagent on day 7 after&#xA0;differentiation. Then RNA was isolated and cDNA was made (see &#x2018;RT&#x2013;qPCR&#x2019;). Then samples were analysed for differential gene expression and splicing by qPCR or PCR followed by Agilent bioanalyzer measurements to assess differences in band sizes resulting from cryptic exon splicing. PCR products were diluted 1:10 in nuclease-free water and resolved on a Bioanalyzer 2100 (Agilent). Bands were quantified with Agilent 2100 Software (Version B.02.08.SI648) using High sensitivity DNA Assay (Version 1.03). UNC13A primers are listed under RT&#x2013;PCR.</p>
      </sec>
      <sec id="Sec20">
        <title>Quantification of TDP-43, UNC13A and UNC13B using quantitative proteomics</title>
        <p id="Par53">i<sup><italic>3</italic></sup>Neurons were collected from 6-well plates on day 17 after the initiation of differentiation. One or two wells were pooled for each biological replicate, <italic>n</italic>&#x2009;=&#x2009;6 for each control and TDP-43-knockdown neurons. To collect cells, wells were washed with PBS, and then SP3 protein extraction was performed to extract intracellular proteins. In brief, we collected and lysed using a very stringent buffer (50&#x2009;mM HEPES, 50&#x2009;mM NaCl, 5&#x2009;mM EDTA 1% SDS, 1% Triton X-100, 1% NP-40, 1% Tween 20, 1% deoxycholate and 1% glycerol) supplemental with cOmplete protease inhibitor cocktail at 1 tablet/10&#x2009;ml ratio. The cell lysate was reduced by 10&#x2009;mM dithiothreitol (30&#x2009;min, 60&#x2009;&#xB0;C) and alkylated using 20&#x2009;mM iodoacetamide (30&#xA0;min, dark, room temperature). The denatured proteins were captured by hydrophilic magnetic beads, and tryptic on-beads digestion was conducted for 16&#x2009;h at 37&#x2009;&#xB0;C. We injected 1&#x2009;&#x3BC;g resulting peptides to a nano liquid chromatography for separation, and subsequently those tryptic peptides were analyzed on an Orbitrap Eclipse mass spectrometer coupled with a FAIMS interface using data-dependent acquisition (DDA) and data-independent acquisition (DIA) controlled by Xcalibur v4.3. The peptides were separated on a 120&#x2009;min LC gradient with 2-35% solvent B (0.1% FA, 5% DSMO in acetonitrile), and FAIMS&#x2019;s compensation voltages were set to &#x2212;50, &#x2212;65 and &#x2212;80. For DDA, we used MS1 resolution at 12,000 and cycle time was selected for 3&#x2009;s, MS2 fragments were acquired by linear ion trap. For DIA, we used 8&#x2009;<italic>m</italic>/<italic>z</italic> isolation windows (400&#x2013;1,000&#x2009;<italic>m</italic>/<italic>z</italic> range), cycle time was set to 3&#x2009;s, and MS2 resolution was set to 30,000. The DDA and DIA MS raw files were searched against Uniprot-Human-Proteome_UP000005640 database with 1% FDR using Proteome Discoverer (v2.4) and Spectronaut (v14.1), respectively. The raw intensity of quantified peptides was normalized by total peptides intensity identified in the same sample. The DDA quantified TDP-43- and UNC13A-derived unique and sharing peptides were parsed out and used for protein quantification. Specifically, we visualized and quantified the unique peptides of UNC13A using their MS/MS fragment ion intensity acquired by DIA.</p>
      </sec>
      <sec id="Sec21">
        <title>Nanopore sequencing and analysis</title>
        <p id="Par54">RNA from four FTLD-TDP patient samples and four SHSY-5Y samples (two with doxycycline-induced TDP-43 knockdown and two untreated controls) was reverse transcribed using Superscript IV (Thermo Fisher Scientific) using a specific reverse transcription primer following the manufacturer recommendations, but with the volumes halved. Following heat inactivation of the reverse transcriptase, the samples were treated with RNase H (NEB) for 20&#x2009;min at 37&#x2009;&#xB0;C, then diluted fourfold with Phusion HF mastermix (Thermo Fisher Scientific). Two rounds of nested PCR were performed to generate pure amplicons spanning the exon upstream of the CE and the exon downstream of the TDP-43 regulated intron retention, with thermolabile exoI treatment in between (NEB). To ensure complete amplification of amplicons, a 10 min extension time was used (approximately 10&#xD7; longer than recommended by the manufacturer&#x2019;s protocol). Nanopore-compatible overhangs were then added by PCR and the products were validated by agarose electrophoresis, followed by barcode addition using primers 5&#x2013;12 from the Nanopore PCR barcoding kit (SQK-PBK004). Following ligase-free rapid adaptor addition (SQK-PBK004) the products were loaded onto and sequenced with a MinION. Demultiplexing and basecalling was performed in real time using the GUPPY basecaller.</p>
        <p id="Par55">Raw fastqs were aligned to a section of chromosome 19 containing the entire UNC13A gene (17690344-17599328; GRCh38.p13) using Minimap2<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> with settings &#x201C;-ax splice&#x201D;. Downstream analysis was performed using a custom R script (<ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/unc13a_cryptic_splicing">https://github.com/frattalab/unc13a_cryptic_splicing</ext-link>) that quantified alignment to the regions of interest (the CE, the intron retention and their flanking exons), filtering for reads that were long enough to contain both the CE and intron retention so as not to bias the analysis against reads containing both events. Correct assignment was verified manually by visualizing differently classified reads.</p>
        <p id="Par56">Reverse transcription primer, CACATTGCCTGTGCCCTTAAC; nested PCR 1 forward, GACGTGTGGTACAACCTGGA; nested PCR 1 reverse, CACTCTTCAATGTGCGGCTG; nested PCR 2 forward, CTGACAAATCTGCCGTGTCG; nested PCR 2 reverse, GAAGCTGGTAGCAAACACCC; add overhang forward, TTTCTGTTGGTGCTGATATTGC CTGACAAATCTGCCGTGTCG; add overhang reverse, ACTTGCCTGTCGCTCTATCTTC GAAGCTGGTAGCAAACACCC.</p>
      </sec>
      <sec id="Sec22">
        <title>Ribosome profiling</title>
        <p id="Par57">For ribosome-profiling experiments, i<sup>3</sup>Neurons were grown on 15&#x2009;cm plates, one plate per biological replicate for control (<italic>n</italic>&#x2009;=&#x2009;4) and TDP-43-knockdown (<italic>n</italic>&#x2009;=&#x2009;4) neurons. On day 17, i<sup>3</sup>Neuron culture medium was replaced 90&#x2009;min before collecting the neurons to boost translation. Then the medium was removed, cells were washed with cold PBS, PBS was removed and 900&#x2009;&#x3BC;l of cold lysis buffer (20&#x2009;mM Tris pH 7.4, 150&#x2009;mM NaCl, 5 mM MgCl<sub>2</sub>, 1&#x2009;mM DTT (freshly made), 100&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup> CHX, 1% TX100; 25 U&#xA0;ml<sup>&#x2212;</sup><sup>1</sup> Turbo DNase I) was added to each 15&#x2009;cm plate. Lysed cells were scraped and pipetted into microcentrifuge tubes on ice. Cells were then passed through a 26-gauge needle 10 times, and then centrifuged twice at 19,000<italic>g</italic> at 4&#x2009;&#xB0;C, for 10&#x2009;min, each time moving the supernatant to a fresh tube. Tubes containing supernatant were flash frozen in liquid nitrogen and stored at &#x2212;80&#x2009;&#xB0;C until processing.</p>
        <p id="Par58">Ribosome footprints from three biological replicates of both TDP-43-knockdown control samples were generated and purified as described, using a sucrose cushion<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> and a customized library preparation method based on revised iCLIP<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. No ribosomal RNA depletion step was performed, and libraries were sequenced on an Illumina Hi-Seq 4000 machine (SR100). Reads were demultiplexed and adaptor/quality trimmed using Ultraplex<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, then aligned with Bowtie2<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> against a reference file containing abundant ncRNAs that are common contaminants of ribosome profiling, including rRNAs. Reads that did not pre-map were then aligned against the human genome with STAR<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> and the resulting BAM files were deduplicated with UMI-tools<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Multi-mapping reads were discarded and reads 28&#x2013;30&#xA0;nt in length were selected for analysis. FeatureCounts<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> was used to count footprints aligning to annotated coding sequences, and DESeq2<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> was used for differential expression analysis, using default parameters in both cases. Periodicity analysis was performed using a custom R script, using transcriptome-aligned bam files. Raw data have been uploaded to E-MTAB-10235.</p>
      </sec>
      <sec id="Sec23">
        <title>ALS and FTD panel genes</title>
        <p id="Par59">To find ALS and FTD &#x2018;green&#x2019; panel genes&#x2014;those with diagnostic level of evidence that have been approached for testing by NHS in England&#x2014;&#x2018;Amyotrophic lateral sclerosis/motor neuron disease (Version 1.33)&#x2019; and &#x2018;Early onset dementia (encompassing fronto-temporal dementia and prion disease) (Version 1.48)&#x2019; were downloaded from PanelApp<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.</p>
      </sec>
      <sec id="Sec24">
        <title>Genome-wide association study data</title>
        <p id="Par60">Harmonized summary statistics for the latest ALS GWAS<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> were downloaded from the NHGRI-EBI GWAS catalogue<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> (accession GCST005647). Locus plots were created using LocusZoom<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>, using linkage disequilibrium values from the 1000 Genomes European superpopulation<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>.</p>
      </sec>
      <sec id="Sec25">
        <title>NYGC ALS Consortium RNA-seq cohort</title>
        <p id="Par61">Our analysis contains 377 patients with 1,349 neurological tissue samples from the NYGC ALS dataset, including non-neurological disease controls, FTLD, ALS, FTD with ALS (ALS-FTLD), or ALS with suspected Alzheimer&#x2019;s disease (ALS-AD). Patients with FTD were classified according to a pathologist&#x2019;s diagnosis of FTD with TDP-43 inclusions (FTLD-TDP), or those with FUS or Tau aggregates. ALS samples were divided into the following subcategories using the available Consortium metadata: ALS with or without reported SOD1 or FUS mutations. All non-SOD1 or FUS ALS samples were grouped as ALS-TDP in this work for simplicity, although reporting of postmortem TDP-43 inclusions was not systematic and therefore not integrated into the metadata. Confirmed TDP-43 pathology postmortem was reported for all FTLD-TDP samples.</p>
        <p id="Par62">Sample processing, library preparation, and RNA-seq quality control have been extensively described in previous papers<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. In brief, RNA was extracted from flash-frozen postmortem tissue using TRIzol (Thermo Fisher Scientific) chloroform, and RNA-Seq libraries were prepared from 500&#x2009;ng total RNA using the KAPA Stranded RNA-Seq Kit with RiboErase (KAPA Biosystems) for ribosomal RNA depletion. Pooled libraries (average insert size: 375 bp) passing the quality criteria were sequenced either on an Illumina HiSeq 2500 (125 bp paired end) or an Illumina NovaSeq (100 bp paired end). The samples had a median sequencing depth of 42&#x2009;million read pairs, with a range between 16 and 167&#x2009;million read pairs.</p>
        <p id="Par63">Samples were uniformly processed, including adapter trimming with Trimmomatic and alignment to the hg38 genome build using STAR (2.7.2a)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> with indexes from GENCODE v30. Extensive quality control was performed using SAMtools<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> and Picard Tools<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> to confirm sex and tissue of origin.</p>
        <p id="Par64">Uniquely mapped reads within the <italic>UNC13A</italic> locus were extracted from each sample using SAMtools. Any read marked as a PCR duplicate by Picard Tools was discarded. Splice junction reads were then extracted with RegTools<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> using a minimum of 8 bp as an anchor on each side of the junction and a maximum intron size of 500 kb. Junctions from each sample were then clustered together using LeafCutter<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> with relaxed junction filtering (minimum total reads per junction&#x2009;=&#x2009;30, minimum fraction of total cluster reads&#x2009;=&#x2009;0.0001). This produced a matrix of junction counts across all samples.</p>
        <p id="Par65">The CE was considered detected in a sample if there was at least one uniquely mapped spliced read supporting either the short CE acceptor or the CE donor. As the long CE acceptor was detected consistently in control cerebellum samples, as part of an unannotated cerebellum-enriched 35 bp exon containing a stop codon between exons 20 and 21(Extended Data Fig. <xref rid="Fig14" ref-type="fig">10 a, b</xref>), we excluded the long CE acceptor for quantification of <italic>UNC13A</italic> CE <italic>&#x3A8;</italic> in patient tissue. Only samples with at least 30 spliced reads at the exon locus were included for correlations. In Fig.&#xA0; <xref rid="Fig4" ref-type="fig">4a</xref>,&#xA0;only cortical samples that were concordant for genotypes at <italic>rs12973192</italic> and <italic>rs12608932</italic>, had both <italic>STMN2</italic> and <italic>UNC13A</italic> CE detected, and had at least 30 spliced reads at the exon locus were included in the analysis. Cell-type deconvolution was performed using the top 100 most specific marker genes from neurons, astrocytes, oligodendrocytes, endothelial cells and microglia derived by single-cell RNA sequencing<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> with the dtangle<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. The NYGC ALS Consortium samples presented in this work were acquired through various IRB protocols from member sites and the Target ALS postmortem tissue core and transferred to the NYGC in accordance with all applicable foreign, domestic, federal, state, and local laws and regulations for processing, sequencing, and analyses. The Biomedical Research Alliance of New York (BRANY) IRB serves as the central ethics oversight body for NYGC ALS Consortium. Ethical approval was given and is effective until 22 August 2022. Informed consent has been obstained from all participants.</p>
      </sec>
      <sec id="Sec26">
        <title>Ethics</title>
        <p id="Par66">Brains were donated to the Queen Square Brain Bank (QSBB) for Neurological Disorders (QSBB) and the NeuroResource tissue bank (UCL Queen Square Institute of Neurology). All tissue samples were donated with the full informed consent. Accompanying clinical and demographic data of all cases used in this study were stored electronically in compliance with the 20181998 Data Protection Act and are summarized in Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref>. Ethical approval for the study was obtained from the NHS research ethics committee (RNEC) and in accordance with the Human Tissue Authority&#x2019;s codes of practice and standards under license number 12198. We have conformed with all relevant ethical regulations related to informed consent and anonymization of patient data analysed in the manuscript.</p>
      </sec>
      <sec id="Sec27">
        <title>Gene transcript model harmonization</title>
        <p id="Par67">To ensure consistency between RNA-seq, re-analysis of published iCLIP data, and the NYGC ALS Consortium RNA-seq cohort, we confirmed that both the ENSEMBL gene minor version and transcripts for <italic>UNC13A</italic> and <italic>UNC13B</italic> are identical between the three GENCODE annotations used across our team.</p>
      </sec>
      <sec id="Sec28">
        <title>BaseScope assay</title>
        <p id="Par68">To validate a BaseScope assay for UNC13A cryptic exons, we first performed the assay in i<sup>3</sup>Neurons with CRISPRi depletion of control or a non-targeting guide. Neurons were plated on 8-well IBIDI slides, 0.2&#x2009;million per well and then fixed with 4% paraformaldehyde for 10&#x2009;min on day 7 after the initiation of differentiation. Neurons were then dehydrated and stored for ~1 week at &#x2212;20C. Neurons were then rehydrated and pretreated following the recommendations of the RNAscope&#xAE; Assay for Adherent Cells, using 30% hydrogen peroxide for 8&#x2009;min and a 1:15 dilution of the RNAscope Protease III. Then the BaseScope v2-RED assay was performed using our <italic>UNC13A</italic> CE target probe (BA-Hs-UNC13A-O1-1zz-st) according to manufacturer guidelines (Advanced Cell Diagnostics). Following fast red solution, wells were washed 2&#xD7; with PBS, and incubated overnight at 4&#xA0;&#xB0;C in 0.5% Triton-X and 3% BSA containing primary antibodies: rabbit TDP43 (proteintech 12892-1-AP, 1:1,000 dilution) and mouse TUBB3 (Biolegend 801201, 1:5,000 dilution). The next morning, wells were washed three times with PBS and treated with secondary antibodies Alexa Fluor 488 anti-rabbit (Jackson Immuno 711-545-152) and Alexa Fluor 647 anti-mouse (Jackson Immuno 715-605-151), and Hoechst 33342 (Thermo Scientific) at 1:10,000 dilution for 1&#x2009;h at room temperature. Wells were then washed 3&#xD7; with PBS and imaged on an inverted spinning disk confocal microscope (Nikon Eclipse T1), using a 60&#xD7; 1.40 NA oil-immersion objective. Confocal images were then processed in FIJI.</p>
        <p id="Par69">Frozen tissue from the frontal cortex of FTLD-TDP (<italic>n</italic>&#x2009;=&#x2009;9), FTLD-TAU (<italic>n</italic>&#x2009;=&#x2009;4) and control (<italic>n</italic>&#x2009;=&#x2009;5) cases were sectioned at 10&#x2009;&#xB5;m thickness onto Plus+Frost microslides (Solmedia). Immediately prior to use, sections were dried at room temperature and fixed for 15&#x2009;min in pre-chilled 4% paraformaldehyde. Sections were then dehydrated in increasing grades of ethanol and pre-treated with RNAscope hydrogen peroxide (10&#x2009;min, room temperature) and protease IV (30&#x2009;min, room temperature). The BaseScope v2-RED assay was performed using our <italic>UNC13A</italic> CE target probe (BA-Hs-UNC13A-O1-1zz-st) according to manufacturer guidelines with no modifications (Advanced Cell Diagnostics,). Sections were nuclei counterstained in Mayer&#x2019;s haematoxylin (BDH) and mounted (VectaMount). Slides were also incubated with a positive control probe (Hs-PPIB-1 ZZ) targeting a common housekeeping gene and a negative control probe (DapB-1 ZZ) which targets a bacterial gene to assess background signal (&lt;1&#x2013;2 foci per approximately 100 nuclei). Representative images were taken at &#xD7;60 magnification.</p>
        <p id="Par70">Hybridized sections were imaged and analysed blinded to disease status. Slides were scanned using an Olympus VS120 slide scanner at &#xD7;20 magnification and equal sized (34.5&#x2009;mm<sup>2</sup>) regions of interest were extracted from the centre of each section. The total number of red foci, which should identify single transcripts harbouring the <italic>UNC13A</italic> CE event, were manually counted in ImageJ (v1.52p). Foci frequency was background-corrected by subtracting the signal obtained with the negative control probe in the same experiment.</p>
      </sec>
      <sec id="Sec29">
        <title>UNC13A genotypes in the NYGC ALS Consortium</title>
        <p id="Par71">Whole-genome sequencing was carried out for all donors, from DNA extracted from blood or brain tissue.Full details of sample preparation and quality control will be published in a future manuscript. In brief, paired-end 150-bp reads were aligned to the GRCh38 human reference using the Burrows-Wheeler Aligner (BWA-MEM v0.7.15)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> and processed using the GATK best-practices workflow. This includes marking of duplicate reads by the use of Picard tools<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> (v2.4.1), followed by local realignment around indels, and base quality score recalibration using the Genome Analysis Toolkit<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup> (v3.5). Genotypes for <italic>rs12608932</italic> and <italic>rs12973192</italic> were then extracted for the samples.</p>
      </sec>
      <sec id="Sec30">
        <title>Targeted RNA-seq</title>
        <p id="Par72">RNA was isolated from temporal cortex tissue of 10 FTLD-TDP and 4 control brains (6 male, 4 female, average age at death 70.6&#xA0;&#xB1;&#xA0;5.8&#xA0;yr, average disease duration 10.98&#xA0;&#xB1;&#xA0;5.9&#xA0;yr) full metadata provide in&#xA0;<xref rid="MOESM8" ref-type="media">Supplementary Table 5</xref>. Fifty milligrams of flash-frozen tissue was homogenized in 700&#x2009;&#xB5;l of Qiazol (Qiagen) using a TissueRuptor II (Qiagen). Chloroform was added and RNA subsequently extracted following the spin-column protocol from the miRNeasy kit with DNase digestion (Qiagen). RNA was eluted off the column in 50&#x2009;&#xB5;l of RNAse-free water. RNA quantity and quality were evaluated using a spectrophotometer.</p>
        <p id="Par73">Purified RNA was reverse transcribed with Superscript IV (Thermo Fisher Scientific) using either sequence-specific primers containing sample-specific barcodes or random hexamers, following the manufacturer recommendations. Unique molecular identifiers (UMIs) and part of the P5 Illumina sequence were added either during first- or second-strand-synthesis (with Phusion HF 2&#xD7; Master Mix) respectively. Barcoded primers were removed with exonuclease I treatment (NEB; 30&#x2009;min) and subsequently bead&#x2013;size selection of RT&#x2013;PCR products (TotalPureNGS, Omega Biotek). Three rounds of nested PCR using Phusion HF 2&#xD7; Master Mix (New England Biolabs) were used to obtain highly specific amplicons for the <italic>UNC13A</italic> cryptic, followed by gel extraction and a final round of PCR in which the full length P3/P5 Illumina sequences were added. Samples were sequenced with an Illumina HiSeq 4000 machine (SR100).</p>
        <p id="Par74">Raw reads were demultiplexed, adaptor/quality trimmed and UMIs were extracted with Ultraplex<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, then aligned to the hg38 genome with STAR<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. To control for mapping biases, a VCF containing rs12973192 was used and alignments that failed to pass WASP filtering were ignored. Reads were deduplicated via analysis of UMIs with a custom R script; to avoid erroneous detection of UMIs due to sequencing errors, UMI sequences with significant similarity to greatly more abundant UMIs were discarded&#x2014;this methodology was tested using simulated data, and final results were manually verified. Raw reads for targeted RNA-seq are available at E-MTAB-10237.</p>
        <p id="Par75">Primers used are listed in&#xA0;<xref rid="MOESM10" ref-type="media">Supplementary Table 7</xref>.</p>
      </sec>
      <sec id="Sec31">
        <title>Splicing reporters</title>
        <p id="Par76">One variant of the <italic>UNC13A</italic> exon 20, intron 20 and exon 21 sequence was synthesized and cloned into a pIRES-EGFP vector (Clontech) by BioCat. The repeat expansion, containing four extra copies of the CATC repeats (ten instead of the six found in the reference genome), was added via Gibson assembly of a PCR-linearized plasmid and a dsDNA insert generated by annealing two synthesized ssDNA oligos (oligos used: unc13mg_bb_FWD: AATGGGTGGGTGGATGAATGGAAGGATG, unc13mg_bb_REV: TCTACCCATCTGACTATCAACAAATTCACC, Unc13_Repeat_add_AntiSense: CCCACCCATTCATCCATTTGTCCATCTGCCTATACATCCATCCATCCATCCATCCATCCATCCATCCATCCATCTACCTATCTACCCATC, Unc13_Repeat_add_Sense: GATGGGTAGATAGGTAGATGGATGGATGGATGGATGGATGGATGGATGGATGGATGTATAGGCAGATGGACAAATGGATGAATGGGTGGG). Plasmids with all four possible combinations of the SNPs were then generated by PCR-based site directed mutagenesis (primers used: healthy_exon_SNP_REV: CTTTTATCTACTCATCACTCATTC, healthy_exon_SNP_FWD: GATGGATGGAGAGATGGG, healthy_intron_SNP_REV: CCATCCATTTTTCGTCTGTC, healthy_intron_SNP_FWD: TTGGATAAATTGATGGGTGGATG. risk_exon_SNP_FWD: CATGGATGGAGAGATGGG, risk_exon_SNP_REV: CTTTTATCTACTCATCACTCATTC). Plasmids were propagated in Stbl3 bacteria (Thermo Fisher Scientific) grown at 30&#x2009;&#xB0;C due to the observed instability of the plasmids in DH5alpha cells grown at 37&#x2009;&#xB0;C. Similarly, the two UG/UC mutants were generated by PCR-based site directed mutagenesis of the &#x2018;healthy&#x2019; plasmid (primers used: UG_UC_1_F: CGATGGAGAGATGGGTGAG, UG_UC_1_R: ATCCTTTTATCTACTCATCAC, UG_UC_2_F: CGAGAGATGGGTGAGTAC, UG_UC_2_R: ATCCATCCTTTTATCTACTC). All plasmids were verified by Sanger sequencing.</p>
        <p id="Par77">To reduce the impact of sample-to-sample variation on our analysis, we generated (via PCR site-directed mutagenesis) a modified healthy minigene with an alternative primer binding site downstream of the <italic>UNC13A</italic> sequence, before the polyA site, which had no detectable impact on CE splicing. This enabled co-transfection of 1. a minigene featuring a specific combination of variants and 2. the modified control (healthy) minigene into the same population of cells; the cryptic splicing level of each could then be determined by specific RT&#x2013;PCR amplification of each minigene from the same cDNA, thus ensuring that the observed differences between variants did not simply reflect differences between cells grown in different dishes.</p>
        <p id="Par78">TDP-43 inducible knockdown SH-SY5Y cells were electroporated with 1.5&#x2009;&#x3BC;g each of the variant and healthy minigene DNA with the Ingenio electroporation kit (Mirus) using the A-023 setting on an Amaxa II nucleofector (Lonza). The cells were then left untreated or treated for 6 days with 1&#x2009;&#x3BC;g&#xA0;ml<sup>&#x2212;1</sup> doxycycline before RNA extraction. Reverse transcription was performed with RervertAid (Thermo Scientific) and cDNA was amplified by nested PCR with minigene-specific primers (5&#x2032;-TCCTCACTCTCTGACGAGG-3&#x2032; and 5&#x2032;-CATGGCGGTCGACCTAG-3&#x2032; or 5&#x2032;-TGGTCGCCATACTGTCATG-3&#x2032; (for the healthy cotransfection control)) followed by <italic>UNC13A</italic>-specific primers 5&#x2032;-CAAGCGAACTGACAAATCTGCCGTGTCG-3&#x2032; and 5&#x2032;-CGACACGGCAGATTTGTCAGTTCGCTTG-3&#x2032;. PCR products were resolved on a TapeStation 4200 (Agilent) and bands were quantified with TapeStation Systems Software v3.2 (Agilent).</p>
      </sec>
      <sec id="Sec32">
        <title>Heptamer analysis</title>
        <p id="Par79">Binding enrichment <italic>E</italic>-scores were downloaded from Ray et al. (2013)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Seven-nucleotide sequences that overlapped with either the exonic or intronic SNPs were extracted using a sliding-window approach. Using a custom R script (<ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/unc13a_cryptic_splicing/">https://github.com/frattalab/unc13a_cryptic_splicing/</ext-link>), the average <italic>E</italic>-scores for each RBP were calculated for each set of 7-mers, and the RBPs were ranked by effect size of the SNPs on average <italic>E</italic>-score.</p>
      </sec>
      <sec id="Sec33">
        <title>TDP-43 protein purification</title>
        <p id="Par80">His-tagged human TDP-43 (amino acids 102 to 269) was expressed in BL21-DE3 Gold <italic>Escherichia coli</italic> (Agilent) as previously described<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. Bacteria were lysed by 2 h of gentle shaking in lysis buffer (50&#x2009;mM sodium phosphate pH 8, 300&#x2009;mM NaCl, 30&#x2009;mM imidazole, 1&#x2009;M urea, 1% v/v Triton X-100, 5&#x2009;mM &#x3B2;-mercaptoethanol, with Roche EDTA-free cOmplete protease inhibitor) at room temperature. Samples were centrifuged at 16,000&#x2009;rpm in a Beckman 25.50 rotor at 4&#x2009;&#xB0;C for 10&#x2009;min, and the supernatant was clarified by vacuum filtration (0.22&#x2009;&#xB5;m).</p>
        <p id="Par81">The clarified lysate was loaded onto a 5&#x2009;ml His-Trap HP column (Cytiva) equilibrated with buffer A (50&#x2009;mM sodium phosphate pH 8, 300&#x2009;mM NaCl, 20&#x2009;mM imidazole) using an AKTA Pure system, and eluted with a linear gradient of 0-100% buffer B (50&#x2009;mM sodium phosphate pH 8, 300&#x2009;mM NaCl, 500&#x2009;mM imidazole) over 90 column volumes. The relevant fractions were then analysed by SDS&#x2013;PAGE and then either extensively dialysed (3.5&#x2009;kDa cutoff) against isothermal titration calorimetry (ITC) buffer (50&#x2009;mM sodium phosphate pH 7.4, 100&#x2009;mM NaCl, 1&#x2009;mM TCEP) at 4&#x2009;&#xB0;C, or flash frozen in liquid nitrogen.</p>
      </sec>
      <sec id="Sec34">
        <title>Isothermal titration calorimetry</title>
        <p id="Par82">RNAs with sequences 5&#x2032;-AAGGAUGGAUGGAG-3&#x2032; (CE SNP healthy), 5&#x2032;-AAGCAUGGAUGGAG-3&#x2032; (CE SNP risk), 5&#x2032;-AAAAAUGGAUGGUUGGAU-3&#x2032; (intron SNP healthy) and 5&#x2032;-AAAAAUGGAUGGGUGGAU-3&#x2032; (intron SNP risk) were synthesized by Merck, resuspended in Ultrapure water, then dialysed against the same stock of ITC buffer used for TDP-43 dialysis (above) overnight at 4&#x2009;&#xB0;C using 1&#x2009;kDa Pur-a-lyzer tubes (Merck). Protein and RNA concentrations after dialysis were calculated by A280 and A260 absorbance respectively. ITC measurements were performed on a MicroCal PEAQ-ITC calorimeter (Malvern Panalytical). Titrations were performed at 25&#x2009;&#xB0;C with TDP-43 (9.6&#x2013;12&#x2009;&#xB5;M) in the cell and RNA (96&#x2013;120&#x2009;&#xB5;M) in the syringe. Data were analysed using the MicroCal PEAQ-ITC analysis software using nonlinear regression with the One set of sites model. For each experiment, the heat associated with ligand dilution was measured and subtracted from the raw data.</p>
      </sec>
      <sec id="Sec35">
        <title>iCLIP of SH-SH5Y and minigene-transfected HEK 293T cells</title>
        <p id="Par83">SH-SY5Y cells were grown to 80% confluence in two 10&#x2009;cm dishes. HEK 293T cells were grown to 80% confluence and transfected with either the 2&#xD7; healthy or 2&#xD7; risk minigenes using Lipofectamine 3000 (Thermofisher Scientific). Each replicate consisted of 2&#xD7; 3.5&#x2009;cm dishes, with two replicates per sample, for eight dishes total. Plasmid (1.25&#x2009;&#x3BC;g) was used for each dish, measured via Nanodrop (Thermo Fisher Scientific), combined with 2.5&#x2009;&#x3BC;l of Lipofectamine 3000 and P3000 reagent diluted in 250&#x2009;&#x3BC;l (2&#xA0;&#xD7; 125&#x2009;&#x3BC;l) of Opti-MEM I following the manufacturer protocol (Thermo Fisher Scientific). Cells were UV crosslinked on ice and subjected to iCLIP analysis following the iiCLIP protocol<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. In brief, medium RNase I was added to cell lysate for RNA fragmentation. Immunoprecipitations were performed with 4&#x2009;&#x3BC;g of TDP-43 antibody ((Proteintech, Rabbit anti-TDP-43 cat. no. 10782-2-AP) coupled with 100&#x2009;&#x3BC;l of protein A or G dynabeads (for SH-SY5Y or HEK 293T, respectively) per sample. The complexes were then size-separated with SDS&#x2013;PAGE and visualized by Odyssey scanning. cDNA was synthesized with Superscript IV Reverse Transcriptase (Life Technologies). cDNA was then circularized. After PCR amplification, libraries were removed from primers with Ampure beads and QCed for sequencing. Libraries were sequenced on an Illumina HiSeq4000 machine (SR100).</p>
        <p id="Par84">For SH-SH5Y iCLIP, downstream analysis was performed with the iMAPS server. For data from HEK 293T cells, after demultiplexing the reads with Ultraplex, we initially aligned to the human genome using STAR<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, which showed that&#x2009;&gt;5% of uniquely aligned reads mapped solely to the genomic region that is contained in the minigene. Given the high prior probability of reads mapping to the minigene, we therefore instead used Bowtie2 to align to the respective minigene sequences alone, thus minimizing mis-mapping biases that could be caused by the SNPs<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> with settings &#x201C;--norc --no-unal --rdg 50,50 --rfg 50,50 --score-min L,&#x2212;2,&#x2212;0.2 --end-to-end -N 1&#x201D;, then filtered for reads with no alignment gaps, and length&#x2009;&gt;25 nt. Due to the exceptional read depth and high library complexity, we did not perform PCR deduplication to avoid UMI saturation at signal peaks. All downstream analysis was performed using custom R scripts; to avoid biases due to differing transfection efficiencies, crosslink densities were normalized by the total number of minigene crosslinks for each sample. Raw data are available at E-MTAB-10297.</p>
      </sec>
      <sec id="Sec36">
        <title>Reporting summary</title>
        <p id="Par85">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this paper.</p>
      </sec>
    </sec>
    <sec id="Sec37" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par86">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-04436-3.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_4436_MOESM1_ESM.pdf"><label>Supplementary Figure 1</label><caption><p>Uncropped immunoblots from Extended Data Fig. 3f. Red dashed boxes indicate regions shown in the figure. UNC13B, Tubulin and TDP-43 are from the same membrane. UNC13A is blotted on a separate membrane.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_4436_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_4436_MOESM3_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_4436_MOESM4_ESM.xls"><label>Supplementary Table 1</label><caption><p>Gene expression and cryptic splicing status of ALS and FTLD associated genes in i<sup>3</sup>Neurons.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41586_2022_4436_MOESM5_ESM.xls"><label>Supplementary Table 2</label><caption><p>Cell lines used in this study.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41586_2022_4436_MOESM6_ESM.xls"><label>Supplementary Table 3</label><caption><p>Effect of read length on <italic>UNC13A</italic> CE detection in ALS/FTLD-TDP.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41586_2022_4436_MOESM7_ESM.xls"><label>Supplementary Table 4</label><caption><p>Relationship between <italic>UNC13A</italic> CE PSI in patients and <italic>UNC13A</italic> risk SNPs and known covariates.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41586_2022_4436_MOESM8_ESM.xls"><label>Supplementary Table 5</label><caption><p>Metadata targeted RNA-seq.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41586_2022_4436_MOESM9_ESM.xls"><label>Supplementary Table 6</label><caption><p>Hg38 coordinates for splice junctions used to calculate PSI.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41586_2022_4436_MOESM10_ESM.xls"><label>Supplementary Table 7</label><caption><p>Primers used for targeted RNA-seq in temporal cortex of 10 FTLD-TDP brains.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="41586_2022_4436_MOESM11_ESM.csv"><label>Supplementary Data 1</label><caption><p>List of differentially spliced junctions between control and TDP-43-knockdown i3Neurons (Fig. 1a).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM12"><media xlink:href="41586_2022_4436_MOESM12_ESM.csv"><label>Supplementary Data 2</label><caption><p>List of differentially expressed genes between control and TDP-43-knockdown i3Neurons (Fig. 1b).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM13"><media xlink:href="41586_2022_4436_MOESM13_ESM.csv"><label>Supplementary Data 3</label><caption><p>List of differentially ribosomal profiling genes between control and TDP-43-knockdown i3Neurons (Fig 2c).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM14"><media xlink:href="41586_2022_4436_MOESM14_ESM.xlsx"><label>Supplementary Data 4</label><caption><p>Average thermodynamic parameters obtained from ITC experiments.</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec38">
          <title>Extended data figures and tables</title>
          <p id="Par89">
<fig id="Fig5"><label>Extended Data Fig. 1</label><caption><title><italic>UNC13A</italic> and <italic>UNC13B</italic> are misspliced after TDP-43 knockdown across neuronal lines.</title><p>(<bold>a, b</bold>) RNA-seq traces from IGV<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> of representative samples from control (top) and <italic>TARDBP</italic> KD (bottom) in i<sup>3</sup>Neurons showing intron retention in <italic>UNC13A</italic> (A) (mean 4.50&#x2009;&#xB1;&#x2009;1.50 increased IR in KD) and <italic>UNC13B</italic> (mean 1.86&#x2009;&#xB1;&#x2009;0.63 increased IR in KD)(B), overlaid with published TDP-43 iCLIP peaks<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> (<bold>c</bold>) Histogram showing number of basescope cryptic foci per nuclei in control (blue) and TDP-43 KD (grey) in WTC11-derived i<sup>3</sup>Neurons, p&#x2009;&lt;&#x2009;0.0001 unpaired t-test. (<bold>d, e</bold>) RT-qPCR levels of <italic>TARDBP</italic> and <italic>UNC13A</italic> with a non-targeting control sgRNA (sgTARDBP &#x2212;), an intermediate TDP-43 KD (sgTARDBP +) or a higher TDP-43 KD (sgTARDBP ++) in WTC11-derived (<bold>d</bold>) and NCRM-5-derived i<sup>3</sup>Neurons (<bold>e</bold>). n&#x2009;=&#x2009;4 biological replicates sgTARDBP &#x2212; (<bold>d</bold>), n&#x2009;=&#x2009;6 biological replicates sgTARDBP &#x2212; (<bold>e</bold>), sgTARDBP + (<bold>d, e</bold>) and ++ (<bold>d, e</bold>). plotted as means&#x2009;&#xB1;&#x2009;SEM. (<bold>f</bold>) Representative images of <italic>UNC13A</italic> CE RT-PCR products (<bold>g</bold>) Quantification of the lower gel in (<bold>f</bold>) plotted as means&#x2009;&#xB1;&#x2009;SEM, n&#x2009;=&#x2009;6 biological replicates non-targeting control sgRNA (sgTARDBP &#x2212;), sgTARDBP +, sgTARDBP ++. Upper gel is quantified in Fig. <xref rid="Fig1" ref-type="fig">1h</xref>. One-way ANOVA with multiple comparisons. (<bold>h&#x2013;k</bold>) Expression of TDP-43 regulated splicing in <italic>UNC13A</italic>(<bold>h, i</bold>) and <italic>UNC13B</italic>(<bold>j, k</bold>) across neuronal datasets<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> in control (blue) and TDP-43 KD (yellow). Intron retention (IR)(<bold>i, k</bold>) and CE and fsE PSI (<bold>h, j</bold>) significantly increase after TDP-43 depletion in most experiments, Wilcoxon test (<bold>l</bold>) Relative gene expression levels for <italic>TARDBP</italic> across neuronal datasets<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. Normalized RNA counts are shown as relative to control mean. Numbers show log<sub>2</sub> fold change calculated by DESeq2. Significance shown as adjusted p-values from DESeq2. For (h&#x2013;l) biological replicates are: iPSC MN Ctrl KD n&#x2009;=&#x2009;12, TDP-43 KD n&#x2009;=&#x2009;6; i<sup>3</sup>N Ctrl KD n&#x2009;=&#x2009;4, TDP-43 KD n&#x2009;=&#x2009;3; SH-SY5Y, SK-N-DZ<sup>a</sup>, and SK-N-DZ<sup>b</sup> Ctrl KD n&#x2009;=&#x2009;3, TDP-43 KD n&#x2009;=&#x2009;3, Significance levels reported as * (p&#x2009;&lt;&#x2009;0.05) ** (p&#x2009;&lt;&#x2009;0.01) *** (p&#x2009;&lt;&#x2009;0.001) **** (p&#x2009;&lt;&#x2009;0.0001).</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig5_ESM" id="d32e4776"/></fig>
</p>
          <p id="Par90">
<fig id="Fig6"><label>Extended Data Fig. 2</label><caption><title>Validation of <italic>UNC13A</italic> and <italic>UNC13B</italic> misplicing after TDP-43 KD across multiple neuronal cell lines.</title><p>Targeted nanopore sequencing reveals <italic>UNC13A</italic> CE and IR events occur largely independently in-vitro. (<bold>a</bold>) Sanger sequencing of cryptic bands in both SH-SY5Y and SK-N-DZ cells confirm the CE splice junctions. (<bold>b, c</bold>) Crosslink density across <italic>UNC13A</italic> (chr19) (b) and <italic>UNC13B</italic> (chr9) (<bold>c</bold>) genomic loci from novel iCLIP on endogenous TDP-43 in SH-SHY5Y cells. Crosslink densities for both genes show peaks at the CE/fsE (red) and retained introns (blue). Coordinates shown in hg38. (<bold>d</bold>) Percentage of all targeted <italic>UNC13A</italic> long reads in SH-SY5Y cells containing either neither CE nor IR, both, or either CE or IR. Most reads in both control and TDP-43 KD contain neither event, and while IR event is present in controls, CE is only detected in TDP-43 KD. (<bold>e</bold>) Representative trace in TDP-43 KD of <italic>UNC13A</italic> targeted long reads showing transcript containing either the CE or IR, and transcripts with neither.</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig6_ESM" id="d32e4827"/></fig>
</p>
          <p id="Par91">
<fig id="Fig7"><label>Extended Data Fig. 3</label><caption><title>Reduction of <italic>UNC13A</italic> and <italic>UNC13B</italic> after TDP-43 knockdown correlates with TDP-43 levels and is caused by nonsense-mediated decay.</title><p>Relative gene expression levels for <italic>UNC13A</italic> (<bold>a</bold>) and <italic>UNC13B</italic> (<bold>b</bold>) after TDP-43 knockdown across neuronal cell lines<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. Normalized RNA counts are shown as relative to control mean. Numbers show log fold change calculated by DESeq2. Significance shown as adjusted p-values from DESeq2. Number of replicates as in Extended data Fig. <xref rid="Fig5" ref-type="fig">1 H-L</xref> (<bold>c, d</bold>) RT-qPCR analysis shows <italic>TDP-43, UNC13A</italic> and <italic>UNC13B</italic> gene expression is reduced by <italic>TARDBP</italic> shRNA knockdown in both SH-SY5Y and SK-N-DZ human cell lines. Graphs represent the means&#x2009;&#xB1;&#x2009;SEM, n&#x2009;=&#x2009;6 biological replicates, one sample t-test. (<bold>e</bold>) The 5&#x2019; ends of 29 nt reads relative to the annotated start codon from a representative ribosome profiling dataset (TDP-43 KD replicate B). As expected, we detected strong three-nucleotide periodicity, and a strong enrichment of reads across the annotated coding sequence relative to the upstream untranslated region. (<bold>f</bold>) UNC13A, UNC13B, and TDP-43 protein levels, measured by Western Blot, with varying levels of DOX-inducible TDP-43 knockdown in SH-SY5Y cells. Tubulin is used as endogenous control, n&#x2009;=&#x2009;3. For gel source data, see Supplementary Figure 1. (<bold>g</bold>) Quantification of RT-PCR products from the transcripts containing <italic>UNC13A</italic> CE, <italic>UNC13A</italic> intron retention, <italic>UNC13B</italic> fsE, and <italic>UNC13B</italic> intron retention, with varying levels of DOX-inducible TDP-43 knockdown in SH-SY5Y cells. Graphs represent the means&#x2009;&#xB1;&#x2009;SEM n&#x2009;=&#x2009;3 biological replicates. (<bold>h</bold>) UPF1 siRNA knock-down led to the rescue of <italic>hnRNPL</italic> (positive control), <italic>UNC13A</italic>, and <italic>UNC13B</italic> transcripts, but not <italic>STMN2</italic>. Graphs represent the means&#x2009;&#xB1;&#x2009;SEM, n&#x2009;=&#x2009;4 biological replicates, one-sample t-test. (<bold>l</bold>) <italic>UNC13A</italic> CE containing-transcript PSI is increased after UPF1 knockdown in i<sup>3</sup>Neurons. Graphs represent the means&#x2009;&#xB1;&#x2009;SEM, n&#x2009;=&#x2009;6 biological replicates. (<bold>j</bold>) RT-PCR products from <italic>UNC13A</italic> in the setting of mild TDP-43 knockdown (&#x201C;+&#x201D;, as for Figure <xref rid="Fig2" ref-type="fig">2C</xref> and S4G) with the addition of either DMSO (control) or CHX (NMD inhibition). (<bold>k</bold>) Quantification of (<bold>j</bold>) Graphs represent the means&#x2009;&#xB1;&#x2009;SEM, n&#x2009;=&#x2009;4 biological replicates. Significance levels reported as * (p&#x2009;&lt;&#x2009;0.05) ** (p&#x2009;&lt;&#x2009;0.01) *** (p&#x2009;&lt;&#x2009;0.001) **** (p&#x2009;&lt;&#x2009;0.0001).</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig7_ESM" id="d32e4946"/></fig>
</p>
          <p id="Par92">
<fig id="Fig8"><label>Extended Data Fig. 4</label><caption><title>Sample technical factors in NYGC tissue samples do not vary in a systematic way.</title><p>(<bold>a</bold>) <italic>UNC13A</italic> expression across tissues and disease subtypes in the NYGC ALS Consortium RNA-seq dataset. Expression normalised as transcripts per million (TPM). Cortical regions have noticeably higher <italic>UNC13A</italic> expression than the spinal cord. (<bold>b</bold>) total RNA-seq library size (log10 scaled) (<bold>c</bold>) RNA integrity score (RIN) (<bold>d</bold>) Cell type decomposition across NYGC ALS Consortium RNA-seq dataset. While there are differences between tissues and disease-subtypes on these technical factors, specificity of <italic>UNC13A</italic> CE detection to tissues presumed to contain TDP-43 proteinopathy cannot be explained by these technical factors. Box plots (<bold>a&#x2013;d</bold>): boundaries 25&#x2013;75th percentiles; midline, median; whiskers, Tukey style. Wilcoxon test, significance levels reported as * (p&#x2009;&lt;&#x2009;0.05) ** (p&#x2009;&lt;&#x2009;0.01) *** (p&#x2009;&lt;&#x2009;0.001) **** (p&#x2009;&lt;&#x2009;0.0001).</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig8_ESM" id="d32e4985"/></fig>
</p>
          <p id="Par93">
<fig id="Fig9"><label>Extended Data Fig. 5</label><caption><title>Differences in sample technical factors where <italic>UNC13A</italic> CE was detected and undetected vary between cortical and spinal tissues.</title><p>Targeted long reads in FTLD frontal cortex show that <italic>UNC13A</italic> CE and IR occur independently in-vivo. (<bold>a</bold>) Detection rate of <italic>UNC13A</italic> CE across tissues by RNA sequencing platform and read length. <italic>UNC13A</italic> CE was more likely to be detected in cervical spinal cord and motor cortex when sequenced on machines with 125 bp compared to 100 bp. (b) No significant differences in total RNA-seq library size (log10 scaled). (c) RNA integrity score (RIN) was significantly lower in motor and temporal cortices in samples where <italic>UNC13A</italic> was detected. (d) Cell type decomposition revealed that samples with <italic>UNC13A</italic> CE detected had a higher proportion of neurons in cervical and lumbar spinal cord, whereas in frontal, temporal, and motor cortex samples with <italic>UNC13A</italic> CE detected had a lower proportion of neurons, and in motor and temporal cortex samples with <italic>UNC13A</italic> CE detected had a higher proportion of astrocytes. Astrocy. - Astrocytes, Endothi. - Endothelial, Microgl. - Microglia. Neur. - Neurons, Oligiodendr. - Oligiodendrycytes. P-values shown are from Fisher&#x2019;s exact test (<bold>a</bold>) or Wilcoxon test (<bold>b&#x2013;d</bold>). N tissue samples show below in brackets. Box plots (<bold>a&#x2013;d</bold>): boundaries 25-75th percentiles; midline, median; whiskers, Tukey style. (<bold>e</bold>) Percentage of targeted <italic>UNC13A</italic> long reads with TDP-43 regulated splice events that contain either both, CE, or IR in four in FTLD frontal cortices. (<bold>f</bold>) Percentage of all targeted <italic>UNC13A</italic> long reads in (<bold>a</bold>) containing neither CE nor IR, both, or either CE or IR.</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig9_ESM" id="d32e5062"/></fig>
</p>
          <p id="Par94">
<fig id="Fig10"><label>Extended Data Fig. 6</label><caption><title>Expression of shorter <italic>UNC13B</italic> isoform in human neuronal tissue masks detection of <italic>UNC13B</italic> fsE across NYGC tissue samples.</title><p>(<bold>a</bold>) Expression of splice junction reads supporting the <italic>UNC13B</italic> fsE across tissues and disease subtypes. Junction counts are normalised by library size in millions (junctions per million). Expression of UNC13B fsE is present across controls and ALS/FTLD-non-TDP tissues. Wilcoxon test, significance levels reported as * (p&#x2009;&lt;&#x2009;0.05) ** (p&#x2009;&lt;&#x2009;0.01) *** (p&#x2009;&lt;&#x2009;0.001) **** (p&#x2009;&lt;&#x2009;0.0001). (<bold>b</bold>) Diagram showing three of the <italic>UNC13B</italic> transcripts, including the APPRIS<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> principal isoform <italic>UNC13B-207</italic> (blue), the NMD sensitive isoform <italic>UNC13B-208</italic> (green), and the shorter isoform <italic>UNC13B-210</italic> which shares the fsE (light green highlight) and one of the splicing junctions supporting the fsE as <italic>UNC13B-208</italic>. (<bold>c</bold>) Expression of three <italic>UNC13B</italic> isoforms across NYGC cohort and in the five in vitro TDP-43 knockdowns experiments<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. <italic>UNC13B-210</italic> is expressed across in vivo human tissues, whereas there is almost no expression of <italic>UNC13B-210</italic> in any of the in vitro experiments. Box plots (<bold>a, c</bold>): boundaries 25&#x2013;75th percentiles; midline, median; whiskers, Tukey style.</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig10_ESM" id="d32e5134"/></fig>
</p>
          <p id="Par95">
<fig id="Fig11"><label>Extended Data Fig. 7</label><caption><title>TDP-43 regulated <italic>UNC13A</italic> and <italic>UNC13B</italic> introns are expressed across human neuronal tissues in NYGC tissue samples.</title><p><italic>STMN2</italic> CE PSI correlates with TDP-43 regulated cryptics across NYGC RNA-seq dataset. IRratio<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> in <italic>UNC13A</italic> exon 31&#x2212;32 (<bold>a</bold>) and <italic>UNC13B</italic> exon 21&#x2212;22 (<bold>b</bold>) across NYGC tissue samples. <italic>UNC13A</italic> IR was lower in ALS-TDP cases than in controls in cervical spinal, frontal and motor cortices, and higher in FTLD-TDP cases than controls in frontal and temporal cortices. Possibly this reflects differences in the effects of cell type composition in disease state. Box plots (<bold>a, b</bold>): boundaries 25&#x2013;75th percentiles; midline, median; whiskers, Tukey style..Wilcoxon test, significance levels reported as * (p&#x2009;&lt;&#x2009;0.05) ** (p&#x2009;&lt;&#x2009;0.01) *** (p&#x2009;&lt;&#x2009;0.001) **** (p&#x2009;&lt;&#x2009;0.0001). (<bold>c&#x2013;e</bold>) Correlation in ALS/FTLD-TDP cortex between <italic>RAP1GAP</italic> CE (<bold>c</bold>), <italic>PFKP</italic> CE (<bold>d</bold>), and <italic>UNC13A</italic> CE (<bold>e</bold>) with <italic>STMN2</italic> CE PSI in patients with at least 30 spliced reads across the CE locus. Spearman&#x2019;s correlation.</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig11_ESM" id="d32e5204"/></fig>
</p>
          <p id="Par96">
<fig id="Fig12"><label>Extended Data Fig. 8</label><caption><title><italic>UNC13A</italic> risk alleles increase <italic>UNC13A</italic> CE expression after TDP-43 depletion by altering TDP-43 binding affinity across the UNC13A CE-containing intron.</title><p>(<bold>a</bold>) <italic>UNC13A</italic> CE PSI by genotype (Wilcoxon test) Box plots: boundaries 25-75th percentiles; midline, median; whiskers, Tukey style. (<bold>b</bold>) Effect of CE or intronic SNP on the correlation between STMN2 and UNC13A CE PSI in ALS/FTD cortex in samples with at least 30 junction reads across the CE locus. Spearman&#x2019;s correlation. (<bold>c</bold>) Raw tapestation gel images of <italic>UNC13A</italic> CE products in 2H and 2R minigines and quantification of the PCR products. Graphs represent the means&#x2009;&#xB1;&#x2009;SEM(n&#x2009;=&#x2009;3 biological replicates); Two-way ANOVA (<bold>d</bold>) Raw tapestation gel images corresponding to Fig. <xref rid="Fig4" ref-type="fig">4e</xref>. Two sets of primers were used to amplify either control (top row) or mutant minigene (bottom row). Left panel: single transfections were performed to ensure primer specificity. Right panel: three biological replicates of the double transfections. (<bold>e</bold>) Fractional changes at iCLIP peaks for 2R versus 2H minigene (mean and 75% confidence interval shown). Peaks that are within 50nt of each SNP are highlighted. (f) Mean crosslink density around the exonic (top) and intronic (bottom) SNPs in the 2H (red) and 2R (blue) minigenes, relative to the 5&#x2019; end of minigene (error bars&#x2009;=&#x2009;standard deviation; dashed lines show SNP positions). (<bold>g, h</bold>) Individual TDP-43 E-scores for the CE (<bold>g</bold>) and intronic (<bold>h</bold>) heptamers for which there was data<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> (<bold>i</bold>) Average change in E-value (measure of binding enrichment) across proteins for heptamers containing risk/healthy intronic SNP allele; TDP-43 is indicated in red. Significance levels reported as * (p&#x2009;&lt;&#x2009;0.05) ** (p&#x2009;&lt;&#x2009;0.01) *** (p&#x2009;&lt;&#x2009;0.001) **** (p&#x2009;&lt;&#x2009;0.0001).</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig12_ESM" id="d32e5265"/></fig>
</p>
          <p id="Par97">
<fig id="Fig13"><label>Extended Data Fig. 9</label><caption><title>Binding of TDP-43 to SNP-containing intronic RNA.</title><p>(<bold>a&#x2013;d</bold>) ITC measurement of the interaction of TDP-43 with 14-nt RNA containing the CE SNP (<bold>a, b</bold>) and intronic SNP (<bold>c, d</bold>) healthy sequence. A representative data set is reported, with raw data (<bold>a, c</bold>) and integrated heat plot (<bold>b, d</bold>). Circles indicate the integrated heat; the curve represents the best fit. (<bold>e</bold>) Raw Tapestation gel images corresponding to Fig. <xref rid="Fig4" ref-type="fig">4j</xref>. For each experiment, two RT-PCRs were performed with a different primer set which either amplified a control minigene (top row; minigene 2H) or a mutant minigene (bottom row). Left: single transfections to ensure specificity of primers for either the control or the mutant minigene. Right: Three replicates of double transfections with control minigene 2H and either mutant minigene.</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig13_ESM" id="d32e5301"/></fig>
</p>
          <p id="Par98">
<fig id="Fig14"><label>Extended Data Fig. 10</label><caption><title>One of the splice junctions for UNC13A CE overlaps with an unannotated exon expressed in control cerebellum.</title><p>(<bold>a</bold>) Expression of splice junction reads supporting the <italic>UNC13A</italic> CE across tissues and disease subtypes. Junction counts are normalised by library size in millions (junctions per million). The long novel acceptor junction is expressed across all disease subtypes in the cerebellum. Box plots: boundaries 25&#x2013;75th percentiles; midline, median; whiskers, Tukey style. (<bold>b</bold>) Example RNA-seq traces from IGV showing <italic>UNC13A</italic> cerebellar exon which shares the long novel acceptor junction as the <italic>UNC13A</italic> CE.</p></caption><graphic position="anchor" xlink:href="41586_2022_4436_Fig14_ESM" id="d32e5330"/></fig>
</p>
        </sec>
        <sec id="Sec40">
          <title>Source data</title>
          <p id="Par100">
<media position="anchor" xlink:href="41586_2022_4436_MOESM15_ESM.xlsx" id="MOESM15"><caption><p>Source Data Fig. 1</p></caption></media>
<media position="anchor" xlink:href="41586_2022_4436_MOESM16_ESM.xlsx" id="MOESM16"><caption><p>Source Data Fig. 2</p></caption></media>
<media position="anchor" xlink:href="41586_2022_4436_MOESM17_ESM.xlsx" id="MOESM17"><caption><p>Source Data Fig. 3</p></caption></media>
<media position="anchor" xlink:href="41586_2022_4436_MOESM18_ESM.xlsx" id="MOESM18"><caption><p>Source Data Fig. 4</p></caption></media>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Anna-Leigh Brown, Oscar G. Wilkins, Matthew J. Keuss, Sarah E. Hill</p>
      </fn>
      <fn>
        <p>A list of authors and their affiliations appears online</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-04436-3.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-04436-3.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank F. Allain for the His-tagged TDP-43 plasmid; C. Stuani, F. Weissmann, M. Watson and K. Stott for guidance on TDP-43 purification and ITC; A. Isaacs and P. Whiting for support with shRNA&#xA0;experiments;&#xA0;N. Seyfried for input on proteomic experiments; and J. Vargas for his scientific insights and engaging conversations. This work was supported by grants from UK Medical Research Council MR/R005184/1 (E.M.C.F. and P.F.), FC001002 (J.U.); NIH U54NS123743 (P.F.); UK Motor Neurone Disease Association (P.F.); Rosetrees Trust (P.F. and A.G.); Chan Zuckerberg Initiative (M.E.W.); The Robert Packard Center for ALS Research (M.E.W., P.F. and E.M.C.F.); AriSLA (E.B.); Alzheimers Society (A.G.); NIH T32 GM136577 (S.S.); NIH National Institute of Aging R56-AG055824 and U01-AG068880 (J.H. and T.R.) European Union&#x2019;s Horizon 2020 research and innovation programme 835300 (J.U.); Cancer Research UK FC001002 (J.U.); Wellcome Trust FC001002 (J.U.); Collaborative Center for X-linked Dystonia-Parkinsonism (W.C.L. and E.M.C.F.). P.F. is supported by a UK Medical Research Council Senior Clinical Fellowship and Lady Edith Wolfson Fellowship (MR/M008606/1 and MR/S006508/1), the UCLH NIHR Biomedical Research Centre; M.E.W. and S.E.H. are supported by the NIH Intramural Research Program of the National Institutes of Neurological Disorders and Stroke; O.G.W. is supported by a Wellcome Trust Studentship; M.Z. is supported by the Neurological Research&#xA0;Trust;&#xA0;S.C. is supported by NIH Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; A.B. is supported by Eisai and the Wolfson Foundation; S.E.H. is supported by a Brightfocus Foundation postdoctoral research fellowship; T.L. is supported by an Alzheimer&#x2019;s Research UK senior fellowship; G.S. is supported by a Wellcome Trust Investigator Award (107116/Z/15/Z) and UK Dementia Research Institute Foundation award (UKDRI-1005); M.S. is supported by a UKRI Future Leaders Fellowship (MR/T042184/1); S.B.-S. is supported by a UK Motor Neurone Disease Association and Masonic Charitable Foundation PhD Studentship (893-792); M.H. is supported by a Lady Edith Wolfson Senior Non-Clinical Fellowship (959-799); S.S. is supported by the NIH Oxford&#x2013;Cambridge Scholars Program.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>Conceptualization: A.-L.B., O.G.W., M.J.K., S.E.H., J.H., M.E.W. and P.F. Data curation: A.-L.B., O.G.W., M.Z., W.C.L. and S.B.-S. Formal analysis: A.-L.B., O.G.W., M.J.K., M.Z., W.C.L., S.B.-S., A.B., M.H., E.K.G., S.S., J.F.R., S.L.C. and D.R. Funding acquisition: P.F., M.E.W. and E.B. Investigation: A.-L.B., O.G.W., M.J.K., S.E.H., M.Z., W.C.L., F.C.Y.L., L.M., Y.A.Q., S.B.-S., A.B., A.G., M.H., E.K.G., S.S., J.F.R., S.L.C., D.R., E.K.G. and S.L.C. Methodology: A.-L.B., O.G.W., M.J.K., S.E.H., J.H., M.E.W. and P.F. Project administration: P.F. and M.E.W. Resources: H.P., T.L., E.B., D.F. and J.N. Software: A.-L.B., O.G.W., M.Z., S.B.-S., J.H. and M.J.K. Supervision: P.F., M.E.W., J.H., J.U., M.S., T.R., T.L., E.M.C.F., G.S. and T.F. Visualization: A.-L.B., O.G.W., M.J.K., W.C.L. and S.E.H. Writing, original draft: A.-L.B., O.G.W., M.J.K., M.E.W. and P.F. Writing, review and editing: S.E.H., W.C.L., E.B., J.U., J.H., M.E.W., P.F. A.-L.B., O.G.W. M.J.K. and S.E.H. contributed equally; therefore each may place their name first in author order when referencing this manuscript in personal communications.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="FPar1">
        <title>Peer review information</title>
        <p id="Par87"><italic>Nature</italic> thanks Noa Lipstein, Magdalini Polymenidou and the other, anonymous, reviewers for their contribution to the peer review of this work. Peer review reports are available.</p>
      </sec>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>A minimum dataset to reproduce analyses is freely available at<ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/unc13a_cryptic_splicing/tree/main/data">https://github.com/frattalab/unc13a_cryptic_splicing/tree/main/data</ext-link>. RNA-seq data for i3Neurons, SH-SY5Y and SK-N-DZ<sup>a</sup> are available through the European Nucleotide Archive (ENA) under accession <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB42763">PRJEB42763</ext-link>. NYGC ALS Consortium RNA-seq<italic>:</italic> RNA-seq data generated through the NYGC ALS Consortium in this study can be accessed via the NCBI GEO database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137810">GSE137810</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE124439">GSE124439</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116622">GSE116622</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153960">GSE153960</ext-link>). To request immediate access to new data generated by the NYGC ALS Consortium and for samples provided through the Target ALS Postmortem Core, complete a genetic data request form at CGND_help@nygenome.org. NYGC ALS Consortium genotypes for the common SNPs in this study <italic>rs129731921</italic> and <italic>rs12608932</italic> are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/unc13a_cryptic_splicing/blob/main/data/nygc_junction_information.csv">https://github.com/frattalab/unc13a_cryptic_splicing/blob/main/data/nygc_junction_information.csv</ext-link>.&#xA0;<xref rid="Sec40" ref-type="sec">Source data</xref> are provided with this paper.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>Analysis code and data to reproduce figures are freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/unc13a_cryptic_splicing/">https://github.com/frattalab/unc13a_cryptic_splicing/</ext-link>. The tool for demultiplexing iCLIP reads is freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/ulelab/ultraplex">https://github.com/ulelab/ultraplex</ext-link>. Snakemake pipelines to perform RNA-seq alignment, splicing and parsing splice junction files are freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/rna_seq_snakemake/">https://github.com/frattalab/rna_seq_snakemake/</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/splicing/">https://github.com/frattalab/splicing/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/bedops_parse_star_junctions/">https://github.com/frattalab/bedops_parse_star_junctions/</ext-link>. The Snakemake pipeline for analysing publicly available iCLIP is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/frattalab/pipeline_iclip">https://github.com/frattalab/pipeline_iclip</ext-link>.</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par88">A patent application related to this work has been filed. The technology described in this work has been protected in the patent PCT/EP2021/084908 and UK patent 2117758.9 (patent applicant, UCL Business Ltd and NIH; status pending), in which A.-L.B., O.G.W., M.J.K., S.E.H., M.E.W. and P.F. are named as inventors. The other authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Es</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide association study identifies 19p13.3 (<italic>UNC13A</italic>) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis</article-title>
          <source>Nat. Genet.</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>1083</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="pmid">19734901</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pottier</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD</article-title>
          <source>Acta Neuropathol.</source>
          <year>2019</year>
          <volume>137</volume>
          <fpage>879</fpage>
          <lpage>899</lpage>
          <pub-id pub-id-type="pmid">30739198</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diekstra</surname>
              <given-names>FP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>C9orf72 and <italic>UNC13A</italic> are shared risk loci for ALS and FTD: a genome-wide meta-analysis</article-title>
          <source>Ann. Neurol.</source>
          <year>2014</year>
          <volume>76</volume>
          <fpage>120</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">24931836</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Ke</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Ittner</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Halliday</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>ALS/FTLD: experimental models and reality</article-title>
          <source>Acta Neuropathol.</source>
          <year>2017</year>
          <volume>133</volume>
          <fpage>177</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">28058507</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neumann</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>
          <source>Science</source>
          <year>2006</year>
          <volume>314</volume>
          <fpage>130</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">17023659</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>A-L</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W-W</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>W-J</given-names>
            </name>
          </person-group>
          <article-title>Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum</article-title>
          <source>J. Med. Genet.</source>
          <year>2017</year>
          <volume>54</volume>
          <fpage>145</fpage>
          <lpage>154</lpage>
          <pub-id pub-id-type="pmid">28087719</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ling</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Pletnikova</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Troncoso</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD</article-title>
          <source>Science</source>
          <year>2015</year>
          <volume>349</volume>
          <fpage>650</fpage>
          <lpage>655</lpage>
          <pub-id pub-id-type="pmid">26250685</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melamed</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration</article-title>
          <source>Nat. Neurosci.</source>
          <year>2019</year>
          <volume>22</volume>
          <fpage>180</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">30643298</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klim</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair</article-title>
          <source>Nat. Neurosci.</source>
          <year>2019</year>
          <volume>22</volume>
          <fpage>167</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">30643292</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prudencio</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia</article-title>
          <source>J. Clin. Invest.</source>
          <year>2020</year>
          <volume>130</volume>
          <fpage>6080</fpage>
          <lpage>6092</lpage>
          <pub-id pub-id-type="pmid">32790644</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandopulle</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcription factor&#x2013;mediated differentiation of human iPSCs into neurons</article-title>
          <source>Curr. Protoc. Cell Biol.</source>
          <year>2018</year>
          <volume>79</volume>
          <fpage>e51</fpage>
          <pub-id pub-id-type="pmid">29924488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived Neurons</article-title>
          <source>Neuron</source>
          <year>2019</year>
          <volume>104</volume>
          <fpage>239</fpage>
          <lpage>255.e12</lpage>
          <pub-id pub-id-type="pmid">31422865</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Scalable production of iPSC-derived human neurons to identify Tau-lowering compounds by high-content screening</article-title>
          <source>Stem Cell Rep.</source>
          <year>2017</year>
          <volume>9</volume>
          <fpage>1221</fpage>
          <lpage>1233</lpage>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Humphrey</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Emmett</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fratta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Isaacs</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Plagnol</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Quantitative analysis of cryptic splicing associated with TDP-43 depletion</article-title>
          <source>BMC Med. Genomics</source>
          <year>2017</year>
          <volume>10</volume>
          <fpage>38</fpage>
          <pub-id pub-id-type="pmid">28549443</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolas</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide analyses identify <italic>KIF5A</italic> as a novel ALS gene</article-title>
          <source>Neuron</source>
          <year>2018</year>
          <volume>97</volume>
          <fpage>1268</fpage>
          <lpage>1283.e6</lpage>
          <pub-id pub-id-type="pmid">29566793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels</article-title>
          <source>Nat. Genet.</source>
          <year>2019</year>
          <volume>51</volume>
          <fpage>1560</fpage>
          <lpage>1565</lpage>
          <pub-id pub-id-type="pmid">31676867</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diekstra</surname>
              <given-names>FP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>UNC13A is a modifier of survival in amyotrophic lateral sclerosis</article-title>
          <source>Neurobiol. Aging</source>
          <year>2012</year>
          <volume>33</volume>
          <fpage>630.e3-8</fpage>
          <pub-id pub-id-type="pmid">22118904</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Placek</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>UNC13A</italic> polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis</article-title>
          <source>Neurobiol. Aging</source>
          <year>2019</year>
          <volume>73</volume>
          <fpage>190</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">30368160</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>UNC13A</italic> variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis</article-title>
          <source>Neurol. Sci.</source>
          <year>2019</year>
          <volume>40</volume>
          <fpage>2293</fpage>
          <lpage>2302</lpage>
          <pub-id pub-id-type="pmid">31201598</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karczewski</surname>
              <given-names>KJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>581</volume>
          <fpage>434</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">32461654</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Appocher</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Major hnRNP proteins act as general TDP-43 functional modifiers both in <italic>Drosophila</italic> and human neuronal cells</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2017</year>
          <volume>45</volume>
          <fpage>8026</fpage>
          <lpage>8045</lpage>
          <pub-id pub-id-type="pmid">28575377</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tollervey</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterising the RNA targets and position-dependent splicing regulation by TDP-43; implications for neurodegenerative diseases</article-title>
          <source>Nat. Neurosci.</source>
          <year>2011</year>
          <volume>14</volume>
          <fpage>452</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">21358640</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>EY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons</article-title>
          <source>Cell Rep.</source>
          <year>2019</year>
          <volume>27</volume>
          <fpage>1409</fpage>
          <lpage>1421.e6</lpage>
          <pub-id pub-id-type="pmid">31042469</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zetoune</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues</article-title>
          <source>BMC Genet.</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>83</fpage>
          <pub-id pub-id-type="pmid">19061508</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Couratier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Corcia</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lautrette</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nicol</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marin</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>ALS and frontotemporal dementia belong to a common disease spectrum</article-title>
          <source>Rev. Neurol.</source>
          <year>2017</year>
          <volume>173</volume>
          <fpage>273</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="pmid">28449882</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">Ma, X. R. et al. TDP-43 represses cryptic exon inclusion in the FTD&#x2013;ALS gene <italic>UNC13A</italic>. <italic>Nature</italic>10.1038/s41586-022-04424-7 (2022).</mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ray</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A compendium of RNA-binding motifs for decoding gene regulation</article-title>
          <source>Nature</source>
          <year>2013</year>
          <volume>499</volume>
          <fpage>172</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">23846655</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corder</surname>
              <given-names>EH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&#x2019;s disease in late onset families</article-title>
          <source>Science</source>
          <year>1993</year>
          <volume>261</volume>
          <fpage>921</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="pmid">8346443</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dittman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Unc13: a multifunctional synaptic marvel</article-title>
          <source>Curr. Opin. Neurobiol.</source>
          <year>2019</year>
          <volume>57</volume>
          <fpage>17</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">30690332</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Augustin</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rosenmund</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>S&#xFC;dhof</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Brose</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles</article-title>
          <source>Nature</source>
          <year>1999</year>
          <volume>400</volume>
          <fpage>457</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="pmid">10440375</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varoqueaux</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>9037</fpage>
          <lpage>9042</lpage>
          <pub-id pub-id-type="pmid">12070347</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varoqueaux</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sons</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Plomp</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Brose</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse</article-title>
          <source>Mol. Cell. Biol.</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>5973</fpage>
          <lpage>5984</lpage>
          <pub-id pub-id-type="pmid">15988013</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaquero-Garcia</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>
          <source>eLife</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>e11752</fpage>
          <pub-id pub-id-type="pmid">26829591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorvaldsd&#xF3;ttir</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Mesirov</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration</article-title>
          <source>Brief. Bioinform.</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>178</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">22517427</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>APPRIS 2017: principal isoforms for multiple gene sets</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2018</year>
          <volume>46</volume>
          <fpage>D213</fpage>
          <lpage>D217</lpage>
          <pub-id pub-id-type="pmid">29069475</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Middleton</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IRFinder: assessing the impact of intron retention on mammalian gene expression</article-title>
          <source>Genome Biol.</source>
          <year>2017</year>
          <volume>18</volume>
          <fpage>51</fpage>
          <pub-id pub-id-type="pmid">28298237</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilbert</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-scale CRISPR-mediated control of gene repression and activation</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>647</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="pmid">25307932</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="other">Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. <italic>Bioinformatics</italic><bold>29</bold>, 15&#x2013;21 (2013).</mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frankish</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GENCODE reference annotation for the human and mouse genomes</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2019</year>
          <volume>47</volume>
          <fpage>D766</fpage>
          <lpage>D773</lpage>
          <pub-id pub-id-type="pmid">30357393</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>
          <source>Bioinformatics</source>
          <year>2014</year>
          <volume>30</volume>
          <fpage>923</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">24227677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Love</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Anders</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
          <source>Genome Biol.</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>550</fpage>
          <pub-id pub-id-type="pmid">25516281</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patro</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Duggal</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Love</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Irizarry</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Kingsford</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title>
          <source>Nat. Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>417</fpage>
          <lpage>419</lpage>
          <pub-id pub-id-type="pmid">28263959</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M&#xF6;lder</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sustainable data analysis with Snakemake</article-title>
          <source>F1000Research</source>
          <year>2021</year>
          <volume>10</volume>
          <fpage>33</fpage>
          <pub-id pub-id-type="pmid">34035898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quinlan</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>841</fpage>
          <lpage>842</lpage>
          <pub-id pub-id-type="pmid">20110278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Livak</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Schmittgen</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x2212;&#x394;&#x394;<italic>C</italic>T</sup> method</article-title>
          <source>Methods</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>402</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="pmid">11846609</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereverzev</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Method for quantitative analysis of nonsense-mediated mRNA decay at the single cell level</article-title>
          <source>Sci. Rep.</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>7729</fpage>
          <pub-id pub-id-type="pmid">25578556</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Humphrey</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2020</year>
          <volume>48</volume>
          <fpage>6889</fpage>
          <lpage>6905</lpage>
          <pub-id pub-id-type="pmid">32479602</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Minimap2: pairwise alignment for nucleotide sequences</article-title>
          <source>Bioinformatics</source>
          <year>2018</year>
          <volume>34</volume>
          <fpage>3094</fpage>
          <lpage>3100</lpage>
          <pub-id pub-id-type="pmid">29750242</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGlincy</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Ingolia</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>Transcriptome-wide measurement of translation by ribosome profiling</article-title>
          <source>Methods</source>
          <year>2017</year>
          <volume>126</volume>
          <fpage>112</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">28579404</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <mixed-citation publication-type="other">Lee, F. C. Y. et al. An improved iCLIP protocol. Preprint at 10.1101/2021.08.27.457890 (2021).</mixed-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilkins</surname>
              <given-names>OG</given-names>
            </name>
            <name>
              <surname>Capitanchik</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Luscombe</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Ule</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ultraplex: A rapid, flexible, all-in-one fastq demultiplexer</article-title>
          <source>Wellcome Open Res.</source>
          <year>2021</year>
          <volume>6</volume>
          <fpage>141</fpage>
          <pub-id pub-id-type="pmid">34286104</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langmead</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Fast gapped-read alignment with Bowtie 2</article-title>
          <source>Nat. Methods</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>357</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="pmid">22388286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Heger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sudbery</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy</article-title>
          <source>Genome Res.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>491</fpage>
          <lpage>499</lpage>
          <pub-id pub-id-type="pmid">28100584</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buniello</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2019</year>
          <volume>47</volume>
          <fpage>D1005</fpage>
          <lpage>D1012</lpage>
          <pub-id pub-id-type="pmid">30445434</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pruim</surname>
              <given-names>RJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>LocusZoom: regional visualization of genome-wide association scan results</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>2336</fpage>
          <lpage>2337</lpage>
          <pub-id pub-id-type="pmid">20634204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>1000 Genomes Project Consortium</collab>
          </person-group>
          <article-title>A global reference for human genetic variation</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>526</volume>
          <fpage>68</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">26432245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tam</surname>
              <given-names>OH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia</article-title>
          <source>Cell Rep.</source>
          <year>2019</year>
          <volume>29</volume>
          <fpage>1164</fpage>
          <lpage>1177.e5</lpage>
          <pub-id pub-id-type="pmid">31665631</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <mixed-citation publication-type="other">Picard toolkit. Broad Institute, GitHub Repository <ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/">https://broadinstitute.github.io/picard/</ext-link> (Broad Institute, 2019).</mixed-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="other">Cotto, K. C. et al. RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splicing variants in cancer. Preprint at 10.1101/436634 (2021)</mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>YI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Annotation-free quantification of RNA splicing using LeafCutter</article-title>
          <source>Nat. Genet.</source>
          <year>2018</year>
          <volume>50</volume>
          <fpage>151</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">29229983</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darmanis</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A survey of human brain transcriptome diversity at the single cell level</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2015</year>
          <volume>112</volume>
          <fpage>7285</fpage>
          <lpage>7290</lpage>
          <pub-id pub-id-type="pmid">26060301</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunt</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Freytag</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bahlo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gagnon-Bartsch</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A. dtangle: accurate and robust cell type deconvolution</article-title>
          <source>Bioinformatics</source>
          <year>2019</year>
          <volume>35</volume>
          <fpage>2093</fpage>
          <lpage>2099</lpage>
          <pub-id pub-id-type="pmid">30407492</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <mixed-citation publication-type="other">Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at <ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1303.3997">https://arxiv.org/abs/1303.3997</ext-link> (2013).</mixed-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DePristo</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
          <source>Nat. Genet.</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>491</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="pmid">21478889</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKenna</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
          <source>Genome Res.</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>1297</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="pmid">20644199</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lukavsky</surname>
              <given-names>PJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <year>2013</year>
          <volume>20</volume>
          <fpage>1443</fpage>
          <lpage>1449</lpage>
          <pub-id pub-id-type="pmid">24240615</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0404511</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">7473</journal-id>
      <journal-id journal-id-type="nlm-ta">Science</journal-id>
      <journal-id journal-id-type="iso-abbrev">Science</journal-id>
      <journal-title-group>
        <journal-title>Science (New York, N.Y.)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-8075</issn>
      <issn pub-type="epub">1095-9203</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35357917</article-id>
      <article-id pub-id-type="pmc">8979283</article-id>
      <article-id pub-id-type="doi">10.1126/science.abj6965</article-id>
      <article-id pub-id-type="manuscript">NIHMS1764181</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>SEGMENTAL DUPLICATIONS AND THEIR VARIATION IN A COMPLETE HUMAN GENOME<xref rid="FN3" ref-type="fn">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Vollger</surname>
            <given-names>Mitchell R.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guitart</surname>
            <given-names>Xavi</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dishuck</surname>
            <given-names>Philip C.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mercuri</surname>
            <given-names>Ludovica</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harvey</surname>
            <given-names>William T.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gershman</surname>
            <given-names>Ariel</given-names>
          </name>
          <xref rid="A3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Diekhans</surname>
            <given-names>Mark</given-names>
          </name>
          <xref rid="A4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sulovari</surname>
            <given-names>Arvis</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Munson</surname>
            <given-names>Katherine M.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lewis</surname>
            <given-names>Alexandra P.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hoekzema</surname>
            <given-names>Kendra</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porubsky</surname>
            <given-names>David</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Ruiyang</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nurk</surname>
            <given-names>Sergey</given-names>
          </name>
          <xref rid="A5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koren</surname>
            <given-names>Sergey</given-names>
          </name>
          <xref rid="A5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miga</surname>
            <given-names>Karen H.</given-names>
          </name>
          <xref rid="A4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phillippy</surname>
            <given-names>Adam M.</given-names>
          </name>
          <xref rid="A5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Timp</surname>
            <given-names>Winston</given-names>
          </name>
          <xref rid="A3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ventura</surname>
            <given-names>Mario</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eichler</surname>
            <given-names>Evan E.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="A6" ref-type="aff">6</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</aff>
      <aff id="A2"><label>2</label>Department of Biology, University of Bari, Aldo Moro, Bari 70125, Italy</aff>
      <aff id="A3"><label>3</label>Department of Molecular Biology and Genetics, Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA</aff>
      <aff id="A4"><label>4</label>UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, CA, USA</aff>
      <aff id="A5"><label>5</label>Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</aff>
      <aff id="A6"><label>6</label>Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P1"><bold>Author contributions:</bold> Identification of SDs in T2T-CHM13 and analysis: M.R.V.; PacBio genome sequence generation: K.M.M., A.P.L., K.H.; FISH experiments and analysis: L.M., M.V., M.R.V., E.E.E.; Iso-Seq analysis: P.C.D., M.R.V., R.L.; <italic toggle="yes">TBC1D3</italic> analysis: X.G., M.R.V.; copy number analysis: M.R.V., W.T.H.; inversion analysis: D.P., M.R.V.; T2T-CHM13 assembly generation: S.N., S.K., A.M.P.; refinement of SD annotations near centromeres: K.H.M., M.R.V.; UCSC browser: M.D., W.T.H., M.R.V.; methylation analysis: M.R.V., A.G., W.T., E.E.E.; analysis of regions with genomic instability: M.R.V., A.S.; organization of tables: M.R.V., P.C.D., X.G.; organization of <xref rid="SD1" ref-type="supplementary-material">supplementary material</xref>: M.R.V.; display items: M.R.V., X.G., P.C.D.; manuscript writing: M.R.V., E.E.E., and X.G. with input from all authors.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>22</day>
        <month>12</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>10</month>
        <year>2022</year>
      </pub-date>
      <volume>376</volume>
      <issue>6588</issue>
      <fpage>eabj6965</fpage>
      <lpage>eabj6965</lpage>
      <abstract id="ABS1">
        <p id="P2">Despite their importance in disease and evolution, highly identical segmental duplications (SDs) are among the last regions of the human reference genome (GRCh38) to be fully sequenced. Using a complete telomere-to-telomere human genome (T2T-CHM13), we present a comprehensive view of human SD organization. SDs account for nearly one-third of the additional sequence increasing the genome-wide estimate from 5.4% to 7.0% (218 Mbp). An analysis of 268 human genomes shows that 91% of the previously unresolved T2T-CHM13 SD sequence (68.3 Mbp) better represents human copy number variation. Comparing long-read assemblies from human (n=12) and nonhuman primate (n=5) genomes, we systematically reconstruct the evolution and structural haplotype diversity of biomedically relevant and duplicated genes. This analysis reveals patterns of structural heterozygosity and evolutionary differences in SD organization between humans and other primates.</p>
      </abstract>
      <abstract id="ABS2" abstract-type="summary">
        <title>STRUCTURED ABSTRACT</title>
        <sec id="S1">
          <title>Introduction:</title>
          <p id="P3">Large high-identity duplicated sequences, termed segmental duplications (SDs), are frequently the last regions of genomes to be sequenced and assembled. While the human reference genome provided a road map of the SD landscape, more than 50% of the remaining gaps correspond to regions of complex SDs.</p>
        </sec>
        <sec id="S2">
          <title>Rationale:</title>
          <p id="P4">SDs are major sources of evolutionary gene innovations and contribute disproportionately to genetic variation within and between ape species. A complete human genome (T2T-CHM13) has the potential to identify genes and uncover patterns of human genetic variation.</p>
        </sec>
        <sec id="S3">
          <title>Results:</title>
          <p id="P5">We identified 51 Mbp of additional human SD in T2T-CHM13 and now estimate that 7% of the human genome consists of SDs (218 Mbp of 3.1 Gbp). SDs make up two-thirds (45.0/68.1 Mbp) of acrocentric short arms and are the largest SDs in the human genome (<xref rid="F1" ref-type="fig">Fig. 0a</xref>). Additionally, 54% of acrocentric SDs are copy number variable or map to different chromosomes among six individuals examined. A detailed comparison between the current reference genome (GRCh38) and T2T-CHM13 for SD content identifies 81 Mbp of previously unresolved or structurally variable SDs. Short-read whole-genome sequence data from a diversity panel of 268 humans shows that human copy number is nine times (59.26/6.55 Mbp) more likely to match T2T-CHM13 rather than GRCh38, including 119 protein-coding genes (<xref rid="F1" ref-type="fig">Fig. 0b</xref>). Using long-read-sequencing data from 25 human haplotypes, we investigated patterns of human genetic variation identifying significant increases in structural and single-nucleotide diversity. We identified gene-rich regions (e.g., <italic toggle="yes">TBC1D3</italic>) that vary by hundreds of kilobase pairs and gene copy number between individuals showing some of the highest genome-wide structural heterozygosity (85&#x2013;90%). Our analysis identified 182 candidate protein-encoding genes as well as the complete sequence for structurally variable gene models that were previously unresolved. Among these is the complete gene structure of lipoprotein A (<italic toggle="yes">LPA</italic>) including the expanded Kringle IV repeat domain. Reduced copies of this domain are among the strongest genetic associations with cardiovascular disease, especially among African Americans, and sequencing of multiple human haplotypes not only identified copy number variation but also other forms of rare coding variation potentially relevant to disease risk. Finally, we compared global methylation and expression patterns between duplicated and unique genes. Transcriptionally inactive duplicate genes are more likely to map to hypomethylated genomic regions; however, specifically over the transcription start site we observe an increase in methylation suggesting that as many as two-thirds of duplicated genes are epigenetically silenced. Additionally, SD genes show a high degree of concordance between methylation profiles and transcription levels allowing us to define the actively transcribed members of high-identity gene families that are otherwise indistinguishable by coding sequence.</p>
        </sec>
        <sec id="S4">
          <title>Conclusion:</title>
          <p id="P6">A complete human genome provides a more comprehensive understanding of the organization, expression, and regulation of duplicated genes. Our analysis reveals underappreciated patterns of human genetic diversity and suggests unique features of methylation and gene regulation. This resource will serve as a critical baseline for improved gene annotation, genotyping, and novel associations for some of the most dynamic regions of our genome.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28538723</article-id>
      <article-id pub-id-type="pmc">5536180</article-id>
      <article-id pub-id-type="doi">10.1038/nature22400</article-id>
      <article-id pub-id-type="manuscript">NIHMS872467</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Genomic epidemiology reveals multiple introductions of Zika virus into the United States</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grubaugh</surname>
            <given-names>Nathan D</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ladner</surname>
            <given-names>Jason T</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kraemer</surname>
            <given-names>Moritz UG</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dudas</surname>
            <given-names>Gytis</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>Amanda L</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gangavarapu</surname>
            <given-names>Karthik</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wiley</surname>
            <given-names>Michael R</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>White</surname>
            <given-names>Stephen</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Th&#xE9;z&#xE9;</surname>
            <given-names>Julien</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Magnani</surname>
            <given-names>Diogo M</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prieto</surname>
            <given-names>Karla</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reyes</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bingham</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paul</surname>
            <given-names>Lauren M</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robles-Sikisaka</surname>
            <given-names>Refugio</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Glenn</given-names>
          </name>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pronty</surname>
            <given-names>Darryl</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barcellona</surname>
            <given-names>Carolyn M</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Metsky</surname>
            <given-names>Hayden C</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baniecki</surname>
            <given-names>Mary Lynn</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barnes</surname>
            <given-names>Kayla G</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chak</surname>
            <given-names>Bridget</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freije</surname>
            <given-names>Catherine A</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gladden-Young</surname>
            <given-names>Adrianne</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gnirke</surname>
            <given-names>Andreas</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>Cynthia</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MacInnis</surname>
            <given-names>Bronwyn</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matranga</surname>
            <given-names>Christian B</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Daniel J</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qu</surname>
            <given-names>James</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schaffner</surname>
            <given-names>Stephen F</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tomkins-Tinch</surname>
            <given-names>Christopher</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>West</surname>
            <given-names>Kendra L</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Winnicki</surname>
            <given-names>Sarah M</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wohl</surname>
            <given-names>Shirlee</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yozwiak</surname>
            <given-names>Nathan L</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quick</surname>
            <given-names>Joshua</given-names>
          </name>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fauver</surname>
            <given-names>Joseph R</given-names>
          </name>
          <xref ref-type="aff" rid="A14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>Kamran</given-names>
          </name>
          <xref ref-type="aff" rid="A15">15</xref>
          <xref ref-type="aff" rid="A16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brent</surname>
            <given-names>Shannon E</given-names>
          </name>
          <xref ref-type="aff" rid="A15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reiner</surname>
            <given-names>Robert C</given-names>
            <suffix>Jr.</suffix>
          </name>
          <xref ref-type="aff" rid="A17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lichtenberger</surname>
            <given-names>Paola N</given-names>
          </name>
          <xref ref-type="aff" rid="A18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ricciardi</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>Varian K</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watkins</surname>
            <given-names>David I</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cone</surname>
            <given-names>Marshall R</given-names>
          </name>
          <xref ref-type="aff" rid="A19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kopp</surname>
            <given-names>Edgar W</given-names>
            <suffix>IV</suffix>
          </name>
          <xref ref-type="aff" rid="A19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hogan</surname>
            <given-names>Kelly N</given-names>
          </name>
          <xref ref-type="aff" rid="A19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cannons</surname>
            <given-names>Andrew C</given-names>
          </name>
          <xref ref-type="aff" rid="A19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jean</surname>
            <given-names>Reynald</given-names>
          </name>
          <xref ref-type="aff" rid="A20">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Monaghan</surname>
            <given-names>Andrew J</given-names>
          </name>
          <xref ref-type="aff" rid="A21">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garry</surname>
            <given-names>Robert F</given-names>
          </name>
          <xref ref-type="aff" rid="A22">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loman</surname>
            <given-names>Nicholas J</given-names>
          </name>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Faria</surname>
            <given-names>Nuno R</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porcelli</surname>
            <given-names>Mario C</given-names>
          </name>
          <xref ref-type="aff" rid="A23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vasquez</surname>
            <given-names>Chalmers</given-names>
          </name>
          <xref ref-type="aff" rid="A23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nagle</surname>
            <given-names>Elyse R</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cummings</surname>
            <given-names>Derek AT</given-names>
          </name>
          <xref ref-type="aff" rid="A24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stanek</surname>
            <given-names>Danielle</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rambaut</surname>
            <given-names>Andrew</given-names>
          </name>
          <xref ref-type="aff" rid="A25">25</xref>
          <xref ref-type="aff" rid="A26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sanchez-Lockhart</surname>
            <given-names>Mariano</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sabeti</surname>
            <given-names>Pardis C</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
          <xref ref-type="aff" rid="A27">27</xref>
          <xref ref-type="aff" rid="A28">28</xref>
          <xref ref-type="aff" rid="A29">29</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gillis</surname>
            <given-names>Leah D</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Michael</surname>
            <given-names>Scott F</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bedford</surname>
            <given-names>Trevor</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pybus</surname>
            <given-names>Oliver G</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Isern</surname>
            <given-names>Sharon</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palacios</surname>
            <given-names>Gustavo</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
          <xref rid="FN4" ref-type="author-notes">$</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Andersen</surname>
            <given-names>Kristian G</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A11">11</xref>
          <xref ref-type="aff" rid="A30">30</xref>
          <xref rid="FN3" ref-type="author-notes">#</xref>
          <xref rid="FN4" ref-type="author-notes">$</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
<label>1</label>Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA</aff>
      <aff id="A2">
<label>2</label>Center for Genome Sciences, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA</aff>
      <aff id="A3">
<label>3</label>Department of Zoology, University of Oxford, Oxford OX1 3PS, UK</aff>
      <aff id="A4">
<label>4</label>Boston Children&#x2019;s Hospital, Boston, MA 02115, USA</aff>
      <aff id="A5">
<label>5</label>Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A6">
<label>6</label>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA</aff>
      <aff id="A7">
<label>7</label>Department of Biological Sciences, College of Arts and Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA</aff>
      <aff id="A8">
<label>8</label>Bureau of Public Health Laboratories, Division of Disease Control and Health Protection, Florida Department of Health, Miami, FL 33125, USA</aff>
      <aff id="A9">
<label>9</label>Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136, USA</aff>
      <aff id="A10">
<label>10</label>Bureau of Epidemiology, Division of Disease Control and Health Protection, Florida Department of Health, Tallahassee, FL 32399, USA</aff>
      <aff id="A11">
<label>11</label>Scripps Translational Science Institute, La Jolla, CA 92037, USA</aff>
      <aff id="A12">
<label>12</label>The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</aff>
      <aff id="A13">
<label>13</label>Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK</aff>
      <aff id="A14">
<label>14</label>Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA</aff>
      <aff id="A15">
<label>15</label>Li Ka Shing Knowledge Institute, St Michael&#x2019;s Hospital, Toronto, ON M5B 1T8, Canada</aff>
      <aff id="A16">
<label>16</label>Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON M5B 1T8, Canada</aff>
      <aff id="A17">
<label>17</label>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98121, USA</aff>
      <aff id="A18">
<label>18</label>Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL 33155, USA</aff>
      <aff id="A19">
<label>19</label>Bureau of Public Health Laboratories, Division of Disease Control and Health Protection, Florida Department of Health, Tampa, FL 33612, USA</aff>
      <aff id="A20">
<label>20</label>Florida Department of Health in Miami-Dade County, Miami, FL 33125, USA</aff>
      <aff id="A21">
<label>21</label>National Center for Atmospheric Research, Boulder, CO 80307, USA</aff>
      <aff id="A22">
<label>22</label>Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA</aff>
      <aff id="A23">
<label>23</label>Miami-Dade County Mosquito Control, Miami, FL 33178 USA</aff>
      <aff id="A24">
<label>24</label>Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA</aff>
      <aff id="A25">
<label>25</label>Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3FL, UK</aff>
      <aff id="A26">
<label>26</label>Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA</aff>
      <aff id="A27">
<label>27</label>Center for Systems Biology, Department of Organismic and Evolutionary Biology, Harvard University, Cambridge MA 02138, USA</aff>
      <aff id="A28">
<label>28</label>Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston MA 02115, USA</aff>
      <aff id="A29">
<label>29</label>Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA</aff>
      <aff id="A30">
<label>30</label>Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA</aff>
      <author-notes>
        <corresp id="FN1">Correspondence and requests for materials should be addressed to K.G.A (<email>andersen@scripps.edu</email>) or G.P. (<email>gustavo.f.palacios.ctr@mail.mil</email>)</corresp>
        <fn id="FN2">
          <label>*</label>
          <p>co-first</p>
        </fn>
        <fn id="FN3">
          <label>#</label>
          <p>co-senior</p>
        </fn>
        <fn id="FN4">
          <label>$</label>
          <p>co-corresponding</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>30</day>
        <month>4</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>6</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>24</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <volume>546</volume>
      <issue>7658</issue>
      <fpage>401</fpage>
      <lpage>405</lpage>
      <!--elocation-id from pubmed: 10.1038/nature22400-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract>
        <p id="P1">Zika virus (ZIKV) is causing an unprecedented epidemic linked to severe congenital syndromes<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup>. In July 2016, mosquito-borne ZIKV transmission was reported in the continental United States and since then, hundreds of locally-acquired infections have been reported in Florida<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>. To gain insights into the timing, source, and likely route(s) of ZIKV introduction, we tracked the virus from its first detection in Florida by sequencing ZIKV genomes from infected patients and <italic>Aedes aegypti</italic> mosquitoes. We show that at least four introductions, but potentially as many as 40, contributed to the outbreak in Florida and that local transmission likely started in the spring of 2016 - several months before initial detection. By analyzing surveillance and genetic data, we discovered that ZIKV moved among transmission zones in Miami. Our analyses show that most introductions are linked to the Caribbean, a finding corroborated by the high incidence rates and traffic volumes from the region into the Miami area. Our study provides an understanding of how ZIKV initiates transmission in new regions.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P2">ZIKV transmission in the Americas was first reported in Brazil in May 2015<sup><xref rid="R5" ref-type="bibr">5</xref></sup>, though the virus was likely introduced 1&#x2013;2 years prior to its detection<sup><xref rid="R6" ref-type="bibr">6</xref>&#x2013;<xref rid="R8" ref-type="bibr">8</xref></sup>. By January 2016, ZIKV cases were reported from several South and Central American countries and most islands in the Caribbean<sup><xref rid="R9" ref-type="bibr">9</xref></sup>. Like dengue virus (DENV) and chikungunya virus (CHIKV), ZIKV is vectored primarily by <italic>Aedes</italic> mosquitoes<sup><xref rid="R10" ref-type="bibr">10</xref>&#x2013;<xref rid="R13" ref-type="bibr">13</xref></sup>. The establishment of the peridomestic species <italic>Ae. aegypti</italic> in the Americas<sup><xref rid="R14" ref-type="bibr">14</xref></sup> has facilitated DENV, CHIKV, and now likely ZIKV to become endemic in this region<sup><xref rid="R15" ref-type="bibr">15</xref></sup>. In the continental United States, transient outbreaks of DENV and CHIKV have been reported in regions of Texas and Florida<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R16" ref-type="bibr">16</xref>&#x2013;<xref rid="R21" ref-type="bibr">21</xref></sup> with abundant seasonal <italic>Ae. aegypti</italic> populations<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup>.</p>
    <p id="P3">The 2016 ZIKV outbreak in Florida generated 256 confirmed ZIKV infections<sup><xref rid="R4" ref-type="bibr">4</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). While transmission was confirmed across four counties in Florida (<xref rid="F1" ref-type="fig">Fig. 1b</xref>), the outbreak was most intense in Miami-Dade County (241 infections). Although the case location could not always be determined, at least 114 (47%) infections were likely acquired in one of three distinct transmission zones: Wynwood, Miami Beach, and Little River (<xref rid="F1" ref-type="fig">Fig. 1c&#x2013;d</xref>).</p>
    <p id="P4">Using mosquito surveillance data, we determined the extent of mosquito-borne ZIKV transmission in Miami. Of the 24,351 mosquitoes collected from June to November 2016, 99.8% were <italic>Ae. aegypti</italic> and 8 pools of &#x2264; 50 mosquitoes tested positive for ZIKV (<xref rid="F1" ref-type="fig">Fig. 1c</xref>, <xref rid="F5" ref-type="fig">Extended Data Fig. 1</xref>). From these pools, we estimated that ~1 out of 1,600 <italic>Ae. aegypti</italic> mosquitoes were infected (0.061%, 95% CI: 0.028&#x2013;0.115%, <xref rid="F5" ref-type="fig">Extended Data Fig. 1a</xref>). This is similar to infection rates during DENV and CHIKV outbreaks<sup><xref rid="R23" ref-type="bibr">23</xref></sup>. Although we did not detect ZIKV-infected mosquitoes outside Miami Beach (<xref rid="F1" ref-type="fig">Fig. 1c</xref>), we found that the number of human ZIKV cases correlated strongly with <italic>Ae. aegypti</italic> abundance within each transmission zone (Spearman r = 0.61, <xref rid="F1" ref-type="fig">Fig. 1d</xref>, <xref rid="F5" ref-type="fig">Extended Data Fig. 1b</xref>). This suggests that <italic>Ae. aegypti</italic> mosquitoes were the primary mode of transmission and that changes to vector abundance impacted human infection rates. We found that the application of insecticides<sup><xref rid="R3" ref-type="bibr">3</xref></sup> suppressed mosquito populations during periods of intensive usage (<xref rid="F5" ref-type="fig">Extended Data Fig. 1c</xref>), and therefore likely contributed to ZIKV clearance.</p>
    <p id="P5">We sequenced 39 ZIKV genomes from clinical and mosquito samples without cell culture<sup><xref rid="R24" ref-type="bibr">24</xref></sup> (<xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1a</xref>). Our ZIKV dataset included 29 genomes from patients with locally-acquired infections (<xref rid="F1" ref-type="fig">Fig. 1d</xref>) and 7 from <italic>Ae. aegypti</italic> pools (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). We also sequenced 3 ZIKV genomes from travel-associated cases from Florida. Our dataset included cases from all transmission zones in Miami (<xref rid="F1" ref-type="fig">Fig. 1d</xref>) and represented ~11% of all confirmed locally-acquired cases in Florida. We made all sequence data openly available (PRJNA342539, PRJNA356429) immediately after data generation.</p>
    <p id="P6">We reconstructed phylogenetic trees from our ZIKV genomes along with 65 published genomes from other affected regions (<xref rid="F2" ref-type="fig">Fig. 2</xref>, <xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref> and <xref rid="F7" ref-type="fig">3</xref>). We found that the Florida ZIKV genomes formed four distinct lineages (labeled F1&#x2013;F4, <xref rid="F2" ref-type="fig">Fig. 2a</xref>), three of which (F1&#x2013;F3) belonged to the same clade (labeled A, <xref rid="F2" ref-type="fig">Fig. 2a</xref>). We only sampled a single human case each from the F3 and F4 lineages, consistent with limited transmission (<xref rid="F2" ref-type="fig">Fig. 2a</xref>). The other two Florida lineages (F1&#x2013;F2) comprised ZIKV genomes from human and mosquito samples within Miami-Dade County (<xref rid="F2" ref-type="fig">Fig. 2b</xref>).</p>
    <p id="P7">Using time-structured phylogenies<sup><xref rid="R25" ref-type="bibr">25</xref></sup>, we estimated that at least four separate introductions were responsible for the locally-acquired cases observed in our dataset. The phylogenetic placement of lineage F4 clearly indicates that it resulted from an independent introduction of a lineage distinct from those in clade A (<xref rid="F2" ref-type="fig">Fig. 2a</xref>). For the two well-supported nodes linking lineages F1&#x2013;F2 (labeled B, <xref rid="F2" ref-type="fig">Fig. 2a</xref>) and F1&#x2013;F3 (A, <xref rid="F2" ref-type="fig">Fig. 2a</xref>), we estimated the time of the most recent common ancestor (tMRCA) to be during the summer of 2015 (95% highest posterior density [HPD]: June&#x2013;September, 2015). Our data displayed a strong clock signal (<xref rid="F6" ref-type="fig">Extended Data Fig. 2b</xref>) and tMRCA estimates were robust across a range of models (<xref rid="T1" ref-type="table">Extended Data Table 1a</xref>). Thus while F1&#x2013;F3 belong to clade A, any fewer than three distinct introductions leading to these lineages would have required undetected transmission of ZIKV in Florida for approximately one year (<xref rid="F2" ref-type="fig">Fig. 2a</xref>).</p>
    <p id="P8">To estimate the likelihood of a single ZIKV transmission chain persisting for over a year, we modeled spread under different assumptions of the basic reproductive number (<italic>R</italic><sub>0</sub>). Using the number of locally-acquired and travel-associated cases, along with the number of observed genetic lineages, we estimated an <italic>R</italic><sub>0</sub> between 0.5 and 0.8 in Miami-Dade County (<xref rid="F8" ref-type="fig">Extended Data Fig. 4</xref>). Even at the upper end of this range, the probability of a single transmission chain persisting for over a year is extremely low (~0.5%, <xref rid="F2" ref-type="fig">Fig. 2c</xref>). This is especially true considering the low <italic>Ae. aegypti</italic> abundance during the winter months (<xref rid="F5" ref-type="fig">Extended Data Fig. 1d</xref>).</p>
    <p id="P9">Given the low probability of long-term persistence, we expect that our ZIKV genomes (F1&#x2013;F4) were the result of at least four introductions. Differences in surveillance practices and a high number of travel-associated cases (<xref rid="F1" ref-type="fig">Fig. 1a</xref>), however, likely mean that unsampled ZIKV introductions also contributed to the outbreak. To estimate the total number of ZIKV introductions, we modeled scenarios that resulted in 241 locally-acquired cases within Miami-Dade County, and found that with <italic>R</italic><sub>0</sub> values of 0.5&#x2013;0.8, we expect 17&#x2013;42 (95% CI 3&#x2013;63) separate introductions to have contributed to the outbreak (<xref rid="F2" ref-type="fig">Fig. 2d</xref>). The majority of these introductions would likely have generated a single secondary case that was undetected in our genetic sampling (<xref rid="F8" ref-type="fig">Extended Data Fig. 4a</xref>). Incorporating under-reporting in a sensitivity analysis increases <italic>R</italic><sub>0</sub> estimates slightly to 0.7&#x2013;0.9 (<xref rid="F8" ref-type="fig">Extended Data Fig. 4f&#x2013;i</xref>).</p>
    <p id="P10">The two main ZIKV lineages, F1 and F2, included the majority of genomes from Florida (92%, <xref rid="F2" ref-type="fig">Fig. 2a</xref>). Assuming they represent two independent introductions, we estimated when each of these lineages arrived in Florida. The probability densities for the tMRCAs of both F1 and F2 were centered around March&#x2013;April, 2016 (<xref rid="F2" ref-type="fig">Fig. 2b</xref>, 95% HPD: January&#x2013;May, 2016). The estimated timing for these introductions corresponds with suitable <italic>Ae. aegypti</italic> populations in Miami-Dade County<sup><xref rid="R26" ref-type="bibr">26</xref></sup> (<xref rid="F5" ref-type="fig">Extended Data Fig. 1d</xref>) and suggests that ZIKV transmission could have started at least two months prior to its detection in July 2016 (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). The dates of the introductions could be more recent if multiple F1 or F2 lineage viruses arrived independently. However, more than 2 introductions would be necessary to substantially change our estimates for the timing of the earliest introduction.</p>
    <p id="P11">To understand transmission dynamics within Miami, we analyzed our genomic data together with case data from the Florida Department of Health (DOH, <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1a</xref>). While spatially distinct, the three ZIKV transmission zones occurred within ~5 km of each other (<xref rid="F1" ref-type="fig">Fig. 1c</xref>) and we found that the ZIKV infections associated with each zone overlapped temporally (<xref rid="F1" ref-type="fig">Fig. 1d</xref>). Our ZIKV genomes with zone assignments all belonged to lineages F1 and F2, but neither of these lineages were confined to a single zone (<xref rid="F2" ref-type="fig">Fig. 2b</xref>). In fact, we detected both F1 and F2 lineage viruses from <italic>Ae. aegypti</italic> collected from the same trap 26 days apart (mosquitoes 5 and 8, <xref rid="F2" ref-type="fig">Fig. 2b</xref>). These findings suggest that ZIKV moved among areas of Miami.</p>
    <p id="P12">Determining the sources and routes of ZIKV introductions could help mitigate future outbreaks. We found that lineages F1&#x2013;F3 clustered with ZIKV genomes sequenced from the Dominican Republic and Guadeloupe (<xref rid="F2" ref-type="fig">Fig. 2</xref>, <xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref> and <xref rid="F7" ref-type="fig">3</xref>). In contrast, F4 clustered with genomes from Central America (<xref rid="F2" ref-type="fig">Fig. 2</xref>, <xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref> and <xref rid="F7" ref-type="fig">3</xref>). These findings suggest that while ZIKV outbreaks occurred throughout the Americas, the Caribbean islands were the main source of establishing local ZIKV transmission in Florida. Because of severe undersampling of ZIKV genomes, however, we cannot rule out other source areas. Similarly, even though we found that the Florida ZIKV genomes clustered together with sequences from the Dominican Republic, our results do not prove that ZIKV entered Florida from this country.</p>
    <p id="P13">We investigated ZIKV infection rates and travel patterns to corroborate our phylogenetic evidence for Caribbean introductions. We found that the Caribbean islands bore the highest ZIKV incidence rates (<xref rid="F2" ref-type="fig">Fig. 2b</xref>), despite Brazil and Colombia reporting the highest absolute number of cases (January to June, 2016, <xref rid="F3" ref-type="fig">Fig. 3a</xref>, <xref rid="F9" ref-type="fig">Extended Data Fig. 5</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1b</xref>). During the same time period, we estimated that ~3 million travelers arrived from the Caribbean, accounting for 54% of the total traffic into Miami, with the vast majority (~2.4 million) arriving via cruise ships (<xref rid="F3" ref-type="fig">Fig. 3b</xref>, <xref rid="F10" ref-type="fig">Extended Data Fig. 6</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1b</xref>). Combining the infection rates with travel capacities, we estimated that ~60&#x2013;70% of ZIKV infected travelers arrived from the Caribbean (<xref rid="F3" ref-type="fig">Fig. 3c</xref> and <xref rid="F11" ref-type="fig">Extended Data Fig. 7a</xref>). We also found that the number of travel-associated ZIKV cases correlated strongly with the expected number of importations from the Caribbean (Spearman r = 0.8, <xref rid="F3" ref-type="fig">Fig. 3d</xref>, <xref rid="F11" ref-type="fig">Extended Data Fig. 7b</xref>). Finally, 67% of the travel-associated infections in Florida reported recent travel to the Caribbean (<xref rid="F3" ref-type="fig">Fig. 3e</xref>); however, their mode of travel is unknown. Taken together, these findings suggest that a high incidence of ZIKV in the Caribbean, combined with frequent travel, could have played a key role in the establishment of ZIKV transmission in Florida. These findings, however, do not indicate that cruise ships themselves are risk factors for human ZIKV infection, but only that they served as a major mode of transportation from areas with active transmission. In addition, ZIKV exposure may vary among individuals depending on their purpose of travel and therefore we cannot determine the specific contribution of ZIKV-infected travelers arriving via airlines or cruise ships.</p>
    <p id="P14">The majority of the Florida ZIKV outbreak occurred in Miami-Dade County (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). To determine if there is a higher potential for ZIKV outbreaks in this area, we analyzed incoming passenger traffic from regions with ZIKV transmission along with local <italic>Ae. aegypti</italic> abundance. We estimated that Miami and nearby Fort Lauderdale received ~72% of traffic (<xref rid="F4" ref-type="fig">Fig. 4</xref>) and Miami received more air and sea traffic from ZIKV endemic areas than any other city in the United States (<xref rid="F12" ref-type="fig">Extended Data Fig. 8</xref>). During January to April 2016, we estimated that <italic>Ae. aegypti</italic> abundance was highest in southern Florida<sup><xref rid="R22" ref-type="bibr">22</xref></sup> (<xref rid="F4" ref-type="fig">Fig. 4</xref>, <xref rid="F5" ref-type="fig">Extended Data Fig. 1d</xref>, <xref rid="F12" ref-type="fig">Extended Data Fig. 8</xref>). By June, most of Florida and several cities across the South likely supported high <italic>Ae. aegypti</italic> populations<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup> (<xref rid="F12" ref-type="fig">Extended Data Fig. 8</xref>); however, most of this region has not reported local <italic>Ae. aegypti</italic>-borne virus transmission in at least 60 years<sup><xref rid="R19" ref-type="bibr">19</xref></sup>. In fact, the only region outside of Florida with local ZIKV transmission is southern Texas<sup><xref rid="R27" ref-type="bibr">27</xref></sup>, which is also the only other region with recent DENV outbreaks<sup><xref rid="R19" ref-type="bibr">19</xref>&#x2013;<xref rid="R21" ref-type="bibr">21</xref></sup>. Therefore, the combination of travelers, mosquito ecology, and human population density likely make Miami one of the few places in the continental United States at risk for <italic>Ae. aegypti</italic>-borne virus outbreaks<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup>.</p>
    <p id="P15">The extent of ZIKV transmission in Florida was unprecedented, with more reported ZIKV cases in 2016 (256) than DENV cases since 2009 (136)<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref></sup>. This case difference may be reflected by lower incidence of endemic DENV than epidemic ZIKV in source countries<sup><xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref></sup>, resulting in fewer DENV importations (reported travel cases since 2009: 654 DENV and 1,016 ZIKV)<sup><xref rid="R4" ref-type="bibr">4</xref></sup>. Given that the majority of ZIKV infections are asymptomatic<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup>, the true number of ZIKV cases was likely much higher. Despite this, we estimated that the average <italic>R</italic><sub>0</sub> was less than 1 and therefore multiple introductions were necessary to give rise to the observed outbreak<sup><xref rid="R32" ref-type="bibr">32</xref></sup>. The high volume of traffic entering Florida from ZIKV-affected regions, especially the Caribbean, likely provided a substantial supply of ZIKV-infected individuals<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. Because Florida is unlikely to sustain long-term ZIKV transmission<sup><xref rid="R32" ref-type="bibr">32</xref></sup>, the potential for future ZIKV outbreaks in this region is dependent upon activity elsewhere. Therefore, we expect that outbreaks in Florida will cycle with the ZIKV transmission dynamics in the Americas<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup>.</p>
    <sec sec-type="methods" id="S1" specific-use="web-only">
      <title>Methods</title>
      <sec id="S2">
        <title>Ethical statement</title>
        <p id="P16">This work was evaluated and approved by relevant Institutional Review Boards (IRB)/Ethics Review Committees at The Scripps Research Institute (TSRI) and the US Army Medical Research Institute of Infectious Diseases (USAMRIID) Office of Human Use and Ethics. This work was conducted as part of the public health response in Florida and samples were collected under a waiver of consent granted by the Florida DOH Human Research Protection Program. The work received a non-human subjects research designation (category 4 exemption) by the Florida DOH since this research was performed with leftover clinical diagnostic samples involving no more than minimal risk. All samples were deidentified prior to receipt by the study investigators.</p>
      </sec>
      <sec id="S3">
        <title>Florida Zika virus case data</title>
        <p id="P17">Weekly reports of international travel-associated and locally-acquired ZIKV infections diagnosed in Florida were obtained from the Florida DOH mosquito-borne disease surveillance system<sup><xref rid="R4" ref-type="bibr">4</xref></sup>. Dates of symptom onset from the Miami transmission zones (Wynwood, Miami Beach, and Little River) determined by the Florida DOH investigation process were obtained from the ZIKV resource website<sup><xref rid="R35" ref-type="bibr">35</xref></sup> and daily updates<sup><xref rid="R36" ref-type="bibr">36</xref></sup>. International travel-associated ZIKV case counts in the United States (outside of Florida) were obtained from the CDC<sup><xref rid="R37" ref-type="bibr">37</xref></sup>. The local and travel-associated ZIKV case numbers for Florida were obtained from the Florida DOH. The one local ZIKV infection diagnosed in Duval County was believed to have originated elsewhere in Florida. Therefore, this case is listed as &#x201C;unknown origin&#x201D; in <xref rid="F1" ref-type="fig">Fig. 1b</xref>. In <xref rid="F3" ref-type="fig">Fig. 3e</xref>, only the countries visited by 5 or more times by ZIKV-infected travelers diagnosed in Florida are shown. Countries with 5 or fewer visits were aggregated into an &#x201C;other&#x201D; category by region (<italic>i.e.</italic>, Caribbean, South America, or Central America).</p>
      </sec>
      <sec id="S4">
        <title>Clinical sample collection and RNA extraction</title>
        <p id="P18">Clinical samples from locally-acquired ZIKV infections were collected from June 22 to October 11, 2016. The Florida DOH identified persons with compatible illness and clinical samples were shipped to the Bureau of Public Health Laboratories for confirmation by qRT-PCR and antibody tests following interim guidelines<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R38" ref-type="bibr">38</xref>&#x2013;<xref rid="R40" ref-type="bibr">40</xref></sup>. Clinical specimens (whole blood, serum, saliva, or urine) submitted for analysis were refrigerated or frozen at &#x2264; &#x2212;70&#xB0;C until RNA was extracted. RNA was extracted using the RNAeasy kit (QIAGEN), MagMAX for Microarrays Total RNA Isolation Kit (Ambion), or MagNA Pure LC 2.0 or 96 Systems (Roche Diagnostics). Purified RNA was eluted into 50&#x2013;100 &#x3BC;L using the supplied elution buffers, immediately frozen at &#x2264; &#x2212;70&#xB0;C, and transported on dry ice. The Florida DOH also provided investigation data for these samples, including symptom onset dates and, when available, assignments to the zone where infection likely occurred (<xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1</xref>).</p>
      </sec>
      <sec id="S5">
        <title>Mosquito collection, RNA extraction, and entomological data analysis</title>
        <p id="P19">24,351 <italic>Ae. aegypti</italic> and <italic>Ae. albopictus</italic> mosquitoes (sorted into 2,596 pools) were collected throughout Miami-Dade County during June to November, 2016 using BG-Sentinel mosquito traps (Biogents AG). Up to 50 mosquitoes of the same species and sex were pooled per trap. The pooled mosquitoes were stored in RNAlater (Invitrogen), RNA was extracted using either the RNAeasy kit (QIAGEN) or MagMAX for Microarrays Total RNA Isolation Kit (Ambion), and ZIKV RNA was detected by qRT-PCR targeting the envelope protein coding region<sup><xref rid="R40" ref-type="bibr">40</xref></sup> or the Trioplex qRT-PCR kit<sup><xref rid="R41" ref-type="bibr">41</xref></sup>. ZIKV infection rates were calculated per 1,000 female <italic>Ae. aegypti</italic> mosquitoes using the bias-corrected maximum likelihood estimate (MLE)<sup><xref rid="R42" ref-type="bibr">42</xref></sup>. Days of insecticide usage by the Miami-Dade Mosquito Control were inferred from the zone-specific ZIKV activities timelines published by the Florida DOH<sup><xref rid="R35" ref-type="bibr">35</xref></sup>.</p>
      </sec>
      <sec id="S6">
        <title>Relative monthly <italic>Ae. aegypti</italic> abundance</title>
        <p id="P20">For the purpose of this study we used <italic>Ae. aegypti</italic> suitability maps from Kraemer <italic>et al</italic>.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> and derived monthly estimates based on the statistical relationships between mosquito presence and environmental correlates<sup><xref rid="R43" ref-type="bibr">43</xref></sup>. Following Hwang <italic>et al</italic>.<sup><xref rid="R44" ref-type="bibr">44</xref></sup> we used a simple mathematical formula to transform the probability of detection maps into mosquito abundance maps. In order to do so, we assumed P (Y=1) where Y is a binary variable (presence/absence). Using a Poisson distribution X() to govern the abundance of mosquitoes, the probability of not observing any mosquitoes can be related to the probability of absence as: P(X=0)=P(Y=0). We used the following transformation to generate abundance (&#x3BB;) estimates per county in Florida: 
<disp-formula id="FD1"><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>&#x3BB;</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>&#x3BB;</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mo>log</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>&#x3BB;</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mo>log</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p>
        <p id="P21">We did not consider <italic>Ae. albopictus</italic> abundance in this study because 99.8% of mosquitoes collected in Miami-Dade County were <italic>Ae. aegypti</italic>. Relative Ae. aegypti abundance in major U.S. cities presented in <xref rid="F12" ref-type="fig">Extended Data Fig. 8</xref> was estimated as previously described<sup><xref rid="R22" ref-type="bibr">22</xref></sup>.</p>
      </sec>
      <sec id="S7">
        <title>Zika virus quantification</title>
        <p id="P22">ZIKV genome equivalents (GE) were quantified by qRT-PCR. At TSRI, ZIKV qRT-PCR was performed as follows: ZIKV RNA standards were transcribed from the ZIKV NS5 region (8651&#x2013;9498 nt) using the T7 forward primer (5&#x2032; - TAA TAC GAC TCA CTA TAG GGA GA TCA GGC TCC TGT CAA AAC CC - 3&#x2032;), reverse primer (5&#x2032; - AGT GAC AAC TTG TCC GCT CC - 3&#x2032;), and the T7 Megascript kit (Ambion). For qRT-PCR, primers and a probe targeting the NS5 region (9014&#x2013;9123 nt) were designed using the ZIKV isolate PRVABC59 (GenBank: KU501215): forward primer (5&#x2032;-AGT GCC AGA GCT GTG TGT AC - 3&#x2032;), reverse primer (5&#x2032; - TCT AGC CCC TAG CCA CAT GT - 3&#x2032;), and FAM-fluorescent probe (5&#x2032; - GGC AGC CGC GCC ATC TGG T - 3&#x2032;). The qRT-PCR assays were performed in 25 &#x3BC;l reactions using the iScript One-step RT-PCR Kit for probes (Bio-Rad Laboratories Inc.) and 2 &#x3BC;l of sample RNA. Amplification was performed at 50&#xB0;C for 20 min, 95&#xB0;C for 3 min, and 40 cycles of 95&#xB0;C for 10 s and 57&#xB0;C for 10 s. Fluorescence was read at the end of the 57&#xB0;C annealing-extension step. 10-fold dilutions of the ZIKV RNA transcripts (2 &#x3BC;l/reaction) were used to create a standard curve for quantification of ZIKV GE/&#x3BC;l of RNA. The lower limits of quantification are 4 GE/&#x3BC;l RNA, or at a cycle threshold of ~36.</p>
        <p id="P23">ZIKV GE were quantified at USAMRIID using the University of Bonn ZIKV envelope protein (Bonn E) qRT-PCR assay<sup><xref rid="R45" ref-type="bibr">45</xref></sup>. RNA standards were transcribed using an amplicon generated from a ZIKV plasmid containing T7 promoter at the start of the 5&#x2032; untranslated region (UTR). The plasmid was designed using the ZIKV isolate BeH819015 (GenBank: KU365778.1) and the amplicon included nts 1&#x2013;4348, which covers the 5&#x2032; UTR, C, prM, M, E, NS1, and NS2 regions. The qRT-PCR assays were performed in 25 &#x3BC;l reactions using the SuperScript III platinum One-step qRT-PCR Kit (ThermoFisher) and 2 &#x3BC;l of sample RNA was used. Amplification was performed following conditions as previously described<sup><xref rid="R45" ref-type="bibr">45</xref></sup>. 10-fold dilutions of the ZIKV RNA transcripts (5 &#x3BC;l/reaction) were used to create a standard curve for quantification of ZIKV GE/&#x3BC;l of RNA.</p>
      </sec>
      <sec id="S8">
        <title>Amplicon-based Zika virus sequencing</title>
        <p id="P24">ZIKV sequencing at TSRI was performed using an amplicon-based approach using the ZikaAsian V1 scheme, as described<sup><xref rid="R24" ref-type="bibr">24</xref></sup>. This approach is similar to &#x201C;RNA jackhammering&#x201D; to sequence low-quality viral samples developed by Worobey <italic>et al.</italic><sup><xref rid="R46" ref-type="bibr">46</xref></sup>. Briefly, cDNA was reverse transcribed from 5 &#x3BC;l of RNA using SuperScript IV (Invitrogen). ZIKV cDNA (2.5 &#x3BC;l/reaction) was amplified in 35 &#xD7; 400 bp fragments from two multiplexed PCR reactions using Q5 DNA High-fidelity Polymerase (New England Biolabs). The amplified ZIKV cDNA fragments (50 ng) were prepared for sequencing using the Kapa Hyper prep kit (Kapa Biosystems) and SureSelect XT2 indexes (Agilent). Agencourt AMPure XP beads (Beckman Coulter) were used for all purification steps. Paired-end 251 nt reads were generated on the MiSeq using the V2 500 cycle or V3 600 cycle kits (Illumina).</p>
        <p id="P25">Trimmomatic was used to remove primer sequences (first 22 nt from the 5&#x2032; end of the reads, which is the maximum length of the primers used for the multiplexed PCR) and bases at both ends with Phred quality score &lt; 20<sup><xref rid="R47" ref-type="bibr">47</xref></sup>. The reads were then aligned to the complete genome of a ZIKV isolate from the Dominican Republic, 2016 (GenBank: KU853012) using Novoalign v3.04.04 (<ext-link ext-link-type="uri" xlink:href="www.novocraft.com">www.novocraft.com</ext-link>). Samtools was used to sort the aligned BAM files and to generate alignment statistics<sup><xref rid="R48" ref-type="bibr">48</xref></sup>. Snakemake was used as the workflow management system<sup><xref rid="R49" ref-type="bibr">49</xref></sup>. The code and reference indexes for the pipeline can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/andersen-lab/zika-pipeline">https://github.com/andersen-lab/zika-pipeline</ext-link>. ZIKV-aligned reads were visually inspected using Geneious v9.1.5<sup><xref rid="R50" ref-type="bibr">50</xref></sup> before generating consensus sequences. A minimum of 3&#xD7; read-depth coverage, in support of the consensus, was required to make a base call.</p>
      </sec>
      <sec id="S9">
        <title>Enrichment-based Zika virus sequencing</title>
        <p id="P26">ZIKV sequencing at USAMRIID was performed using a targeted enrichment approach. Sequencing libraries were prepared using the TruSeq RNA Access Library Prep kit (Illumina) with custom ZIKV probes. The set included 866 unique probes each of which was 80 nt in length (<xref rid="SD4" ref-type="supplementary-material">Supplementary Table 2a</xref>). The probes were designed to cover the entire ZIKV genome and to encompass the genetic diversity present on GenBank on January 14, 2016. In total, 26 ZIKV sequences were used during probe design (<xref rid="SD4" ref-type="supplementary-material">Supplementary Table 2b</xref>). Extracted RNA was fragmented at 94 &#xB0;C for 0&#x2013;60 s and each sample was enriched separately using a quarter of the reagents specified in the manufacturer&#x2019;s protocol. Samples were barcoded, pooled and sequenced using the MiSeq Reagent kit v3 (Illumina) on an Illumina MiSeq with a minimum of 2 &#xD7; 151 bp reads. Dual indexing, with no overlapping indices, was used.</p>
        <p id="P27">The random hexamer associated with read one and the Illumina adaptors were removed from the sequencing reads using Cutadapt v1.9.dev1<sup><xref rid="R51" ref-type="bibr">51</xref></sup>, and low-quality reads/bases were filtered using Prinseq-lite v0.20.3<sup><xref rid="R52" ref-type="bibr">52</xref></sup>. Reads were aligned to a reference genome (GenBank: KX197192.1) using Bowtie2 v2.0.6<sup><xref rid="R53" ref-type="bibr">53</xref></sup>, duplicates were removed with Picard (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard">http://broadinstitute.github.io/picard</ext-link>), and a new consensus was generated using a combination of Samtools v0.1.18<sup><xref rid="R48" ref-type="bibr">48</xref></sup> and custom scripts (<ext-link ext-link-type="uri" xlink:href="https://github.com/jtladner/Scripts/blob/master/reference-based_assembly/consensus_fasta.py">https://github.com/jtladner/Scripts/blob/master/reference-based_assembly/consensus_fasta.py</ext-link>). Only bases with Phred quality score &#x2265; 20 were utilized in consensus calling, and a minimum of 3&#xD7; read-depth coverage, in support of the consensus, was required to make a call; positions lacking this depth of coverage were treated as missing (<italic>i.e.</italic> called as &#x201C;N&#x201D;).</p>
      </sec>
      <sec id="S10">
        <title>Validation and comparison of sequencing methods</title>
        <p id="P28">The consensus ZIKV sequences from FL01M and FL03M generated by sequencing 35 &#xD7; 400 bp amplicons on the MiSeq were validated using the following approaches: 1) sequencing the 35 &#xD7; 400 bp amplicons on the Ion S5 platform (ThermoFisher), 2) sequencing amplicons generated using an Ion AmpliSeq&#xAE; (ThermoFisher) panel customly targeted towards ZIKV on the Ion S5 platform, and 3) sequencing 5 &#xD7; 2,150&#x2013;2,400 bp ZIKV amplicons on the MiSeq. For Ion library preparation, cDNA was synthesized using the SuperScript VILO kit (ThermoFisher). ThermoFisher designed 875 custom ZIKV primers to produce 75 amplicons of ~200 bp in two PCR reactions for use with their Ion AmpliSeq Library Kit 2.0. The reagent FuPa was used to digest the modified primer sequences after amplification. The DNA templates were loaded onto Ion 520 chips using the Ion Chef and sequenced on the Ion S5 with the 200 bp output (ThermoFisher). The 35 &#xD7; 400 bp amplicons generated for the MiSeq as described above were introduced into the Ion workflow using the Ion AmpliSeq Library Kit 2.0, but without fragmentation. Primers to amplify 2,150&#x2013;2,400 bp ZIKV fragments (<xref rid="SD4" ref-type="supplementary-material">Supplementary Table 2c</xref>) were kindly provided by Shelby O&#x2019;Connor, Dawn Dudly, Dave O&#x2019;Connor, and Dane Gellerup (AIDS Vaccine Research Laboratory, University of Wisconsin, Madison). Each fragment was amplified individually by PCR using the cDNA generated above, Q5 DNA High-fidelity Polymerase, and the following thermocycle conditions: 55 &#xB0;C for 30 m, 94 &#xB0;C for 2 m, 35 cycles of 94 &#xB0;C for 15 s, 56 &#xB0;C for 30 s, and 68 &#xB0;C for 3.5 m, 68 &#xB0;C for 10 m, and held at 4 &#xB0;C until use. Each PCR product was purified using Agencourt AMPure XP beads, sheared to 300 to 400 nt fragments using the Covaris S2 sonicator, indexed and prepared for sequencing as described above, and sequenced using the MiSeq V2 500 cycle kit (paired-end 251 nt reads). Compared to the consensus sequences generated using 35 &#xD7; 400 bp amplicons on the MiSeq, there were no consensus-level mismatches in the coding sequence using any of the other three approaches (<xref rid="T2" ref-type="table">Extended Data Table 2</xref>). There were, however, some mismatches in the 5&#x2032; and 3&#x2032; UTRs (where the genomic RNA is heavily structured), likely a result of PCR bias and decreased coverage depth.</p>
        <p id="P29">At least 95% of the ZIKV genome was covered from samples with as low as 4 and 9 GE/&#x3BC;l RNA from the amplicon and enrichment approaches, respectively. These results are similar to our previously determined clinical range of 10&#x2013;16 ZIKV GE/&#x3BC;l RNA to achieve at least 95% genome coverage using our amplicon-based approach<sup><xref rid="R24" ref-type="bibr">24</xref></sup>. On average, the amplicon-based sequencing approach covered 97% of the ZIKV genome (&#x2265;3&#xD7; read-depth) and the targeted enrichment approach covered 82% of the ZIKV genome from clinical samples (<xref rid="SD4" ref-type="supplementary-material">Supplementary Table 2d</xref>).</p>
      </sec>
      <sec id="S11">
        <title>Phylogenetic analyses</title>
        <p id="P30">All published and available complete ZIKV genomes of the Asian genotype from the Pacific and the Americas were retrieved from GenBank public database as of December 2016. Public sequences (n=65) were codon-aligned together with ZIKV genomes generated in this study (n=39) using MAFFT<sup><xref rid="R54" ref-type="bibr">54</xref></sup> and inspected manually. The multiple alignment contained 104 ZIKV sequences collected between 2013 and 2016, from the Pacific (American Samoa, French Polynesia, and Tonga), Brazil, other South and Central Americas (Guatemala, Mexico, Suriname, and Venezuela), the Caribbean (Dominican Republic, Guadeloupe, Haiti, Martinique, and Puerto Rico), and the United States (<xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref>).</p>
        <p id="P31">In order to determine the temporal signal of the sequence dataset, a maximum likelihood (ML) phylogeny was first reconstructed with PhyML<sup><xref rid="R55" ref-type="bibr">55</xref></sup> using the general time-reversible (GTR) nucleotide substitution model and gamma distributed rates amongst sites<sup><xref rid="R56" ref-type="bibr">56</xref></sup> (<xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref>), which was identified as the best fitting model for ML inference by jModelTest2<sup><xref rid="R57" ref-type="bibr">57</xref></sup>. Then, a correlation between root-to-tip genetic divergence and date of sampling was conducted in TempEst<sup><xref rid="R58" ref-type="bibr">58</xref></sup>.</p>
        <p id="P32">Bayesian phylogenetic analyses were performed using BEAST v.1.8.4<sup><xref rid="R25" ref-type="bibr">25</xref></sup> to infer time-structured phylogenies. We used an SDR06 nucleotide substitution model<sup><xref rid="R59" ref-type="bibr">59</xref></sup> with a non-informative continuous time Markov chain reference prior (CTMC)<sup><xref rid="R60" ref-type="bibr">60</xref></sup> on the molecular clock rate. Replicate analyses using multiple combinations of molecular clock and coalescent models were explored to select the best fitting model by marginal likelihood comparison using path-sampling and stepping-stone estimation approaches<sup><xref rid="R61" ref-type="bibr">61</xref>&#x2013;<xref rid="R63" ref-type="bibr">63</xref></sup> (<xref rid="T1" ref-type="table">Extended Data Table 1b</xref>). The best fit model was a relaxed molecular clock along with a Bayesian Skyline model<sup><xref rid="R64" ref-type="bibr">64</xref></sup>. All the Bayesian analyses were run for 30 million Markov chain Monte Carlo steps, sampling parameters and trees every 3000 generations (BEAST XML file and MCC tree available in <xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref>). Support values for all nodes are embedded in the phylogenetic tree files (<xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref>). Tree visualizations were generated with baltic (github.com/blab/baltic).</p>
        <p id="P33">The travel-associated ZIKV genomes add to the Caribbean dataset, but do not directly influence our conclusions about the source of ZIKV introductions into Florida.</p>
      </sec>
      <sec id="S12" sec-type="cases">
        <title>Expected number and distribution of local cases from Zika virus importations</title>
        <p id="P34">We used branching process theory<sup><xref rid="R65" ref-type="bibr">65</xref>,<xref rid="R66" ref-type="bibr">66</xref></sup> to generate the offspring distribution (subsequent local cases) that is expected from a single introduction. The offspring distribution <italic>L</italic> is modelled with a negative binomial distribution with mean <italic>R</italic><sub>0</sub> and over-dispersion parameter <italic>k.</italic> The total number of cases <italic>j</italic> that is caused by a single importation (including the index case) after an infinite time<sup><xref rid="R67" ref-type="bibr">67</xref></sup> has the following form: 
<disp-formula id="FD2"><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">&#x393;</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mi>j</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x393;</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace width="0.16667em"/><mml:mi mathvariant="normal">&#x393;</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mfrac><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mi>k</mml:mi></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mi>k</mml:mi></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mi>j</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mfrac></mml:mrow></mml:math></disp-formula></p>
        <p id="P35">The parameter <italic>k</italic> represents the variation in the number of secondary cases generated by each case of ZIKV<sup><xref rid="R65" ref-type="bibr">65</xref></sup>. In the case of vector borne diseases, local heterogeneity is high due to a variety of factors such as mosquito population abundance, human to mosquito interaction, and control interventions<sup><xref rid="R68" ref-type="bibr">68</xref>&#x2013;<xref rid="R73" ref-type="bibr">73</xref></sup>. Here, we assumed high heterogeneity (<italic>k</italic>=0.1) following previous estimates for vector borne diseases<sup><xref rid="R66" ref-type="bibr">66</xref></sup>. This distribution <italic>L</italic> is plotted in <xref rid="F8" ref-type="fig">Extended Data Fig. 4a</xref>. For the following, we took a forward simulation approach, drawing random samples from this distribution. All estimates were based on 100,000 random simulations.</p>
        <p id="P36">We used this formula to estimate the probability of observing 241 local cases in Miami-Dade County alongside 320 travel-associated cases. We approached this by sampling 320 introduction events from <italic>L</italic> and calculating the total number of local cases in the resulting outbreak (<xref rid="F8" ref-type="fig">Extended Data Fig. 4b</xref>). We also calculated the likelihood of observing 241 local cases in the total outbreak (<xref rid="F8" ref-type="fig">Extended Data Fig. 4c</xref>), finding that the MLE of <italic>R</italic><sub>0</sub> lies between 0.35 and 0.55. As a sensitivity analysis, we additionally modelled introductions with the assumption that only 50% of travelers were infectious at time of arrival into Miami-Dade County, resulting in an MLE of <italic>R</italic><sub>0</sub> of 0.45&#x2013;0.8.</p>
        <p id="P37">We further used this formula to address the probability of observing 3 distinct genetic clusters (F1, F2 and F3) representing 3 introduction events in a sample of 27 ZIKV genomes from Miami-Dade County. We approached this by sampling introduction events until we accumulated 241 local cases according to <italic>L</italic>, arriving at <italic>N</italic> introduction events with case counts (<italic>j</italic><sub>1</sub>, <italic>j</italic><sub>2</sub>, &#x2026; <italic>j<sub>N</sub></italic>). We then sampled 27 cases <italic>without replacement</italic> from (<italic>j</italic><sub>1</sub>, <italic>j</italic><sub>2</sub>, &#x2026; <italic>j<sub>N</sub></italic>) following a hypergeometric distribution and recorded the number of distinct clusters drawn in the sample. We found that higher values of <italic>R</italic><sub>0</sub> resulted in fewer distinct clusters within the sample of 27 genomes (<xref rid="F8" ref-type="fig">Extended Data Fig. 4d</xref>). We additionally calculated the likelihood of sampling 3 distinct genetic clusters in 27 genomes (<xref rid="F8" ref-type="fig">Extended Data Fig. 4e</xref>), finding an MLE estimate of <italic>R</italic><sub>0</sub> of 0.7&#x2013;0.9. Additionally, as a sensitivity analysis we modelled a preferential sampling process in which larger clusters are more likely to be drawn from than smaller clusters. Here, we used a parameter <italic>&#x3B1;</italic> that enriches the hypergeometric distribution following (<italic>j</italic><sub>1</sub><italic><sup>&#x3B1;</sup></italic>, <italic>j</italic><sub>2</sub><italic><sup>&#x3B1;</sup></italic>, &#x2026; <italic>j<sub>N</sub><sup>&#x3B1;</sup></italic>). In this case, we found an MLE estimate of <italic>R</italic><sub>0</sub> of 0.5&#x2013;0.9.</p>
        <p id="P38">Using the overlap of estimates of <italic>R</italic><sub>0</sub> from local case counts (0.35&#x2013;0.8) and genetic clusters (0.5&#x2013;0.9), we arrived at a 95% uncertainty range of <italic>R</italic><sub>0</sub> of 0.5&#x2013;0.8. As an additional sensitivity analysis, we incorporated under-reporting in which either 50% of travel-associated cases and 25% of local cases are reported or in which 10% of travel-associated cases and 5% of local cases are reported. We find differential reporting of travel and local cases results in increased mean <italic>R</italic><sub>0</sub> estimates when comparing counts of travel-associated to local cases (<xref rid="F8" ref-type="fig">Extended Data Figure 4f&#x2013;g</xref>). Additionally, we find that under-reporting increases estimates of <italic>R</italic><sub>0</sub> from the sampling analysis (<xref rid="F8" ref-type="fig">Extended Data Figure 4h&#x2013;i</xref>). Thus, moderate under-reporting is consistent with <italic>R</italic><sub>0</sub> estimates of ~0.8.</p>
        <p id="P39">We additionally perform birth-death stochastic simulations assuming a serial interval with mean 20 days<sup><xref rid="R15" ref-type="bibr">15</xref></sup>. We record the number of stochastic simulations still persisting after a particular number of days for different values of <italic>R</italic><sub>0</sub> (<xref rid="F2" ref-type="fig">Fig. 2c</xref>).</p>
      </sec>
      <sec id="S13">
        <title>Zika virus incidence rates</title>
        <p id="P40">Weekly suspected and confirmed ZIKV case counts from countries and territories within the Americas with local transmission (January 1 to September 18, 2016) were obtained from the Pan American Health Organization (PAHO)<sup><xref rid="R30" ref-type="bibr">30</xref></sup>. In most cases, the weekly case numbers per country were only reported in bar graphs. We contacted PAHO multiple times with the hope of gaining access to the raw data included in the bar graphs, but our requests were unfortunately denied. Therefore we used WebPlotDigitizer v3.10 (<ext-link ext-link-type="uri" xlink:href="http://arohatgi.info/WebPlotDigitizer">http://arohatgi.info/WebPlotDigitizer</ext-link>) to estimate the numbers. We compared the actual ZIKV case numbers reported in Ecuador<sup><xref rid="R74" ref-type="bibr">74</xref></sup> (only country with available raw data and reported cases &gt; 10 per week) to our estimates from the PAHO bar graphs and found that the WebPlotDigitizer was ~99% accurate (<xref rid="F9" ref-type="fig">Extended Data Fig. 5a&#x2013;b</xref>).</p>
        <p id="P41">Country and territory total population sizes to calculate weekly and monthly ZIKV incidence rates were also obtained from PAHO<sup><xref rid="R75" ref-type="bibr">75</xref></sup>. Incidence rates calculated from countries and territories in the Americas during January to June, 2016 (based on the earliest introduction time estimates until the first known cases) were used as an estimate for infection likelihood to investigate sources of ZIKV introductions.</p>
      </sec>
      <sec id="S14">
        <title>Airline and cruise ship traffic</title>
        <p id="P42">To investigate whether the transmission of ZIKV in Florida coincides with travel patterns from ZIKV endemic regions, we obtained the number of passengers arriving at airports in Florida via commercial air travel. We collated flight data from countries and territories in the Americas with local ZIKV transmission between January and June, 2016 (based on the earliest introduction time estimates until the first known cases, <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1b</xref>), arriving at all commercial airports in Florida. The data were obtained from the International Air Transportation Association, which collects data on an estimated 90% of all passenger trips worldwide. Nelson <italic>et al</italic>.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> previously reported flight data from 33 countries with ZIKV transmission entering major United States airports during October 2014 through September 2015, which we used to assess the potential for ZIKV introductions outside of Florida.</p>
        <p id="P43">Schedules for cruise ships visiting Miami, Port Canaveral, Port Everglades, Fort Lauderdale, Key West, Jacksonville (all in Florida), Houston, Galveston (both in Texas), Charleston (South Carolina) and New Orleans (Louisiana) ports in the year 2016 were collated from <ext-link ext-link-type="uri" xlink:href="www.cruisett.com">www.cruisett.com</ext-link> and confirmed by cross-referencing ship logs reported by Port of Miami and reported ship schedules from <ext-link ext-link-type="uri" xlink:href="www.miamidade.gov/portmiami/">www.miamidade.gov/portmiami/</ext-link>. Scheduled cruise ship capacities were extracted from <ext-link ext-link-type="uri" xlink:href="www.cruisemapper.com">www.cruisemapper.com</ext-link>. Every country/territory with ZIKV transmission visited by a cruise ship 10 days (the approximate mean time to ZIKV clearance in human blood [<italic>i.e.</italic>, the infectious period])<sup><xref rid="R76" ref-type="bibr">76</xref></sup> prior to arrival was counted as contributing the ship&#x2019;s capacity worth of passengers to Miami to the month of arrival (<xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1b</xref>). While the air traffic was based on the reported number of travelers, we estimated the sea traffic by ship capacity. Lee and Ramdeen<sup><xref rid="R77" ref-type="bibr">77</xref></sup> reported that the average occupancy of cruise ships traveling to the Caribbean Islands exceeded 100% in 2011, and according to the Florida-Caribbean Cruise Association<sup><xref rid="R78" ref-type="bibr">78</xref></sup>, it remained &gt;100% in 2015. Occupancy data for 2016 was not available at the time of publication, but we assumed that it was also near 100%.</p>
      </sec>
      <sec id="S15">
        <title>Expected number of travelers infected with Zika virus</title>
        <p id="P44">We estimated the expected number of travelers entering Miami who were infected with ZIKV (&#x3BB;) by using the total travel capacity (<italic>C</italic>) and the likelihood of ZIKV infection (infections (<italic>I</italic>) per person (<italic>N</italic>)) from each country/territory (<italic>i</italic>): 
<disp-formula id="FD3"><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mi>&#x3BB;</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mo>&#x2211;</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfrac><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mrow></mml:math></disp-formula></p>
        <p id="P45">We summed the number of expected infected travelers from each country/territory with ZIKV transmission by region and travel method (flights or cruises). The number of ZIKV cases reported by each country are likely under-estimates in part because the majority of ZIKV infections are asymptomatic<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup>. We normalized some of the potential reporting variances between countries by reporting the data as the relative proportion of infected travelers (<xref rid="F3" ref-type="fig">Fig. 3c</xref>, <xref rid="F11" ref-type="fig">Extended Data Fig. 7a</xref>) and as the absolute number of infected travelers (<xref rid="F3" ref-type="fig">Fig. 3d</xref>, <xref rid="F11" ref-type="fig">Extended Data Fig. 7b</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1b</xref>) from each region. We also accounted for potential reporting biases with incidence rates by using ZIKV attack rates (<italic>i.e.</italic>, proportion infected before epidemic burnout) to estimate peak transmission intensity. Attack rates were calculated using a susceptible&#x2013;infected&#x2013;recovered (SIR) transmission model derived from seroprevalence studies and environmental factors as described<sup><xref rid="R79" ref-type="bibr">79</xref></sup>. Using attack rates as an estimate of infection likelihood, we predict that ~60% of the infected travelers entering Miami came from the Caribbean (<xref rid="F11" ref-type="fig">Extended Data 7b</xref>), which is in agreement with our methods using incidence rates of ~60&#x2013;70% (<xref rid="F3" ref-type="fig">Fig. 3c</xref>). A list of countries and territories used in these analyses can be found in <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1b</xref>.</p>
      </sec>
      <sec id="S16">
        <title>Maps</title>
        <p id="P46">The maps presented in our figures were generated using Matplotlib<sup><xref rid="R80" ref-type="bibr">80</xref></sup> and ESRI basemaps (<ext-link ext-link-type="uri" xlink:href="www.esri.com/data/basemaps">www.esri.com/data/basemaps</ext-link>). The software and basemaps are open source and &#x201C;freely available to anyone&#x201D;.</p>
      </sec>
      <sec id="S17">
        <title>Data availability</title>
        <p id="P47">All ZIKV sequencing data is available under the NCBI BioProjects PRJNA342539 and PRJNA356429. Individual sample GenBank access numbers are listed in <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 1a</xref>. All other data is available in the Extended Data, <xref rid="SD1" ref-type="supplementary-material">Supplemental Information</xref>, or upon request.</p>
      </sec>
    </sec>
    <sec id="S18">
      <title>Extended Data</title>
      <fig id="F5" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 1</label>
        <caption>
          <title>Miami-Dade mosquito surveillance and relative <italic>Aedes aegypti</italic> abundance</title>
          <p id="P48">(<bold>a</bold>) Mosquito surveillance data reported from June 21 to November 28, 2016 was used to evaluate the risk of ZIKV infection from mosquito-borne transmission in Miami. A total of 24,306 <italic>Ae. aegypti</italic> and 45 <italic>Ae. albopictus</italic> were collected. Trap nights are the total number of times each trap site was used and the trap locations are shown in <xref rid="F1" ref-type="fig">Fig. 1d</xref> (some &#x201C;Other Miami&#x201D; trap sites are located outside of mapped region). Up to 50 mosquitoes of the same species and trap night were pooled together for ZIKV RNA testing. The infection rates were calculated using a maximum likelihood estimate (MLE). None of the <italic>Ae. albopictus</italic> pools contained ZIKV RNA. (<bold>b</bold>) The number of weekly ZIKV cases (based on symptoms onset) was correlated with mean <italic>Ae. aegypti</italic> abundance per trap night determined from the same week and zone (Spearman r = 0.61). This suggests that when the virus is present, mosquito abundance numbers alone could be used to target control efforts. (<bold>c</bold>) Insecticide usage, including truck and aerial adulticides and larvacides, by the Miami-Dade Mosquito Control in Wynwood (left) and Miami Beach (right) was overlaid with <italic>Ae. aegypti</italic> abundance per trap night to demonstrate that intense usage of insecticides may have helped to reduce local mosquito populations. (<bold>d</bold>) Relative <italic>Ae. aegypti</italic> abundance for each Florida county and month was estimated using a multivariate regression model, demonstrating spatial and temporal heterogeneity for the risk of ZIKV infection.</p>
        </caption>
        <graphic xlink:href="nihms872467f5"/>
      </fig>
      <fig id="F6" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 2</label>
        <caption>
          <title>Maximum likelihood tree and root-to-tip regression of Zika virus genomes from Pacific islands and the epidemic in Americas</title>
          <p id="P49">(<bold>a</bold>) Maximum likelihood tree of publicly available ZIKV sequences and sequences generated in this study (n=104). tips are coloured by location, labels in bold indicate sequences generated in this study, Florida clusters F1&#x2013;F4 are indicated by vertical lines to the right of the tree. Bootstrap support values are shown at key nodes. All other support values can be found in <xref rid="SD1" ref-type="supplementary-material">Supplementary File 1</xref>. (<bold>b</bold>) Linear regression of sample tip dates against divergence from root based on sequences with known collection dates estimates an evolutionary rate for the ZIKV phylogeny of 1.10&#xD7;10<sup>&#x2212;3</sup> nucleotide substitutions/site/year (subs/site/yr). This is consistent with BEAST analyses using a relaxed molecular clock and a Bayesian Skyline tree prior, the best-performing combination of clock and demographic model according to marginal likelihood estimates (<xref rid="T1" ref-type="table">Extended Data Table 1c</xref>), which estimated an evolutionary rate of 1.21&#xD7;10<sup>&#x2212;3</sup> (95% highest posterior density: 1.01 &#x2013; 1.43&#xD7;10<sup>&#x2212;3</sup>) subs/site/yr (<xref rid="T1" ref-type="table">Extended Data Table 1a</xref>). These values are in agreement with previous estimates calculated based on ZIKV genomes from Brazil<sup><xref rid="R6" ref-type="bibr">6</xref></sup>.</p>
        </caption>
        <graphic xlink:href="nihms872467f6"/>
      </fig>
      <fig id="F7" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 3</label>
        <caption>
          <title>Molecular clock dating of Zika virus clades</title>
          <p id="P50">Maximum clade credibility (MCC) tree of ZIKV genomes collected from Pacific islands and the epidemic in Americas (n=104). Circles at the tips are colored based on origin location. Clade posterior probabilities are indicated by white circles filled with black relative to the support. A posterior probability of 1 fills the entire circle black. The grey violin plot indicates the 95% highest posterior density (HPD) interval for the tMRCA of the American epidemic. We estimated that the tMRCA for the ongoing epidemic in the Americas occurred during October, 2013 (node AM, <xref rid="T1" ref-type="table">Extended Table 1</xref>, 95% HPD: August, 2013-January, 2014), which is consistent with previous analysis based on ZIKV genomes from Brazil<sup><xref rid="R6" ref-type="bibr">6</xref></sup>.</p>
        </caption>
        <graphic xlink:href="nihms872467f7"/>
      </fig>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 4</label>
        <caption>
          <title>Estimation of basic reproductive number and number of introductions in Miami-Dade County</title>
          <p id="P51">(<bold>a</bold>) Probability distribution of estimated total number of cases caused by a single introduction (excluding the index case) for different values of <italic>R</italic><sub>0</sub>. (<bold>b</bold>) Mean and 95% CI for total number of local cases caused by 320 introduction events (<italic>i.e.</italic>, travel-associated cases diagnosed in Miami-Dade County) for different values of <italic>R</italic><sub>0</sub> and for different assumptions of proportion of infectious travelers. (<bold>c</bold>) Log likelihood of observing 241 local cases in Miami-Dade County with 320 introduction events for different values of <italic>R</italic><sub>0</sub> along with 95% maximum likelihood estimate (MLE) bounds on <italic>R</italic><sub>0</sub>. (<bold>d</bold>) Mean and 95% uncertainty interval for total number of distinct phylogenetic clusters observed in 27 sequenced ZIKV genomes from human cases diagnosed in Miami-Dade County for different values of <italic>R</italic><sub>0</sub> and for different assumptions of sampling bias, from <italic>&#x3B1;</italic>=1 (no sampling bias) to <italic>&#x3B1;</italic>=2 (skewed toward preferentially sampling larger clusters). (<bold>e</bold>) Log likelihood of observing 3 clusters (<italic>i.e.</italic>, ZIKV lineages F1, F2, and F4, <xref rid="F2" ref-type="fig">Fig. 2a</xref>) in 27 sequenced cases for different values of <italic>R</italic><sub>0</sub> along with 95% MLE bounds on <italic>R</italic><sub>0</sub>. (<bold>f</bold>) Mean and 95% CI for total number of local cases caused by 320 observed travel-associated cases with travel-associated vs local reporting rates of 50%/25% and 10%/5%. This assumes 50% of travelers are infectious. (<bold>g</bold>) Log likelihood of observing 241 local cases with 320 introduction events for different values of <italic>R</italic><sub>0</sub> along with 95% MLE bounds on <italic>R</italic><sub>0</sub> with travel-associated vs local reporting rates of 50%/25% and 10%/5%. (<bold>h</bold>) Mean and 95% uncertainty interval for total number of distinct phylogenetic clusters observed in 27 sequenced ZIKV genomes for different values of <italic>R</italic><sub>0</sub> and for assumptions of local reporting rate of 5% and 25%. This assumes preferential sampling (<italic>&#x3B1;</italic>=2). (<bold>i</bold>) Log likelihood of observing 3 clusters in 27 sequenced cases for different values of <italic>R</italic><sub>0</sub> along with 95% MLE bounds on <italic>R</italic><sub>0</sub> with local reporting rate of 5% and 25%. At 5% local reporting rate, 0 of the 100,000 replicates for all <italic>R</italic><sub>0</sub> values showed 3 clusters.</p>
        </caption>
        <graphic xlink:href="nihms872467f8"/>
      </fig>
      <fig id="F9" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 5</label>
        <caption>
          <title>Weekly reported Zika virus case numbers and incidence rates in the Americas</title>
          <p id="P52">(<bold>a</bold>) Most ZIKV case numbers reported by PAHO<sup><xref rid="R30" ref-type="bibr">30</xref></sup> were only available as bar graphs (raw data was not made available to us at the time of request). Therefore we used the WebPlotDigitizer to estimate the weekly case numbers from the PAHO bar graphs. ZIKV cases reported from Ecuador was the only data set to include a link to the actual case numbers that also had &gt;10 cases per week<sup><xref rid="R74" ref-type="bibr">74</xref></sup>. To validate the WebPlotDigitizer, we compared the weekly reported case numbers from Ecuador to our estimates. (<bold>b</bold>) The reported and estimated case numbers were strongly correlated (Spearman r = 0.9981). The WebPlotDigitizer was used to estimate the ZIKV case numbers for all subsequent analysis. (<bold>c</bold>) ZIKV cases (suspected and confirmed) and (<bold>d</bold>) incidence rates (normalized per 100,000 population) are shown for each country or territory with available data per epidemiological week from January 1 to September 18, 2016. (<bold>e</bold>) Each country or territory with available data is colored by its reported ZIKV incidence rate from January to June, 2016 (the time frame for analysis of ZIKV introductions into Florida).</p>
        </caption>
        <graphic xlink:href="nihms872467f9"/>
      </fig>
      <fig id="F10" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 6</label>
        <caption>
          <title>Cruise and flight traffic entering Miami from regions with Zika virus transmission</title>
          <p id="P53">The estimated number of passengers entering Miami, by either (<bold>a</bold>) cruises or (<bold>b</bold>) flights, from each country or territory in the Americas with ZIKV transmission per month (left panel). The center map and inset show the cumulative numbers of travelers entering Miami during January to June, 2016 (the time frame for analysis of ZIKV introductions into Florida) from each country or territory per method of travel. (<bold>c</bold>) The total traffic (<italic>i.e.</italic> cruises and flights) is shown entering Miami per month.</p>
        </caption>
        <graphic xlink:href="nihms872467f10"/>
      </fig>
      <fig id="F11" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 7</label>
        <caption>
          <title>Expected number of Zika virus infected travelers from the Caribbean is correlated with the total observed number of travel-associated infections</title>
          <p id="P54">(<bold>a</bold>) In order to account for potential biases in ZIKV reporting accuracies, we also estimated the proportion of infected travelers using projected ZIKV attack rates<sup><xref rid="R79" ref-type="bibr">79</xref></sup> (<italic>i.e.</italic> predicted proportion of population infected before epidemic burnout). About 60% of the infected travelers are expected to have arrived from the Caribbean, similar to our results using incidence rates (<xref rid="F3" ref-type="fig">Fig. 3c</xref>). (<bold>b</bold>) The expected number of travel-associated ZIKV cases were estimated by the number of travelers coming into Miami from each country/territory (travel capacity) and the in-country/territory infection likelihood (incidence rate per person) per week. The expected travel cases were summed from all of the Americas (left), Caribbean (left center), South America (right center), and Central America (right) and plotted with the observed travel-associated ZIKV cases. Numbers in each plot indicate Spearman correlation coefficients. Negative Spearman r coefficients indicated a negative correlation between the number of expected and observed travel cases.</p>
        </caption>
        <graphic xlink:href="nihms872467f11"/>
      </fig>
      <fig id="F12" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 8</label>
        <caption>
          <title>Greater early season potential for Zika virus introductions into Miami</title>
          <p id="P55">The monthly cruise ship and airline<sup><xref rid="R28" ref-type="bibr">28</xref></sup> capacity from countries/territories with ZIKV transmission for the major United States travel hubs (shown as circle diameter) with monthly potential <italic>Ae. aegypti</italic> abundance (circle color), as previously estimated<sup><xref rid="R22" ref-type="bibr">22</xref></sup>. The abundance ranges were chosen with respect to the May-Oct Miami mean: &#x201C;None to low&#x201D; (&lt;2%), &#x201C;Low to moderate&#x201D; (2&#x2013;25%), &#x201C;Moderate to high (25&#x2013;75%), and &#x201C;High&#x201D; (&gt;75%). Mosquito-borne transmission is unlikely in the &#x201C;None to low&#x201D; range. Cruise capacities from Houston and Galveston, Texas were combined.</p>
        </caption>
        <graphic xlink:href="nihms872467f12"/>
      </fig>
      <table-wrap id="T1" position="anchor" orientation="portrait">
        <label>Extended Data Table 1</label>
        <caption>
          <p id="P56">(a) Time of the most recent common ancestor and evolutionary rate and (b) Model selection to infer time-structured phylogenies.</p>
        </caption>
        <table frame="void" rules="none">
          <thead>
            <tr>
              <th colspan="10" valign="bottom" align="left" rowspan="1">a</th>
            </tr>
            <tr>
              <th valign="middle" rowspan="3" align="left" colspan="1">Model combination</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">Clade AM tMRCA</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">Clade A tMRCA</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">Clade B tMRCA</th>
            </tr>
            <tr>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
            </tr>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1">Mean</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Lower 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Higher 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Mean</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Lower 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Higher 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Mean</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Lower 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Higher 95% HPD</th>
            </tr>
            <tr>
              <th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Constant</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.87</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.65</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2014.09</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.59</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.43</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.76</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.70</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.52</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.86</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Exponential</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.90</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.69</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2014.09</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.55</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.36</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.72</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.66</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.47</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.83</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Bayesian Skyline</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.92</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.70</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2014.12</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.56</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.38</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.74</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.69</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.50</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.86</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Constant</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.95</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.66</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2014.21</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.70</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.49</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.88</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.82</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.63</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.03</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Exponential</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.95</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.70</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2014.19</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.62</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.39</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.81</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.73</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.51</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.93</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Bayesian Skyline</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.97</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2013.72</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2014.23</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.62</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.40</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.81</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.76</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.54</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.94</td>
            </tr>
            <tr>
              <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
              <td colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></td>
              <td colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></td>
            </tr>
          </tbody>
        </table>
        <table frame="void" rules="none">
          <thead>
            <tr>
              <th valign="middle" rowspan="3" align="left" colspan="1">Model combination</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">Clade F1 tMRCA</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">Clade F2 tMRCA</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">Evolutionary Rate</th>
            </tr>
            <tr>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
            </tr>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1">Mean</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Lower 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Higher 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Mean</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Lower 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Higher 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Mean</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Lower 95% HPD</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Higher 95% HPD</th>
            </tr>
            <tr>
              <th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Constant</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.16</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.02</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.28</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.16</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.00</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.31</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.09E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.27E-04</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.23E-03</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Exponential</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.12</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.97</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.25</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.13</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.94</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.28</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.08E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.35E-04</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.23E-03</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Bayesian Skyline</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.25</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.13</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.36</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.24</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.06</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.37</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.13E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.80E-04</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.28E-03</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Constant</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.19</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.05</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.31</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.21</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.05</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.36</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.22E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.95E-04</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.47E-03</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Exponential</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.14</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.98</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.27</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.16</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2015.98</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.32</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.17E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">9.68E-04</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.39E-03</td>
            </tr>
            <tr>
              <td colspan="4" align="left" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
              <td colspan="3" align="center" valign="bottom" rowspan="1">
<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Bayesian Skyline</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.27</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.16</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.38</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.27</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.08</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2016.39</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.21E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.01E-03</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1.43E-03</td>
            </tr>
            <tr>
              <td colspan="4" valign="bottom" align="left" rowspan="1">
<hr/></td>
              <td colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></td>
              <td colspan="3" valign="bottom" align="center" rowspan="1">
<hr/></td>
            </tr>
          </tbody>
        </table>
        <table frame="below" rules="rows">
          <thead>
            <tr>
              <th colspan="5" valign="bottom" align="left" rowspan="1">b</th>
            </tr>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Model combination</th>
              <th valign="bottom" align="center" rowspan="1" colspan="1">Path Sampling</th>
              <th valign="bottom" align="center" rowspan="1" colspan="1">Ranking</th>
              <th valign="bottom" align="center" rowspan="1" colspan="1">Stepping Stone</th>
              <th valign="bottom" align="center" rowspan="1" colspan="1">Ranking</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Constant</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20379.871</td>
              <td align="center" valign="top" rowspan="1" colspan="1">5</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20384.201</td>
              <td align="center" valign="top" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Exponential</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20375.747</td>
              <td align="center" valign="top" rowspan="1" colspan="1">4</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20379.272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">4</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Strict, Bayesian Skyline</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20358.676</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20363.748</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Constant</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20381.228</td>
              <td align="center" valign="top" rowspan="1" colspan="1">6</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20385.807</td>
              <td align="center" valign="top" rowspan="1" colspan="1">6</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Exponential</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20370.555</td>
              <td align="center" valign="top" rowspan="1" colspan="1">3</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20374.418</td>
              <td align="center" valign="top" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UCLN, Bayesian Skyline</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20354.940</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1</td>
              <td align="center" valign="top" rowspan="1" colspan="1">&#x2212;20361.218</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p id="P57">HPD, highest posterior density. Dates listed as proportion of days elapsed with a year. Clades refer to <xref rid="F2" ref-type="fig">Fig. 2a</xref>.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="T2" position="anchor" orientation="portrait">
        <label>Extended Data Table 2</label>
        <caption>
          <p id="P58">Validation of sequencing results.</p>
        </caption>
        <table frame="below" rules="rows">
          <thead>
            <tr>
              <th valign="bottom" rowspan="2" align="left" colspan="1">Sample</th>
              <th valign="bottom" rowspan="2" align="center" colspan="1">Amplicon method</th>
              <th valign="bottom" rowspan="2" align="center" colspan="1">NGS platform</th>
              <th colspan="3" valign="bottom" align="center" rowspan="1">
                <underline>Mismatches/nucleotides covered</underline>
                <xref rid="TFN2" ref-type="table-fn">a</xref>
              </th>
            </tr>
            <tr>
              <th valign="bottom" align="center" rowspan="1" colspan="1">3&#x2032;UTR</th>
              <th valign="bottom" align="center" rowspan="1" colspan="1">CDS</th>
              <th valign="bottom" align="center" rowspan="1" colspan="1">5&#x2032; UTR</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">FL01M</td>
              <td align="center" valign="top" rowspan="1" colspan="1">35 &#xD7; 400 bp</td>
              <td align="center" valign="top" rowspan="1" colspan="1">Ion S5</td>
              <td align="center" valign="top" rowspan="1" colspan="1">1/80</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/10272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">7/252</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="center" valign="top" rowspan="1" colspan="1">75 &#xD7; ~200 bp<xref rid="TFN3" ref-type="table-fn">b</xref></td>
              <td align="center" valign="top" rowspan="1" colspan="1">Ion S5</td>
              <td align="center" valign="top" rowspan="1" colspan="1">2/75</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/10272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">4/205</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="center" valign="top" rowspan="1" colspan="1">5 &#xD7; ~2,200 bp</td>
              <td align="center" valign="top" rowspan="1" colspan="1">MiSeq</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/80</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/10272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/32</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">FL03M</td>
              <td align="center" valign="top" rowspan="1" colspan="1">35 &#xD7; 400 bp</td>
              <td align="center" valign="top" rowspan="1" colspan="1">Ion S5</td>
              <td align="center" valign="top" rowspan="1" colspan="1">3/87</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/10272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">20/252</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="center" valign="top" rowspan="1" colspan="1">75 &#xD7; ~200 bp<xref rid="TFN3" ref-type="table-fn">b</xref></td>
              <td align="center" valign="top" rowspan="1" colspan="1">Ion S5</td>
              <td align="center" valign="top" rowspan="1" colspan="1">4/78</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/10272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">5/198</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="center" valign="top" rowspan="1" colspan="1">5 &#xD7; ~2,200 bp</td>
              <td align="center" valign="top" rowspan="1" colspan="1">MiSeq</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/82</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/10272</td>
              <td align="center" valign="top" rowspan="1" colspan="1">0/32</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN2">
            <label>a</label>
            <p id="P59">Compared to the consensus genomes generated by sequencing 35 &#xD7; 400 bp amplicons on the MiSeq.</p>
          </fn>
          <fn id="TFN3">
            <label>b</label>
            <p id="P60">Amplicons produced using Ion AmpliSeq and 875 custom ZIKV primers.</p>
          </fn>
          <fn id="TFN4">
            <p id="P61">NGS, next-generation sequencing; UTR, untranslated region; CDS, coding sequence.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="supplementary-material" id="S19">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>supp_info</label>
        <media xlink:href="NIHMS872467-supplement-supp_info.docx" orientation="portrait" xlink:type="simple" id="d36e3303" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>supp_rawdata</label>
        <media xlink:href="NIHMS872467-supplement-supp_rawdata.zip" orientation="portrait" xlink:type="simple" id="d36e3307" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <label>supp_table1</label>
        <media xlink:href="NIHMS872467-supplement-supp_table1.xlsx" orientation="portrait" xlink:type="simple" id="d36e3311" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD4">
        <label>supp_table2</label>
        <media xlink:href="NIHMS872467-supplement-supp_table2.xlsx" orientation="portrait" xlink:type="simple" id="d36e3315" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S20">
      <p>We thank J. Weger-Lucarelli, G. Ebel, C. Moore, B. Alto, G. Donatti, and S. Taylor for discussions, E. Spencer for IRB and logistics support, M. Pilcher for sequencing assistance, and G. Schroth and S. Gross for designing and providing enrichment probes. N.D.G. is supported by NIH training grant 5T32AI007244-33. G.D. is supported by the Mahan Postdoctoral Fellowship from the Computational Biology Program at Fred Hutch. K.G.B. is supported by the ASTMH Shope Fellowship. N.R.F. is funded by a Sir Henry Dale Fellowship (Wellcome Trust/Royal Society Grant 204311/Z/16/Z). D.A.T.C. was supported by US NIH MIDAS program (U54-GM088491) and CDC Cooperative Agreement U01CK000510. A.R. is supported by EU Seventh Framework Programme (FP7/2007-2013) under Grant 278433-PREDEMICS, ERC Grant 260864, Horizon 2020 Grant 643476-COMPARE. T.B. is a Pew Biomedical Scholar and is supported by NIH R35 GM119774-01. O.G.P. received funding from EU ERC Seventh Framework Programme (FP7/2007-2013)/ERC number 614725-PATHPHYLODYN and the USAID Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102). S.I. and S.F.M. are supported by NIH NIAID 4R01AI099210-04. ZIKV sequencing at USAMRIID was supported by DARPA (PI: C. Kane). K.G.A. is a Pew Biomedical Scholar, and is supported by NIH NCATS CTSA UL1TR001114, NIAID contract HHSN272201400048C, and The Ray Thomas Foundation. The content of this publication does not necessarily reflect the views or policies of the US Army, the Department of Health and Human Services, the CDC, or the Florida DOH.</p>
    </ack>
    <fn-group>
      <fn id="FN5" fn-type="con">
        <p>
          <bold>Author Contributions</bold>
        </p>
        <p>All contributions are listed in order of authorship. Designed the experiments: N.D.G., J.T.L., G.D., M.U.G.K., D.A.T.C., P.C.S, L.D.G., S.F.M., T.B., O.G.P., S.I., G.P., and K.G.A.; Collected samples: A.L.T., S.W., D.M.M., A.B., L.M.P., D.P., P.N.L., M.R., V.K.B., D.I.W., M.R.C., E.W.K., K.N.H., A.C.C., R.J., M.C.P., C.V., D.S., L.D.G., S.F.M., and S.I.; Performed the sequencing: N.D.G., M.W.R., K.P., D.R., R.R.-S., G.O., and E.N.; Provided data, reagents, or protocols: N.D.G., J.T.L., G.D., M.U.G.K., K.G., M.R.W., R.R.-S., G.O., H.C.M., M.L.B., K.G.B., B.C., C.A.F., A.G.-Y., A.G., C.L., B.M., C.B.M., D.J.P., J.Q., S.F.S., C.T.-T., K.L.M., S.M.W., S.W., N.L.Y., J.Q., J.R.F., K.K., S.E.B., A.J.M., R.F.G., N.J.L., M.C.P., C.V., P.C.S., S.F.M., and S.I.; Analyzed the data: N.D.G., J.T.L., G.D., M.U.G.K., K.G., J.T., J.R.F., R.C.R., N.R.F., D.A.T.C., A.K., M.S.-L., T.B., S.F.M, O.G.P., S.I., and K.G.A.; Edited manuscript: G.D., M.U.G.K., J.T., S.F.S., A.R., T.B., O.G.P., S.I., and G.P.; Wrote manuscript: N.D.G., J.T.L., and K.G.A.; All authors read and approved the manuscript.</p>
      </fn>
      <fn fn-type="COI-statement" id="FN6">
        <p>The authors declare no competing financial interests.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="book">
          <source>Zika virus and complications</source>
          <publisher-name>World Health Organization</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/features/qa/zika/en/">http://www.who.int/features/qa/zika/en/</ext-link></comment>
          <date-in-citation>Accessed: 1st November 2016</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazear</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere</article-title>
          <source>J Virol</source>
          <volume>90</volume>
          <fpage>4864</fpage>
          <lpage>4875</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26962217</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Likos</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Local Mosquito-Borne Transmission of Zika Virus - Miami-Dade and Broward Counties, Florida, June-August 2016</article-title>
          <source>MMWR Morb Mortal Wkly Rep</source>
          <volume>65</volume>
          <fpage>1032</fpage>
          <lpage>1038</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27684886</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="book">
          <source>Mosquito-Borne Disease Surveillance</source>
          <publisher-name>Florida Department of Health</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.floridahealth.gov/diseases-and-conditions/mosquito-borne-diseases/surveillance.html">http://www.floridahealth.gov/diseases-and-conditions/mosquito-borne-diseases/surveillance.html</ext-link></comment>
          <date-in-citation>Accessed: 10th January 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hennessey</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Staples</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Zika Virus Spreads to New Areas &#x2014; Region of the Americas, May 2015&#x2013;January 2016</article-title>
          <source>MMWR Morb Mortal Wkly Rep</source>
          <volume>65</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26766396</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faria</surname>
              <given-names>NR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Zika virus in the Americas: Early epidemiological and genetic findings</article-title>
          <source>Science</source>
          <volume>352</volume>
          <fpage>345</fpage>
          <lpage>349</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27013429</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faria</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Quick</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morales</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Theze</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de Jesus</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Epidemic establishment and cryptic transmission of Zika virus in Brazil and the Americas</article-title>
          <comment>bioRxiv</comment>
          <year>2017</year>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metsky</surname>
              <given-names>HC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome sequencing reveals Zika virus diversity and spread in the Americas</article-title>
          <comment>bioRxiv</comment>
          <volume>109348</volume>
          <year>2017</year>
          <pub-id pub-id-type="doi">10.1101/109348</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="book">
          <source>Regional Zika Epidemiological Update (Americas)</source>
          <publisher-name>Pan American Health Organization</publisher-name>
          <year>2016</year>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=11599&amp;Itemid=41691&amp;lang=en">http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=11599&amp;Itemid=41691&amp;lang=en</ext-link></comment>
          <date-in-citation>Accessed: 1st December 2016</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weger-Lucarelli</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vector Competence of American Mosquitoes for Three Strains of Zika Virus</article-title>
          <source>PLoS Negl Trop Dis</source>
          <volume>10</volume>
          <fpage>e0005101</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27783679</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guerbois</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Outbreak of Zika virus infection, Chiapas State, Mexico, 2015, and first confirmed transmission by Aedes aegypti mosquitoes in the Americas</article-title>
          <source>J Infect Dis</source>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira-de-Brito</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>First detection of natural infection of Aedes aegypti with Zika virus in Brazil and throughout South America</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <volume>0</volume>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chouin-Carneiro</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential Susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika Virus</article-title>
          <source>PLoS Negl Trop Dis</source>
          <volume>10</volume>
          <fpage>e0004543</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26938868</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraemer</surname>
              <given-names>MUG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus</article-title>
          <source>Elife</source>
          <volume>4</volume>
          <fpage>e08347</fpage>
          <year>2015</year>
          <pub-id pub-id-type="pmid">26126267</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferguson</surname>
              <given-names>NM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Countering the Zika epidemic in Latin America</article-title>
          <source>Science</source>
          <volume>353</volume>
          <fpage>353</fpage>
          <lpage>354</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27417493</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teets</surname>
              <given-names>FD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Origin of the dengue virus outbreak in Martin County, Florida, USA 2013</article-title>
          <source>Virol Rep</source>
          <volume>1&#x2013;2</volume>
          <fpage>2</fpage>
          <lpage>8</lpage>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graham</surname>
              <given-names>AS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mosquito-associated dengue virus, Key West, Florida, USA, 2010</article-title>
          <source>Emerg Infect Dis</source>
          <volume>17</volume>
          <fpage>2074</fpage>
          <lpage>2075</lpage>
          <year>2011</year>
          <pub-id pub-id-type="pmid">22099104</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kendrick</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Notes from the field: transmission of chikungunya virus in the continental United States&#x2014;Florida, 2014</article-title>
          <source>MMWR Morb Mortal Wkly Rep</source>
          <volume>63</volume>
          <fpage>1137</fpage>
          <year>2014</year>
          <pub-id pub-id-type="pmid">25474035</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouri</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Return of epidemic dengue in the United States: implications for the public health practitioner</article-title>
          <source>Public Health Rep</source>
          <volume>127</volume>
          <fpage>259</fpage>
          <lpage>266</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">22547856</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramos</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidemic Dengue and Dengue Hemorrhagic Fever at the Texas&#x2013;Mexico Border: Results of a Household-based Seroepidemiologic Survey, December 2005</article-title>
          <source>Am J Trop Med Hyg</source>
          <volume>78</volume>
          <fpage>364</fpage>
          <lpage>369</lpage>
          <year>2008</year>
          <pub-id pub-id-type="pmid">18337327</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>KO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of dengue fever cases in Houston, Texas, with evidence of autochthonous transmission between 2003 and 2005</article-title>
          <source>Vector Borne Zoonotic Dis</source>
          <volume>13</volume>
          <fpage>835</fpage>
          <lpage>845</lpage>
          <year>2013</year>
          <pub-id pub-id-type="pmid">24107180</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monaghan</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>On the Seasonal Occurrence and Abundance of the Zika Virus Vector Mosquito Aedes Aegypti in the Contiguous United States</article-title>
          <source>PLoS Curr</source>
          <volume>8</volume>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dzul-Manzanilla</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence of vertical transmission and co-circulation of chikungunya and dengue viruses in field populations of Aedes aegypti (L.) from Guerrero, Mexico</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <volume>110</volume>
          <fpage>141</fpage>
          <lpage>144</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26711697</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quick</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples</article-title>
          <comment>bioRxiv</comment>
          <volume>098913</volume>
          <year>2017</year>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drummond</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Suchard</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rambaut</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Bayesian phylogenetics with BEAUti and the BEAST 1.7</article-title>
          <source>Mol Biol Evol</source>
          <volume>29</volume>
          <fpage>1969</fpage>
          <lpage>1973</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">22367748</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robert</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modeling Mosquito-Borne Disease Spread in U.S. Urbanized Areas: The Case of Dengue in Miami</article-title>
          <source>PLoS One</source>
          <volume>11</volume>
          <fpage>e0161365</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27532496</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCarthy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>First US case of Zika virus infection is identified in Texas</article-title>
          <source>BMJ</source>
          <volume>352</volume>
          <fpage>i212</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26762624</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Travel Volume to the United States from Countries and U.S. Territories with Local Zika Virus Transmission</article-title>
          <source>PLoS Curr</source>
          <volume>8</volume>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="book">
          <source>Dengue in Puerto Rico</source>
          <publisher-name>The Centers for Disease Control and Prevention</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/dengue/about/inpuerto.html">https://www.cdc.gov/dengue/about/inpuerto.html</ext-link></comment>
          <date-in-citation>Accessed: 17th March 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="book">
          <source>Zika-Epidemiological Report</source>
          <publisher-name>Pan American Health Organization</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=11603&amp;Itemid=41696&amp;lang=en">http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=11603&amp;Itemid=41696&amp;lang=en</ext-link></comment>
          <date-in-citation>Accessed: 1st December 2016</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duffy</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Zika virus outbreak on Yap Island, Federated States of Micronesia</article-title>
          <source>N Engl J Med</source>
          <volume>360</volume>
          <fpage>2536</fpage>
          <lpage>2543</lpage>
          <year>2009</year>
          <pub-id pub-id-type="pmid">19516034</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dinh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chowell</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mizumoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishiura</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Estimating the subcritical transmissibility of the Zika outbreak in the State of Florida, USA, 2016</article-title>
          <source>Theor Biol Med Model</source>
          <volume>13</volume>
          <fpage>20</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27829439</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nunes</surname>
              <given-names>MRT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Air travel is associated with intracontinental spread of dengue virus serotypes 1&#x2013;3 in Brazil</article-title>
          <source>PLoS Negl Trop Dis</source>
          <volume>8</volume>
          <fpage>e2769</fpage>
          <year>2014</year>
          <pub-id pub-id-type="pmid">24743730</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="book">
          <source>Basemaps</source>
          <publisher-name>ESRI</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.esri.com/data/basemaps">http://www.esri.com/data/basemaps</ext-link></comment>
          <date-in-citation>Accessed: 1st October 2016</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="book">
          <source>Zika virus</source>
          <publisher-name>Florida Department of Health</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.floridahealth.gov/diseases-and-conditions/zika-virus/index.html?utm_source=flhealthIndex">http://www.floridahealth.gov/diseases-and-conditions/zika-virus/index.html?utm_source=flhealthIndex</ext-link></comment>
          <date-in-citation>Accessed: 10th January 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="book">
          <source>Daily Zika update</source>
          <publisher-name>Florida Department of Health</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.floridahealth.gov/newsroom/all-articles.html">http://www.floridahealth.gov/newsroom/all-articles.html</ext-link></comment>
          <date-in-citation>Accessed: 10th January 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="book">
          <source>Zika virus case counts in the US</source>
          <publisher-name>The Centers for Disease Control and Prevention</publisher-name>
          <year>2016</year>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/zika/geo/united-states.html">http://www.cdc.gov/zika/geo/united-states.html</ext-link></comment>
          <date-in-citation>Accessed: 10th January 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabe</surname>
              <given-names>IB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interim Guidance for Interpretation of Zika Virus Antibody Test Results</article-title>
          <source>MMWR Morb Mortal Wkly Rep</source>
          <volume>65</volume>
          <fpage>543</fpage>
          <lpage>546</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27254248</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waggoner</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Pinsky</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Zika Virus: Diagnostics for an Emerging Pandemic Threat</article-title>
          <source>J Clin Microbiol</source>
          <volume>54</volume>
          <fpage>860</fpage>
          <lpage>867</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26888897</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lanciotti</surname>
              <given-names>RS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007</article-title>
          <source>Emerg Infect Dis</source>
          <volume>14</volume>
          <fpage>1232</fpage>
          <lpage>1239</lpage>
          <year>2008</year>
          <pub-id pub-id-type="pmid">18680646</pub-id>
        </element-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <element-citation publication-type="journal">
          <article-title>Interim Guidance for Zika Virus Testing of Urine - United States, 2016</article-title>
          <source>MMWR Morb Mortal Wkly Rep</source>
          <volume>65</volume>
          <fpage>474</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27171368</pub-id>
        </element-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Biggerstaff</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>PooledInfRate, version 4.0</article-title>
          <source>An Excel Add-In to Compute Infection Rates from Pooled Data</source>
          <publisher-name>Centers for Disease Control</publisher-name>
          <publisher-loc>Fort Collins, CO</publisher-loc>
          <year>2009</year>
        </element-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogoch</surname>
              <given-names>II</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study</article-title>
          <source>Lancet Infect Dis</source>
          <year>2016</year>
          <pub-id pub-id-type="doi">10.1016/S1473-3099(16)30270-5</pub-id>
        </element-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hwang</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Estimating abundance from presence/absence maps</article-title>
          <source>Methods Ecol Evol</source>
          <volume>2</volume>
          <fpage>550</fpage>
          <lpage>559</lpage>
          <year>2011</year>
        </element-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corman</surname>
              <given-names>VM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical comparison, standardization and optimization of Zika virus molecular detection</article-title>
          <source>Bull World Health Organ</source>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Worobey</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>1970s and &#x2018;Patient 0&#x2019; HIV-1 genomes illuminate early HIV/AIDS history in North America</article-title>
          <source>Nature</source>
          <year>2016</year>
          <pub-id pub-id-type="doi">10.1038/nature19827</pub-id>
        </element-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolger</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lohse</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Usadel</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>
          <source>Bioinformatics</source>
          <volume>30</volume>
          <fpage>2114</fpage>
          <lpage>2120</lpage>
          <year>2014</year>
          <pub-id pub-id-type="pmid">24695404</pub-id>
        </element-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <year>2009</year>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xF6;ster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rahmann</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Building and documenting workflows with python-based snakemake</article-title>
          <source>OASIcs-OpenAccess Series in Informatics</source>
          <volume>26</volume>
          <publisher-name>Schloss Dagstuhl-Leibniz-Zentrum fuer Informatik</publisher-name>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kearse</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data</article-title>
          <source>Bioinformatics</source>
          <volume>28</volume>
          <fpage>1647</fpage>
          <lpage>1649</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">22543367</pub-id>
        </element-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>
          <source>EMBnet journal</source>
          <volume>17</volume>
          <fpage>10</fpage>
          <lpage>12</lpage>
          <year>2011</year>
        </element-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmieder</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Quality control and preprocessing of metagenomic datasets</article-title>
          <source>Bioinformatics</source>
          <volume>27</volume>
          <fpage>863</fpage>
          <lpage>864</lpage>
          <year>2011</year>
          <pub-id pub-id-type="pmid">21278185</pub-id>
        </element-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langmead</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Fast gapped-read alignment with Bowtie 2</article-title>
          <source>Nat Methods</source>
          <volume>9</volume>
          <fpage>357</fpage>
          <lpage>359</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">22388286</pub-id>
        </element-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Standley</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title>
          <source>Mol Biol Evol</source>
          <volume>30</volume>
          <fpage>772</fpage>
          <lpage>780</lpage>
          <year>2013</year>
          <pub-id pub-id-type="pmid">23329690</pub-id>
        </element-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guindon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gascuel</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood</article-title>
          <source>Syst Biol</source>
          <volume>52</volume>
          <fpage>696</fpage>
          <lpage>704</lpage>
          <year>2003</year>
          <pub-id pub-id-type="pmid">14530136</pub-id>
        </element-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods</article-title>
          <source>J Mol Evol</source>
          <volume>39</volume>
          <fpage>306</fpage>
          <lpage>314</lpage>
          <year>1994</year>
          <pub-id pub-id-type="pmid">7932792</pub-id>
        </element-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darriba</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Taboada</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Doallo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Posada</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>jModelTest 2: more models, new heuristics and parallel computing</article-title>
          <source>Nat Methods</source>
          <volume>9</volume>
          <fpage>772</fpage>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rambaut</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Max Carvalho</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pybus</surname>
              <given-names>OG</given-names>
            </name>
          </person-group>
          <article-title>Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen)</article-title>
          <source>Virus Evol</source>
          <volume>2</volume>
          <fpage>vew007</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27774300</pub-id>
        </element-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shapiro</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rambaut</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Drummond</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences</article-title>
          <source>Mol Biol Evol</source>
          <volume>23</volume>
          <fpage>7</fpage>
          <lpage>9</lpage>
          <year>2006</year>
          <pub-id pub-id-type="pmid">16177232</pub-id>
        </element-citation>
      </ref>
      <ref id="R60">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>MAR</given-names>
            </name>
            <name>
              <surname>Suchard</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Bayesian analysis of elapsed times in continuous-time Markov chains</article-title>
          <source>The Canadian Journal of Statistics/La Revue Canadienne de Statistique</source>
          <volume>36</volume>
          <fpage>355</fpage>
          <lpage>368</lpage>
          <year>2008</year>
        </element-citation>
      </ref>
      <ref id="R61">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baele</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty</article-title>
          <source>Mol Biol Evol</source>
          <volume>29</volume>
          <fpage>2157</fpage>
          <lpage>2167</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">22403239</pub-id>
        </element-citation>
      </ref>
      <ref id="R62">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Improving marginal likelihood estimation for Bayesian phylogenetic model selection</article-title>
          <source>Syst Biol</source>
          <volume>60</volume>
          <fpage>150</fpage>
          <lpage>160</lpage>
          <year>2011</year>
          <pub-id pub-id-type="pmid">21187451</pub-id>
        </element-citation>
      </ref>
      <ref id="R63">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gelman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>XL</given-names>
            </name>
          </person-group>
          <article-title>Simulating Normalizing Constants: From Importance Sampling to Bridge Sampling to Path Sampling</article-title>
          <source>Stat Sci</source>
          <volume>13</volume>
          <fpage>163</fpage>
          <lpage>185</lpage>
          <year>1998</year>
        </element-citation>
      </ref>
      <ref id="R64">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drummond</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Rambaut</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pybus</surname>
              <given-names>OG</given-names>
            </name>
          </person-group>
          <article-title>Bayesian coalescent inference of past population dynamics from molecular sequences</article-title>
          <source>Mol Biol Evol</source>
          <volume>22</volume>
          <fpage>1185</fpage>
          <lpage>1192</lpage>
          <year>2005</year>
          <pub-id pub-id-type="pmid">15703244</pub-id>
        </element-citation>
      </ref>
      <ref id="R65">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Churcher</surname>
              <given-names>TS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Public health. Measuring the path toward malaria elimination</article-title>
          <source>Science</source>
          <volume>344</volume>
          <fpage>1230</fpage>
          <lpage>1232</lpage>
          <year>2014</year>
          <pub-id pub-id-type="pmid">24926005</pub-id>
        </element-citation>
      </ref>
      <ref id="R66">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lloyd-Smith</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Schreiber</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kopp</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Getz</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Superspreading and the effect of individual variation on disease emergence</article-title>
          <source>Nature</source>
          <volume>438</volume>
          <fpage>355</fpage>
          <lpage>359</lpage>
          <year>2005</year>
          <pub-id pub-id-type="pmid">16292310</pub-id>
        </element-citation>
      </ref>
      <ref id="R67">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishiura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sleeman</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Mode</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Estimating the transmission potential of supercritical processes based on the final size distribution of minor outbreaks</article-title>
          <source>J Theor Biol</source>
          <volume>294</volume>
          <fpage>48</fpage>
          <lpage>55</lpage>
          <year>2012</year>
          <pub-id pub-id-type="pmid">22079419</pub-id>
        </element-citation>
      </ref>
      <ref id="R68">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perkins</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Le Menach</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Heterogeneity, mixing, and the spatial scales of mosquito-borne pathogen transmission</article-title>
          <source>PLoS Comput Biol</source>
          <volume>9</volume>
          <fpage>e1003327</fpage>
          <year>2013</year>
          <pub-id pub-id-type="pmid">24348223</pub-id>
        </element-citation>
      </ref>
      <ref id="R69">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraemer</surname>
              <given-names>MUG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Big city, small world: density, contact rates, and transmission of dengue across Pakistan</article-title>
          <source>J R Soc Interface</source>
          <volume>12</volume>
          <fpage>20150468</fpage>
          <year>2015</year>
          <pub-id pub-id-type="pmid">26468065</pub-id>
        </element-citation>
      </ref>
      <ref id="R70">
        <label>70</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraemer</surname>
              <given-names>MUG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015&#x2013;16: a modelling study</article-title>
          <source>Lancet Infect Dis</source>
          <volume>17</volume>
          <fpage>330</fpage>
          <lpage>338</lpage>
          <year>2017</year>
          <month>3</month>
          <pub-id pub-id-type="pmid">28017559</pub-id>
        </element-citation>
      </ref>
      <ref id="R71">
        <label>71</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Struchiner</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Rockl&#xF6;v</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wilder-Smith</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Massad</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Increasing Dengue Incidence in Singapore over the Past 40 Years: Population Growth, Climate and Mobility</article-title>
          <source>PLoS One</source>
          <volume>10</volume>
          <fpage>e0136286</fpage>
          <year>2015</year>
          <pub-id pub-id-type="pmid">26322517</pub-id>
        </element-citation>
      </ref>
      <ref id="R72">
        <label>72</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fauver</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Temporal and Spatial Variability of Entomological Risk Indices for West Nile Virus Infection in Northern Colorado: 2006&#x2013;2013</article-title>
          <source>J Med Entomol</source>
          <volume>53</volume>
          <fpage>425</fpage>
          <lpage>434</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">26718715</pub-id>
        </element-citation>
      </ref>
      <ref id="R73">
        <label>73</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rockl&#xF6;v</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread of Zika Virus in Europe</article-title>
          <source>EBioMedicine</source>
          <volume>9</volume>
          <fpage>250</fpage>
          <lpage>256</lpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27344225</pub-id>
        </element-citation>
      </ref>
      <ref id="R74">
        <label>74</label>
        <element-citation publication-type="web">
          <collab>Ministry of Public Health, Ecuador</collab>
          <source>National Direction of Epidemiological Surveillance for Vector Transmitted Diseases (Spanish)</source>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.salud.gob.ec/wp-content/uploads/2015/12/GACETA-ZIKA_SE5corregido.pdf">http://www.salud.gob.ec/wp-content/uploads/2015/12/GACETA-ZIKA_SE5corregido.pdf</ext-link></comment>
          <date-in-citation>Accessed: 19th March 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R75">
        <label>75</label>
        <element-citation publication-type="book">
          <source>Zika Cumulative Cases</source>
          <publisher-name>Pan American Health Organization</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=12390&amp;Itemid=42090&amp;lang=en">http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=12390&amp;Itemid=42090&amp;lang=en</ext-link></comment>
          <date-in-citation>Accessed: 1st December 2016</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R76">
        <label>76</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lessler</surname>
              <given-names>JT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Times to key events in the course of Zika infection and their implications: a systematic review and pooled analysis</article-title>
          <source>Bull World Health Organ</source>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="R77">
        <label>77</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ramdeen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Cruise ship itineraries and occupancy rates</article-title>
          <source>Tourism Manage</source>
          <volume>34</volume>
          <fpage>236</fpage>
          <lpage>237</lpage>
          <year>2013</year>
          <month>2</month>
        </element-citation>
      </ref>
      <ref id="R78">
        <label>78</label>
        <element-citation publication-type="book">
          <source>FCCA Research &amp; Statistics</source>
          <publisher-name>Florida-Caribbean Cruise Association</publisher-name>
          <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.f-cca.com/research.html">http://www.f-cca.com/research.html</ext-link></comment>
          <date-in-citation>Accessed: 1st March 2017</date-in-citation>
        </element-citation>
      </ref>
      <ref id="R79">
        <label>79</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perkins</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Siraj</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Ruktanonchai</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kraemer</surname>
              <given-names>MUG</given-names>
            </name>
            <name>
              <surname>Tatem</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Model-based projections of Zika virus infections in childbearing women in the Americas</article-title>
          <source>Nat Microbiol</source>
          <volume>1</volume>
          <fpage>16126</fpage>
          <year>2016</year>
          <pub-id pub-id-type="pmid">27562260</pub-id>
        </element-citation>
      </ref>
      <ref id="R80">
        <label>80</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunter</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Matplotlib: A 2D Graphics Environment</article-title>
          <source>Comput Sci Eng</source>
          <volume>9</volume>
          <fpage>90</fpage>
          <lpage>95</lpage>
          <year>2007</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Zika virus outbreak in Florida</title>
        <p>(<bold>a</bold>) Weekly counts of confirmed travel-associated and locally-acquired ZIKV cases in 2016. (<bold>b</bold>) Four counties reported locally-acquired ZIKV cases in 2016: Miami-Dade (241), Broward (5), Palm Beach (8), Pinellas (1), and unknown origin (1). (<bold>c</bold>) The locations of mosquito traps and collected <italic>Ae. aegypti</italic> mosquitoes found to contain ZIKV RNA (ZIKV+) in relation to the transmission zones within Miami. (<bold>d</bold>) Temporal distribution of weekly ZIKV cases (left y-axis), sequenced cases (bottom), and <italic>Ae. aegypti</italic> abundance per trap night (right y-axis) associated with the three described transmission zones. ZIKV cases and sequences are plotted in relation to symptom onset dates (n=18). Sequenced cases without onset dates or that occurred outside of the transmission zones are not shown (n=10). Human cases and <italic>Ae. aegypt</italic>i abundance per week were positively correlated (Spearman r = 0.61, <xref rid="F5" ref-type="fig">Extended Data Fig. 1b</xref>). The maps were generated using open source basemaps<sup><xref rid="R34" ref-type="bibr">34</xref></sup>.</p>
      </caption>
      <graphic xlink:href="nihms872467f1"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Multiple introductions of Zika virus into Florida</title>
        <p>(<bold>a</bold>) Maximum clade credibility (MCC) tree of ZIKV genomes sequenced from outbreaks in the Pacific islands and the epidemic in the Americas. Tips are colored based on collection location. The five tips outlined in blue but filled with a different color indicate ZIKV cases in the United States associated with travel (fill color indicates the probable location of infection). Clade posterior probabilities are indicated by white circles filled with black relative to the level of support. The grey violin plot indicates the 95% highest posterior density (HPD) interval for the tMRCA for the epidemic in the Americas (AM). Lineage F4 contains two identical ZIKV genomes from the same patient. (<bold>b</bold>) A zoomed in version of the whole MCC tree showing the collection locations of Miami-Dade sequences and whether they were sequenced from mosquitoes (numbers correspond to trap locations in <xref rid="F1" ref-type="fig">Fig. 1c</xref>). 95% HPD intervals are shown for the tMRCAs (<bold>c</bold>) The probability of ZIKV persistence after introduction for different <italic>R</italic><sub>0</sub>. Persistence is measured as the number of days from initial introduction of viral lineages until their extinction. Vertical dashed lines show the inferred mean persistence time for lineages F1, F2 and B based on their tMRCA. (<bold>d</bold>) Total number of introductions (mean with 95% CI) that contributed to the outbreak of 241 local cases in Miami-Dade County for different <italic>R</italic><sub>0</sub>.</p>
      </caption>
      <graphic xlink:href="nihms872467f2"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Frequent opportunities for Zika virus introductions into Miami from the Caribbean</title>
        <p>(<bold>a</bold>) Reported ZIKV cases per country/territory from January to June, 2016 normalized by total population. (<bold>b</bold>) The number of estimated travelers entering Miami during January to June, 2016 by method of travel. (<bold>c</bold>) The number of travelers and the reported ZIKV incidence rate for the country/territory of origin were used to estimate the proportion of infected travelers coming from each region with ZIKV in the Americas. (<bold>d</bold>) The observed number of weekly travel-associated ZIKV cases in Florida were plotted with the expected number of ZIKV-infected travelers (as estimated in panel c) coming from all of the Americas (grey line) and the regional contributions (colored areas). (<bold>e</bold>) The countries visited by the 1,016 travel-associated ZIKV cases diagnosed in Florida.</p>
      </caption>
      <graphic xlink:href="nihms872467f3"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <title>Southern Florida has a high potential for <italic>Aedes aegypti</italic>-borne virus outbreaks</title>
        <p>The estimated number of travelers per month (circles) entering Florida cities via flights and cruise ships were plotted with estimated relative <italic>Ae. aegypti</italic> abundance. Only cities receiving &gt;10,000 passengers per month are shown. Relative <italic>Ae. aegypti</italic> abundance for every month is shown in <xref rid="F5" ref-type="fig">Extended Data Fig. 1d</xref>.</p>
      </caption>
      <graphic xlink:href="nihms872467f4"/>
    </fig>
  </floats-group>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">31748746</article-id>
      <article-id pub-id-type="pmc">6897368</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-019-1775-1</article-id>
      <article-id pub-id-type="manuscript">NIHMS1540824</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <collab>The Glioma Longitudinal Analysis (GLASS) Consortium</collab>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barthel</surname>
            <given-names>Floris P.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A54">54</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Johnson</surname>
            <given-names>Kevin C.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A54">54</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Varn</surname>
            <given-names>Frederick S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moskalik</surname>
            <given-names>Anzhela D.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanner</surname>
            <given-names>Georgette</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kocakavuk</surname>
            <given-names>Emre</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anderson</surname>
            <given-names>Kevin J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abiola</surname>
            <given-names>Olajide</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aldape</surname>
            <given-names>Kenneth</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alfaro</surname>
            <given-names>Kristin D.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alpar</surname>
            <given-names>Donat</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amin</surname>
            <given-names>Samirkumar B.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ashley</surname>
            <given-names>David M.</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bandopadhayay</surname>
            <given-names>Pratiti</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barnholtz-Sloan</surname>
            <given-names>Jill S.</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beroukhim</surname>
            <given-names>Rameen</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bock</surname>
            <given-names>Christoph</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brastianos</surname>
            <given-names>Priscilla K.</given-names>
          </name>
          <xref ref-type="aff" rid="A14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brat</surname>
            <given-names>Daniel J.</given-names>
          </name>
          <xref ref-type="aff" rid="A15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brodbelt</surname>
            <given-names>Andrew R.</given-names>
          </name>
          <xref ref-type="aff" rid="A16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bruns</surname>
            <given-names>Alexander F.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bulsara</surname>
            <given-names>Ketan R.</given-names>
          </name>
          <xref ref-type="aff" rid="A17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chakrabarty</surname>
            <given-names>Aruna</given-names>
          </name>
          <xref ref-type="aff" rid="A18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chakravarti</surname>
            <given-names>Arnab</given-names>
          </name>
          <xref ref-type="aff" rid="A19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chuang</surname>
            <given-names>Jeffrey H.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A20">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Claus</surname>
            <given-names>Elizabeth B.</given-names>
          </name>
          <xref ref-type="aff" rid="A21">21</xref>
          <xref ref-type="aff" rid="A22">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cochran</surname>
            <given-names>Elizabeth J.</given-names>
          </name>
          <xref ref-type="aff" rid="A23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Connelly</surname>
            <given-names>Jennifer</given-names>
          </name>
          <xref ref-type="aff" rid="A23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costello</surname>
            <given-names>Joseph F.</given-names>
          </name>
          <xref ref-type="aff" rid="A24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Finocchiaro</surname>
            <given-names>Gaetano</given-names>
          </name>
          <xref ref-type="aff" rid="A25">25</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fletcher</surname>
            <given-names>Michael N.</given-names>
          </name>
          <xref ref-type="aff" rid="A26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>French</surname>
            <given-names>Pim J.</given-names>
          </name>
          <xref ref-type="aff" rid="A27">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gan</surname>
            <given-names>Hui K.</given-names>
          </name>
          <xref ref-type="aff" rid="A28">28</xref>
          <xref ref-type="aff" rid="A29">29</xref>
          <xref ref-type="aff" rid="A30">30</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>Mark R.</given-names>
          </name>
          <xref ref-type="aff" rid="A31">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gould</surname>
            <given-names>Peter V.</given-names>
          </name>
          <xref ref-type="aff" rid="A32">32</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grimmer</surname>
            <given-names>Matthew R.</given-names>
          </name>
          <xref ref-type="aff" rid="A24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iavarone</surname>
            <given-names>Antonio</given-names>
          </name>
          <xref ref-type="aff" rid="A33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ismail</surname>
            <given-names>Azzam</given-names>
          </name>
          <xref ref-type="aff" rid="A18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jenkinson</surname>
            <given-names>Michael D.</given-names>
          </name>
          <xref ref-type="aff" rid="A16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khasraw</surname>
            <given-names>Mustafa</given-names>
          </name>
          <xref ref-type="aff" rid="A34">34</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hoon</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kouwenhoven</surname>
            <given-names>Mathilde C.M.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LaViolette</surname>
            <given-names>Peter S.</given-names>
          </name>
          <xref ref-type="aff" rid="A23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Meihong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lichter</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="A26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ligon</surname>
            <given-names>Keith L.</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lowman</surname>
            <given-names>Allison K.</given-names>
          </name>
          <xref ref-type="aff" rid="A23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malta</surname>
            <given-names>Tathiane M.</given-names>
          </name>
          <xref ref-type="aff" rid="A35">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mazor</surname>
            <given-names>Tali</given-names>
          </name>
          <xref ref-type="aff" rid="A24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McDonald</surname>
            <given-names>Kerrie L.</given-names>
          </name>
          <xref ref-type="aff" rid="A36">36</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Molinaro</surname>
            <given-names>Annette M.</given-names>
          </name>
          <xref ref-type="aff" rid="A24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nam</surname>
            <given-names>Do-Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="A37">37</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nayyar</surname>
            <given-names>Naema</given-names>
          </name>
          <xref ref-type="aff" rid="A14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>Ho Keung</given-names>
          </name>
          <xref ref-type="aff" rid="A38">38</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ngan</surname>
            <given-names>Chew Yee</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Niclou</surname>
            <given-names>Simone, P.</given-names>
          </name>
          <xref ref-type="aff" rid="A39">39</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Niers</surname>
            <given-names>Johanna M.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Noushmehr</surname>
            <given-names>Houtan</given-names>
          </name>
          <xref ref-type="aff" rid="A35">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Noorbakhsh</surname>
            <given-names>Javad</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ormond</surname>
            <given-names>D. Ryan</given-names>
          </name>
          <xref ref-type="aff" rid="A40">40</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Chul-Kee</given-names>
          </name>
          <xref ref-type="aff" rid="A41">41</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poisson</surname>
            <given-names>Laila M.</given-names>
          </name>
          <xref ref-type="aff" rid="A35">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rabadan</surname>
            <given-names>Raul</given-names>
          </name>
          <xref ref-type="aff" rid="A33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Radlwimmer</surname>
            <given-names>Bernhard</given-names>
          </name>
          <xref ref-type="aff" rid="A26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Ganesh</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reifenberger</surname>
            <given-names>Guido</given-names>
          </name>
          <xref ref-type="aff" rid="A42">42</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sa</surname>
            <given-names>Jason K.</given-names>
          </name>
          <xref ref-type="aff" rid="A43">43</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schuster</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shaw</surname>
            <given-names>Brian L.</given-names>
          </name>
          <xref ref-type="aff" rid="A14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Short</surname>
            <given-names>Susan C.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sillevis Smitt</surname>
            <given-names>Peter A.</given-names>
          </name>
          <xref ref-type="aff" rid="A27">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sloan</surname>
            <given-names>Andrew E.</given-names>
          </name>
          <xref ref-type="aff" rid="A44">44</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smits</surname>
            <given-names>Marion</given-names>
          </name>
          <xref ref-type="aff" rid="A27">27</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suzuki</surname>
            <given-names>Hiromichi</given-names>
          </name>
          <xref ref-type="aff" rid="A45">45</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tabatabai</surname>
            <given-names>Ghazaleh</given-names>
          </name>
          <xref ref-type="aff" rid="A46">46</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Van Meir</surname>
            <given-names>Erwin G.</given-names>
          </name>
          <xref ref-type="aff" rid="A47">47</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watts</surname>
            <given-names>Colin</given-names>
          </name>
          <xref ref-type="aff" rid="A48">48</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weller</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="A49">49</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wesseling</surname>
            <given-names>Pieter</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A50">50</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Westerman</surname>
            <given-names>Bart A.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Widhalm</surname>
            <given-names>Georg</given-names>
          </name>
          <xref ref-type="aff" rid="A51">51</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Woehrer</surname>
            <given-names>Adelheid</given-names>
          </name>
          <xref ref-type="aff" rid="A52">52</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alfred Yung</surname>
            <given-names>W.K.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zadeh</surname>
            <given-names>Gelareh</given-names>
          </name>
          <xref ref-type="aff" rid="A53">53</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>GLASS Consortium</collab>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huse</surname>
            <given-names>Jason T.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Groot</surname>
            <given-names>John F.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stead</surname>
            <given-names>Lucy F.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verhaak</surname>
            <given-names>Roel G.W.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="CR1" ref-type="corresp">&#xA5;</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.</aff>
      <aff id="A2"><label>2</label>Amsterdam UMC, Vrije Universiteit Amsterdam, Departments of Neurology, Neurosurgery, Pathology, Brain Tumor Center Amsterdam, de Boelelaan 1117, Amsterdam, Netherlands</aff>
      <aff id="A3"><label>3</label>Leeds Institute of Medical Research at St James&#x2019;s, University of Leeds, LS9 7TF, UK.</aff>
      <aff id="A4"><label>4</label>DKFZ Division of Translational Neurooncology at the West German Cancer Center, German Cancer Consortium Partner Site &amp; Department of Neurosurgery, University Hospital Essen, 45147 Essen, Germany</aff>
      <aff id="A5"><label>5</label>National Cancer Institute, Bethesda, MD 20892, USA</aff>
      <aff id="A6"><label>6</label>Departments of Neuro-Oncology, Neurosurgery, Pathology, Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77031, USA</aff>
      <aff id="A7"><label>7</label>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria</aff>
      <aff id="A8"><label>8</label>1<sup>st</sup> Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary</aff>
      <aff id="A9"><label>9</label>Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, North Carolina 27710, USA</aff>
      <aff id="A10"><label>10</label>Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA</aff>
      <aff id="A11"><label>11</label>Broad Institute, 415 Main Street, Cambridge, MA 02142, USA</aff>
      <aff id="A12"><label>12</label>Department of Population and Quantitative Health Sciences and Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, 2103 Cornell Rd, WRB 2-526, Cleveland, Ohio 44106, USA</aff>
      <aff id="A13"><label>13</label>Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria</aff>
      <aff id="A14"><label>14</label>Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA 02114, USA</aff>
      <aff id="A15"><label>15</label>Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago IL, 60611, USA</aff>
      <aff id="A16"><label>16</label>University of Liverpool &amp; Walton Centre NHS Trust, Liverpool, L9 7LJ, UK</aff>
      <aff id="A17"><label>17</label>Division of Neurosurgery, The University of Connecticut Health Center, Farmington, CT, USA</aff>
      <aff id="A18"><label>18</label>Leeds Teaching Hospital NHS Trust, St James&#x2019;s University Hospital, Leeds, LS9 7TF, UK</aff>
      <aff id="A19"><label>19</label>Department of Radiation Oncology, Arthur G. James Hospital/Ohio State Comprehensive Cancer Center, Columbus, OH, 43210, USA</aff>
      <aff id="A20"><label>20</label>UConn Health, Department of Genetics and Genome Sciences, Farmington, CT, 06030, USA</aff>
      <aff id="A21"><label>21</label>Yale University School of Public Health, New Haven, CT, 06511, USA</aff>
      <aff id="A22"><label>22</label>Department of Neurosurgery, Brigham and Women&#x2019;s Hospital, Boston, MA, USA</aff>
      <aff id="A23"><label>23</label>Departments of Neurology, Pathology, Radiology and Biomedical Engineering, Medical College of Wisconsin, Milwaukee, WI USA</aff>
      <aff id="A24"><label>24</label>Department of Neurosurgery, University of California San Francisco, CA 94143, USA</aff>
      <aff id="A25"><label>25</label>Fondazione IRCCS Istituto Neurologico Besta, Milano, Italy</aff>
      <aff id="A26"><label>26</label>Division of Molecular Genetics, Heidelberg Center for Personalized Oncology, German Cancer Research Consortium, German Cancer Research Center (DKFZ), Heidelberg, Germany</aff>
      <aff id="A27"><label>27</label>Departments of Neurology, Radiology and Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands</aff>
      <aff id="A28"><label>28</label>Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia</aff>
      <aff id="A29"><label>29</label>La Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australia</aff>
      <aff id="A30"><label>30</label>Department of Medicine, University of Melbourne, Heidelberg, Victoria, AustraliaNeuro-oncology Branch, National Institutes of Health, Bethesda, Maryland, 20892, USA</aff>
      <aff id="A31"><label>31</label>Neuro-oncology Branch, National Institutes of Health, Bethesda, Maryland, 20892, USA</aff>
      <aff id="A32"><label>32</label>Anatomic Pathology Service, H&#xF4;pital de l&#x2019;Enfant-J&#xE9;sus, CHU de Qu&#xE9;bec-Universit&#xE9; Laval, Qu&#xE9;bec QC G1J 1Z4, Canada</aff>
      <aff id="A33"><label>33</label>Departments of Neurology, Pathology, Cell Biology, Systems Biology and Biomedical Informatics, Institute for Cancer Genetics, Columbia University Medical Center, New York, New York 10032, USA</aff>
      <aff id="A34"><label>34</label>Cooperative Trials Group for Neuro-Oncology (COGNO) NHMRC Clinical Trials Centre, The University of Sydney, New South Wales, Australia</aff>
      <aff id="A35"><label>35</label>Departments of Neurosurgery, Public Health Sciences, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI 48202, USA</aff>
      <aff id="A36"><label>36</label>Cure Brain Cancer Biomarkers and Translational Research Group, Prince of Wales Clinical School, UNSW Sydney, Australia</aff>
      <aff id="A37"><label>37</label>Department of Neurosurgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea</aff>
      <aff id="A38"><label>38</label>Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, 1/F, Prince of Wales Hospital, Shatin, Hong Kong</aff>
      <aff id="A39"><label>39</label>Department of Oncology, Luxembourg Institute of Health, Luxembourg</aff>
      <aff id="A40"><label>40</label>Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado, 80045, USA</aff>
      <aff id="A41"><label>41</label>Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea</aff>
      <aff id="A42"><label>42</label>Institute of Neuropathology, Heinrich Heine University D&#xFC;sseldorf, D&#xFC;sseldorf, Germany</aff>
      <aff id="A43"><label>43</label>Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea</aff>
      <aff id="A44"><label>44</label>Department of Neurosurgery, University Hospitals-Case Medical Center, Seidman Cancer Center, and the Case Comprehensive Cancer Center, Cleveland, Ohio 44106, USA</aff>
      <aff id="A45"><label>45</label>The Hospital for Sick Children, Toronto, ON, M5G1X8, Canada</aff>
      <aff id="A46"><label>46</label>Interdiscplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, DKTK Partner Site T&#xFC;bingen, Eberhard Karls University T&#xFC;bingen, Germany</aff>
      <aff id="A47"><label>47</label>Department of Neurosurgery, School of Medicine and Winship Cancer Institute of Emory U University; 1365C Clifton Rd. NE, Atlanta, GA30084, USA</aff>
      <aff id="A48"><label>48</label>Institute of Cancer Genome Sciences, Department of Neurosurgery, University of Birmingham, UK</aff>
      <aff id="A49"><label>49</label>Department of Neurology, University Hospital Zurich, Zurich, Switzerland</aff>
      <aff id="A50"><label>50</label>Princess M&#xE1;xima Center for Pediatric Oncology, Utrecht, The Netherlands</aff>
      <aff id="A51"><label>51</label>Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria</aff>
      <aff id="A52"><label>52</label>Institute of Neurology, Medical University of Vienna, 1090 Vienna, Austria</aff>
      <aff id="A53"><label>53</label>Division of Neurosurgery, Department of Surgery, University Health Network, Toronto, C Canada.</aff>
      <aff id="A54"><label>54</label>These authors contributed equally.</aff>
      <author-notes>
        <corresp id="CR1"><label>&#xA5;</label>Correspondence to <email>roel.verhaak@jax.org</email>.</corresp>
        <fn fn-type="con" id="FN1">
          <p id="P1">CONTRIBUTIONS</p>
          <p id="P2">D.M.A., D.A., P.B., J.S.B., R.B., C.B., P.K.B., D.J.B., A.B., A.C., E.J.C., J.C., G.F., M.N.F., Antonio I., M.D.J., M.K., P.S.L., M.L., P.L., K.L.L., T.M.M., A.M.M., D.N., N.N., H.N., C.Y.N., S.P.N., Houtan N., D.R.O., C.P., L.M.P., G.R., B.R., J.K.S., S.C.S., A.E.S., M.S., L.F.S., H.S., E.G.V.M., C.W., M.W., G.W., A.W., contributed to sample acquisition and processing, sequencing data coordination was performed by H.K, F.P.B and K.C.J., and clinical data coordination by A.D.M., and O.A.. Data analysis was led by F.P.B. and K.C.J. in collaboration with S.B.A., P.B., B.C., J.H.C., H.K., E.K, T.M.M., H.N., J.N., M.S., L.F.S., G.T., F.S.V. and R.G.W.V.. Clinical analysis was performed by A.D.M., L.M.P., and C.W.. Pathology review was completed, in part, by Aruna Chakrabarty, J.T.H., Azzam Ismail., and A.W.. F.P.B., K.C.J., A.D.M., F.S.V., and R.G.W.V. wrote the manuscript. K.D.A. and J.F.D. took charge in coordinating GLASS-MDACC; L.F.S. was the lead coordinator of the GLASS-Leeds cohort and B.A.W. of GLASS-Netherlands. R.G.W.V was the project lead and coordinator. Funding for the project was received by K.D.A., E.B.C., H.G., J.T.H., S.C.S., L.F.S.. All co-authors discussed the results and commented on the manuscript and <xref rid="SD1" ref-type="supplementary-material">Supplementary Information</xref>.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>10</day>
        <month>10</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>11</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>20</day>
        <month>5</month>
        <year>2020</year>
      </pub-date>
      <volume>576</volume>
      <issue>7785</issue>
      <fpage>112</fpage>
      <lpage>120</lpage>
      <!--elocation-id from pubmed: 10.1038/s41586-019-1775-1-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <p id="P3">The evolutionary processes that drive universal therapeutic resistance in adult patients with diffuse glioma remain unclear<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup>. Here, we analyzed temporally separated DNA sequencing data and matched clinical annotation from 222 patients with glioma. Through mutational and copy number analyses across the three major subtypes of diffuse glioma, we observed that driver genes detected at initial disease were retained at recurrence, while there was little evidence of recurrence-specific gene alterations. Treatment with alkylating-agents resulted in a hypermutator phenotype at different rates across glioma subtypes, and hypermutation was not associated with differences in survival. Acquired aneuploidy was frequently detected in recurrent gliomas characterized by presence of an IDH mutation but without 1p/19q codeletion and further converged with acquired cell cycle alterations and poor outcomes. We show that the clonal architecture of each tumor remains similar over time and that absence of clonal selection was associated with increased survival. Finally, we did not observe differences in immunoediting levels between initial and recurrent glioma. Our results collectively argue that the strongest selective pressures occur early during glioma development and that current therapies shape this evolution in a largely stochastic manner.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="S1">
      <title>INTRODUCTION</title>
      <p id="P4">Diffuse glioma is the most common malignant brain tumor in adults and invariably relapse despite treatment with surgery, radiotherapy, and chemotherapy. The molecular landscape of glioma at diagnosis has been extensively characterized <sup><xref rid="R3" ref-type="bibr">3</xref>-<xref rid="R9" ref-type="bibr">9</xref></sup>. While these efforts have led to the identification of driver genes and clinically relevant subtypes<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>, it is unknown how the glioma genetic landscape evolves over time and in response to therapy.</p>
      <p id="P5">Intratumoral heterogeneity is a well-recognized characteristic of gliomas and results from selective pressures such as a limited availability of nutrients, clonal competition, and treatment<sup><xref rid="R12" ref-type="bibr">12</xref>-<xref rid="R15" ref-type="bibr">15</xref></sup>. Tumors are thought to circumvent these growth bottlenecks via dynamic competition of subclones resulting in the most favorable environment for tumor sustenance<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. Recent studies have suggested that stochastic changes in clone frequency (i.e. neutral evolution) and immunogenic surveillance may further contribute to the observed intratumoral heterogeneity<sup><xref rid="R16" ref-type="bibr">16</xref><xref rid="R17" ref-type="bibr">17</xref></sup>. An understanding of evolutionary dynamics at multiple time points is needed to develop strategies aimed at delaying or preventing the onset of tumor progression.</p>
      <p id="P6">To investigate clonal dynamics over time and in response to therapeutic pressures, we established the Glioma Longitudinal Analysis (GLASS) Consortium. GLASS is a community-driven effort that seeks to overcome the logistical challenges in constructing adequately powered longitudinal genomic glioma datasets by pooling datasets from patients treated at institutions worldwide <sup><xref rid="R18" ref-type="bibr">18</xref></sup>. We have analyzed longitudinal profiles across the three molecular glioma subtypes to identify the molecular processes active at initial and recurrent time points. These analyses identified few common features of glioma evolution across subtypes, and instead pointed toward highly variable and patient-specific trajectories of genomic alterations.</p>
    </sec>
    <sec id="S2">
      <title>RESULTS</title>
      <sec id="S3">
        <title>GLASS cohort</title>
        <p id="P7">We pooled existing and newly generated longitudinal DNA sequencing datasets from 288 patients treated at 35 hospitals (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 1</xref>, <xref rid="F5" ref-type="fig">Extended Data Fig. 1</xref>). After applying quality filters, tumor samples from 222 patients with high-quality data in at least two time points were classified according to molecular markers into three major glioma subtypes: 1. IDH-mutant and chromosome 1p/19q co-deleted (IDHmutant-codel; n = 25) 2. IDH-mutant without chromosome 1p/19q codeletion (IDHmutant-noncodel; n = 63) and 3. IDH wild type (IDHwt; n = 134), in alignment with the World Health Organization classification of Central Nervous System tumors <sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. For each patient we selected two time-separated tumor samples, henceforth initial and recurrence, for further analysis.</p>
      </sec>
      <sec id="S4">
        <title>Mutational burdens and processes over time</title>
        <p id="P8">We first evaluated temporal changes in mutational burden and processes to understand general patterns of glioma evolution. Mutation burdens in initial tumors were comparable with previously reported rates <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup>. 2.20 mutations (single-nucleotide variants and small insertions/deletions) per Megabase (Mutations/Mb) for IDHmutant-codels; 2.52 Mutations/Mb for IDHmutant-noncodels; and 2.85 Mutations/Mb for IDHwt glioma (<xref rid="F1" ref-type="fig">Fig. 1a</xref>; <xref rid="F6" ref-type="fig">Extended Data Fig. 2a</xref>). Excluding DNA hypermutation cases (&gt; 10 Mutations/Mb, n = 35), the mutation burden increased after recurrence in 70% of the cohort (<xref rid="F6" ref-type="fig">Extended Data Fig. 2a</xref>). To study changes during tumor progression, we separated mutations into three fractions: initial only, recurrence only, or shared. Interestingly, private fraction but not shared fraction mutation burdens were comparable between subtypes (<xref rid="F6" ref-type="fig">Extended Data Fig. 2b</xref>). Patient age at diagnosis was significantly associated with the shared mutational burden and to a lesser extent the mutation burden private to the initial tumor (<xref rid="F6" ref-type="fig">Extended Data Fig. 2c</xref>). On average, tumors with longer time to recurrence had slightly higher mutation burdens (<xref rid="F6" ref-type="fig">Extended Data Fig. 2d</xref>).</p>
        <p id="P9">These fraction-specific differences in mutation burden suggested that the activity of distinct mutational processes may also be time-dependent. We therefore classified mutations in each fraction according to the Catalogue of Somatic Mutations in Cancer (COSMIC) signature database<sup><xref rid="R20" ref-type="bibr">20</xref></sup>. As expected, signature activity was closely related to subtype and fraction (<xref rid="F1" ref-type="fig">Fig. 1b</xref>, <xref rid="F7" ref-type="fig">Extended Data Fig. 3a</xref>). Signature 1 (aging) was nearly always the dominant signature amongst shared mutations in IDHwt tumors, whereas the shared fraction in IDHmut-noncodel and IDHmut-codel tumors - tumor subtypes associated with a younger age of diagnosis - additionally showed a strong presence of signature 16 (unknown etiology). Signatures 3 (double strand break repair) and 15 (mismatch repair) along with signature 8 (unknown etiology) were mostly confined to the private fractions, suggesting that these processes were of lesser importance to tumor maintenance than those associated with aging.</p>
        <p id="P10">Treatment of glioma includes alkylating agents that can induce post-treatment hypermutation<sup><xref rid="R21" ref-type="bibr">21</xref>-<xref rid="R23" ref-type="bibr">23</xref></sup>. We observed enrichment of the associated signature 11 in recurrent tumors with a mutational load exceeding 10 Mutations/Mb and treated with alkylating agents (<xref rid="F1" ref-type="fig">Fig. 1a</xref>, <xref rid="F7" ref-type="fig">Extended Data Fig. 3b</xref>). Treatment-associated hypermutation occurred most frequently among IDHmutant-noncodels (47%), followed by IDHmutant-codels (25%), and IDHwt gliomas (16%) (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). The difference in the proportion of hypermutation events was significantly different between the three glioma subtypes (Fisher&#x2019;s exact-test <italic>P</italic> = 2.0e-03), suggesting that IDHmutant noncodels are most sensitive to developing a hypermutator phenotype <sup><xref rid="R24" ref-type="bibr">24</xref></sup>.</p>
        <p id="P11">Treatment-induced hypermutation has been associated with disease progression<sup><xref rid="R23" ref-type="bibr">23</xref></sup>. We did not find overall survival differences between alkylating agent-treated hypermutators and alkylating agent-treated non-hypermutators independent of age, subtype, and <italic>MGMT</italic> methylation status (<xref rid="F1" ref-type="fig">Fig. 1d</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Table 2a</xref>-<xref rid="SD3" ref-type="supplementary-material">b</xref>). In order to further assess the pathogenicity of acquired mutations, we studied their clonality<sup><xref rid="R25" ref-type="bibr">25</xref></sup>. Newly acquired clonal mutations have penetrated most of the tumor (i.e., a selective sweep) between initial and recurrence and mark clonal expansion <sup><xref rid="R26" ref-type="bibr">26</xref></sup>. Conversely, acquired subclonal mutations are less prevalent, and therefore less likely to drive disease progression. Previous reports have suggested that alkylating agent-associated mutations hypermutation are frequently clonal<sup><xref rid="R27" ref-type="bibr">27</xref></sup>. We found that in 48% of hypermutated tumors a majority of the recurrence-only mutations were clonal, potentially reflecting cases where a selective sweep occurred (<xref rid="F8" ref-type="fig">Extended Data Fig. 4a</xref>). However, IDHmut-noncodel hypermutators with predominantly clonal mutations did not show differences in survival compared with those harboring predominantly subclonal mutations (log-rank test <italic>P</italic> = 0.38, <xref rid="F8" ref-type="fig">Extended Data Fig. 4b</xref>). Alkylating agents such as temozolomide prolong survival of adult patients with glioma<sup><xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup>. Our results show that treatment-induced hypermutation is common across subtypes and does not associate with a reduced overall survival supporting the noted benefit of alkylating agent therapy.</p>
      </sec>
      <sec id="S5">
        <title>Selective pressures during glioma evolution</title>
        <p id="P12">Environmental and treatment-induced pressures may drive changes in clonal architecture at recurrence. To evaluate selection over time we clustered copy number changes and mutations based on their cancer cell fraction (CCF). CCF values represent the fraction of cancer cells harboring a given alteration and reflect the relative timing of events, since alterations that are present in a subset of cancer cells likely occurred later than events present in all cancer cells (<xref rid="F2" ref-type="fig">Fig. 2a</xref>). Most tumors (84%) demonstrated a mutational cluster with CCF &gt; 50% that persisted from the initial tumor into recurrence, likely reflecting the tumor trunk and harboring the tumor-initiating driver mutations (<xref rid="F2" ref-type="fig">Fig. 2b</xref>, <xref rid="F9" ref-type="fig">Extended Data Fig. 5a</xref>)<sup><xref rid="R30" ref-type="bibr">30</xref></sup>. To determine changes in clonal dominance over time we ranked clusters within each sample by their CCF and found similarities in clonal architecture throughout the course of disease (Kendall rank correlation, tau = 0.20, <italic>P</italic> = 3.76E-24, <xref rid="F2" ref-type="fig">Fig. 2b</xref>, <xref rid="F9" ref-type="fig">Extended Data Fig. 5b</xref>-<xref rid="F9" ref-type="fig">d</xref>). These results suggested that the clonal structure at initial disease mostly persisted into recurrence.</p>
        <p id="P13">To deepen our assessment of selective pressures, we evaluated selection in initial and recurrent tumors by determining the normalized ratio between non-synonymous and synonymous mutations (dNdScv). Higher ratios (&gt; 1) suggest positive selection, and ratios less than one suggest negative selection . We found evidence for positive selection at both time points despite differences between subtypes (<xref rid="F2" ref-type="fig">Fig. 2c</xref>). Separating mutations into mutational fractions demonstrated that shared but not private mutations showed positive dN/dS ratios in all three glioma subtypes indicating that only shared mutations (including truncal mutations) are likely subject to positive selection (<xref rid="F2" ref-type="fig">Fig. 2c</xref>). The dN/dS ratio of initial-only mutations showed that these are neither positively nor negatively selected for, while recurrence-only mutations were subject to negative selection in IDHwt.</p>
        <p id="P14">To verify the reduced selective pressure in the private mutations we used an orthogonal method to test for evidence of selection (neutralitytestr)<sup><xref rid="R31" ref-type="bibr">31</xref></sup>. The method uses variant allele frequency distributions and estimated mutation rates to detect whether profiles significantly deviate from a model of neutral evolution (i.e. as depicted by a linear relationship in <xref rid="F2" ref-type="fig">Fig. 2d</xref>). In accordance with dNdScv results, private mutations demonstrated dynamics consistent with neutral evolution (<xref rid="F2" ref-type="fig">Fig. 2d</xref>). Shared subclonal mutations deviated from linearity and were consistent with selection both in non-hypermutators and hypermutators (<xref rid="F2" ref-type="fig">Fig. 2d</xref>, <xref rid="F10" ref-type="fig">Extended Data Fig. 6a</xref>-<xref rid="F10" ref-type="fig">b</xref>), providing additional evidence that the strongest selective forces occur early in gliomagenesis.</p>
        <p id="P15">Cohort-level analysis of selection masks the heterogeneity that exists in individual evolutionary trajectories. To determine the selective effects at each tumor time point we used a Bayesian framework (SubClonalSelection) which simultaneously provides sample-specific probabilities for both selection and neutrality while modeling sources of noise in sequencing data. The classification of a sample as &#x201C;selection&#x201D; or &#x201C;neutral&#x201D; is determined by whichever model has the greater probability. Classification as &#x201C;neutral&#x201D; reflects the accumulation of random mutations that are not subject to selection. Given the stringent algorithm requirements, 183 patients were included in this analysis with at least one time point, and 104 patients with both time points (16 IDHmutant-codels, 29 IDHmutant-noncodels, 59 IDHwt, <xref rid="SD4" ref-type="supplementary-material">Supplementary Table 3</xref>). Neutral to neutral was the most common evolutionary trajectory across all three subtypes (52%), and IDHwt tumors displayed the highest observed selection at any time point with selection detected in 64% of tumors (Fisher&#x2019;s exact test <italic>P</italic> = 0.01, <xref rid="F2" ref-type="fig">Fig. 2e</xref>, <xref rid="SD4" ref-type="supplementary-material">Supplementary Table 3</xref>). IDHwt gliomas with evidence for selection at recurrence had a shorter overall survival than IDHwt gliomas classified as neutral at recurrence (<italic>P</italic> = 2.7E-02; log-rank statistic, <xref rid="F2" ref-type="fig">Fig. 2f</xref>), suggesting that subclonal competition associates with more aggressive tumor behavior. To address the limitations of smaller sample sizes in the IDH-mutant subtypes, we performed a Cox proportional hazards model including age at first diagnosis, all three glioma subtypes, and mode of selection at recurrence. This analysis revealed that selection at recurrence was significantly associated with shorter survival across subtypes (HR = 1.53 95% CI 1.00&#x2013;2.41, <italic>P</italic> = 4.8E-02, <xref rid="SD5" ref-type="supplementary-material">Supplementary Table 4</xref>). We next investigated whether radiation and chemotherapy imposed a selective effect, by comparing the evolutionary status at recurrence with treatment and other clinical variables. We did not observe significant associations between subclonal selection and radiation therapy or chemotherapy (Fisher&#x2019;s exact-test <italic>P</italic> &gt; 0.05, <xref rid="SD6" ref-type="supplementary-material">Supplementary Table 5</xref>), suggesting that standard therapeutic approaches for glioma have limited impact on the subclonal tumor architecture. While high-depth sequencing datasets may be required to detect subtle selective effects<sup><xref rid="R26" ref-type="bibr">26</xref></sup>, our analyses raise the possibility that the survival benefit derived from standard chemoradiation results from tumor cell elimination where treatment sensitivity of individual cells is not determined by genetic factors.</p>
      </sec>
      <sec id="S6">
        <title>Driver alteration frequencies across time</title>
        <p id="P16">We evaluated how stability, acquisition, and loss of mutation and copy number drivers<sup><xref rid="R6" ref-type="bibr">6</xref></sup> over time impact glioma evolution. We used dNdScv to nominate 12 candidate mutation driver genes at both time points (<italic>Q</italic> &lt; 0.05, <xref rid="F3" ref-type="fig">Fig. 3a</xref>, <xref rid="F11" ref-type="fig">Extended Data Fig. 7a</xref>) and determined significant copy number alterations that recapitulated previously identified drivers (<xref rid="F11" ref-type="fig">Extended Data Fig. 7b</xref>). Mutations in <italic>IDH1</italic> and co-occurring 1p/19q chromosome-arm loss have been suggested as glioma-initiating events<sup><xref rid="R1" ref-type="bibr">1</xref></sup>, which was corroborated by the observation that these events were never lost or acquired during the surgical interval (<xref rid="F3" ref-type="fig">Fig. 3a</xref>, <xref rid="F12" ref-type="fig">Extended Data Fig. 8a</xref>). Similarly, we observed that <italic>TERT</italic> promoter mutations were almost always shared in the IDHmutant-codel and IDHwt, though many samples lacked sufficient coverage in this GC-rich region. Chromosome 7 gains and chromosome 10 losses were present in a large majority of IDHwt initial tumors and persisted into recurrence.</p>
        <p id="P17">Shifts in the fraction of cancer cells harboring an event may also indicate a time dependency of drivers. We determined changes in cellular prevalence of shared driver events by ordering events in each sample by their CCF (<xref rid="F13" ref-type="fig">Extended Data Fig. 9</xref>). <italic>ATRX</italic> mutations in IDHmutant-noncodel initial tumors demonstrated lower CCFs than <italic>TP53</italic> (<italic>P</italic> = 0.03) and <italic>IDH1</italic> (<italic>P</italic> = 0.10) mutations, suggesting <italic>IDH1</italic> and <italic>TP53</italic> mutations precede <italic>ATRX</italic> inactivation<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. There was no difference in CCF between <italic>IDH1</italic> and <italic>TP53</italic> amongst initial gliomas (<italic>P</italic> = 0.98), however, <italic>IDH1</italic> mutations demonstrated significantly lower CCFs compared with <italic>TP53</italic> (<italic>P</italic> = 0.0018) in recurrent gliomas. We did not observe any CCF differences among driver mutations detected in IDHwt tumors at either time point. Chromosome 10 deletion CCFs were higher compared to chromosome 7 amplifications (<italic>P</italic> = 0.0036) implying that chromosome 10 deletions arise earlier <sup><xref rid="R32" ref-type="bibr">32</xref></sup>. Similarly, there was no difference in CCF between <italic>CDKN2A</italic> deletion and <italic>EGFR</italic> amplification (<italic>P</italic> = 0.70). <italic>EGFR</italic> and chromosomal arm events significantly differed (i.e. 10p del vs <italic>EGFR</italic> amp, P = 0.0019) but not <italic>CDKN2A</italic> deletion and chromosomal events (i.e. 10p del vs CDKN2A del, P = 0.33). The consistently high CCF for <italic>EGFR</italic> amplifications could indicate that these events precede even some larger chromosomal aberrations, while not excluding the possibility that high levels of extrachromosomal <italic>EGFR</italic>
<sup><xref rid="R33" ref-type="bibr">33</xref></sup> artificially inflate CCF.</p>
        <p id="P18">Longitudinal changes in CCF values provide additional insights into evolutionary dynamics. For instance, the CCF value may increase when a driver event is linked to clonal expansion, or conversely, decrease when a clone is outcompeted. Most individual drivers did not demonstrate significant consistent CCF changes between the initial tumor and recurrence (<xref rid="F14" ref-type="fig">Extended Data Fig. 10a</xref>). A notable exception was the <italic>TP53</italic> mutation CCF that increased over time (<italic>P</italic> = 0.037) in IDHmut-noncodels, but not IDHwt gliomas (<italic>P</italic> = 0.13, <xref rid="F14" ref-type="fig">Extended Data Fig. 10b</xref>). We did not observe any differences in <italic>IDH1</italic> CCF over time among IDHmut-noncodel tumors, possibly because the general trend of these tumors to increase in CCF is counteracted by the biological loss of relevance of mutant <italic>IDH1</italic> over time (<xref rid="F14" ref-type="fig">Extended Data Fig. 10c</xref>). Indeed, a gross comparison of all shared mutation CCFs revealed an increase in recurrent IDHmut-noncodel tumors (<italic>P</italic> &lt; 0.0001), which may reflect increased clonality and a reduction in intratumoral heterogeneity (<xref rid="F14" ref-type="fig">Extended Data Fig. 10d</xref>). In contrast, shared CCFs decreased in IDHwt tumors, potentially indicating a general increase in intratumoral heterogeneity at recurrence (<italic>P</italic> &lt; 0.0001, <xref rid="F14" ref-type="fig">Extended Data Fig. 10d</xref>). We confirmed that IDHmutant-noncodel CCF increases and IDHwt decreases were not biased by patients with high mutation burden through the classification of patient-specific shared mutation CCF change (<xref rid="F14" ref-type="fig">Extended Data Fig. 10e</xref>).</p>
        <p id="P19">We next investigated whether specific somatic alterations were acquired or lost over time. Gene-specific enrichment of many recurrence-only mutations was found in hypermutated tumors, but there was no enrichment for somatic gene alterations in non-hypermutators suggesting that glioma recurrence is not directed by particular sets of mutations (<xref rid="F12" ref-type="fig">Extended Data Fig. 8b</xref>). Within subtypes we detected an enrichment in <italic>CDKN2A</italic> homozygous deletions (<xref rid="F3" ref-type="fig">Fig. 3a</xref>, <xref rid="F12" ref-type="fig">Extended Data Fig. 8a</xref>) in recurrent IDHmutant-noncodels, which was corroborated by additional cell cycle gene alterations (focal gain of <italic>CCND2, CDK4</italic>, <italic>CDK6</italic>, and mutation or homozygous loss of <italic>RB1</italic>). Mutations in cell cycle checkpoint control genes are associated with genomic instability <sup><xref rid="R34" ref-type="bibr">34</xref></sup>. Therefore, we analyzed aneuploidy levels by determining the proportion of the genome that had undergone aneuploidy events (<xref rid="F15" ref-type="fig">Extended Data Fig. 11a</xref>-<xref rid="F15" ref-type="fig">b</xref>). We observed that IDHmutant-noncodel tumors had a higher level of aneuploidy at recurrence (Wilcoxon rank sum test <italic>P</italic> = 1.4E-06 total aneuploidy, <italic>p</italic> = 8.6E-03 arm-level aneuploidy, <xref rid="F15" ref-type="fig">Extended Data Fig. 11c</xref>-<xref rid="F15" ref-type="fig">d</xref>) with tumors carrying acquired cell cycle gene alterations displaying the largest increases in aneuploidy (<italic>P</italic> = 7.6E-06; Wilcoxon rank sum test, <xref rid="F3" ref-type="fig">Fig. 3b</xref>). We reasoned that <italic>CDKN2A</italic> deletions may precede aneuploidy. Homozygous <italic>CDKN2A</italic> deletions had significantly higher CCFs compared to average CNV CCF across the genome (as a surrogate for aneuploidy related copy number changes), suggesting that <italic>CDKN2A</italic> loss occurred prior to aneuploidy (<xref rid="F3" ref-type="fig">Fig. 3c</xref>). These alterations may hasten disease progression as patients with either cell cycle alterations or the largest increases in aneuploidy at recurrence demonstrated significantly shorter survival than patients without these alterations (log-rank test <italic>P</italic> &lt; 0.0001, <xref rid="F3" ref-type="fig">Fig. 3d</xref>). Taken together, the persistence of drivers over time and the paucity of consistent change imply that therapy does not result in selection of specific sets of molecular changes.</p>
      </sec>
      <sec id="S7">
        <title>Immunoediting activity in glioma</title>
        <p id="P20">We next investigated how the immune microenvironment affects evolutionary trajectories. The immune system may prune tumor cells carrying immunogenic (neo-)antigens, resulting in the selection of subclones capable of evading the immune response. Evidence of this immunoediting process has been shown in several cancer types, including glioma <sup><xref rid="R35" ref-type="bibr">35</xref>-<xref rid="R38" ref-type="bibr">38</xref></sup>, and suggests active immunosurveillance that may be therapeutically exploited <sup><xref rid="R39" ref-type="bibr">39</xref></sup>. We computationally predicted neoantigen-causing mutations<sup><xref rid="R40" ref-type="bibr">40</xref></sup>. As expected, the neoantigen load across the GLASS cohort was strongly correlated with exonic mutation burden (Spearman&#x2019;s Rho = 0.89), with 42% of nonsynonymous exonic mutations giving rise to neoantigens on average. This fraction did not significantly differ by glioma subtype or between initial and recurrent tumors (<italic>P &gt;</italic> 0.05, Wilcoxon rank-sum test; <xref rid="F4" ref-type="fig">Fig. 4a</xref>). The most common neoantigen arose from the clonal R132H mutation in <italic>IDH1</italic> and was present in of 22 out of 88 IDH-mutant initial and recurrent tumors. Beyond mutations in <italic>IDH1</italic>, no mutations gave rise to a neoantigen found in more than three tumors at a given timepoint (<xref rid="SD7" ref-type="supplementary-material">Supplementary Table 6</xref>). Across the dataset, neoantigens and non-immunogenic mutations exhibited similar changes in cancer cell fractions between initial and recurrent tumors indicating a lack of neoantigen-specific selection processes over time (<xref rid="F16" ref-type="fig">Extended Data Fig. 12a</xref>).</p>
        <p id="P21">We then examined the extent to which immunoediting occurred by comparing each sample&#x2019;s observed neoantigen rate to an expected rate that was empirically derived from our dataset. The output of this approach is a normally distributed set of ratios centered at 1. Samples with an observed-to-expected neoantigen ratio &lt; 1 exhibit evidence of neoantigen depletion relative to the rest of the dataset, and thus are more likely to have been immunoedited. We found that none of the three glioma subtypes harbored observed-to-expected ratios that significantly differed from 1 (<italic>P</italic> &gt; 0.05, one sample t-test), though IDHwt tumors exhibited significantly lower scores compared to IDHmut-noncodels (t-test, <italic>P</italic> = 0.04; <xref rid="F4" ref-type="fig">Fig. 4b</xref>). We additionally did not observe an association between the observed-to-expected ratio and survival when adjusting for subtype and age (Wald test, <italic>P</italic> &gt; 0.05), nor was there a difference between samples with neutral evolution dynamics compared to those exhibiting evidence of subclonal selection. When comparing samples longitudinally, we found that the observed-to-expected neoantigen ratio was strongly correlated between initial and recurrent tumors of each patient (Pearson&#x2019;s R = 0.73, <italic>P</italic> = 5E-38), suggesting that the neoantigen depletion level in the recurrence reflects that of the initial tumor (<xref rid="F4" ref-type="fig">Fig. 4c</xref>).</p>
        <p id="P22">Immunoediting is most likely to take place in the tumors with high cytolytic activity and low levels of immunosuppressive activity<sup><xref rid="R38" ref-type="bibr">38</xref></sup>. Hypermutators, which have high neoantigen loads, have previously been associated with highly cytolytic microenvironments <sup><xref rid="R37" ref-type="bibr">37</xref></sup>. However, we did not observe any differences in the observed-to-expected neoantigen ratio between hypermutated recurrent tumors and their initial counterparts, nor did we observe differences between hypermutated and non-hypermutated recurrent tumors, indicating that immunoediting activity is not related to the total number of mutations in a sample (Wilcoxon rank-sum test <italic>P</italic> &gt; 0.05; <xref rid="F16" ref-type="fig">Extended Data Fig. 12b</xref>). To more directly determine whether there were immunologic factors associated with neoantigen depletion, we analyzed CIBERSORT immune cell fractions from a subset of samples that had undergone expression profiling in a previous study (n = 84 from 42 tumor pairs) <sup><xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup>. Initial tumors with an observed-to-expected neoantigen ratio &gt;1 exhibited significantly higher levels of CD4+ T cells than those with a ratio &lt; 1, while recurrent tumors with a ratio &gt; 1 exhibited significantly higher levels of macrophages, neutrophils, and significantly lower levels of plasma cells relative to those with ratio &lt; 1 (<italic>P</italic> &lt; 0.05, Wilcoxon rank-sum test; <xref rid="F16" ref-type="fig">Extended Data Fig. 12c</xref>).</p>
        <p id="P23">While we did not detect many factors associated with the observed-to-expected neoantigen ratio, we did observe that the ratio was significantly associated with the total number of unique HLA loci in a patient (Spearman&#x2019;s Rho = 0.28, <italic>P</italic> = 2E-9), reflecting similar findings in lung cancer<sup><xref rid="R42" ref-type="bibr">42</xref></sup>. This may bias analyses comparing the ratio across patients. To determine whether immunoediting varies over time in a patient-agnostic manner, we compared the observed-to-expected neoantigen ratio derived from a sample&#x2019;s clonal mutations, which likely arose earlier in tumor evolution, to that derived from their subclonal mutations, which likely arose later. We did not observe a significant difference in the observed-to-expected neoantigen ratio of each patient&#x2019;s clonal and subclonal neoantigens, regardless of glioma subtype or whether the sample was an initial tumor or recurrence (<italic>P</italic> &gt; 0.05, paired t-test; <xref rid="F4" ref-type="fig">Fig. 4d</xref>). Together, these analyses suggest that neoantigens in glioma are not exposed to differing levels of selective pressure throughout their development.</p>
      </sec>
    </sec>
    <sec id="S8">
      <title>DISCUSSION</title>
      <p id="P24">We reconstructed the evolutionary trajectories of 222 patients with glioma to better understand treatment failures and tumor progression. The longitudinal molecular profiles revealed common features such as acquired hypermutation and aneuploidy, but highlighted the individualistic paths of post-treatment glioma evolution. Our results provide evidence that current standard of care therapies do not frequently coerce glioma down predictable paths. Instead, an unexpected number of gliomas appeared to stochastically evolve following early driver events. We expect that continuing to profile patient tumors over time using comprehensive sequencing approaches will identify additional common evolutionary paths. Our results here highlight the exciting prospects of several ongoing efforts that may inform new glioma therapies.</p>
      <p id="P25">The observation that treatment-induced hypermutation occurred across subtypes, but did not confer a detrimental effect on patient survival leaves the clinical significance of glioma hypermutation uncertain<sup><xref rid="R21" ref-type="bibr">21</xref>-<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup>. Future analyses that consider the number of therapy cycles and <italic>MGMT</italic> DNA methylation status will help to elucidate factors that predispose tumors to hypermutation and identify therapies that effectively exploit this phenotype&#x2019;s vulnerabilities (e.g., high mutation burden). Acquired cell cycle alterations and aneuploidy in recurrent IDHmut-noncodel gliomas also provide a rationale to target these more aggressive phenotypes with CDK inhibitors<sup><xref rid="R43" ref-type="bibr">43</xref></sup> or with compounds that disrupt microtubule dynamics<sup><xref rid="R44" ref-type="bibr">44</xref></sup>. Finally, our analyses revealed that immunoediting activity does not vary in glioma over time, though we did observe variation between individual patients. Additional molecular and immunological data are needed to fully understand the impact this variability has on glioma evolution and to devise therapies directed at a glioma&#x2019;s immunogenicity<sup><xref rid="R17" ref-type="bibr">17</xref></sup>. To this end, we found that clonal neoantigens arising from the <italic>IDH1</italic> R132H mutation persisted from the initial tumor into the recurrence, justifying neoantigen vaccine approaches as treatments for initial and recurrent glioma<sup><xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref></sup>.</p>
      <p id="P26">Collectively, these findings help shape our perspective on what constitutes an optimal treatment, and what approaches would result in the greatest removal or killing of glioma cells possible. Genomic characterization efforts such as TCGA have greatly increased our understanding of glioma biology, but were limited to a single snapshot in evolutionary time. The GLASS resource provides a framework to study the patterns of glioma evolution and treatment response.</p>
    </sec>
    <sec id="S9">
      <title>Methods</title>
      <sec id="S10">
        <title>Data reporting</title>
        <p id="P27">No statistical methods were used to predetermine sample size.</p>
      </sec>
      <sec id="S11">
        <title>DNA sequencing and data collection</title>
        <p id="P28">The GLASS dataset consists of both unpublished and published sequencing data as outlined in <xref rid="SD2" ref-type="supplementary-material">Supplementary Table 1</xref>. Among the cohort were exomes from 436 glioma samples (200 patients), whole-genome from 165 glioma samples (78 patients), with overlapping exome/whole-genome data on 78 glioma samples (38 patients). A matching germline sequence was available for all patients. The dataset includes 257 sets of at least two time-separated tumor samples, seventeen standalone recurrences, and 19 patients with at least two geographically distinct tumor portions. More specifically, the dataset includes exome or whole-genome sequencing data on 211 primary gliomas, 234 first recurrences, 32 second recurrences, 11 third recurrences and one fourth recurrence (<xref rid="SD8" ref-type="supplementary-material">Supplementary Table 7</xref>).</p>
        <p id="P29">Newly generated whole genome sequencing data for the Chinese University of Hong Kong (HK), Northern Sydney Cancer Centre (NS) and MD Anderson Cancer Center (MD) cohorts were subjected to 150 base paired-end sequencing. The HK samples were sequenced using a HiSeqX while the NS and MD cohorts were sequenced using a NovaSeq according to Illumina&#x2019;s protocols. Whole exome capture was performed using the following platforms as reported in previous publications. Agilent SureSelect Human All Exon 50Mb capture kit was used for patients SF-0001- SF-0021, Agilent SureSelect Human All Exon V4 capture kit was used for patients SF-0024 &#x2013; SF-0029 in the UC San Francisco cohort. Agilent SureSelect Human All Exon v4 or v5 was used to capture samples in the Kyoto University cohort. Samsung Medical Center cohort reported using Agilent SureSelect kit for patients SM-R056 &#x2013; SM-R071, SM-R075, SM-R076, SM-R095- SM-R114 while Illumina TruSeq Exome-capture kit was used for patient SM-R072. Exome capture was performed using Agilent SureSelect Human All Exon 50 Mb in The Cancer Genome Atlas (TCGA)-GBM cohort and Agilent SureSelect Human All Exon v2.0, 44Mb kit in the TCGA-LGG cohort. Columbia University cases were captured using Agilent V3 50M kit, sequencing 90bp PE for samples R009-TP, R009R1, R011TP, R011R1, R014TP, R014R1, R017-R1, R018-R1, R019-R1. Mapping files of initial tumor and normal samples of patients R017 &#x2013; R019 were obtained from TCGA through CG-hub. All other samples were captured using Agilent SureSelect XT Human All Exon v4 Kit, PE, 80M reads, 150X on target coverage. Samples in the Henry Ford Hospital cohort were multiplexed and sequenced using Illumina HiSeq 2000 by the Sequencing and Microarray Facility at an average target exome coverage of 100&#xD7; using 76-bp paired-end reads. Samples in the HK cohort were subjected to 75 base paired-end sequencing for HK-0001 &#x2013; HK-0004 as performed NextSeq in high output mode. In the Leeds Cohort (LU) SureSelectXT V5 kit (PE100) was used to construct exome libraries. Illumina TruSeq Exome capture kit was used for samples at the Medical University of Vienna &#x2013; CeMM.</p>
      </sec>
      <sec id="S12">
        <title>GLASS identifiers</title>
        <p id="P30">A GLASS barcode system was created, based on TCGA barcode design, in an effort to de-identify patient information and provide an organized framework for the different pieces of the dataset.</p>
        <p id="P31">GLASS barcodes are composed of 24 characters. The first four characters specify the project (either GLSS or TCGA). All datasets submitted to the GLASS consortium, published and unpublished, were given the GLSS project ID. Samples that were part of the TCGA cohorts (TCGA GBM and TCGA LGG) were given a TCGA designation. The next two characters designate the center where the samples were either acquired or sequenced (<xref rid="SD8" ref-type="supplementary-material">Supplementary Table 7</xref>). This is followed by the four-character center specific patient identification that was kept as close as possible to the patient identification provided by the collaborators to allow a simplified trace back process. Patient data is divided by a relative sample type, such as initial tumor (TP), recurrent tumor (R1), normal tissue (NB, NM, etc), or metastatic tumor sample (M1). If there was more than one recurrence the relative number was specified following &#x201C;R&#x201D;. Some patients had surgeries for which a biospecimen was unavailable. Thus, a surgical number was also provided to indicate temporal ordering (<xref rid="SD9" ref-type="supplementary-material">Supplementary Table 8</xref>). To include spatially separated samples the portion designation was added, which is followed by one character specifying the type of analyte, either DNA (D) or RNA (R). As there is variation in the sequencing analysis, a three-character designation represents either whole genome (WGS) or whole exome sequencing (WXS). The last part of the GLASS barcode is a six-character designation unique to each barcode that was randomly generated.</p>
      </sec>
      <sec id="S13">
        <title>Computational pipelines</title>
        <p id="P32">All pipelines were developed using snakemake 5.2.2 <sup><xref rid="R47" ref-type="bibr">47</xref></sup>. Unless otherwise stated, all tools mentioned are part of the GATK 4 suite <sup><xref rid="R48" ref-type="bibr">48</xref></sup>. All data was collected at a central location (The Jackson Laboratory) and was analyzed using homogenous pipelines capable of processing both raw fastq files as well as re-process previously analyzed bam files.</p>
      </sec>
      <sec id="S14">
        <title>Alignment and pre-processing</title>
        <p id="P33">Data pre-processing was conducted in accordance to the GATK Best Practices using GATK 4.0.10.1. Briefly, aligned BAM files were separated by read group, sanitized and stripped of alignments and attributes using &#x2018;RevertSam&#x2019;, giving one unaligned BAM (uBAM) file per readgroup. Uniform readgroups were assigned to uBAM files using &#x2018;AddOrReplaceReadgroups&#x2019;. Similarly, unaligned fastq files were assigned uniformly designated readgroup attributes and converted to uBAM format using &#x2018;FastqToSam&#x2019;. uBAM files underwent quality control using &#x2018;FastQC 0.11.7&#x2019;. Sequencing adapters were marked using &#x2018;MarkIlluminaAdapters&#x2019;. uBAM files were finally reverted to interleaved fastq format using &#x2018;SamToFastq&#x2019;, aligned to the b37 genome (&#x2018;human_g1k_v37_decoy&#x2019;) using &#x2018;BWA MEM 0.7.17&#x2019;, attributes were restored using &#x2018;MergeBamAlignment&#x2019;. &#x2018;MarkDuplicates&#x2019; was then used to merge aligned BAM files from multiple readgroups and to mark PCR and optical duplicates across identical sequencing libraries. Lastly, base recalibration was performed using &#x2018;BaseRecalibrator&#x2019; followed by &#x2018;ApplyBQSR&#x2019;. Coverage statistics were gathered using &#x2018;CollectWgsMetrics&#x2019;. Alignment QC was performed running &#x2018;ValidateSamFile&#x2019; on the final BAM file and QC results were inspected using &#x2018;MultiQC 1.6a0&#x2019; <sup><xref rid="R49" ref-type="bibr">49</xref></sup>. A haplotype database for fingerprinting was generated using a modified version of the code on <ext-link ext-link-type="uri" xlink:href="https://github.com/naumanjaved/fingerprint_maps">https://github.com/naumanjaved/fingerprint_maps</ext-link>. The tool &#x2018;CrosscheckFingerprints&#x2019; was used to confirm that all readgroups within a sample belong to the same individual, and that all samples from one individual match. Any mismatches were marked and excluded from further analysis.</p>
      </sec>
      <sec id="S15">
        <title>Variant detection</title>
        <p id="P34">Variant detection was performed in accordance to the GATK Best practices using GATK 4.1.0.0. Germline variants were called from control samples using Mutect2 in artifact detection mode and pooled into a cohort-wide panel of normals. Somatic variants were subsequently called in individual tumor samples (single-sample mode) and in entire patients using GATK 4.1 Mutect2 in multi-sample mode. Mutect2 was given matched control samples, the aforementioned panel of normals and the gnomAD germline resource as additional controls. Cross-sample contamination was evaluated using &#x2018;GetPileupSummaries&#x2019; and &#x2018;CalculateContamination&#x2019; run for both tumor and matching control samples. Read orientation artifacts were evaluated using &#x2018;CollectF1R2Counts&#x2019; and &#x2018;LearnReadOrientationModel&#x2019;. Somatic likelihood, read orientation, sequence context, germline and contamination filters were applied using &#x2018;FilterMutectCalls&#x2019;.</p>
      </sec>
      <sec id="S16">
        <title>Variant post-processing</title>
        <p id="P35">BCFTools 1.9 was used to normalize, sort and index variants<sup><xref rid="R50" ref-type="bibr">50</xref></sup>. A consensus VCF was generated from all variants in the cohort, removing any duplicate variants. The consensus VCF file was annotated using GATK 4.1 Funcotator and the v1.6.20190124s annotation data source. Allele frequencies (AFs) from multi-sample Mutect2 were used to compare AFs between related samples. Multi-sample Mutect2 calls and filters mutations across a patient as a whole and does not determine mutation calls in a single samples. Single-sample mutation calls were overlaid on the multi-sample calls to infer whether variants were called in individual samples. Single-sample called variants that were not present in the multi-sample callset were discarded.</p>
      </sec>
      <sec id="S17">
        <title>Mutational burden</title>
        <p id="P36">Mutational burden was calculated as the number of mutations per megabase (Mb) sequenced. A minimum coverage threshold of 15x was required for each base. DNA hypermutation was defined for recurrent tumors with greater than 10 mutations per Mb sequenced as these values were considered outliers (1.5 times the interquartile range above the upper quartile). Notably, there were a few initial gliomas that demonstrated a mutational frequency above 10 mutations per Mb. However, the &#x201C;hypermutation&#x201D; classification was restricted to only patients with this level at recurrence since these likely reflect different evolutionary paths.</p>
      </sec>
      <sec id="S18">
        <title>Mutational signatures</title>
        <p id="P37">The relative contributions of the COSMIC mutational signatures were determined from a patient&#x2019;s initial-only, recurrence-only, and shared mutations by solving the non-negative-least squares (NNLS) problem for each set of mutations using the 30 signatures from version 2 (March 2015). Six signatures were dominantly enriched in at least 3% of the fractions and we resolved the NNLS using the reduced six-signature model to increase accuracy and reduce noise.</p>
      </sec>
      <sec id="S19">
        <title>Copy number segmentation</title>
        <p id="P38">Copy number identification was performed according to the GATK Best Practices and is outlined briefly here. The pipeline differs slightly for whole genomes and whole exomes. For genomes, the genome was segmented into 10kb bins using &#x2018;PreprocessIntervals&#x2019;. For exomes, overlapping regions between several commonly used capture kits (Broad Human Exome b37, Nextera Rapid Capture, TruSeq Exome, SeqCap EZ Exome V3, Agilent SureSelect V4, Agilent SureSelect V7) were identified using &#x2018;bedtools multiIntersectBed&#x2019;. The tool &#x2018;PreprocessIntervals&#x2019; was used to apply 1kb padding and to merge overlapping intervals. In parallel, &#x2018;SelectVariants&#x2019; was used to subset the gnomAD resource of germline variants to variants with a population AF greater than 5%. Next, &#x2018;CollectReadcounts&#x2019; was used to count reads in the bins generated by &#x2018;PreprocessIntervals&#x2019; separately for autosomes and allosomes. In parallel, &#x2018;CollectAllelicCounts&#x2019; was used to count reference and alternate reads at gnomAD variant sites with a population AF greater than 5%. The cohort was subsequently split into batches determined by sequencing center and &#x2018;CreateReadCountPanelOfNormals&#x2019; was used to create a panel of normal (PON) for each batch. PONs were created separately for allosomes and autosomes, and allosomes were separated further by sex. To further improve the panel of normals, GC content annotation of each interval as determined by &#x2018;AnnotateIntervals&#x2019; were given. Next, &#x2018;DenoiseReadCounts&#x2019; was used to denoise the binned readcounts output by &#x2018;CollectReadCounts&#x2019;, given a PON determined by batch, chromosomes (allosomes or autosomes) and sex. Denoised copy ratios were plotted and inspected for quality concerns using &#x2018;PlotDenoisedCopyRatios&#x2019;. The tool &#x2018;ModelSegments&#x2019; is an implementation of a gaussian-kernel binary-segmentation algorithm and was used to merge contiguous segments and assign copy and allelic ratios. The results of this segmentation were plotted using &#x2018;PlotModeledSegments&#x2019; and inspected for quality concerns.</p>
      </sec>
      <sec id="S20">
        <title>Copy number calling</title>
        <p id="P39">A copy number caller loosely based on GATK &#x2018;CallCopyRatioSegments&#x2019; (which in turn is based off of ReCapSeg) and GISTIC was implemented to call both arm-level and high-level copy number changes, respectively<sup><xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr">52</xref></sup>.</p>
        <p id="P40">Segments (from &#x2018;ModelSegments&#x2019;) with a non-log2 copy ratio between 0.9 and 1.1 were determined to be neutral. These segments were then weighted by length and a weighted mean and standard deviation (sd) non-log2 copy ratio (once-filtered) were determined again. Outlier segments are removed and once again a weighted mean and sd non-log2 copy ratio (twice-filtered) were determined. Segments with a non-log2 copy ratio between 0.9 and 1.1 and segments within two standard deviations of the twice-filtered mean were determined to be neutral, and segments outside of these boundaries were determined to have a low-level amplification or deletion, depending on the direction.</p>
        <p id="P41">The weighted mean and sd of the non-log2 copy ratio (once-filtered) was then determined individually for each chromosome arm. Outlier segments were removed and the weighted mean and sd of the non-log2 copy ratio (twice-filtered) was determined again. In order to determine a high-level amplification and deletion threshold, the most highly amplified and deleted chromosome arms were selected, respectively. The twice-filtered mean plus (high level amplification) or minus (high level deletion) two times the sd of the selected arms were used as high-level thresholds.</p>
        <p id="P42">Gene level copy number were called by intersecting the gene boundaries with the segment intervals and by calculating the weighted non-log2 copy ratio for that gene. The copy number call for that gene was then determined by comparing the gene-level non-log2 copy ratio to the previously determined thresholds.</p>
      </sec>
      <sec id="S21">
        <title>dNdScv</title>
        <p id="P43">The R package dNdScv<sup><xref rid="R53" ref-type="bibr">53</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://github.com/im3sanger/dndscv">https://github.com/im3sanger/dndscv</ext-link>) was run using the default and recommended parameters for all mutations in initial tumor samples, recurrent tumor samples, and for each mutational fraction (unique to initial, unique to recurrent and shared). All analyses were conducted separately within the three main tumor subtypes.</p>
      </sec>
      <sec id="S22">
        <title>Aneuploidy calculation</title>
        <p id="P44">The most reductive metric of aneuploidy was computed by taking the size of all non-neutral segments divided by the size of all segments. The resulting aneuploidy value indicates the proportion of the segmented genome that is non-diploid.</p>
        <p id="P45">In parallel, an arm-level aneuploidy score modeled after a previously described method was computed<sup><xref rid="R54" ref-type="bibr">54</xref></sup>. Briefly, adjacent segments with identical arm-level calls (&#x2212;1, 0 or 1) were merged into a single segment with a single call. For each merged/reduced segment, the proportion of the chromosome arm it spans was calculated. Segments spanning greater than 80% of the arm length resulted in a call of either &#x2212;1 (loss), 0 (neutral) or +1 (gain) to the entire arm, or NA if no contiguous segment spanned at least 80% of the arm&#x2019;s length. For each sample the number of arms with a non-neutral event was finally counted. The resulting aneuploidy score is a positive integer with a minimum value of 0 (no chromosomal arm-level events detected) and a maximum value of 39 (total number of autosomal chromosome arms excluding the short arms for chromosomes 13, 14, 15, 21, and 22).</p>
      </sec>
      <sec id="S23">
        <title>Estimates of evolutionary pressures</title>
        <p id="P46">Evolutionary pressures were evaluated both by variant status and glioma subtype using the neutralitytestr algorithm as previously described (R-package: neutralitytestr version: 0.0.2, <ext-link ext-link-type="uri" xlink:href="https://github.com/marcjwilliams1/neutralitytestr">https://github.com/marcjwilliams1/neutralitytestr</ext-link>)<sup><xref rid="R31" ref-type="bibr">31</xref></sup>. Individual variant allele frequency vectors were merged at the level of glioma subtype by variant status. Only mutations found in copy-neutral regions should were included in these analyses. For all else, default parameters were used. Merged VAF distributions were deemed to be selected when the neutral null hypothesis was rejected using several metrics. Tests for neutrality required that both R<sup>2</sup> values &lt; 0.98 and the area between the two curves of 1) merged VAF data and 2) a normalized distribution expected under neutrality to be significantly different.</p>
        <p id="P47">The SubclonalSelection algorithm was applied to GLASS mutation data to measure the selection strength in individual tumor samples (Julia package: SubclonalSelection, <ext-link ext-link-type="uri" xlink:href="https://github.com/marcjwilliams1/SubClonalSelection.jl">https://github.com/marcjwilliams1/SubClonalSelection.jl</ext-link>)<sup><xref rid="R16" ref-type="bibr">16</xref></sup>. Patients that had samples at both timepoints with a TITAN-defined purity estimate &gt;= 0.5 and &gt;= 25 subclonal mutations in non-diploid regions were included. Mean coverage across all mutations was used as the &#x201C;read_depth&#x201D; input parameter and the model was run with the recommended 10<sup>6</sup> iterations and 1000 particles. Samples were classified as neutral or selected based on the model that had the highest probability, in line with the prior applications to TCGA data<sup><xref rid="R16" ref-type="bibr">16</xref></sup>. Classification based on the highest model probability yielded stable results there was not a significant change in proportions when setting a higher classification probability threshold (<italic>P</italic> &gt; 0.05, Pearson&#x2019;s Chi-square test, for both probability thresholds of 0.6 and 0.7). At all three probability thresholds (0.5, 0.6, and 0.7), Kaplan-Meier survival analyses between selection at recurrence and overall survival continued to indicate that patients with IDHwt tumors that were selected had a worse overall survival (<italic>P</italic> = 0.03 (n=81), <italic>P</italic> = 0.01 (n=66), <italic>P</italic> = 0.01 (n=56) respectively).</p>
      </sec>
      <sec id="S24">
        <title>Mutation clonality</title>
        <p id="P48">Each patient&#x2019;s clonal architecture was inferred using PyClone (version 0.13.1) by grouping SNVs into clonal clusters (<ext-link ext-link-type="uri" xlink:href="https://github.com/aroth85/pyclone">https://github.com/aroth85/pyclone</ext-link>)<sup><xref rid="R55" ref-type="bibr">55</xref></sup>. The patient-level input mutation matrix was reduced by limiting to sites with at least 30x coverage across all samples. PyClone was subsequently ran using a binomial density model, connected initiation, and 10000 iterations. Sample purities were provided for each patient and parental copy number (minor and major allele counts) from TITAN were given. PyClone results were post-processed using a burn-in of 1000, thin of 1, minimum cluster size of 2 and a maximum number of clusters per patient of 12. Individual mutations were determined to be clonal if the PyClone cancer cell fraction (CCF) values were &gt;= 0.5, subclonal for mutations with CCF &gt;= 0.1 and CCF &lt;0.5, mutations were considered non-clonal when CCF &lt; 0.1 as previously described <sup><xref rid="R56" ref-type="bibr">56</xref></sup>.</p>
      </sec>
      <sec id="S25">
        <title>CNV clonality</title>
        <p id="P49">Allele specific copy number, tumor purity and ploidy estimates were derived using a probabilistic model (TITAN, version 1.19.1) for both whole genome and whole exome sequencing samples <sup><xref rid="R57" ref-type="bibr">57</xref></sup>. TITAN was supplied with the tumor denoised readcounts output by GATK DenoiseReadCounts and the tumor allelic counts at loci found to be heterozygous in control samples output by ModelSegments. An &#x2018;alphaK&#x2019; (and &#x2018;alphaKHigh&#x2019;) parameter of 2500 and 10000 was used for exomes and genomes, respectively. The patient sex was provided in order to improve fitting allosomes. For each tumor-control pair TITAN was ran assuming an initial ploidy of two or three, and assuming 1 to 3 clusters, resulting in a total of six possible solutions per tumor/control pair. To select the optimal solution, TITAN&#x2019;s internal selectSolution function was used with a threshold of 0.15 giving additional weight to diploid solutions.</p>
      </sec>
      <sec id="S26">
        <title>Timing analysis</title>
        <p id="P50">The CCF values output by TITAN or PyClone were used for separately timing copy number changes or mutations. To time specific copy number changes in genes, the average CCF for that gene was calculated. When timing mutations in genes, the highest CCF amongst the non-synonymous mutations was taken.</p>
      </sec>
      <sec id="S27">
        <title>Neoantigen analyses</title>
        <p id="P51">Neoantigens in this analysis were defined as all 8&#x2013;11-mer peptides that arose from an exonic nonsynonymous SNV or indel and bound their respective patient&#x2019;s HLA class I molecules at a binding affinity score (IC50) that was &#x2264; 500 nM and better than or equal to the wild-type form of the peptide. Each patient&#x2019;s 4-digit HLA class I types were inferred using OptiType (version 1.3.1, <ext-link ext-link-type="uri" xlink:href="https://github.com/FRED-2/OptiType">https://github.com/FRED-2/OptiType</ext-link>) run on each patient&#x2019;s matched normal sample<sup><xref rid="R58" ref-type="bibr">58</xref></sup>. VCF files for each tumor sample were annotated using Variant Effect Predictor (ensembl) with the Downstream and Wildtype plugins. Neoantigens from these VCFs were then called using pVACseq (version 4.0.10, <ext-link ext-link-type="uri" xlink:href="https://github.com/griffithlab/pVAC-Seq">https://github.com/griffithlab/pVAC-Seq</ext-link>)<sup><xref rid="R40" ref-type="bibr">40</xref></sup> run using netMHCpan (version 2.8, <ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/NetMHCpan-2.8/">http://www.cbs.dtu.dk/services/NetMHCpan-2.8/</ext-link>)<sup><xref rid="R59" ref-type="bibr">59</xref></sup>. For each pVACseq run, epitope length was set to 8, 9, 10, or 11, minimum binding affinity fold-change was set to 1, and downstream sequence length was set to full, with default parameters used for all other settings.</p>
        <p id="P52">Downstream neoantigen analyses were performed using the pVACseq output linked to its respective mutation information. Neoantigen-causing mutations were defined as all mutations that gave rise to at least one neoantigen. The observed-to-expected neoantigen ratio was calculated using a previously developed approach that compares each tumor&#x2019;s observed neoantigen rate to an empirically derived expected rate that assumes no selection against neoantigen-causing mutations<sup><xref rid="R38" ref-type="bibr">38</xref></sup>: From the gold set samples in the GLASS cohort (n = 222), define <inline-formula><mml:math display="inline" id="M4" overflow="scroll"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>N</mml:mi><mml:mo>&#xAF;</mml:mo></mml:mover><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> to be the expected number of nonsynonymous missense SNVs per synonymous SNV with trinucleotide context <italic>s</italic>. <inline-formula><mml:math display="inline" id="M5" overflow="scroll"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>B</mml:mi><mml:mo>&#xAF;</mml:mo></mml:mover><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is then defined as the expected number of neoantigen-generating missense SNVs per nonsynonymous missense SNV with trinucleotide context <italic>s</italic>. For a given sample <italic>i</italic>, define <italic>Y<sub>i</sub></italic> as the sample&#x2019;s set of synonymous SNVs and <italic>s</italic>(<italic>m</italic>) to be a synonymous SNV with trinucleotide context <italic>m</italic>. The expected number of nonsynonymous missense SNVs, <italic>N<sub>pred</sub></italic>, and neoantigen-causing mutations, <italic>B<sub>pred</sub></italic>, can then be calculated as follows:
<disp-formula id="FD1"><mml:math display="block" id="M1" overflow="scroll"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>&#x2208;</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:munder><mml:msub><mml:mover accent="true"><mml:mi>N</mml:mi><mml:mo>&#xAF;</mml:mo></mml:mover><mml:mrow><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula>
<disp-formula id="FD2"><mml:math display="block" id="M2" overflow="scroll"><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>&#x2208;</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:munder><mml:msub><mml:mover accent="true"><mml:mi>N</mml:mi><mml:mo>&#xAF;</mml:mo></mml:mover><mml:mrow><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mover accent="true"><mml:mi>B</mml:mi><mml:mo>&#xAF;</mml:mo></mml:mover><mml:mrow><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:math></disp-formula></p>
        <p id="P53">To obtain sample <italic>i</italic>&#x2019;s final neoantigen depletion ratio <italic>R<sub>i</sub></italic>, the observed number of neoantigen-causing mutations in the sample, <italic>B<sub>obs,i</sub></italic> is divided by the sample&#x2019;s observed number of nonsynonymous missense SNVs, <italic>N<sub>obs,i</sub></italic>, and then this ratio is divided by the ratio of <italic>B<sub>pred,i</sub></italic> and <italic>N<sub>pred,i</sub></italic>. Thus:
<disp-formula id="FD3"><mml:math display="block" id="M3" overflow="scroll"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#x2215;</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">&#x2215;</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p>
        <p id="P54">For analyses examining clonal/subclonal neoantigen ratios, the observed and expected numbers were calculated by subsetting a sample&#x2019;s SNVs by the respective criteria and then recalculating the ratio as described above. To mitigate overfitting, all analyses presented here utilized samples from patients with at least 3 neoantigen-causing mutations in their primary and recurrent tumors.</p>
      </sec>
      <sec id="S28">
        <title>Immune cell analyses</title>
        <p id="P55">CIBERSORT relative immune cell fraction data used in downstream neoantigen analyses were downloaded from a previous publication<sup><xref rid="R37" ref-type="bibr">37</xref></sup>.</p>
      </sec>
      <sec id="S29">
        <title>Statistical methods</title>
        <p id="P56">All data analyses were conducted in R 3.4.2, Python 2.7.15, PostgreSQL 10.5, and Julia 0.7. All survival analyses including Kaplan-Meier plots and Cox proportional hazards models were conducted using the R packages survival and survminer.</p>
      </sec>
      <sec sec-type="data-availability" id="S30">
        <title>Data availability</title>
        <p id="P57">All deidentified, non-protected access somatic variant profiles and clinical data are accessible via Synapse (<ext-link ext-link-type="uri" xlink:href="http://synapse.org/glass">http://synapse.org/glass</ext-link>). Raw data of the various sequencing datasets can be obtained per the overview provided in the Supplement.</p>
      </sec>
      <sec id="S31">
        <title>Code availability</title>
        <p id="P58">All custom scripts and pipelines are available on the project&#x2019;s github page (<ext-link ext-link-type="uri" xlink:href="https://github.com/TheJacksonLaboratory/GLASS">https://github.com/TheJacksonLaboratory/GLASS</ext-link>).</p>
      </sec>
    </sec>
    <sec sec-type="extended-data" id="S32">
      <title>Extended Data</title>
      <fig id="F5" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 1 &#x2223;</label>
        <caption>
          <title>Sample Selection.</title>
          <p id="P59"><bold>a.</bold> Quality control workflow steps identifying all GLASS samples available as a resource and the identification of the highest quality set of patient pairs (<italic>n</italic> = 222) used for the presented mutational and copy number analyses. <bold>b.</bold> Additional available datasets.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0005"/>
      </fig>
      <fig id="F6" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 2 &#x2223;</label>
        <caption>
          <title>Mutation burden by time point and subtype.</title>
          <p id="P60"><bold>a.</bold> Boxplots and paired lines depicting coverage adjusted mutation frequencies in initial and matched recurrent samples across three subtypes. Wilcoxon signed-rank test P-values and sample sizes are indicated. <bold>b.</bold> Bee swarm plot depicting coverage adjusted mutation frequencies in fractions by subtype. Dashed line indicates the mean. One-way ANOVA P-values comparing three subtypes are indicated. <bold>c.</bold> Scatter plot showing the relationship between age at diagnosis and coverage adjusted mutation burdens by subtype and fraction. Linear model P-values are indicated and were adjusted by subtype. <bold>d.</bold> Similar to the analysis presented in <bold>c</bold>, but showing the relationship between time to recurrence and coverage adjusted mutation burdens.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0006"/>
      </fig>
      <fig id="F7" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 3 &#x2223;</label>
        <caption>
          <title>Mutational signatures by fraction and subtype.</title>
          <p id="P61"><bold>a.</bold> Correlation plot showing the Pearson&#x2019;s chi-squared (X<sup>2</sup>) residuals for each signature by fraction and subtype. A X<sup>2</sup> was performed for each subtype and P-values are indicated. Positive residuals (blue) indicate a positive correlation, whereas negative residuals (red) indicate an anticorrelation. The point size reflects the contribution to X<sup>2</sup> estimate. <bold>b.</bold> The same ordered of patients as <xref rid="F1" ref-type="fig">Fig. 1a</xref> along with relevant clinical information is provided alongside the fraction-specific mutational signatures. PyClone mutational clusters are also presented.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0007"/>
      </fig>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 4 &#x2223;</label>
        <caption>
          <title>Hypermutator clonality.</title>
          <p id="P62"><bold>a.</bold> Bar plots represent counts of recurrence-only mutations per hypermutator tumor that were known to receive alkylating agent therapy and were successfully run through the PyClone algorithm. Colors indicate mutation clonality and color intensity indicates whether the mutations resulted in coding changes. <bold>b.</bold> Kaplan-Meier curve comparing alkylating agent-treated patients with IDHmut-noncodel hypermutator tumors that were predominantly clonal (<italic>n</italic> = 8), predominantly subclonal (<italic>n</italic> = 7), versus IDHmut-noncodel non-hypermutators known to be treated with alkylating agents and had available PyClone data (<italic>n</italic> = 17). Log-rank P-value is shown.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0008"/>
      </fig>
      <fig id="F9" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 5 &#x2223;</label>
        <caption>
          <title>Clonal structure evolution over time.</title>
          <p id="P63"><bold>a.</bold> The minimum cancer cell fraction of the most persistent (shared between initial and recurrence) PyClone cluster. <bold>b.</bold> Comparison of PyClone clusters ranked by CCF in matched initial and recurrent tumors, as <xref rid="F2" ref-type="fig">Fig. 2b</xref> but separated by subtype. <bold>c-d.</bold> Examples of cluster CCF dynamics over time in three separate samples, including <bold>(c)</bold> two multi-timepoint samples <bold>(d)</bold> and one multi-sector sample. These additional data are available in the GLASS resource, but only two time-separated samples were used throughput the manuscript to ensure clarity.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0009"/>
      </fig>
      <fig id="F10" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 6 &#x2223;</label>
        <caption>
          <title>Variant allele fraction distribution</title>
          <p id="P64"><bold>(a)</bold> Non-hypermutator variant allele fraction distributions for copy neutral variants in coding regions (n = 181 patients). Variants are separated by subtype, fraction, and also whether the variant was non-synonymous or synonymous mutation in a coding region. R<sup>2</sup> goodness-of-fit measure and associated P-values are shown for both mutation types. Note that this data considers only the coding portion of genome while <xref rid="F2" ref-type="fig">Fig. 2d</xref> presents both coding and non-coding. <bold>(b)</bold> The cumulative distribution of the subclonal mutations in copy-neutral regions for hypermutators (n = 31 patients). For each variant fraction and subtype, the R<sup>2</sup> goodness-of-fit measure and P-values are shown.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0010"/>
      </fig>
      <fig id="F11" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 7 &#x2223;</label>
        <caption>
          <title>Driver gene nomination.</title>
          <p id="P65"><bold>a.</bold> Local (gene-wise) dNdScv estimates by subtype (rows) and fraction (columns). Genes are sorted by Q-value and P-value. The Q-value is shown in color, whereas the P-value is indicated in light gray. The Q-value threshold of 0.05 is indicated by a horizontal red line. <bold>b.</bold> GISTIC significant amplification (red) and deletion (blue) plots in initial (left) and recurrent tumors (right). Chromosomal locations are ordered on the y-axis, Q-values are shown on the x-axis, and selected drivers are indicated by their chromosomal location on the right.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0011"/>
      </fig>
      <fig id="F12" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 8 &#x2223;</label>
        <caption>
          <title>Driver acquisition over time</title>
          <p id="P66"><bold>a.</bold> Tabulated numbers of SNV (top) and CNV (bottom) driver events that were shared, initial-only, or recurrence-only. P-values were obtained using a two-sided Fisher test comparing the initial-only fraction to the recurrence-only fraction testing for acquisition. <bold>b.</bold> One-sided Fisher test comparing the initial-only fraction to the recurrence-only fraction amongst previously implicated glioma drivers testing for driver acquisition. P-values were adjusted for multiple testing using the FDR (x-axis). Hypermutators (red) and non-hypermutators (black) were separately analyzed.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0012"/>
      </fig>
      <fig id="F13" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 9 &#x2223;</label>
        <caption>
          <title>Intra-tumor CCF comparison.</title>
          <p id="P67">Ladder plots comparing the CCF of co-occurring drivers in single tumor samples. The color of the lines and points indicates whether the sample shown is an initial (brown) or recurrent (green) tumor. Two-sided Wilcoxon rank-sum test P-values are shown for all initial samples, all recurrent samples, as well as all samples (black).</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0013"/>
      </fig>
      <fig id="F14" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 10 &#x2223;</label>
        <caption>
          <title>Between time point intra-patient CCF comparison.</title>
          <p id="P68"><bold>a.</bold> Driver-gene CCF comparison between initial and matched recurrences. Lines are colored by variant classification. Two-sided Wilcoxon rank-sum test P-values are shown. <bold>b.</bold>
<italic>TP53</italic> CCF by subtype, otherwise as in <bold>(a)</bold>. <bold>c.</bold>
<italic>IDH1</italic> CCF by subtype, otherwise as in <bold>(a)</bold>. <bold>d.</bold> Ladder plot visualizing CCF change across all SNVs between initial and recurrent tumors, separated by subtype. Wilcoxon rank-sum test was used to test for differences between time points. <bold>e.</bold> Initial and recurrent mutations in each patient were compared using a Wilcoxon rank-sum test. Bar plot with counts of patients in each subtype are shown. Patients lacking significant change are shown in yellow, those with a significant increase or decrease are shown in dark and light blue, respectively.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0014"/>
      </fig>
      <fig id="F15" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 11 &#x2223;</label>
        <caption>
          <title>Aneuploidy calculation</title>
          <p id="P69"><bold>a.</bold> Heatmap displaying the chromosomal arm-level events (x-axis) with patients represented in each row. Patients are placed in the same order for both the initial (left) and recurrence (right). White space was inserted as a break between the three subtypes. <bold>b.</bold> Distribution of total aneuploidy difference. Acquired aneuploidy determination (upper-quartile) indicated with a red line. <bold>c.</bold> Comparison of aneuploidy score between initial and recurrent tumors separated by subtype <bold>d.</bold> As <bold>(c)</bold>, comparing aneuploidy value.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0015"/>
      </fig>
      <fig id="F16" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 12 &#x2223;</label>
        <caption>
          <title>Neoantigen evolution and cellular analysis</title>
          <p id="P70"><bold>a.</bold> Bar plots representing the number of shared mutations that give rise to neoantigens (top row, &#x201C;immunogenic&#x201D;) and those that do not give rise to neoantigens (bottom row, &#x201C;non-immunogenic&#x201D;) stratified by longitudinal clonality (&#x201C;(clonality in initial)-(clonality in recurrence)&#x201D;) and further separated by subtype. Percentage of longitudinal clonality per subtype and mutation immunogenicity are presented above the respective bars. <bold>b.</bold>
<italic>Left:</italic> Ladder plot depicting the difference in observed-to-expected neoantigen ratio between the initial and recurrent tumors of patients with hypermutated tumors at recurrence. Each set of points connected by a line represents one tumor (<italic>n =</italic> 70). <italic>Right:</italic> Boxplot depicting the distribution of observed to expected neoantigen ratios in recurrent tumors stratified by hypermutator status (<italic>n</italic> = 35 and 183 for hypermutators and non-hypermutators, respectively). Each box spans quartiles, with the lines representing the median ratio for each group. Whiskers represent absolute range, excluding outliers. P-values for panel b were calculated using a paired and unpaired two-sided t-test, respectively. <bold>c.</bold> Stacked bar plots depicting the average relative fraction of 11 CIBERSORT cell types in the neoantigen depleted (&lt; 1) and non-depleted (&gt; 1) initial and recurrent tumor subgroups. Asterisks to the right of each plot indicate a significant difference (<italic>P</italic> &lt; 0.05, Wilcoxon rank-sum test) between the depleted and non-depleted groups for the noted cell type at that time.</p>
        </caption>
        <graphic xlink:href="nihms-1540824-f0016"/>
      </fig>
    </sec>
    <sec sec-type="supplementary-material" id="SM1">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>Sup_Info</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Info.docx" orientation="portrait" xlink:type="simple" id="d36e2579" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>Sup_Tab1</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab1.xlsx" orientation="portrait" xlink:type="simple" id="d36e2583" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <label>Sup_Tab2</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab2.xlsx" orientation="portrait" xlink:type="simple" id="d36e2587" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD4">
        <label>Sup_Tab3</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab3.xlsx" orientation="portrait" xlink:type="simple" id="d36e2591" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD5">
        <label>Sup_Tab4</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab4.xlsx" orientation="portrait" xlink:type="simple" id="d36e2595" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD6">
        <label>Sup_Tab5</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab5.xlsx" orientation="portrait" xlink:type="simple" id="d36e2599" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD7">
        <label>Sup_Tab6</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab6.xlsx" orientation="portrait" xlink:type="simple" id="d36e2603" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD8">
        <label>Sup_Tab7</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab7.xlsx" orientation="portrait" xlink:type="simple" id="d36e2607" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD9">
        <label>Sup_Tab8</label>
        <media xlink:href="NIHMS1540824-supplement-Sup_Tab8.xlsx" orientation="portrait" xlink:type="simple" id="d36e2611" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S33">
      <title>ACKNOWLEDGEMENTS</title>
      <p id="P71">This work is dedicated to the memory of Simone Bischoff-Lardenoije and is made possible by the patients and their families whom generously contributed to this study. This work is supported by the National Brain Tumor Society, Oligo Research Fund; Cancer Center Support grants P30CA16672 and P30CA034196; Cancer Prevention &amp; Research Institute of Texas (CPRIT) grant number R140606; Agilent Technologies (R.G.W.V.); the National Institutes of Health- National Cancer institute for the following grants: NCI CA170278 (L.M.P., M.M.T., N.H.), NCI R01CA222146 (L.M.P, N.H.), NCI R01CA230031 (J.H.C., J.N.), NCI R01CA188288 (J.S.B., R.B., P.B., K.L.L., A.C., A.E.S.), R01CA179044 (Antonio Iavarone), U54CA193313 (Antonio Iavarone). The National Brain Tumor Society (W.K.A.Y.; J.D.G). Brain Tumour Northwest tissue bank (including the Walton research tissue bank) is supported by the Sidney Driscol Neuroscience Foundation and part of the Walton Centre and Lancashire Teaching Hospitals NHS Foundation Trusts (A.B., M.D.J.). This work was supported by a generous gift from the Dabbiere family (J.F.C.). Support is also provided by a Leeds Charitable Foundation grant (9R11/14&#x2010;11 to LFS), University of Leeds Academic Fellowship (11001061) (L.F.S.) and Studentship (11061191) (G.T.) as well as Leeds Teaching Hospitals NHS Trust (Aruna Chakravarti, Azzam Ismail). The Leeds Multidisciplinary Research Tissue Bank staff was funded by the PPR Foundation and The University of Leeds (S.C.S.). Funds were received from The Brain Tumour Charity (C.W., Grants 10/136 &amp; GN-000580, B.A.W., 200450). G.T. is funded by EKFS 2015_Kolleg_14. R01CA218144 (P.S.L, E.J.C, J.C. A.K.L.) and Strain for the Brain, Milwaukee, WI (P.S.L, E.J.C, J.C. A.K.L.). E.K is recipient of an MD-Fellowship by the Boehringer Ingelheim Fonds and is supported by the German National Academic Foundation. The Leeds Multidisciplinary Research Tissue Bank staff was funded by the PPR Foundation and part of the University of Leeds (S.C.S.). GLASS-Austria was funded by the Austrian Science Fund project KLI394 (A.W.). GLASS-Germany was funded by the German Ministry of Education and Research (BMBF) 031A425 (G.R., P.L.) and German Cancer Aid (DKH) 70&#x2013;3163-Wi 3 (M.W.). GLASS-NL receives support from KWF/Dutch Cancer Society project11026 (MCMK, PW, RGWV, PJF, JMN, MS, BAW). We thank the University of Colorado Denver Central Nervous System Biorepository (D.R.O.) for providing tissue samples. Sponsoring was also received from the National Institute of Neurological Disorders and Stroke (NINDS R01NS094615, R.G.), National Health and Medical Research Council project grant (A.M.D.). F.S.V. is supported by a postdoctoral fellowship from The Jane Coffin Childs Memorial Fund for Medical Research. F.P.B. is supported by the JAX Scholar program and the National Cancer Institute (K99 CA226387); K.C.J. is the recipient of an American Cancer Society Fellowship (130984-PF-17&#x2013;141-01-DMC). We thank the Jackson Laboratory Clinical and Translation Support team for coordinating all data transfer agreements. We thank Matt Wimsatt for assistance in graphic design.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement" id="FN2">
        <p id="P72">CONFLICTS OF INTEREST</p>
        <p id="P73">R.G.W.V. declares equity in Boundless Bio, Inc. M.K. receives research grants from BMS and ABBVie. P.K.B. is a consultant for Lilly, Genentech-Roche, Angiochem and Tesaro. P.K.B. receives institutional funding from Merck and Pfizer and honoraria from Merch and Genentech-Roche. W.K.A.Y serves in a consulting or advisory role at DNAtrix Therapeutics. M.W. receives funding from Acceleron, Actelion, Bayer, Isarna, Merck, Sharp &amp; Dohme, Merck (EMD, Darmstadt), Novocure, OGD2, Pigur and Roche as well as honoraria from BMS, Celldex, Immunocellular Therapeutics, Isarna, Magforce, Merck, Sharp &amp; Dohme, Merck (EMD, Darmstadt), Northwest Biotherapeutics, Novocure, Pfizer, Roche, Teva and Tocagen. G.R. receives funding from Roche and Merck (EMD, Darmstadt) as well as honoraria from AbbVie. M.S. is a central reviewer for Parexel Ltd and honoraria are paid to the institution. G.T. reports personal fees from Bristol-Myers-Squibb, personal fees from AbbVie, personal fees from Novocure, personal fees from Medac, travel grants from Bristol-Myers-Squibb, education grants from Novocure, research grants from Roche Diagnostics, research grants from Medac, membership in the National Steering board of the TIGER NIS (Novocure) and the International Steering board of the ON-TRK NIS (Bayer).</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Barthel</surname><given-names>FP</given-names></name>, <name><surname>Wesseling</surname><given-names>P</given-names></name> &amp; <name><surname>Verhaak</surname><given-names>RGW</given-names></name>
<article-title>Reconstructing the molecular life history of gliomas</article-title>. <source>Acta Neuropathol</source>
<volume>135</volume>, <fpage>649</fpage>&#x2013;<lpage>670</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s00401-018-1842-y</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29616301</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Sturm</surname><given-names>D</given-names></name>
<etal/>
<article-title>Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge</article-title>. <source>Nat Rev Cancer</source>
<volume>14</volume>, <fpage>92</fpage>&#x2013;<lpage>107</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nrc3655</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24457416</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Bettegowda</surname><given-names>C</given-names></name>
<etal/>
<article-title>Mutations in CIC and FUBP1 contribute to human oligodendroglioma</article-title>. <source>Science</source>
<volume>333</volume>, <fpage>1453</fpage>&#x2013;<lpage>1455</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1210557</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21817013</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>S</given-names></name>
<etal/>
<article-title>A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival</article-title>. <source>Genes Dev</source>
<volume>27</volume>, <fpage>1462</fpage>&#x2013;<lpage>1472</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gad.213686.113</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23796897</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><article-title>Cancer Genome Atlas Research, N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways</article-title>. <source>Nature</source>
<volume>455</volume>, <fpage>1061</fpage>&#x2013;<lpage>1068</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature07385</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18772890</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Ceccarelli</surname><given-names>M</given-names></name>
<etal/>
<article-title>Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma</article-title>. <source>Cell</source>
<volume>164</volume>, <fpage>550</fpage>&#x2013;<lpage>563</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.12.028</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">26824661</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal">TCGA_Network <etal/>
<article-title>Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas</article-title>. <source>N Engl J Med</source>
<volume>372</volume>, <fpage>2481</fpage>&#x2013;<lpage>2498</lpage>, doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1402121</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26061751</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Verhaak</surname><given-names>RG</given-names></name>
<etal/>
<article-title>Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1</article-title>. <source>Cancer Cell</source>
<volume>17</volume>, <fpage>98</fpage>&#x2013;<lpage>110</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2009.12.020</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20129251</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Yan</surname><given-names>H</given-names></name>
<etal/>
<article-title>IDH1 and IDH2 mutations in gliomas</article-title>. <source>N Engl J Med</source>
<volume>360</volume>, <fpage>765</fpage>&#x2013;<lpage>773</lpage>, doi:<pub-id pub-id-type="doi">10.1056/NEJMoa0808710</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19228619</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Louis</surname><given-names>DN</given-names></name>
<etal/>
<article-title>International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading</article-title>. <source>Brain Pathol</source>
<volume>24</volume>, <fpage>429</fpage>&#x2013;<lpage>435</lpage>, doi:<pub-id pub-id-type="doi">10.1111/bpa.12171</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24990071</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Louis</surname><given-names>DN</given-names></name>
<etal/>
<article-title>The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary</article-title>. <source>Acta Neuropathol</source>
<volume>131</volume>, <fpage>803</fpage>&#x2013;<lpage>820</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s00401-016-1545-1</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27157931</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Venteicher</surname><given-names>AS</given-names></name>
<etal/>
<article-title>Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq</article-title>. <source>Science</source>
<volume>355</volume>, doi:<pub-id pub-id-type="doi">10.1126/science.aai8478</pub-id> (<year>2017</year>).</mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>AP</given-names></name>
<etal/>
<article-title>Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma</article-title>. <source>Science</source>
<volume>344</volume>, <fpage>1396</fpage>&#x2013;<lpage>1401</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1254257</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24925914</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Snuderl</surname><given-names>M</given-names></name>
<etal/>
<article-title>Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma</article-title>. <source>Cancer Cell</source>
<volume>20</volume>, <fpage>810</fpage>&#x2013;<lpage>817</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2011.11.005</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">22137795</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Sottoriva</surname><given-names>A</given-names></name>
<etal/>
<article-title>Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>110</volume>, <fpage>4009</fpage>&#x2013;<lpage>4014</lpage>, doi:<pub-id pub-id-type="doi">10.1073/pnas.1219747110</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23412337</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>MJ</given-names></name>
<etal/>
<article-title>Quantification of subclonal selection in cancer from bulk sequencing data</article-title>. <source>Nat Genet</source>
<volume>50</volume>, <fpage>895</fpage>&#x2013;<lpage>903</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41588-018-0128-6</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29808029</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Nejo</surname><given-names>T</given-names></name>
<etal/>
<article-title>Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma</article-title>. <source>Cancer Immunol Res</source>, doi:<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-18-0599</pub-id> (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Consortium</surname><given-names>G</given-names></name>
<article-title>Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium</article-title>. <source>Neuro Oncol</source>
<volume>20</volume>, <fpage>873</fpage>&#x2013;<lpage>884</lpage>, doi:<pub-id pub-id-type="doi">10.1093/neuonc/noy020</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29432615</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>H</given-names></name>
<etal/>
<article-title>Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor</article-title>. <source>Cell</source>
<volume>175</volume>, <fpage>1665</fpage>&#x2013;<lpage>1678 e1618</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.09.038</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">30343896</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Alexandrov</surname><given-names>LB</given-names></name>
<etal/>
<article-title>Signatures of mutational processes in human cancer</article-title>. <source>Nature</source>
<volume>500</volume>, <fpage>415</fpage>&#x2013;<lpage>421</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature12477</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23945592</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>J</given-names></name>
<etal/>
<article-title>Clonal evolution of glioblastoma under therapy</article-title>. <source>Nat Genet</source>
<volume>48</volume>, <fpage>768</fpage>&#x2013;<lpage>776</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng.3590</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27270107</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>H</given-names></name>
<etal/>
<article-title>Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution</article-title>. <source>Genome Res</source>
<volume>25</volume>, <fpage>316</fpage>&#x2013;<lpage>327</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gr.180612.114</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25650244</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>BE</given-names></name>
<etal/>
<article-title>Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma</article-title>. <source>Science</source>
<volume>343</volume>, <fpage>189</fpage>&#x2013;<lpage>193</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1239947</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24336570</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Hunter</surname><given-names>C</given-names></name>
<etal/>
<article-title>A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy</article-title>. <source>Cancer Res</source>
<volume>66</volume>, <fpage>3987</fpage>&#x2013;<lpage>3991</lpage>, doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-0127</pub-id> (<year>2006</year>).<pub-id pub-id-type="pmid">16618716</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Jolly</surname><given-names>C</given-names></name> &amp; <name><surname>Van Loo</surname><given-names>P</given-names></name>
<article-title>Timing somatic events in the evolution of cancer</article-title>. <source>Genome Biol</source>
<volume>19</volume>, <fpage>95</fpage>, doi:<pub-id pub-id-type="doi">10.1186/s13059-018-1476-3</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">30041675</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Turajlic</surname><given-names>S</given-names></name>, <name><surname>Sottoriva</surname><given-names>A</given-names></name>, <name><surname>Graham</surname><given-names>T</given-names></name> &amp; <name><surname>Swanton</surname><given-names>C</given-names></name>
<article-title>Resolving genetic heterogeneity in cancer</article-title>. <source>Nat Rev Genet</source>, doi:<pub-id pub-id-type="doi">10.1038/s41576-019-0114-6</pub-id> (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>S</given-names></name>
<etal/>
<article-title>Temozolomide-associated hypermutation in gliomas</article-title>. <source>Neuro Oncol</source>
<volume>20</volume>, <fpage>1300</fpage>&#x2013;<lpage>1309</lpage>, doi:<pub-id pub-id-type="doi">10.1093/neuonc/noy016</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29452419</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Baumert</surname><given-names>BG</given-names></name>
<etal/>
<article-title>Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033&#x2013;26033): a randomised, open-label, phase 3 intergroup study</article-title>. <source>Lancet Oncol</source>
<volume>17</volume>, <fpage>1521</fpage>&#x2013;<lpage>1532</lpage>, doi:<pub-id pub-id-type="doi">10.1016/S1470-2045</pub-id>(16)30313&#x2013;8 (<year>2016</year>).<pub-id pub-id-type="pmid">27686946</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Buckner</surname><given-names>JC</given-names></name>
<etal/>
<article-title>Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma</article-title>. <source>N Engl J Med</source>
<volume>374</volume>, <fpage>1344</fpage>&#x2013;<lpage>1355</lpage>, doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1500925</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27050206</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Yap</surname><given-names>TA</given-names></name>, <name><surname>Gerlinger</surname><given-names>M</given-names></name>, <name><surname>Futreal</surname><given-names>PA</given-names></name>, <name><surname>Pusztai</surname><given-names>L</given-names></name> &amp; <name><surname>Swanton</surname><given-names>C</given-names></name>
<article-title>Intratumor heterogeneity: seeing the wood for the trees</article-title>. <source>Sci Transl Med</source>
<volume>4</volume>, <fpage>127ps110</fpage>, doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3003854</pub-id> (<year>2012</year>).</mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>MJ</given-names></name>, <name><surname>Werner</surname><given-names>B</given-names></name>, <name><surname>Barnes</surname><given-names>CP</given-names></name>, <name><surname>Graham</surname><given-names>TA</given-names></name> &amp; <name><surname>Sottoriva</surname><given-names>A</given-names></name>
<article-title>Identification of neutral tumor evolution across cancer types</article-title>. <source>Nat Genet</source>
<volume>48</volume>, <fpage>238</fpage>&#x2013;<lpage>244</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng.3489</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">26780609</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Korber</surname><given-names>V</given-names></name>
<etal/>
<article-title>Evolutionary Trajectories of IDH(WT) Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis</article-title>. <source>Cancer Cell</source>
<volume>35</volume>, <fpage>692</fpage>&#x2013;<lpage>704 e612</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ccell.2019.02.007</pub-id> (<year>2019</year>).<pub-id pub-id-type="pmid">30905762</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>deCarvalho</surname><given-names>AC</given-names></name>
<etal/>
<article-title>Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma</article-title>. <source>Nat Genet</source>
<volume>50</volume>, <fpage>708</fpage>&#x2013;<lpage>717</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41588-018-0105-0</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29686388</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Giam</surname><given-names>M</given-names></name> &amp; <name><surname>Rancati</surname><given-names>G</given-names></name>
<article-title>Aneuploidy and chromosomal instability in cancer: a jackpot to chaos</article-title>. <source>Cell Div</source>
<volume>10</volume>, <fpage>3</fpage>, doi:<pub-id pub-id-type="doi">10.1186/s13008-015-0009-7</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26015801</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Marty</surname><given-names>R</given-names></name>, <name><surname>Thompson</surname><given-names>WK</given-names></name>, <name><surname>Salem</surname><given-names>RM</given-names></name>, <name><surname>Zanetti</surname><given-names>M</given-names></name> &amp; <name><surname>Carter</surname><given-names>H</given-names></name>
<article-title>Evolutionary Pressure against MHC Class II Binding Cancer Mutations</article-title>. <source>Cell</source>
<volume>175</volume>, <fpage>416</fpage>&#x2013;<lpage>428 e413</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.08.048</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">30245014</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>McGranahan</surname><given-names>N</given-names></name>
<etal/>
<article-title>Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution</article-title>. <source>Cell</source>
<volume>171</volume>, <fpage>1259</fpage>&#x2013;<lpage>1271 e1211</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2017.10.001</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">29107330</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Q</given-names></name>
<etal/>
<article-title>Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment</article-title>. <source>Cancer Cell</source>
<volume>32</volume>, <fpage>42</fpage>&#x2013;<lpage>56 e46</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ccell.2017.06.003</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">28697342</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Rooney</surname><given-names>MS</given-names></name>, <name><surname>Shukla</surname><given-names>SA</given-names></name>, <name><surname>Wu</surname><given-names>CJ</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name> &amp; <name><surname>Hacohen</surname><given-names>N</given-names></name>
<article-title>Molecular and genetic properties of tumors associated with local immune cytolytic activity</article-title>. <source>Cell</source>
<volume>160</volume>, <fpage>48</fpage>&#x2013;<lpage>61</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.12.033</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25594174</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Dunn</surname><given-names>GP</given-names></name>, <name><surname>Bruce</surname><given-names>AT</given-names></name>, <name><surname>Ikeda</surname><given-names>H</given-names></name>, <name><surname>Old</surname><given-names>LJ</given-names></name> &amp; <name><surname>Schreiber</surname><given-names>RD</given-names></name>
<article-title>Cancer immunoediting: from immunosurveillance to tumor escape</article-title>. <source>Nat Immunol</source>
<volume>3</volume>, <fpage>991</fpage>&#x2013;<lpage>998</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ni1102-991</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">12407406</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Hundal</surname><given-names>J</given-names></name>
<etal/>
<article-title>pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens</article-title>. <source>Genome Med</source>
<volume>8</volume>, <fpage>11</fpage>, doi:<pub-id pub-id-type="doi">10.1186/s13073-016-0264-5</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">26825632</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>AM</given-names></name>
<etal/>
<article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>. <source>Nat Methods</source>
<volume>12</volume>, <fpage>453</fpage>&#x2013;<lpage>457</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">25822800</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Rosenthal</surname><given-names>R</given-names></name>
<etal/>
<article-title>Neoantigen-directed immune escape in lung cancer evolution</article-title>. <source>Nature</source>
<volume>567</volume>, <fpage>479</fpage>&#x2013;<lpage>485</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41586-019-1032-7</pub-id> (<year>2019</year>).<pub-id pub-id-type="pmid">30894752</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Raub</surname><given-names>TJ</given-names></name>
<etal/>
<article-title>Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft</article-title>. <source>Drug Metab Dispos</source>
<volume>43</volume>, <fpage>1360</fpage>&#x2013;<lpage>1371</lpage>, doi:<pub-id pub-id-type="doi">10.1124/dmd.114.062745</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26149830</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>van den Bent</surname><given-names>M</given-names></name>
<etal/>
<article-title>Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study</article-title>. <source>Cancer Chemother Pharmacol</source>
<volume>80</volume>, <fpage>1209</fpage>&#x2013;<lpage>1217</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s00280-017-3451-1</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">29075855</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>Keskin</surname><given-names>DB</given-names></name>
<etal/>
<article-title>Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial</article-title>. <source>Nature</source>
<volume>565</volume>, <fpage>234</fpage>&#x2013;<lpage>239</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41586-018-0792-9</pub-id> (<year>2019</year>).<pub-id pub-id-type="pmid">30568305</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Schumacher</surname><given-names>T</given-names></name>
<etal/>
<article-title>A vaccine targeting mutant IDH1 induces antitumour immunity</article-title>. <source>Nature</source>
<volume>512</volume>, <fpage>324</fpage>&#x2013;<lpage>327</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature13387</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">25043048</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>Koster</surname><given-names>J</given-names></name> &amp; <name><surname>Rahmann</surname><given-names>S</given-names></name>
<article-title>Snakemake-a scalable bioinformatics workflow engine</article-title>. <source>Bioinformatics</source>
<volume>34</volume>, <fpage>3600</fpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/bty350</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29788404</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Van der Auwera</surname><given-names>GA</given-names></name>
<etal/>
<article-title>From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline</article-title>. <source>Curr Protoc Bioinformatics</source>
<volume>43</volume>, 11 10 <fpage>11</fpage>&#x2013;<lpage>33</lpage>, doi:<pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">25431634</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Ewels</surname><given-names>P</given-names></name>, <name><surname>Magnusson</surname><given-names>M</given-names></name>, <name><surname>Lundin</surname><given-names>S</given-names></name> &amp; <name><surname>Kaller</surname><given-names>M</given-names></name>
<article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title>. <source>Bioinformatics</source>
<volume>32</volume>, <fpage>3047</fpage>&#x2013;<lpage>3048</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btw354</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27312411</pub-id></mixed-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>
<etal/>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>. <source>Bioinformatics</source>
<volume>25</volume>, <fpage>2078</fpage>&#x2013;<lpage>2079</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <mixed-citation publication-type="journal"><name><surname>Mermel</surname><given-names>CH</given-names></name>
<etal/>
<article-title>GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers</article-title>. <source>Genome Biol</source>
<volume>12</volume>, <fpage>R41</fpage>, doi:<pub-id pub-id-type="doi">10.1186/gb-2011-12-4-r41</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21527027</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Beroukhim</surname><given-names>R</given-names></name>
<etal/>
<article-title>Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>, <fpage>20007</fpage>&#x2013;<lpage>20012</lpage>, doi:<pub-id pub-id-type="doi">10.1073/pnas.0710052104</pub-id> (<year>2007</year>).<pub-id pub-id-type="pmid">18077431</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Martincorena</surname><given-names>I</given-names></name>
<etal/>
<article-title>Universal Patterns of Selection in Cancer and Somatic Tissues</article-title>. <source>Cell</source>
<volume>171</volume>, <fpage>1029</fpage>&#x2013;<lpage>1041 e1021</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2017.09.042</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">29056346</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>AM</given-names></name>
<etal/>
<article-title>Genomic and Functional Approaches to Understanding Cancer Aneuploidy</article-title>. <source>Cancer Cell</source>
<volume>33</volume>, <fpage>676</fpage>&#x2013;<lpage>689 e673</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ccell.2018.03.007</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29622463</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <mixed-citation publication-type="journal"><name><surname>Roth</surname><given-names>A</given-names></name>
<etal/>
<article-title>PyClone: statistical inference of clonal population structure in cancer</article-title>. <source>Nat Methods</source>
<volume>11</volume>, <fpage>396</fpage>&#x2013;<lpage>398</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nmeth.2883</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">24633410</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <mixed-citation publication-type="journal"><name><surname>Turajlic</surname><given-names>S</given-names></name>
<etal/>
<article-title>Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal</article-title>. <source>Cell</source>
<volume>173</volume>, <fpage>581</fpage>&#x2013;<lpage>594</lpage> e512, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.03.057</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29656895</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <mixed-citation publication-type="journal"><name><surname>Ha</surname><given-names>G</given-names></name>
<etal/>
<article-title>TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data</article-title>. <source>Genome Res</source>
<volume>24</volume>, <fpage>1881</fpage>&#x2013;<lpage>1893</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gr.180281.114</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">25060187</pub-id></mixed-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <mixed-citation publication-type="journal"><name><surname>Szolek</surname><given-names>A</given-names></name>
<etal/>
<article-title>OptiType: precision HLA typing from next-generation sequencing data</article-title>. <source>Bioinformatics</source>
<volume>30</volume>, <fpage>3310</fpage>&#x2013;<lpage>3316</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btu548</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">25143287</pub-id></mixed-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <mixed-citation publication-type="journal"><name><surname>Hoof</surname><given-names>I</given-names></name>
<etal/>
<article-title>NetMHCpan, a method for MHC class I binding prediction beyond humans</article-title>. <source>Immunogenetics</source>
<volume>61</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s00251-008-0341-z</pub-id> (<year>2009</year>).<pub-id pub-id-type="pmid">19002680</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1 &#x2223;</label>
      <caption>
        <title>Temporal changes in glioma mutational burden and processes.</title>
        <p id="P74"><bold>a</bold>. Each column represents a single patient (<italic>n</italic> = 222) at two separate timepoints grouped by glioma subtype and ordered left-to-right by decreasing mutation frequency at recurrence. Top, mutation frequency differences between initial and recurrent tumors. Blue dotted line indicates increased mutation frequency while a red dotted line indicates decreased mutational frequency. Stacked bar plot reflects the proportion of total mutations shared (mustard), private to initial (magenta), or private to recurrence (blue). Clinical information including hypermutation status, therapy, and grade changes. <bold>b</bold>. Stacked bar plot (n=219) indicating the dominant mutational signature among initial, recurrent and shared mutation fractions stratified by glioma subtype. <bold>c</bold>. The proportion of glioma recurrences with alkylating agent-related hypermutation, grouped by glioma subtype. Fisher&#x2019;s exact test was used to compare proportions between subtypes. <bold>d</bold>. Kaplan-Meier curve depicting overall survival in hypermutant (red) versus non-hypermutant (blue) alkylating agent treated patients amongst IDHwt (left, <italic>n</italic> = 99) and IDHmut-noncodel (right, <italic>n</italic> = 32) tumors. Log-rank test P-values are shown.</p>
      </caption>
      <graphic xlink:href="nihms-1540824-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2 &#x2223;</label>
      <caption>
        <title>Quantifying selective pressures during glioma evolution.</title>
        <p id="P75"><bold>a</bold>. Schematic depiction of cancer cell fraction (CCF) values during tumor evolution indicating clonality and associated relative timing. <bold>b.</bold> Comparison of PyClone clusters ranked by CCF in matched initial and recurrent tumors. <bold>c</bold>. <italic>Left</italic>: dN/dS ratio for all variants (i.e. global) in initial and recurrent tumors for each subtype. Hypermutators were not included (<italic>n</italic> = 187). Dots represent the global dN/dS ratio with associated Wald confidence intervals. <italic>Right</italic>: global dN/dS ratios for variant fractions per subtype. <bold>d.</bold> Cumulative distribution of subclonal mutations by their inverse variant allele frequency. Mutations were separated by timepoint, variant fraction, and glioma subtype. Deviation from a linear relationship, significant Kolmogorov-Smirnov P-values and R<sup>2</sup> below 0.98 indicate selection. <bold>e.</bold> Sankey plot indicating the breakdown of SubClonalSelection evolutionary modes by subtype and therapy (<italic>n</italic> = 104). The sizes of the bands reflect sample sizes and band colors highlight the glioma subtype. Gray coloring reflects instances when treatment information was not available. <bold>f.</bold> Kaplan-Meier curve showing survival differences between IDHwt recurrent tumors demonstrating selection (<italic>n</italic> = 39) compared with neutrally evolving tumors (<italic>n</italic> = 44). Log-rank P-value is indicated.</p>
      </caption>
      <graphic xlink:href="nihms-1540824-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Fig. 3 &#x2223;</label>
      <caption>
        <title>Patterns of glioma driver frequencies over time.</title>
        <p id="P76"><bold>a.</bold> Driver dynamics for SNVs nominated by the dNdScv and CNVs nominated by GISTIC (<italic>n</italic> = 222). Each column represents a single patient at two separate time points stratified by subtype and ordered left-to-right by the number of driver alterations. The degree of aneuploidy difference (recurrence &#x2013; initial) offers a summary metric for increases (&gt; 0) or decreases (&lt; 0) in aneuploidy at recurrence. Variants are marked and different shapes indicate whether a variant was shared or private. The variant type is depicted by its color. Stacked bar plots accompanying each gene/arm provide cohort-level proportions for whether the alteration was shared, lost, or acquired. <bold>b.</bold> Aneuploidy comparison in matching initial and recurrent IDHmut-noncodel tumors. <bold>c.</bold> Within-sample CCF comparison of <italic>CDKN2A</italic> homozygous deletion (homdel) to genome-wide CCF as a proxy for aneuploidy. A relative higher CCF indicates temporal precedence. Wilcoxon signed-rank test P-value is indicated. <bold>d.</bold> Kaplan-Meier curve comparing survival in IDHmut-noncodel tumors with an alteration in the cell cycle, acquired aneuploidy, or both (shades of red) versus unaltered IDHmut-noncodel tumors (blue). Log-rank P-value is shown.</p>
      </caption>
      <graphic xlink:href="nihms-1540824-f0003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Fig. 4 &#x2223;</label>
      <caption>
        <title>Neoantigen selection during tumor progression.</title>
        <p id="P77"><bold>a.</bold> Mean proportion of coding mutations giving rise to neoantigens (neoantigens/nonsynonymous) stratified by glioma subtype and timepoint (<italic>n</italic> = 222). Error bars represent standard deviation. <bold>b.</bold> Boxplot depicting the distribution of observed to expected neoantigen ratios in the GLASS cohort stratified by glioma subtype. P-value was calculated using the Wilcoxon rank-sum test. Each box spans quartiles, with the lines representing the median ratio for each group. Whiskers represent absolute range, excluding outliers. <bold>c.</bold> Scatterplot depicting the association between the observed-to-expected neoantigen ratio in a patient&#x2019;s initial versus recurrent tumor. Each point represents a single patient. R represents Pearson correlation coefficient. Panels b and c only include samples with at least 3 neoantigens in the initial and recurrent tumors (<italic>n =</italic> 131, 63, and 24 for IDHwt, IDHmut-noncodel, and IDHmut-codel, respectively). <bold>d.</bold> Ladder plot depicting the difference in observed-to-expected neoantigen ratio between a tumor&#x2019;s clonal and subclonal neoantigens. Each set of points connected by a line represents one tumor. Tumors are stratified by whether they were a patient&#x2019;s initial or recurrent tumor. Lines are colored by each patient&#x2019;s glioma subtype. Panel d only includes samples with at least 3 clonal neoantigens and at least 3 subclonal neoantigens in both the initial and recurrent tumors (<italic>n =</italic> 35, 20 and 9 for IDHwt, IDHmut-noncodel, and IDHmut-codel, respectively). P-value was calculated using a paired two-sided t-test. Colors in each panel represent the glioma subtype and are denoted at the bottom of the figure.</p>
      </caption>
      <graphic xlink:href="nihms-1540824-f0004"/>
    </fig>
  </floats-group>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">30518860</article-id>
      <article-id pub-id-type="pmc">6347970</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-018-0783-x</article-id>
      <article-id pub-id-type="manuscript">NIHMS1509772</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Complex Mammalian-like Hematopoietic System Found in a Colonial Chordate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Rosental</surname>
            <given-names>Benyamin</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Kowarsky</surname>
            <given-names>Mark</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seita</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Corey</surname>
            <given-names>Daniel M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ishizuka</surname>
            <given-names>Katherine J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palmeri</surname>
            <given-names>Karla J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Shih-Yu</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sinha</surname>
            <given-names>Rahul</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okamoto</surname>
            <given-names>Jennifer</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mantalas</surname>
            <given-names>Gary</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Manni</surname>
            <given-names>Lucia</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raveh</surname>
            <given-names>Tal</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Clarke</surname>
            <given-names>D. Nathaniel</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Jonathan M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Newman</surname>
            <given-names>Aaron M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Neff</surname>
            <given-names>Norma F.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nolan</surname>
            <given-names>Garry P.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quake</surname>
            <given-names>Stephen R.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weissman</surname>
            <given-names>Irving L.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Voskoboynik</surname>
            <given-names>Ayelet</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Institute for Stem Cell Biology and Regenerative Medicine, and Ludwig Center, Stanford University School of Medicine.</aff>
      <aff id="A2"><label>2</label>Department of Biology, Stanford University, Hopkins Marine Station, Pacific Grove, CA 93950, USA.</aff>
      <aff id="A3"><label>3</label>Department of Physics, Stanford University, CA 94305, USA.</aff>
      <aff id="A4"><label>4</label>AI based Healthcare and Medical Data Analysis Standardization Unit, Medical Sciences Innovation Hub Program, RIKEN, Tokyo 103-0027, Japan.</aff>
      <aff id="A5"><label>5</label>Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.</aff>
      <aff id="A6"><label>6</label>Departments of Applied Physics and Bioengineering, Stanford University, and Chan Zuckerberg Biohub, San Francisco CA 94158, USA.</aff>
      <aff id="A7"><label>7</label>Department of Molecular Cellular and Developmental Biology, University of California Santa Cruz, Santa Cruz CA, USA.</aff>
      <aff id="A8"><label>8</label>Dipartimento di Biologia, Universit&#xE0; degli Studi di Padova, Padova, Italy.</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <label>*</label>
          <p id="P1">These authors jointly supervised this work.</p>
        </fn>
        <fn fn-type="con" id="FN2">
          <p id="P2">Author contributions</p>
          <p id="P3">Conception and design B.R., A.V., M.K., S.R.Q., I.L.W.; Mariculture K.J.I, K.J.P.; Flow cytometry and sorting B.R.; CyTOF screening and cluster analysis B.R., S.Y.C., G.P.N.; RNA isolation and library preparation B.R., K.J.P., R.S., A.V.; Sequencing J.O., G.M., N.F.N.; Sequencing analysis and developed analytical tools M.K., J.S, A.M.N., S.R.Q.; Immunological assays B.R.; Microscopy and experimental design B.R., D.M.C., K.J.I., D.N.C., A.V; Electron microscopy L.M.; BHF localization to the membrane and serum validation J.M.T, B.R., A.V.; Transplantation B.R.; Writing of manuscript B.R., A.V., M.K., T.R., K.J.P., I.L.W.; Technical support and conceptual advice N.F.N., D.M.C., A.M.N., T.R., G.P.N., S.R.Q., A.V., I.L.W.</p>
        </fn>
        <corresp id="CR1">Correspondence to <email>benyamin@stanford.edu</email>, <email>ayeletv@stanford.edu</email> and <email>irv@stanford.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>22</day>
        <month>10</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>12</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>05</day>
        <month>6</month>
        <year>2019</year>
      </pub-date>
      <volume>564</volume>
      <issue>7736</issue>
      <fpage>425</fpage>
      <lpage>429</lpage>
      <!--elocation-id from pubmed: 10.1038/s41586-018-0783-x-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <title>Summary</title>
        <p id="P4">Hematopoiesis is an essential process that evolved in multicellular animals. At the heart of this process are hematopoietic stem cells (HSCs), which are multipotent, self-renewing and generate the entire repertoire of blood and immune cells throughout an animal&#x2019;s life<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. While there are comprehensive studies on vertebrate HSC self-renewal, differentiation, physiological regulation and niche occupation, relatively little is known about their evolutionary origin and their niches. Here we study the hematopoietic system of <italic>Botryllus schlosseri</italic>, a colonial tunicate that has vasculature, circulating blood cells, and interesting stem cell biology and immunity characteristics<sup><xref rid="R2" ref-type="bibr">2</xref>&#x2013;<xref rid="R8" ref-type="bibr">8</xref></sup>. Self-recognition between genetically compatible <italic>B. schlosseri</italic> colonies leads to the formation of natural parabionts with shared circulation, whereas incompatible colonies reject each other <sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup>. Using flow-cytometry, whole-transcriptome sequencing of defined cell populations and diverse functional assays, we identified HSCs, progenitors, immune-effector cells, and an HSC niche, and demonstrated that self-recognition inhibits allospecific cytotoxic reactions. Our study reveals that HSC and myeloid lineage immune cells emerged in a common ancestor of tunicates and vertebrates, and these results also suggest that hematopoietic bone marrow and the <italic>B. schlosseri</italic> endostyle niche evolved from a common origin.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P5">Charles Darwin recognized that the study of tunicates is critical to understand the evolution of vertebrates - tunicates were later discovered to be a sister group of vertebrates<sup><xref rid="R9" ref-type="bibr">9</xref></sup><sup>&#x2013;</sup><sup><xref rid="R11" ref-type="bibr">11</xref></sup>. To gain insight into the evolution of the mammalian hematopoietic system we characterized the hematopoietic and immune system in the colonial tunicate <italic>Botryllus schlosseri</italic>.</p>
    <p id="P6"><italic>B. schlosseri</italic> colonies produce genetically identical individuals (zooids) through stem cell mediated cyclical budding<sup><xref rid="R5" ref-type="bibr">5</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1a-b</xref>). Every week, developed buds replace their parent zooids which then undergo synchronized programmed cell death<sup><xref rid="R12" ref-type="bibr">12</xref></sup> (<xref rid="SD8" ref-type="supplementary-material">Video S1</xref>). When colonies touch, their extracorporeal vasculature either fuse or reject<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1c</xref>; <xref rid="SD9" ref-type="supplementary-material">Video S2</xref>). This self-nonself recognition process is controlled by the highly polymorphic <italic>BHF</italic> gene and requires at least one shared <italic>BHF</italic> allele for fusion<sup><xref rid="R7" ref-type="bibr">7</xref></sup>. We adapted fluorescence-activated cell sorting<sup><xref rid="R13" ref-type="bibr">13</xref></sup> (FACS) to separate <italic>B. schlosseri</italic> cells and isolated 34 cell populations using size, granularity, natural auto-fluorescence,and reagents such as antibodies that differentially bind to live cells (CD49d, CD57, BHF), Concanavalin-A, and alkaline phosphatase (AP) expression (<xref rid="F5" ref-type="fig">Extended Data Fig. 1</xref>-<xref rid="F6" ref-type="fig">2</xref>, <xref rid="T1" ref-type="table">Extended Data Tables 1</xref>, <xref rid="T2" ref-type="table">2a</xref>). We sequenced the transcriptome of 23 sorted cell populations, the hierarchical endpoint populations of our FACS gating strategy (<xref rid="F5" ref-type="fig">Extended Data Fig. 1c-d</xref>, <xref rid="SD3" ref-type="supplementary-material">Table S1</xref>), and found correlations between gene expression profiles, morphology, and marker expression (<xref rid="F7" ref-type="fig">Extended Data Fig. 3</xref>). The cluster of cell populations CP25, 33 and 34, had 235 differentially upregulated genes known to be expressed in vertebrate blood and hematopoietic systems (<xref rid="F8" ref-type="fig">External Data Fig 4a</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S2</xref>)<sup><xref rid="R14" ref-type="bibr">14</xref></sup>. Analysis of this gene set by Gene Expression Commons<sup><xref rid="R15" ref-type="bibr">15</xref></sup> against genes expression data from 39 distinct mouse hematopoietic stem, progenitor and differentiated cells revealed significant expression overlap between CP25, 33 and 34, and mammalian hematopoietic stem, progenitor and myeloid lineage cells (<xref rid="F2" ref-type="fig">Fig. 2a</xref>, <xref rid="SD4" ref-type="supplementary-material">Tables S2</xref>, <xref rid="SD5" ref-type="supplementary-material">S3</xref>).</p>
    <p id="P7">To measure the ability of these candidate HSC populations (cHSC) to differentiate into other cell types, cells were transplanted from orange donor colonies to compatible colonies (<xref rid="F2" ref-type="fig">Fig. 2b</xref>). Twenty days following transplantation the unpigmented cHSC populations (CP25, 33, 34) from the orange donor colony differentiated into orange pigment cells within the recipient colonies, as evident by upregulation of the mixed pigmented colonies and reduction in pure blue colonies, a trend that was not observed in the control (CP18) and uninjected colonies (<xref rid="F2" ref-type="fig">Fig. 2c</xref>). To test the multilineage differentiation capacity, the cHSC population and control population were isolated, labeled with a fluorescent membrane dye (DiO), and transplanted into compatible recipient colonies without cytoreductive treatments of the recipients. Three weeks following transplantation 76% of transplanted cHSCs were detected in a different FACS gate than the original versus less than 30% of the transplanted cells from the control group (<xref rid="F2" ref-type="fig">Fig. 2d-f</xref>; <xref rid="F9" ref-type="fig">Extended Data Fig. 5a</xref>).</p>
    <p id="P8">To identify the cHSC niches, the cHSC population and a control population (CP3) were isolated, labeled with a lipophilic dye (DiD) and injected into labeled (CFSE) compatible colonies. 5&#x2013;10 days after transplantation, DiD-labeled cHSC populations migrated in the recipient colony and aggregated in two known <italic>B. schlosseri</italic> stem cell niches, the <italic>endostyle</italic> and the <italic>cell islands</italic>. The endostyle niche, located at the anterior subendostylar sinus (endo-niche), has been identified as a somatic stem cell niche, and the cell islands niche is considered a germline stem cell niche<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup> (<xref rid="F2" ref-type="fig">Fig 2g</xref>; <xref rid="F9" ref-type="fig">Extended Data Fig. 5b</xref>). Ermak (1976), reported the presence of proliferating cells and hemoblasts near the endostyle and around the branchial sac&#x2019;s stigmata in the juvenile <italic>Ciona intestinalis</italic><sup><xref rid="R17" ref-type="bibr">17</xref></sup>. Indeed blood cells with a hemoblast (cHSC) morphology and proliferating cells are abundant in the <italic>B. schlosseri</italic> endo-niche<sup><xref rid="R6" ref-type="bibr">6</xref></sup> (<xref rid="F2" ref-type="fig">Fig. 2h</xref>, <xref rid="F9" ref-type="fig">Extended Data Fig 5c-d</xref>). The control population (CP3) does not express a gene signature of the hematopoietic system, but does have a germline gene expression signature and is localized to a known germline stem cell niche<sup><xref rid="R16" ref-type="bibr">16</xref></sup>, the cell islands (<xref rid="F8" ref-type="fig">Extended Data Fig. 4c</xref> and <xref rid="F9" ref-type="fig">5b</xref>). The <italic>B. schlosseri</italic> cHSCs localized towards known somatic stem cell niche (the endo-niche), similar to the homing process of mammalian HSC&#x2019;s to the bone marrow<sup><xref rid="R18" ref-type="bibr">18</xref>&#x2013;<xref rid="R20" ref-type="bibr">20</xref></sup>. The endostyle is a complex tissue with defined anatomical structures and molecular features<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R21" ref-type="bibr">21</xref>&#x2013;<xref rid="R24" ref-type="bibr">24</xref></sup>. We sequenced its transcriptome (n=10) and compared them to the transcriptome of whole colonies (n=34). Homologous genes that were significantly upregulated in the endostyle were analyzed by GeneAnalytics<sup><xref rid="R14" ref-type="bibr">14</xref></sup>, revealing a shared expression of 327 genes between the endostyle and human hematopoietic bone marrow (<xref rid="F2" ref-type="fig">Fig. 2i</xref> left, <xref rid="F10" ref-type="fig">Extended Data Fig 6a</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S2</xref>, <xref rid="SD6" ref-type="supplementary-material">S4</xref>). This finding was further supported by Gene Expression Commons<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R25" ref-type="bibr">25</xref></sup> (<xref rid="F10" ref-type="fig">Extended Data Fig. 6b</xref>). We queried previously obtained <italic>Ciona robusta in situ</italic> expression data<sup><xref rid="R21" ref-type="bibr">21</xref></sup> for endostyle associated genes and found them to be similar (<xref rid="F2" ref-type="fig">Fig. 2i</xref> right; <xref rid="F10" ref-type="fig">Extended Data Fig. 6c</xref>).</p>
    <p id="P9">In mammals, innate cellular immune responses are mediated in part by phagocytosis: the engulfment of target cells, and both adaptive immunity and innate immunity cytotoxicity: the direct killing of the target cells. We used diverse <italic>ex-vivo</italic> phagocytosis assays to identify phagocytic cells and track their cell population (<xref rid="F11" ref-type="fig">Extended Data Fig 7</xref>). These assays revealed three major phagocytic populations which includes two previously described phagocytic cells: amoebocytes (within CP4 and 18), large phagocytes<sup><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup> (within CP13) and a novel population, the candidate myeloid cell population (within CP7 and 10) (<xref rid="F11" ref-type="fig">Extended Data Fig. 7</xref>). The myeloid cells were the main contributors to phagocytosis, as evidenced by &gt;40% contribution to each of the phagocytosis assays, the large phagocytes contributed mainly to allogeneic phagocytosis (<xref rid="F11" ref-type="fig">Extended Data Fig. 7a</xref>).</p>
    <p id="P10">We did not find a cell population with a clear mammalian cytotoxic gene expression signature. Morula cells (MC), which contain phenoloxidase, accumulate in rejection points and have been proposed as cytotoxic cells that mediate rejection<sup><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup>. We detected MC in population CP18, but in lower levels than expected, prompting us to look for a candidate precursor cell. We studied the large granular lymphocyte-like (LGL) cells (enriched in CP31) as a potential candidate, since its morphology resembles Natural Killer (NK) cells, the innate immunity cytotoxic cells of mammals<sup><xref rid="R30" ref-type="bibr">30</xref></sup>. <italic>Ex-vivo</italic> experiments revealed a transition of purified LGL cells into MC after two days <italic>ex-vivo</italic> (<xref rid="F3" ref-type="fig">Fig. 3a</xref>, labeled 1&#x2013;4), suggesting that the LGL cells are the cytotoxic MC which become pigmented granular MC following activation.</p>
    <p id="P11">Cytotoxicity assays that compared the ability of morula and LGL cells to induce cytotoxicity revealed that isolated LGL cells had significantly higher cytotoxicity compared to isolated MC and control population (CP3; <xref rid="F12" ref-type="fig">Extended Data Fig. 8a</xref>). Overnight incubations of isolated LGL cells in either a syngeneic (self) or an allogeneic (nonself) challenge led to a transition of 60% of the LGL cells that were incubated with allogeneic cells to MC. Only about 10% of the LGL cells that were incubated with syngeneic cells became MC (<xref rid="F12" ref-type="fig">Extended Data Fig. 8b</xref>). Upon activation, LGL change their morphology, develop granularity and pigmentation, presumably due to phenoloxidase activation, and become MC (<xref rid="F3" ref-type="fig">Fig 3a</xref>, <xref rid="F12" ref-type="fig">Extended data Fig. 8b-c</xref>). This set of experiments demonstrates that the LGL cells are the cytotoxic cell population. The term &#x201C;cytotoxic morula cell&#x201D; will be used to describe the LGL cells.</p>
    <p id="P12">Analysis of the genes that were differentially upregulated by the highly enriched cytotoxic morula cell population (CP31), revealed 52 unannotated genes with no human or mouse homologs. Among them, 21 genes carry domains that are associated with functions of cytotoxic cells like recognition or lysis and C-type lectin, a domain contained in human NK cell receptors (<xref rid="SD7" ref-type="supplementary-material">Table S5</xref>). Among the 18 differentially upregulated genes that do have sequence homology to genes in vertebrates, 14 are associated with at least one of the following functions: cellular recognition, cytotoxicity or peptidase activity, leukocyte homing and general immune response (<xref rid="F3" ref-type="fig">Fig. 3b</xref>). CP31 also expresses tyrosinase, the vertebrate homolog gene to phenoloxidase which is one of the main enzymes found in MC<sup><xref rid="R28" ref-type="bibr">28</xref></sup>, 7-fold higher compared to the other cells. While we did not find a <italic>B. schlosseri</italic> cell population that had a significant lymphoid lineage signature, Geneset Activity Analysis suggests that the MC enriched CP19 has expression resemblance to mouse T-cells, B cells, and immature NK cells (<xref rid="F8" ref-type="fig">Extended Data Fig. 4d</xref>). This list does not include any gene that is associated with known adaptive immunity function (<xref rid="SD4" ref-type="supplementary-material">Table S2</xref>).</p>
    <p id="P13">To test whether allogeneic cells interact <italic>in-vivo</italic> during rejection whole colonies were differentially labeled, set near each other and monitored by live imaging (<xref rid="F3" ref-type="fig">Fig. 3d</xref>, <xref rid="SD10" ref-type="supplementary-material">Video S3</xref>). Direct contact between allogeneic cells was detected during rejection within the points of rejection (POR; <xref rid="F3" ref-type="fig">Fig. 3d</xref>, lower right). Next, we performed allogeneic phagocytosis and cytotoxicity assays. Assays were set between cells taken from compatible colonies (sharing one BHF allele), rejecting colonies (no shared BHF allele) or self (same colony) (<xref rid="F3" ref-type="fig">Fig. 3e</xref>). Confocal microscopy was used to validate phagocytosis and in the cytotoxicity assays, specific lysis were validated by increasing ratios between effector to target cells (<xref rid="F12" ref-type="fig">External Data Fig. 8d-e</xref>). The experiment was accomplished by differential labelling of cells originating from either the same colony, two different compatible or rejecting colonies. A significant increase of cellular cytotoxicity was detected between cells that were derived from rejecting colonies compared to cells derived from either compatible or the same colonies (<xref rid="F3" ref-type="fig">Fig. 3e</xref>, <xref rid="F12" ref-type="fig">External Data Fig. 8e</xref>). Since all the treatments led to similar levels of phagocytosis we concluded that cytotoxicity is the immune effector mechanism of the cellular allogeneic response.</p>
    <p id="P14">In a third set of experiments, we tested whether blocking BHF would affect the cytotoxic reaction. Cytotoxicity assays between compatible and rejecting colonies revealed significantly higher cytotoxicity between rejecting colonies with mock serum (<xref rid="F3" ref-type="fig">Fig. 3f</xref>). Blocking BHF with serum containing polyclonal anti-BHF antibodies which bind live <italic>B. schlosseri</italic> cells (<xref rid="F6" ref-type="fig">Extended Data Fig. 2e</xref>, <xref rid="T2" ref-type="table">Extended Data Table 2a</xref>), enhanced cell lysis between compatible colonies to the level observed in rejecting colonies (<xref rid="F3" ref-type="fig">Fig. 3f</xref>). This treatment did not affect the level of cell lysis observed in rejecting colonies (<xref rid="F3" ref-type="fig">Fig. 3f</xref>). These results revealed that BHF is a major histocompatibility factor essential for self-recognition. Similar to NK inhibition by MHC, blocking BHF revealed that the self-BHF recognition is a major inhibitory mechanism of cytotoxicity. These results and the observation that fusion occurs when colonies share at least one <italic>BHF</italic> allele<sup><xref rid="R7" ref-type="bibr">7</xref></sup>, demonstrate that, as in NK recognition, the cellular cytotoxicity mechanism in <italic>B. schlosseri</italic> is based on &#x2018;missing self&#x2019;<sup><xref rid="R31" ref-type="bibr">31</xref></sup>.</p>
    <p id="P15">The <italic>B. schlosseri</italic> hematopoietic and immune systems combine features of vertebrates and invertebrates (<xref rid="F4" ref-type="fig">Fig. 4</xref>). <italic>B. schlosseri</italic> shares morphological and molecular characteristics with the vertebrate HSC and myeloid lineage including cells that take part in phagocytosis. It also has amoebocytes and large phagocytes with morphologies resembling invertebrate cell types<sup><xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup>. The <italic>B. schlosseri</italic> cytotoxic morula cells carry imprints reminiscent of vertebrates&#x2019; lymphocytes, but mainly express tunicate-specific gene repertoire (<xref rid="F3" ref-type="fig">Fig. 3b</xref>, <xref rid="F8" ref-type="fig">Extended Data Fig. 4d</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S2</xref>, <xref rid="SD7" ref-type="supplementary-material">S5</xref>). Several studies describe morula-like cells with phenoloxidase activity in other invertebrate species<sup><xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup>. Studying novel gene sets that are expressed by the cytotoxic morula cells and finding the BHF inhibition pathway will most likely reveal novel mechanisms to delimit self from non-self and target pathogens.</p>
    <sec id="S1">
      <title>Methods</title>
      <sec id="S2">
        <title>Colony development, labeling and allorecognition assays</title>
        <p id="P16"><italic>The life cycle of B. schlosseri</italic>, includes both sexual and asexual reproduction pathways. Sexual reproduction starts with fertilization and progresses through classic embryonic stages into a tadpole larva featuring chordate characteristics such as tail, notochord, neural tube and striated musculature. Upon hatching, the motile tadpole settles on a substrate and metamorphoses into an oozoid, with a sessile body plan (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). The oozoid begins a cyclical budding process of asexual reproduction, forming a colony of genetically identical zooids and buds (<xref rid="F1" ref-type="fig">Fig. 1b</xref>). The colonial individuals are united under a single gelatinous tunic by a network of blood vessels, which terminate in sausage shaped protrusions, ampullae (<xref rid="F1" ref-type="fig">Fig. 1a-c</xref>). Throughout adult life, <italic>B. schlosseri</italic> generates its entire body every two weeks. This stem cell mediated cycle of development includes the formation of all body organs including the heart, respiratory system, digestive system, and neural complex. Sexual reproduction commences when the ovary and testis are formed.</p>
        <p id="P17">Mariculture procedures have been described previously<sup><xref rid="R35" ref-type="bibr">35</xref></sup>. Briefly, <italic>B. schlosseri</italic> colonies were collected from the marina in Monterey, California. Individual colonies were tied to 3&#xD7;5-cm glass slides and placed 5 cm opposite another glass slide in a slide rack. The slide rack was placed into an aquarium, and within a few days the sexually reproduced tadpoles hatched, swam to the settlement slide, and metamorphosed into the adult body plan. Single colonies were then transferred to individual slides and used in the diverse experiments.</p>
        <p id="P18">When two genetically distinct colonies or individuals encounter one another, they can either fuse to form a chimera with a common vasculature, or reject one another<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1c</xref>; <xref rid="SD9" ref-type="supplementary-material">Video S2</xref>). This self-nonself recognition process is controlled by <italic>BHF</italic>, a single polymorphic histocompatibility gene<sup><xref rid="R7" ref-type="bibr">7</xref></sup>. Fusion requires at least one shared <italic>BHF</italic> allele: upon fusion, circulating somatic and germline stem cells from both colonies compete for dominance of the somatic and germline organs and also contribute to the formation of new buds<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup>. Additionally, the buds in one of the chimeric partners often fail to develop<sup><xref rid="R8" ref-type="bibr">8</xref></sup>. This developmental failure is an immune-cell based rejection of bud cells that operate within a <italic>BHF</italic> histocompatible chimera. The process involves inflammation and recruitment of cytotoxic cells, and is thus comparable to mammalian chronic transplant rejection<sup><xref rid="R7" ref-type="bibr">7</xref></sup>.</p>
        <p id="P19">Juvenile colonies were labeled with distinct fluorescent stains (CellTrace CFSE Green, Invitrogen #C34554; CellTrace FarRed, Invitrogen #C34572) and positioned in controlled fusion/ rejection reactions (<xref rid="F3" ref-type="fig">Fig. 3d</xref>). For allorecognition assays, colonies were labeled using CFSE dye (5 mM stock solution) and Far Red dye (1 mM stock solution) in a dilution of 1 &#x3BC;l of dye to 1 ml of filtered seawater. Naive colonies were then bathed in this solution for 60 minutes, allowed to recover then washed and placed in &#x3BC;-Dishes (ibidi &#x3BC;-Dish 50mm-low uncoated) for observation. Images were obtained using a confocal fluorescence microscope (LSM700 Axio Observer.Z1, ZEISS).</p>
      </sec>
      <sec id="S3">
        <title>FACS analysis</title>
        <p id="P20">For cell isolation, colonies were starved for at least 24 hours prior to dissociation with a fine blade into cell suspensions. Cells were filtered through a 40 &#x3BC;m mesh using a sterile 1 ml syringe pump (a similar procedure to murine spleen dissociation), washed and collected in staining media: 3.3x PBS, 2% FCS and 10 mM Hepes. No enzymatic dissociation was used and the presence of FCS was enough to prevent cell aggregation. After gating on Propidium Iodide (PI), negative cells (using two dimensional plots due to natural fluorescence of <italic>B. schlosseri</italic> cells), were analyzed using size - forward scatter (FSC) and granularity - side scatter (SSC) panel on log scale using BD FACS Aria-II. We isolated 11 cell populations based on their size (FSC), granularity (SSC) and natural auto-fluorescence (<xref rid="F5" ref-type="fig">Extended Data Fig. 1b</xref>). These purified populations were analyzed according to morphology by light microscopy and defined according to previous cellular work characterizing <italic>B. schlosseri</italic> cell populations<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup>. We then screened a large assortment of antibodies and reagents using mass cytometry (CyTOF) and FACS, to identify cell surface markers that show differential binding to distinct cell populations (<xref rid="T1" ref-type="table">Extended Data Tables 1</xref>, <xref rid="T2" ref-type="table">2a</xref>; <xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref>). The cluster analysis programs SPADE and viSNE were applied to create a differentiation panel of the resultant screened markers (<xref rid="F5" ref-type="fig">Extended Data Fig. 1a</xref>). Using CD49d, CD57, BHF (a mouse anti-serum that was developed against the BHF protein), Concanavalin-A, and alkaline phosphatase (AP), together with size, granularity, and natural auto-fluorescence, we succeeded in defining a total of 34 cell populations - 24 of these are the hierarchical endpoint populations of our FACS gating strategy (<xref rid="F5" ref-type="fig">Extended Data Fig. 1c-d</xref>). CP17 was composed of dead cells and cell debris, and was therefore excluded.</p>
        <p id="P21">Thirty-four gated populations were analyzed following cell labeling. 5 million cells were suspended in 200&#x3BC;l of staining media prior to FACS analysis: Alkaline Phosphatase (AP) Live Stain (Life Technologies A14353) 1&#x3BC;l, CD49d PE-Cy7 (BioLegend 304313: Clone 9F10) 1&#x3BC;g, CD57 Pacific Blue (BioLegend 322316; clone HCD57) 0.25&#x3BC;g, Concanavalin-A (ConA) AlexaFluor-633 (Sigma) 2&#x3BC;g, mouse anti-BHF serum 1:100 and anti-mouse secondary Cy5-Cy7 (SantaCruz) (<xref rid="T1" ref-type="table">Extended Data Table 1</xref>-<xref rid="T2" ref-type="table">2a</xref>). The specific excitation laser and optical filter for emission measurements was as follows [excitation laser in nm and filters stated as long pass (LP) and band pass (BP)]: 488 nm(505LP 530/30BP)- AP, 488 nm(755LP 780/60BP)- CD49d, 405nm(450/50BP)- CD57, 633 nm(660/20BP)-ConA,633 nm(755LP 780/60BP)-BHF. Cells were sorted into 18 well flat &#x3BC;-Slides coated with poly-L-Lysine (ibidi) for live imaging.</p>
      </sec>
      <sec id="S4">
        <title>Anti-BHF serum</title>
        <p id="P22">We created the mouse anti-BHF serum with Thermo Scientific Pierce Protein Biology. The nucleotide sequence that was used for the <italic>BHF</italic> (759 bp) alpha allele, a <italic>BHF</italic> allele that is common in our mariculture facility:</p>
        <p id="P23">
          <monospace>ATGGTGCACGATACCGAGCAATTGCTCGCCCAAGGTCACCACGAAGAGGAAACCGAATGTGGGAAATACGGAAAGCTGCCGGAGAAAGGCAGCGAATGCAAGAAACATGGCATATTTTGCCGAATCCTGACTGCGTTACATTTGAAGAAGAGGAGAACTGAACACGATCATCAAAAGTTACTGTCCGAGTCGCAAGAGCATCTCGACGCTTCGACAAAGAAGACCAAGAAAAAAGCCAAGAAGGACAAACGCAAAAACAAACCGCCCAAGAAAGATTCAGAAACTAGCAAGCCCGCTCAGACCACGATTTCAAGACTCCCATCAAACAGAAACAATAACAACGCAAACAGCTTCGCTACCACTTACGAAAAATTCGACAACGACTCACTGTGCTCTGTCGACTTAATACCGGTCGATATCGAATTTTGGGACATGGAGAACGAACCAGTCGACCAACTACCCCACGAAATCCTGGAATCTGTTCATATGTACGGCGACGATCGGTTCGGCGAACGCCTCATTGATAGAGCCCAAAATAAATACGCCCCGTTGGACGAAAAGCAACGGTCCGAGTCCCACGGCGCTGGGGAGTACTTAAAGCATCAGTGGAAGGGTCAGGGGGCCAAAAAAGCGCGCAAGAGAATTCGAACTGTGATGAAGGCTACTTGGCAATCTCTACAAGCGGGCGCTAGATCGCAAACAGCTTTTTTGAACCCTCAGGGTGCGGTGTCGGCGGCCCTTGTACAAAACAGGAGATAA</monospace>
        </p>
        <p id="P24">The BHF was cloned into pET23b vector including C-term His-Tag, and produced in DH5a cells. Validation of the mouse serum binding to BHF was done by Thermo Scientific Pierce Protein Biology using ELISA. We used FACS to validate that the anti-BHF mouse serum did bind to <italic>Botryllus</italic> live cells. Labeling of live cells (PI negative) by the anti-BHF serum demonstrate that BHF is presented on the membrane (<xref rid="F6" ref-type="fig">External Data Fig. 2e</xref>). The localization of the BHF to the membrane has been previously described<sup><xref rid="R36" ref-type="bibr">36</xref></sup>. Our assumption is that if a serum can recognize BHF on the membrane it will be able to block its interaction with a recognition receptor.</p>
      </sec>
      <sec id="S5">
        <title>CyTOF mass cytometry screening</title>
        <p id="P25">CyTOF and its cluster analysis programs SPADE and viSNE were used to screen a large assortment of antibodies against human cell-surface antigens that would cross-react with <italic>B. schlosseri</italic> cells and could potentially differentiate cellular populations (<xref rid="T1" ref-type="table">Extended Data Table 1</xref>, <xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref>). The cluster analysis programs SPADE and viSNE that were developed to analyze CyTOF data<sup><xref rid="R37" ref-type="bibr">37</xref></sup> were applied to create a differentiation panel of the resultant screened markers (<xref rid="F5" ref-type="fig">Extended Data Fig. 1</xref>).</p>
        <p id="P26">For the screen of 49 antibodies, live cells were labeled for 30 minutes on ice in staining media (3.3x PBS, 2% FCS and 10 mM Hepes) with different antibodies labeled with elemental isotopes <xref rid="T1" ref-type="table">(Extended Data Table 1)</xref>, followed by two washes with staining media. After washing, cells were fixed in 4% PFA in 1x PBS, washed once with staining media and then incubated at room temperature for 20 min in an iridium-containing DNA intercalator (Fluidigm) in 1.5% paraformaldehyde in 1x PBS. Prior to measurement on a mass cytometer, cell samples were washed once with staining media and twice with water<sup><xref rid="R37" ref-type="bibr">37</xref></sup> (Fluidigm). Analysis of the FCS files were done with Cytobank and FlowJo. Antibodies with positive signals were validated by FACS as summarized in <xref rid="T1" ref-type="table">Extended Data Table 1</xref>.</p>
      </sec>
      <sec id="S6">
        <title>Tissue dissection, RNA extraction, purification, and transcriptome sequencing</title>
        <sec id="S7">
          <title>FACS sorted cell population:</title>
          <p id="P27">We used the protocol described in Koh et al. 2016 to extract RNA from FACS sorted cells (n=24)<sup><xref rid="R38" ref-type="bibr">38</xref></sup>. Twenty three endpoint populations were sequenced, in addition to CP2, which was composed of all live cells. CP17 was composed of dead cells and cell debris, and therefore was excluded in the population analysis. 20,000 cells of each sequenced population were sorted in 750 &#x3BC;l Trizol-LS (Invitrogen #10296010 ) using a 100 &#x3BC;m nozzle. Cells were vortexed and incubated for 10 minutes at room temperature prior to freezing in &#x2212;80 C. After thawing, cells were washed with chloroform, and RNA was isolated according to the manufacturer&#x2019;s directions, with minor modifications. Linear polyacrylamide (LPA) carrier (Sigma Aldrich # 56575&#x2013;1ML) was added to enhance recovery of RNA, followed by DNase I treatment per manufacturer&#x2019;s instructions (Qiagen RNeasy micro kit, # 74004).</p>
        </sec>
        <sec id="S8">
          <title>Whole colony samples:</title>
          <p id="P28">We used the protocol described in Voskoboynik et al 2013 to extract RNA from whole colonies (n=34)<sup><xref rid="R6" ref-type="bibr">6</xref></sup>.</p>
          <p id="P29">The 34 whole colony samples include all tissues in the colonies.</p>
        </sec>
        <sec id="S9">
          <title>Endostyle samples:</title>
          <p id="P30">Insulin syringes were used to dissect endotyles (n=10). The endostyle is a long glandular groove extending medially at the ventral face of the zooids branchial sac along its anterior posterior axis<sup><xref rid="R23" ref-type="bibr">23</xref></sup>. The endostyle is immersed in blood cells flowing through the large subendostylar sinus and other sinuses and is innervated by the main and lateral subendostylar nerves<sup><xref rid="R39" ref-type="bibr">39</xref>,<xref rid="R40" ref-type="bibr">40</xref></sup>. The endostyle epithelium consists of eight distinct anatomical zones, each defined by a specific gene expression profile<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup>. The 10 endostyle samples taken for RNAseq include the endostyle epithelial cells, cells circulating in the subendostylar sinuses and the main and lateral subendostylar nerves that are extending along the endostyle anterior posterior axis. Dissected endostyles samples were flash frozen in liquid nitrogen to minimize RNA degradation and stored at &#x2212;80 C. Using a mechanized Konte tissue grinder and pestle, samples were homogenized in the presence of lysis buffer (Qiagen RNAeasy Microkit #74004), and total RNA was extracted following the manufacturer&#x2019;s protocol. Resultant RNA was cleaned and concentrated (Zymo Research RNA Clean and Concentrator-5, R1015) and analyzed by an Agilent 2100 Bioanalyzer for quality analysis prior to library preparation. cDNA libraries were then prepared from high quality samples (RIN &gt; 8) using Ovation RNA-seq v2(Nugen). Size selection was performed prior to barcoding using Zymo Research Select-a-Size DNA Clean and Concentrator Kit (D4080); Libraries were barcoded using NEBnext Ultra DNA Library Prep Kit Master for Illumina (New England Biolabs, E7370S) and NEBNext Multiplex Oligos for Illumina (New England Biolabs, E6609S). Barcoded library samples were then sequenced on an Illumina NextSeq 500 (2&#xD7;150bp, producing an average of 15 million reads/cell population).</p>
        </sec>
      </sec>
      <sec id="S10">
        <title>Cytotoxicity and phagocytosis assays.</title>
        <p id="P31">Three different <italic>ex-vivo</italic> phagocytosis assays were used to identify the <italic>B. schlosseri</italic> myeloid lineage phagocytic cell populations: i) phagocytosis of fluorescent beads, ii) phagocytosis of a fluorescently labeled marine bacteria (Vibrio diazotrophicus) and iii) allogeneic phagocytosis, where we tested the capability of cells from different colonies to engulf allogeneic cells (<xref rid="F11" ref-type="fig">Extended Data Fig. 7</xref>). FACS was used to identify the phagocytic cells in each of the <italic>ex-vivo</italic> assays and to track its cell population. Confocal microscopy and ImageStream analysis were used to confirm engulfment (<xref rid="F11" ref-type="fig">Extended Data Fig. 7</xref>).</p>
        <sec id="S11">
          <title>Bacteria and beads phagocytosis assays:</title>
          <p id="P32">cells (10<sup>5</sup> cells/200 &#x3BC;l) were incubated overnight at 18&#xB0;C in a 2:1 ratio of beads: cells using Fluoresbrite&#xAE; YG Carboxylate Microspheres 1.00&#x3BC;m (Polysciences). To measure phagocytosis of bacteria, the marine bacteria <italic>Vibrio diazotrophicus</italic> was heat inactivated in 95&#xB0; C for 5 minutes, and labeled with Alexa Fluor 647 (Invitrogen #A20006). The analysis of cells positive to beads or cells positive to bacteria was done by flow cytometry using two fluorescent channels - the green channel was used to detect beads and the far-red channel was used to detect bacteria (<xref rid="F11" ref-type="fig">Extended Data Fig. 7</xref>). FlowJo V10 (FlowJo) was used to analyze the flow cytometry data.</p>
        </sec>
        <sec id="S12">
          <title>Phagocytosis of allogeneic cells:</title>
          <p id="P33">the labeling and incubation of cells were done as describe for the cytotoxicity assay bellow. Phagocytosis was measured as double positive cells in the FACS plots of the two labeling markers. Due to the natural fluorescence of <italic>B. schlosseri</italic> cells, the level of double positive cells in wells with separation of each one of the labels was reduced from the double positive in the experimental wells (about 5% background). To validate phagocytosis, cells were sorted and observed by confocal microscopy. To compare cytotoxicity to phagocytosis, the optimal ratio (1:1) for allogeneic phagocytosis was prepared and compared to cytotoxicity at the same ratio, using 10<sup>5</sup> cells of each labeled group per well.</p>
          <p id="P34">FACS-based cytotoxicity assay<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup> to measure killing of cells <italic>in-vitro</italic>. Isolated <italic>B. schlosseri</italic> cells were labeled using CFSE (5uM; Life technologies) and Far Red dye (1uM; Life technologies) for 30 minutes at 18&#xB0; C to distinguish effector and target cells and washed twice in staining media: 3.3x PBS, 2% FCS and 10 mM Hepes. Cells were incubated overnight in 96 well U shaped plates at 18<sup>o</sup>C at different effector: target ratios in staining media. After adding Propidium Iodide (PI) to wells to test cell viability, cells were analyzed by FACS. The target or the effector cells were gated on two dimensional analysis using the labeling dyes (CFSE and Far Red dye). Spontaneous lysis was measured as the percentage of PI positive cells in gated target cells in wells without effector cells, and sample lysis was quantified as the percentage of PI positive cells in gated target cells. Specific lysis was calculated as follows: Specific lysis %=100x((sample lysis-spontaneous lysis)/(100-spontaneous lysis)). The gating of FACS analysis was on two dimensional plots due to the natural fluorescence of <italic>B. schlosseri</italic> cells. For BHF blocking assays, anti-BHF polyclonal mouse serum was used 1:200, or mock serum as control. Colonies with known fusion/rejection outcomes from our mariculture facility were used to measure allogeneic cytotoxicity and phagocytosis. Cytotoxicity and phagocytosis assays were done in triplicates.</p>
        </sec>
      </sec>
      <sec id="S13">
        <title>Cell Transplantation</title>
        <p id="P35"><italic>B. schlosseri</italic> colonies have the ability to fuse spontaneously, thereby facilitating natural &#x2018;transplantation&#x2019; or parabiosis assays between genetically compatible yet distinct colonies (those sharing a <italic>BHF</italic> allele) without requiring radiation-induced elimination of the host&#x2019;s stem cells<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup>. Furthermore, based on this feature cells can be sorted and transplanted between compatible <italic>B. schlosseri</italic> colonies. The differentiation potential of transplanted cells can be tested by a pigmentation-based assay, using distinctly pigmented donor and recipient colonies (e.g. blue vs orange)<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup>. The colors of the pigment cells in <italic>B. schlosseri</italic> are genetically determined<sup><xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R43" ref-type="bibr">43</xref></sup>. Pigment cells, identified as CP8, circulate in the vasculature and are linked to the hematopoietic lineages by gene expression (<xref rid="F8" ref-type="fig">Extended Data Fig. 4b</xref>). Additionally, the transparent body allows for real time monitoring and tracing of labeled cells by time-lapse microscopy<sup><xref rid="R6" ref-type="bibr">6</xref></sup>. Using these methods and a FACS-based differentiation assay developed for this study we assayed the differentiation potential and homing sites of <italic>B. schlosseri</italic> candidate HSC (cHSC) populations. The experiment of rescuing lethally irradiated recipients was not performed since those experiments were not shown to work in the <italic>B. schlosseri</italic> model<sup><xref rid="R44" ref-type="bibr">44</xref></sup>.</p>
        <p id="P36">Cell were sorted directly into staining media (3.3x PBS based; 75% of final volume) in order to minimize cellular stress using a 100 &#x3BC;m nozzle. Following sorting cells were labeled with DiD or DiO membrane dye (Life technologies) in order to visualize or identify the transplanted population, and suspended in a final concentration of 10<sup>5</sup> cells/&#x3BC;l. 10<sup>5</sup> cells were injected into recipient colonies near the zooid&#x2019;s heart, using a microinjector (Narishige, Japan) as described in Voskoboynik et al. 2008<sup>6</sup>.</p>
        <p id="P37">Two transplantation assays were used to measure the ability of a specific cell population to differentiate into other cell types: i) a pigment cell based differentiation assay (donor chimerism) (<xref rid="F2" ref-type="fig">Fig. 2b-c</xref>), and ii) a FACS analysis based differentiation assay (<xref rid="F2" ref-type="fig">Fig. 2d-f</xref>).</p>
        <p id="P38">The cHSC population transplanted includes CP25, CP33, CP34. As a control we used CP18 (includes CP19, 20, 21) which share molecular signature with the pigment cell population and is located close to the pigment cells populations on the FACS plots (<xref rid="F5" ref-type="fig">Extended Data Fig. 1</xref>). The analysis of the pigment cell based differentiation experiment (<xref rid="F2" ref-type="fig">Fig. 2b-c</xref>) was done in a single blind manner 20 days following transplantation, n=42 transplanted colonies; 16-cHSC, 15-control population, 11-uninjected.</p>
        <p id="P39">In the FACS analysis based differentiation assay (<xref rid="F2" ref-type="fig">Fig. 2d-f</xref>) the cHSC population (CP25, CP33, CP34) and the CP18 control population (CP19, 20, 21) were labeled by DiO and transplanted to compatible colonies. 3 weeks following transplantation, transplanted colonies were pooled for the analysis by FACS into two pools from each experimental group, having at least 5 transplanted colonies in each pool. Percentage of the cells remaining in each of the original gates on the FSC and SSC was measured, CP9 for CP18 (CP19, 20, 21) and CP10+7 for the cHSC population (CP25, 33, 34) based on the FACS gating hierarchies in <xref rid="F5" ref-type="fig">Extended Data Figure 1d</xref>. In addition we estimated cell proliferation level by measuring levels of DiO fluorescence 3 weeks following transplantation of labeled cells (<xref rid="F9" ref-type="fig">Extended Data Fig. 5a</xref>).</p>
        <p id="P40">For localization assays two sets of experiments were performed: a total of 14 colonies labeled with CFSE on ibidi 50 mm uncoated &#x3BC;-dishes, were transplanted with DiD labeled cells (<xref rid="F2" ref-type="fig">Fig. 2g</xref>, <xref rid="F9" ref-type="fig">Extended Data 5b</xref>). cHSC DiD labeled cells were transplanted to 6 colonies, 4 colonies were transplanted with DiD labeled CP3, and 4 colonies were not injected and used as a control for natural fluorescent background. Focusing on known <italic>B. schlosseri</italic> stem cells niches (the subendostylar sinus and the cell islands<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup>), we tested the ability of transplanted cHSC&#x2019;s and control cells (CP3) to migrate to these sites. An additional channel was used to validate auto-fluorescent cells. For the subendostylar sinus (the endo-niche) there were no transplanted cells detected for CP3 (0/4) or the un-injected colonies (0/4), whereas 5/6 colonies were positive to cHSC cells, showing significant localization of the cHSC to the subendostylar sinus; P=0.048 Fisher&#x2019;s exact test, two tailed. However, in the cell islands although 4/4 were positive with CP3, 5/6 positive to cHSC, and 2/4 were positive in the un-injected colonies, there is a high concentration of auto-fluorescent cells in the CI.</p>
      </sec>
      <sec id="S14">
        <title>Histology and Immunohistochemistry</title>
        <p id="P41">Hematoxylin and Eosin (H&amp;E) staining: cells were incubated overnight on glass slides coated with Poly-L-lysine (Sigma) and fixed by 4% PFA in 0.1M MOPS in 0.5M NaCl, pH 7.5 for 10 min and washed with PBS. The slides were stained with Harris Hematoxylin for 5 minutes and 2% Eosin Y for 1 minute <xref rid="F5" ref-type="fig">(Extended Data Fig 1e)</xref>.</p>
        <p id="P42">Immunohistochemistry was based on Braden et al. 2014<sup><xref rid="R45" ref-type="bibr">45</xref></sup>. The labeling was done using rabbit anti Phospho-Histone H3 (pHH3; Cell Signaling, 9701) at a concentration of 1:500 (<xref rid="F9" ref-type="fig">Extended Data Fig. 5d</xref>).</p>
      </sec>
      <sec id="S15">
        <title>Electron Microscopy</title>
        <p id="P43">Colonies were fixed overnight in 1.5% glutaraldehyde buffered with 0.2 M sodium cacodylate, 1.6% NaCl, pH 7.4. After washing in buffer and post-fixation in 1% OsO4 in 0.2 M cacodylate buffer plus 1.6% NaCl, specimens were dehydrated and embedded in Araldite. Sections were counterstained with toluidine blue, and for EM sections were stained for contrast with uranyl acetate and lead citrate. Micrographs were taken with a FEI Tecnai G2 electron microscope (operating at 100 kV) (<xref rid="F9" ref-type="fig">Extended Data Fig 5c</xref>).</p>
      </sec>
      <sec id="S16">
        <title>Differential expression analysis</title>
        <p id="P44">Determination of gene counts was performed using a Snakemake<sup><xref rid="R46" ref-type="bibr">46</xref></sup> pipeline. An outline of the steps is as follows: i) low quality bases and adapter sequences were removed using Trimmomatic<sup><xref rid="R47" ref-type="bibr">47</xref></sup> (version 0.32) ii) overlapping paired end reads were merged using FLASH<sup><xref rid="R48" ref-type="bibr">48</xref></sup> (version 1.2.11) iii) reads were aligned to the UniVec Core database using Bowtie2<sup><xref rid="R49" ref-type="bibr">49</xref></sup> (version 2.2.4) to remove biological vector and control sequences, iv) reads were aligned to the <italic>Botryllus schlosseri</italic> transcriptome with BWA<sup><xref rid="R50" ref-type="bibr">50</xref></sup> (&#x201C;mem&#x201D; algorithm, version 0.7.12), v) aligned reads were sorted and indexed using SAMtools, PCR duplicates removed using PICARD (&#x201C;MarkDuplicates&#x201D; tool, version 1.128) and then transcript level counts directly counted from the BAM file.</p>
        <p id="P45">Differential expression was performed using edgeR<sup><xref rid="R51" ref-type="bibr">51</xref></sup>. In detail: the gene counts were compiled into a tabular format and loaded into R. Genes were retained with at least five counts per million in at least 80% of the smaller number of the compared samples. A simple model was used to compare the two sets of populations, with p-values adjusted using the Benjamini-Hochberg method to produce a false discovery rate (FDR). FDRs less than 0.05 were called as being differentially expressed. The comparisons between cell populations were performed in a one-vs-all approach, followed by selective aggregating of similar populations. Initially each population was compared to all others (except for CP2 which was an aggregate of all cells). Then all sets of two populations were compared to the remaining, with the best two being grouped together. The metric used is: if A is the set of genes found to be differentially expressed in population A vs all others, and n(A) is the number of genes in that set, then find the maximum of n(AB) - n(A or B). This attempts to find those populations that when grouped together are more distinct from all others compared to the populations individually. After this grouping was performed multiple times, the maximum was no longer above zero, and a new metric was used. This method was used to find the two groups of populations that maximized n(AB)<sup><xref rid="R2" ref-type="bibr">2</xref></sup>/(n(A or B) + 1). This aimed to find the populations that fractionally were the most similar. The mergings are as follows: CP33+CP34, CP3+CP23, CP8+CP20, CP21+CP22, CP24+CP26, CP25+CP33+CP34, CP12+CP14, CP5+CP32, CP29+CP36, CP19+CP31, CP15+CP16, CP30+CP35. The number of characteristic, highly expressed genes found per population(s) relative to the other populations varied from 0&#x2013;2229 (mean 232), with only 23% possessing homology to mouse or human genes with the remaining 77% of these genes being mostly <italic>B. schlosseri</italic> or tunicate specific.</p>
        <p id="P46">For visualization, the 250 genes with the largest weights in the first 11 principal components (explaining 90% of the variance in mean-adjusted log-transformed gene counts) were used to cluster the different cell populations in a heatmap (<xref rid="F7" ref-type="fig">Extended Data Fig. 3a</xref>). Many of the populations have visually similar gene expression patterns (for example: CP3, 5 and 23; and CP25, 33 and 34), and in general, samples that were adjacent in FACS-space are also similar in expression-space (<xref rid="F7" ref-type="fig">Extended Data Fig. 3b</xref>, 67% of neighbors in agreement) indicating a correlation between gene expression profile and morphology and marker expression.</p>
      </sec>
      <sec id="S17">
        <title>Gene domain finding</title>
        <p id="P47">The protein sequence of CP31 associated non-homologous genes (N=52) was saved to individual FASTA files. These were processed using the python-based RESTful client for InterPro5 (version 5.28&#x2013;67.0) on ENSEMBLE&#x2019;s website using the default options to search for annotated domains within ascidian-specific genes that dominate the Botryllus cytotoxic morula cells (<xref rid="SD7" ref-type="supplementary-material">Table S5</xref>). Unannotated genes domain revealed: transmembrane domains (n=7), cell interaction and sugar binding domains (n=4) and signal peptides (n=3). This analysis also revealed genes with toxin and peptidases domains (g6777, g43113), hydrolase (g61144) and complement and coagulation domains (g6900, g69753). Moreover, g15971 contains a C-type lectin domain, a domain contained in human NK cell receptors (<xref rid="SD7" ref-type="supplementary-material">Table S5</xref>).</p>
      </sec>
      <sec id="S18">
        <title>Geneset Activity Analysis on Gene Expression Commons</title>
        <p id="P48">Gene Expression Commons (<ext-link ext-link-type="uri" xlink:href="https://gexc.riken.jp/">https://gexc.riken.jp</ext-link>) provides gene expression dynamic-range and threshold to distinguish active expression from inactive expression for each gene by computing a massive amount of publicly available microarray data<sup><xref rid="R15" ref-type="bibr">15</xref></sup>. Once a user submits raw microarray data of a particular cell type, the Gene Expression Commons returns gene expression activity referred to the dynamic-range for each gene, and if expression level exceeds the threshold, the gene is labeled &#x201C;active gene&#x201D;. In the Weissman lab, we purified and generated microarray data for each step of adult mouse hematopoiesis as well as several stromal cell types. A gene expression profile of each cell type becomes public domain (or available to the public) through the Gene Expression Commons platform.</p>
        <p id="P49">For this project, we developed a new function on the Gene Expression Commons platform entitled Geneset Activity Analysis. A user can create a Geneset, a set of genes of interest. Then the significance of the association between a given gene set and a set of active genes in the cell type is examined by Fisher&#x2019;s exact test.</p>
      </sec>
    </sec>
    <sec sec-type="extended-data" id="S19">
      <title>Extended Data</title>
      <fig id="F5" orientation="portrait" position="anchor">
        <label>Extended Data Figure 1</label>
        <caption>
          <title><italic>B. schlosseri</italic> Cell Sorting Workflow.</title>
          <p id="P50">a, Outline of cell purification process. Unsorted cells (light microscopy) are loaded into a FACS (i) and sorted resulting in morphological observation (ii). Cells were labeled by diverse markers and screened by CyTOF (iii) for differential labeling. Based on SPADE cluster analysis (iv) markers were selected for FACS gating (v) before a final sort was performed (vi; c). <bold>b</bold>, Sorting based on FCS/SSC in the lower panel, and natural fluorescence in the upper panels. The analysis is after gating PI negative cells (live cells). The specific excitation laser and optical filter for emission measurements was as follows [excitation laser in nm and filters stated as long pass (LP) and band pass (BP)]: 488nm for FSC and SSC, 488nm(550LP 575/25BP)- PE, 405nm(450/50BP)-Pacific Blue, 633nm(660/20BP)-APC, 633nm(690LP 710/50BP)-APC-Cy5.5. Nomenclature based on <sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup>. Experiment was performed three times. Scale bar 20 &#x3BC;m. <bold>c,</bold> Sorting panels of 34 cell populations using: FSC, SSC (central panel), CD49d, CD57, Concanavalin-A (ConA), BHF and AP, after gating PI negative cells (live cells). Central panel is FCS/SSC from which additional populations were differentiated. The specific excitation laser and optical filter for emission measurements was as follows [excitation laser in nm and filters stated as long pass (LP) and band pass (BP)]: 488nm(505LP 530/30BP)- AP, 488nm(755LP 780/60BP)- CD49d, 405nm(450/50BP)- CD57, 633nm(660/20BP)-ConA,633nm(755LP 780/60BP)-BHF.<bold>d,</bold> Hierarchy of sorted cell populations by main parameters of differentiation. For example, the control populations used in <xref rid="F2" ref-type="fig">Fig. 2b-e</xref>, CP19, 20, 21 are all included in CP18. CP18 is derived from CP9.<bold>e,</bold> H&amp;E staining of the end point cell populations isolated in a rectangle of original population by FSC/SSC. Live imaging was done three times, H&amp;E one experiment with 3 replicates. Color key (reflected in subparts <bold>c-d</bold>) for different populations identified in this study and the figures that further describe them.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0005"/>
      </fig>
      <fig id="F6" orientation="portrait" position="anchor">
        <label>Extended Data Figure 2</label>
        <caption>
          <title>Screen for differentiation markers of cell populations for FACS based sorting.</title>
          <p id="P51"><bold>a-b</bold>, Examples of screened antibodies by CyTOF Mass cytometry with <italic>B. schlosseri</italic> cells analyzed by two dimensional mass spectrometry. CyTof Screen was performed once. <bold>a,</bold> Examples of antibodies considered as nonspecific binders due to the same binding patterns by different antibodies. <bold>b</bold>, Examples of antibodies considered as specific binders due to the cell population that is bound by one antibody but not the other (red rectangle). <bold>c-d</bold>, Examples of validation screen by flow cytometry of antibodies with specific binding by CyTOF, done in two dimensional fluorescence excited by the same laser due to autofluorescence. FACS validation for negative was done twice and positive three times. <bold>c</bold>, Negative validation of CCR2 labeled with PE. <bold>d</bold>, Positive validation of CD57 labeled with Pacific Blue. <bold>e,</bold> Flow cytometry of live <italic>B. schlosseri</italic> cells labeled with anti-BHF mouse serum. Each mouse serum independent serum collection was checked. Anti-mouse Alexa Fluor-647 was used as a secondary antibody. <bold>f,</bold> Example of positive differential labeling by the lectin Concanavalin-A in PE-Cy7 by FACS. Experiment was performed three times. <bold>g</bold>, Confocal imagery of membrane Concanavalin-A labeling in Alexa Fluor-633 in red and Hoechst DNA labeling in blue. Experiment was performed once. Scale bar 20 &#x3BC;m.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0006"/>
      </fig>
      <fig id="F7" orientation="portrait" position="anchor">
        <label>Extended Data Figure 3</label>
        <caption>
          <title><italic>B. schlosseri</italic> cell population clustering based on transcriptome analysis</title>
          <p id="P52"><bold>a</bold>, 250 genes with the largest weights in the first 11 principal components (explaining 90% of the variance in mean-adjusted log-transformed gene counts) were used to cluster the different cell populations in a heatmap. <bold>b,</bold> Transcriptome sequencing of <italic>B. schlosseri</italic> cell populations compared to FACS analysis. 2D projection of the distances between transcriptomes of cell populations based on all differential genes. Lines are drawn between the nearest two neighbors. Blue: corresponds to the FACS adjacency of the populations in the differentiation panel, in red: genetic level proximity that is not predicted by FACS panel adjacency. 20/30 genetic level cellular populations&#x2019; proximity were predicted by FACS. Width of lines is inversely proportional to the distances.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0007"/>
      </fig>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Figure 4</label>
        <caption>
          <title>Gene expression of <italic>B. schlosseri</italic> cell populations.</title>
          <p id="P53"><bold>a</bold>, Enrichment scores of the top nine systems (left), nine tissues (center), and ten cell types (right) of annotated genes up-regulated in CP33, 34 and 25 using the GeneAnalytics tool compared to human. In systems the hematopoietic system is the highest score, in tissues the blood is the highest score, and within the cells, the granulocytes and HSC have the highest scores. <bold>b-d,</bold> Geneset Activity Analyses using the Gene Expression Commons tool on a mouse hematopoiesis model of different <italic>B. schlosseri</italic> cell populations. <bold>b</bold>, Analysis of CP8 (pigment cells) based on 12 significantly upregulated genes, showing that CP8 is part of the hematopoietic system with gene activity resembling known cell type. <bold>c</bold>, Analysis of CP3 (small cells) based on 235 significantly upregulated genes, showing that this population is significantly not part of the hematopoietic system. On the bottom: enrichment scores of the top ten tissues using CP3 genes by GeneAnalytics tool compared to human, the highest score is the testis suggesting this population is a gonadal population. <bold>d</bold>, Analysis of CP19 (enriched with morula cells) based on 96 upregulated genes (p&lt;0.25), showing that CP19 has gene activity as cells in the lymphoid lineage using Geneset analysis.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0008"/>
      </fig>
      <fig id="F9" orientation="portrait" position="anchor">
        <label>Extended Data Figure 5</label>
        <caption>
          <title>Subendostylar sinuses as an HSC niche.</title>
          <p id="P54"><bold>a,</bold> Reduction in DiO fluorescence suggesting cell proliferation, three weeks after transplantation. Experiment was performed once with two pools for each population from 5 animals each. <bold>b</bold>, Candidate HSC (cHSC) population and a control population (CP3) were isolated, labeled with DiD and transplanted into CFSE labeled compatible colonies, <italic>in-vivo</italic> tracing of transplanted cells migration was used to identify niches. There were no cells detected for CP3 (0/4) or the un-injected colonies (0/4) in the subendostylar sinus, whereas 5/6 colonies were positive to cHSC cells, showing significant localization of the cHSC to the subendostylar sinus;; P=0.048 Fisher&#x2019;s exact test, two tailed. Although in the cell islands 4/4 were positive with CP3, 5/6 positive to cHSC, and 2/4 positive in the un-injected colonies, there are high levels of auto-fluorescent cells in the cell islands. Full images panels of <xref rid="F2" ref-type="fig">figure 2g</xref>. <bold>c</bold>, Transverse sections of an adult zooid counterstained with toluidine blue (top two left) where endostyle (green arrow) and endo-niche (blue arrow) are enlarged (Scale bar: 30 &#x3BC;m). Electron microscopy section of the same animal endostyle and endo-niche (right and bottom enlarged). Yellow arrowheads indicate cells with hemoblast (HSC) morphology that are enriched within the endo-niche (Scale bar: 5 &#x3BC;m). Experiment was performed three times. Full images panels of <xref rid="F2" ref-type="fig">figure 2b</xref>. <bold>d</bold>, Immunohistochemistry with antibodies to Phospho-Histone H3, suggesting mitotic cells in the endostyle region in the developing primary bud and also in the adult zooid endostyle.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0009"/>
      </fig>
      <fig id="F10" orientation="portrait" position="anchor">
        <label>Extended Data Figure 6</label>
        <caption>
          <title>Gene expression of an HSC niche - the endostyle.</title>
          <p id="P55"><bold>a</bold>, comparison between the transcriptome sequence data from ten samples of dissected endostyles and the transcriptome of 34 whole colonies revealed a list of 327 genes that were significantly upregulated in the endostyle with homology to genes expressed in human hematopoietic bone marrow, heatmap of the top 100 (by logFC) of the bone marrow-associated endostyle genes is presented. <bold>b,</bold> Geneset Activity Analysis of top 200 genes upregulated in the <italic>B. schlosseri</italic> endostyle associated with the blood system, found by RNAseq (this study) using the Gene Expression Commons tool on a mouse hematopoiesis model. The enriched populations are bone marrow stromal cells and HSCs <bold>c</bold>, Similar analysis, but for <italic>Ciona robusta</italic> based on previous <italic>in-situ</italic> work<sup><xref rid="R21" ref-type="bibr">21</xref></sup> revealed enriched mouse bone marrow stromal cells as well, based on 188 genes that are expressed in <italic>C. robusta</italic> endostyle and are associate with the blood system.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0010"/>
      </fig>
      <fig id="F11" orientation="portrait" position="anchor">
        <label>Extended Data Figure 7</label>
        <caption>
          <title>Discovery of a Myeloid Lineage Phagocytic Population.</title>
          <p id="P56"><bold>a,</bold> FACS analysis of <italic>B. schlosseri</italic> cells that are fluorescently positive in one of three phagocytosis assays performed: (first and second) phagocytosis of green fluorescent beads, (third) phagocytosis of <italic>Vibrio diazotrophicus</italic> labeled with AF647, and (fourth) allogeneic phagocytosis. Three phagocytic populations were identified: amoebocytes (A), myeloid cells (M), and large phagocytes (LP). Experiment was repeated twice. The myeloid cells were the main contributors to phagocytosis, as evident by &gt;40% contribution to each of the phagocytosis assays. The large phagocytes contribute mainly to allogeneic phagocytosis compared to other assays. <bold>b,</bold> Live images of the three isolated phagocytic populations. Experiment was performed three times, scale bar 20 &#x3BC;m. <bold>c,</bold> We isolated the three main phagocytic populations and a small cell population (CP3) as a control, and incubated each one with fluorescent beads to validate engulfment capacity of each population. Experiment was repeated twice. FACS analysis of green fluorescent beads phagocytosis of sorted populations are shown. <bold>d,</bold> Amoebocytes, myeloid cells, and large phagocytes all had significantly higher engulfment rates than the small cell population. Moreover, amoebocytes, myeloid cells had significantly higher cell percentages than the large phagocyte population. Two samples of each sorted populations&#x2019; percentage analysis. Unpaired T-test, two-tailed *P&lt;0.05, Mean. <bold>e,</bold> Representative confocal images of the three phagocytic populations after engulfment of beads. Scale bar 20 &#x3BC;m. <bold>f,</bold> ImageStream analysis confirmed that the three phagocytic populations assayed engulfed the beads. The positive cells have mainly morphology of: amoebocytes, myeloid cells, and large phagocytes. Experiment was performed once on ImageStream. Representative images of the three phagocytic populations after engulfment of beads. Scale bar 7 &#x3BC;m.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0011"/>
      </fig>
      <fig id="F12" orientation="portrait" position="anchor">
        <label>Extended Data Figure 8</label>
        <caption>
          <title>Cytotoxicity and the two morphs of morula cells (MC) at point of rejection (POR).</title>
          <p id="P57"><bold>a,</bold> Cytotoxicity assays of isolated LGL cells compared to small cells, and to isolated MC. In both cases the LGL cells had significantly higher cytotoxicity compared to the other cell types. The experiment with isolated cells was performed twice with triplicates. Unpaired T-test, two-tailed *P=0.003, **P=0.0013, Mean. <bold>b,</bold> LGL cells were isolated (upper left) and incubated overnight either in syngeneic (upper right) or in allogeneic challenge (lower left). FSC/ SSC analysis of LGL cell (lower population) and MC (upper population). Small caption of light microscopy pictures of cells after the incubation. (Lower right) Analysis of LGL and morula cells in syngeneic compare to allogeneic challenge. Experiment was performed once with duplicates and validated by light microscopy. Mean. <bold>c,</bold> An H&amp;E section of <italic>B. schlosseri</italic> colonies undergoing rejection. In the ampule (AMP) the inactivated form of cytotoxic MC/ large granular lymphocytes like cells (LGL) can be observed (left). On the other hand the activated form with the brown pigmentation of MC can be observed at POR (right). <bold>d,</bold> Confocal imagery of phagocytosis assays to validate the allogeneic engulfment. In the panels colony labeled with CFSE in green and colony labeled with DiD in red after allogeneic phagocytosis assay. Large phagocytic cells can be seen after engulfment of allogeneic cells or vesicles. Experiment of allogeneic phagocytosis validation by confocal imaging was performed twice. Scale bar 20 &#x3BC;m, <bold>e,</bold> Example of cytotoxicity assay in different Effector to Target ratios (E:T), where the targets are compatible or rejecting colony cells to the effector colony. In the rejecting colony, specific lysis is significantly higher. The experiment was performed three times with triplicates. ANOVA two-factor with replication, *P=0.0015, Mean, SD.</p>
        </caption>
        <graphic xlink:href="nihms-1509772-f0012"/>
      </fig>
      <table-wrap id="T1" position="anchor" orientation="portrait">
        <label>Extended data Table 1</label>
        <caption>
          <title>Screened antibodies by CyTOF for binding of <italic>B. schlosseri</italic> cells.</title>
          <p id="P58">A screen of 49 antibodies that would cross-react with <italic>B. schlosseri</italic> cells and could potentially differentiate cellular populations. Symbol: represents the element, mass: is the elemental isotope mass, antigen: is the human antigen against which the antibody was produced, antibody clone, and antibody supplier. CyTOF column represents whether the <italic>B. schlosseri</italic> cell population was positive or not, low means less than 1% of cells were positive. FACS column represents whether there was binding by the same antibody clone by flow cytometry.</p>
        </caption>
        <table frame="box" rules="all">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" valign="top" rowspan="1" colspan="1">Symbol</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Mass</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Panel1<break/>antigen</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Clone</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Supplier</th>
              <th align="left" valign="top" rowspan="1" colspan="1">CyTOF</th>
              <th align="left" valign="top" rowspan="1" colspan="1">FACS</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Panel2<break/>antigen</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Clone</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Supplier</th>
              <th align="left" valign="top" rowspan="1" colspan="1">CyTOF</th>
              <th align="left" valign="top" rowspan="1" colspan="1">FACS</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Pd/Cd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>110&#x2013;114</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">S4.1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Invitrogen</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">In</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>113</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">M-T701</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">In</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>115</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD45</td>
              <td align="left" valign="top" rowspan="1" colspan="1">HI30</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">La</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>139</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD57</td>
              <td align="left" valign="top" rowspan="1" colspan="1">HCD57</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (low)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (~14%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">RPA-2.10</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (low)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Pr</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>141</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">NKp46</td>
              <td align="left" valign="top" rowspan="1" colspan="1">195314</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D system</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD61</td>
              <td align="left" valign="top" rowspan="1" colspan="1">VI-PL2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Nd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>142</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD48</td>
              <td align="left" valign="top" rowspan="1" colspan="1">TU145</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Nd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>144</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CCR5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">HEK/l/85a</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD94</td>
              <td align="left" valign="top" rowspan="1" colspan="1">DX22</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (low)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Nd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>145</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">LILRB1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">292319</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Nd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>146</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD309</td>
              <td align="left" valign="top" rowspan="1" colspan="1">89106</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Sm</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>147</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD8</td>
              <td align="left" valign="top" rowspan="1" colspan="1">RPA-T8</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Nd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>148</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">KIR3DL1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">DX9</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CRTAM</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Cr24.1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Sm</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>149</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">DNAM1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">DX11</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Eu</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>151</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">NKG2D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1D11</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD84</td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD84.1.21</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Sm</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>152</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">TNFR2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">22235</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Eu</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>153</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">NKG2C</td>
              <td align="left" valign="top" rowspan="1" colspan="1">134522</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (low)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Sm</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>154</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">NKp44</td>
              <td align="left" valign="top" rowspan="1" colspan="1">P44&#x2013;8</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">Notchl</td>
              <td align="left" valign="top" rowspan="1" colspan="1">MHN1&#x2013;519</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Gd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>155</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CRACC</td>
              <td align="left" valign="top" rowspan="1" colspan="1">162.1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Gd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>156</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">KIR2DL3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">180701</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Gd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>158</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD161</td>
              <td align="left" valign="top" rowspan="1" colspan="1">HP-3G10</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">clecl2A</td>
              <td align="left" valign="top" rowspan="1" colspan="1">50C1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Tb</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>159</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CDllc</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Bul5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Gd</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>160</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">NKp30</td>
              <td align="left" valign="top" rowspan="1" colspan="1">210845</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">2B4</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Cl.7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Beckman</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Dy</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>161</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD15</td>
              <td align="left" valign="top" rowspan="1" colspan="1">W6D3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD4</td>
              <td align="left" valign="top" rowspan="1" colspan="1">RPA-T4</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Dy</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>162</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD49d</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9F10</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (~28%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Dy</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>163</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD16</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3G8</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">KIR2DLS1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">EB6.B</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Beckman</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Er</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>166</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">TIGIT</td>
              <td align="left" valign="top" rowspan="1" colspan="1">M BSA43</td>
              <td align="left" valign="top" rowspan="1" colspan="1">eBioscience</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">KIR3DL2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">DX31</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Gift from Dr. Lanier</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Er</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>167</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD27</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0323</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CCR7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">G043H7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Er</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>168</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">KIR2DL1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">143211</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CCR2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">48607</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Er</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>170</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CDlla</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Hllll</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CDllbact</td>
              <td align="left" valign="top" rowspan="1" colspan="1">CBRM1/5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Yb</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>172</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">KIR2DL4</td>
              <td align="left" valign="top" rowspan="1" colspan="1">181703</td>
              <td align="left" valign="top" rowspan="1" colspan="1">R&amp;D</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD34</td>
              <td align="left" valign="top" rowspan="1" colspan="1">8G12</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (low)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Yb</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>173</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD33</td>
              <td align="left" valign="top" rowspan="1" colspan="1">WM53</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Yb</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>174</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">CD 144</td>
              <td align="left" valign="top" rowspan="1" colspan="1">TEA1/31</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Beckman</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">NKG2A</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Z199</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Beckman</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Lu</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>175</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">KLRG1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13F12F2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">ThermoFisher</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Yb</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>176</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">CD56</td>
              <td align="left" valign="top" rowspan="1" colspan="1">NCAM16.2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">BD</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Yes (low)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Ir</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>191/193</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">DNA</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">Sigma</td>
              <td align="left" valign="top" rowspan="1" colspan="1">All cells</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">DNA</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">Sigma</td>
              <td align="left" valign="top" rowspan="1" colspan="1">All cells</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Pt</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>195</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">cisplatin</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">Sigma</td>
              <td align="left" valign="top" rowspan="1" colspan="1">No</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1">Sigma</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T2" position="anchor" orientation="portrait">
        <label>Extended data Table 2</label>
        <caption>
          <title>Flow cytometry binding of <italic>B. schlosseri</italic> cells, and references the phagocytic and cytotoxic cells in different organisms for <xref rid="F4" ref-type="fig">Fig 4</xref>.</title>
          <p id="P59"><bold>a,</bold> The column &#x201C;% positive cells&#x201D; is the percentage of the cells that were positively labeled by the marker. For Alkaline Phosphatase (AP), &#x201C;high&#x201D; _represents cells that labeled strongly and &#x201C;mid&#x201D;- cells that are positively labeled but not high. <bold>b,</bold> Rows contain references and any notes for each of the organisms reviewed in the production of <xref rid="F4" ref-type="fig">Fig 4</xref>.</p>
        </caption>
        <table frame="box" rules="all">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>a</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>Lectin</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>Fluorophore</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>% positive cells</bold>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">ConA</td>
              <td align="left" valign="top" rowspan="1" colspan="1">AF-633</td>
              <td align="left" valign="top" rowspan="1" colspan="1">45%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">PNA</td>
              <td align="left" valign="top" rowspan="1" colspan="1">PE-Cy7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">16%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">UEA</td>
              <td align="left" valign="top" rowspan="1" colspan="1">PE-Cy7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">30%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>Additional markers</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Alkaline Phosphatase</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Green</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9% high 25% mid</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Anti-BHF polyclonal</td>
              <td align="left" valign="top" rowspan="1" colspan="1">AF-647</td>
              <td align="left" valign="top" rowspan="1" colspan="1">35%</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>b</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>Animal:</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>Phagocytic cells</bold>
              </td>
              <td align="left" valign="top" rowspan="1" colspan="1">
                <bold>Cytotoxic cells</bold>
              </td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Homo</italic> (human)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Myeloid lineage review<sup><xref rid="R52" ref-type="bibr">52</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Review<sup><xref rid="R53" ref-type="bibr">53</xref></sup></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Danio</italic> (zebrafish)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Myeloid lineage review<sup><xref rid="R54" ref-type="bibr">54</xref></sup>, phagocytosis<sup><xref rid="R55" ref-type="bibr">55</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Recognition molecules<sup><xref rid="R56" ref-type="bibr">56</xref></sup>, cytotoxity<sup><xref rid="R55" ref-type="bibr">55</xref></sup>, cell types<sup><xref rid="R57" ref-type="bibr">57</xref></sup></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Petromyzon</italic> (lamprey)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Myeloid lineage<sup><xref rid="R58" ref-type="bibr">58</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Lymphoid lineage review<sup><xref rid="R59" ref-type="bibr">59</xref></sup>(cytotoxity was not shown)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Branchiostoma</italic> (lancelet)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Large phagocytes<sup><xref rid="R60" ref-type="bibr">60</xref></sup>, some suggestion of amoebocytes<sup><xref rid="R61" ref-type="bibr">61</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Strongylocentrotus</italic> (sea urchin)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Phagocytic cells review<sup><xref rid="R32" ref-type="bibr">32</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Suggestion that colorless spherule cells are cytotoxic morula cells in review<sup><xref rid="R32" ref-type="bibr">32</xref></sup></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Drosophila</italic>(fruit fly)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Amoebocytes<sup><xref rid="R62" ref-type="bibr">62</xref></sup>, plasmatocytes or pupal macrophage-like have resemblance to the large phagocytes<sup><xref rid="R63" ref-type="bibr">63</xref></sup><sup>,</sup><sup><xref rid="R64" ref-type="bibr">64</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Crystal cells that contain the enzymes for melanization for cytotoxcity could resemble the morula cells at the enzymatc level<sup><xref rid="R63" ref-type="bibr">63</xref></sup><sup>,</sup><sup><xref rid="R64" ref-type="bibr">64</xref></sup></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Limulus</italic>(horseshoe crab)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Amoebocytes and granular phagocytes in review<sup><xref rid="R33" ref-type="bibr">33</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Cells with prophenoloxidase and melanization process in review<sup><xref rid="R33" ref-type="bibr">33</xref></sup><sup><xref rid="R34" ref-type="bibr">34</xref></sup></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>Tridacna</italic>(clam)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Amoebocytes and eosinophilic granular hemocytes that resemble large phagocytes<sup><xref rid="R65" ref-type="bibr">65</xref></sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">Morulla cells<sup><xref rid="R65" ref-type="bibr">65</xref></sup></td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="supplementary-material" id="SM1">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>1</label>
        <media xlink:href="NIHMS1509772-supplement-1.docx" orientation="portrait" xlink:type="simple" id="d36e2683" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD10">
        <label>video 3</label>
        <media xlink:href="NIHMS1509772-supplement-video_3.mp4" orientation="portrait" xlink:type="simple" id="d36e2687" position="anchor" mimetype="video"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>Reporting Summary</label>
        <media xlink:href="NIHMS1509772-supplement-Reporting_Summary.pdf" orientation="portrait" xlink:type="simple" id="d36e2691" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <label>Table S1</label>
        <media xlink:href="NIHMS1509772-supplement-Table_S1.csv" orientation="portrait" xlink:type="simple" id="d36e2695" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD4">
        <label>Table S2</label>
        <media xlink:href="NIHMS1509772-supplement-Table_S2.xlsx" orientation="portrait" xlink:type="simple" id="d36e2699" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD5">
        <label>Table S3</label>
        <media xlink:href="NIHMS1509772-supplement-Table_S3.xlsx" orientation="portrait" xlink:type="simple" id="d36e2703" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD6">
        <label>Table S4</label>
        <media xlink:href="NIHMS1509772-supplement-Table_S4.xlsx" orientation="portrait" xlink:type="simple" id="d36e2707" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD7">
        <label>Table S5</label>
        <media xlink:href="NIHMS1509772-supplement-Table_S5.xlsx" orientation="portrait" xlink:type="simple" id="d36e2711" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD8">
        <label>video 1</label>
        <media xlink:href="NIHMS1509772-supplement-video_1.mp4" orientation="portrait" xlink:type="simple" id="d36e2715" position="anchor" mimetype="video"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD9">
        <label>video 2</label>
        <media xlink:href="NIHMS1509772-supplement-video_2.mp4" orientation="portrait" xlink:type="simple" id="d36e2719" position="anchor" mimetype="video"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S20">
      <title>Acknowledgments</title>
      <p id="P60">The authors would like to thank Chris Lowe, Chiara Anselmi, Ivan Dimov, Seth Karten, Chris Patton, Judy Thompson, Patty Lovelace, Ronnie Voskoboynik, Nathaniel Fernhoff, Wan-Jin Lu, Pauline Chu, Kipp Weiskopf, Matan Oren, John Lee, Barbara Compton, Kevin Uhlinger, Tejaswitha Naik, and Terry Storm for invaluable technical advice and help. This study was supported by NIH grants R56AI089968, R01AG037968 and RO1GM100315 (to I.L.W., S.R.Q., and A.V.). The Virginia and D. K. Ludwig Fund for Cancer Research, a grant from the Siebel Stem Cell Institute and Stinehart-Reed grant (to I.L.W.). L.M. was supported by PRIN - Prot. 2015NSFHXF. B.R. was supported by the Postdoctoral Fellowship of the Human Frontier Science Program Organization LT000591/2014-L, the NIH Immunology training grant 5T32AI07290&#x2013;28 and the NIH Hematology training grant T32 HL120824&#x2013;03.</p>
    </ack>
    <fn-group>
      <fn id="FN3">
        <p id="P61">Sequencing Data</p>
        <p id="P62">Sequencing data can be found on the NCBI Sequence Read Archive under accession PRJNA414486.</p>
      </fn>
      <fn id="FN4">
        <p id="P63"><bold>Data availability:</bold> Sequencing data can be found on the NCBI Sequence Read Archive under accession PRJNA414486. RPKM values of gene expression and differential expression analysis results are in Supplementary Table 1. All other relevant data are available in the manuscript.</p>
      </fn>
      <fn fn-type="COI-statement" id="FN5">
        <p id="P64">Competing interests</p>
        <p id="P65">The authors declare no competing interests.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>Stem cells: units of development, units of regeneration, and units in evolution</article-title>. <source>Cell</source>
<volume>100</volume>, <fpage>157</fpage>&#x2013;<lpage>168</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">10647940</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><name><surname>Sabbadin</surname><given-names>A</given-names></name>
<article-title>Le basi genetiche della capacita di fusione fra colonies in Botryllus schlosseri (Ascidiacea)</article-title>. <source>Rend Accad Naz Lincei Ser</source>
<volume>8</volume>
<issue>32</issue>, <fpage>1031</fpage>&#x2013;<lpage>1035</lpage> (<year>1962</year>).</mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><name><surname>Scofield</surname><given-names>VL</given-names></name>, <name><surname>Schlumpberger</surname><given-names>JM</given-names></name>, <name><surname>West</surname><given-names>LA</given-names></name> &amp; <name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>Protochordate allorecognition is controlled by a MHC-like gene system</article-title>. <source>Nature</source>
<volume>295</volume>, <fpage>499</fpage>&#x2013;<lpage>502</lpage> (<year>1982</year>).<pub-id pub-id-type="pmid">7057909</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><name><surname>Stoner</surname><given-names>DS</given-names></name>, <name><surname>Rinkevich</surname><given-names>B</given-names></name> &amp; <name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>Heritable germ and somatic cell lineage competitions in chimeric colonial protochordates</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>96</volume>, <fpage>9148</fpage>&#x2013;<lpage>9153</lpage> (<year>1999</year>).<pub-id pub-id-type="pmid">10430910</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><name><surname>Laird</surname><given-names>DJ</given-names></name>, <name><surname>De Tomaso</surname><given-names>AW</given-names></name> &amp; <name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>Stem cells are units of natural selection in a colonial ascidian</article-title>. <source>Cell</source>
<volume>123</volume>, <fpage>1351</fpage>&#x2013;<lpage>1360</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16377573</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><name><surname>Voskoboynik</surname><given-names>A</given-names></name>
<etal/>
<article-title>Identification of the endostyle as a stem cell niche in a colonial chordate</article-title>. <source>Cell Stem Cell</source>
<volume>3</volume>, <fpage>456</fpage>&#x2013;<lpage>464</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18940736</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><name><surname>Voskoboynik</surname><given-names>A</given-names></name>
<etal/>
<article-title>Identification of a colonial chordate histocompatibility gene</article-title>. <source>Science</source>
<volume>341</volume>, <fpage>384</fpage>&#x2013;<lpage>387</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23888037</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><name><surname>Corey</surname><given-names>DM</given-names></name>
<etal/>
<article-title>Developmental cell death programs license cytotoxic cells to eliminate histocompatible partners</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>113</volume>, <fpage>6520</fpage>&#x2013;<lpage>6525</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27217570</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><name><surname>Darwin</surname><given-names>C</given-names></name>
<source>On the origin of the species by natural selection</source>. (<year>1859</year>).</mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><name><surname>Delsuc</surname><given-names>F</given-names></name>, <name><surname>Brinkmann</surname><given-names>H</given-names></name>, <name><surname>Chourrout</surname><given-names>D</given-names></name> &amp; <name><surname>Philippe</surname><given-names>H</given-names></name>
<article-title>Tunicates and not cephalochordates are the closest living relatives of vertebrates</article-title>. <source>Nature</source>
<volume>439</volume>, <fpage>965</fpage>&#x2013;<lpage>968</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16495997</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><name><surname>Voskoboynik</surname><given-names>A</given-names></name>
<etal/>
<article-title>The genome sequence of the colonial chordate, Botryllus schlosseri</article-title>. <source>elife</source>
<volume>2</volume>, <fpage>e00569</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23840927</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><name><surname>Lauzon</surname><given-names>RJ</given-names></name>, <name><surname>Patton</surname><given-names>CW</given-names></name> &amp; <name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>A morphological and immunohistochemical study of programmed cell death in Botryllus schlosseri (Tunicata, Ascidiacea)</article-title>. <source>Cell Tissue Res</source>. <volume>272</volume>, <fpage>115</fpage>&#x2013;<lpage>127</lpage> (<year>1993</year>).<pub-id pub-id-type="pmid">8386984</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><name><surname>Hulett</surname><given-names>HR</given-names></name>, <name><surname>Bonner</surname><given-names>WA</given-names></name>, <name><surname>Barrett</surname><given-names>J</given-names></name> &amp; <name><surname>Herzenberg</surname><given-names>LA</given-names></name>
<article-title>Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence</article-title>. <source>Science</source>
<volume>166</volume>, <fpage>747</fpage>&#x2013;<lpage>749</lpage> (<year>1969</year>).<pub-id pub-id-type="pmid">4898615</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><name><surname>Ben-Ari Fuchs</surname><given-names>S</given-names></name>
<etal/>
<article-title>Geneanalytics: an integrative gene set analysis tool for next generation sequencing, rnaseq and microarray data</article-title>. <source>OMICS</source>
<volume>20</volume>, <fpage>139</fpage>&#x2013;<lpage>151</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26983021</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><name><surname>Seita</surname><given-names>J</given-names></name>
<etal/>
<article-title>Gene Expression Commons: an open platform for absolute gene expression profiling</article-title>. <source>PLoS ONE</source>
<volume>7</volume>, <fpage>e40321</fpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22815738</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><name><surname>Rinkevich</surname><given-names>Y</given-names></name>
<etal/>
<article-title>Repeated, long-term cycling of putative stem cells between niches in a basal chordate</article-title>. <source>Dev. Cell</source>
<volume>24</volume>, <fpage>76</fpage>&#x2013;<lpage>88</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23260626</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><name><surname>Ermak</surname><given-names>TH</given-names></name>
<article-title>The hematogenic tissues of tunicates</article-title>. <source>Phylogeny of thymus and bone marrow-bursa cells</source> (<year>1976</year>).</mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><name><surname>Adams</surname><given-names>GB</given-names></name>
<etal/>
<article-title>Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor</article-title>. <source>Nature</source>
<volume>439</volume>, <fpage>599</fpage>&#x2013;<lpage>603</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16382241</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><name><surname>Yusuf</surname><given-names>RZ</given-names></name> &amp; <name><surname>Scadden</surname><given-names>DT</given-names></name>
<article-title>Homing of hematopoietic cells to the bone marrow</article-title>. <source>J. Vis. Exp</source>. (<year>2009</year>). doi:<pub-id pub-id-type="doi">10.3791/1104</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><name><surname>Wright</surname><given-names>DE</given-names></name>, <name><surname>Wagers</surname><given-names>AJ</given-names></name>, <name><surname>Gulati</surname><given-names>AP</given-names></name>, <name><surname>Johnson</surname><given-names>FL</given-names></name> &amp; <name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>Physiological migration of hematopoietic stem and progenitor cells</article-title>. <source>Science</source>
<volume>294</volume>, <fpage>1933</fpage>&#x2013;<lpage>1936</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11729320</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><name><surname>Ogasawara</surname><given-names>M</given-names></name>
<etal/>
<article-title>Gene expression profiles in young adult Ciona intestinalis</article-title>. <source>Dev. Genes Evol</source>. <volume>212</volume>, <fpage>173</fpage>&#x2013;<lpage>185</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12012232</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><name><surname>Ca&#xF1;estro</surname><given-names>C</given-names></name>, <name><surname>Bassham</surname><given-names>S</given-names></name> &amp; <name><surname>Postlethwait</surname><given-names>JH</given-names></name>
<article-title>Evolution of the thyroid: anterior-posterior regionalization of the Oikopleura endostyle revealed by Otx, Pax2/5/8, and Hox1 expression</article-title>. <source>Dev. Dyn</source>. <volume>237</volume>, <fpage>1490</fpage>&#x2013;<lpage>1499</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18386819</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><name><surname>Burighel</surname><given-names>P</given-names></name> &amp; <name><surname>Cloney</surname><given-names>RA</given-names></name> in <source>Microscopic anatomy of invertebrates</source> (eds. <name><surname>Harrison</surname><given-names>FW</given-names></name> &amp; <name><surname>Ruppert</surname><given-names>EE</given-names></name>) <fpage>221</fpage>&#x2013;<lpage>347</lpage> (<year>1997</year>).</mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><name><surname>Ogasawara</surname><given-names>M</given-names></name>, <name><surname>Lauro</surname><given-names>RD</given-names></name> &amp; <name><surname>Satoh</surname><given-names>N</given-names></name>
<article-title>Ascidian homologs of mammalian thyroid transcription factor-1 gene are expressed in the endostyle</article-title>. <source>Zoological science</source> (<year>1999</year>).</mixed-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>JY</given-names></name>
<etal/>
<article-title>Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche</article-title>. <source>Nature</source>
<volume>530</volume>, <fpage>223</fpage>&#x2013;<lpage>227</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26863982</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><name><surname>Ballarin</surname><given-names>L</given-names></name> &amp; <name><surname>Cima</surname><given-names>F</given-names></name>
<article-title>Cytochemical properties of Botryllus schlosseri haemocytes: indications for morpho-functional characterisation</article-title>. <source>European journal of histochemistry: EJH</source> (<year>2005</year>).</mixed-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><name><surname>Lauzon</surname><given-names>RJ</given-names></name>, <name><surname>Brown</surname><given-names>C</given-names></name>, <name><surname>Kerr</surname><given-names>L</given-names></name> &amp; <name><surname>Tiozzo</surname><given-names>S</given-names></name>
<article-title>Phagocyte dynamics in a highly regenerative urochordate: insights into development and host defense</article-title>. <source>Dev. Biol</source>. <volume>374</volume>, <fpage>357</fpage>&#x2013;<lpage>373</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23174529</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><name><surname>Franchi</surname><given-names>N</given-names></name> &amp; <name><surname>Ballarin</surname><given-names>L</given-names></name>
<article-title>Immunity in protochordates: the tunicate perspective</article-title>. <source>Front. Immunol</source>. <volume>8</volume>, <fpage>674</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28649250</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><name><surname>Oren</surname><given-names>M</given-names></name>
<etal/>
<article-title>Marine invertebrates cross phyla comparisons reveal highly conserved immune machinery</article-title>. <source>Immunobiology</source>
<volume>218</volume>, <fpage>484</fpage>&#x2013;<lpage>495</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">22884351</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><name><surname>Timonen</surname><given-names>T</given-names></name>, <name><surname>Ortaldo</surname><given-names>JR</given-names></name> &amp; <name><surname>Herberman</surname><given-names>RB</given-names></name>
<article-title>Characteristics of human large granular lymphocytes and relationship to natural killer and K cells</article-title>. <source>J. Exp. Med</source>. <volume>153</volume>, <fpage>569</fpage>&#x2013;<lpage>582</lpage> (<year>1981</year>).<pub-id pub-id-type="pmid">6166701</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><name><surname>Ljunggren</surname><given-names>HG</given-names></name> &amp; <name><surname>K&#xE4;rre</surname><given-names>K</given-names></name>
<article-title>In search of the &#x201C;missing self&#x201D;: MHC molecules and NK cell recognition</article-title>. <source>Immunol. Today</source>
<volume>11</volume>, <fpage>237</fpage>&#x2013;<lpage>244</lpage> (<year>1990</year>).<pub-id pub-id-type="pmid">2201309</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <mixed-citation publication-type="book"><name><surname>Smith</surname><given-names>LC</given-names></name>, <name><surname>Ghosh</surname><given-names>J</given-names></name>, <name><surname>Buckley</surname><given-names>KM</given-names></name>, <name><surname>Clow</surname><given-names>LA</given-names></name> &amp; <etal/> in <source>Invertebrate Immunity</source> (ed. <name><surname>S&#xF6;derh&#xE4;ll</surname><given-names>K</given-names></name>) <fpage>260</fpage>&#x2013;<lpage>301</lpage> (<publisher-name>Springer</publisher-name>, <year>2010</year>).</mixed-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <mixed-citation publication-type="book"><name><surname>Kawabata</surname><given-names>S</given-names></name> in <source>Invertebrate Immunity</source> (ed. <name><surname>S&#xF6;derh&#xE4;ll</surname><given-names>K</given-names></name>) <fpage>122</fpage>&#x2013;<lpage>136</lpage> (<publisher-name>Springer</publisher-name>, <year>2010</year>).</mixed-citation>
      </ref>
      <ref id="R34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><name><surname>Ballarin</surname><given-names>L</given-names></name>
<article-title>Ascidian cytotoxic cells: state of the art and research perspectives</article-title>. <source>Inv. Surv. J</source> (<year>2012</year>).</mixed-citation>
      </ref>
    </ref-list>
    <ref-list>
      <title>Extended References</title>
      <ref id="R35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><name><surname>Boyd</surname><given-names>HC</given-names></name>, <name><surname>Brown</surname><given-names>SK</given-names></name>, <name><surname>Harp</surname><given-names>JA</given-names></name> &amp; <etal/>
<article-title>Growth and sexual maturation of laboratory-cultured Monterey Botryllus schlosseri</article-title>. <source>Biol Bull</source>
<volume>170</volume>, <fpage>91</fpage>&#x2013;<lpage>109</lpage> (<year>1986</year>).</mixed-citation>
      </ref>
      <ref id="R36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><name><surname>Taketa</surname><given-names>DA</given-names></name> &amp; <name><surname>De Tomaso</surname><given-names>AW</given-names></name>
<article-title>Botryllus schlosseri allorecognition: tackling the enigma</article-title>. <source>Dev. Comp. Immunol</source>. <volume>48</volume>, <fpage>254</fpage>&#x2013;<lpage>265</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">24709050</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><name><surname>Bendall</surname><given-names>SC</given-names></name>
<etal/>
<article-title>Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum</article-title>. <source>Science</source>
<volume>332</volume>, <fpage>687</fpage>&#x2013;<lpage>696</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21551058</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><name><surname>Koh</surname><given-names>PW</given-names></name>
<etal/>
<article-title>An atlas of transcriptional, chromatin accessibility, and surface marker changes in human mesoderm development</article-title>. <source>Sci. Data</source>
<volume>3</volume>, <fpage>160109</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27996962</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><name><surname>Burighel</surname><given-names>P</given-names></name> &amp; <name><surname>Brunetti</surname><given-names>R</given-names></name>
<article-title>The circulatory system in the blastozooid of the colonial ascidian Botryllus schlosseri (Pallas)</article-title>. <source>Italian Journal of Zoology</source> (<year>1971</year>).</mixed-citation>
      </ref>
      <ref id="R40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><name><surname>Zaniolo</surname><given-names>G</given-names></name>, <name><surname>Lane</surname><given-names>NJ</given-names></name>, <name><surname>Burighel</surname><given-names>P</given-names></name> &amp; <name><surname>Manni</surname><given-names>L</given-names></name>
<article-title>Development of the motor nervous system in ascidians</article-title>. <source>J. Comp. Neurol</source>. <volume>443</volume>, <fpage>124</fpage>&#x2013;<lpage>135</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">11793351</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><name><surname>Edri-Brami</surname><given-names>M</given-names></name>
<etal/>
<article-title>Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells</article-title>. <source>PLoS ONE</source>
<volume>7</volume>, <fpage>e35772</fpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22666317</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><name><surname>Sabbadin</surname><given-names>A</given-names></name> &amp; <name><surname>Graziani</surname><given-names>G</given-names></name>
<article-title>Microgeographical and ecological distribution of colour morphs of Botryllus schlosseri (Ascidiacea)</article-title>. <source>Nature</source>
<volume>213</volume>, <fpage>815</fpage>&#x2013;<lpage>816</lpage> (<year>1967</year>).<pub-id pub-id-type="pmid">6031815</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><name><surname>Cima</surname><given-names>F</given-names></name>
<etal/>
<article-title>Life history and ecological genetics of the colonial ascidian Botryllus schlosseri</article-title>. <source>Zoologischer Anzeiger - A Journal of Comparative Zoology</source>
<volume>257</volume>, <fpage>54</fpage>&#x2013;<lpage>70</lpage> (<year>2015</year>).</mixed-citation>
      </ref>
      <ref id="R44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><name><surname>Laird</surname><given-names>DJ</given-names></name> &amp; <name><surname>Weissman</surname><given-names>IL</given-names></name>
<article-title>Continuous development precludes radioprotection in a colonial ascidian</article-title>. <source>Developmental &amp; Comparative Immunology</source> (<year>2004</year>).</mixed-citation>
      </ref>
      <ref id="R45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><name><surname>Braden</surname><given-names>BP</given-names></name>
<etal/>
<article-title>Vascular regeneration in a basal chordate is due to the presence of immobile, bi-functional cells</article-title>. <source>PLoS ONE</source>
<volume>9</volume>, <fpage>e95460</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24736432</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><name><surname>K&#xF6;ster</surname><given-names>J</given-names></name> &amp; <name><surname>Rahmann</surname><given-names>S</given-names></name>
<article-title>Snakemake--a scalable bioinformatics workflow engine</article-title>. <source>Bioinformatics</source>
<volume>28</volume>, <fpage>2520</fpage>&#x2013;<lpage>2522</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22908215</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><name><surname>Bolger</surname><given-names>AM</given-names></name>, <name><surname>Lohse</surname><given-names>M</given-names></name> &amp; <name><surname>Usadel</surname><given-names>B</given-names></name>
<article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>
<volume>30</volume>, <fpage>2114</fpage>&#x2013;<lpage>2120</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24695404</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><name><surname>Mago&#x10D;</surname><given-names>T</given-names></name> &amp; <name><surname>Salzberg</surname><given-names>SL</given-names></name>
<article-title>FLASH: fast length adjustment of short reads to improve genome assemblies</article-title>. <source>Bioinformatics</source>
<volume>27</volume>, <fpage>2957</fpage>&#x2013;<lpage>2963</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21903629</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><name><surname>Langmead</surname><given-names>B</given-names></name> &amp; <name><surname>Salzberg</surname><given-names>SL</given-names></name>
<article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat. Methods</source>
<volume>9</volume>, <fpage>357</fpage>&#x2013;<lpage>359</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22388286</pub-id></mixed-citation>
      </ref>
      <ref id="R50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name> &amp; <name><surname>Durbin</surname><given-names>R</given-names></name>
<article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinformatics</source>
<volume>26</volume>, <fpage>589</fpage>&#x2013;<lpage>595</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20080505</pub-id></mixed-citation>
      </ref>
      <ref id="R51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>McCarthy</surname><given-names>DJ</given-names></name> &amp; <name><surname>Smyth</surname><given-names>GK</given-names></name>
<article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>
<volume>26</volume>, <fpage>139</fpage>&#x2013;<lpage>140</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><name><surname>Wolff</surname><given-names>L</given-names></name> &amp; <name><surname>Humeniuk</surname><given-names>R</given-names></name>
<article-title>Concise review: erythroid versus myeloid lineage commitment: regulating the master regulators</article-title>. <source>Stem Cells</source>
<volume>31</volume>, <fpage>1237</fpage>&#x2013;<lpage>1244</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23559316</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><name><surname>Rosental</surname><given-names>B</given-names></name>
<etal/>
<article-title>The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells</article-title>. <source>Curr. Med. Chem</source>. <volume>19</volume>, <fpage>1780</fpage>&#x2013;<lpage>1791</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22414084</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><name><surname>Potts</surname><given-names>KS</given-names></name> &amp; <name><surname>Bowman</surname><given-names>TV</given-names></name>
<article-title>Modeling myeloid malignancies using zebrafish</article-title>. <source>Front. Oncol</source>. <volume>7</volume>, <fpage>297</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29255698</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>55.</label>
        <mixed-citation publication-type="journal"><name><surname>Moss</surname><given-names>LD</given-names></name>
<etal/>
<article-title>Identification of phagocytic cells, NK-like cytotoxic cell activity and the production of cellular exudates in the coelomic cavity of adult zebrafish</article-title>. <source>Dev. Comp. Immunol</source>. <volume>33</volume>, <fpage>1077</fpage>&#x2013;<lpage>1087</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19477195</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>56.</label>
        <mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>S</given-names></name>
<etal/>
<article-title>The zebrafish activating immune receptor Nitr9 signals via Dap12</article-title>. <source>Immunogenetics</source>
<volume>59</volume>, <fpage>813</fpage>&#x2013;<lpage>821</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17891481</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>57.</label>
        <mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>Q</given-names></name>
<etal/>
<article-title>Dissecting hematopoietic and renal cell heterogeneity in adult zebrafish at single-cell resolution using RNA sequencing</article-title>. <source>J. Exp. Med</source>. <volume>214</volume>, <fpage>2875</fpage>&#x2013;<lpage>2887</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28878000</pub-id></mixed-citation>
      </ref>
      <ref id="R58">
        <label>58.</label>
        <mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>Q</given-names></name>
<etal/>
<article-title>Characterization of Lamprey IL-17 Family Members and Their Receptors</article-title>. <source>J. Immunol</source>. <volume>195</volume>, <fpage>5440</fpage>&#x2013;<lpage>5451</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26491201</pub-id></mixed-citation>
      </ref>
      <ref id="R59">
        <label>59.</label>
        <mixed-citation publication-type="journal"><name><surname>Hirano</surname><given-names>M</given-names></name>, <name><surname>Das</surname><given-names>S</given-names></name>, <name><surname>Guo</surname><given-names>P</given-names></name> &amp; <name><surname>Cooper</surname><given-names>MD</given-names></name>
<article-title>4 The Evolution of Adaptive Immunity in Vertebrates</article-title>. <source>Advances in immunology</source> (<year>2011</year>).</mixed-citation>
      </ref>
      <ref id="R60">
        <label>60.</label>
        <mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>Y</given-names></name>, <name><surname>Huang</surname><given-names>G</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Yuan</surname><given-names>S</given-names></name> &amp; <name><surname>Liu</surname><given-names>J</given-names></name>
<article-title>The primitive immune system of amphioxus provides insights into the ancestral structure of the vertebrate immune system</article-title>. <source>Developmental &amp; &#x2026;</source> (<year>2010</year>).</mixed-citation>
      </ref>
      <ref id="R61">
        <label>61.</label>
        <mixed-citation publication-type="journal"><name><surname>Rhodes</surname><given-names>CP</given-names></name>, <name><surname>Ratcliffe</surname><given-names>NA</given-names></name> &amp; <name><surname>Rowley</surname><given-names>AF</given-names></name>
<article-title>Presence of coelomocytes in the primitive chordate amphioxus (Branchiostoma lanceolatum)</article-title>. <source>Science</source>
<volume>217</volume>, <fpage>263</fpage>&#x2013;<lpage>265</lpage> (<year>1982</year>).<pub-id pub-id-type="pmid">7089565</pub-id></mixed-citation>
      </ref>
      <ref id="R62">
        <label>62.</label>
        <mixed-citation publication-type="journal"><name><surname>Mu&#xF1;oz-Ch&#xE1;puli</surname><given-names>R</given-names></name>, <name><surname>Carmona</surname><given-names>R</given-names></name>, <name><surname>Guadix</surname><given-names>JA</given-names></name>, <name><surname>Mac&#xED;as</surname><given-names>D</given-names></name> &amp; <name><surname>P&#xE9;rez-Pomares</surname><given-names>JM</given-names></name>
<article-title>The origin of the endothelial cells: an evo-devo approach for the invertebrate/vertebrate transition of the circulatory system</article-title>. <source>Evol. Dev</source>. <volume>7</volume>, <fpage>351</fpage>&#x2013;<lpage>358</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15982372</pub-id></mixed-citation>
      </ref>
      <ref id="R63">
        <label>63.</label>
        <mixed-citation publication-type="journal"><name><surname>Lanot</surname><given-names>R</given-names></name>, <name><surname>Zachary</surname><given-names>D</given-names></name>, <name><surname>Holder</surname><given-names>F</given-names></name> &amp; <name><surname>Meister</surname><given-names>M</given-names></name>
<article-title>Postembryonic hematopoiesis in Drosophila</article-title>. <source>Dev. Biol</source>. <volume>230</volume>, <fpage>243</fpage>&#x2013;<lpage>257</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11161576</pub-id></mixed-citation>
      </ref>
      <ref id="R64">
        <label>64.</label>
        <mixed-citation publication-type="journal"><name><surname>Meister</surname><given-names>M</given-names></name> &amp; <name><surname>Lagueux</surname><given-names>M</given-names></name>
<article-title>Drosophila blood cells</article-title>. <source>Cell. Microbiol</source>. <volume>5</volume>, <fpage>573</fpage>&#x2013;<lpage>580</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12925127</pub-id></mixed-citation>
      </ref>
      <ref id="R65">
        <label>65.</label>
        <mixed-citation publication-type="journal"><name><surname>Nakayama</surname><given-names>K</given-names></name>, <name><surname>Nomoto</surname><given-names>AM</given-names></name> &amp; <name><surname>Nishijima</surname><given-names>M</given-names></name>
<article-title>Morphological and Functional Characterization of Hemocytes in the Giant ClamTridacna crocea</article-title>. <source>Journal of invertebrate</source>
<italic>&#x2026;</italic> (<year>1997</year>).</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title><bold><italic>B. schlosseri</italic></bold> Anatomy and Natural Transplantation Reactions.</title>
        <p id="P66"><bold>a</bold>, Diagram of a zooid (ventral view) and primary bud (BUD), embedded within a tunic (TUN), with vasculature (V) connected to the zooid and bud which terminates in ampullae (AMP), the zooid has a branchial sac consisting of the endostyle (END) and stigmata (S), cell islands (CI), digestive system (DS) and heart (H). <bold>b,</bold> Live imaging of a colony (dorsal view), developing buds (BUD) are connected to the parental zooids (Z), all are connected to blood vessels, zooid&#x2019;s siphons (SI) and central nervous system (CNS) are observed <bold>c,</bold> Live imaging of colonies undergoing fusion (top) and rejection (bottom), arrows point to fused vasculature and points of rejection (POR). Scale bar 0.2 mm.</p>
      </caption>
      <graphic xlink:href="nihms-1509772-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Multilineage Differentiation Capacity, Homing Sites of cHSC and their niches.</title>
        <p id="P67"><bold>a</bold>, Geneset Activity Analysis genes upregulated (n=235) in candidate HSCs (CP25, 33, and 34) using the Gene Expression Commons tool on a mouse hematopoiesis model. The enriched populations are HSCs and the myeloid lineage. <bold>b,</bold> Candidate HSCs and a control cell population (CP18) from an orange pigmented donor colony were transplanted into compatible recipient colonies with blue, orange, or mixture of the two pigmented cells. Upper panel shows live imaging. Scale bar 0.2 mm. <bold>c,</bold> Significant reduction of the ratio of blue colonies and significant upregulation of the ratio of mixed pigmented colonies (Fisher&#x2019;s exact test, two tailed, *P=0.006, **P=0.004), 20 days post-cHSC transplantation.<bold>d-f,</bold> cHSC and a control cell population (CP18) were labeled with DiO and transplanted into compatible colonies (<bold>d</bold>). Three weeks after transplantation DiO<sup>+</sup> cells (<bold>d</bold> right panel) from the recipient colonies were analyzed by FACS. 24% of the cHSC transplanted cells were detected in their original gate (<bold>e</bold> right panel in red), the rest were detected in other gates. The majority of the transplanted cells from the control group were detected in the original gate (<bold>e</bold> left panel in green). Experiment was performed twice. <bold>f,</bold> percent of the cells from both cHSC and control populations detected in gates different from their original gate, three weeks following transplantation. Experiment was performed on two pools of 5 animals of each population, unpaired T-test, two-tailed, *P=0.024, means. <bold>g,</bold> cHSC and a control (CP3) were isolated, labeled with DiD (violet) and transplanted into CFSE (green) labeled compatible colonies. Five to ten days following transplantation, only the cHSC populations homed to the endo-niche (5/6) compared to control (0/4). P=0.048 Fisher&#x2019;s exact test, two tailed, in yellow indicated endostyle, scale bar 20 &#x3BC;m. <bold>h,</bold> Electron microscopy section of the endostyle and subendostylar sinus (endo-niche). Yellow arrowheads indicate cells with hemoblast (cHSC) morphology. Performed three times. Scale bar 5 &#x3BC;m. <bold>i,</bold> Enriched blood-associated mammalian cell-types for highly expressed genes in the <italic>B. schlosseri</italic> endostyle (RNAseq) and the solitary tunicate <italic>Ciona robusta</italic> endostyle (ISH)<sup><xref rid="R21" ref-type="bibr">21</xref></sup>.</p>
      </caption>
      <graphic xlink:href="nihms-1509772-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Allorecognition is mediated by cytotoxic cells through BHF recognition.</title>
        <p id="P68"><bold>a,</bold> Observation of isolated large granular lymphocyte-like (LGL) cells after two days <italic>ex-vivo</italic>. 1- morphology of original isolated cells, 2&#x2013;3- granular and light pigmented cells, and 4 - granular pigmented morula cell (MC). The experiment was performed three times. <bold>b,</bold> Representation of homolog annotated genes differentially upregulated by LGL enriched population CP31. *TYRP2 (homolog of Phenoloxidase) is not differentially expressed, but is 7-fold higher in CP31. Left side is a table indicating gene association with immunity functions. <bold>c</bold>, <italic>BHF</italic> expression levels in the cell populations. <bold>d</bold>, Colony labeled with cell tracker far red (top left), and with CFSE in green (top right). Ampullae touching (bottom left), and in points of rejection (bottom right), mixture of cells is observed in the area of the necrotic tissue (yellow dashed line), the experiment was repeated three times. Scale bar 0.2mm. <bold>e,</bold> Phagocytosis and cytotoxicity assays were set between compatible, incompatible, or self. Significantly upregulation of cytotoxicity between cells taken from incompatible colonies are observed. The experiment with 10<sup>5</sup>: 10<sup>5</sup> cell ratio was performed twice with two to four samples in each treatment, and validated by additional experiments in different ratios. Unpaired T-test, two-tailed *P=0.023, mean. <bold>f,</bold> Blocking of BHF with anti BHF serum. Compatible colony target cells in blue and incompatible colony target cells in red. Mock serum-solid line and anti-BHF serum-dashed line. The blocking of BHF significantly upregulated the cytotoxicity of compatible targets compared to mock serum. The experiment was performed three times with duplicates or triplicates. ANOVA two-factor with replication, *P=0.0008, Mean, SD.</p>
      </caption>
      <graphic xlink:href="nihms-1509772-f0003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <title>Evolution of cellular immune system.</title>
        <p id="P69">Invertebrate and vertebrate species, information regarding their cellular immune systems. The table to the right describes the type of immune associated cells found in each animal. Colonial tunicates contain immune system cells found in both invertebrate and vertebrate species. While amoebocytes and large phagocytes are found in <italic>B. schlosseri</italic> and other invertebrate species (yellow and orange), myeloid lineage phagocytic cells were so far found only in <italic>B. schlosseri</italic> and vertebrates (red). Cytotoxic morula cells were identified in <italic>B. schlosseri</italic> and most likely exist in a few other invertebrate species (turquoise), but were not identified in vertebrates. Although a classic lymphoid lineage was found only in vertebrates (blue), there is a cellular population and additional molecular analysis suggesting the existence of mainly undifferentiated lymphoid cells in <italic>B. schlosseri</italic>. The cellular allorecognition molecules identified in each species are stated in column six: Immunoglobulin superfamily MHC, KIRs and TCR, leucine rich repeats receptors of the VLRs, and the BHF. The symbol &#x201C;?&#x201D; &#x2013; represents missing functional or molecular validation. Data source summarized in <xref rid="T2" ref-type="table">Extended Data Table 2b</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1509772-f0004"/>
    </fig>
  </floats-group>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">32076265</article-id>
      <article-id pub-id-type="pmc">7055484</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-020-2028-z</article-id>
      <article-id pub-id-type="manuscript">NIHMS1546843</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>&#x3B3;&#x3B4;T cells and adipocyte IL-17RC control fat innervation and thermogenesis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Bo</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Chengcheng</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>Xing</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Resch</surname>
            <given-names>Jon M.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jedrychowski</surname>
            <given-names>Mark P.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Zongfang</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Desai</surname>
            <given-names>Bhavna N.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Banks</surname>
            <given-names>Alexander S.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lowell</surname>
            <given-names>Bradford B.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mathis</surname>
            <given-names>Diane</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Spiegelman</surname>
            <given-names>Bruce M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA</aff>
      <aff id="A2"><label>2</label>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A3"><label>3</label>Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology</aff>
      <aff id="A4"><label>4</label>Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA</aff>
      <aff id="A5"><label>5</label>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A6"><label>6</label>Current address: Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA</aff>
      <aff id="A7"><label>7</label>These authors contributed equally</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P1">Author contributions</p>
          <p id="P2">B.H. and B.M.S. conceived and directed the study. B.H., C.J., X.Z., J.R., Z.Y., B.B.L., D.M. and B.M.S designed and performed experiments and analyzed the data. M.P.J. performed mass spectrometry analysis. J.R., Z.Y. and B.B.L. helped with chemogenetic experiment. B.N.D and A.B. helped with CLAMS studies. B.H., C.J., X.Z. and B.M.S wrote the manuscript with comments from all authors. All authors provided input and reviewed the manuscript.</p>
        </fn>
        <corresp id="CR1">Correspondence and requests for materials should be addressed to Dr. Bruce Spiegelman. <email>bruce_spiegelman@dfci.harvard.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>26</day>
        <month>12</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>2</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>8</month>
        <year>2020</year>
      </pub-date>
      <volume>578</volume>
      <issue>7796</issue>
      <fpage>610</fpage>
      <lpage>614</lpage>
      <!--elocation-id from pubmed: 10.1038/s41586-020-2028-z-->
      <permissions>
        <license license-type="permissions-link">
          <license-p>Reprints and permissions information is available at <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/reprints">www.nature.com/reprints</ext-link>.</license-p>
        </license>
        <license>
          <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<uri xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <p id="P3">The sympathetic nervous system innervates peripheral organs to regulate their function and maintain homeostasis, whereas target cells also produce neurotrophic factors to promote sympathetic innervation<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup>. The molecular basis of this bi-directional communication remains to be fully elucidated. Here we use thermogenic adipose tissue as a model system to show that T cells, specifically &#x3B3;&#x3B4;T cells, play a critical role in promoting sympathetic innervation, at least in part through driving TGF&#x3B2;1 expression in parenchymal cells via IL-17 Receptor C. Adipose-specific ablation of IL-17 Receptor C reduces TGF&#x3B2;1 expression in adipocytes, impairs local sympathetic innervation and causes obesity and other metabolic phenotypes consistent with defective thermogenesis; innervation can be fully rescued by restoring TGF&#x3B2;1 expression. Ablating &#x3B3;&#x3B4;T cells and the IL-17 Receptor C signaling pathway also impairs sympathetic innervation in salivary glands and the lung. These findings demonstrate T cell/parenchymal cell coordination to regulate sympathetic innervation.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P4">The sympathetic nervous system controls various physiological processes, such as vascular tone, cardiac output, glandular secretion and thermogenesis, to maintain homeostasis in response to environmental cues<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. Whereas sympathetic nerves modulate the activity of end-organs via the release of various neurotransmitters, target cells of innervation also produce factors to influence the development, maturation or activity of sympathetic nerves<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. The staggering complexity of target cells of innervation, coupled with the emerging picture of distinct populations of sympathetic neurons<sup><xref rid="R3" ref-type="bibr">3</xref></sup>, suggests that a multitude of such factors or pathways may be employed in a context-dependent manner. Given the limited known cases of target-derived factors that contribute to neuronal development, maturation and activity, the molecular basis of the bi-directional communication between sympathetic nerves and target cells remains to be fully elucidated.</p>
    <p id="P5">Thermogenic adipose tissue is richly innervated by sympathetic nerves<sup><xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R7" ref-type="bibr">7</xref></sup>. Local sympathetic axon terminals release the neurotransmitter norepinephrine (NE) to stimulate lipolysis in brown and beige adipocytes via the canonical &#x3B2;-adrenergic receptor/cAMP/PKA pathway. The released free acid is then oxidized in mitochondria and the harnessed chemical energy is dissipated in the form of heat via both uncoupled and coupled respiration, a process known as adaptive thermogenesis<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R8" ref-type="bibr">8</xref>&#x2013;<xref rid="R11" ref-type="bibr">11</xref></sup>. Importantly, previous studies have shown that sympathetic innervation of thermogenic adipose tissue is regulated by adipocyte-expressed genes, including the transcription regulator PRDM16, the ER membrane protein CLSTN3&#x3B2; and a neurotrophic factor S100B; thus, suggesting that thermogenic adipose tissue is an appropriate system to study how peripheral targets communicate with the sympathetic nervous system<sup><xref rid="R12" ref-type="bibr">12</xref>&#x2013;<xref rid="R14" ref-type="bibr">14</xref></sup>.</p>
    <p id="P6">Adipose tissue is infiltrated by various types of innate and adaptive immune cells. Previous studies have uncovered the contribution of innate immune cells, particularly anti-inflammatory macrophages, eosinophils, and type 2 innate lymphoid cells (ILC2s), to adipose thermogenesis<sup><xref rid="R15" ref-type="bibr">15</xref></sup>. Here we show that T cells, specifically &#x3B3;&#x3B4;T cells, play a key role in sympathetic innervation of thermogenic adipose tissue, thereby maintaining whole-body energy homeostasis. Mechanistically, &#x3B3;&#x3B4;T cells and IL-17F drives TGF&#x3B2;1 expression in adipocytes via IL-17 Receptor C signaling. Adipocyte-derived TGF&#x3B2;1 in turn promotes sympathetic innervation. Importantly, this pathway is found to be functionally important in multiple types of target tissue of sympathetic innervation other than BAT, and thus likely represents a neurotrophic mechanism of general implication.</p>
    <sec id="S1">
      <title>Results</title>
      <sec id="S2">
        <title>&#x3B3;&#x3B4; T cells promote adaptive thermogenesis</title>
        <p id="P7">To evaluate the role of lymphocytes in adaptive thermogenesis, wild-type (WT) and Rag2<sup>&#x2212;/&#x2212;</sup> mice, which lack both B cells and T cells, were subjected to a cold tolerance test. Rag2<sup>&#x2212;/&#x2212;</sup> mice exhibited significantly impaired cold tolerance compared with WT littermates (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). To further delineate the contribution of different lymphocyte compartments to this phenotype, we then examined the cold tolerance of Tcr&#x3B1;<sup>&#x2212;/&#x2212;</sup>, muMT<sup>&#x2212;/&#x2212;</sup> and TCR&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice, which lack &#x3B1;&#x3B2; T cells, B cells and &#x3B3;&#x3B4; T cells respectively. muMT<sup>&#x2212;/&#x2212;</sup> and Tcr&#x3B1;<sup>&#x2212;/&#x2212;</sup> mice have either a normal or only a mildly compromised cold tolerance; in contrast, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice showed markedly compromised cold tolerance, similar to the Rag2<sup>&#x2212;/&#x2212;</sup> mice (<xref rid="F1" ref-type="fig">Fig. 1b</xref>, <xref rid="F1" ref-type="fig">c</xref> and <xref rid="F1" ref-type="fig">d</xref>). Importantly, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice displayed reduced oxygen consumption upon acute cold challenge and increased lipid content in brown adipose tissue (BAT) compared with WT littermates, both of which suggest BAT dysfunction (<xref rid="F4" ref-type="fig">Extended Data Fig. 1a</xref> and <xref rid="F4" ref-type="fig">b</xref>). There was no significant difference in food intake, motor activity or cold-induced shivering between Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> and WT mice (<xref rid="F4" ref-type="fig">Extended Data Fig. 1c</xref> and <xref rid="F4" ref-type="fig">d</xref>).</p>
        <p id="P8">Flow cytometry analysis revealed a significant population of &#x3B3;&#x3B4;T cells in BAT are V&#x3B3;6+ &#x3B3;&#x3B4;T cells (<xref rid="F4" ref-type="fig">Extended Data Fig. 1e</xref> and <xref rid="F4" ref-type="fig">f</xref>). Contrary to Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice, the V&#x3B3;6V&#x3B4;1 transgenic mice, in which V&#x3B3;6<sup>+</sup>V&#x3B4;1<sup>+</sup> &#x3B3;&#x3B4;T cells are overrepresented<sup><xref rid="R16" ref-type="bibr">16</xref></sup>, displayed enhanced cold tolerance compared with WT littermates, providing further evidence that &#x3B3;&#x3B4;T cells promote BAT thermogenesis (<xref rid="F1" ref-type="fig">Fig. 1e</xref>).</p>
        <p id="P9">IL-17A and IL-17F are the key effector cytokines produced by V&#x3B3;6+ &#x3B3;&#x3B4;T cells<sup><xref rid="R17" ref-type="bibr">17</xref>&#x2013;<xref rid="R20" ref-type="bibr">20</xref></sup>. Interestingly, we found cold exposure significantly induced the expression of IL-17F in BAT, whereas IL-17A expression was below detection in the same context (<xref rid="F4" ref-type="fig">Extended Data Fig.1g</xref>). To further identify the functional importance of these two cytokines in BAT thermogenesis, we subjected Il17a<sup>&#x2212;/&#x2212;</sup> and Il17f<sup>&#x2212;/&#x2212;</sup> mice to acute cold challenge and found Il17f<sup>&#x2212;/&#x2212;</sup> but not Il17a<sup>&#x2212;/&#x2212;</sup> mice exhibited markedly impaired cold tolerance (<xref rid="F1" ref-type="fig">Fig. 1f</xref> and <xref rid="F1" ref-type="fig">g</xref>). Taken together, these data-suggest that IL-17F but not IL-17A plays a critical role in adaptive thermogenesis.</p>
      </sec>
      <sec id="S3">
        <title>Adipocyte IL-17RC promotes thermogenesis</title>
        <p id="P10">Two IL-17 receptors, IL-17 RA and IL-17RC, exist in mice, while IL-17RC binds only IL-17F<sup><xref rid="R21" ref-type="bibr">21</xref>&#x2013;<xref rid="R24" ref-type="bibr">24</xref></sup>. IL-17RC is more abundantly expressed in thermogenic adipocytes at the mRNA level than IL-17RA (<xref rid="F5" ref-type="fig">Extended Data Fig. 2a</xref> and <xref rid="F5" ref-type="fig">b</xref>). Whole-body deficiency in IL-17RC but not IL-17RA phenocopied Il17f<sup>&#x2212;/&#x2212;</sup> mice in cold tolerance test (<xref rid="F1" ref-type="fig">Fig. 1h</xref> and <xref rid="F5" ref-type="fig">Extended Data Fig. 2c</xref>), suggesting IL-17RC is the cognate receptor for IL-17F in the context of adaptive thermogenesis.</p>
        <p id="P11">To further dissect whether IL-17RC signaling in adipocytes contributes to thermogenesis, we generated adipocyte-specific IL-17RC knockout mice (<italic>adiponectin-cre</italic>; <italic>il17rc</italic><sup>fl/fl,</sup> hereby named AdIl17RC KO). Upon acute cold exposure, the AdIl17RC KO mice exhibited impaired cold tolerance compared with control mice, phenocopying Rag2<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> and Il17f<sup>&#x2212;/&#x2212;</sup> mice (<xref rid="F1" ref-type="fig">Fig. 1i</xref>). AdIl17RC KO also displayed higher lipid content in their BAT in comparison with control (<xref rid="F5" ref-type="fig">Extended Data Fig. 2d</xref>). Importantly, restricting IL-17RC deletion to thermogenic adipocytes by using <italic>ucp1</italic>-cre;<italic>Il17rc</italic><sup><italic>fl/fl</italic></sup> mice caused a similar cold-intolerant phenotype (<xref rid="F5" ref-type="fig">Extended Data Fig. 2e</xref>), which further confirms that IL-17RC signaling in the UCP1-positive thermogenic adipocytes is important for adaptive thermogenesis. Furthermore, AdIl17RCKO;V&#x3B3;6V&#x3B4;1 transgenic mice phenocopied AdIl17RC KO upon cold challenge, providing further evidence that IL-17RC signaling in adipocyte is required for the thermogenesis-enhancing activity of V&#x3B3;6<sup>+</sup>V&#x3B4;1<sup>+</sup> &#x3B3;&#x3B4;T cells (<xref rid="F5" ref-type="fig">Extended Data Fig. 2f</xref>).</p>
        <p id="P12">Defective adipose thermogenesis is often associated with susceptibility to diet-induced obesity and glucose tolerance. Indeed, when we challenged AdIl17RC KO mice with a high fat diet, they gained weights more rapidly than their WT littermates (<xref rid="F1" ref-type="fig">Fig. 1j</xref>). AdIl17RC KO mice exhibited reduced oxygen consumption in comparison to their littermate controls, before the divergence in their body weights (<xref rid="F5" ref-type="fig">Extended Data Fig. 2g</xref>); no significant differences in food intake or physical movements were observed (<xref rid="F5" ref-type="fig">Extended Data Fig. 2h</xref> and <xref rid="F5" ref-type="fig">i</xref>), suggesting the increased weight gain is caused by reduced energy expenditure. AdIl17RC KO also displayed impaired glucose tolerance, increased lipid accumulation in BAT, aggravated liver steatosis, and enlarged inguinal and epididymal WAT depots on high fat diet (<xref rid="F1" ref-type="fig">Fig. 1k</xref>, <xref rid="F1" ref-type="fig">l</xref> and <xref rid="F1" ref-type="fig">m</xref> and <xref rid="F5" ref-type="fig">Extended Data Fig. 2j</xref> and <xref rid="F5" ref-type="fig">k</xref>). These metabolic phenotypes support an important role of adipocyte IL-17RC in promoting thermogenesis.</p>
      </sec>
      <sec id="S4">
        <title>IL-17RC promotes adipose innervation</title>
        <p id="P13">We then examined the underlying causes of the impaired adaptive thermogenesis in AdIl17RC KO mice. The decreased cold tolerance of AdIl17RC KO mice was associated with lower oxygen consumption rates compared with WT littermates (<xref rid="F2" ref-type="fig">Fig. 2a</xref>). Surprisingly, we did not observe altered oxygen consumption rate in AdIl17RC KO receiving stimulation via a &#x3B2;3-adrenergic agonist (CL316, 243) injection (<xref rid="F2" ref-type="fig">Fig. 2b</xref>); this suggests that the impaired thermogenesis of the AdIl17RC KO mice might result from deficiencies upstream of the &#x3B2;3-adrenergic receptor.</p>
        <p id="P14">Because sympathetic nerves are the major source of NE in BAT, we performed tyrosine hydroxylase (TH) and tubulin &#x3B2;3 (TUBB3) staining to assess sympathetic nerves in WT and AdIl17RC KO BAT. The volume and intensity of both TH and TUBB3 staining were significantly reduced in the BAT of AdIl17RC KO compared with the WT (<xref rid="F2" ref-type="fig">Fig. 2c</xref> and <xref rid="F2" ref-type="fig">d</xref>). These observations indicate there is both reduced growth of sympathetic axons and protein levels of TH and TUBB3 in those axons, possibly suggesting a deficiency in neurotrophic factors promoting both growth and maturation of sympathetic axons. Importantly, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup>, Rag2<sup>&#x2212;/&#x2212;</sup> and Il17f<sup>&#x2212;/&#x2212;</sup> but not Il17a<sup>&#x2212;/&#x2212;</sup> mice exhibited similarly reduced TH and TUBB3 staining in BAT (<xref rid="F2" ref-type="fig">Fig. 2e</xref>, <xref rid="F2" ref-type="fig">f</xref> and <xref rid="F6" ref-type="fig">Extended Data Fig. 3a</xref> and <xref rid="F6" ref-type="fig">b</xref>); V&#x3B3;6V&#x3B4;1 transgenic mice displayed the opposite phenotype (<xref rid="F2" ref-type="fig">Fig. 2g</xref> and <xref rid="F2" ref-type="fig">h</xref>). Decreased TH staining was also observed in subcutaneous fat of AdIl17RC KO mice (<xref rid="F6" ref-type="fig">Extended Data Fig. 3c</xref>). These results indicate that the &#x3B3;&#x3B4; T cell/adipocyte IL-17RC signaling pathway promotes sympathetic innervation of thermogenic adipose tissue.</p>
        <p id="P15">To investigate whether Il17rc governs functional sympathetic innervation of BAT, we chemogenetically activated sympathetic premotor neurons and assessed the downstream BAT response using a previously established VGLUT3(<italic>Slc17a8)-ires-cre</italic> mouse model<sup><xref rid="R12" ref-type="bibr">12</xref></sup>. We crossed the VGLUT3(<italic>Slc17a8)-ires-cre</italic> mouse line<sup><xref rid="R25" ref-type="bibr">25</xref></sup> to Il17rc KO and V&#x3B3;6V&#x3B4;1 transgenic lines and then stereotaxically injected Cre-dependent AAV-hM3Dq-mCherry into the medullary raphe region of the brain stem to drive stable expression of the transgene specifically in the VGLUT3-expressing neurons. Injection of clozapine-N-oxide (CNO), a ligand of hM3Dq but not the control vehicle to mice receiving AAV-hM3Dq-mCherry, induced c-fos expression in the medullary raphe region, thus confirming that CNO specifically activates sympathetic premotor neurons in the medullary raphe region (<xref rid="F6" ref-type="fig">Extended Data Fig. 3d</xref>). We next examined BAT thermal response of Il17rc KO and transgenic mice to CNO. The response was dampened from 1.0&#xB0;C in WT mice to 0.4&#xB0;C in KO mice but enhanced from 0.9&#xB0;C in control mice to 1.6&#xB0;C in transgenic mice (<xref rid="F2" ref-type="fig">Fig. 2i</xref> and <xref rid="F2" ref-type="fig">j</xref>). Taken together, these findings strongly suggest that ablation of Il17rc impairs functional sympathetic innervation of thermogenic adipose tissue, whereas over-representation of V&#x3B3;6<sup>+</sup>V&#x3B4;1<sup>+</sup> &#x3B3;&#x3B4;T cells has the opposite effect.</p>
        <p id="P16">In support of the notion that the thermogenic defect in the AdIl17RC KO mice is caused by impaired adipose innervation, we found that the cold intolerance of the AdIl17RC KO mice could be rescued by enhancing the fat-specific neurotrophic pathway of CLSTN3&#x3B2;/S100B<sup><xref rid="R12" ref-type="bibr">12</xref></sup>. Specifically, forced expression of S100b or Clstn3&#x3B2; in BAT of AdIl17RC KO mice led to reduced lipid accumulation in BAT, enhanced cold tolerance, and increased BAT innervation compared with controls (<xref rid="F6" ref-type="fig">Extended Data Fig. 3e</xref>&#x2013;<xref rid="F6" ref-type="fig">g</xref> for S100b-AAV and <xref rid="F6" ref-type="fig">h</xref>&#x2013;<xref rid="F6" ref-type="fig">j</xref> for Clstn3&#x3B2;-AAV).</p>
      </sec>
      <sec id="S5">
        <title>IL-17RC in innervation of other tissues</title>
        <p id="P17">IL-17RC is widely expressed in multiple murine tissues. This prompted us to ask whether the IL-17F/IL-17C pathway represents a neurotrophic mechanism generally implicated in additional tissues. Indeed, we observed decreased TH and TUBB3 volume and intensity in the salivary gland of Il17rc<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup>, Rag2<sup>&#x2212;/&#x2212;</sup>, Il17f<sup>&#x2212;/&#x2212;</sup> mice but not Il17a<sup>&#x2212;/&#x2212;</sup> mice, and in lung bronchi of Il17rc<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> and Rag2<sup>&#x2212;/&#x2212;</sup> mice (<xref rid="F6" ref-type="fig">Extended Data Fig.3 k</xref>&#x2013;<xref rid="F6" ref-type="fig">m</xref> and <xref rid="F6" ref-type="fig">o</xref>). In contrast, no reduction in TH and TUBB3 staining was observed in the salivary gland of the AdIl17RC KO mice (<xref rid="F6" ref-type="fig">Extended Data Fig. 3n</xref>). Taken together, these data strongly suggest that the &#x3B3;&#x3B4;T cell/IL-17RC pathway contributes to sympathetic innervation in multiple tissues.</p>
      </sec>
      <sec id="S6">
        <title>IL-17RC promotes TGF&#x3B2;1 expression</title>
        <p id="P18">To understand mechanistically how the IL-17F/IL-17RC pathway promotes sympathetic innervation, we analyzed the proteomic and transcriptomic profiles of WT and AdIl17RC KO BAT by protein mass-spectrometry and RNA-seq respectively (<xref rid="F3" ref-type="fig">Fig. 3a</xref> and <xref rid="F3" ref-type="fig">b</xref>). Pathway enrichment analysis of genes downregulated both at the RNA and the protein level in the KO compared with controls revealed the Epithelial Mesenchymal Transition and the TGF&#x3B2; signaling pathways (<xref rid="F7" ref-type="fig">Extended Data Fig. 4a</xref>). We confirmed the downregulation of a set of collagen genes (Col1a1, Col3a1, and Col5a1), (known targets of TGF&#x3B2;), and TGF&#x3B2;1 itself in the AdIl17RC KO BAT by qPCR (<xref rid="F3" ref-type="fig">Fig. 3a</xref>, <xref rid="F3" ref-type="fig">b</xref> and <xref rid="F7" ref-type="fig">Extended Data Fig. 4b</xref>). IL-17F has been shown to drive TGF&#x3B2;1 expression in endothelial cells<sup><xref rid="R26" ref-type="bibr">26</xref></sup>. Here we observed reduced TGF&#x3B2;1 expression in the adipocytes from AdIl17RC KO BAT (<xref rid="F3" ref-type="fig">Fig. 3c</xref>), suggesting IL-17F is also important to drive TGF&#x3B2;1 expression in adipocytes. Furthermore, reduced Tgfb1 expression was observed in the salivary gland and lung of Il17rc<sup>&#x2212;/&#x2212;</sup> mice, as well as in the BAT, salivary gland and lung of Rag2<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> and Il17f<sup>&#x2212;/&#x2212;</sup> mice (<xref rid="F7" ref-type="fig">Extended Data Figure 4c</xref>&#x2013;<xref rid="F7" ref-type="fig">e</xref>). Taken together, these results showed that ablation of the IL-17F/IL-17RC pathway leads to downregulated expression of TGF&#x3B2;1 in multiple tissues.</p>
      </sec>
      <sec id="S7">
        <title>TGF&#x3B2;1 promotes sympathetic innervation</title>
        <p id="P19">Previous studies have shown TGF&#x3B2; possesses neurotrophic activity in certain contexts<sup><xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup>. We therefore hypothesized that downregulation of TGF&#x3B2;1 signaling might explain, at least in part, the defective sympathetic innervation in multiple tissues as a result of IL-17RC ablation. To test this idea, we examined whether forced expression of TGF&#x3B2;1 is sufficient to alleviate the defect in BAT sympathetic innervation and thermogenesis of AdIl17RC KO mice. Indeed, restoration of TGF&#x3B2;1 expression specifically in brown adipocytes of AdIl17RC KO mice lead to strongly reduced lipid accumulation, increased TH/TUBB3 staining in BAT, and enhanced cold tolerance compared with controls (<xref rid="F3" ref-type="fig">Fig. 3d</xref>&#x2013;<xref rid="F3" ref-type="fig">f</xref> and <xref rid="F8" ref-type="fig">Extended Data Fig. 5a</xref>). Consistent with this, blocking TGF&#x3B2; signaling with a neutralizing antibody or a small-molecule inhibitor sensitized WT mice to cold exposure (<xref rid="F8" ref-type="fig">Extended Data Fig. 5b</xref> and <xref rid="F8" ref-type="fig">c</xref>). Furthermore, AAV-driven expression of TGF&#x3B2;1 also increased TH/TUBB3 staining in salivary gland of Il17rc KO and Rag2 KO mice. (<xref rid="F8" ref-type="fig">Extended Data Fig. 5d</xref>&#x2013;<xref rid="F8" ref-type="fig">g</xref>). Taken together, these results support the idea that the IL-17F/IL-17RC pathway plays a critical role in promoting sympathetic innervation. At least a substantial part of this appears to be through the TGF&#x3B2;1 signaling pathway.</p>
      </sec>
    </sec>
    <sec id="S8">
      <title>Discussion</title>
      <p id="P20">Sympathetic innervation of peripheral organs regulates their function and maintains homeostasis. These nerves are, in turn, also under influence of factors produced by the target cells of innervation. The molecular basis of this important bi-directional communication remains to be fully elucidated. By using thermogenic adipose tissue as a model system, we show that T cells, through an axis defined by &#x3B3;&#x3B4; T cells and IL-17RC, plays a critical role in promoting sympathetic innervation, at least in part through driving TGF&#x3B2;1 expression in parenchymal cells. Our conclusion is supported by highly consistent phenotypes across a comprehensive set of mouse genetics models, including Rag2<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup>, IL-17F<sup>&#x2212;/&#x2212;</sup>, global and tissue-specific IL-17RC KO. &#x3B3;&#x3B4; T cells have been previously linked to body temperature control through IL-17A<sup><xref rid="R29" ref-type="bibr">29</xref></sup>; however, our data clearly showed that IL-17F deficiency, but not IL-17A deficiency, caused a profound defect in BAT thermogenesis. Consistent with this finding are the phenotypes displayed by adipose-specific KO of IL-17RC, which binds and is activated by only IL-17F but not IL-17A in mice. More importantly, our findings demonstrate the &#x3B3;&#x3B4; T cells /IL-17RC/TGF&#x3B2;1 axis as a critical mechanism involved in the sympathetic innervation of multiple tissues. Moving forward, it will be interesting to see whether the human &#x3B3;&#x3B4;T cell compartment and IL-17RC signaling plays an important role in the sympathetic innervation.</p>
      <p id="P21">TGF&#x3B2;1 plays an important role in multiple aspects of central nervous system development and function<sup><xref rid="R28" ref-type="bibr">28</xref></sup>. Although TGF&#x3B2;1 is reported to be involved in peripheral nerve repair, its role in the peripheral nervous system development and function has not been extensively explored<sup><xref rid="R30" ref-type="bibr">30</xref></sup>. Our data support a critical role of IL-17F-driven TGF&#x3B2;1 signaling in controlling sympathetic innervation in multiple peripheral tissues. Our observations that viral or pharmacological intervention in the TGF&#x3B2;1 pathway could modulate sympathetic innervation in adult mice suggest that TGF&#x3B2;1 could dynamically regulate the growth and maturation level of sympathetic nerves in a post-developmental manner. This mode of action is rather distinct from known target-derived neurotrophic factors, such as NGF, and may therefore reveal a new mechanism of crosstalk between sympathetic nerves and end-organs. The direct target and molecular mechanism of TGF&#x3B2;1&#x2019;s effect on sympathetic nerves are unclear at this stage; TGF&#x3B2;1 may act directly on neuronal receptors, or indirectly via remodeling the extracellular matrix or modulating the abundance/activity of additional neurotrophic factors. Further investigation is required to distinguish between these possibilities.</p>
      <p id="P22">In summary, our data uncovered an unexpected immuno-regulatory mechanism of sympathetic innervation in multiple tissues, including thermogenic adipose tissue, and might provide a therapeutic opportunity of promoting thermogenic fat activity for treating obesity and associated metabolic disorders.</p>
    </sec>
    <sec id="S9">
      <title>Methods</title>
      <sec id="S10">
        <title>Mouse</title>
        <p id="P23">Rag2&#x2212;/&#x2212; mice (008449), Tcr&#x3B4;&#x2212;/&#x2212; mice (002120), muMT&#x2212;/&#x2212; mice (002288), Tcr&#x3B1;&#x2212;/&#x2212; mice (002116), Il17a&#x2212;/&#x2212; mice (016879) were from Jackson Lab. Il17f&#x2212;/&#x2212; mice were from Dr. Sarah L. Gaffen and Dr.Yoichiro Iwakura&#x2019;s lab, Il17rc&#x2212;/&#x2212; and Il17ra&#x2212;/&#x2212; were from Amgen, Il17RC<sup>flox/flox</sup> mice were from Dr. Jay K. Kolls&#x2019; lab<sup><xref rid="R31" ref-type="bibr">31</xref></sup>. V&#x3B3;6V&#x3B4;1 Tg mice were from Dr. Diane Mathis&#x2019; lab. Adiponectin Cre mice (028020) and UCP1 Cre mice (024670) were from Jackson lab<sup><xref rid="R32" ref-type="bibr">32</xref></sup>. VGLUT3-ires-Cre mice were from Dr. Bradford Lowell&#x2019;s lab<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. TGF&#x3B2; antibody (Bioxcell # BE0057 Clone 1D11.16.8) and Isotype control antibody (Bioxcell # BE0083) were i.p. injected to WT B6 mice for 3 weeks at 10mg/kg 3 times a week. sb431542 was i.p. injected to WT B6 mice at 4.2mg/kg/day for 3 weeks. All animal studies were approved by the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center.</p>
      </sec>
      <sec id="S11">
        <title>Cold tolerance assay</title>
        <p id="P24">Mice were pre-acclimated at thermoneutrality (28-30&#xB0;C) for 1wk and then shifted to 4&#xB0;C. Body temperature was measured with a rectal probe (Physitemp, RET3) and a reader (Physitemp, BAT-12) and implanted temperature probes (Bio Medic Data Systems, IPTT-300) with a transponder (Bio Medic Data Systems, DAS-7007R)<sup><xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup>.</p>
      </sec>
      <sec id="S12">
        <title>Whole-mount immunofluorescence</title>
        <p id="P25">Th whole-mount immunostaining of subcutaneous inguinal WAT was performed as described in Chi et al<sup><xref rid="R14" ref-type="bibr">14</xref></sup>.</p>
      </sec>
      <sec id="S13">
        <title>Cryo-section immunostaining</title>
        <p id="P26">Tissue was harvested immediately after euthanizing mice and fixed with 4% paraformaldehyde overnight. Tissue was then washed with PBS for 5 times, 10 min each and incubated in PBS/30% sucrose for 8 h and then frozen in Tissue-Tek O.C.T. Compound (Sakura Finetek, 4583). Frozen tissue was cut into 30 &#x3BC;m sections on a Leica CM3050 S cryostat. Sections were briefly rinsed with PBS and blocked with PBS/0.3% Triton X-100/5% FBS overnight. Sections were then stained with Th antibody (AB1542, EMD Millipore, 1:200) and Tubb3 antibody (ab52623, Abcam, 1:200) for 2 days. Sections were washed with PBS/0.03% Triton X-100/5% FBS for 5 times, 1 h each and then stained with anti-sheep Alexa Fluor 488, anti-sheep Alexa Fluor 568, anti-sheep Alexa Fluor 647 (Thermo Fisher, A-11015, A-21099 and A-21448,1:500) and anti-rabbit Alexa Fluor 647 (Thermo Fisher, A-21245, 1:500) for 2 days. Sections were washed with PBS/0.3% Triton X-100/5% FBS for 5 times, 1 h each and then mounted in ProLong Diamond Antifade Mountant (Thermo Fisher, P36965). Images were taken on a Nikon A1R point scanning confocal microscope.</p>
      </sec>
      <sec id="S14">
        <title>Image analysis</title>
        <p id="P27">For each animal, at least six sections of adipose tissues were imaged and analyzed. Images were imported to Imaris (Bitplane) and surface renderings of Th or Tubb3 fluorescence were generated using the &#x201C;surface&#x201D; function. Signals on and around blood vessels were manually selected and removed from the final quantifications. Volume measurements of Th/Tubb3 signals were normalized to the volume of the imaging field. In each experiment, the function parameters were kept the same between genotypes.</p>
      </sec>
      <sec id="S15">
        <title>Flow cytometry</title>
        <p id="P28">BAT were collected, cut into small pieces, and digested with collagenase II (Sigma) and DNase I for 30 minutes at 37&#xB0;C. Dissociated tissues was then filtered with a 100 &#x3BC;m cell strainer. Spleen and lymph node samples were grinded up and passed through a 70 &#x3BC;m cell strainer. After blocking FcgRIII/II with an anti-CD16/CD32 mAb (eBioscience), single cell suspensions were stained with the following antibodies: CD45.2 (104), TCR&#x3B2; (H57-597), TCR&#x3B3;&#x3B4; (GL3), CD3(17A2), IL-17F (9D3.1C8), CD27 (LG.3A10), purchased from eBioscience, BD or Biolegend. Biotinylated antiamphiregulin antibody was purchased from R&amp;D Systems. For staining of the V&#x3B3;6V&#x3B4;1+ TCR, cells were labeled first with the anti-TCR&#x3B3;&#x3B4; mAb (GL3), and then incubated with the supernatant from the 17D1 hybridoma followed by staining with the goat-anti-rat IgM (Jackson Immunoresearch Laboratories) secondary antibody as previously described<sup><xref rid="R36" ref-type="bibr">36</xref></sup>. Flow cytometry was performed on the LSR II or LSRFortessa (BD), and data were analyzed by the FlowJo software (Treestar).</p>
      </sec>
      <sec id="S16">
        <title>Mass spectrometry analysis</title>
        <p id="P29">Quantitative whole tissue proteomics analysis was performed as below.</p>
        <sec id="S17">
          <title>Protein Digestion and Isobaric Labeling</title>
          <p id="P30">Protein elutions were precipitated in 20 % trichloroacetic acid on ice overnight, spun for 30 minutes at 15,000 RPM and washed three times with 500 &#x3BC;L of HPLC grade acetone. Protein pellets were further dried under vacuum centrifugation until they were completely dried. Pellets were resuspended in 8 M urea containing 50 mM HEPES, pH 8.5(75 &#x3BC;L), diluted to 4 M urea and digested with 1 &#x3BC;g of LysC (Wako) overnight at room temperature. Digests were diluted further to a 1.5 M urea concentration and 0.5 &#x3BC;g of trypsin (Promega) for 6 hours at 37 &#xB0;C. Digests were acidified with 5 &#x3BC;L of 20% formic acid (FA) to a pH ~2 and were subsequently desalted by C18 StageTips (3M Empore).</p>
          <p id="P31">Digested elutions were resuspended in 25 &#x3BC;L of 200 mM HEPES, pH 8.5. The TMT6 reagents (Thermo Fisher) (0.8 mgs) were dissolved in 40 &#x3BC;L of dry acetonitrile (ACN), and 2 &#x3BC;L of the solution was added to each tube. After incubating for 1 h at room temperature (23 &#xB0;C), the reaction was quenched by adding 2 &#x3BC;L of 5% w/v hydroxylamine. Labeled peptides, were combined and subsequently desalted by C18 StageTips prior to injection onto the mass spectrometer.</p>
          <p id="P32">BAT tissue was extracted and snap frozen in liquid N<sub>2</sub> until further use. BAT tissues were lysed with 3 mL SDS lysis buffer (2.0 % SDS w/v, 200 mM NaCl, 5 mM DTT, EDTA free protease inhibitor cocktail (Promega) and 50 mM HEPES, pH 8.5) using an Omni tissue homogenizer. Extracts were reduced with at 57 &#xB0;C for 30 minutes and cysteine residues alkylated with iodoacetamide (14 mM) in the dark (45 min). Extracts were purified by methanol/chloroform precipitation and pellets were washed with ice cold acetone. Pellets were resuspended in 8 M urea containing 50 mM HEPES, pH 8.5, and protein concentrations were measured by BCA assay (Thermo Scientific) prior to protease digestion. 200 &#x3BC;g of protein was diluted to 4 M urea and digested overnight with 5 &#x3BC;g LysC (Wako). Digests were diluted further to a 1.5 M urea concentration and 5 &#x3BC;g of trypsin (Promega) was added for 6 hours at 37 &#xB0;C. Digests were acidified with 50 &#x3BC;L of 20% formic acid (FA) and subsequently desalted by C18 solid-phase extraction (SPE) (50 mg, Sep-Pak, Waters). Digested BAT peptides were resuspended in 100 &#x3BC;L of 200 mM HEPES, pH 8.5. Ten &#x3BC;L of TMT6 reagents was added to each solution for 1 h at room temperature (23 &#xB0;C). After incubating, the reaction was quenched by adding 4 &#x3BC;L of 5% w/v hydroxylamine. Labeled peptides, were combined and subsequently desalted by C18 solid-phase extraction (SPE) (50 mg, Sep-Pak, Waters) prior to basic pH reversed-phase separation (bpHrp).</p>
        </sec>
        <sec id="S18">
          <title>Basic pH reversed-phase separation (bpHrp)</title>
          <p id="P33">TMT labeled peptides were solubilized in 500 &#x3BC;L solution containing 5% ACN/10 mM ammonium bicarbonate, pH 8.0 and separated by an Agilent 300 Extend C18 column (5 mm particles, 4.6 mm ID and 220 mm in length). An Agilent 1100 binary pump coupled with a photodiode array (PDA) detector (Thermo Scientific) was used to separate the peptides. A 40 minute linear gradient from 20% to 40% acetonitrile in 10 mM ammonium bicarbonate pH 8 (flow rate of 0.8 mL/min) separated the peptide mixtures into a total of 96 fractions (33 seconds). A total of 96 Fractions were consolidated into 12 samples in a checkerboard fashion, acidified with 20 &#x3BC;L of 20% formic acid and vacuum dried to completion. Each sample was re-dissolved in 5% FA/5% ACN, desalted via StageTips prior to LC-MS/MS analysis.</p>
        </sec>
        <sec id="S19">
          <title>Liquid chromatography and tandem mass spectrometry (LC-MS/MS)</title>
          <p id="P34">All LC-MS/MS experiments were performed on an LTQ Orbitrap Fusion (Thermo Fisher) coupled with Agilent 1200 binary HPLC pump (Agilent Technologies) and a Famos auto sampler (LC Packings). Peptides were separated onto an 75 &#x3BC;m I.D. microcapillary column packed first with ~1 cm of Magic C4 resin (5 &#x3BC;m, 100 &#xC5;, Michrom Bioresources) followed by ~20 cm of Maccel C18AQ resin (3 &#x3BC;m , 200 &#xC5;, Nest Group). Peptides were separated by applying a gradient from 10 to 25% ACN in 0.125% FA over 180 min at ~250 nL/min. Electrospray ionization was enabled through applying a voltage of 1.8 kV using an inert gold electrode.</p>
          <p id="P35">The instrument was operated in data-dependent mode with a 60 s (+/&#x2212; 10 ppm window) expiration time, FTMS1 spectra collection at 120,000 resolution, an AGC target of 500,000 and a max injection time of 200 ms. The ten most intense ions were selected for MS2 fragmentation and precursors were filtered according to charge state (required &gt;1 <italic>z</italic>). Isolation width was set at 0.7 <italic>m/z</italic>. ITMS2 spectra were collected at an AGC of 18,000, max injection time of 120 ms and CID collision energy of 35%. For the FTMS3 acquisition, the Orbitrap was operated at 30,000 resolution with an AGC target of 50,000. The max injection time was set to 250 ms incorporating an HCD collision energy of 55%. Synchronous-precursor-selection (SPS) was enabled to include up to 10 MS2 fragment ions in the FTMS3 spectra.</p>
        </sec>
        <sec id="S20">
          <title>MS data processing and spectra assignment</title>
          <p id="P36">A compendium of in-house developed software was used to convert acquired mass spectrometric data from the .RAW file to the mzxml format. Erroneous assignments of peptide ion charge state and monoisotopic m/z were also corrected by the software. The Sequest algorithm was used to assign MS2 spectra by searching the data against a protein sequence database including Mouse Uniprot Database (download date June, 2013) and known contaminants such as porcine trypsin and human keratins. A forward (target) database component was followed by a decoy component including all listed protein sequences. Searches were performed using a 30 ppm precursor ion tolerance and requiring both peptide termini to be consistent with trypsin specificity. Six-plex TMT labels on lysine residues and peptide N termini (+ 229.16293 Da) were set as static modifications and oxidation of methionine residues (+ 15.99492 Da) as a variable modification. An MS2 spectra assignment false discovery rate (FDR) of less than 1% was achieved by applying the target-decoy database search strategy<sup><xref rid="R37" ref-type="bibr">37</xref></sup>. Filtering was performed using a linear discrimination analysis method to create one combined filter parameter from the following peptide ion and MS2 spectra properties: XCorr and &#x394;Cn, peptide ion mass accuracy, and peptide length. Linear discrimination scores were used to assign probabilities to each MS2 spectrum for being assigned correctly and these probabilities were further used to filter the dataset with an MS2 spectra assignment FDR to obtain a protein identification FDR of less than 1 %<sup><xref rid="R38" ref-type="bibr">38</xref></sup>.</p>
        </sec>
        <sec id="S21">
          <title>Determination of TMT reporter ion intensities</title>
          <p id="P37">For reporter ion quantification, a 0.03 m/z window centered on the theoretical m/z value of each reporter ion was monitored for ions, and the maximum intensity of the signal to the theoretical m/z value was recorded. Reporter ion intensities were de-normalized by multiplication with the ion accumulation time for each MS2 or MS3 spectrum and adjusted based on the overlap of isotopic envelopes of all reporter ions. Following reporter ion signal extraction, the isotopic impurities of the TMT reagent were corrected using the values specified by the manufacturer. Total signal to noise values for all peptides were summed for each TMT channel and all values were adjusted to account for variance. For each identified peptide, a total minimum signal to noise value of 100 was implemented.</p>
        </sec>
      </sec>
      <sec id="S22">
        <title>RNAseq library preparation and sequencing</title>
        <p id="P38">Libraries were prepared using Illumina TruSeq stranded mRNAseq kit from 500ng of purified total RNA according to the manufacturer&#x2019;s protocol. The finished dsDNA libraries were quantified by Qubit fluorometer, Agilent TapeStation 2200, and RT-qPCR using the Kapa Biosystems library quantification kit according to manufacturer&#x2019;s protocols. Uniquely indexed libraries were pooled in equimolar ratios and sequenced on an Illumina NextSeq500 with single-end 75bp reads by the Dana-Farber Cancer Institute Molecular Biology Core Facilities.</p>
      </sec>
      <sec id="S23">
        <title>RNAseq Analysis</title>
        <p id="P39">Sequenced reads were aligned to the UCSC mm9 reference genome assembly and gene counts were quantified using STAR (v2.5.1b)<sup><xref rid="R39" ref-type="bibr">39</xref></sup>. Differential gene expression testing was performed by DESeq2 (v1.10.1)<sup><xref rid="R40" ref-type="bibr">40</xref></sup> and normalized read counts (FPKM) were calculated using cufflinks (v2.2.1)<sup><xref rid="R41" ref-type="bibr">41</xref></sup>. RNAseq analysis was performed using the VIPER snakemake pipeline<sup><xref rid="R42" ref-type="bibr">42</xref></sup>.</p>
      </sec>
      <sec id="S24">
        <title>Indirect Calorimetry</title>
        <p id="P40">Animals were housed individually in metabolic chambers under a 12 hr light/dark cycle with free access to food and water. Whole body metabolic rate was measured using the Oxymax open-circuit indirect calorimeter, Comprehensive Lab Animal Monitoring System (CLAMS, Columbus Instruments). Cold exposure or CL 316,243 (Sigma-Aldrich; 1 mgkg<sup>&#x2212;1</sup>) i.p. injection into mice started at the indicated time.</p>
      </sec>
      <sec id="S25">
        <title>Electromyography (EMG)</title>
        <p id="P41">Mice were individually restrained to limit non-shivering muscle activity and two EMG needle electrodes were inserted subcutaneously above the nuchal muscles in the back of the neck. EMG leads were connected to a computerized data acquisition system via a communicator. EMG data were collected and burst activity was determined as described previously<sup><xref rid="R43" ref-type="bibr">43</xref></sup>. Briefly, EMG data were collected from the implanted electrodes at a sampling rate of 2 kHz using LabChart 8 Pro Software (ADInstruments). The raw signal was converted to root mean square activity. Root mean square activity was analysed for shivering bursts in 10 s windows.</p>
      </sec>
      <sec id="S26">
        <title>AAV injection</title>
        <p id="P42">Six-week old male mice were anesthetized with isoflurane and an incision was made above the interscapular area to expose the underlying adipose tissue. About 3*10^11 AAV particles were injected into each BAT lobe and the incision was closed with suture. Mice received one injection of meloxicam (2 mg/kg) 24 h before surgery and another injection immediately after surgery. Mice were allowed to recover for 3 weeks before analysis. AAV8-Tgfb1, AAV8-DIO-TGF&#x3B2;1, AAV8-S100b and AAV8-DIO-Clstn3&#x3B2; were packaged at the Boston Children&#x2019;s Hospital ViralCore.</p>
      </sec>
      <sec id="S27">
        <title>Stereotaxic surgery and viral injections</title>
        <p id="P43">For viral injections into the medullary raphe, six- to eight-week-old male VGLUT3-ires-Cre+ mice were anesthetized with a ketamine (100 mg kg-1) and xylazine (10 mg kg<sup>&#x2212;1</sup>) cocktail diluted in 0.9% saline and placed into a stereotaxic apparatus (David Kopf model 940). An incision was made to expose the skull and a small hole was drilled 5.9 mm posterior and 0 mm medial/lateral from bregma. A pulled glass micropipette (20-40 &#x3BC;m diameter tip) was used for stereotaxic injections of adeno-associated virus (AAV). Three injections, 6.0 mm ventral to bregma, at medial/lateral &#x2212;0.15 mm, 0 mm, and +0.15 mm were used to target the medullary raphe. Virus was injected (15 nl per injection) by an air pressure system using picoliter air puffs through a solenoid valve (Clippard EV 24VDC) pulsed by a Grass S48 stimulator to control injection speed (20 nl min<sup>&#x2212;1</sup>). The pipette was removed 1 minute after each injection and, upon completion of the final injection, the incision was closed using Vetbond tissue adhesive (3M). Subcutaneous injection of sustained release Meloxicam (4 mg kg<sup>&#x2212;1</sup>) was provided as postoperative care. Chemogenetic experiments utilized AAV8-hSyn-DIO-hM3Dq-mCherry packaged at the Boston Children&#x2019;s Hospital Viral Core (Addgene plasmid 44361; donating investigator, Dr. Bryan Roth). Animals were allowed to recover from stereotaxic surgery a minimum of 21 days prior to initiation of any experiments. Following each experimental procedure, accuracy of AAV injections was confirmed via post-hoc histological analysis of mCherry fluorescent protein reporters. All subjects determined to be surgical &#x201C;misses&#x201D; based on little or absent reporter expression were removed from analyses.</p>
      </sec>
      <sec id="S28">
        <title>Histology</title>
        <p id="P44">Mice were terminally anesthetized with 7% choral hydrate (500 mg kg<sup>&#x2212;1</sup>; Sigma Aldrich) diluted in saline and transcardially perfused first with 0.1 M phosphate-buffered saline (PBS) then 10% neutral-buffered formalin solution (NBF; Thermo Fisher Scientific). Brains were extracted and post-fixed overnight at 4&#xB0; C in NBF. The next day brains were switched to PBS containing 20% sucrose for cryoprotection. Finally, brains were sectioned coronally at 30 &#x3BC;m on a freezing microtome (Leica Biosystems), and stored in cryoprotectant solution at &#x2212;20&#xB0; C until used for immunofluorescence. For immunofluorescence, Brain tissue sections were washed 3X in PBS prior to a blocking step containing 3% normal donkey serum and 0.4% Triton X-100 in PBS for one hour at room temperature. Primary antibody was prepared in the same blocking solution and incubated overnight at the following concentrations: Rat anti-mCherry (Life Technologies - M11217) 1:3,000, Rabbit anti- c-Fos (EMD Millipore - ABE457) 1:3,000. The next day sections were washed 5X in PBS, then incubated for 2 hours at room temperature in Alexa Fluor fluorescent secondary antibody (Life Technologies; 1:1,000) prepared in blocking solution. Finally, sections were washed 3X in PBS, mounted on gelatin-coated slides, and coverslipped with Vectashield mounting media containing DAPI (Vector Labs). Fluorescent images were captured using an Olympus VS120 slide-scanning microscope.</p>
      </sec>
      <sec id="S29">
        <title>Chemogenetic activation of BAT assay</title>
        <p id="P45">To monitor BAT response in real time, temperature probes (Bio Medic Data Systems, IPTT-300) were implanted into the interscapular region of mice and temperature was read with a transponder (Bio Medic Data Systems, DAS-7007R). To activate sympathetic neurons, mice were i.p. injected with saline or Clozapine N-oxide (Sigma, C0832) at 1 mg/kg.</p>
      </sec>
      <sec id="S30">
        <title>Quantitative PCR</title>
        <p id="P46">The following primers were used for qPCR analysis of gene expression: TGF&#x3B2;1-fwd,CCTGTCCAAACTAAGGC; rev,GGTTTTCTCATAGATGGCG; Ncor2 fwd ACTGCCGCCCCTAAACGCAC; rev GGACCTCGGGATGCCTTGCG; Col1a1 F TAG GCC ATT GTG TAT GCA GC; Col1a1 R: ACA TGT TCA GCT TTG TGG ACC; Col3a1 F: TAG GAC TGA CCA AGG TGG CT; Col3a1 R: GGA ACC TGG TTT CTT CTC ACC; Col5a1 F: AAG CGT GGG AAA CTG CTC TCC TAT; Col5a1 R: AGC AGT TGT AGG TGA CGT TCT GGT; IL17F-F: CTG GAG GAT AAC ACT GTG AGA GT; IL17F-R: TGC TGA ATG GCG ACG GAG TTC; Il17A F: CTC CAG AAG GCC CTC AGA CTA C; Il17A R: AGC TTT CCC TCC GCA TTG ACA CAG; Actb F: GGTCCACACCCGCCACCA; R: CACATGCCGGAGCCGTTGTC; Cyclophilin F: F:GGAGATGGCACAGGAGGAA; R:GCCCGTAGTGCTTCAGCTT; Primers for other genes were described previously<sup><xref rid="R44" ref-type="bibr">44</xref></sup>.</p>
      </sec>
      <sec id="S31">
        <title>Data reporting</title>
        <p id="P47">No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.</p>
      </sec>
    </sec>
    <sec sec-type="extended-data" id="S32">
      <title>Extended Data</title>
      <fig id="F4" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 1</label>
        <caption>
          <p id="P48">&#x3B3;&#x3B4;T cells promote adaptive thermogenesis.</p>
          <p id="P49"><bold>a,</bold> Reduced oxygen consumption (VO2) of Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice during cold exposure measured by indirect calorimetry (n=9 mice). Data are mean &#xB1; SEM and analyzed by Two-way ANOVA. <bold>b</bold>, Increased lipid accumulation in the BAT of Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice (H&amp;E histology), scale bar=100um. Data represent at least 2-3 independent experiments with similar results. <bold>c</bold>, No significant difference of food intake and physical movement in WT and Tcr&#x3B4; KO mice by indirect calorimetry (n=9 mice). <bold>d,</bold> No significant change of EMG RMS muscle activity in WT and Tcr&#x3B4; KO mice during cold exposure (n=4 mice). <bold>e,</bold> A significant population of &#x3B3;&#x3B4;T cells in BAT are V&#x3B3;6V&#x3B4;1+ (n=6 mice). <bold>f,</bold> Flow cytometry analysis of &#x3B3;&#x3B4; &#x3A4; cells in BAT. <bold>g,</bold> cold exposure (6hr) upregulate IL-17F mRNA in BAT (n=5 mice). Data represent at least 2-3 independent experiments with similar results. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA</p>
        </caption>
        <graphic xlink:href="nihms-1546843-f0004"/>
      </fig>
      <fig id="F5" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 2</label>
        <caption>
          <p id="P50">IL-17RC deficiency predispose mice to cold sensitivity and obesity.</p>
          <p id="P51"><bold>a, b,</bold> Il17rc mRNA expression level shown by translating ribosomal affinity purification (TRAP) from (<bold>a</bold>) ADIPONECTIN positive cells (ADIPONECTIN-TRAP) (n=3 mice)and (<bold>b</bold>) UCP1-positive cells (UCP1-TRAP, BAT) (BAT, iWAT n=3 mice; eWAT n=2 mice); <bold>c,</bold> Il17ra<sup>&#x2212;/&#x2212;</sup> mice are not sensitive to cold exposure (WT n=13, Il17ra<sup>&#x2212;/&#x2212;</sup>n=10 mice). <bold>d,</bold> Increased lipid accumulation in the BAT of AdIl17RCKO mice (H&amp;E histology), scale bar =100um. Data represent at least 2-3 independent experiments with similar results. <bold>e,</bold> UCP1-Cre;Il17rcfl/fl KO mice are sensitive to acute cold exposure (WT n=7, UCP1-Cre;Il17rcfl/fl KO n=6 mice). <bold>f,</bold> AdIl17RCKO;V&#x3B3;6V&#x3B4;1 transgenic mice are sensitive to acute cold exposure (WT n=8; AdIl17RCKO;V&#x3B3;6V&#x3B4;1, AdIl17RCKO n=5 mice). <bold>g,</bold> Decreased high fat diet-induced oxygen consumption (VO2) by indirect calorimetry (2wks after the start of high fat diet feeding) (n=8 mice). <bold>h, i,</bold> Physical movement (X-total counts) and food intake are not different in WT and AdIl17RCKO mice (n=8). <bold>j, k,</bold> iWAT (<bold>j</bold>) and eWAT (<bold>k</bold>)H&amp;E histology of HFD treated WT and AdIl17RCKO mice (n=8 mice). Scale bar =50um. Data represent at least 2-3 independent experiments with similar results. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA.</p>
        </caption>
        <graphic xlink:href="nihms-1546843-f0005"/>
      </fig>
      <fig id="F6" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 3</label>
        <caption>
          <p id="P52">IL-17RC signaling deficiency impairs sympathetic innervation in adipose and multiple tissue</p>
          <p id="P53">
<bold>a,</bold> Reduced sympathetic innervation of BAT in Rag2 KO mice by TH (green) and tubb3 (yellow) staining (n=6 mice). <bold>b,</bold> Reduced sympathetic innervation of BAT in Il17f<sup>&#x2212;/&#x2212;</sup> but not Il17a<sup>&#x2212;/&#x2212;</sup> mice by TH (green) and tubb3 (yellow) staining (WT n=6, Il17f<sup>&#x2212;/&#x2212;</sup> n=5, Il17a<sup>&#x2212;/&#x2212;</sup> n=3 mice). Data are mean &#xB1; SEM and analyzed by One-way ANOVA and Bonferroni&#x2019;s multiple comparisons test. Scale bar=50um. <bold>c,</bold> Reduced sympathetic innervation of iWAT in AdIl17RCKO mice by TH staining (n=6 mice). Scale bar=100um. <bold>d</bold>, FOS immunoreactivity and thermogenic response to CNO administration. Scale bars, 100 &#x3BC;m. Data represent 2-3 independent experiments with similar results. <bold>e,</bold> Forced expression of S100b by s100b-AAV rescues the cold sensitivity in AdIl17RCKO mice (n=5 mice). <bold>f,</bold> Decreased lipid accumulation in the s100b-AAV treated BAT (H&amp;E histology). Data represent 2 independent experiments with similar results. <bold>g,</bold> Forced expression of S100b by s100b-AAV increases adipose innervation in AdIl17RCKO mice by TH (green) and TUBB3 (yellow) staining (n=6 mice). <bold>h,</bold> Forced expression of Clstn3&#x3B2; by clstn3&#x3B2;-DIO-AAV rescues the cold sensitivity in AdIl17RCKO mice (n=5 mice). <bold>i,</bold> Decreased lipid accumulation in the clstn3&#x3B2;-AAV treated BAT (H&amp;E histology), scale bar =100um. <bold>j</bold>, Forced expression of clstn3&#x3B2; by clstn3&#x3B2;-DIO-AAV increases adipose innervation in AdIl17RCKO mice by TH (green) and TUBB3 (yellow) staining (n=6 mice). scale bar=50um. Data represent 2 independent experiments with similar results. <bold>k,</bold> Reduced sympathetic innervation of salivary glands (SG) in Il17rc KO mice by TH staining (green) and TUBB3 immunostaining (yellow) of WT and Il17rc KO SG (n=6 mice). <bold>l,</bold> Reduced sympathetic innervation of SG in Tcr&#x3B4; KO, Il17f KO but not Il17a KO mice by TH (green) and TUBB3 (yellow) staining (WT n=6, Tcr&#x3B4; KO n=6, Il17f KO n=6, Il17a KO n=3 mice). Data are mean &#xB1; SEM and analyzed by One-way ANOVA and Bonferroni&#x2019;s multiple comparisons test. <bold>m,</bold> Reduced neuronal innervation of SG in Rag2 KO mice by TH (green) and TUBB3 (yellow) staining. (n=4 mice). <bold>n,</bold> No significant difference of sympathetic innervation of SG in AdIl17rcKO mice by TH (green) and TUBB3 (yellow) staining (n=3 mice). Scale bar=50um. Data represent at least 2-3 independent experiments. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA. <bold>o,</bold> Reduced sympathetic innervation of bronchi in Rag2<sup>&#x2212;/&#x2212;</sup> and Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> mice by TH and TUBB3 staining (WT n=8, Rag2 KO n=3, Tcr&#x3B4; KO n=4, Il17rc KO n=3 mice). Data represent at least 2 independent experiments with similar results. Scale bar=50um. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA.</p>
        </caption>
        <graphic xlink:href="nihms-1546843-f0006"/>
      </fig>
      <fig id="F7" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 4</label>
        <caption>
          <p id="P54">Reduced Tgfb1 and collagen genes in AdIl17rcKO mice</p>
          <p id="P55"><bold>a,</bold> Pathway enrichment analysis of genes downregulated both at the RNA and the protein level in the AdIl17RCKO BAT compared with littermate controls. <bold>b,</bold> Reduced TGF&#x3B2;1, Col1a1, Col3a1, Col5a1 and Ncor2 mRNA expression in BAT of AdIl17rcKO mice (n=3 mice). Data represent at least 2-3 independent experiments. <bold>c, d, e,</bold> Reduced TGF&#x3B2;1 mRNA expression in BAT, SG and Lung of Il17rc KO, Tcr&#x3B4; KO, Il17f KO and Rag2 KO mice (BAT (WT n=7, Il17rc KO n=6; WT n=5, Tcr&#x3B4; KO n=6, Il17f KO n=6; WT, Rag2 KO n=4 mice); SG (WT n=4, Il17rc KO n=4; WT, Tcr&#x3B4; KO, Il17f KO n=3; WT, Rag2 KO n=3 mice); Lung (WT n=5, Il17rc KO n=4; WT n=6, Tcr&#x3B4; KO n=4, Il17f KO n=6; WT, Rag2 KO n=6 mice)). Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test, One-way ANOVA and Bonferroni&#x2019;s multiple comparisons test.</p>
        </caption>
        <graphic xlink:href="nihms-1546843-f0007"/>
      </fig>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 5</label>
        <caption>
          <p id="P56">TGF&#x3B2; blocking sensitize mice to acute cold exposure</p>
          <p id="P57"><bold>a,</bold> Decreased lipid accumulation in the TGF&#x3B2;1-AAV treated BAT (H&amp;E histology). Data represent 2 independent experiments with similar results. <bold>b,</bold> WT mice treated with TGF&#x3B2; neutralizing antibody for 3 weeks are sensitive to cold exposure(n=6 mice). <bold>c,</bold> WT mice treated with TGF&#x3B2; inhibitor for 3 weeks are sensitive to cold exposure(n=8). <bold>d, e,</bold> Forced expression of TGF&#x3B2;1-AAV increases the SG TH (<bold>d)</bold> and TUBB3 (<bold>e</bold>) immuno-staining in Il17rc KO mice (n=6 mice). <bold>f, g</bold>, Forced expression of TGF&#x3B2;1-AAV increases SG TH and TUBB3 immuno-staining in Rag2 KO mice by TH(<bold>f</bold>) and TUBB3 (<bold>g</bold>) staining (n=6 mice). scale bar=50um. Data represent 2-3 independent experiments. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA.</p>
        </caption>
        <graphic xlink:href="nihms-1546843-f0008"/>
      </fig>
    </sec>
  </body>
  <back>
    <ack id="S33">
      <title>Acknowledgements</title>
      <p id="P58">We thank Marie L. Mather from Dr. Eleftheria Maratos-Flier&#x2019;s lab, Dr. Eleftheria Maratos-Flier, Ryan Garrity, and Zhaoming Deng, Amir Mina and Dimitrije Cabarkapa from Alex Banks&#x2019; lab for help with CLAMS studies. We thank Dr. Sarah L. Gaffen and Dr.Yoichiro Iwakura for sharing the IL-17F&#x2212;/&#x2212; mice, Dr. Jay K. Kolls for the IL-17RC<sup>flox/flox</sup> mice, Amgen for the IL-17RC&#x2212;/&#x2212; and IL-17RA&#x2212;/&#x2212; mice. We thank Alexander Mann, Natasha Asinovski and Kimie Hattori for the V&#x3B3;6V&#x3B4;1 Tg mice and 17D1 antibody. We thank Chen Zhao for help with the immunofluorescence staining and confocal imaging analysis. We thank Lawrence Kazak and Edward T Chounchani for help with EMG study. We thank Dr. Rosemary J. Akhurst and Sugandha Basu for sharing mice. We thank Nikon Imaging Center at Harvard Medical School for all imaging studies; the Rodent Histology Core at Harvard Medical School for histology studies; the viral core at Children&#x2019;s Hospital Boston for AAV production; we thank the Neurobiology Department and the Neurobiology Imaging Facility for consultation and instrument availability that supported this work. This facility is supported in part by the Neural Imaging Center as part of an NINDS P30 Core Center grant #NS072030. We thank Zach Herbert, Andrew Caruso and members from the Molecular Biology Core Facilities at the Dana-Farber Cancer Institute for RNAseq analysis. We thank Yi, Dina and all members of the Spiegelman lab, and people form Dr. Mathis&#x2019; lab for help and input in this project. Bo Hu is a Cancer Research Institute/Leonard Kahn Foundation Fellow. C.J. is supported by a K99 Award (CA226400) from the National Cancer Institute (NCI). This work was supported by grants to B.M.S. from the NIH DK 31405 and from the JPB Foundation</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement" id="FN2">
        <p id="P59">Competing interests</p>
        <p id="P60">The authors declare no competing interests.</p>
      </fn>
      <fn id="FN3">
        <p id="P61">Statistics and reproducibility</p>
        <p id="P62">All experiments have been successfully repeated with similar results for at least two to three times.</p>
      </fn>
      <fn id="FN4">
        <p id="P63">Data Availability Statements</p>
        <p id="P64">Any relevant data are available from the corresponding author upon reasonable request.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>Reference</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>McCorry</surname><given-names>LK</given-names></name>
<article-title>Physiology of the autonomic nervous system</article-title>. <source>Am J Pharm Educ</source>
<volume>71</volume>, <fpage>78</fpage>, doi:<pub-id pub-id-type="doi">10.5688/aj710478</pub-id> (<year>2007</year>).<pub-id pub-id-type="pmid">17786266</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Mattson</surname><given-names>MP</given-names></name> &amp; <name><surname>Wan</surname><given-names>R</given-names></name>
<article-title>Neurotrophic factors in autonomic nervous system plasticity and dysfunction</article-title>. <source>Neuromolecular Med</source>
<volume>10</volume>, <fpage>157</fpage>&#x2013;<lpage>168</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s12017-007-8021-y</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18172785</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Furlan</surname><given-names>A</given-names></name>
<etal/>
<article-title>Visceral motor neuron diversity delineates a cellular basis for nipple- and pilo-erection muscle control</article-title>. <source>Nat Neurosci</source>
<volume>19</volume>, <fpage>1331</fpage>&#x2013;<lpage>1340</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nn.4376</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27571008</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Morrison</surname><given-names>SF</given-names></name>
<article-title>Central neural control of thermoregulation and brown adipose tissue</article-title>. <source>Auton Neurosci</source>
<volume>196</volume>, <fpage>14</fpage>&#x2013;<lpage>24</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.autneu.2016.02.010</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">26924538</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Lowell</surname><given-names>BB</given-names></name> &amp; <name><surname>Spiegelman</surname><given-names>BM</given-names></name>
<article-title>Towards a molecular understanding of adaptive thermogenesis</article-title>. <source>Nature</source>
<volume>404</volume>, <fpage>652</fpage>&#x2013;<lpage>660</lpage>, doi:<pub-id pub-id-type="doi">10.1038/35007527</pub-id> (<year>2000</year>).<pub-id pub-id-type="pmid">10766252</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Bachman</surname><given-names>ES</given-names></name>
<etal/>
<article-title>betaAR signaling required for diet-induced thermogenesis and obesity resistance</article-title>. <source>Science</source>
<volume>297</volume>, <fpage>843</fpage>&#x2013;<lpage>845</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1073160</pub-id> (<year>2002</year>).<pub-id pub-id-type="pmid">12161655</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Daniel</surname><given-names>H</given-names></name> &amp; <name><surname>Derry</surname><given-names>DM</given-names></name>
<article-title>Criteria for differentiation of brown and white fat in the rat</article-title>. <source>Can J Physiol Pharmacol</source>
<volume>47</volume>, <fpage>941</fpage>&#x2013;<lpage>945</lpage> (<year>1969</year>).<pub-id pub-id-type="pmid">5353554</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>W</given-names></name>
<etal/>
<article-title>Sympathetic neuro-adipose connections mediate leptin-driven lipolysis</article-title>. <source>Cell</source>
<volume>163</volume>, <fpage>84</fpage>&#x2013;<lpage>94</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.08.055</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26406372</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Cannon</surname><given-names>B</given-names></name> &amp; <name><surname>Nedergaard</surname><given-names>J</given-names></name>
<article-title>Brown adipose tissue: function and physiological significance</article-title>. <source>Physiol Rev</source>
<volume>84</volume>, <fpage>277</fpage>&#x2013;<lpage>359</lpage>, doi:<pub-id pub-id-type="doi">10.1152/physrev.00015.2003</pub-id> (<year>2004</year>).<pub-id pub-id-type="pmid">14715917</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Fedorenko</surname><given-names>A</given-names></name>, <name><surname>Lishko</surname><given-names>PV</given-names></name> &amp; <name><surname>Kirichok</surname><given-names>Y</given-names></name>
<article-title>Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria</article-title>. <source>Cell</source>
<volume>151</volume>, <fpage>400</fpage>&#x2013;<lpage>413</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2012.09.010</pub-id> (<year>2012</year>).<pub-id pub-id-type="pmid">23063128</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Kazak</surname><given-names>L</given-names></name>
<etal/>
<article-title>A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat</article-title>. <source>Cell</source>
<volume>163</volume>, <fpage>643</fpage>&#x2013;<lpage>655</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.09.035</pub-id> (<year>2015</year>).<pub-id pub-id-type="pmid">26496606</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>X</given-names></name>
<etal/>
<article-title>Innervation of thermogenic adipose tissue via a calsyntenin 3beta-S100b axis</article-title>. <source>Nature</source>
<volume>569</volume>, <fpage>229</fpage>&#x2013;<lpage>235</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41586-019-1156-9</pub-id> (<year>2019</year>).<pub-id pub-id-type="pmid">31043739</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Seale</surname><given-names>P</given-names></name>
<etal/>
<article-title>Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice</article-title>. <source>J Clin Invest</source>
<volume>121</volume>, <fpage>96</fpage>&#x2013;<lpage>105</lpage>, doi:<pub-id pub-id-type="doi">10.1172/JCI44271</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21123942</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Chi</surname><given-names>J</given-names></name>
<etal/>
<article-title>Three-Dimensional Adipose Tissue Imaging Reveals Regional Variation in Beige Fat Biogenesis and PRDM16-Dependent Sympathetic Neurite Density</article-title>. <source>Cell Metab</source>
<volume>27</volume>, <fpage>226</fpage>&#x2013;<lpage>236</lpage>
<fpage>e223</fpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2017.12.011</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29320703</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Villarroya</surname><given-names>F</given-names></name>, <name><surname>Cereijo</surname><given-names>R</given-names></name>, <name><surname>Villarroya</surname><given-names>J</given-names></name>, <name><surname>Gavalda-Navarro</surname><given-names>A</given-names></name> &amp; <name><surname>Giralt</surname><given-names>M</given-names></name>
<article-title>Toward an Understanding of How Immune Cells Control Brown and Beige Adipobiology</article-title>. <source>Cell Metab</source>
<volume>27</volume>, <fpage>954</fpage>&#x2013;<lpage>961</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2018.04.006</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29719233</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Sim</surname><given-names>GK</given-names></name>, <name><surname>Olsson</surname><given-names>C</given-names></name> &amp; <name><surname>Augustin</surname><given-names>A</given-names></name>
<article-title>Commitment and maintenance of the alpha beta and gamma delta T cell lineages</article-title>. <source>J Immunol</source>
<volume>154</volume>, <fpage>5821</fpage>&#x2013;<lpage>5831</lpage> (<year>1995</year>).<pub-id pub-id-type="pmid">7751631</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Papotto</surname><given-names>PH</given-names></name>, <name><surname>Ribot</surname><given-names>JC</given-names></name> &amp; <name><surname>Silva-Santos</surname><given-names>B</given-names></name> IL-17(<issue>+</issue>) <article-title>gammadelta T cells as kick-starters of inflammation</article-title>. <source>Nat Immunol</source>
<volume>18</volume>, <fpage>604</fpage>&#x2013;<lpage>611</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ni.3726</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">28518154</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Vantourout</surname><given-names>P</given-names></name> &amp; <name><surname>Hayday</surname><given-names>A</given-names></name>
<article-title>Six-of-the-best: unique contributions of gammadelta T cells to immunology</article-title>. <source>Nat Rev Immunol</source>
<volume>13</volume>, <fpage>88</fpage>&#x2013;<lpage>100</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nri3384</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23348415</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Cua</surname><given-names>DJ</given-names></name> &amp; <name><surname>Tato</surname><given-names>CM</given-names></name>
<article-title>Innate IL-17-producing cells: the sentinels of the immune system</article-title>. <source>Nat Rev Immunol</source>
<volume>10</volume>, <fpage>479</fpage>&#x2013;<lpage>489</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nri2800</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20559326</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>C</given-names></name>
<etal/>
<article-title>Commensal Microbiota Promote Lung Cancer Development via gammadelta T Cells</article-title>. <source>Cell</source>
<volume>176</volume>, <fpage>998</fpage>&#x2013;<lpage>1013</lpage>
<fpage>e1016</fpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.12.040</pub-id> (<year>2019</year>).<pub-id pub-id-type="pmid">30712876</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>AW</given-names></name> &amp; <name><surname>Gaffen</surname><given-names>SL</given-names></name> IL-17RC: a partner in IL-17 signaling and beyond. <source>Semin Immunopathol</source>
<volume>32</volume>, <fpage>33</fpage>&#x2013;<lpage>42</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s00281-009-0185-0</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20012905</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>W</given-names></name> &amp; <name><surname>Dong</surname><given-names>C</given-names></name>
<article-title>IL-17 cytokines in immunity and inflammation</article-title>. <source>Emerg Microbes Infect</source>
<volume>2</volume>, <fpage>e60</fpage>, doi:<pub-id pub-id-type="doi">10.1038/emi.2013.58</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">26038490</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Ouyang</surname><given-names>W</given-names></name>, <name><surname>Kolls</surname><given-names>JK</given-names></name> &amp; <name><surname>Zheng</surname><given-names>Y</given-names></name>
<article-title>The biological functions of T helper 17 cell effector cytokines in inflammation</article-title>. <source>Immunity</source>
<volume>28</volume>, <fpage>454</fpage>&#x2013;<lpage>467</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2008.03.004</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18400188</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Iwakura</surname><given-names>Y</given-names></name>, <name><surname>Ishigame</surname><given-names>H</given-names></name>, <name><surname>Saijo</surname><given-names>S</given-names></name> &amp; <name><surname>Nakae</surname><given-names>S</given-names></name>
<article-title>Functional specialization of interleukin-17 family members</article-title>. <source>Immunity</source>
<volume>34</volume>, <fpage>149</fpage>&#x2013;<lpage>162</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.012</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21349428</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>L</given-names></name>
<etal/>
<article-title>Identification of spinal circuits involved in touch-evoked dynamic mechanical pain</article-title>. <source>Nature Neuroscience</source>
<volume>20</volume>, <fpage>804</fpage>&#x2013;<lpage>814</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nn.4549</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">28436981</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Starnes</surname><given-names>T</given-names></name>
<etal/>
<article-title>Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production</article-title>. <source>J Immunol</source>
<volume>167</volume>, <fpage>4137</fpage>&#x2013;<lpage>4140</lpage>, doi:<pub-id pub-id-type="doi">10.4049/jimmunol.167.8.4137</pub-id> (<year>2001</year>).<pub-id pub-id-type="pmid">11591732</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Brionne</surname><given-names>TC</given-names></name>, <name><surname>Tesseur</surname><given-names>I</given-names></name>, <name><surname>Masliah</surname><given-names>E</given-names></name> &amp; <name><surname>Wyss-Coray</surname><given-names>T</given-names></name>
<article-title>Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain</article-title>. <source>Neuron</source>
<volume>40</volume>, <fpage>1133</fpage>&#x2013;<lpage>1145</lpage>, doi:<pub-id pub-id-type="doi">10.1016/s0896-6273(03)00766-9</pub-id> (<year>2003</year>).<pub-id pub-id-type="pmid">14687548</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Krieglstein</surname><given-names>K</given-names></name>, <name><surname>Strelau</surname><given-names>J</given-names></name>, <name><surname>Schober</surname><given-names>A</given-names></name>, <name><surname>Sullivan</surname><given-names>A</given-names></name> &amp; <name><surname>Unsicker</surname><given-names>K</given-names></name>
<article-title>TGF-beta and the regulation of neuron survival and death</article-title>. <source>J Physiol Paris</source>
<volume>96</volume>, <fpage>25</fpage>&#x2013;<lpage>30</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">11755780</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Kohlgruber</surname><given-names>AC</given-names></name>
<etal/>
<article-title>gammadelta T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis</article-title>. <source>Nat Immunol</source>
<volume>19</volume>, <fpage>464</fpage>&#x2013;<lpage>474</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41590-018-0094-2</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29670241</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Sulaiman</surname><given-names>W</given-names></name> &amp; <name><surname>Nguyen</surname><given-names>DH</given-names></name>
<article-title>Transforming growth factor beta 1, a cytokine with regenerative functions</article-title>. <source>Neural Regen Res</source>
<volume>11</volume>, <fpage>1549</fpage>&#x2013;<lpage>1552</lpage>, doi:<pub-id pub-id-type="doi">10.4103/1673-5374.193223</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27904475</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <ref-list>
      <title>Methods Reference</title>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>P</given-names></name>
<etal/>
<article-title>Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation</article-title>. <source>Immunity</source>
<volume>44</volume>, <fpage>659</fpage>&#x2013;<lpage>671</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.007</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">26982366</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Eguchi</surname><given-names>J</given-names></name>
<etal/>
<article-title>Transcriptional control of adipose lipid handling by IRF4</article-title>. <source>Cell Metab</source>
<volume>13</volume>, <fpage>249</fpage>&#x2013;<lpage>259</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2011.02.005</pub-id> (<year>2011</year>).<pub-id pub-id-type="pmid">21356515</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>L</given-names></name>
<etal/>
<article-title>Identification of spinal circuits involved in touch-evoked dynamic mechanical pain</article-title>. <source>Nat Neurosci</source>
<volume>20</volume>, <fpage>804</fpage>&#x2013;<lpage>814</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nn.4549</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">28436981</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Gerhart-Hines</surname><given-names>Z</given-names></name>
<etal/>
<article-title>The nuclear receptor Rev-erbalpha controls circadian thermogenic plasticity</article-title>. <source>Nature</source>
<volume>503</volume>, <fpage>410</fpage>&#x2013;<lpage>413</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature12642</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">24162845</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Emmett</surname><given-names>MJ</given-names></name>
<etal/>
<article-title>Histone deacetylase 3 prepares brown adipose tissue for acute thermogenic challenge</article-title>. <source>Nature</source>
<volume>546</volume>, <fpage>544</fpage>&#x2013;<lpage>548</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature22819</pub-id> (<year>2017</year>).<pub-id pub-id-type="pmid">28614293</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Roark</surname><given-names>CL</given-names></name>
<etal/>
<article-title>Subset-specific, uniform activation among V gamma 6/V delta 1+ gamma delta T cells elicited by inflammation</article-title>. <source>J Leukoc Biol</source>
<volume>75</volume>, <fpage>68</fpage>&#x2013;<lpage>75</lpage>, doi:<pub-id pub-id-type="doi">10.1189/jlb.0703326</pub-id> (<year>2004</year>).<pub-id pub-id-type="pmid">14525969</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Elias</surname><given-names>JE</given-names></name> &amp; <name><surname>Gygi</surname><given-names>SP</given-names></name>
<article-title>Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry</article-title>. <source>Nat Methods</source>
<volume>4</volume>, <fpage>207</fpage>&#x2013;<lpage>214</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nmeth1019</pub-id> (<year>2007</year>).<pub-id pub-id-type="pmid">17327847</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Huttlin</surname><given-names>EL</given-names></name>
<etal/>
<article-title>A tissue-specific atlas of mouse protein phosphorylation and expression</article-title>. <source>Cell</source>
<volume>143</volume>, <fpage>1174</fpage>&#x2013;<lpage>1189</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2010.12.001</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">21183079</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Dobin</surname><given-names>A</given-names></name>
<etal/>
<article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>
<volume>29</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id> (<year>2013</year>).<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Love</surname><given-names>MI</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name> &amp; <name><surname>Anders</surname><given-names>S</given-names></name>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>
<volume>15</volume>, <fpage>550</fpage>, doi:<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id> (<year>2014</year>).<pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Trapnell</surname><given-names>C</given-names></name>
<etal/>
<article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat Biotechnol</source>
<volume>28</volume>, <fpage>511</fpage>&#x2013;<lpage>515</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nbt.1621</pub-id> (<year>2010</year>).<pub-id pub-id-type="pmid">20436464</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Cornwell</surname><given-names>M</given-names></name>
<etal/>
<article-title>VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis</article-title>. <source>BMC Bioinformatics</source>
<volume>19</volume>, <fpage>135</fpage>, doi:<pub-id pub-id-type="doi">10.1186/s12859-018-2139-9</pub-id> (<year>2018</year>).<pub-id pub-id-type="pmid">29649993</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Hodges</surname><given-names>MR</given-names></name>
<etal/>
<article-title>Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons</article-title>. <source>J Neurosci</source>
<volume>28</volume>, <fpage>2495</fpage>&#x2013;<lpage>2505</lpage>, doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4729-07.2008</pub-id> (<year>2008</year>).<pub-id pub-id-type="pmid">18322094</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>X</given-names></name>
<etal/>
<article-title>Lysine-specific demethylase 1 promotes brown adipose tissue thermogenesis via repressing glucocorticoid activation</article-title>. <source>Genes Dev</source>
<volume>30</volume>, <fpage>1822</fpage>&#x2013;<lpage>1836</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gad.285312.116</pub-id> (<year>2016</year>).<pub-id pub-id-type="pmid">27566776</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <title>&#x3B3;&#x3B4; T cells and adipocyte Il17rc control adaptive thermogenesis.</title>
        <p id="P65"><bold>a, b, c, d,</bold> Rag2<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup>, Tcr&#x3B1;<sup>&#x2212;/&#x2212;</sup> but not muMT<sup>&#x2212;/&#x2212;</sup> mice are sensitive to acute cold exposure (WT littermate n=13, Rag2<sup>&#x2212;/&#x2212;</sup> n=10; WT littermate n=15, muMT<sup>&#x2212;/&#x2212;</sup> n=10; WT littermate n=13, Tcr&#x3B1;<sup>&#x2212;/&#x2212;</sup> n=9; WT littermate n=10, Tcr&#x3B4;<sup>&#x2212;/&#x2212;</sup> n=9 mice). Data are mean &#xB1; SEM and analyzed by Two-way ANOVA. <bold>e,</bold> V&#x3B3;6V&#x3B4;1 transgenic mice are protected from cold exposure (V&#x3B3;6V&#x3B4;1- n=8, V&#x3B3;6V&#x3B4;1+ n=7 mice); Il17f<sup>&#x2212;/&#x2212;</sup> mice (<bold>f</bold>) but not Il17a<sup>&#x2212;/&#x2212;</sup> mice (<bold>g</bold>) are sensitive to acute cold exposure (WT littermate n=10, Il17f<sup>&#x2212;/&#x2212;</sup> n=10, WT littermate n=11, Il17a<sup>&#x2212;/&#x2212;</sup> n=13 mice). Data represent at least 2-3 independent experiments. Data are mean &#xB1; SEM and analyzed by Two-way ANOVA. <bold>h,</bold> Il17rc<sup>&#x2212;/&#x2212;</sup> mice are sensitive to cold exposure (n=9 mice); <bold>i,</bold> AdIl17RCKO mice are sensitive to cold exposure (WT littermate n=11, AdIl17RCKO n=9 mice). <bold>j</bold>, AdIl17RCKO mice are more obese on HFD; <bold>k,</bold> AdIl17RCKO mice have impaired glucose tolerance on HFD; <bold>l, m,</bold> AdIl17RCKO mic have increased lipid droplet deposition in BAT and liver on HFD (n=8 mice). Data represent at least 2-3 independent experiments with similar results. Data are mean &#xB1; SEM and analyzed by Two-way ANOVA.</p>
      </caption>
      <graphic xlink:href="nihms-1546843-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <title>IL-17RC signaling deficiency impairs innervation in brown fat.</title>
        <p id="P66"><bold>a,</bold> AdIl17RCKO mice have reduced oxygen consumption (VO2) after acute cold exposure by indirect calorimetry (n=8 mice). <bold>b,</bold> No significant change of oxygen consumption (VO2) after CL 316,243 injection indirect calorimetry (n=6 mice). Data are mean &#xB1; SEM and analyzed by Two-way ANOVA. <bold>c, d,</bold> Reduced sympathetic innervation of BAT in AdIl17RCKO mice by TH (<bold>c</bold>) and TUBB3 immunostaining; (<bold>d</bold>) of WT and AdIl17RCKO BAT (n=6 mice). Data represent at least 3 independent experiments with similar results <bold>e, f,</bold> Reduced sympathetic innervation of BAT in Tcr&#x3B4; KO mice by TH (<bold>e</bold>) and TUBB3 (<bold>f</bold>) staining. Data represent at least 3 independent experiments with similar results <bold>g, h</bold> Increased sympathetic innervation of BAT in V&#x3B3;6V&#x3B4;1 Tg mice by TH (<bold>g</bold>) and TUBB3 (<bold>h</bold>) staining (n=6 mice). Data represent at least 3 independent experiments with similar results. <bold>i, j,</bold> Thermogenic response to CNO administration in wild-type and Il17rc-knockout mice (WT littermate n= 5, Il17rc KO n= 8 mice) (<bold>i</bold>), and wild-type and V&#x3B3;6V&#x3B4;1 Tg mice (WT littermate n=7, V&#x3B3;6V&#x3B4;1 Tg n=6 mice). (<bold>j</bold>). Scale bar=50um. Data represent at least 2-3 independent experiments with similar results. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA.</p>
      </caption>
      <graphic xlink:href="nihms-1546843-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3.</label>
      <caption>
        <title>IL-17RC promotes sympathetic innervation in BAT through TGF&#x3B2;1 signaling</title>
        <p id="P67"><bold>a, b,</bold> Reduced TGF&#x3B2;1 and Col1a1, Col1a2, Col3a1, Col5a1, Col5a3 and Ncor2 protein expression (<bold>a</bold>) (n=5 mice) and RNA (<bold>b</bold>) (n=3 mice) in AdIl17RCKO BAT. Data are analyzed by unpaired Student&#x2019;s two-sided t-test and as described in the method section <bold>c</bold>, Reduced TGF&#x3B2;1 mRNA in isolated mature adipocytes from AdIl17RCKO BAT (n=3 mice). Data are mean &#xB1; SEM and analyzed by One-way ANOVA and Bonferroni&#x2019;s multiple comparisons test. <bold>d,</bold> Forced expression of TGF&#x3B2;1 by TGF&#x3B2;1-DIO-AAV rescues the cold sensitivity in AdIl17RCKO mice (n=6 mice). <bold>e, f,</bold> Forced expression of TGF&#x3B2;1 by TGF&#x3B2;1-DIO-AAV increases adipose innervation in AdIl17RCKO mice by TH(<bold>e</bold>) and TUBB3 (<bold>f</bold>) staining (n=6 mice). scale bar=50um. Data represent 2-3 independent experiments. Data are mean &#xB1; SEM and analyzed by unpaired Student&#x2019;s two-sided t-test and Two-way ANOVA.</p>
      </caption>
      <graphic xlink:href="nihms-1546843-f0003"/>
    </fig>
  </floats-group>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">36261518</article-id>
      <article-id pub-id-type="pmc">9668749</article-id>
      <article-id pub-id-type="publisher-id">5325</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-05325-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Semi-automated assembly of high-quality diploid human reference genomes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8931-5049</contrib-id>
          <name>
            <surname>Jarvis</surname>
            <given-names>Erich D.</given-names>
          </name>
          <address>
            <email>ejarvis@rockefeller.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7554-5991</contrib-id>
          <name>
            <surname>Formenti</surname>
            <given-names>Giulio</given-names>
          </name>
          <address>
            <email>gformenti@rockefeller.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rhie</surname>
            <given-names>Arang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9744-131X</contrib-id>
          <name>
            <surname>Guarracino</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Chentao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7545-2162</contrib-id>
          <name>
            <surname>Wood</surname>
            <given-names>Jonathan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4805-9058</contrib-id>
          <name>
            <surname>Tracey</surname>
            <given-names>Alan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4957-7807</contrib-id>
          <name>
            <surname>Thibaud-Nissen</surname>
            <given-names>Francoise</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8651-1615</contrib-id>
          <name>
            <surname>Vollger</surname>
            <given-names>Mitchell R.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8414-8966</contrib-id>
          <name>
            <surname>Porubsky</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>Haoyu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Asri</surname>
            <given-names>Mobin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2396-0656</contrib-id>
          <name>
            <surname>Logsdon</surname>
            <given-names>Glennis A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carnevali</surname>
            <given-names>Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5395-1457</contrib-id>
          <name>
            <surname>Chaisson</surname>
            <given-names>Mark J. P.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chin</surname>
            <given-names>Chen-Shan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cody</surname>
            <given-names>Sarah</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Collins</surname>
            <given-names>Joanna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7441-532X</contrib-id>
          <name>
            <surname>Ebert</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0213-4777</contrib-id>
          <name>
            <surname>Escalona</surname>
            <given-names>Merly</given-names>
          </name>
          <xref ref-type="aff" rid="Aff17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6450-7551</contrib-id>
          <name>
            <surname>Fedrigo</surname>
            <given-names>Olivier</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fulton</surname>
            <given-names>Robert S.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fulton</surname>
            <given-names>Lucinda L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garg</surname>
            <given-names>Shilpa</given-names>
          </name>
          <xref ref-type="aff" rid="Aff18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0743-3637</contrib-id>
          <name>
            <surname>Gerton</surname>
            <given-names>Jennifer L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ghurye</surname>
            <given-names>Jay</given-names>
          </name>
          <xref ref-type="aff" rid="Aff20">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Granat</surname>
            <given-names>Anastasiya</given-names>
          </name>
          <xref ref-type="aff" rid="Aff21">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0516-5827</contrib-id>
          <name>
            <surname>Green</surname>
            <given-names>Richard E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harvey</surname>
            <given-names>William</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2319-2482</contrib-id>
          <name>
            <surname>Hasenfeld</surname>
            <given-names>Patrick</given-names>
          </name>
          <xref ref-type="aff" rid="Aff22">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hastie</surname>
            <given-names>Alex</given-names>
          </name>
          <xref ref-type="aff" rid="Aff23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9991-8089</contrib-id>
          <name>
            <surname>Haukness</surname>
            <given-names>Marina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jaeger</surname>
            <given-names>Erich B.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff21">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jain</surname>
            <given-names>Miten</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kirsche</surname>
            <given-names>Melanie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5489-9045</contrib-id>
          <name>
            <surname>Kolmogorov</surname>
            <given-names>Mikhail</given-names>
          </name>
          <xref ref-type="aff" rid="Aff25">25</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2798-3794</contrib-id>
          <name>
            <surname>Korbel</surname>
            <given-names>Jan O.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff22">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1472-8962</contrib-id>
          <name>
            <surname>Koren</surname>
            <given-names>Sergey</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3047-4250</contrib-id>
          <name>
            <surname>Korlach</surname>
            <given-names>Jonas</given-names>
          </name>
          <xref ref-type="aff" rid="Aff26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3492-1102</contrib-id>
          <name>
            <surname>Lee</surname>
            <given-names>Joyce</given-names>
          </name>
          <xref ref-type="aff" rid="Aff23">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7492-3703</contrib-id>
          <name>
            <surname>Li</surname>
            <given-names>Daofeng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff27">27</xref>
          <xref ref-type="aff" rid="Aff28">28</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lindsay</surname>
            <given-names>Tina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lucas</surname>
            <given-names>Julian</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4813-2403</contrib-id>
          <name>
            <surname>Luo</surname>
            <given-names>Feng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff29">29</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9376-1030</contrib-id>
          <name>
            <surname>Marschall</surname>
            <given-names>Tobias</given-names>
          </name>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mitchell</surname>
            <given-names>Matthew W.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff30">30</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1987-0914</contrib-id>
          <name>
            <surname>McDaniel</surname>
            <given-names>Jennifer</given-names>
          </name>
          <xref ref-type="aff" rid="Aff31">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nie</surname>
            <given-names>Fan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff32">32</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Olsen</surname>
            <given-names>Hugh E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2585-3037</contrib-id>
          <name>
            <surname>Olson</surname>
            <given-names>Nathan D.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff31">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pesout</surname>
            <given-names>Trevor</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Potapova</surname>
            <given-names>Tamara</given-names>
          </name>
          <xref ref-type="aff" rid="Aff19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Puiu</surname>
            <given-names>Daniela</given-names>
          </name>
          <xref ref-type="aff" rid="Aff33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Regier</surname>
            <given-names>Allison</given-names>
          </name>
          <xref ref-type="aff" rid="Aff34">34</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruan</surname>
            <given-names>Jue</given-names>
          </name>
          <xref ref-type="aff" rid="Aff35">35</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salzberg</surname>
            <given-names>Steven L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sanders</surname>
            <given-names>Ashley D.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff36">36</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schatz</surname>
            <given-names>Michael C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff24">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schmitt</surname>
            <given-names>Anthony</given-names>
          </name>
          <xref ref-type="aff" rid="Aff37">37</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>Valerie A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Selvaraj</surname>
            <given-names>Siddarth</given-names>
          </name>
          <xref ref-type="aff" rid="Aff37">37</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5252-3434</contrib-id>
          <name>
            <surname>Shafin</surname>
            <given-names>Kishwar</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shumate</surname>
            <given-names>Alaina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4963-8211</contrib-id>
          <name>
            <surname>Stitziel</surname>
            <given-names>Nathan O.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
          <xref ref-type="aff" rid="Aff27">27</xref>
          <xref ref-type="aff" rid="Aff38">38</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stober</surname>
            <given-names>Catherine</given-names>
          </name>
          <xref ref-type="aff" rid="Aff22">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Torrance</surname>
            <given-names>James</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wagner</surname>
            <given-names>Justin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff31">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1516-0480</contrib-id>
          <name>
            <surname>Wang</surname>
            <given-names>Jianxin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff32">32</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wenger</surname>
            <given-names>Aaron</given-names>
          </name>
          <xref ref-type="aff" rid="Aff26">26</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4680-0682</contrib-id>
          <name>
            <surname>Xiao</surname>
            <given-names>Chuanle</given-names>
          </name>
          <xref ref-type="aff" rid="Aff39">39</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zimin</surname>
            <given-names>Aleksey V.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff33">33</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6860-1521</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Guojie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff40">40</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6800-242X</contrib-id>
          <name>
            <surname>Wang</surname>
            <given-names>Ting</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
          <xref ref-type="aff" rid="Aff27">27</xref>
          <xref ref-type="aff" rid="Aff28">28</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4874-2874</contrib-id>
          <name>
            <surname>Li</surname>
            <given-names>Heng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garrison</surname>
            <given-names>Erik</given-names>
          </name>
          <xref ref-type="aff" rid="Aff41">41</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1533-4575</contrib-id>
          <name>
            <surname>Haussler</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff42">42</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hall</surname>
            <given-names>Ira</given-names>
          </name>
          <xref ref-type="aff" rid="Aff43">43</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zook</surname>
            <given-names>Justin M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff31">31</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8246-4014</contrib-id>
          <name>
            <surname>Eichler</surname>
            <given-names>Evan E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2983-8934</contrib-id>
          <name>
            <surname>Phillippy</surname>
            <given-names>Adam M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paten</surname>
            <given-names>Benedict</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2237-513X</contrib-id>
          <name>
            <surname>Howe</surname>
            <given-names>Kerstin</given-names>
          </name>
          <address>
            <email>kj2@sanger.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Miga</surname>
            <given-names>Karen H.</given-names>
          </name>
          <address>
            <email>khmiga@ucsc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author" id="IAu1">
          <collab>Human Pangenome Reference Consortium</collab>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.134907.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2166 1519</institution-id><institution>Vertebrate Genome Laboratory, </institution><institution>The Rockefeller University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.413575.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 1581</institution-id><institution>Howard Hughes Medical Institute, </institution></institution-wrap>Chevy Chase, MD USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution>Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, </institution><institution>National Institutes of Health, </institution></institution-wrap>Bethesda, MD USA </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.510779.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 9414 6915</institution-id><institution>Genomics Research Centre, Human Technopole, </institution><institution>Viale Rita Levi-Montalcini, </institution></institution-wrap>Milan, Italy </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.21155.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2034 1839</institution-id><institution>BGI-Shenzhen, </institution></institution-wrap>Shenzhen, China </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.10306.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0606 5382</institution-id><institution>Tree of Life, </institution><institution>Wellcome Sanger Institute, </institution></institution-wrap>Cambridge, UK </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution>National Center for Biotechnology Information, National Library of Medicine, </institution><institution>National Institutes of Health, </institution></institution-wrap>Bethesda, MD USA </aff>
        <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000000122986657</institution-id><institution>Department of Genome Sciences, </institution><institution>University of Washington School of Medicine, </institution></institution-wrap>Seattle, WA USA </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Department of Data Sciences, </institution><institution>Dana-Farber Cancer Institute, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Biomedical Informatics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>UC Santa Cruz Genomics Institute, </institution><institution>University of California, </institution></institution-wrap>Santa Cruz, CA USA </aff>
        <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.507326.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 6090 4941</institution-id><institution>Chan Zuckerberg Initiative, </institution></institution-wrap>Redwood City, CA USA </aff>
        <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution>Quantitative and Computational Biology, </institution><institution>University of Southern California, </institution></institution-wrap>Los Angeles, CA USA </aff>
        <aff id="Aff14"><label>14</label>Foundation for Biological Data Science, Belmont, CA USA </aff>
        <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>McDonnell Genome Institute, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, MO USA </aff>
        <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.411327.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9917</institution-id><institution>Institute for Medical Biometry and Bioinformatics, Medical Faculty, </institution><institution>Heinrich Heine University, </institution></institution-wrap>D&#xFC;sseldorf, Germany </aff>
        <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>Department of Biomolecular Engineering, </institution><institution>University of California Santa Cruz, </institution></institution-wrap>Santa Cruz, CA USA </aff>
        <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Department of Biology, </institution><institution>University of Copenhagen, </institution></institution-wrap>Copenhagen, Denmark </aff>
        <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.250820.d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9420 1591</institution-id><institution>Stowers Institute for Medical Research, </institution></institution-wrap>Kansas City, MO USA </aff>
        <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.504403.6</institution-id><institution>Dovetail Genomics, </institution></institution-wrap>Scotts Valley, CA USA </aff>
        <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.185669.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3954</institution-id><institution>Illumina, Inc., </institution></institution-wrap>San Diego, CA USA </aff>
        <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.4709.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0495 846X</institution-id><institution>European Molecular Biology Laboratory, </institution><institution>Genome Biology Unit, </institution></institution-wrap>Heidelberg, Germany </aff>
        <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.470262.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0473 1353</institution-id><institution>Bionano Genomics, </institution></institution-wrap>San Diego, CA USA </aff>
        <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Computer Science, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD USA </aff>
        <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Computer Science and Engineering, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA USA </aff>
        <aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.423340.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0640 9878</institution-id><institution>Pacific Biosciences, </institution></institution-wrap>Menlo Park, CA USA </aff>
        <aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>Department of Genetics, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, MO USA </aff>
        <aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>The Edison Family Center for Genome Sciences and Systems Biology, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, MO USA </aff>
        <aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.26090.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0665 0280</institution-id><institution>School of Computing, </institution><institution>Clemson University, </institution></institution-wrap>Clemson, SC USA </aff>
        <aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.282012.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0627 5048</institution-id><institution>Coriell Institute for Medical Research, </institution></institution-wrap>Camden, NJ USA </aff>
        <aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.94225.38</institution-id><institution-id institution-id-type="ISNI">000000012158463X</institution-id><institution>Material Measurement Laboratory, </institution><institution>National Institute of Standards and Technology, </institution></institution-wrap>Gaithersburg, MD USA </aff>
        <aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution>Hunan Provincial Key Lab on Bioinformatics, School of Computer Science and Engineering, </institution><institution>Central South University, </institution></institution-wrap>Changsha, China </aff>
        <aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Biomedical Engineering, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD USA </aff>
        <aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.511991.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 5831</institution-id><institution>DNAnexus, </institution></institution-wrap>Mountain View, CA USA </aff>
        <aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.410727.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0526 1937</institution-id><institution>Agricultural Genomics Institute, </institution><institution>Chinese Academy of Agricultural Sciences, </institution></institution-wrap>Shenzhen, China </aff>
        <aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.419491.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 1014 0849</institution-id><institution>Berlin Institute for Medical Systems Biology, </institution><institution>Max Delbr&#xFC;ck Center for Molecular Medicine in the Helmholtz Association (MDC), </institution></institution-wrap>Berlin, Germany </aff>
        <aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.504177.0</institution-id><institution>Arima Genomics, </institution></institution-wrap>San Diego, CA USA </aff>
        <aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.4367.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2355 7002</institution-id><institution>Cardiovascular Division, John T. Milliken Department of Internal Medicine, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, USA </aff>
        <aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.12981.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2360 039X</institution-id><institution>State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, </institution><institution>Sun Yat-sen University, </institution></institution-wrap>Guangzhou, China </aff>
        <aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.13402.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 1759 700X</institution-id><institution>Center for Evolutionary &amp; Organismal Biology, </institution><institution>Zhejiang University School of Medicine, </institution></institution-wrap>Hangzhou, China </aff>
        <aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.267301.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9246</institution-id><institution>Department of Genetics, Genomics and Informatics, </institution><institution>University of Tennessee Health Science Center, </institution></institution-wrap>Memphis, TN USA </aff>
        <aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.205975.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0740 6917</institution-id><institution>Department of Ecology and Evolutionary Biology, </institution><institution>University of California Santa Cruz, </institution></institution-wrap>Santa Cruz, CA USA </aff>
        <aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>10</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>10</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>611</volume>
      <issue>7936</issue>
      <fpage>519</fpage>
      <lpage>531</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>12</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">The current human reference genome, GRCh38, represents over 20 years of effort to generate a high-quality assembly, which has benefitted society<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. However, it still has many gaps and errors, and does not represent a biological genome as it is a blend of multiple individuals<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Recently, a high-quality telomere-to-telomere reference, CHM13, was generated with the latest long-read technologies, but it was derived from a hydatidiform mole cell line with a nearly homozygous genome<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. To address these limitations, the Human Pangenome Reference Consortium formed with the goal of creating high-quality, cost-effective, diploid genome assemblies for a pangenome reference that represents human genetic diversity<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Here, in our first scientific report, we determined which combination of current genome sequencing and assembly approaches yield the most complete and accurate diploid genome assembly with minimal manual curation. Approaches that used highly accurate long reads and parent&#x2013;child data with graph-based haplotype phasing during assembly outperformed those that did not. Developing a combination of the top-performing methods, we generated our first high-quality diploid reference assembly, containing only approximately four gaps per chromosome on average, with most chromosomes within &#xB1;1% of the length of CHM13. Nearly 48% of protein-coding genes have non-synonymous amino acid changes between haplotypes, and centromeric regions showed the highest diversity. Our findings serve as a foundation for assembling near-complete diploid human genomes at scale for a pangenome reference to capture global genetic variation from single nucleotides to structural rearrangements.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Which combination of current genome sequencing and assembly approaches results in high-quality, complete diploid genome assemblies is determined.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Genome assembly algorithms</kwd>
        <kwd>Centromeres</kwd>
        <kwd>Genomics</kwd>
        <kwd>Genetic variation</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">The initial draft of the human reference genome was the outcome of over a decade of effort by the Human Genome Project (HGP), with cost exceeding US$2.7 billion (over US$5 billion at today&#x2019;s value)<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. Its current build, GRCh38, reflects another decade of additional effort by the Genome Reference Consortium and others to correct the primary assembly. It was created from physical maps of thousands of individually sequenced 40&#x2013;2,000-kb bacterial artificial chromosomes (BACs), yeast artificial chromosomes (YACs) and fosmid clones, supplemented with whole-genome sequence data<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. It is a combination of DNA sequences from 20 anonymous volunteers, with one individual representing approximately 70% of the sequence<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Over the years, the primary assembly was improved from having over 150,000 gaps to just 995 gaps in the current GRCh38 assembly<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Therefore, despite being one of the most complete human reference genomes available, GRCh38 represents an incomplete composite and does not adequately capture the spectrum of human global genomic variation<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>.</p>
      <p id="Par4">In the years following the HGP, several technological limitations prevented the generation of new human reference genomes of similar or higher quality at scale. Sequence duplications much larger than the sequence read lengths are particularly challenging to assemble. Although resequencing efforts using less expensive short reads contributed to revealing more single-nucleotide variation (SNV), these&#xA0;SNVs, and more so structural variations (SVs), are not fully captured<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. The sequencing enzymes used often have difficulty reading through regions with complex structures, such as GC-rich regions found in promoters that regulate gene expression<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. It is also now clear that merging diverse haplotypes into a single haploid assembly, even from the same individual, introduces multiple types of errors<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>, including: switch errors in which variants from each haplotype are assembled into the same pseudo-haplotype; false duplications and associated gaps in which more divergent haplotype homologues are assembled as separate false paralogues; and nucleotide consensus errors due to collapses between haplotypes. One also needs diploid assemblies to: separately assemble the X and Y sex chromosomes; determine maternal and paternal gene expression imprinting, which can lead to haplotype-specific diseases<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>; and determine functional consequences of allele combinations that co-segregate on the same haplotype<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>.</p>
      <p id="Par5">Major improvements have since been made in sequence read lengths<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>, long read nucleotide accuracy<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, contig algorithms, scaffolding contigs into chromosomes<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR18">18</xref>&#x2013;<xref ref-type="bibr" rid="CR20">20</xref></sup>, haplotype phasing<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x2013;<xref ref-type="bibr" rid="CR23">23</xref></sup> and technologies with reduced sequencing cost. These advances include those made by the Vertebrate Genomes Project (VGP)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, the Human Genome Structural Variation Consortium (HGSVC)<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and the Telomere-to-Telomere (T2T) consortium, which produced the first complete human reference genome, of the CHM13 cell line<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. CHM13 originated from a hydatidiform mole, in which an ovum without maternal chromosomes was fertilized by one sperm, which then duplicated its DNA, leading to two nearly identical paternal haploid complements with an X chromosome (46,XX), eliminating the need to separate haplotypes and purge associated diploid assembly errors. Completing the T2T-CHM13 assembly also required a substantial amount of manual curation by dozens of people over many months, with different groups focused on each chromosome. Thus, despite improvements, additional developments are needed to assemble diploid genomes at high quality and at scale, which we believe to be critical for clinically relevant samples and understanding human genetic variation.</p>
      <p id="Par6">To help overcome these limitations, in 2019 the National Human Genome Research Institute (NHGRI) invested in an international Human Pangenome Reference Consortium (HPRC), with an aspired goal of producing a high-quality pangenome reference representing over 99% of human genetic diversity for minor alleles of at least 1% or higher frequency in the human population<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. We estimate that one could start to approach this goal with complete de novo assemblies of approximately 450 individuals (for example, 900 haplotypes) from the world population (Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>). That is, a primary goal of the HPRC is to build high-quality diploid assemblies from multiple individuals and then merge them to build a pangenome graph<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Starting in 2020, we tested the current best practices in sequencing technologies and automated assembly algorithms on one human sample, HG002, an openly consented Ashkenazi individual from the Personal Genome Project<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. We included parental samples (HG003-father and HG004-mother) for trio-based assemblies, in which parental sequence data were used to sort haplotypes in the offspring sequence data<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. Extensive evaluation of the resulting assemblies alongside GRCh38 and CMH13 led to new approaches that yielded the best values in over 60 metrics and new biological discoveries, including uncovering more genetic variation between haplotypes. We also identified areas of needed improvement to achieve automated complete and error-free diploid genome assemblies.</p>
    </sec>
    <sec id="Sec2">
      <title>Data types and algorithms</title>
      <p id="Par7">We chose HG002 because of available previous extensive public data<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> and variant benchmarks<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> generated by the Genome in a Bottle (GIAB) consortium. As a male sample, it enables the assembly and evaluation of both X and Y chromosomes. We obtained or generated additional state-of-the-art sequence data types, including PacBio HiFi long reads and Oxford Nanopore (ONT) long reads (more than 10&#x2009;kb) for generating contigs, and long-range link information (for example, 10X linked reads, Hi-C linked reads, optical maps and Strand-seq) for scaffolding the contigs (Supplementary Table <xref rid="MOESM4" ref-type="media">1</xref>). These choices were made on the basis of lessons learned for producing high-quality assemblies from other consortia (for example, VGP<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, T2T<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and HGSVC<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>) or individual laboratories<sup><xref ref-type="bibr" rid="CR27">27</xref>&#x2013;<xref ref-type="bibr" rid="CR29">29</xref></sup>. In particular, long-read-based assemblies are more contiguous and more structurally accurate than short-read-based assemblies, long-range linking information can place contigs into chromosome-level scaffolds, and haplotype phasing and high base accuracy help to prevent false duplications and other common assembly errors.</p>
      <p id="Par8">We generated the high-molecular-weight DNA from an early passage (#4-10) HG002 immortalized lymphoblastoid cell line (LCL) derived from B lymphocytes, because cell lines are easier to isolate high-quality DNA, can be returned to without new blood collections and are useful for future functional gene experiments in a given genetic background. We analysed chromosome status in mitotic chromosome spreads of the LCL and found most spreads maintained a diploid 46,XY karyotype, with a small proportion being tetraploid <bold>(</bold>Supplementary Fig. <xref rid="MOESM1" ref-type="media">1a,b</xref>). We also did not observe large-scale within and between structural chromosomal abnormalities. A minor frequency of tetraploid karyotypes should not present a major concern for assembly as it is an exact genome doubling event.</p>
      <p id="Par9">We made an open call to the international genome community for an assembly bakeoff (that is, assemblathon) to produce the most complete and highest-quality, automated genome assembly possible of HG002 with the data provided (<ext-link ext-link-type="uri" xlink:href="https://humanpangenome.org/hg002/">https://humanpangenome.org/hg002/</ext-link>). We generated high sequence coverage for all technologies, so that different coverage levels could be tested, but asked that all assemblers test at least the same downsampled manufacturer recommended levels to prevent coverage as a variable when comparing different assembly algorithms. We received 23 assembly combinations, from 14 groups, including HPRC members, that used different data types and algorithms for contiging, scaffolding and/or haplotype phasing when attempted (Table <xref rid="Tab1" ref-type="table">1</xref>); we named them asm1 to asm23, with suffixes a/b for haplotypes. Among these 23, 12 assembly algorithms were used: Canu and HiCanu<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, CrossStitch, DipAsm<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, FALCON Unzip<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, Flye<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, hifiasm<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, Maryland Super-Read Celera Assembler (MaSuRCA)<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, NECAT<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, Peregrine<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, Shasta<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> and wtdbg<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> (Table <xref rid="Tab1" ref-type="table">1</xref>). We classified the assemblies into four categories: (1) diploid scaffolded assemblies, which attempted to assemble comparable contigs and scaffolds of both haplotypes or two pseudohaplotypes (mixed paternal and maternal-derived sequences); (2) diploid contig-only assemblies, which attempted to assemble only contigs of both haplotypes and/or pseudohaplotypes or a more complete assembly representing one pseudohaplotype; (3) haploid scaffolded assemblies, in which contigs and scaffolds were merged into one pseudohaplotype; and (4) haploid contig-only assemblies, in which only contigs were generated and merged into one pseudohaplotype (Table <xref rid="Tab1" ref-type="table">1</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2a,b</xref>). CrossStitch and MaSuRCA are reference-based (to GRCh38 in this study), in which MaSuRCA used GRCh38 to order and orient assembled HG002 contigs into chromosome-level scaffolds, followed by gap filling with the GRCh38 sequence. Although these assemblies (asm1, asm15 and asm17) are not &#x2018;pure&#x2019; de novo, they are included to establish a baseline for capturing variation guided by a reference assembly. Following the VGP model<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, we assessed over 60 metrics under 14 categories (Supplementary Table <xref rid="MOESM4" ref-type="media">2</xref>). About one-third of these metrics were calculated with the Merqury <italic>k</italic>-mer analysis tool<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, which we automated. Rather than having a ground-truth, most of these metrics measured the level of consistency of data types relative to the assemblies.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of sequencing and assembly approaches tested</p></caption><table frame="hsides" rules="groups"><thead><tr><th>ID</th><th>Pipeline</th><th>Technologies</th><th>Contigs</th><th>Scaffolders</th><th>Team</th></tr></thead><tbody><tr><td colspan="6"><bold><italic>Diploid contig and scaffold assemblies</italic></bold></td></tr><tr><td>asm23a,b</td><td>Trio VGP</td><td>CLR, 10X, BN and Hi-C</td><td>Trio Canu</td><td>Trio based: Scaff10x, Bionano solve and Salsa</td><td>Rockefeller</td></tr><tr><td>asm10a,b</td><td>DipAsm</td><td>HiFi and HiC</td><td>Peregrine</td><td>DipAsm, 3D-DNA, HapCUT2 and Whatshap</td><td>UCPH</td></tr><tr><td>asm2a,b</td><td>DipAsm HiRise</td><td>HiFi and HiC</td><td>Peregrine</td><td>HiRise and HapCUT2</td><td>Dovetail</td></tr><tr><td>asm22a,b</td><td>DipAsm Salsa</td><td>HiFi and HiC</td><td>Peregrine</td><td>Salsa and HapCUT2</td><td>Dovetail</td></tr><tr><td>asm14a,b</td><td>PGAS</td><td>HiFi and Strand-seq</td><td>Peregrine</td><td>SaaRclust</td><td>HHU + UW</td></tr><tr><td>asm17a,b</td><td>CrossStitch</td><td>HiFi, ONT-UL and HiC</td><td>CrossStitch</td><td>Ref-based to GRCh38 and HapCUT2</td><td>JHU</td></tr><tr><td colspan="6"><bold><italic>Diploid contig assemblies</italic></bold></td></tr><tr><td>asm6a,b</td><td>Trio Flye ONT std</td><td>ONT</td><td>Trio Flye</td><td>NA</td><td>NHGRI</td></tr><tr><td>asm7a,b</td><td>Trio Flye ONT-UL</td><td>ONT-UL more than 100&#x2009;kb</td><td>Trio Flye</td><td>NA</td><td>NHGRI</td></tr><tr><td>asm19a,b</td><td>Trio HiCanu</td><td>HiFi</td><td>Trio HiCanu</td><td>NA</td><td>NHGRI</td></tr><tr><td>asm20a,b</td><td>Trio HiPeregrine</td><td>HiFi</td><td>Trio Peregrine</td><td>NA</td><td>NHGRI</td></tr><tr><td>asm9a,b</td><td>Trio hifiasm</td><td>HiFi</td><td>Trio hifiasm</td><td>NA</td><td>DFCI Harvard</td></tr><tr><td>asm11a,b</td><td>DipAsm HiRise</td><td>HiFi and HiC</td><td>Peregrine</td><td>NA</td><td>UCPH</td></tr><tr><td>asm3a,b</td><td>Peregrine HiFi 25&#x2009;kb</td><td>HiFi long</td><td>Peregrine</td><td>NA</td><td>FBDS</td></tr><tr><td>asm4a,b</td><td>Peregrine HiFi 20&#x2009;kb</td><td>HiFi</td><td>Peregrine</td><td>NA</td><td>FBDS</td></tr><tr><td>asm16a,b</td><td>FALCON Unzip</td><td>HiFi</td><td>FALCON unzip</td><td>NA</td><td>PacBio</td></tr><tr><td>asm8a,b</td><td>HiCanu</td><td>HiFi</td><td>HiCanu and Purge_dups</td><td>NA</td><td>NHGRI</td></tr><tr><td colspan="6"><bold><italic>Merged haploid contig and scaffold assemblies</italic></bold></td></tr><tr><td>asm5</td><td>Flye ONT</td><td>ONT and HiFi</td><td>Flye</td><td>Flye</td><td>UCSD</td></tr><tr><td>asm18</td><td>Shasta ONT HiRise</td><td>ONT-UL and Hi-C</td><td>Shasta</td><td>HiRise</td><td>UCSC-CZI</td></tr><tr><td>asm21</td><td>Shasta ONT Salsa</td><td>ONT-UL and Hi-C</td><td>Shasta</td><td>Salsa2</td><td>UCSC-CZI</td></tr><tr><td>asm15</td><td>MaSuRCA Flye ONT</td><td>ONT-UL more than 120&#x2009;kb and HiFi</td><td>Flye</td><td>Reference based to GRCh38 and MaSuRCA</td><td>JHU</td></tr><tr><td>asm1</td><td>MaSuRCA Combo</td><td>Old ONT, Ill and HiFi</td><td>MaSuRCA</td><td>Reference based to GRCh38 and MaSuRCA</td><td>JHU</td></tr><tr><td colspan="6"><bold><italic>Merged haploid contig assemblies</italic></bold></td></tr><tr><td>asm3a</td><td>Peregrine HiFi 25K</td><td>HiFi long</td><td>Peregrine</td><td>NA</td><td>FBDS</td></tr><tr><td>asm4a</td><td>Peregrine HiFi</td><td>HiFi</td><td>Peregrine</td><td>NA</td><td>FBDS</td></tr><tr><td>asm13</td><td>wtdbg2 HiFi</td><td>HiFi and Ill</td><td>wtdbg2</td><td>NA</td><td>CAAS-AGIS</td></tr><tr><td>asm12</td><td>NECAT ONT</td><td>ONT (no UL)</td><td>NECAT</td><td>NA</td><td>Clemson</td></tr><tr><td colspan="6"><bold><italic>Final diploid</italic></bold></td></tr><tr><td>HPRC mat,pat</td><td>Trio HPRC v1.0</td><td>HiFi, ONT-UL, BN and Hi-C</td><td>Trio hifiasm</td><td>Trio based: Bionano Solve, Salsa, gap fill and curated</td><td>HPRC</td></tr></tbody></table><table-wrap-foot><p>Listed are the 23 assemblies generated, categorized into four broad types based on whether there were diploid or merged haploid, and scaffolded or contigs only. Details on sequencing technologies are in Supplementary Table <xref rid="MOESM4" ref-type="media">1</xref>. Details on assemblers are in Supplementary Table <xref rid="MOESM4" ref-type="media">2a,b</xref>. NA, not applicable.</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec3">
      <title>Contamination and organelle genomes</title>
      <p id="Par10">We screened for non-human DNA and found that all de novo assemblies had between 1 and 25 contigs or scaffolds with library adaptor sequence contamination, which were not successfully removed during read preprocessing (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2c</xref>). The presence of adaptor sequences on reads with human sequences introduced gaps between the human-based contigs; reads with adaptor alone were concatenated to make adaptor-only contigs (Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>). We also found instances of assembled bacterial (<italic>Escherichia coli</italic>) and yeast (<italic>Saccharomyces cerevisiae</italic>) genomes, either as standalone contigs or scaffolds (three assemblies), chimeric with human genomic DNA (four assemblies), or both (four assemblies; Extended Data Fig. <xref rid="Fig6" ref-type="fig">1b</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2c</xref>). There were typically 0&#x2013;6 copies of these microbial genomes per assembly, except in the wtdgb2 assembly with 35 <italic>E. coli</italic> and 46 <italic>S. cerevisiae</italic> contigs. For the other assemblies, microbial contamination was inadvertently removed before submission due to: (1) not matching the GRCh38 reference for the reference-based assemblies; (2) filtering out scaffolds below a specific size; or (3) moving from the primary to the alternate assembly.</p>
      <p id="Par11">There were also from 1 to approximately 40 assembled human mitochondrial (MT) contigs in approximately 74% (17 out of 23) of the assemblies (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2c</xref>). In the trio-based assemblies, the MT genomes were all associated with the maternal haplotype, indicating that the MT reads were correctly sorted during haplotype phasing before generating contigs (in the VGP Trio assembly, the MT genome&#xA0;was purposely included in both haplotypes to avoid NUMT overpolishing<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>). Most MT contigs were full-length genomes, further demonstrating<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> that with long reads most new assembly algorithms can assemble a MT genome in one contig. Part of the reason for the differential presence of MT genomes in the assemblies is presumably due to differential read length thresholds used for initial contig assembly; the higher the size threshold, the less likely MT reads will be included<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
    </sec>
    <sec id="Sec4">
      <title>Highly contiguous phased assemblies</title>
      <p id="Par12">Our assembly targets were an expected maternal genome size of approximately 3.06&#x2009;Gb (22 autosomes + X) and paternal size of approximately 2.96&#x2009;Gb (22 autosomes + Y), given the expected X (155.3&#x2009;Mb) and Y (approximately 60&#x2009;Mb) difference of about 96&#x2009;Mb<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Almost all assemblies, including the diploid assemblies, were close to the expected sizes of a human genome (approximately 3.0&#x2009;Gb; range 2.8&#x2013;3.1&#x2009;Gb; Extended Data Fig. <xref rid="Fig7" ref-type="fig">2a&#x2013;c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2d&#x2013;f</xref>). Only the diploid pair asm19a and asm19b were bigger, by approximately 3%. In the trio-based assemblies, the maternal (mat) haplotypes were all longer than the paternal (pat) haplotypes, consistent with sex chromosome differences. In the non-trio diploid assemblies, each haplotype was more similar in length, skewed towards the expected size of the maternal haplotype, consistently finding either X and part of Y in both haplotypes or missing Y altogether (Supplementary Table <xref rid="MOESM4" ref-type="media">2d</xref>, assessed for the diploid scaffolded assemblies). The assemblies that came closest to the theoretical size (98&#x2013;100%) for both maternal and paternal haplotypes were the Trio VGP scaffolded (asm23a,b) and the Trio hifiasm (asm9a,b) assemblies (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2a</xref>). The scaffolded assemblies had quite a range, approximately 40&#x2009;kb to 50&#x2009;Mb, of missing sequence (total Ns), in the gaps between contigs and trailing Ns at scaffold ends (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2f</xref>). In comparison, GRCh38 has approximately 151&#x2009;Mb of N bases. With the exception of Bionano optical maps, most scaffolding tools place arbitrary gap sizes. Most assemblies also had between 0.3% and 2.3% false duplications (according to <italic>k</italic>-mer counts; Extended Data Fig. <xref rid="Fig7" ref-type="fig">2d</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2g</xref>), the highest in asm19a and asm19b, which could explain why they were bigger than expected<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. GRCh38 also still contains false duplications<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>, although difficult to estimate precisely due to the complex mixture of haplotypes.</p>
      <p id="Par13">In terms of continuity, our goal was to minimize the number of gaps for a theoretical maximum gapless contig NG50 that equals chromosome NG50 of approximately 155&#x2009;Mb for human (in which half of the assembled contigs are this size and bigger)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Most assemblies had contig NG50 sizes in the range of 20&#x2013;50&#x2009;Mb (approximately 13&#x2013;32% of the theoretical maximum), including for both haplotypes of some of the diploid assemblies (Fig. <xref rid="Fig1" ref-type="fig">1a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2e</xref>), indicating partial chromosomal length contigs. Exceptions well below NG50 of 20&#x2009;Mb were: the alternative (alt) haplotypes from the FALCON Unzip or HiCanu approaches that generate a partial diploid assembly by design (asm16b and asm8b, respectively), with the primary pseudohaplotype being more contiguous (asm16a and asm8a); both haplotypes of the Dovetail implementation of the DipAsm assembler (asm2 and asm22), in which Hi-C data were used to phase the haplotypes. By contrast, the original implementation of DipAsm created two assemblies with contig NG50s greater than 20&#x2009;Mb (asm10a,b). Not surprisingly, the assembly (asm7a,b) that used the ONT ultralong (ONT-UL) reads (more than 100&#x2009;kb) had the highest contig NG50s (48.6&#x2009;Mb maternal and 39.8&#x2009;Mb paternal). The trio-based ONT and hifiasm (asm9a,b) HiFi assemblies had the fewest contigs (approximately 600&#x2013;900) of all diploid assemblies (Extended Data Fig. <xref rid="Fig8" ref-type="fig">3a</xref>). All scaffolded assemblies had scaffold NG50 values ranging from 80 to 155&#x2009;Mb (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>; 52&#x2013;100% of the theoretical maximum). All non-trio diploid scaffolded assemblies had 23&#x2013;30 scaffolds, at or close to the expected 23 chromosomes per haplotype (Supplementary Table <xref rid="MOESM4" ref-type="media">2f</xref>). However, this particular metric comparison is made less informative as DipAsm inherently filters out scaffolds less than 10&#x2009;kb, Phased Genome Assembly using Strand-seq (PGAS) excludes contigs less than 500&#x2009;kb as the Strand-seq signal is too sparse to scaffold small contigs, and CrossStitch only includes contigs or scaffolds that align to the GRCh38 reference. The Trio VGP scaffolded assembly (asm23a,b) that did not exclude scaffolds on the basis of size or alignment to a reference, had, not surprisingly, a much higher number of scaffolds (over 2,000 each) but fewer gaps among those scaffolds (673 maternal and 917 paternal) relative to DipAsm and PGAS assemblies (900&#x2013;4,000 within scaffold gaps; Extended Data Fig. <xref rid="Fig8" ref-type="fig">3b,c</xref>). The size of the largest scaffold (max) for most assemblies approached the size of chromosome 1 (248&#x2009;Mb; range of 132&#x2013;242&#x2009;Mb; Supplementary Table <xref rid="MOESM4" ref-type="media">2f</xref>). Together, these findings demonstrate an important shift in recent assembly tools to generate two separate chromosome-level assemblies per individual, representing the two haplotypes or pseudohaplotypes, albeit with gaps.<fig id="Fig1"><label>Fig. 1</label><caption><title>Assembly continuity, phasing and base call accuracy metrics.</title><p><bold>a</bold>, Contig NG50 values<bold>. b</bold>, Scaffold NG50 values<bold>. c</bold>, Haplotype phase block NG50 values. <bold>d</bold>, QV base call accuracy; as an example, QV60 is about one error per megabase. The dashed lines separate the assemblies into the four major categories as described in Table <xref rid="Tab1" ref-type="table">1</xref>. The colours designate the type of haplotype phasing performed: Trio phasing using parental data, endogenous phasing using self-data, partial endogenous phasing, merging of haplotypes, and final references with various phasing approaches. The grey shaded regions in <bold>b</bold> are not applicable for scaffold metrics, as these are contig-only assemblies; however, the Flye assembler inserts gaps into contigs where there is uncertainty of a repeat sequence, and the purge_dups function applied to the HiCanu contigs removes false duplications within contigs and creates a gap in the removed location. The grey shading in <bold>c</bold> indicates not applicable for phase blocks, because GRCh38 has many haplotypes and CHM13 is from a haploid (hap) cell line. The numbers in parentheses along the <italic>x</italic> axis are the assembly numbers. alt, alternate;&#xA0;mat, maternal; pat, paternal; phap, psuedo-haplotype;&#xA0;pri, primary; std., standard ONT read length; S-seq., Strand-Seq; UL., ultra-long ONT read length.</p></caption><graphic xlink:href="41586_2022_5325_Fig1_HTML" id="d32e2507"/></fig></p>
      <p id="Par14">Despite the high levels of contiguity among the assemblies, manual curation using gEVAL alignments<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, Bionano maps and Hi-C interaction plots (Extended Data Fig. <xref rid="Fig9" ref-type="fig">4a</xref>) revealed a handful to several hundred scaffolding errors per assembly, including: missed joins, contigs that should have been brought together as neighbours in the same scaffold; misjoins, colocalized contigs within scaffolds that do not belong together; and erroneous inversions or false duplications classified as other errors (Supplementary Table <xref rid="MOESM4" ref-type="media">2h</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">2a&#x2013;c</xref>). There were also within contigs errors: chimeric joins without a gap; sequence expansions; and sequence collapses (Supplementary Table <xref rid="MOESM4" ref-type="media">2h</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">2d</xref>). There was no one approach, without using a highly curated reference (that is, CrossStitch or MaSuRCA; asm1, asm15 and asm17), that was free of one or more scaffold or contig errors in an automated process. For a complementary, quantitative measure of structural accuracy, we used Strand-seq data, generated by a method that selectively sequences the plus (Crick) and minus (Watson) strands of genomic DNA from cultured cells<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. Nearly all assemblies had 1&#x2013;25 (average of 6.5) misorientation errors (inversions or reverse complements), totalling from 1 to approximately 746&#x2009;Mb (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2i</xref>). An exception was asm14, which used Strand-seq for scaffolding. The non-Strand-seq assembly with the least misorientation errors was Trio hifiasm (asm9a,b), with only one to two small inversions. Over half of the assemblies had 1&#x2013;9 chimeric contig errors (average of 2.6), with the Trio hifiasm paternal (asm9a) assembly having the most (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2i</xref>). Overall, each approach avoided at least one type of error that others did not.</p>
    </sec>
    <sec id="Sec5">
      <title>Consensus base accuracy</title>
      <p id="Par15">Assembly base accuracy is critical for subsequent annotation of protein-coding genes and non-coding regulatory DNA, as well as for the characterization of genetic variation. To estimate base accuracy, we compared <italic>k</italic>-mer frequencies between unassembled Illumina sequencing reads and each assembly. PGAS Strand-seq (asm14a,b) achieved the highest consensus base accuracy (QV) among scaffolded diploid assemblies, whereas Trio hifiasm (asm9a,b) and HiCanu (asm8a) achieved the highest among the contig-only diploid assemblies (QV or 50 or higher, or no more than 1 base call error per 100,000&#x2009;bp; Fig. <xref rid="Fig1" ref-type="fig">1d</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2j</xref>). Among the merged haploid assemblies, Fly ONT.phap (asm5) performed best, with two rounds of base call polishing each with ONT and HiFi reads. What these four assemblies share in common is the use of HiFi reads, either for high-level read or contig filtering (asm14a,b and asm8a), polishing (asm5), and/or phasing of haplotypes (asm9a,b). Obtaining such a high degree of base accuracy (QV of 50 or higher) with long reads has only been a recent advance, due to the higher accuracy of HiFi reads<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.</p>
    </sec>
    <sec id="Sec6">
      <title>Variant benchmarking</title>
      <p id="Par16">To determine how well each assembly correctly reveals haplotype variation, we developed a benchmark variant calling pipeline. We aligned each assembly to GRCh38, used dipcall<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> to call variants and compared them to a manually validated ground truth, the v4.2.1 small variant HG002 benchmark from GIAB<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, following the Global Alliance for Genomics and Health (GA4GH) benchmarking best practices<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. For the haploid assemblies, we developed separate performance metrics that ignore genotype errors (when only one haplotype has to match the benchmark variant). We found that all diploid-based assemblies had high true-positive rates above 90% for SNVs, whereas the haploid assemblies were all around 40%, due to merging of haplotypes that exclude many heterozygous variants (Extended Data Fig. <xref rid="Fig11" ref-type="fig">6a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">3a</xref>). As expected, the haploid assembly values were higher (65&#x2013;74%) when ignoring genotype (Supplementary Table <xref rid="MOESM4" ref-type="media">3a</xref>). The Trio hifiasm diploid assembly (asm9) had the highest true-positive rate (99.47%). When examining variants in the harder-to-assemble segmental duplications, most of the diploid assembler performances dropped by 9&#x2013;32%, whereas the Trio hifiasm and Trio HiCanu dropped by only 5&#x2013;6% (Supplementary Table <xref rid="MOESM4" ref-type="media">3a</xref>). When we assessed the accuracy of small insertions or deletions (indels; less than 50&#x2009;bp) between haplotypes, which are particularly problematic and highly variable due to their association with short tandem repeats, all HiFi-based diploid assemblies outperformed (true positive of approximately 92&#x2013;98%) the haploid assemblies (approximately 38&#x2013;59%), as well as the ONT diploid assemblies (about 52&#x2013;58%; Extended Data Fig. <xref rid="Fig11" ref-type="fig">6b</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">3b</xref>); the latter was due to the high indel error rate in ONT reads. The Trio hifiasm (asm9a,b) assembly had the highest combination of true-positive rates for both SNVs and small indels.</p>
      <p id="Par17">As a result of these findings, the Trio hifiasm assembly was used to further improve the GIAB benchmark for SNVs, small indels and larger SVs (indels, inversions and translocations) in 273 challenging, medically relevant genes that were not well represented in the GIAB v4.2.1 benchmark or the GIAB v0.6 SV benchmark. Extensive curation by GIAB found that the Trio hifiasm assembly produced more accurate variant calls across SNVs, small indels and SVs in these challenging regions, and the primary error type fixed was inaccurate genotypes in highly homozygous regions, particularly for indels in long homopolymers<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. These results demonstrate that diploid assemblies are not only highly concordant but exceed existing variant benchmarks in regions resolved by mapping-based methods. Thus, they show the greatest promise for resolving more challenging regions and variants not included in current benchmarks.</p>
    </sec>
    <sec id="Sec7">
      <title>Annotation</title>
      <p id="Par18">We performed annotation for each assembly by aligning the human NCBI RefSeq transcriptome dataset of 78,492 transcripts from 27,225 autosomal genes to them, and measured mapping statistics, using GRCh38 and CHM13 assemblies as controls. Most of the HG002 assemblies had 100&#x2013;400 genes with no transcript alignment (over 1,600 for the haploid wtdbg2 asm13 assembly; Extended Data Fig. <xref rid="Fig12" ref-type="fig">7a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2k</xref>). Exceptions were the Trio VGP (asm23a,b), Trio HiCanu (asm19a,b), Trio hifiasm (asm9a,b) and reference-based assemblies (asm1, asm15 and asm17) with only approximately 60&#x2013;70 unaligned genes for each haplotype, twice the missing number of 36 for GRCh38 but similar to 66 missing genes for CHM13. There were about a dozen genes present in GRCh38 and asm17 that used it as a reference, but not in any of the other HG002 assemblies or CHM13, showing a bias of false gene presence (presumably gap filled from GRCh38) for reference-based assembly methods. Most of the contig-only assemblies had more genes (approximately 100&#x2013;500) split between contigs than the scaffolded assemblies (Extended Data Fig. <xref rid="Fig12" ref-type="fig">7a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2k</xref>), consistent with scaffolding bringing separate parts of more genes together. The Trio VGP (asm23a,b) scaffolded assembly and Trio hifiasm (asm9a,b) contig-only assembly had the fewest split genes (approximately 30&#x2013;40) among the de novo assemblies, the reference-based assemblies had even fewer (1&#x2013;9) and even less than GRCh38 (10 genes). Most assemblies had 100&#x2013;700 genes (over 4,000 in the alts of asm16b and asm8b) that were less than 95% complete, except for the Trio VGP, Trio hifiasm and reference-based assemblies with only 32&#x2013;89 incomplete genes (Extended Data Fig. <xref rid="Fig12" ref-type="fig">7b</xref>). For almost all assemblies, there were 200&#x2013;600 genes apparently collapsed as assessed by overlapping transcript mapping, with those that used HiFi having the least collapses (Extended Data Fig. <xref rid="Fig12" ref-type="fig">7c</xref>). Similarly, the number of genes that required frameshift error corrections were approximately 1,000 for assemblies that used continuous long reads (CLRs; Trio VGP, asm23a,b), about 1,500 that used the 25-kb longer but less accurate HiFi reads (asm3 and asm4), approximately 6,000&#x2013;16,000 (more than half of the genes) that used unpolished ONT reads, but only about 100&#x2013;200 genes with the shorter (15&#x2009;kb) but more accurate HiFi reads (Extended Data Fig. <xref rid="Fig12" ref-type="fig">7a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2k</xref>). These findings demonstrate that a critical combination of read length, base accuracy, structural accuracy and haplotype phasing are necessary to obtain the most complete and accurate annotation possible.</p>
    </sec>
    <sec id="Sec8">
      <title>Trios and higher phasing accuracy</title>
      <p id="Par19">The original Trio assembly approach of binning long reads into their respective maternal and paternal haplotypes before generating contigs was implemented with the Canu contig assembler, as TrioCanu<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>; but this approach had not yet been tested in a head-to-head comparison with different assemblers and data types. Here we tested haplotype-binned reads with different contig assembly algorithms (Flye, HiCanu, hifiasm and Peregrine), different long-read data types (HiFi, CLR and ONT) and with trio-sorted scaffolding data types (10X-linked reads, optical maps and Hi-C). We found that all trio-based approaches yielded higher phasing of the same haplotype than their non-trio counterparts. Trios that used HiFi or CLR data had the largest NG50 haplotype phase blocks (approximately 10&#x2013;30&#x2009;Mb versus less than roughly 0.2&#x2013;5.0&#x2009;Mb; Fig. <xref rid="Fig1" ref-type="fig">1c</xref>), the lowest haplotype switch errors within contigs or scaffolds (about 0.01&#x2013;0.02% versus 0.20&#x2013;7.3%; Extended Data Fig. <xref rid="Fig13" ref-type="fig">8a</xref>), the highest number of phased bp (Extended Data Fig. <xref rid="Fig13" ref-type="fig">8b</xref>) and the most complete separation (approximately 99%) of paternal and maternal haplotype <italic>k</italic>-mers when using HiFi reads (Extended Data Fig. <xref rid="Fig13" ref-type="fig">8c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2l,m</xref>). Several of the trio approaches (Trio HiCanu and Trio hifiasm) yielded the least collapsed sequence (Extended Data Fig. <xref rid="Fig14" ref-type="fig">9a&#x2013;c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2n</xref>). The only non-trio method that approached the phasing accuracy for maternal and paternal alleles of a trio method used Strand-seq for phasing and scaffolding (asm14; Fig. <xref rid="Fig1" ref-type="fig">1c</xref> and Extended Data Fig. <xref rid="Fig13" ref-type="fig">8a</xref>), but it suffered from having the highest within-scaffold errors (Supplementary Fig. <xref rid="MOESM1" ref-type="media">2c</xref>). The trio-based ONT contig assemblies had lower haplotype phase blocks (NG50s of approximately 3&#x2013;6&#x2009;Mb; Fig. <xref rid="Fig1" ref-type="fig">1c</xref>) and higher haplotype switch errors (approximately 0.3&#x2013;0.5%; Extended Data Fig. <xref rid="Fig13" ref-type="fig">8a</xref>), presumably owing to their higher sequence error rates. In contrast to previous findings<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, the VGP trio assemblies did not have the lowest haplotype false duplication rates, as assessed by either <italic>k</italic>-mers or BUSCO duplicate gene copies (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2d</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2g</xref>). This appears to be due to improvements in the higher read accuracy of PacBio HiFi versus CLR; the latter was used for the VGP trio assembly.</p>
    </sec>
    <sec id="Sec9">
      <title>Graph phasing is more complete and accurate</title>
      <p id="Par20">The trio-based approaches fell into two principal categories: (1) those that use parental reads to haplotype bin the reads of the child before assembly (for example, Trio VGP, Trio Flye, Trio HiCanu and Trio Peregrine); or (2) those that generate an assembly graph of the genome of the child first and then label haplotypes in the graph using the parental reads (for example, Trio hifiasm). As presented in a complementary study conducted simultaneously<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> and further advanced here, we found that the graph-based phasing approach generally outperformed the two-step binning trio approach when high-accuracy long reads were used to build the initial assembly graph. In particular, among the diploid assemblies, the Trio hifiasm maternal (asm9a) and paternal (asm9b) assemblies had the highest combination of high-quality metric values, including the highest QV (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>), the third highest NG50 haplotype phase blocks (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>; Trio VGP was the highest), the highest genome completeness (Supplementary Table <xref rid="MOESM4" ref-type="media">2k</xref>), among the least false duplications (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2d</xref>), the fewest contigs (Extended Data Fig. <xref rid="Fig8" ref-type="fig">3a</xref>), among the lowest haplotype switch errors (Extended Data Fig. <xref rid="Fig13" ref-type="fig">8a</xref>) and the least collapsed repeats (Extended Data Fig. <xref rid="Fig14" ref-type="fig">9a,b</xref>). These findings indicate that graph-based phasing of the assembly is more accurate and complete as the combination of the graph with haplotype information can correct errors made by either method alone. A prerequisite to highly accurate graph-based haplotype phasing is a well-resolved diploid assembly graph, as generated from high-accuracy long reads (for example, HiFi).</p>
    </sec>
    <sec id="Sec10">
      <title>Pan-assembly alignment</title>
      <p id="Par21">To identify both shared and distinct features of the assemblies, we utilized a pangenomic approach, performing an all-versus-all alignment for 45 assemblies (both haplotypes; Extended Data Fig. <xref rid="Fig15" ref-type="fig">10a</xref>), excluding the alternate contigs or unitigs of pseudohaplotype assemblies as they were highly fragmented. We annotated the alignment according to chromosomes in GRCh38 and CHM13. Pairwise Jaccard similarity analyses on the autosomes (chromosomes 1&#x2013;22) clustered the Trio hifiasm and Trio HiCanu assemblies as more similar to each other and distinct from the other assemblies (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>); at one branch higher, these trio assemblies clustered with the other trios (except Trio HiPeregrine) and with the MaSuRCA and CrossStitch reference-based assemblies. The remaining assemblies subclustered mostly by assembly pipeline, indicating that assembly approach drives their similarities the most. More pronounced than the autosomes, Jaccard similarity analyses on the XY sex chromosomes grouped all trio-based paternal assemblies into one cluster, with distinctions among themselves, relative to all of the remaining assemblies into a sister supercluster with the trio-based maternal assemblies (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). This finding is consistent with chromosome X and part or none of chromosome Y being present in both haplotypes with non-trio assemblers (Supplementary Table <xref rid="MOESM4" ref-type="media">2d</xref>). Two exceptions were the haploid Flye ONT.phap assembly (asm5) and the reference-based CrossStitch hap1 assembly (asm17a), which grouped with the trio paternal assemblies and had a more complete Y chromosome (asm17a) due to using the GRCh38 Y chromosome as a reference. Principal component analysis (PCA) on Euclidean distances between assemblies supported these conclusions, in which the trio-based autosomes (concatenated 1 through 22) clustered by parental haplotype without the presence of the sex chromosomes in the fourth dimension (Fig. <xref rid="Fig2" ref-type="fig">2c,d</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">3a,b</xref> with reduced labels). The Trio hifiasm and Trio HiCanu autosome assemblies were the most distinctly clustered by parental haplotype. Clustering on each autosome alone and then performing a machine learning algorithm (support vector classifier) to find whether a dimension with a hyperplane that distinctly and maximally separates the trio-based maternal and paternal haplotypes exists, revealed such a dimension (first to ninth, most often the second), explaining 3&#x2013;12% of the clustering variance (Supplementary Table <xref rid="MOESM4" ref-type="media">4</xref>). The degree of separation (that is, PCA % variance) negatively correlated with the relative size of the centromere for each autosome (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>). These findings indicate that the trio-based assemblies have the maximal separation of parental haplotypes, the centromeres contribute less to this signal, and this serves as a benchmark for further developing tools for better separation of haplotypes in non-trio assemblies.<fig id="Fig2"><label>Fig. 2</label><caption><title>Multidimensional relationship among assemblies.</title><p><bold>a</bold>,<bold>b</bold>, Clustering of pairwise Jaccard similarities between pairs of assemblies, for the autosomes 1&#x2013;22 (<bold>a</bold>) and the X and Y sex chromosomes (<bold>b</bold>). In the heatmap, the lighter the blue (Jaccard similarity index closer to 1), the more similar the assemblies (1 indicates identical assemblies). Assemblies are annotated with four different colour-coded classifications. <bold>c</bold>,<bold>d</bold>, PCA on the multidimensional Euclidean distances among assemblies, for the autosomes 1&#x2013;22 (<bold>c</bold>) and the X and Y sex chromosomes (<bold>d</bold>). PCA dimensions shown are those in which the paternal and maternal haplotypes separated the strongest. <bold>e</bold>, Correlation between centromere&#xA0;size relative to&#xA0;chromosome size (%) and PCA variance (%) in the dimension where the Trio-based autosome assemblies separated by haplotype. <bold>f</bold>, Graph-based alignment of a 5-Mb region of human chromosome 6 containing the MHC locus of the Trio-based assemblies and GRCh38 and CHM13 references. Each colour is a different assembled haplotype. The Trio hifiasm assembly and the final HG002 assembly that used Trio hifiasm assembled the entire MHC locus in one single contig.</p></caption><graphic xlink:href="41586_2022_5325_Fig2_HTML" id="d32e2804"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>High-quality HPRC-HG002 diploid reference</title>
      <p id="Par22">On the basis of our findings, we developed a pipeline that combines the best practices of all approaches and used it to generate a higher-quality diploid de novo assembly (Extended Data Fig. <xref rid="Fig15" ref-type="fig">10b</xref>). We first removed the remaining HiFi reads with unremoved vectors (adaptors) using HiFiAdapterFilt (Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>). We then generated HiFi maternal and paternal contigs with the graph-based haplotype phasing of Trio hifiasm v0.14.1. This updated version incorporates bug fixes that we found after generating the initial HG002 assemblies, including:&#xA0;(1) enhancing contig QV by constructing the contig golden path through high-quality portions of error corrected reads; (2) resolving more segmental duplications by selecting high-occurrence seeds at the overlapping stage; and (3) improving contig N50 by rescuing contained reads that break contigs on one haplotype when the read actually comes from the other haplotype<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> (Supplementary Fig. <xref rid="MOESM1" ref-type="media">4</xref>). In addition, we titrated child and parental coverages with hifiasm and found a level (approximately 130&#xD7; child HiFi; approximately 300&#xD7; parent Illumina) given the data that yielded an optimal contiguity and the lowest haplotype switch error (Supplementary Fig. <xref rid="MOESM1" ref-type="media">4</xref>). We then separately scaffolded the maternal and paternal HiFi-based contigs with maternal and paternal Bionano optical maps. Conflicts between the HiFi contigs and Bionano optical maps were manually evaluated (curation 1), in which we accepted 5 of 15 maternal and 3 of 13 paternal joins or breaks indicated by the Bionano maps (Supplementary Table <xref rid="MOESM4" ref-type="media">5a</xref>). The majority of these conflicts (25 of 28) were in segmental duplications and centromeres, particularly of the acrocentric chromosomes (chromosomes 15, 21 and 22), and included haplotype SV differences in HG002; the remaining three were in known tandemly repeated genes (<italic>IgK</italic>, <italic>IgH</italic> and <italic>TSP</italic>), where the first two were processed by programmatic structural variation associated with B lymphocytes. We then further scaffolded the paternal and maternal assemblies with haplotype-filtered (Meryl) Hi-C (Dovetail&#xA0;OmniC) data and the Salsa 2.3 algorithm. Scaffolding with Arima Hi-C v2 data yielded similar results. We performed manual curation (curation 2) using Hi-C contact maps, which resulted in 7&#x2013;8 scaffold breaks and 44&#x2013;50 additional joins in each haplotype assembly (Extended Data Fig. <xref rid="Fig9" ref-type="fig">4b</xref> and Supplementary Tables <xref rid="MOESM4" ref-type="media">2h</xref> and <xref rid="MOESM4" ref-type="media">5b</xref>). Most of the breaks were at centromeres to allow satellite placement.</p>
      <p id="Par23">Next, we filled gaps with a conservative version of the pipeline used in the initial T2T-CHM13 assembly<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. ONT-UL reads were base recalled with Guppy 4.2.2, haplotype binned using trio-Canu and assembled into haplotype-specific contigs using Flye. Draft ONT-UL contigs were polished to increase consensus accuracy. Variant calls were generated using Medaka on ONT long reads, and filtered with Merfin<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> using <italic>k</italic>-mers from Illumina short reads and then applied to increase the quality of the consensus sequence. The polished contigs were aligned to their respective haplotypes of the curated HiFi-based scaffolds from the Hi-C step above and used to fill gaps. This resulted in ten and five gaps filled in the maternal and paternal assemblies, respectively. Of these 15 gaps, 10 contained GA-rich repeats and 2 were long segmental duplications (Supplementary Fig. <xref rid="MOESM1" ref-type="media">5</xref>). The final manual curation (curation 3) fixed 37 items in the maternal and 60 in the paternal assemblies (Supplementary Tables <xref rid="MOESM4" ref-type="media">2h</xref> and <xref rid="MOESM4" ref-type="media">5c</xref>), much fewer than the hundreds of manual fixes that normally would be required (for example, Extended Data Fig. <xref rid="Fig9" ref-type="fig">4a</xref>). A contamination screen removed multiple (41 maternal and 45 paternal) human EBV viral genomes (contigs) used to transform the LCLs as well as a yeast contig in the paternal assembly; we did not find any non-human contamination within the human contigs and scaffolds. Approximately 98% of the remaining sequence was assignable to the 22 autosomes and the X and Y sex chromosomes (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). These new assemblies were named HPRC-HG002.mat.v1.0 and HPRC-HG002.pat.v1.0 references.<fig id="Fig3"><label>Fig. 3</label><caption><title>Near-complete haplotype separation of scaffolds.</title><p><bold>a</bold>, Hi-C contact maps to the final curated HPRC-HG002 paternal (left) and maternal (middle) assemblies in comparison to the CHM13 assembly (right). Values designate chromosome numbers, from largest to smallest size for each assembly. <bold>b</bold>, Blob plot using Illumina parental <italic>k</italic>-mers for the scaffolds of the HPRC-HG002 haplotypes. <bold>c</bold>, Percent size of HG002 diploid assembled chromosomes relative to CHM13 chromosomes, without including Ns. <bold>d</bold>, Comparison of absolute chromosome size values of all three assemblies, without including Ns. <bold>e</bold>, Number of remaining gaps in the chromosomes of each HG002 haplotype. Asterisks indicate assembled contigs with no gaps: maternal chromosomes 11 and 12, and assembled paternal chromosomes 21 and 22 without complete short arms.</p></caption><graphic xlink:href="41586_2022_5325_Fig3_HTML" id="d32e2905"/></fig></p>
      <p id="Par24">These two de novo assemblies exhibited the highest quality across most metrics, compared with the bakeoff assemblies and the GRCh38 reference: the largest contig (62.9 and 81.6&#x2009;Mb) and comparable scaffold (154.4 and 146.7&#x2009;Mb) NG50s, close to the theoretical scaffold maximum (Fig. <xref rid="Fig1" ref-type="fig">1a,b</xref>); the fewest contigs and gaps in scaffolds (Extended Data Fig. <xref rid="Fig8" ref-type="fig">3a&#x2013;c</xref>); the highest QVs (approximately 60; Fig. <xref rid="Fig1" ref-type="fig">1d</xref>); the most complete haplotype phasing (Fig. <xref rid="Fig3" ref-type="fig">3b</xref> and Extended Data Fig. <xref rid="Fig13" ref-type="fig">8a&#x2013;c</xref>) with NG50 phase blocks of 106.7 and 90.4&#x2009;Mb, respectively (Fig. <xref rid="Fig1" ref-type="fig">1c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2j</xref>); the least collapsed repeats (18.5 and 17.6&#x2009;Mb, respectively; Extended Data Fig. <xref rid="Fig13" ref-type="fig">8a,b</xref>); among the highest values in annotation metrics (Extended Data Fig. <xref rid="Fig12" ref-type="fig">7a&#x2013;d</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2m</xref>); and among the highest SNV and small indel true-positive rates (Supplementary Table <xref rid="MOESM4" ref-type="media">3a,b</xref>). They clustered closest with the Trio hifiasm and Trio HiCanu assemblies (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Assessing against GIAB HG002 benchmarks against GRCh38, this diploid assembly produced highly accurate SNV concordance (F1 score) of 99.7% and small indel concordance of 98.6%, which were 0.2% and 0.8% lower, respectively, than the best-performing mapping-based variant callers in a 2020 precision FDA Truth Challenge<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. We found that 70% of the discordant SNVs fell in segmental duplications, most with complex SVs that could not be accurately benchmarked. In fact, many of these differences appeared to be more accurate in the new HPRC-HG002 assemblies than in the mapping-based benchmark or precision FDA entries. The primary limitation of the assemblies was small indels in homopolymers and in 51&#x2013;200-bp tandem repeats, making up 80% of all discordant indels; curation revealed that the final HPRC-HG002 assemblies had infrequent errors due to collapsing haplotypes and/or to noise in the starting HiFi reads. When benchmarking larger SVs in the new HG002 assemblies with respect to the GRCh37 GIAB v0.6 SV benchmark, which excludes segmental duplications and centromeres<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, the true-positive rate was 98% (compared with 93% for asm9a,b) and precision was 89%, with most putative errors just differences in SV representation in tandem repeats or errors in the benchmark. Some known difficult-to-assemble repetitive gene families were completely assembled in one contig, including the approximately 5-Mb histocompatibility complex (MHC) containing over 220 genes (Fig. <xref rid="Fig2" ref-type="fig">2f</xref>), in which variants were more than 99.99% concordant with the GIAB v4.2.1 benchmark. Overall, this high concordance between the assembly-based variants, existing benchmarks and higher accuracy than the benchmarks, demonstrates substantial promise for phased, whole-genome assemblies.</p>
      <p id="Par25">Performance in most metrics, particularly for the HG002 maternal haplotype, were on par with the T2T-CHM13 v1.1 assembly (Fig. <xref rid="Fig1" ref-type="fig">1</xref> and Extended Data Figs. <xref rid="Fig7" ref-type="fig">2</xref>,<xref rid="Fig8" ref-type="fig">3</xref> and <xref rid="Fig12" ref-type="fig">7</xref>&#x2013;<xref rid="Fig14" ref-type="fig">9</xref>), including comparable Hi-C profiles (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). We aligned the two HG002 haplotype assemblies to CHM13 (with Y from GRCh38), and found high correlations (Supplementary Table <xref rid="MOESM4" ref-type="media">6</xref>). Most assembled HG002 chromosomes (32 of n2&#x2009;=&#x2009;46) were 98.0&#x2013;99.9% complete (not including gaps) relative to the length of CHM13 (Fig. <xref rid="Fig3" ref-type="fig">3c,d</xref>). Chromosome 9 was the expected size, but 10% smaller than&#xA0;in CHM13 due to a known approximately 10-Mb large satellite duplication in CHM13 (ref. <sup><xref ref-type="bibr" rid="CR5">5</xref></sup>). The biggest exceptions were the short arms of the acrocentric chromosomes, with chromosomes 21 and 22 being the two outliers at approximately 85% of&#xA0;the length of CHM13 for the maternal and about 75% for the paternal haplotype (Fig. <xref rid="Fig3" ref-type="fig">3c,d</xref>); the short arms of these chromosomes are notoriously difficult to assemble owing to their highly repetitive shared structure consisting of rDNA arrays, satellite arrays and segmental duplications<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Yet, the remainder of the paternal chromosomes 21 and 22, as well as maternal chromosomes 11 and 12 had no gaps, and the remaining autosomes had an average of four gaps each (range 1&#x2013;12; Fig. <xref rid="Fig3" ref-type="fig">3e</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">6</xref>). Most of these gaps were in centromeres or acrocentric regions (Fig. <xref rid="Fig4" ref-type="fig">4a,b</xref>). All HG002 unplaced or unlocalized scaffolds that mapped to CHM13 were in the centromeres, especially of the acrocentric chromosomes (chromosomes 13, 14, 15, 21 and 22) or telomeres (asterisk in Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). The centromeres also had the greatest amount of unaligned sequences due to greater divergence between HG002 and CHM13 haplotypes (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>); the two ends of the Y chromosome aligned to CHM13 X chromosome, because the psuedoautosomal region at the ends of the HG002 Y chromosome has higher identity to the CHM13 X chromosome than to the GRCh38 Y chromosome.<fig id="Fig4"><label>Fig. 4</label><caption><title>HPRC-HG002 features.</title><p><bold>a</bold>, Chromosome alignments between HPRC-HG002 maternal (top) and paternal (bottom) assemblies and CHM13 and the Y chromosome of GRCh38. Haplotype separation is nearly complete, and thus colours are solid blue (paternal) and red (maternal). Colour values were determined by the number of aligned haplotype-specific <italic>k</italic>-mers. A few ambiguous alignment blocks (purple) are highly repetitive regions, where it is hard to extract enough haplotype-specific <italic>k</italic>-mers. The black tick marks indicate gaps between contigs. Unaligned regions, which are mostly centromeric satellites, are shown in grey. <bold>b</bold>, Circos plot of the heterozygosity landscape between the two HG002 haploid assemblies. Tracks from inside out: synonymous amino acid changes; non-synonymous changes; SNV density (window size of 500&#x2009;kb, range of 0&#x2013;3.1%), and small deletion and small insertion (less than 50&#x2009;bp) density (window size of 1&#x2009;Mb, range of 0&#x2013;850); large indel density (50&#x2009;bp or more, window size of 1&#x2009;Mb, count of 0&#x2013;20) and copy number variant (CNV) density (window size of 1&#x2009;Mb, count of 0&#x2013;77). The black line links in the outermost circles denote intrachromosomal translocations (50&#x2009;bp or more) between paternal (inner) and maternal (outer) assemblies. The orange bars indicate inversions (50&#x2009;bp or more), the red bars denote centromeres and the grey triangles indicate gaps. CDS, coding sequence.</p></caption><graphic xlink:href="41586_2022_5325_Fig4_HTML" id="d32e3032"/></fig></p>
      <p id="Par26">To determine whether any of the chromosomes were T2T complete, we examined hard-to-assemble regions, centromeres and telomeres. Diploid HiFi sequence coverage and <italic>k</italic>-mer analyses revealed that the centromeres of 5 of 46 chromosomes (maternal 11, 12 and 16 and paternal 21 and 22) had no haplotype switch errors, no collapsed repeats and no gaps (Extended Data Fig. <xref rid="Fig14" ref-type="fig">9d</xref>, Supplementary Table <xref rid="MOESM4" ref-type="media">7a&#x2013;c</xref> and Supplementary Figs. <xref rid="MOESM1" ref-type="media">6</xref> and <xref rid="MOESM1" ref-type="media">7</xref>). We found complete canonical telomere repeats (TTAGGG) on the q and p arms for six maternal and ten paternal chromosomes, whereas nearly all others had one or the other arm (Extended Data Fig. <xref rid="Fig16" ref-type="fig">11a&#x2013;c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">7d</xref>). The approximately 70 unlocalized scaffolds on chromosomes and the several hundred remaining small unplaced scaffolds without a chromosome were largely centromeric satellites and telomeric repeats (Supplementary Table <xref rid="MOESM4" ref-type="media">7e</xref>). Overall, although there was no chromosome that was T2T, most were near complete, with few errors in centromeres or missing telomeres. These findings highlight that a mostly automatically generated, haplotype phased and near T2T assembly is now possible, and the remaining development needed is for the centromeres and telomeric ends. These two assemblies are available without restrictions in the INSDC archives under accession numbers GCA_021951015.1 (maternal) and GCA_021950905.1 (paternal).</p>
    </sec>
    <sec id="Sec12">
      <title>Missing genes among haplotypes</title>
      <p id="Par27">From the annotation analyses of 27,225 autosomal genes, we identified 106 genes that are completely missing from one or more of the four reference assemblies: GRCh38 (32 genes), the HG002 haplotypes (61 maternal and 65 paternal genes) and T2T-CHM13 v1.1 (62 genes; Supplementary Table <xref rid="MOESM4" ref-type="media">8</xref>). Among these, 20 genes were absent from all four assemblies. There was greater overlap of 74% (46 of 62 genes) not present in CHM13 and one or both HG002 haplotypes (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The inverse had lower overlap, with 64% (39 of 61) for the HG002.mat and 62% (40 of 65) for the HG002.pat haplotype also absent in CHM13. Similarly, the maternal and paternal haplotypes of HG002 shared 66% (40 of 61) and 62% (40 of 65) of gene loss with each other, respectively. Conversely, CHM13 and each HG002 haplotype had 11&#x2013;17 genes absent specific to them (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). However, 51 of the total HPRC-HG002.pat unaligned genes were present in one or more of the Trio paternal bakeoff assemblies, indicating that either they were missed in the HPRC-HG002.v1 reference assemblies or they were false haplotype duplications in the bakeoff assemblies. False duplication is possible given that two-thirds of the 106 genes missing among the four reference assemblies were in repetitive gene families (Supplementary Table <xref rid="MOESM4" ref-type="media">8</xref>), including the MHC HLA immune cluster, keratin-associated proteins, olfactory receptors and 18S and 5&#x2013;8S RNA genes. There were also several long intergenic non-protein coding RNA genes and over 30 microRNA genes. The absences cannot also be explained by annotation artefacts (Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">3</xref>). Overall, these findings indicate a diversity of missing genes, including repetitive genes, among individuals and haplotypes within an individual.<fig id="Fig5"><label>Fig. 5</label><caption><title>Genes with no aligned transcript and thus presumed absent in the four main reference assemblies compared.</title><p><italic>n</italic> refers to the number of genes absent in each reference assembly. Values in the four-way Venn diagram are the number of shared or uniquely absent genes among the four assemblies.</p></caption><graphic xlink:href="41586_2022_5325_Fig5_HTML" id="d32e3094"/></fig></p>
    </sec>
    <sec id="Sec13">
      <title>Greater diversity between haplotypes</title>
      <p id="Par28">With a more complete diploid human assembly, we performed heterozygosity analysis between haplotypes, following approaches that we used on a VGP Trio-based marmoset assembly<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. We noted a remarkably high amount of autosomal heterozygosity between haplotypes (3.3% of total bp, including approximately 2.6 million SNVs; about 631,000 small SVs (less than 50&#x2009;bp); 11,600 large SVs (50&#x2009;bp or more); or 3,294,604&#x2009;bp of variants total; Fig. <xref rid="Fig4" ref-type="fig">4b</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">9</xref>). Most of the additional variation was in the newly assembled centromeres, with sharp peaks in SNVs, indels, inversions and intrachromosomal translocations (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). This is partially due to the lower alignments in highly repetitive centromeric satellites, which in turn can be due to higher diversity in centromeres between haplotypes. When not including the centromeres, autosomal heterozygosity in total bp was approximately threefold less (1.2%; Supplementary Table <xref rid="MOESM4" ref-type="media">9</xref>), closer to previous measures between human haplotypes<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. The increased diversity in the centromeres, although expected, was not seen at this level in the marmoset trio assembly<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. This difference is probably due to the marmoset assembly using higher error rate CLR PacBio reads, leading to largely collapsed centromeric repeats, as well as to species differences or individual differences. The reason can be resolved with future population-level analyses on assemblies generated using the approaches developed here.</p>
      <p id="Par29">The SVs included 59 large (more than 500&#x2009;bp) inversions (Fig. <xref rid="Fig4" ref-type="fig">4b</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">10</xref>). Of these, 41 had clear Watson&#x2013;Crick Strand-seq alignment orientations, revealing that 30 inversions had the correct orientations, but three paternal and eight maternal had the incorrect orientation (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5b,c</xref>). The source of these few orientation errors appeared to be long stretches of segmental duplications on either side of the inversions, where either orientation aligns (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5d&#x2013;f</xref>). The SVs included 7,892 copy number variations between haplotypes (Supplementary Table <xref rid="MOESM4" ref-type="media">9</xref>), of which 220 were protein-coding gene expansions relative to GRCh38 from 81 gene families (Supplementary Table <xref rid="MOESM4" ref-type="media">11</xref>), approximately threefold higher than the average of 75 genes determined from less-complete short-read assemblies from the 1000 Genomes Project<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Of these, four genes had remarkable differences in copy number between haplotypes (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>): (1) tandem arrays of family with sequence similarity 90 member A (<italic>FAM90A</italic>) members present at 32 maternal, 20 paternal and 16 GRCh38 copies; (2) an expansion of nuclear pore complex interacting protein member B8 (<italic>NPIPB8</italic>) with 6 maternal, 10 paternal and 6 GRCh38 copies; (3) Tre-2, Bub2p and Cdc16p domain family member 3 (<italic>TBC1D3</italic><bold>)</bold> with 11 maternal, 17 paternal and 13 GRCh38 copies; and (4) an expansion of 9 copies of the Kringle domain in lipoprotein A (<italic>LPA</italic>) in the paternal versus the maternal haplotype (Supplementary Table <xref rid="MOESM4" ref-type="media">11</xref>). Raw HiFi read coverage analyses of these genes did not show evidence of collapsed repeats (resolved in Supplementary Table <xref rid="MOESM4" ref-type="media">11</xref>), indicating that the haplotype differences are not assembly artefacts. The first two genes (<italic>FAM90A</italic> and <italic>NPIPB8</italic>) are thought to be primate specific or more rapidly evolving in primates<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>; <italic>TBC1D3</italic> is only found in great apes, and is associated with increased cortical brain folding and expansion in humans<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>; additional copies of the Kringle domain of <italic>LPA</italic> have been associated with increased atherosclerosis and coronary artery disease<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. One interpretation of these findings is that in the ancestral primate lineage, duplications of these genes were selected for primate brain-specific traits.</p>
      <p id="Par30">Among the 12,241 SNVs (not including indels) located in CDS that were annotated for both haplotypes, 6,397 (52.3%) SNVs in 4,119 genes were synonymous leading to no change in the amino acid sequence, and 5,844 (47.7%) SNVs in 3,690 genes were non-synonymous, changing the amino acid sequence between haplotypes (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). Of 3,690, 2,466 genes had exclusively non-synonymous differences and were significantly enriched (false discovery rate&#x2009;&lt;&#x2009;0.01) for metabolism, smell, taste and HSV1 viral infection functions (Supplementary Table <xref rid="MOESM4" ref-type="media">12</xref>). These findings are consistent with more rapid evolution of smell and taste receptor genes than the average gene family in some species<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>.</p>
      <p id="Par31">A well-phased diploid assembly provides an opportunity to investigate mosaicism within haplotypes. We aligned the Illumina reads against our final diploid reference, called SNVs and found an average minor allele proportion of 0.0466% and 0.0468% for the maternal and paternal haplotypes, respectively (Supplementary Fig. <xref rid="MOESM1" ref-type="media">8a</xref>); this is tenfold lower than mosaicism seen in the common marmoset using the same approach<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>, a species that has genetic chimerism between twins and triplets in utero. There was a higher prevalence of mosaicism on the smaller chromosomes in HG002 (chromosomes 13&#x2013;22; Supplementary Fig. <xref rid="MOESM1" ref-type="media">8b</xref>), indicative of greater mutational load on them. We also separately compared blood versus LCL genomes of another sample (HG06807), assembled with hifiasm, and did not find evidence of an increase in mosaicism (Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">4</xref>). We did, however, find three small inversions (1.6&#x2013;10&#x2009;kb in size) in the maternal haplotype of the LCL genome (Supplementary Fig. <xref rid="MOESM1" ref-type="media">9</xref>). These findings suggest that our measure is of endogenous mosaicism, but there could be rare SV changes in LCLs.</p>
      <p id="Par32">We also assessed whether we could detect MT genome&#xA0;mosaicism (that is, heteroplasmy) by mapping all maternal-derived and paternal-derived HiFi reads. A total of 11,938 HiFi reads aligned to our MT genome&#xA0;assembly. We found six SNPs at more than 1% frequency (above the read error rate), which we interpret as mitochondrial heteroplasmy (Supplementary Fig. <xref rid="MOESM1" ref-type="media">10</xref>). In one case, the major allele (T) was supported by 8,033 reads (97%, 4,186+ and 3,847&#x2212;), whereas the minor allele (C) was supported by 202 reads (2%, 94+ and 108&#x2212;). We note that our MT genome&#xA0;assembly represents a consensus of reads with this mosaicism. Overall, a more complete human diploid genome assembly reveals a greater amount of genetic diversity in the nuclear genome than otherwise expected, more copy number variation in genes associated with primate specific-traits, and nuclear and MT genome mosaicism.</p>
    </sec>
    <sec id="Sec14">
      <title>A look towards the future</title>
      <p id="Par33">This study allowed us to determine which current approaches yield the best values in quality metrics for diploid maternal-derived and paternal-derived genomes of an individual. Key factors were the use of trio-parental sequence data to sort haplotype sequences in the child, a graph-based approach to resolve these haplotypes during the assembly process rather than before or after it, and combining different sequence data types and assembly tools in which each approach captures information missed by another. Haplotype binning of reads before assembly (for example, Trio HiCanu) was prone to mispartition of some reads, leading to lower phasing metric values than graphed-based phasing (for example, Trio hifiasm).</p>
      <p id="Par34">These findings confirm and advance on those recently reported by the VGP<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, HGSVC<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and T2T<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> consortia. The initial VGP pipeline used PacBio CLR reads, which were less accurate than the more recent PacBio HiFi reads. The improved accuracy of the HiFi reads reduces the need for short-read polishing of the assemblies. More accurate long reads also allowed generation of larger contigs, reduction of collapsed repetitive sequences in the centromeres and increased haplotype phasing accuracy<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Instead of FALCON-Unzip that had produced a more complete pseudohaplotype and a fragmented alternate haplotype, hifiasm, DipAsm, PGAS and CrossStitch produce two comparable pseudohaplotypes. An advance adopted from the T2T approach used on CHM13 was development of a tool for automated incorporation of polished ONT assemblies for gap filling, but here for both haplotypes, independently. We also made advances on the Trio assembly approach, by not only haplotype phasing the long reads and Hi-C reads but also the Bionano optical maps. These advancements lead to near-complete phased haplotypes. All major components of the current pipeline developed here are available on the Galaxy platform, and in modular form with different steps that can be optionally performed (<ext-link ext-link-type="uri" xlink:href="https://assembly.usegalaxy.eu/">https://assembly.usegalaxy.eu/</ext-link>)<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. What remains is developing diploid assembly methods that prevent the remaining collapses, gaps and switch errors in the centromeric satellite arrays, large human satellite arrays and short arms of the acrocentric chromosomes.</p>
      <p id="Par35">On the basis of the findings in this study, the HPRC decided to use the trio graph-partitioning approach of hifiasm to generate the contigs of the first 47 individuals (94 haplotypes) that will contribute to the first human pangenome reference (BioProject <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA730822">PRJNA730822</ext-link>)<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. The contig assembly metrics on these additional individuals had similar high values as we present here for HG002, indicating that overfitting of algorithms or parameters on one individual did not occur. We initially used 35&#xD7; HiFi coverage for these individuals based on manufacturer recommendations. However, this was not sufficient to cover all regionsof the genome for assembly, and thus we used 130&#xD7; HiFi coverage. Subsequent tests with improved algorithms on humans and other species suggest that we can lower HiFi coverage from 130&#xD7; to 50&#x2013;60&#xD7; to get the most complete assembly before curation. The trio and a non-trio version of hifiasm followed by the scaffolding with Hi-C (and/or Bionano) used here for HPRC-HG002 have been adopted by other large-scale sequencing projects, such as the VGP, the Earth Biogenome Project and the Darwin Tree of Life Project. Improvements have also been made to some of the other assembly algorithms since the versions tested here thus far<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR60">60</xref></sup>; the trio graph-based approach with trio-based scaffolding still yields the best combination of values in metrics. The results and methods developed here help to set the standard and benchmarks for future studies.</p>
      <p id="Par36">Future efforts will be necessary to develop a phasing method that does not require parental sequence data and works as well as a trio method. This will make it possible to generate equivalent diploid reference assemblies for human and non-human organisms where parental data may not be available. Towards this end, using Hi-C or Strand-seq data for haplotype phasing are promising alternatives, as both types of data contain within-chromosome haplotype information of an individual. To date, three methods have successfully used Hi-C, including FALCON Phase<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, hifiasm (Hi-C)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and pstools<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, and another has used Strand-seq<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> to generate maternal and paternal phased long-read-based human genome assemblies with fewer switch errors, including on HG002. As with trio binning, these approaches appear to work best when phasing is integrated with the assembly process, but further improvements are necessary to match or surpass the quality seen with a parental trio graph-based approach used here.</p>
      <p id="Par37">We used ONT-UL reads to fill in GA-rich repeats and other challenging sequence gaps between the HiFi-based contigs. A potential alternative is the PacBio CLR reads that do not make it to HiFi accuracy contain some of the GA-rich repeats, and could be used to fill in some of these gaps. The remaining few gaps per chromosome in the HG002 assemblies are mostly restricted to the hardest-to-assemble regions around segmental duplications, centromeres, telomeres, rDNA arrays and other complex repeats, many with differences between haplotypes. Direct integration of ONT-UL data within the assembly graph and manual curation were necessary for finishing these regions in the T2T-CHM13 assembly<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Thus, integration of both HiFi and ONT-UL data in a diploid assembly graph, combined with long-range phasing information from trios, Hi-C or Strand-seq may soon enable automated T2T diploid genome assemblies<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. For each of these additional approaches, the amount of read coverage needs to be titrated. Furthermore, the ability to produce higher coverage cheaper and faster continues to improve for all technologies. For those who wish to contribute assemblies to the human pangenome references, we encourage them to utilize our recommended processes to obtain the highest-quality assemblies possible; we also encourage contribution of new methods to further improve the quality and completeness of human and other species genome assemblies. We believe that generating complete, haplotype phased and accurate genome assemblies will be critical for generating accurate pangenome graphs.</p>
      <p id="Par38">The new biological discoveries made here demonstrate that even with a single individual, additional genetic diversity contributing to the human population can be found. Using these methods for the generation of additional diploid human genomes and creation of a human reference pangenome should enable a more-complete picture of human genetic diversity, greater accuracy for precision medicine for haplotype-specific diseases and a greater understanding of the biology of genomes.</p>
    </sec>
    <sec id="Sec15" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec16">
        <title>Cell lines</title>
        <p id="Par39">The GM24385 (RRID:CVCL_1C78) EBV-immortalized LCL of HG002 was obtained from the National Institute for General Medical Sciences (NIGMS) Human Genetic Cell Repository at the Coriell Institute for Medical Research. This cell line was used to generate the Oxford Nanopore sequencing and Bionano mapping data. For the Illumina and Pacific Biosciences sequencing data, NIST Reference Material (RM) 8391 DNA was used, which was prepared from a large batch of GM24385 to control for differences arising during cell growth. For paternal (HG003) and maternal (HG004) samples, DNA was extracted from cell lines publicly available as GM24149 (RRID:CVCL_1C54) and GM24143 (RRID:CVCL_1C48), respectively, and Illumina sequencing of DNA from NIST RM 8392 (containing vials of HG002, HG003 and HG004) was used.</p>
      </sec>
      <sec id="Sec17">
        <title>Chromosome spreads and FISH</title>
        <p id="Par40">For chromosome spreads preparation, GM24385 LCL cells were arrested in mitosis by the addition of Karyomax colcemid solution (0.1&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup>; Life Technologies) to the growth medium for 6&#x2009;h. Cells were collected by centrifugation at 200<italic>g</italic> for 5&#x2009;min and incubated in 0.4% KCl swelling solution for 10&#x2009;min. Swollen cells were pre-fixed by addition of freshly prepared methanol: acetic acid (3:1) fixative solution (approximately 100&#x2009;&#x3BC;l per 10&#x2009;ml total volume). Pre-fixed cells were collected by centrifugation at 200<italic>g</italic> for 5&#x2009;min and fixed in methanol: acetic acid (3:1) fixative solution. Spreads were dropped on a glass slide and incubated at 65&#x2009;&#xB0;C overnight. Before hybridization, slides were treated with 1&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> RNAse A (1:100 from Qiagen) in 2&#xD7; SSC for at least 45&#x2009;min at 37&#x2009;&#xB0;C and then dehydrated in a 70%, 80% and 100% ethanol series for 2&#x2009;min each. Denaturation of spreads was performed in 70% formamide/2&#xD7; SSC solution at 72&#x2009;&#xB0;C for 1.5&#x2009;min and immediately stopped by immersing slides in ethanol series pre-chilled to &#x2212;20&#x2009;&#xB0;C. Fluorescently labelled DNA probes (DXZ1 for the X chromosome from Cytocell, and made in-house for the Y chromosome probe) were denatured separately in hybridization buffer (Empire Genomics) by heating to 80&#x2009;&#xB0;C for 10&#x2009;min before applying to denatured slides. Spreads were hybridized to probes under HybriSlip hybridization cover (GRACE Biolabs) sealed with Cytobond (SciGene) in a humidified chamber at 37&#x2009;&#xB0;C for 72&#x2009;h. After hybridization, slides were washed in 50% formamide/2&#xD7; SSC three times for 5&#x2009;min at 45&#x2009;&#xB0;C, then in 1&#xD7; SSC solution at 45&#x2009;&#xB0;C for 5&#x2009;min twice, and at room temperature once. Slides were then rinsed with double deionized H<sub>2</sub>O, air dried and mounted in Vectashield containing DAPI (Vector Laboratories). Images were acquired on the LSM710 confocal microscope (Zeiss) using the &#xD7;63/1.40 NA oil objective or on the Nikon TiE microscope equipped with &#xD7;100 objective NA 1.45, Yokogawa CSU-W1 spinning disk and Flash 4.0 sCMOS camera. Image processing and chromosome counts were performed in FIJI.</p>
      </sec>
      <sec id="Sec18">
        <title>Genome sequencing</title>
        <p id="Par41">The sequence data used for this study (HG002 Data Freeze v1.0) are available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0">https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0</ext-link>). DNA samples were extracted from large homogenized growths of B lymphoblastoid cell lines of HG002, HG003 and HG004 from the Coriell Institute for Medical Research.</p>
        <sec id="Sec19">
          <title>Illumina reads</title>
          <sec id="FPar1">
            <title>Paired-end reads</title>
            <p id="Par42">Whole-genome data, TruSeq (LT) libraries, 300x PCR-free paired-end 150&#x2009;bp + 40x, PCR-free paired-end 250&#x2009;bp on Illumina HiSeq 2500, were from GIAB<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. HG002 was sequenced to 51.7&#xD7; coverage, HG003 to 69.1&#xD7; and HG004 to 70.6&#xD7;.</p>
          </sec>
        </sec>
        <sec id="Sec20">
          <title>Long-molecule linked reads</title>
          <p id="Par43">For 10X Genomics reads, Chromium Genome Platform from 10X Genomics was sequenced to two depths: 51.7&#xD7; coverage and a deeper 84.4&#xD7; coverage (300&#x2009;Gb) dataset. Additional data are available from BioProject: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA527321">PRJNA527321</ext-link>. For Transposase Enzyme Linked Long-read Sequencing (TELL-seq) linked reads, these reads were made available from another study<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>.</p>
        </sec>
        <sec id="Sec21">
          <title>PacBio reads</title>
          <p id="Par44">DNA was sheared to approximately 20&#x2009;kb with a Megaruptor 3, libraries were prepared with SMRTbell Express Template Prep Kit 2.0 and size selected with SageELF to the targeted size (15&#x2009;kb, 19&#x2009;kb, 20&#x2009;kb or 25&#x2009;kb), and sequenced on the Sequel II System with Chemistry 2.0 (15&#x2009;kb or 20&#x2009;kb libraries; 36&#xD7; and 16&#xD7; coverage, respectively), pre-2.0 Early Access Chemistry (15&#x2009;kb, 19&#x2009;kb and 25 kb libraries; 24&#xD7;, 14&#xD7; and 11&#xD7; coverage, respectively) and Sequel System with Chemistry 3.0 (15&#x2009;kb libraries; 28&#xD7; coverage). For PacBio CLRs, libraries were prepared with SMRTbell Express Template Prep Kit 2.0, size selected to a target size (more than 30&#x2009;kb), and sequenced on a Sequel II System with Chemistry 1.0 and Chemistry 2.0 to more than 60-fold coverage from two SMRT cells.</p>
        </sec>
        <sec id="Sec22">
          <title>ONT reads</title>
          <p id="Par45">All of the ONT sequencing for HG0002 was run on PromethION and GridION sequencing instruments. The GridION uses MinION flow cells and the PromethION uses PromethION flow cells. Both flow cells used the same ONT R9.4.1 sequencing chemistry. Sequencing libraries were prepared for PromethION sequencing, with the unshearedsequencing library prep protocol. We used 28 PromethION flow cells to generate a total of 658&#xD7; coverage (assuming 3.1-Gb genome size) and approximately 51&#xD7; coverage with 100&#x2009;kb+ reads, although we never used all 658&#xD7; for any one assembly. GridION sequencing prepared libraries with the ultralong sequencing library prep protocol and used 106 MinION flow cells to generate a total of approximately 52&#xD7; coverage (assuming 3.1-Gb genome size) and approximately 15&#xD7; coverage of 100&#x2009;kb+ reads<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. More recently, we obtained 10&#xD7;+ of more than 100&#x2009;kb per ultralong PromethION flow cell.</p>
        </sec>
        <sec id="Sec23">
          <title>Hi-C linked reads</title>
          <p id="Par46">Two different Hi-C datasets were made with two distinct protocols, to reach as uniform coverage across the genome as possible: Dovetail Omni-C (named Hi-C1) and Arima Genomics High Coverage Hi-C (named Hi-C2) protocols. For Hi-C1, about 100,000 cultured HG002 cells were processed for proximity ligation libraries without restriction enzymes. High-coverage (69&#xD7;) sequencing was done on a Nova-seq (250&#x2009;bp PE). For Hi-C2, two libraries were prepared from two cell culture replicates and sequenced with 2&#xD7; 150&#x2009;bp and 2&#xD7; 250&#x2009;bp Illumina reactions each. The combination of restriction enzymes represent ten possible cut sites: ^GATC, G^ANTC, C^TNAG and T^TAA; &#x2018;^&#x2019; is the cut site on the plus DNA strand, and the 'N' can be any of the four genomic bases.</p>
        </sec>
        <sec id="Sec24">
          <title>Strand-seq</title>
          <p id="Par47">Strand-specific libraries were generated as previously described<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, from 192 barcoded single-cells and sequenced on a NextSeq Illumina platform. The 192 barcoded single-cell libraries were pooled for sequencing of the HG002 sample. Raw demultiplexed fastq files from the paired-end sequencing run (80-bp read lengths) were uploaded for each single-cell library. These data can be found at <ext-link ext-link-type="uri" xlink:href="https://s3-us-west-2.amazonaws.com/human-pangenomics/index.html?prefix=HG002/hpp_HG002_NA24385_son_v1/Strand_seq/">https://s3-us-west-2.amazonaws.com/human-pangenomics/index.html?prefix=HG002/hpp_HG002_NA24385_son_v1/Strand_seq/</ext-link>.</p>
        </sec>
        <sec id="Sec25">
          <title>Optical maps</title>
          <p id="Par48">Bionano DLE1 data were collected with throughput of 1,303&#x2009;Gb (molecules of more than 150&#x2009;kb) and Read N50 of 293&#x2009;kb (molecules of more than 150&#x2009;kb) provided by Bionano Genomics and the GIAB Consortium.</p>
        </sec>
      </sec>
      <sec id="Sec26">
        <title>Genome assembly pipelines tested</title>
        <p id="Par49">The assembly bakeoff was an open public science experiment and evaluation, in which researchers of the HRPC and anyone in the scientific community could contribute, with the goal of creating the highest-quality de novo assembly possible, of one or both haplotypes, using an automated process. We did this by contacting known assembly experts, sending out announcements on consortium email list (for example, HPRC, VGP, T2T, HGSVC and GIAB), and announcements on HRPC-associated websites (<ext-link ext-link-type="uri" xlink:href="https://humanpangenome.org/hg002/">https://humanpangenome.org/hg002/</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0">https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0</ext-link>). We grouped the assembly pipelines tested into five categories according to whether contigs only or contigs and scaffolds were generated, and whether the contigs and/or scaffolds were haplotype phased or merged as a pseudohaplotype (Table <xref rid="Tab1" ref-type="table">1</xref>). The assemblies were further classified by whether parental trio data were used and whether they were reference based or de novo (Table <xref rid="Tab1" ref-type="table">1</xref>). The assemblies were assigned ID numbers on the basis of the order received by the consortium evaluation team, and in no part reflect order of assembly metric quality. All but two assemblies (asm3 and asm23) that used PacBio data used the recommended downsampled HiFi SMRT cell runs from the 15-kb and 20-kb insert libraries totalling approximately 34&#xD7; coverage (<ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0#hg002-data-freeze-v10-recommended-downsampled-data-mix">https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0#hg002-data-freeze-v10-recommended-downsampled-data-mix</ext-link>). Asm3 used the 19-kb, 20-kb and 25-kb insert libraries. Asm23 used PacBio CLRs. The specific method details for each assembly pipeline, under each of the five major categories, are described below.</p>
        <sec id="Sec27">
          <title>Diploid scaffold assemblies</title>
          <sec id="FPar2">
            <title>Trio binning phasing VGP pipeline 1.6 (asm23)</title>
            <p id="Par50">This assembly was based on a modified version of the VGP trio pipeline 1.6 (ref. <sup><xref ref-type="bibr" rid="CR11">11</xref></sup>). All data types (PacBio CLRs, 10XG linked-reads, Bionano maps and Hi-C2 reads) were haplotype binned or filtered by haplotype. In brief, CLRs were binned (hapUnknownFraction = 0.01) and assembled into contigs using HiCanu<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> v1.8. NA24143 (maternal HG004) and NA24149 (paternal HG003) 250-bp PE Illumina reads were used for binning. CLR coverage of the child (HG002) was 74&#xD7; and 72&#xD7; for the maternal and paternal haplotypes, respectively. To polish the contigs, the binned CLRs were used for each respective haplotype with Arrow (variantCaller v2.3.3). The two haplotype contigs were then purged from each other using purge_dups v1.0 (ref. <sup><xref ref-type="bibr" rid="CR65">65</xref></sup>), conducted in the haploid mode (calcuts -d1) and only JUNK and OVLP were removed. To these contigs, Bionano molecules were aligned and assigned to the haplotype bin with higher alignment confidence. Bionano molecules aligning equally well to both parental haplotype contigs (alignment score discrepancies of less than equal to 10<sup>&#x2212;2</sup>) were randomly split into two clusters equally and assigned to the bins. The same method of splitting the molecules was used for molecules aligning to neither of the parental assemblies (<ext-link ext-link-type="uri" xlink:href="https://github.com/andypang0714/Bionano_Trio_binning">https://github.com/andypang0714/Bionano_Trio_binning</ext-link>). Binned Bionano molecules were then assembled to haploid assemblies. Cross-checking was then performed by aligning the paternal and maternal Bionano assemblies to the parental assemblies to identify regions where both parents shared the same allele, and the best allele was picked for the next round of trio binning and assemblies. 10XG and Hi-C reads were filtered for <italic>k</italic>-mers of the alternate haplotype using Meryl (<ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/meryl/tree/master/src/meryl">https://github.com/marbl/meryl/tree/master/src/meryl</ext-link>), and a custom script that is part of the VGP trio pipeline 1.6 was used to exclude read pairs containing <italic>k</italic>-mers only found in the other haplotype. With this prepared data, three rounds of scaffolding were then conducted on each haplotype, sequentially with the binned 10XG reads using Scaff10x v4.2, binned Bionano maps with Solve v3.4 and binned Hi-C linked reads with Salsa v2.2. The assemblies were not further polished as they already reached Q40 as judged by Merqury. Compute time was not tracked. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/VGP/vgp-assembly/tree/master/pipeline">https://github.com/VGP/vgp-assembly/tree/master/pipeline</ext-link>).</p>
          </sec>
          <sec id="FPar3">
            <title>DipAsm contig and scaffolding pipeline (asm10)</title>
            <p id="Par51">This assembly is based on a protocol similar to DipAsm reported in ref. <sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. PacBio HiFi reads were first assembled into unphased contigs using Peregrine. Contigs were grouped and ordered into scaffolds with Hi-C2 data. The HiFi reads were then mapped to scaffolds using minimap2 and heterozygous SNPs called using DeepVariant<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. The heterozygous SNP calls were phased with both HiFi and Hi-C2 data using HapCUT2 (ref. <sup><xref ref-type="bibr" rid="CR67">67</xref></sup>) and Whatshap<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. The reads were then partitioned on the basis of their phase using a custom script. The partitioned reads were re-assembled into phased contigs using Peregrine. The contigs were then ordered and joined together with 100 Ns to produce phased scaffolds. Compute time was not tracked. The source code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/shilpagarg/DipAsm">https://github.com/shilpagarg/DipAsm</ext-link>.</p>
          </sec>
          <sec id="FPar4">
            <title>Dovetail DipAsm variant pipeline (asm2 and asm22)</title>
            <p id="Par52">The Dovetail pipeline used is a variation of the DipAsm pipeline previously described<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The main difference is that DipAsm used HiFi reads for SNP calling with DeepVariant and the Dovetail protocol used Omni-C reads (Hi-C1) for SNP calling with FreeBayes. In particular, PacBio HiFi reads were assembled into contigs using the Peregrine assembler with default parameters. These contigs were joined into chromosome-scale scaffolds using Dovetail Omni-C data and either HiRise (Dovetail Genomics; asm2) or Salsa2 (ref. <sup><xref ref-type="bibr" rid="CR18">18</xref></sup>) (asm22) scaffolders. Omni-C reads were then aligned to scaffolds and haplotype SNPs were called using FreeBayes. These SNPs were then phased with HapCUT2 and Omni-C long-range links to obtain chromosome-scale phased blocks. These phased SNPs were used to partition HiFi and Omni-C reads into two haplotypes. Reads for which the partitioning could not be done ambiguously were assigned to both haplotypes. Phased HiFi reads for each haplotype were assembled again with Peregrine and scaffolded with haplotype-specific Omni-C reads to obtain chromosome-scale phased scaffolds. Compute time was not tracked. All of the tools were run on AWS EC2 with c5d.9xlarge instance type. The source code for HiRise is proprietary. The source code for Salsa2 is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/SALSA/commit/974589f3302b773dcf0f20c3332fe9daf009fb93">https://github.com/marbl/SALSA/commit/974589f3302b773dcf0f20c3332fe9daf009fb93</ext-link>).</p>
          </sec>
          <sec id="FPar5">
            <title>PGAS pipeline (asm14)</title>
            <p id="Par53">The recent PGAS diploid genome assembly pipeline has been previously described<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. First, a non-haplotype resolved (&#x2018;squashed&#x2019;) contig assembly was generated from PacBio HiFi reads using Peregrine v0.1.5.5 (<ext-link ext-link-type="uri" xlink:href="http://github.com/cschin/Peregrine">github.com/cschin/Peregrine</ext-link>). Illumina short reads from the Strand-seq data<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> were aligned against this squashed assembly to identify contigs that most likely originate from the same chromosome based on similar Watson&#x2013;Crick strand inheritance patterns<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. This information was then used to cluster the contigs into roughly chromosome-scale clusters, which helps to avoid chimeric chromosome assemblies, allows for parallelization of the assembly pipeline and facilitates phasing. Next, heterozygous SNVs were identified based on long-read alignments against the clustered assembly with DeepVariant v0.9.0. To obtain chromosome-scale haplotypes, integrative phasing with WhatsHap<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> was performed, combining local dense phase information derived from long reads with global sparse phase information inferred from Strand-seq alignments. Next, phased heterozygous SNVs were used to assign each HiFi read to its corresponding haplotype (&#x2018;haplo-tagging&#x2019;) or remain in the fraction of haplotype-unassigned reads. The haplotags were used to split the HiFi reads into two haploid read sets, which, together with the haplotype-unassigned reads, were the input to assemble two haplotype contig sequences per chromosome-scale cluster with Peregrine v0.1.5.5. After polishing the contigs for two rounds with Racon v1.4.10 (ref. <sup><xref ref-type="bibr" rid="CR71">71</xref></sup>) and the haploid long-read datasets, the per chromosome cluster assemblies were merged to create a genome-scale diploid assembly. The final round of scaffolding of each haplotype was performed with the short reads from the Strand-seq data, on HiFi contigs with a minimum size of 500&#x2009;kb. This size thresholding was necessary as the contig order can only be inferred from strand-state changes resulting from sister chromatid exchanges (SCEs; a process during DNA replication in which two sister chromatids break, rejoin and physically exchange regions of the parental strands). SCEs are low-frequency events that are thus less likely to produce a traceable signal with decreasing contig size. The complete assembly pipeline run required less than 2,000&#x2009;CPU hours on a three-node cluster (3 &#xD7; 36C, 1.4&#x2009;TB of RAM) with a peak RAM usage of around 600&#x2009;GB (squashed Peregrine assembly). The source code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/ptrebert/project-diploid-assembly">https://github.com/ptrebert/project-diploid-assembly</ext-link>; pipeline parameter version 8.</p>
          </sec>
          <sec id="FPar6">
            <title>CrossStitch (asm17)</title>
            <p id="Par54">The assembly was produced using CrossStitch, a reference-based pipeline for diploid genome assembly. SNPs and small indels were called with respect to GRCh38 for HG002 from alignments of unbinned 30&#xD7; PacBio HiFi reads. Variant calling was performed on this BAM using DeepVariant v0.9 (ref. <sup><xref ref-type="bibr" rid="CR66">66</xref></sup>) and the PacBio model. A full set of commands and parameters are available on the PacBio case study: <ext-link ext-link-type="uri" xlink:href="https://github.com/google/deepvariant/blob/r0.9/docs/deepvariant-pacbio-model-case-study.md">https://github.com/google/deepvariant/blob/r0.9/docs/deepvariant-pacbio-model-case-study.md</ext-link>. Larger SVs were called by running Sniffles v1.0.11 (with parameters -s 10 -l 10 --min_homo_af 0.7) on minimap2 v2.17 alignments of the HiFi reads and refining these calls with Iris v1.0.1 (<ext-link ext-link-type="uri" xlink:href="https://github.com/mkirsche/Iris">https://github.com/mkirsche/Iris</ext-link>)<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Then, the SNVs and small indel variants (less than 30&#x2009;bp) called from DeepVariant were phased using HapCUT2 v1.1 on the ONT + Hi-C alignments, and these phase blocks were used to assign a haplotype to each HiFi read. SV phasing was performed by observing the reads supporting each heterozygous SV call and assigning the variant to the haplotype that the majority of the reads came from. Finally, vcf2diploid (<ext-link ext-link-type="uri" xlink:href="https://github.com/abyzovlab/vcf2diploid">https://github.com/abyzovlab/vcf2diploid</ext-link>) from the AlleleSeq algorithm<sup><xref ref-type="bibr" rid="CR73">73</xref></sup> was used to incorporate small variant and SV calls into a template consisting of the GRCh38 reference genome sequence, producing the final assembly for HG002. The end-to-end assembly took less than 2 days on a high-memory machine at JHU using at most 40 cores at a time. Peak RAM utilization was less than 100&#x2009;GB. The source code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/schatzlab/crossstitch">https://github.com/schatzlab/crossstitch</ext-link> (commit ID: e49527b).</p>
          </sec>
        </sec>
        <sec id="Sec28">
          <title>Diploid contig assemblies</title>
          <sec id="FPar7">
            <title>Trio binning Flye ONT pipeline (asm6 and asm7)</title>
            <p id="Par55">Following a trio-based assembly approach<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, parental Illumina 21-mers were counted in the child, maternal and paternal read sets (full sets, not subset coverage recommendations). Haplotype-specific mers were created using Merqury v1.0 (ref. <sup><xref ref-type="bibr" rid="CR36">36</xref></sup>) and Meryl v1.0 (<ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/meryl">https://github.com/marbl/meryl</ext-link>) with the command: hapmers.sh.sh mat.k21.meryl pat.k21.meryl child.k21.meryl. These short reads were then used to bin ONT standard long (asm6) or ultralong more than 100-kb (asm7) reads into their maternal-specific and paternal-specific haplotypes. The ONT recommended subset reads were then assigned using splitHaplotigs in Canu v2.0 (ref. <sup><xref ref-type="bibr" rid="CR17">17</xref></sup>) with the command: splitHaplotype -cl 1000 -memory 32 -threads 28 -R HG002_ucsc_ONT_lt100kb.fastq.gz \ -R HG002_giab_ULfastqs_guppy3.2.4.fastq.gz \ -H ./0-kmers/haplotype-DAD.meryl 6 ./haplotype-DAD.fasta.gz \ -H ./0-kmers/haplotype-MOM.meryl 6 ./haplotype-MOM.fasta.gz \ -A ./haplotype-unknown.fasta.gz.</p>
            <p id="Par56">Flye v2.7-b1585 (ref. <sup><xref ref-type="bibr" rid="CR30">30</xref></sup>) was then run on the binned reads to generate maternal and paternal contigs with the command: fly --threads 128 --min-overlap 10000 --asm-coverage 40 -out_dir &lt;MOM/DAD&gt; --genome-size 3.1g --nano-raw haplotype-&lt;DAD/MOM&gt;.fasta.gz. Flye sometimes inserts gaps when it is not certain of a repeat sequence, and thus some contigs appear as scaffolds. However, the assembly is still contig level. No base-level polishing (with short or long reads) was conducted on the assembly. The ONT standard Flye runs took approximately 1,200&#x2009;CPU hours (20 wall clock hours) and 500&#x2009;GB of memory. The ONT-UL assemblies took approximately 3,000&#x2009;CPU hours (60 wall clock hours) and 800&#x2009;GB of memory. The source codes for Canu, Mercury and Flye are available (<ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/canu">https://github.com/marbl/canu</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/merqury">https://github.com/marbl/merqury</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/fenderglass/Flye">https://github.com/fenderglass/Flye</ext-link>).</p>
          </sec>
          <sec id="FPar8">
            <title>Trio binning HiCanu contig pipeline (asm19)</title>
            <p id="Par57">Following a trio-based assembly approach<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, parental Illumina 21-mers were counted in the child, maternal and paternal read sets (full sets, not subset coverage recommendations). Haplotype-specific mers were created using Merqury v1.0 (ref. <sup><xref ref-type="bibr" rid="CR36">36</xref></sup>) and Meryl v1.0 (<ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/meryl">https://github.com/marbl/meryl</ext-link>) with the command: hapmers.sh mat.k21.meryl pat.k21.meryl child.k21.meryl. The HiFi-recommended 34&#xD7; subset reads were then assigned to using splitHaplotigs in Canu v2.0 (ref. <sup><xref ref-type="bibr" rid="CR17">17</xref></sup>) with the command: splitHaplotype -cl 1000 -memory 32 -threads 28 -R m64012_190920_173625.fastq.gz -R m64012_190921_234837.fastq.gz -R m64011_190830_220126.Q20.fastq.gz -R m64011_190901_095311.Q20.fastq.gz -H ./0-kmers/haplotype-DAD.meryl 6 ./haplotype-DAD.fasta.gz -H ./0-kmers/haplotype-MOM.meryl 6 ./haplotype-MOM.fasta.gz -A ./haplotype-unknown.fasta.gz. Any reads that were unclassified were randomly divided into two bins. The resulting maternal and paternal read sets were independently assembled with HiCanu<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> v2.0 with the commands: canu -p 'asm' 'gridOptions=--time=4:00:00 --partition=quick,norm' 'gridOptionsCns=--time=30:00:00 --partition=norm ' 'genomeSize=3.1g' 'gfaThreads=48' 'batOptions= -eg 0.01 -sb 0.01 -dg 6 -db 6 -dr 1 -ca 50 -cp 5' -pacbio-hifi haplotype-[DAD|MOM].fasta.gz haplotype-unknown-batch[1|2].fastq.gz. The source codes are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/canu">https://github.com/marbl/canu</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/merqury">https://github.com/marbl/merqury</ext-link>. Publication is available<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.</p>
            <p id="Par58">All runs used the &#x2018;quick&#x2019; partition of the NIH Biowulf cluster (<ext-link ext-link-type="uri" xlink:href="https://hpc.nih.gov">https://hpc.nih.gov</ext-link>). HiCanu required approximately 1,400&#x2009;CPU hours per haplotype (19 wall clock hours) and no single job required more than 64&#x2009;GB of memory.</p>
          </sec>
          <sec id="FPar9">
            <title>Trio binning Peregrine contig pipeline (asm20)</title>
            <p id="Par59">The same binned reads as for asm19 were used for this assembly. The reads were assembled with Peregrine v0.1.5.3+0.gd1eeebc.dirty with the command yes yes | python3 Peregrine/bin/pg_run.py asm \ input.list 24 24 24 24 24 24 24 24 24 \ --with-consensus --shimmer-r 3 --best_n_ovlp 8 \ --output ./. The input.list specifies the appropriate haplotype input reads. Compute time was not tracked. The source codes can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/cschin/Peregrine">https://github.com/cschin/Peregrine</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/merqury">https://github.com/marbl/merqury</ext-link>.</p>
          </sec>
          <sec id="FPar10">
            <title>Trio phasing hifiasm contig pipeline (asm9)</title>
            <p id="Par60">Hifiasm finds alignments between HiFi reads and corrects sequencing errors observed in alignments<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. It labels a corrected read with its inferred parental origin using parent-specific 31-mers counted from parental short reads. HiFi reads in long homozygous regions do not have parent-specific 31-mers and are thus unlabelled. Hifiasm then builds a string graph from read overlaps that carries read labels. It traces paternal and maternal reads in the graph to generate paternal and maternal contigs, respectively. We collected paternal 31-mers from short reads with &#x2018;yak count -b37 -o sr-pat.yak sr-pat.fq.gz&#x2019; (and similarly for maternal) and assembled HiFi reads with &#x2018;hifiasm &#x2212;1 sr-pat.yak &#x2212;2 sr-mat.yak hifi-reads.fq.gz&#x2019;. The assembly took 305&#x2009;CPU hours. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/chhylp123/hifiasm/releases/tag/v0.3">https://github.com/chhylp123/hifiasm/releases/tag/v0.3</ext-link>).</p>
          </sec>
          <sec id="FPar11">
            <title>DipAsm contig pipeline (asm11)</title>
            <p id="Par61">The assembly pipeline mimics the DipAsm steps explained for asm10. The pipeline takes as input HiFi and Hi-C datasets and outputs the phased contigs. Initially, the pipeline produces unphased contigs using Peregrine and then these unphased contigs are scaffolded to produce chromosome-scale sequences using HiRise. Afterwards, the heterozygous SNPs are called and are phased using HiFi and Hi-C data. These phased SNPs are informative sites to partition HiFi reads to haplotypes on the chromosome level. The phased reads are then assembled using Peregrine to produce phased contigs.</p>
          </sec>
          <sec id="FPar12">
            <title>Peregrine contig pipeline (asm3 and asm4)</title>
            <p id="Par62">The Peregrine assembler<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> was used to generate contigs on the HiFi reads, using either the full coverage sequence (asm3) consisting of 19-kb, 20-kb and longer 25-kb read libraries or downsampled to 34&#xD7; and shorter 15-kb reads (asm4). A module was written to separate likely true-variant sites from differences between reads caused by sequencing errors. This was done by using the overlap data from the Peregrine assembler overlapping modules with additional alignment analysis. The variants of the read overlapped data were analysed to get a subset of variants that should belong to the same haplotypes. The reads with the same set of variants were considered to be haplotype consistent, and the overlaps between those haplotype-consistent reads were considered for constructing the contig assembly. Overlaps between different haplotypes or different repeats from the analysis results were ignored. It is expected that the generated contigs are from single haplotypes in those regions, which have enough heterozygous variants. Compute time was not tracked. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/cschin/Peregrine_dev/commit/93d416707edf257c4bcb29b9693c3fda25d97a29">https://github.com/cschin/Peregrine_dev/commit/93d416707edf257c4bcb29b9693c3fda25d97a29</ext-link>). The most up-to-date Peregrine code can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/cschin/Peregrine-2021">https://github.com/cschin/Peregrine-2021</ext-link>.</p>
          </sec>
          <sec id="FPar13">
            <title>FALCON-Unzip contig pipeline (asm16)</title>
            <p id="Par63">FALCON-Unzip<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> version 2.2.4-py37hed50d52_0 was run on reads from four SMRT cells from two HiFi libraries (15&#x2009;kb and 20&#x2009;kb, 34&#xD7; coverage total reads) with &#x2018;input_type = preads, length_cutoff_pr = 8000, ovlp_daligner_option = -k24 -h1024 -e.98 -l1500 -s100, ovlp_HPCdaligner_option = -v -B128 -M24, ovlp_DBsplit_option = -s400, overlap_filtering_setting = --max-diff 200 --max-cov 200 --min-cov 2 --n-core 24 --min-idt 98 --ignore-indels&#x2019; for the initial contig assembly and default parameters for unzipping haplotypes. The assembly took 2,540&#x2009;CPU-core hours on nodes with Intel Xeon processor E5-2600 v4. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://anaconda.org/bioconda/pb-falcon/2.2.4/download/linux-64/pb-falcon-2.2.4-py37hed50d52_0.tar.bz2">https://anaconda.org/bioconda/pb-falcon/2.2.4/download/linux-64/pb-falcon-2.2.4-py37hed50d52_0.tar.bz2</ext-link>).</p>
          </sec>
          <sec id="FPar14">
            <title>HiCanu purge dups contig phasing pipeline (asm8)</title>
            <p id="Par64">HiCanu<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> v2.0 was used with the command canu -p 'asm' 'gridOptions=--time=4:00:00 --partition=quick,norm' 'gridOptionsCns=--time=30:00:00 --partition=norm ' 'genomeSize=3.1g' 'gfaThreads=48' -pacbio-hifi m64012_190920_173625.fastq.gz m64012_190921_234837.fastq.gz m64011_190830_220126.Q20.fastq.gz m64011_190901_095311.Q20.fastq.gz.</p>
            <p id="Par65">Purge_dups<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> was used to remove alternate haplotypes (GitHub commit ID: b5ce3276773608c7fb4978a24ab29fdd0d65f1b5), with the thresholds of 5 7 11 30 22 42. Purge_dups introduces gaps near the purged sequenced regions of the contigs, and thus some contigs appear as scaffolds. However, the assembly is still contig level. HiCanu required approximately 1,800&#x2009;CPU hours and no single job required more than 64&#x2009;GB of memory (22 wall clock hours). Purge_dups required 40&#x2009;CPU hours and less than 1&#x2009;GB of memory.</p>
          </sec>
        </sec>
        <sec id="Sec29">
          <title>Haploid scaffold assemblies</title>
          <sec id="FPar15">
            <title>Flye ONT pipeline (asm5)</title>
            <p id="Par66">Flye v2.7b-b1579 (ref. <sup><xref ref-type="bibr" rid="CR30">30</xref></sup>) was used to assemble (downsampled) ONT reads into contigs, using the default parameters with extra &#x2018;--asm-coverage 50 --min-overlap 10000&#x2019; options. Two iterations of the Flye polishing module were applied using ONT reads, followed by two polishing iterations using HiFi reads. Finally, Flye graph-based scaffolding module was run on the polished contigs, which generated 54 scaffold connections and slightly improved the assembly contiguity. Assembly took approximately 5,000&#x2009;CPU hours and polishing (ONT + HiFi) took approximately 3,000&#x2009;CPU hours. Peak RAM usage was approximately 900&#x2009;GB. The pipeline was run on a single computational node with two Intel Xeon 8164 CPUs, with 26 cores each and 1.5&#x2009;TB of RAM. The source code can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/fenderglass/Flye/">https://github.com/fenderglass/Flye/</ext-link> (commit ID: ec206f8).</p>
          </sec>
          <sec id="FPar16">
            <title>Shasta ONT + HiC (asm18 and asm21)</title>
            <p id="Par67">The Shasta assembler<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> was used to assemble ONT reads into contigs. The contigs were polished using PEPPER (<ext-link ext-link-type="uri" xlink:href="https://github.com/kishwarshafin/pepper">https://github.com/kishwarshafin/pepper</ext-link>), which also uses only the ONT reads. The contigs were scaffolded with Omni Hi-C (Hi-C1) using HiRise (asm18) or Salsa v2.0 (asm21). Compute time was not tracked. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/chanzuckerberg/shasta">https://github.com/chanzuckerberg/shasta</ext-link>).</p>
          </sec>
          <sec id="FPar17">
            <title>Flye and MaSuRCA (asm15)</title>
            <p id="Par68">A subset of downsampled ONT-UL data that contained approximately 38&#xD7; genome coverage of 120-kb reads or longer was used. The ONT reads were assembled into contigs using the Flye assembler<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> v2.5. The contigs were polished with downsampled 30&#xD7; coverage of PacBio HiFi 15-kb and 20-kb reads, using POLCA, a tool distributed with the MaSuRCA<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. To scaffold and assign the assembled contigs to chromosomes, a reference-based scaffolding method was used embodied in the chromosome_scaffolder script included in MaSuRCA. GRCh38.p12 was used as a reference (without the ALT scaffolds) for scaffolding, with the chromosome_scaffolder option enabled, which allows it to fill in the gaps in scaffolds, where possible, with GRCh38 sequence, in lowercase letters. The final assembly was named JHU_HG002_v0.1. Compute time was not tracked. The source code can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/alekseyzimin/masurca">https://github.com/alekseyzimin/masurca</ext-link>.</p>
          </sec>
          <sec id="FPar18">
            <title>MaSuRCA (asm1)</title>
            <p id="Par69">MaSuRCA v3.3.1 (ref. <sup><xref ref-type="bibr" rid="CR32">32</xref></sup>) with default parameters was run on the combined Illumina, ONT and PacBio HiFi data to obtain a set of contigs designated the Ash1 v0.5 assembly. The ONT and PacBio data were an earlier release, from 2018, and the read lengths were shorter than the later release used by most other methods in this evaluation. After initial scaffolding, MaSuRCA was used to remove redundant haplotype-variant scaffolds by aligning the assembly to itself and looking for scaffolds that were completely covered by another larger scaffold and that were more than 97% identical to the larger scaffold. To scaffold and assign the assembled contigs to chromosomes, we used a reference-based scaffolding method embodied in the chromosome_scaffolder script included in MaSuRCA. We used the GRCh38.p12 as the reference (without the ALT scaffolds), and we enabled an option in chromosome_scaffolder that allows it to fill in gaps with the GRCh38 sequence, using lowercase letters. Finally, we examined SNVs reported at high frequency in an Ashkenazi population from the Genome Aggregation Database (gnomAD). GnomAD v3.0 contains SNV calls from short-read whole-genome data from 1,662 Ashkenazi individuals. At 273,866 heterozygous SNV sites where HG002 contained the Ashkenazi major allele and where our assembly used a minor allele, we replaced the allele in Ash1 with the Ashkenazi major allele. A publication of the final curated asm1 assembly has been made<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Compute time was not tracked. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/alekseyzimin/masurca">https://github.com/alekseyzimin/masurca</ext-link>).</p>
          </sec>
        </sec>
        <sec id="Sec30">
          <title>Haploid contig assemblies</title>
          <sec id="FPar19">
            <title>wtdbg2 (asm13)</title>
            <p id="Par70">The standard wtdbg2 assembly pipeline<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> was applied on HiFi reads. Parameters '-k 23 -p 0 -S 0.8 --no-read-clip --aln-dovetail -1' were customized to improve the contiguity. The source code is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/ruanjue/wtdbg2">https://github.com/ruanjue/wtdbg2</ext-link>; commit ID: d6667e78bbde00232ff25d3b6f16964cc7639378). Commands and parameters used were: &#x2018;#!/bin/bash&#x2019;; &#x2018;wtdbg2 -k 23 -p 0 -AS 4 -s 0.8 -g 3g -t 96 --no-read-clip --aln-dovetail -1 -fo dbg -i ../rawdata/SRR10382244.&#x2019;; &#x2018;fasta -i ../rawdata/SRR10382245.fasta -i ../rawdata/SRR10382248.fasta -i ../rawdata/SRR10382249.fasta&#x2019;; &#x2018;wtpoa-cns -t 96 -i dbg.ctg.lay.gz -fo dbg.raw.fa&#x2019;; &#x2018;minimap2 -I64G -ax asm20 -t96 -r2k dbg.raw.fa ../rawdata/SRR10382244.fasta ../rawdata/SRR10382245.fasta&#x2019;; &#x2018;../rawdata/SRR10382248.fasta ../rawdata/SRR10382249.fasta | samtools sort -m 2g -@96 -o dbg.bam&#x2019;; &#x2018;samtools view -F0x900 dbg.bam | wtpoa-cns -t 96 -d dbg.raw.fa -i - -fo dbg.cns.fa&#x2019;; &#x2018;ref. <sup><xref ref-type="bibr" rid="CR35">35</xref></sup>&#x2019;; &#x2018;compute time&#x2019;; &#x2018;wtdbg2: real 20,349.731&#x2009;s, user 1,178,897.390&#x2009;s, sys 18,351.090&#x2009;s, maxrss 194,403,704.0&#x2019;; &#x2018;kB, maxvsize 209,814,736.0&#x2009;kB&#x2019;; &#x2018;wtpoa-cns(1): real 3,350.517&#x2009;s, user 260,551.730&#x2009;s, sys 1,040.200&#x2009;s, maxrss 9,978,492.0&#x2019;; &#x2018;kB, maxvsize 15,839,032.0&#x2009;kB&#x2019;; &#x2018;wtpoa-cns(2):real 2,181.084&#x2009;s, user 149,528.810&#x2009;s, sys 815.380&#x2009;s, maxrss 11,134,244.0&#x2009;kB&#x2019;; &#x2018;maxvsize 16,012,012.0&#x2009;kB&#x2019;; &#x2018;others: unknown&#x2019;.</p>
          </sec>
          <sec id="FPar20">
            <title>NECAT Feng Luo group (asm12)</title>
            <p id="Par71">We used the NECAT assembler<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> to assemble ONT reads of HG002, which contained about 53&#xD7; coverage excluding ONT-UL reads. The command &#x2018;necat.pl config cfg&#x2019; was first used to generate the parameter file 'cfg'. The default values in 'cfg' were replaced with the following parameters: &#x2018;GENOME_SIZE&#x2009;=&#x2009;3000000000, THREADS&#x2009;=&#x2009;64, PREP_OUTPUT_COVERAGE=40, OVLP_FAST_OPTIONS=-n 500 -z 20 -b 2000 -e 0.5 -j 0 -u 1 -a 1000&#x2019;, &#x2018;OVLP_SENSITIVE_OPTIONS=-n 500 -z 10 -e 0.5 -j 0 -u 1 -a 1000, CNS_FAST_OPTIONS=-a 2000 -x 4 -y 12 -l 1000 -e 0.5 -p 0.8 -u 0, CNS_SENSITIVE_OPTIONS=-a 2000 -x 4 -y 12 -l 1000 -e 0.5 -p 0.8 -u 0, TRIM_OVLP_OPTIONS=-n 100 -z 10 -b 2000 -e 0.5 -j 1 -u 1 -a 400, ASM_OVLP_OPTIONS=-n 100 -z 10 -b 2000 -e 0.5 -j 1 -u 0 -a 400, CNS_OUTPUT_COVERAGE=40&#x2019;. The command &#x2018;necat.pl bridge cfg&#x2019; was run to generate the final contigs. It took approximately 12,555&#x2009;CPU hours (error correction 2,500&#x2009;h, assembling 8,123&#x2009;h, bridging 1,216&#x2009;h, polishing 716&#x2009;h) on a 4-core 24-thread Intel(R) Xeon(R) 2.4&#x2009;GHz CPU (CPU E7-8894[v4]) machine with 3&#x2009;TB of RAM. The source code can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/xiaochuanle/NECAT">https://github.com/xiaochuanle/NECAT</ext-link> (commit ID: 47c6c23).</p>
          </sec>
        </sec>
      </sec>
      <sec id="Sec31">
        <title>HPRC-HG002 references</title>
        <p id="Par72">HiFi reads with adaptors were removed with HiFiAdapterFilt (<ext-link ext-link-type="uri" xlink:href="https://github.com/sheinasim/HiFiAdapterFilt">https://github.com/sheinasim/HiFiAdapterFilt</ext-link>). After removing reads with adaptors and other problems we went from 133&#xD7; to 130&#xD7; (using a genome size of 3.1&#x2009;Gb). Maternal and paternal contigs were generated from 130&#xD7; coverage of the remaining HiFi reads using hifiasm v0.14.1 in trio mode. Any remaining adapter sequences were hard masked in the assemblies and any contigs that were identified as contamination were removed. Both maternal and paternal assemblies were screened for mitochondrial sequences using BLAST against the reference sequence NC_012920.1, and the results were filtered with a modified version of MitoHiFi (<ext-link ext-link-type="uri" xlink:href="https://github.com/marcelauliano/MitoHiFi">https://github.com/marcelauliano/MitoHiFi</ext-link>). Mitochondrial contigs were removed from the assemblies and mapped against the reference sequence with Minimap2 (with -cx asm5 --cs). The contig with the highest alignment score (AS field: DP alignment score) were pulled, and if there were multiple, the contig with the lowest number of mismatches (NM field) was chosen. The selected contig was then rotated to match the reference sequence and appended to the maternal assembly.</p>
        <p id="Par73">The remaining maternal and paternal HiFi contigs were then separately scaffolded with paternal and maternal Trio-Bionano Solve v1.6 maps (205&#xD7; and 195&#xD7;), respectively. Conflicts between the Bionano maps and PacBio HiFi-based contigs were manually reviewed by three experts and decisions were made to accept or reject the cuts proposed by Bionano Solve. Further scaffolding of the paternal and maternal scaffolds was done with Salsa v2.3 and approximately 40&#xD7; OmniC Hi-C reads excluding reads from the other haplotype with Meryl; that is, paired reads with <italic>k</italic>-mers only seen in one parent were removed before mapping and scaffolding. The resulting scaffolds were manually curated to ensure the proper order and orientation of contigs within the scaffolds, leading to additional joins and breaks. In parallel, approximately 78&#xD7; ONT-UL reads were haplotype-binned with Canu v2.1 using Illumina short reads of the parents and then were assembled into their respective maternal and paternal contigs using Flye v2.8.3-b1695 with --min-overlap 10000. Bases were recalled with Guppy v4.2.2 before the assembly. The contigs were polished calling variants with Medaka (<ext-link ext-link-type="uri" xlink:href="https://github.com/nanoporetech/medaka">https://github.com/nanoporetech/medaka</ext-link>). The variants were filtered with Merfin using <italic>k</italic>-mers derived from Illumina short reads. Bcftools was used to apply the variants. The resulting ONT-UL assembly was used to patch gaps of the scaffolded HiFi-based assembly, using custom scripts (<ext-link ext-link-type="uri" xlink:href="https://github.com/gf777/misc/tree/master/HPRC%20HG002/for_filling">https://github.com/gf777/misc/tree/master/HPRC%20HG002/for_filling</ext-link>). Finally, a decontamination and an additional round of manual curation were conducted<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>.</p>
        <sec id="Sec32">
          <title>Trio binning with optical mapping</title>
          <p id="Par74">Using the Bionano direct label and stain chemistry and the Saphyr machine, high coverage of Bionano optical maps were generated of the HG002 (son), HG003 (father) and HG004 (mother) trio of samples and each assembled into diploid assemblies (Supplementary Table <xref rid="MOESM4" ref-type="media">13</xref>) with Bionano Solve 3.6. To separate the paternal and maternal alleles in the child assembly, the child molecules were aligned to the father and mother assemblies and assigned to the bin with higher alignment confidence. Molecules that aligned equally well (alignment score difference &#x227C; 10<sup>&#x2212;2</sup>) to the parents were split into two clusters equally and assigned to the bins. Similarly, molecules that aligned to neither of the parents were split into two clusters equally and assigned to the bins. As this method utilizes the unique SV sites in the diploid assemblies of parents to bin the molecules, it does not distinguish molecules for regions where the parents have the same SVs. Without special adjustment for the sex chromosome, this method does not eliminate the assembly of the X chromosome in the paternal assembly but the contigs are much shorter due to the missing proband molecules of regions where the father has unique SVs.</p>
          <p id="Par75">To further improve the separation of the parental alleles, a cross-checking step is performed. The binned paternal and maternal assemblies are aligned to both the father and mother assemblies (cross_check_alignment.py with RefAligner 11741 and optArguments_customized_for_diploid_reference.xml). Using these alignments, regions where the parents share an allele but are homozygous in one and heterozygous in the other are identified. For example, in regions where the father has allele AA and the mother has allele AB, the B allele of the proband would be from the maternal and the A allele would be from the paternal side. Unless there are nearby SVs, molecules with allele A in the child can align equally to both parents, where the maternal assembly will then also include allele A, but with cross-checking, the correct allele (allele B) is identified and the wrong allele (allele A) gets eliminated through breaking it in the maternal assembly. A total of 54 regions of such characteristics were identified and broken in the paternal assembly, and 45 regions were identified and broken in the maternal assembly (haplotype_segregation_cross_check_rscript.R, haplotype_segregation_cut_step.py). Breaking at these regions allowed further separation of alleles in the next round of trio binning, using the binned and cross-checked assemblies as anchors. For the trio binning after cross-checking, 586&#x2009;Gb of the probe molecules were binned to the paternal haplotype and 615&#x2009;Gb binned to the maternal haplotype. These binned molecules were then assembled into the paternal haploid assembly (2.98&#x2009;Gb with N50 of 79.22&#x2009;Mb) and the maternal haploid assembly (2.96&#x2009;Gb with N50 of 66.60&#x2009;Mb) using Bionano Solve 3.6.</p>
        </sec>
      </sec>
      <sec id="Sec33">
        <title>Evaluation methods</title>
        <p id="Par76">For evaluation, we considered the following overarching framework. The &#x2018;assumed truth&#x2019; is not one given a &#x2018;true assembly&#x2019;, but rather the consensus of multiple types of evidence. This evidence includes reference-free consistency between all raw data types (for example, HiFi, ONT, Illumina and Bionano) and the assembly, orthogonal data (for example, Strand-seq), and relative to complete and accurate T2T-CHM13 assembly of another individual, although haploid. We used the Mercury analysis tool kit for many metrics, which uses a <italic>k</italic>-mer approach on the raw sequence reads and/or the genome assembly to estimate QV, level of false duplication, degree of haplotype separation and assembly completeness<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Here we automated the Mercury took kit, for more rapid analyses of assemblies (<ext-link ext-link-type="uri" xlink:href="https://dockstore.org/workflows/github.com/human-pangenomics/hpp_production_workflows/Merqury:master?tab=info">https://dockstore.org/workflows/github.com/human-pangenomics/hpp_production_workflows/Merqury:master?tab=info</ext-link>).</p>
        <sec id="Sec34">
          <title>Contamination and manual curation</title>
          <p id="Par77">Curation was conducted as described in the VGP<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. In brief, for contamination identification, a succession of searches was used to identify potential contaminants in the generated assemblies. This included: (1) a megaBLAST98 search against a database of common contaminants (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/pub/kitts/contam_in_euks.fa.gz">ftp://ftp.ncbi.nlm.nih.gov/pub/kitts/contam_in_euks.fa.gz</ext-link>); and (2) a vecscreen (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/vecscreen/">https://www.ncbi.nlm.nih.gov/tools/vecscreen/</ext-link>) search against a database of adaptor sequences (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/pub/kitts/adaptors_for_screening_euks.fa">ftp://ftp.ncbi.nlm.nih.gov/pub/kitts/adaptors_for_screening_euks.fa</ext-link>). The mitochondrial genome was identified by a megaBLAST search against a database of known organelle genomes (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/blast/db/FASTA/mito.nt.gz">ftp://ftp.ncbi.nlm.nih.gov/blast/db/FASTA/mito.nt.gz</ext-link>). Organelle matches embedded in nuclear sequences were found to be NuMTs. On the basis of lessons learned in this study, we created an automated contamination removal pipeline (<ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/hpp_production_workflows/blob/master/QC/wdl/tasks/contamination.wdl">https://github.com/human-pangenomics/hpp_production_workflows/blob/master/QC/wdl/tasks/contamination.wdl</ext-link>).</p>
          <p id="Par78">For structural error identification, for each assembly, all sequence data (CLR, HiFi, ONT and optical maps) were aligned and analysed in gEVAL (<ext-link ext-link-type="uri" xlink:href="https://vgp-geval.sanger.ac.uk/index.html">https://vgp-geval.sanger.ac.uk/index.html</ext-link>). Separately, Hi-C data were mapped to the primary assembly and visualized using HiGlass. These alignments were then used by curators to identify mis-joins, missed joins and other anomalies. We identified sex chromosomes on the basis of half coverage alignments to sex chromosomes in GRCh38.</p>
          <p id="Par79">We categorized the assembly structural errors as follows: &#x2018;missed joins&#x2019; are contigs that should have been neighbours in a scaffold, but were kept apart, including on different scaffolds. Missed joins are only counted if they could be resolved during curation with the available data, thereby implying that an automated process should have been able to get them right. &#x2018;Misjoins&#x2019; are the opposite situation, colocalized contigs within scaffolds that do not belong together, where one of them is often an erroneous translocation. &#x2018;Other&#x2019; includes additional structural errors, which in some cases appear as erroneous inversions or false duplications. &#x2018;Unlocalized&#x2019; is a sequence found in an assembly that is associated with a specific chromosome but cannot be ordered or oriented on that chromosome with the available data. &#x2018;Unplaced&#x2019; are contigs or scaffolds that could not be placed on a chromosome. Finally, a &#x2018;chimeric contig&#x2019; is a continuous gapless sequence that includes either an erroneous join without a gap, sequence expansions or sequence collapses.</p>
        </sec>
        <sec id="Sec35">
          <title>Continuity metrics</title>
          <p id="Par80">Assembly continuity statistics were collected using asm_stats.sh from the VGP pipeline (<ext-link ext-link-type="uri" xlink:href="https://github.com/VGP/vgp-assembly/tree/master/pipeline/stats">https://github.com/VGP/vgp-assembly/tree/master/pipeline/stats</ext-link>)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, using a genome size of 3&#x2009;Gb for calculating NG50 values. All N bases were considered as gaps.</p>
        </sec>
        <sec id="Sec36">
          <title>Completeness, phasing and base call accuracies</title>
          <p id="Par81">We collected 21-mers from Illumina reads of HG002 (250-bp paired end) and the parental genomes (HG003 and HG004) using Meryl<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, and used Merqury<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> to calculate QV, completeness and phasing statistics. Like continuity metrics, phase block NG50 was obtained using a genome size of 3&#x2009;Gb. False duplications were post-calculated using false_duplications.sh in Merqury and spectra-cn histogram files for each haploid representation of the assemblies.</p>
        </sec>
        <sec id="Sec37">
          <title>Collapsed analyses</title>
          <p id="Par82">We calculated collapsed and expandable sequences using previously described methods<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. In brief, we aligned downsampled HiFi reads from HG002 independently to each assembly of HG002 and defined collapsed bases as regions in the assembly with greater than expected coverage (mean plus at least three standard deviations) that were at least 15&#x2009;kb in length. We performed analyses with common repeat collapses included and excluded, defining common repeat collapses as sequences that were over 75% common repeat elements as identified by RepeatMasker (v4.1.0) and TRF (v4.09). This filter removed many collapses corresponding to alpha satellite and human satellite to get a better estimate of collapsed segmental duplications. Furthermore, we defined expandable Mb as the estimate of how much sequence would be in the collapsed regions had they been correctly assembled. We estimated this by multiplying the length of each collapse against the read depth divided by the average genome coverage. The code used for this analysis is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/mrvollger/SDA">https://github.com/mrvollger/SDA</ext-link> (commit ID: 23fa175).</p>
        </sec>
        <sec id="Sec38">
          <title>Strand-seq analyses</title>
          <p id="Par83">To evaluate structural accuracy of each assembly, we first aligned Strand-seq data from HG002 to each assembly using BWA-MEM (version 0.7.15-r1140)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> with the default parameters. Subsequently, all secondary and supplementary alignments were removed using SAMtools (version 1.9)<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> and duplicate reads were marked using Sambamba (version 0.6.8)<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. Duplicated reads and reads with mapping quality less than 10 were removed before subsequent Strand-seq data analysis. To evaluate structural and directional contiguity of each assembly, we used R package SaaRclust<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> with the following parameters: bin.size&#x2009;=&#x2009;200,000; step.size&#x2009;=&#x2009;200,000; prob.th&#x2009;=&#x2009;0.25; bin.method = 'fixed'; min.contig.size&#x2009;=&#x2009;100,000; min.region.to.order&#x2009;=&#x2009;500,000; ord.method = 'greedy'; num.clusters&#x2009;=&#x2009;100; remove.always.WC = TRUE; mask.regions = FALSE; and max.cluster.length.mbp&#x2009;=&#x2009;300. SaaRclust automatically reports contigs that probably contain a misassembly and marks them as either misorientation (change in directionality of a piece of contig) or chimerism (regions of a contig that originate from different chromosomes). To reduce false-positive calls, we report only misoriented and chimeric regions that are at least 400&#x2009;kb and 1&#x2009;Mb in length, respectively. Current version of the R package SaaRclust can be found at <ext-link ext-link-type="uri" xlink:href="https://github.com/daewoooo/SaaRclust">https://github.com/daewoooo/SaaRclust</ext-link> (devel branch).</p>
          <p id="Par84">To evaluate large (50&#x2009;kb or more) inversion accuracy in the final HPRC-HG002 assembly of this study, we aligned Strand-seq separately to maternal and paternal haplotypes. Only chromosomes or scaffolds of 1&#x2009;Mb or more were processed. We used breakpointR<sup><xref ref-type="bibr" rid="CR78">78</xref></sup> to detect changes in read directionality and thus putative misassemblies across all Strand-seq libraries. We concatenated all directional reads across all available Strand-seq libraries using the breakpointR function &#x2018;synchronizeReadDir&#x2019;. Next, we used the breakpointR function &#x2018;runBreakpointr&#x2019; to detect regions that are homozygous (&#x2018;ww&#x2019;; &#x2018;HOM&#x2019;) or heterozygous inverted (&#x2018;wc&#x2019;; &#x2018;HET&#x2019;) using the following parameters: bamfile = &lt;composite_file&gt;, pairedEndReads = FALSE, chromosomes = [chromosomes/scaffolds &gt;= 1&#x2009;Mb], windowsize&#x2009;=&#x2009;50,000, binMethod = "size", background&#x2009;=&#x2009;0.1, minReads&#x2009;=&#x2009;50, genoT = 'binom'. Regions designated as &#x2018;HOM&#x2019; have the majority of reads in the minus direction, suggesting a homozygous inversion or misorientation assembly error. Those designated at &#x2018;HET&#x2019; have roughly equal mixture of plus and minus reads, validating a true heterozygous inversion. In an ideal scenario, one would expect that assembly directionality matches the directionality of Strand-seq reads and thus no homozygous inverted regions should be visible.</p>
        </sec>
        <sec id="Sec39">
          <title>Variation benchmark analysis</title>
          <p id="Par85">We used v4.2.1 GIAB benchmark variants with GA4GH, with v3.0 stratifications, which enabled comparative performance assessment inside and outside challenging genomic regions such as segmental duplications, homopolymers and tandem repeats<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Benchmarking tools from GIAB and GA4GH enabled performance to be stratified by type of error (for example, genotyping errors) and genome context (for example, segmental duplications). Variants were first called using the dipcall assembly variant calling pipeline (<ext-link ext-link-type="uri" xlink:href="https://github.com/lh3/dipcall">https://github.com/lh3/dipcall</ext-link>)<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Dipcall first aligns an assembly to the GRCh38 reference genome (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCA/000/001/405/GCA_000001405.15_GRCh38/seqs_for_alignment_pipelines.ucsc_ids/GCA_000001405.15_GRCh38_no_alt_analysis_set.fna.gz">ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCA/000/001/405/GCA_000001405.15_GRCh38/seqs_for_alignment_pipelines.ucsc_ids/GCA_000001405.15_GRCh38_no_alt_analysis_set.fna.gz</ext-link>) using minimap2 (<ext-link ext-link-type="uri" xlink:href="https://github.com/lh3/minimap2">https://github.com/lh3/minimap2</ext-link>)<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. We used optimized alignment parameters -z200000,10000 to improve alignment contiguity, as this is known to improve variant recall in regions with dense variation, such as the MHC<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>. Dipcall uses the resulting alignment to generate a bed file with haplotype coverage and call variants. All filtered variants except those with the GAP2 filter were removed. GAP2-filtered variants occurred particularly in primary-alternate assemblies in homozygous regions where the alternate contig was missing. These GAP2 variants were kept as filtered to give separate performance metrics, and treated as a homozygous variant with respect to GRCh38 by changing the genotype field from 1|. to 1|1. The resulting variant calls were benchmarked using hap.py v0.3.12 with the RTG Tools (v3.10.1) vcfeval comparison engine (<ext-link ext-link-type="uri" xlink:href="https://github.com/Illumina/hap.py">https://github.com/Illumina/hap.py</ext-link>)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Earlier versions of hap.py and vcfeval do not output lenient regional variant matches to the FP.al field. The hap.py comparison was performed with the v4.2.1 GIAB HG002 small-variant benchmark vcf and bed (<ext-link ext-link-type="uri" xlink:href="https://ftp-trace.ncbi.nlm.nih.gov/ReferenceSamples/giab/release/AshkenazimTrio/HG002_NA24385_son/NISTv4.2.1/GRCh38/">https://ftp-trace.ncbi.nlm.nih.gov/ReferenceSamples/giab/release/AshkenazimTrio/HG002_NA24385_son/NISTv4.2.1/GRCh38/</ext-link>)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and V3.0 of the GIAB genome stratifications (10.18434/mds2-2499). To improve reproducibility and transparency, Snakemake (<ext-link ext-link-type="uri" xlink:href="https://snakemake.readthedocs.io/en/stable/">https://snakemake.readthedocs.io/en/stable/</ext-link>)<sup><xref ref-type="bibr" rid="CR81">81</xref></sup> was used for pipeline construction and execution (10.18434/mds2-2578). The extensive performance metrics output by hap.py in the extended.csv files were summarized in the following metrics for completeness, correctness and hard regions.</p>
          <p id="Par86">Completeness metric values were calculated from SNV, where the false negative (FN) rate or recall was used&#xA0;to assess how much of the benchmark does the callset cover, in which 100% means capturing all variants and 0% means capturing none. These completeness metric values were calculated at different stringencies with SNP.Recall or as a true positive. &#x2018;SNP.Recall_ignoreGT&#x2019; is a measure of how well the assembly captures at least one of the variant alleles, and is considered true positive if at least one allele in a variant was called correctly, regardless of whether genotype was correct. This is calculated from &#x2018;(SNP.TRUTH.TP + SNP.FP.gt)/SNP.TRUTH.TOTAL&#x2019; for the row with &#x2018;ALL&#x2019; in the FILTER column. &#x2018;SNP.Recall&#x2019; is a measure of how well the assembly represents genotypes, and counted as true positive if the variant and genotype are called correctly. When only one contig is present, we assumed the region is homozygous. This is calculated from METRIC.Recall for Type=SNP, SubType=*, SUBSET=*, FILTER=ALL. &#x2018;SNP.Recall.fullydiploid&#x2019; is a measure of how well the assembly represents both haplotypes correctly, requiring that exactly one contig from each haplotype align to the location (contigs smaller than 10&#x2009;kb are ignored by dipcall by default). This is calculated from METRIC.Recall for Type=SNP, SubType=*, SUBSET=*, FILTER=PASS.</p>
          <p id="Par87">Correctness metric values were calculated from the false-positive rate for SNVs and indels, converted into a phred scaled per base error rate. Each SNP and indel was counted as a single error on one haplotype regardless of size and genotype. &#x2018;QV_dip_snp_indel&#x2019; is the error rate in all benchmark regions, calculated as &#x2018;&#x2212;10 &#xD7; log<sub>10</sub>((SNP.QUERY.FP + INDEL.QUERY.FP)/(Subset.IS_CONF.Size &#xD7; 2))&#x2019;. &#x2018;NoSegDup.QV_dip_snp_indel&#x2019; is the same as QV_dip_snp_indel, except that it excludes segmental duplication regions.</p>
          <p id="Par88">Hard region metric values were calculated for particularly difficult-to-assemble regions such as segmental duplications. &#x2018;Segdup.QV_dip_snp_indel&#x2019; is the same as the &#x2018;QV_dip_snp_indel&#x2019; correctness metric, but only for segmental duplication regions.</p>
          <p id="Par89">To benchmark SVs, we aligned the final HG002 assembly to GRCh37 and used truvari v3.1.0 to benchmark variants against the GIAB tier 1 v0.6 benchmark vcf in v0.6.2 benchmark regions.</p>
        </sec>
        <sec id="Sec40">
          <title>BUSCO analyses</title>
          <p id="Par90">Busco completeness for the 41 assemblies was calculated with BUSCO v3.1.0 using the mammalia_odb9 lineage set (<ext-link ext-link-type="uri" xlink:href="https://busco-archive.ezlab.org/v3/">https://busco-archive.ezlab.org/v3/</ext-link>)<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>.</p>
        </sec>
        <sec id="Sec41">
          <title>Annotations</title>
          <p id="Par91">Human RefSeq transcripts of type &#x2018;known&#x2019; (with NM or NR prefixes<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>) were queried from RefSeq on 8 December 2021. The query to access these is: &#x2018;Homo_sapiens[organism] AND srcdb_refseq_known[properties] AND biomol_rna[properties]&#x2019;, although because of curation, this query will return a different set of transcripts today that it did in December 2021. Each transcript is the child of exactly one gene, but a given gene can be the parent of multiple transcripts (alternative variants). The returned 81,571 transcripts were aligned to the 43 assembled haplotypes and to GRCh38 (GCF_000001405.26) and T2T-CHM13 v1.1 (GCA_009914755.3). The coding transcripts and non-coding transcripts longer than 300&#x2009;bp were first aligned with BLAST (e-value of 0.0001, word size 28 and best-hits options best_hit_overhang&#x2009;=&#x2009;0.1 and best_hit_score_edge&#x2009;=&#x2009;0.1) to the genomes masked with RepeatMasker (<ext-link ext-link-type="uri" xlink:href="http://www.repeatmasker.org">www.repeatmasker.org</ext-link>)<sup><xref ref-type="bibr" rid="CR84">84</xref></sup> or WindowMasker<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. Sets of results obtained with both masking methods were passed to the global alignment algorithm Splign<sup><xref ref-type="bibr" rid="CR86">86</xref></sup> (75% minimum exon identity, 50% minimum compartment identity and 20% minimum singleton identity) to refine the splice junctions and align exons missed by BLAST. Sequences for which no alignment with coverage higher than 95% of the query and sequences with unaligned overhangs at the 5&#x2032; or 3&#x2032; end were realigned with BLAST and Splign to the unmasked genome, and then submitted to the same filter. Non-coding transcripts shorter than 300&#x2009;bp were aligned with BLAST to the unmasked genome (e-value of 0.0001, word size 16, 98% identity and best-hits options best_hit_overhang&#x2009;=&#x2009;0.1 and best_hit_score_edge&#x2009;=&#x2009;0.1) and then with Splign (75% minimum exon identity, minimum compartment identity and minimum singleton identity) and submitted to the same filter as the other transcripts. The alignments for each transcript were then ranked on the basis of identity and coverage. Transcripts that aligned best to GRCh38 sex chromosomes were filtered out of the alignments to all assemblies, resulting in 78,492 transcripts in 27,225 corresponding autosomal genes, for which we calculated the statistics in Supplementary Table <xref rid="MOESM4" ref-type="media">2k</xref>.</p>
          <p id="Par92">Several measures for assembly completeness and correctness, and for sequence accuracy were compared across all assembly haplotypes: (1) genes with unaligned transcripts, either due to one or more transcript alignments being absent or too low in sequence identity; (2) split genes, across two or more scaffolds; (3) low-coverage genes, with less than 95% of the coding sequence in the assembly; (4) dropped genes, most often due to collapsed regions in the assembly; and (5) genes with frameshifted CDSs, where the best-ranking alignment requires insertions or deletions to compensate for suspected insertions or deletions in the genomic sequence that cause frameshift errors. For category 4, as each RefSeq transcript is associated with a single gene<sup><xref ref-type="bibr" rid="CR87">87</xref></sup> and genes are not expected to overlap, unless explicitly known to, collapsed regions were identified as loci where transcripts from multiple genes co-aligned, and measured as the count of genes for which the best alignment of a transcript needed to be dropped to resolve the conflict. A set of 119 genes with transcripts that failed to align to either GRCh38, T2T-CHM13 v1.1, HG002.mat or HG002.pat were examined further. A total of 106 of these had no other aligned transcripts and were therefore completely missing from one or more assemblies. The remaining 13 genes had some but not all children transcript spliced variants that aligned.</p>
        </sec>
      </sec>
      <sec id="Sec42">
        <title>Pangenomic assessment of the assemblies</title>
        <p id="Par93">We performed pairwise alignments for all chromosomes of all 45 assemblies with the wfmash sequence aligner (<ext-link ext-link-type="uri" xlink:href="https://github.com/ekg/wfmash">https://github.com/ekg/wfmash</ext-link>; commit ID: 09e73eb), requiring homologous regions at least 300&#x2009;kb long and nucleotide identity of at least 98%. We used the alignment between all assemblies to build a pangenome graph with the seqwish variation graph inducer<sup><xref ref-type="bibr" rid="CR88">88</xref></sup> (commit ID: ccfefb0), ignoring alignment matches shorter than 79&#x2009;bp (to remove possible spurious relationships caused by short repeated homologies). To obtain chromosome-specific pangenome graphs, contigs were partitioned by aligning all of them with wfmash against the GRCh38 and CHM13 reference sequences. Graph statistics, visualizations and pairwise Jaccard similarities and Euclidean distances between haplotypes were obtained with the ODGI toolkit<sup><xref ref-type="bibr" rid="CR89">89</xref></sup> (commit ID: 67a7e5b). We performed the multidimensional analyses in the R development environment (version 3.6.3), equipped with the following packages: tidyverse (version 1.3.0), RColorBrewer (version 1.1.2), ggplot2 (version 3.3.3), ggrepel (version 0.9.1) and stats (version 3.6.3). Specifically, we applied the classical multidimensional scaling on the Euclidean distance matrix to perform the PCA. Pangenome graphs at selected loci were built and visualized by using the PGGB pipeline (commit ID: 5d26011) and the ODGI toolkit. Code and links to data resources used to build the pangenome graphs to perform the multidimensional analyses and to produce all of the figures can be found at the following repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/AndreaGuarracino/HG002_assemblies_assessment">https://github.com/AndreaGuarracino/HG002_assemblies_assessment</ext-link>.</p>
      </sec>
      <sec id="Sec43">
        <title>Heterozygosity analysis</title>
        <p id="Par94">To call the full spectrum of heterozygosity between the two haploid sequences, we directly compared two haploid assemblies using Mummer (v4.0.0rc1) with the parameters of &#x2018;nucmer -maxmatch -l 100 -c 500&#x2019;. SNP and small indels were generated by &#x2018;delta-filter -m -i 90 -l 100&#x2019; and followed by &#x2018;dnadiff&#x2019;. Several custom scripts were used to analyse the Mummer output, as described in our previous marmoset study (<ext-link ext-link-type="uri" xlink:href="https://github.com/comery/marmoset">https://github.com/comery/marmoset</ext-link>). We used SyRi<sup><xref ref-type="bibr" rid="CR90">90</xref></sup> (v1.5) to detect SVs from Mummer alignments using default parameters. SVs in which more than half the feature consisted of gaps were excluded. For CNVs, we only included local tandem contractions or expansions; whole-genome copy number changes were not included in these results. To avoid false positives caused by assembly issues and insufficient detection power, we only included intrachromosomal translocations (50&#x2009;bp or more) in which haplotypes reciprocally share the best alignment.</p>
      </sec>
      <sec id="Sec44">
        <title>Alignments between reference assemblies</title>
        <p id="Par95">All scaffolds of the final HG002 maternal and paternal assemblies were aligned by minimap2 to the T2T-CHM13 reference and the Y chromosome of GRCh38. Some of the contigs within the HG002 scaffolds had alternate alignments to CHM13, which we did not include in the analyses to avoid the ambiguity. The phase density of contigs were calculated using the parental short reads. We then extracted haplotype-specific <italic>k</italic>-mers from contigs and determined the colour value by the number of these <italic>k</italic>-mers.</p>
      </sec>
      <sec id="Sec45">
        <title>Gene duplication analysis</title>
        <p id="Par96">Gene duplications were measured using multi-mapped gene bodies and read depth.&#xA0; Gencode v29 transcripts were aligned using minimap2 (version 2.17-r941) to annotate gene models. The genomic sequence of each gene was re-mapped to both HPRC-HG002 v1.0 maternal and paternal assemblies allowing for multimapped alignments. Gene duplications were counted as genome sequences aligned with at least 90% identity and 90% of the length of the original gene. Spurious duplications were annotated by mapping all reads back to each haplotype assembly, and filtering on low (less than 0.05) read depth. The code to annotate duplicated genes is available (<ext-link ext-link-type="uri" xlink:href="https://github.com/ChaissonLab/SegDupAnnotation/releases/tag/vHPRC">https://github.com/ChaissonLab/SegDupAnnotation/releases/tag/vHPRC</ext-link>).</p>
      </sec>
      <sec id="Sec46">
        <title>Consent</title>
        <p id="Par97">Informed consent was obtained by the Personal Genome Project, which permits open sharing of genomic data, phenotype information and redistribution of cell lines and derived products.</p>
      </sec>
      <sec id="Sec47">
        <title>Reporting summary</title>
        <p id="Par98">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
      </sec>
    </sec>
    <sec id="Sec48" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par99">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-05325-5.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_5325_MOESM1_ESM.pdf"><label>Supplementary Information</label><caption><p>This file contains Supplementary Notes 1-4, Supplementary Figures 1-10, Supplementary Table 14, and Supplementary references.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_5325_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_5325_MOESM3_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_5325_MOESM4_ESM.xlsx"><label>Supplementary Tables</label><caption><p>This file contains Supplementary Tables 1-13.</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec49">
          <title>Extended data figures and tables</title>
          <p id="Par102">
<fig id="Fig6"><label>Extended Data Fig. 1</label><caption><title>Non-human and organelle genomes found in the human genome assemblies.</title><p><bold>a</bold>, The number of contigs that had remaining library clone vector sequences in each assembly. Medium used a blastn score 19-29; strong a score &gt; 30 <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/vecscreen/about/">https://www.ncbi.nlm.nih.gov/tools/vecscreen/about/</ext-link>. <bold>b</bold>, The number of contigs with non-human yeast and <italic>E.coli</italic> sequences. Values above columns are the specific numbers. <bold>c</bold>, The number of endogenous mitochondrial genome sequences found in each assembly.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig6_ESM" id="d32e4585"/></fig>
</p>
          <p id="Par103">
<fig id="Fig7"><label>Extended Data Fig. 2</label><caption><title>Assembly size and false duplication metrics.</title><p><bold>a</bold>, Percent assembly sizes of expected maternal with Chr X (3,054,832,041&#x2009;bp) or paternal with Y (2,995,432,041&#x2009;bp) for trio-based assemblies, or simply relative to maternal size for all other assemblies<bold>. b</bold>, Total summed length of all contigs<bold>. c</bold>, Total summed length of scaffolds, with proportion contributed by Ns (red) in gaps. <bold>d</bold>, estimated percent of assembly size that is due to false duplications based on k-mer values for each haplotype. Color coding and gray shaded regions are as described in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig7_ESM" id="d32e4613"/></fig>
</p>
          <p id="Par104">
<fig id="Fig8"><label>Extended Data Fig. 3</label><caption><title>Contig, scaffold, and gap metrics.</title><p><bold>a</bold>, Total number of contigs in each assembly<bold>. b</bold>, Total number of scaffolds in each assembly. <bold>c</bold>, Total number of gaps in each assembly. Values above the maximum on the y-axis are written in the graph so as to not visually scale down the majority of the results. Color coding and gray shaded regions are as described in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig8_ESM" id="d32e4638"/></fig>
</p>
          <p id="Par105">
<fig id="Fig9"><label>Extended Data Fig. 4</label><caption><title>Hi-C contact maps.</title><p><bold>a</bold>, Example Hi-C contact maps for bakeoff maternal (mat) and paternal (pat) haplotype assemblies. The Trio VGP scaffolded assembly has several dozen large joins and many small ones to make from the off-diagonal signals. The Trio hifiasm contig only assembly as expected has many more needed. <bold>b</bold>, Reference HPRC HG002 assemblies for each haplotype before and after manual curation, showing less off diagonal signals and no major scaffolds/contigs not placed in chromosomes after curation.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig9_ESM" id="d32e4657"/></fig>
</p>
          <p id="Par106">
<fig id="Fig10"><label>Extended Data Fig. 5</label><caption><title>Strand-seq validations.</title><p><bold>a</bold>, Total number and total Mb of chimeric and misorientation errors for each assembly according to Strand-seq validations. <bold>b</bold>, Large (&gt; 50&#x2009;kb) Strand-seq supported and unsupported inversions (x location; n&#x2009;=&#x2009;59) between HG002 haplotypes. HET, regions with roughly equal mixture of plus (Crick) and minus (Watson) Strand-seq reads supporting the heterozygous inversions (yellow, n&#x2009;=&#x2009;30). HOM, regions with Strand-seq reads mapped to the opposite orientation in disagreement with heterozygous inversions and thus a possible assembly error (blue, n&#x2009;=&#x2009;11). <bold>c</bold>, Barplot of total size and total number of regions genotyped as HET and HOM validated inversions. <bold>d-f</bold>, Example heterozygous assembly inversions that matched (<bold>d</bold>) or did not match (<bold>e,f</bold>) the Strand-seq read direction in the final HG002 assembly. First track: Known morbid CNVs (red, deletions; blue, duplications). Second track: Segmental duplications (black marks - DupMasker) in the paternal assembly. Third and fourth tracks: Coverage of Strand-seq reads aligned to the HG002 paternal and maternal assemblies (binsize: 50&#x2009;kb, stepsize: 1&#x2009;kb) with Crick (teal, above) and Watson (below, orange) read counts. Regions with roughly equal coverage of Watson and Crick counts represent validated heterozygous inversions, as only one homolog is inverted with respect to the de novo assembly (<bold>d</bold>); Regions with only Watson coverage orientation represent an assembly error, because assembly directionality does not match Strand-seq read directionality (<bold>e,f</bold>). Vertical dotted lines highlight the predicted breakpoints of assembly errors as well as predicted heterozygous inversion.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig10_ESM" id="d32e4695"/></fig>
</p>
          <p id="Par107">
<fig id="Fig11"><label>Extended Data Fig. 6</label><caption><title>Variant benchmarking.</title><p><bold>a</bold>, True positive percent of known SNVs found between HG002 haplotypes in each assembly. <bold>b</bold>, True positive percent of known small indels found between HG002 haplotypes in each assembly. For the diploid assemblies, comparisons were made between the two haplotypes (maternal vs paternal for the trio assemblies; haplotype 1 vs haplotype 2 for the non-trio assemblies). For the haploid assemblies, we scored as TP if at least one of the variants were found.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig11_ESM" id="d32e4714"/></fig>
</p>
          <p id="Par108">
<fig id="Fig12"><label>Extended Data Fig. 7</label><caption><title>Annotation benchmarking.</title><p><bold>a</bold>, Side-by-side comparisons of gene transcripts that did not align to each assembly (blue) versus those that were split between two or more scaffolds/contigs (red). <bold>b</bold>, Number of genes that had less than 95% the length covered in the assembly. <bold>c</bold>, Genes in the assemblies with overlapping transcripts due to possible collapse in the assemblies. <bold>d</bold>, Genes requiring frameshift corrections to make a complete protein. Values written in the graphs are for those off the chart, in order to not mask the lower values of most other assemblies.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig12_ESM" id="d32e4739"/></fig>
</p>
          <p id="Par109">
<fig id="Fig13"><label>Extended Data Fig. 8</label><caption><title>Haplotype phasing metrics.</title><p><bold>a</bold>, Haplotype switch errors within scaffolds and/or contigs of each assembly (lower % is more accurate). Values written in the graphs for the haploid assemblies (greens) are off the chart, in order to not mask the lower switch error values of most other assemblies. <bold>b</bold>, Total Gb of each assembly that has been haplotype phased (~3.0 is the theoretical maximum of the maternal haplotype; 2.9 for the paternal). <bold>c</bold>, Haplotype phasing completeness according to parental <italic>k-mer</italic> statistics for each assembly. A complete phased assembly will have both maternal (blue) and paternal (red) each at 100% without mixture from the other. The trio approaches had nearly full phase separation, whereas the non-trio approaches nearly had half and half separation because there was not an attempt to phase across contigs or scaffolds/chromosomes belonging to the same maternal or paternal haplotypes. Combined values over 100% indicate a mixture of haplotype presumably due to false duplications; although values under 100% could still have false duplications.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig13_ESM" id="d32e4764"/></fig>
</p>
          <p id="Par110">
<fig id="Fig14"><label>Extended Data Fig. 9</label><caption><title>Collapsed sequence metrics.</title><p><bold>a</bold>, Estimated amount of bp that are collapsed in each assembly (smaller is better). Collapses are most often due to repetitive sequences. <bold>b</bold>, Estimated amount of bp that are potentially expandable. The smaller, the more accurate the assembly. We estimate that most of these collapses are in centromeric regions and satellites, with a smaller proportion coming from segmental duplications. Abbreviations and color coding explanations are the same as in Fig. <xref rid="Fig1" ref-type="fig">1</xref> legend. <bold>c</bold>, Example collapse region of one of the HG002 assemblies, where read coverage pile up in the collapsed region is two or more times higher than the mean coverage of the genome. <bold>d</bold>, Example of HiFi read coverage across a centromere, of HG002 maternal Chr 11, showing no evidence of collapsed repeats or coverage dropouts.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig14_ESM" id="d32e4792"/></fig>
</p>
          <p id="Par111">
<fig id="Fig15"><label>Extended Data Fig. 10</label><caption><title>Pangenome alignment and generation of high-quality HPRC-HG002 v1.0 diploid assemblies.</title><p><bold>a</bold>, Output of graph-based alignment of all chromosomes concatenated from all 45 HG002 assemblies (both haplotypes of diploid assemblies). Red vs Black, different orientations. Dendogram at bottom is a clustering of the alignments. <bold>b</bold>, HPRC v1.0 pipeline developed to produce the reference quality HPRC-HG002 v1.0 maternal and paternal assemblies. All steps shown are highlighted for the maternal data. The key steps of the pipeline are available in the Galaxy Server (<ext-link ext-link-type="uri" xlink:href="https://assembly.usegalaxy.eu/">https://assembly.usegalaxy.eu/</ext-link>) and best practices from this study at <ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/hpp_production_workflows/wiki/Assembly-Best-Practices">https://github.com/human-pangenomics/hpp_production_workflows/wiki/Assembly-Best-Practices</ext-link>.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig15_ESM" id="d32e4821"/></fig>
</p>
          <p id="Par112">
<fig id="Fig16"><label>Extended Data Fig. 11</label><caption><title>Example presence of telomeres.</title><p><bold>a</bold>, Telomere repeats within 10&#x2009;kb of each arm of HG002 Chr 1, paternal haplotype. The darker the density, the higher the repeat copy number. <bold>b-c</bold>, Density of telomere repeats for each arm, in 200&#x2009;bp bins. 33 x 6-bp repeats is the theoretical maximum per 200&#x2009;bp. <bold>d</bold>, Telomere repeats within 10&#x2009;kb only found for the q-arm of HG002 Chr 12, maternal haplotype. <bold>e-f</bold>, Canonical pattern of the telomere repeats only found in the q-arm of the HG002 Chr 12, maternal assembly. Color coding, the different types of repeats found within 1 Mb of each arm. The similar patterns between Chr 1 and 12 indicate that only the p-arm telomere is missing from Chr 12.</p></caption><graphic position="anchor" xlink:href="41586_2022_5325_Fig16_ESM" id="d32e4847"/></fig>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p>A list of authors and affiliations appears at the end of the paper.</p>
      </fn>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Erich D. Jarvis, Giulio Formenti</p>
      </fn>
      <fn>
        <p>A list of authors and their affiliations appear at the end of the paper</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-05325-5.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-05325-5.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>Certain commercial equipment, instruments or materials are identified to specify adequately experimental conditions or reported results. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the equipment, instruments or materials identified are necessarily the best available for the purpose. T.M. and P.E. (asm14 team) acknowledge the computational infrastructure and support provided by the Centre for Information and Media Technology at Heinrich Heine University D&#xFC;sseldorf. We thank P. Audano of the Eichler laboratory for bioinformatic support. This work utilized the computational resources of the National Institutes of Health HPC Biowulf cluster (<ext-link ext-link-type="uri" xlink:href="https://hpc.nih.gov">https://hpc.nih.gov</ext-link>). M.C.S and M.&#xA0;Kirsche (asm17 team) acknowledge A.&#xA0;Carroll and P.-C.&#xA0;Chang from Google AI for&#xA0;assistance running DeepVariant.&#xA0;The primary source of funding for this study was from NHGRI grant U01HG010971 (<ext-link ext-link-type="uri" xlink:href="https://grants.nih.gov/grants/guide/rfa-files/rfa-hg-19-004.html">https://grants.nih.gov/grants/guide/rfa-files/rfa-hg-19-004.html</ext-link>). Additional funding included: Howard Hughes Medical Institute (to E.D.J.), NHGRI grants HG002385 and HG010169 (to E.E.E.), and&#xA0;NHGRI grant&#xA0;R01HG011274-01 (to K.H.M). The computational resources and personnel support for the DipAsm assemblies were HG010906/HG/NHGRI NIH HHS and NNF21OC0069089 to S.G.; NCI U01CA253481 to M.C.S.; and NSF DBI-1627442 to M.C.S. T.M. and P.E. (asm14 team) acknowledge the support by the BMBF-funded de.NBI Cloud within the German Network for Bioinformatics Infrastructure (de.NBI) (031A532B, 031A533A, 031A533B, 031A534A, 031A535A, 031A537A, 031A537B, 031A537C, 031A537D and 031A538A), and the German Research Foundation (391137747 to T.M.), and the National Natural Science Foundation of China (62150048 to J.&#xA0;Wang). E.D.J., E.E.E. and D.H. are investigators of the Howard Hughes Medical Institute. This work was supported in part by the National Center for Biotechnology Information of the National Library of Medicine, National Institutes of Health; the Intramural Research Program of the NHGRI, National Institutes of Health; and by National Institute of Standards and Technology intramural research funding.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>E.D.J. co-coordinated evaluation, performed analyses and wrote the paper. K.H. co-coordinated evaluation and curation. K.H.M. provided overall coordination. A.&#xA0;Rhie performed the mercury metric evaluations. T.L. carried out the assembly validations. V.A.S. performed genome alignment and annotation and/or frameshift issues. B.P. carried out the ONT assemblies and provided overall coordination. M.H., T.&#xA0;Pesout and K.S. performed the Shasta assembly, CAT-annotation and QUAST. J.M.Z., I.H., J.M., N.D.O., J.&#xA0;Wagner and A.&#xA0;Regier performed the variant analyses. E.B.J. provided Illumina data. E.E.E. and M.R.V. performed the segmental duplication assembly (SDA)&#xA0;and collapsed duplication analyses. P.E. performed assembly asm14.&#xA0;D.&#xA0;Porubsky performed&#xA0;inversion validation and Strand-seq analyses. W.H. provided bioinformatic support. H.L. carried out genome assembly and overall analyses. S.G. performed genome assembly and phasing evaluation. E.G. and A.&#xA0;Guarracino carried out pangenome alignments, Jaccard, PCA and MHC. M.E. performed PacBio HiFi adaptor assessments. F.T.-N. performed annotations, gene loss and associated analyses. Curation was done by J.&#xA0;Wood, J.C., J.T. and A.T. J.L.G., T.&#xA0;Potapova and M.W.M. performed karyotype and cell culture analyses. M.A. carried out genome assemblies and titration. A.&#xA0;Granat generated Illumina data. C.Y. and G.Z. performed heterozygosity circos plot analyses. G.A.L. carried out centromere and telomere analyses. G.F. provided asm23 and the final HRPC HG002 references. H.C. provided asm9. S.K. provided asm6, asm7, asm19, asm20 and MHC evaluation. A.M.P. coordinated assembly. J.G. provided asm2 and asm22. T.M. and P.E. provided asm14. M.C.S. provided asm17. M.&#xA0;Kirsche provided asm17. C.-S.C. provided asm3 and asm4. J.K. and A.W. provided asm16. S.L.S. provided asm1 and asm15. J.R. provided asm13. F.N., C.X., J.&#xA0;Wang and F.L. provided asm12. A.V.Z. provided asm1 and asm15. A.&#xA0;Shumate and D.&#xA0;Puiu provided asm1. M.J.P.C. performed HG002 reference segmental duplication expansions. P.C. and T.&#xA0;Pesout performed Shasta assembly. N.O.S. carried out sample collection, processing and coordination. O.F. performed Bionano analyses. M.&#xA0;Kolmogorov carried out Flye haploid assemblies. J.&#xA0;Lucas carried out sample processing, analyses and submissions. M.J. generated nanopore data, performed analysis and managed data. R.E.G. performed Dovetail Genomics Hi-C. S.S. and A.&#xA0;Schmitt performed Arima Genomics Hi-C. R.S.F. carried out PacBio production activities and evaluation methods. H.E.O. generated nanopore data. A.D.S., J.O.K., P.H. and C.S. produced Strand-seq data. A.H. and J.&#xA0;Lee provided Bionano diploid assembly maps. D.H. and T.W. provided HPRC coordination. L.L.F., D.L. and S.C. carried out logistics and data release, and provided project support.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="FPar21">
        <title>Peer review information</title>
        <p id="Par100"><italic>Nature</italic> thanks Tyler Alioto, Adam Ameur and Bjarni Halldorsson for their contribution to the peer review of this work. <xref rid="MOESM3" ref-type="media">Peer reviewer reports</xref> are available.</p>
      </sec>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>All raw sequence data used in this study are available at the following HPRC GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0">https://github.com/human-pangenomics/HG002_Data_Freeze_v1.0</ext-link>. The final HPRC-HG002 curated assemblies are available in the NCBI under the BioProject IDs <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA794175">PRJNA794175</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA794172">PRJNA794172</ext-link>, with the accession numbers GCA_021951015.1 and GCA_021950905.1, for the maternal and paternal haplotypes, respectively. Assemblies, variant calls and GIAB benchmarking results are available at 10.18434/mds2-2578.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>The following codes were used for the assemblies and analyses of this study. Detailed use of codes are mentioned in the methods and main text. For assemblers: Bionano Trio Binning <ext-link ext-link-type="uri" xlink:href="https://github.com/andypang0714/Bionano_Trio_binning">https://github.com/andypang0714/Bionano_Trio_binning</ext-link>; Canu <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/canu">https://github.com/marbl/canu</ext-link>; CrossStitch <ext-link ext-link-type="uri" xlink:href="https://github.com/schatzlab/crossstitch">https://github.com/schatzlab/crossstitch</ext-link>; DipAsm <ext-link ext-link-type="uri" xlink:href="https://github.com/shilpagarg/DipAsm">https://github.com/shilpagarg/DipAsm</ext-link>; FALCON-Unzip: <ext-link ext-link-type="uri" xlink:href="https://anaconda.org/bioconda/pb-falcon/2.2.4/download/linux-64/pb-falcon-2.2.4-py37hed50d52_0.tar.bz2">https://anaconda.org/bioconda/pb-falcon/2.2.4/download/linux-64/pb-falcon-2.2.4-py37hed50d52_0.tar.bz2</ext-link>; Flye <ext-link ext-link-type="uri" xlink:href="https://github.com/fenderglass/Flye">https://github.com/fenderglass/Flye</ext-link>; HiCanu <ext-link ext-link-type="uri" xlink:href="https://bioinformaticshome.com/tools/wga/descriptions/HiCANU.html">https://bioinformaticshome.com/tools/wga/descriptions/HiCANU.html</ext-link>; hifiasm <ext-link ext-link-type="uri" xlink:href="https://github.com/chhylp123/hifiasm/releases/tag/v0.3">https://github.com/chhylp123/hifiasm/releases/tag/v0.3</ext-link>; HPRC v1 pipeline: <ext-link ext-link-type="uri" xlink:href="https://github.com/gf777/misc/tree/master/HPRC%20HG002/for_filling">https://github.com/gf777/misc/tree/master/HPRC%20HG002/for_filling</ext-link>; MaSuRCA <ext-link ext-link-type="uri" xlink:href="https://github.com/alekseyzimin/masurca">https://github.com/alekseyzimin/masurca</ext-link>; MitoHiFi <ext-link ext-link-type="uri" xlink:href="https://github.com/marcelauliano/MitoHiFi">https://github.com/marcelauliano/MitoHiFi</ext-link>; NECAT <ext-link ext-link-type="uri" xlink:href="https://github.com/xiaochuanle/NECAT">https://github.com/xiaochuanle/NECAT</ext-link>; Peregrine <ext-link ext-link-type="uri" xlink:href="https://github.com/cschin/Peregrine">https://github.com/cschin/Peregrine</ext-link>; PGAS pipeline <ext-link ext-link-type="uri" xlink:href="https://github.com/ptrebert/project-diploid-assembly">https://github.com/ptrebert/project-diploid-assembly</ext-link>; SALSA <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/SALSA/commit/974589f3302b773dcf0f20c3332fe9daf009fb93">https://github.com/marbl/SALSA/commit/974589f3302b773dcf0f20c3332fe9daf009fb93</ext-link>; Shasta <ext-link ext-link-type="uri" xlink:href="https://github.com/chanzuckerberg/shasta">https://github.com/chanzuckerberg/shasta</ext-link>; VGP Trio binning assembly tools: <ext-link ext-link-type="uri" xlink:href="https://github.com/VGP/vgp-assembly/tree/master/pipeline">https://github.com/VGP/vgp-assembly/tree/master/pipeline</ext-link>; and wtdbg2 <ext-link ext-link-type="uri" xlink:href="https://github.com/ruanjue/wtdbg2">https://github.com/ruanjue/wtdbg2</ext-link>. For base polishing: Medaka <ext-link ext-link-type="uri" xlink:href="https://github.com/nanoporetech/medaka">https://github.com/nanoporetech/medaka</ext-link>; Mercury <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/merqury">https://github.com/marbl/merqury</ext-link>; and PEPPER <ext-link ext-link-type="uri" xlink:href="https://github.com/kishwarshafin/pepper">https://github.com/kishwarshafin/pepper</ext-link>. For processing and analysis tools: automated analyses <ext-link ext-link-type="uri" xlink:href="https://dockstore.org/workflows/github.com/human-pangenomics/hpp_production_workflows/Merqury:master?tab=info">https://dockstore.org/workflows/github.com/human-pangenomics/hpp_production_workflows/Merqury:master?tab=info</ext-link>; automated contamination removal <ext-link ext-link-type="uri" xlink:href="https://github.com/human-pangenomics/hpp_production_workflows/blob/master/QC/wdl/tasks/contamination.wdl">https://github.com/human-pangenomics/hpp_production_workflows/blob/master/QC/wdl/tasks/contamination.wdl</ext-link>; CutAdapt <ext-link ext-link-type="uri" xlink:href="https://github.com/marcelm/cutadapt">https://github.com/marcelm/cutadapt</ext-link>; HiFiAdapterFilt <ext-link ext-link-type="uri" xlink:href="https://github.com/sheinasim/HiFiAdapterFilt">https://github.com/sheinasim/HiFiAdapterFilt</ext-link>; hap.py <ext-link ext-link-type="uri" xlink:href="https://github.com/Illumina/hap.py">https://github.com/Illumina/hap.py</ext-link>; Meryl <ext-link ext-link-type="uri" xlink:href="https://github.com/marbl/meryl/tree/master/src/meryl">https://github.com/marbl/meryl/tree/master/src/meryl</ext-link>; pangenome assessment <ext-link ext-link-type="uri" xlink:href="https://github.com/AndreaGuarracino/HG002_assemblies_assessment">https://github.com/AndreaGuarracino/HG002_assemblies_assessment</ext-link>; SaaRclust <ext-link ext-link-type="uri" xlink:href="https://github.com/daewoooo/SaaRclust">https://github.com/daewoooo/SaaRclust</ext-link>; SDA <ext-link ext-link-type="uri" xlink:href="https://github.com/mrvollger/SDA">https://github.com/mrvollger/SDA</ext-link>; and SegDupAnnotation <ext-link ext-link-type="uri" xlink:href="https://github.com/ChaissonLab/SegDupAnnotation/releases/tag/vHPRC">https://github.com/ChaissonLab/SegDupAnnotation/releases/tag/vHPRC</ext-link>.</p>
    </notes>
    <notes id="FPar22" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par101">E.E.E. was a scientific advisory board member of Variant Bio, Inc. J.K. and A.W. were full-time employees at Pacific Biosciences, a company developing single-molecule sequencing technologies. A.H. and J.&#xA0;Lee. were employees of Bionano Genomics, a company developing optical maps for genome assembly. J.G. and R.E.G. were affiliated with Dovetail Genomics, a company developing genome assembly tools, including Hi-C. A.&#xA0;Granat and E.B.J. were employees of Ilumina, Inc., a genome company generating short reads. A.&#xA0;Schmitt and S.S. were employees of Arima Genomics, a company developing Hi-C data for genome assemblies. All other authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lander</surname>
              <given-names>ES</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Initial sequencing and analysis of the human genome</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>409</volume>
          <fpage>860</fpage>
          <lpage>921</lpage>
          <pub-id pub-id-type="pmid">11237011</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>VA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly</article-title>
          <source>Genome Res.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>849</fpage>
          <lpage>864</lpage>
          <pub-id pub-id-type="pmid">28396521</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sherman</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Pan-genomics in the human genome era</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>243</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">32034321</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Logsdon</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Vollger</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Eichler</surname>
              <given-names>EE</given-names>
            </name>
          </person-group>
          <article-title>Long-read human genome sequencing and its applications</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>597</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="pmid">32504078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nurk</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The complete sequence of a human genome</article-title>
          <source>Science</source>
          <year>2022</year>
          <volume>376</volume>
          <fpage>44</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">35357919</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Human Pangenome Project: a global resource to map genomic diversity</article-title>
          <source>Nature</source>
          <year>2022</year>
          <volume>604</volume>
          <fpage>437</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">35444317</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giani</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Gallo</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Gianfranceschi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Formenti</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Long walk to genomics: history and current approaches to genome sequencing and assembly</article-title>
          <source>Comput. Struct. Biotechnol. J.</source>
          <year>2020</year>
          <volume>18</volume>
          <fpage>9</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">31890139</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>1000 Genomes Project Consortium</collab>
            <etal/>
          </person-group>
          <article-title>A global reference for human genetic variation</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>526</volume>
          <fpage>68</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">26432245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="other">Ko, B. J. et al. Widespread false gene gains caused by duplication errors in genome assemblies. <italic>Genome Biol.</italic>10.1186/s13059-022-02764-1 (2022).</mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ebert</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Haplotype-resolved diverse human genomes and integrated analysis of structural variation</article-title>
          <source>Science</source>
          <year>2021</year>
          <volume>372</volume>
          <fpage>eabf7117</fpage>
          <pub-id pub-id-type="pmid">33632895</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhie</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Towards complete and error-free genome assemblies of all vertebrate species</article-title>
          <source>Nature</source>
          <year>2021</year>
          <volume>592</volume>
          <fpage>737</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="pmid">33911273</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Kim, J. et al. False gene and chromosome losses in genome assemblies caused by GC content variation and repeats. <italic>Genome Biol.</italic>10.1186/s13059-022-02765-0 (2022).</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Berg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Computing genetic imprinting expressed by haplotypes</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2009</year>
          <volume>573</volume>
          <fpage>189</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="pmid">19763929</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bailey-Wilson</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Linkage analysis in the next-generation sequencing era</article-title>
          <source>Hum. Hered.</source>
          <year>2011</year>
          <volume>72</volume>
          <fpage>228</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="pmid">22189465</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Haplotyping by linked-read sequencing (HLRS) of the genetic disease carriers for preimplantation genetic testing without a proband or relatives</article-title>
          <source>BMC Med. Genomics</source>
          <year>2020</year>
          <volume>13</volume>
          <fpage>117</fpage>
          <pub-id pub-id-type="pmid">32819358</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amarasinghe</surname>
              <given-names>SL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Opportunities and challenges in long-read sequencing data analysis</article-title>
          <source>Genome Biol.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>30</fpage>
          <pub-id pub-id-type="pmid">32033565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nurk</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HiCanu: accurate assembly of segmental duplications, satellites, and allelic variants from high-fidelity long reads</article-title>
          <source>Genome Res.</source>
          <year>2020</year>
          <volume>30</volume>
          <fpage>1291</fpage>
          <lpage>1305</lpage>
          <pub-id pub-id-type="pmid">32801147</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghurye</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrating Hi-C links with assembly graphs for chromosome-scale assembly</article-title>
          <source>PLoS Comput. Biol.</source>
          <year>2019</year>
          <volume>15</volume>
          <fpage>e1007273</fpage>
          <pub-id pub-id-type="pmid">31433799</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durand</surname>
              <given-names>NC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom</article-title>
          <source>Cell Syst.</source>
          <year>2016</year>
          <volume>3</volume>
          <fpage>99</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">27467250</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bocklandt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hastie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Bionano genome mapping: high-throughput, ultra-long molecule genome analysis system for precision genome assembly and haploid-resolved structural variation discovery</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <year>2019</year>
          <volume>1129</volume>
          <fpage>97</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="pmid">30968363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chin</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phased diploid genome assembly with single-molecule real-time sequencing</article-title>
          <source>Nat. Methods</source>
          <year>2016</year>
          <volume>13</volume>
          <fpage>1050</fpage>
          <lpage>1054</lpage>
          <pub-id pub-id-type="pmid">27749838</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koren</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>De novo assembly of haplotype-resolved genomes with trio binning</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>1174</fpage>
          <lpage>1182</lpage>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kronenberg</surname>
              <given-names>ZN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extended haplotype-phasing of long-read de novo genome assemblies using Hi-C</article-title>
          <source>Nat. Commun.</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>1935</fpage>
          <pub-id pub-id-type="pmid">33911078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ball</surname>
              <given-names>MP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A public resource facilitating clinical use of genomes</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2012</year>
          <volume>109</volume>
          <fpage>11920</fpage>
          <lpage>11927</lpage>
          <pub-id pub-id-type="pmid">22797899</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zook</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extensive sequencing of seven human genomes to characterize benchmark reference materials</article-title>
          <source>Sci. Data</source>
          <year>2016</year>
          <volume>3</volume>
          <fpage>160025</fpage>
          <pub-id pub-id-type="pmid">27271295</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">Wagner, J. et al. Benchmarking challenging small variants with linked and long reads. <italic>Cell Genomics.</italic><bold>2</bold>, 100128 (2022).</mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaisson</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Resolving the complexity of the human genome using single-molecule sequencing</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>517</volume>
          <fpage>608</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="pmid">25383537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shafin</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nanopore sequencing and the Shasta toolkit enable efficient de novo assembly of eleven human genomes</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2020</year>
          <volume>38</volume>
          <fpage>1044</fpage>
          <lpage>1053</lpage>
          <pub-id pub-id-type="pmid">32686750</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garg</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chromosome-scale, haplotype-resolved assembly of human genomes</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2021</year>
          <volume>39</volume>
          <fpage>309</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">33288905</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kolmogorov</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Pevzner</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Assembly of long, error-prone reads using repeat graphs</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>540</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="pmid">30936562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Concepcion</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Haplotype-resolved de novo assembly using phased assembly graphs with hifiasm</article-title>
          <source>Nat. Methods</source>
          <year>2021</year>
          <volume>18</volume>
          <fpage>170</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">33526886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimin</surname>
              <given-names>AV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The MaSuRCA genome assembler</article-title>
          <source>Bioinformatics</source>
          <year>2013</year>
          <volume>29</volume>
          <fpage>2669</fpage>
          <lpage>2677</lpage>
          <pub-id pub-id-type="pmid">23990416</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficient assembly of nanopore reads via highly accurate and intact error correction</article-title>
          <source>Nat. Commun.</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>60</fpage>
          <pub-id pub-id-type="pmid">33397900</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="other">Chin, C.-S. &amp; Khalak, A. Human genome assembly in 100 minutes. Preprint at <italic>bioRxiv</italic>10.1101/705616 (2019).</mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate long-read assembly with wtdbg2</article-title>
          <source>Nat. Methods</source>
          <year>2020</year>
          <volume>17</volume>
          <fpage>155</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">31819265</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Walenz</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Koren</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Phillippy</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Merqury: reference-free quality, completeness, and phasing assessment for genome assemblies</article-title>
          <source>Genome Biol.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>245</fpage>
          <pub-id pub-id-type="pmid">32928274</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Formenti</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complete vertebrate mitogenomes reveal widespread repeats and gene duplications</article-title>
          <source>Genome Biol.</source>
          <year>2021</year>
          <volume>22</volume>
          <fpage>120</fpage>
          <pub-id pub-id-type="pmid">33910595</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silkaitis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lemos</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Sex-biased chromatin and regulatory cross-talk between sex chromosomes, autosomes, and mitochondria</article-title>
          <source>Biol. Sex Differ.</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>2</fpage>
          <pub-id pub-id-type="pmid">24422881</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="other">Aganezov, S. et al. A complete reference genome improves analysis of human genetic variation. <italic>Science</italic><bold>376</bold>, 6588 (2022).</mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Howe</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Significantly improving the quality of genome assemblies through curation</article-title>
          <source>Gigascience</source>
          <year>2021</year>
          <volume>10</volume>
          <fpage>giaa153</fpage>
          <pub-id pub-id-type="pmid">33420778</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A synthetic-diploid benchmark for accurate variant-calling evaluation</article-title>
          <source>Nat. Methods</source>
          <year>2018</year>
          <volume>15</volume>
          <fpage>595</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="pmid">30013044</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krusche</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Best practices for benchmarking germline small-variant calls in human genomes</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>555</fpage>
          <lpage>560</lpage>
          <pub-id pub-id-type="pmid">30858580</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="other">Wagner, J. et al. Curated variation benchmarks for challenging medically relevant autosomal genes. <italic>Nat. Biotechnol.</italic><bold>40</bold>, 672&#x2013;680 (2022).</mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <mixed-citation publication-type="other">Hui, J., Shomorony, I., Ramchandran, K. &amp; Courtade, T. A. Overlap-based genome assembly from variable-length reads. In <italic>2016 IEEE International Symposium on Information Theory (ISIT)</italic> 1018&#x2013;1022 (IEEE, 2016).</mixed-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Formenti</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Merfin: improved variant filtering, assembly evaluation and polishing via k-mer validation</article-title>
          <source>Nat. Methods</source>
          <year>2022</year>
          <volume>19</volume>
          <fpage>696</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="pmid">35361932</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">Olson, N. D. et al. Precision FDA Truth Challenge V2: Calling variants from short- and long-reads in difficult-to-map regions. <italic>Cell Genom.</italic>10.1016/j.xgen.2022.100129 (2022).</mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zook</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A robust benchmark for detection of germline large deletions and insertions</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2020</year>
          <volume>38</volume>
          <fpage>1347</fpage>
          <lpage>1355</lpage>
          <pub-id pub-id-type="pmid">32541955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evolutionary and biomedical insights from a marmoset diploid genome assembly</article-title>
          <source>Nature</source>
          <year>2021</year>
          <volume>594</volume>
          <fpage>227</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">33910227</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samuels</surname>
              <given-names>DC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Heterozygosity ratio, a robust global genomic measure of autozygosity and its association with height and disease risk</article-title>
          <source>Genetics</source>
          <year>2016</year>
          <volume>204</volume>
          <fpage>893</fpage>
          <lpage>904</lpage>
          <pub-id pub-id-type="pmid">27585849</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Handsaker</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Large multiallelic copy number variations in humans</article-title>
          <source>Nat. Genet.</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>296</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="pmid">25621458</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosch</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>2007</year>
          <volume>16</volume>
          <fpage>2572</fpage>
          <lpage>2582</lpage>
          <pub-id pub-id-type="pmid">17684299</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cantsilieris</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An evolutionary driver of interspersed segmental duplications in primates</article-title>
          <source>Genome Biol.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>202</fpage>
          <pub-id pub-id-type="pmid">32778141</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ju</surname>
              <given-names>X-C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The hominoid-specific gene TBC1D3 promotes generation of basal neural progenitors and induces cortical folding in mice</article-title>
          <source>eLife</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>e18197</fpage>
          <pub-id pub-id-type="pmid">27504805</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Copy number variation of the lipoprotein(a) (LPA) gene is associated with coronary artery disease in a southern Han Chinese population</article-title>
          <source>Int. J. Clin. Exp. Med.</source>
          <year>2014</year>
          <volume>7</volume>
          <fpage>3669</fpage>
          <lpage>3677</lpage>
          <pub-id pub-id-type="pmid">25419416</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McBride</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Rapid evolution of smell and taste receptor genes during host specialization in <italic>Drosophila sechellia</italic></article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>4996</fpage>
          <lpage>5001</lpage>
          <pub-id pub-id-type="pmid">17360391</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jalili</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2020</year>
          <volume>48</volume>
          <fpage>W395</fpage>
          <lpage>W402</lpage>
          <pub-id pub-id-type="pmid">32479607</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <mixed-citation publication-type="other">Liao, W.-W. et al. A draft human pangenome reference. Preprint at <italic>bioRxiv</italic>10.1101/2022.07.09.499321 (2022).</mixed-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porubsky</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fully phased human genome assembly without parental data using single-cell strand sequencing and long reads</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2021</year>
          <volume>39</volume>
          <fpage>302</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="pmid">33288906</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <mixed-citation publication-type="other">Cheng, H. et al. Haplotype-resolved assembly of diploid genomes without parental data. <italic>Nat. Biotechnol.</italic><bold>40,</bold> 1332&#x2013;1335 (2022).</mixed-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shumate</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assembly and annotation of an Ashkenazi human reference genome</article-title>
          <source>Genome Biol.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>129</fpage>
          <pub-id pub-id-type="pmid">32487205</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garg</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Computational methods for chromosome-scale haplotype reconstruction</article-title>
          <source>Genome Biol.</source>
          <year>2021</year>
          <volume>22</volume>
          <fpage>101</fpage>
          <pub-id pub-id-type="pmid">33845884</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="other">Rautiainen, M. et al. Verkko: telomere-to-telomere assembly of diploid chromosomes. Preprint at <italic>bioRxiv</italic>10.1101/2022.06.24.497523 (2022).</mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ultralow-input single-tube linked-read library method enables short-read second-generation sequencing systems to routinely generate highly accurate and economical long-range sequencing information</article-title>
          <source>Genome Res.</source>
          <year>2020</year>
          <volume>30</volume>
          <fpage>898</fpage>
          <lpage>909</lpage>
          <pub-id pub-id-type="pmid">32540955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jain</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nanopore sequencing and assembly of a human genome with ultra-long reads</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>338</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="pmid">29431738</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guan</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identifying and removing haplotypic duplication in primary genome assemblies</article-title>
          <source>Bioinformatics</source>
          <year>2020</year>
          <volume>36</volume>
          <fpage>2896</fpage>
          <lpage>2898</lpage>
          <pub-id pub-id-type="pmid">31971576</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poplin</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A universal SNP and small-indel variant caller using deep neural networks</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>983</fpage>
          <lpage>987</lpage>
          <pub-id pub-id-type="pmid">30247488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edge</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bafna</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>HapCUT2: robust and accurate haplotype assembly for diverse sequencing technologies</article-title>
          <source>Genome Res.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>801</fpage>
          <lpage>812</lpage>
          <pub-id pub-id-type="pmid">27940952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porubsky</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dense and accurate whole-chromosome haplotyping of individual genomes</article-title>
          <source>Nat. Commun.</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>1293</fpage>
          <pub-id pub-id-type="pmid">29101320</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Falconer</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DNA template strand sequencing of single-cells maps genomic rearrangements at high resolution</article-title>
          <source>Nat. Methods</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>1107</fpage>
          <lpage>1112</lpage>
          <pub-id pub-id-type="pmid">23042453</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghareghani</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Strand-seq enables reliable separation of long reads by chromosome via expectation maximization</article-title>
          <source>Bioinformatics</source>
          <year>2018</year>
          <volume>34</volume>
          <fpage>i115</fpage>
          <lpage>i123</lpage>
          <pub-id pub-id-type="pmid">29949971</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaser</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sovi&#x107;</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nagarajan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>&#x160;iki&#x107;</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate de novo genome assembly from long uncorrected reads</article-title>
          <source>Genome Res.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>737</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="pmid">28100585</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <mixed-citation publication-type="other">Kirsche, M. et al. Jasmine: population-scale structural variant comparison and analysis. Preprint at <italic>bioRxiv</italic>10.1101/2021.05.27.445886 (2021).</mixed-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozowsky</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>AlleleSeq: analysis of allele-specific expression and binding in a network framework</article-title>
          <source>Mol. Syst. Biol.</source>
          <year>2011</year>
          <volume>7</volume>
          <fpage>522</fpage>
          <pub-id pub-id-type="pmid">21811232</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vollger</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-read sequence and assembly of segmental duplications</article-title>
          <source>Nat. Methods</source>
          <year>2019</year>
          <volume>16</volume>
          <fpage>88</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">30559433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>589</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="pmid">20080505</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarasov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vilella</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Cuppen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nijman</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Prins</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Sambamba: fast processing of NGS alignment formats</article-title>
          <source>Bioinformatics</source>
          <year>2015</year>
          <volume>31</volume>
          <fpage>2032</fpage>
          <lpage>2034</lpage>
          <pub-id pub-id-type="pmid">25697820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porubsky</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>breakpointR: an R/Bioconductor package to localize strand state changes in Strand-seq data</article-title>
          <source>Bioinformatics</source>
          <year>2020</year>
          <volume>36</volume>
          <fpage>1260</fpage>
          <lpage>1261</lpage>
          <pub-id pub-id-type="pmid">31504176</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Minimap2: pairwise alignment for nucleotide sequences</article-title>
          <source>Bioinformatics</source>
          <year>2018</year>
          <volume>34</volume>
          <fpage>3094</fpage>
          <lpage>3100</lpage>
          <pub-id pub-id-type="pmid">29750242</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chin</surname>
              <given-names>C-S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A diploid assembly-based benchmark for variants in the major histocompatibility complex</article-title>
          <source>Nat. Commun.</source>
          <year>2020</year>
          <volume>11</volume>
          <fpage>4794</fpage>
          <pub-id pub-id-type="pmid">32963235</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xF6;ster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rahmann</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Snakemake&#x2014;a scalable bioinformatics workflow engine</article-title>
          <source>Bioinformatics</source>
          <year>2012</year>
          <volume>28</volume>
          <fpage>2520</fpage>
          <lpage>2522</lpage>
          <pub-id pub-id-type="pmid">22908215</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waterhouse</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>BUSCO applications from quality assessments to gene prediction and phylogenomics</article-title>
          <source>Mol. Biol. Evol.</source>
          <year>2018</year>
          <volume>35</volume>
          <fpage>543</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">29220515</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Leary</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2016</year>
          <volume>44</volume>
          <fpage>D733</fpage>
          <lpage>D745</lpage>
          <pub-id pub-id-type="pmid">26553804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <mixed-citation publication-type="other">Smit, A. F. A., Hubley, R. &amp; Green, P. Repeatmasker Open 3.0 (Institute of Systems Biology, 1996).</mixed-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgulis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gertz</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;ffer</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Agarwala</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>WindowMasker: window-based masker for sequenced genomes</article-title>
          <source>Bioinformatics</source>
          <year>2006</year>
          <volume>22</volume>
          <fpage>134</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">16287941</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kapustin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Souvorov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tatusova</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lipman</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Splign: algorithms for computing spliced alignments with identification of paralogs</article-title>
          <source>Biol. Direct</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>20</fpage>
          <pub-id pub-id-type="pmid">18495041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>GR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene: a gene-centered information resource at NCBI</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2015</year>
          <volume>43</volume>
          <fpage>D36</fpage>
          <lpage>D42</lpage>
          <pub-id pub-id-type="pmid">25355515</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <mixed-citation publication-type="other">Garrison, E. &amp; Guarracino, A. Unbiased pangenome graphs. Preprint at <italic>bioRxiv</italic>10.1101/2022.02.14.480413 (2022).</mixed-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guarracino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heumos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nahnsen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Prins</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garrison</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>ODGI: understanding pangenome graphs</article-title>
          <source>Bioinformatics</source>
          <year>2022</year>
          <volume>38</volume>
          <fpage>3319</fpage>
          <lpage>3326</lpage>
          <pub-id pub-id-type="pmid">35552372</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jiao</surname>
              <given-names>W-B</given-names>
            </name>
            <name>
              <surname>Schneeberger</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>SyRI: finding genomic rearrangements and local sequence differences from whole-genome assemblies</article-title>
          <source>Genome Biol.</source>
          <year>2019</year>
          <volume>20</volume>
          <fpage>277</fpage>
          <pub-id pub-id-type="pmid">31842948</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35545679</article-id>
      <article-id pub-id-type="pmc">9272728</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-04701-5</article-id>
      <article-id pub-id-type="manuscript">NIHMS1817571</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A natural mutator allele shapes mutation spectrum variation in mice</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sasani</surname>
            <given-names>Thomas A.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ashbrook</surname>
            <given-names>David G.</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beichman</surname>
            <given-names>Annabel C.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Lu</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palmer</surname>
            <given-names>Abraham A.</given-names>
          </name>
          <xref rid="A3" ref-type="aff">3</xref>
          <xref rid="A4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Robert W.</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pritchard</surname>
            <given-names>Jonathan K.</given-names>
          </name>
          <xref rid="A5" ref-type="aff">5</xref>
          <xref rid="A6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harris</surname>
            <given-names>Kelley</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="A7" ref-type="aff">7</xref>
          <xref rid="CR2" ref-type="corresp">&#x2709;</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Genome Sciences, University of Washington, Seattle, WA, USA.</aff>
      <aff id="A2"><label>2</label>Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA.</aff>
      <aff id="A3"><label>3</label>Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.</aff>
      <aff id="A4"><label>4</label>Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.</aff>
      <aff id="A5"><label>5</label>Department of Genetics, Stanford University, Stanford, CA, USA.</aff>
      <aff id="A6"><label>6</label>Department of Biology, Stanford University, Stanford, CA, USA.</aff>
      <aff id="A7"><label>7</label>Computational Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</aff>
      <author-notes>
        <corresp id="CR1"><bold>Correspondence and requests for materials</bold> should be addressed to Kelley Harris.</corresp>
        <fn fn-type="con" id="FN1">
          <p id="P1">Author contributions</p>
          <p id="P2">T.A.S., D.G.A., A.A.P., R.W.W., J.K.P. and K.H. contributed to study conceptualization and design. D.G.A., L.L., J.K.P., A.A.P. and R.W.W. contributed to data curation, including maintenance of the BXD family, DNA sequencing and data warehousing. T.A.S., D.G.A., K.H. and A.C.B. contributed to formal data analysis. T.A.S. and K.H. wrote the original draft of the manuscript. T.A.S., D.G.A., A.C.B., A.A.P., R.W.W., J.K.P. and K.H. contributed to review and editing of the manuscript.</p>
        </fn>
        <corresp id="CR2">
<label>&#x2709;</label>
<email>harriske@uw.edu</email>
</corresp>
        <fn fn-type="COI-statement" id="FN3">
          <p id="P59"><bold>Competing interests</bold> The authors declare no competing interests.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>30</day>
        <month>6</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>5</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>11</day>
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <volume>605</volume>
      <issue>7910</issue>
      <fpage>497</fpage>
      <lpage>502</lpage>
      <permissions>
        <license>
          <license-p>under exclusive licence to Springer Nature Limited 2022</license-p>
        </license>
        <license>
          <license-p><bold>Reprints and permissions information</bold> is available at <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/reprints">http://www.nature.com/reprints</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <p id="P3">Although germline mutation rates and spectra can vary within and between species, common genetic modifiers of the mutation rate have not been identified in nature<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. Here we searched for loci that influence germline mutagenesis using a uniquely powerful resource: a panel of recombinant inbred mouse lines known as the BXD, descended from the laboratory strains C57BL/6J (B haplotype) and DBA/2J (D haplotype). Each BXD lineage has been maintained by brother&#x2013;sister mating in the near absence of natural selection, accumulating de novo mutations for up to 50 years on a known genetic background that is a unique linear mosaic of B and D haplotypes<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. We show that mice inheriting D haplotypes at a quantitative trait locus on chromosome 4 accumulate C&gt;A germline mutations at a 50% higher rate than those inheriting B haplotypes, primarily owing to the activity of a C&gt;A-dominated mutational signature known as SBS18. The B and D quantitative trait locus haplotypes encode different alleles of <italic toggle="yes">Mutyh</italic>, a DNA repair gene that underlies the heritable cancer predisposition syndrome that causes colorectal tumors with a high SBS18 mutation load<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>. Both B and D <italic toggle="yes">Mutyh</italic> alleles are present in wild populations of <italic toggle="yes">Mus musculus domesticus</italic>, providing evidence that common genetic variation modulates germline mutagenesis in a model mammalian species.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35477154</article-id>
      <article-id pub-id-type="pmc">9157047</article-id>
      <article-id pub-id-type="publisher-id">4769</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-04769-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>ABO</italic> genotype alters the gut microbiota by regulating GalNAc levels in pigs</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Yang</surname>
            <given-names>Hui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Wu</surname>
            <given-names>Jinyuan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Xiaochang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Yunyan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Yifeng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Min</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Qin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ke</surname>
            <given-names>Shanlin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>He</surname>
            <given-names>Maozhang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>Hao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>Shaoming</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xiong</surname>
            <given-names>Xinwei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Hui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Zhe</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Zhongzi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gong</surname>
            <given-names>Huanfa</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tong</surname>
            <given-names>Xinkai</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Yizhong</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Junwu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9694-094X</contrib-id>
          <name>
            <surname>Charlier</surname>
            <given-names>Carole</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coppieters</surname>
            <given-names>Wouter</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1325-3085</contrib-id>
          <name>
            <surname>Shagam</surname>
            <given-names>Lev</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Zhiyan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2859-8855</contrib-id>
          <name>
            <surname>Ai</surname>
            <given-names>Huashui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Bin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4124-2375</contrib-id>
          <name>
            <surname>Georges</surname>
            <given-names>Michel</given-names>
          </name>
          <address>
            <email>michel.georges@uliege.be</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7112-448X</contrib-id>
          <name>
            <surname>Chen</surname>
            <given-names>Congying</given-names>
          </name>
          <address>
            <email>chcy75@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6940-667X</contrib-id>
          <name>
            <surname>Huang</surname>
            <given-names>Lusheng</given-names>
          </name>
          <address>
            <email>lushenghuang@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411859.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1808 3238</institution-id><institution>National Key Laboratory for Swine Genetic Improvement and Production Technology, Ministry of Science and Technology of China, </institution><institution>Jiangxi Agricultural University, </institution></institution-wrap>Nanchang, PR China </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.4861.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0805 7253</institution-id><institution>Unit of Animal Genomics, GIGA-Institute and Faculty of Veterinary Medicine, </institution><institution>University of Liege, </institution></institution-wrap>Liege, Belgium </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>606</volume>
      <issue>7913</issue>
      <fpage>358</fpage>
      <lpage>367</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>7</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>4</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</copyright-statement>
        <license>
          <license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">The composition of the intestinal microbiome varies considerably between individuals and is correlated with health<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Understanding the extent to which, and how, host genetics contributes to this variation is essential yet has proved to be difficult, as few associations have been replicated, particularly in humans<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Here we study the effect of host genotype on the composition of the intestinal microbiota in a large mosaic pig population. We show that, under conditions of exacerbated genetic diversity and environmental uniformity, microbiota composition and the abundance of specific taxa are heritable. We map a quantitative trait locus affecting the abundance of Erysipelotrichaceae species and show that it is caused by a 2.3&#x2009;kb deletion in the gene encoding <italic>N</italic>-acetyl-galactosaminyl-transferase that underpins the ABO blood group in humans. We show that this deletion is a &#x2265;3.5-million-year-old trans-species polymorphism under balancing selection. We demonstrate that it decreases the concentrations of <italic>N</italic>-acetyl-galactosamine in the gut, and thereby reduces the abundance of Erysipelotrichaceae that can import and catabolize <italic>N</italic>-acetyl-galactosamine. Our results provide very strong evidence for an effect of the host genotype on the abundance of specific bacteria in the intestine combined with insights into the molecular mechanisms that underpin this association. Our data pave the way towards identifying the same effect in rural&#xA0;human populations.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">The host blood-type-associated <italic>ABO</italic> genotype affects the abundance of specific bacteria in the pig intestine.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Agricultural genetics</kwd>
        <kwd>Genome-wide association studies</kwd>
        <kwd>Microbiome</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">It is increasingly recognized that a comprehensive understanding of the physiology and pathology of organisms requires integrated analysis of the host and its multiple microbiota<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. In humans, the composition of the intestinal microbiota is associated with physiological and pathological parameters, including HDL cholesterol, fasting glucose levels and body mass index<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. In livestock, ruminal microbiome composition is associated with methane production and feed efficiency<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. These correlations reflect a complex interplay between host and microbiota that may include direct (causal) effects of the microbiome on the host&#x2019;s physiology<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Several phenotypes correlated with microbiota composition are heritable<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. This leads to the hypothesis that the genotype of the host may in part determine the composition of the microbiota, which may in turn affect the host&#x2019;s phenotype<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. It implies that the composition of the microbiota is partially heritable. Although studies in rodents support this<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, evidence is less convincing in humans. Initial reports did not reveal a higher microbiota resemblance between monozygotic twins compared with dizygotic twins, suggesting a limited effect of the host genotype<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Better-powered studies provided evidence for a significant effect of host genetics on the abundance of taxa, particularly Christensenellaceae<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Loci that underpin microbiota heritability have remained difficult to identify in humans. Apart from variants that cause persistent expression of lactase (<italic>LCT</italic>) and are associated with decreased <italic>Bifidobacterium</italic> abundance, other GWAS loci have proven to be difficult to replicate<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref></sup>. The analysis of larger human cohorts is needed to gain a better understanding of the genetic architecture of microbiota composition.</p>
      <p id="Par4">To decipher the genetic architecture of intestinal microbiota composition in a large monogastric omnivore, we report the generation of a mosaic pig population and the longitudinal characterization of its intestinal microbiota. We observed a strong effect of the host genotype on microbiota composition and identified a locus with large effect on the abundance of specific taxa by controlling the concentration of <italic>N</italic>-acetyl-galactosamine in the gut and thereby affecting some of the species that use this metabolite as a carbon source.</p>
    </sec>
    <sec id="Sec2">
      <title>A mosaic pig population to study complex traits</title>
      <p id="Par5">We generated a large (&gt;7,500) mosaic population by intercrossing the offspring of 61 F<sub>0</sub> founders from four Chinese and four western breeds for more than 10 generations (Supplementary Table <xref rid="MOESM4" ref-type="media">1</xref> and Extended Data Fig. <xref rid="Fig7" ref-type="fig">1</xref>). Animals were reared in uniform housing and feeding conditions. We analysed more than 200 phenotypes (pertaining to body composition, physiology, disease resistance and behaviour), obtained transcriptome, epigenome and chromatin interaction data from multiple tissues, and collected plasma metabolome and microbiome data in up to 954 F<sub>6</sub> and 892 F<sub>7</sub> animals. The F<sub>0</sub> animals were whole-genome sequenced at an average depth of 28.4-fold, and the F<sub>6</sub> and F<sub>7</sub> animals were sequence at an average depth of 8.0-fold. We called genotypes at 23.8&#x2009;million single-nucleotide polymorphisms (SNPs) and 6.4&#x2009;million insertion&#x2013;deletions (indels) with a minor allele frequency (MAF) of &#x2265;0.03 (&gt;1/100&#x2009;bp). The nucleotide diversity (<italic>&#x3C0;</italic>) (that is, the proportion of nucleotide sites that differ between homologous sequences in two breeds) between two Chinese breeds and between two European breeds was similar to that between <italic>Homo sapiens</italic> and <italic>Homo neanderthalensis</italic> (~3&#x2009;&#xD7;&#x2009;10<sup>&#x2212;3</sup>)<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, whereas the <italic>&#x3C0;</italic> between a Chinese and a European breed approached half of that between human and chimpanzee (~4.3&#x2009;&#xD7;&#x2009;10<sup>&#x2212;3</sup>)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. The proportion of the eight founder genomes in F<sub>6</sub> and F<sub>7</sub> ranged from 11.2% to 14.7% at the genome level, and from 4.9% to 22.1% at the chromosome level. The median number of variants in high linkage disequilibrium (LD) (<italic>r</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.9) with an index variant was 30, and the median maximal distance with a variant in high LD (<italic>r</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.9) was 54&#x2009;kb (Extended Data Fig. <xref rid="Fig7" ref-type="fig">1</xref>).</p>
    </sec>
    <sec id="Sec3">
      <title>The intestinal microbiota of the healthy pig</title>
      <p id="Par6">We collected faeces at days 25 (suckling period), 120 (growing period) and 240 (slaughter day), as well as caecal and ileal content (F<sub>6</sub> and F<sub>7</sub>) and caecal and ileal mucosal scrapings (F<sub>7</sub> only) at day 240 (7 sample types, 12 data series). We generated 16S rRNA tags (V3&#x2013;V4) for an average of 426 animals per data series (5,110 samples) (Supplementary Table <xref rid="MOESM4" ref-type="media">2.1</xref>). Tags were rarefied and clustered in 32,032 operational taxonomic units (OTUs). A total of 12,054 OTUs amounting to 98.7% of reads were retained and annotated to 41 phyla, 87 classes, 149 orders, 207 families, 360 genera and 150 species. The average microbiota composition of the 12 data series indicated high consistency across F<sub>6</sub> and F<sub>7</sub>, yet marked differences between sample types (Fig. <xref rid="Fig1" ref-type="fig">1a, b</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2.2</xref>). Even at the family level, some taxa were found to be nearly sample-type specific (Extended Data Fig. <xref rid="Fig8" ref-type="fig">2</xref>). The proteobacteria Enterobacteriaceae, Pseudomonadaceae and Pasteurellaceae, the firmicutes Clostridiaceae, Peptostreptococcaceae, Bacillaceae and Leuconostocaceae, and the actinobacteria Microbacteriaceae were at least ten times more abundant in ileal samples than in any other sample type. Among those, Leuconostocaceae were nearly digesta specific, whereas Pseudomonadaceae were nearly mucosa specific. The Bacteroidetes Odoribacteraceae and Rikenellaceae were at least ten times more abundant in day 25 faeces samples than in any other sample type. The firmicutes Christensenellaceae were nearly ten times more abundant in faeces samples than in any other sample type. This confirms that limiting the analysis of the intestinal microbiota to adult faeces can provide only a partial view of its complexity and the factors that determine it<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. <italic>&#x3B1;</italic>-Diversity of faeces was lower at day 25 compared with at days 120&#x2013;240, reminiscent of the enrichment of the intestinal flora between childhood and adulthood in humans<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. <italic>&#x3B1;</italic>-Diversity was lower for ileal content than for caecal content and mucosa (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). <italic>&#x3B2;</italic>-Diversity tended to be inversely proportional to <italic>&#x3B1;</italic>-diversity, being higher for day 25 than for day 120 and 240 faeces. Variation in pairwise Bray&#x2013;Curtis dissimilarities was highest for ileal content, which had the lowest <italic>&#x3B1;</italic>-diversity (Fig. <xref rid="Fig1" ref-type="fig">1d</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">2.3</xref>). The microbiota composition of pig day 240 (D240) faeces was more similar to that of human than to that of mouse faeces (Extended Data Fig. <xref rid="Fig8" ref-type="fig">2</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Intestinal microbiota of the healthy pig.</title><p><bold>a</bold>, Joint principal coordinate analysis (PCoA) of 5,110 16S rRNA profiles. F<sub>6</sub> day 25 faeces (D25, mauve), day 120 faeces (D120, red), day 240 faeces (D240, green), ileal content (IC, light blue), caecum content (CC, dark blue) (left). Middle, as described for the left plot but for F<sub>7</sub>. Right, F<sub>7</sub> ileal content (IC, light blue), caecum content (CC, dark blue), ileal mucosa (IM, pink), caecal mucosa (CM, brown). <bold>b</bold>, The average microbiota composition of the 12 data series. Taxa are coloured by phylum and family within phylum, highlighting 43 families among the top 15 in at least one data series. The names of the corresponding phyla and families are shown in the key. The average composition of 106 human faeces and 6 mouse faeces (C57BL/6) samples is shown. <bold>c</bold>, <italic>&#x3B1;</italic>-Diversity values (Shannon&#x2019;s index) for the 12 data series coloured as in <bold>a</bold>. Sample sizes are provided in Supplementary Table <xref rid="MOESM4" ref-type="media">2.1</xref>. The box plots show the median (centre line), interquartile range (box limits), 1.5&#xD7; the interquartile range span (whiskers) and outliers (dots). <bold>d</bold>, <italic>&#x3B2;</italic>-Diversity values (pair-wise&#xA0;Bray&#x2013;Curtis distances) for the 12 data series coloured as in <bold>a</bold>. Distances were computed for all sample&#xA0;pairs. Sample numbers and box plots are as described in <bold>c</bold>.</p></caption><graphic xlink:href="41586_2022_4769_Fig1_HTML" id="d32e691"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Microbiota heritability in mosaic pigs</title>
      <p id="Par7">We first examined the relationship between genetic relatedness (genome-wide SNP identity by state) and microbiota dissimilarity (Bray&#x2013;Curtis distance, all taxa combined)<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. We used two approaches to mitigate confounding of genetics and environment: (1) we restricted the analyses to full-sibling littermates raised in the same environment, and (2) we confronted genetic similarity and microbiota dissimilarity across generations (F<sub>6</sub> and F<sub>7</sub>). Both approaches supported an effect of genetics on microbiota composition manifested by significant negative correlations between genetic similarity and microbiota dissimilarity (Fig. <xref rid="Fig2" ref-type="fig">2a, b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Heritability of microbiota composition in mosaic pigs.</title><p><bold>a</bold>, Correlation between genome-wide kinship (<italic>&#x398;</italic>) and microbiome dissimilarity (Bray&#x2013;Curtis distance) within litter. The correlation (Spearman's <italic>r</italic>) was measured separately for the 12 data series. <italic>P</italic> values (one-sided) were computed by permutation. Adjusted <italic>r</italic> values were below the 50th percentile of the permutation values for 11 out of 12 (<italic>P</italic>&#x2009;=&#x2009;0.0029). The empirical <italic>P</italic> value (one-sided) of <italic>r</italic> was &#x2264;0.05/12&#x2009;=&#x2009;0.004 (Bonferroni corrected) for two&#xA0;data series. <italic>P</italic> values were combined across the 12 data series yielding an overall <italic>P</italic> value of 3&#x2009;&#xD7;&#x2009;10<sup>&#x2212;4</sup>. The number of litters (<italic>l</italic>) and animal pairs (<italic>n</italic>) used are given for each data series. <bold>b</bold>, The correlation between genome-wide kinship and microbiome dissimilarity (Bray&#x2013;Curtis distance) across generations. We considered all possible pairs of F<sub>6</sub> and F<sub>7</sub> animals (not including sow&#x2013;offspring pairs). Analyses were conducted for the five traits measured in both F<sub>6</sub> and F<sub>7</sub>. <italic>r</italic>, <italic>p</italic> and <italic>n</italic> are as described in <bold>a</bold>. <italic>r</italic> values were below the 50th percentile of the permutation values for the five analysed sample types (<italic>P</italic>&#x2009;=&#x2009;0.03). The empirical <italic>P</italic> value (one-sided) of <italic>r</italic> was &#x2264;0.05/5&#x2009;=&#x2009;0.01 (Bonferroni corrected) for one&#xA0;sample type. <italic>P</italic> values for the five sample types were combined yielding an overall <italic>P</italic> value of 0.013. <bold>c</bold>, The frequency distribution of heritabilities of individual taxa sorted by sample type (left) or taxonomic level (right). The values obtained by joint analysis of F<sub>6</sub> and F<sub>7</sub>. <bold>d</bold>, Total heritabilities<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> computed by sample type and taxonomic level.</p></caption><graphic xlink:href="41586_2022_4769_Fig2_HTML" id="d32e824"/></fig></p>
      <p id="Par8">We then evaluated the heritability (<italic>h</italic><sup>2</sup>) of the abundances of individual taxa/OTUs using F<sub>6</sub> and F<sub>7</sub> jointly (Fig. <xref rid="Fig2" ref-type="fig">2c</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">3.1</xref>). We computed total heritabilities (average heritability weighted by abundance)<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> separately by sample type and taxonomic level. Total heritabilities were generally low (&#x2264;11.8%), yet higher for faecal (average D240, 10.2%) than for content samples (average ileal content, 5.7%) and lower for OTUs (average, 6.6%) than for higher taxonomic levels (average, 7.5%) (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>). The correlation between <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{h}^{2}}$$\end{document}</tex-math><mml:math id="M2"><mml:mover accent="true"><mml:mrow><mml:msup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>&#x2C6;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq1.gif"/></alternatives></inline-formula> estimates obtained separately in F<sub>6</sub> and F<sub>7</sub> was positive and significant for D120 (<italic>P</italic>&#x2009;=&#x2009;4.2&#x2009;&#xD7;&#x2009;10<sup>&#x2212;5</sup>), D240 (<italic>P</italic>&#x2009;=&#x2009;2.2&#x2009;&#xD7;&#x2009;10<sup>&#x2212;16</sup>) and caecum content (<italic>P</italic>&#x2009;=&#x2009;2.3&#x2009;&#xD7;&#x2009;10<sup>&#x2212;3</sup>), supporting genuine genetic effects (Extended Data Fig. <xref rid="Fig9" ref-type="fig">3</xref>). We established a list of the 55 most likely heritable taxa/OTUs on the basis of congruent <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{{h}^{2}}$$\end{document}</tex-math><mml:math id="M4"><mml:mover accent="true"><mml:mrow><mml:msup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>&#x2C6;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq2.gif"/></alternatives></inline-formula> estimates in F<sub>6</sub> (&#x2265;0.15), F<sub>7</sub> (&#x2265;0.15), and across F<sub>6</sub> and F<sub>7</sub> (&#x2265;0.10) (Supplementary Table <xref rid="MOESM4" ref-type="media">3.1</xref>). It included the order Campylobacterales in D240 faeces, the species <italic>Bacteroides coprophilus</italic> in D25 faeces, and 53 OTUs of which two (D240&#xA0;faeces, caecum content) were assigned to Christensenellaceae, five to Ruminococcaceae (four&#xA0;in D240&#xA0;faeces, one in&#xA0;caecum content), one (D25) to <italic>Ruminococcus</italic>, one (D25) to <italic>Phascolarctobacterium</italic>, and one (D240) to RF32; that is, taxons characterized by <italic>h</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.10 in human studies<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. With the exception of RF32, all of these belong to the order Clostridiales.</p>
    </sec>
    <sec id="Sec5">
      <title>A miQTL affecting Erysipelotrichaceae species</title>
      <p id="Par9">Heritability quantifies the proportion of additive genetic variance but does not foretell genetic architecture: phenotypes with low heritability may be affected by variants with major effects, whereas highly heritable traits may be very polygenic. To gain insights into the genetic architecture of the gut microbiota composition in this population, we performed a genome-wide association study (GWAS). We applied two statistical models testing SNP effects on taxa abundance and taxa presence/absence, respectively<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. We ran GWAS separately by sample type, taxon and generation for a total of 57,557 GWAS (involving 8,490 taxa) (Supplementary Table <xref rid="MOESM4" ref-type="media">4.1</xref>). This yielded 1,527 genome-wide significant signals (<italic>P</italic>&#xA0;&#x2264;5&#x2009;&#xD7;&#x2009;10<sup>&#x2212;8</sup>). For these, we performed meta-analyses across sample types, separately in F<sub>6</sub> and F<sub>7</sub> (Extended Data Fig. <xref rid="Fig10" ref-type="fig">4</xref>). We identified six signals exceeding the experiment-wide discovery threshold (<italic>P</italic> =&#xA0;1.5&#x2009;&#xD7;&#x2009;10<sup>&#x2212;12</sup>) in one cohort and the experiment-wide replication threshold (<italic>P</italic> =&#xA0;0.007) in the other (Fig. <xref rid="Fig3" ref-type="fig">3a</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">4.2</xref>&#x2013;<xref rid="MOESM4" ref-type="media">4.3</xref>). All lead SNPs mapped within 3,037&#x2009;bp from each other (chromosome 1) and were in high LD (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). They affected two OTUs (OTU476 and OTU327) as well as the genus p-75-a5, to which OTU476 is assigned. All three are Erysipelotrichaceae.<fig id="Fig3"><label>Fig. 3</label><caption><title>A miQTL affecting Erysipelotrichaceae species.</title><p><bold>a</bold>, The result of genome-wide meta-analysis (across sample types) in F<sub>6</sub> and F<sub>7</sub> for OTU476. Reported log-transformed <italic>P</italic> values are nominal (that is, not corrected for multiple testing). <bold>b</bold>, Local magnified views of chromosome 1 (272.8&#x2013;273&#x2009;Mb) of OTU476 and OTU327 in F<sub>6</sub> and F<sub>7</sub>. log-transformed nominal <italic>P</italic> values as in <bold>a</bold>. <bold>c</bold>, log[1/<italic>P</italic>] values in F<sub>6</sub> (<italic>x</italic>-axis) and F<sub>7</sub> (<italic>y</italic>-axis) for the association between SNP 1_272907239 and the abundance of 8,490 OTUs for all of the sample types and two analyses methods (abundance and presence/absence, explaining the two OTU476 values) (left). OTUs belonging to p-75-a5 and Erysipelotrichaceae are shown in red and yellow, respectively. Right, comparison of the distribution of association (1_272907239) <italic>P</italic> values for p-75-a5 and Erysipelotrichaceae OTUs with other OTUs in F<sub>6</sub> and F<sub>7</sub>. Box plots are as described in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. The notches in the boxes correspond to 95% confidence intervals of the median values. Distributions were compared using Wilcoxon&#x2019;s rank-sum test. <italic>P</italic> values (nominal) of the comparisons are given above the horizontal lines. <bold>c</bold>, LD (<italic>r</italic><sup>2</sup>) between the four top SNPs and the 2.3&#x2009;kb ABO deletion in F<sub>6</sub> and F<sub>7</sub>.</p></caption><graphic xlink:href="41586_2022_4769_Fig3_HTML" id="d32e1090"/></fig></p>
      <p id="Par10">To determine whether this microbiota QTL (miQTL) affects other taxa, we plotted the F<sub>6</sub> and F<sub>7</sub> association log[1/<italic>P</italic>] for lead SNP 1_272907239 and the 8,490 studied OTUs. OTU476 and OTU327 stood out as highly significant in F<sub>6</sub> and F<sub>7</sub> (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). Yet the <italic>P</italic> values for the 31 other p-75-a5 OTUs and the 83 other Erysipelotrichaceae OTUs were significantly shifted towards lower <italic>P</italic> values in both cohorts (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>), and the sign was consistent with that for OTU476, OTU327 and p-75-a5 (Extended Data Fig. <xref rid="Fig10" ref-type="fig">4</xref>). This suggests that the chromosome 1 miQTL affects other species in this family. Notably, the <italic>h</italic><sup>2</sup> for p-75-a5 and OTU476 deviated significantly from 0 in D240 (0.10 and 0.14) and D120 (0.13 and 0.13) faeces, and <italic>h</italic><sup><italic>2</italic></sup> estimates for OTU327 in D120 faeces (0.13) (Supplementary Table <xref rid="MOESM4" ref-type="media">4.4</xref>).</p>
      <p id="Par11"><italic>QQ</italic> plots obtained after removing chromosome 1 variants (272.8&#x2013;273.1&#x2009;Mb interval) did not show convincing evidence for residual inflation of log[1/<italic>P</italic>] (Extended Data Fig. <xref rid="Fig10" ref-type="fig">4</xref>). Thus, the residual <italic>h</italic><sup><italic>2</italic></sup> is most likely highly polygenic.</p>
    </sec>
    <sec id="Sec6">
      <title>A 3.5-million-year-old deletion in the pig <italic>ABO</italic> orthologue</title>
      <p id="Par12">All lead SNPs map to the 3&#x2032; end of the porcine <italic>N</italic>-acetyl-galactosaminyl transferase gene underlying the ABO blood group in humans (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). This is a strong candidate that modulates interactions with several pathogens<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and was recently suggested to affect the intestinal microbiota in healthy humans<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x2013;<xref ref-type="bibr" rid="CR23">23</xref></sup>. A 2.3&#x2009;kb deletion encompassing the last exon has been reported in pigs<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. We showed that it was in near-perfect LD (<italic>r</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.94) with the lead SNPs in our population (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>). We confirmed its boundaries and showed that it results from an intrachromosomal recombination between short interspersed nuclear elements (SINEs). We showed using RNA-sequencing (RNA-seq) and expression quantitative trait loci (eQTL) analysis in 300 F<sub>7</sub> caecum samples that the deleted allele produces reduced amounts (around 1/3 of normal) of a 7.4&#x2009;kb transcript (with alternative eighth and ninth exons) encoding a protein that lost 62% of its amino-acids, including 7 out of 8 active sites<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). Our results indicate that the 2.3&#x2009;kb deletion creates a null allele (hereafter, the <italic>O</italic> allele) and that is a very strong candidate for the causative miQTL mutation (Extended Data Figs. <xref rid="Fig11" ref-type="fig">5</xref> and <xref rid="Fig12" ref-type="fig">6</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>A 3.5-million-year-old deletion in the pig <italic>ABO</italic> orthologue causes the miQTL.</title><p><bold>a</bold>, The structure of the porcine <italic>AO</italic> blood group gene. IGV (Integrated Genome Viewer)&#xA0;view of the genotypes of the 61 F<sub>0</sub> animals showing 145 variants in a ~5&#x2009;kb interval spanning the 2.3&#x2009;kb deletion. The top two red rectangles show the 2.3&#x2009;kb deletion. Homozygous alternative (light blue), heterozygous (dark blue) and homozygous reference (grey)&#xA0;genotypes are shown. The horizontal blue arrows mark SINEs that have mediated intrachromosomal recombination. The vertical black arrows mark the top variants from Fig. <xref rid="Fig3" ref-type="fig">3b</xref>. The effect of the 2.3&#x2009;kb deletion on acetyl-galactosaminyl transferase transcripts is shown, including the creation of alternative exons 8 and 9, and the reduction of transcript levels to around one-third of normal. <bold>b</bold>, The effect of the <italic>AO</italic> genotype (<italic>AA</italic>, <italic>AO</italic> or <italic>OO</italic>) on the abundance of OTU476. The effect of the <italic>A</italic> allele is dominant over that of the <italic>O</italic> allele, and the miQTL effect is detected in the caecum (content and mucosa) and in day 120 and 240 faeces samples. Sample sizes are provided in Supplementary Table <xref rid="MOESM4" ref-type="media">4.1</xref>. The box plots are as described in Fig. <xref rid="Fig3" ref-type="fig">3d</xref>. <bold>c</bold>, Unweighted pair group method with arithmetic mean dendrogram based on the sequence similarity between 14 <italic>AA</italic> and 34 <italic>OO</italic> animals in a 5&#x2009;kb window centred on the 2.3&#x2009;kb deletion. CH, Chinese; EU, European; RU, Russian; DOM, domestic pigs; WB, wild boars; PHAC_AFR, common warthog; SUS_VERR, Javan warty pig; SUS_CEB, Visayan warty pig; SUS_SCR_VII, Sumatran wild boar. Breeds: BX, Bamaxiang; EH, Erhualian; LA, Laiwu; LD, Landrace; LW, Large White; PT, Pi&#xE9;train; TB, Tibetan; WD, White Duroc. <bold>d</bold>, The peak of reduced population differentiation coinciding with the 2.3&#x2009;kb deletion (red) in the porcine <italic>AO</italic> gene (blue). The position on chromosome 1 is shown on the <italic>x</italic>-axis; and 1/(mean <italic>F</italic> statistic) for all variants in a 2&#x2009;kb sliding window is shown on the <italic>y</italic>-axis. The <italic>F</italic> statistic was computed as the ratio of the between-breed mean squares and the within-breed mean squares for the dosage of <italic>O</italic> allele. Chr., chromosome.</p></caption><graphic xlink:href="41586_2022_4769_Fig4_HTML" id="d32e1297"/></fig></p>
      <p id="Par13">We examined the effect of the <italic>AO</italic> genotype on the abundance of OTU476, OTU327 and p-75-a5. The results showed that (1) the effect of the <italic>A</italic> allele is dominant over the <italic>O</italic> allele (Supplementary Table <xref rid="MOESM4" ref-type="media">5.1</xref>), and (2) that the effect manifests in D120 and D240 faeces, caecal content as well as mucosa, but not in D25 faeces and D240 ileal content and mucosa (Fig. <xref rid="Fig4" ref-type="fig">4b</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">5.1</xref>). In these samples (D120, D240, caecum content, caecal mucosa), the <italic>AO</italic> genotype explained 7.9%, 3.2% and 6.6% of the variation in the abundance of OTU476, OTU327 and genus p-75-a5 (Supplementary Table <xref rid="MOESM4" ref-type="media">5.2</xref>). Notably, the abundance of OTU476 and OTU327 was highest in caecal content (around 0.92% and 0.02% of reads in <italic>AA/AO</italic> animals, and around 0.47% and 0.003% of reads in <italic>OO</italic> animals, respectively; Extended Data Fig. <xref rid="Fig11" ref-type="fig">5</xref>).</p>
      <p id="Par14">In primates, the <italic>ABO</italic> locus is under strong balancing selection that has perpetuated identical-by-descent alleles segregating in humans, gibbons and Old World monkeys for tens of millions of years<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. We analysed the sequences of the 61 F<sub>0</sub> (<italic>Sus scrofa domestica</italic>), 18 wild boars (9 Asian, 9 European) (<italic>Sus scrofa</italic>), 1 Indonesian wild boar from Sumatra (<italic>Sus scrofa vittatus</italic>), 1 Visayan warty pig from the Philippines (<italic>Sus cebifrons</italic>), 1 Javan warty pig from Indonesia (<italic>Sus verrucosus</italic>) and one common warthog from Africa (<italic>Phacochoerus africanus</italic>) in a 50&#x2009;kb window spanning the <italic>AO</italic> gene. Asian and European wild boars diverged from a common <italic>S. scrofa</italic> ancestor around 1&#x2009;million years ago (Ma), <italic>S. scrofa</italic> and <italic>S. s. vittatus</italic> around 1.5&#x2009;Ma, <italic>S. scrofa</italic> and <italic>S. cebifrons/verrucosus</italic> around 3.5&#x2009;Ma, and <italic>S. scrofa</italic> and <italic>P. africanus</italic> around 10&#x2009;Ma<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. The 2.3&#x2009;kb deletion segregated in all eight F<sub>0</sub> breeds, in all Asian and European/American wild-boar populations, and in <italic>S. cebifrons</italic> (Supplementary Table <xref rid="MOESM4" ref-type="media">5.3</xref>). The sequence of the deletion breakpoint was identical in all of the samples, confirming the identical-by-descent nature of the porcine <italic>O</italic> allele (Extended Data Fig. <xref rid="Fig13" ref-type="fig">7</xref>). Consistent with the hypothesis of an ancestral trans-species polymorphism (rather than hybridization), the <italic>O</italic> allele of <italic>S. cebifrons</italic> lay outside the cluster of <italic>S. scrofa O</italic> alleles (Fig. <xref rid="Fig4" ref-type="fig">4c</xref> and Extended Data Fig. <xref rid="Fig13" ref-type="fig">7</xref>). Further supporting balancing selection, the <italic>AO</italic> gene showed a marked decrease in population differentiation maximizing at the 2.3&#x2009;kb deletion (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). Thus, although largely unknown, the underlying selective forces have operated in at least two mammalian branches (primates and suidae), over substantially long periods and broad geographical ranges, pointing towards their pervasive nature (Extended Data Fig. <xref rid="Fig13" ref-type="fig">7</xref>).</p>
    </sec>
    <sec id="Sec7">
      <title>The miQTL affects caecal GalNAc concentrations</title>
      <p id="Par15">As in humans, the porcine <italic>AO</italic> gene is broadly expressed, yet is particularly expressed in the intestines (Extended Data Fig. <xref rid="Fig13" ref-type="fig">7</xref>). The <italic>N</italic>-acetyl-galactosaminyl-transferase encoded by the <italic>A</italic> allele adds <italic>N</italic>-acetyl-<sc>d</sc>-galactosamine (GalNAc, <italic>&#x3B1;</italic>1-3 linkage) to H and Lewis antigens present on glycan substrates, including the heavily glycosylated mucins, which can be used as carbon source by intestinal bacteria<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> (Extended Data Fig. <xref rid="Fig14" ref-type="fig">8</xref>). We reasoned that, owing to the abundance of intestinal mucus, the <italic>O</italic> allele might reduce the concentration of GalNAc in the intestine, thereby reducing the growth of bacterial species that are dependent on this sugar. We measured the concentration of free GalNAc, <italic>N</italic>-acetylglucosamine (GlcNAc) and <italic>N</italic>-acetylmannosamine (ManNAc) isomers (hereafter, HexNAc) in the caecum content of 278 D240 animals (124 F<sub>7</sub> and 154 Duroc&#x2009;&#xD7;&#x2009;Landrace&#x2009;&#xD7;&#x2009;Large White) using liquid chromatography coupled with tandem mass spectrometry (LC&#x2013;MS/MS). Intestinal HexNAc in pigs comprises approximately equal proportions of the GlcNAc and GalNAc isomers<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Dosage of the <italic>A</italic> allele (additive model)&#xA0;increased (<italic>P</italic>&#x2009;=&#x2009;5.7&#x2009;&#xD7;&#x2009;10<sup>&#x2212;9</sup>) caecal HexNAc concentrations (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). Assuming that the increase is due only to GalNAc (given the enzymatic activity of the <italic>A</italic> allele), <italic>AA</italic> animals have at least twice the amount of free GalNAc compared with <italic>OO</italic> animals (Fig. <xref rid="Fig5" ref-type="fig">5a</xref> and Extended Data Fig. <xref rid="Fig15" ref-type="fig">9</xref>). Non-zero values in <italic>OO</italic> animals are primarily due to GlcNAc/ManNAc, and are probably also due to non-A antigen host and dietary GalNAc (GalNAc is ubiquitous at the core of all <italic>O</italic>-glycans, including intestinal mucins, and is a component of glycosaminoglycans such as chondroitin sulfate). Note that the effect of the <italic>A</italic> allele appears to be dominant on bacterial abundance, yet additive on GalNAc concentrations (<italic>P</italic> value of likelihood ratio test against the additive model&#x2009;=&#x2009;0.12). This indicates that the additional increase in GalNAc availability in <italic>AA</italic> animals (versus <italic>AO</italic> animals) does not further favour the growth of OTU476, OTU327 and p-75-a5.<fig id="Fig5"><label>Fig. 5</label><caption><title>The miQTL acts by increasing GalNAc concentrations and affects GalNAc-using bacteria.</title><p><bold>a</bold>, The effect of <italic>AO</italic> genotype on GalNAc concentrations in caecal content (<italic>n</italic><sub>AA</sub>&#x2009;=&#x2009;33, <italic>n</italic><sub>AO</sub>&#x2009;=&#x2009;118, <italic>n</italic><sub>OO</sub>&#x2009;=&#x2009;127). Concentrations were corrected for batch effect and scaled between 0 and 1 to equalize residual variance. <italic>P</italic> values (two-sided and nominal) for genotype contrasts were computed using Wilcoxon&#x2019;s tests. The box plots are as described in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. <bold>b</bold>, The correlation between GalNAc concentration and OTU476 abundance within the <italic>AO</italic> genotype. Area under the curve (AUC) values for GalNAc corrected for batch effect and <italic>AO</italic> genotype and scaled as described above. The <italic>P</italic> value (nominal, two-sided) of Spearman&#x2019;s correlation is given (<italic>P</italic>&#x2009;=&#x2009;0.012). The shaded area corresponds to the 95% confidence region for the regression fit. <bold>c</bold>, Same as in <bold>b</bold>, with animals coloured by <italic>AO</italic> genotype. <bold>d</bold>, The GalNAc transport and catabolic pathway in OTU476-like strains. GalNAc-6-P, <italic>N</italic>-acetylgalactosamine-6-phosphate; GalN-6-P, galactosamine-6-P; Tag_6-P, tagatose-6-phosphate; Tag-1,6-PP, tagatose-1,6-biphosphate; GAP, glyceraldehyde-3-phosphate; DHAP, dihydroxyacetone-phosphate; 3PG, 3-phosphoglycerate; Pyr, pyruvate; Lact, lactate. Enzymes encoded in the GalNAc operon are shown in blue. Metabolites considered in the metabolic flux analysis are shown in bold. <bold>e</bold>, The proportion of <sup>13</sup>C-labelled metabolites determined by GC&#x2013;MS in the OTU476-like strain (4-8-110) fed <sup>13</sup>C-labelled (red) versus regular GalNAc (green). <bold>f</bold>, In vivo (germ-free mice) <italic>E. coli</italic> versus OTU476-like strain competition with and without GalNAc. The proportion of 16S rRNA reads mapping to the 4-8-110 reference rRNA sequence versus <italic>E. coli</italic> rRNA sequence (that is, 1 minus the proportions shown in the figure correspond to reads mapping to the <italic>E. coli</italic> 16S rRNA) in the caecum content and faeces of 10 germ-free mice (Kunming line) inoculated by gavage with a pure culture of 4-8-110 and <italic>E. coli</italic> and force-fed with GalNAc (red bars) versus PBS (green bars). <italic>P</italic> values (nominal, two-sided, uncorrected) comparing the difference in abundance were determined using Wilcoxon tests.</p></caption><graphic xlink:href="41586_2022_4769_Fig5_HTML" id="d32e1638"/></fig></p>
      <p id="Par16">Showing that the <italic>O</italic> deletion (1) reduces caecal GalNAc concentrations, and (2) reduces the abundance of OTU476, OTU327 and p-75-a5 does not prove that one causes the other. The effect on bacterial abundance could be mediated by an unidentified mechanism independent of GalNAc. However, the hypothesis that it is the change in GalNAc concentrations that causes the change in bacterial abundance makes a testable prediction. In this case, we may expect to observe a &#x2018;residual&#x2019; correlation between GalNAc concentrations and bacterial abundance &#x2018;within&#x2019; the <italic>AO</italic> genotype, that is, by blocking the effect of the <italic>AO</italic> genotype and exploiting other sources of variation of GalNAc and bacterial abundance (Extended Data Fig. <xref rid="Fig14" ref-type="fig">8</xref>). We performed these analyses and observed the predicted positive correlation for OTU476 (<italic>P</italic>&#x2009;=&#x2009;0.012) and p-75-a5 (<italic>P</italic>&#x2009;=&#x2009;0.010), consistently within the three genotypes (<italic>AA</italic>, <italic>AO</italic> and <italic>OO</italic>). The correlation was positive (and consistent within the three genotypes) albeit not significant (<italic>P</italic>&#x2009;=&#x2009;0.3) for the less abundant OTU327 (Fig. <xref rid="Fig5" ref-type="fig">5b, c</xref> and Extended Data Fig. <xref rid="Fig15" ref-type="fig">9</xref>).</p>
      <p id="Par17">Taken together, these results make a strong case that the <italic>AO</italic> genotype affects intestinal GalNAc concentrations, and that this affects the abundance of some Erysipelotrichaceae species.</p>
    </sec>
    <sec id="Sec8">
      <title>miQTL-responsive bacteria use GalNAc</title>
      <p id="Par18">To be used as carbon source by intestinal bacteria, GalNAc needs (1) to be released from the glycan structures by secreted glycoside hydrolases (GHs), (2) to be imported across the bacterial membranes by dedicated transport systems (TR), and (3) to be converted into intermediates of central metabolism by a specific catabolic pathway (CP). Although some bacteria have both GHs and TR&#x2013;CP for specific monosaccharides, other bacteria have only the GHs (donors) or the TR&#x2013;CP (acceptors)<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. We reasoned that the bacteria that would respond to the miQTL would have a complete GalNAc TR&#x2013;CP system (with or without GHs). To test this, we (1) isolated two bacterial strains (4-8-110 and 4-15-1) with a V3&#x2013;V4 sequence similarity of 100% and 99.8% with OTU476, respectively, and sequenced their genome using the Oxford Nanopore Promethion system, and (2) built 3,111 metagenomic assembled genomes (MAGs) from shotgun data of 92 porcine intestinal samples, including 248 Erysipelotrichaceae. We compiled a list of 24 genes implicated in GalNAc use (TR&#x2013;CP)<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR31">31</xref>&#x2013;<xref ref-type="bibr" rid="CR36">36</xref></sup>. These encode (1) 11 components of three GalNAc transporter systems (AgaPTS: <italic>agaE</italic>, <italic>agaF</italic>, <italic>agaV</italic>, <italic>agaW</italic>; TonB dependent transporter: <italic>omp</italic>, <italic>agaP</italic>, <italic>agaK</italic>; GnbPTS: <italic>gnbA</italic>, <italic>gnbB</italic>, <italic>gnbC</italic>, <italic>gnbD</italic>), (2) two GalNAc-6P deacetylases (<italic>agaA</italic>, <italic>nagA</italic>), (3) two galactosamine-6P (<italic>GalN-6P</italic>) isomerase and/or deaminases (<italic>agaI</italic>, <italic>agaS</italic>), (4) three tagatose-6P kinases (<italic>pfka</italic>, <italic>lacC</italic>, <italic>fruK</italic>), (5) four tagatose-1,6-PP aldolases or aldolase subunits (<italic>gatY-kbaY</italic>, <italic>gatZ-kbaZ</italic>, <italic>lacD</italic>, <italic>fba</italic>) and (6) two regulon repressors (<italic>agaR</italic>, <italic>gntR</italic>), for a total of six essential pathway constituents (Fig. <xref rid="Fig5" ref-type="fig">5d</xref> and Supplementary Table <xref rid="MOESM4" ref-type="media">6</xref>). Genes involved in the use of specific sugars tend to cluster and form operons of potentially coregulated genes (regulons) that support all or most of the essential TR&#x2013;CP steps. The steps that are not encoded by the operon may be complemented in <italic>trans</italic> by genes encoding enzymes that may be less substrate-specific<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. We searched for orthologues of the 24 genes in the two OTU476-like genomes and 3,111 MAGs. We generated two scores to evaluate the ability of bacterial species to use GalNAc. The first (pathway score) counted the number of essential steps in GalNAc use (out of six) that could be accomplished by the orthologues detected in the genome, irrespective of map position. The second (regulon score) counted the number of essential GalNAc-use steps that could be fulfilled by orthologues that were clustered in the genome, that is, forming a potential operon. We used <italic>agaS</italic> as an anchor gene to establish the regulon score<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. The first notable observation was that at least one orthologue of <italic>agaS</italic> was found in the two (that is, all) OTU476-like strains, in 31% of Erysipelotrichaceae MAGs (<italic>n</italic>&#x2009;=&#x2009;248), yet in only 2.9% of other MAGs (<italic>n</italic>&#x2009;=&#x2009;2,863). The second was that both scores were significantly higher for Erysipelotrichaceae compared with the other MAGs (<italic>P</italic><sub>pathway</sub>&#x2009;=&#x2009;2.0&#x2009;&#xD7;&#x2009;10<sup>&#x2212;16</sup> and <italic>P</italic><sub>regulon</sub>&#x2009;=&#x2009;2.0&#x2009;&#xD7;&#x2009;10<sup>&#x2212;16</sup>), and for the two OTU476-like strains compared with Erysipelotrichaceae and non-Erysipelotrichaceae MAGs combined (<italic>P</italic><sub>pathway</sub>&#x2009;=&#x2009;2.2&#x2009;&#xD7;&#x2009;10<sup>&#x2212;3</sup> and <italic>P</italic><sub>regulon</sub>&#x2009;=&#x2009;1.2&#x2009;&#xD7;&#x2009;10<sup>&#x2212;5</sup>) (Extended Data Fig. <xref rid="Fig16" ref-type="fig">10</xref>). The two OTU476-like strains were characterized by a cluster with eight GalNAc genes, including orthologues of the four components of the AgaPTS transporter system (<italic>agaE</italic>, <italic>agaF</italic>, <italic>agaV</italic>, <italic>agaW</italic>), of nagA deacetylase, of agaS deaminase/isomerase, of fruK kinase and of the gatZ-kbaZ aldolase subunit (Extended Data Fig. <xref rid="Fig16" ref-type="fig">10</xref>). This amounted to a score of five for both pathway and regulon, corresponding, respectively, to the top 4.7% and 0.35% out of 3,113&#xA0;MAGs, demonstrating the uncommon status of OTU476-like strains with regard to GalNAc use. Neither the 4-15-1 nor 4-8-110 genome encode GHs that are known to have <italic>&#x3B1;</italic>-<italic>N</italic>-acetylgalactosaminidase activity specific for the A antigen<sup><xref ref-type="bibr" rid="CR39">39</xref>&#x2013;<xref ref-type="bibr" rid="CR41">41</xref></sup>, suggesting that these strains are acceptors only.</p>
      <p id="Par19">To confirm that the OTU476-like strains are able to import and catabolize GalNAc, we grew the 4-8-110 strain in the presence of <sup>13</sup>C-labelled GalNAc and checked the appearance of <sup>13</sup>C-labelled catabolites in the bacterial pellet using gas chromatography coupled with MS (GC&#x2013;MS). After 13&#x2009;h of culture, around 29% of glyceraldehyde-3-P and around 25% of dihydoxyacetone phosphate (the products of the conversion of tagatose-1,6-bisphosphate by gatZ aldolase) were labelled with <sup>13</sup>C, demonstrating the use of GalNAc by strain 4-8-110. Approximately 23% of 3-phosphoglycerate and around 17% of lactate molecules but none of TCA metabolites were <sup>13</sup>C-labelled, underscoring the predominance of glycolysis over oxidative phosphorylation in this anaerobe (Fig. <xref rid="Fig5" ref-type="fig">5d, e</xref>).</p>
      <p id="Par20">We further performed a gavage experiment in germ free mice to test the effect of the addition of GalNAc on the relative growth of 4-8-110 and <italic>Escherichia coli</italic> in vivo. We gavaged mice either with GalNAc (200&#x2009;mg&#x2009;kg<sup>&#x2212;1</sup> live weight, yielding caecal GalNAc concentrations comparable to <italic>AA</italic> pigs; Extended Data Fig. <xref rid="Fig15" ref-type="fig">9</xref>) or phosphate-buffered saline (PBS), as well as a mixture of <italic>E. coli</italic> and the 4-8-110 OTU476-like strain. We euthanized the mice at day 12 and measured the relative abundance of <italic>E. coli</italic> and 4-8-110 using 16S rRNA sequencing in the caecum and faeces. Strain 4-8-110 was in essence not detectable in PBS-gavaged mice, whereas it accounted for an average of 0.9% of reads in the caecum content (<italic>P</italic>&#x2009;=&#x2009;0.0079) and 0.7% of reads in the faeces (<italic>P</italic>&#x2009;=&#x2009;0.0097) of GalNAc-gavaged mice (Fig. <xref rid="Fig5" ref-type="fig">5f</xref>).</p>
    </sec>
    <sec id="Sec9">
      <title>GalNAc operon of miQTL-sensitive bacteria</title>
      <p id="Par21">At least 65 MAGs (including <italic>E. coli</italic> and other non-<italic>Erysipelotrichacea</italic> species) contain orthologues for the five key GalNAc TR&#x2013;CP steps as do 4-15-1 and 4-8-110. We wondered why the chromosome 1 miQTL does not affect these species. The organization of their GalNAc operons may provide a hint. The GalNAc clusters of non-Erysipelotrichaceae species have the features of genuine regulons. The relevant ORFs tend to be adjacent to each other (spanning around 10&#x2009;kb) and on the same strand, compatible with polycistronic mRNAs enabling coregulated expression. By contrast, the open reading frames (ORFs) of the GalNAc clusters of the two OTU476-like strains and at least one studied Erysipelotrichaceae span around 50&#x2009;kb and 30&#x2009;kb, respectively, and are distributed on both strands. Neither genome contained orthologues of <italic>agaR</italic> or <italic>gntR</italic>, which are negative regulators of GalNAc regulons and were observed in all other GalNAc-rich MAGs (Fig. <xref rid="Fig6" ref-type="fig">6a</xref> and Extended Data Fig. <xref rid="Fig17" ref-type="fig">11</xref>). This suggests that, in contrast to <italic>E. coli</italic> and other species, the OTU476-like strains and some Erysipelotrichaceae cannot sense GalNAc concentrations and induce expression of the genes necessary for GalNAc use only when needed<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>, but rather may express these constitutively. To test this hypothesis, we grew the two OTU476-like strains and <italic>E. coli</italic> with and without GalNAc in the medium and analysed their transcriptome using RNA-seq. The GalNAc regulon of <italic>E. coli</italic> was tightly regulated, with a near complete absence of transcription in the absence of GalNAc, and around 300-fold upregulation in its presence. By contrast, in the OTU476-like 4-15-1 strain, GalNAc TR&#x2013;CP genes were expressed at nearly equal levels with and without GalNAc, as predicted. Strain 4-15-1 expression levels in the absence of GalNAc were higher than <italic>E. coli</italic> expression levels in the presence of GalNAc. The expression pattern in the 4-8-110 strain was intermediate between <italic>E. coli</italic> and 4-15-1: GalNAc genes were expressed in the absence of GalNAc (albeit at low levels) yet were upregulated (around five to tenfold) in its presence (Fig. <xref rid="Fig6" ref-type="fig">6a</xref>). The difference in the response of the transcriptome to GalNAc addition between OTU476-like strains and <italic>E. coli</italic> response was not limited to the GalNAc operon. Although addition of GalNAc did not have noticeable effects on genes outside of the GalNAc regulon in <italic>E. coli</italic>, it altered the expression of &#x2265;605 and 225 genes (<italic>q</italic>&#x2009;&#x2264;&#x2009;0.05) in 4-15-1 and 4-8-110, respectively (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). Six KEGG pathways were consequently perturbed in both strains (FDR&#x2009;&#x2264;&#x2009;0.05): metabolic pathways, pyrimidine metabolism, alanine, aspartate and glutamate metabolism, biosynthesis of antibiotics, ABC transporters and biosynthesis of secondary metabolites (Supplementary Table <xref rid="MOESM4" ref-type="media">7</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><title>The GalNAc operon organization and transcriptome response of miQTL-responsive bacteria.</title><p><bold>a</bold>, The GalNAc operon organization and local transcriptome response to GalNAc addition in OTU476-like strains and <italic>E. coli</italic>. Top, GalNAc operon organization. Identified ORFs are represented as coloured boxes. Genes implicated in GalNAc import and catabolism are shown in red if they are part of the cluster and in green if located elsewhere in the genome. Genes with a known function unrelated to GalNAc are shown in blue. ORFs with an uncharacterized gene product are shown in grey. Gene acronyms are given next to the corresponding boxes. ORFs transcribed from the top and bottom strand are shown above and below the dotted line, respectively. The respective transcriptional directions are marked by arrows. Bottom, local gene expression levels (fragments per kb of exon model per million mapped reads (FPKM)) with (dark colour) and without (light colour) addition of GalNAc in the growth medium. The colours for the ORFs with a known function (GalNAc gene (red), other gene (blue)) are the same as in the top panels. The error bars are the s.e.m. from three replicates (individual values are shown as dots). <bold>b</bold>, The global transcriptome response to GalNAc addition in OTU476-like strains and <italic>E. coli</italic>. The log<sub>2</sub>-transformed fold change in expression for all genes in the respective genomes (4,419 in <italic>E. coli</italic>, 1,119 in OTU476-like strains, ranked according to genomic position) after addition of GalNAc in the medium is shown. GalNAc genes are shown in red and other genes are shown in blue. Insets: corresponding <italic>QQ</italic> plots showing the near absence of effects on genes other than the GalNAc regulon in <italic>E. coli</italic> versus the widespread response in OTU476-like strains. The <italic>P</italic> values used to generate the <italic>QQ</italic> plots are nominal, and were determined using DISEQ2.</p></caption><graphic xlink:href="41586_2022_4769_Fig6_HTML" id="d32e2038"/></fig></p>
    </sec>
    <sec id="Sec10" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par22">In humans, the <italic>ABO</italic> genotype affects susceptibility to various viral (including SARS-CoV-1 and 2), bacterial and protozoan pathogens<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>, and possibly the composition of the intestinal microbiota<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x2013;<xref ref-type="bibr" rid="CR23">23</xref></sup>. Invoked mechanisms are usually immune related, including pathogen adhesion, toxin binding, soluble decoys and natural antibodies<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. We provide strong evidence that the miQTL reported in this research functions by affecting intestinal GalNAc concentrations, and thereby the growth of GalNAc-using bacteria. A puzzling finding is that not all species with the ability to use GalNAc as a carbon source appear to be affected. We suggest that this could be connected to the observation that the GalNAc operon is inducible in species like <italic>E. coli</italic>, while being constitutively expressed at high levels in at least some of the OTU476-like strains. The GalNAc gene cluster as seen in the OTU476-like strains is a possible evolutionary intermediate towards the formation of a genuine regulon as seen in <italic>E. coli</italic>, facilitating horizontal transmission of a &#x2018;selfish&#x2019; functional gene ensemble even if not yet adaptively coregulated<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. The distinct behaviour of the GalNAc operon in the 4-15-1 and 4-8-110 strains in response to GalNAc may be indicative of an evolving regulatory mechanism distinct from the canonical repressor-based regulon system. These findings suggest an alternative modus operandi of the miQTL. Bacteria affected by it may not be at an advantage when GalNAc is present at a relatively higher concentration in the intestinal content (as in <italic>AA</italic> and <italic>AO</italic> animals), but rather at a disadvantage when GalNAc is present at low concentrations (as in <italic>OO</italic> animals) due to wasting energy transcribing and translating useless genes. By tightly regulating the expression of their operon in response to ambient GalNAc availability, species like <italic>E. coli</italic> may fair equally well in the gut of <italic>AA/AO</italic> pigs as in that of <italic>OO</italic> pigs and, therefore, not be affected by the miQTL. Note that, in addition to the distinct organization of their GalNAc operon, the transcriptome of the two studied OTU476-like strain responds more to GalNAc addition than that of <italic>E. coli</italic>. The precise significance of this observation remains to be established but may indicate alternative or additional factors that underpin differential sensitivity to the miQTL.</p>
      <p id="Par23"><italic>FUT2</italic>-null alleles segregate in humans&#xA0;and in homozygotic individuals; this&#xA0;precludes synthesis of the type I H antigen and therefore epistatically of the type I A and/or B antigens in non-<italic>O</italic> individuals<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> (Extended Data Fig. <xref rid="Fig14" ref-type="fig">8</xref>). Although the <italic>FUT2</italic><sup><italic>H117R</italic></sup> variant segregated in our population, there was no evidence for an effect of that or any other <italic>FUT2</italic> variant on the abundance of OTU476, OTU327 or p-75-a5 with or without conditioning on <italic>AO</italic> genotype (data not shown).</p>
      <p id="Par24">The effect of the <italic>ABO</italic> genotype on intestinal microbiota composition in humans remains somewhat controversial. Despite suggestive evidence in a small (<italic>n</italic>&#x2009;=&#x2009;71) cohort of separate microbiota-based clustering of <italic>AB</italic> and <italic>B</italic> versus <italic>A</italic> and <italic>O</italic> individuals<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, a subsequent study in a larger cohort (<italic>n</italic>&#x2009;=&#x2009;1,503) could not detect experiment-wide significant effects of the <italic>ABO</italic> genotype on gut microbiota composition<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. More recently, an effect of <italic>ABO</italic> genotype was reported on the abundance of OTUs assigned respectively to <italic>Faecalibacterium</italic> and <italic>Bacteroides</italic> in a cohort of around 9,000 German individuals<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, but this was not confirmed in a subsequent study (~18,000 individuals)<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. We examined the effect of the ABO blood group on the abundance of around 75 OTUs assigned to Erysipelotrichaceae in human gut samples (Extended Data Fig. <xref rid="Fig18" ref-type="fig">12</xref>). None of the OTUs detected in human were as closely related to the pig OTU476, OTU327 or p-75-a5 as these were to each other. We found no evidence for an effect of ABO blood group on the abundance of any of these. What underlies the difference between pigs and humans is unclear. Either Erysipelotrichaceae strains susceptible to the <italic>ABO</italic> genotype are not present at sufficient levels in humans, or the carbohydrate composition of human intestinal content makes these strains less sensitive to variations in GalNAc concentrations. The abundance of p-75-a5 was found to differ significantly between African subsistence categories and to be highest in pastoralists (as compared to hunter-gatherers and agro-pastoralists) possibly as a result of interaction with livestock<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>. Repeating the experiments in pastoralists may reveal the same miQTL effect detected in this study.</p>
      <p id="Par25">While this paper was in the last phase of the publication process two papers came out reporting an effect of <italic>ABO</italic> genotype on intestinal microbiota composition in human, albeit on distinct taxa<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>.</p>
    </sec>
    <sec id="Sec11" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec12">
        <title>Animal rearing and sample collection</title>
        <p id="Par26">This study focused on the sixth (F<sub>6</sub>) and seventh (F<sub>7</sub>) generation of a mosaic population generated as follows. An average of 3.6 boars (range, 3&#x2013;4) and 4 sows (range, 2&#x2013;5) from four indigenous Chinese pig breeds (Erhualian (EH), Bamaxiang (BX), Tibetan (TB), Laiwu (LA)) and four commercial European/American pig breeds (Landrace (LD), Large White (LW), Duroc (WD) and Pi&#xE9;train (PT)) were successfully mated, constituting the F<sub>0</sub> generation. For each Chinese breed, the boars were mated with the sows of one European breed, and the sows with the boars of another European breed to produce the F<sub>1</sub> generation. Thus, every Chinese and every European breed is parent breed of two distinct F<sub>1</sub> hybrid combinations each, for a total of eight F<sub>1</sub> combinations (BX&#x2013;LW, BX&#x2013;PT, LA&#x2013;PT, LA&#x2013;LD, TB&#x2013;LD, TB&#x2013;WD, EH&#x2013;WD, EH&#x2013;LW). The F<sub>2</sub> generation was obtained by mating each F<sub>1</sub> hybrid combination with two others that did not share parental breeds for a total of eight F<sub>2</sub> combinations (BX&#x2013;LW &#xD7; LA&#x2013;PT, BX&#x2013;PT &#xD7; LA&#x2013;LD, LA&#x2013;PT &#xD7; TB&#x2013;LD, LA&#x2013;LD &#xD7; TB&#x2013;WD, TB&#x2013;LD &#xD7; EH&#x2013;WD, TB&#x2013;WD &#xD7; EH&#x2013;LW, EH&#x2013;WD &#xD7; BX&#x2013;LW, EH&#x2013;LW &#xD7; BX&#x2013;PT). Every F<sub>2</sub> combination was obtained by reciprocally crossing an average of 4 boars from one F<sub>1</sub> combination with an average of 7.25 sows from the other. The F<sub>3</sub> generation was obtained by mating each of the eight F<sub>2</sub> hybrid combinations with the only complementary F<sub>2</sub> combination that did not share any parental breeds for a total of four F<sub>3</sub> combinations (BX&#x2013;LW&#x2013;LA&#x2013;PT &#xD7; TB&#x2013;LD&#x2013;EH&#x2013;WD, BX&#x2013;PT&#x2013;LA&#x2013;LD &#xD7; TB&#x2013;WD&#x2013;EH&#x2013;LW, LA&#x2013;PT&#x2013;TB&#x2013;LD &#xD7; EH&#x2013;WD&#x2013;BX&#x2013;LW, LA&#x2013;LD&#x2013;TW&#x2013;WD &#xD7; EH&#x2013;LW&#x2013;BX&#x2013;PT) expected to each have around 12.5% of their genome from each of the founder breeds. Every F<sub>3</sub> combination was obtained by reciprocally crossing an average of 7 boars from one F<sub>2</sub> combination with an average of 10.8 sows from the complementary one. The F<sub>4</sub>, F<sub>5</sub>, F<sub>6</sub> and F<sub>7</sub> generations were obtained by intercrossing 57 boars &#xD7; 75 sows (F<sub>3</sub> to F<sub>4</sub>), 62 boars &#xD7; 97 sows (F<sub>4</sub> to F<sub>5</sub>), 85 boars &#xD7; 170 sows (F<sub>5</sub> to F<sub>6</sub>) and 82 boars &#xD7; 111 sows (F<sub>6</sub> to F<sub>7</sub>) (Supplementary Table <xref rid="MOESM4" ref-type="media">1</xref>).</p>
        <p id="Par27">All F<sub>6</sub> and F<sub>7</sub> animals were born and reared at the experimental farm of the National Key Laboratory for swine Genetic Improvement and Production Technology, Jiangxi Agricultural University (Nanchang, Jiangxi) under standard and uniform housing and feeding conditions. Piglets remained with their mother during the suckling period and were weaned at about 46 days of age. Litters were transferred to 12-pig fattening pens with automatic feeders (Osborne Industries), minimizing splitting and merging of litters. All pigs were fed twice per day with formula diets containing 16% crude protein, 3,100&#x2009;kJ digestible energy, 0.78% lysine, 0.6% calcium and 0.5% phosphorus. Water was available ad libitum from nipple drinkers. Males were castrated at 80 days. Faecal samples were manually collected from the rectum of experimental pigs at the ages of 25, 120 and 240 days, dispensed in 2&#x2009;ml tubes, flash-frozen in liquid nitrogen and stored at &#x2212;80&#x2009;&#xB0;C. The animals were slaughtered at day 240. The ileum and caecum were sealed at both ends with a sterile rope and extracted from the carcass. Within 30 min after slaughter, ileal and caecal luminal content were collected (F<sub>6</sub> and F<sub>7</sub> animals), the ileum and caecum were rinsed with sterile saline solution, and samples of ileal and caecal mucosa were scraped with a sterile microscopic slide (F<sub>7</sub> animals only). Approximately 1&#x2009;g of content or scrapings was packed in 2&#x2009;ml sterile freezer tubes, flash-frozen in liquid nitrogen and stored at &#x2212;80&#x2009;&#xB0;C. The number of samples of the different types available for further analysis are provided in Supplementary Table <xref rid="MOESM4" ref-type="media">2.1</xref>. All of the animals included in the analyses were healthy and did not receive any antibiotic treatment within one month of sample collection. All of the procedures involving animals were approved by the Ethics Committee of the Jiangxi Agricultural University (no. JXAU2011-006).</p>
      </sec>
      <sec id="Sec13">
        <title>Genotyping by sequencing the F<sub>0</sub>, F<sub>6</sub> and F<sub>7</sub> generations</title>
        <p id="Par28">Genomic DNA was extracted from ear punches using a standard phenol&#x2013;chloroform-based DNA-extraction protocol. DNA concentrations were measured using the Nanodrop-1000 instrument (Thermo Fisher Scientific), and the DNA quality of all of the samples was assessed by agarose (0.8%) gel electrophoresis. Genomic DNA was sheared to 300&#x2013;400&#x2009;bp fragment size. The 3&#x2032;-ends were adenylated and indexed primers were ligated. The libraries were amplified by PCR using Phusion High-Fidelity DNA polymerase (NEB) according to the recommendations of the manufacturer (Illumina). The libraries were loaded onto the Illumina X-10 instrument (Illumina) for 2&#x2009;&#xD7;&#x2009;150&#x2009;bp paired-end sequencing by Novogene. We removed reads with a quality score of &#x2264;20 for &#x2265;50% of bases or &#x2265;10% missing (<italic>N</italic>) bases. Read quality was checked using Fastqc (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Clean reads were aligned to the <italic>S. scrofa</italic> reference genome assembly 11.1<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> using BWA (v.0.7.17)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. BAM files of mapped reads were sorted by chromosome position using SAMTools (v.1.6)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Indel realignment and marking of duplicates were performed using Picard (v.2.21.4, <ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard">http://broadinstitute.github.io/picard</ext-link>). Individual genotypes were called from BAM files using Platypus (v.0.8.1)<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Individual genotypes were merged into a single VCF file using PLINK (v.1.9)<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> encompassing a total of 39.3&#x2009;million variants including 31,094,663 SNPs and 8,266,390 INDELs. Missing genotypes were imputed with Beagle (v.40)<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Genomic variants with MAF&#x2009;&lt;&#x2009;0.03 were removed.</p>
      </sec>
      <sec id="Sec14">
        <title>Computing nucleotide diversity</title>
        <p id="Par29">Nucleotide diversity between pairs of breeds was computed from variant frequencies as follows:<disp-formula id="Equa"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\pi }_{i}=(\mathop{\sum }\limits_{j=1}^{{n}_{i}}1-({f}_{ij}^{{\rm{A}}}\times {f}_{ij}^{{\rm{B}}})-((1-{f}_{ij}^{{\rm{A}}})\times (1-{f}_{ij}^{{\rm{B}}})))/w$$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x3C0;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:munderover><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msubsup><mml:mo>&#xD7;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>&#xD7;</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>w</mml:mi></mml:mrow></mml:math><graphic xlink:href="41586_2022_4769_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where <italic>&#x3C0;</italic><sub><italic>i</italic></sub> is the nucleotide diversity in window <italic>i</italic>, <italic>n</italic><sub><italic>i</italic></sub> is the number of variants in window <italic>i</italic>, <inline-formula id="IEq3"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{{ij}}^{{\rm{A}}}$$\end{document}</tex-math><mml:math id="M8"><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq3.gif"/></alternatives></inline-formula> is the frequency of variant <italic>j</italic> of window <italic>i</italic> in breed <italic>A</italic>,<inline-formula id="IEq4"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\,{f}_{{ij}}^{{\rm{B}}}$$\end{document}</tex-math><mml:math id="M10"><mml:mrow><mml:mspace width=".25em"/><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq4.gif"/></alternatives></inline-formula> is the frequency of variant <italic>j</italic> of window <italic>i</italic> in breed B, and <italic>w</italic> is the size of the windows in base pairs. The overall nucleotide diversity for a pair of breeds A and B was computed as the average of <italic>&#x3C0;</italic><sub><italic>i</italic></sub> across all of the windows. The numbers reported are averages of overall nucleotide diversities for multiple pairs of breeds (within European, within Chinese, between European, between Chinese, between European and Chinese), computed for a window size of 1&#x2009;million base pairs.</p>
      </sec>
      <sec id="Sec15">
        <title>Estimating the contribution of the eight founder breeds in the F<sub>6</sub> and F<sub>7</sub> generation at the genome and chromosome level</title>
        <p id="Par30">We estimated the proportion of the genome of the eight founder breeds in the F<sub>6</sub> and F<sub>7</sub> generation according to ref. <sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Assume that the total number of variants segregating in the mosaic population is <italic>n</italic><sub>T</sub>. Each of these variants has a frequency in each one of the founder breeds which we denote <inline-formula id="IEq5"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{1}^{0.1}\to {f}_{{n}_{{\rm{T}}}}^{0.1}$$\end{document}</tex-math><mml:math id="M12"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>&#x2192;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq5.gif"/></alternatives></inline-formula> for breed 1, <inline-formula id="IEq6"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{1}^{0.2}\to {f}_{{n}_{{\rm{T}}}}^{0.2}$$\end{document}</tex-math><mml:math id="M14"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>&#x2192;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq6.gif"/></alternatives></inline-formula> for breed 2, and so on, as well as a frequency in the F<sub>6</sub> (or F<sub>7</sub>) generation, which we refer to as <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{1}^{6}\to {{\rm{f}}}_{{n}_{{\rm{T}}}}^{6}$$\end{document}</tex-math><mml:math id="M16"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msubsup><mml:mo>&#x2192;</mml:mo><mml:msubsup><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq7.gif"/></alternatives></inline-formula>. We assume that there is a total of <italic>B</italic> breeds. We denote the proportion of the genome of breed 1 in generation F<sub>6</sub> (or F<sub>7</sub>) as <italic>P</italic><sub>1</sub>, of breed 2 in generation F<sub>6</sub> (or F<sub>7</sub>) as P<sub>2</sub>, and so on. We estimated the values of <italic>P</italic><sub>1</sub>, <italic>P</italic><sub>2</sub>, and so on, using a set of linear equations:<disp-formula id="Equb"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{1}^{6}={\sum }_{j=1}^{B}({P}_{j}\times {f}_{1}^{0.j})$$\end{document}</tex-math><mml:math id="M18" display="block"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>B</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&#xD7;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="41586_2022_4769_Article_Equb.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equc"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\vdots $$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mo>&#x22EE;</mml:mo></mml:math><graphic xlink:href="41586_2022_4769_Article_Equc.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equd"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{i}^{6}={\sum }_{j=1}^{B}({P}_{j}\times {f}_{i}^{0.j})$$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>B</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&#xD7;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="41586_2022_4769_Article_Equd.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Eque"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\vdots $$\end{document}</tex-math><mml:math id="M24" display="block"><mml:mo>&#x22EE;</mml:mo></mml:math><graphic xlink:href="41586_2022_4769_Article_Eque.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equf"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{{n}_{{\rm{T}}}}^{6}={\sum }_{j=1}^{B}({P}_{j}\times {f}_{{n}_{{\rm{T}}}}^{0.j}).$$\end{document}</tex-math><mml:math id="M26" display="block"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>B</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&#xD7;</mml:mo><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="41586_2022_4769_Article_Equf.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par31">We used standard least square methods (lm function in R) to find the solutions of <italic>P</italic><sub><italic>j</italic></sub> that minimize the residual sum of squares. This was done for the entire genome, as well as by autosome.</p>
      </sec>
      <sec id="Sec16">
        <title>16S rRNA data collection and processing</title>
        <p id="Par32">Microbial DNA was extracted from faeces, luminal content and mucosal scrapings using the QIAamp Fast DNA stool Mini Kit according to the manufacturer&#x2019;s recommendations (Qiagen). DNA concentrations were measured using the Nanodrop-1000 instrument (Thermo Fisher Scientific), and DNA quality was assessed by agarose (0.8%) gel electrophoresis. The V3&#x2013;V4 hypervariable region of the 16S rRNA gene was amplified with the barcode fusion primers (338F: 5-ACTCCTACGGGAGGCAGCAG-3, 806R: 5-GGACTACHVGGGTWTCTAAT-3) with 56&#x2009;&#xB0;C annealing temperature. After purification, PCR products were used for constructing libraries and sequenced on the Illumina MiSeq platform (Illumina) at Major Bio. The 16S rRNA sequencing data were submitted to the CNGB database and have accession number <ext-link ext-link-type="uri" xlink:href="https://db.cngb.org/search/project/CNP0001069/">CNP0001069</ext-link>. The raw 16S rRNA gene sequencing reads were demultiplexed and primer and barcode sequences were trimmed using Trimmomatic (v.0.39)<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. Reads with &#x2265;10 consecutive same or ambiguous bases were eliminated. Clean paired-end reads were merged (minimum 10&#x2009;bp overlap) into tags using FLASH (v.1.2.11)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. The average number of tags per sample was around 40,888 (Supplementary Table <xref rid="MOESM4" ref-type="media">2.1</xref>). Chimeric reads were removed using USEARCH (v.7.0.1090)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Sequencing data were rarefied to 19,632 tags, that is, the lowest number of tags per sample. Tags were clustered in OTUs with VSEARCH (v.2.8.1)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> using 97% as the similarity threshold. OTUs that would not have &#x2265;3 reads in at least two samples or were detected in &#x2264;0.2% of the samples were ignored. In the end, 12,054 OTUs accounting for an average of 98.7% of total reads per sample were used for further analysis. The mean number of tags for the 12,054 OTUs retained for further analyses was 1.6 (range, 0.01&#x2013; 702.2). OTUs were matched to taxa using the Greengenes (v.13.5) database and the RDP classifier (v.2.2)<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. PCoA was performed with the ape and vegan R packages (v.3.5.3) using Bray&#x2013;Curtis dissimilarities. Shannon&#x2019;s index was used as <italic>&#x3B1;</italic>-diversity metric and computed using mothur (v.1.43.0)<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Bray&#x2013;Curtis dissimilarity was used as <italic>&#x3B2;</italic>-diversity metric and computed using vegdist of the vegan package in R (v.3.5.3). The mouse faecal microbiome data were from ref. <sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. The human faecal microbiome data were 16S rRNA data from 106 healthy individuals (L.S. et al., manuscript in preparation).</p>
      </sec>
      <sec id="Sec17">
        <title>Measuring the heritability of microbiota composition (all taxa combined)</title>
        <p id="Par33">We first estimated the effect of host genetics on the composition of the intestinal microbiome by measuring the correlation between genome-wide kinship and microbiome dissimilarity. We computed genome-wide kinship (<italic>&#x398;</italic>) for all pairs of relevant individuals using the SNP genotypes at the above-mentioned 30.2&#x2009;million DNA variants using either GEMMA (v.0.97)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> or GCTA (v.1.26)<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. Both programs yielded estimates of <italic>&#x398;</italic> with the same distribution after standardization, albeit different raw values. We report results obtained using GEMMA (v.0.97). Microbiome dissimilarity was measured using the Bray&#x2013;Curtis dissimilarity computed using the vegan R function<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> and abundances of all OTUs. We computed Spearman&#x2019;s (rank-based) correlations using the corrtest function in R (v.3.5.3). We first performed this analysis for each sample type and generation separately within litter, that is, only considering pairs of full-siblings born within the same litter, therefore in essence following ref. <sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. We then performed the analysis across the F<sub>6</sub> and F<sub>7</sub> generations. The pairs of individuals considered were all F<sub>6</sub>&#x2013;F<sub>7</sub> animal pairs, which included no parent&#x2013;offspring pairs. To account for dependencies characterizing the data, <italic>P</italic> values were determined empirically by permutation testing. We performed 1,000 permutations of kinship coefficients and Bray&#x2013;Curtis dissimilarities within litter. Vectors of OTU abundances were permuted within litters, Bray&#x2013;Curtis distances were recomputed and correlated with the unpermuted kinships. The empirical <italic>P</italic> value was determined as the proportion of permutations that yielded a Spearman&#x2019;s correlation that was as low or lower than that obtained with the real data.</p>
      </sec>
      <sec id="Sec18">
        <title>Measuring the heritability of the abundance of individual taxa</title>
        <p id="Par34">Heritabilities of log-transformed abundances of specific taxa/OTUs were estimated using a linear mixed model implemented with the lme4QTL R-package (v.3.5.3)<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. <italic>P</italic> values for the heritability estimates were computed using the associated lrt_h2 function<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. We first estimated heritabilities using information from the F<sub>6</sub> and F<sub>7</sub> generation jointly (F<sub>6</sub> plus F<sub>7</sub>). The model included individual animal (that is, polygenic effect), dam, litter, pen and batch as random effects and generation as a fixed effect. The additive genetic relationship matrix determining covariances between individual animal effects was computed using GCTA (v.1.26)<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. This F<sub>6</sub> plus F<sub>7</sub> analysis extracts information from the correlation between kinship and phenotypic resemblance (1) between F<sub>6</sub> animals (within F<sub>6</sub>), (2) between F<sub>7</sub> animals (within F<sub>7</sub>) and (3) between F<sub>6</sub> and F<sub>7</sub> animals (between F<sub>6</sub> and F<sub>7</sub>). To evaluate whether these three sources of information were consistent, we also estimated&#x2014;for each taxon&#xA0;or&#xA0;OTU&#x2014;the three heritabilities separately. The within F<sub>6</sub> and within F7 heritabilities were estimated using the same mixed model (except for the absence of the fixed generation effect) and lme4QTL package as for the F<sub>6</sub> plus F<sub>7</sub> analysis. The between F<sub>6</sub> and F<sub>7</sub> heritabilities were estimated by regressing the squared difference in abundance on additive relationship according to ref. <sup><xref ref-type="bibr" rid="CR69">69</xref></sup>&#x2014;narrow sense heritability was estimated as <inline-formula id="IEq8"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$-\hat{\beta }/(2{\hat{\sigma }}_{P}^{2})$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>&#x3B2;</mml:mi></mml:mrow><mml:mo>&#x2C6;</mml:mo></mml:mover><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#x3C3;</mml:mi></mml:mrow><mml:mo>&#x2C6;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq8.gif"/></alternatives></inline-formula> where <inline-formula id="IEq9"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\hat{\beta }$$\end{document}</tex-math><mml:math id="M30"><mml:mover accent="true"><mml:mrow><mml:mi>&#x3B2;</mml:mi></mml:mrow><mml:mo>&#x2C6;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq9.gif"/></alternatives></inline-formula> is the least-square regression coefficient and <inline-formula id="IEq10"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\hat{\sigma }}_{P}^{2}$$\end{document}</tex-math><mml:math id="M32"><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#x3C3;</mml:mi></mml:mrow><mml:mo>&#x2C6;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq10.gif"/></alternatives></inline-formula> an estimate of the phenotypic variance (Extended Data Fig. <xref rid="Fig9" ref-type="fig">3</xref>). The total heritability of the intestinal microbiome was further computed from the heritabilities and abundance of individual taxa/OTU according to ref. <sup><xref ref-type="bibr" rid="CR2">2</xref></sup>.</p>
      </sec>
      <sec id="Sec19">
        <title>Mapping miQTL</title>
        <p id="Par35">miQTL were mapped using the GenABEL R package (v.3.5.3)<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>, applying two models according to ref. <sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. The first fitted a linear regression between allelic dosage and log<sub>10</sub>-transformed taxa abundance (additive model). It was applied to all SNPs with MAF&#x2009;&#x2265;&#x2009;0.05 (in the corresponding data series) and taxa (that is, at all taxonomic levels including OTU) with non-null abundance in at least 20% of samples (in the corresponding data series), ignoring samples with null abundance if those represented more than 5% of samples. The second fitted a logistic regression model between allelic dosage and taxon presence/absence in the corresponding sample (binary model). It was applied only to taxa present in &#x2265;20% and &#x2264;95% of individuals and SNPs with MAF&#x2009;&#x2265;&#x2009;10% (as the test statistic was inflated under the null when using this model with MAF&#x2009;&lt;&#x2009;10%; Extended Data Fig. <xref rid="Fig10" ref-type="fig">4</xref>). Both models included sex, slaughter batch (21 for F<sub>6</sub>, 23 for F<sub>7</sub>) and the three first genomic principal components as fixed covariates. GWAS were conducted separately for each taxon &#xD7; data series combination and <italic>P</italic> values were concomitantly adjusted for residual stratification by genomic control. <italic>P</italic> values were combined across traits and/or taxa using a <italic>Z</italic>-score. <italic>P</italic> values were converted to signed <italic>Z</italic>-values using the inverse of the standard normal distribution and summed to give a <italic>Z</italic>-score. <italic>Z</italic>-scores were initially calculated using METAL (v.3.0)<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. To compute the <italic>P</italic> value of the corresponding <italic>Z</italic>-score while accounting for the correlation that exists between the phenotypic values of a given cohort across traits, we also computed the genome-wide (that is, across all of the tested SNPs) average (<inline-formula id="IEq11"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\bar{Z}$$\end{document}</tex-math><mml:math id="M34"><mml:mover accent="true"><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mo>&#xAE;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq11.gif"/></alternatives></inline-formula>) and standard deviation (<inline-formula id="IEq12"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\sigma }_{Z}$$\end{document}</tex-math><mml:math id="M36"><mml:msub><mml:mrow><mml:mi>&#x3C3;</mml:mi></mml:mrow><mml:mrow><mml:mi>Z</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq12.gif"/></alternatives></inline-formula>) of the <italic>Z</italic> score. The <italic>P</italic> value of <italic>Z</italic> scores was (conservatively) computed by assuming that <inline-formula id="IEq13"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left(Z-\bar{Z}\right)/{\sigma }_{Z}$$\end{document}</tex-math><mml:math id="M38"><mml:mrow><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi>Z</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mo>&#xAE;</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x3C3;</mml:mi></mml:mrow><mml:mrow><mml:mi>Z</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq13.gif"/></alternatives></inline-formula> is distributed as <italic>N</italic> (0,1) under the null hypothesis. Both approaches yielded similar results.</p>
      </sec>
      <sec id="Sec20">
        <title>De novo assembly of the <italic>A</italic> allele of the porcine <italic>AO</italic> acetyl-galactosaminyl transferase gene</title>
        <p id="Par36">We extracted high-quality genomic DNA from longissimus dorsi of a Bamaxiang female&#xA0;using a phenol&#x2013;chloroform-based extraction method (Novogene Biotech). A 40&#x2009;kb SMRTbell DNA library (Pacific Biosciences)&#xA0;was prepared using BluePippin for DNA size selection (Sage Science) and then sequenced on the PacBio Sequel platform (Pacific Biosciences) with P6-C4 chemistry at Novogene Biotech. We obtained a total of 18,148,470 subreads with an <italic>N</italic><sub>50</sub> length of 17,273&#x2009;bp. Moreover, a paired-end library with insert size of 350&#x2009;bp was constructed and sequenced on the Illumina Novaseq 6000 PE150 platform (2&#x2009;&#xD7;&#x2009;150bp reads) at Novogene Biotech. PacBio reads were self-corrected using Canu (v.1.7.1) before assembly with Flye (v.2.4.2)<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Errors in the primary assembly were first corrected using PacBio subreads using racon (v.1.4.10)<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>, and Illumina paired-end reads were then mapped to the contigs using bwa-mem<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> to polish the contigs using Pilon (v.1.23, Broad Institute)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. Lastz (v.1.02.00)<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> and Minimap2 (v.2.17-r941)<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> were used to compare the Bamaxiang contig and the 40&#x2009;kb sequence spanning the <italic>ABO</italic> gene of the <italic>S. scrofa</italic> build 11.1 reference genome.</p>
      </sec>
      <sec id="Sec21">
        <title>Developing a PCR assay to distinguish between <italic>AA</italic>, <italic>AO</italic> and <italic>OO</italic> pigs</title>
        <p id="Par37">We designed two pairs of primers to genotype the deletion in the F<sub>6</sub> and F<sub>7</sub> populations. The first pair of primers was located respectively within intron 7 of the ABO gene and downstream of the deletion (FP: 5&#x2032;-GAGTTCCCCTTGTGGCTCAGT-3&#x2032;, RP: 5&#x2032;- TTGCCTAAGTCTACCCCTGTGC-3&#x2032;). The second pair of primers was located in exon 8 (FP2: 5&#x2032;-CGCCAGTCCTTCACCTACGAAC-3&#x2032;, RP2: 5&#x2032;-CGGTTCCGAATCTCTGCGTG-3&#x2032;). PCR amplification was performed in a 25&#x2009;&#xB5;l reaction containing 50&#x2009;ng genomic DNA and 1.5&#x2009;U of LA Taq DNA polymerase (Takara) under thermocycle conditions of 94&#x2009;&#xB0;C for 4&#x2009;min; 35 cycles of 94&#x2009;&#xB0;C for 1&#x2009;min, 1&#x2009;min at specific annealing temperature for each set of primers and 72&#x2009;&#xB0;C for 2&#x2009;min; and 72&#x2009;&#xB0;C for 10&#x2009;min on a PE 9700 thermal cycler (Applied Biosystem).</p>
      </sec>
      <sec id="Sec22">
        <title>RNA-seq and eQTL analysis</title>
        <p id="Par38">A total of 300 caecum tissue samples from F<sub>7</sub> pigs that also had microbiota and genotype data were used to extract total RNA with TRIzol (Invitrogen) according to the manufacturer&#x2019;s manual. Total RNA was electrophoresed on 1% agarose gels. RNA purity and integrity were assessed using an eNanoPhotometer spectrophotometer (Implen) and a Bioanalyzer 2100 system (Agilent Technologies). A Qubit3.0 Fluorometer (Life Technologies) was used to measure RNA concentrations. Total RNA (2&#x2009;&#xB5;g) of each sample was used to constructed RNA-seq libraries, using the NEBNext UltraTMR NA Library Prep Kit for Illumina (NEB) according to the manufacturer&#x2019;s protocol. In brief, oligo(dT) magnetic beads (Invitrogen) were used to enrich mRNA, which was then fragmented using a fragmentation buffer (Ambion, USA). cDNA was synthesized using 6&#x2009;bp random primers and reverse transcriptase (Invitrogen). After purification, cDNA was end-repaired, and index codes and sequencing adaptors were ligated. After PCR amplification, purification and quantification, the libraries were sequenced on the Novaseq-6000 platform using 2&#x2009;&#xD7;&#x2009;150&#x2009;bp paired-end sequencing. Clean data were obtained by removing adapter reads, poly-N and low-quality reads from raw data. Cleaned reads from each sample were mapped to the complete <italic>ABO</italic> sequence from the Bamaxiang reference genome with the <italic>A</italic> allele at the <italic>ABO</italic> locus constructed by the authors using STAR (v.020201)<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. Samtools (v.1.6)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> was used to convert SAM format to BAM format. The read counts mapping to <italic>ABO</italic> (exon 1 to 7) were quantified for each sample using featureCounts (v.1.6.4)<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. The expression abundance of the <italic>ABO</italic> gene was normalized to FPKM. Gender and batch were treated as covariates to correct for gene expression levels, and the corrected residuals were used for subsequent analyses. GEMMA (v.0.97)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> was used to analyse the association of <italic>ABO</italic> expression level with genome-wide variants using a linear mixed model.</p>
      </sec>
      <sec id="Sec23">
        <title>Whole-genome sequencing and bioinformatic analysis for wild boars, <italic>S. verrucosus</italic> and <italic>S. cebifrons</italic></title>
        <p id="Par39">The genomes of six Russian wild boars, one Sumatran wild boar and one African warty hog were sequenced on the Illumina HiSeq X Ten platform at Novogene Biotech. Furthermore, six Chinese wild boars were sequenced in a previous study<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>, and we downloaded the genome sequencing data for eight other pigs from NCBI. Finally, we used a total of 22 genomes to call SNPs in the porcine <italic>ABO</italic> gene using GATK (v.4.2)<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. We replaced the <italic>ABO</italic> gene of the <italic>S. scrofa</italic> build 11.1 genome with the 50&#x2009;kb Bamaxiang contig sequence containing the <italic>A</italic> allele of <italic>ABO</italic> gene. The cleaned reads of the 22 individuals were aligned to the modified <italic>S. scrofa</italic> reference genome (build 11.1) using BWA (v.0.7.17)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>.</p>
      </sec>
      <sec id="Sec24">
        <title>Phylogenetic analysis of the <italic>O</italic> alleles in the <italic>Sus</italic> genus</title>
        <p id="Par40">We applied GATK (v4.2) to perform indel realignment, and proceeded to SNP and INDEL discovery and genotyping with UnifiedGenotyper across all 83 samples simultaneously using standard hard filtering parameters according to GATK best practices recommendations<sup><xref ref-type="bibr" rid="CR81">81</xref>,<xref ref-type="bibr" rid="CR82">82</xref></sup>. We restricted the analysis to the 14 <italic>AA</italic> and 34 <italic>OO</italic> animals, therefore circumventing the need to phase the corresponding genotypes. We defined windows of varying size (0.5 to 50&#x2009;kb) centred around the 2.3&#x2009;kb deletion. For all pairs of individuals, we computed a running sum over all of the variants in the window adding 0 when both animals had genotype <italic>AA</italic> (alternate) or <italic>RR</italic> (reference), 1&#xA0;when one animal was <italic>AA</italic> and the other <italic>RR</italic>, and 0.5 in all other cases. The nucleotide diversity for the corresponding animal pair was then computed as the running sum divided by the window size in bp. We ignored the variants located in the 2.3&#x2009;kb deletion in this computation. The ensuing matrix of pairwise nucleotide diversities was then used for hierarchical clustering and dendrogram construction using the hclust (method=&#x201C;average&#x201D;) R function corresponding to the unweighted pair group method with arithmetic mean (UPGMA).</p>
      </sec>
      <sec id="Sec25">
        <title>Analysis of population differentiation</title>
        <p id="Par41">We quantified the degree of population differentiation by computing the effect of breed on the variance of allelic dosage using a standard one-way ANOVA fixed-effect model and a <italic>F</italic>-statistic computed as the ratio of the between breed mean squares (BMS) and within breed mean squares (WMS)<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. BMS and WMS were computed as:<disp-formula id="Equg"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{BMS}}=(\mathop{\sum }\limits_{i=1}^{B}\mathop{\sum }\limits_{j=1}^{{n}_{i}}{(\overline{{y}_{i}}-\overline{{y}_{{\rm{T}}}})}^{2})/(B-1)$$\end{document}</tex-math><mml:math id="M40" display="block"><mml:mrow><mml:mi mathvariant="normal">BMS</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:munderover><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>B</mml:mi></mml:munderover><mml:mrow><mml:munderover><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mrow></mml:mover><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mi>B</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="41586_2022_4769_Article_Equg.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equh"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\rm{WMS}}=(\mathop{\sum }\limits_{i=1}^{B}\mathop{\sum }\limits_{j=1}^{{n}_{i}}{({y}_{ji}-\overline{{y}_{i}})}^{2})/({N}_{{\rm{T}}}-B)$$\end{document}</tex-math><mml:math id="M42" display="block"><mml:mrow><mml:mi mathvariant="normal">WMS</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:munderover><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>B</mml:mi></mml:munderover><mml:mrow><mml:munderover><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:msup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mi>B</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="41586_2022_4769_Article_Equh.gif" position="anchor"/></alternatives></disp-formula>where <italic>y</italic><sub><italic>ij</italic></sub> is the allelic dosage of the alternate allele in individual <italic>j</italic> (of <italic>n</italic><sub><italic>i</italic></sub>) of breed <italic>i</italic> (of <italic>B</italic>), <inline-formula id="IEq14"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\bar{{y}_{{\rm{i}}}}$$\end{document}</tex-math><mml:math id="M44"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#xAE;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq14.gif"/></alternatives></inline-formula> is the average allelic dosage in breed <italic>i</italic> (of B), and <inline-formula id="IEq15"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\bar{{y}_{{\rm{T}}}}$$\end{document}</tex-math><mml:math id="M46"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#xAE;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41586_2022_4769_Article_IEq15.gif"/></alternatives></inline-formula> is the average allelic dosage in the entire dataset. We computed the average of the corresponding <italic>F</italic>-statistic for all variants within a sliding window of fixed physical size (2&#x2009;kb in Fig. <xref rid="Fig5" ref-type="fig">5e</xref>), and took the inverse of this mean as measure of population similarity. The corresponding profiles were nearly identical to those obtained by computing average <italic>F</italic><sub>ST</sub> values (fixation index) across variants (and taking the inverse) following ref. <sup><xref ref-type="bibr" rid="CR84">84</xref></sup>.</p>
      </sec>
      <sec id="Sec26">
        <title>Profiling <italic>ABO</italic> gene expression level at various adult and embryo tissues</title>
        <p id="Par42">Total RNA was extracted using Trizol from 15 tissues (lung, hypophysis, skin, spinal cord, liver, spleen, muscle, hypothalamus, heart, blood, brain, caecum, stomach, duodenum and kidney) collected from an adult Bamaxiang sow and a Duroc pig embryo (day 75). RNA quality was monitored by agarose (1%) gel electrophoresis, and using the RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies). RNA concentration was measured using Qubit RNA Assay Kit in Qubit 2.0 Flurometer (Life Technologies). Total RNA (1&#x2009;&#xB5;g) of each sample was used to constructed RNA-seq libraries. Sequencing libraries were generated using the TruSeq RNA Library Preparation Kit (Illumina) according to the manufacturer&#x2019;s recommendations, and index codes were added to attribute sequences to each sample. In brief, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. First-strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (RNase H<sup>&#x2212;</sup>). Second-strand cDNA synthesis was subsequently performed using DNA polymerase I and RNase H. The remaining overhangs were converted into blunt ends by exonuclease/polymerase activities. After adenylation of the 3&#x2032; ends of the DNA fragments, Illumina adaptors were ligated. To select cDNA fragments of preferentially around 350&#x2013;400&#x2009;bp in length, the library fragments were purified with AMPure XP system (Beckman Coulter). PCR was performed using Phusion High-Fidelity DNA polymerase, Universal PCR primers and Index (X) Primer. PCR products were purified (AMPure XP system) and the library quality was assessed on the Agilent Bioanalyzer 2100 system. Clustering of the index-coded samples was performed on the cBot Cluster Generation System using the TruSeq PE Cluster Kit v3-cBot-HS (Illumia) according to the manufacturer&#x2019;s instructions. Sequencing was performed on the Illumina NovaSeq platform and 150&#x2009;bp paired-end reads were generated. Filtered reads were obtained by removing adapter sequences, poly-N and low-quality reads. Cleaned reads were mapped to the complete <italic>ABO</italic> sequence from the Bamaxiang reference genome sequence using HISAT2 (v.2.2.1)<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. Samtools (v.1.6)<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> was used to convert SAM format to BAM format. The read counts mapping to ABO (exon 1 to 7) were quantified for each sample using featureCounts (v.1.6.4)<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. To adjust for the effect of sequencing depth, the expression abundance of <italic>ABO</italic> gene was normalized to Transcripts Per Million (TPM). Expression abundance of <italic>ABO</italic> was used to cluster and visualize the expression level of the 15 tissues from an adult Bamaxiang sow and a Duroc pig embryo using the functions dist(), hclust(), as.dendrogram() and set() implemented in R package stats and dendextend.</p>
      </sec>
      <sec id="Sec27">
        <title>Testing the effect of the <italic>AO</italic> genotype on other phenotypes</title>
        <p id="Par43">The associations between the 2.3&#x2009;kb <italic>ABO</italic> deletion and 150 traits were calculated in the F<sub>6</sub> and F<sub>7</sub> populations based on a meta-analysis combining the effects. The observed <italic>P</italic> value for a trait was calculated by testing a weighted mean of <italic>Z</italic> scores from F<sub>6</sub> and F<sub>7</sub> generations as follows: <italic>Z</italic>&#x2009;=&#x2009;(<italic>Z</italic><sub>1</sub><italic>W</italic><sub>1</sub>&#x2009;+&#x2009;<italic>Z</italic><sub>2</sub><italic>W</italic><sub>2</sub>)/(<italic>W</italic><sub>1</sub>&#x2009;+&#x2009;<italic>W</italic><sub>2</sub>), where <italic>Z</italic><sub>1</sub>&#x2009;=&#x2009;<italic>b</italic><sub>1</sub>/SE<sub>1</sub> and <italic>Z</italic><sub>2</sub>&#x2009;=&#x2009;<italic>b</italic><sub>2</sub>/SE<sub>2</sub>, <italic>W</italic><sub>1</sub>&#x2009;=&#x2009;1/(SE<sub>1</sub>)<sup>2</sup> and <italic>W</italic><sub>2</sub>&#x2009;=&#x2009;1/(SE<sub>2</sub>)<sup>2</sup>, where the subscripts 1 and 2 denote F<sub>6</sub> and F<sub>7</sub> generations, respectively; <italic>b</italic><sub>1</sub>, <italic>b</italic><sub>2</sub>, SE<sub>1</sub> and SE<sub>2</sub> were additive effects and standard errors of <italic>ABO</italic> locus on a given trait estimated from a linear mixed model, which accounted for population structure using a genomic relationship matrix derived from whole genome marker genotypes. A total of 250 and 254 traits were tested in the F<sub>6</sub> and F<sub>7</sub> generations, and 150 traits that were shared in the F<sub>6</sub> and F<sub>7</sub> generations were used for meta-analysis.</p>
      </sec>
      <sec id="Sec28">
        <title>Determination of the concentration of <italic>N</italic>-acetyl-galactosamine in caecal lumen</title>
        <p id="Par44">Targeted LC&#x2013;MS/MS analysis was performed to determine the concentration of the mixture of GalNAc, GlcNAc and ManNAc isomers (referred to as HexNAc) in caecal lumen samples. Samples of caecal content were collected at D240 for 124 F<sub>7</sub> and 154 animals from a Duroc &#xD7; Landrace &#xD7; Large White commercial population. The samples were lyophilized, grounded into powder by a Mixer Mill MM 400 (30&#x2009;Hz, 1&#x2009;min) (Retsch) and stored at &#x2212;80&#x2009;&#xB0;C until use. Approximately 15&#x2009;mg of powder was weighed and extracted with 500&#x2009;&#xB5;l of 70% methanol/water. The mixture was vortexed for 10&#x2009;min, and centrifuged at around 16,000<italic>g</italic> and 4&#x2009;&#xB0;C for 10&#x2009;min. Supernatant (300&#x2009;&#x3BC;l) was transferred into a new centrifuge tube, placed at &#x2212;20&#x2009;&#xB0;C for 30&#x2009;min, and centrifuged again at 16,128<italic>g</italic> at 4&#x2009;&#xB0;C for 3&#x2009;min. Finally, 150&#x2009;&#x3BC;l of the supernatant was collected for further LC&#x2013;MS analysis. Separation was performed in a 50&#x2009;mm&#x2009;&#xD7;&#x2009;2.1&#x2009;mm&#x2009;&#xD7;&#x2009;1.8&#x2009;&#xB5;m ACQUITY UPLC BEH C18 Column (Waters) in an ExionLC AD System (AB Sciex). Linear ion trap and triple quadrupole scans were performed on the Applied Biosystems 6500 Triple Quadrupole (QTRAP 6500) system equipped with an ESI Turbo Ion-Spray interface. The operation was performed under positive ion mode and controlled by Analyst software (v.1.6.3) (Sciex). The ESI source parameters were set as follows: ion source: ESI+, source temperature: 550&#x2009;&#xB0;C, ion spray voltage (IS): 5,500&#x2009;V (Positive), curtain gas (CUR): 35&#x2009;psi. The GalNAc was analysed using multiple reaction monitoring. We established a standard curve using increasing and known amounts of GalNAc standard and used it to determine GalNAc concentrations per gram of dried caecal content.</p>
      </sec>
      <sec id="Sec29">
        <title>Measuring the correlation between GalNAc concentrations and bacterial abundance within the <italic>AO</italic> genotype</title>
        <p id="Par45">Raw AUC (GalNAc) or bacterial abundances were showing considerable batch-to-batch variation both with regards to means and variances. We therefore transformed them to ranks within batch and projected these uniformly between 0 and 1, yielding equalized means of 0.5 and standard deviations&#x2009;&#x2248;&#x2009;0.3 (scaled batch-corrected ranks). We then applied the same approach within <italic>AO</italic> genotype to the scaled batch-corrected ranks yielding scaled, batch- and genotype-corrected ranks. We computed Spearman&#x2019;s correlations between the GalNAc and abundance scaled ranks.</p>
      </sec>
      <sec id="Sec30">
        <title>Isolating 4-8-110 and 4-15-1</title>
        <p id="Par46">Faecal samples were collected from the rectum of healthy pigs at about 120 days and transferred immediately to anaerobic conditions. Fresh samples were homogenized with sterile 1&#xD7; PBS (pH&#x2009;7.0) in an anaerobic glovebox (Electrotek), which contained 10% hydrogen, 10% carbon dioxide and 80% nitrogen. The faecal suspension was diluted 10<sup>&#x2212;6</sup>, 10<sup>&#x2212;7</sup>, 10<sup>&#x2212;8</sup> and 10<sup>&#x2212;9</sup>-fold, and plated on GAM medium (Nissui Pharmaceutical). Plates were incubated at 37&#x2009;&#xB0;C for 3 days in an anaerobic glovebox. Single clones were picked and streaked until pure colonies were obtained on GAM medium. Full-length 16S rRNA gene sequencing was performed after amplification using the following primers: 27 forward: 5&#x2032;-AGAGTTTGATCCTGGCCTCAG-3&#x2032;; and 1492 reverse, 5&#x2032;-GGTTACCTTGTTACGACTT-3&#x2032;). The isolates were stored at &#x2212;80&#x2009;&#xB0;C in GAM broth containing 16% of glycerol until further use.</p>
      </sec>
      <sec id="Sec31">
        <title>Oxford Nanopore sequencing</title>
        <p id="Par47">The strains 4-8-110 and 4-15-1 were recovered on GAM medium. Cells were collected at the period of logarithmic growth. Genomic DNA was extracted using the Blood &amp; Cell Culture DNA Midi Kit (Qiagen) according to the manufacturer&#x2019;s protocol. Libraries for whole-genome sequencing of the strains were constructed and sequenced on an ONT PromethION (Oxford Nanopore Technology) at NextOmics. To correct sequencing errors, a library for second-generation sequencing was also constructed for each of the two strains and sequenced (2&#x2009;&#xD7;&#x2009;100&#x2009;bp) on the BGISEQ platform (BGI). Bioinformatic analyses of sequencing data were performed following refs. <sup><xref ref-type="bibr" rid="CR72">72</xref>,<xref ref-type="bibr" rid="CR86">86</xref></sup>. In brief, after quality control, the sequencing data were assembled using flye (v.2.6)<sup><xref ref-type="bibr" rid="CR72">72</xref></sup> with the parameter: --nano-raw, and the assembled genomes were corrected by combining the Oxford Nanopore data with the second-generation sequencing data using pilon with the default parameters. The encoded genes were predicted using prodigal (v.2.6.3) (parameter: -p none-g 11)<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>.</p>
      </sec>
      <sec id="Sec32">
        <title>MAG assembly</title>
        <p id="Par48">A total of 92 faecal samples from eight pig populations, four intestinal locations and different ages were used for metagenomic sequencing and construction of MAGs. Microbial DNA was extracted as described above. The libraries for metagenomic sequencing were constructed according to the manufacturer&#x2019;s instructions (Illumina), with an insert size of 350&#x2009;bp for each sample, and 2&#x2009;&#xD7;&#x2009;150&#x2009;bp paired-ends sequenced on the NovaSeq 6000 platform. Raw sequencing data were filtered to remove adapter sequences and low-quality reads using fastp (v.0.19.41)<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>. Host genomic DNA sequences were filtered out using BWA (v.0.7.17)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. The clean reads of each sample were assembled into contigs using MEGAHIT (v.1.1.3) with the option &#x2018;--min-count 2 --k-min 27 --k-max 87 --k-step 10 --min-contig-len 500&#x2019;<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>. Single-sample metagenomic binning was performed using two different binning algorithms &#x2018;--metabat2 --maxbin2&#x2019; using the metaWRAP package (v.1.1.1)<sup><xref ref-type="bibr" rid="CR90">90</xref></sup>. The bins (MAGs) generated by the two binning algorithms were evaluated for quality and combined to form a MAG set using the bin_refinement module in metaWRAP (v.1.1.1). Metagenomic sequences were further assembled to optimize MAGs using the reassemble_bins module of metaSPAdes (v.3.15.3) in the metaWRAP pipeline. CheckM (v.1.0.12) was used to estimate the completeness and contamination of each MAG<sup><xref ref-type="bibr" rid="CR91">91</xref></sup>. The MAGs with completeness &lt;50% and contamination &gt;5% were filtered out. Non-redundant MAGs were generated by dRep (v.2.3.2) at threshold of 99% average nucleotide identity (ANI)<sup><xref ref-type="bibr" rid="CR92">92</xref></sup>.</p>
      </sec>
      <sec id="Sec33">
        <title>Bioinformatic analyses</title>
        <p id="Par49">Gene prediction in MAGs was carried out using the annotate_bins module in metaWRAP (v.1.1.1). The FASTA file of amino acid sequences translated from coding genes was used to perform KEGG annotation using Ghost KOALA tool (v.2.2)<sup><xref ref-type="bibr" rid="CR93">93</xref></sup> on the KEGG website (<ext-link ext-link-type="uri" xlink:href="https://www.kegg.jp/ghostkoala/">https://www.kegg.jp/ghostkoala/</ext-link>). Taxonomic classification of MAGs was performed using PhyloPhlAn (v.0.99)<sup><xref ref-type="bibr" rid="CR94">94</xref></sup>. The graphs in Fig. <xref rid="Fig5" ref-type="fig">5b, c</xref> were generated using custom Perl (v.5.10.1) and R scripts (v.3.5.3). Pathway and regulon scores were computed using a custom Perl script. Both scores included (1) one point for import (having orthologues of either the four components of AgaPTS (<italic>agaE</italic>, <italic>agaF</italic>, <italic>agaV</italic> and <italic>agaW</italic>) and/or the three components of the TonB dependent transporter (<italic>omp</italic>, <italic>agaP</italic> and <italic>agaK</italic>) and/or the four components of the GnbPTS transporter (<italic>gnbA</italic>, <italic>gnbB</italic>, <italic>gnbC</italic> and <italic>gnbD</italic>), (2) one point for GalNAc deacetylase activity (having an orthologue of <italic>agaA</italic> and/or <italic>nagA</italic>), (3) one point for GalN deaminase/isomerase (having on orthologue of <italic>agaS</italic>), (4) one point for tagatose-6-P kinase (having an orthologue of <italic>pfkA</italic> and/or <italic>lacC</italic> and/or <italic>fruK</italic>), and (5) one point for tagatose-1,6-PP aldolase (having an orthologue of <italic>gatY</italic> and/or <italic>gatZ</italic> and/or <italic>lacD</italic> and/or <italic>fba</italic>). For the pathway score, the orthologues could be located anywhere in the MAG; for the regulon score, they had to be located on the same sequence contig and in close proximity (2.5% of genome size) to the anchor gene <italic>agaS</italic><sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. For the top hits, we manually checked whether proximity was confirmed either by the replication of the order in more than one MAG and/or by the colocalization of the genes on one and the same sequence contig. The effect of the MAG type (OTU476-like, Erysipelotrichaceae and others), completion, contig and genome size on pathway and regulon scores was estimated using the R lm function, and was highly significant. The <italic>P</italic> values for the Erysipelotrichaceae versus other contrast were directly obtained from the lm function. To conservatively estimate the <italic>P</italic> value of OTU476-like versus Erysipelotrichaceae&#x2009;+&#x2009;others we generated score residuals corrected for completion, contig number and genome size, and determined how many MAGs had scores as high or higher than the OTU476-like strains. The <italic>P</italic> values reported in Extended Data Fig. <xref rid="Fig16" ref-type="fig">10</xref> correspond to the square of these proportions as there are two OTU476-like strains with same GalNAc cluster organization.</p>
      </sec>
      <sec id="Sec34">
        <title>Determining the metabolic flux ratios from <sup>13</sup>C experiments by GC&#x2013;MS</title>
        <p id="Par50"><sup>13</sup>C-labelled GalNAc (<italic>N</italic>-acetyl-<sc>d</sc>-[UL-<sup>13</sup>C<sub>6</sub>]galactosamine) (99% isotopic purity of <sup>13</sup>C) was bought from ZZBIO (Shanghai). The 4-8-110 strain was cultured in 6&#x2009;ml of GAM medium (Nissui Pharmaceuticals) adding 1&#x2009;g&#x2009;l<sup>&#x2212;1</sup> of <sup>13</sup>C-labelled GalNAc or regular GalNAc (as control) in an anaerobic glovebox (Electrotek) in triplicate as described above. After 13&#x2009;h of culture, the cultures were centrifuged for 5&#x2009;min at 1,500<italic>g</italic>. Bacterial cells were resuspended in 0.6&#x2009;ml of cold (&#x2212;40&#x2009;&#xB0;C) 50% aqueous methanol containing 100&#x2009;&#xB5;M of norvaline as internal standard, plunged in dry ice for 30&#x2009;min and then thawed on ice. We added 0.4&#x2009;ml of chloroform, vortexed for 30&#x2009;s, centrifuged for 10&#x2009;min at 17,530<italic>g</italic> (4&#x2009;&#xB0;C), transferred the supernatant to new 1.5&#x2009;ml tubes and dried the sample at &#x2212;105&#x2009;&#xB0;C in a FreeZone Freeze Dryers (Labconco). Metabolites were derivatized for GC&#x2013;MS analysis as follows. First, 70&#x2009;&#x3BC;l of pyridine was added to the dried pellet and incubated for 20&#x2009;min at 80&#x2009;&#xB0;C. After cooling, 30&#x2009;&#xB5;l of <italic>N-tert</italic>-butyldimethylsilyl-<italic>N</italic>-methyltrifluoroacetamide (Sigma-Aldrich) was added and the samples were reincubated for 60&#x2009;min at 80&#x2009;&#xB0;C before centrifugation for 10&#x2009;min at 17,530<italic>g</italic> (4&#x2009;&#xB0;C). The supernatant was transferred to an autosampler vial for GC/MS analysis. A Shimadzu QP-2010 Ultra GC-MS system was programmed for an injection temperature of 250&#x2009;&#xB0;C and injected with 1&#x2009;&#xB5;l of sample. The GC oven temperature started at 110&#x2009;&#xB0;C for 4&#x2009;min, rising to 230&#x2009;&#xB0;C at 3&#x2009;&#xB0;C&#x2009;min<sup>&#x2212;1</sup> and then to 280&#x2009;&#xB0;C at 20&#x2009;&#xB0;C&#x2009;min<sup>&#x2212;1</sup> with a final hold at this temperature for 2&#x2009;min. The GC flow rate with helium carrier gas was 50&#x2009;cm&#x2009;s<sup>&#x2212;1</sup>. The GC column used was a 20&#x2009;m&#x2009;&#xD7;&#x2009;0.25&#x2009;mm&#x2009;&#xD7;&#x2009;0.25&#x2009;mm Rxi-5&#x2009;ms. The GC&#x2013;MS interface temperature was 300&#x2009;&#xB0;C and the ion source temperature was set at 200&#x2009;&#xB0;C, with 70&#x2009;V ionization voltage. The mass spectrometer was set to scan <italic>m</italic>/<italic>z</italic> range 50&#x2013;800, with a 1&#x2009;kV detector. GC&#x2013;MS data were analysed to determine isotope labelling. To determine <sup>13</sup>C labelling, the mass distribution for known fragments of metabolites was extracted from the mass spectra. For each fragment, the retrieved data comprised mass intensities for the lightest isotopomer (without any heavy isotopes, M0), and isotopomers with increasing unit mass relative to M0. The mass distributions were normalized by dividing by the sum over all isoptomers and corrected for the natural abundance of heavy isotopes of the elements H, O and C using 7&#x2009;&#xD7;&#x2009;7 matrix-based probabilistic methods as described previously<sup><xref ref-type="bibr" rid="CR95">95</xref>&#x2013;<xref ref-type="bibr" rid="CR97">97</xref></sup> and implemented in MATLAB (release R2021a). Labelling results are expressed as the average fraction of the particular compound that contains isotopic label from the particular precursor.</p>
      </sec>
      <sec id="Sec35">
        <title>Gavage experiment</title>
        <p id="Par51">4-8-110 and an <italic>E. coli</italic> strain isolated from caecal content (with 4-15-1 and 4-8-110) were cultured in GAM medium (Nissui Pharmaceuticals) for 13&#x2009;h and 4&#x2009;h, respectively, in an anaerobic glovebox (Electrotek) as described above. Optical density values were adjusted to 0.2 by addition of GAM medium, glycerol added to 1/6 of the final volume, and aliquots were stored at &#x2212;80&#x2009;&#xB0;C. Germ-free mice (Kunming line) were provided by Huazhong Agricultural University. All of the experimental procedures involving mice were approved by the Ethics Committee in Huazhong Agricultural University (HZAUMO-2021-0077). Two groups (A and B) of five female mice each were housed in two separate cages (temperature, 25&#x2009;&#xB1;&#x2009;2&#x2009;&#xB0;C; humidity, 45&#x2013;60%; light cycle, 12&#x2009;h&#x2013;12&#x2009;h light&#x2013;dark; light hours, 06:30&#x2013;18:30). Mice were gavaged with 100&#x2009;&#x3BC;l of PBS (group A) or 100&#x2009;&#x3BC;l of PBS + 80&#x2009;g&#x2009;l<sup>&#x2212;1</sup> GalNAc (corresponding to 8&#x2009;mg per 100&#x2009;&#x3BC;l or ~200&#x2009;mg&#x2009;kg<sup>&#x2212;1</sup> of live weight) (group B) directly in the mouth with a sterile syringe twice per day (09:00 and 16:00) for 10 consecutive days (days 2 to 11). All of the mice were further gavaged with 150&#x2009;&#x3BC;l of the 4-8-110 glycerol stocks (see above) once per day (at 16:00) for five consecutive days (days 3 to 7), and with 150&#x2009;&#x3BC;l of the <italic>E. coli</italic> glycerol stocks (see above) once per day (at 16:00) for three consecutive days (days 5 to 7). The mice were euthanized 5 days after the last bacterial inoculation (on day 12, based on ref. <sup><xref ref-type="bibr" rid="CR98">98</xref></sup>), and caecal content and faeces were collected for each mouse. Bacterial DNA was extracted using the QIAamp fast DNA stool mini kit (Qiagen). The V3&#x2013;V4 region of the 16S rRNA gene was amplified and sequenced using the methods described above. Reads were mapped to the V3&#x2013;V4 sequence of the previously determined 4-8-110 and <italic>E. coli</italic> strains. An average of 99.74% of the reads mapped either to the 4-8-110 or <italic>E. coli</italic> reference sequences.</p>
      </sec>
      <sec id="Sec36">
        <title>Testing the inducibility of the GalNAc operon and transcriptome response upon GalNAc addition in <italic>E. coli</italic> and the OTU476-like strains</title>
        <sec id="Sec37">
          <title>Bacterial growth</title>
          <p id="Par52">Bacteria were grown in an anaerobic glovebox (Electrotek) containing 10% hydrogen, 10% carbon dioxide and 80% nitrogen at 37&#x2009;&#xB0;C. Samples (4&#x2009;ml) were pipetted after gentle shaking to measure optical density at 600&#x2009;nm (OD<sub>600</sub>) using an ultraviolet spectrophotometer (Yoke Instrument). Experiments were conducted in triplicate.</p>
        </sec>
        <sec id="Sec38">
          <title>RNA extraction</title>
          <p id="Par53">The cultured bacterial cells of the two OTU476 like strains (4-8-110 and 4-15-1) and <italic>E. coli</italic> were collected at the end of the exponential growth phase (11&#x2009;h and 4&#x2009;h, respectively). Total RNA was extracted from bacterial cells using TRIzol Reagent according to the manufacturer&#x2019;s manuals (Thermo Fisher Scientific), and genomic DNA was removed using DNase I (TaKara). The quantity and quality of total RNA were evaluated using a 2100 Bioanalyser (Agilent) and NanoDrop-2000 (Thermo Fisher Scientific). The RNA samples with OD<sub>260/280</sub>&#x2009;=&#x2009;1.8&#x2013;2.0, OD<sub>260/230</sub>&#x2009;&#x2265;&#x2009;2.0, RIN&#x2009;&#x2265;&#x2009;6.5, 28S:18S&#x2009;&#x2265;&#x2009;1.0, &#x2265;100&#x2009;ng&#x2009;&#x3BC;l<sup>&#x2212;1</sup> and &#x2265;2&#x2009;&#x3BC;g were used to construct libraries for RNA-seq.</p>
        </sec>
        <sec id="Sec39">
          <title>Construction of libraries and sequencing</title>
          <p id="Par54">The libraries for RNA-seq were constructed according to the TruSeq RNA sample preparation Kit (Illumina) using 2&#x2009;&#x3BC;g of total RNA. In brief, rRNA was removed from total RNA using the Ribo-Zero Magnetic kit (Epicenter). All mRNAs were broken into short fragments (200&#x2009;nucleotides) by adding fragmentation buffer. Double-stranded cDNA was synthesized using the SuperScript double-stranded cDNA synthesis kit (Invitrogen) with random hexamer primers (Illumina). cDNA was processed for end-repair, phosphorylation and A base addition according to library construction protocol (Illumina). The constructed libraries were sequenced on the NovaSeq 6000 platform with a 2&#x2009;&#xD7;&#x2009;150&#x2009;bp paired-end strategy. Base calling and quality value calculations were performed using the Illumina GA Pipeline (v.1.6) (Illumina).</p>
        </sec>
        <sec id="Sec40">
          <title>Bioinformatics analysis</title>
          <p id="Par55">To obtain clean reads, low-quality sequences, reads with more than 5% of N bases (unknown bases) and reads containing adaptor sequences were removed from the raw data with a Perl script. The cleaned sequences were mapped to the reference genomic sequences of two OTU476 like strains (generated by ourselves as described above) and <italic>E. coli</italic> (GenBank: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000913.3">NC_000913.3</ext-link>) using Bowtie2 (v.2.4.2)<sup><xref ref-type="bibr" rid="CR99">99</xref></sup>. The read counts mapping to the reference genomes were quantified for each sample using featureCounts (v.1.6.4). The fragments per kilobase of exon model per million mapped reads method was used to calculate the gene expression level. We used the DESeq2 package<sup><xref ref-type="bibr" rid="CR100">100</xref></sup> in R (v.g3.5.3) to test for differential expression.</p>
        </sec>
      </sec>
      <sec id="Sec41">
        <title>Analysing the effect of the <italic>ABO</italic> genotype on the abundance of Erysipelotrichaceae in humans</title>
        <sec id="Sec42">
          <title>Samples</title>
          <p id="Par56">The data used correspond to the previously described CEDAR cohort<sup><xref ref-type="bibr" rid="CR101">101</xref></sup>, which included 300 healthy individuals of European descent who were visiting the University Hospital (CHU) from the University of Li&#xE8;ge as part of a national screening campaign for colon cancer. Blood samples and intestinal biopsies (ileum, colon and rectum) were collected with full consent. The experimental protocol was approved by the ethics committee of the University of Li&#xE8;ge Academic Hospital. Informed consent was obtained before donation in agreement with the recommendations of the declaration of Helsinki for experiments involving human participants.</p>
        </sec>
        <sec id="Sec43">
          <title>Sequencing</title>
          <p id="Par57">For microbiota analysis, DNA was extracted from biopsies using the QIAamp DNA Stool Mini Kit (QIAgen). Three 16S rRNA amplicons corresponding to the V1&#x2013;V2, V3&#x2013;V4 and V5&#x2013;V6 variable regions were generated in separate PCR reactions and processed for paired-end (2&#x2009;&#xD7;&#x2009;300&#x2009;bp) NGS sequencing on the MiSeq instrument (Illumina) following the standard protocol at the GIGA genomics core facility.</p>
        </sec>
        <sec id="Sec44">
          <title>Data processing</title>
          <p id="Par58">Reads were QV20 trimmed from the 3&#x2032; end, demultiplexed, primer sequences were removed using the bbduk tool&#xA0;(version 38.82)<sup><xref ref-type="bibr" rid="CR102">102</xref></sup>. Reads mapping to the human genome were eliminated using the BBTools suite (v.38.82). The corresponding pipeline was constructed using Snakemake (v.7.0.1)<sup><xref ref-type="bibr" rid="CR103">103</xref></sup>. Further analyses were performed using QIIME 2 (v.2018.11)<sup><xref ref-type="bibr" rid="CR104">104</xref></sup>. The paired-end reads were denoised and joined using the DADA2 plugin (v.1.16)<sup><xref ref-type="bibr" rid="CR105">105</xref></sup> using batch-specific trimming length parameters yielding 9.1&#xB1;&#x2009;2.0&#x2009;kb amplicon sequence variants (ASVs) per run for V1&#x2013;V2, 4.5&#x2009;&#xB1;&#x2009;1.6&#x2009;kb for V3&#x2013;V4 and 6.8&#x2009;&#xB1;&#x2009;0.67&#x2009;kb for V5&#x2013;V6 amplicons. ASVs mapping to known contaminant taxa as well as ASVs with abundance negatively correlated with coverage depth were removed. Samples that contained more than 20% contaminant ASVs were eliminated from further analyses. ASVs were then clustered to 97% identity level OTUs using the DNACLUST program (v.r3)<sup><xref ref-type="bibr" rid="CR106">106</xref></sup>. After OTU assignment, read counts were rarefied to 10,000 (V1&#x2013;V2 and V5&#x2013;V6) and 5,000 (V3&#x2013;V4). As intestinal location only explored a minor proportion of the variance in OTU abundance (L.S. et al., manuscript in preparation), OTU abundances were averaged across locations. Local alignment identity of the detected ASVs with the OTU476 and OTU327 from the pig microbiome were measured using blastn<sup><xref ref-type="bibr" rid="CR107">107</xref></sup>.</p>
        </sec>
        <sec id="Sec45">
          <title>Association analysis with ABO blood group</title>
          <p id="Par59">The effect of ABO blood group on standardized abundances of individual OTUs was performed using a linear model (lm R function) including (1) ABO blood group (A, B, AB or O), (2) secretor status, (3) sex, (4) smoking status, (5) age and (6) body mass index. Analyses were conducted separately for the different amplicons.</p>
        </sec>
      </sec>
      <sec id="Sec46">
        <title>Reporting summary</title>
        <p id="Par60">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this paper.</p>
      </sec>
    </sec>
    <sec id="Sec47" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par61">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-04769-z.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_4769_MOESM1_ESM.pdf"><label>Supplementary Information</label><caption><p>Supplementary Discussion 1&#x2013;3.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_4769_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_4769_MOESM3_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_4769_MOESM4_ESM.xlsx"><caption><p>Supplementary Tables 1&#x2013;7.</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec48">
          <title>Extended data figures and tables</title>
          <p id="Par64">
<fig id="Fig7"><label>Extended Data Fig. 1</label><caption><title>Generating a large mosaic pig population for genetic analysis of complex phenotypes.</title><p>(a) Rotational breeding design used for the generation of a large mosaic pig population for the genetic analysis of complex phenotypes, with sampling scheme for faeces (D25, D120, D240), luminal content of the ileum (IC) and caecum (CC), and mucosal scrapings in the ileum (IM) and caecum (CM). BX: Bamaxiang, EH: Erhualian, LA: Laiwu, TB: Tibetan, LW: Large White, LD: Landrace, PT: Pi&#xE9;train, WD: White Duroc. (b) Average similarity (1 &#x2013; <bold><italic>&#x3C0;</italic></bold><italic>)</italic> between allelic sequences sampled within and between the eight founder breeds. The colour intensity ranges from black (breeds with lowest allelic similarity: BX vs WD, 1 - 4.3x10<sup>&#x2212;3</sup>) to bright red (breed with highest allelic similarity: WD, 1 - 1.8x10<sup>&#x2212;3</sup>). The acronyms for the breeds are as in (a). More than 30 million variants with MAF &#x2265; 3% segregate in this population, i.e. more than one variant every 100 base pairs. This is slightly lower than the 40 million high quality variants segregating in the mouse collaborative cross<sup><xref ref-type="bibr" rid="CR108">108</xref></sup>. (c) Comparison of the average nucleotide diversity (<bold><italic>&#x3C0;</italic></bold>, i.e. the proportion of sites that differ between two chromosomes sampled at random in the population(s)) within and between European (Eur) and Asian (As) domestic pigs, and between modern European (HS<sub>Eur</sub>), Asian humans (HS<sub>As</sub>), Neanderthal (Neand) and Chimpanzee (Pan Trogl). The average nucleotide diversity within the four Chinese founder breeds was ~2.5x10<sup>&#x2212;3</sup> and within the four European founder breeds ~2.0x10<sup>&#x2212;3</sup>. By comparison, <italic>&#x3C0;</italic>-values within African and within Asian/European human populations are ~9x10<sup>&#x2212;4</sup> and ~8x10<sup>&#x2212;4</sup>, respectively<sup><xref ref-type="bibr" rid="CR109">109</xref>,<xref ref-type="bibr" rid="CR110">110</xref></sup>. Thus, against intuition (as domestication is often assumed to have severely reduced effective population size) the within population diversity is &gt;2-fold higher in domestic pigs than in human populations, as previously reported<sup><xref ref-type="bibr" rid="CR111">111</xref>&#x2013;<xref ref-type="bibr" rid="CR113">113</xref></sup>. Nucleotide diversities between Chinese founder breeds and between European founder breeds were ~3.6x10<sup>&#x2212;3</sup> and ~2.5x10<sup>&#x2212;3</sup>, respectively, i.e. 1.44-fold and 1.25-fold higher than the respective within-breed <italic>&#x3C0;</italic>-values. These <italic>&#x3C0;</italic>-values are of the same order of magnitude as the sequence divergence between <italic>Homo sapiens</italic> and Neanderthals/Denosivans (~3x10<sup>&#x2212;3</sup>, ref. <sup><xref ref-type="bibr" rid="CR15">15</xref></sup>). By comparison, <italic>&#x3C0;</italic>-values between Africans, Asians and Europeans are typically &#x2264; ~1x10<sup>&#x2212;3</sup> (ref. <sup><xref ref-type="bibr" rid="CR109">109</xref></sup>). The nucleotide diversity between Chinese and European breeds averaged ~4.3x10<sup>&#x2212;3</sup>. This <italic>&#x3C0;</italic>-value is similar to the divergence between <italic>M. domesticus</italic> and <italic>M. castaneus</italic><sup><xref ref-type="bibr" rid="CR114">114</xref></sup>, and close to halve the ~1% difference between chimpanzee and human<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Note that Chinese and European pig breeds are derived from Chinese and European wild boars, respectively, which are thought to have diverged ~1 million years ago<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, while <italic>M. domesticus</italic> and <italic>M. castaneus</italic> are thought to have diverged &#x2264; 500,000 years ago<sup><xref ref-type="bibr" rid="CR114">114</xref></sup>. (d) Autosome-specific estimates of the genomic contributions of the eight founder breeds in the F6 and F7 generation. We used a linear model incorporating all variants to estimate the average contribution of the eight founder breeds in the F6 and F7 generation at genome and chromosome level<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. At genome-wide level, the proportion of the eight founder breed genomes ranged from 11.2% (respectively 11.5%) to 14.1% (14.7%) in the F6 (F7) generations. At chromosome-specific level, the proportion of the eight founder breeds ranged from 6.7% (respectively 4.9%) to 20.7% (22.1%) in the F6 (F7) generations. The genomic contribution of the eight founder breeds in the F6 and F7 generation is remarkably uniform and close to expectations (i.e. 12.5%) both at genome-wide and chromosome-wide level, suggesting comparable levels of genetic diversity across the entire genome. This does not preclude that more granular examination may reveal local departures from expectations, or under-representation of incompatible allelic combinations at non-syntenic loci. (e-f) Indicators of achievable mapping resolution in the F6 generation: (e) Frequency distribution (density) of the number of variants in high LD (<italic>r</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.9) with an &#x201C;index&#x201D; variant (was computed separately for all variants considered sequentially as the &#x201C;index&#x201D;), corresponding to the expected size of &#x201C;credible sets&#x201D; in GWAS<sup><xref ref-type="bibr" rid="CR115">115</xref></sup>. The red vertical line corresponds to the genome-wide median. The green vertical line corresponds to the mapping resolution achieved in this study for the ABO locus (see hereafter). (f) Frequency distribution (density) of the maximum distance between an index variant and a variant in high LD (<italic>r</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.9) with it, defining the spread of credible sets. Red and green vertical lines are as in (D).</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig7_ESM" id="d32e4857"/></fig>
</p>
          <p id="Par65">
<fig id="Fig8"><label>Extended Data Fig. 2</label><caption><title>Characterizing the age- and location-specific composition of the intestinal microbiome of the healthy pig.</title><p>(a) Definition of a core intestinal microbiome of the pig. A total of 58 OTUs that were annotated to 21 taxa were identified in &gt;95% of day 120 and 240 faeces and caecum content samples of both F6 and F7 generations, hence defined as core bacterial taxa. (b) The compositions of the porcine and human intestinal microbiota are closer to each other than either is to that of the mouse. Boxplots are as is Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. The number of samples available for analysis were 1281 pigs, 106 humans and 6 mice. (c) Abundances (F6-F7 averages when available) of the 43 families represented in Fig. <xref rid="Fig1" ref-type="fig">1b</xref> in the seven sample types relative to the sample type in which they are the most abundant (red &#x2013; blue scale). The families are ordered according to the sample type in which they are the most abundant. The colour-code for phyla is as in Fig. <xref rid="Fig1" ref-type="fig">1b</xref>. Columns are added for comparison with mouse and human. Mouse data are from Fig. <xref rid="Fig1" ref-type="fig">1</xref> in Suzuki &amp; Nachman<sup><xref ref-type="bibr" rid="CR116">116</xref></sup>, and human data from Fig. <xref rid="Fig6" ref-type="fig">6</xref> in Vuik et al<sup><xref ref-type="bibr" rid="CR117">117</xref></sup>. P_I: proximal ileum, D_IL: distal ileum, C: caecum, CO: colon, RE: rectum, F: faeces. The families differing the most with regards to location-specific distribution between species include <italic>Helicobacteriaceae</italic>, <italic>Veillonellaceae</italic>, <italic>Lactobacillaceae</italic> and <italic>Streptocaccaceae</italic>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig8_ESM" id="d32e4907"/></fig>
</p>
          <p id="Par66">
<fig id="Fig9"><label>Extended Data Fig. 3</label><caption><title>Evaluating the heritability of intestinal microbiota composition in the mosaic pig population.</title><p>Correlation between heritability estimates of taxa/OTUs in F6 and F7 generation by sample type (D25, D120, D240, CC and IC). Correlation coefficients (r) and associated p-values (p) were computed using heritability estimates that were pre-corrected for bacterial abundance (residuals of linear model). Heritability estimates indeed tend to slightly increase with taxa abundance. Yet, results show that this effect cannot account for the observed correlations between F6 and F7 estimates in D120, D240 and CC, hence pointing towards genuine genetic effects. The shaded areas correspond to the 95% confidence region for the regression fit. Correlation coefficients and two-sided p-values were computed using Spearman&#x2019;s rank-based method. Reported p-values are nominal (i.e. uncorrected for multiple testing).</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig9_ESM" id="d32e4921"/></fig>
</p>
          <p id="Par67">
<fig id="Fig10"><label>Extended Data Fig. 4</label><caption><title>Identifying a microbiota QTL (miQTL) with major effect on the abundance of Erysipelotrichaceae species by whole genome sequence based GWAS.</title><p>(a) Schematic illustration of the samples and SNPs used for the two types of analyses (abundance and presence/absence) performed for miQTL mapping. (b) (Upper) Distribution of log(1/p) values for 1,527 sets of 11 p-values obtained in 11 data-series for a SNP x taxon x analysis model combination that yielded a genome-wide significant signal (p &lt; 5 x 10<sup>&#x2212;8</sup>) in the 12<sup>th</sup> data-series. (Lower) Distribution of log(1/p) values for 1,527 sets of 11 p-values obtained in the same data-series and with the same analysis model as in (upper) but with randomly selected SNP x taxon combinations matching the ones in (upper) for MAF and taxa abundance. Log(1/p) values were computed using GenABEL as described in Methods. Corresponding p-values are nominal and two-sided. (c) Correlation between the average (F6 and F7) taxon heritability, and the average (F6 and F7) number of genome-wide significant (<italic>p &#x2264;</italic>5 &#xD7; 10<sup>&#x2212;8</sup>) miQTL for D240 faecal samples. The shaded area corresponds to the 95% confidence region for the regression fit. Correlation coefficient and associated p-values are Spearman&#x2019;s. (d) <italic>QQ</italic> plot for 1,527 (number of signals (SNP x taxon x model x one data series in one cohort) exceeding the genome-wide log(1/p) threshold value of 7.3) sets of &#x2264; 5-7 p-values (same SNP x taxon x model, all data series in the other cohort) for real SNPs (Blue: quantitative model; Green: binary model), and matched sets of &#x2264; 5-7 p-values corresponding to randomly selected SNP x taxon combinations matched for MAF and abundance or presence/absence rate (Brown: quantitative model; Yellow: binary model). Log (1/p) values were computed using GenABLE as described in Methods. Corresponding p-values are nominal and two-sided. (e) Same <italic>QQ</italic> plot as in (C) after removal of all SNPs in the chromosome 1: 272.8-273.1Mb interval. Log(1/p) values were computed using GenABLE as described in Methods. Corresponding p-values are nominal and two-sided. (f) Distribution of the association log(1/p) values and corresponding signed z-scores for SNP 1_272907239 and 31 p-75-a5 OTUs (red) and 83 Erysipelotrichaceae (yellow) OTUs, showing an enrichment of effects with same sign as for OTU476 and OTU327. Log(1/p) values were computed using Metal (v3.0) as described in Methods. Corresponding p-values are nominal and two-sided. See also Supplemental discussion&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig10_ESM" id="d32e4957"/></fig>
</p>
          <p id="Par68">
<fig id="Fig11"><label>Extended Data Fig. 5</label><caption><title>The chromosome 1 miQTL is caused by a 2.3&#x2009;kb deletion in the orthologue of the human ABO gene.</title><p>(a) Breakpoints of the 2.3 kb deletion showing the role of a duplicated SINE sequence in mediating an intra-chromosomal recombination. (b) Illustrative example of allelic balance for the <italic>cG146C</italic> SNP in an AA homozygote and of allelic imbalance for the same SNP in an AO heterozygote. (c) (Upper) eQTL analysis for the porcine AO gene maximizing at the exact position of the 2.3&#x2009;kb deletion (p = 1.9x10<sup>&#x2212;43</sup>) and showing the additive effect of the A allele increasing transcript levels ~3-fold (inset; FPKM: Fragments Per Kilobase of transcript per Million mapped reads). The &#x201C;n&#x2019;s&#x201D; correspond to the number of animals of each genotype available for analysis. Boxplots are as in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. (Lower) Genome wide eQTL scan for the porcine ABO gene showing the strong cis-eQTL signal on chromosome 1. eQTL analysis was conducted with GEMMA (v0.97)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Reported log-transformed p-values are nominal and two-sided. (d) Effect of N-acetyl-galactosaminyl transferase genotype (AA, AO or OO) on abundance of OTU327 and p-75-a5 in the twelve data series. Absence of an effect of N-acetyl-galactosaminyl transferase genotype (AA, AO or OO) on abundance of <italic>E. coli</italic> in the twelve data series. Sample sizes are as in STable 4.1. Boxplots are as in Fig. <xref rid="Fig3" ref-type="fig">3d</xref>. (e) Abundance of OTU476, OTU327 and p-75-a5 in the twelve data series. Violin plots with indication of the median. Numbers (n&#x2019;s) are as in STable 4.1. See also Supplemental discussion&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig11_ESM" id="d32e4994"/></fig>
</p>
          <p id="Par69">
<fig id="Fig12"><label>Extended Data Fig. 6</label><caption><title>cis-eQTL analyses in the vicinity of the chromosome 1 miQTLK supports the causality of the 2.3&#x2009;kb deletion.</title><p>(a) Cis-eQTL analysis for the porcine N-acetyl-galactosaminyl transferase (&#x201C;ABO&#x201D;), <italic>GBTG1</italic>, <italic>LCN1</italic> (=<italic>OBP2B</italic>), <italic>MED22</italic> and <italic>SURF6</italic> genes in caecum. The blue triangle corresponds to the top SNP for the miQTL. The red triangles correspond to the top SNPs for the respective cis-eQTL. Only for N-acetyl-galactosaminyl transferase are blue and red variants the same. eQTL analyses were conducted with GEMMA (v0.97)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Reported log-transformed p-values are nominal and two-sided. (b) Effect of <italic>AO</italic> genotype on the expression levels of the corresponding genes in caecum. There was no evidence for an effect of AO genotype on the expression of any of these genes other than ABO. The number of AA, AO and OO samples available for cis-eQTL analysis for each gene are given (n). Boxplots are as in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. We tested the difference in gene expression level between pairs of genotype classes using a two-sided t-test. (c) Effect of the top cis-eQTL SNPs (blue triangles in A) on OTU476 abundance. Only the top cis-eQTL SNPs for ABO has an effect on OTU476 abundance. The number of AA, AO and OO samples available for miQTL analysis for each gene are given (n). Boxplots are as in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>. We tested the difference in bacterial abundance between pairs of genotype classes using a two-sided t-test.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig12_ESM" id="d32e5037"/></fig>
</p>
          <p id="Par70">
<fig id="Fig13"><label>Extended Data Fig. 7</label><caption><title>The 2.3&#x2009;kb deletion in the orthologue of the human ABO gene is 3.5 million years old and under balancing selection.</title><p>(a) UPGMA tree based on nucleotide diversities between 14 AA and 34 OO animals in windows of increasing size (0.5 to 40&#x2009;kb) centred on the 2.3&#x2009;kb deletion in the porcine N-acetyl-galactosaminyl transferase gene (porcine O allele). PA: <italic>Phacochaerus Africanus</italic>, SC: <italic>Sus cebifrons</italic>, SV: <italic>Sus verrucosus</italic>, SU: <italic>Sus scrofa vittatus</italic>, CB: Chinese wild boar, RB: Russian wild boar, EB: European wild boar, ERH: Erhualian, BX: Bamaxiang, T: Tibetan, LA: Laiwu, LR: Landrace, LW: Large White, PI: Pi&#xE9;train, WD: White Duroc. Context: To gain additional insights in the age of the porcine <italic>O</italic> allele, we generated phylogenetic trees of the A and O alleles of 14 AA and 34 OO animals including domestic pigs, wild boars, Visayan and Javanese warty pigs, and common African warthog. Examination of their local SNP genotypes (50K window encompassing the ABO gene) reveals traces of ancestral recombinations between O and A haplotypes as close as 300 and 800 base pairs from the proximal and distal deletion breakpoints, respectively, as well as multiple instances of homoplasy that may either be due to recombination, gene conversion or recurrent de novo mutations. On their own, these signatures support the old age of the O allele. We constructed UPGMA trees based on nucleotide diversity for windows ranging from 500&#x2009;bp to 40&#x2009;kb centred on the 2.3&#x2009;kb deletion. Smaller windows have a higher likelihood to compare the genuine ancestral O versus A states, yet yield less robust trees because they are based on smaller number of variants. Larger windows will increasingly be contaminated with recombinant A-O haplotypes blurring the sought signal. Indeed, for windows &#x2265; 20&#x2009;kb or more, the gene tree corresponds to the species tree, while for windows &#x2264; 15&#x2009;kb the tree sorts animals by AA vs OO genotype. For all windows &#x2264; 15&#x2009;kb the <italic>Sus cebifrons</italic> O allele maps outside of the <italic>Sus scrofa</italic> O allele supporting a deep divergence (rather than hybridization) and hence the old age of the O allele. Of note, for windows &#x2264;1.2&#x2009;kb, the warthog A allele is more closely related to the <italic>Sus</italic> A alleles than to the <italic>Sus</italic> O alleles (ED7A). This suggests that the O allele may be older than the divergence of the <italic>Phacochoerus</italic> and <italic>Sus</italic> A alleles, i.e. &gt; 10 MYA. It will be interesting to study larger numbers of warthog to see whether the same 2.3&#x2009;kb deletion exists in this and other related species as well. (b) Alignment of ~900 base pairs of the O alleles of domestic pigs (Bamaxian), European and Asian wild boars, and <italic>Sus cebufrons</italic> demonstrating that these are identical-by-descent. The SINE element that is presumed to have mediated the recombinational event that caused to 2.3&#x2009;kb deletion is highlighted in red. Context: To further support their identity-by-descent we aligned ~900 base pairs (centred on the position of the 2.3&#x2009;kb deletion) of the O alleles of domestic pig, European and Asian wild boars and <italic>Sus cebifrons</italic>. The sequences were nearly identical further supporting our hypothesis. It is noteworthy that the old age of the &#x201C;O&#x201D; allele must have contributed to the remarkable mapping resolution (&#x2264;3&#x2009;kb) that was achieved in this study. In total, 42 variants were in near perfect LD (<italic>r</italic><sup>2</sup>&#x2009;&#x2265;&#x2009;0.9) with the 2.3&#x2009;kb deletion in the F0 generation, spanning 2,298&#x2009;bp (1,522 on the proximal side, and 762 on the distal side of the 2.3&#x2009;kb deletion). This 2.3&#x2009;kb span is lower than genome-wide expectations (17th percentile), presumably due to the numerous cross-overs that have accrued since the birth of the 2.3&#x2009;kb deletion that occurred in the distant past. Yet the number of informative variants within this small segment is higher than genome-wide average of (57% percentile) also probably due at least in part to the accumulation of numerous mutations since the remote time of coalescence of the A and O alleles (see Fig. <xref rid="Fig1" ref-type="fig">1d</xref> in main text). (c) <italic>QQ</italic> plots for the effect of AO genotype on 150 phenotypes pertaining to meat quality, growth, carcass composition, hematology, health, and other phenotypes in the F6 and F7 generation. P-values were obtained using a mixed model followed by meta-analysis (weighted Z score) across the F6 and F7 generations as described in Methods. log-transformed p-values used for the <italic>QQ</italic> plot are nominal and two-sided. Context: Our findings in suidae are reminiscent of the trans-species polymorphism of the ABO gene in primates attributed to balancing selection<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The phenotype driving balancing selection remain largely unknown yet a tug of war with pathogens is usually invoked: synthesized glycans may affect pathogen adhesion, toxin binding or act as soluble decoys, while naturally occurring antibodies may be protective<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. In humans, the O allele may protect against malaria<sup><xref ref-type="bibr" rid="CR118">118</xref></sup>, <italic>E. Coli</italic> and <italic>Salmonella</italic> enteric infection<sup><xref ref-type="bibr" rid="CR119">119</xref></sup>, SARS-CoV-1<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, SARS-CoV-2<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> and schistosomiasis<sup><xref ref-type="bibr" rid="CR120">120</xref>&#x2013;<xref ref-type="bibr" rid="CR122">122</xref></sup>, while being a possible risk factor for cholera<sup><xref ref-type="bibr" rid="CR123">123</xref></sup>, <italic>H. pylori</italic><sup><xref ref-type="bibr" rid="CR124">124</xref></sup> and norovirus infection<sup><xref ref-type="bibr" rid="CR125">125</xref></sup>. Whatever the underlying selective force, it appears to have operated independently in at least two mammalian branches (primates and suidae), over exceedingly long periods of time, and over broad geographic ranges, hence pointing towards its pervasive nature. To gain insights in what selective forces might underpin the observed balanced polymorphism, we tested the effect of porcine AO genotype on &gt;150 traits measured in the F6 and F7 generations pertaining to carcass composition, growth, meat quality, hematological parameters, disease resistance and behaviour. No significant effects were observed when accounting for multiple testing, including those pertaining to immunity and disease resistance. (d) Expression profile of the AO gene in a panel of adult and embryonic porcine tissues (own RNA-Seq data).</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig13_ESM" id="d32e5163"/></fig>
</p>
          <p id="Par71">
<fig id="Fig14"><label>Extended Data Fig. 8</label><caption><title>The chromosome 1 miQTL affects caecal N-acetyl-D-galactosamine (GalNAc) concentrations which are correlated with the abundance of <italic>Erysipelotyrichaceae</italic> species within <italic>AO</italic> genotype: theory.</title><p>(a) ABO and <bold><italic>&#x3B1;</italic></bold>-gal epitopes in pigs and human. The glycosyltransferase gene located on 9q34.2 and underpinning the human ABO blood group is characterized in most human populations by three major alleles: (i) <italic>I</italic><sup><italic>A</italic></sup> encoding a <italic>&#x3B1;</italic>-3-N-acetyl-D-galactosaminyltransferase that is adding GalNAc to H and Lewis antigens (yielding the A antigen) on various glycoproteins including mucins secreted in the intestinal lumen, (ii) <italic>I</italic><sup><italic>B</italic></sup> encoding a <italic>&#x3B1;</italic>-3-D-galactosyltransferase that is adding galactose to the same antigens (yielding the B antigen), and (iii) the inactive <italic>I</italic><sup><italic>O</italic></sup> null allele that precludes expression of either the A and/or the B antigen. Mutations in the fucosyltransferase 2 gene (<italic>FUT2</italic>) preclude formation of the H antigen on secreted proteins and hence the detection of A and B antigens in secretions<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The pig orthologue of the human ABO glycosyltransferase gene is located on the telomeric end of porcine chromosome 1q, and is characterized by two major alleles: (i) the <italic>A</italic> allele, encoding a <italic>&#x3B1;</italic>-3-N-acetyl-D-galactosaminyltransferase that is adding GalNAc to H and Lewis antigens, similar to the human <italic>I</italic><sup><italic>A</italic></sup> allele, and (ii) the O allele corresponding to a null allele as a result of a 2.3&#x2009;kb deletion similar to the human <italic>I</italic><sup><italic>O</italic></sup> allele<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Thus, the B antigen (Gal<italic>&#x3B1;</italic>1-3(Fuc<italic>&#x3B1;</italic>1-2)Gal<italic>&#x3B2;</italic>1-4GlcNAc-R) is not observed in pig populations. However, what is found abundantly on the surface of cells in many tissues is the so-called &#x201C;<italic>&#x3B1;</italic>-gal epitope&#x201D; (Gal<italic>&#x3B1;</italic>1-3Gal<italic>&#x3B2;</italic>1-4GlcNAc-R), which results from the addition of a galactose to the Gal<italic>&#x3B2;</italic>1-4GlcNAc-R precursor by a <italic>&#x3B1;</italic>1,3galactosyltransferase encoded by the <italic>GGTA1</italic> gene. The orthologue of the GGTA1 gene is non-functional in human and Old World non-human primates, which, however, have high titers of circulating anti-<italic>&#x3B1;</italic>-gal antibodies contributing to acute rejection of xenografts<sup><xref ref-type="bibr" rid="CR126">126</xref>,<xref ref-type="bibr" rid="CR127">127</xref></sup>. (b) Identifying whether changes in GalNAc concentration are the cause of the observed changes in abundance of Erysipelotrichaceae species by searching for a correlation between the two phenotypes &#x201C;within AO genotype&#x201D;. (b1) If <italic>AO</italic> genotype is associated with the abundance of Erysipelotrichaceae species and GalNAc concentrations by virtue of different molecular mechanisms (for instance because they involved distinct causative mutations albeit in linkage disequilibrium, or because the gene has an as of yet unknown other activity that is causing the change in bacterial abundance, independently of its glycosyltransferase activity), there is no reason to expect a correlation between bacterial abundance and GalNAc concentration within <italic>AO</italic> genotype (red horizontal lines in the dotted circles). There is of course a correlation across genotypes that is due to the fact that AO genotype has a (direct or indirect) effect on both phenotypes. (b2) If, on the other hand, <italic>AO</italic> genotype causes the change in GalNAc concentration (which is very likely given its known enzymatic activity) which then causes the change in the abundance of Erysipelotrichaceae species, one can expect that bacterial abundance and GalNAc concentration will be correlated, also within <italic>AO</italic> genotype, as indicated by the sloped red lines within the dotted ellipses. This is what is observed with the real data.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig14_ESM" id="d32e5293"/></fig>
</p>
          <p id="Par72">
<fig id="Fig15"><label>Extended Data Fig. 9</label><caption><title>The chromosome 1 miQTL affects caecal N-acetyl-D-galactosamine (GalNAc) concentrations which are correlated with the abundance of <italic>Erysipelotyrichaceae</italic> species within <italic>AO</italic> genotype: results.</title><p>(a) Positive correlation between caecal GalNAc concentrations and bacterial abundance (upper panels: p-75-a5; lower panels: OTU327) &#x201C;within AO genotype&#x201D;. GalNAc concentrations and bacterial abundances were corrected for batch effects and <italic>AO</italic> genotype and scaled between 0 and 1 to equalize residual variance. Correlations were computed using all samples jointly and Spearman&#x2019;s rank-based test; corresponding p-values (nominal; two-sided) are given (left panels). Regression lines are shown for the different AO genotypes separately (right panels); all of them are positive. Note that the scatter plots for p-75-a5 are not identical but very similar to those for OTU476 (Fig. <xref rid="Fig5" ref-type="fig">5b, c</xref>). This is because OTU476 accounts for most of the p-75-a5 genus in caecum content (see also Extended Data Fig. <xref rid="Fig11" ref-type="fig">5</xref>). These data can therefore not be considered to be independent. The shaded areas correspond to the 95% confidence regions for the regression fit. (b) Comparison of the free GalNAc concentrations in caecal content of OO, AO and AA pigs as well as in caecal content of germ-free mice gavaged with 200mg/kg GalNAc. Concentrations were determined in freeze-dried caecal content powder using LC-MS/MS. Number of analyzed samples are given (n). Boxplots are as in Fig. <xref rid="Fig1" ref-type="fig">1c</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig15_ESM" id="d32e5325"/></fig>
</p>
          <p id="Par73">
<fig id="Fig16"><label>Extended Data Fig. 10</label><caption><title>The chromosome 1 miQTL affects bacteria with a functional GalNAc import and catabolic pathway.</title><p>Presence anywhere in the genome (green), presence in close proximity to <italic>agaS</italic> (red), or absence (black) of the orthologues of 24 genes implicated in the GalNAc TR/CP pathway in the genome of (i) two OTU476 like strains (4-15-1 and 4-8-110), (ii) 248 MAGs assigned to the Erysipelotrichaceae family, and (iii) 2,863 MAGs assigned to other bacterial families. The two lanes on the right of the three panels correspond to the Regulon (red) and Pathway (green) score respectively. Both scores range from 0 (black) to 6 (bright red or green). Means (range) for the corresponding dataset are given on top. P-values (nominal, two-sided, uncorrected) of the pathway and regulon scores were computed using a linear model described in Methods.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig16_ESM" id="d32e5342"/></fig>
</p>
          <p id="Par74">
<fig id="Fig17"><label>Extended Data Fig. 11</label><caption><title>Different GalNAc operon structure and transcriptome response in miQTL-sensitive versus -insensitive GalNAc utilizing bacteria.</title><p>Maps of GalNAc &#x201C;operons&#x201D; in one of the two OTU476-like strains (NB: The organization of the GalNAc gene cluster was identical in both 4-15-1 and 4-8-110 strains), and six MAGs assigned respectively to an Erysipelotrichaceae, <italic>E. coli</italic> (an Enterobacteriaceae), a <italic>Collinsella</italic> (a <italic>Coriobacteriaceae</italic>), a <italic>Fusobacteriaceae</italic>, a <italic>Firmicutes</italic> and a <italic>Clostridium</italic>. Identified Open Reading Frames (ORFs) are represented as coloured boxes. Genes implicated in GalNAc import and catabolism are in red if they are part of the cluster and in green if located elsewhere in the genome. Genes with a known function unrelated to GalNAc are in blue. ORFs with uncharacterized gene product in gray. Gene acronyms are given next to the corresponding boxes. ORFs transcribed from the top (respectively bottom) strand are above (below) the dotted line. The respective transcriptional directions are marked by the arrows. The source of information used to confirm the map order is given (finished genome, multiple MAGs, single contig).</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig17_ESM" id="d32e5376"/></fig>
</p>
          <p id="Par75">
<fig id="Fig18"><label>Extended Data Fig. 12</label><caption><title>No effect of ABO genotype on intestinal Erysipelotrichaceae abundance in human.</title><p>Volcano and <italic>QQ</italic> plots for 43 (V1-V2), 20 (V3-V4) and 9 (V5-V6) OTUs classified as Erysipelotrichaceae for the contrasts (a) [AA, AO and AB] versus [BB, BO and OO], (b) [BB, BO and AB] versus [AA, AO and OO], and (c) [OO] versus [all others]. The shaded areas correspond to the 95% confidence intervals of the spread of the <italic>QQ</italic> plot under the null hypothesis of no QTL. The actual points are always within these intervals precluding us to reject the null hypothesis. P-values (nominal, two-sided) were computed using the linear model described in Methods and hereafter. See also Supplemental discussion&#xA0;<xref rid="MOESM1" ref-type="media">3</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4769_Fig18_ESM" id="d32e5399"/></fig>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Hui Yang, Jinyuan Wu</p>
      </fn>
      <fn>
        <p>These authors jointly supervised this work: Michel Georges, Congying Chen, Lusheng Huang</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-04769-z.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-04769-z.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Y. He, S. Xiao, W. Li, Y. Guo and Y. Xing for assistance in the construction of the experimental mosaic pig populations; Y. Su and J. Li for preparation of reagents and management of samples; Y. Momozawa, R. Mariman, M. Mni, L. Karim and M. Dekkers for generating the CEDAR-1 16S rRNA data; the staff at the Jiangxi Department for Education, the Ministry of Science and Technology of P. R. China, the Ministry of Agriculture and Rural Affairs of P. R. China, and Jiangxi department of Science and Technology for their long-term support of the swine heterogeneous stock project; and the members of the MIQUANT consortium for comments and discussions. L.H. is supported by The National Natural Science Foundation of China (31790410) and National pig industry technology system (CARS-35); C. Chen by the National Natural Science Foundation of China (31772579); H.Y. by the National Postdoctoral Program for Innovative Talent (no. BX201700102); L.S. by the FNRS IBD-GI-Seq project; M.G. by the Chinese Thousand Talents Program, the Belgian EOS &#x2018;Miquant&#x2019; project and the FNRS (CDR &#x2018;GEM&#x2019; project). C. Charlier is a senior research associate at the FNRS.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>H.Y. analysed the 16S rRNA sequence data, performed GWAS, meta-analyses and local association analyses, computed heritabilities of individual taxa, contributed to ABO genotyping and analysed the effect of the 2.3&#x2009;kb deletion on taxa abundance. J.W. analysed the composition of the microbiome, including PCoA analyses, <italic>&#x3B2;</italic>- and <italic>&#x3B1;</italic>-diversity, correlations between kinship and microbiome dissimilarities, isolated the OTU476-like strains, performed the GalNAc feeding experiments, measured the concentrations of GalNAc in the caecal lumen, analysed the GalNAc import and use pathway in the MAGs, and contributed to ABO genotyping. X.H. participated in 16S rRNA sequencing (F<sub>6</sub>) and GWAS (F<sub>6</sub>). Y.&#xA0;Zhou performed metagenome sequencing analysis, analysed the GalNAc import and use pathway in MAGs, analysed the RNA-seq data from caecum samples and contributed to ABO genotyping. Y.&#xA0;Zhang participated in the preparation of the genotype data from whole-genome sequence information, participated in the computation of the genomic contribution of the different breeds in the F<sub>6</sub> and F<sub>7</sub> generation and the definition of expected mapping resolution, performed LD analyses, performed eQTL analysis for the <italic>ABO</italic> gene, participated in the characterization and sequence analysis of the <italic>ABO</italic> gene, including definition of the 2.3&#x2009;kb deletion, and in the balancing selection and trans-species polymorphism analyses. M.L. assisted with the isolation of the OTU476-like strains, the GalNAc feeding experiments and genotyping of the <italic>ABO</italic> gene. Q.L. assisted with measuring the concentrations of GalNAc in caecal lumen. S.K., M.H., H.F., S.F., X.X., H.J., Z.C. and J.G. assisted with the experiments. Z.Z.,&#xA0;X.T.,&#xA0; Z.W., H.G. and Y.H. assisted with the preparation of genotype data from whole-genome sequencing data and conducted the analysis of the Nanopore data of the <italic>ABO</italic> region. J.M. assisted with the construction of the mosaic population. H.A. assisted with the bioinformatic analysis of the <italic>ABO</italic> region, de novo assembly of the <italic>A</italic> allele, and evolutionary analysis of the <italic>ABO</italic> alleles. L.S. analysed the effect of <italic>ABO</italic> genotype on intestinal microbiota composition in humans. W.C. assisted in the analysis of the sequencing data for the trans-species polymorphisms. C. Charlier supervised the characterization of the <italic>ABO</italic> gene and the 2.3&#x2009;kb deletion and the corresponding haplotype structure in the F<sub>0</sub>, F<sub>6</sub> and F<sub>7</sub> population and for the trans-species polymorphism. B.Y. prepared the genotype data of whole-genome variants, assisted with raising the heterogeneous stock, and participated in the computation of the genomic contribution of the different breeds in the F<sub>6</sub> and F<sub>7</sub> generation and the definition of expected mapping resolution. M.G. supervised the bioinformatic and statistical analyses, performed bioinformatic and statistical analyses, and wrote the paper. C. Chen codesigned the study, supervised experiments, supervised bioinformatic and statistical analyses of gut microbiome, and wrote the paper. L.H. created the swine heterogeneous stock, designed the study, directed the project, supervised the experiments and analyses, and wrote the paper.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="FPar1">
        <title>Peer review information</title>
        <p id="Par62"><italic>Nature</italic> thanks Catherine Lozupone, Vincent Plagnol and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.&#xA0;<xref rid="MOESM3" ref-type="media">Peer reviewer reports</xref> are available.</p>
      </sec>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>All the 16S rRNA sequencing data, the metagenomics sequence data and the RNA-seq data were submitted to the GSA database under accession numbers <ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/gsa/browse/CRA006230">CRA006230</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/gsa/browse/CRA006239">CRA006239</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/gsa/browse/CRA006240">CRA006240</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/gsa/browse/CRA006216">CRA006216</ext-link>. The genotype data were deposited at the GVM (<ext-link ext-link-type="uri" xlink:href="http://bigd.big.ac.cn/gvm/getProjectDetail?project=GVM000310">http://bigd.big.ac.cn/gvm/getProjectDetail?project=GVM000310</ext-link>)&#xA0;under the GSA database under accession number GVM000310. The GWAS summary statistics are available at Figshare (10.6084/m9.figshare.19313960). The whole-genome sequencing data of experimental pigs have been deposited in the GSA database (<ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/browse/CRA006383">https://ngdc.cncb.ac.cn/gsa/browse/CRA006383</ext-link>) under accession number CRA006383. The source data are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/yanghuijxau/Manuscript-microbiota-ABO">https://github.com/yanghuijxau/Manuscript-microbiota-ABO</ext-link>).</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>Codes to replicate the findings and the source data are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/yanghuijxau/Manuscript-microbiota-ABO">https://github.com/yanghuijxau/Manuscript-microbiota-ABO</ext-link>).</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par63">The authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kundu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Blacher</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Elinav</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pettersson</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Our gut microbiome: the evolving inner self</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>171</volume>
          <fpage>1481</fpage>
          <lpage>1493</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.11.024</pub-id>
          <pub-id pub-id-type="pmid">29245010</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothschild</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title>
          <source>Nature</source>
          <year>2018</year>
          <volume>555</volume>
          <fpage>210</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1038/nature25973</pub-id>
          <pub-id pub-id-type="pmid">29489753</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Hara</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>ALA</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>LL</given-names>
            </name>
          </person-group>
          <article-title>The role of the gut microbiome in cattle production and health: driver or passenger?</article-title>
          <source>Annu. Rev. Anim. Biosci.</source>
          <year>2020</year>
          <volume>8</volume>
          <fpage>199</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-animal-021419-083952</pub-id>
          <pub-id pub-id-type="pmid">32069435</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>TSB</given-names>
            </name>
            <name>
              <surname>Raes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The human gut microbiome: from association to modulation</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>172</volume>
          <fpage>1198</fpage>
          <lpage>1215</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.044</pub-id>
          <pub-id pub-id-type="pmid">29522742</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polderman</surname>
              <given-names>TJC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Meta-analysis of the heritability of human traits based on 50 years of twin studies</article-title>
          <source>Nat. Genet.</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>702</fpage>
          <lpage>709</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3285</pub-id>
          <pub-id pub-id-type="pmid">25985137</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polubriaginof</surname>
              <given-names>FCG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disease heritability inferred from familial relationships reported in medical records</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>173</volume>
          <fpage>1692</fpage>
          <lpage>1704</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.04.032</pub-id>
          <pub-id pub-id-type="pmid">29779949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benson</surname>
              <given-names>AK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2010</year>
          <volume>107</volume>
          <fpage>18933</fpage>
          <lpage>18938</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1007028107</pub-id>
          <pub-id pub-id-type="pmid">20937875</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yatsunenko</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human gut microbiome viewed across age and geography</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>486</volume>
          <fpage>222</fpage>
          <lpage>227</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11053</pub-id>
          <pub-id pub-id-type="pmid">22699611</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goodrich</surname>
              <given-names>JK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human genetics shape the gut microbiome</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>789</fpage>
          <lpage>799</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.053</pub-id>
          <pub-id pub-id-type="pmid">25417156</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blekhman</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Host genetic variation impacts microbiome compoistion across human body sites</article-title>
          <source>Genome Biol.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>191</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0759-1</pub-id>
          <pub-id pub-id-type="pmid">26374288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turpin</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of host genome with intestinal microbial composition in a large healthy cohort</article-title>
          <source>Nat. Genet.</source>
          <year>2016</year>
          <volume>48</volume>
          <fpage>1413</fpage>
          <lpage>1417</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3693</pub-id>
          <pub-id pub-id-type="pmid">27694960</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonder</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The effect of host genetics on the gut microbiome</article-title>
          <source>Nat. Genet.</source>
          <year>2016</year>
          <volume>48</volume>
          <fpage>1407</fpage>
          <lpage>1412</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3663</pub-id>
          <pub-id pub-id-type="pmid">27694959</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota</article-title>
          <source>Nat. Genet.</source>
          <year>2016</year>
          <volume>48</volume>
          <fpage>1396</fpage>
          <lpage>1406</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3695</pub-id>
          <pub-id pub-id-type="pmid">27723756</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide associations of human gut microbiome variation and implications for causal inference analyses</article-title>
          <source>Nat. Microbiol.</source>
          <year>2020</year>
          <volume>5</volume>
          <fpage>1079</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="doi">10.1038/s41564-020-0743-8</pub-id>
          <pub-id pub-id-type="pmid">32572223</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sankararaman</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genomic landscape of Neanderthal ancestry in present-day humans</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>507</volume>
          <fpage>354</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1038/nature12961</pub-id>
          <pub-id pub-id-type="pmid">24476815</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patterson</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic evidence for complex speciation of humans and chimpanzees</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>441</volume>
          <fpage>1103</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="doi">10.1038/nature04789</pub-id>
          <pub-id pub-id-type="pmid">16710306</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donaldson</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Mazmanian</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Gut biogeography of the bacterial microbiota</article-title>
          <source>Nat. Rev. Microbiol.</source>
          <year>2016</year>
          <volume>14</volume>
          <fpage>20</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1038/nrmicro3552</pub-id>
          <pub-id pub-id-type="pmid">26499895</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radjabzadeh</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diversity, compositional and functional differences between gut microbiota of children and adults</article-title>
          <source>Sci. Rep.</source>
          <year>2020</year>
          <volume>10</volume>
          <fpage>1040</fpage>
          <pub-id pub-id-type="doi">10.1038/s41598-020-57734-z</pub-id>
          <pub-id pub-id-type="pmid">31974429</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goodrich</surname>
              <given-names>JK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic determinants of the gut microbiome in UK twins</article-title>
          <source>Cell Host Microbe</source>
          <year>2016</year>
          <volume>19</volume>
          <fpage>731</fpage>
          <lpage>743</lpage>
          <pub-id pub-id-type="doi">10.1016/j.chom.2016.04.017</pub-id>
          <pub-id pub-id-type="pmid">27173935</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooling</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Blood groups in infection and host susceptibility</article-title>
          <source>Clin. Microbiol. Rev.</source>
          <year>2015</year>
          <volume>28</volume>
          <fpage>801</fpage>
          <lpage>870</lpage>
          <pub-id pub-id-type="doi">10.1128/CMR.00109-14</pub-id>
          <pub-id pub-id-type="pmid">26085552</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R&#xFC;hlemann</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome</article-title>
          <source>Nat. Genet.</source>
          <year>2021</year>
          <volume>53</volume>
          <fpage>147</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-020-00747-1</pub-id>
          <pub-id pub-id-type="pmid">33462482</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopera-Maya</surname>
              <given-names>EE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch microbiome project</article-title>
          <source>Nat. Genet.</source>
          <year>2022</year>
          <volume>54</volume>
          <fpage>143</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-021-00992-y</pub-id>
          <pub-id pub-id-type="pmid">35115690</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qin</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort</article-title>
          <source>Nat. Genet.</source>
          <year>2022</year>
          <volume>54</volume>
          <fpage>134</fpage>
          <lpage>142</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-021-00991-z</pub-id>
          <pub-id pub-id-type="pmid">35115689</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>MK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Determination of complete sequence information of the human ABO blood group orthologous gene in pigs and breed differences in blood type frequencies</article-title>
          <source>Gene</source>
          <year>2018</year>
          <volume>640</volume>
          <fpage>1</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/j.gene.2017.09.047</pub-id>
          <pub-id pub-id-type="pmid">28966132</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Design of glycosyl transferase inhibitors: serine analogues as pyrophosphate surrogates?</article-title>
          <source>ChemPlusChem</source>
          <year>2015</year>
          <volume>80</volume>
          <fpage>1525</fpage>
          <lpage>1532</lpage>
          <pub-id pub-id-type="doi">10.1002/cplu.201500282</pub-id>
          <pub-id pub-id-type="pmid">31973382</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE9;gurel</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The ABO blood group is a trans-species poilymorphism in primates</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2012</year>
          <volume>109</volume>
          <fpage>18493</fpage>
          <lpage>18498</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1210603109</pub-id>
          <pub-id pub-id-type="pmid">23091028</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groenen</surname>
              <given-names>MAM</given-names>
            </name>
          </person-group>
          <article-title>A decade of pig genome sequencing: windo on pig domestication and evolution</article-title>
          <source>Genet. Sel. Evol.</source>
          <year>2016</year>
          <volume>48</volume>
          <fpage>23</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1186/s12711-016-0204-2</pub-id>
          <pub-id pub-id-type="pmid">27025270</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravcheev</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Thiele</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Comparative genomic analysis of the human gut microbiome reveals a broad distribution of metabolic pathways for the degradation of host-synthesized mucin glycans and utilization of mucin-derived monosaccharides</article-title>
          <source>Front. Genet.</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>111</fpage>
          <pub-id pub-id-type="doi">10.3389/fgene.2017.00111</pub-id>
          <pub-id pub-id-type="pmid">28912798</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tailford</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mucin glycan foraging in the human gut microbiome</article-title>
          <source>Front. Genet.</source>
          <year>2015</year>
          <volume>6</volume>
          <fpage>81</fpage>
          <pub-id pub-id-type="doi">10.3389/fgene.2015.00081</pub-id>
          <pub-id pub-id-type="pmid">25852737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lien</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Dietary influences on the secretion into and degradation of mucin in the digestive tract of monogastric animals and humans</article-title>
          <source>J. Anim. Feed Sci.</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>223</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="doi">10.22358/jafs/67980/2001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brinkk&#xF6;tter</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Kl&#xF6;ss</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Alpert</surname>
              <given-names>C-A</given-names>
            </name>
            <name>
              <surname>Lengeler</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Pathways for the utilization of <italic>N</italic>-acetyl-galactosamine and galactosamine in <italic>Escherichia coli</italic></article-title>
          <source>Mol. Microbiol.</source>
          <year>2000</year>
          <volume>37</volume>
          <fpage>125</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.01969.x</pub-id>
          <pub-id pub-id-type="pmid">10931310</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodionov</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genomic encyclopedia of sugar utilization pathways in the <italic>Shewanella</italic> genus</article-title>
          <source>BMC Genom.</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>494</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-11-494</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leyn</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rodionov</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-acetylgalactosamine utilization pathway and regulon in proteobacteria</article-title>
          <source>J. Biol. Chem.</source>
          <year>2012</year>
          <volume>287</volume>
          <fpage>28047</fpage>
          <lpage>28056</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M112.382333</pub-id>
          <pub-id pub-id-type="pmid">22711537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Genetic analysis of the roles of agaA, agaI, and agaS genes in the <italic>N</italic>-acetyl-<sc>d</sc>-galactosamine and <sc>d</sc>-galactosamine catabolic pathways in <italic>Escherichia coli</italic> strains O157:H7 and C</article-title>
          <source>BMC Microbiol.</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>94</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2180-13-94</pub-id>
          <pub-id pub-id-type="pmid">23634833</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bidart</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Rodriguez-Diaz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Monedoro</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Yebra</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>A unique gene cluster for the utilization of the mucosal and human milk-associated glycans galacto-<italic>N</italic>-biose and lacto-<italic>N</italic>-biose in <italic>Lactobacillus casei</italic></article-title>
          <source>Mol. Microbiol.</source>
          <year>2014</year>
          <volume>93</volume>
          <fpage>521</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="doi">10.1111/mmi.12678</pub-id>
          <pub-id pub-id-type="pmid">24942885</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Two novel regulators of <italic>N</italic>-acetyl-galactosamine utilization pathway and distinct roles in bacterial infections</article-title>
          <source>Microbiol. Open</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>983</fpage>
          <lpage>1000</lpage>
          <pub-id pub-id-type="doi">10.1002/mbo3.307</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawrence</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Selfish operons: the evolutionary impact of gene clustering in prokrayotes and eukaryotes</article-title>
          <source>Curr. Opin. Genet. Dev.</source>
          <year>1999</year>
          <volume>9</volume>
          <fpage>642</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="doi">10.1016/S0959-437X(99)00025-8</pub-id>
          <pub-id pub-id-type="pmid">10607610</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koonin</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>Evolution of genome architecture</article-title>
          <source>Int. J. Biochem. Cell Biol.</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>298</fpage>
          <lpage>306</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biocel.2008.09.015</pub-id>
          <pub-id pub-id-type="pmid">18929678</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lombard</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The carbohydrate-active enzymes database (CAZy) in 2013</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>D490</fpage>
          <lpage>D495</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt1178</pub-id>
          <pub-id pub-id-type="pmid">24270786</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rahfeld</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An enzymatic pathway in the human gut microbiome that converts A to universal O type blood</article-title>
          <source>Nat. Microbiol.</source>
          <year>2019</year>
          <volume>4</volume>
          <fpage>1475</fpage>
          <lpage>1585</lpage>
          <pub-id pub-id-type="doi">10.1038/s41564-019-0469-7</pub-id>
          <pub-id pub-id-type="pmid">31182795</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="other">Rahfled, P. et al. Prospecting for microbial &#x3B1;-<italic>N</italic>-acetylgalactosaminidases yields a new class of GH31 <italic>O-</italic>glycanase. J. Biol. Chem. 294, 16400&#x2013;16415.</mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ABO blood group and susceptibility to severe acute respiratory syndrome</article-title>
          <source>JAMA</source>
          <year>2005</year>
          <volume>293</volume>
          <fpage>1450</fpage>
          <lpage>1451</lpage>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="other">Ellinghaus, D. et al. The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis. Preprint at <italic>medRxiv</italic>10.1101/2020.05.31.20114991 (2020).</mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blancher</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Evolution of the <italic>ABO</italic> supergene family</article-title>
          <source>ISBT Sci. Ser.</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>201</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="doi">10.1111/voxs.12044</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makivuokko</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association between the ABO blood group and the human intestinal microbiota composition</article-title>
          <source>BMC Microbiol.</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>94</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2180-12-94</pub-id>
          <pub-id pub-id-type="pmid">22672382</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davenport</surname>
              <given-names>ER</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins</article-title>
          <source>BMC Genom.</source>
          <year>2016</year>
          <volume>17</volume>
          <fpage>941</fpage>
          <lpage>955</lpage>
          <pub-id pub-id-type="doi">10.1186/s12864-016-3290-1</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurilshikov</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Large-scale association analyses identify host factors influencing human gut microbiome composition</article-title>
          <source>Nat. Genet.</source>
          <year>2021</year>
          <volume>53</volume>
          <fpage>156</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-020-00763-1</pub-id>
          <pub-id pub-id-type="pmid">33462485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malmuthuge</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Griebel</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>LL</given-names>
            </name>
          </person-group>
          <article-title>Taxonomic identification of commensal bacteria associated with the mucosa and digesta throughout the gastrointestinal tracts of preweaned calves</article-title>
          <source>Appl. Environ. Microbiol.</source>
          <year>2014</year>
          <volume>80</volume>
          <fpage>2021</fpage>
          <lpage>2028</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.03864-13</pub-id>
          <pub-id pub-id-type="pmid">24441166</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanson</surname>
              <given-names>MEB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Population structure of human gut bacteria in a diverse cohort from rural Tanzania and Botswana</article-title>
          <source>Genome Biol.</source>
          <year>2019</year>
          <volume>20</volume>
          <fpage>16</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-018-1616-9</pub-id>
          <pub-id pub-id-type="pmid">30665461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <mixed-citation publication-type="other">Warr, A. et al. An improved pig reference genome sequence to enable pig genetics and genomics research. Gigascience 9 (2019).</mixed-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>589</fpage>
          <lpage>595</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id>
          <pub-id pub-id-type="pmid">20080505</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rimmer</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications</article-title>
          <source>Nat. Genet.</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>912</fpage>
          <lpage>918</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3036</pub-id>
          <pub-id pub-id-type="pmid">25017105</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>CC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Second-generation PLINK: rising to the challenge of larger and richer datasets</article-title>
          <source>Gigascience</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>7</fpage>
          <pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id>
          <pub-id pub-id-type="pmid">25722852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Browning</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Browning</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
          <article-title>Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2007</year>
          <volume>81</volume>
          <fpage>1084</fpage>
          <lpage>1097</lpage>
          <pub-id pub-id-type="doi">10.1086/521987</pub-id>
          <pub-id pub-id-type="pmid">17924348</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coppieters</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Karim</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Georges</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>SNP-based quantitative deconvolution of biological mixtures: application to the detection of cows with subclinical mastitis by whole genome sequencing of tank milk</article-title>
          <source>Genome Res.</source>
          <year>2020</year>
          <volume>30</volume>
          <fpage>1201</fpage>
          <lpage>1207</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.256172.119</pub-id>
          <pub-id pub-id-type="pmid">32591360</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolger</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lohse</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Usadel</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>
          <source>Bioinformatics</source>
          <year>2014</year>
          <volume>30</volume>
          <fpage>2114</fpage>
          <lpage>2120</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
          <pub-id pub-id-type="pmid">24695404</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mago&#x10D;</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>FLASH: fast length adjustment of short reads to improve genome assemblies</article-title>
          <source>Bioinformatics</source>
          <year>2011</year>
          <volume>27</volume>
          <fpage>2957</fpage>
          <lpage>2963</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btr507</pub-id>
          <pub-id pub-id-type="pmid">21903629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edgar</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Search and clustering orders of magnitude faster than BLAST</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>2460</fpage>
          <lpage>2461</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btq461</pub-id>
          <pub-id pub-id-type="pmid">20709691</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rognes</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Flouri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Quince</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mahe</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>VSEARCH: a versatile open source tool for metagenomics</article-title>
          <source>PeerJ</source>
          <year>2016</year>
          <volume>4</volume>
          <fpage>e2584</fpage>
          <pub-id pub-id-type="doi">10.7717/peerj.2584</pub-id>
          <pub-id pub-id-type="pmid">27781170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Garrity</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Tiedje</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy</article-title>
          <source>Appl. Environ. Microbiol.</source>
          <year>2007</year>
          <volume>73</volume>
          <fpage>5261</fpage>
          <lpage>5267</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.00062-07</pub-id>
          <pub-id pub-id-type="pmid">17586664</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schloss</surname>
              <given-names>PD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities</article-title>
          <source>Appl. Environ. Microbiol.</source>
          <year>2009</year>
          <volume>75</volume>
          <fpage>7537</fpage>
          <lpage>7541</lpage>
          <pub-id pub-id-type="doi">10.1128/AEM.01541-09</pub-id>
          <pub-id pub-id-type="pmid">19801464</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheema</surname>
              <given-names>MU</given-names>
            </name>
            <name>
              <surname>Pluznick</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Gut microbiota plays a central role to modulate the plasma and fecal metabolomes in response to angiotensin II</article-title>
          <source>Hypertension</source>
          <year>2019</year>
          <volume>74</volume>
          <fpage>184</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.13155</pub-id>
          <pub-id pub-id-type="pmid">31154901</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Stephens</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide efficient mixed-model analysis for association studies</article-title>
          <source>Nat. Genet.</source>
          <year>2012</year>
          <volume>44</volume>
          <fpage>821</fpage>
          <lpage>824</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.2310</pub-id>
          <pub-id pub-id-type="pmid">22706312</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Goddard</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Visscher</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>GCTA: a tool for genome-wide complex trait analysis</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2011</year>
          <volume>88</volume>
          <fpage>76</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.11.011</pub-id>
          <pub-id pub-id-type="pmid">21167468</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixon</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>VEGAN, a package of R functions for community ecology</article-title>
          <source>J. Veg. Sci.</source>
          <year>2003</year>
          <volume>14</volume>
          <fpage>927</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1654-1103.2003.tb02228.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Visscher</surname>
              <given-names>PM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings</article-title>
          <source>PLoS Genet.</source>
          <year>2006</year>
          <volume>2</volume>
          <fpage>e41</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.0020041</pub-id>
          <pub-id pub-id-type="pmid">16565746</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziyatdinov</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>lme4QTL: linear mixed models with flexible covariance structure for genetic studies of related individuals</article-title>
          <source>BMC Bioinform.</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>68</fpage>
          <pub-id pub-id-type="doi">10.1186/s12859-018-2057-x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haseman</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Elston</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>The investigation of linkage between a quantitative trait and a marker locus</article-title>
          <source>Behav. Genet.</source>
          <year>1972</year>
          <volume>2</volume>
          <fpage>3</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01066731</pub-id>
          <pub-id pub-id-type="pmid">4157472</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aulchenko</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Ripke</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Isaacs</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>van Duijn</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>GenABEL: an R library for genome-wide association analysis</article-title>
          <source>Bioinformatics</source>
          <year>2007</year>
          <volume>23</volume>
          <fpage>1294</fpage>
          <lpage>1296</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btm108</pub-id>
          <pub-id pub-id-type="pmid">17384015</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willer</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Abecasis</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>METAL: fast and efficient meta-analysis of genomewide association scans</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>2190</fpage>
          <lpage>2191</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btq340</pub-id>
          <pub-id pub-id-type="pmid">20616382</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kolmogorov</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Pevzner</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Assembly of long, error-prone reads using repeat graphs</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>540</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-019-0072-8</pub-id>
          <pub-id pub-id-type="pmid">30936562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaser</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sovic</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nagarajan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sikic</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Fast and accurate de novo genome assembly from long uncorrected reads</article-title>
          <source>Genome Res.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>737</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.214270.116</pub-id>
          <pub-id pub-id-type="pmid">28100585</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <mixed-citation publication-type="other">Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at <italic>arXiv</italic><ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1303.3997">https://arxiv.org/abs/1303.3997</ext-link> (2013).</mixed-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>BJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>e112963</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0112963</pub-id>
          <pub-id pub-id-type="pmid">25409509</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <mixed-citation publication-type="other">Harris, R. S. <italic>Improved Pairwise Alignment of Genomic DNA</italic>. PhD thesis, Pennsylvania State Univ. (2007).</mixed-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Minimap2: pairwise alignment for nucleotide sequences</article-title>
          <source>Bioinformatics</source>
          <year>2018</year>
          <volume>34</volume>
          <fpage>3094</fpage>
          <lpage>3100</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bty191</pub-id>
          <pub-id pub-id-type="pmid">29750242</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobin</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
          <source>Bioinformatics</source>
          <year>2013</year>
          <volume>29</volume>
          <fpage>15</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
          <pub-id pub-id-type="pmid">23104886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>
          <source>Bioinformatics</source>
          <year>2014</year>
          <volume>30</volume>
          <fpage>923</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
          <pub-id pub-id-type="pmid">24227677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ai</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adaptation and possible ancient interspecies introgression in pigs identified by whole-genome sequencing</article-title>
          <source>Nat. Genet.</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>217</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3199</pub-id>
          <pub-id pub-id-type="pmid">25621459</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van der Auwera</surname>
              <given-names>GA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>From FastQ data to high confidence variant calls: the genome analysis Toolkit best practices pipeline</article-title>
          <source>Curr. Protoc. Bioinform.</source>
          <year>2013</year>
          <volume>43</volume>
          <fpage>11.10.11</fpage>
          <lpage>11.10.33</lpage>
          <pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DePristo</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
          <source>Nat. Genet.</source>
          <year>2011</year>
          <volume>43</volume>
          <fpage>491</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
          <pub-id pub-id-type="pmid">21478889</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weir</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Cockerham</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Estimating <italic>F</italic>-statistics for the analysis of population structure</article-title>
          <source>Evolution</source>
          <year>1984</year>
          <volume>38</volume>
          <fpage>1358</fpage>
          <lpage>1370</lpage>
          <pub-id pub-id-type="pmid">28563791</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nei</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title><italic>F</italic>-statistics and analysis of gene diversity in subdivided populations</article-title>
          <source>Ann. Hum. Genet.</source>
          <year>1977</year>
          <volume>41</volume>
          <fpage>225</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-1809.1977.tb01918.x</pub-id>
          <pub-id pub-id-type="pmid">596830</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Paggi</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>907</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id>
          <pub-id pub-id-type="pmid">31375807</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunt</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Circlator: automated circularization of genome assemblies using long sequencing reads</article-title>
          <source>Genome Biol.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>294</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0849-0</pub-id>
          <pub-id pub-id-type="pmid">26714481</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyatt</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prodigal: prokaryotic gene recognition and translation initiation site identification</article-title>
          <source>BMC Bioinform.</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>119</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-11-119</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title>
          <source>Bioinformatics</source>
          <year>2018</year>
          <volume>34</volume>
          <fpage>i884</fpage>
          <lpage>i890</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id>
          <pub-id pub-id-type="pmid">30423086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MEGAHIT v1.0: a fast and scalable metagenome assembler driven by advanced methodologies and community practices</article-title>
          <source>Methods</source>
          <year>2016</year>
          <volume>102</volume>
          <fpage>3</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ymeth.2016.02.020</pub-id>
          <pub-id pub-id-type="pmid">27012178</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uritskiy</surname>
              <given-names>GV</given-names>
            </name>
            <name>
              <surname>DiRuggiero</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>MetaWRAP&#x2014;a flexible pipeline for genome-resolved metagenomic data analysis</article-title>
          <source>Microbiome</source>
          <year>2018</year>
          <volume>6</volume>
          <fpage>158</fpage>
          <pub-id pub-id-type="doi">10.1186/s40168-018-0541-1</pub-id>
          <pub-id pub-id-type="pmid">30219103</pub-id>
        </element-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parks</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Imelfort</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Skennerton</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Hugenholtz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tyson</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes</article-title>
          <source>Genome Res.</source>
          <year>2015</year>
          <volume>25</volume>
          <fpage>1043</fpage>
          <lpage>1055</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.186072.114</pub-id>
          <pub-id pub-id-type="pmid">25977477</pub-id>
        </element-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olm</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Banfield</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>dRep: a tool for fast and accurate genomic comparisons that enables improved genome recovery from metagenomes through de-replication</article-title>
          <source>ISME J.</source>
          <year>2017</year>
          <volume>11</volume>
          <fpage>2864</fpage>
          <lpage>2868</lpage>
          <pub-id pub-id-type="doi">10.1038/ismej.2017.126</pub-id>
          <pub-id pub-id-type="pmid">28742071</pub-id>
        </element-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanehisa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morishima</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>BlastKOALA and GhostKOALA: KEGG tools for functional characterization of genome and metagenome sequences</article-title>
          <source>J. Mol. Biol.</source>
          <year>2016</year>
          <volume>428</volume>
          <fpage>726</fpage>
          <lpage>731</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2015.11.006</pub-id>
          <pub-id pub-id-type="pmid">26585406</pub-id>
        </element-citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segata</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bornigen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>XC</given-names>
            </name>
            <name>
              <surname>Huttenhower</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>PhyloPhlAn is a new method for improved phylogenetic and taxonomic placement of microbes</article-title>
          <source>Nat. Commun.</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>2304</fpage>
          <pub-id pub-id-type="doi">10.1038/ncomms3304</pub-id>
          <pub-id pub-id-type="pmid">23942190</pub-id>
        </element-citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways</article-title>
          <source>Nat. Cancer</source>
          <year>2020</year>
          <volume>1</volume>
          <fpage>737</fpage>
          <lpage>747</lpage>
        </element-citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nanchen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuhrer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Determination of metabolic flux rartios from <sup>13</sup>C-experiments and gas chromatography-mass spectrometry data: protocol and principles</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2007</year>
          <volume>358</volume>
          <fpage>177</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-59745-244-1_11</pub-id>
          <pub-id pub-id-type="pmid">17035687</pub-id>
        </element-citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Winden</surname>
              <given-names>WA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Correcting mass isoptopomer distributions for naturally occurring isotopes</article-title>
          <source>Biotechnol. Bioeng.</source>
          <year>2002</year>
          <volume>80</volume>
          <fpage>477</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="doi">10.1002/bit.10393</pub-id>
          <pub-id pub-id-type="pmid">12325156</pub-id>
        </element-citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Staley</surname>
            </name>
            <etal/>
          </person-group>
          <article-title>Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning</article-title>
          <source>Microbiome</source>
          <year>2017</year>
          <volume>5</volume>
          <fpage>87</fpage>
          <pub-id pub-id-type="doi">10.1186/s40168-017-0306-2</pub-id>
          <pub-id pub-id-type="pmid">28760163</pub-id>
        </element-citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Langmead</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Fast gapped-read alignment with Bowtie 2</article-title>
          <source>Nat. Methods</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>357</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id>
          <pub-id pub-id-type="pmid">22388286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Love</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Anders</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
          <source>Genome Biol.</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>550</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
          <pub-id pub-id-type="pmid">25516281</pub-id>
        </element-citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Momozawa</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes</article-title>
          <source>Nat. Commun.</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>2427</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-018-04365-8</pub-id>
          <pub-id pub-id-type="pmid">29930244</pub-id>
        </element-citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <mixed-citation publication-type="other">Bushnell, B. <italic>BBMap: A Fast, Accurate, Splice-Aware Aligner</italic> (version 38.82) <ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/bbmap/">https://sourceforge.net/projects/bbmap/</ext-link> (2014).</mixed-citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xF6;ster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rahmann</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Snakemake: a scalable bioinformatics workflow engine</article-title>
          <source>Bioinformatics</source>
          <year>2012</year>
          <volume>28</volume>
          <fpage>2520</fpage>
          <lpage>2522</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts480</pub-id>
          <pub-id pub-id-type="pmid">22908215</pub-id>
        </element-citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolyen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rideout</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dillon</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Bokulich</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Caporaso</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>852</fpage>
          <lpage>857</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-019-0209-9</pub-id>
          <pub-id pub-id-type="pmid">31341288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Callahan</surname>
              <given-names>BJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DADA2: high-resolution sample inference from Illumina amplicon data</article-title>
          <source>Nat. Methods</source>
          <year>2016</year>
          <volume>13</volume>
          <fpage>581</fpage>
          <lpage>583</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.3869</pub-id>
          <pub-id pub-id-type="pmid">27214047</pub-id>
        </element-citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghodsi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pop</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>DNACLUST: accurate and efficient clustering of phylogenetic marker genes</article-title>
          <source>BMC Bioinform.</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>271</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-12-271</pub-id>
        </element-citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Altschul</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Gish</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Lipman</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Basic local alignment search tool</article-title>
          <source>J. Mol. Biol.</source>
          <year>1990</year>
          <volume>215</volume>
          <fpage>403</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id>
          <pub-id pub-id-type="pmid">2231712</pub-id>
        </element-citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Srivastava</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genomes of the mouse collaborative cross</article-title>
          <source>Genetics</source>
          <year>2017</year>
          <volume>206</volume>
          <fpage>537</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="doi">10.1534/genetics.116.198838</pub-id>
          <pub-id pub-id-type="pmid">28592495</pub-id>
        </element-citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global patterns of human DNA sequence variation in a 10-kb region on chromosome 1</article-title>
          <source>Mol. Biol. Evol.</source>
          <year>2001</year>
          <volume>18</volume>
          <fpage>214</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a003795</pub-id>
          <pub-id pub-id-type="pmid">11158380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>The 1000 Genomes Project Consortium.</collab>
          </person-group>
          <article-title>A map of human genome variation from population-scale sequencing</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>467</volume>
          <fpage>1061</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="doi">10.1038/nature09534</pub-id>
          <pub-id pub-id-type="pmid">20981092</pub-id>
        </element-citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frantz</surname>
              <given-names>LAF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence of long-term gene flow and selection during domestication from analyses of Eurasian wild and domestic pig genomes</article-title>
          <source>Nat. Genet.</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>1141</fpage>
          <lpage>1148</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.3394</pub-id>
          <pub-id pub-id-type="pmid">26323058</pub-id>
        </element-citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charlier</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NGS-based reverse genetic screen for common embryonic lethal mutations compromising fertility in livestock</article-title>
          <source>Genome Res.</source>
          <year>2016</year>
          <volume>26</volume>
          <fpage>1333</fpage>
          <lpage>1341</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.207076.116</pub-id>
          <pub-id pub-id-type="pmid">27646536</pub-id>
        </element-citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georges</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Charlier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Harnessing genomic information for livestock improvement</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2019</year>
          <volume>20</volume>
          <fpage>135</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="doi">10.1038/s41576-018-0082-2</pub-id>
          <pub-id pub-id-type="pmid">30514919</pub-id>
        </element-citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geraldes</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inferring the history of speciation in house mice from autosomal, X-linked, Y-linked and mitochondrial genes</article-title>
          <source>Mol. Ecol.</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>5349</fpage>
          <lpage>5363</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-294X.2008.04005.x</pub-id>
          <pub-id pub-id-type="pmid">19121002</pub-id>
        </element-citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fine-mapping inflammatory bowel disease loci to single-variant resolution</article-title>
          <source>Nature</source>
          <year>2017</year>
          <volume>547</volume>
          <fpage>173</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.1038/nature22969</pub-id>
          <pub-id pub-id-type="pmid">28658209</pub-id>
        </element-citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Nachman</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Spatial heterogeneity of gut microbioal composition along the gastrointestinal tract in natural populatiions of house mice</article-title>
          <source>PLoS ONE</source>
          <year>2016</year>
          <volume>11</volume>
          <fpage>e0163720</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0163720</pub-id>
          <pub-id pub-id-type="pmid">27669007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vuik</surname>
              <given-names>FER</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Composition of the mucosa-associated microbiota along the entire gastrointestinal tract of human individuals</article-title>
          <source>UEG J.</source>
          <year>2019</year>
          <volume>7</volume>
          <fpage>897</fpage>
          <lpage>907</lpage>
          <pub-id pub-id-type="doi">10.1177/2050640619852255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rowe</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Blood group O protects against severe <italic>Plasmodium falciparum</italic> malaria through the mechanism of reduced rosetting</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>17471</fpage>
          <lpage>17476</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0705390104</pub-id>
          <pub-id pub-id-type="pmid">17959777</pub-id>
        </element-citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Tolchin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Enteric bacterial agents and the ABO blood groups</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>1971</year>
          <volume>23</volume>
          <fpage>135</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">4933519</pub-id>
        </element-citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Camus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bina</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Carlier</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>ABO blood groups and clinical forms of schistosomiasis mansoni</article-title>
          <source>Trans. R. Soc. Trop. Med. Hyg.</source>
          <year>1977</year>
          <volume>71</volume>
          <fpage>182</fpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(77)90094-3</pub-id>
          <pub-id pub-id-type="pmid">877997</pub-id>
        </element-citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>FEL</given-names>
            </name>
            <name>
              <surname>Bortolini</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>JLA</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>CRM</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>A, B, O blood groups and hepatosplenic form of schistosomiasis mansoni (Symmer&#x2019;s fibrosis)</article-title>
          <source>Trans. R. Soc. Trop. Med. Hyg.</source>
          <year>1977</year>
          <volume>73</volume>
          <fpage>238</fpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(79)90224-4</pub-id>
        </element-citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ndamba</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gomo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nyazema</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Makaza</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kaondera</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>Schistosomiasis infection in relation to the ABO blood groups among school children in Zimbabwe</article-title>
          <source>Acta Trop.</source>
          <year>1997</year>
          <volume>65</volume>
          <fpage>181</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="doi">10.1016/S0001-706X(97)00671-2</pub-id>
          <pub-id pub-id-type="pmid">9177580</pub-id>
        </element-citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhuri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cholera and blood groups</article-title>
          <source>Lancet</source>
          <year>1977</year>
          <volume>2</volume>
          <fpage>404</fpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(77)90332-4</pub-id>
          <pub-id pub-id-type="pmid">70614</pub-id>
        </element-citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boren</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Attachment of <italic>Helicobacter pylori</italic> to human gastric epithelium mediated by blood group antigens</article-title>
          <source>Science</source>
          <year>1993</year>
          <volume>262</volume>
          <fpage>1892</fpage>
          <lpage>1895</lpage>
          <pub-id pub-id-type="doi">10.1126/science.8018146</pub-id>
          <pub-id pub-id-type="pmid">8018146</pub-id>
        </element-citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindesmith</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human susceptibility and resistance to Norwalk virus infection</article-title>
          <source>Nat. Med.</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>548</fpage>
          <lpage>553</lpage>
          <pub-id pub-id-type="doi">10.1038/nm860</pub-id>
          <pub-id pub-id-type="pmid">12692541</pub-id>
        </element-citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <mixed-citation publication-type="other">Galili, U. in <italic>&#x3B1;-Gal and Anti-Gal</italic> (eds Galili, U. &amp; Avila, J. L.) Vol. 32, 1&#x2013;23 (Springer, 1999).</mixed-citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prather</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Genetically modified pigs for medicine and agriculture</article-title>
          <source>Biotechnol. Genetic Eng. Rev.</source>
          <year>2008</year>
          <volume>25</volume>
          <fpage>245</fpage>
          <lpage>266</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0404511</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">7473</journal-id>
      <journal-id journal-id-type="nlm-ta">Science</journal-id>
      <journal-id journal-id-type="iso-abbrev">Science</journal-id>
      <journal-title-group>
        <journal-title>Science (New York, N.Y.)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-8075</issn>
      <issn pub-type="epub">1095-9203</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">30872525</article-id>
      <article-id pub-id-type="pmc">7336390</article-id>
      <article-id pub-id-type="doi">10.1126/science.aaw1026</article-id>
      <article-id pub-id-type="manuscript">NIHMS1598895</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chakraborty</surname>
            <given-names>Abhishek A.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Laukka</surname>
            <given-names>Tuomas</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Myllykoski</surname>
            <given-names>Matti</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ringel</surname>
            <given-names>Alison E.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Booker</surname>
            <given-names>Matthew A.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tolstorukov</surname>
            <given-names>Michael Y.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeff Meng</surname>
            <given-names>Yuzhong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meier</surname>
            <given-names>Samuel R.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jennings</surname>
            <given-names>Rebecca B.</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Creech</surname>
            <given-names>Amanda L.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herbert</surname>
            <given-names>Zachary T.</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Spinelli</surname>
            <given-names>Jessica</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McBrayer</surname>
            <given-names>Samuel K.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Olenchock</surname>
            <given-names>Benjamin A.</given-names>
          </name>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jaffe</surname>
            <given-names>Jacob D.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haigis</surname>
            <given-names>Marcia C.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beroukhim</surname>
            <given-names>Rameen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Signoretti</surname>
            <given-names>Sabina</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koivunen</surname>
            <given-names>Peppi</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref rid="CR1" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaelin</surname>
            <given-names>William G.</given-names>
            <suffix>Jr.</suffix>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A12">12</xref>
          <xref rid="CR1" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, MA 02215, USA</aff>
      <aff id="A2"><label>2</label>Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland</aff>
      <aff id="A3"><label>3</label>Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A4"><label>4</label>Department of Informatics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA</aff>
      <aff id="A5"><label>5</label>Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</aff>
      <aff id="A6"><label>6</label>Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A7"><label>7</label>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A8"><label>8</label>The Harvard-MIT Program in Health Sciences and Technology, Harvard Medical School, Boston, MA</aff>
      <aff id="A9"><label>9</label>Department of Pathology, Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A10"><label>10</label>Molecular Biology Core Facility, Dana-Farber Cancer Institute and Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, MA 02215, USA</aff>
      <aff id="A11"><label>11</label>Division of Cardiovascular Medicine, Department of Medicine, The Brigham and Women&#x2019;s Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA</aff>
      <aff id="A12"><label>12</label>Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P1">Author Contributions:</p>
          <p id="P2">A.A.C. and W.G.K. conceived experiments and wrote the manuscript, A.A.C, T.L., M.M., A.E.R., A.C., R.J., and J.S. performed experiments. A.A.C., T.L., M.M, A.E.R, M.A.B, M.Y.T, Y.J.M., S.M., S.K.M, B.O., Z.T.H, S.M., J.J., S.S., M.H., R.B., P.K., and W.G.K. analyzed data.</p>
        </fn>
        <corresp id="CR1"><label>*</label>Corresponding author. <email>william_kaelin@dfci.harvard.edu</email> (W.G.K.); <email>Peppi.Karppinen@oulu.fi</email> (P.K.)</corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>31</day>
        <month>5</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>3</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>3</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>06</day>
        <month>7</month>
        <year>2020</year>
      </pub-date>
      <volume>363</volume>
      <issue>6432</issue>
      <fpage>1217</fpage>
      <lpage>1222</lpage>
      <!--elocation-id from pubmed: 10.1126/science.aaw1026-->
      <abstract id="ABS1">
        <p id="P3">Oxygen sensing is central to metazoan biology and has implications for human disease. Mammalian cells express multiple oxygen-dependent enzymes called 2-oxoglutarate (OG)-dependent dioxygenases (2-OGDDs), but they vary in their oxygen affinities and hence their ability to sense oxygen. The 2-OGDD histone demethylases control histone methylation. Hypoxia increases histone methylation, but whether this reflects direct effects on histone demethylases, or indirect effects caused by the hypoxic-induction of the HIF (Hypoxia-inducible Factor) transcription factor or the 2-OG antagonist 2-hydroxyglutarate (2-HG), is unclear. Here we report that hypoxia promotes histone methylation in a HIF- and 2-HG-independent manner. We found that the H3K27 histone demethylase KDM6A/UTX, but not its paralog KDM6B, is oxygen-sensitive. KDM6A loss, like hypoxia, prevented H3K27 demethylation and blocked cellular differentiation. Restoring H3K27 methylation homeostasis in hypoxic cells reversed these effects. Thus oxygen directly affects chromatin regulators to control cell fate.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Science</journal-id>
      <journal-id journal-id-type="iso-abbrev">Science</journal-id>
      <journal-id journal-id-type="publisher-id">SCIENCE</journal-id>
      <journal-id journal-id-type="hwp">science</journal-id>
      <journal-title-group>
        <journal-title>Science (New York, N.y.)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-8075</issn>
      <issn pub-type="epub">1095-9203</issn>
      <publisher>
        <publisher-name>American Association for the Advancement of Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33495308</article-id>
      <article-id pub-id-type="pmc">7963219</article-id>
      <article-id pub-id-type="publisher-id">abf9302</article-id>
      <article-id pub-id-type="doi">10.1126/science.abf9302</article-id>
      <article-categories>
        <subj-group subj-group-type="article-type">
          <subject>Report</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Reports</subject>
        </subj-group>
        <subj-group subj-group-type="legacy-article-type">
          <subject>Reports</subject>
        </subj-group>
        <subj-group subj-group-type="field">
          <subject>Evolution</subject>
          <subject>Microbio</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prospective mapping of viral mutations that escape antibodies used to treat COVID-19</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6713-6904</contrib-id>
          <name>
            <surname>Starr</surname>
            <given-names>Tyler N.</given-names>
          </name>
          <xref ref-type="award" rid="award719367"/>
          <xref ref-type="award" rid="award719368"/>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="afn1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7202-3349</contrib-id>
          <name>
            <surname>Greaney</surname>
            <given-names>Allison J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="author-notes" rid="afn1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6703-3841</contrib-id>
          <name>
            <surname>Addetia</surname>
            <given-names>Amin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6014-4749</contrib-id>
          <name>
            <surname>Hannon</surname>
            <given-names>William W.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3192-7840</contrib-id>
          <name>
            <surname>Choudhary</surname>
            <given-names>Manish C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dingens</surname>
            <given-names>Adam S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9914-9662</contrib-id>
          <name>
            <surname>Li</surname>
            <given-names>Jonathan Z.</given-names>
          </name>
          <xref ref-type="award" rid="award719370"/>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1267-3408</contrib-id>
          <name>
            <surname>Bloom</surname>
            <given-names>Jesse D.</given-names>
          </name>
          <xref ref-type="award" rid="award719372"/>
          <xref ref-type="award" rid="award719373"/>
          <xref ref-type="award" rid="award719363"/>
          <xref ref-type="award" rid="award719366"/>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">&#x2020;</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.</aff>
        <aff id="aff2"><label>2</label>Department of Genome Sciences, University of Washington, Seattle, WA 98109, USA.</aff>
        <aff id="aff3"><label>3</label>Medical Scientist Training Program, University of Washington, Seattle, WA 98109, USA.</aff>
        <aff id="aff4"><label>4</label>Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA 98109, USA.</aff>
        <aff id="aff5"><label>5</label>Brigham and Women&#x2019;s Hospital, Harvard Medical School, Boston, MA 02115, USA.</aff>
        <aff id="aff6"><label>6</label>Howard Hughes Medical Institute, Seattle, WA 98109, USA.</aff>
      </contrib-group>
      <author-notes>
        <fn id="afn1" fn-type="equal">
          <label>*</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
        <corresp id="cor1"><label>&#x2020;</label>Corresponding author. Email: <email xlink:href="jbloom@fredhutch.org">jbloom@fredhutch.org</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>19</day>
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <!--epub date from history-->
      <pub-date pub-type="epub">
        <day>25</day>
        <month>1</month>
        <year>2021</year>
      </pub-date>
      <volume>371</volume>
      <issue>6531</issue>
      <fpage>850</fpage>
      <lpage>854</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>12</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>1</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>American Association for the Advancement of Science</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense" start_date="2021-02-19">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution license</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="editor">
        <title>Mapping antibody escape in SARS-CoV-2</title>
        <p>Several antibodies are in use or under development as therapies to treat COVID-19. As new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants emerge, it is important to predict whether they will remain susceptible to antibody treatment. Starr <italic>et al.</italic> used a yeast library that covers all mutations to the SARS-CoV-2 receptor-binding domain that do not strongly disrupt binding to the host receptor (ACE2) and mapped how these mutations affect binding to three leading anti&#x2013;SARS-CoV-2 antibodies. The maps identify mutations that escape antibody binding, including a single mutation that escapes both antibodies in the Regeneron antibody cocktail. Many of the mutations that escape single antibodies are circulating in the human population.</p>
        <p><italic>Science</italic>, this issue p. 850</p>
      </abstract>
      <abstract abstract-type="teaser">
        <p>Complete maps of SARS-CoV-2 mutations that escape the Regeneron monoclonal antibody cocktail help explain viral evolution in a treated patient.</p>
      </abstract>
      <abstract>
        <p>Antibodies are a potential therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the risk of the virus evolving to escape them remains unclear. Here we map how all mutations to the receptor binding domain (RBD) of SARS-CoV-2 affect binding by the antibodies in the REGN-COV2 cocktail and the antibody LY-CoV016. These complete maps uncover a single amino acid mutation that fully escapes the REGN-COV2 cocktail, which consists of two antibodies, REGN10933 and REGN10987, targeting distinct structural epitopes. The maps also identify viral mutations that are selected in a persistently infected patient treated with REGN-COV2 and during in vitro viral escape selections. Finally, the maps reveal that mutations escaping the individual antibodies are already present in circulating SARS-CoV-2 strains. These complete escape maps enable interpretation of the consequences of mutations observed during viral surveillance.</p>
      </abstract>
      <funding-group>
        <award-group id="award719372">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000011</institution-id>
              <institution>Howard Hughes Medical Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>Investigator</award-id>
        </award-group>
        <award-group id="award719373">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000011</institution-id>
              <institution>Howard Hughes Medical Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>Investigator</award-id>
        </award-group>
        <award-group id="award719363">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000060</institution-id>
              <institution>National Institute of Allergy and Infectious Diseases</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01AI127893</award-id>
        </award-group>
        <award-group id="award719366">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000060</institution-id>
              <institution>National Institute of Allergy and Infectious Diseases</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01AI141707</award-id>
        </award-group>
        <award-group id="award719791">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000865</institution-id>
              <institution>Bill and Melinda Gates Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>INV-004949</award-id>
        </award-group>
        <award-group id="award719367">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100001021</institution-id>
              <institution>Damon Runyon Cancer Research Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>DRG-2381-19</award-id>
        </award-group>
        <award-group id="award719370">
          <funding-source>
            <institution-wrap>
              <institution>Massachusetts Consortium for Pathogen Readiness</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <award-group id="award719368">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100001906</institution-id>
              <institution>Washington Research Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>Innovation Fellow</award-id>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Number-color-figs</meta-name>
          <meta-value>3</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Number-figs</meta-name>
          <meta-value>4</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Editor</meta-name>
          <meta-value>Valda Vinson</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>Copyeditor</meta-name>
          <meta-value>Nida Masiulis</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Antibodies are being developed as therapeutics to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). Antibodies against some other viruses can be rendered ineffective by viral mutations that are selected during treatment of infected patients (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>, <xref rid="R3" ref-type="bibr"><italic>3</italic></xref>) or that spread globally to confer resistance on entire viral clades (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). Therefore, determining which SARS-CoV-2 mutations escape key antibodies is essential for assessing how mutations observed during viral surveillance may affect the efficacy of antibody treatments.</p>
    <p>Most leading anti&#x2013;SARS-CoV-2 antibodies target the viral receptor binding domain (RBD), which mediates binding to the angiotensin-converting enzyme 2 (ACE2) receptor (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>, <xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). We recently developed a deep mutational scanning method to map how all mutations to the RBD affect its function and recognition by antiviral antibodies (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>, <xref rid="R8" ref-type="bibr"><italic>8</italic></xref>). This method involves creating libraries of RBD mutants, expressing them on the surface of yeast, and using fluorescence-activated cell sorting and deep sequencing to quantify how each mutation affects RBD folding, ACE2 affinity (measured across a titration series), and antibody binding (fig. S1A). In this study, we used the duplicate mutant libraries described in (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>), which consist of barcoded RBD variants that cover 3804 of the 3819 possible amino acid mutations. Our libraries were made in the genetic background of the RBD from the early isolate Wuhan-Hu-1, which still represents the most common RBD sequence, although several mutants are currently increasing in frequency (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>, <xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). We mapped how the 2034 mutations that do not strongly disrupt RBD folding and ACE binding (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>) affected binding by recombinant forms of the two antibodies in Regeneron&#x2019;s REGN-COV2 cocktail (REGN10933 and REGN10987) (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>, <xref rid="R12" ref-type="bibr"><italic>12</italic></xref>) and Eli Lilly&#x2019;s LY-CoV016 antibody (also known as CB6 or JS016) (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>) (fig. S1B). REGN-COV2 was recently granted emergency use authorization for treatment of COVID-19 (<xref rid="R14" ref-type="bibr"><italic>14</italic></xref>), whereas LY-CoV016 is currently in phase 3 clinical trials (<xref rid="R15" ref-type="bibr"><italic>15</italic></xref>).</p>
    <p>We completely mapped RBD mutations that escape binding by the three individual antibodies as well as the REGN-COV2 cocktail (<xref ref-type="fig" rid="F1">Fig. 1, A and B</xref>, and zoomable maps at <ext-link ext-link-type="uri" xlink:href="https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/">https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/</ext-link>). REGN10933 and REGN10987 are escaped by largely nonoverlapping sets of mutations in the RBD&#x2019;s receptor binding motif (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), consistent with structural work showing that these antibodies target distinct epitopes in this motif (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>). But unexpectedly, one mutation [Glu<sup>406</sup>&#x2192;Trp (E406W)] strongly escapes the cocktail of both antibodies (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). The escape map for LY-CoV016 also reveals escape mutations at a number of different sites in the RBD (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Although some escape mutations impair the RBD&#x2019;s ability to bind ACE2 or be expressed in properly folded form, many come at little or no cost to these functional properties, according to prior deep mutational scanning measurements using yeast-displayed RBD (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>) (color gradient in <xref ref-type="fig" rid="F1">Fig. 1, A and B</xref>, indicates loss of ACE2 affinity and in fig. S2 indicates decrease in RBD expression).</p>
    <fig id="F1" fig-type="figure" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Complete maps of mutations that escape binding by the REGN-COV2 antibodies and Ly-CoV016.</title>
        <p>(<bold>A</bold>) Maps for antibodies in REGN-COV2. Line plots at left show escape at each site in the RBD (summed effects of all mutations at each site). Sites of strong escape (purple underlines) are shown in logo plots at right. The height of each letter is proportional to how strongly that amino acid mutation mediates escape, with a per-mutation &#x201C;escape fraction&#x201D; of 1 corresponding to complete escape. The <italic>y</italic>-axis scale is different for each row, so, for instance, E406W escapes all REGN antibodies but is most visible for the cocktail as it is swamped out by other sites of escape for the individual antibodies. See <ext-link ext-link-type="uri" xlink:href="https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/">https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/</ext-link> for zoomable versions. Letters are colored according to how mutations affect the RBD&#x2019;s affinity for ACE2 as measured via yeast display (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>), with yellow indicating poor affinity and brown indicating good affinity; see fig. S2, A and B, for maps colored by how mutations affect expression of folded RBD and fig. S2, C and D, for distribution of effects on ACE2 affinity and RBD expression across all mutations observed among circulating viral isolates. (<bold>B</bold>) Map, as in (A), for LY-CoV016. (<bold>C</bold>) Validation of key mutations in neutralization assays using spike-pseudotyped lentiviral particles. We chose to validate mutations predicted to have large effects or that are present at high frequency among circulating SARS-CoV-2 isolates (e.g., N439K). Each point indicates the fold increase in the median inhibitory concentration (IC<sub>50</sub>) for a mutation relative to the unmutated wild-type (WT) spike, which contains D614G. The dotted blue line at 1 indicates WT-like neutralization, and values &gt;1 indicate increased neutralization resistance. Point colors indicate whether escape was expected at that site from the maps. Point shapes indicate that the fold change is censored (an upper or lower limit) owing to the IC<sub>50</sub> being outside the dilution series used. Most mutants were tested in duplicate and thus have two points. Full neutralization curves are shown in fig. S3. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.</p>
      </caption>
      <graphic xlink:href="371_850_F1"/>
    </fig>
    <p>To validate the antigenic effects of key mutations, we performed neutralization assays using spike-pseudotyped lentiviral particles and found concordance between the antibody binding escape maps and neutralization assays (<xref ref-type="fig" rid="F1">Fig. 1C</xref> and fig. S3). As expected from the maps for the REGN-COV2 antibodies, a mutation at site 486 escaped neutralization only by REGN10933, whereas mutations at sites 439 and 444 escaped neutralization only by REGN10987&#x2014;and so none of these mutations escaped the cocktail. But E406W escaped both individual REGN-COV2 antibodies and thus also strongly escaped the cocktail. Structural analyses and viral-escape selections led Regeneron to posit that no single amino acid mutation could escape both antibodies in the cocktail (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>, <xref rid="R12" ref-type="bibr"><italic>12</italic></xref>), but our complete maps identify E406W as a cocktail escape mutation. E406W affects the REGN-COV2 antibodies in a relatively specific way and does not grossly perturb the function of the RBD, given that it only mildly reduces neutralization by LY-CoV016 (<xref ref-type="fig" rid="F1">Fig. 1C</xref>) and the titers of spike-pseudotyped lentiviral particles (fig. S3F).</p>
    <p>To explore whether our escape maps are consistent with how the virus evolves under antibody selection, we first examined data from Regeneron&#x2019;s viral escape&#x2013;selection experiments in which spike-expressing vesicular stomatitis virus (VSV) was grown in cell culture in the presence of either REGN10933, REGN10987, or the REGN-COV2 cocktail (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>). That work identified five escape mutations from REGN10933, two from REGN10987, and none from the cocktail (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). All seven cell culture&#x2013;selected mutations were prominent in our escape maps while also being accessible by just a single-nucleotide change to the wild-type codon in the Wuhan-Hu-1 RBD sequence (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), demonstrating concordance between the escape maps and viral evolution under antibody pressure in cell culture. Notably, E406W is not accessible by a single-nucleotide change, which may explain why it was not identified by the Regeneron cocktail selections despite being relatively well tolerated for RBD folding and ACE2 affinity.</p>
    <fig id="F2" fig-type="figure" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <title>Escape maps are consistent with viral mutations selected in cell culture and a persistently infected patient.</title>
        <p>(<bold>A</bold>) Viral escape mutations selected by Regeneron with spike-pseudotyped VSV in cell culture in the presence of antibody (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>). (<bold>B</bold>) Escape maps like those in <xref ref-type="fig" rid="F1">Fig. 1A</xref>, but showing only mutations accessible by single-nucleotide changes to the Wuhan-Hu-1 sequence, with nongray colors indicating mutations in cell culture (red), the infected patient (blue), or both (purple). Figure S5 shows these maps colored by how mutations affect ACE2 affinity or RBD expression. (<bold>C</bold>) Dynamics of RBD mutations in a patient treated with REGN-COV2 at day 145 of infection (black dot-dash vertical line). E484A rose in frequency in linkage with F486I, but because E484A is not an escape mutation in our maps, it is not shown in other panels. See also fig. S4. (<bold>D</bold>) The escape mutations that arise in cell culture and the infected patient are single-nucleotide&#x2013;accessible and escape antibody binding without imposing a large cost on ACE2 affinity [as measured using yeast display (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>)]. Each point is a mutation, with shape and color indicating whether it is accessible and selected during viral growth. Points farther to the right on the <italic>x</italic> axis indicate stronger escape from antibody binding; points higher up on the <italic>y</italic> axis indicate higher ACE2 affinity.</p>
      </caption>
      <graphic xlink:href="371_850_F2"/>
    </fig>
    <p>To determine whether the escape maps could inform analysis of viral evolution in infected humans, we examined deep sequencing data from a persistently infected immunocompromised patient who was treated with REGN-COV2 at day 145 after diagnosis with COVID-19 (<xref rid="R16" ref-type="bibr"><italic>16</italic></xref>). The late administration of the treatment allowed ample time for the patient&#x2019;s viral population to accumulate genetic diversity, some of which could have been driven by immune pressure, because the patient mounted a weak autologous neutralizing antibody response before treatment (<xref rid="R16" ref-type="bibr"><italic>16</italic></xref>). Administration of REGN-COV2 was followed by rapid changes in the frequencies of five amino acid mutations in the RBD (<xref ref-type="fig" rid="F2">Fig. 2C</xref> and fig. S4). Our escape maps showed that three of these mutations escaped REGN10933 and that one escaped REGN10987 (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Notably, the mutations did not all sweep to fixation after antibody treatment; instead, there were competing rises and falls (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). This pattern has been observed in the adaptive within-host evolution of other viruses (<xref rid="R17" ref-type="bibr"><italic>17</italic></xref>, <xref rid="R18" ref-type="bibr"><italic>18</italic></xref>) and can arise from genetic hitchhiking and competition among viral lineages. Both these forces appear to be at play in the persistently infected patient (<xref ref-type="fig" rid="F2">Fig. 2C</xref> and fig. S4C): E484A (not an escape mutation in our maps) hitchhikes with F486I (which escapes REGN10933) after treatment, and the viral lineage carrying N440D and Q493K (which escape REGN10987 and REGN10933, respectively) competes first with the REGN10933 escape-mutant Y489H and then with the lineage carrying E484A and F486I and the Q493K lineage.</p>
    <p>Three of the four escape mutations in the REGN-COV2&#x2013;treated patient were not identified in Regeneron&#x2019;s viral cell culture selections (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), illustrating an advantage of complete maps. Viral selections are incomplete in the sense that they only identify whatever mutations are stochastically selected in that particular cell culture experiment. In contrast, complete maps annotate all mutations, which could include mutations that arise for reasons unrelated to treatment but incidentally affect antibody binding.</p>
    <p>Of course, viral evolution is shaped by functional constraints as well as pressure to evade antibodies. The mutations selected in cell culture and the patient consistently met the following criteria: They escaped antibody binding, were accessible via a single-nucleotide change, and imposed little or no cost on ACE2 affinity [as measured by prior deep mutational scanning using yeast-displayed RBD (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>)] (<xref ref-type="fig" rid="F2">Fig. 2D</xref> and fig. S5). Therefore, complete maps of how mutations affect key biochemical phenotypes of the RBD (e.g., ACE and antibody binding) can be used to assess likely paths of viral evolution. One caveat is that over longer evolutionary time frames, the space of tolerated mutations could shift as a result of epistatic interactions, as has been observed in viral immune and drug escape (<xref rid="R19" ref-type="bibr"><italic>19</italic></xref>&#x2013;<xref rid="R21" ref-type="bibr"><italic>21</italic></xref>).</p>
    <p>The complete maps enable us to assess what escape mutations are already present among circulating SARS-CoV-2. We examined all human-derived SARS-CoV-2 sequences available as of 11 January 2021 and found a substantial number of RBD mutations that escaped one or more of the antibodies (<xref ref-type="fig" rid="F3">Fig. 3</xref>). However, the only escape mutations present in &gt;0.1% of sequences were the REGN10933 escape-mutant Y453F [0.3% of sequences; see also (<xref rid="R12" ref-type="bibr"><italic>12</italic></xref>)], the REGN10987 escape-mutant N439K [1.7% of sequences; see also <xref ref-type="fig" rid="F1">Fig. 1C</xref> and (<xref rid="R22" ref-type="bibr"><italic>22</italic></xref>)], and the LY-CoV016 escape-mutant K417N (0.1% of sequences; see also <xref ref-type="fig" rid="F1">Fig. 1C</xref>). Y453F is associated with independent outbreaks linked to mink farms in the Netherlands and Denmark (<xref rid="R23" ref-type="bibr"><italic>23</italic></xref>, <xref rid="R24" ref-type="bibr"><italic>24</italic></xref>); notably, the mink sequences themselves sometimes also contain other escape mutations, such as F486L (<xref rid="R24" ref-type="bibr"><italic>24</italic></xref>). N439K is prevalent in Europe, where it has constituted a large percentage of sequences from regions including Scotland and Ireland (<xref rid="R22" ref-type="bibr"><italic>22</italic></xref>, <xref rid="R25" ref-type="bibr"><italic>25</italic></xref>). K417N is present in the B.1.351 lineage first identified in South Africa (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). Another mutation of current interest is N501Y, which is present in B.1.351 and also the B.1.1.7 lineage originally identified in the United Kingdom (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>). Our maps indicate that N501Y has no effect on either of the REGN-COV2 antibodies and has only a modest effect on LY-CoV016 (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
    <fig id="F3" fig-type="figure" orientation="portrait" position="float">
      <label>Fig. 3</label>
      <caption>
        <title>Antibody escape mutations in circulating SARS-CoV-2.</title>
        <p>For each antibody or antibody combination, the escape score for each mutation is plotted versus its frequency among the 317,866 high-quality human-derived SARS-CoV-2 sequences on GISAID (<xref rid="R26" ref-type="bibr"><italic>26</italic></xref>) as of 11 January 2021. Escape mutations with notable GISAID frequencies are labeled. The REGN-COV2 cocktail escape mutation E406W requires multiple nucleotide changes from the Wuhan-Hu-1 RBD sequence and is not observed among sequences in GISAID. Other mutations to residue E406 (E406Q and E406D) are observed with low frequency counts, but neither of these mutant amino acids is a single-nucleotide mutation away from W either.</p>
      </caption>
      <graphic xlink:href="371_850_F3"/>
    </fig>
    <p>To determine whether the escape maps could be rationalized from the structural interfaces of the antibodies and RBD, we projected the maps onto crystal or cryo&#x2013;electron microscopy structures (<xref ref-type="fig" rid="F4">Fig. 4A</xref>; interactive versions at <ext-link ext-link-type="uri" xlink:href="https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/">https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/</ext-link>). As might be expected, escape mutations generally occur in the antibody-RBD interface. However, structures alone are insufficient to predict which mutations mediate escape. For example, LY-CoV016 uses both its heavy and light chains to bind a wide epitope overlapping the ACE2-binding surface, but escape is dominated by mutations at RBD residues that contact the heavy-chain complementarity-determining regions (<xref ref-type="fig" rid="F4">Fig. 4A</xref> and fig. S6, E to G). In contrast, escape from REGN10933 and REGN10987 mostly occurs at RBD residues that pack at the antibody heavy- and light-chain interface (<xref ref-type="fig" rid="F4">Fig. 4A</xref> and fig. S6, A to D). The E406W mutation that escapes the REGN-COV2 cocktail occurs at a residue not in contact with either antibody (<xref ref-type="fig" rid="F4">Fig. 4, A and B</xref>). Although E406 is in closer structural proximity to LY-CoV016 (<xref ref-type="fig" rid="F4">Fig. 4B</xref> and fig. S6H), the E406W mutation has a much smaller impact on this antibody (<xref ref-type="fig" rid="F1">Fig. 1, B and C</xref>), suggesting a long-range structural mechanism specific to the REGN-COV2 antibodies (fig. S6I). Taken together, mutations at RBD residues that contact antibody do not always mediate escape, and several prominent escape mutations occur at residues not in contact with antibody (<xref ref-type="fig" rid="F4">Fig. 4B</xref> and fig. S6, D and G).</p>
    <fig id="F4" fig-type="figure" orientation="portrait" position="float">
      <label>Fig. 4</label>
      <caption>
        <title>Structural context of escape mutations.</title>
        <p>(<bold>A</bold>) Escape maps projected on antibody-bound RBD structures. [REGN10933 and REGN10987: Protein Data Bank (PDB) ID 6XDG (<xref rid="R11" ref-type="bibr"><italic>11</italic></xref>); LY-CoV016: PDB ID 7C01 (<xref rid="R13" ref-type="bibr"><italic>13</italic></xref>)]. Antibody heavy- and light-chain variable domains are shown as blue cartoons, and the RBD surface is colored to indicate how strongly mutations at that site mediate escape (white indicates no escape, red indicates strongest escape site for that antibody or cocktail). Sites where no mutations are functionally tolerated are colored gray. (<bold>B</bold>) For each antibody, sites were classified as direct antibody contacts (non-hydrogen atoms within 4 &#xC5; of antibody), antibody-proximal (4 to 8 &#xC5;), or antibody-distal (&gt;8 &#xC5;). Each point indicates a site, classified as escape (red) or non-escape (black). The dashed gray line indicates the cutoff used to classify sites as escape or non-escape (see materials and methods for details). Red and black numbers indicate how many sites in each category are escape or non-escape sites, respectively. Interactive visualizations are at <ext-link ext-link-type="uri" xlink:href="https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/">https://jbloomlab.github.io/SARS-CoV-2-RBD_MAP_clinical_Abs/</ext-link>, and hypothesized mechanisms of escape and additional structural details for labeled points are shown in fig. S6.</p>
      </caption>
      <graphic xlink:href="371_850_F4"/>
    </fig>
    <p>In this study, we have completely mapped mutations that escape three leading anti&#x2013;SARS-CoV-2 antibodies. These maps demonstrate that prior characterization of escape mutations was incomplete, having identified neither a single amino acid mutation that escapes both antibodies in the REGN-COV2 cocktail nor most mutations that arose in a persistently infected patient treated with the cocktail. Of course, our maps still do not answer the most pressing question: Will SARS-CoV-2 evolve widespread resistance to these antibodies? But certainly, it is concerning that so many escape mutations impose little cost on RBD folding or receptor affinity and that some are already present at low levels among circulating viruses. Ultimately, it will be necessary to wait and see what mutations spread as SARS-CoV-2 circulates in the human population. Our work will help with the &#x201C;seeing,&#x201D; by enabling immediate interpretation of the effects of the mutations cataloged by viral genomic surveillance.</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank K. Crawford for help with neutralization assays; A. Feder, D. Veesler, N. King, and D. Ellis for helpful comments; and the Fred Hutch Flow Cytometry and Genomics facilities for assistance. <bold>Funding:</bold> This work was supported by the NIAID (R01AI127893 and R01AI141707 to J.D.B. and T32AI083203 to A.J.G.), the Gates Foundation (INV-004949 to J.D.B.), and the Massachusetts Consortium for Pathogen Readiness through grants from the Evergrande Fund (to J.Z.L.). Scientific computing at Fred Hutch is supported by ORIP grant S10OD028685. T.N.S. is a Washington Research Foundation Innovation Fellow at the University of Washington Institute for Protein Design and an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2381-19). J.D.B. is an investigator of the Howard Hughes Medical Institute. <bold>Author contributions:</bold> T.N.S., A.J.G., A.S.D., and J.D.B. designed the study. T.N.S., A.J.G., A.A., and A.S.D. performed the experiments. T.N.S., A.J.G., and J.D.B. analyzed the experimental data. J.Z.L. and M.C.C. sequenced the persistent infection, and W.W.H. analyzed that data. T.N.S., A.A., W.W.H., and J.D.B. wrote the initial draft, and all authors edited the final version. <bold>Competing interests:</bold> J.Z.L. has consulted for Abbvie and Jan Biotech. The other authors declare no competing interests. <bold>Data and materials availability:</bold> Raw sequencing data are on the NCBI SRA under BioProject PRJNA639956/BioSample SAMN16850904 (escape mapping) and BioProject PRJNA681234 (patient sequencing). Computer code and processed data for the escape mapping are at (<xref rid="R27" ref-type="bibr"><italic>27</italic></xref>) and <ext-link ext-link-type="uri" xlink:href="https://github.com/jbloomlab/SARS-CoV-2-RBD_MAP_clinical_Abs">https://github.com/jbloomlab/SARS-CoV-2-RBD_MAP_clinical_Abs</ext-link>. Code and data for the patient sequencing are at (<xref rid="R28" ref-type="bibr"><italic>28</italic></xref>) and <ext-link ext-link-type="uri" xlink:href="https://github.com/jbloomlab/SARS-CoV-2_chronic-infection-seq">https://github.com/jbloomlab/SARS-CoV-2_chronic-infection-seq</ext-link>. The sequences of the antibodies are provided via citations in the materials and methods, the cells and plasmids for the neutralization assays are available in BEI Resources and AddGene (see materials and methods for details), and the yeast mutant libraries are available to academic researchers upon request with a completed material transfer agreement. We gratefully acknowledge the authors from the originating laboratories and the submitting laboratories, who generated and shared via GISAID genetic sequence data on which this research is based (all contributors listed at <ext-link ext-link-type="uri" xlink:href="https://github.com/jbloomlab/SARS-CoV-2-RBD_MAP_clinical_Abs/blob/main/data/gisaid_hcov-19_acknowledgement_table_2021_01_11.pdf">https://github.com/jbloomlab/SARS-CoV-2-RBD_MAP_clinical_Abs/blob/main/data/gisaid_hcov-19_acknowledgement_table_2021_01_11.pdf</ext-link>). This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.</p>
    </ack>
    <app-group>
      <app>
        <title>Supplementary Materials</title>
        <supplementary-material content-type="local-data">
          <p>
            <ext-link ext-link-type="uri" xlink:href="https://science.sciencemag.org/content/371/6531/850/suppl/DC1">science.sciencemag.org/content/371/6531/850/suppl/DC1</ext-link>
          </p>
          <p>Materials and Methods</p>
          <p>Figs. S1 to S6</p>
          <p>References (<xref rid="R29" ref-type="bibr"><italic>29</italic></xref>&#x2013;<xref rid="R39" ref-type="bibr"><italic>39</italic></xref>)</p>
          <p>MDAR Reproducibility Checklist</p>
          <p>Data S1</p>
        </supplementary-material>
      </app>
      <app>
        <p><ext-link ext-link-type="uri" xlink:href="https://en.bio-protocol.org/cjrap.aspx?eid=10.1126/science.abf9302">View/request a protocol for this paper from <italic>Bio-protocol</italic></ext-link>.</p>
      </app>
    </app-group>
    <ref-list>
      <title>References and Notes</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names>
<surname>Renn</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Fu</surname></string-name>, <string-name><given-names>X.</given-names>
<surname>Hu</surname></string-name>, <string-name><given-names>M. D.</given-names>
<surname>Hall</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Simeonov</surname></string-name></person-group>, 
<article-title>Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2</article-title>. <source>Trends Pharmacol. Sci.</source>
<volume>41</volume>, 
<fpage>815</fpage>&#x2013;<lpage>829</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1016/j.tips.2020.07.004</pub-id><pub-id pub-id-type="pmid">32829936</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names>
<surname>Caskey</surname></string-name>, <string-name><given-names>F.</given-names>
<surname>Klein</surname></string-name>, <string-name><given-names>J. C. C.</given-names>
<surname>Lorenzi</surname></string-name>, <string-name><given-names>M. S.</given-names>
<surname>Seaman</surname></string-name>, <string-name><given-names>A. P.</given-names>
<surname>West</surname>
<suffix>Jr.</suffix></string-name>., <string-name><given-names>N.</given-names>
<surname>Buckley</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Kremer</surname></string-name>, <string-name><given-names>L.</given-names>
<surname>Nogueira</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Braunschweig</surname></string-name>, <string-name><given-names>J. F.</given-names>
<surname>Scheid</surname></string-name>, <string-name><given-names>J. A.</given-names>
<surname>Horwitz</surname></string-name>, <string-name><given-names>I.</given-names>
<surname>Shimeliovich</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Ben-Avraham</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Witmer-Pack</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Platten</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>Lehmann</surname></string-name>, <string-name><given-names>L. A.</given-names>
<surname>Burke</surname></string-name>, <string-name><given-names>T.</given-names>
<surname>Hawthorne</surname></string-name>, <string-name><given-names>R. J.</given-names>
<surname>Gorelick</surname></string-name>, <string-name><given-names>B. D.</given-names>
<surname>Walker</surname></string-name>, <string-name><given-names>T.</given-names>
<surname>Keler</surname></string-name>, <string-name><given-names>R. M.</given-names>
<surname>Gulick</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>F&#xE4;tkenheuer</surname></string-name>, <string-name><given-names>S. J.</given-names>
<surname>Schlesinger</surname></string-name>, <string-name><given-names>M. C.</given-names>
<surname>Nussenzweig</surname></string-name></person-group>, 
<article-title>Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117</article-title>. <source>Nature</source>
<volume>522</volume>, 
<fpage>487</fpage>&#x2013;<lpage>491</lpage> (<year>2015</year>). <pub-id pub-id-type="doi">10.1038/nature14411</pub-id><pub-id pub-id-type="pmid">25855300</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. R.</given-names>
<surname>Kugelman</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Kugelman-Tonos</surname></string-name>, <string-name><given-names>J. T.</given-names>
<surname>Ladner</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Pettit</surname></string-name>, <string-name><given-names>C. M.</given-names>
<surname>Keeton</surname></string-name>, <string-name><given-names>E. R.</given-names>
<surname>Nagle</surname></string-name>, <string-name><given-names>K. Y.</given-names>
<surname>Garcia</surname></string-name>, <string-name><given-names>J. W.</given-names>
<surname>Froude</surname></string-name>, <string-name><given-names>A. I.</given-names>
<surname>Kuehne</surname></string-name>, <string-name><given-names>J. H.</given-names>
<surname>Kuhn</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Bavari</surname></string-name>, <string-name><given-names>L.</given-names>
<surname>Zeitlin</surname></string-name>, <string-name><given-names>J. M.</given-names>
<surname>Dye</surname></string-name>, <string-name><given-names>G. G.</given-names>
<surname>Olinger</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Sanchez-Lockhart</surname></string-name>, <string-name><given-names>G. F.</given-names>
<surname>Palacios</surname></string-name></person-group>, 
<article-title>Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail</article-title>. <source>Cell Rep.</source>
<volume>12</volume>, 
<fpage>2111</fpage>&#x2013;<lpage>2120</lpage> (<year>2015</year>). <pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.038</pub-id><pub-id pub-id-type="pmid">26365189</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>E. A. F.</given-names>
<surname>Sim&#xF5;es</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Forleo-Neto</surname></string-name>, <string-name><given-names>G. P.</given-names>
<surname>Geba</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Kamal</surname></string-name>, <string-name><given-names>F.</given-names>
<surname>Yang</surname></string-name>, <string-name><given-names>H.</given-names>
<surname>Cicirello</surname></string-name>, <string-name><given-names>M. R.</given-names>
<surname>Houghton</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Rideman</surname></string-name>, <string-name><given-names>Q.</given-names>
<surname>Zhao</surname></string-name>, <string-name><given-names>S. L.</given-names>
<surname>Benvin</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Hawes</surname></string-name>, <string-name><given-names>E. D.</given-names>
<surname>Fuller</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Wloga</surname></string-name>, <string-name><given-names>J. M. N.</given-names>
<surname>Pizarro</surname></string-name>, <string-name><given-names>F. M.</given-names>
<surname>Munoz</surname></string-name>, <string-name><given-names>S. A.</given-names>
<surname>Rush</surname></string-name>, <string-name><given-names>J. S.</given-names>
<surname>McLellan</surname></string-name>, <string-name><given-names>L.</given-names>
<surname>Lipsich</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Stahl</surname></string-name>, <string-name><given-names>G. D.</given-names>
<surname>Yancopoulos</surname></string-name>, <string-name><given-names>D. M.</given-names>
<surname>Weinreich</surname></string-name>, <string-name><given-names>C. A.</given-names>
<surname>Kyratsous</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Sivapalasingam</surname></string-name></person-group>, 
<article-title>Suptavumab for the prevention of medically attended respiratory syncytial virus infection in preterm infants</article-title>. <source>Clin. Infect. Dis.</source>
<elocation-id>ciaa951</elocation-id> (<year>2020</year>). <pub-id pub-id-type="doi">10.1093/cid/ciaa951</pub-id><pub-id pub-id-type="pmid">32897368</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D.</given-names>
<surname>Wrapp</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Wang</surname></string-name>, <string-name><given-names>K. S.</given-names>
<surname>Corbett</surname></string-name>, <string-name><given-names>J. A.</given-names>
<surname>Goldsmith</surname></string-name>, <string-name><given-names>C.-L.</given-names>
<surname>Hsieh</surname></string-name>, <string-name><given-names>O.</given-names>
<surname>Abiona</surname></string-name>, <string-name><given-names>B. S.</given-names>
<surname>Graham</surname></string-name>, <string-name><given-names>J. S.</given-names>
<surname>McLellan</surname></string-name></person-group>, 
<article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title>. <source>Science</source>
<volume>367</volume>, 
<fpage>1260</fpage>&#x2013;<lpage>1263</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1126/science.abb2507</pub-id><pub-id pub-id-type="pmid">32075877</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. C.</given-names>
<surname>Walls</surname></string-name>, <string-name><given-names>Y.-J.</given-names>
<surname>Park</surname></string-name>, <string-name><given-names>M. A.</given-names>
<surname>Tortorici</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Wall</surname></string-name>, <string-name><given-names>A. T.</given-names>
<surname>McGuire</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Veesler</surname></string-name></person-group>, 
<article-title>Structure, function, and antigenicity of the sars-CoV-2 spike glycoprotein</article-title>. <source>Cell</source>
<volume>181</volume>, 
<fpage>281</fpage>&#x2013;<lpage>292.e6</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmid">32155444</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>T. N.</given-names>
<surname>Starr</surname></string-name>, <string-name><given-names>A. J.</given-names>
<surname>Greaney</surname></string-name>, <string-name><given-names>S. K.</given-names>
<surname>Hilton</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Ellis</surname></string-name>, <string-name><given-names>K. H. D.</given-names>
<surname>Crawford</surname></string-name>, <string-name><given-names>A. S.</given-names>
<surname>Dingens</surname></string-name>, <string-name><given-names>M. J.</given-names>
<surname>Navarro</surname></string-name>, <string-name><given-names>J. E.</given-names>
<surname>Bowen</surname></string-name>, <string-name><given-names>M. A.</given-names>
<surname>Tortorici</surname></string-name>, <string-name><given-names>A. C.</given-names>
<surname>Walls</surname></string-name>, <string-name><given-names>N. P.</given-names>
<surname>King</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Veesler</surname></string-name>, <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding</article-title>. <source>Cell</source>
<volume>182</volume>, 
<fpage>1295</fpage>&#x2013;<lpage>1310.e20</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1016/j.cell.2020.08.012</pub-id><pub-id pub-id-type="pmid">32841599</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. J.</given-names>
<surname>Greaney</surname></string-name>, <string-name><given-names>T. N.</given-names>
<surname>Starr</surname></string-name>, <string-name><given-names>P.</given-names>
<surname>Gilchuk</surname></string-name>, <string-name><given-names>S. J.</given-names>
<surname>Zost</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Binshtein</surname></string-name>, <string-name><given-names>A. N.</given-names>
<surname>Loes</surname></string-name>, <string-name><given-names>S. K.</given-names>
<surname>Hilton</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Huddleston</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Eguia</surname></string-name>, <string-name><given-names>K. H. D.</given-names>
<surname>Crawford</surname></string-name>, <string-name><given-names>A. S.</given-names>
<surname>Dingens</surname></string-name>, <string-name><given-names>R. S.</given-names>
<surname>Nargi</surname></string-name>, <string-name><given-names>R. E.</given-names>
<surname>Sutton</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Suryadevara</surname></string-name>, <string-name><given-names>P. W.</given-names>
<surname>Rothlauf</surname></string-name>, <string-name><given-names>Z.</given-names>
<surname>Liu</surname></string-name>, <string-name><given-names>S. P. J.</given-names>
<surname>Whelan</surname></string-name>, <string-name><given-names>R. H.</given-names>
<surname>Carnahan</surname></string-name>, <string-name><given-names>J. E.</given-names>
<surname>Crowe</surname>
<suffix>Jr.</suffix></string-name>., <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition</article-title>. <source>Cell Host Microbe</source>
<volume>29</volume>, 
<fpage>44</fpage>&#x2013;<lpage>57.e9</lpage> (<year>2021</year>). <pub-id pub-id-type="doi">10.1016/j.chom.2020.11.007</pub-id><pub-id pub-id-type="pmid">33259788</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="web">A. Rambaut, N. Loman, O. Pybus, W. Barclay, J. Barrett, A. Carabelli, T. Connor, T. Peacock, D. Robertson, E. Volz, &#x201C;Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations,&#x201D; Virological.org (2020); <ext-link ext-link-type="uri" xlink:href="https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563">https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563</ext-link>.</mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="web">H. Tegally, E. Wilkinson, M. Giovanetti, A. Iranzadeh, V.Fonseca, J. Giandhari, D. Doolabh, S. Pillay, E. J. San, N. Msomi, K. Mlisana, A. von Gottberg, S.Walaza, M. Allam, A. Ismail, T. Mohale, A. J. Glass, S. Engelbrecht, G. V. Zyl, W. Preiser, F.Petruccione, A. Sigal, D. Hardie, G. Marais, M. Hsiao, S. Korsman, M.-A. Davies, L. Tyers, I. Mudau,D. York, C. Maslo, D. Goedhals, S. Abrahams, O. Laguda-Akingba, A. Alisoltani-Dehkordi, A. Godzik,C. K. Wibmer, B. T. Sewell, J. Louren&#xE7;o, L. C. J. Alcantara, S. L. K. Pond, S. Weaver, D.Martin, R. J. Lessells, J. N. Bhiman, C. Williamson, T. de Oliveira, Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv 2020.12.21.20248640 [Preprint]. 22 December 2020. <pub-id pub-id-type="doi">10.1101/2020.12.21.20248640</pub-id>.</mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names>
<surname>Hansen</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Baum</surname></string-name>, <string-name><given-names>K. E.</given-names>
<surname>Pascal</surname></string-name>, <string-name><given-names>V.</given-names>
<surname>Russo</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Giordano</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Wloga</surname></string-name>, <string-name><given-names>B. O.</given-names>
<surname>Fulton</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Yan</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Koon</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Patel</surname></string-name>, <string-name><given-names>K. M.</given-names>
<surname>Chung</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Hermann</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Ullman</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Cruz</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Rafique</surname></string-name>, <string-name><given-names>T.</given-names>
<surname>Huang</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Fairhurst</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>Libertiny</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Malbec</surname></string-name>, <string-name><given-names>W. Y.</given-names>
<surname>Lee</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Welsh</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Farr</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Pennington</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Deshpande</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Cheng</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Watty</surname></string-name>, <string-name><given-names>P.</given-names>
<surname>Bouffard</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Babb</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Levenkova</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>Chen</surname></string-name>, <string-name><given-names>B.</given-names>
<surname>Zhang</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Romero Hernandez</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Saotome</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Zhou</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Franklin</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Sivapalasingam</surname></string-name>, <string-name><given-names>D. C.</given-names>
<surname>Lye</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Weston</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Logue</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Haupt</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Frieman</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Chen</surname></string-name>, <string-name><given-names>W.</given-names>
<surname>Olson</surname></string-name>, <string-name><given-names>A. J.</given-names>
<surname>Murphy</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Stahl</surname></string-name>, <string-name><given-names>G. D.</given-names>
<surname>Yancopoulos</surname></string-name>, <string-name><given-names>C. A.</given-names>
<surname>Kyratsous</surname></string-name></person-group>, 
<article-title>Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail</article-title>. <source>Science</source>
<volume>369</volume>, 
<fpage>1010</fpage>&#x2013;<lpage>1014</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1126/science.abd0827</pub-id><pub-id pub-id-type="pmid">32540901</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names>
<surname>Baum</surname></string-name>, <string-name><given-names>B. O.</given-names>
<surname>Fulton</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Wloga</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Copin</surname></string-name>, <string-name><given-names>K. E.</given-names>
<surname>Pascal</surname></string-name>, <string-name><given-names>V.</given-names>
<surname>Russo</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Giordano</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Lanza</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Negron</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Ni</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Wei</surname></string-name>, <string-name><given-names>G. S.</given-names>
<surname>Atwal</surname></string-name>, <string-name><given-names>A. J.</given-names>
<surname>Murphy</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Stahl</surname></string-name>, <string-name><given-names>G. D.</given-names>
<surname>Yancopoulos</surname></string-name>, <string-name><given-names>C. A.</given-names>
<surname>Kyratsous</surname></string-name></person-group>, 
<article-title>Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies</article-title>. <source>Science</source>
<volume>369</volume>, 
<fpage>1014</fpage>&#x2013;<lpage>1018</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1126/science.abd0831</pub-id><pub-id pub-id-type="pmid">32540904</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R.</given-names>
<surname>Shi</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>Shan</surname></string-name>, <string-name><given-names>X.</given-names>
<surname>Duan</surname></string-name>, <string-name><given-names>Z.</given-names>
<surname>Chen</surname></string-name>, <string-name><given-names>P.</given-names>
<surname>Liu</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Song</surname></string-name>, <string-name><given-names>T.</given-names>
<surname>Song</surname></string-name>, <string-name><given-names>X.</given-names>
<surname>Bi</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>Han</surname></string-name>, <string-name><given-names>L.</given-names>
<surname>Wu</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Gao</surname></string-name>, <string-name><given-names>X.</given-names>
<surname>Hu</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Zhang</surname></string-name>, <string-name><given-names>Z.</given-names>
<surname>Tong</surname></string-name>, <string-name><given-names>W.</given-names>
<surname>Huang</surname></string-name>, <string-name><given-names>W. J.</given-names>
<surname>Liu</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Wu</surname></string-name>, <string-name><given-names>B.</given-names>
<surname>Zhang</surname></string-name>, <string-name><given-names>L.</given-names>
<surname>Wang</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Qi</surname></string-name>, <string-name><given-names>H.</given-names>
<surname>Feng</surname></string-name>, <string-name><given-names>F.-S.</given-names>
<surname>Wang</surname></string-name>, <string-name><given-names>Q.</given-names>
<surname>Wang</surname></string-name>, <string-name><given-names>G. F.</given-names>
<surname>Gao</surname></string-name>, <string-name><given-names>Z.</given-names>
<surname>Yuan</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Yan</surname></string-name></person-group>, 
<article-title>A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2</article-title>. <source>Nature</source>
<volume>584</volume>, 
<fpage>120</fpage>&#x2013;<lpage>124</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1038/s41586-020-2381-y</pub-id><pub-id pub-id-type="pmid">32454512</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="web">Regeneron Pharmaceuticals, Inc., &#x201C;Regeneron&#x2019;s casirivimab and imdevimab antibody cocktail for COVID-19 is first combination therapy to receive FDA emergency use authorization,&#x201D; press release (21 November 2020); <ext-link ext-link-type="uri" xlink:href="https://investor.regeneron.com/news-releases/news-release-details/regenerons-regen-cov2-first-antibody-cocktail-covid-19-receive/">https://investor.regeneron.com/news-releases/news-release-details/regenerons-regen-cov2-first-antibody-cocktail-covid-19-receive/</ext-link>.</mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="web">Eli Lilly and Company, &#x201C;A phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of LY3819253 alone and in combination with LY3832479 in preventing SARS-CoV-2 infection and COVID-19 in skilled nursing and assisted living facility residents and staff; a NIAID and Lilly Collaborative Study&#x201D; (Clinical trial registration NCT04497987, clinicaltrials.gov, 2020); <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04497987">https://clinicaltrials.gov/ct2/show/NCT04497987</ext-link>.</mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>B.</given-names>
<surname>Choi</surname></string-name>, <string-name><given-names>M. C.</given-names>
<surname>Choudhary</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Regan</surname></string-name>, <string-name><given-names>J. A.</given-names>
<surname>Sparks</surname></string-name>, <string-name><given-names>R. F.</given-names>
<surname>Padera</surname></string-name>, <string-name><given-names>X.</given-names>
<surname>Qiu</surname></string-name>, <string-name><given-names>I. H.</given-names>
<surname>Solomon</surname></string-name>, <string-name><given-names>H.-H.</given-names>
<surname>Kuo</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Boucau</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Bowman</surname></string-name>, <string-name><given-names>U. D.</given-names>
<surname>Adhikari</surname></string-name>, <string-name><given-names>M. L.</given-names>
<surname>Winkler</surname></string-name>, <string-name><given-names>A. A.</given-names>
<surname>Mueller</surname></string-name>, <string-name><given-names>T. Y.-T.</given-names>
<surname>Hsu</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Desjardins</surname></string-name>, <string-name><given-names>L. R.</given-names>
<surname>Baden</surname></string-name>, <string-name><given-names>B. T.</given-names>
<surname>Chan</surname></string-name>, <string-name><given-names>B. D.</given-names>
<surname>Walker</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Lichterfeld</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Brigl</surname></string-name>, <string-name><given-names>D. S.</given-names>
<surname>Kwon</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Kanjilal</surname></string-name>, <string-name><given-names>E. T.</given-names>
<surname>Richardson</surname></string-name>, <string-name><given-names>A. H.</given-names>
<surname>Jonsson</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Alter</surname></string-name>, <string-name><given-names>A. K.</given-names>
<surname>Barczak</surname></string-name>, <string-name><given-names>W. P.</given-names>
<surname>Hanage</surname></string-name>, <string-name><given-names>X. G.</given-names>
<surname>Yu</surname></string-name>, <string-name><given-names>G. D.</given-names>
<surname>Gaiha</surname></string-name>, <string-name><given-names>M. S.</given-names>
<surname>Seaman</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Cernadas</surname></string-name>, <string-name><given-names>J. Z.</given-names>
<surname>Li</surname></string-name></person-group>, 
<article-title>Persistence and evolution of SARS-CoV-2 in an immunocompromised host</article-title>. <source>N. Engl. J. Med.</source>
<volume>383</volume>, 
<fpage>2291</fpage>&#x2013;<lpage>2293</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1056/NEJMc2031364</pub-id><pub-id pub-id-type="pmid">33176080</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. S.</given-names>
<surname>Xue</surname></string-name>, <string-name><given-names>T.</given-names>
<surname>Stevens-Ayers</surname></string-name>, <string-name><given-names>A. P.</given-names>
<surname>Campbell</surname></string-name>, <string-name><given-names>J. A.</given-names>
<surname>Englund</surname></string-name>, <string-name><given-names>S. A.</given-names>
<surname>Pergam</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Boeckh</surname></string-name>, <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>Parallel evolution of influenza across multiple spatiotemporal scales</article-title>. <source>eLife</source>
<volume>6</volume>, 
<elocation-id>e26875</elocation-id> (<year>2017</year>). <pub-id pub-id-type="doi">10.7554/eLife.26875</pub-id><pub-id pub-id-type="pmid">28653624</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. F.</given-names>
<surname>Feder</surname></string-name>, <string-name><given-names>S.-Y.</given-names>
<surname>Rhee</surname></string-name>, <string-name><given-names>S. P.</given-names>
<surname>Holmes</surname></string-name>, <string-name><given-names>R. W.</given-names>
<surname>Shafer</surname></string-name>, <string-name><given-names>D. A.</given-names>
<surname>Petrov</surname></string-name>, <string-name><given-names>P. S.</given-names>
<surname>Pennings</surname></string-name></person-group>, 
<article-title>More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1</article-title>. <source>eLife</source>
<volume>5</volume>, 
<elocation-id>e10670</elocation-id> (<year>2016</year>). <pub-id pub-id-type="doi">10.7554/eLife.10670</pub-id><pub-id pub-id-type="pmid">26882502</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name>, <string-name><given-names>L. I.</given-names>
<surname>Gong</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Baltimore</surname></string-name></person-group>, 
<article-title>Permissive secondary mutations enable the evolution of influenza oseltamivir resistance</article-title>. <source>Science</source>
<volume>328</volume>, 
<fpage>1272</fpage>&#x2013;<lpage>1275</lpage> (<year>2010</year>). <pub-id pub-id-type="doi">10.1126/science.1187816</pub-id><pub-id pub-id-type="pmid">20522774</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L. I.</given-names>
<surname>Gong</surname></string-name>, <string-name><given-names>M. A.</given-names>
<surname>Suchard</surname></string-name>, <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>Stability-mediated epistasis constrains the evolution of an influenza protein</article-title>. <source>eLife</source>
<volume>2</volume>, 
<elocation-id>e00631</elocation-id> (<year>2013</year>). <pub-id pub-id-type="doi">10.7554/eLife.00631</pub-id><pub-id pub-id-type="pmid">23682315</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>T. H.</given-names>
<surname>Zhang</surname></string-name>, <string-name><given-names>L.</given-names>
<surname>Dai</surname></string-name>, <string-name><given-names>J. P.</given-names>
<surname>Barton</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Du</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Tan</surname></string-name>, <string-name><given-names>W.</given-names>
<surname>Pang</surname></string-name>, <string-name><given-names>A. K.</given-names>
<surname>Chakraborty</surname></string-name>, <string-name><given-names>J. O.</given-names>
<surname>Lloyd-Smith</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Sun</surname></string-name></person-group>, 
<article-title>Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease</article-title>. <source>PLOS Genet.</source>
<volume>16</volume>, 
<elocation-id>e1009009</elocation-id> (<year>2020</year>). <pub-id pub-id-type="doi">10.1371/journal.pgen.1009009</pub-id><pub-id pub-id-type="pmid">33085662</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="web">E. C. Thomson, L. E. Rosen, J. G. Shepherd, R. Spreafico, A. da Silva Filipe, J. A. Wojcechowskyj, C. Davis, L. Piccoli, D. J. Pascall, J. Dillen, S. Lytras, N. Czudnochowski, R. Shah, M. Meury, N. Jesudason, A. De Marco, K. Li, J. Bassi, A. O&#x2019;Toole, D. Pinto, R. M. Colquhoun, K. Culap, B. Jackson, F. Zatta, A. Rambaut, S. Jaconi, V. B. Sreenu, J. Nix, I. Zhang, R. F. Jarrett, W. G. Glass, M. Beltramello, K. Nomikou, M. Pizzuto, L. Tong, E. Cameroni, T. I. Croll, N. Johnson, J. Di Iulio, A. Wickenhagen, A. Ceschi, A. M. Harbison, D. Mair, P. Ferrari, K. Smollett, F. Sallusto, S. Carmichael, C. Garzoni, J. Nichols, M. Galli, J. Hughes, A. Riva, A. Ho, M. Schiuma, M. G. Semple, P. J. M. Openshaw, E. Fadda, J. K. Baillie, J. D. Chodera, S. J. Rihn, S. J. Lycett, H. W. Virgin, A. Telenti, D. Corti, D. L. Robertson, G. Snell, Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. <italic>Cell</italic>
<ext-link ext-link-type="uri" xlink:href="https://10.1016/j.cell.2021.01.037">10.1016/j.cell.2021.01.037</ext-link> (2021).</mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="web">European Centre for Disease Prevention and Control, Rapid Risk Assessment: Detection of new SARS-CoV-2 variants related to mink, ECDC, Stockholm, 12 November 2020; <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/publications-data/detection-new-sars-cov-2-variants-mink">www.ecdc.europa.eu/en/publications-data/detection-new-sars-cov-2-variants-mink</ext-link>.</mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>B. B.</given-names>
<surname>Oude Munnink</surname></string-name>, <string-name><given-names>R. S.</given-names>
<surname>Sikkema</surname></string-name>, <string-name><given-names>D. F.</given-names>
<surname>Nieuwenhuijse</surname></string-name>, <string-name><given-names>R. J.</given-names>
<surname>Molenaar</surname></string-name>, <string-name><given-names>E.</given-names>
<surname>Munger</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Molenkamp</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>van der Spek</surname></string-name>, <string-name><given-names>P.</given-names>
<surname>Tolsma</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Rietveld</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Brouwer</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Bouwmeester-Vincken</surname></string-name>, <string-name><given-names>F.</given-names>
<surname>Harders</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Hakze-van der Honing</surname></string-name>, <string-name><given-names>M. C. A.</given-names>
<surname>Wegdam-Blans</surname></string-name>, <string-name><given-names>R. J.</given-names>
<surname>Bouwstra</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>GeurtsvanKessel</surname></string-name>, <string-name><given-names>A. A.</given-names>
<surname>van der Eijk</surname></string-name>, <string-name><given-names>F. C.</given-names>
<surname>Velkers</surname></string-name>, <string-name><given-names>L. A. M.</given-names>
<surname>Smit</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Stegeman</surname></string-name>, <string-name><given-names>W. H. M.</given-names>
<surname>van der Poel</surname></string-name>, <string-name><given-names>M. P. G.</given-names>
<surname>Koopmans</surname></string-name></person-group>, 
<article-title>Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans</article-title>. <source>Science</source>
<volume>371</volume>, 
<fpage>172</fpage>&#x2013;<lpage>177</lpage> (<year>2021</year>). <pub-id pub-id-type="doi">10.1126/science.abe5901</pub-id><pub-id pub-id-type="pmid">33172935</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="web">A. T. Chen, K. Altschuler, S. H. Zhan, Y. A. Chan, B. E. Deverman, COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interest. bioRxiv 2020.09.23.310565 [Preprint]. 28 September 2020. <pub-id pub-id-type="doi">10.1101/2020.09.23.310565</pub-id>.</mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names>
<surname>Elbe</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Buckland-Merrett</surname></string-name></person-group>, 
<article-title>Data, disease and diplomacy: GISAID&#x2019;s innovative contribution to global health</article-title>. <source>Glob. Chall.</source>
<volume>1</volume>, 
<fpage>33</fpage>&#x2013;<lpage>46</lpage> (<year>2017</year>). <pub-id pub-id-type="doi">10.1002/gch2.1018</pub-id><pub-id pub-id-type="pmid">31565258</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="data">T. Starr, J. Bloom, A. Greaney, A. Addetia, jbloomlab/SARS-CoV-2-RBD_MAP_clinical_Abs: Science revision, Zenodo, (2021); <pub-id pub-id-type="doi">10.5281/zenodo.4443311</pub-id>.</mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="data">W. Hannon, jbloomlab/SARS-CoV-2_chronic-infection-seq:Archived for publication, Version 1, Zenodo (2021); <pub-id pub-id-type="doi">10.5281/zenodo.4433185</pub-id>.</mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. E.</given-names>
<surname>Wentz</surname></string-name>, <string-name><given-names>E. V.</given-names>
<surname>Shusta</surname></string-name></person-group>, 
<article-title>A novel high-throughput screen reveals yeast genes that increase secretion of heterologous proteins</article-title>. <source>Appl. Environ. Microbiol.</source>
<volume>73</volume>, 
<fpage>1189</fpage>&#x2013;<lpage>1198</lpage> (<year>2007</year>). <pub-id pub-id-type="doi">10.1128/AEM.02427-06</pub-id><pub-id pub-id-type="pmid">17189442</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names>
<surname>Shang</surname></string-name>, <string-name><given-names>G.</given-names>
<surname>Ye</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Shi</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Wan</surname></string-name>, <string-name><given-names>C.</given-names>
<surname>Luo</surname></string-name>, <string-name><given-names>H.</given-names>
<surname>Aihara</surname></string-name>, <string-name><given-names>Q.</given-names>
<surname>Geng</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Auerbach</surname></string-name>, <string-name><given-names>F.</given-names>
<surname>Li</surname></string-name></person-group>, 
<article-title>Structural basis of receptor recognition by SARS-CoV-2</article-title>. <source>Nature</source>
<volume>581</volume>, 
<fpage>221</fpage>&#x2013;<lpage>224</lpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.1038/s41586-020-2179-y</pub-id><pub-id pub-id-type="pmid">32225175</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names>
<surname>Otwinowski</surname></string-name>, <string-name><given-names>D. M.</given-names>
<surname>McCandlish</surname></string-name>, <string-name><given-names>J. B.</given-names>
<surname>Plotkin</surname></string-name></person-group>, 
<article-title>Inferring the shape of global epistasis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>115</volume>, 
<fpage>E7550</fpage>&#x2013;<lpage>E7558</lpage> (<year>2018</year>). <pub-id pub-id-type="doi">10.1073/pnas.1804015115</pub-id><pub-id pub-id-type="pmid">30037990</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. H. D.</given-names>
<surname>Crawford</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Eguia</surname></string-name>, <string-name><given-names>A. S.</given-names>
<surname>Dingens</surname></string-name>, <string-name><given-names>A. N.</given-names>
<surname>Loes</surname></string-name>, <string-name><given-names>K. D.</given-names>
<surname>Malone</surname></string-name>, <string-name><given-names>C. R.</given-names>
<surname>Wolf</surname></string-name>, <string-name><given-names>H. Y.</given-names>
<surname>Chu</surname></string-name>, <string-name><given-names>M. A.</given-names>
<surname>Tortorici</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Veesler</surname></string-name>, <string-name><given-names>M.</given-names>
<surname>Murphy</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Pettie</surname></string-name>, <string-name><given-names>N. P.</given-names>
<surname>King</surname></string-name>, <string-name><given-names>A. B.</given-names>
<surname>Balazs</surname></string-name>, <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays</article-title>. <source>Viruses</source>
<volume>12</volume>, 
<fpage>513</fpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.3390/v12050513</pub-id><pub-id pub-id-type="pmid">32384820</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. H. D.</given-names>
<surname>Crawford</surname></string-name>, <string-name><given-names>A. S.</given-names>
<surname>Dingens</surname></string-name>, <string-name><given-names>R.</given-names>
<surname>Eguia</surname></string-name>, <string-name><given-names>C. R.</given-names>
<surname>Wolf</surname></string-name>, <string-name><given-names>N.</given-names>
<surname>Wilcox</surname></string-name>, <string-name><given-names>J. K.</given-names>
<surname>Logue</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>Shuey</surname></string-name>, <string-name><given-names>A. M.</given-names>
<surname>Casto</surname></string-name>, <string-name><given-names>B.</given-names>
<surname>Fiala</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Wrenn</surname></string-name>, <string-name><given-names>D.</given-names>
<surname>Pettie</surname></string-name>, <string-name><given-names>N. P.</given-names>
<surname>King</surname></string-name>, <string-name><given-names>A. L.</given-names>
<surname>Greninger</surname></string-name>, <string-name><given-names>H. Y.</given-names>
<surname>Chu</surname></string-name>, <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection</article-title>. <source>J. Infect. Dis.</source>
<elocation-id>jiaa618</elocation-id> (<year>2020</year>). <pub-id pub-id-type="doi">10.1093/infdis/jiaa618</pub-id><pub-id pub-id-type="pmid">33000143</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names>
<surname>K&#xF6;ster</surname></string-name>, <string-name><given-names>S.</given-names>
<surname>Rahmann</surname></string-name></person-group>, 
<article-title>Snakemake&#x2014;A scalable bioinformatics workflow engine</article-title>. <source>Bioinformatics</source>
<volume>28</volume>, 
<fpage>2520</fpage>&#x2013;<lpage>2522</lpage> (<year>2012</year>). <pub-id pub-id-type="doi">10.1093/bioinformatics/bts480</pub-id><pub-id pub-id-type="pmid">22908215</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names>
<surname>Chen</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Zhou</surname></string-name>, <string-name><given-names>Y.</given-names>
<surname>Chen</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Gu</surname></string-name></person-group>, 
<article-title>fastp: An ultra-fast all-in-one FASTQ preprocessor</article-title>. <source>Bioinformatics</source>
<volume>34</volume>, 
<fpage>i884</fpage>&#x2013;<lpage>i890</lpage> (<year>2018</year>). <pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="web">H. Li, Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. <ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/1303.3997">arXiv:1303.3997</ext-link> [q-bio.GN] (26 May 2013).</mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names>
<surname>Katoh</surname></string-name>, <string-name><given-names>D. M.</given-names>
<surname>Standley</surname></string-name></person-group>, 
<article-title>MAFFT multiple sequence alignment software version 7: Improvements in performance and usability</article-title>. <source>Mol. Biol. Evol.</source>
<volume>30</volume>, 
<fpage>772</fpage>&#x2013;<lpage>780</lpage> (<year>2013</year>). <pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id><pub-id pub-id-type="pmid">23329690</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S. K.</given-names>
<surname>Hilton</surname></string-name>, <string-name><given-names>J.</given-names>
<surname>Huddleston</surname></string-name>, <string-name><given-names>A.</given-names>
<surname>Black</surname></string-name>, <string-name><given-names>K.</given-names>
<surname>North</surname></string-name>, <string-name><given-names>A. S.</given-names>
<surname>Dingens</surname></string-name>, <string-name><given-names>T.</given-names>
<surname>Bedford</surname></string-name>, <string-name><given-names>J. D.</given-names>
<surname>Bloom</surname></string-name></person-group>, 
<article-title>dms-view: Interactive visualization tool for deep mutational scanning data</article-title>. <source>J. Open Source Softw.</source>
<volume>5</volume>, 
<fpage>2353</fpage> (<year>2020</year>). <pub-id pub-id-type="doi">10.21105/joss.02353</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>B. J.</given-names>
<surname>Grant</surname></string-name>, <string-name><given-names>A. P. C.</given-names>
<surname>Rodrigues</surname></string-name>, <string-name><given-names>K. M.</given-names>
<surname>ElSawy</surname></string-name>, <string-name><given-names>J. A.</given-names>
<surname>McCammon</surname></string-name>, <string-name><given-names>L. S. D.</given-names>
<surname>Caves</surname></string-name></person-group>, 
<article-title>Bio3d: An R package for the comparative analysis of protein structures</article-title>. <source>Bioinformatics</source>
<volume>22</volume>, 
<fpage>2695</fpage>&#x2013;<lpage>2696</lpage> (<year>2006</year>). <pub-id pub-id-type="doi">10.1093/bioinformatics/btl461</pub-id><pub-id pub-id-type="pmid">16940322</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">29144460</article-id>
      <article-id pub-id-type="pmc">5884449</article-id>
      <article-id pub-id-type="doi">10.1038/nature24302</article-id>
      <article-id pub-id-type="manuscript">NIHMS950957</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Inflammation-induced IgA<sup>+</sup> cells dismantle anti-liver cancer immunity</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shalapour</surname>
            <given-names>Shabnam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Xue-Jia</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bastian</surname>
            <given-names>Ingmar N.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brain</surname>
            <given-names>John</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Burt</surname>
            <given-names>Alastair D.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aksenov</surname>
            <given-names>Alexander A.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vrbanac</surname>
            <given-names>Alison F.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Weihua</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Perkins</surname>
            <given-names>Andres</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsutani</surname>
            <given-names>Takaji</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhong</surname>
            <given-names>Zhenyu</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dhar</surname>
            <given-names>Debanjan</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Navas-Molina</surname>
            <given-names>Jose A.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loomba</surname>
            <given-names>Rohit</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Downes</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Ruth T.</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Evans</surname>
            <given-names>Ronald M.</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dorrestein</surname>
            <given-names>Pieter C.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Knight</surname>
            <given-names>Rob</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benner</surname>
            <given-names>Christopher</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Anstee</surname>
            <given-names>Quentin M.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Karin</surname>
            <given-names>Michael</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
<label>1</label>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California San Diego (UCSD), 9500 Gilman Drive, La Jolla, California 92093, USA</aff>
      <aff id="A2">
<label>2</label>Biomedical Translational Research Institute and The First Affiliated Hospital, Jinan University, Guangzhou 510632, China</aff>
      <aff id="A3">
<label>3</label>Liver Research Group, Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK</aff>
      <aff id="A4">
<label>4</label>Faculty of Health and Medical Sciences, University of Adelaide, South Australia 5005, Australia</aff>
      <aff id="A5">
<label>5</label>Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego (UCSD), 9500 Gilman Drive, La Jolla, California 92093, USA</aff>
      <aff id="A6">
<label>6</label>Departments of Pediatrics and Computer Science &amp; Engineering, University of California San Diego (UCSD), 9500 Gilman Drive, La Jolla, California 92093, USA</aff>
      <aff id="A7">
<label>7</label>R&amp;D Department, Repertoire Genesis Incorporation, Ibaraki, Osaka 567-0085, Japan</aff>
      <aff id="A8">
<label>8</label>Department of Medicine, University of California San Diego (UCSD), 9500 Gilman Drive, La Jolla, California 92093, USA</aff>
      <aff id="A9">
<label>9</label>NAFLD Research Center, Division of Gastroenterology, Department of Medicine, University of California San Diego (UCSD), La Jolla, California 92093, USA</aff>
      <aff id="A10">
<label>10</label>Gene Expression Laboratory, Howard Hughes Medical Institute, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA</aff>
      <aff id="A11">
<label>11</label>Center for Microbiome Innovation, University of California San Diego (UCSD), La Jolla, California 92093, USA</aff>
      <author-notes>
        <corresp id="FN1">Correspondence and requests for materials should be addressed to M.K. (<email>karinoffice@ucsd.edu</email>) or S.S. (<email>sshalapour@ucsd.edu</email>)</corresp>
        <fn fn-type="COI-statement" id="FN5">
          <p>The authors declare no competing financial interests.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>16</day>
        <month>3</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>16</day>
        <month>11</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>5</month>
        <year>2018</year>
      </pub-date>
      <volume>551</volume>
      <issue>7680</issue>
      <fpage>340</fpage>
      <lpage>345</lpage>
      <!--elocation-id from pubmed: 10.1038/nature24302-->
      <permissions>
        <license license-type="permissions-link">
          <license-p>Reprints and permissions information is available at <ext-link ext-link-type="uri" xlink:href="www.nature.com/reprints">www.nature.com/reprints</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p id="P1">The role of adaptive immunity in early cancer development is controversial. Here we show that chronic inflammation and fibrosis in humans and mice with non-alcoholic fatty liver disease is accompanied by accumulation of liver-resident immunoglobulin-A-producing (IgA<sup>+</sup>) cells. These cells also express programmed death ligand 1 (PD-L1) and interleukin-10, and directly suppress liver cytotoxic CD8<sup>+</sup> T lymphocytes, which prevent emergence of hepatocellular carcinoma and express a limited repertoire of T-cell receptors against tumour-associated antigens. Whereas CD8<sup>+</sup> T-cell ablation accelerates hepatocellular carcinoma, genetic or pharmacological interference with IgA<sup>+</sup> cell generation attenuates liver carcinogenesis and induces cytotoxic T-lymphocyte-mediated regression of established hepatocellular carcinoma. These findings establish the importance of inflammation-induced suppression of cytotoxic CD8<sup>+</sup> T-lymphocyte activation as a tumour-promoting mechanism.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0404511</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">7473</journal-id>
      <journal-id journal-id-type="nlm-ta">Science</journal-id>
      <journal-id journal-id-type="iso-abbrev">Science</journal-id>
      <journal-title-group>
        <journal-title>Science (New York, N.Y.)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-8075</issn>
      <issn pub-type="epub">1095-9203</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35771910</article-id>
      <article-id pub-id-type="pmc">9262715</article-id>
      <article-id pub-id-type="doi">10.1126/science.abm1741</article-id>
      <article-id pub-id-type="manuscript">NIHMS1820958</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>Rongxin</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="FN1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xia</surname>
            <given-names>Chenglong</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="FN1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Close</surname>
            <given-names>Jennie L.</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Meng</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>He</surname>
            <given-names>Jiang</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Zhengkai</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Halpern</surname>
            <given-names>Aaron R.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Long</surname>
            <given-names>Brian</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>Jeremy A.</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lein</surname>
            <given-names>Ed S.</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhuang</surname>
            <given-names>Xiaowei</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="CR1" ref-type="corresp">&#x2020;</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Department of Physics, Harvard University, Cambridge, MA 02138, USA.</aff>
      <aff id="A2"><label>2</label>Allen Institute for Brain Science, Seattle, WA 98109, USA.</aff>
      <author-notes>
        <fn fn-type="equal" id="FN1">
          <label>*</label>
          <p id="P1">These authors contributed equally to this work</p>
        </fn>
        <fn fn-type="con" id="FN2">
          <p id="P2"><bold>Author contributions:</bold> E.L. and X.Z. conceived the study. R.F., C.X., and X.Z. designed experiments with input from J.C., M.Z., J.H., B.L., J.M. and E.L.. M.Z. and J.H. performed human tissue MERFISH protocol testing. C.X. and J.M. designed the MERFISH gene panel. J.C. performed human tissue processing and quality testing. R.F., C.X., Z.H., and A.H. performed MERFISH experiments. R.F. and C.X. performed data analysis. R.F., C.X., J.C., B.L., J.M., E.L., and X.Z. evaluated experimental results. R.F. and X.Z. wrote the paper with input from C.X., J.C., M.Z., J.H., Z.H., A.H., B.L., J.M. and E.L.. X.Z. oversaw the project.</p>
        </fn>
        <corresp id="CR1"><label>&#x2020;</label>Corresponding author. <email>zhuang@chemistry.harvard.edu</email> (X.Z.)</corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>5</day>
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>6</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>08</day>
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <volume>377</volume>
      <issue>6601</issue>
      <fpage>56</fpage>
      <lpage>62</lpage>
      <permissions>
        <license>
          <license-p>exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</license-p>
        </license>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This work is licensed under a <uri xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.</license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <p id="P3">The human cerebral cortex has tremendous cellular diversity. How different cell types are organized in the human cortex and how cellular organization varies across species remain unclear. Here, we performed spatially resolved single-cell profiling of 4,000 genes using multiplexed error-robust FISH (MERFISH), identified &gt;100 transcriptionally distinct cell populations, and generated a molecularly defined and spatially resolved cell atlas of the human middle and superior temporal gyrus. We further explored cell-cell interactions arising from soma contact or proximity in a cell-type-specific manner. Comparison with the mouse cortex showed conservation in the laminar organization of cells and differences in somatic interactions across species. Notably, our data revealed human-specific cell-cell proximity patterns and showed a markedly increased enrichment for interactions between neurons and non-neuronal cells in the human cortex.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P4">The human cerebral cortex comprises billions of cells of distinct types (<xref rid="R1" ref-type="bibr">1</xref>). The spatial organizations and interactions of these cells play a critical role in shaping and maintaining various brain functions (<xref rid="R2" ref-type="bibr">2</xref>). For instance, interactions between neuronal and non-neuronal cells are essential for axonal conduction, synaptic transmission, and tissue homeostasis, and are required for normal functioning of the brain (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>). Disruption of such cell-cell interactions contributes to various neurological disorders, such as autism (<xref rid="R5" ref-type="bibr">5</xref>), schizophrenia (<xref rid="R6" ref-type="bibr">6</xref>), and Alzheimer&#x2019;s diseases (<xref rid="R7" ref-type="bibr">7</xref>). Yet, we only have a limited understanding of the organizations and interactions of different cell types in the human cortex.</p>
    <p id="P5">Recent single-cell RNA sequencing (scRNA-seq) analysis has revealed a diversity of transcriptionally distinct cell populations in the human middle temporal gyrus (MTG) (<xref rid="R8" ref-type="bibr">8</xref>). Combining scRNA-seq with microdissection (<xref rid="R8" ref-type="bibr">8</xref>), and more recently <italic toggle="yes">in situ</italic> sequencing targeting 120 genes (<xref rid="R9" ref-type="bibr">9</xref>), have revealed the laminar organization of these transcriptionally defined neuronal cell types, in particular the excitatory neurons, in the human MTG. These studies, however, did not provide the spatial relationship between cell types at high resolution and a systematic characterization of cell-cell interactions among this high diversity of cell types is still lacking. Single-cell transcriptomics and epigenomics analyses have also provided rich insights into the evolution of cellular diversity and molecular signatures of cell types in mouse, marmoset and human cortex (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R11" ref-type="bibr">11</xref>), but how the spatial relationship and interactions between different cell types vary across species remains largely unclear.</p>
    <sec id="S1">
      <title>Single-cell transcriptome imaging of the human cortex</title>
      <p id="P6">Single-cell transcriptome imaging allows <italic toggle="yes">in situ</italic> gene expression profiling of individual cells and hence high-resolution spatial mapping of cell-type organization in complex tissues. Here, we demonstrate single-cell transcriptome imaging of the human brain using multiplexed error-robust fluorescence <italic toggle="yes">in situ</italic> hybridization (MERFISH) (<xref rid="R12" ref-type="bibr">12</xref>). We performed MERFISH measurements of the human MTG and superior temporal gyrus (STG) from fresh-frozen neurosurgical and postmortem brain samples, targeting 4,000 genes (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). These genes included 764 differentially expressed marker genes in cell clusters derived from single-nucleus SMART-seq data of the MTG (<xref rid="R8" ref-type="bibr">8</xref>) and additional expressed genes largely randomly selected to increase the gene coverage. This allowed us to include potential marker genes not identified in the SMART-seq data, and functionally important genes such as ligands and receptors. To overcome the high autofluorescence background in human tissues due to lipofuscin, we photobleached the samples with light-emitting diode arrays (<xref rid="R13" ref-type="bibr">13</xref>) prior to MERFISH imaging. We then used expansion microscopy (<xref rid="R14" ref-type="bibr">14</xref>) to reduce the molecular crowding associated with imaging a large number of genes (<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>).</p>
      <p id="P7">Individual RNA molecules were identified and assigned to segmented cells to determine the single-cell expression profiles (<xref rid="F1" ref-type="fig">Fig. 1B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S1</xref>). We imaged five tissue sections from neurosurgical MTG samples (two male individuals, 36 and 32 years old) and five sections from postmortem STG samples (two male individuals, 29 and 42 years old). MERFISH expression data showed excellent reproducibility between replicates (<xref rid="SD1" ref-type="supplementary-material">fig. S2</xref>, <xref rid="SD1" ref-type="supplementary-material">A</xref> and <xref rid="SD1" ref-type="supplementary-material">B</xref>), high correlation between neurosurgical MTG and postmortem STG samples albeit with a lower total transcript count in the latter likely due to RNA degradation (<xref rid="SD1" ref-type="supplementary-material">fig. S2C</xref>), and high correlation with bulk RNA sequencing data (<xref rid="SD1" ref-type="supplementary-material">fig. S3</xref>).</p>
      <p id="P8">To test whether the molecular crowding associated with imaging 4,000 genes caused substantial reduction in the detection efficiency, we performed MERFISH imaging on 250 of the 764 marker genes (in two expanded tissue sections for detection efficiency assessment and three additional unexpanded sections to increase the number of cells imaged). The detection efficiency of the 4000-gene measurements was on average ~57% of that of the 250-gene measurements on expanded sections, with high correlation between the two measurements (<xref rid="SD1" ref-type="supplementary-material">fig. S4</xref>).</p>
    </sec>
    <sec id="S2">
      <title>Cell-type classification of the human cortex</title>
      <p id="P9">We identified transcriptionally distinct cell populations using the single-cell expression profiles derived from the 4,000-gene MERFISH data. First-level clustering identified excitatory and inhibitory neurons, as well as major subclasses of non-neuronal cells including microglia, astrocytes, oligodendrocytes, oligodendrocyte progenitor cells (OPCs), endothelial cells and mural cells, as characterized by the marker genes identified by SMART-seq (<xref rid="R8" ref-type="bibr">8</xref>) (<xref rid="SD1" ref-type="supplementary-material">fig. S5</xref>).</p>
      <p id="P10">We then performed separate clustering analyses of the inhibitory and excitatory neurons from the MERFISH data, which showed excellent correspondence to those independently determined from the SMART-seq data (<xref rid="SD1" ref-type="supplementary-material">fig. S6</xref>). To combine information from both datasets, we performed integrated analysis of MERFISH and SMART-seq data (<xref rid="SD1" ref-type="supplementary-material">fig. S7</xref>, <xref rid="SD1" ref-type="supplementary-material">A</xref> and <xref rid="SD1" ref-type="supplementary-material">B</xref>). This analysis classified inhibitory neurons into four subclasses (denoted by marker genes <italic toggle="yes">SST</italic>, <italic toggle="yes">VIP</italic>, <italic toggle="yes">PVALB</italic> and <italic toggle="yes">LAMP5</italic>, respectively) and excitatory neurons into nine subclasses (L2/3 IT, L4/5 IT, L5 IT, L6 IT, L6 IT <italic toggle="yes">CAR3</italic>, L5 ET, L5/6 NP, L6 CT, L6b), with most subclasses further sub-divided into multiple clusters (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Because non-neuronal cells were depleted from the SMART-seq dataset (<xref rid="R8" ref-type="bibr">8</xref>), we identified clusters within individual subclasses of non-neuronal cells from the 4,000-gene MERFISH data alone (<xref rid="F1" ref-type="fig">Fig. 1C</xref> and <xref rid="SD1" ref-type="supplementary-material">fig. S7C</xref>). Altogether, we identified a total of 125 transcriptionally distinct cell populations in the human MTG and STG, including 29 excitatory, 39 inhibitory, 57 non-neuronal clusters (<xref rid="F1" ref-type="fig">Fig. 1C</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S7</xref>), revealing not only a high diversity of neurons but also a high diversity of non-neuronal cells in the human cortex. To include the 250-gene data for downstream analysis, we performed supervised classification to predict their cell type labels (at the cluster level for neurons and subclass level for non-neuronal cells) based on annotations from the 4,000-gene data.</p>
    </sec>
    <sec id="S3">
      <title>Cell compositions of the human and mouse cortex</title>
      <p id="P11">Quantitative analysis of the cell composition using the MERFISH data showed that the human MTG and STG (white matter excluded) were composed of 26% excitatory neurons, 11% inhibitory neurons, and 63% non-neuronal cells (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). The excitatory neurons were predominantly IT neurons (~93%), with only a small fraction of non-IT neurons (L6 CT, L5 ET, L5/6 NP and L6b cells) (<xref rid="F1" ref-type="fig">Fig. 1E</xref>, <bold>left</bold>). The IT neurons were sub-divided into 46% L2/3 IT, 18% L4/5 IT, 19% L5 IT, 13% L6 IT and 4% L6 IT <italic toggle="yes">CAR3</italic> cells (<xref rid="F1" ref-type="fig">Fig. 1E</xref>, <bold>middle</bold>). The inhibitory neurons were composed of 13% <italic toggle="yes">LAMP5</italic>, 26% <italic toggle="yes">PVALB</italic>, 30% <italic toggle="yes">SST</italic>, and 31% <italic toggle="yes">VIP</italic> cells (<xref rid="F1" ref-type="fig">Fig. 1E</xref>, <bold>right</bold>).</p>
      <p id="P12">Next, we compared the cell composition between human and mouse cortices. Human STG contains the auditory cortex, whereas human MTG does not have a counterpart in mouse, with the mouse temporal associated area (TEa) considered the closest ortholog. We thus considered two MERFISH datasets covering several regions of the mouse cortex: i) our recently reported 258-gene MERFISH dataset of the primary motor cortex (MOp) (<xref rid="R17" ref-type="bibr">17</xref>); ii) we additionally performed MERFISH experiments on a more posterior part of the mouse cortex, containing the visual cortex (VIS), auditory cortex (AUD), and TEa (<xref rid="SD1" ref-type="supplementary-material">fig. S8</xref>) using a similar gene panel and experimental protocol as for the MOp (<xref rid="R17" ref-type="bibr">17</xref>). Similar cell compositions were observed across these different mouse cortical regions (<xref rid="F1" ref-type="fig">Fig. 1</xref>, <xref rid="F1" ref-type="fig">D</xref> and <xref rid="F1" ref-type="fig">E</xref>).</p>
      <p id="P13">The human MTG and STG, however, exhibited substantially different cell composition compared to these mouse cortical regions. We observed a lower proportion of excitatory neurons and a higher proportion of glial cells (including astrocytes, oligodendrocytes, OPCs and microglia) in the human cortex (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). The glia-to-neuron ratio was 1.4, consistent with results from various human cortical regions using other cell counting methods (<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>), and five times higher than the ratio observed in mouse (<xref rid="F1" ref-type="fig">Fig. 1D</xref>) (<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R20" ref-type="bibr">20</xref>). The excitatory-to-inhibitory neuron ratio was 2.3 in human, in line with recent independent measurements (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R11" ref-type="bibr">11</xref>) and three times lower than the ratio observed in mouse (<xref rid="F1" ref-type="fig">Fig. 1D</xref>) (<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R20" ref-type="bibr">20</xref>).</p>
      <p id="P14">Among the excitatory neurons, the non-IT neuron proportion dropped from 29% in mouse to 7% in human (<xref rid="F1" ref-type="fig">Fig. 1E</xref>, <bold>left</bold>), consistent with recent observations that L5 ET and L6 CT are less abundant in the primates than in mouse (<xref rid="R11" ref-type="bibr">11</xref>). The dominance of IT neurons in human suggests an increased emphasis of intra-cortical communications in human. For inhibitory neurons, we observed a decrease in the proportion of <italic toggle="yes">PVALB</italic> neurons and an increase in the proportion of <italic toggle="yes">VIP</italic> neurons in human compared to mouse (<xref rid="F1" ref-type="fig">Fig. 1E</xref>, <bold>right</bold>). In behaving animals, <italic toggle="yes">VIP</italic> interneurons regulate inhibition of excitatory neurons through inhibition of other interneurons and such disinhibition facilitates modulation of sensory response and network dynamics by behavioral state and learning (<xref rid="R21" ref-type="bibr">21</xref>). The observed increase in <italic toggle="yes">VIP</italic> interneuron proportion thus suggests a potential mechanism for the enhanced capability of state-dependent sensory processing and learning-related neuronal dynamics in human.</p>
    </sec>
    <sec id="S4">
      <title>Spatial organizations of cells in the human and mouse cortex</title>
      <p id="P15"><italic toggle="yes">In situ</italic> identification of cell types by MERFISH allowed us to map their spatial organizations. In human, we observed a laminar organization of IT neurons across the cortical depth, whereas other excitatory neurons, including L5 ET, L5/6 NP, L6 CT and L6b, were populated mostly in the deep layers (<xref rid="F2" ref-type="fig">Fig. 2</xref>; <xref rid="SD1" ref-type="supplementary-material">figs. S9</xref> and <xref rid="SD1" ref-type="supplementary-material">S10</xref>), as expected (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R22" ref-type="bibr">22</xref>). Among inhibitory neurons, <italic toggle="yes">VIP</italic> and <italic toggle="yes">LAMP5</italic> were enriched in upper layers (L1&#x2013;L3), while <italic toggle="yes">PVALB</italic> and <italic toggle="yes">SST</italic> were more broadly distributed across the layers (<xref rid="F2" ref-type="fig">Fig. 2</xref>; <xref rid="SD1" ref-type="supplementary-material">figs. S9</xref> and <xref rid="SD1" ref-type="supplementary-material">S10</xref>), consistent with pervious observations (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R22" ref-type="bibr">22</xref>). Notably, at the cluster level, inhibitory neurons also adopted a laminar organization, with many inhibitory clusters primarily restricted to one cortical layer, or even a sub-portion of a layer (<xref rid="F2" ref-type="fig">Fig. 2B</xref>
<bold>middle</bold>; <xref rid="SD1" ref-type="supplementary-material">fig. S9</xref>), enriching and refining the knowledge of layer-restricted inhibitory neuron distributions (<xref rid="R8" ref-type="bibr">8</xref>). These spatial organizations of neurons were largely similar to those observed in the mouse cortex (<xref rid="SD1" ref-type="supplementary-material">figs. S10</xref> and <xref rid="SD1" ref-type="supplementary-material">S11</xref>) (<xref rid="R17" ref-type="bibr">17</xref>).</p>
      <p id="P16">Despite the overall conservation of laminar organization, we also found human-mouse differences for some neuronal cell types. For instance, the L6b neurons were broadly dispersed in L6 and extending into L5 and white matter in human MTG and STG, whereas in mouse L6b formed a thin layer at the bottom of L6 (<xref rid="F3" ref-type="fig">Fig. 3A</xref>), consistent with previous findings (<xref rid="R22" ref-type="bibr">22</xref>, <xref rid="R23" ref-type="bibr">23</xref>). The L4/5 IT neurons formed a dense and thin layer in the human MTG and STG, giving rise to a substantially higher density of excitatory neurons in L4 (<xref rid="F3" ref-type="fig">Fig. 3</xref>, <xref rid="F3" ref-type="fig">B</xref> and <xref rid="F3" ref-type="fig">C</xref>
<bold>top</bold>). In contrast, the density of excitatory neurons in the mouse cortex was more uniform across L2/3 to L6 (<xref rid="F3" ref-type="fig">Fig. 3C</xref>). As L4 is known to vary between different cortical regions, whether this difference is region- or species-specific remains an open question although the several mouse cortical regions that we examined exhibited a similar density profile. We also observed a different cortical-depth dependence for the excitatory-to-inhibitory neuron ratio between human and mouse (<xref rid="F3" ref-type="fig">Fig. 3C</xref>).</p>
      <p id="P17">Notably, non-neuronal cells also exhibited laminar organization in the human cortex. Oligodendrocytes were enriched in the deeper layers and white matter and depleted in the upper layers (L1&#x2013;L3) (<xref rid="SD1" ref-type="supplementary-material">fig. S10</xref>) (<xref rid="R9" ref-type="bibr">9</xref>). Although astrocytes, microglia, OPCs, endothelial cells and mural cells were dispersed across all cortical layers at the subclass level (<xref rid="SD1" ref-type="supplementary-material">fig. S10</xref>), these cell types exhibited a laminar organization at the cluster level (<xref rid="F2" ref-type="fig">Fig. 2B</xref>
<bold>bottom</bold>). For example, the ASC i cluster was localized in L1, likely representing interlaminar astrocytes (<xref rid="R24" ref-type="bibr">24</xref>), ASC ii was enriched in L1 and L2/3, ASC iii and ASC iv were enriched in L2/3 and L4, ASC v &#x2013; ix were dispersed across L2&#x2013;L6, and ASC x and xi were enriched in L6 and white matter (<xref rid="F2" ref-type="fig">Fig. 2B</xref>
<bold>bottom</bold>), enriching our understanding of astrocyte diversity and organization (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R25" ref-type="bibr">25</xref>, <xref rid="R26" ref-type="bibr">26</xref>). Similarly, nearly all non-neuronal subclasses exhibited a gradually evolving cell composition across the cortical depth (<xref rid="F2" ref-type="fig">Fig. 2B</xref>
<bold>bottom</bold>).</p>
    </sec>
    <sec id="S5">
      <title>Cell-cell interactions in the human and mouse cortex</title>
      <p id="P18">High-resolution measurements of the spatial relationship between cells by MERFISH allowed us to predict cell-cell interactions arising from somatic contact or paracrine signaling (<xref rid="R27" ref-type="bibr">27</xref>, <xref rid="R28" ref-type="bibr">28</xref>), which can be inferred from soma contact or proximity that occurred at a higher frequency than by random chance. Our MERFISH images showed frequent somatic contact or proximity between cells (<xref rid="F4" ref-type="fig">Fig. 4A</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S12</xref>, <xref rid="SD1" ref-type="supplementary-material">A</xref> and <xref rid="SD1" ref-type="supplementary-material">B</xref>). Interestingly, although the cell density in the human cortex was three times lower than that in mouse (<xref rid="SD1" ref-type="supplementary-material">fig. S12C</xref>), the median centroid distance between nearest-neighbor cells in human was nearly identical to that in mouse and comparable to the mean soma size (<xref rid="SD1" ref-type="supplementary-material">fig. S12</xref>, <xref rid="SD1" ref-type="supplementary-material">B</xref> and <xref rid="SD1" ref-type="supplementary-material">D</xref>), suggesting that specific mechanisms may exist to maintain or enhance cell-cell interactions in the expanded human cortex. To examine whether these potential cell-cell interactions were cell-type specific, we considered cell types at the subclass level and calculated the frequency at which soma contact or proximity, determined based on centroid distances (<xref rid="SD1" ref-type="supplementary-material">fig. S12A</xref>), was observed between two subclasses of cells. We then determined whether this frequency was significantly greater than random chance, hence reflecting an enrichment, by comparing the observed frequency with the expected frequencies from random spatial permutations that disrupted the spatial relationship between neighboring cells while preserving the local density of each cell type (<xref rid="SD1" ref-type="supplementary-material">figs. S13</xref>&#x2013;<xref rid="SD1" ref-type="supplementary-material">S15</xref>).</p>
      <p id="P19">Notably, we observed cell-type specific patterns for soma contact or proximity enrichment in the human cortex that were different from the mouse cortex (<xref rid="F4" ref-type="fig">Fig. 4B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S16</xref>). Similar human-mouse differences were observed when we used segmented cell boundaries instead of distances between cell centroids to determine contacting cell-pairs (<xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>).</p>
      <p id="P20">Inhibitory neurons and some deep-layer excitatory neurons in human showed a tendency to form contacting or proximity pairs among cells within the same subclass (<xref rid="F4" ref-type="fig">Fig. 4B</xref>, <bold>left</bold>; <xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>). These results were further supported by examining the distances from individual neurons to their nearest neighbors in the same or different types (<xref rid="F4" ref-type="fig">Fig. 4C</xref>
<bold>top</bold>). This tendency was also observed in mouse but to a lesser degree for some neuronal types (<xref rid="F4" ref-type="fig">Fig. 4</xref>, <xref rid="F4" ref-type="fig">B</xref> and <xref rid="F4" ref-type="fig">C</xref>), consistent with the previous observation that inhibitory neurons in mouse tend to form intra-subtype nearest-neighbor pairs (<xref rid="R29" ref-type="bibr">29</xref>). Some non-neuronal cell types also exhibited such tendency for intra-type soma proximity, but with noticeable differences between human and mouse. For example, we observed enrichment for soma contact or proximity among astrocytes in human but not in mouse (<xref rid="F4" ref-type="fig">Fig. 4B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>). It has been shown that the processes of neighboring astrocytes intermingle substantially more in human compared to mouse (<xref rid="R25" ref-type="bibr">25</xref>, <xref rid="R26" ref-type="bibr">26</xref>, <xref rid="R30" ref-type="bibr">30</xref>). Whether these observations are related to our findings here remains an open question.</p>
      <p id="P21">A notable human-mouse difference was observed for glial-vascular interactions. The human, but not mouse, cortex exhibited enrichment for soma contact or proximity between glial and vascular cells (<xref rid="F4" ref-type="fig">Fig. 4B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>). MERFISH images showed that the cell bodies of oligodendrocytes and microglia were often clustered around vascular structures formed by endothelial and mural cells (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). These observations are corroborated by a recent electron microscopy study (<xref rid="R30" ref-type="bibr">30</xref>), which showed that oligodendrocyte and microglial cell bodies are adjacent to blood vessels whereas astrocytes contact blood vessels primarily with their end feet but not cell bodies. Quantifications of MERFISH images showed that more microglia and oligodendrocytes, but not astrocytes, formed somatic contacts with blood vessels in human than in mouse (<xref rid="F5" ref-type="fig">Fig. 5B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S18</xref>).</p>
      <p id="P22">The most remarkable cross-species differences on cell-cell interactions were observed between neurons and glial cells, in particular oligodendrocytes and microglia. We observed substantial enrichment for soma contact or proximity between neurons and oligodendrocytes, including both mature oligodendrocytes and OPCs, in human (<xref rid="F4" ref-type="fig">Fig. 4B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>). Although somatic contacts between neurons and oligodendrocytes were also observed in mouse and could represent bona fide interactions, the frequency of such events did not significantly exceed that expected from random chance. Moreover, a single neuron often formed contacts with several oligodendrocytes and OPCs in human, whereas such multi-way contacts were not enriched in mouse when compared to random chance (<xref rid="F5" ref-type="fig">Fig. 5</xref>, <xref rid="F5" ref-type="fig">A</xref> and <xref rid="F5" ref-type="fig">C</xref>).</p>
      <p id="P23">In human, among OPCs, a specific subpopulation exhibited a higher tendency to contact neurons. Our analyses of both MERFISH and SMART-seq data (<xref rid="R8" ref-type="bibr">8</xref>) showed that ~50% of the OPCs expressed Glutamate Decarboxylase 1 (<italic toggle="yes">GAD1</italic>), a gene encoding an enzyme that synthesizes GABA, whereas Glutamate Decarboxylase 2 (<italic toggle="yes">GAD2</italic>) and the GABA transporter gene <italic toggle="yes">VGAT</italic> (<italic toggle="yes">SLC32A1</italic>) were not expressed in OPCs (<xref rid="SD1" ref-type="supplementary-material">fig. S19A</xref>). Compared to <italic toggle="yes">GAD1</italic>-negative OPCs, <italic toggle="yes">GAD1</italic>-positive OPCs exhibited a higher frequency to contact neurons (<xref rid="SD1" ref-type="supplementary-material">fig. S19</xref>, <xref rid="SD1" ref-type="supplementary-material">B</xref> and <xref rid="SD1" ref-type="supplementary-material">C</xref>).</p>
      <p id="P24">Finally, our data revealed human-mouse differences in microglia-neuron interactions. In the human MTG and STG, microglia frequently juxtaposed with neurons (<xref rid="F5" ref-type="fig">Fig. 5A</xref>), likely representing satellite microglia (<xref rid="R31" ref-type="bibr">31</xref>). In addition, these satellite microglia exhibited a greater degree of enrichment for soma contact or proximity with excitatory neurons compared to inhibitory neurons (<xref rid="F4" ref-type="fig">Fig. 4B</xref>, <bold>left</bold>; <xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>; <xref rid="F5" ref-type="fig">Fig. 5</xref>, <xref rid="F5" ref-type="fig">A</xref> and <xref rid="F5" ref-type="fig">D</xref>). Moreover, among excitatory IT neurons, the tendency to contact microglia decreased with cortical depth (<xref rid="F5" ref-type="fig">Fig. 5D</xref>). In contrast, no significant enrichment in microglia-neuron contact was observed in the mouse cortex (<xref rid="F4" ref-type="fig">Fig. 4B</xref>; <xref rid="SD1" ref-type="supplementary-material">fig. S17</xref>; <xref rid="F5" ref-type="fig">Fig. 5D</xref>).</p>
      <p id="P25">Furthermore, we identified ligand&#x2013;receptor pairs enriched in contacting pairs of microglia and IT neurons from the MERFISH data (<xref rid="F5" ref-type="fig">Fig. 5E</xref>), further validated by single-molecule FISH measurements (<xref rid="SD1" ref-type="supplementary-material">fig. S20</xref>). Among these, several ligands and receptors are genetically associated with neurodegenerative diseases (<xref rid="F5" ref-type="fig">Fig. 5E</xref>), for instance, Alpha-2-macroglobulin (<italic toggle="yes">A2M</italic>) is genetically associated with Alzheimer&#x2019;s disease (<xref rid="R32" ref-type="bibr">32</xref>), low-density lipoprotein receptor-related protein 1 (<italic toggle="yes">LRP1</italic>) is a master regulator of tau uptake and spread (<xref rid="R33" ref-type="bibr">33</xref>), and neurexin (NRXN1/3) is implicated in Autism (<xref rid="R34" ref-type="bibr">34</xref>).</p>
    </sec>
    <sec id="S6">
      <title>Discussion</title>
      <p id="P26">Here, we demonstrated 4000-gene MERFISH imaging of human brain tissues. Our MERFISH images enabled <italic toggle="yes">in situ</italic> identification of &gt;100 neuronal and non-neuronal cell populations and comprehensive mapping of the spatial organization of these cells in the human MTG and STG, resulting in a molecularly defined and spatially resolved cell atlas with high granularity. The cell composition in these human cortical regions showed marked differences from that observed in several mouse cortical regions. The spatial organization of cells showed both common and divergent features between human and mouse. Although we cannot exclude the possibility that some of these differences are due to different cortical regions, we consider this less likely because the different mouse cortical regions examined exhibited similar cell-type compositions and organizations, and the same was true for the human MTG and STG.</p>
      <p id="P27">These high-spatial-resolution cell atlases allowed us to systematically characterize proximity-based somatic interactions in a cell-type specific manner and revealed differences in cell-cell interactions between human and mouse. The differences were particularly striking for interactions between neuronal and non-neuronal cells. We observed substantially increased enrichment for soma contact or proximity between neurons and oligodendrocytes in the human cortex as compared to mouse. Perineuronal oligodendrocytes (<xref rid="R35" ref-type="bibr">35</xref>) can provide metabolic support to neurons (<xref rid="R36" ref-type="bibr">36</xref>). Hence, the observed increase in contact enrichment between oligodendrocytes and neurons may be a result of evolutionary adaptation to higher energy demands during the firing of individual neurons in the human brain (<xref rid="R37" ref-type="bibr">37</xref>). In addition, we observed preferential enrichment for contact or proximity between microglia and excitatory neurons, as compared to inhibitory neurons, in the human cortex, whereas the mouse cortex did not exhibit significant enrichment for such microglia-neuron contact. Satellite microglia can help maintain tissue homeostasis (<xref rid="R38" ref-type="bibr">38</xref>) and human genetics evidences suggest that microglia play a protective role that lowers the incidence of some neurodegenerative diseases (<xref rid="R39" ref-type="bibr">39</xref>). Our observation may thus represent a functional interaction between microglia and excitatory neurons in human. Interestingly, some ligand-receptor pairs genetically associated with neurodegenerative diseases were enriched in contacting microglia-neuron pairs as compared to non-interacting microglia and neurons, suggesting a possible molecular basis underlying the observed microglia-neuron interactions and a potential connection of these cell-cell interactions to neurodegenerative diseases. It has been suggested that evolution of non-neuronal cells follows a more complex pattern than simply increasing the cell abundance, but additionally involves the diversification of glial cells (<xref rid="R40" ref-type="bibr">40</xref>). Our observations of the enhanced enrichment for interactions between neurons and glia in the human cortex further expand upon this view.</p>
    </sec>
    <sec sec-type="supplementary-material" id="SM1">
      <title>Supplementary Material</title>
      <supplementary-material id="SD1" position="float" content-type="local-data">
        <label>Supplementary Materials</label>
        <media xlink:href="NIHMS1820958-supplement-Supplementary_Materials.pdf" id="d64e884" position="anchor"/>
      </supplementary-material>
      <supplementary-material id="SD2" position="float" content-type="local-data">
        <label>Table S1</label>
        <media xlink:href="NIHMS1820958-supplement-Table_S1.csv" id="d64e887" position="anchor"/>
      </supplementary-material>
      <supplementary-material id="SD3" position="float" content-type="local-data">
        <label>Table S2</label>
        <media xlink:href="NIHMS1820958-supplement-Table_S2.gz" id="d64e890" position="anchor"/>
      </supplementary-material>
      <supplementary-material id="SD4" position="float" content-type="local-data">
        <label>Table S3</label>
        <media xlink:href="NIHMS1820958-supplement-Table_S3.csv" id="d64e893" position="anchor"/>
      </supplementary-material>
      <supplementary-material id="SD5" position="float" content-type="local-data">
        <label>Table S4</label>
        <media xlink:href="NIHMS1820958-supplement-Table_S4.gz" id="d64e896" position="anchor"/>
      </supplementary-material>
      <supplementary-material id="SD6" position="float" content-type="local-data">
        <label>Table S5</label>
        <media xlink:href="NIHMS1820958-supplement-Table_S5.csv" id="d64e899" position="anchor"/>
      </supplementary-material>
      <supplementary-material id="SD7" position="float" content-type="local-data">
        <label>Table S6</label>
        <media xlink:href="NIHMS1820958-supplement-Table_S6.csv" id="d64e902" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S8">
      <title>Acknowledgments:</title>
      <p id="P29">We thank T. Bakken, W. Allen and C. E. Ang for helpful comments on the manuscript, and R. Hodge and J. Nyhus for assistance in postmortem sample preparation.</p>
      <sec id="S9">
        <title>Funding:</title>
        <p id="P30">This work is in part supported by the National Institutes of Health and Chan Zuckerberg Initiative. R.F. is a Howard Hughes Medical Institute Fellow of the Damon Runyon Cancer Research Foundation. X.Z. is a Howard Hughes Medical Institute Investigator.</p>
      </sec>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement" id="FN3">
        <p id="P31">Competing interests:</p>
        <p id="P32">C.X. and X.Z. are inventors on patents applied for by Harvard University related to MERFISH. X.Z. is a co-founder and consultant of Vizgen.</p>
      </fn>
      <fn id="FN4">
        <p id="P401">Supplementary Materials</p>
        <p id="P402">
<xref rid="SD1" ref-type="supplementary-material">Materials and Methods</xref>
</p>
        <p id="P403"><xref rid="R44" ref-type="bibr">References 44</xref>&#x2013;<xref rid="R54" ref-type="bibr">54</xref></p>
        <p id="P405"><xref rid="SD1" ref-type="supplementary-material">Figs. S1</xref> to <xref rid="SD1" ref-type="supplementary-material">S20</xref></p>
        <p id="P406"><xref rid="SD2" ref-type="supplementary-material">Tables S1</xref> to <xref rid="SD7" ref-type="supplementary-material">S6</xref></p>
      </fn>
    </fn-group>
    <sec sec-type="data-availability" id="S7">
      <title>Data and materials availability:</title>
      <p id="P28">MERFISH data are available at Dryad (<xref rid="R41" ref-type="bibr">41</xref>). The SMART-seq data is available at <ext-link xlink:href="https://portal.brain-map.org/atlases-and-data/rnaseq/human-mtg-smart-seq" ext-link-type="uri">https://portal.brain-map.org/atlases-and-data/rnaseq/human-mtg-smart-seq</ext-link>. All other data are in the main paper or supplement. The MERFISH image acquisition software is available at Zenodo (<xref rid="R42" ref-type="bibr">42</xref>). The analysis software is available at Zenodo (<xref rid="R43" ref-type="bibr">43</xref>).</p>
    </sec>
    <ref-list>
      <title>References and Notes</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><name><surname>Herculano-Houzel</surname><given-names>S</given-names></name>, <article-title>The human brain in numbers: a linearly scaled-up primate brain</article-title>. <source>Front. Hum. Neurosci</source>
<volume>3</volume> (<year>2009</year>), doi:<pub-id pub-id-type="doi">10.3389/neuro.09.031.2009</pub-id>.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><name><surname>Lui</surname><given-names>JH</given-names></name>, <name><surname>Hansen</surname><given-names>DV</given-names></name>, <name><surname>Kriegstein</surname><given-names>AR</given-names></name>, <article-title>Development and Evolution of the Human Neocortex</article-title>. <source>Cell</source>. <volume>146</volume>, <fpage>18</fpage>&#x2013;<lpage>36</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21729779</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><name><surname>Fields</surname><given-names>RD</given-names></name>, <name><surname>Stevens-Graham</surname><given-names>B</given-names></name>, <article-title>New Insights into Neuron-Glia Communication</article-title>. <source>Science</source>. <volume>298</volume>, <fpage>556</fpage>&#x2013;<lpage>562</lpage> (<year>2002</year>).<pub-id pub-id-type="pmid">12386325</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><name><surname>Barres</surname><given-names>BA</given-names></name>, <article-title>The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease</article-title>. <source>Neuron</source>. <volume>60</volume>, <fpage>430</fpage>&#x2013;<lpage>440</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18995817</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="book"><name><surname>Scuderi</surname><given-names>C</given-names></name>, <name><surname>Verkhratsky</surname><given-names>A</given-names></name>, in <source>Progress in Molecular Biology and Translational Science</source> (<publisher-name>Elsevier</publisher-name>, <year>2020</year>), vol. <volume>173</volume>, pp. <fpage>301</fpage>&#x2013;<lpage>330</lpage>.<pub-id pub-id-type="pmid">32711814</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><name><surname>Bernstein</surname><given-names>H-G</given-names></name>, <name><surname>Steiner</surname><given-names>J</given-names></name>, <name><surname>Bogerts</surname><given-names>B</given-names></name>, <article-title>Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy</article-title>. <source>Expert Review of Neurotherapeutics</source>. <volume>9</volume>, <fpage>1059</fpage>&#x2013;<lpage>1071</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19589054</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><name><surname>Salter</surname><given-names>MW</given-names></name>, <name><surname>Stevens</surname><given-names>B</given-names></name>, <article-title>Microglia emerge as central players in brain disease</article-title>. <source>Nat Med</source>. <volume>23</volume>, <fpage>1018</fpage>&#x2013;<lpage>1027</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28886007</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><name><surname>Hodge</surname><given-names>RD</given-names></name>
<etal/>, <article-title>Conserved cell types with divergent features in human versus mouse cortex</article-title>. <source>Nature</source>. <volume>573</volume>, <fpage>61</fpage>&#x2013;<lpage>68</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31435019</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><name><surname>Langseth</surname><given-names>CM</given-names></name>
<etal/>, <article-title>Comprehensive in situ mapping of human cortical transcriptomic cell types</article-title>. <source>Commun Biol</source>. <volume>4</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">33398033</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>C</given-names></name>
<etal/>, <article-title>Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex</article-title>. <source>Science</source>. <volume>357</volume>, <fpage>600</fpage>&#x2013;<lpage>604</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28798132</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><name><surname>Bakken</surname><given-names>TE</given-names></name>
<etal/>, <article-title>Comparative cellular analysis of motor cortex in human, marmoset and mouse</article-title>. <source>Nature</source>. <volume>598</volume>, <fpage>111</fpage>&#x2013;<lpage>119</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">34616062</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>KH</given-names></name>, <name><surname>Boettiger</surname><given-names>AN</given-names></name>, <name><surname>Moffitt</surname><given-names>JR</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Zhuang</surname><given-names>X</given-names></name>, <article-title>Spatially resolved, highly multiplexed RNA profiling in single cells</article-title>. <source>Science</source>. <volume>348</volume>, <fpage>aaa6090</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25858977</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Chakrabartty</surname><given-names>A</given-names></name>, <article-title>Cost-effective elimination of lipofuscin fluorescence from formalin-fixed brain tissue by white phosphor light emitting diode array</article-title>. <source>Biochem. Cell Biol</source>
<volume>94</volume>, <fpage>545</fpage>&#x2013;<lpage>550</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27824490</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>F</given-names></name>, <name><surname>Tillberg</surname><given-names>PW</given-names></name>, <name><surname>Boyden</surname><given-names>ES</given-names></name>, <article-title>Expansion microscopy</article-title>. <source>Science</source>. <volume>347</volume>, <fpage>543</fpage>&#x2013;<lpage>548</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25592419</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>C</given-names></name>, <name><surname>Fan</surname><given-names>J</given-names></name>, <name><surname>Emanuel</surname><given-names>G</given-names></name>, <name><surname>Hao</surname><given-names>J</given-names></name>, <name><surname>Zhuang</surname><given-names>X</given-names></name>, <article-title>Spatial transcriptome profiling by MERFISH reveals subcellular RNA compartmentalization and cell cycle-dependent gene expression</article-title>. <source>Proc Natl Acad Sci USA</source>. <volume>116</volume>, <fpage>19490</fpage>&#x2013;<lpage>19499</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31501331</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>G</given-names></name>, <name><surname>Moffitt</surname><given-names>JR</given-names></name>, <name><surname>Zhuang</surname><given-names>X</given-names></name>, <article-title>Multiplexed imaging of high-density libraries of RNAs with MERFISH and expansion microscopy</article-title>. <source>Sci Rep</source>. <volume>8</volume>, <fpage>4847</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29555914</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>M</given-names></name>
<etal/>, <article-title>Spatially resolved cell atlas of the mouse primary motor cortex by MERFISH</article-title>. <source>Nature</source>. <volume>598</volume>, <fpage>137</fpage>&#x2013;<lpage>143</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">34616063</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><name><surname>Sherwood</surname><given-names>CC</given-names></name>
<etal/>, <article-title>Evolution of increased glia-neuron ratios in the human frontal cortex</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <volume>103</volume>, <fpage>13606</fpage>&#x2013;<lpage>13611</lpage> (<year>2006</year>).</mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><name><surname>von Bartheld</surname><given-names>CS</given-names></name>, <name><surname>Bahney</surname><given-names>J</given-names></name>, <name><surname>Herculano-Houzel</surname><given-names>S</given-names></name>, <article-title>The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting: Quantifying neurons and glia in human brain</article-title>. <source>J. Comp. Neurol</source>
<volume>524</volume>, <fpage>3865</fpage>&#x2013;<lpage>3895</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27187682</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><name><surname>Keller</surname><given-names>D</given-names></name>, <name><surname>Er&#xF6;</surname><given-names>C</given-names></name>, <name><surname>Markram</surname><given-names>H</given-names></name>, <article-title>Cell Densities in the Mouse Brain: A Systematic Review</article-title>. <source>Front. Neuroanat</source>
<volume>12</volume>, <fpage>83</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30405363</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><name><surname>Letzkus</surname><given-names>JJ</given-names></name>, <name><surname>Wolff</surname><given-names>SBE</given-names></name>, <name><surname>L&#xFC;thi</surname><given-names>A</given-names></name>, <article-title>Disinhibition, a Circuit Mechanism for Associative Learning and Memory</article-title>. <source>Neuron</source>. <volume>88</volume>, <fpage>264</fpage>&#x2013;<lpage>276</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26494276</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>H</given-names></name>
<etal/>, <article-title>Large-Scale Cellular-Resolution Gene Profiling in Human Neocortex Reveals Species-Specific Molecular Signatures</article-title>. <source>Cell</source>. <volume>149</volume>, <fpage>483</fpage>&#x2013;<lpage>496</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22500809</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><name><surname>Juda&#x161;</surname><given-names>M</given-names></name>, <name><surname>Sedmak</surname><given-names>G</given-names></name>, <name><surname>Pletikos</surname><given-names>M</given-names></name>, <article-title>Early history of subplate and interstitial neurons: from Theodor Meynert (1867) to the discovery of the subplate zone (1974): History of subplate zone and interstitial neurons</article-title>. <source>Journal of Anatomy</source>. <volume>217</volume>, <fpage>344</fpage>&#x2013;<lpage>367</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20979585</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><name><surname>Colombo</surname><given-names>JA</given-names></name>, <name><surname>Reisin</surname><given-names>HD</given-names></name>, <article-title>Interlaminar astroglia of the cerebral cortex: a marker of the primate brain</article-title>. <source>Brain Research</source>. <volume>1006</volume>, <fpage>126</fpage>&#x2013;<lpage>131</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15047031</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><name><surname>Oberheim</surname><given-names>NA</given-names></name>
<etal/>, <article-title>Uniquely Hominid Features of Adult Human Astrocytes</article-title>. <source>Journal of Neuroscience</source>. <volume>29</volume>, <fpage>3276</fpage>&#x2013;<lpage>3287</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19279265</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><name><surname>Sosunov</surname><given-names>AA</given-names></name>
<etal/>, <article-title>Phenotypic Heterogeneity and Plasticity of Isocortical and Hippocampal Astrocytes in the Human Brain</article-title>. <source>Journal of Neuroscience</source>. <volume>34</volume>, <fpage>2285</fpage>&#x2013;<lpage>2298</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24501367</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><name><surname>Armingol</surname><given-names>E</given-names></name>, <name><surname>Officer</surname><given-names>A</given-names></name>, <name><surname>Harismendy</surname><given-names>O</given-names></name>, <name><surname>Lewis</surname><given-names>NE</given-names></name>, <article-title>Deciphering cell&#x2013;cell interactions and communication from gene expression</article-title>. <source>Nat Rev Genet</source>
<volume>22</volume>, <fpage>71</fpage>&#x2013;<lpage>88</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">33168968</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>J</given-names></name>, <name><surname>Slowikowski</surname><given-names>K</given-names></name>, <name><surname>Zhang</surname><given-names>F</given-names></name>, <article-title>Single-cell transcriptomics in cancer: computational challenges and opportunities</article-title>. <source>Exp Mol Med</source>. <volume>52</volume>, <fpage>1452</fpage>&#x2013;<lpage>1465</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32929226</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>
<etal/>, <article-title>Three-dimensional intact-tissue sequencing of single-cell transcriptional states</article-title>. <source>Science</source>. <volume>361</volume>, <fpage>eaat5691</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29930089</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><name><surname>Shapson-Coe</surname><given-names>A</given-names></name>
<etal/>, <article-title>A connectomic study of a petascale fragment of human cerebral cortex</article-title>. <source>bioRxiv</source>, doi:<pub-id pub-id-type="doi">10.1101/2021.05.29.446289</pub-id>.</mixed-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><name><surname>Stratoulias</surname><given-names>V</given-names></name>, <name><surname>Venero</surname><given-names>JL</given-names></name>, <name><surname>Tremblay</surname><given-names>M</given-names></name>, <name><surname>Joseph</surname><given-names>B</given-names></name>, <article-title>Microglial subtypes: diversity within the microglial community</article-title>. <source>EMBO J</source>. <volume>38</volume> (<year>2019</year>), doi:<pub-id pub-id-type="doi">10.15252/embj.2019101997</pub-id>.</mixed-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><name><surname>Blacker</surname><given-names>D</given-names></name>
<etal/>, <article-title>Alpha-2 macroglobulin is genetically associated with Alzheimer disease</article-title>. <source>Nat Genet</source>. <volume>19</volume>, <fpage>357</fpage>&#x2013;<lpage>360</lpage> (<year>1998</year>).<pub-id pub-id-type="pmid">9697696</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><name><surname>Rauch</surname><given-names>JN</given-names></name>
<etal/>, <article-title>LRP1 is a master regulator of tau uptake and spread</article-title>. <source>Nature</source>. <volume>580</volume>, <fpage>381</fpage>&#x2013;<lpage>385</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32296178</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><name><surname>S&#xFC;dhof</surname><given-names>TC</given-names></name>, <article-title>Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits</article-title>. <source>Cell</source>. <volume>171</volume>, <fpage>745</fpage>&#x2013;<lpage>769</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29100073</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><name><surname>Baumann</surname><given-names>N</given-names></name>, <name><surname>Pham-Dinh</surname><given-names>D</given-names></name>, <article-title>Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System</article-title>. <source>Physiological Reviews</source>. <volume>81</volume>, <fpage>871</fpage>&#x2013;<lpage>927</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11274346</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><name><surname>Philips</surname><given-names>T</given-names></name>, <name><surname>Rothstein</surname><given-names>JD</given-names></name>, <article-title>Oligodendroglia: metabolic supporters of neurons</article-title>. <source>Journal of Clinical Investigation</source>. <volume>127</volume>, <fpage>3271</fpage>&#x2013;<lpage>3280</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28862639</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><name><surname>Lennie</surname><given-names>P</given-names></name>, <article-title>The Cost of Cortical Computation</article-title>. <source>Current Biology</source>. <volume>13</volume>, <fpage>493</fpage>&#x2013;<lpage>497</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12646132</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Barres</surname><given-names>BA</given-names></name>, <article-title>Microglia and macrophages in brain homeostasis and disease</article-title>. <source>Nat Rev Immunol</source>. <volume>18</volume>, <fpage>225</fpage>&#x2013;<lpage>242</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29151590</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><name><surname>Hansen</surname><given-names>DV</given-names></name>, <name><surname>Hanson</surname><given-names>JE</given-names></name>, <name><surname>Sheng</surname><given-names>M</given-names></name>, <article-title>Microglia in Alzheimer&#x2019;s disease</article-title>. <source>Journal of Cell Biology</source>. <volume>217</volume>, <fpage>459</fpage>&#x2013;<lpage>472</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29196460</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40.</label>
        <mixed-citation publication-type="book"><name><surname>Verkhratsky</surname><given-names>A</given-names></name>, <name><surname>Ho</surname><given-names>MS</given-names></name>, <name><surname>Parpura</surname><given-names>V</given-names></name>, in <source>Neuroglia in Neurodegenerative Diseases</source>, <name><surname>Verkhratsky</surname><given-names>A</given-names></name>, <name><surname>Ho</surname><given-names>MS</given-names></name>, <name><surname>Zorec</surname><given-names>R</given-names></name>, <name><surname>Parpura</surname><given-names>V</given-names></name>, Eds. (<publisher-name>Springer Singapore</publisher-name>, <publisher-loc>Singapore</publisher-loc>, <year>2019</year>), <comment>vol. 1175 of Advances in Experimental Medicine and Biology</comment>, pp. <fpage>15</fpage>&#x2013;<lpage>44</lpage>.</mixed-citation>
      </ref>
      <ref id="R41">
        <label>41.</label>
        <mixed-citation publication-type="book"><name><surname>Fang</surname><given-names>R</given-names></name>
<etal/>, <source>Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH</source>, <publisher-name>Dryad</publisher-name> (<year>2022</year>); <pub-id pub-id-type="doi">10.5061/dryad.x3ffbg7mw</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42.</label>
        <mixed-citation publication-type="book"><name><surname>Babcock</surname><given-names>H</given-names></name>
<etal/>, <source>ZhuangLab/storm-control: v2019.06.28 release</source>. <publisher-name>Zenodo</publisher-name> (<year>2022</year>); doi:<pub-id pub-id-type="doi">10.5281/zenodo.3264857</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43.</label>
        <mixed-citation publication-type="book"><name><surname>Fang</surname><given-names>R</given-names></name>
<etal/>, <source>r3fang/MERlin: v0.2.0_20220413</source>. <publisher-name>Zenodo</publisher-name> (<year>2022</year>); doi: <pub-id pub-id-type="doi">10.5281/zenodo.6459546</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><name><surname>Moffitt</surname><given-names>JR</given-names></name>
<etal/>, <article-title>Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region</article-title>. <source>Science</source>. <volume>362</volume>, <fpage>eaau5324</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30385464</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><name><surname>Moffitt</surname><given-names>JR</given-names></name>
<etal/>, <article-title>High-throughput single-cell gene-expression profiling with multiplexed error-robust fluorescence in situ hybridization</article-title>. <source>Proc Natl Acad Sci USA</source>. <volume>113</volume>, <fpage>11046</fpage>&#x2013;<lpage>11051</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27625426</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>F</given-names></name>
<etal/>, <article-title>Nanoscale imaging of RNA with expansion microscopy</article-title>. <source>Nat Methods</source>. <volume>13</volume>, <fpage>679</fpage>&#x2013;<lpage>684</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27376770</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><name><surname>Stringer</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <name><surname>Michaelos</surname><given-names>M</given-names></name>, <name><surname>Pachitariu</surname><given-names>M</given-names></name>, <article-title>Cellpose: a generalist algorithm for cellular segmentation</article-title>. <source>Nat Methods</source>. <volume>18</volume>, <fpage>100</fpage>&#x2013;<lpage>106</lpage> (<year>2021</year>).<pub-id pub-id-type="pmid">33318659</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><name><surname>M&#xF6;lder</surname><given-names>F</given-names></name>
<etal/>, <article-title>Sustainable data analysis with Snakemake</article-title>. <source>F1000Res</source>. <volume>10</volume>, <fpage>33</fpage> (<year>2021</year>).<pub-id pub-id-type="pmid">34035898</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><name><surname>Hafemeister</surname><given-names>C</given-names></name>, <name><surname>Satija</surname><given-names>R</given-names></name>, <article-title>Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression</article-title>. <source>Genome Biol</source>. <volume>20</volume>, <fpage>296</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31870423</pub-id></mixed-citation>
      </ref>
      <ref id="R50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><name><surname>Becht</surname><given-names>E</given-names></name>
<etal/>, <article-title>Dimensionality reduction for visualizing single-cell data using UMAP</article-title>. <source>Nat Biotechnol</source>. <volume>37</volume>, <fpage>38</fpage>&#x2013;<lpage>44</lpage> (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><name><surname>Stuart</surname><given-names>T</given-names></name>
<etal/>, <article-title>Comprehensive Integration of Single-Cell Data</article-title>. <source>Cell</source>. <volume>177</volume>, <fpage>1888</fpage>&#x2013;<lpage>1902.e21</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31178118</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><name><surname>Traag</surname><given-names>VA</given-names></name>, <name><surname>Waltman</surname><given-names>L</given-names></name>, <name><surname>van Eck</surname><given-names>NJ</given-names></name>, <article-title>From Louvain to Leiden: guaranteeing well-connected communities</article-title>. <source>Sci Rep</source>. <volume>9</volume>, <fpage>5233</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30914743</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><name><surname>Kiselev</surname><given-names>VY</given-names></name>
<etal/>, <article-title>SC3: consensus clustering of single-cell RNA-seq data</article-title>. <source>Nat Methods</source>. <volume>14</volume>, <fpage>483</fpage>&#x2013;<lpage>486</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28346451</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><name><surname>Ovesn&#xFD;</surname><given-names>M</given-names></name>, <name><surname>K&#x159;&#xED;&#x17E;ek</surname><given-names>P</given-names></name>, <name><surname>Borkovec</surname><given-names>J</given-names></name>, <name><surname>&#x160;vindrych</surname><given-names>Z</given-names></name>, <name><surname>Hagen</surname><given-names>GM</given-names></name>, <article-title>ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging</article-title>. <source>Bioinformatics</source>. <volume>30</volume>, <fpage>2389</fpage>&#x2013;<lpage>2390</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24771516</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig position="float" id="F1">
      <label>Fig. 1.</label>
      <caption>
        <title>Spatially resolved single-cell transcriptome profiling of the human cortex by MERFISH.</title>
        <p id="P33">(<bold>A</bold>) Schematic of 4000-gene MERFISH measurements of the human MTG and STG using a 48-bit error-correcting code. (<bold>B</bold>) Example MERFISH images. Left: MERFISH image of a single field-of-view, with maximum projection across all 48 bits shown. Middle: Zoomed-in image of the boxed region. Right: Decoded RNA molecules of the zoomed-in region. Scale bars indicate the real size of the sample prior to expansion. (<bold>C</bold>) Cell-type classification of the MTG and STG from MERFISH data and the expression of a subset of marker genes. EXC: excitatory neurons; INH: inhibitory neurons; ASC: astrocytes; MGC: microglial cells; OGC: oligodendrocytes; OPC: oligodendrocyte progenitor cells; ENDO: endothelial cells; MURAL: mural cells; IT: intratelencephalic-projecting neurons; ET: extratelencephalic-projecting neurons; NP: near-projecting neurons; CT: cortico-thalamic projecting neurons. The size and color of each dot correspond to the percentage of cells expressing the gene in each cluster and the average normalized expression level, respectively. (<bold>D</bold>) Proportions of excitatory neurons, inhibitory neurons, and major subclasses of non-neuronal cells in human MTG and STG and four mouse cortical regions including MOp, VIS, AUD and TEa. (<bold>E</bold>) Proportion of subclasses of excitatory neurons (left), IT neurons (middle), and inhibitory neurons (right) in human MTG and STG and the four mouse cortical regions.</p>
      </caption>
      <graphic xlink:href="nihms-1820958-f0001" position="float"/>
    </fig>
    <fig position="float" id="F2">
      <label>Fig. 2.</label>
      <caption>
        <title>Laminar organization of cell types in the human and mouse cortex.</title>
        <p id="P34">(<bold>A</bold>) Spatial maps of subclasses of excitatory neurons, inhibitory neurons, and glial cells determined by MERFISH in a human MTG slice and a mouse slice containing VIS, AUD and TEa. Indicated subclasses are shown in colors and other cells are in grey. (<bold>B</bold>) Cortical-depth distribution of excitatory (top), inhibitory (middle) and non-neuronal (bottom) clusters in the human MTG. The dashed grey lines mark the approximate layer boundaries. WM: white matter.</p>
      </caption>
      <graphic xlink:href="nihms-1820958-f0002" position="float"/>
    </fig>
    <fig position="float" id="F3">
      <label>Fig. 3.</label>
      <caption>
        <title>Cortical-depth distributions of L6b, L4/5 IT, and excitatory-to-inhibitory neuronal ratio.</title>
        <p id="P35">(<bold>A-B</bold>) Spatial maps of L6b (<bold>A</bold>) and L4/5 IT (<bold>B</bold>) neurons in a human MTG slice (top), a human STG slice (second), a VIS-containing region (third) and AUD containing region (bottom) in a mouse slice. (<bold>C</bold>) Normalized cortical-depth distributions of excitatory (EXC) and inhibitory (INH) neurons, E:I ratio, and E:I ratio z-score in human (top) and mouse (bottom) cortex. E:I ratio: the ratio between the numbers of excitatory and inhibitory neurons.</p>
      </caption>
      <graphic xlink:href="nihms-1820958-f0003" position="float"/>
    </fig>
    <fig position="float" id="F4">
      <label>Fig. 4.</label>
      <caption>
        <title>Cell-type-specific cell-cell interactions in the human and mouse cortex</title>
        <p id="P36">. (<bold>A</bold>) Spatial map of excitatory neurons, inhibitory neurons, and six major subclasses of non-neuronal cells in a human MTG slice (left) and a zoomed-in image of the boxed region (right). Colored shapes are cell nuclei segmentations. (<bold>B</bold>) Enrichment map of pairwise soma contact or proximity for subclasses of cells in human (left) and mouse (right) cortex. The color of the dots indicates the fold change between the observed frequency of soma contact or proximity and the average expected frequency from the spatial permutations that disrupt the spatial relationship between neighboring cells (<xref rid="SD1" ref-type="supplementary-material">fig. S13</xref>). The size of the dots indicates the significance level of the enrichment. FDR: P-value determined with upper-tailed Z-test and adjusted to FDR by the BH procedure. (<bold>C</bold>) Distributions of the nearest-neighbor distances from cells in individual subclasses to cells in the same subclass (&#x201C;to self&#x201D;, red) or other subclasses (&#x201C;to other&#x201D;, blue) in human (top) and mouse (bottom) cortex. FDR: P-value determined with the Wilcoxon rank-sum one-sided test and adjusted to FDR by the BH procedure.</p>
      </caption>
      <graphic xlink:href="nihms-1820958-f0004" position="float"/>
    </fig>
    <fig position="float" id="F5">
      <label>Fig. 5.</label>
      <caption>
        <title>Interactions between glial and vascular cells and between glial cells and neurons in the human and mouse cortex</title>
        <p id="P37">. (<bold>A</bold>) Spatial map of subclasses of cells in a human STG slice. Top right: Zoom-in of boxed region i. A blood vessel with juxtaposed glial cells is marked by dashed line. Middle right: Zoom-in of boxed region ii. Multiway contacts between neurons and oligodendrocytes and/or OPCs are marked by dashed lines. Bottom right: Zoom-in of boxed region iii. Contacting pairs of neurons and microglia are marked by dash lines. Colored and grey shapes are cell nuclei segmentations, (<bold>B</bold>) Average numbers of microglia, oligodendrocytes, OPCs, and astrocytes adjacent to each identified blood vessel in human (blue) and mouse (orange). Error bars are standard deviation (N = 3,415 vascular structures). * FDR &lt; 1e-3 (as determined in <xref rid="F4" ref-type="fig">Fig. 4B</xref>). (<bold>C</bold>) The significance level of multiway contacts between neurons and oligodendrocytes and/or OPCs in human (blue) and mouse (orange) cortex. The significance level was determined by comparing the observed contact frequency with the expected frequencies from spatial permutations as described in <xref rid="SD1" ref-type="supplementary-material">fig. S13</xref>. FDR: P-values determined with an upper-tailed Z-test and adjusted to FDR by the BH procedure. (<bold>D</bold>) The ratio between observed contact frequency and expected contact frequency (from spatial permutations) between microglia and L2/3 IT, L4/5 IT, L5 IT, L6 IT, and inhibitory neurons in human (left) and mouse (right). In the box plot, midline is the median, box edges are 75<sup>th</sup> and 25<sup>th</sup> percentiles, and whiskers indicate 1.5 times the interquartile range. * FDR &lt; 1e-3 (as determined in <xref rid="F4" ref-type="fig">Fig. 4B</xref>). (<bold>E</bold>) Enrichment of ligand-receptor pairs in contacting microglia and IT neurons. The color and size of the dots correspond to the fold change and significance level of the observed ligand-receptor scores over their expected values. FDR as determined in (<bold>C</bold>).</p>
      </caption>
      <graphic xlink:href="nihms-1820958-f0005" position="float"/>
    </fig>
  </floats-group>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0404511</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">7473</journal-id>
      <journal-id journal-id-type="nlm-ta">Science</journal-id>
      <journal-id journal-id-type="iso-abbrev">Science</journal-id>
      <journal-title-group>
        <journal-title>Science (New York, N.Y.)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-8075</issn>
      <issn pub-type="epub">1095-9203</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34353948</article-id>
      <article-id pub-id-type="pmc">8733867</article-id>
      <article-id pub-id-type="doi">10.1126/science.abg5289</article-id>
      <article-id pub-id-type="manuscript">NIHMS1753799</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>De novo</italic> assembly, annotation, and comparative analysis of 26 diverse maize genomes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hufford</surname>
            <given-names>Matthew B.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seetharam</surname>
            <given-names>Arun S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Woodhouse</surname>
            <given-names>Margaret R.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chougule</surname>
            <given-names>Kapeel M.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ou</surname>
            <given-names>Shujun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Jianing</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ricci</surname>
            <given-names>William A.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>Tingting</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Olson</surname>
            <given-names>Andrew</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qiu</surname>
            <given-names>Yinjie</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coletta</surname>
            <given-names>Rafael Della</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tittes</surname>
            <given-names>Silas</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hudson</surname>
            <given-names>Asher I.</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marand</surname>
            <given-names>Alexandre P.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>Sharon</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Zhenyuan</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Bo</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tello-Ruiz</surname>
            <given-names>Marcela K.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piri</surname>
            <given-names>Rebecca D.</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Na</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Dong won</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>Yibing</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O&#x2019;Connor</surname>
            <given-names>Christine H.</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Xianran</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gilbert</surname>
            <given-names>Amanda M.</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baggs</surname>
            <given-names>Erin</given-names>
          </name>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krasileva</surname>
            <given-names>Ksenia V.</given-names>
          </name>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Portwood</surname>
            <given-names>John L.</given-names>
            <suffix>II</suffix>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cannon</surname>
            <given-names>Ethalinda K.S.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Andorf</surname>
            <given-names>Carson M.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Manchanda</surname>
            <given-names>Nancy</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Snodgrass</surname>
            <given-names>Samantha J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hufnagel</surname>
            <given-names>David E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Qiuhan</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pedersen</surname>
            <given-names>Sarah</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Syring</surname>
            <given-names>Michael L.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kudrna</surname>
            <given-names>David A.</given-names>
          </name>
          <xref ref-type="aff" rid="A15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Llaca</surname>
            <given-names>Victor</given-names>
          </name>
          <xref ref-type="aff" rid="A16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fengler</surname>
            <given-names>Kevin</given-names>
          </name>
          <xref ref-type="aff" rid="A16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schmitz</surname>
            <given-names>Robert J.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ross-Ibarra</surname>
            <given-names>Jeffrey</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
          <xref ref-type="aff" rid="A17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>Jianming</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gent</surname>
            <given-names>Jonathan I.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hirsch</surname>
            <given-names>Candice N.</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ware</surname>
            <given-names>Doreen</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dawe</surname>
            <given-names>R. Kelly</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref rid="CR1" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Ecology, Evolution, and Organismal Biology, Iowa State University, Ames, IA 50011</aff>
      <aff id="A2"><label>2</label>Genome Informatics Facility, Iowa State University, Ames, IA 50011</aff>
      <aff id="A3"><label>3</label>USDA-ARS Corn Insects and Crop Genetics Research Unit, Iowa State University, Ames, IA 50011</aff>
      <aff id="A4"><label>4</label>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724</aff>
      <aff id="A5"><label>5</label>Department of Genetics, University of Georgia, Athens, GA 30602</aff>
      <aff id="A6"><label>6</label>Department of Plant Biology, University of Georgia, Athens, GA 30602</aff>
      <aff id="A7"><label>7</label>Institute of Bioinformatics, University of Georgia, Athens, GA 30602</aff>
      <aff id="A8"><label>8</label>Department of Agronomy, Iowa State University, Ames, IA 50011</aff>
      <aff id="A9"><label>9</label>Department of Agronomy and Plant Genetics, University of Minnesota, St. Paul, MN 55108</aff>
      <aff id="A10"><label>10</label>Center for Population Biology, University of California, Davis, CA 95616</aff>
      <aff id="A11"><label>11</label>Department of Evolution and Ecology, University of California, Davis, CA 95616</aff>
      <aff id="A12"><label>12</label>Department of Ecology, Evolution, and Behavior, University of Minnesota, St. Paul, MN 55108</aff>
      <aff id="A13"><label>13</label>Department of Plant and Microbial Biology, University of California, Berkeley, CA 94720</aff>
      <aff id="A14"><label>14</label>Virus and Prion Research Unit, National Animal Disease Center, USDA-ARS, Ames, IA, 50010</aff>
      <aff id="A15"><label>15</label>Arizona Genomics Institute, School of Plant Sciences, University of Arizona, Tucson, AZ 85721</aff>
      <aff id="A16"><label>16</label>Corteva Agriscience, Johnston, IA 50131</aff>
      <aff id="A17"><label>17</label>Genome Center, University of California, Davis, CA 95616</aff>
      <aff id="A18"><label>18</label>USDA ARS NAA Robert W. Holley Center for Agriculture and Health, Agricultural Research Service, Ithaca, NY 14853</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P1"><bold>Author contributions:</bold> Conceptualization &#x2013; RKD, DW, MBH, CNH, JIG; Data curation &#x2013; MW, AS, KMC, SO, JL, SW, APM, ZL, BW, MKT-R, JLP, EKSC, CMA; Formal analysis &#x2013; AS, MW, KMC, SO, JL, WAR, TG, AO, YQ, RDC, ST, APM, AIH, SW, ZL, BW, MKT-R, RDP, YZ, CHO, XL, AMG, EB, JLP, NM, SJS, QJ, SP, MLS, KF, JIG; Funding acquisition - RKD, DW, MBH, CNH, JIG; RJS; Investigation &#x2013; DK, DAK, NW, DEH, VL, KF, JIG; Methodology &#x2013; MBH, DW, CNH, AS, MW, KF, WAR, JL, RJS, JIG, JR-I, JY, RKD; Project administration &#x2013; RKD, MBH, DW, CNH, JIG; Software &#x2013; AS, DEH, NM, SO; Supervision &#x2013; MBH, DW, RKD, CNH, JIG, KVK, JIG, RJS, JR-I, JY; Visualization &#x2013; MW, AS, JL, WAR, YQ, KMC, SO, WAR, RDP, SJS, CNH, JIG; Writing &#x2013; MBH, RKD, CNH, JIG.</p>
        </fn>
        <corresp id="CR1"><label>*</label>correspondence to: <email>kdawe@uga.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>9</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>06</day>
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>06</day>
        <month>2</month>
        <year>2022</year>
      </pub-date>
      <volume>373</volume>
      <issue>6555</issue>
      <fpage>655</fpage>
      <lpage>662</lpage>
      <!--elocation-id from pubmed: 10.1126/science.abg5289-->
      <abstract id="ABS1">
        <p id="P2">We report <italic>de novo</italic> genome assemblies, transcriptomes, annotations, and methylomes for the 26 inbreds that serve as the founders for the maize nested association mapping population. The number of pan-genes in these diverse genomes exceeds 103,000, with approximately a third found across all genotypes. The results demonstrate that the ancient tetraploid character of maize continues to degrade by fractionation to the present day. Excellent contiguity over repeat arrays and complete annotation of centromeres revealed additional variation in major cytological landmarks. We show that combining structural variation with SNPs can improve the power of quantitative mapping studies. Finally, we document variation at the level of DNA methylation, and demonstrate that unmethylated regions are enriched for cis-regulatory elements that contribute to phenotypic variation.</p>
      </abstract>
      <abstract id="ABS2" abstract-type="summary">
        <title>One sentence summary:</title>
        <p id="P3">A multi-genome analysis of maize reveals previously unknown variation in gene content, genome structure, and methylation.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">32581361</article-id>
      <article-id pub-id-type="pmc">7116693</article-id>
      <article-id pub-id-type="manuscript">EMS112368</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-020-2435-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pervasive lesion segregation shapes cancer genome evolution</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aitken</surname>
            <given-names>Sarah J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Anderson</surname>
            <given-names>Craig J.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Connor</surname>
            <given-names>Frances</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pich</surname>
            <given-names>Oriol</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sundaram</surname>
            <given-names>Vasavi</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feig</surname>
            <given-names>Christine</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rayner</surname>
            <given-names>Tim F.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lukk</surname>
            <given-names>Margus</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aitken</surname>
            <given-names>Stuart</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luft</surname>
            <given-names>Juliet</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kentepozidou</surname>
            <given-names>Elissavet</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arnedo-Pac</surname>
            <given-names>Claudia</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beentjes</surname>
            <given-names>Sjoerd V.</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Davies</surname>
            <given-names>Susan E.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Drews</surname>
            <given-names>Ruben M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ewing</surname>
            <given-names>Ailith</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kaiser</surname>
            <given-names>Vera B.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khamseh</surname>
            <given-names>Ava</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>L&#xF3;pez-Arribillaga</surname>
            <given-names>Erika</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Redmond</surname>
            <given-names>Aisling M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santoyo-Lopez</surname>
            <given-names>Javier</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sent&#xED;s</surname>
            <given-names>In&#xE9;s</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Talmane</surname>
            <given-names>Lana</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yates</surname>
            <given-names>Andrew D.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Semple</surname>
            <given-names>Colin A.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>L&#xF3;pez-Bigas</surname>
            <given-names>N&#xFA;ria</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A10">10</xref>
          <xref ref-type="aff" rid="A11">11</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Flicek</surname>
            <given-names>Paul</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Odom</surname>
            <given-names>Duncan T.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A12">12</xref>
          <xref ref-type="aff" rid="A13">13</xref>
          <xref ref-type="corresp" rid="CR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>Martin S.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A13">13</xref>
          <xref ref-type="corresp" rid="CR1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
<label>1</label>Cancer Research UK - Cambridge Institute, University of Cambridge, Cambridge, UK</aff>
      <aff id="A2">
<label>2</label>Department of Pathology, University of Cambridge, Cambridge, UK</aff>
      <aff id="A3">
<label>3</label>Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK</aff>
      <aff id="A4">
<label>4</label>MRC Human Genetics Unit, MRC Institute of Genetics &amp; Molecular Medicine, University of Edinburgh, Edinburgh, UK</aff>
      <aff id="A5">
<label>5</label>European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK</aff>
      <aff id="A6">
<label>6</label>Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain</aff>
      <aff id="A7">
<label>7</label>School of Mathematics and Maxwell Institute, University of Edinburgh, Edinburgh, UK</aff>
      <aff id="A8">
<label>8</label>Higgs Centre for Theoretical Physics, University of Edinburgh, Edinburgh, UK</aff>
      <aff id="A9">
<label>9</label>Edinburgh Genomics (Clinical), The University of Edinburgh, Edinburgh, UK</aff>
      <aff id="A10">
<label>10</label>Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain</aff>
      <aff id="A11">
<label>11</label>Instituci&#xF3; Catalana de Recerca i Estudis Avan&#xE7;ats (ICREA), Barcelona, Spain</aff>
      <aff id="A12">
<label>12</label>German Cancer Research Center (DKFZ), Heidelberg, Germany</aff>
      <aff id="A13">
<label>13</label>Liver Cancer Evolution Consortium</aff>
      <author-notes>
        <corresp id="CR1"><label>*</label>Correspondence and materials requests should be addressed to Duncan T. Odom <email>Duncan.Odom@cruk.cam.ac.uk</email> and Martin S. Taylor <email>martin.taylor@igmm.ed.ac.uk</email></corresp>
        <fn fn-type="COI-statement" id="FN2">
          <p id="P92">
<bold>Competing interests</bold>
</p>
          <p id="P93">P.F. is a member of the Scientific Advisory Boards of Fabric Genomics, Inc., and Eagle Genomics, Ltd.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>21</day>
        <month>1</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>7</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>6</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>04</day>
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <volume>583</volume>
      <issue>7815</issue>
      <fpage>265</fpage>
      <lpage>270</lpage>
      <abstract>
        <title>Summary</title>
        <p id="P1">Cancers arise through the acquisition of oncogenic mutations and grow through clonal expansion<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup>. Here we reveal that most mutagenic DNA lesions are not resolved as mutations within a single cell-cycle. Instead, DNA lesions segregate unrepaired into daughter cells for multiple cell generations, resulting in the chromosome-scale phasing of subsequent mutations. We characterise this process in mutagen-induced mouse liver tumours and show that DNA replication across persisting lesions can produce multiple alternative alleles in successive cell divisions, thereby generating both multi-allelic and combinatorial genetic diversity. The phasing of lesions enables the accurate measurement of strand biased repair processes, the quantification of oncogenic selection, and the fine mapping of sister chromatid exchange events. Finally, we demonstrate that lesion segregation is a unifying property of exogenous mutagens, including UV light and chemotherapy agents in human cells and tumours, which has profound implications for the evolution and adaptation of cancer genomes.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33429418</article-id>
      <article-id pub-id-type="pmc">7987233</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-020-03148-w</article-id>
      <article-id pub-id-type="manuscript">NIHMS1656482</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grant</surname>
            <given-names>Rogan A.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="FN1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morales-Nebreda</surname>
            <given-names>Luisa</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="FN1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Markov</surname>
            <given-names>Nikolay S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="FN1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Swaminathan</surname>
            <given-names>Suchitra</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Querrey</surname>
            <given-names>Melissa</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guzman</surname>
            <given-names>Estefany R.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abbott</surname>
            <given-names>Darryl A.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Donnelly</surname>
            <given-names>Helen K.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Donayre</surname>
            <given-names>Alvaro</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goldberg</surname>
            <given-names>Isaac A.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Klug</surname>
            <given-names>Zasu M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Borkowski</surname>
            <given-names>Nicole</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Ziyan</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kihshen</surname>
            <given-names>Hermon</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Politanska</surname>
            <given-names>Yuliya</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sichizya</surname>
            <given-names>Lango</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>Mengjia</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shilatifard</surname>
            <given-names>Ali</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qi</surname>
            <given-names>Chao</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lomasney</surname>
            <given-names>Jon W.</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Argento</surname>
            <given-names>A. Christine</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kruser</surname>
            <given-names>Jacqueline M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malsin</surname>
            <given-names>Elizabeth S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pickens</surname>
            <given-names>Chiagozie O.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>Sean B.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Walter</surname>
            <given-names>James M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pawlowski</surname>
            <given-names>Anna E.</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nannapaneni</surname>
            <given-names>Prasanth</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abdala-Valencia</surname>
            <given-names>Hiam</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bharat</surname>
            <given-names>Ankit</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gottardi</surname>
            <given-names>Cara J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Budinger</surname>
            <given-names>GR Scott</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref rid="CR1" ref-type="corresp">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Misharin</surname>
            <given-names>Alexander V.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref rid="CR1" ref-type="corresp">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singer</surname>
            <given-names>Benjamin D.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref rid="CR1" ref-type="corresp">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wunderink</surname>
            <given-names>Richard G.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref rid="CR1" ref-type="corresp">**</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>The NU SCRIPT Study Investigators</collab>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A2"><label>2</label>Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A3"><label>3</label>Robert H Lurie Comprehensive Cancer Research Center, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A4"><label>4</label>Division of Thoracic Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A5"><label>5</label>Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A6"><label>6</label>Simpson Querrey Institute for Epigenetics, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A7"><label>7</label>Department of Pathology, Feinberg School of Medicine, Northwestern University</aff>
      <aff id="A8"><label>8</label>Clinical and Translational Sciences Institute, Feinberg School of Medicine, Northwestern University</aff>
      <author-notes>
        <fn fn-type="equal" id="FN1">
          <label>*</label>
          <p id="P1">These authors contributed equally to this work and will list themselves first on their CVs.</p>
        </fn>
        <fn fn-type="con" id="FN2">
          <p id="P2">Consortia: The NU SCRIPT Study Investigators:</p>
          <p id="P3">Rogan A. Grant<sup>1</sup>, Luisa Morales-Nebreda<sup>1</sup>, Nikolay S. Markov<sup>1</sup>, Suchitra Swaminathan<sup>2,3</sup>, Melissa Querrey<sup>4</sup>, Estefany R. Guzman<sup>3</sup>, Darryl A. Abbott<sup>3</sup>, Helen K. Donnelly<sup>1</sup>, Alvaro Donayre<sup>1</sup>, Isaac A. Goldberg<sup>1</sup>, Zasu M. Klug<sup>1</sup>, Nicole Borkowski<sup>1</sup>, Ziyan Lu<sup>1</sup>, Hermon Kihshen<sup>1</sup>, Yuliya Politanska<sup>1</sup>, Lango Sichizya<sup>1</sup>, Mengjia Kang<sup>1</sup>, Ali Shilatifard<sup>5,6</sup>, Chao Qi<sup>7</sup>, Jon W. Lomasney<sup>7</sup>, A. Christine Argento<sup>1</sup>, Jacqueline M. Kruser<sup>1</sup>, Elizabeth S. Malsin<sup>1</sup>, Chiagozie O. Pickens<sup>1</sup>, Sean B. Smith<sup>1</sup>, James M. Walter<sup>1</sup>, Anna E. Pawlowski<sup>8</sup>, Daniel Schneider<sup>8</sup>, Prasanth Nannapaneni<sup>8</sup>, Hiam Abdala-Valencia<sup>1</sup>, Ankit Bharat<sup>1,4</sup>, Cara J. Gottardi<sup>1</sup>, GR Scott Budinger<sup>1</sup>, Alexander V. Misharin<sup>1,6</sup>, Benjamin D. Singer<sup>1,5,6</sup>, Richard G. Wunderink<sup>1,6</sup>, Ajay A. Wagh<sup>1</sup>, Alan R. Hauser<sup>9</sup>, Alexis Rose Wolfe<sup>1</sup>, Anjali Thakrar<sup>2</sup>, Anjana V. Yeldandi<sup>7</sup>, Ann A. Wang<sup>1</sup>, Anne R. Levenson<sup>1</sup>, Anthony M. Joudi<sup>1</sup>, Betty Tran<sup>1</sup>, Catherine A. Gao<sup>1</sup>, Chitaru Kurihara<sup>4</sup>, Clara J. Schroedl<sup>1</sup>, Curt M. Horvath<sup>9,10</sup>, Daniel Meza<sup>1</sup>, David D. Odell<sup>4</sup>, David W. Kamp<sup>1</sup>, Deborah R. Winter<sup>2</sup>, Egon A. Ozer<sup>9</sup>, Elisheva D. Shanes<sup>7</sup>, Elizabeth T. Bartom<sup>5,6</sup>, Emily J. Rendleman<sup>5</sup>, Emily M. Leibenguth<sup>1</sup>, Firas Wehbe<sup>8</sup>, Gabrielle Y. Liu<sup>1</sup>, Gaurav T. Gadhvi<sup>2</sup>, Heliodoro Tejedor Navarro<sup>11</sup>, Jacob I. Sznajder<sup>1</sup>, Jane E. Dematte<sup>1</sup>, Jasmine Le<sup>1</sup>, Jason M. Arnold<sup>1</sup>, Joanne C. Du<sup>1</sup>, John Coleman<sup>1</sup>, Joseph I. Bailey<sup>1</sup>, Joseph S. Deters<sup>1</sup>, Justin A. Fiala<sup>1</sup>, Justin Starren<sup>8</sup>, Karen M. Ridge<sup>1</sup>, Katharine Secunda<sup>1</sup>, Kathleen Aren<sup>2</sup>, Khalilah L. Gates<sup>1</sup>, Kristy Todd<sup>1</sup>, Lindsey D. Gradone<sup>1</sup>, Lindsey N. Textor<sup>1</sup>, Lisa F. Wolfe<sup>1</sup>, Lorenzo L. Pesce<sup>4</sup>, Lu&#xED;s A. Nunes Amaral<sup>11</sup>, Madeline L. Rosenbaum<sup>1</sup>, Manoj Kandpal<sup>8</sup>, Manu Jain<sup>1</sup>, Marc A. Sala<sup>1</sup>, Mark Saine<sup>4</sup>, Mary Carns<sup>2</sup>, Michael J. Alexander<sup>1</sup>, Michael J. Cuttica<sup>1</sup>, Michelle H. Prickett<sup>1</sup>, Nabiha H. Khan<sup>5</sup>, Navdeep S. Chandel<sup>1,6</sup>, Nicholas D. Soulakis<sup>8</sup>, Orlyn R. Rivas<sup>1</sup>, Patrick C. Seed<sup>12</sup>, Paul A. Reyfman<sup>1</sup>, Pearl D. Go<sup>8</sup>, Peter H. S. Sporn<sup>1</sup>, Phillip R. Cooper<sup>1</sup>, Rade Tomic<sup>1</sup>, Radhika Patel<sup>1</sup>, Rafael Garza-Castillon<sup>4</sup>, Ravi Kalhan<sup>1</sup>, Richard I. Morimoto<sup>10</sup>, Ruben J. Mylvaganam<sup>1</sup>, Samuel S. Kim<sup>4</sup>, Samuel W.M. Gatesy<sup>13</sup>, Sanket Thakkar<sup>4</sup>, Sarah Ben Maamar<sup>8</sup>, SeungHye Han<sup>1</sup>, Sharon R. Rosenberg<sup>1</sup>, Sophia Nozick<sup>9</sup>, Stefan J. Green<sup>14</sup>, Susan R. Russell<sup>1</sup>, Taylor A. Poor<sup>1</sup>, Taylor J. Zak<sup>7</sup>, Theresa A. Lombardo<sup>8</sup>, Thomas Stoeger<sup>11</sup>, Todd Shamaly<sup>8</sup>, Ziyou Ren<sup>1</sup>.</p>
          <p id="P4"><sup>9</sup> Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University</p>
          <p id="P5"><sup>10</sup> Department of Molecular Biosciences, Weinberg College of Art and Sciences, Northwestern University</p>
          <p id="P6"><sup>11</sup> Department of Chemical and Biological Engineering, McCormick School of Engineering, Northwestern University</p>
          <p id="P7"><sup>12</sup> Division of Pediatric Infectious Diseases, Stanley Manne Research Institute, Ann and Robert H. Lurie Children&#x2019;s Hospital</p>
          <p id="P8"><sup>13</sup> Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University</p>
          <p id="P9"><sup>14</sup> Genome Research Core, University of Illinois at Chicago.</p>
        </fn>
        <fn fn-type="con" id="FN5">
          <p id="P10">Authors contribution:</p>
          <p id="P11">G.R.S.B., A.V.M., B.D.S. and R.G.W. conceived and designed the project and provided funding. R.A.G., L.M.-N., N.S.M., G.R.S.B., A.V.M., B.D.S. and R.G.W. curated and analyzed the data and wrote the manuscript. C.O.P., J.M.K., J.M.W., B.D.S. and R.G.W. performed adjudication of clinical outcomes. A.D., H.K.D., I.A.G., N.B. and Z.M.K. recruited patients into the study and coordinated interactions between clinical and research teams. A.C.A., A.B., B.D.S., C.O.P., E.S.M., G.R.S.B., J.M.K., J.M.W., L.M.-N., R.G.W. and S.B.S. performed BAL procedures and sample collection. A.S. contributed equipment. C.Q. performed clinical microbiological assessment of BAL fluid. J.W.L. performed autopsies on patients who died from COVID-19 and provided biological materials. M.Q. performed RNAscope assay, imaging and analysis. A.E.P., D.S., M.K., P.N., performed programmatic extraction of clinical data and data curation. C.J.G. and E.S.M. coordinated and performed sample collection from healthy volunteers and provided biological materials. D.A.A., E.R.G., A.V.M. and S.S. processed BAL fluid samples and performed flow cytometry and cell sorting. D.A.A., H.K., L.S., R.A.G. and Z.L. performed post-sorting sample processing including RNA isolation for RNA-seq. B.D.S., A.V.M. and S.S. analyzed flow cytometry data. A.V.M. and Z.L. performed single-cell RNA-seq. H.A.-V. and Y.P. performed bulk RNA-seq. All authors provided edits and feedback on the manuscript.</p>
        </fn>
        <corresp id="CR1"><label>**</label>These corresponding authors jointly supervised this work and are listed in alphabetical order.</corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>28</day>
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>1</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>11</day>
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <volume>590</volume>
      <issue>7847</issue>
      <fpage>635</fpage>
      <lpage>641</lpage>
      <!--elocation-id from pubmed: 10.1038/s41586-020-03148-w-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<uri xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <p id="P12">Some patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) develop severe pneumonia and the acute respiratory distress syndrome (ARDS)<sup><xref rid="R1" ref-type="bibr">1</xref></sup>. Distinct clinical features in these patients have led to speculation that the immune response to virus in the SARS-CoV-2-infected alveolus differs from other types of pneumonia<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. We collected bronchoalveolar lavage fluid samples from 88 patients with SARS-CoV-2-induced respiratory failure and 211 patients with known or suspected pneumonia from other pathogens and subjected them to flow cytometry and bulk transcriptomic profiling. We performed single-cell RNA-seq on 10 bronchoalveolar lavage fluid samples collected from patients with severe COVID-19 within 48 hours of intubation. In the majority of patients with SARS-CoV-2 infection, the alveolar space was persistently enriched in T cells and monocytes. Bulk and single-cell transcriptomic profiling suggested that SARS-CoV-2 infects alveolar macrophages, which in turn respond by producing T cell chemoattractants. These T cells produce interferon-gamma to induce inflammatory cytokine release from alveolar macrophages and further promote T cell activation. Collectively, our results suggest that SARS-CoV-2 causes a slowly-unfolding, spatially limited alveolitis in which alveolar macrophages harboring SARS-CoV-2 and T cells form a positive feedback loop that drives persistent alveolar inflammation.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P13">A minority of patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) develop severe pneumonia requiring mechanical ventilation and these patients account for almost all of the morbidity and mortality associated with the infection<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R3" ref-type="bibr">3</xref>&#x2013;<xref rid="R5" ref-type="bibr">5</xref></sup>. The reported 20&#x2013;40% mortality among patients with severe SARS-CoV-2 pneumonia, combined with a severe systemic inflammatory response in some patients, have led to speculation that the pathobiology of SARS-CoV-2 pneumonia is distinct from pneumonia caused by other respiratory viral and bacterial pathogens<sup><xref rid="R2" ref-type="bibr">2</xref></sup>.</p>
    <p id="P14">We obtained bronchoalveolar lavage (BAL) samples from 88 patients with respiratory failure secondary to severe SARS-CoV-2 pneumonia and compared them with BAL samples prospectively collected before and during the pandemic from 211 patients with pneumonia secondary to other pathogens and 42 intubated patients without pneumonia. For many patients, we were able to obtain samples within 48 hours of intubation and sequentially over the course of the illness, allowing us to gain insights about the early pathogenesis and progression of COVID-19-induced respiratory failure. We profiled BAL samples using flow cytometry and performed bulk transcriptomic profiling of alveolar macrophages. Additionally, we performed single-cell RNA-sequencing on BAL fluid collected less than 48 hours after intubation from 10 patients with severe SARS-CoV-2 pneumonia. We used these data to develop a testable hypothesis to explain SARS-CoV-2 pathobiology (<xref rid="F1" ref-type="fig">Fig. 1a</xref>).</p>
    <sec disp-level="2" id="S1">
      <title>Demographics of the cohort:</title>
      <p id="P15">Samples were collected as part of the Successful Clinical Response in Pneumonia Therapy (SCRIPT) Systems Biology Center, an observational study of patients with severe pneumonia, defined as those requiring mechanical ventilation. We prospectively enrolled 88 of the 179 patients with SARS-CoV-2-induced pneumonia and respiratory failure requiring mechanical ventilation in our intensive care unit (ICU) (<xref rid="F1" ref-type="fig">Fig. 1b</xref>, <xref ref-type="fig" rid="F5">Extended Data Fig. 1a</xref>&#x2013;<xref ref-type="fig" rid="F5">c</xref>; <xref rid="T1" ref-type="table">Extended Data Table 1</xref>).</p>
      <p id="P16">We compared patients with COVID-19 with 253 mechanically ventilated patients enrolled in the two years before and during the pandemic. These included patients intubated for reasons other than pneumonia (non-pneumonia control), patients diagnosed with severe non-SARS-CoV-2 viral pneumonia (other viral pneumonia), or patients with severe pneumonia secondary to bacterial or fungal pathogens (other pneumonia). Compared with these patients, patients with SARS-CoV-2 pneumonia were similar in age, race, and sex, but had a significantly higher self-reported Hispanic or Latino ethnicity and body mass index (<xref rid="F1" ref-type="fig">Fig. 1c</xref>&#x2013;<xref rid="F1" ref-type="fig">f</xref>, <xref rid="T1" ref-type="table">Extended Data Table 1</xref>).</p>
      <p id="P17">Severity of illness estimated using the sequential organ failure assessment (SOFA) score and the acute physiology score (APS) was similar in patients with SARS-CoV-2 pneumonia compared with other pneumonia and was comparable to that observed in a recent study of ARDS<sup><xref rid="R6" ref-type="bibr">6</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1g</xref>,<xref rid="F1" ref-type="fig">h</xref>, <xref rid="T1" ref-type="table">Extended Data Table 1</xref>). Patients with severe SARS-CoV-2 pneumonia had longer lengths of stay in the ICU and required longer periods of ventilation compared with all pneumonia and non-pneumonia controls (<xref rid="F1" ref-type="fig">Fig. 1i</xref>,<xref rid="F1" ref-type="fig">j</xref>). On the day of their first BAL, patients with severe SARS-CoV-2 pneumonia had increased levels of C-reactive protein compared with patients with other pneumonias, while other biomarkers of inflammation were similar (<xref ref-type="fig" rid="F5">Extended Data Fig. 1d</xref>&#x2013;<xref ref-type="fig" rid="F5">i</xref>). The BAL sampling rate per day among patients with COVID-19 was not higher than the sampling rate among patients with other pneumonias (see <xref ref-type="fig" rid="F5">Extended Data Fig. 1j</xref>&#x2013;<xref ref-type="fig" rid="F5">l</xref>). Mortality was not different between patients with SARS-CoV-2 pneumonia compared with the entire cohort (<xref rid="F1" ref-type="fig">Fig. 1k</xref>).</p>
    </sec>
    <sec disp-level="2" id="S2">
      <title>BAL fluid composition in SARS-CoV-2 pneumonia.</title>
      <p id="P18">We began by performing flow cytometry on BAL samples collected within 48 hours of intubation (<xref rid="F2" ref-type="fig">Fig. 2a</xref>,<xref rid="F2" ref-type="fig">b</xref>, <xref ref-type="fig" rid="F6">Extended Data Fig. 2a</xref>&#x2013;<xref ref-type="fig" rid="F6">e</xref>). We found that, despite severe pneumonia requiring mechanical ventilation, only 31% of patients with severe COVID-19 exhibited neutrophilia in BAL fluid (<xref rid="F2" ref-type="fig">Fig. 2a</xref>,<xref rid="F2" ref-type="fig">b</xref>). Instead, we found that in patients with severe SARS-CoV-2 pneumonia, the alveolar space was significantly enriched for CD4+ and CD8+ T cells and monocytes (<xref rid="F2" ref-type="fig">Fig. 2a</xref>,<xref rid="F2" ref-type="fig">b</xref>, <xref ref-type="fig" rid="F7">Extended Data Fig. 3a</xref>).</p>
    </sec>
    <sec disp-level="2" id="S3">
      <title>Distinct macrophage response in COVID-19.</title>
      <p id="P19">As macrophages respond to alterations in their micro-environment<sup><xref rid="R7" ref-type="bibr">7</xref></sup>, we reasoned that changes in the alveolar macrophage transcriptome may reflect unique features of the SARS-CoV-2-infected alveolus. We isolated alveolar macrophages from BAL fluid collected within the first 48 hours after intubation from patients with severe SARS-CoV-2 pneumonia and compared them with alveolar macrophages from patients with pneumonia secondary to other pathogens, non-pneumonia controls, and healthy volunteers. k-means clustering of the 1,194 significantly variable genes (q &lt; 0.05, likelihood-ratio test) across diagnosis identified 5 clusters (<xref rid="F2" ref-type="fig">Fig. 2c</xref>, <xref rid="SD2" ref-type="supplementary-material">Supplemental Data Files 1</xref>&#x2013;<xref rid="SD4" ref-type="supplementary-material">3</xref>). Notably, the majority of patients with COVID-19 clustered together. Cluster 1 contained genes specifically upregulated in patients with COVID-19 and was characterized by genes involved in the response to interferon (IFN). Cluster 1 also included genes encoding the chemokines <italic>CCL7</italic>, <italic>CCL8</italic>, and <italic>CCL13,</italic> which drive recruitment of monocytes and T cells.</p>
      <p id="P20">To detect viruses in alveolar macrophages we aligned RNA-seq reads to a hybrid genome including the human, SARS-CoV-2, and Influenza A/California/07/2009 reference genomes. An additional negative-strand SARS-CoV-2 transcript, which is transiently formed during its replication, was added to the SARS-CoV-2 genome to detect replicating virus<sup><xref rid="R8" ref-type="bibr">8</xref></sup>. We detected SARS-CoV-2 transcripts in alveolar macrophage transcriptomes from 67% of samples with PCR-confirmed SARS-CoV-2 infection. In 38% of these samples, we detected both positive- and negative-strand SARS-CoV-2 transcripts (<xref ref-type="fig" rid="F7">Extended Data Fig. 3b</xref>,<xref ref-type="fig" rid="F7">c</xref>).</p>
    </sec>
    <sec disp-level="2" id="S4">
      <title>SARS-CoV-2 pneumonia persists over time.</title>
      <p id="P21">Unlike other types of pneumonia, SARS-CoV-2 pneumonia is characterized by a long duration between symptom onset and the development of respiratory failure (6&#x2013;12 days) and a prolonged course of mechanical ventilation (<xref rid="F1" ref-type="fig">Fig. 1b</xref>,<xref rid="F1" ref-type="fig">i</xref>,<xref rid="F1" ref-type="fig">j</xref>)<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>. To determine whether the unique cellular composition of the BAL fluid and the interferon response signature in alveolar macrophages persists over the course of the disease, we analyzed samples obtained early after intubation (&lt;48 hours) and all samples obtained &gt;48 hours after intubation. Hierarchical clustering of BAL samples from all time points from serially sampled patients as well as direct pairwise comparison of early (&lt;48 hours after intubation) versus late (&gt;48 hours after intubation) samples between groups demonstrated that, in comparison with BAL samples from other pneumonia, samples from patients with COVID-19 were persistently enriched for T cells (<xref rid="F3" ref-type="fig">Fig. 3a</xref>,<xref rid="F3" ref-type="fig">b</xref>; <xref ref-type="fig" rid="F8">Extended Data Fig. 4a</xref>,<xref ref-type="fig" rid="F8">b</xref>). These findings persisted in the 40% of patients with severe SARS-CoV-2 pneumonia who had a superinfecting pathogen detected over the course of mechanical ventilation (<xref rid="T2" ref-type="table">Extended Data Table 2</xref>). Nevertheless, BAL fluid neutrophils were increased in samples collected after 48 hours of mechanical ventilation in patients with COVID-19, likely attributable to the duration of mechanical ventilation and the attendant risk of bacterial superinfection (<xref ref-type="fig" rid="F8">Extended Data Fig. 4c</xref>).</p>
      <p id="P22">We then performed RNA-seq on alveolar macrophages isolated early (&lt;48 hours) and later over the course of mechanical ventilation. k-means clustering of the 2,323 significantly variable genes (q &lt; 0.05, likelihood-ratio test) across diagnoses identified five clusters (<xref rid="F3" ref-type="fig">Fig. 3c</xref>; <xref ref-type="fig" rid="F9">Extended Data Fig. 5a</xref>; <xref rid="SD2" ref-type="supplementary-material">Supplemental Data Files 1</xref>&#x2013;<xref rid="SD4" ref-type="supplementary-material">3</xref>). Of note, genes and related GO biological processes associated with these clusters were remarkably similar to those identified in samples collected within 48 hours after intubation (<xref rid="F2" ref-type="fig">Fig. 2c</xref>). Specifically, samples from patients with COVID-19 continued to cluster together and were differentiated by increased expression of genes in Cluster 1, which was enriched for interferon-response genes and T cell chemokines (<xref rid="F3" ref-type="fig">Fig. 3c</xref>, <xref ref-type="fig" rid="F9">Extended Data Fig. 5a</xref>,<xref ref-type="fig" rid="F9">b</xref>).</p>
      <p id="P23">In order to identify gene modules in alveolar macrophages that distinguish pneumonia type and outcome, we performed weighted gene co-expression network analysis (WGCNA) (<xref ref-type="fig" rid="F9">Extended Data Fig. 5c</xref>, <xref rid="SD2" ref-type="supplementary-material">Supplemental Data File 1</xref>). Module 15 was enriched for interferon-responsive genes and correlated with the detection of SARS-CoV-2 transcripts, levels of C-reactive protein, CD8+ T cell abundance, and COVID-19 diagnosis (R = 0.28, 0.30, 0.28, 0.25, respectively). Notably, all SARS-CoV-2 genes included in this analysis were assigned to this module, further underscoring the relevance of the disease diagnosis category. Consistent with the results of k-means clustering, module 15 was enriched for type I and type II interferon response genes (GO:0060337, GO:0060333). We observed a significant negative correlation between interferon signaling and the duration of mechanical ventilation (<xref ref-type="fig" rid="F9">Extended Data Fig. 5d</xref>&#x2013;<xref ref-type="fig" rid="F9">f</xref>). In addition, we identified modules related to macrophage maturation, including Module 4, which exhibited a positive correlation with the percentage of CD206<sup>hi</sup> alveolar macrophages (R = 0.61), and Module 12, which exhibited a negative correlation with percentage of CD206<sup>hi</sup> macrophages (R = &#x2212;0.62) (<xref ref-type="fig" rid="F9">Extended Data Fig. 5c</xref>). The unique features of SARS-CoV-2 pneumonia are further illustrated by a UMAP projection of all bulk RNA-seq samples, which separated largely by diagnosis, module 15 gene expression, and abundance of T cells (<xref ref-type="fig" rid="F9">Extended Data Fig. 5g</xref>).</p>
      <p id="P24">We took advantage of the serial samples collected from the same patients with COVID-19 and explored the relationship between expression of canonical interferon-response genes and patient outcomes. Analysis of the serial samples from patients with COVID-19 who were discharged home (5 patients) or to an inpatient facility (2 patients) demonstrated decreased expression of interferon-response genes as the disease progressed, while in patients who were discharged to a long-term acute care facility (LTAC, 5 patients) or died (2 patients) the expression of interferon-response genes was largely unchanged (<xref ref-type="fig" rid="F9">Extended Data Fig. 5h</xref>). Consistent with these findings, we observed a significant negative correlation between abundance of SARS-CoV-2 transcripts in patients with confirmed COVID-19 and the time since intubation (&#x3C1; = &#x2212;0.49, Spearman correlation; <xref ref-type="fig" rid="F9">Extended Data Fig. 5i</xref>).</p>
    </sec>
    <sec disp-level="2" id="S5">
      <title>Immune cell circuits in SARS-CoV-2 pneumonia.</title>
      <p id="P25">We performed single-cell RNA-seq on 10 patients with COVID-19 from whom BAL samples were collected within 48 hours of intubation (<xref rid="F4" ref-type="fig">Fig. 4a</xref>, <xref ref-type="fig" rid="F10">Extended Data Fig. 6a</xref>&#x2013;<xref ref-type="fig" rid="F10">d</xref>). We included two additional patients, one with bacterial pneumonia and one non-pneumonia control (<xref ref-type="fig" rid="F10">Extended Data Fig. 6e</xref>&#x2013;<xref ref-type="fig" rid="F10">h</xref>). Analysis of an integrated object resolved multiple clusters corresponding to macrophages and other cell types (<xref rid="SD5" ref-type="supplementary-material">Supplemental Data File 4</xref>). Alveolar macrophages contained six clusters. Four clusters of monocyte-derived alveolar macrophages (MoAM) were characterized by <italic>CCL2</italic> expression and gradually increasing expression of genes associated with alveolar macrophage maturation. The other two clusters expressed markers of tissue-resident alveolar macrophages (TRAM) (<xref rid="F4" ref-type="fig">Fig. 4b</xref>, <xref ref-type="fig" rid="F10">Extended Data Fig. 6a</xref>). We did not detect expression of type I interferons in our single-cell dataset or in other publicly available single-cell RNA-seq datasets<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> obtained from BAL fluid later in the clinical course of patients with COVID-19 (data not shown). In contrast, expression of type II interferon (<italic>IFNG</italic>) was detected in T cells from all 10 patients with COVID-19 (<xref rid="F4" ref-type="fig">Fig. 4c</xref>, <xref ref-type="fig" rid="F10">Extended Data Fig. 6b</xref>). These results suggest that the interferon-response gene signature we observed in alveolar macrophages may be in response to IFN&#x3B3; released from activated T cells.</p>
      <p id="P26">As expected, positive- and negative-strand SARS-CoV-2 transcripts were detected in epithelial cells. Surprisingly, we also detected SARS-CoV-2 transcripts in migratory <italic>CCR7</italic>+ dendritic cells, MoAM2 and TRAM2, which do not express <italic>ACE2</italic> (<xref rid="F4" ref-type="fig">Fig. 4d</xref>, <xref ref-type="fig" rid="F10">Extended Data Fig. 6c</xref>). Coronaviruses generate large numbers of positive-strand transcripts from a single negative-strand template<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. Consistent with this known biology, we detected more transcripts for positive compared with negative strands in both our single-cell and bulk RNA-seq data (<xref ref-type="fig" rid="F7">Extended Data Fig. 3c</xref>, <xref ref-type="fig" rid="F10">Extended Data Fig. 6d</xref> and <xref rid="F4" ref-type="fig">Fig. 4d</xref>). These results suggest that alveolar macrophages harbor SARS-CoV-2 and that they may support viral replication as has been reported for SARS-CoV and MERS-CoV<sup><xref rid="R12" ref-type="bibr">12</xref>&#x2013;<xref rid="R14" ref-type="bibr">14</xref></sup>.</p>
      <p id="P27">TRAM2 harboring SARS-CoV-2 exhibited a distinct transcriptional program compared with uninfected TRAM1 (<xref rid="F4" ref-type="fig">Fig. 4b</xref>,<xref rid="F4" ref-type="fig">h</xref>, <xref ref-type="fig" rid="F10">Extended Data Fig. 6g</xref>,<xref ref-type="fig" rid="F10">h</xref>, <xref rid="SD6" ref-type="supplementary-material">Supplemental Data File 5</xref>). In patients with COVID-19, genes distinguishing infected TRAM2 from non-infected TRAM1 included several chemokines and cytokines important for T cell and monocyte recruitment, such as <italic>CCL4, CCL20</italic>, <italic>CXCL10</italic> and <italic>CXCL11.</italic> TRAM2 also expressed genes <italic>IL1B, TNFSF10</italic>, and <italic>DEFB1</italic> (<xref rid="F4" ref-type="fig">Fig. 4b</xref>,<xref rid="F4" ref-type="fig">e</xref>&#x2013;<xref rid="F4" ref-type="fig">h</xref>, <xref rid="SD7" ref-type="supplementary-material">Supplemental Data File 6</xref>). Finally, infected TRAM2 were marked by increased expression of interferon-response genes compared with non-infected TRAM1 (<xref rid="F4" ref-type="fig">Fig. 4b</xref>,<xref rid="F4" ref-type="fig">h</xref>).</p>
      <p id="P28">IL-6 induces the transcription of clotting factors in the liver and tissue factor in the endothelium to promote thrombosis, and elevated levels of IL-6 predict mortality in patients with COVID-19<sup><xref rid="R15" ref-type="bibr">15</xref>&#x2013;<xref rid="R17" ref-type="bibr">17</xref></sup>. Because single-cell RNA-seq analyses of peripheral blood from patients with COVID-19 failed to identify circulating cells producing IL-6<sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup>, some have suggested that IL-6 is produced by inflammatory cells in the alveolus<sup><xref rid="R17" ref-type="bibr">17</xref></sup>. In our dataset, the overall expression of <italic>IL6</italic> was low and was primarily restricted to very immature MoAM1 originating from two patients (<xref ref-type="fig" rid="F11">Extended Data Fig. 7a</xref>). Furthermore, the expression of <italic>IL6</italic> in BAL fluid cells from patients with COVID-19 was comparable to previously reported <italic>IL6</italic> expression in alveolar macrophages from patients with later-stage COVID-19<sup><xref rid="R9" ref-type="bibr">9</xref></sup> and lower than <italic>IL6</italic> expression observed in stromal and endothelial cells from a published single-cell RNA-seq dataset describing the healthy or fibrotic lung<sup><xref rid="R20" ref-type="bibr">20</xref></sup>. Consistently, in our bulk RNA-seq data from flow cytometry-sorted alveolar macrophages, <italic>IL6</italic> expression was not different between patients with pneumonia secondary to SARS-CoV-2 compared with other respiratory pathogens, although it was higher than in healthy controls, in whom <italic>IL6</italic> transcripts were never detected (<xref ref-type="fig" rid="F9">Extended Data Fig. 5b</xref>). While we did not sample neutrophils, Liao et al. and Chua et al. did not detect increased neutrophil <italic>IL6</italic> expression in their single-cell RNA-seq datasets of BAL fluid from patients with SARS-CoV-2 pneumonia<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup>.</p>
      <p id="P29">In murine models of influenza A viral pneumonia, IFN&#x3B3; drives apoptosis of tissue-resident alveolar macrophages<sup><xref rid="R21" ref-type="bibr">21</xref></sup>. We therefore wondered whether the CD206<sup>hi</sup> alveolar macrophages in patients with severe SARS-CoV-2 pneumonia were truly tissue-resident alveolar macrophages or maturing monocyte-derived alveolar macrophages. We performed cell-type deconvolution of our bulk RNA-seq data and found that in patients with SARS-CoV-2 pneumonia only a small fraction of alveolar macrophages were tissue-resident alveolar macrophages. Instead, the majority of alveolar macrophages were monocyte-derived alveolar macrophages (MoAM3) (<xref ref-type="fig" rid="F11">Extended Data Fig. 7b</xref>,<xref ref-type="fig" rid="F11">c</xref>).</p>
      <p id="P30">The BAL procedure samples cells from a lung segment, which includes many thousands of alveoli. Therefore, the detection of infected and non-infected alveolar macrophages in the same BAL fluid sample in our single cell RNA-seq data suggests infected and uninfected alveoli will co-exist within a single lung segment. To test this prediction, we examined lung tissue from a patient who died from SARS-CoV-2 pneumonia while forgoing treatments, save comfort measures. Using smFISH we detected positive- and negative-strand SARS-CoV-2 transcripts in the lung epithelium and alveolar macrophages (<xref rid="F4" ref-type="fig">Fig. 4i</xref> and <xref rid="SD10" ref-type="supplementary-material">Supplemental Data File 7</xref>, <xref rid="SD12" ref-type="supplementary-material">Supplemental Data Video 1</xref>). Positive-strand SARS-CoV-2 transcripts exhibited diffuse cytoplasmic staining, and the number of punctae exceeded that of negative transcripts. As predicted from our model of lung infection, cells containing SARS-CoV-2 transcripts were also detected in a spatially-restricted manner, as regions of the lung containing the virus were adjacent to the regions with nearly-normal architecture where viral particles were absent.</p>
    </sec>
    <sec id="S6">
      <title>Discussion:</title>
      <p id="P31">A minority of patients with severe SARS-CoV-2 pneumonia develop respiratory failure, but it is these patients who account for almost all of the morbidity, mortality, and socioeconomic cost associated with the COVID-19 pandemic. We systematically sampled the alveolar space in patients with new-onset respiratory failure secondary to SARS-CoV-2 pneumonia and compared these samples with those from a large comparison cohort of patients with pneumonia from other respiratory pathogens collected before and during the pandemic. We used these data to develop a model for the unique pathobiology of SARS-CoV-2 pneumonia (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). Our model proposes that SARS-CoV-2 initially infects and replicates in epithelial cells in the nasopharynx, which express relatively high levels of <italic>ACE2</italic> in comparison with epithelial cells in lower airways or the distal lung<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup>. Whether by progressive movement distally in the tracheobronchial tree or via aspiration of nasopharyngeal contents, some virus gains access to the distal alveolar space. In the alveolar space, SARS-CoV-2 infects alveolar epithelial cells and tissue-resident alveolar macrophages<sup><xref rid="R24" ref-type="bibr">24</xref></sup>. A transcriptional program is activated within infected tissue-resident alveolar macrophages that promotes the recruitment of memory T cells to the alveolar space. There, memory T cells become activated, releasing IFN&#x3B3;, which activates tissue-resident alveolar macrophages harboring SARS-CoV-2. Eventually, these tissue-resident alveolar macrophages die and monocyte-derived alveolar macrophages are recruited, which in turn become infected with SARS-CoV-2 to sustain the inflammatory signaling loop with T cells. These infected alveolar macrophages may act as a Trojan horse, transferring the virus to adjacent lung regions, slowly propagating SARS-CoV-2 infection across the lung.</p>
      <p id="P32">Our model is informed by a wealth of causal data generated in cell and animal models of SARS-CoV-2 and the related coronaviruses SARS-CoV and MERS-CoV. SARS-CoV-2 proteins have been shown to suppress type I interferon responses<sup><xref rid="R24" ref-type="bibr">24</xref>&#x2013;<xref rid="R26" ref-type="bibr">26</xref></sup>, and we did not detect ongoing expression of type I interferons in our bulk or single-cell RNA-seq data<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup>. Our data suggesting that SARS-CoV-2 replicates in alveolar macrophages are consistent with reports that SARS-CoV, MERS-CoV, and SARS-CoV-2 can infect macrophages <italic>in vitro</italic><sup><xref rid="R12" ref-type="bibr">12</xref>&#x2013;<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup>, and the detection of SARS-CoV-2 in alveolar macrophages in autopsy studies of patients with SARS-CoV-2 pneumonia<sup><xref rid="R29" ref-type="bibr">29</xref></sup>.</p>
      <p id="P33">Alveolar macrophage infection might result from phagocytosis of infected alveolar epithelial cells followed by viral escape from the lysosome. Alternatively, alveolar macrophages might be directly infected, as was shown for SARS-CoV and MERS-CoV<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup>. Finally, antibody-dependent enhancement has been suggested from cell and animal models of SARS-CoV and MERS-CoV infection<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup>.</p>
      <p id="P34">Activation of memory T cells leads to IFN&#x3B3; production, local proliferation of activated memory T cells, mounting of inflammatory responses, and recruitment of monocytes and T cells. We observed enrichment of CD4+ and CD8+ T cells in the alveolar space of patients with SARS-CoV-2 pneumonia relative to pneumonia secondary to other pathogens. Furthermore, our single-cell RNA-seq data confirmed production of IFN&#x3B3; by both CD4+ and CD8+ T cells. These results raise the question of how T cells in the alveolar space become activated following SARS-CoV-2 infection. While tissue-resident alveolar macrophages are poor antigen-presenting cells and do not convert na&#xEF;ve T cells into effector T cells<sup><xref rid="R32" ref-type="bibr">32</xref></sup>, a low level of antigen presentation by alveolar macrophages might be sufficient to activate pre-existing memory T cells that cross-react with SARS-CoV-2. Existence of such cross-reactive memory T cells has been reported for SARS-CoV<sup><xref rid="R33" ref-type="bibr">33</xref></sup> and for SARS-CoV-2<sup><xref rid="R34" ref-type="bibr">34</xref>&#x2013;<xref rid="R38" ref-type="bibr">38</xref></sup>. A larger number of SARS-CoV-2 cross-reactive memory T cells was observed independently in elderly people and in patients with severe COVID-19, compared with those with mild COVID-19<sup><xref rid="R38" ref-type="bibr">38</xref></sup>. These cross-reactive T cells exhibited lower avidity and reduced antiviral responses in response to stimulation with SARS-CoV-2 peptides compared with T cells from patients who recovered from COVID-19. This mechanism might explain the epidemiology of severe SARS-CoV-2 pneumonia, which disproportionately affects elderly individuals.</p>
      <p id="P35">Single-cell RNA-seq atlases and smFISH studies of the normal human lung show that only a small number of alveolar epithelial cells express <italic>ACE2</italic>, the gene encoding the receptor for SARS-CoV-2 entry<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup>. In contrast, the sialic acid residues that serve as receptors for influenza A virus are abundantly expressed in alveolar type 2 cells<sup><xref rid="R22" ref-type="bibr">22</xref></sup>. Thus, while influenza A infects large numbers of cells leading to rapid viral replication, widespread injury, robust antiviral responses, and death of infected epithelial cells, infection by SARS-CoV-2 is likely to lead to spatially localized areas of infection. This could explain the localized areas of ground glass infiltrates observed in chest computed tomography in minimally symptomatic patients with COVID-19<sup><xref rid="R39" ref-type="bibr">39</xref></sup>. We speculate that alveolar macrophages harboring SARS-CoV-2 might spread virus between alveoli. For example, tissue-resident alveolar macrophages, once thought to be sessile, were recently shown to travel between alveoli through pores of Kohn, particularly during viral infection<sup><xref rid="R40" ref-type="bibr">40</xref></sup>. In each new area of infection, positive feedback loops between alveolar macrophages harboring the virus and activated T cells could promote persistent injury and inflammation.</p>
      <p id="P36">Our model of SARS-CoV-2 pneumonia as a slowly-progressive, spatially-restricted infection explains some of the unusual clinical features of COVID-19. Most notably, the clinical course of severe SARS-CoV-2 pneumonia is much longer than that of other respiratory viruses. The time from the onset of symptoms to respiratory failure in patients with SARS-CoV-2 infection is 6&#x2013;12 days, compared with 1&#x2013;3 days or even less in patients with influenza A virus infection<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup>. Furthermore, in our cohort the duration of mechanical ventilation and ICU stay were much longer in patients with severe SARS-CoV-2 pneumonia, compared with other respiratory pathogens causing pneumonia, despite a similar severity of illness and mortality. This longer clinical course might also explain some of the systemic complications of the disease. Although sparsely sampled, the levels of inflammatory biomarkers in the blood were similar in patients with COVID-19 and those with other etiologies of pneumonia in our cohort, confirming more recent systematic reports<sup><xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R43" ref-type="bibr">43</xref></sup>. This observation raises the intriguing possibility that the increased number of systemic complications observed in patients with SARS-CoV-2 pneumonia are related to prolonged, rather than higher level, exposure to circulating inflammatory cytokines.</p>
      <p id="P37">In summary, we present a dataset that supports a testable model, in which alveolar macrophages harboring SARS-CoV-2 form positive feedback loops with IFN&#x3B3;-secreting T cells to promote alveolitis in patients with severe COVID-19.</p>
    </sec>
    <sec id="S7">
      <title>Methods:</title>
      <sec id="S8">
        <title>Human subjects:</title>
        <p id="P38">All human subjects research was approved by the Northwestern University Institutional Review Board. Samples from patients with COVID-19, viral pneumonia, other pneumonia, and non-pneumonia controls were collected from participants enrolled in the Successful Clinical Response In Pneumonia Therapy (SCRIPT) study STU00204868. Alveolar macrophages from healthy volunteers were obtained under study STU00206783. Autopsy tissues were obtained per usual protocols and analyzed under study STU00079445. All study participants or their surrogates provided informed consent.</p>
        <p id="P39">Patients &#x2265; 18 years of age with suspicion of pneumonia based on clinical criteria (including but not limited to fever, radiographic infiltrate, and respiratory secretions) were screened for enrollment into the SCRIPT study. Inability to safely perform BAL or NBBAL were considered exclusion criteria<sup><xref ref-type="supplementary-material" rid="SD13">44</xref></sup>. In our center, patients with respiratory failure are intubated based on the judgement of bedside clinicians for worsening hypoxemia, hypercapnia, or work of breathing refractory to high-flow oxygen or non-invasive ventilation modes. Extubation occurs based on the judgement of bedside clinicians following a protocol-driven trial of spontaneous breathing in patients demonstrating physiologic improvement in their cardiorespiratory status during their period of mechanical ventilation.</p>
        <p id="P40">We collected data and samples from patients enrolled in SCRIPT from June 15, 2018 to July 6, 2020 in our intensive care unit (ICU) at Northwestern Memorial Hospital in Chicago. We prospectively enrolled 88 of the 179 patients with SARS-CoV-2-induced pneumonia and respiratory failure requiring mechanical ventilation in our intensive care unit (<xref rid="F1" ref-type="fig">Fig. 1b</xref>, <xref rid="F5" ref-type="fig">Extended Data Fig. 1a</xref>, <xref rid="F5" ref-type="fig">b</xref>; <xref rid="T1" ref-type="table">Extended Data Table 1</xref>), all but one of whom had been discharged at the time of our submission. Management of patients with COVID-19 was guided by protocols published and updated on the Northwestern Medicine intranet as new information became available over the pandemic. Clinical laboratory testing including studies ordered on BAL fluid was at the discretion of the care team; however, quantitative cultures, multiplex PCR (BioFire Film Array Respiratory 2 panel), and automated cell count and differential were recommended by local ICU protocols. Most patients also underwent urinary antigen testing for <italic>Streptococcus pneumoniae</italic> and <italic>Legionella pneumophilia</italic> serogroup 1 on admission. Clinicians were encouraged to manage all patients, including those with COVID-19, according to ARDSNetwork protocols including the use of a higher PEEP/lower FiO<sub>2</sub> strategy for those with severe hypoxemia<sup><xref ref-type="supplementary-material" rid="SD13">45</xref>, <xref ref-type="supplementary-material" rid="SD13">46</xref></sup>. Prone positioning (16 hours per day) was performed in all patients with a PaO<sub>2</sub>/FiO<sub>2</sub> &lt;150 who did not have contraindications<sup><xref ref-type="supplementary-material" rid="SD13">47</xref></sup>. In those who had a response to prone positioning evidenced by improved oxygenation, prone positioning was repeated. Esophageal balloon catheters (Cooper Surgical) were placed at the discretion of the care team to estimate transpulmonary pressure and optimize PEEP, particularly in patients with a higher-than-normal BMI.</p>
        <p id="P41">Autopsy specimen used for sm-FISH (RNAscope) (<xref rid="F4" ref-type="fig">Fig. 4i</xref>): An 81-year old woman with end-stage renal disease and cirrhosis was admitted for a fever of 38.5&#xB0;C. She had a positive nasopharyngeal swab for SARS-CoV-2. The patient developed increased O<sub>2</sub> requirements and was subsequently transferred to the COVID ICU. In the ICU, the decedent developed hypotension to 60s/40s and after discussion with the clinical team, the decedent&#x2019;s family elected to focus on comfort care. The patient died 8 days after admission.</p>
      </sec>
      <sec id="S9">
        <title>NBBAL and BAL procedures:</title>
        <p id="P42">Consent was obtained from patients or their surrogates for bronchoscopic procedures. Bronchoscopic BAL was performed in intubated ICU patients with flexible, single-use Ambu aScope (Ambu) devices. Patients were given sedation and topical anesthetic at the physician proceduralist&#x2019;s discretion. Vital signs were monitored continuously throughout the procedure. The bronchoscope was wedged in the segment of interest based on available chest imaging or intra-procedure observations, aliquots of 30 ml of normal saline at a time, generally 90&#x2013;120 ml total, were instilled and aspirated back. The fluid returned following the first aliquot was routinely discarded. Samples were split (if sufficient return volume was available) and sent for clinical studies and an aliquot reserved for research. A similar procedure was applied to non-bronchoscopic BAL (NBBAL); however, NBBAL was performed with directional (lateral) but not visual guidance, and as usual procedural care by a respiratory therapist rather than a pulmonologist<sup><xref ref-type="supplementary-material" rid="SD13">44</xref></sup>.</p>
        <p id="P43">For bronchoscopies performed in COVID-19 patients, additional precautions were taken to minimize the risk to healthcare workers including only having essential providers present in the room, clamping of the endotracheal tube, transient disconnection of the inspiratory limb from the ventilator, and preloading of the bronchoscope through the adapter<sup><xref ref-type="supplementary-material" rid="SD13">48</xref></sup>. Sedation and neuromuscular blockade to prevent cough, was administered for these procedures at the physician&#x2019;s discretion. In most cases of early bronchoscopy, the procedure was performed immediately after intubation, taking advantage of neuromuscular blockade administered for the intubation procedure.</p>
        <p id="P44">For all patients with COVID-19, samples were collected from regions of greatest chest radiograph abnormality by a critical care physician using a disposable bronchoscope. The majority of samples prior to the pandemic were collected by respiratory therapists using a non-bronchoscopic bronchoalveolar lavage (NBBAL) catheter that is the same diameter as a standard bronchoscope with the catheter directed to the most radiographically affected lung. For both bronchoscopic and NBBAL, the recommended instillate volume was 120 ml and the initial aliquot was discarded if adequate return was obtained<sup><xref ref-type="supplementary-material" rid="SD13">44</xref></sup>.</p>
      </sec>
      <sec id="S10">
        <title>Pneumonia adjudication:</title>
        <p id="P45">Five critical care physicians (JMK, COP, BDS, JMW, RGW) retrospectively adjudicated patients as COVID-19 pneumonia, non-COVID-19 viral pneumonia, pneumonia secondary to other pathogens, or non-pneumonia controls (intubated for reasons other than pneumonia), according to a standardized adjudication procedure (the adjudication protocol can be found in <xref rid="SD8" ref-type="supplementary-material">Supplemental Data File 8</xref>). Non-pneumonia controls were defined as patients who underwent BAL to exclude pneumonia but had negative quantitative cultures, a negative multiplex PCR for viral and bacterial pathogens (when available) and negative urine antigens for <italic>Streptococcus pneumoniae</italic> and <italic>Legionella pneumophilia</italic> serogroup 1, as well as an alternative diagnosis. The treating clinician&#x2019;s impression was considered, but concordance was not required. Subsequent course and the entirety of the clinical record was used for adjudication. Some of the patients adjudicated as non-pneumonia controls developed ventilator-associated pneumonia later in their clinical course. Viral pneumonia was diagnosed based on detection of a respiratory viral pathogen from either a nasopharyngeal swab or BAL fluid in the appropriate clinical setting. Bacterial pneumonia was defined as positive quantitative cultures with &gt; 10^2 colony forming units/ml, detection of a bacterial pathogen by PCR analysis of BAL fluid or a positive urine antigen. Over the course of the study, BAL fluid was analyzed using an MRSA PCR (MRSA/SA SSTI) and the BioFire FilmArray Respiratory 2 (RP2) Panel and Pneumonia panels. SARS-CoV-2 was detected with a variety of assay platforms including the Cepheid Gene Expert, Abbott ID NOW, Becton-Dickinson, and a locally-developed and validated PCR. For some patients without COVID-19, the diagnosis of pneumonia was made based on clinical suspicion, radiographic findings, and response to antimicrobial therapy in the absence of an identified pathogen. Ventilator-associated pneumonia was diagnosed as detection of a new respiratory pathogen using quantitative culture or PCR more than 48 hours after intubation, the detection of a new respiratory pathogen on serial BAL samples, or the reappearance of a respiratory pathogen after a negative BAL on a subsequent study. Clinical laboratory data were obtained from the Northwestern Medicine Enterprise Data Warehouse using Structured Query Language (SQL). APS and SOFA scores were generated from the Electronic Health Record using previously validated programming.</p>
      </sec>
      <sec id="S11">
        <title>Flow cytometry and cell sorting:</title>
        <p id="P46">NBBAL and BAL samples were filtered through a 70-&#x3BC;m cell strainer, pelleted by centrifugation at 300 rcf for 10 min at 4&#xB0;C, followed by hypotonic lysis of red blood cells with 2 ml of BD PharmLyse reagent for 2 minutes. Lysis was stopped by adding 13 ml of MACS buffer (Miltenyi Biotech). Cells were pelleted again and resuspended in 100 &#x3BC;l of 1:10 Fc-Block (Human TruStain FcX, Biolegend) in MACS buffer, and a 10-&#x3BC;l aliquot was taken for counting using K2 Cellometer (Nexcelom) with AO/PI reagent. The volume of Fc-Block was adjusted so the concentration of cells was always less than 5&#xD7;10<sup>7</sup> cells/ml and the fluorophore-conjugated antibody cocktail was added in 1:1 ratio (<xref rid="T3" ref-type="table">Extended Data Table 3</xref>). After incubation at 4&#xB0;C for 30 minutes, cells were washed with 5 ml of MACS buffer, pelleted by centrifugation, and resuspended in 500 &#x3BC;l of MACS buffer with 2 &#x3BC;l of SYTOX Green viability dye (ThermoFisher). Cells were sorted on a FACS Aria III SORP instrument using a 100-&#x3BC;m nozzle at 20 psi. Cells were sorted into 300 &#x3BC;l of MACS buffer for bulk RNA-seq or 300 &#x3BC;l of 2% BSA in PBS for single-cell RNA-seq. Sample processing was performed in BSL-2 facility using BSL-3 practices. Analysis of the flow cytometry data was performed using FlowJo 10.6.2. using uniform sequential gating strategy (<xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref>) reviewed by three investigators (SS, BDS, AVM). Immune populations were defined using canonical markers as shown in <xref rid="F6" ref-type="fig">Extended Data Fig. 2</xref><sup><xref ref-type="supplementary-material" rid="SD13">44</xref>, <xref ref-type="supplementary-material" rid="SD13">49</xref></sup>. Alveolar macrophages were defined by the expression of CD206 (mannose receptor). We further subdivided alveolar macrophages into CD206<sup>lo</sup> alveolar macrophages, which represent differentiating monocyte-derived alveolar macrophages, and CD206<sup>hi</sup> alveolar macrophages, which include both tissue-resident alveolar macrophages, present in the lung prior to the onset of pneumonia, and mature monocyte-derived alveolar macrophages. Since CD206<sup>hi</sup> alveolar macrophages can be found in BAL fluid from both healthy volunteers and patients across different types of pneumonia, and the presence of CD206<sup>lo</sup> alveolar macrophages varies across the patients with pneumonia<sup><xref ref-type="supplementary-material" rid="SD13">49</xref>&#x2013;<xref ref-type="supplementary-material" rid="SD13">51</xref></sup>, we focused our transcriptomic analysis on CD206<sup>hi</sup> alveolar macrophages. Abundance of specific populations in individual BAL fluid samples can be found in <xref rid="SD9" ref-type="supplementary-material">Supplemental Data File 9</xref>.</p>
      </sec>
      <sec id="S12">
        <title>Bulk RNA-seq of flow cytometry-sorted alveolar macrophages:</title>
        <p id="P47">Immediately after sorting, cells were pelleted by centrifugation and lysed in 350 &#x3BC;l of RLT Plus lysis buffer (Qiagen) supplemented with 2-mercaptoethanol. Lysates were stored at &#x2212;80&#xB0;C until RNA isolation using the AllPrep DNA/RNA Micro kit according to the manufacturer&#x2019;s protocol (Qiagen). RNA quality and quantity were assessed using TapeStation 4200 High Sensitivity RNA tapes (Agilent), and RNA-seq libraries were prepared from 250 pg of total RNA using SMARTer Stranded Total RNA-seq Kit v2 (Takara Bio). Libraries were pooled using dual indexing and sequenced on a NextSeq 500 instrument (Illumina), 75 cycles, single-end, to an average sequencing depth of 19.55M reads.</p>
        <p id="P48">FASTQ files were generated using bcl2fastq (Illumina). To enable detection of viral RNA, a custom hybrid genome was prepared by joining FASTA, GFF, and GTF files for GRCh37.87, SARS-CoV-2 (NC_045512.2), and Influenza A/California/07/2009 (GCF_001343785.1), which was the dominant strain of influenza throughout BAL fluid collection at our hospital<sup><xref ref-type="supplementary-material" rid="SD13">52</xref></sup>. An additional negative strand transcript spanning the entirety of the SARS-CoV-2 genome was then added to the GTF and GFF files to enable detection of SARS-CoV-2 replication. Normalized counts tables later revealed high enrichment of SARS-CoV-2 transcripts in diagnosed COVID-19 patients, and enrichment of IAV genes in patients marked as other viral pneumonia. Of note, since our alveolar macrophage sorting strategy for bulk RNA-seq (<xref rid="F6" ref-type="fig">Extended Data Fig. 2a</xref>,<xref rid="F6" ref-type="fig">b</xref>) only focused on CD206<sup>hi</sup> cells, our bulk RNA-seq data likely underestimate infection of alveolar macrophages infected with SARS-CoV-2 (<xref rid="F2" ref-type="fig">Fig. 2d</xref>).</p>
        <p id="P49">To facilitate reproducible analysis, samples were processed using the publicly available nf-core/RNA-seq pipeline version 1.4.2 implemented in Nextflow 19.10.0 using Singularity 3.2.1&#x2013;1 with the minimal command nextflow run nf-core/rnaseq -r 1.4.2 &#x2013;singleEnd -profile singularity &#x2013;reverseStranded --three_prime_clip_r2 3<sup><xref ref-type="supplementary-material" rid="SD13">53</xref>&#x2013;<xref ref-type="supplementary-material" rid="SD13">55</xref></sup>. Briefly, lane-level reads were trimmed using trimGalore! 0.6.4 and aligned to the hybrid genome described above using STAR 2.6.1d<sup><xref ref-type="supplementary-material" rid="SD13">56</xref></sup>. Gene-level assignment was then performed using featureCounts 1.6.4<sup><xref ref-type="supplementary-material" rid="SD13">57</xref></sup>. Putative sample swaps were identified first by comparing known patient sex with sex determined by levels of <italic>XIST</italic> and <italic>RPS4Y1</italic> expression, followed by single nucleotide polymorphism analysis with NGSCheckMate version 1.0.0 in FASTQ mode using default settings<sup><xref ref-type="supplementary-material" rid="SD13">58</xref></sup>. Samples exhibiting unexpected correlation were excluded from analysis.</p>
      </sec>
      <sec id="S13">
        <title>Bulk differential expression analysis:</title>
        <p id="P50">All analysis was performed using custom scripts in R version 3.6.3 using the DESeq2 version 1.26.0 framework<sup><xref ref-type="supplementary-material" rid="SD13">59</xref></sup>. Correspondence between lanes was first confirmed by principal component analysis before merging counts using the command collapseReplicates(). One outlier sample from the Other Pneumonia group with low RIN score and exhibiting extreme deviation on PCA and poor alignment and assignment metrics was excluded from downstream analysis. For differential expression analysis (DEA), both proportion of alveolar macrophage from flow cytometry data and diagnosis were used as explanatory factors. A &#x201C;local&#x201D; model of gene dispersion was employed as this better fit dispersion trends without obvious overfitting, and gene outlier replacement was disabled; otherwise default settings were used. See code for details.</p>
      </sec>
      <sec id="S14">
        <title>k-means clustering of bulk samples.</title>
        <p id="P51">A custom-built function was used (available at <ext-link ext-link-type="uri" xlink:href="https://github.com/NUPulmonary/utils/blob/master/R/k_means_Figure.R">https://github.com/NUPulmonary/utils/blob/master/R/k_means_Figure.R</ext-link>) for k-means clustering. Briefly, variable genes were identified using a likelihood-ratio test (LRT) with local estimates of gene dispersion in DESeq2 with diagnosis as the full model as well as a reduced model corresponding to intercept alone. Genes with q &#x2265; 0.05 were discarded. Extant genes were then clustered using the Hartigan-Wong method with 25 random sets and a maximum of 1000 iterations using the kmeans function in R stats 3.6.3. Samples were then clustered using Ward&#x2019;s method and plotted using pheatmap version 1.0.12. GO term enrichment was then determined using Fisher&#x2019;s exact test in topGO version 2.38.1, with org.Hs.eg.db version 3.10.0 and GO.db version 3.10.0 as references.</p>
      </sec>
      <sec id="S15">
        <title>Weighted gene coexpression network analysis (WGCNA).</title>
        <p id="P52">WGCNA was performed manually using WGCNA version 1.69 with default settings unless otherwise noted<sup><xref ref-type="supplementary-material" rid="SD13">60</xref></sup>. Genes with counts &gt; 5 and detection in at least 10% of samples were included in the analysis. To best capture patterns of co-regulation, a signed network was used. Using the pickSoftThreshold function, we empirically determined a soft threshold of 7 to best fit the network structure. A minimum module size of 30 was chosen to isolate relatively large gene modules. Module eigengenes were then related back to patient and sample metadata using biweight midcorrelation. Module GO enrichment was then determined as above using Fisher&#x2019;s exact test in topGO version 2.38.1, with org.Hs.eg.db version 3.10.0 as a reference. UMAP plotting was performed using uwot version 0.1.8 using the first 20 principal components of the same genes used in WGCNA analysis after Z-scaling and centering, with a minimum distance of 0.2<sup><xref ref-type="supplementary-material" rid="SD13">61</xref></sup>. Default parameters were otherwise used.</p>
      </sec>
      <sec id="S16">
        <title>Single-cell RNA-seq of flow cytometry-sorted BAL cells:</title>
        <p id="P53">For patients with COVID-19 we limited our analysis to samples in which flow cytometry identified distinct populations of CD206<sup>hi</sup> and CD206<sup>lo</sup> macrophages (Patient 1, 2, 3, 4, 5, 7, 8, 9, A and B). We included two additional patients, one with bacterial pneumonia secondary to infection with <italic>Pseudomonas aeruginosa</italic> and <italic>Acinetobacter baumannii</italic> (assigned as &#x201C;other pneumonia&#x201D;, Patient 6) and one intubated for airway protection to facilitate endoscopy for severe gastrointestinal bleeding without pneumonia (assigned as a &#x201C;non-pneumonia control&#x201D;, Patient C) to examine nonspecific effects of inflammation and mechanical ventilation, respectively, on transcriptomic signatures.</p>
        <p id="P54">Samples were enriched via flow cytometry sorting for live cells, excluding granulocytes. Cells were sorted into 2% BSA in DPBS, pelleted by centrifugation at 400 rcf for 5 min at 4&#xB0;C, resuspended in 0.1% BSA in DPBS to ~1000 cells/&#x3BC;l concentration. Concentration was confirmed using K2 Cellometer (Nexcelom) with AO/PI reagent and cells were loaded on 10x Genomics Chip A with Chromium Single Cell 5&#x2019; gel beads and reagents (10x Genomics) aiming to capture ~5,000&#x2013;10,000 cells per library. Libraries were prepared according to the manufacturer&#x2019;s protocol (10x Genomics, CG000086_RevM). After quality checks, single-cell RNA-seq libraries were pooled and sequenced on a NovaSeq 6000 instrument.</p>
        <p id="P55">Data was processed using the Cell Ranger 3.1.0 pipeline (10x Genomics). To enable detection of viral RNA, reads were aligned to a custom hybrid genome containing GRCh38.93 and SARS-CoV-2 (NC_045512.2). An additional negative-strand transcript spanning the entirety of the SARS-CoV-2 genome was then added to the GTF and GFF files to enable detection of SARS-CoV-2 replication. Data were processed using Scanpy v1.5.1<sup><xref ref-type="supplementary-material" rid="SD13">62</xref></sup>, doublets were detected with scrublet v0.2.1<sup><xref ref-type="supplementary-material" rid="SD13">63</xref></sup> and removed, ambient RNA was corrected with FastCAR (<ext-link ext-link-type="uri" xlink:href="https://github.com/LungCellAtlas/FastCAR">https://github.com/LungCellAtlas/FastCAR</ext-link>), and multisample integration was performed with BBKNN v1.3.12<sup><xref ref-type="supplementary-material" rid="SD13">64</xref></sup>. Only human transcripts were used during integration, selection of highly variable genes and clustering, SARS-CoV-2 transcripts did not influence clustering. Gene set enrichment analysis was performed with signatures retrieved from the <ext-link ext-link-type="uri" xlink:href="https://gsea-msigdb.org">gsea-msigdb.org</ext-link> website<sup><xref ref-type="supplementary-material" rid="SD13">65</xref></sup> using following terms: HALLMARK_INTERFERON_GAMMA_RESPONSE M5913, HALLMARK_INTERFERON_ALPHA_RESPONSE M5911. Computations were automated with snakemake v5.5.4<sup><xref ref-type="supplementary-material" rid="SD13">66</xref></sup>.</p>
        <p id="P56">With exclusion of patients A and B, single-cell RNA-seq was performed without multiplexing, using cells from a single patient per single 10x Genomics chip channel. Cells from patients A and B were split into three 10x Genomics chip channels: sample 14 contained cells from patient A, sample 15 contained cells from patient B and sample 16 contained cells from patients A and B multiplexed together. To assign cells from this sample to patients, we used souporcell v2.0<sup><xref ref-type="supplementary-material" rid="SD13">67</xref></sup> (commit 34eade2ad3a361f045a31f53fee58c2e0c49423f) with the list of common variants for GRCh38 genome, provided on the souporcell page. We ran souporcell for samples 14, 15 and 16 with the number of clusters k=2. We computed Pearson correlation between integer-coded single-nucleotide polymorphisms in genotypic clusters in sample pairs 14&#x2013;16 and 15&#x2013;16 to determine which genotypic clusters come from the same patients. Genotypic doublets and unassigned cells were discarded. See code for details.</p>
      </sec>
      <sec id="S46">
        <title>Deconvolution of bulk RNA-seq alveolar macrophage signatures</title>
        <p id="P57">Deconvolution of bulk RNA-seq alveolar macrophage signatures was performed using AutoGeneS v1.0.3<sup><xref ref-type="supplementary-material" rid="SD13">68</xref></sup> and signatures derived from the integrated single-cell RNA-seq object. We used an integrated single-cell RNA-seq object containing the first six subjects included into analysis (patients 1&#x2013;6) to train the AutoGeneS model. Signatures were automatically identified from 4500 highly variable genes with function optimize(ngen=200, seed=0, nfeatures=2000, mode=&#x201D;fixed&#x201D;) (see code at <ext-link ext-link-type="uri" xlink:href="https://github.com/NUPulmonary/2020_Grant">https://github.com/NUPulmonary/2020_Grant</ext-link>). The model was then applied to bulk RNA-seq data to estimate the proportion of specific cell types using regression. We used bulk RNA-seq samples from healthy volunteers (which contain only tissue-resident alveolar macrophages and do not contain inflammatory monocyte-derived alveolar macrophages) to validate and optimize selection of the cluster-specific genes and deconvolution results.</p>
      </sec>
      <sec id="S17">
        <title>RNAscope of paraffin lung slices:</title>
        <p id="P58">RNAscope Multiplex V2 manual assay from ACDbio was performed on paraffin-embedded 5 &#x3BC;m slices of lung tissue using mild digest times according to manufacturer instructions as we have described. Probes used were RNAscope Probe-V-nCoV2019-S-C3 (catalog number 848561) with Akoya Bio Opal Dye 520 using the 488 nm laser line and RNAscope Probe-nCoV2019-orf1ab-sense-C2 (catalog number 859151) with Opal Dye 690 using 640 nm laser line. After RNAscope assay was complete, slides were washed in TBST (1X TBS pH 7.6 with 0.1% Tween-20) for 2 minutes with agitation twice. Slides were incubated in the dark at room temperature for 30 minutes with 10% normal goat serum in 1X TBS with 1% bovine serum albumin (BSA). The blocking solution was removed from slides via gentle flicking. Slides were then incubated in primary antibody solution containing anti-CD206 antibody (clone C-10) conjugated to AF546 (Santa Cruz Biotechnology Cat# sc-376232, RRID:AB_10989352) at 1:100 dilutions in TBS 1% BSA for 1 h at room temperature in the dark. Slides were rinsed using TBST for 5 minutes with agitation twice. Slides were rinsed in TBST buffer for 5 minutes twice. Slides were then mounted and dried overnight. Images were acquired at the Center for Advanced Microscopy at Northwestern University Feinberg School of Medicine using the Nikon W1-Spinning Disk Confocal microscope. Nucleus was added to the images using machine-based learning network trained on one patient using DAPI and brightfield images in Nikon Elements. Final images were rendered using Fiji.</p>
      </sec>
      <sec id="S18">
        <title>Statistical analysis:</title>
        <p id="P59">Statistical analysis was performed using base R version 3.6.3 with tidyverse version 1.3.0<sup><xref ref-type="supplementary-material" rid="SD13">69</xref></sup> and Python 3.6. For all comparisons, normality was first assessed using a Shapiro-Wilk test and manual examination of distributions. For parameters exhibiting a clear lack of normality, nonparametric tests were employed. In cases of multiple testing, P-values were corrected using false-discovery rate (FDR) correction. In Python, we used the mannwhitneyu function from scipy package version 1.3.1<sup><xref ref-type="supplementary-material" rid="SD13">70</xref></sup> for nonparametric tests, and corrected for multiple testing with the statsmodels package version 0.10.1<sup><xref ref-type="supplementary-material" rid="SD13">71</xref></sup>. Adjusted P-values &lt; 0.05 were considered significant. Two-sided statistical tests were performed in all cases.</p>
      </sec>
      <sec id="S19">
        <title>Visualization:</title>
        <p id="P60">Plotting was performed in <xref rid="F1" ref-type="fig">figures 1</xref>, <xref rid="F2" ref-type="fig">2</xref>, <xref rid="F3" ref-type="fig">3</xref>, <xref rid="F5" ref-type="fig">extended data figures 1</xref>, <xref rid="F6" ref-type="fig">2</xref>, and <xref rid="F7" ref-type="fig">3</xref> using ggplot2 version 3.3.1 unless otherwise noted. Comparisons for these figures were added using ggsignif version 0.6.0. Heatmaps on <xref rid="F2" ref-type="fig">figures 2</xref> and <xref rid="F3" ref-type="fig">3</xref> were generated using pheatmap version 1.0.12. Sankey/Alluvial plots on <xref rid="F5" ref-type="fig">Extended Data Fig. 1</xref> were generated using ggalluvial version 0.12.0<sup><xref ref-type="supplementary-material" rid="SD13">72</xref></sup>. Figure layouts for <xref rid="F1" ref-type="fig">Figures 1</xref>, <xref rid="F2" ref-type="fig">2</xref>, <xref rid="F3" ref-type="fig">3</xref>, <xref rid="F4" ref-type="fig">4</xref>, and <xref rid="F5" ref-type="fig">Extended Data Figures 1</xref>, and <xref rid="F7" ref-type="fig">3</xref> were generated using patchwork version 1.01 and edited in Adobe Illustrator 2021. <xref rid="F4" ref-type="fig">Figure 4</xref> and <xref rid="F8" ref-type="fig">extended data figures 4</xref> and <xref rid="F9" ref-type="fig">5</xref> were generated with matplotlib v3.2.1<sup><xref ref-type="supplementary-material" rid="SD13">73</xref></sup>. For all boxplots shown, box limitsq represent the interquartile range (IQR) with a centerline at the median. Whiskers represent the largest point &#x2264; 1.5 * IQR. All points are overlaid.</p>
      </sec>
      <sec id="S20">
        <title>Study limitations:</title>
        <p id="P61">First, this is an observational study, and in the absence of a specific intervention targeting a necessary component of our model, our data are hypothesis-generating. Moreover, our observational cohorts are heterogeneous with respect to treatments received and other processes of care. Second, while we made every attempt to standardize BAL fluid volumes, the number of alveoli sampled and the return volume during both bronchoscopic and non-bronchoscopic BAL is variable. Hence, our observations are relative rather than quantitative. Third, our flow cytometry panels, while rigorous, were limited by the number of antibodies that could be used for high volume characterization of clinical samples. Fourth, our BAL samples were collected as part of clinical care; therefore, sicker patients were more likely to be sampled. Finally, while we made every effort to standardize care for patients with SARS-CoV-2 pneumonia in our ICU, some of our patients were enrolled in clinical trials of remdesivir or sarilumab, many patients received unproven therapies off label including hydroxychloroquine and tocilizumab, and our study largely preceded reports on the use of steroids in patients with severe SARS-CoV-2 pneumonia (<xref rid="T1" ref-type="table">Extended Data Table 1</xref>). Despite these limitations, our systems approach to understand SARS-CoV-2 pathobiology provides a model with testable predictions that can serve as a template for the design of targeted interventions in patients with severe disease.</p>
      </sec>
    </sec>
    <sec sec-type="extended-data" id="S21">
      <title>Extended Data</title>
      <fig id="F5" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 1:</label>
        <caption>
          <title>Overview of the study and biomarkers.</title>
          <p id="P62">We compared BAL fluid obtained sequentially from 88 patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation with 38 patients with confirmed pneumonia secondary to other respiratory viruses (other viral pneumonia), 173 patients with non-viral pneumonia (other pneumonia) and 42 mechanically ventilated patients without pneumonia undergoing BAL (non-pneumonia controls). <bold>a</bold>. Sankey diagram illustrating steps in analysis performed for at least one BAL sample for participants with COVID-19, other viral pneumonia, non-viral pneumonia (other pneumonia), non-pneumonia controls, and healthy controls. This includes samples from patients 1) enrolled in the SCRIPT study (346 patients), 2) analyzed via flow cytometry (241 patients), 3) for whom bulk RNA-seq was performed on flow cytometry-sorted alveolar macrophages (181 patients) and 4) for whom single-cell RNA-seq was performed on cells from BAL fluid (10 patients with SARS-CoV-2 pneumonia, 1 patient with bacterial pneumonia and 1 patient intubated for reasons other than pneumonia (gastrointestinal bleeding requiring endoscopy, a non-pneumonia control)). Some samples were cryopreserved and sorted post-cryorecovery. Because cryopreservation affects the number of neutrophils, these samples were not included in flow cytometric analysis but were used for bulk RNA-seq profiling of flow cytometry-sorted alveolar macrophages. Samples for which flow or bulk RNA-seq analysis was skipped are represented by alluvia flowing over the grouping bars. <bold>b</bold>. Sankey diagram illustrating steps in analysis performed for all BAL samples from participants with COVID-19, other viral pneumonia, non-viral pneumonia (other pneumonia) and non-pneumonia controls. This includes samples from patients 1) enrolled in the SCRIPT study (564 samples), 2) analyzed via flow cytometry (352 samples), 3) for whom bulk RNA-seq was performed on flow cytometry-sorted alveolar macrophages (232 samples) and 4) for whom single-cell RNA-seq was performed on cells from BAL fluid (12 samples). <bold>c</bold>. Self-reported smoking status. Significantly fewer active smokers were observed in the COVID-19 cohort as compared with all control groups (q &lt; 0.05, pairwise Chi-square tests of proportions with continuity and FDR correction). <bold>d&#x2013;i.</bold> Biomarkers: C-reactive protein (CRP), D-dimer, ferritin, procalcitonin, creatine phosphokinase (CPK), lactate dehydrogenase (LDH). The green-shaded area indicates the normal range. <bold>j</bold>. Number of patients remaining on mechanical ventilation. <bold>k</bold>. Number of BAL per day of mechanical ventilation. <bold>l</bold>. The BAL sampling rate per day among patients with COVID-19 was not higher than the sampling rate among patients with other pneumonias.</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0005"/>
      </fig>
      <fig id="F6" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 2:</label>
        <caption>
          <title>Representative gating strategy to identify immune cell subsets in BAL samples.</title>
          <p id="P63"><bold>a</bold>. We developed a gating strategy that allowed us to quantify immune cell populations including monocytes, alveolar macrophage subsets, and T cell subsets. Importantly, we defined alveolar macrophages by their expression of CD206, subdividing them into early monocyte-derived alveolar macrophages (CD206<sup>lo</sup>) and more mature (CD206<sup>hi</sup>) alveolar macrophages. T cells were identified as CD3-positive and further subdivided into CD4+ and CD8+ T cells. Tregs were identified as CD3+CD4+CD25+CD127&#x2212;. Neutrophils were identified as CD15+ cells. Monocytes were identified as HLA-DR+CD4+CD206&#x2212; cells. Of note, only CD206<sup>hi</sup> alveolar macrophages were flow cytometry-sorted for bulk RNA-seq analysis (<xref rid="F2" ref-type="fig">Figs. 2</xref> and <xref rid="F3" ref-type="fig">3</xref>); hence, early monocyte-derived alveolar macrophages (MoAM1 and MoAM2 in our single-cell RNA-seq data, <xref rid="F4" ref-type="fig">Fig. 4a</xref>&#x2013;<xref rid="F4" ref-type="fig">h</xref>) were not captured in bulk RNA-seq. Representative sample from a patient without neutrophilia is shown. Solid red arrows indicate direct sequential gating, dashed blue arrows indicate Boolean &#x201C;not&#x201D; gates. Numbers on plots indicate the percentage of the parent population. Axis labels indicate laser line (UV &#x2013; 355 nm, V &#x2013; 405 nm, B &#x2013; 488 nm, YG &#x2013; 552 nm, R &#x2013; 640 nm), bandpass filter, fluorochrome and antigen/dye. <bold>b</bold>. Representative sample from a patient with neutrophilia illustrates loss of CD206<sup>hi</sup> alveolar macrophages and influx of monocyte-derived CD206<sup>lo</sup> alveolar macrophages. <bold>c&#x2013;d</bold>. Contour plot and histogram overlays illustrating forward (FSC) and side scatter (SSC) properties of the CD3+ T cells (CD3), CD15+ neutrophils (CD15), monocytes, CD206<sup>lo</sup> alveolar macrophages (CD206<sup>lo</sup>), and CD206<sup>hi</sup> alveolar macrophages (CD206<sup>hi</sup>) in the representative sample from a patient without neutrophilia (<bold>c.</bold>) and with neutrophilia (<bold>d.</bold>). Note that neutrophils have higher side scatter than monocytes. <bold>e</bold>. Representative contour plots illustrating a sample with two distinct populations of CD206<sup>hi</sup> alveolar macrophages. Single-cell RNA-seq analysis (<xref rid="F4" ref-type="fig">Fig. 4a</xref>&#x2013;<xref rid="F4" ref-type="fig">h</xref>) suggests that CD206<sup>hi</sup> alveolar macrophages (double-head arrow) are <italic>bona fide</italic> tissue-resident alveolar macrophages.</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0006"/>
      </fig>
      <fig id="F7" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 3.</label>
        <caption>
          <title>At the time of intubation, the alveolar space in patients with severe SARS-CoV-2 pneumonia is enriched for T cells and monocytes and contains alveolar macrophages harboring SARS-CoV-2 RNA.</title>
          <p id="P64"><bold>a</bold>. Proportions of cells detected within 48 hours of intubation (q &lt; 0.05, pairwise Wilcoxon rank-sum tests with FDR correction). Comparisons are not significant unless otherwise noted. <bold>b</bold>. Hierarchical clustering of viral reads for SARS-CoV-2 and influenza A/California/07/2009 virus using Ward&#x2019;s method. Log<sub>10</sub>(DESeq2-normalized counts) are shown. <bold>c</bold>. Cumulative coverage plot of RNA-seq reads from flow cytometry-sorted alveolar macrophages aligned to the SARS-CoV-2 genome.</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0007"/>
      </fig>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 4.</label>
        <caption>
          <title>The BAL fluid from patients with SARS-CoV-2 pneumonia is persistently enriched for T cells irrespective of superinfection status.</title>
          <p id="P65"><bold>a</bold>. Heatmap of flow cytometry data demonstrating composition of BAL samples from all time points, grouped by diagnosis and ordered by the duration of mechanical ventilation. Column headers are color-coded by the diagnosis, duration of mechanical ventilation (white color indicates chronically ventilated patients), and presence or absence of superinfection (&#x201C;Infection Status&#x201D;). &#x201C;Infection Status&#x201D; refers only to the &#x201C;COVID-19&#x201D; and &#x201C;Other Viral Pneumonia&#x201D; groups; blanks in these groups refer to samples for which microbiology data were incomplete and infectious status could not be determined. &#x201C;Viral infection only&#x201D; refers to viral pathogens as the only detected pathogen in a sample and &#x201C;Viral infection with bacterial/fungal superinfection&#x201D; refers to detection of a viral pathogen with one or more bacterial or fungal co-pathogens. <bold>b.</bold> Comparison of percentage of CD206<sup>lo</sup> and CD206<sup>hi</sup> alveolar macrophages between early (&lt;48 hours after intubation) and late (&gt;48 hours of mechanical ventilation) samples (q &lt; 0.05, pairwise Wilcoxon rank-sum tests with FDR correction). <bold>c</bold>. Comparison of CD4+ and CD8+ T cell and neutrophil abundance in the COVID-19 group, with and without superinfection in early and late sampling. Superinfection is represented by lighter bars. Differences between groups are not significant after FDR correction.</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0008"/>
      </fig>
      <fig id="F9" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 5.</label>
        <caption>
          <title>SARS-CoV-2 pneumonia is characterized by a persistent interferon-response signature in alveolar macrophages.</title>
          <p id="P66"><bold>a</bold>. k-means clustering of the 2,323 significantly variable genes (q &lt; 0.05, likelihood-ratio test) across diagnosis, columns represent each individual patient, grouped by diagnosis and ordered by day from first intubation. &#x201C;Infection Status&#x201D; refers only to the &#x201C;COVID-19&#x201D; and &#x201C;Other Viral Pneumonia&#x201D; groups; blanks in these groups refer to samples for which microbiology data were incomplete and infectious status could not be determined. &#x201C;Viral infection only&#x201D; refers to viral pathogens as the only detected pathogen in a sample and &#x201C;Viral infection with bacterial/fungal superinfection&#x201D; refers to detection of a viral pathogen with one or more bacterial or fungal co-pathogens. Representative genes and GO biological processes are shown for each cluster. Column headers are color-coded by diagnosis and duration of mechanical ventilation (white color indicates chronically ventilated patients). <bold>b</bold>. Expression of selected genes between the groups. Note that expression of <italic>IL6</italic> is not increased in any group. All significant comparisons are shown (q &lt; 0.05, Wald test with FDR correction in DESeq2). <bold>c</bold>. Weighted gene co-expression network analysis (WGCNA). <bold>d&#x2013;f</bold>. Interferon-response signatures in alveolar macrophages from patients with COVID-19 gradually decrease over the course of disease. Correlation between average expression of genes from GO:0060337 &#x201C;type I interferon signaling pathway&#x201D; (R = &#x2212;0.51, P = 5.7&#xD7;10<sup>&#x2212;6</sup>, Pearson correlation; panel <bold>d</bold>.), GO:0060333 &#x201C;interferon-gamma-mediated signaling pathway&#x201D; (R = &#x2212;0.22, P = 0.06, Pearson correlation; panel <bold>e</bold>.), module 15 of WGCNA (R = &#x2212;0.40, P = 5.5&#xD7;10<sup>&#x2212;4</sup>, Pearson correlation; panel <bold>f.</bold>) and time on mechanical ventilation. Gray boundaries represent 95% confidence intervals. <bold>g</bold>. UMAP projections of all bulk RNA-seq samples. Average expression of WGCNA module 15 (left) and percent of CD3+ T cells in BAL (right) are shown by point area. <bold>h</bold>. Heatmap demonstrating time-dependent changes in gene expression of the canonical interferon-response genes from module 15 from patients with positive outcomes (discharged home or inpatient facility) or poor outcomes (discharged to a long-term acute care facility (LTAC) or deceased. <bold>i</bold>. Correlation between detection of SARS-CoV-2 reads and disease progression (&#x3C1; = &#x2212;0.49, p = 8.3&#xD7;10<sup>&#x2212;4</sup>, Spearman correlation).</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0009"/>
      </fig>
      <fig id="F10" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 6.</label>
        <caption>
          <title>Single-cell RNA-seq identifies a positive feedback loop between IFN&#x3B3;-producing T cells and SARS-CoV-2-infected alveolar macrophages.</title>
          <p id="P67"><bold>a</bold>. Subsets of alveolar macrophages and T cells are represented by the cells from all 10 patients with COVID-19. <bold>b</bold>. <italic>IFNG</italic> expression is detected in T cells from all 10 patients with COVID-19, T cells with at least one count of <italic>IFNG</italic> were used for analysis. <bold>c</bold>. Detection of the SARS-CoV-2 negative strand. Density projection plot, with expression averaged within hexagonal areas on UMAP. <bold>d</bold>. Coverage plot of single-cell RNA-seq reads aligned to the SARS-CoV-2 genome. Cumulative data from 10 patients. Reads were aligned to genes on the positive strand or to the entire negative strand. <bold>e</bold>. UMAP plot showing integrative analysis of 105,715 cells isolated from 10 patients with severe COVID-19 within 48 hours after intubation (see <xref rid="F4" ref-type="fig">Fig. 4a</xref>&#x2013;<xref rid="F4" ref-type="fig">h</xref>), one intubated patient with bacterial pneumonia and one intubated non-pneumonia control patient. AT1 &#x2013; alveolar epithelial type 1 cells; AT2 &#x2013; alveolar epithelial type 2 cells; DC1 &#x2013; conventional dendritic cells type 1, <italic>CLEC9A</italic>+; DC2 &#x2013; conventional dendritic cells type 2, <italic>CD1C</italic>+; Migratory DC &#x2013; migratory dendritic cells, <italic>CCR7</italic>+; pDC &#x2013; plasmacytoid dendritic cells, <italic>CLEC4C</italic>+; Mixed myeloid &#x2013; mixed cluster containing transitory dendritic cells and very immature monocyte-derived macrophages; TRAM &#x2013; tissue-resident alveolar macrophages; MoAM &#x2013; monocyte-derived alveolar macrophages; iNKT cells &#x2013; invariant natural killer T cells; Treg &#x2013; regulatory T cells, <italic>FOXP3</italic>+. <bold>f</bold>. Cells from non-pneumonia control (patient 6) and a patient with bacterial pneumonia (Patient C) primarily contribute to the TRAM1 cluster and have limited contribution to MoAM clusters. <bold>g</bold>. UMAP plot showing cells from non-pneumonia control (patient 6) and a patient with bacterial pneumonia (Patient C) from the integrative analysis on <xref ref-type="fig" rid="F9">Extended Data Fig. 5e</xref>. <xref ref-type="fig" rid="F9">h</xref>. Presence of co-infection does not affect clustering. UMAP plot showing cells from patients with and without co-infection from the integrative analysis in <xref rid="F4" ref-type="fig">Fig. 4</xref>.</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0010"/>
      </fig>
      <fig id="F11" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 7.</label>
        <caption>
          <title>Deconvolution of bulk RNA-seq demonstrates loss of tissue-resident alveolar macrophages and persistence of mature monocyte-derived alveolar macrophages in patients with severe COVID-19.</title>
          <p id="P68"><bold>a</bold>. Dot plot showing <italic>IL6</italic> expression across cell types. Dot size is proportional to the number of cells expressing <italic>IL6</italic> in the corresponding cluster. Data from this study (G.) are presented per patient, data from Liao et al. 2020 (L.) and Haberman et al. 2020 (H.) are averaged by condition. <bold>b</bold>. Heatmap demonstrating proportion of alveolar macrophage subsets predicted from deconvolution analysis. Data are grouped by condition and ordered by proportion of CD206<sup>hi</sup> alveolar macrophages. <bold>c</bold>. Proportion of alveolar macrophage cell types in patients with COVID-19 in comparison to other types of pneumonia obtained from deconvolution analysis (pairwise Wilcoxon rank-sum tests with FDR correction, * q &lt; 0.05, ** q &lt; 0.01, *** q &lt; 0.001).</p>
        </caption>
        <graphic xlink:href="nihms-1656482-f0011"/>
      </fig>
      <table-wrap id="T1" position="anchor" orientation="portrait">
        <label>Extended Data Table 1:</label>
        <caption>
          <p id="P69">Demographics of the SCRIPT cohort, grouped by diagnosis. All patients were admitted to Northwestern Memorial Hospital in Chicago between June 15, 2018 and July 6, 2020. Bronchoscopy was most commonly performed as part of routine clinical care to guide antimicrobial therapy. Patients with ARDS were managed using a high PEEP, low tidal volume ventilation strategy and were ventilated prone when suggested by ARDSnet guidelines. Patients received steroids and off label IL-6 receptor antagonists (tocilizumab or sarilumab) at the discretion of the clinical team. Any hydroxychloroquine use is reported, but hydroxychloroquine was routinely stopped upon ICU admission. Some patients were enrolled in multicenter placebo-controlled trials of remdesivir or sarilumab, treatment assignment is blinded.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" valign="top" rowspan="1" colspan="1"/>
              <th align="center" valign="top" rowspan="1" colspan="1">COVID-19 (N = 88)</th>
              <th align="center" valign="top" rowspan="1" colspan="1">Non-Pneumonia Control (N = 42)</th>
              <th align="center" valign="top" rowspan="1" colspan="1">Other Pneumonia (N = 173)</th>
              <th align="center" valign="top" rowspan="1" colspan="1">Other Viral Pneumonia (N = 38)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Ethnicity</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Hispanic or Latino</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 88 (43.2%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6/ 42 (14.3%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13/ 173 (7.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">8/ 38 (21.1%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Not Hispanic or Latino</td>
              <td align="left" valign="top" rowspan="1" colspan="1">39/ 88 (44.3%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">33/ 42 (78.6%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">148/ 173 (85.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">27/ 38 (71.1%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown or Not Reported</td>
              <td align="left" valign="top" rowspan="1" colspan="1">11/ 88 (12.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3/ 42 (7.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">12/ 173 (6.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3/ 38 (7.9%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Race</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;American Indian/ Alaska Native</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 88 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 42 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 173 (0.6%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 38 (2.6%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Asian</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 88 (1.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2/ 42 (4.8%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7/ 173 (4.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 38 (2.6%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Black/ African American</td>
              <td align="left" valign="top" rowspan="1" colspan="1">20/ 88 (22.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7/ 42 (16.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 173 (22.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7/ 38 (18.4%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown or Not Reported</td>
              <td align="left" valign="top" rowspan="1" colspan="1">33/ 88 (37.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">5/ 42 (11.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13/ 173 (7.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">4/ 38 (10.5%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;White</td>
              <td align="left" valign="top" rowspan="1" colspan="1">34/ 88 (38.6%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">28/ 42 (66.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">114/ 173 (65.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">25/ 38 (65.8%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Age</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Minimum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">21</td>
              <td align="left" valign="top" rowspan="1" colspan="1">19</td>
              <td align="left" valign="top" rowspan="1" colspan="1">22</td>
              <td align="left" valign="top" rowspan="1" colspan="1">34</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Median (IQR)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">59.50 (46.00, 68.25)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">62.00 (46.75, 71.50)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">65.00 (51.00, 73.00)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">59.50 (52.25, 69.00)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Mean (SD)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">57.09 &#xB1; 14.64</td>
              <td align="left" valign="top" rowspan="1" colspan="1">59.14 &#xB1; 17.89</td>
              <td align="left" valign="top" rowspan="1" colspan="1">61.44 &#xB1; 16.06</td>
              <td align="left" valign="top" rowspan="1" colspan="1">60.66 &#xB1; 13.64</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Maximum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">86</td>
              <td align="left" valign="top" rowspan="1" colspan="1">90</td>
              <td align="left" valign="top" rowspan="1" colspan="1">99</td>
              <td align="left" valign="top" rowspan="1" colspan="1">88</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Sex</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Female</td>
              <td align="left" valign="top" rowspan="1" colspan="1">30/ 88 (34.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">19/ 42 (45.2%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">69/ 173 (39.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">17/ 38 (44.7%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Male</td>
              <td align="left" valign="top" rowspan="1" colspan="1">58/ 88 (65.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">23/ 42 (54.8%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">104/ 173 (60.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">21/ 38 (55.3%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Discharge Status</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Deceased</td>
              <td align="left" valign="top" rowspan="1" colspan="1">22/ 88 (25.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">15/ 42 (35.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">60/ 173 (34.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">14/ 38 (36.8%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Home</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 88 (43.2%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">18/ 42 (42.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">37/ 173 (21.4%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">8/ 38 (21.1%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Inpatient Facility</td>
              <td align="left" valign="top" rowspan="1" colspan="1">16/ 88 (18.2%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7/ 42 (16.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">53/ 173 (30.6%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">14/ 38 (36.8%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;LTAC</td>
              <td align="left" valign="top" rowspan="1" colspan="1">11/ 88 (12.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2/ 42 (4.8%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">22/ 173 (12.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2/ 38 (5.3%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Other</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 88 (1.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 42 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 173 (0.6%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 38 (0.0%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Smoking Status</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Current Smoker</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 88 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6/ 42 (14.3%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">23/ 173 (13.3%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">5/ 38 (13.2%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Never Smoker</td>
              <td align="left" valign="top" rowspan="1" colspan="1">41/ 88 (46.6%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">25/ 42 (59.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">73/ 173 (42.2%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">17/ 38 (44.7%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Past Smoker</td>
              <td align="left" valign="top" rowspan="1" colspan="1">14/ 88 (15.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9/ 42 (21.4%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">62/ 173 (35.8%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">15/ 38 (39.5%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown or Not Reported</td>
              <td align="left" valign="top" rowspan="1" colspan="1">33/ 88 (37.5%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2/ 42 (4.8%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">15/ 173 (8.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1/ 38 (2.6%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Days of Intubation</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Minimum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Median (IQR)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">18.00 (10.00, 33.00)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">4.00 (2.00, 8.75)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.00 (3.00, 13.00)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.00 (3.00, 13.00)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Mean (SD)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">25.48 &#xB1; 25.06</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.93 &#xB1; 11.48</td>
              <td align="left" valign="top" rowspan="1" colspan="1">10.62 &#xB1; 10.98</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9.79 &#xB1; 8.91</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Maximum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">153</td>
              <td align="left" valign="top" rowspan="1" colspan="1">58</td>
              <td align="left" valign="top" rowspan="1" colspan="1">68</td>
              <td align="left" valign="top" rowspan="1" colspan="1">34</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown/ Missing</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1 (0.58%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Length of ICU Stay</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Minimum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Median (IQR)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">21.00 (12.75, 31.50)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">5.50 (3.00, 11.50)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9.00 (5.00, 18.00)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">10.50 (4.50, 13.75)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Mean (SD)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">24.49 &#xB1; 16.96</td>
              <td align="left" valign="top" rowspan="1" colspan="1">10.17 &#xB1; 12.87</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13.87 &#xB1; 13.41</td>
              <td align="left" valign="top" rowspan="1" colspan="1">11.39 &#xB1; 8.10</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Maximum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">85</td>
              <td align="left" valign="top" rowspan="1" colspan="1">68</td>
              <td align="left" valign="top" rowspan="1" colspan="1">84</td>
              <td align="left" valign="top" rowspan="1" colspan="1">33</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown/ Missing</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2 (1.16%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">BMI</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Minimum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">20.62</td>
              <td align="left" valign="top" rowspan="1" colspan="1">16.56</td>
              <td align="left" valign="top" rowspan="1" colspan="1">12.46</td>
              <td align="left" valign="top" rowspan="1" colspan="1">17.34</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Median (IQR)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">31.21 (26.76, 37.09)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">27.41 (24.59, 33.83)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">25.89 (21.90, 32.32)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">26.78 (23.19, 32.75)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Mean (SD)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">33.17 &#xB1; 9.14</td>
              <td align="left" valign="top" rowspan="1" colspan="1">30.77 &#xB1; 9.78</td>
              <td align="left" valign="top" rowspan="1" colspan="1">27.48 &#xB1; 8.15</td>
              <td align="left" valign="top" rowspan="1" colspan="1">28.73 &#xB1; 8.37</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Maximum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">81.81</td>
              <td align="left" valign="top" rowspan="1" colspan="1">70.6</td>
              <td align="left" valign="top" rowspan="1" colspan="1">70.25</td>
              <td align="left" valign="top" rowspan="1" colspan="1">55.76</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown/ Missing</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1 (2.38%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1 (0.58%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">SOFA</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Minimum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.83</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.75</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Median (IQR)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.02 (5.49, 9.33)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6.58 (4.87, 10.49)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6.54 (4.47, 9.66)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6.04 (4.03, 8.88)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Mean (SD)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.44 &#xB1; 2.65</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.38 &#xB1; 3.31</td>
              <td align="left" valign="top" rowspan="1" colspan="1">7.35 &#xB1; 3.62</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6.54 &#xB1; 3.02</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Maximum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">15.84</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13.75</td>
              <td align="left" valign="top" rowspan="1" colspan="1">18.5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13.17</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown/ Missing</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2 (1.16%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0 (0.00%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">APS</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Minimum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">33</td>
              <td align="left" valign="top" rowspan="1" colspan="1">28.25</td>
              <td align="left" valign="top" rowspan="1" colspan="1">21.2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">26.33</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Median (IQR)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">70.27 (57.75, 82.11)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">60.67 (46.31, 80.88)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">64.22 (51.14, 80.55)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">70.60 (51.20, 78.77)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Mean (SD)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">69.54 &#xB1; 16.98</td>
              <td align="left" valign="top" rowspan="1" colspan="1">65.08 &#xB1; 21.89</td>
              <td align="left" valign="top" rowspan="1" colspan="1">66.85 &#xB1; 23.08</td>
              <td align="left" valign="top" rowspan="1" colspan="1">66.68 &#xB1; 19.89</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Maximum</td>
              <td align="left" valign="top" rowspan="1" colspan="1">103.36</td>
              <td align="left" valign="top" rowspan="1" colspan="1">115.5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">161</td>
              <td align="left" valign="top" rowspan="1" colspan="1">106.5</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unknown/ Missing</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13 (14.77%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1 (2.38%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">19 (10.98%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1 (2.63%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Remdesivir Study</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Enrolled</td>
              <td align="left" valign="top" rowspan="1" colspan="1">17/ 88 (19.3%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 42 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 173 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 38 (0.0%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Not Enrolled</td>
              <td align="left" valign="top" rowspan="1" colspan="1">71/ 88 (80.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">42/ 42 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">173/ 173 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 38 (100.0%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Sarilumab Study</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Enrolled</td>
              <td align="left" valign="top" rowspan="1" colspan="1">30/ 88 (34.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 42 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 173 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 38 (0.0%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Not Enrolled</td>
              <td align="left" valign="top" rowspan="1" colspan="1">58/ 88 (65.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">42/ 42 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">173/ 173 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 38 (100.0%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Steroids</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Treated</td>
              <td align="left" valign="top" rowspan="1" colspan="1">30/ 88 (34.1%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 42 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 173 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 38 (0.0%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unreated</td>
              <td align="left" valign="top" rowspan="1" colspan="1">58/ 88 (65.9%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">42/ 42 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">173/ 173 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 38 (100.0%)</td>
            </tr>
            <tr>
              <td colspan="5" align="left" valign="top" rowspan="1">Hydroxychloroquine</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Treated</td>
              <td align="left" valign="top" rowspan="1" colspan="1">17/ 88 (19.3%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 42 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 173 (0.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0/ 38 (0.0%)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Unreated</td>
              <td align="left" valign="top" rowspan="1" colspan="1">71/ 88 (80.7%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">42/ 42 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">173/ 173 (100.0%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">38/ 38 (100.0%)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T2" position="anchor" orientation="portrait">
        <label>Extended Data Table 2:</label>
        <caption>
          <p id="P70">Pneumonia-causing pathogens detected in the SCRIPT cohort.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" valign="top" rowspan="1" colspan="1"/>
              <th align="left" valign="top" rowspan="1" colspan="1">Pathogen</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Achromobacter species</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Acinetobacter baumannii</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Acinetobacter ursingii</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">4</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Elizabethkingia meningoseptica</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Enterobacter aerogenes</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">6</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Enterobacter cloacae complex</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">7</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Enterococcus faecalis</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">8</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Enterococcus faecium</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">9</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Escherichia coli</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">10</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Klebsiella oxytoca</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">11</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Klebsiella pneumoniae</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">12</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Staphylococcus aureus</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">13</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Proteus mirabilis</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">14</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Providencia stuartii</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">15</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Pseudomonas aeruginosa</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">16</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Serratia marcescens</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">17</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Stenotrophomonas maltophilia</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">18</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Stomatococcus species</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">19</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Streptococcus agalactiae (Group B)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">20</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Streptococcus pneumoniae</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">21</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Streptococcus pseudopneumoniae</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">22</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Viridans streptococcus</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T3" position="anchor" orientation="portrait">
        <label>Extended Data Table 3:</label>
        <caption>
          <p id="P71">Flow cytometry panels, reagents and instruments configuration.</p>
        </caption>
        <table frame="box" rules="all">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <tbody>
            <tr>
              <th colspan="8" align="left" valign="middle" rowspan="1">Panel 1: Used in original SCRIPT study prior to March 13, 2020</th>
            </tr>
            <tr>
              <th align="left" valign="top" rowspan="1" colspan="1"/>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Laser</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Filter</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Dye</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Antigen</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Final dilution</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Catalog #/Identifier</th>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">355 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">379/28</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BUV395</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">RPA-T4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 564724, RRID:AB_2738917</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">2</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">750/50</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BUV737</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD25</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">2A3</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 564385, RRID:AB_2744342</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">3</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">405 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">450/50</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">eFluor450</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HLA-DR</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">L243</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# 48-9952-42, RRID:AB_1603291</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">780/60</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BV786</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD15</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HI98</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 563838, RRID:AB_2738444</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">5</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">488 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">530/30</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">SYTOX Green</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">L/D</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">na</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:250</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# S34860</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">6</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">561 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">585/15</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">PE</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD3</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">SK7</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# 12-0036-42, RRID:AB_10805512</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">7</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">610/20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">PECF594</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD127</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HIL-7R</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 562397, RRID:AB_11154212</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">8</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">780/60</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">PECy7</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD206</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">19.2</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# 25-2069-42, RRID:AB_2573426</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">9</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">640 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">670/30</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">APC</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD8</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">SK1</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BioLegend Cat# 344721, RRID:AB_2075390</td>
            </tr>
            <tr>
              <td colspan="8" align="left" valign="top" style="border-right-style: hidden;border-left-style: hidden" rowspan="1"/>
            </tr>
          </tbody>
          <tbody>
            <tr>
              <th colspan="8" align="left" valign="middle" rowspan="1">Panel 2: Used on all samples starting March 13, 2020</th>
            </tr>
            <tr>
              <th align="left" valign="top" rowspan="1" colspan="1"/>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Laser</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Filter</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Dye</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Antigen</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Final dilution</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Catalog #/Identifier</th>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">355 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">379/28</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BUV395</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">RPA-T4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 564724, RRID:AB_2738917</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">2</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">750/50</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BUV737</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD25</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">2A3</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 564385, RRID:AB_2744342</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">3</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">405 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">450/50</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">eFluor450</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HLA-DR</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">L243</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# 48-9952-42, RRID:AB_1603291</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">520/50</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BV510</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD45</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HI30</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BioLegend Cat# 304036, RRID:AB_2561940</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">5</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">780/60</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BV786</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD15</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HI98</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 563838, RRID:AB_2738444</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">6</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">488 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">530/30</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">SYTOX Green</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">L/D</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">na</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:250</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# S34860</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">7</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">561 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">585/15</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">PE</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD3</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">SK7</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# 12-0036-42, RRID:AB_10805512</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">8</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">610/20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">PECF594</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD127</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">HIL-7R</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BD Biosciences Cat# 562397, RRID:AB_11154212</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">9</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">780/60</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">PECy7</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD206</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">19.2</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">Thermo Fisher Scientific Cat# 25-2069-42, RRID:AB_2573426</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">10</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">640 nm</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">670/30</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">APC</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">CD8</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">SK1</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:20</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BioLegend Cat# 344721, RRID:AB_2075390</td>
            </tr>
            <tr>
              <td align="left" valign="bottom" rowspan="1" colspan="1">11</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1"/>
              <td align="left" valign="bottom" rowspan="1" colspan="1">670/30</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">APC</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">EpCAM</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">9C4</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">1:40</td>
              <td align="left" valign="bottom" rowspan="1" colspan="1">BioLegend Cat# 324208, RRID:AB_756082</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="supplementary-material" id="SM1">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>1</label>
        <media xlink:href="NIHMS1656482-supplement-1.docx" orientation="portrait" id="d40e3406" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>1656482_Supp_Data1</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data1.xlsx" orientation="portrait" id="d40e3410" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <label>1656482_Supp_Data2</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data2.csv" orientation="portrait" id="d40e3414" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD4">
        <label>1656482_Supp_Data3</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data3.csv" orientation="portrait" id="d40e3418" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD5">
        <label>1656482_Supp_Data4</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data4.csv" orientation="portrait" id="d40e3422" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD6">
        <label>1656482_Supp_Data5</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data5.csv" orientation="portrait" id="d40e3426" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD7">
        <label>1656482_Supp_Data6</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data6.csv" orientation="portrait" id="d40e3430" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD8">
        <label>1656482_Supp_Data8</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data8.pdf" orientation="portrait" id="d40e3434" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD9">
        <label>1656482_Supp_Data9</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data9.csv" orientation="portrait" id="d40e3438" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD10">
        <label>1656482_Supp_Data7</label>
        <media xlink:href="NIHMS1656482-supplement-1656482_Supp_Data7.tif" orientation="portrait" id="d40e3442" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD11">
        <label>12</label>
        <media xlink:href="NIHMS1656482-supplement-12.pdf" orientation="portrait" id="d40e3447" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD12">
        <label>Supp_Vid1</label>
        <media xlink:href="NIHMS1656482-supplement-Supp_Vid1.mp4" orientation="portrait" id="d40e3451" position="anchor" mimetype="video"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD13">
        <label>13</label>
        <media xlink:href="NIHMS1656482-supplement-13.pdf" orientation="portrait" id="d40e3455" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S22">
      <title>Acknowledgments and funding:</title>
      <p id="P72">Northwestern University Flow Cytometry Core Facility is supported by NCI Cancer Center Support Grant P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Cell sorting was performed on BD FACSAria SORP cell sorter purchased through the support of NIH 1S10OD011996-01. Imaging work was performed at the Northwestern University Center for Advanced Microscopy supported by NCI Cancer Center Support Grant P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. This research was supported in part through the computational resources and staff contributions provided by the Genomics Compute Cluster which is jointly supported by the Feinberg School of Medicine, the Center for Genetic Medicine, and Feinberg&#x2019;s Department of Biochemistry and Molecular Genetics, the Office of the Provost, the Office for Research, and Northwestern Information Technology. The Genomics Compute Cluster is part of Quest, Northwestern University&#x2019;s high-performance computing facility, with the purpose to advance research in genomics. We would like to thank the Office for Research Safety and Institutional Biosafety Committee at Northwestern University for their help and guidance in setting up protocols and workflows for safe processing of samples from patients with COVID-19. Single-cell RNA sequencing was performed with support from Simpsons Querrey Institute for Epigenetics.</p>
      <p id="P73">Rogan Grant was supported by NIH grant T32AG020506-18. Luisa Morales-Nebreda was supported by T32HL076139 and F32HL151127. Ankit Bharat was supported by NIH grants HL145478, HL147290, and HL147575. Cara J. Gottardi was supported by NIH grants GM129312 and HL134800. GR Scott Budinger was supported by NIH grants U19AI135964, P01AG049665, P01AG04966506S1, R01HL147575 and Veterans Affairs grant I01CX001777. Alexander V. Misharin was supported by NIH grants U19AI135964, P01AG049665, R56HL135124, R01HL153312 and NUCATS COVID-19 Rapid Response Grant. Benjamin D. Singer was supported by NIH awards K08HL128867, U19AI135964, R01HL149883, and P01AG049665. Richard G. Wunderink was supported by NIH grant U19AI135964 and a GlaxoSmithKline Distinguished Scholar in Respiratory Health grant from the CHEST Foundation.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement" id="FN6">
        <p id="P74">Authors do not declare conflict of interest.</p>
      </fn>
      <fn id="FN7">
        <p id="P75">Data availability:</p>
        <p id="P76">Bulk RNA-seq counts tables and metadata are included as <xref rid="SD3" ref-type="supplementary-material">Supplemental Data Files 2</xref> and <xref rid="SD4" ref-type="supplementary-material">3</xref>. Single-cell RNA-seq counts tables and integrated objects are available through GEO with accession number GSE155249. Raw data are available through SRA/dbGaP phs002300.v1.p1.</p>
      </fn>
      <fn id="FN8">
        <p id="P77">Code availability:</p>
        <p id="P78">All code used for analysis is available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/NUPulmonary/2020_Grant">https://github.com/NUPulmonary/2020_Grant</ext-link>. High-level bulk and single-cell RNA-seq data can be explored via our in-house data browsers at <ext-link ext-link-type="uri" xlink:href="https://www.nupulmonary.org/covid-19/">https://www.nupulmonary.org/covid-19/</ext-link>.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>
<etal/>
<article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</article-title>. <source>Lancet Respir Med</source>
<volume>8</volume>, <fpage>475</fpage>&#x2013;<lpage>481</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32105632</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><name><surname>Gattinoni</surname><given-names>L</given-names></name>
<etal/>
<article-title>COVID-19 Does Not Lead to a &#x201C;Typical&#x201D; Acute Respiratory Distress Syndrome</article-title>. <source>American Journal of Respiratory and Critical Care Medicine</source> vol. <volume>201</volume>
<fpage>1299</fpage>&#x2013;<lpage>1300</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32228035</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><name><surname>Baud</surname><given-names>D</given-names></name>
<etal/>
<article-title>Real estimates of mortality following COVID-19 infection</article-title>. <source>Lancet Infect. Dis</source>
<volume>20</volume>, <fpage>773</fpage> (<year>2020</year>).</mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>F</given-names></name>
<etal/>
<article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>1054</fpage>&#x2013;<lpage>1062</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32171076</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><collab>RECOVERY Collaborative Group</collab>
<etal/>
<article-title>Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report</article-title>. <source>N. Engl. J. Med</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2021436</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><collab>National Heart, Lung, and Blood Institute PETAL Clinical Trials Network</collab>
<etal/>
<article-title>Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome</article-title>. <source>N. Engl. J. Med</source>
<volume>380</volume>, <fpage>1997</fpage>&#x2013;<lpage>2008</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31112383</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>S</given-names></name>, <name><surname>Alexander</surname><given-names>M</given-names></name>, <name><surname>Misharin</surname><given-names>AV</given-names></name>, <name><surname>Budinger</surname><given-names>GRS</given-names></name> &amp; <comment>Others.</comment>
<article-title>The role of macrophages in the resolution of inflammation</article-title>. <source>J. Clin. Invest</source>
<volume>129</volume>, <fpage>2619</fpage>&#x2013;<lpage>2628</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31107246</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>D</given-names></name>
<etal/>
<article-title>The Architecture of SARS-CoV-2 Transcriptome</article-title>. <source>Cell</source>
<volume>181</volume>, <fpage>914</fpage>&#x2013;<lpage>921.e10</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32330414</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><name><surname>Liao</surname><given-names>M</given-names></name>
<etal/>
<article-title>Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19</article-title>. <source>Nat. Med</source>
<volume>26</volume>, <fpage>842</fpage>&#x2013;<lpage>844</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32398875</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><name><surname>Chua</surname><given-names>RL</given-names></name>
<etal/>
<article-title>COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis</article-title>. <source>Nat. Biotechnol</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1038/s41587-020-0602-4</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><name><surname>Sola</surname><given-names>I</given-names></name>, <name><surname>Almaz&#xE1;n</surname><given-names>F</given-names></name>, <name><surname>Z&#xFA;&#xF1;iga</surname><given-names>S</given-names></name> &amp; <name><surname>Enjuanes</surname><given-names>L</given-names></name>
<article-title>Continuous and Discontinuous RNA Synthesis in Coronaviruses</article-title>. <source>Annu Rev Virol</source>
<volume>2</volume>, <fpage>265</fpage>&#x2013;<lpage>288</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26958916</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>J</given-names></name>
<etal/>
<article-title>Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis</article-title>. <source>J. Infect. Dis</source>
<volume>209</volume>, <fpage>1331</fpage>&#x2013;<lpage>1342</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24065148</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><name><surname>Yip</surname><given-names>MS</given-names></name>
<etal/>
<article-title>Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus</article-title>. <source>Virol. J</source>
<volume>11</volume>, <fpage>82</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24885320</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>CY</given-names></name>
<etal/>
<article-title>Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis</article-title>. <source>J. Virol</source>
<volume>79</volume>, <fpage>7819</fpage>&#x2013;<lpage>7826</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">15919935</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><name><surname>Soberanes</surname><given-names>S</given-names></name>
<etal/>
<article-title>Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis</article-title>. <source>Cell Metab</source>. <volume>29</volume>, <fpage>503</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30726761</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>LC</given-names></name>, <name><surname>McCabe</surname><given-names>C</given-names></name>, <name><surname>Garfield</surname><given-names>B</given-names></name> &amp; <name><surname>Wort</surname><given-names>SJ</given-names></name>
<article-title>Thrombosis and COVID-19 pneumonia: the clot thickens!</article-title>
<source>The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology</source> vol. <volume>56</volume> (<year>2020</year>).</mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><name><surname>Vabret</surname><given-names>N</given-names></name>
<etal/>
<article-title>Immunology of COVID-19: Current State of the Science</article-title>. <source>Immunity</source>
<volume>52</volume>, <fpage>910</fpage>&#x2013;<lpage>941</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32505227</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><name><surname>Wilk</surname><given-names>AJ</given-names></name>
<etal/>
<article-title>A single-cell atlas of the peripheral immune response in patients with severe COVID-19</article-title>. <source>Nat. Med</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1038/s41591-020-0944-y</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name>
<etal/>
<article-title>Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment</article-title>. <source>Cell</source>
<volume>182</volume>, <fpage>1419</fpage>&#x2013;<lpage>1440.e23</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32810438</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><name><surname>Habermann</surname><given-names>AC</given-names></name>
<etal/>
<article-title>Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis</article-title>. <source>Science Advances</source>
<volume>6</volume>, <fpage>eaba1972</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32832598</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><name><surname>Califano</surname><given-names>D</given-names></name>, <name><surname>Furuya</surname><given-names>Y</given-names></name> &amp; <name><surname>Metzger</surname><given-names>DW</given-names></name>
<article-title>Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain</article-title>. <source>J. Immunol</source>
<volume>201</volume>, <fpage>134</fpage>&#x2013;<lpage>144</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29760191</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><name><surname>Sungnak</surname><given-names>W</given-names></name>
<etal/>
<article-title>SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title>. <source>Nat. Med</source>
<volume>26</volume>, <fpage>681</fpage>&#x2013;<lpage>687</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32327758</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><name><surname>Hou</surname><given-names>YJ</given-names></name>
<etal/>
<article-title>SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract</article-title>. <source>Cell</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1016/j.cell.2020.05.042</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><name><surname>Chu</surname><given-names>H</given-names></name>
<etal/>
<article-title>Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19</article-title>. <source>Clin. Infect. Dis</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1093/cid/ciaa410</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><name><surname>Blanco-Melo</surname><given-names>D</given-names></name>
<etal/>
<article-title>Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19</article-title>. <source>Cell</source>
<volume>181</volume>, <fpage>1036</fpage>&#x2013;<lpage>1045.e9</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32416070</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><name><surname>Konno</surname><given-names>Y</given-names></name>
<etal/>
<article-title>SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant</article-title>. <source>Cell Rep</source>. <volume>32</volume>, <fpage>108185</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32941788</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><name><surname>Hadjadj</surname><given-names>J</given-names></name>
<etal/>
<article-title>Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients</article-title>. <source>Science</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1126/science.abc6027</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><name><surname>Jaume</surname><given-names>M</given-names></name>
<etal/>
<article-title>Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc&#x3B3;R pathway</article-title>. <source>J. Virol</source>
<volume>85</volume>, <fpage>10582</fpage>&#x2013;<lpage>10597</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21775467</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><name><surname>Martines</surname><given-names>RB</given-names></name>
<etal/>
<article-title>Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States</article-title>. <source>Emerg. Infect. Dis</source>
<volume>26</volume>, <fpage>2005</fpage>&#x2013;<lpage>2015</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32437316</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><name><surname>Sariol</surname><given-names>A</given-names></name> &amp; <name><surname>Perlman</surname><given-names>S</given-names></name>
<article-title>Lessons for COVID-19 Immunity from Other Coronavirus Infections</article-title>. <source>Immunity</source>
<volume>53</volume>, <fpage>248</fpage>&#x2013;<lpage>263</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32717182</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>L</given-names></name>
<etal/>
<article-title>Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection</article-title>. <source>JCI Insight</source>
<volume>4</volume>, (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><name><surname>Guilliams</surname><given-names>M</given-names></name>, <name><surname>Lambrecht</surname><given-names>BN</given-names></name> &amp; <name><surname>Hammad</surname><given-names>H</given-names></name>
<article-title>Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections</article-title>. <source>Mucosal Immunol</source>. <volume>6</volume>, <fpage>464</fpage>&#x2013;<lpage>473</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23549447</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><name><surname>Gioia</surname><given-names>C</given-names></name>
<etal/>
<article-title>T-Cell response profiling to biological threat agents including the SARS coronavirus</article-title>. <source>Int. J. Immunopathol. Pharmacol</source>
<volume>18</volume>, <fpage>525</fpage>&#x2013;<lpage>530</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16164833</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><name><surname>Grifoni</surname><given-names>A</given-names></name>
<etal/>
<article-title>Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals</article-title>. <source>Cell</source>
<volume>181</volume>, <fpage>1489</fpage>&#x2013;<lpage>1501.e15</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32473127</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><name><surname>Le Bert</surname><given-names>N</given-names></name>
<etal/>
<article-title>SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls</article-title>. <source>Nature</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2550-z</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><name><surname>Mateus</surname><given-names>J</given-names></name>
<etal/>
<article-title>Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans</article-title>. <source>Science</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1126/science.abd3871</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><name><surname>Braun</surname><given-names>J</given-names></name>
<etal/>
<article-title>SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19</article-title>. <source>Nature</source>
<volume>587</volume>, <fpage>270</fpage>&#x2013;<lpage>274</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32726801</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><name><surname>Bacher</surname><given-names>P</given-names></name>
<etal/>
<article-title>Low avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19</article-title>. <source>Immunity</source>
<volume>0</volume>, (<year>2020</year>).</mixed-citation>
      </ref>
      <ref id="R39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><name><surname>Oran</surname><given-names>DP</given-names></name> &amp; <name><surname>Topol</surname><given-names>EJ</given-names></name>
<article-title>Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review</article-title>. <source>Ann. Intern. Med</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.7326/M20-3012</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><name><surname>Neupane</surname><given-names>AS</given-names></name>
<etal/>
<article-title>Patrolling Alveolar Macrophages Conceal Bacteria from the Immune System to Maintain Homeostasis</article-title>. <source>Cell</source>
<volume>183</volume>, <fpage>110</fpage>&#x2013;<lpage>125.e11</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32888431</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><name><surname>Louie</surname><given-names>JK</given-names></name>
<etal/>
<article-title>Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California</article-title>. <source>JAMA</source>
<volume>302</volume>, <fpage>1896</fpage>&#x2013;<lpage>1902</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19887665</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><name><surname>Leisman</surname><given-names>DE</given-names></name>
<etal/>
<article-title>Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes</article-title>. <source>Lancet Respir Med</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30404-5</pub-id><comment>.</comment></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><name><surname>Kox</surname><given-names>M</given-names></name>, <name><surname>Waalders</surname><given-names>NJB</given-names></name>, <name><surname>Kooistra</surname><given-names>EJ</given-names></name>, <name><surname>Gerretsen</surname><given-names>J</given-names></name> &amp; <name><surname>Pickkers</surname><given-names>P</given-names></name>
<article-title>Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions</article-title>. <source>JAMA</source> (<year>2020</year>) doi:<pub-id pub-id-type="doi">10.1001/jama.2020.17052</pub-id><comment>.</comment></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1.</label>
      <caption>
        <title>Schematic and demographics of the SCRIPT cohort.</title>
        <p id="P79"><bold>a</bold>. Schematic illustrating the interpretation of the main findings. 1. The normal alveolus contains <italic>ACE2</italic>-expressing alveolar type 1 and type 2 cells (AT1 and AT2, respectively) and tissue-resident alveolar macrophages (TRAM). 2. SARS-CoV-2 infects AT1 and AT2 cells and TRAM. Infected TRAM express T cell chemokines. 3. Cross-reactive or <italic>de novo</italic>-generated effector-memory T cells recognize SARS-CoV-2 antigens presented by TRAM and produce IFN&#x3B3;, further activating TRAM to produce cytokines and chemokines. 4. Activated T cells proliferate and continue to produce IFN&#x3B3;, eventually leading to death of infected TRAM and recruitment of monocytes, which rapidly differentiate into monocyte-derived alveolar macrophages (MoAM). 5. Recruited MoAM become infected with SARS-CoV-2, continuing to present antigens to T cells and maintaining the feedback loop until viral clearance is achieved. <bold>b.</bold> Timing of hospital admission (square), BAL fluid collection (diamonds), length of mechanical ventilation (bold red line), and hospital stay (thin grey line) in patients with severe COVID-19 grouped by outcomes (crossed open red circles &#x2013; death; green circles &#x2013; discharged). Day 0 is defined as the day of the first intubation. <bold>c</bold>. Distribution of patient age. Differences not significant by pairwise t-test with FDR correction. <bold>d</bold>. Proportions of females (red) and males (blue) (pairwise Chi-square tests of proportions with continuity and FDR correction). <bold>e</bold>. Self-reported ethnicity (pairwise Chi-square tests of proportions with continuity and FDR correction). <bold>f</bold>. Body mass index (BMI) (t-test with FDR correction). <bold>g</bold>. The Sequential Organ Failure Assessment (SOFA) score (pairwise Wilcoxon rank-sum tests with FDR correction). <bold>h</bold>. The Acute Physiology Score (APS) (pairwise Wilcoxon rank-sum tests with FDR correction). <bold>i</bold>. ICU length of stay (pairwise t-tests with FDR correction). <bold>j</bold>. The duration of mechanical ventilation (pairwise t-tests with FDR correction). <bold>k</bold>. Mortality in patients with COVID-19 was similar to patients in other groups (25% vs. 35%, P = 0.10, &#x3C7;<sup>2</sup> = 2.63, Chi-square tests of proportions).</p>
      </caption>
      <graphic xlink:href="nihms-1656482-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2.</label>
      <caption>
        <title>At the time of intubation, the alveolar space in patients with severe SARS-CoV-2 pneumonia is enriched for T cells and monocytes and contains alveolar macrophages harboring SARS-CoV-2 RNA and expressing interferon response genes.</title>
        <p id="P80"><bold>a.</bold> Hierarchical clustering of flow cytometry data from BAL samples collected within 48 hours of intubation. Column headers are color-coded by the diagnosis and presence or absence of co-infection (&#x201C;Infection Status&#x201D;). &#x201C;Infection Status&#x201D; refers only to the &#x201C;COVID-19&#x201D; and &#x201C;Other Viral Pneumonia&#x201D; groups. &#x201C;Viral infection only&#x201D; refers to viral pathogens as the only detected pathogen in a sample and &#x201C;Viral infection with bacterial/fungal co-infection&#x201D; refers to detection of a viral pathogen with one or more bacterial or fungal co-pathogens. Samples were clustered by Euclidean distance using Ward&#x2019;s method. <bold>b.</bold> Proportions of cells detected within 48 hours of intubation (q &lt; 0.05, pairwise Wilcoxon rank-sum tests with FDR correction). Comparisons are not significant unless otherwise noted. <bold>c</bold>. k-means clustering of the 1,194 significantly variable genes (q &lt; 0.05, likelihood-ratio test) across diagnosis. Columns represent each individual sample and are clustered using Ward&#x2019;s method. Column headers are color-coded by the diagnosis and presence or absence of a co-infecting pathogen (&#x201C;Infection Status&#x201D;). &#x201C;Infection Status&#x201D; refers only to the &#x201C;COVID-19&#x201D; and &#x201C;Other Viral Pneumonia&#x201D; groups; blanks in these groups refer to samples for which microbiology data were incomplete and infectious status could not be determined. &#x201C;Viral infection only&#x201D; refers to viral pathogens as the only detected pathogen in a sample and &#x201C;Viral infection with bacterial/fungal co-infection&#x201D; refers to detection of a viral pathogen with one or more bacterial or fungal co-pathogens. Representative genes and GO biological processes are shown for each cluster.</p>
      </caption>
      <graphic xlink:href="nihms-1656482-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Fig. 3.</label>
      <caption>
        <title>The BAL fluid from patients with SARS-CoV-2 pneumonia is persistently enriched for T cells and characterized by an interferon-response signature in alveolar macrophages.</title>
        <p id="P81"><bold>a.</bold> Hierarchical clustering of flow cytometry analysis of BAL samples from all time points from patients with serial sampling (n &gt; 1) based on their composition. Column headers are color-coded by the diagnosis, patient, duration of mechanical ventilation, and presence or absence of superinfection (&#x201C;Infection Status&#x201D;). &#x201C;Infection Status&#x201D; refers only to the &#x201C;COVID-19&#x201D; and &#x201C;Other Viral Pneumonia&#x201D; groups; blanks in these groups refer to samples for which microbiology data were incomplete and infectious status could not be determined. &#x201C;Viral infection only&#x201D; refers to viral pathogens as the only detected pathogen in a sample and &#x201C;Viral infection with bacterial/fungal superinfection&#x201D; refers to detection of a viral pathogen with one or more bacterial or fungal co-pathogens. Samples were clustered by Euclidean distance using Ward&#x2019;s method. <bold>b.</bold> Comparison of percentage of CD4+ and CD8+ T cells and neutrophils between early (&lt;48 hours after intubation) and late (&gt;48 hours of mechanical ventilation) samples (q &lt; 0.05, pairwise Wilcoxon rank-sum tests with FDR correction). <bold>c.</bold> k-means clustering of the 2,323 significantly variable genes (q &lt; 0.05, likelihood-ratio test) across diagnosis, columns represent each individual patient and clustered using Ward&#x2019;s method. Representative genes and GO biological processes are shown for each cluster. Column headers are color-coded by the diagnosis, duration of mechanical ventilation (white color indicates chronically ventilated patients), and presence or absence of superinfection (&#x201C;Infection Status&#x201D;). &#x201C;Infection Status&#x201D;, &#x201C;Viral infection only&#x201D; and &#x201C;Viral infection with bacterial/fungal superinfection&#x201D; are as in panel <bold>a.</bold></p>
      </caption>
      <graphic xlink:href="nihms-1656482-f0003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Fig. 4.</label>
      <caption>
        <title>Single-cell RNA-seq identifies a positive feedback loop between IFN&#x3B3;-producing T cells and SARS-CoV-2-infected alveolar macrophages.</title>
        <p id="P82"><bold>a</bold>. UMAP plot showing integrated analysis of 77,146 cells isolated from 10 patients with severe COVID-19 within 48 hours after intubation. AT1 &#x2013; alveolar epithelial type 1 cells; AT2 &#x2013; alveolar epithelial type 2 cells; DC1 &#x2013; conventional dendritic cells type 1, <italic>CLEC9A</italic>+; DC2 &#x2013; conventional dendritic cells type 2, <italic>CD1C</italic>+; Migratory DC &#x2013; migratory dendritic cells, <italic>CCR7</italic>+; pDC &#x2013; plasmacytoid dendritic cells, <italic>CLEC4C</italic>+; Mixed myeloid &#x2013; mixed cluster containing transitory dendritic cells and very immature monocyte-derived macrophages; TRAM &#x2013; tissue-resident alveolar macrophages; MoAM &#x2013; monocyte-derived alveolar macrophages; iNKT cells &#x2013; invariant natural killer T cells; Treg &#x2013; regulatory T cells, <italic>FOXP3</italic>+. <bold>b.</bold> Heatmap demonstrating expression of the selected genes of interest in two subsets of tissue-resident (TRAM1 and TRAM2) and four subsets of monocyte-derived (MoAM1, MoAM2, MoAM3, MoAM4) alveolar macrophages. Each column represents a single patient with COVID-19. <bold>c</bold>. Expression of <italic>IFNG</italic> is restricted to T cells. <bold>d</bold>. Detection of SARS-CoV-2 transcripts. Plot shows cumulative number of SARS-CoV-2 genes plus negative strand. <bold>e-g</bold>. Specific upregulation of selected cytokines and chemokines in TRAM2: <italic>CXCL10</italic> (<bold>e.</bold>), <italic>CCL4</italic> (<bold>f.</bold>), <italic>IL1B</italic> (<bold>g.</bold>). Density projection plots, expression averaged within hexagonal areas on UMAP. <bold>h</bold>. Heatmap demonstrating selected differentially expressed genes between two subsets of tissue-resident alveolar macrophages (TRAM1 and TRAM2). <bold>i</bold>. SARS-CoV-2 infection is spatially restricted. Combined immunofluorescence microscopy for CD206, a marker of mature macrophages (red arrows), and smFISH (RNAscope) for positive- (yellow arrowheads) and negative-strand (cyan doublehead arrows) SARS-CoV-2 transcripts. Inserts show infected and non-infected CD206-positive alveolar macrophages in the adjacent alveoli.</p>
      </caption>
      <graphic xlink:href="nihms-1656482-f0004"/>
    </fig>
  </floats-group>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35418676</article-id>
      <article-id pub-id-type="pmc">9021019</article-id>
      <article-id pub-id-type="publisher-id">4570</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-04570-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Nonlinear control of transcription through enhancer&#x2013;promoter interactions</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Zuin</surname>
            <given-names>Jessica</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0677-3293</contrib-id>
          <name>
            <surname>Roth</surname>
            <given-names>Gregory</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7702-6207</contrib-id>
          <name>
            <surname>Zhan</surname>
            <given-names>Yinxiu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1041-8913</contrib-id>
          <name>
            <surname>Cramard</surname>
            <given-names>Julie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Redolfi</surname>
            <given-names>Josef</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piskadlo</surname>
            <given-names>Ewa</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mach</surname>
            <given-names>Pia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kryzhanovska</surname>
            <given-names>Mariya</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3729-6709</contrib-id>
          <name>
            <surname>Tihanyi</surname>
            <given-names>Gergely</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kohler</surname>
            <given-names>Hubertus</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eder</surname>
            <given-names>Mathias</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leemans</surname>
            <given-names>Christ</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0284-0404</contrib-id>
          <name>
            <surname>van Steensel</surname>
            <given-names>Bas</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6230-4216</contrib-id>
          <name>
            <surname>Meister</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smallwood</surname>
            <given-names>Sebastien</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9664-9087</contrib-id>
          <name>
            <surname>Giorgetti</surname>
            <given-names>Luca</given-names>
          </name>
          <address>
            <email>luca.giorgetti@fmi.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.482245.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2110 3787</institution-id><institution>Friedrich Miescher Institute for Biomedical Research, </institution></institution-wrap>Basel, Switzerland </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.6612.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0642</institution-id><institution>University of Basel, </institution></institution-wrap>Basel, Switzerland </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.430814.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 1393</institution-id><institution>Division of Gene Regulation and Oncode Institute, Netherlands Cancer Institute, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>University of Bern, </institution></institution-wrap>Bern, Switzerland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>13</day>
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>604</volume>
      <issue>7906</issue>
      <fpage>571</fpage>
      <lpage>577</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>4</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>2</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Chromosome structure in mammals is thought to regulate transcription by modulating three-dimensional interactions between enhancers and promoters, notably through CTCF-mediated loops and topologically associating domains (TADs)<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref></sup>. However, how chromosome interactions are actually translated into transcriptional outputs remains unclear. Here, to address this question, we use an assay to position an enhancer at large numbers of densely spaced chromosomal locations relative to a fixed promoter, and measure promoter output and interactions within a genomic region with minimal regulatory and structural complexity. A quantitative analysis of hundreds of cell lines reveals that the transcriptional effect of an enhancer depends on its contact probabilities with the promoter through a nonlinear relationship. Mathematical modelling suggests that nonlinearity might arise from transient enhancer&#x2013;promoter interactions being translated into slower promoter bursting dynamics in individual cells, therefore uncoupling the temporal dynamics of interactions from those of transcription. This uncovers a potential mechanism of how distal enhancers act from large genomic distances, and of how topologically associating domain boundaries block distal enhancers. Finally, we show that enhancer strength also determines absolute transcription levels as well as the sensitivity of a promoter to CTCF-mediated transcriptional insulation. Our measurements establish general principles for the context-dependent role of chromosome structure in long-range transcriptional regulation.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">The transcriptional effect of an enhancer depends on its contact probabilities with the promoter through a nonlinear relationship, and enhancer strength determines absolute transcription levels as well as the sensitivity of a promoter to CTCF-mediated transcriptional insulation.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Chromatin</kwd>
        <kwd>Transcriptional regulatory elements</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">Transcriptional control in mammals critically depends on enhancers, which control tissue specificity and developmental timing of many genes<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Enhancers are often located hundreds of kilobases away from target promoters and are thought to control gene expression by interacting with the promoters in the three-dimensional space of the nucleus. Chromosome conformation capture (3C) methods<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> revealed that enhancer&#x2013;promoter interactions predominantly occur within sub-megabase domains known as topologically associating domains (TADs). These mainly arise from nested looping interactions between sites that are bound by the DNA-binding protein CTCF that act as barriers for the loop extrusion activity of cohesin<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p>
      <p id="Par4">TAD boundaries and CTCF loops are thought to favour enhancer&#x2013;promoter communication within specific genomic regions and disfavour it with respect to surrounding sequences<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. However, this view has recently been challenged by reports that disruption of TAD boundaries<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup> or depletion of CTCF and cohesin<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup> do not lead to systematic changes in gene expression, and that some regulatory sequences can act across TAD boundaries<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The manipulation of single CTCF sites has also been reported to result in variable effects on gene expression<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR14">14</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref></sup>. The very notion that physical proximity is required for transcriptional regulation has been questioned by the observed lack of correlation between transcription and proximity in single cells<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. Thus, it is highly debated whether there are indeed general principles that determine how physical interactions enable or prevent enhancer action<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Enhancer&#x2013;promoter genomic distance might also contribute to transcriptional regulation<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>, but it is unclear whether an enhancer acts uniformly within a TAD<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>, or whether its effect depends on the genomic distance from a promoter<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>.</p>
    </sec>
    <sec id="Sec2">
      <title>Enhancer action depends on genomic distance</title>
      <p id="Par5">Addressing these questions requires a quantitative understanding of the relationship between transcription and enhancer&#x2013;promoter interactions in conditions in which confounding effects by additional regulatory and structural interactions are minimized. Here we provide such a description using an experimental assay in which an enhancer is mobilized from an initial location and reinserted at large numbers of genomic positions with respect to a promoter. This enables the measurement of transcription levels as a function of the enhancer location and, therefore, of enhancer&#x2013;promoter contact frequencies (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). Specifically, we generated mouse embryonic stem (mES) cells carrying a transgene in which a promoter drives the expression of enhanced green fluorescent protein (eGFP). The <italic>eGFP</italic> transcript is split in two by a piggyBac transposon containing the cognate enhancer of the promoter (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). After expression of the PBase transposase, the transposon is excised and reintegrated randomly into the genome, but preferentially in the vicinity of the initial site<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Excision leads to reconstitution of functional eGFP of which the expression is used to isolate clonal cell lines by sorting single eGFP<sup>+</sup> cells (Fig. <xref rid="Fig1" ref-type="fig">1c, d</xref>). This enables the rapid generation of hundreds of cell lines, each with the enhancer in a distinct genomic position. Enhancer position and eGFP expression are then determined in every cell line (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Enhancer action depends on the genomic distance from the promoter and is constrained by TAD boundaries.</title><p><bold>a</bold>, Mobilization of an enhancer around its target promoter to measure transcription as a function of their genomic distance. <bold>b</bold>, Schematic of the transgene: a promoter drives transcription of an <italic>eGFP</italic> gene split by a piggyBac-enhancer cassette. ITR, inverted terminal repeats. <bold>c</bold>, After expression of PBase, the piggyBac-enhancer cassette is excised and randomly reinserted, occasionally leading to eGFP expression. <bold>d</bold>, Sorting of single eGFP<sup>+</sup> cells results in cell lines in which the enhancer drives transcription from a single position. Splinkerette PCR and flow cytometry analysis are used to determine the enhancer position and promoter expression levels. <bold>e</bold>, Capture-C (6.4&#x2009;kb resolution) analysis and genomic datasets in mES cells across 2.6&#x2009;Mb centred around the selected TAD with both of the internal CTCF motifs deleted (dashed squares; &#x394;&#x394;CTCF, double CTCF&#xA0;site deletion&#xA0;). The dashed line indicates the position of the future insertion of the transgene carrying the <italic>Sox2</italic> promoter and SCR. A, active; N, neutral; R, repressive; Chr, chromosome. <bold>f</bold>, Representative flow cytometry profiles from founder mES cells, a promoter-only control cell line and eGFP<sup>+</sup> cell lines with mobilized SCR. The light&#xA0;blue line indicates the mean eGFP levels in the promoter-only line. The numbers show the median eGFP intensities. AU, arbitrary units. <bold>g</bold>, eGFP levels in individual eGFP<sup>+</sup> cell lines over cell passages. The numbers show the median eGFP values. <bold>h</bold>, Normalized mean eGFP intensities in individual eGFP<sup>+</sup> cell lines as a function of SCR genomic position. The red dots are data from 135 individual cell lines; data are mean&#x2009;&#xB1;&#x2009;s.d. <italic>n</italic>&#x2009;=&#x2009;3 measurements on different days. The black dots show the average values within equally spaced 20&#x2009;kb bins. The dashed red line shows the spline interpolation of average values. Mean mRNA numbers were inferred using smRNA-FISH calibration (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1h</xref>). The light blue area shows the interval between the mean&#x2009;&#xB1;&#x2009;s.d. of eGFP levels in three promoter-only cell lines. <bold>i</bold>, Data as in <bold>h</bold>, colour-coded according to SCR genomic orientation.</p></caption><graphic xlink:href="41586_2022_4570_Fig1_HTML" id="d32e553"/></fig></p>
      <p id="Par6">To minimize confounding effects, we integrated the transgene within a 560&#x2009;kb TAD on chromosome 15 carrying minimal regulatory and structural complexity. This TAD does not contain expressed genes or active enhancers, is mostly composed of &#x2018;neutral&#x2019; chromatin<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> except for a repressive ~80&#x2009;kb region at its 3&#x2032; side (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1a</xref>), and displays minimal structure mediated by two internal forward CTCF sites (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1a, b</xref>). To further decrease the structural complexity, we deleted the two internal CTCF sites. This led to the loss of the associated loops (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1c</xref>) and resulted in a simple homogeneous internal structure, as revealed by capture-C with tiled oligonucleotides spanning 2.9&#x2009;Mb around the transgene (Fig. <xref rid="Fig1" ref-type="fig">1e</xref> and Extended Data Fig. <xref rid="Fig6" ref-type="fig">1c</xref>).</p>
      <p id="Par7">We first heterozygously inserted a single copy (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1e</xref>) of a version of the transgene carrying the mouse <italic>Sox2</italic> promoter and the essential 4.8&#x2009;kb region of its distal enhancer known as <italic>Sox2</italic> control region (SCR)<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup> (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1d</xref> and Methods), from which we deleted its single CTCF site, which is not essential for transcriptional regulation at the endogenous locus<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Transgene insertion did not lead to substantial structural rearrangements within the TAD besides new moderate interactions with the CTCF sites at the 3&#x2032; and 5&#x2032; end of the TAD (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1f</xref>). Mobilization of the piggyBac-SCR cassette led to random genomic reinsertions with a preference for chromosome 15 itself (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1g</xref>). Individual experiments resulted in several tens of cell lines of which the eGFP levels were unimodally distributed (Fig. <xref rid="Fig1" ref-type="fig">1f</xref>), generally higher than those detected in control lines in which transcription was driven by the <italic>Sox2</italic> promoter alone (Fig. <xref rid="Fig1" ref-type="fig">1f</xref>), and remained stable over cell passages (Fig. <xref rid="Fig1" ref-type="fig">1g</xref>). Mean eGFP levels in single cell lines were linearly correlated with average numbers of <italic>eGFP</italic> mRNAs measured using single-molecule RNA fluorescence in situ hybridization (smRNA-FISH) (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1h</xref>). We therefore used flow cytometry as a readout of transcriptional activity.</p>
      <p id="Par8">Mapping of piggyBac-SCR positions in more than 300 cell lines revealed that, although in around 15% of them the transposon had not been successfully mobilized, in 99% of those in which it had (262 out of 264), the enhancer reinserted within the initial TAD (Fig. <xref rid="Fig1" ref-type="fig">1h</xref> and Extended Data Fig. <xref rid="Fig6" ref-type="fig">1i</xref>). In the two cell lines in which the enhancer transposed outside the TAD, eGFP levels were comparable to basal transcription driven by promoter-only control cell lines (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1j</xref>). Notably, within the TAD, expression levels decreased with increasing enhancer&#x2013;promoter genomic distance (Fig. <xref rid="Fig1" ref-type="fig">1h</xref>). Genomic distance accounted for a tenfold dynamic range in gene expression, from around 5 to 60 mRNAs per cell on average on the basis of smRNA-FISH calibration (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1h</xref>). Insertions downstream of the non-transcribed <italic>Npr3</italic> gene generated lower transcription levels (Fig. <xref rid="Fig1" ref-type="fig">1h</xref>), possibly because this is a predominantly repressive region. Mild positive and negative deviations from the average decay in transcription levels indeed correlated with local enrichment in active and repressive chromatin states, respectively (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1k</xref>). Consistent with the classical notion derived from reporter assays that enhancer activity is independent of genomic orientation<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, enhancers inserted in forward or reverse orientations generated equivalent transcription levels (Fig. <xref rid="Fig1" ref-type="fig">1i</xref>). Interestingly, cell-to-cell heterogeneity in eGFP levels (assessed using coefficients of variation (CVs)) showed an opposite trend to mean expression levels and increased with increasing enhancer&#x2013;promoter genomic distance (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1l</xref>; examples of eGFP intensity distributions are provided in Extended Data Fig. <xref rid="Fig6" ref-type="fig">1m</xref>). Importantly, these results did not depend on the specific fluorescence gate used to define eGFP<sup>+</sup> cells (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1n, o</xref>). Together, these data show that the range of activity of the enhancer extends to the entire TAD and is delimited by its boundaries. However, transcription levels and their cell-to-cell variability quantitatively depend on enhancer&#x2013;promoter genomic distance.</p>
    </sec>
    <sec id="Sec3">
      <title>Enhancer contacts modulate burst frequency</title>
      <p id="Par9">We next examined the relationship between transcription levels and contact probabilities. Although reads from the wild-type allele might underemphasize changes introduced by the heterozygous insertion of the transgene, contact patterns detected in capture-C did not change substantially in individual cell lines in which the SCR was mobilized compared to the founder line before piggyBac mobilization (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2a</xref>). Thus, the ectopic enhancer and promoter do not create prominent specific interactions, which enabled us to use capture-C data from the founder line (Methods)<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> to infer contact probabilities between promoter and enhancer locations (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). Contact probabilities steeply decayed with increasing genomic distance from the promoter, fell considerably while approaching TAD boundaries (from 1 to around 0.05) and further dropped by a factor of around 3 across boundaries (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). This is consistent with previous estimations<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> confirmed using cross-linking and ligation-free methods<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> and is representative of the contact probabilities experienced by promoters in mES cells (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2b, c</xref>). However, such a trend is at odds with our observation that transcription levels rather mildly decreased inside the TAD and dropped to promoter-only levels outside its boundaries (Fig. <xref rid="Fig1" ref-type="fig">1h</xref> and Extended Data Fig. <xref rid="Fig7" ref-type="fig">2d</xref>). Interestingly, plotting the mean <italic>eGFP</italic> mRNA numbers as a function of contact probabilities revealed a highly nonlinear relationship (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>The promoter on rate is a sigmoidal function of enhancer&#x2013;promoter contact probabilities.</title><p><bold>a</bold>, Capture-C (6.4&#x2009;kb resolution) analysis of the founder cell line used for the experiments in Fig. <xref rid="Fig1" ref-type="fig">1</xref> after converting read counts into contact probabilities (top) (Methods). Bottom, cross-section showing contact probabilities from the ectopic <italic>Sox2</italic> transgene. Insets: magnification of contact probability across the TAD boundaries. <bold>b</bold>, Mean <italic>eGFP</italic> mRNA numbers per cell plotted against contact probabilities between the ectopic <italic>Sox2</italic> promoter and SCR insertions. The red dots show individual cell lines. The black dots show the average values within equally spaced 20&#x2009;kb bins&#x2009;&#xB1;&#x2009;s.d. The number of cell lines per bin varies from 1 to 28. <bold>c</bold>, Representative smRNA-FISH images from cell lines in which <italic>eGFP</italic> transcription is driven by the <italic>Sox2</italic> promoter alone (left) or by the SCR located at different distances and contact probabilities (right). Scale bar, 10&#x2009;&#xB5;m. <bold>d</bold>, Distributions of mRNA numbers per cell measured in the cell lines shown in <bold>c</bold>. The error bars show the minimum and maximum frequency. <italic>n</italic>&#x2009;=&#x2009;3 technical replicates. The line shows the best fit of the phenomenological two-state model to the experimental data shown in <bold>b</bold> and <bold>d</bold>. <bold>e</bold>, Best fit to experimental data of <bold>b</bold> and <bold>d</bold>. Best-fit parameters are shown in Extended Data Fig. <xref rid="Fig8" ref-type="fig">3b</xref>. <bold>f</bold>, Description of the phenomenological two-state model with a variable on rate. The Hill function describes the dependency of <italic>k</italic><sub>on</sub> on contact probability (<italic>p</italic><sub>c</sub>). <inline-formula id="IEq8"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{0}$$\end{document}</tex-math><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq8.gif"/></alternatives></inline-formula> and <inline-formula id="IEq9"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{1}$$\end{document}</tex-math><mml:math id="M4"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq9.gif"/></alternatives></inline-formula> are the minimum and maximum on rates, respectively; <italic>c</italic> and <italic>h</italic> are the Hill function critical threshold and the sensitivity parameter, respectively.&#xA0;&#x2205; symbolizes&#xA0;degraded RNA. <bold>g</bold>, The best-fitting Hill function for <italic>k</italic><sub>on</sub> (in units of mRNA lifetime <italic>&#x3B4;</italic>), corresponding to a sigmoidal curve. <bold>h</bold>, Close-up of <bold>e</bold>, highlighting the predicted insulation outside the TAD boundaries (red and green shaded areas). Data are presented as in <bold>b</bold>.</p></caption><graphic xlink:href="41586_2022_4570_Fig2_HTML" id="d32e860"/></fig></p>
      <p id="Par10">We sought to understand whether such a nonlinear relationship could be related to how enhancer&#x2013;promoter interactions translate into transcription in individual cells. Transcription occurs in intermittent bursts<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> that give rise to variable mRNA numbers in single cells. smRNA-FISH analysis revealed substantial cell-to-cell variability in <italic>eGFP</italic> mRNA numbers in a panel of cell lines in which promoter&#x2013;SCR contact probabilities ranged from zero (promoter-only control cell line) to one (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>). Similar to eGFP protein distributions (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2e</xref>), CVs of mRNA distributions increased with decreasing contact probabilities (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2f</xref>). Bursty promoter behaviour can generally be described in terms of a two-state model of gene expression<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> in which the promoter stochastically switches with rates <italic>k</italic><sub>on</sub> and <italic>k</italic><sub>off</sub> between an OFF and an ON state in which transcription can initiate with rate <italic>&#xB5;</italic>. Consistent with this notion, mRNA number distributions (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>) and mean transcription levels (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>) in individual cell lines could be well approximated by a phenomenological two-state model in which the &#x2018;on&#x2019; rate <italic>k</italic><sub>on</sub> (and therefore the burst frequency) nonlinearly depends on enhancer&#x2013;promoter contact probability through a Hill function (Fig. <xref rid="Fig2" ref-type="fig">2f</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Information</xref>, model description). Interestingly, the best agreement with experimental data occurred with a Hill coefficient (<italic>h</italic>) of 2.8 (95% confidence interval&#x2009;=&#x2009;2.4&#x2013;3.2; Extended Data Fig. <xref rid="Fig8" ref-type="fig">3a, b</xref>). This corresponds to a sigmoidal transcriptional response in which the enhancer would be no longer able to activate the promoter outside the approximately threefold drop in contact probabilities generated by TAD boundaries (Fig. <xref rid="Fig2" ref-type="fig">2g, h</xref>). Importantly the sigmoidal behaviour of <italic>k</italic><sub>on</sub> was not an artefact due to systematic errors in estimation of contact probabilities (Extended Data Fig. <xref rid="Fig8" ref-type="fig">3c</xref>), confounding effects of CTCF sites and repressive chromatin in the 3&#x2032; part of the TAD, or inclusion of promoter-only cell lines in the fit (Extended Data Fig. <xref rid="Fig8" ref-type="fig">3d</xref>). Alternative two-state models in which &#x2018;off&#x2019; or initiation rates depend on contact probability rather than the on rate failed to reproduce the observed decrease in CV with contact probabilities (<xref rid="MOESM1" ref-type="media">Supplementary Information</xref>, model description).</p>
    </sec>
    <sec id="Sec4">
      <title>Mechanistic model of enhancer regulation</title>
      <p id="Par11">We next examined which mechanism could in principle generate such a phenomenological two-state model with sigmoidal modulation of <italic>k</italic><sub>on</sub>. Enhancer&#x2013;promoter contacts are stochastic<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup> and probably dynamic<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> in single cells. Molecular processes that are thought to transmit regulatory information from enhancers to promoters (such as recruitment of transcription factors and coactivators, assembly of the Mediator complex<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>), as well as those that are associated with promoter operation itself (such as pre-initiation complex assembly, RNA polymerase II pausing and release<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>) are also stochastic and dynamic<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. We reasoned that the interplay between the timescales of these processes might generate nonlinear effects, as was recently hypothesized to explain promoter bursting<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. To investigate this concept in a quantitative manner, we developed a mechanistic model describing the simple hypothesis that, in single cells, the on rate of the promoter is transiently increased after stochastic interactions with an enhancer. We assumed that enhancer&#x2013;promoter interactions occur and disassemble with rates <italic>k</italic><sub>close</sub> and <italic>k</italic><sub>far</sub>, corresponding to a steady-state contact probability of <italic>k</italic><sub>close</sub>/(<italic>k</italic><sub>close</sub>&#x2009;+&#x2009;<italic>k</italic><sub>far</sub>) (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). When the enhancer is close to the promoter, it triggers one or more (<italic>n</italic>) reversible regulatory steps that transmit information to the promoter with forward and reverse rates <italic>k</italic><sub>forward</sub> and <italic>k</italic><sub>back</sub> (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). These steps are an abstract representation of any stochastic regulatory processes occurring at the enhancer&#x2013;promoter interface. When the enhancer is far, no information is transmitted to the promoter and regulatory steps can only revert at rate <italic>k</italic><sub>back</sub> (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>). The promoter operates in a basal two-state regime with a small on rate (<inline-formula id="IEq12"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{basal}}$$\end{document}</tex-math><mml:math id="M6"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>basal</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq12.gif"/></alternatives></inline-formula>) (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>) unless all regulatory steps have been completed. In this case, the promoter transiently enters an &#x2018;enhanced&#x2019; two-state regime with a higher on rate (<inline-formula id="IEq13"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M8"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq13.gif"/></alternatives></inline-formula>), thus transiently increasing its transcriptional activity (Fig. <xref rid="Fig3" ref-type="fig">3c</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Information</xref>, model description). A transient increase in promoter activity therefore requires enhancer interactions that are either long enough (Extended Data Fig. <xref rid="Fig9" ref-type="fig">4a</xref>) or frequent enough (Extended Data Fig. <xref rid="Fig9" ref-type="fig">4b</xref>) to allow the completion of the <italic>n</italic> regulatory steps.<fig id="Fig3"><label>Fig. 3</label><caption><title>A mechanistic model of enhancer&#x2013;promoter communication.</title><p><bold>a</bold>, Stochastic promoter&#x2013;enhancer interactions occur and disassemble with rates <italic>k</italic><sub>close</sub> and <italic>k</italic><sub>far</sub>. <bold>b</bold>, In the close state, the enhancer can trigger <italic>n</italic> reversible regulatory steps with forward and reverse rates <italic>k</italic><sub>forward</sub> and <italic>k</italic><sub>back</sub>. In the far state, regulatory steps can revert only at rate <italic>k</italic><sub>back</sub>. <bold>c</bold>, The promoter operates in a basal two-state regime with a small on rate (<inline-formula id="IEq10"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{basal}}$$\end{document}</tex-math><mml:math id="M10"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>basal</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq10.gif"/></alternatives></inline-formula>) unless all <italic>n</italic> regulatory steps have been completed, in which case it transiently enters an enhanced two-state regime with a higher on rate (<inline-formula id="IEq11"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M12"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq11.gif"/></alternatives></inline-formula>). <bold>d</bold>, Schematic of the parameter constraints under which the mechanistic model reduces to an apparent two-state model: <italic>k</italic><sub>close,far</sub>&#x2009;&#x226B;&#x2009;<italic>k</italic><sub>forward,back</sub>&#x2009;&#x226B;&#x2009;<inline-formula id="IEq14"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{basal,enh}}$$\end{document}</tex-math><mml:math id="M14"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>basal,enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq14.gif"/></alternatives></inline-formula>,&#x2009;<italic>k</italic><sub>off</sub>,&#x2009;<italic>&#xB5;</italic>. <bold>e</bold>, Representative single-cell dynamics of enhancer&#x2013;promoter interactions, promoter regulatory steps and promoter states predicted by the mechanistic model with <italic>n</italic>&#x2009;=&#x2009;5 and rates satisfying the constraint on timescales described in <bold>d</bold> (time unit, 1/<italic>&#x3B4;</italic>). <bold>f</bold>, Reduction of the mechanistic model to an apparent two-state model. The equation describes how the apparent on rate <inline-formula id="IEq15"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{app}}$$\end{document}</tex-math><mml:math id="M16"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>app</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq15.gif"/></alternatives></inline-formula> depends on contact probability (<italic>p</italic><sub>c</sub>) and other parameters of the mechanistic model. <bold>g</bold>, Dependency of <inline-formula id="IEq16"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{app}}$$\end{document}</tex-math><mml:math id="M18"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>app</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq16.gif"/></alternatives></inline-formula> on contact probability, illustrated for the best fitting parameters shown in <bold>h</bold> and <bold>i</bold>. <bold>h</bold>, Best fit of the apparent two-state model to the experimental transcriptional response shown in Fig. <xref rid="Fig2" ref-type="fig">2b</xref>. <bold>i</bold>, Best fit of the apparent two-state model to the experimental mRNA distributions shown in Fig. <xref rid="Fig2" ref-type="fig">2c</xref>. Best-fit parameters are shown in Extended Data Fig. <xref rid="Fig9" ref-type="fig">4c</xref>.</p></caption><graphic xlink:href="41586_2022_4570_Fig3_HTML" id="d32e1304"/></fig></p>
      <p id="Par12">This mechanistic model does not generally reproduce the phenomenological two-state behaviour observed in Fig. <xref rid="Fig2" ref-type="fig">2e, f</xref> for the ectopic <italic>Sox2</italic> promoter. However, when the timescales of enhancer&#x2013;promoter interactions are faster than those of intermediate regulatory steps, and both are faster than the promoter&#x2019;s intrinsic bursting dynamics (<italic>k</italic><sub>close,far</sub>&#x2009;&#x226B;&#x2009;<italic>k</italic><sub>forward,back</sub>&#x2009;&#x226B;<inline-formula id="IEq17"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{basal,enh}}$$\end{document}</tex-math><mml:math id="M20"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>basal,enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq17.gif"/></alternatives></inline-formula>,&#x2009;<italic>k</italic><sub>off</sub>,&#x2009;<italic>&#xB5;</italic>) (Fig. <xref rid="Fig3" ref-type="fig">3d, e</xref>), the mechanistic model reduces to an apparent two-state model (Fig. <xref rid="Fig3" ref-type="fig">3f</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Information</xref>, model description). If forward transitions through <italic>n</italic>&#x2009;<italic>&gt;</italic>&#x2009;1 regulatory steps are favoured over backward reactions (<italic>k</italic><sub>forward</sub>&#x2009;&gt;&#x2009;<italic>k</italic><sub>back</sub>), then the on rate of the apparent two-state model (<inline-formula id="IEq18"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{app}}$$\end{document}</tex-math><mml:math id="M22"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>app</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq18.gif"/></alternatives></inline-formula>) depends sigmoidally on contact probabilities (Fig. <xref rid="Fig3" ref-type="fig">3g</xref>). This shows that, in principle, the promoter&#x2019;s phenomenological two-state behaviour with sigmoidal modulation of <italic>k</italic><sub>on</sub> observed in Fig. <xref rid="Fig2" ref-type="fig">2e, f</xref> could arise from stochastic enhancer&#x2013;promoter interactions being transmitted into slower promoter ON/OFF dynamics through small numbers of intermediate regulatory processes. The resulting sigmoidal transcriptional response would enable an enhancer to act efficiently even when contact probabilities rapidly decay away from the promoter (Extended Data Fig. <xref rid="Fig7" ref-type="fig">2d</xref>), and contribute to block enhancer action when small drops in contact probabilities occur across TAD boundaries (Fig. <xref rid="Fig2" ref-type="fig">2h</xref>). The mechanistic model also predicts that enhancer&#x2013;promoter contacts should not correlate with transcription bursts (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>), as recently suggested by simultaneous imaging of <italic>Sox2</italic> transcription and genomic locations flanking the endogenous <italic>Sox2</italic> and SCR<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p>
      <p id="Par13">Finally, we verified that, when reduced to a two-state model, the mechanistic model could simultaneously fit the experimental transcriptional response to contact probabilities and smRNA-FISH distributions (Fig. <xref rid="Fig3" ref-type="fig">3h, i</xref>). Best agreement occurred with five intermediate regulatory steps (95% confidence interval&#x2009;=&#x2009;3&#x2013;7; Extended Data Fig. <xref rid="Fig9" ref-type="fig">4c, d</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Information</xref>, model description) and, consistent with previous observations<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, promoter ON/OFF transitions that&#xA0;occur in the timescale of several minutes (considering that the time unit in the model is mRNA lifetime, expected to be around 1.5&#x2009;h)<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> (Extended Data Fig. <xref rid="Fig9" ref-type="fig">4c, d</xref>). Regulatory processes at the interface between enhancers and promoters have been estimated to occur in the order of tens of seconds<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>, consistent with the condition that intermediate regulatory steps should be faster than bursting kinetics (Fig. <xref rid="Fig3" ref-type="fig">3f</xref>). The requirement that enhancer&#x2013;promoter interactions should be even faster (Fig. <xref rid="Fig3" ref-type="fig">3f</xref>) therefore predicts that they should occur on a timescale of seconds or less.</p>
    </sec>
    <sec id="Sec5">
      <title>Enhancer strength controls insulation levels</title>
      <p id="Par14">We next set out to examine whether CTCF binding affects the observed nonlinear relationship between transcription and contact probabilities. To this aim, we repeated the enhancer mobilization assay in mES cells in which only one of the two internal CTCF sites was homozygously deleted. The remaining forward CTCF site is located 36&#x2009;kb downstream of the transgene and loops onto the reverse CTCF sites at the 3&#x2032; end of the domain (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). SCR mobilization in this context resulted in 172 cell lines of which the transcription levels were indistinguishable from those generated in the &#x2018;empty&#x2019; TAD, except across the CTCF site that severely, but not completely, insulated the ectopic <italic>Sox2</italic> promoter from the enhancer (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). Transcription levels across the CTCF site were about 60% lower than those generated in the absence of the CTCF site (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). Strikingly, this occurred in the absence of notable changes in the promoter&#x2019;s interaction probabilities with the region downstream of the CTCF site, at least in the current experimental set-up (capture-C data with 6.4&#x2009;kb resolution) (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). This suggests that a single CTCF site might exert transcriptional insulation through additional mechanisms beyond simply driving physical insulation, possibly depending on site identity<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> and flanking sequences<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.<fig id="Fig4"><label>Fig. 4</label><caption><title>Insulation by a single CTCF site exceeds contact probability changes.</title><p><bold>a</bold>, Capture-C (6.4&#x2009;kb resolution) analysis of founder mES cell lines in the absence (&#x394;&#x394;CTCF) or presence (single CTCF-site deletion, &#x394;CTCF) of a forward CTCF motif 36&#x2009;kb downstream of the transgene, and the corresponding differential map. The grey pixels show &#x2018;noisy&#x2019; interactions that did not pass quality control filters (Methods). The dotted boxes and arrows indicate the position of the CTCF site and the structural changes it generates. <bold>b</bold>, The normalized mean&#x2009;&#xB1;&#x2009;s.d. eGFP levels in 172 individual eGFP<sup>+</sup> cell lines following SCR mobilization in &#x394;CTCF mES cells (green dots); <italic>n</italic>&#x2009;=&#x2009;3 measurements performed on different days. The black dots show the mean&#x2009;&#xB1;&#x2009;s.d. values within equally spaced 20&#x2009;kb bins. The green dashed line shows the spline interpolation of average eGFP values. The vertical pink line shows the position of the CTCF site at +36&#x2009;kb. The red dashed line shows the trend of eGFP levels in the &#x394;&#x394;CTCF background (compare with Fig. <xref rid="Fig1" ref-type="fig">1h</xref>). The blue line shows the promoter-only eGFP level as in Fig. <xref rid="Fig1" ref-type="fig">1h</xref>. <bold>c</bold>, Magnification of spline interpolants of GFP<sup>+</sup> cell lines in the absence (&#x394;&#x394;CTCF, red dashed line) or presence (&#x394;CTCF, green dashed line) of the CTCF binding site at +36&#x2009;kb (vertical pink line) (left). The numbers represent the percentage fold changes between trendlines. Bottom, the percentage fold changes as a function of distance from the promoter. Right, contact probabilities from the location of the ectopic <italic>Sox2</italic> transgene in &#x394;&#x394;CTCF (red line) and &#x394;CTCF (green line) mES cells.</p></caption><graphic xlink:href="41586_2022_4570_Fig4_HTML" id="d32e1531"/></fig></p>
      <p id="Par15">The SCR is a strong enhancer that accounts for most of the transcriptional activity of endogenous <italic>Sox2</italic><sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. We reasoned that a weaker enhancer should lead to a different transcriptional response to contact probabilities with the promoter. There are two ways in which the parameters in the model shown in Fig. <xref rid="Fig3" ref-type="fig">3f</xref> might change when reducing enhancer strength. The ratio between transition rates through regulatory steps <italic>k</italic><sub>forward</sub> and <italic>k</italic><sub>back</sub> (<inline-formula id="IEq1"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta $$\end{document}</tex-math><mml:math id="M24"><mml:mi>&#x3B2;</mml:mi></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq1.gif"/></alternatives></inline-formula> in Fig. <xref rid="Fig3" ref-type="fig">3h</xref>) might decrease, resulting in a slower transmission of regulatory information (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). This would generate a transcriptional response with maximal transcriptional levels that are similar to those generated by the SCR but different sensitivity to changes in contact probabilities (Fig. <xref rid="Fig5" ref-type="fig">5a</xref>). Alternatively (although not exclusively), the on rate in the enhanced promoter regime <inline-formula id="IEq19"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M26"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq19.gif"/></alternatives></inline-formula> could decrease (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>). This would conserve the shape of the transcriptional response but decrease the maximal transcription level&#xA0;(Fig. <xref rid="Fig5" ref-type="fig">5b</xref>). To test these predictions, we performed the enhancer mobilization assay using a truncated version of the SCR (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5a</xref>). This contained only one of the two ~1.5&#x2009;kb subregions that share similar transcription-factor-binding sites<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and independently operate as weaker enhancers of the <italic>Sox2</italic> promoter in transient reporter assays<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5b</xref>). Mobilization of the truncated SCR in mES cells with a forward CTCF site downstream of the promoter (compare with Fig. <xref rid="Fig4" ref-type="fig">4a</xref>) led to 74 eGFP<sup>+</sup> cell lines displaying approximately twofold lower transcription levels compared with those generated by the full-length SCR at comparable genomic distances (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>). In contrast to the full-length SCR, the truncated enhancer was completely insulated from the promoter by the CTCF site (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>). Thus, the level of functional insulation generated by the same CTCF site depends on the strength of the enhancer. In the region upstream of the CTCF sites, the transcriptional response generated by the truncated SCR (Fig. <xref rid="Fig5" ref-type="fig">5d</xref>) was in quantitative agreement with model predictions under the hypothesis that enhancer strength decreases the on rate rather than changing the intermediate regulatory steps (Fig. <xref rid="Fig5" ref-type="fig">5b</xref>), and could be predicted using the full-length SCR best-fit parameters with a two-fold decreased <inline-formula id="IEq20"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M28"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq20.gif"/></alternatives></inline-formula>. This further strengthens our interpretation that enhancer strength modulates the ability of the promoter to turn on, possibly by regulating chromatin state, transcription factor binding or RNA polymerase II dynamics at the promoter<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup> .<fig id="Fig5"><label>Fig. 5</label><caption><title>Enhancer strength modulates promoter on rates and determines insulation levels through a CTCF site.</title><p><bold>a</bold>, Model predictions under the hypothesis that decreasing enhancer strength results in a slower flow of regulatory information to the promoter. <bold>b</bold>, Model predictions as in <bold>a</bold>, under the alternative hypothesis that decreasing enhancer strength modifies the enhanced on rate (<inline-formula id="IEq21"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M30"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq21.gif"/></alternatives></inline-formula>). <bold>c</bold>, Normalized eGFP levels in in 74 individual GFP<sup>+</sup> cell lines (brown dots; the error bars show the s.d. of <italic>n</italic>&#x2009;=&#x2009;3 measurements performed on different days), binned data (orange dots) and data trend (brown dashed line) after mobilization of the truncated SCR in the &#x394;CTCF background. Trends of eGFP levels in individual GFP<sup>+</sup> cell lines in which the SCR was mobilized either in the &#x394;&#x394;CTCF background (red dashed line; Fig. <xref rid="Fig1" ref-type="fig">1h</xref>) or in the &#x394;CTCF background (green dashed line; Fig. <xref rid="Fig4" ref-type="fig">4b</xref>) are shown for comparison. Promoter-only eGFP levels (light blue) are shown as in Fig. <xref rid="Fig1" ref-type="fig">1h</xref>. <bold>d</bold>, The transcriptional response of the truncated SCR (green line) can be predicted from the best fit to the full-length SCR (purple line) with a modified enhanced on rate (<inline-formula id="IEq22"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M32"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq22.gif"/></alternatives></inline-formula>). Data are mean&#x2009;&#xB1;&#x2009;s.d. eGFP values were calculated within equally spaced 20&#x2009;kb bins as in <bold>c</bold>; the number of cell lines per bin varies from 1 to 56.</p></caption><graphic xlink:href="41586_2022_4570_Fig5_HTML" id="d32e1746"/></fig></p>
      <p id="Par16">In the nonlinear transcriptional response that we identified, high sensitivity in the low contact probability regime (that is, at long genomic distances) might contribute to secure insulation by TAD boundaries of even strong enhancers such as the SCR. Interestingly, in mES cells, the contact probabilities of most (~75%) active promoters with the nearest TAD boundary are comparable to those experienced by the ectopic <italic>Sox2</italic> promoter in our experiments (lower than 0.2) (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5c</xref>). These promoters should therefore experience the same insulation mechanisms. The remaining promoters are closer (or adjacent) to a TAD boundary and therefore experience larger contact probabilities with the boundary, at which the transcriptional response is less sensitive (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5d</xref>). However, interestingly, drops in contact probabilities across a boundary increase with decreasing genomic distance from the boundary itself (Extended Data Fig. <xref rid="Fig10" ref-type="fig">5d</xref>). This might contribute to the functional insulation of this class of promoters. Boundaries associated with clusters of CTCF sites might also benefit from the fact that insulation from CTCF sites can exceed the changes in contact probabilities that they generate (Fig. <xref rid="Fig4" ref-type="fig">4</xref>).</p>
    </sec>
    <sec id="Sec6" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par17">Our study provides unbiased and systematic measurements of promoter output as a function of large numbers of enhancer positions with minimal confounding effects. The analysis of hundreds of cell lines enables us to move beyond locus-specific observations, and establishes a quantitative framework for understanding the role of chromosome structure in long-range transcriptional regulation. Our data reveal that, within a TAD, absolute transcription levels generated by an enhancer depend on its genomic distance from the promoter and are determined by a nonlinear relationship with their contact probabilities. Minimal regulatory and structural complexities introduce deviations from this behaviour and might therefore confound its detection outside a highly controlled genomic environment, notably when studying regulatory sequences in their endogenous context<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Mathematical modelling suggests that the observed nonlinear transcriptional response involves a modulation of the promoter&#x2019;s burst frequency, which could arise from transient enhancer&#x2013;promoter interactions being translated into slower promoter bursting dynamics in individual cells. In addition to readily explaining the absence of correlation between transcription and physical proximity in single-cell experiments, this argues that the absence of such correlation should not be interpreted as the absence of causality. Although alternative explanations cannot be ruled out (such as cooperative effects through biomolecular condensates<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>), our model provides a simple explanatory framework for both population-averaged and single-cell behaviour of enhancer-driven transcription, based on a minimal set of general and realistic hypotheses. Future live-cell imaging experiments with improved spatial and temporal resolution<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> will probably enable the testing of the model&#x2019;s prediction that enhancer&#x2013;promoter interactions should occur on a timescale of seconds or less, therefore enabling the assessment of the model&#x2019;s premises. Finally, our study reveals that enhancer strength is not only a determinant of absolute transcription levels, but also of the level of insulation provided by CTCF. Our data therefore imply that transcriptional insulation is not an intrinsic absolute property of TAD boundaries or CTCF interactions but, rather, a graded variable depending on enhancer strength, boundary strength and distance from a promoter.</p>
    </sec>
    <sec id="Sec10" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec11">
        <title>Culture of embryonic stem cells</title>
        <p id="Par18">All cell lines are based on E14 mES cells, provided by E. Heard&#x2019;s laboratory. Cells were cultured on gelatin-coated culture plates in Glasgow minimum essential medium (Sigma-Aldrich, G5154) supplemented with 15% fetal calf serum (Eurobio Abcys), 1% <sc>l</sc>-glutamine (Thermo Fisher Scientific, 25030024), 1% sodium pyruvate MEM (Thermo Fisher Scientific, 11360039), 1% MEM non-essential amino acids (Thermo Fisher Scientific, 11140035) 100&#x2009;&#xB5;M &#x3B2;-mercaptoethanol, 20&#x2009;U&#x2009;ml<sup>&#x2212;1</sup> leukaemia inhibitory factor (Miltenyi Biotec, premium grade) in 8% CO<sub>2</sub> at 37&#x2009;&#xB0;C. Cells were tested for mycoplasma contamination once a month and no contamination was detected. After piggyBac-enhancer transposition, cells were cultured in standard E14 medium supplemented with 2i (1&#x2009;&#xB5;M MEK inhibitor PDO35901 (Axon, 1408) and 3&#x2009;&#xB5;M GSK3 inhibitor CHIR 99021 (Axon, 1386)).</p>
      </sec>
      <sec id="Sec12">
        <title>Generation of enhancer&#x2013;promoter piggyBac targeting vectors</title>
        <p id="Par19">Homology arms necessary for the knock-in, the <italic>Sox2</italic> promoter, the SCR and the truncated version of the SCR (Ei) were amplified from E14 mES cell genomic DNA by Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific, F549) using primers compatible with Gibson assembly cloning (NEB, E2611). The targeting vector was generated starting from the 3-SB-EF1-PBBAR-SB plasmid<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, gifted by Rob Mitra. To clone homology arms into the vector, BspEI and BclI restriction sites were introduced using Q5 Site-Directed Mutagenesis Kit (NEB, E0554). The left homology arm was cloned using Gibson assembly strategy by linearizing the vector with BspEI (NEB, R0540). The right homology arm was cloned using Gibson assembly strategy by linearizing the vector with BclI (NEB, R0160). The <italic>Sox2</italic> promoter was cloned by first removing the Ef1a promoter from the 3-SB-EF1-PBBAR-SB vector using NdeI (NEB, R0111) and SalI (NEB, R0138) and subsequently using Gibson assembly strategy. The SCR and its truncated version (truncated SCR or Ei) were cloned between the piggyBac transposon-specific inverted terminal repeat sequences (ITR) by linearizing the vector with BamHI (NEB, R3136) and NheI (NEB, R3131). A transcriptional pause sequence from the human alpha2 globin gene and an SV40 poly(A) sequence were inserted at both 5&#x2032; and 3&#x2032; ends of the enhancers using Gibson assembly strategy. A selection cassette carrying the puromycin resistance gene driven by the PGK promoter and flanked by FRT sites was cloned in front of the <italic>Sox2</italic> promoter by linearizing the piggyBac vector with the AsiSI (NEB, R0630) restriction enzyme. A list of the primers used for cloning is provided in&#xA0;<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>.</p>
      </sec>
      <sec id="Sec13">
        <title>Generation of founder mES cell lines carrying the piggyBac transgene</title>
        <p id="Par20">The gRNA sequence for the knock-in of the piggyBac transgene on chromosome 15 was designed using the online tool (<ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE">https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE</ext-link>) and purchased from Microsynth AG. gRNA sequence was cloned into the PX459 plasmid (Addgene) using the BsaI restriction site. E14 mES cell founder lines carrying the piggyBac transgene were generated using nucleofection with the Amaxa 4D-Nucleofector X-Unit and the P3 Primary Cell 4D-Nucleofector X Kit (Lonza, V4XP-3024 KT). Cells (2&#x2009;&#xD7;&#x2009;10<sup>6</sup>) were collected with accutase (Sigma-Aldrich, A6964) and resuspended in 100&#x2009;&#xB5;l transfection solution (82&#x2009;&#xB5;l primary solution, 18&#x2009;&#x3BC;l supplement, 1&#x2009;&#x3BC;g piggyBac targeting vector carrying the SCR, truncated SCR or promoter alone, and 1&#x2009;&#xB5;g of PX459 ch15_gRNA/Cas9) and transferred into a single Nucleocuvette (Lonza). Nucleofection was performed using the protocol CG110. Transfected cells were directly seeded in prewarmed 37&#x2009;&#xB0;C culture in E14 standard medium. Then, 24&#x2009;h after transfection, 1&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup> of puromycin (InvivoGen, ant-pr-1) was added to the medium for 3&#x2009;days to select cells transfected with PX459 gRNA/Cas9 vector. Cells were then cultured in standard E14 medium for an additional 4&#x2009;days. To select cells with insertion of the piggyBac targeting vector, a second pulse of puromycin was carried out by culturing cells in standard medium supplemented with 1&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup> of puromycin. After 3&#x2009;days of selection, single cells were isolated by fluorescence-activated cell sorting (FACS) on 96-well plates. Sorted cells were kept for 2&#x2009;days in standard E14 medium supplemented with 100&#x2009;&#x3BC;g&#x2009;&#xB5;l<sup>&#x2212;1</sup> primocin (InvivoGen, ant-pm-1) and 10&#x2009;&#xB5;M ROCK inhibitor (STEMCELL Technologies, Y-27632). Cells were then cultured in standard E14 medium with 1&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup> of puromycin. Genomic DNA was extracted by lysing cells with lysis buffer (100&#x2009;mM Tris-HCl pH&#x2009;8.0, 5&#x2009;mM EDTA, 0.2% SDS, 50&#x2009;mM NaCl, proteinase K and RNase) and subsequent isopropanol precipitation. Individual cell lines were analysed by genotyping PCR to determine heterozygous insertion of the piggyBac donor vector. Cell lines showing the corrected genotyping pattern were selected and expanded. A list of the primers used for genotyping is provided in&#xA0;<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>.</p>
      </sec>
      <sec id="Sec14">
        <title>Puromycin resistance cassette removal</title>
        <p id="Par21">Cells (1&#x2009;&#xD7;&#x2009;10<sup>6</sup>) were transfected with 2&#x2009;&#xB5;g of a pCAG-FlpO-P2A-HygroR plasmid encoding for the flippase (Flp) recombinase using Lipofectamine 3000 (Thermo Fisher Scientific, L3000008) according to the manufacturer&#x2019;s instructions. Transfected cells were cultured in standard E14 medium for 7&#x2009;days. Single cells were then isolated using FACS on 96-well plates. Genomic DNA was extracted by lysing cells with lysis buffer (100&#x2009;mM Tris-HCl pH&#x2009;8.0, 5&#x2009;mM EDTA, 0.2% SDS, 50&#x2009;mM NaCl, proteinase K and RNase) and subsequent isopropanol precipitation. Individual cell lines were analysed by genotyping PCR to verify the deletion of the puromycin resistance cassette. A list of the primers used for genotyping is provided in&#xA0;<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>. Cell lines showing the correct genotyping pattern were selected and expanded. Selected cell lines were processed for targeted Nanopore sequencing with Cas9-guided adapter ligation (nCATS)<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> and only the ones showing unique integration of the piggyBac donor vector were used as founder lines for the enhancer mobilization experiments.</p>
      </sec>
      <sec id="Sec15">
        <title>Mobilization of the piggyBac-enhancer cassette</title>
        <p id="Par22">A mouse codon-optimized version of the piggyBac transposase (PBase) was cloned in frame with the red fluorescent protein tagRFPt (Evrogen) into a pBroad3 vector (pBroad3_hyPBase_IRES_tagRFPt) using Gibson assembly cloning (NEB, E2611). Cells (2&#x2009;&#xD7;&#x2009;10<sup>5</sup>) were transfected with 0.5&#x2009;&#xB5;g of pBroad3_hyPBase_IRES_tagRFPt using Lipofectamine 3000 (Thermo Fisher Scientific, L3000008) according to the manufacturer&#x2019;s instructions. To increase the probability of enhancer transposition, typically 12 independent PBase transfections were performed at the same time in 24-well plates. Transfection efficiency as well as expression levels of hyPBase_IRES_tagRFPt transposase within the cell population were monitored by flow cytometry analysis. Then, 7&#x2009;days after transfection with PBase, individual eGFP<sup>+</sup> cell lines were isolated using FACS in 96-well plates. Sorted cells were kept for 2&#x2009;days in standard E14 medium supplemented with 100&#x2009;&#x3BC;g&#x2009;ml<sup>&#x2212;1</sup> primocin (InvivoGen, ant-pm-1) and 10&#x2009;&#xB5;M ROCK inhibitor (STEMCELL Technologies, Y-27632). Cells were cultured in E14 standard medium for additional 7&#x2009;days and triplicated for genomic DNA extraction, flow cytometry analysis and freezing.</p>
      </sec>
      <sec id="Sec16">
        <title>Sample preparation for mapping piggyBac-enhancer insertion sites in individual cell lines</title>
        <p id="Par23">Mapping of enhancer insertion sites in individual cell lines was performed using splinkerette PCR. The protocol was performed as described previously<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> with a small number of modifications. Genomic DNA from individual eGFP<sup>+</sup> cell lines was extracted from 96-well plates using the Quick-DNA Universal 96 Kit (Zymo Research, D4071) according to the manufacturer&#x2019;s instructions. Purified genomic DNA was digested by 0.5&#x2009;&#xB5;l of Bsp143I restriction enzyme (Thermo Fisher Scientific, FD0784) for 15&#x2009;min at 37&#x2009;&#xB0;C followed by a heat-inactivation step at 65&#x2009;&#xB0;C for 20&#x2009;min. Long (HMSpAa) and short (HMSpBb) splinkerette adapters were first resuspended with 5&#xD7; NEBuffer 2 (NEB, B7002) to reach a concentration of 50&#x2009;&#xB5;M. Then, 50&#x2009;&#xB5;l of HMSpA adapter was mixed with 50&#x2009;&#xB5;l of HMSpBb adapter (Aa+Bb) to reach a concentration of 25&#x2009;&#xB5;M. The adapter mix was denatured and annealed by heating it to 95&#x2009;&#xB0;C for 5&#x2009;min and then cooling to room temperature. Then, 25&#x2009;pmol of annealed splinkerette adapters was ligated to the digested genomic DNA using 5&#x2009;U of T4 DNA ligase (Thermo Fisher Scientific, EL0011) and incubating the samples for 1&#x2009;h at 22&#x2009;&#xB0;C followed by a heat-inactivation step at 65&#x2009;&#xB0;C for 10&#x2009;min. For splinkerette amplifications, PCR 1 was performed combining 2&#x2009;&#xB5;l of the splinkerette sample, 1&#x2009;U of Platinum Taq polymerase (Thermo Fisher Scientific, 10966034), 0.1&#x2009;&#xB5;M of HMSp1 and 0.1&#x2009;&#xB5;M of PB5-1 (or PB3-1) primer, and splinkerette PCR 2 was performed using 2&#x2009;&#xB5;l of PCR&#xA0;1, 1&#x2009;U of Platinum Taq polymerase (Thermo Fisher Scientific, 10966034), 0.1&#x2009;&#xB5;M of HMSp2 and 0.1&#x2009;&#xB5;M of PB5-5 (or PB3-2) primer. The quality of PCR amplification was checked by agarose gel electrophoresis. Samples were sent for Sanger Sequencing (Microsynth AG) using the PB5-2 (or PB3-2) primer. A list of the primers used for splinkerette PCRs and sequencing is provided in&#xA0;<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>. Mapping of enhancer insertion sites in individual cell lines was performed as described in the &#x2018;Mapping of piggyBac-enhancer insertion sites in individual cell lines&#x2019; section.</p>
      </sec>
      <sec id="Sec17">
        <title>Flow cytometry eGFP fluorescence intensity measurements and analysis</title>
        <p id="Par24">eGFP<sup>+</sup> cell lines were cultured in serum&#x2009;+&#x2009;2i medium for 2 weeks before flow cytometry measurements. eGFP levels of individual cell lines were measured on the BD LSRII SORP flow cytometer using BD High Throughput Sampler (HTS), which enabled sample acquisition in 96-well plate format. Measurements were repeated three times for each clone. Mean eGFP fluorescence intensities were calculated for each clone using FlowJo and all three replicates were averaged.</p>
      </sec>
      <sec id="Sec18">
        <title>Normalization of mean eGFP fluorescence intensities</title>
        <p id="Par25">Mean eGFP fluorescence levels of each cell line measured in flow cytometry were first corrected by subtracting the mean eGFP fluorescence intensities measured in wild-type E14 mES cells cultured in the same 96-well plate. The resulting mean intensities were then normalized by dividing them by the average mean intensities of all cell lines where the SCR was located within a 40&#x2009;kb window centred at the promoter location, and multiplied by a common factor.</p>
      </sec>
      <sec id="Sec19">
        <title>Sample preparation for high-throughput sequencing of piggyBac-enhancer insertion sites</title>
        <p id="Par26">Cells (5&#x2009;&#xD7;&#x2009;10<sup>5</sup>) were transfected with 2&#x2009;&#xB5;g of PBase using Lipofectamine 3000 (Thermo Fisher Scientific, L3000008) according to the manufacturer&#x2019;s instructions. Transfection efficiency as well as expression levels of PBase within the cell population were monitored by flow cytometry analysis. Then, 5&#x2009;days after transfection with PBase, genomic DNA was purified using the DNeasy Blood &amp; Tissue Kit (Qiagen, 69504). To reduce the contribution from cells in which excision of piggyBac-enhancer did not occur, we depleted eGFP sequences using an in vitro Cas9 digestion strategy. gRNA sequences for eGFP depletion were designed using the online tool (<ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE">https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE</ext-link>) (<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>). Custom-designed Alt-R CRISPR-Cas9 crRNAs containing the gRNA sequences targeting eGFP (gRNA_1_3PRIME and gRNA_2_3PRIME), Alt-R CRISPR-Cas9 tracrRNA (IDT, 1072532) and Alt-R <italic>Streptococcus pyogenes</italic> Cas9 enzyme (IDT, 1081060) were purchased from IDT. In vitro cleavage of the eGFP fragment by Cas9 was performed according to the IDT protocol &#x2018;In vitro cleavage of target DNA with ribonucleoprotein complex&#x2019;. In brief, 100&#x2009;&#x3BC;M of Alt-R CRISPR&#x2013;Cas9 crRNA and 100&#x2009;&#x3BC;M of Alt-R CRISPR&#x2013;Cas9 tracrRNA were assembled by heating the duplex at 95&#x2009;&#xB0;C for 5&#x2009;min and allowing to cool to room temperature (15&#x2013;25&#x2009;&#xB0;C). To assemble the RNP complex, 10&#x2009;&#x3BC;M of Alt-R guide RNA (crRNA:tracrRNA) and 10&#x2009;&#x3BC;M of Alt-R <italic>Sp</italic>Cas9 enzyme were incubated at room temperature for 45&#x2009;min. To perform in vitro digestion of eGFP, 300&#x2009;ng of genomic DNA extracted from the pool cells transfected with the PBase was incubated for 2&#x2009;h with 1&#x2009;&#x3BC;M Cas9/RNP. After the digestion, 40&#x2009;&#xB5;g of proteinase K was added and the digested sample was further incubated at 56&#x2009;&#xB0;C for 10&#x2009;min to release the DNA substrate from the Cas9 endonuclease. After purification using AMPURE beads XP (Beckman Coulter, A63881), genomic DNA was digested by 0.5&#x2009;&#xB5;l of Bsp143I restriction enzyme (Thermo Fisher Scientific, FD0784) for 15&#x2009;min at 37&#x2009;&#xB0;C followed by a heat-inactivation step at 65&#x2009;&#xB0;C for 20&#x2009;min. Annealed splinkerette adapters (Aa+Bb; 125&#x2009;pmol) were then ligated to the digested genomic DNA using 30&#x2009;U of T4 DNA ligase HC (Thermo Fisher Scientific, EL0013), and the samples were incubated for 1&#x2009;h at 22&#x2009;&#xB0;C followed by a heat-inactivation step at 65&#x2009;&#xB0;C for 10&#x2009;min. For splinkerette amplifications, 96 independent PCR 1 reactions were performed combining 100&#x2009;ng of the splinkerette sample, 1&#x2009;U of Platinum Taq polymerase (Thermo Fisher Scientific, 10966034), 0.1&#x2009;&#xB5;M of HMSp1 and 0.1&#x2009;&#xB5;M of PB3-1 primer, and splinkerette PCR 2 was performed using 4&#x2009;&#xB5;l of PCR 1 product, 1&#x2009;U of Platinum Taq polymerase (Thermo Fisher Scientific, 10966034), 0.1&#x2009;&#xB5;M of HMSp2 and 0.1&#x2009;&#xB5;M of PB3-2 primer. A list of the primers used for splinkerette PCRs is provided in&#xA0;<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>. Splinkerette amplicon products were processed using the NEB Ultra II kit according to the manufacturer&#x2019;s protocol, using 50&#x2009;ng of input material. Mapping of genome-wide insertions was performed as described in the &#x2018;Mapping of piggyBac-enhancer insertion sites in population-based splinkerette PCR&#x2019; section.</p>
      </sec>
      <sec id="Sec20">
        <title>Sample preparation for tagmentation-based mapping of PiggyBac insertions</title>
        <p id="Par27">PiggyBac integrations in pools of cells were mapped using a Tn5-transposon-based ITR mapping technique based on ref. <sup><xref ref-type="bibr" rid="CR53">53</xref></sup> with minor alterations. Cells (2&#x2009;&#xD7;&#x2009;10<sup>5</sup>) were transfected with 0.5&#x2009;&#xB5;g of PBase using Lipofectamine 3000 (Thermo Fisher Scientific, L3000008) according to the manufacturer&#x2019;s instructions in 24-well plates. Eight independent transfections were performed in parallel. Transfection efficiency as well as expression levels of PBase within the cell population were monitored by flow cytometry analysis. Then, 7&#x2009;days after transfection with PBase, 6 cell pools of 10,000 cells from low GFP values (gates low 1 and low 2) and 6 cell pools of 337 cells of high GFP values (gate high) were sorted in a 24-well plate. Sorted cells were kept for 2&#x2009;days in standard E14 medium supplemented with 100&#x2009;&#x3BC;g&#x2009;ml<sup>&#x2212;1</sup> primocin (InvivoGen, ant-pm-1) and 10&#x2009;&#xB5;M ROCK inhibitor (StemCell Technologies, Y-27632). Cells were cultured in E14 standard medium for either 1 passage (pools from gates low 1 and low 2) or 2 passages (pools from gate high) and genomic DNA from individual pools was extracted using the Quick-DNA Miniprep Plus Kit (Zymo Research, D4069) according to the manufacturer&#x2019;s instructions. The Tn5 transposon was produced as described in ref. <sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. The tagmentation reaction was performed as follows. The primers TAC0101 &amp; TAC0102 (45&#x2009;&#x3BC;l of 100&#x2009;&#x3BC;M) each were mixed with 10&#x2009;&#x3BC;l 10&#xD7; Tris-EDTA (pH&#x2009;8) and annealed by heating to 95&#x2009;&#xB0;C followed by a slow ramp down (0.1&#x2009;&#xB0;C&#x2009;s<sup>&#x2212;1</sup>) until 4&#x2009;&#xB0;C. The transposome is obtained by combining the adapters (1&#x2009;&#x3BC;l of 1:2 diluted adapters) and the Tn5 transposon (1.5&#x2009;&#x3BC;l of 2.7&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> stock) in 18.7&#x2009;&#x3BC;l Tn5 dilution buffer (20&#x2009;mM HEPES, 500&#x2009;mM NaCl, 25% glycerol) and incubating the mix for 1&#x2009;h at 37&#x2009;&#xB0;C. The tagmentation was performed by mixing 100&#x2009;ng of genomic DNA with 1&#x2009;&#xB5;l of assembled transposome, 4&#x2009;&#xB5;l 5&#xD7; TAPS-PEG buffer (50&#x2009;mM TAPS-NAOH, 25&#x2009;mM MgCl<sub>2</sub>, 8% (v/v) PEG8000) in a final volume of 20&#x2009;&#xB5;l. The reaction was incubated at 55&#x2009;&#xB0;C for 10&#x2009;min and quenched with 0.2% SDS afterwards. For the best mapping results, both sides of the PiggyBac transposon were processed to obtain 5&#x2032; ITR- and 3&#x2032; ITR-specific libraries. First, we enriched our target region by linear amplification PCR with 3&#x2032; ITR-specific (TAC0006) and 5&#x2032; ITR-specific (TAC0099) primers. The PCR mix was 3&#x2009;&#xB5;l of tagmented DNA, 1&#x2009;&#xB5;l of 1&#x2009;&#x3BC;M enrichment primer, 2&#x2009;&#xB5;l dNTPs (10&#x2009;mM), 4&#x2009;&#xB5;l 5&#xD7; Phusion HF Buffer (NEB), 0.25&#x2009;&#x3BC;l Phusion HS Flex polymerase (2&#x2009;U&#x2009;&#xB5;l<sup>&#x2212;1</sup>, NEB), in a final volume of 20&#x2009;&#xB5;l and amplified as follows: 30&#x2009;s at 98&#x2009;&#xB0;C; 45 cycles of 10&#x2009;s at 98&#x2009;&#xB0;C, 20&#x2009;s at 62&#x2009;&#xB0;C and 30&#x2009;s at 72&#x2009;&#xB0;C; then 20&#x2009;s at 72&#x2009;&#xB0;C. PCR 1 of the library preparation was performed using TAC0161 (3&#x2032; ITR) and TAC0110 (5&#x2032; ITR) in combination with N5xx (Illumina, Nextera Index Kit). The PCR mix was 5&#x2009;&#xB5;l of enrichment PCR, 1&#x2009;&#xB5;l of 10&#x2009;&#x3BC;M primers, 2&#x2009;&#xB5;l dNTPs (10&#x2009;mM), 4&#x2009;&#xB5;l 5&#xD7; Phusion HF Buffer and 0.25&#x2009;&#xB5;l Phusion HS Flex polymerase (NEB), in a final volume of 25&#x2009;&#xB5;l and amplified as follows: 30&#x2009;s at 98&#x2009;&#xB0;C; 3 cycles of 10&#x2009;s at 98&#x2009;&#xB0;C, 20&#x2009;s at 62&#x2009;&#xB0;C and 30&#x2009;s at 72&#x2009;&#xB0;C; and 8 cycles of 10&#x2009;s at 98&#x2009;&#xB0;C, 50&#x2009;s at 72&#x2009;&#xB0;C. In PCR 2 the N7xx (Illumina, Nextera Index Kit) adapters were added to the PiggyBac specific locations asfollows. PCR was performed with TAC0103 (both ITRs) and N7xx. The PCR mix was 2&#x2009;&#xB5;l of PCR1, 1&#x2009;&#xB5;l of 10&#x2009;&#x3BC;M primers, 2&#x2009;&#xB5;l dNTPs (10&#x2009;mM), 4&#x2009;&#xB5;l 5&#xD7; Phusion HF Buffer and 0.25&#x2009;&#xB5;l Phusion polymerase (Thermo Fisher Scientific), in a final volume of 22&#x2009;&#xB5;l and amplified as follows: 30&#x2009;s at 98&#x2009;&#xB0;C; 10 cycles of 10&#x2009;s at 98&#x2009;&#xB0;C, 20&#x2009;s at 63&#x2009;&#xB0;C and 30&#x2009;s at 72&#x2009;&#xB0;C. Then, 5&#x2009;&#xB5;l of library was checked on a 1% agarose gel and different samples were pooled according to smear intensity. Finally, the library was purified by bead purification using CleanPCR (CleanNA) beads at a ratio 1:0.8 sample:beads. The final library was sequenced using the Illumina MiSeq (150&#x2009;bp, paired-end) system. Mapping of genome-wide insertions was performed as described in the &#x2018;Mapping of piggyBac-enhancer insertion sites by tagmentation&#x2019; section.</p>
      </sec>
      <sec id="Sec21">
        <title>Deletion of genomic regions containing CTCF-binding sites</title>
        <p id="Par28">gRNA sequences for depletion of the genomic regions containing the CTCF-binding sites were designed using the online tool (<ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE">https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE</ext-link>) and purchased from Microsynth AG (<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>). gRNA sequences were cloned into the PX459 plasmid (Addgene) using the BsaI restriction site. To remove the first forward CTCF-binding site (chromosome 15: 11520474&#x2013;11520491), 3&#x2009;&#xD7;&#x2009;10<sup>5</sup> cells were transfected with 0.5&#x2009;&#xB5;g of PX459 CTCF_KO_gRNA3/Cas9 and 1&#x2009;&#xB5;g of PX459 CTCF_KO_gRNA10/Cas9 plasmids using Lipofectamine 2000 (Thermo Fisher Scientific, 11668019) according to the manufacturer&#x2019;s instructions. To remove the second forward CTCF-binding sites (chromosome 15: 11683162&#x2013;11683179), 1&#x2009;&#xD7;&#x2009;10<sup>6</sup> cells were transfected with 1&#x2009;&#xB5;g of PX459 gRNA2_CTCF_KO/Cas9 and 1&#x2009;&#xB5;g of PX459 gRNA6_CTCF_KO/Cas9 plasmids using Lipofectamine 2000 (Thermo Fisher Scientific, 11668019) according to the manufacturer&#x2019;s instructions. Then, 24&#x2009;h after transfection, 1&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup> of puromycin was added to the medium for 3&#x2009;days. Cells were then cultured in standard E14 medium for an additional 4&#x2009;days. To select cell lines with homozygous deletion, single cells were isolated by FACS on 96-well plate. Sorted cells were kept for 2&#x2009;days in E14 standard medium supplemented with 100&#x2009;&#x3BC;g&#x2009;ml<sup>&#x2212;1</sup> primocin (InvivoGen, ant-pm-1) and 10&#x2009;&#xB5;M ROCK inhibitor (STEMCELL Technologies, Y-27632). Cells were then cultured in standard E14 medium. Genomic DNA was extracted by lysing cells with lysis buffer (100&#x2009;mM Tris-HCl pH&#x2009;8.0, 5&#x2009;mM EDTA, 0.2% SDS, 50&#x2009;mM NaCl, proteinase K and RNase) and subsequent isopropanol precipitation. Individual cell lines were analysed by genotyping PCR to determine homozygous deletion of the genomic regions containing the CTCF-binding sites. Cell lines showing the corrected genotyping pattern were selected and expanded. A list of the primers used for genotyping is provided in&#xA0;<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>.</p>
      </sec>
      <sec id="Sec22">
        <title>smRNA-FISH</title>
        <p id="Par29">Cells were collected with accutase (Sigma-Aldrich, A6964) and adsorbed on poly-<sc>l</sc>-lysine (Sigma-Aldrich, P8920) precoated coverslips. Cells were then fixed with 3% PFA (EMS, 15710) in PBS for 10&#x2009;min at room temperature, washed with PBS and kept in 70% ethanol at &#x2212;20&#x2009;&#xB0;C. After at least 24&#x2009;h incubation in 70% ethanol, the coverslips were incubated for 10&#x2009;min with freshly prepared wash buffer composed of 10% formamide (Millipore Sigma, S4117) in 2&#xD7; SSC (Sigma-Aldrich, S6639). The coverslips were hybridized overnight (around 16&#x2009;h) at 37&#x2009;&#xB0;C in freshly prepared hybridization buffer composed of 10% formamide, 10% dextran sulfate (Sigma-Aldrich, D6001) in 2&#xD7; SSC and containing 125&#x2009;nM of RNA-FISH probe sets against <italic>Sox2</italic> labelled with Quasar 670 (Stellaris) and against eGFP labelled with Quasar 570 (Stellaris). After hybridization, the coverslips were washed twice with wash buffer prewarmed to 37&#x2009;&#xB0;C for 30&#x2009;min at 37&#x2009;&#xB0;C with shaking, followed by 5&#x2009;min incubation with 500&#x2009;ng&#x2009;ml<sup>&#x2212;1</sup> DAPI solution (Sigma-Aldrich, D9564) in PBS (Sigma-Aldrich, D8537). The coverslips were then washed twice in PBS and mounted on slides with Prolong Gold medium (Invitrogen, P36934) and cured at room temperature for 24&#x2009;h. The coverslips were then sealed and imaged within 24&#x2009;h.</p>
      </sec>
      <sec id="Sec23">
        <title>RNA-FISH image acquisition</title>
        <p id="Par30">Images were acquired on a Zeiss Axion Observer Z1 microscope equipped with 100&#x2009;mW 561&#x2009;nm and 100&#x2009;mW 642&#x2009;nm HR diode solid-state lasers, an Andor iXion 885 EMCCD camera, and an &#x3B1; Plan-Fluar &#xD7;100/1.45&#x2009;NA oil-immersion objective. Quasar 570 signal was collected with the DsRed ET filter set (AHF Analysentechnik, F46-005), Quasar 670 with Cy5 HC mFISH filter set (AHF Analysentechnik, F36-760) and DAPI with the Sp. Aqua HC-mFISH filter set (AHF Analysentechnik, F36-710). The typical exposure time for RNA-FISH probes was set to around 300&#x2013;500&#x2009;ms with 15&#x2013;20 EM gain and 100% laser intensity. DAPI signal was typically imaged with an exposure time of 20&#x2009;ms with EM gain 3 and 50% laser intensity. The pixel size of the images was 0.080&#x2009;&#xD7;&#x2009;0.080&#x2009;&#xB5;m with a <italic>z</italic>-step of 0.25&#x2009;&#xB5;m for around 55&#x2013;70 <italic>z</italic>-planes.</p>
      </sec>
      <sec id="Sec24">
        <title>Image processing and quantification of mRNA numbers</title>
        <p id="Par31">Raw images were processed in KNIME, python and Fiji to extract the numbers of RNAs per cell. The KNIME workflow described below is based on a previously published workflow<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. <italic>z</italic>-stacks were first projected to a maximal projection for each fluorescence channel. Individual cells were then segmented using the DAPI channel using Gaussian convolution (&#x3C3;&#x2009;=&#x2009;3), followed by filtering using global threshold with Otsu filter, watershed and connected component analysis for nuclei segmentation. Cytoplasmic areas were then estimated with seeded watershed. Cells with nuclei partially outside the frame of view were automatically excluded. Cells containing obvious artifacts, wrongly segmented or not fully captured in <italic>xyz</italic> dimensions were manually excluded from the final analysis. Spot detection is based on the Laplacian of Gaussian method implemented in TrackMate<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. For the channels containing RNA-FISH probes signal, RNAs spots were detected after background subtraction (rolling ball radius 20&#x2013;25&#x2009;pixels) by selecting spot size 0.2&#x2009;&#x3BC;m and threshold for spot detection based on visual inspection of multiple representative images. Spot detection is based on the Laplacian of Gaussian method from TrackMate. Subpixel localization of RNA spots was detected for RNA channels and a list of spots per cell for each experimental condition and replicate was generated. Spots in each channel were then aggregated by cell in python to extract the number of RNAs per cell.</p>
      </sec>
      <sec id="Sec25">
        <title>Enhancer reporter assays</title>
        <p id="Par32">To generate vectors for the enhancer reporter assay, the <italic>Sox2</italic> promoter, SCR and the truncated versions of the SCR (Ei and Eii) were amplified from E14 mES cell genomic DNA with Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific, F549) using primers compatible with Gibson assembly strategy. The <italic>Sox2</italic> promoter was cloned into the 3-SB-EF1-PBBAR-SB vector as described above. The SCR and the truncated versions Ei and Eii were cloned in front of the <italic>Sox2</italic> promoter by linearizing the vector with AgeI (NEB, R3552) and subsequently using Gibson assembly cloning. A transcriptional pause sequence from the human &#x3B1;2-globin gene and an SV40 poly(A) sequence was inserted at both the 5&#x2032; and 3&#x2032; ends of the enhancers. To test enhancers activity, 3&#x2009;&#xD7;&#x2009;10<sup>5</sup> cells were co-transfected with 0.5&#x2009;&#xB5;g of the different versions piggyBac vectors and 0.5&#x2009;&#xB5;g of pBroad3_hyPBase_IRES_tagRFPt using Lipofectamine 2000 (Thermo Fisher Scientific, 11668019) according to the manufacturer&#x2019;s instructions. As a control, only 0.5&#x2009;&#xB5;g of the&#xA0;piggyBac vector carrying the Sox2 promoter was transfected. 24&#x2009;h after transfection, cells were collected and analysed by flow cytometry.</p>
      </sec>
      <sec id="Sec26">
        <title>Capture-C sample preparation</title>
        <p id="Par33">Cells (20&#x2009;&#xD7;&#x2009;10<sup>6</sup>) were cross-linked with 1% formaldehyde (EMS, 15710) for 10&#x2009;min at room temperature and quenched with glycine (final concentration, 0.125&#x2009;M). Cells were lysed in 1&#x2009;M Tris-HCl pH&#x2009;8.0, 5&#x2009;M NaCl and 10% NP40 and complete protease inhibitor (Sigma-Aldrich, 11836170001) and enzymatically digested using 1,000&#x2009;U of MboI (NEB, R0147). Digested chromatin was then ligated at 16&#x2009;&#xB0;C with 10,000&#x2009;U of T4 DNA ligase (NEB, M0202) in ligase buffer supplemented with 10% Triton X-100 (Sigma-Aldrich, T8787) and 240&#x2009;&#xB5;g of BSA (NEB, B9000). Ligated samples were de-cross-linked with 400&#x2009;&#x3BC;g proteinase&#x2009;K (Macherey Nagel, 740506) at 65&#x2009;&#xB0;C and phenol&#x2013;chloroform purified. 3C library preparation and target enrichment using a custom-designed collection of 6,979 biotinylated RNA &#x2018;baits&#x2019; targeting single MboI restriction fragments chromosome 15: 10283500&#x2013;13195800 (mm9) (<xref rid="MOESM5" ref-type="media">Supplementary Table 2</xref>; Agilent Technologies; designed as in ref. <sup><xref ref-type="bibr" rid="CR57">57</xref></sup>) were performed according to the SureSelectXT Target Enrichment System for Illumina Paired-End Multiplexed Sequencing Library protocol. The only exceptions were the use of 9&#x2009;&#xB5;g of 3C input material (instead of 3&#x2009;&#xB5;g) and shearing of DNA using Covaris sonication with the following settings: duty factor: 10%; peak incident power: 175; cycles per burst: 200; treatment time: 480&#x2009;s; bath temperature: 4&#x2009;&#xB0;C to 8&#x2009;&#xB0;C).</p>
      </sec>
      <sec id="Sec27">
        <title>Targeted nCATS analysis</title>
        <p id="Par34">gRNA sequences targeting specific genomic regions of chromosome 15 external to the homology arms of the transgene were designed using the online tool (<ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE">https://eu.idtdna.com/site/order/designtool/index/CRISPR_SEQUENCE</ext-link>) (<xref rid="MOESM3" ref-type="media">Supplementary Table 1</xref>). Custom-designed Alt-R CRISPR&#x2013;Cas9 crRNAs (5 crRNAs targeting the region upstream and 5 crRNAs targeting the region downstream the integrated transgene), Alt-R CRISPR&#x2013;Cas9 tracrRNA (IDT, 1072532) and Alt-R <italic>Sp</italic>Cas9 enzyme (IDT, 1081060) were purchased from IDT. Sample preparation and Cas9 enrichment were performed according to a previously described protocol<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> with a few modifications. Genomic DNA from mES cell founder lines was extracted using the Gentra Puregene Cell Kit (Qiagen, 158745) according to the manufacturer&#x2019;s instructions. The quality of the high molecular mass DNA was checked using the TapeStation (Agilent) system. Typically, 5&#x2009;&#xB5;g of high molecular mass DNA was processed for incubation using shrimp alkaline phosphatase (rSAP; NEB, M0371) for 30&#x2009;min at 37&#x2009;&#xB0;C followed by 5&#x2009;min at 65&#x2009;&#xB0;C to dephosphorylate DNA-free ends. For Cas9 enrichment of the target region, all ten Alt-R CRISPR-Cas9 crRNAs were first pooled at an equimolar amount (100&#x2009;&#xB5;M) and subsequently incubated with 100&#x2009;&#xB5;M of Alt-R CRISPR&#x2013;Cas9 tracrRNA at 95&#x2009;&#xB0;C for 5&#x2009;min to assemble the Alt-R guide RNA duplex (crRNA:tracrRNA). To assemble the RNP complex, 4&#x2009;pmol of Alt-R <italic>Sp</italic>Cas9 enzyme was incubated with 8&#x2009;pmol Alt-R guide RNA (crRNA:tracrRNA) at room temperature for 20&#x2009;min. In vitro digestion and A-tailing of the DNA were performed by adding 10&#x2009;&#xB5;l of the RNP complex, 10&#x2009;mM of dATP (NEB, N0440) and 5&#x2009;U of Taq Polymerase (NEB, M0267) and incubating the samples for 30&#x2009;min at 37&#x2009;&#xB0;C followed by 5&#x2009;min at 72&#x2009;&#xB0;C. Adapter ligation for Nanopore sequencing was performed using the Ligation Sequencing Kit (Nanopore, SQK-CAS109) according to the manufacturer&#x2019;s instructions. After purification with AMPure PB beads (Witec, 100-265-900), the samples were loaded into the MniION system, selecting the SQK-CAS109 protocol.</p>
      </sec>
      <sec id="Sec28">
        <title>Nanopore sequencing analysis</title>
        <p id="Par35">To map Nanopore sequencing reads, we first built a custom genome consisting of the transgene sequence flanked by ~10&#x2009;kb mouse genomic sequence upstream and downstream of the target integration site. The custom genome can be found at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhanyinx/Zuin_Roth_2021/blob/main/Nanopore/cassette/cassette.fa">https://github.com/zhanyinx/Zuin_Roth_2021/blob/main/Nanopore/cassette/cassette.fa</ext-link>). Reads were mapped to the custom genome using minimap2 (v.2.17-r941) with the &#x2018;-x map-ont&#x2019; parameter. Nanopore sequencing analysis has been implemented using Snakemake workflow (v.3.13.3). Reads were visualized using IGV (v.2.9.4). The full workflow can be found at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhanyinx/Zuin_Roth_2021">https://github.com/zhanyinx/Zuin_Roth_2021</ext-link>).</p>
      </sec>
      <sec id="Sec29">
        <title>RNA-sequencing sample preparation and analysis</title>
        <p id="Par36">Mouse embryonic stem cells were collected with accutase (5&#x2009;min, 37&#x2009;&#xB0;C) and counted. Cells (3&#x2009;&#xD7;&#x2009;10<sup>5</sup>) were lysed with 300&#x2009;&#xB5;l TRIzol reagent. RNA was extracted using the Direct-Zol RNA extraction kit from Zymo. Library preparation was performed after Illumina TruSeq Stranded mRNA-seq according to the manufacturer protocol. Reads were mapped to the <italic>Mus musculus</italic> genome (build mm9) using STAR<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, using the following options: --outSJfilterReads Unique --outFilterType BySJout --outFilterMultimapNmax 10 --alignSJoverhangMin 6 --alignSJDBoverhangMin 2 --outFilterMismatchNoverLmax 0.04 --alignIntronMin 20 --alignIntronMax 1000000 --outSAMstrandField intronMotif --outFilterIntronMotifs RemoveNoncanonicalUnannotated --outSAMtype BAM SortedByCoordinate --seedSearchStartLmax 50 --twopassMode basic. Gene expression was quantified using qCount from QuasR package<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> using the &#x2018;TxDb.Mmusculus.UCSC.mm9.knownGene&#x2019; database for gene annotation&#xA0;(Bioconductor package:&#xA0;Carlson M and Maintainer BP. TxDb.Mmusculus.UCSC.mm9.knownGene: Annotation package for TxDb object(s); R package v.3.2.2). Active promoters were defined as genes with log<sub>2</sub>[RPKM&#x2009;+&#x2009;0.1] higher than 1.5.</p>
      </sec>
      <sec id="Sec30">
        <title>Capture-C analysis</title>
        <p id="Par37">Capture-C data were analysed using HiC-Pro<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> (v.2.11.4); the parameters can be found at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhanyinx/Zuin_Roth_2021">https://github.com/zhanyinx/Zuin_Roth_2021</ext-link>). In brief, read pairs were mapped to the mouse genome (build mm9). Chimeric reads were recovered after recognition of the ligation site. Only unique valid pairs mapping to the target regions were used to build contact maps. Iterative correction<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> was then applied to the binned data. The target regions can be found at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhanyinx/Zuin_Roth_2021">https://github.com/zhanyinx/Zuin_Roth_2021</ext-link>). For SCR_&#x394;&#x394;CTCF, SCR_&#x394;CTCF and the derived clonal lines, data from replicate one were used to make the quantification and plots throughout the manuscript.</p>
      </sec>
      <sec id="Sec31">
        <title>Differential capture-C maps</title>
        <p id="Par38">To evaluate the structural perturbation induced by the insertion of the transgene and the mobilization of the enhancer (ectopic sequences), we accounted for differences in genomic distances due to the presence of the ectopic sequence. In the founder cell line (for example, SCR_&#x394;&#x394;CTCF), insertion of the transgene modifies the genomic distance between loci upstream and downstream the insertion site. To account for these differences, we generated distance-normalized capture-C maps in which each entry corresponds to the interaction normalized to the corrected genomic distance between the interacting bins. Outliers (defined using the interquartile rule) or bins with no reported interactions from capture-C were treated as noise and filtered out. Singletons, defined as the top 0.1 percentile of <italic>Z</italic>-score, were also filtered out. The <italic>Z</italic>-score is defined as (obs&#x2009;&#x2013;&#x2009;exp)/stdev, where obs is the capture-C signal for a given interaction and exp and stdev are the genome-wide average and standard deviation, respectively, of capture-C signals at the genomic distance separating the two loci. We next calculated the ratios between distance normalized and noise-filtered capture-C maps. A bilinear smoothing with a window of 2 bins was applied to the ratio maps to evaluate the structural perturbation induced by the insertion of the ectopic sequence.</p>
      </sec>
      <sec id="Sec32">
        <title>Chromatin state calling with ChromHMM</title>
        <p id="Par39">Chromatin states were called using ChromHMM<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> with four states. The list of histone modification datasets used is provided in <xref rid="MOESM6" ref-type="media">Supplementary Table 3</xref>. States with enrichment in H3K9me3 and H3K27me3 were merged, therefore resulting in three chromatin states: active (enriched in H3K27ac, H3K36me3, H3K4me1 and H3K9ac), repressive (enriched in H3K9me3 and H3K27me3) and neutral (no enrichment).</p>
      </sec>
      <sec id="Sec33">
        <title>Mapping of piggyBac-enhancer insertion sites in population-based splinkerette PCR</title>
        <p id="Par40">To identify true-positive enhancer re-insertion sites, we first filtered out reads containing eGFP fragments. We then retained only read pairs for which one side mapped to the ITR sequence and the other side mapped to the splinkerette adapter sequence. We mapped separately the ITR/splinkerette sides of the read pair to the mouse genome (build mm9) using BWA mem<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> with the default parameters. Only integration sites that had more than 20 reads from both ITR and splinkerette sides were retained.</p>
      </sec>
      <sec id="Sec34">
        <title>Mapping of piggyBac-enhancer insertion sites in individual cell lines</title>
        <p id="Par41">To map the enhancer position in individual cell lines, Sanger sequencing (Microsynth) without the adapter sequences were filtered out. The first 24&#x2009;bp of each read after the adapter was then mapped to the mouse genome (mm9) using vmatchPattern (Biostrings v.2.58.0). The script used to map Sanger sequencing can be found at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhanyinx/Zuin_Roth_2021">https://github.com/zhanyinx/Zuin_Roth_2021</ext-link>).</p>
      </sec>
      <sec id="Sec35">
        <title>Mapping of piggyBac-enhancer insertion sites by tagmentation</title>
        <p id="Par42">Before aligning paired-end sequencing reads, reads were filtered using an adaptation of cutadapt<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, processing each read pair in multiple steps. Sequence patterns originating from Tn5 and each ITR were removed. The paired-end reads coming from both ITRs were treated the same. First, the presence of the unique part of the 5&#x2032; ITR and 3&#x2032; ITR sequence was detected at the start of the second read of the pair and, if present, this sequence was trimmed. Next, the sequence up to and including the TTAA site that was found on both the 5&#x2032;ITR and 3&#x2032;ITR was trimmed off. This sequence only partly contained the respective primers used for each ITR, and was used to filter reads that contained the sequence expected for a correct PCR product starting at the transposon. The sequence up to, but not including, the TTAA was removed. Next, all of the other sequence patterns coming from either Tn5 or the ITR were removed from the 5&#x2032; end of the first read in the pair and the 3&#x2032; end of both reads.</p>
        <p id="Par43">After filtering and trimming the reads, the reads were aligned to a reference genome with an in silico insertion of the split-GFP construct, but with a single TTAA motif instead of the PiggyBac transposon. This was done by aligning the homology arms found in the plasmid against mm10 reference genome. The complete sequence on the reference matching both arms was replaced by the plasmid sequence inserted.</p>
        <p id="Par44">Alignment was performed using Bowtie2 with the fragment length set to a minimum of 0&#x2009;bp and maximum of 2,000&#x2009;bp and the very-sensitive option was used. After reads were aligned to the genome, sambamba<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> was used to remove duplicates and samtools<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> was used to filter out read pairs that were not properly paired. We then designated, for each read pair, the position of the first 4 nucleotides of the second read as a putative insertion site. To calculate the fraction of reads originating from the non-mobilized position, the number of read pairs that overlapped the non-mobilized position (the TTAA replacing the PiggyBac of the in silico insert) was divided over the total number of reads originating from putative insertion sites supported by at least one read pair with a mapping quality higher than 2. Confident insertions were identified as those with at least one read for both 5&#x2032; and 3&#x2032; ITR.</p>
      </sec>
      <sec id="Sec36">
        <title>Calibration of the mean number of mRNAs per cell with smRNA-FISH</title>
        <p id="Par45">A linear model was used to predict the average number of eGFP mRNAs on the basis of the mean eGFP intensity. The model was fitted on 7 data points corresponding to the average number of eGFP mRNAs obtained using single-molecule RNA fluorescence in situ and the mean eGFP intensity obtained by flow cytometry (Extended Data Fig. <xref rid="Fig6" ref-type="fig">1h</xref>; <italic>R</italic><sup>2</sup>&#x2009;=&#x2009;0.9749, <italic>P</italic>&#x2009;&lt;&#x2009;0.0001, <italic>t</italic>-test).</p>
      </sec>
      <sec id="Sec37">
        <title>Mathematical model and parameter fitting</title>
        <p id="Par46">The phenomenological two-state model (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) and the apparent two-state model deduced from the mechanistic enhancer&#x2013;promoter model (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) were both fitted simultaneously to the mean eGFP levels measured in individual cell lines and to the distributions of RNA numbers measured by smRNA-FISH in six cell lines where the SCR was located at different distances from the promoter. The mean number of mRNAs was calculated analytically and the steady-state distribution of the number of mRNA per cell was approximated numerically (<xref rid="MOESM1" ref-type="media">Supplementary Information</xref>, model description). The parameters for the phenomenological two-state model are the minimum on rate <inline-formula id="IEq23"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{0}$$\end{document}</tex-math><mml:math id="M34"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq23.gif"/></alternatives></inline-formula>, the minimum on rate <inline-formula id="IEq24"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{1}$$\end{document}</tex-math><mml:math id="M36"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq24.gif"/></alternatives></inline-formula>, the off rate <italic>k</italic><sub>off</sub>, the initiation rate <italic>&#xB5;</italic> and the constant <italic>c</italic> and Hill exponent <italic>h</italic>,&#xA0;which together control the nonlinear dependency of <italic>k</italic><sub>on</sub> on contact probability. The parameters for the apparent two-state model are the basal on rate <inline-formula id="IEq25"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{basal}}$$\end{document}</tex-math><mml:math id="M38"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>basal</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq25.gif"/></alternatives></inline-formula>, the enhanced on rate <inline-formula id="IEq26"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M40"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq26.gif"/></alternatives></inline-formula>, the off rate <italic>k</italic><sub>off</sub>, the initiation rate <italic>&#xB5;</italic>, the ratio between the forward and backward rates of the regulatory steps <italic>&#x3B2;</italic> and the number of regulatory steps <italic>n</italic>. All of these parameters were considered to be free in the fitting procedure. The apparent two-state model was also fitted to the binned mean number of mRNA molecules inferred from the eGFP<sup>+</sup> cell lines with the truncated version of the SCR (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). In this case, three versions of the apparent two-state model were fitted to the data using log-transformed likelihood ratios. The parameter <italic>&#x3B2;</italic> (version 1) or <inline-formula id="IEq27"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${k}_{{\rm{on}}}^{\mathrm{enh}}$$\end{document}</tex-math><mml:math id="M42"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">on</mml:mi></mml:mrow><mml:mrow><mml:mi>enh</mml:mi></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq27.gif"/></alternatives></inline-formula> (model 2) or both (model 3) were considered to be free parameters, whereas the other parameters were fixed to the best fit values obtained for the full-length SCR dataset. Using log-transformed likelihood ratios, the fit of the three versions was compared to the fit of the model for which all of the parameters were considered to be free. The mathematical description of the enhancer&#x2013;promoter communication model, the derivation of the apparent two-state model, and the fitting procedures are explained in detail in the&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Information</xref> (model description).</p>
      </sec>
      <sec id="Sec38">
        <title>Reporting summary</title>
        <p id="Par47">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this paper.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par48">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-04570-y.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_4570_MOESM1_ESM.pdf"><label>Supplementary Information</label><caption><p>Model description and gating strategy.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_4570_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_4570_MOESM3_ESM.xlsx"><label>Supplementary Table 1</label><caption><p>Lists of primers used in the study.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_4570_MOESM4_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41586_2022_4570_MOESM5_ESM.xlsx"><label>Supplementary Table 2</label><caption><p>List of oligonucleotides used in capture-C experiments.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41586_2022_4570_MOESM6_ESM.xlsx"><label>Supplementary Table 3</label><caption><p>List of datasets used to call chromatin states using ChromHMM.</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec8">
          <title>Extended data figures and tables</title>
          <p id="Par51">
<fig id="Fig6"><label>Extended Data Fig. 1</label><caption><title>Enhancer action is modulated by genomic distance from the target promoter and constrained by TAD boundaries.</title><p>a. Top: capture-C contact map at 6.4&#x2009;kb resolution in wild-type (WT) mES&#xA0;cells in a 2.6&#x2009;Mb region centred around the neutral TAD on chromosome 15 we used for the experiments. Vertical grey lines: TAD boundaries. Bottom: genomic datasets and ChromHMM analysis showing that the chosen TAD is devoid of active and repressive chromatin states, with the exception of 80&#x2009;kb at the 3b at t which is enriched in repressive chromatin states. b. Close-up view of panel <bold>a</bold>, highlighting the presence of CTCF-mediated chromatin loops (dotted boxes) in WT mES&#xA0;cells. c. capture-C contact map at 6.4&#x2009;kb resolution for the same region as panel b in the cell line with double CTCF site deletions. CTCF deletions lead to loss of CTCF-mediated chromatin loops (dotted boxes). d. Top: UCSC snapshot of the endogenous <italic>Sox2</italic> locus and <italic>Sox2</italic> control region (SCR). Bottom: close-up views showing the regions of the <italic>Sox2</italic> promoter, the SCR region found in ref. <sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and the SCR used in the transgene construct. e. IGV snapshot showing nanopore sequencing reads mapped to a modified mouse genome including the transgene integration. Reads spanning from genomic DNA upstream the left homology arm to genomic DNA downstream the right homology arm confirmed single insertion of the transgene. f. capture-C maps at 6.4&#x2009;kb resolution of the mES&#xA0;cell line with double CTCF sites deletion (left) and the founder mES&#xA0;cell line with transgene insertion (centre). Right: differential contact map. Grey pixels correspond to &#x2018;noisy&#x2019; interactions that did not satisfy our quality control filters (see Methods). Transgene insertion induces new mild interactions with CTCF sites at the 3. and 5a extremities of the TAD (arrows). g. Barplot showing the fraction of piggyBac-SCR reinsertions genome-wide determined by Illumina sequencing of splinkerette PCR products from a pool of cells after PBase expression. See Methods for a detailed description of the protocol. h. Top: Representative smRNA-FISH image and flow cytometry profiles over different passages in a cell line where the SCR was mobilized in the immediate vicinity of the ectopic <italic>Sox2</italic> promoter. Scale bar, 10 <inline-formula id="IEq2"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mu m.$$\end{document}</tex-math><mml:math id="M44"><mml:mi>&#x3BC;</mml:mi><mml:mi>m</mml:mi><mml:mo>.</mml:mo></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq2.gif"/></alternatives></inline-formula> Bottom: Linear relationship between the mean eGFP intensity and the average number of eGFP mRNAs measured using smRNA-FISH for seven single cell lines (<inline-formula id="IEq3"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}=0.9749$$\end{document}</tex-math><mml:math id="M46"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>0.9749</mml:mn></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq3.gif"/></alternatives></inline-formula>, <inline-formula id="IEq4"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p &lt; 0.0001,$$\end{document}</tex-math><mml:math id="M48"><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.0001</mml:mn><mml:mo>,</mml:mo></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq4.gif"/></alternatives></inline-formula> t-test). Error bars on the x-axis: standard deviation of three measurements performed on different days, as in Fig. <xref rid="Fig1" ref-type="fig">1h</xref>. Error bars on the y-axis: standard deviation of three technical replicates. i. Normalized mean eGFP intensities levels in individual eGFP+ cell lines are plotted as a function of the genomic position of the SCR in individual eGFP+ lines. Data from 127 individual cell lines (light red dots) from a single experiment are presented as mean +\- standard deviation (n=3 measurements performed in different days, as in Fig. <xref rid="Fig1" ref-type="fig">1g</xref>). Average eGFP values calculated within equally spaced 20&#x2009;kb bins (black dots) are shown. Mean mRNA numbers per cell were inferred from eGFP counts using calibration with smRNA-FISH, see Extended Data Fig. 1h. Shaded light blue area indicates the interval between mean +/- standard deviation of eGFP levels in three promoter-only cell lines. j. Same plot as Fig. <xref rid="Fig1" ref-type="fig">1h</xref> showing the only two SCR insertions we detected outside the TAD boundaries (brown dot) and on another chromosome (yellow dot). k. Left: Log10 average eGFP expression (from Fig. <xref rid="Fig1" ref-type="fig">1h</xref>) as a function of log10 absolute genomic distance between transgene position and SCR reinsertion. Points are colour-coded as in panel A (chromHMM active, neutral, and repressive states). Black line denotes linear regression. Black circles denote SCR reinsertions within the Npr3 gene body. Right: deviations of eGFP expression levels from the linear regression correlate with chromatin states called using ChromHMM (n: active&#x2009;=&#x2009;16; neutral&#x2009;=&#x2009;83; Npr3&#x2009;=&#x2009;17; repressive&#x2009;=&#x2009;7). Reinsertion of SCR within active or repressive regions respectively increases or decreases enhancer activity compared to neutral regions. Box plot: centre line denotes the median; boxes denote lower and upper quartiles (Q1 and Q3, respectively); whiskers denote 1.5x the interquartile region (IQR) below Q1 and above Q3; points denote outliers. l. Coefficients of variation (CV) of eGFP levels measured by flow cytometry plotted against SCR insertion locations in eGFP+ cell lines (light red dots). Data are presented as mean +/- standard deviation (n&#x2009;=&#x2009;3 measurements in different days). Shaded light blue area indicates the interval between mean +/- standard deviation of eGFP level CVs in three promoter-only cell lines. m. Representative eGFP distributions (normalized to mean eGFP level) in clones with increasing absolute genomic distance (1.7&#x2009;kb, 42.4&#x2009;kb, 112.5&#x2009;kb, and 259.43&#x2009;kb) between the mobilized enhancer and the ectopic <italic>Sox2</italic> promoter. Vertical line indicates normalized mean eGFP levels. n. FACS plot showing standard (top) and less stringent (bottom) gates on eGFP levels used for single cells sort and insertion analysis of corresponding clonal cell lines. o. Left: FACS plot showing the gates used to sort pools of cells for tagmentation-based mapping of PiggyBac-enhancer insertions. For gates &#x201C;low 1&#x201D; and &#x201C;low 2&#x201D;, six pools of 10000 cells were sorted while for gate &#x201C;high&#x201D;, six pools of 337 cells were sorted. Gate &#x201C;high&#x201D; corresponds to the standard gate used to isolate eGFP positive cell lines for the mobilization experiments. Centre: Barplot showing the fraction of sequencing reads mapping to non-mobilized enhancer cassette determined by tagmentation-based mapping from the different pools sorted in gates &#x201C;low 1&#x201D;, &#x201C;low 2&#x201D; and &#x201C;high&#x201D;. See Methods for a detailed description of the protocol. Right: Numbers and genomic locations of confident insertion sites (identified as those with at least one read for both 5&#x2032;oth 5 mapping from the different pools sorted in gates &#x201C;low 1&#x201D;, &#x201C;low 2&#x201D; and &#x201C;higeGFP gates.</p></caption><graphic position="anchor" xlink:href="41586_2022_4570_Fig6_ESM" id="d32e2605"/></fig>
</p>
          <p id="Par52">
<fig id="Fig7"><label>Extended Data Fig. 2</label><caption><title>Analysis of chromosome structure around the transgenic locus and genome-wide in mES&#xA0;cells.</title><p>a. Top: capture-C maps (6.4&#x2009;kb resolution) of four cell lines where the SCR (black arrow) has been reinserted at different distances from the promoter (blue arrow). Bottom: differential contact map between individual cell lines and the founder line. Grey pixels: correspond to &#x2018;noisy&#x2019; interactions that did not satisfy quality control filters (see Methods). Right: barplot showing the change in average interaction probabilities between the SCR reinsertion and the cassette, calculated using a square of 5 bins (6.4&#x2009;kb resolution) centred at the cassette SCR reinsertion interaction. b. Left: example of Hi-C heatmap in mES&#xA0;cells at 6.4&#x2009;kb resolution. Centre: scheme depicting how the probability of interaction between a promoter and the region immediately before the nearest TAD boundary (P<sub>in</sub>, 12.8&#x2009;kb i.e. two 6.4&#x2009;kb bins before the boundary called using CaTCH<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>) and after the nearest TAD boundary (P<sub>out</sub>) are calculated. Right: distribution of contact probability between all active promoters in mES&#xA0;cellss and the closest inner TAD boundary (P<sub>in</sub>) (n&#x2009;=&#x2009;9655). Box plot description as in Extended Data Fig. <xref rid="Fig6" ref-type="fig">1k</xref>. c. Box plots showing the distribution of contact probability changes within the TAD and across the closest TADs boundary for all active promoters in mES&#xA0;cells (n&#x2009;=&#x2009;9655) whose contact probability outside the TAD is higher than 0.001 (n&#x2009;=&#x2009;834). Box plot description as in Extended Data Fig. <xref rid="Fig6" ref-type="fig">1k</xref>; outliers not shown. d. Contact probabilities of the founder line from the location of the ectopic <italic>Sox2</italic> transgene (black line) and normalized averaged mean number of mRNAs per cell (highest value&#x2009;=&#x2009;1) generated in individual eGFP+ lines by the SCR mobilization are plotted as a function of its genomic position (dashed red line). The average is calculated within equally spaced 20&#x2009;kb bins as in Fig. <xref rid="Fig1" ref-type="fig">1h</xref> (black dots). e. Coefficients of variation (CV) of eGFP levels measured by flow cytometry plotted against contact probabilities between the ectopic <italic>Sox2</italic> promoter and the locations of SCR insertions. Data are presented as mean values +/- standard deviation (n&#x2009;=&#x2009;3measurements in different days). Shaded light blue area indicates the interval between mean +/- standard deviation of eGFP level CVs in three promoter-only cell lines. f. Coefficients of variation (CV) of mRNA number per cell measured by smRNA-FISH plotted against contact probabilities between the ectopic <italic>Sox2</italic> promoter and the locations of SCR in the cell the lines shown in Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, d. Data are presented as mean values +/- standard deviation (n&#x2009;=&#x2009;3 technical replicates).</p></caption><graphic position="anchor" xlink:href="41586_2022_4570_Fig7_ESM" id="d32e2654"/></fig>
</p>
          <p id="Par53">
<fig id="Fig8"><label>Extended Data Fig. 3</label><caption><title>Phenomenological two-state model fitting and robustness analysis.</title><p>a. Parameter values and 95% confidence intervals for the best fitting phenomenological two-state model. The rates are in the unit of RNA decay rate (<inline-formula id="IEq5"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta $$\end{document}</tex-math><mml:math id="M50"><mml:mi>&#x3B4;</mml:mi></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq5.gif"/></alternatives></inline-formula>). b. Profile likelihood functions for all the parameters of the phenomenological two-state model. The red dashed line shows the threshold used to calculate the 95% confidence intervals (see&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Model description</xref> for more details). c. Best fit of the phenomenological two-state model under different perturbations of the contact probabilities. Panels with blue curves show the best fit transcriptional responses when the scaling exponent of the contact probabilities was artificially set to 0.4, 0.5, 0.6, 0.7, 0.8, and 0.9. The scaling exponent of the original contact probabilities is 0.77. Panels with orange curves show the best fit transcriptional responses when contact probabilities were artificially increased by a factor 1/x with x&#x2009;=&#x2009;0.1,...,0.9 with step of 0.1. Data are presented as average eGFP values calculated within equally spaced 20&#x2009;kb bins +/- standard deviation (n&#x2009;=&#x2009;number of cell lines per bin), as in Fig. <xref rid="Fig1" ref-type="fig">1h</xref>. d. Left: Normalized mean eGFP intensities in individual eGFP+ cell lines are plotted as a function of the genomic position of the SCR. Data from 135 individual cell lines (light red dots) are presented as mean +/- standard deviation (n&#x2009;=&#x2009;3 measurements performed on different days, as in panel g). Shaded grey area indicates the genomic regions that were excluded from the fit shown in the right panel. Right: Best fit of the phenomenological two-state model in the absence of the promoter-only control cell line and the cell lines with insertions that landed beyond the first CTCF site at the 3&#x2032; of the TAD (region highlighted in the left panel). Data are presented as average eGFP values calculated within equally spaced 20&#x2009;kb bins +/- standard deviation (n&#x2009;=&#x2009;number of cell lines per bin). e. Profile likelihood function for the Hill coefficient for the fit described in panel <bold>d</bold>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4570_Fig8_ESM" id="d32e2687"/></fig>
</p>
          <p id="Par54">
<fig id="Fig9"><label>Extended Data Fig. 4</label><caption><title>Fit of the mechanistic enhancer&#x2013;promoter model and robustness analysis.</title><p>a. Schematic description of the dynamics of the mechanistic model (here with two regulatory steps (<italic>n</italic>=2) for illustration). This case illustrates a scenario where, the enhancer&#x2013;promoter interaction is long enough to allow the completion of the <italic>2</italic> regulatory steps and transiently increases the promoter activity. b. In an alternative scenario, the interactions are shorter but frequent enough to allow the completion of the <italic>2</italic> regulatory steps and transiently increase the promoter activity. c. Parameter values and 95% confidence intervals for the best fitting apparent two-state model. The rates are in the unit of RNA decay rate (<inline-formula id="IEq7"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta $$\end{document}</tex-math><mml:math id="M52"><mml:mi>&#x3B4;</mml:mi></mml:math><inline-graphic xlink:href="41586_2022_4570_Article_IEq7.gif"/></alternatives></inline-formula>). d. Profile likelihood functions for all the parameters of the apparent two-state model. Red dashed lines show the threshold used to calculate the 95% confidence intervals (see&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Model description</xref> for more details).</p></caption><graphic position="anchor" xlink:href="41586_2022_4570_Fig9_ESM" id="d32e2723"/></fig>
</p>
          <p id="Par55">
<fig id="Fig10"><label>Extended Data Fig. 5</label><caption><title>Dependence of transcription levels and insulation on enhancer strength.</title><p>a. Top: UCSC genome browser snapshot of the endogenous <italic>Sox2</italic> locus and Sox2 control region (SCR). Bottom: close-up view showing the SCR (black) identified in ref. <sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and the enhancer regions used in the transient reporter assays shown in panel <bold>b</bold>. Full-length enhancer is in red (same as in Fig. <xref rid="Fig1" ref-type="fig">1</xref>); truncated versions are in brown (Ei) and orange (Eii). Experiments in Fig. <xref rid="Fig5" ref-type="fig">5</xref> were performed with Ei. b. Flow cytometry analysis of mES&#xA0;cells transiently transfected with PBase-RFP and different versions of split eGFP plasmids carry either no enhancer, or the full-length SCR (red, see panel <bold>a</bold>), or the first (brown-Ei) or second (orange-Eii) SCR subregions in front of the Sox2 promoter. Transcription levels generated upon co-transfection with PBase are higher in the presence of the full-length SCR compared to truncated versions. Numbers in each quadrant represent the % of cells either negative or RFP, GFP and RFP-GFP positive. c. Top: distribution of contact probabilities between all active promoters in mES cells&#xA0;and the nearest inner TAD boundaries, calculated as in Extended Data Fig. <xref rid="Fig7" ref-type="fig">2b</xref>. Bottom panel: Model prediction for the mean eGFP mRNA numbers per cell plotted against contact probabilities shown as a comparison (same as Fig. <xref rid="Fig2" ref-type="fig">2e</xref>). Shaded areas correspond to promoters with contact probability with the closest TAD boundary below 0.2. d. Left panel: scheme of how the probabilities of interaction between promoter and the region before (P<sub>in</sub>) and after the TAD boundary (P<sub>out</sub>) are calculated, same criteria as in Extended Data Fig. <xref rid="Fig7" ref-type="fig">2b</xref>. Central panel: promoters with higher contact probabilities with TAD boundaries experience stronger drops of contact probability across boundaries. Right panel: promoters closer to TAD boundaries experience a stronger drop of contact probability across boundaries.</p></caption><graphic position="anchor" xlink:href="41586_2022_4570_Fig10_ESM" id="d32e2772"/></fig>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Jessica Zuin, Gregory Roth</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-04570-y.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-04570-y.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank R. Mitra for sharing the piggyBac-splitGFP vector; A. Boettiger and J.Y. Xiao for discussions on modelling; M. Michalski and S. Andrews for capture-C primer design; L. Gelman and J. Eglinger for help with microscopy and image analysis; and G. Natoli, D. Sch&#xFC;beler, H. Grosshans and E. Nora for discussions and comments on the manuscript. J.Z. was supported by a Marie Sk&#x142;odowska-Curie grant (748091 &#x2018;3DQuant&#x2019;). Research in the Giorgetti laboratory is funded by the Novartis Foundation, the European Research Council (ERC) (759366 'BioMeTre') and Marie Sk&#x142;odowska-Curie Innovative Training Networks (813327 &#x2018;ChromDesign&#x2019; and 813282 &#x2018;PEP-NET&#x2019;) under the European Union&#x2019;s Horizon 2020 research and innovation program, and the Swiss National Science Foundation (310030_192642). Research in the Meister laboratory is supported by the Swiss National Science Foundation (IZCOZ0_189884/31003A_176226 to P.&#xA0;Meister.). Research in the van Steensel laboratory is supported by ERC Advanced Grant 694466 &#x2018;GoCADiSC&#x2019;.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>L.G. and J.Z. conceived and designed the study. J.Z., J.C., E.P., M.K. and G.T. performed the experiments. G.R. wrote and analysed the mathematical model. H.K. provided assistance with flow cytometry. J.C., P.&#xA0;Meister. and S.S. contributed to setting up nCATS. S.S. also provided assistance with high-throughput sequence experiments. J.Z., J.C., J.R. and P.&#xA0;Mach. generated cell lines. M.E., C.L. and B.v.S. assisted with tagmentation-based mapping of insertions. G.R. and Y.Z. analysed the data, except for flow cytometry and single-clone insertion mapping (J.Z.) and smRNA-FISH (E.P.). L.G. wrote the paper with G.R., J.Z. and Y.Z., and input from all of the authors.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="FPar1">
        <title>Peer review information</title>
        <p id="Par49"><italic>Nature</italic> thanks Mikhail Spivakov and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p>
      </sec>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>All capture-C, RNA-seq, Oxford Nanopore, tagmentation and population-based splinkerette PCR sequencing fastq files generated in this study have been uploaded to the Gene Expression Omnibus (GEO) under accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE172257">GSE172257</ext-link>. The following public databases were used: BSgenome.Mmusculus.UCSC.mm9 (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/data/annotation/html/BSgenome.Mmusculus.UCSC.mm9.html">https://bioconductor.org/packages/release/data/annotation/html/BSgenome.Mmusculus.UCSC.mm9.html</ext-link>), TxDb.Mmusculus.UCSC.mm9.knownGene (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/data/annotation/html/TxDb.Mmusculus.UCSC.mm9.knownGene.html">https://bioconductor.org/packages/release/data/annotation/html/TxDb.Mmusculus.UCSC.mm9.knownGene.html</ext-link>).</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>Custom codes generated in this study are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhanyinx/Zuin_Roth_2021">https://github.com/zhanyinx/Zuin_Roth_2021</ext-link> (cHiC, Nanopore, Insertion mapping); <ext-link ext-link-type="uri" xlink:href="https://github.com/gregroth/Zuin_Roth_2021">https://github.com/gregroth/Zuin_Roth_2021</ext-link> (mathematical model); and <ext-link ext-link-type="uri" xlink:href="https://github.com/vansteensellab/tagmap_hopping/tree/giorgetti">https://github.com/vansteensellab/tagmap_hopping/tree/giorgetti</ext-link> (tagmentation-based mapping of PiggyBac insertions)).</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par50">The authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nora</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial partitioning of the regulatory landscape of the X-inactivation centre</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <fpage>381</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11049</pub-id>
          <pub-id pub-id-type="pmid">22495304</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dowen</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>374</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.030</pub-id>
          <pub-id pub-id-type="pmid">25303531</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lupi&#xE1;&#xF1;ez</surname>
              <given-names>DG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions</article-title>
          <source>Cell</source>
          <year>2015</year>
          <volume>161</volume>
          <fpage>1012</fpage>
          <lpage>1025</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2015.04.004</pub-id>
          <pub-id pub-id-type="pmid">25959774</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hnisz</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of proto-oncogenes by disruption of chromosome neighborhoods</article-title>
          <source>Science</source>
          <year>2016</year>
          <volume>351</volume>
          <fpage>aad9024</fpage>
          <pub-id pub-id-type="doi">10.1126/science.aad9024</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Long</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Prescott</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Wysocka</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ever-changing landscapes: transcriptional enhancers in development and evolution</article-title>
          <source>Cell</source>
          <year>2016</year>
          <volume>167</volume>
          <fpage>1170</fpage>
          <lpage>1187</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2016.09.018</pub-id>
          <pub-id pub-id-type="pmid">27863239</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCord</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Giorgetti</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Chromosome conformation capture and beyond: toward an integrative view of chromosome structure and function</article-title>
          <source>Mol. Cell</source>
          <year>2020</year>
          <volume>77</volume>
          <fpage>688</fpage>
          <lpage>708</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2019.12.021</pub-id>
          <pub-id pub-id-type="pmid">32001106</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fudenberg</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Formation of chromosomal domains by loop extrusion</article-title>
          <source>Cell Rep.</source>
          <year>2016</year>
          <volume>15</volume>
          <fpage>2038</fpage>
          <lpage>2049</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.085</pub-id>
          <pub-id pub-id-type="pmid">27210764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flavahan</surname>
              <given-names>WA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Insulator dysfunction and oncogene activation in IDH mutant gliomas</article-title>
          <source>Nature</source>
          <year>2016</year>
          <volume>529</volume>
          <fpage>110</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1038/nature16490</pub-id>
          <pub-id pub-id-type="pmid">26700815</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghavi-Helm</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression</article-title>
          <source>Nat. Genet.</source>
          <year>2019</year>
          <volume>51</volume>
          <fpage>1272</fpage>
          <lpage>1282</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-019-0462-3</pub-id>
          <pub-id pub-id-type="pmid">31308546</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Despang</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional dissection of the <italic>Sox9</italic>&#x2013;<italic>Kcnj2</italic> locus identifies nonessential and instructive roles of TAD architecture</article-title>
          <source>Nat. Genet.</source>
          <year>2019</year>
          <volume>51</volume>
          <fpage>1263</fpage>
          <lpage>1271</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-019-0466-z</pub-id>
          <pub-id pub-id-type="pmid">31358994</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nora</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted degradation of CTCF decouples local insulation of chromosome domains from genomic compartmentalization</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>169</volume>
          <fpage>930</fpage>
          <lpage>944</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.05.004</pub-id>
          <pub-id pub-id-type="pmid">28525758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>SSP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin loss eliminates all loop domains</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>171</volume>
          <fpage>305</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.09.026</pub-id>
          <pub-id pub-id-type="pmid">28985562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galupa</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A conserved noncoding locus regulates random monoallelic <italic>Xist</italic> expression across a topological boundary</article-title>
          <source>Mol. Cell</source>
          <year>2020</year>
          <volume>77</volume>
          <fpage>352</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2019.10.030</pub-id>
          <pub-id pub-id-type="pmid">31759823</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CRISPR inversion of CTCF sites alters genome topology and enhancer/promoter function</article-title>
          <source>Cell</source>
          <year>2015</year>
          <volume>162</volume>
          <fpage>900</fpage>
          <lpage>910</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2015.07.038</pub-id>
          <pub-id pub-id-type="pmid">26276636</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanssen</surname>
              <given-names>LLP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tissue-specific CTCF-cohesin-mediated chromatin architecture delimits enhancer interactions and function in vivo</article-title>
          <source>Nat. Cell Biol.</source>
          <year>2017</year>
          <volume>19</volume>
          <fpage>952</fpage>
          <lpage>961</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb3573</pub-id>
          <pub-id pub-id-type="pmid">28737770</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CTCF mediates dosage and sequence-context-dependent transcriptional insulation through formation of local chromatin domains</article-title>
          <source>Nat. Genet.</source>
          <year>2021</year>
          <volume>53</volume>
          <fpage>1064</fpage>
          <lpage>1074</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-021-00863-6</pub-id>
          <pub-id pub-id-type="pmid">34002095</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de&#xA0;Wit</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CTCF binding polarity determines chromatin looping</article-title>
          <source>Mol. Cell</source>
          <year>2015</year>
          <volume>60</volume>
          <fpage>676</fpage>
          <lpage>684</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.023</pub-id>
          <pub-id pub-id-type="pmid">26527277</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodr&#xED;guez-Carballo</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chromatin topology and the timing of enhancer function at the <italic>HoxD</italic> locus</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2020</year>
          <volume>117</volume>
          <fpage>31231</fpage>
          <lpage>31241</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.2015083117</pub-id>
          <pub-id pub-id-type="pmid">33229569</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benabdallah</surname>
              <given-names>NS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Decreased enhancer&#x2013;promoter proximity accompanying enhancer activation</article-title>
          <source>Mol. Cell</source>
          <year>2019</year>
          <volume>76</volume>
          <fpage>473</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2019.07.038</pub-id>
          <pub-id pub-id-type="pmid">31494034</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Live-cell imaging reveals enhancer-dependent Sox2 transcription in the absence of enhancer proximity</article-title>
          <source>eLife</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>e41769</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.41769</pub-id>
          <pub-id pub-id-type="pmid">31124784</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiao</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Hafner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boettiger</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>How subtle changes in 3D structure can create large changes in transcription</article-title>
          <source>eLife</source>
          <year>2021</year>
          <volume>10</volume>
          <fpage>e64320</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.64320</pub-id>
          <pub-id pub-id-type="pmid">34240703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukaya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Enhancer control of transcriptional bursting</article-title>
          <source>Cell</source>
          <year>2016</year>
          <volume>166</volume>
          <fpage>358</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.025</pub-id>
          <pub-id pub-id-type="pmid">27293191</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fulco</surname>
              <given-names>CP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activity-by-contact model of enhancer&#x2013;promoter regulation from thousands of CRISPR perturbations</article-title>
          <source>Nat. Genet.</source>
          <year>2019</year>
          <volume>51</volume>
          <fpage>1664</fpage>
          <lpage>1669</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-019-0538-0</pub-id>
          <pub-id pub-id-type="pmid">31784727</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Devenney</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Lettice</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Mapping the Shh long-range regulatory domain</article-title>
          <source>Development</source>
          <year>2014</year>
          <volume>141</volume>
          <fpage>3934</fpage>
          <lpage>3943</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.108480</pub-id>
          <pub-id pub-id-type="pmid">25252942</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Symmons</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional and topological characteristics of mammalian regulatory domains</article-title>
          <source>Genome Res.</source>
          <year>2014</year>
          <volume>24</volume>
          <fpage>390</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.163519.113</pub-id>
          <pub-id pub-id-type="pmid">24398455</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Symmons</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Shh topological domain facilitates the action of remote enhancers by reducing the effects of genomic distances</article-title>
          <source>Dev. Cell</source>
          <year>2016</year>
          <volume>39</volume>
          <fpage>529</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2016.10.015</pub-id>
          <pub-id pub-id-type="pmid">27867070</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sites</article-title>
          <source>Mol. Cell. Biol.</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>1317</fpage>
          <lpage>1330</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.00670-12</pub-id>
          <pub-id pub-id-type="pmid">23358416</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ernst</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kellis</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ChromHMM: automating chromatin-state discovery and characterization</article-title>
          <source>Nat. Methods</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>215</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.1906</pub-id>
          <pub-id pub-id-type="pmid">22373907</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>HY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential</article-title>
          <source>Genes Dev.</source>
          <year>2014</year>
          <volume>28</volume>
          <fpage>2699</fpage>
          <lpage>2711</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.248526.114</pub-id>
          <pub-id pub-id-type="pmid">25512558</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CRISPR reveals a distal super-enhancer required for Sox2 expression in mouse embryonic stem cells</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>e114485</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0114485</pub-id>
          <pub-id pub-id-type="pmid">25486255</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schaffner</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Enhancers, enhancers&#x2014;from their discovery to today&#x2019;s universe of transcription enhancers</article-title>
          <source>Biol. Chem.</source>
          <year>2015</year>
          <volume>396</volume>
          <fpage>311</fpage>
          <lpage>327</lpage>
          <pub-id pub-id-type="doi">10.1515/hsz-2014-0303</pub-id>
          <pub-id pub-id-type="pmid">25719310</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giorgetti</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Predictive polymer modeling reveals coupled fluctuations in chromosome conformation and transcription</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>157</volume>
          <fpage>950</fpage>
          <lpage>963</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.025</pub-id>
          <pub-id pub-id-type="pmid">24813616</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dekker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mirny</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>The 3D genome as moderator of chromosomal communication</article-title>
          <source>Cell</source>
          <year>2016</year>
          <volume>164</volume>
          <fpage>1110</fpage>
          <lpage>1121</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2016.02.007</pub-id>
          <pub-id pub-id-type="pmid">26967279</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redolfi</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DamC reveals principles of chromatin folding in vivo without crosslinking and ligation</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <year>2019</year>
          <volume>26</volume>
          <fpage>471</fpage>
          <lpage>480</lpage>
          <pub-id pub-id-type="doi">10.1038/s41594-019-0231-0</pub-id>
          <pub-id pub-id-type="pmid">31133702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coulon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Eukaryotic transcriptional dynamics: from single molecules to cell populations</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>572</fpage>
          <lpage>584</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg3484</pub-id>
          <pub-id pub-id-type="pmid">23835438</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peccoud</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ycart</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Markovian modeling of gene-product synthesis</article-title>
          <source>Theor. Popul. Biol.</source>
          <year>1995</year>
          <volume>48</volume>
          <fpage>222</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="doi">10.1006/tpbi.1995.1027</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amano</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chromosomal dynamics at the <italic>Shh</italic> locus: limb bud-specific differential regulation of competence and active transcription</article-title>
          <source>Dev. Cell</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>47</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2008.11.011</pub-id>
          <pub-id pub-id-type="pmid">19097946</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bintu</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Super-resolution chromatin tracing reveals domains and cooperative interactions in single cells</article-title>
          <source>Science</source>
          <year>2018</year>
          <volume>362</volume>
          <fpage>eaau1783</fpage>
          <pub-id pub-id-type="doi">10.1126/science.aau1783</pub-id>
          <pub-id pub-id-type="pmid">30361340</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dynamic interplay between enhancer&#x2013;promoter topology and gene activity</article-title>
          <source>Nat. Genet.</source>
          <year>2018</year>
          <volume>50</volume>
          <fpage>1296</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="doi">10.1038/s41588-018-0175-z</pub-id>
          <pub-id pub-id-type="pmid">30038397</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vernimmen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bickmore</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>The hierarchy of transcriptional activation: from enhancer to promoter</article-title>
          <source>Trends Genet.</source>
          <year>2015</year>
          <volume>31</volume>
          <fpage>696</fpage>
          <lpage>708</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tig.2015.10.004</pub-id>
          <pub-id pub-id-type="pmid">26599498</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nguyen</surname>
              <given-names>VQ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatiotemporal coordination of transcription preinitiation complex assembly in live cells</article-title>
          <source>Mol. Cell</source>
          <year>2021</year>
          <volume>81</volume>
          <fpage>3560</fpage>
          <lpage>3575</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2021.07.022</pub-id>
          <pub-id pub-id-type="pmid">34375585</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krebs</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide single-molecule footprinting reveals high RNA polymerase II turnover at paused promoters</article-title>
          <source>Mol. Cell</source>
          <year>2017</year>
          <volume>67</volume>
          <fpage>411</fpage>
          <lpage>422</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.027</pub-id>
          <pub-id pub-id-type="pmid">28735898</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>W-K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mediator and RNA polymerase II clusters associate in transcription-dependent condensates</article-title>
          <source>Science</source>
          <year>2018</year>
          <volume>361</volume>
          <fpage>412</fpage>
          <lpage>415</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aar4199</pub-id>
          <pub-id pub-id-type="pmid">29930094</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lammers</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>HG</given-names>
            </name>
          </person-group>
          <article-title>A matter of time: using dynamics and theory to uncover mechanisms of transcriptional bursting</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <year>2020</year>
          <volume>67</volume>
          <fpage>147</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2020.08.001</pub-id>
          <pub-id pub-id-type="pmid">33242838</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horvathova</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The dynamics of mRNA turnover revealed by single-molecule imaging in single cells</article-title>
          <source>Mol. Cell</source>
          <year>2017</year>
          <volume>68</volume>
          <fpage>615</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2017.09.030</pub-id>
          <pub-id pub-id-type="pmid">29056324</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-molecule dynamics of enhanceosome assembly in embryonic stem cells</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>156</volume>
          <fpage>1274</fpage>
          <lpage>1285</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.01.062</pub-id>
          <pub-id pub-id-type="pmid">24630727</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="other">Anania, C. et al. In vivo dissection of a clustered-CTCF domain boundary reveals developmental principles of regulatory insulation. Preprint at <italic>bioRxiv</italic>10.1101/2021.04.14.439779 (2021).</mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="other">Bialek, W., Gregor, T. &amp; Tka&#x10D;ik, G. Action at a distance in transcriptional regulation. Preprint at <italic>arXiv</italic>10.48550/arXiv.1912.08579 (2019).</mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#xE3;o</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Gabriele</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Tracking and interpreting long-range chromatin interactions with super-resolution live-cell imaging</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <year>2021</year>
          <volume>70</volume>
          <fpage>18</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2020.11.002</pub-id>
          <pub-id pub-id-type="pmid">33310227</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An optimized, broadly applicable piggyBac transposon induction system</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2017</year>
          <volume>45</volume>
          <fpage>e55</fpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkx305</pub-id>
          <pub-id pub-id-type="pmid">28082389</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilpatrick</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted nanopore sequencing with Cas9-guided adapter ligation</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2020</year>
          <volume>38</volume>
          <fpage>433</fpage>
          <lpage>438</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-020-0407-5</pub-id>
          <pub-id pub-id-type="pmid">32042167</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uren</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites</article-title>
          <source>Nat. Protoc.</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>789</fpage>
          <lpage>798</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2009.64</pub-id>
          <pub-id pub-id-type="pmid">19528954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <mixed-citation publication-type="other">Stern, D. L. Tagmentation-based mapping (TagMap) of mobile DNA genomic insertion sites. Preprint at <italic>bioRxiv</italic>10.1101/037762 (2017).</mixed-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schep</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance</article-title>
          <source>Mol. Cell</source>
          <year>2021</year>
          <volume>81</volume>
          <fpage>2216</fpage>
          <lpage>2230</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2021.03.032</pub-id>
          <pub-id pub-id-type="pmid">33848455</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <mixed-citation publication-type="other">Voigt, F., Eglinger, J. &amp; Chao, J. A. in <italic>RNA Detection: Methods and Protocols</italic> (ed. Gaspar, I.) 373&#x2013;384 (Springer, 2018).</mixed-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tinevez</surname>
              <given-names>J-Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TrackMate: an open and extensible platform for single-particle tracking</article-title>
          <source>Methods</source>
          <year>2017</year>
          <volume>115</volume>
          <fpage>80</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ymeth.2016.09.016</pub-id>
          <pub-id pub-id-type="pmid">27713081</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schoenfelder</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements</article-title>
          <source>Genome Res.</source>
          <year>2015</year>
          <volume>25</volume>
          <fpage>582</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.185272.114</pub-id>
          <pub-id pub-id-type="pmid">25752748</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobin</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
          <source>Bioinformatics</source>
          <year>2013</year>
          <volume>29</volume>
          <fpage>15</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
          <pub-id pub-id-type="pmid">23104886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaidatzis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lerch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hahne</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Stadler</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>QuasR: quantification and annotation of short reads in R</article-title>
          <source>Bioinformatics</source>
          <year>2015</year>
          <volume>31</volume>
          <fpage>1130</fpage>
          <lpage>1132</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btu781</pub-id>
          <pub-id pub-id-type="pmid">25417205</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Servant</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HiC-Pro: an optimized and flexible pipeline for Hi-C data processing</article-title>
          <source>Genome Biol.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>259</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0831-x</pub-id>
          <pub-id pub-id-type="pmid">26619908</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imakaev</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Iterative correction of Hi-C data reveals hallmarks of chromosome organization</article-title>
          <source>Nat. Methods</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>999</fpage>
          <lpage>1003</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.2148</pub-id>
          <pub-id pub-id-type="pmid">22941365</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="other">Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at <italic>arXiv</italic>10.48550/arXiv.1303.3997 (2013).</mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>
          <source>EMBnet J.</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>10</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarasov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vilella</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Cuppen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nijman</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Prins</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Sambamba: fast processing of NGS alignment formats</article-title>
          <source>Bioinformatics</source>
          <year>2015</year>
          <volume>31</volume>
          <fpage>2032</fpage>
          <lpage>2034</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btv098</pub-id>
          <pub-id pub-id-type="pmid">25697820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Sequence Alignment/Map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhan</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reciprocal insulation analysis of Hi-C data shows that TADs represent a functionally but not structurally privileged scale in the hierarchical folding of chromosomes</article-title>
          <source>Genome Res.</source>
          <year>2017</year>
          <volume>27</volume>
          <fpage>479</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.212803.116</pub-id>
          <pub-id pub-id-type="pmid">28057745</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33177708</article-id>
      <article-id pub-id-type="pmc">9097329</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-020-2905-5</article-id>
      <article-id pub-id-type="manuscript">NIHMS1795714</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Persistent transcriptional programmes are associated with remote memory</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Michelle B.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="A5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Xian</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
          <xref rid="A3" ref-type="aff">3</xref>
          <xref rid="A5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quake</surname>
            <given-names>Stephen R.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="A4" ref-type="aff">4</xref>
          <xref rid="CR1" ref-type="corresp">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>S&#xFC;dhof</surname>
            <given-names>Thomas C.</given-names>
          </name>
          <xref rid="A2" ref-type="aff">2</xref>
          <xref rid="A3" ref-type="aff">3</xref>
          <xref rid="CR1" ref-type="corresp">&#x2020;</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Bioengineering, Stanford University, Stanford, CA, USA.</aff>
      <aff id="A2"><label>2</label>Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA, USA.</aff>
      <aff id="A3"><label>3</label>Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA.</aff>
      <aff id="A4"><label>4</label>Chan Zuckerberg Biohub, Stanford, CA, USA.</aff>
      <aff id="A5"><label>5</label>These authors contributed equally: Michelle B. Chen, Xian Jiang.</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P1"><bold>Author contributions</bold> X.J. and T.C.S. designed the animal experiments. M.B.C. and S.R.Q. designed the single-cell RNA sequencing experiments. X.J. performed the animal experiments, brain dissection, and in situ hybridization and imaging. M.B.C. performed the brain dissociation, flow cytometry, single-cell library preparation and sequencing pipelines. M.B.C. performed all single-cell RNA sequencing data and image analysis, with input from X.J., S.R.Q. and T.C.S. M.B.C. wrote the manuscript with substantial contributions from X.J., S.R.Q. and T.C.S. T.C.S. and S.R.Q. oversaw the project.</p>
        </fn>
        <corresp id="CR1"><label>&#x2020;</label>
<bold>Correspondence and requests for materials</bold> should be addressed to S.R.Q. and T.C.S. <email>steve@quake-lab.org</email>; <email>tcs1@stanford.edu</email></corresp>
        <fn fn-type="COI-statement" id="FN2">
          <p id="P49"><bold>Competing interests</bold> The authors declare no competing interests.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>27</day>
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>11</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>5</month>
        <year>2022</year>
      </pub-date>
      <volume>587</volume>
      <issue>7834</issue>
      <fpage>437</fpage>
      <lpage>442</lpage>
      <abstract id="ABS1">
        <p id="P2">The role of gene expression during learning and in short-term memories has been studied extensively<sup><xref rid="R1" ref-type="bibr">1</xref>&#x2013;<xref rid="R3" ref-type="bibr">3</xref></sup>, but less is known about remote memories, which can persist for a lifetime<sup><xref rid="R4" ref-type="bibr">4</xref></sup>. We used long-term contextual fear memory as a paradigm to probe the single-cell gene expression landscape that underlies remote memory storage in the medial prefrontal cortex. Remarkably, we found persistent activity-specific transcriptional alterations in diverse populations of neurons that lasted for weeks after fear learning. Out of a vast plasticity-coding space, we identified membrane-fusion genes that could have important roles in the maintenance of remote memory. Unexpectedly, astrocytes and microglia also acquired persistent gene expression signatures that were associated with remote memory, suggesting that they actively contribute to memory circuits. The discovery of gene expression programmes associated with remote memory engrams adds an important dimension of activity-dependent cellular states to existing brain taxonomy atlases and sheds light on the elusive mechanisms of remote memory storage.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35978191</article-id>
      <article-id pub-id-type="pmc">9452302</article-id>
      <article-id pub-id-type="publisher-id">5094</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-05094-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spatial profiling of chromatin accessibility in mouse and human tissues</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9975-8086</contrib-id>
          <name>
            <surname>Deng</surname>
            <given-names>Yanxiang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bartosovic</surname>
            <given-names>Marek</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9785-7929</contrib-id>
          <name>
            <surname>Ma</surname>
            <given-names>Sai</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8466-9868</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Di</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1228-5923</contrib-id>
          <name>
            <surname>Kukanja</surname>
            <given-names>Petra</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7878-4923</contrib-id>
          <name>
            <surname>Xiao</surname>
            <given-names>Yang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Su</surname>
            <given-names>Graham</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Yang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qin</surname>
            <given-names>Xiaoyu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosoklija</surname>
            <given-names>Gorazd B.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dwork</surname>
            <given-names>Andrew J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
          <xref ref-type="aff" rid="Aff8">8</xref>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0265-6586</contrib-id>
          <name>
            <surname>Mann</surname>
            <given-names>J. John</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9513-245X</contrib-id>
          <name>
            <surname>Xu</surname>
            <given-names>Mina L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2737-9810</contrib-id>
          <name>
            <surname>Halene</surname>
            <given-names>Stephanie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff12">12</xref>
          <xref ref-type="aff" rid="Aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1368-6756</contrib-id>
          <name>
            <surname>Craft</surname>
            <given-names>Joseph E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leong</surname>
            <given-names>Kam W.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3574-7641</contrib-id>
          <name>
            <surname>Boldrini</surname>
            <given-names>Maura</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2247-9393</contrib-id>
          <name>
            <surname>Castelo-Branco</surname>
            <given-names>Gon&#xE7;alo</given-names>
          </name>
          <address>
            <email>goncalo.castelo-branco@ki.se</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7805-8059</contrib-id>
          <name>
            <surname>Fan</surname>
            <given-names>Rong</given-names>
          </name>
          <address>
            <email>rong.fan@yale.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff11">11</xref>
          <xref ref-type="aff" rid="Aff17">17</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Biomedical Engineering, </institution><institution>Yale University, </institution></institution-wrap>New Haven, CT USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Yale Stem Cell Center and Yale Cancer Center, </institution><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0546 1623</institution-id><institution>Klarman Cell Observatory, </institution><institution>Broad Institute of MIT and Harvard, </institution></institution-wrap>Cambridge, MA USA </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Biomedical Engineering, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Psychiatry, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.413734.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8499 1112</institution-id><institution>Division of Molecular Imaging and Neuropathology, </institution><institution>New York State Psychiatric Institute, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.419383.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2183 7908</institution-id><institution>Macedonian Academy of Sciences &amp; Arts, </institution></institution-wrap>Skopje, Republic of Macedonia </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Pathology and Cell Biology, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Radiology, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Pathology, </institution><institution>Yale University School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
        <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Section of Hematology, Department of Internal Medicine, </institution><institution>Yale University School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
        <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Yale Center for RNA Science and Medicine, </institution><institution>Yale University School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
        <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Department of Immunobiology, </institution><institution>Yale University School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
        <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>Department of Systems Biology, </institution><institution>Columbia University Irving Medical Center, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Ming Wai Lau Centre for Reparative Medicine, Stockholm node, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff>
        <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution>Human and Translational Immunology Program, </institution><institution>Yale School of Medicine, </institution></institution-wrap>New Haven, CT USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>8</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>8</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>609</volume>
      <issue>7926</issue>
      <fpage>375</fpage>
      <lpage>383</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>8</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>7</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Cellular&#xA0;function in tissue is dependent on the local environment, requiring new methods for spatial mapping of biomolecules and cells in the tissue context<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The emergence of spatial transcriptomics has enabled genome-scale gene expression mapping<sup><xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref></sup>, but the ability to capture spatial epigenetic information of tissue at the cellular level and genome scale is lacking. Here we describe a method for spatially resolved chromatin accessibility profiling of tissue sections using next-generation sequencing (spatial-ATAC-seq) by combining in situ Tn5 transposition chemistry<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and microfluidic deterministic barcoding<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Profiling mouse embryos using spatial-ATAC-seq delineated tissue-region-specific epigenetic landscapes and identified gene regulators involved in the development of the central nervous system. Mapping the accessible genome in the mouse and human brain revealed the intricate arealization of brain regions. Applying spatial-ATAC-seq to tonsil tissue resolved the spatially distinct organization of immune cell types and states in lymphoid follicles and extrafollicular zones. This technology progresses spatial biology by enabling spatially resolved chromatin accessibility profiling to improve our understanding of cell identity, cell state and cell fate decision in relation to epigenetic underpinnings in development and disease.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Spatial-ATAC-seq&#x2014;spatially&#xA0;resolved chromatin accessibility profiling of tissue sections using next-generation sequencing&#x2014;delineated tissue-region-specific epigenetic landscapes in mouse embryos&#xA0;and identified gene regulators involved in the development of the central nervous system&#xA0;and the lymphoid tissue.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Chromatin analysis</kwd>
        <kwd>Epigenomics</kwd>
        <kwd>Fluorescence imaging</kwd>
        <kwd>Next-generation sequencing</kwd>
        <kwd>Epigenetics in the nervous system</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">Single-cell sequencing presents a tangible way to define cell types and states <sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, but the tissue dissociation process leads to the loss of spatial context. Moreover, the method of isolation in single-cell technologies may preferentially select certain cell types or perturb cellular states as a result of the dissociation or other environmental stresses<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Spatial transcriptomics emerged to address these challenges and to transform how we delineate cellular functions and states in the native tissue environment<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref></sup>. To investigate the mechanisms underlying the spatial organization of different cell types and functions in the tissue context, it is highly desired to examine not only gene expression but also epigenetic underpinnings such as chromatin accessibility<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> in a spatially resolved manner. Spatial epigenetic mapping would help us to uncover the causative relationship that determines what drives tissue organization and function. To date, the ability to spatially map epigenetic states, such as chromatin accessibility, directly in a tissue section at the genome scale and cellular level is lacking.</p>
      <p id="Par4">Assay for transposase-accessible chromatin using sequencing (ATAC-seq) was developed and was further applied to single cells<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. Imaging chromatin accessibility in fixed cells using fluorescence-labelled DNA oligomers assembled in Tn5 (ATACsee)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> suggests that it is feasible to profile chromatin accessibility in situ. Microdissecting tissues from specific regions followed by scATAC-seq enables the profiling of accessible chromatin from a region of interest<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. However, spatially resolved chromatin accessibility mapping over a tissue section at the cellular level has not been possible. Here we applied a spatial barcoding scheme to DNA oligomers that were inserted into the accessible genomic loci by Tn5 transposition to realize spatial-ATAC-seq: high-spatial-resolution genome-wide mapping of chromatin accessibility in tissue at the cellular level. The results from mouse embryos delineated the region-specific epigenetic landscapes and gene regulators involved in the development of the central nervous system (CNS). We also applied spatial epigenomics to human tissues, including tonsils and the hippocampus. Spatial-ATAC-seq revealed a spatially distinct organization of immune cell types and states in relation to lymphoid follicles and extrafollicular zones. This technology adds a new dimension to spatial biology by bringing spatial chromatin accessibility to the field and may offer a wide range of applications in the study of normal development and pathogenesis.</p>
    </sec>
    <sec id="Sec2">
      <title>Spatial-ATAC-seq design and workflow</title>
      <p id="Par5">The workflow for spatial-ATAC-seq is shown in Fig. <xref rid="Fig1" ref-type="fig">1a,b</xref> and Extended Data Fig. <xref rid="Fig5" ref-type="fig">1</xref>. Tn5 transposition was performed in a fixed tissue section and adapters containing a ligation linker were inserted into accessible genomic loci. Next, barcodes A (A1&#x2013;A50) and B (B1&#x2013;B50) with linkers were introduced using microchannels and were ligated to the 5&#x2032; end of the Tn5 oligo through successive rounds of ligation, resulting in distinct combinations. The tissue slides were imaged such that spatially barcoded accessible chromatin can be correlated with the tissue morphology. After forming a spatially barcoded tissue mosaic (2,500 tiles), reverse cross-linking was performed to release barcoded DNA fragments, which were amplified by PCR for library preparation. To evaluate the performance of in situ transposition and ligation, the cells stained with 4&#x2032;,6-diamidino-2-phenylindole (DAPI) were fixed on a glass slide, followed by Tn5 transposition and ligation of a barcode A with fluorescein isothiocyanate (FITC). The resulting images revealed a strong overlap between the nucleus (blue) and FITC (green) signals, indicating the successful insertion of adapters into accessible chromatin loci with ligated barcode A in nuclei only (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Spatial-ATAC-seq design, workflow and data quality.</title><p><bold>a</bold>, Schematic workflow. Tn5 transposition was performed in tissue sections, followed by in situ ligation of two sets of DNA barcodes (A1&#x2013;A50, B1&#x2013;B50).&#xA0;<bold>b</bold>, Microfluidic&#xA0;crossflow scheme. <bold>c</bold>, Validation of in situ transposition and ligation using fluorescent DNA probes. Tn5 transposition was performed in 3T3 cells on a glass slide stained with DAPI (blue). Next, FITC-labelled barcode A was ligated to the adapters on the transposase-accessible genomic DNA. Scale bar, 50&#x2009;&#xB5;m. <bold>d</bold>, Aggregate spatial chromatin accessibility profiles recapitulated published profiles of ATAC-seq in the liver of E13 mouse embryos. <bold>e</bold>, Comparison of the number of unique fragments between spatial-ATAC-seq and 10x scATAC-seq. <bold>f</bold>, Comparison of the fraction of TSS fragments between spatial-ATAC-seq and 10x scATAC-seq. <bold>g</bold>, Comparison of the fraction of mitochondrial fragments between spatial-ATAC-seq and 10x scATAC-seq. <bold>h</bold>, Comparison of the fraction of reads in peaks (FRiP) between spatial-ATAC-seq and 10x scATAC-seq. The number of pixels/cells in E11: 2,162; E13: 2,275; brain: 2,500; tonsil: 2,488; scATAC-seq: 3,789. The box plots show the median (centre line), the first and third quartiles (box limits), and 1.5&#xD7; the interquartile range (whiskers). <bold>i</bold>, Comparison of the insert size distribution of ATAC-seq fragments between spatial-ATAC-seq and 10x scATAC-seq. <bold>j</bold>, Comparison of the enrichment of ATAC-seq reads around TSSs between spatial-ATAC-seq and 10x scATAC-seq. Colouring is consistent with <bold>i</bold>. <bold>k</bold>, The TSS enrichment score versus unique nuclear fragments per cell in human tonsils.</p></caption><graphic xlink:href="41586_2022_5094_Fig1_HTML" id="d32e715"/></fig></p>
      <p id="Par6">As we proceeded to develop spatial-ATAC-seq, we went through several versions of chemistry to achieve a high yield and a high signal-to-noise ratio (Supplementary Fig. <xref rid="MOESM1" ref-type="media">1a</xref>). We then applied the optimized protocol to different tissue types and assessed the data quality (Fig. <xref rid="Fig1" ref-type="fig">1d&#x2013;k</xref>) (spatial-ATAC-seq pixels may contain more than one nucleus, which is based on the tissue type and cell size; for the embryonic day 10 (E10) mouse embryo, on average, there were 1&#x2013;2 cells per 10&#x2009;&#x3BC;m pixel and 25 cells per 50&#x2009;&#x3BC;m pixel<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>). In a 50&#x2009;&#xB5;m E13 mouse embryo experiment, aggregate profiles accurately reproduced the bulk measurement. Furthermore, signals around <italic>Slc4a1</italic> were specifically enriched in the liver region but not in the brain (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). In other experiments, we obtained a median of 36,303 (E11) and 100,786 (E13) unique fragments per pixel of which 15% (E11) and 14% (E13) of the fragments overlapped with transcription start site (TSS) regions, and 10% (E11) and 8% (E13) were in peaks. Moreover, the proportion of mitochondrial fragments was low for both E11 and E13 (1%). For the 20&#x2009;&#xB5;m experiment with mouse postnatal day 21 (P21) brain and human tonsil, we obtained a median of 7,647 (brain) and 14,939 (tonsil) unique fragments per pixel of which 18% of fragments fell within the TSS regions, and 24% (brain) and 14% (tonsil) were in peaks. The fraction of read pairs mapping to the mitochondria was 13% (brain) and 3% (tonsil), and the variability in the percentage of mitochondrial fragments may come from a different type of tissue (Fig. <xref rid="Fig1" ref-type="fig">1e&#x2013;h</xref>; as a reference, 10&#xD7; non-spatial scATAC-seq obtained a median of 17,321 unique fragments per cell, 23% TSS fragments and 0.4% mitochondrial reads). We also found that pixels that are not in the tissue had significantly fewer unique fragments compared with pixels in the tissue (Supplementary Fig. <xref rid="MOESM1" ref-type="media">1c,d</xref>). Moreover, the insert size distribution was consistent with the capture of nucleosomal and subnucleosomal fragments for all of the tissue types (Fig. <xref rid="Fig1" ref-type="fig">1i&#x2013;k</xref>). We also performed correlation analysis between replicates, which showed high reproducibility (<italic>r</italic>&#x2009;=&#x2009;0.95) (Supplementary Fig. <xref rid="MOESM1" ref-type="media">1b</xref>).</p>
    </sec>
    <sec id="Sec3">
      <title>Spatial mapping of the E13 mouse embryo</title>
      <p id="Par7">We next sought to identify cell types de novo from the E13 mouse embryo. Unsupervised clustering identified eight main clusters, that revealed distinct spatial patterns that agreed with the tissue histology (Fig. <xref rid="Fig2" ref-type="fig">2a&#x2013;c</xref> and Extended Data Fig. <xref rid="Fig6" ref-type="fig">2</xref>). For example, cluster 1 represents the fetal liver and cluster 2 is specific to the spine region, including dorsal root ganglia (DRG) with chromatin accessibility for <italic>Sox10</italic> (Supplementary Fig. <xref rid="MOESM1" ref-type="media">2a,b,i,j</xref>). Cluster 3 to cluster 5 are associated with the peripheral nervous system and CNS. Cluster 6 includes several cell types that are present in the developing limbs and cluster 8 encompasses several developing internal organs. To benchmark spatial-ATAC-seq data, we projected the ENCODE organ-specific ATAC-seq data onto our uniform manifold approximation and projection (UMAP) embedding<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. In general, the cluster identification matched well with the bulk ATAC-seq projection (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2d&#x2013;g</xref>) and distinguished all of the major developing tissues and organs (some inconsistency between bulk data and spatial-ATAC-seq data is probably attributed to the pixels that may contain multiple cell types). We further examined cell-type-specific marker genes, identified as differential between clusters (false-discovery rate (FDR)&#x2009;&lt;&#x2009;0.05, log<sub>2</sub>-transformed fold change (FC)&#x2009;&#x2265;&#x2009;0.25) and estimated the expression of these genes from our chromatin accessibility on the basis of the overall signal at a given locus<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, Extended Data Fig. <xref rid="Fig6" ref-type="fig">2c,h</xref> and Supplementary Table <xref rid="MOESM3" ref-type="media">1</xref>). <italic>Sptb</italic>, which has a role in the stability of erythrocyte membranes<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, was activated extensively in the liver. <italic>Syt8</italic>&#x2014;belonging to the synaptotagmin family, which is important in exocytosis during neurotransmission<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>&#x2014;had a high level of gene activity in the spine and DRG regions. <italic>Ascl1</italic>, which encodes a transcription factor that is involved in the commitment and differentiation of neuron and oligodendrocytes<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, showed strong enrichment in the brain and also the dorsal spinal cord (Fig. <xref rid="Fig2" ref-type="fig">2c</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">2e,f</xref>). <italic>Sox10</italic> marks oligodendroglia and Schwann cells and presented high accessibility in the DRGs, but also in the brain and spinal cord region (Supplementary Fig. <xref rid="MOESM1" ref-type="media">2a,b</xref>). <italic>Olig2</italic> is a marker of neural progenitors and oligodendroglia<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and is expressed in a limited region of the ventral spinal cord, in the ventral domains of the forebrain and in some posterior regions (brain stem, midbrain and hindbrain)&#x2014;regions that also present high chromatin accessibility at the <italic>Olig2</italic> locus (Supplementary Fig. <xref rid="MOESM1" ref-type="media">2c,d</xref>). Interestingly, <italic>Olig2</italic> chromatin accessibility occurs in the dorsal forebrain at E13 (Supplementary Fig. <xref rid="MOESM1" ref-type="media">2c</xref>), suggesting the possibility of epigenetic priming at this region and stage without the activation of gene expression<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. <italic>Ror2</italic> correlates with the early formation of the chondrocytes and cartilage, and it was highly expressed in the limb<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Pathway analysis revealed that cluster 1 was associated with erythrocyte differentiation, cluster 5 corresponded to forebrain development and cluster 6 was involved in limb development, consistent with anatomical annotations (Supplementary Fig. <xref rid="MOESM1" ref-type="media">3</xref>). Moreover, we further investigated the expression patterns in the spine, and some genes showed epigenetic gradients along the anterior&#x2013;posterior axis (Supplementary Fig. <xref rid="MOESM1" ref-type="media">4</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Spatial chromatin accessibility mapping of E13 mouse embryos.</title><p><bold>a</bold>, An unbiased clustering analysis was performed on the basis of the chromatin accessibility of all tissue pixels (50&#x2009;&#x3BC;m pixel size). An overlay of clusters with the tissue image reveals that the spatial chromatin accessibility clusters precisely match the anatomical regions. For better visualization, we scaled the size of the pixels. <bold>b</bold>, UMAP embedding of the unsupervised clustering analysis for chromatin accessibility. Cluster identities and colouring of clusters are consistent with <bold>a</bold>. <bold>c</bold>, The spatial mapping of gene scores for selected marker genes in different clusters and the chromatin accessibility at selected genes are highly tissue specific. <bold>d</bold>, Integration of scRNA-seq from E13.5 mouse embryos<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and spatial-ATAC-seq data. Unsupervised clustering of the combined data was coloured by different cell types. MOCA, Mouse Organogenesis Cell Atlas. <bold>e</bold>, Anatomical annotation of major tissue regions based on the haematoxylin and eosin (H&amp;E)-stained image. <bold>f</bold>, Spatial mapping of selected cell types identified by label transferring from scRNA-seq to spatial-ATAC-seq data. <bold>g</bold>, Pseudotemporal reconstruction from the developmental process from radial glia, postmitotic premature neurons, to excitatory neurons plotted in space. <bold>h</bold>, The dynamics of the gene scores of selected genes along the pseudotime shown in <bold>g</bold>. <bold>i</bold>, The dynamics of the chromatin accessibility of individual regulatory elements at <italic>Pou3f2</italic> and <italic>Nova2</italic> (highlighted in grey boxes). Scale bar, 20&#x2009;kb.</p></caption><graphic xlink:href="41586_2022_5094_Fig2_HTML" id="d32e918"/></fig></p>
      <p id="Par8">In addition to the inference of cell-type-specific marker genes, our approach also enabled the identification of cell-type-specific chromatin regulatory elements (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3</xref>), providing a resource for defining regulatory elements as cell-type-specific reporters. We examined cell-type-specific transcription factor regulators using deviations of transcription factor motifs (FDR&#x2009;&lt;&#x2009;0.05, log<sub>2</sub>[FC]&#x2009;&#x2265;&#x2009;0.1) and found that the most enriched motifs in the peaks that are more accessible in the fetal liver correspond to GATA transcription factors, consistent with their well-studied role in erythroid differentiation<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3c,d</xref>). Cluster 5 is enriched for the SOX6 motif, supporting its role in CNS development. <italic>Hoxd11</italic>, which marks the posterior patterning and has a role in limb morphogenesis, was enriched in the limb (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3d</xref>). We further conducted enrichment analysis using GREAT, and the pathways matched well with the anatomical annotation (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3e</xref>).</p>
      <p id="Par9">We then integrated the spatial-ATAC-seq data with single-cell RNA-sequencing (scRNA-seq) data to assign cell types to each cluster<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> (Fig. <xref rid="Fig2" ref-type="fig">2d&#x2013;f</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">5a</xref>). For example, the definitive erythroid cells appeared predominantly in the liver. Intermediate mesoderm was identified in the internal organ region, and radial glia were mainly distributed in the CNS. A refined clustering process also enabled the identification of subpopulations in excitatory neurons with distinct spatial distributions, marker genes and chromatin regulatory elements (Supplementary Fig. <xref rid="MOESM1" ref-type="media">5b&#x2013;d</xref>). During embryonic development, dynamic changes in chromatin accessibility across time and space help to regulate the formation of complex tissue architectures and terminally differentiated cell types. In the embryonic CNS, radial glia function as primary progenitors or neural stem cells, which give rise to various types of neuron<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. We therefore sought to recover the developmental trajectory and examine how the developmental processes proceed across the tissue space. We focused on the course of differentiation from radial glia towards excitatory neurons with postmitotic premature neurons as the immediate state. Spatial projection of each pixel&#x2019;s pseudotime revealed the spatially organized developmental trajectory in neurons (Fig. <xref rid="Fig2" ref-type="fig">2g</xref>). We observed that cells early in differentiation clustered around the ventricles in the developing brainstem, whereas those farther away exhibited a more differentiated phenotype. We then identified changes in gene score across this developmental process, and observed high chromatin accessibility in radial glia at <italic>Sox2</italic> and <italic>Pax6</italic> loci, genes encoding transcription factors that are necessary for progenitor self-renewal identity<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. As expected, there was a clear reduction in accessibility in the transition to postmitotic premature neurons and excitatory neurons, which instead presented chromatin opening at genes expressed in mature neurons, such as <italic>Ntng1</italic> and <italic>Car10</italic> (ref.&#xA0;<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>) (Fig. <xref rid="Fig2" ref-type="fig">2h</xref>). We also used the correlation of peak accessibility to predict the interactions between regulatory regions and found dynamically regulated promoter interactions with specific enhancers, such as <italic>Pou3f2</italic> and <italic>Nova2</italic> (Fig. <xref rid="Fig2" ref-type="fig">2i</xref>)<italic>. Pou3f2</italic> (also known as <italic>Brn2</italic>), encodes a transcription factor that is expressed in mice in late progenitors and postmitotic neurons<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> and that has been shown to be involved in neural development for the production of specific neuronal populations<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Our analysis shows a reduction of chromatin accessibility at a specific <italic>Brn2</italic> enhancer during the transition from radial glial to postmitotic&#xA0;premature neurons, but not at other <italic>cis</italic>-regulatory regions, suggesting a role of this region in <italic>Brn2</italic> transcription. A similar decrease in chromatin accessibility was observed in excitatory neurons for a specific intronic enhancer of <italic>Nova2</italic>, which encodes an RNA-binding protein that is expressed in neurons<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Thus, our data indicated that spatial-ATAC-seq enables mapping at the spatial level of the chromatin accessibility dynamics at important regulatory regions during neural lineage commitment.</p>
    </sec>
    <sec id="Sec4">
      <title>Spatial mapping of the E11 mouse embryo</title>
      <p id="Par10">To further map chromatin accessibility during mouse fetal development, we profiled mouse embryos at an earlier stage (E11) and identified four clusters with distinct spatial patterns, which showed good agreement with the anatomy (Extended Data Figs. <xref rid="Fig8" ref-type="fig">4a,b</xref> and&#xA0;<xref rid="Fig9" ref-type="fig">5a,b</xref>). Cluster 1 is located in the fetal liver and aorta&#x2013;gonad&#x2013;mesonephros (AGM), which are related to embryonic haematopoiesis. Cluster 2 and cluster 3 consist of tissues associated with neuronal development, such as the mouse brain and neural tube. Cluster 4 includes the embryonic facial prominence, internal organs and limb. Furthermore, cluster identification matched the ENCODE organ-specific bulk ATAC-seq projection onto the UMAP (Extended Data Fig. <xref rid="Fig9" ref-type="fig">5d&#x2013;g</xref>).</p>
      <p id="Par11">We further surveyed the chromatin accessibility that distinguished each cluster (FDR&#x2009;&lt;&#x2009;0.05, log<sub>2</sub>[FC]&#x2009;&#x2265;&#x2009;0.25) (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4c</xref> and Extended Data Fig. <xref rid="Fig9" ref-type="fig">5c</xref>). For example, <italic>Slc4a1</italic>, which is required for normal flexibility and the stability of the erythrocyte membrane and for normal erythrocyte shape<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, was highly accessible in the liver and AGM. <italic>Nova2</italic>, which is involved in RNA splicing or metabolism regulation in a specific subset of developing neurons<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, was highly enriched in the brain and neural tube. <italic>Rarg</italic>, which has an essential role in limb bud development, skeletal growth and matrix homeostasis, was activated extensively in the embryonic facial prominence and limb<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Moreover, a Gene Ontology (GO) enrichment analysis identified the development processes consistent with the anatomical annotation (Supplementary Fig. <xref rid="MOESM1" ref-type="media">6</xref>). To gain deeper insights into the regulatory factors, we clustered chromatin regulatory elements and examined the enrichment for transcription-factor-binding motifs (Extended Data Fig. <xref rid="Fig10" ref-type="fig">6</xref>). We observed a strong enrichment of the motifs for <italic>Gata2</italic> and <italic>Ascl2</italic> (Extended Data Fig. <xref rid="Fig10" ref-type="fig">6c,d</xref>) in the clusters associated with embryonic haematopoiesis and neuronal development<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, respectively (FDR&#x2009;&lt;&#x2009;0.05, log<sub>2</sub>[FC]&#x2009;&#x2265;&#x2009;0.1). These master regulators further validated the unique identity of each cluster. Furthermore, the pathways matched well with the anatomical annotation in the enrichment analysis using GREAT (Extended Data Fig. <xref rid="Fig10" ref-type="fig">6e</xref>).</p>
      <p id="Par12">To assign cell types to each cluster, we integrated the spatial-ATAC-seq data with the scRNA-seq<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4d&#x2013;f</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">7</xref>). The primitive erythroid cells, which are crucial for early embryonic erythroid development, were strongly enriched in the liver and AGM. Radial glia, postmitotic premature neurons and inhibitory neuron progenitors were found in the brain and neural tube. We observed abundant chondrocytes and osteoblasts in the embryonic facial prominence, and the limb mesenchyme was highly enriched in the limb region. Furthermore, compared with E13, hepatocytes and white blood cells could not be identified in the E11 liver region, suggesting that these cell types emerged at the later developmental time points. We also reconstructed the developmental trajectory from radial glia to excitatory neurons (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4g&#x2013;j</xref>) and identified the changes in neuron-development-related genes, which recapitulated transcription factor deviations across this developmental process, including <italic>Notch1</italic>, which is highly expressed in the radial glia and regulates neural stem cell number and function during development<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4h</xref>). Moreover, with increased spatial resolution (20&#x2009;&#xB5;m pixel size), spatial-ATAC-seq was able to resolve more cell types, such as a thin layer of notochord cells identified in cluster 3 (Extended Data Fig. <xref rid="Fig11" ref-type="fig">7</xref>).</p>
      <p id="Par13">To assess the temporal dynamics of chromatin accessibility more directly during development, we identified dynamic peaks that exhibit a significant change in accessibility from the E11 to E13 mouse embryo within fetal liver and excitatory neurons. We observed significant differences in the chromatin accessibility of fetal liver and excitatory neurons between different developmental stages (Supplementary Fig. <xref rid="MOESM1" ref-type="media">8</xref>). In particular, chromatin accessibility profiles of the fetal liver at E13 were enriched for GATA motif sequences (Supplementary Fig. <xref rid="MOESM1" ref-type="media">8d,f</xref>)&#x2014;transcription factors that are known to be important in erythroid differentiation<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Moreover, the EGR1 motif was enriched in the excitatory neurons at E13 (Supplementary Fig. <xref rid="MOESM1" ref-type="media">8g</xref>), which has functional implications during brain development, particularly for the specification of excitatory neurons<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>.</p>
    </sec>
    <sec id="Sec5">
      <title>Spatial mapping of the mouse and human brain</title>
      <p id="Par14">To further benchmark and integrate the spatial-ATAC-seq data with available scATAC-seq and scRNA-seq datasets, we applied spatial-ATAC-seq profiling to the P21 mouse brain coronal section at bregma 1 (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). Although nuclear staining with 7-aminoactinomycin D (7-AAD) resolved only the outline of the lateral ventricle (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>), unsupervised clustering identified seven clusters with a unique spatial distribution, revealing the intricate arealization of this brain region (Fig. <xref rid="Fig3" ref-type="fig">3c,d</xref>). These clusters showed unique accessibility within marker gene regions (FDR&#x2009;&lt;&#x2009;0.05, log<sub>2</sub>[FC]&#x2009;&#x2265;&#x2009;0.1) for excitatory neurons (<italic>Khdrbs3</italic>, cluster 1), medium spiny neurons (<italic>Pde10a</italic>, cluster 2), lateral septal nucleus (<italic>Dgkg</italic>, cluster 4), corpus-callosum-enriched oligodendrocytes (<italic>Mobp</italic>, cluster 6) and ventricular-zone-enriched astroependymal cells (<italic>Fgfr3</italic>, cluster 7<italic>)</italic> (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>). Integration and co-embedding the spatial-ATAC-seq data with the scATAC-seq atlas<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> validated the identity of the clusters (Fig. <xref rid="Fig3" ref-type="fig">3f,g</xref>&#xA0;and Supplementary Table <xref rid="MOESM4" ref-type="media">2</xref>). Label transfer from scRNA-seq<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> to spatial-ATAC-seq further confirmed the population assignments and revealed precise spatial localizations of the inferred cell identities (Fig. <xref rid="Fig3" ref-type="fig">3h</xref> and Extended Data Fig. <xref rid="Fig12" ref-type="fig">8</xref>). Integration with scATAC-seq and scRNA-seq data also helped to deconvolve additional cell types; for example, astrocytes, ependymal cells and subventricular zone neuroblasts within the C7 astroependymal cluster. A subpopulation of cluster 5, a cluster containing vascular cells, was assigned as arterial vascular smooth muscle cells and, accordingly, might line a thin layer of blood vessel, which could not be resolved at a lower spatial resolution (Fig. <xref rid="Fig3" ref-type="fig">3h</xref>, Extended Data Fig. <xref rid="Fig12" ref-type="fig">8b</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">9</xref>). Moreover, cells within the oligodendrocyte lineage could be assigned into distinct populations within a continuum from oligodendrocyte progenitors to mature, differentiated oligodendrocytes (Fig. <xref rid="Fig3" ref-type="fig">3f,g</xref> and Extended Data Fig. <xref rid="Fig12" ref-type="fig">8a,b</xref>). Although immature oligodendrocyte populations, such as differentiation-committed oligodendrocyte precursors, did not show clear spatial preferences for any of the analysed regions, we observed an enrichment of myelin-forming oligodendrocytes and mature oligodendrocytes within the white-matter region of the corpus callosum (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8b</xref>). Interestingly, integration of our previously generated spatial H3K4me3 and H3K27me3 CUT&amp;Tag datasets with single-cell CUT&amp;Tag could not fully deconvolute the spatial progenitor and mature oligodendrocyte identities<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, underscoring the power of spatial-ATAC-seq to deconvolve cell types in the brain. Finally, we used the spatial-ATAC-seq data to identify pixels with a single nucleus, which would be equivalent to scATAC-seq data (Fig. <xref rid="Fig3" ref-type="fig">3i,j</xref>). We next visualized the gene scores in a heat map, demonstrating the ability of spatial-ATAC-seq to generate scATAC-seq profiles (Fig. <xref rid="Fig3" ref-type="fig">3k</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Spatial chromatin accessibility mapping and integrative analysis of P21 mouse brain with a 20&#x2009;&#xB5;m pixel size.</title><p><bold>a</bold>, Bright-field image of a mouse brain tissue section and the region of interest for mapping (red dashed box). Scale bar, 1&#x2009;mm. <bold>b</bold>, Fluorescence image of nuclear staining with 7-AAD in the region of interest for spatial-ATAC-seq mapping.&#xA0;Scale bar, 200&#x2009;&#xB5;m. <bold>c</bold>,<bold>d</bold>, Unsupervised clustering analysis (<bold>c</bold>) and the spatial distribution (<bold>d</bold>) of each cluster in the mouse brain. For better visualization, we scaled the size of the pixels. <bold>e</bold>, Spatial mapping of gene scores for selected marker genes in different clusters. <bold>f</bold>,<bold>g</bold>, Integration of scATAC-seq from mouse brains<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> (<bold>f</bold>) and spatial-ATAC-seq (<bold>g</bold>). <bold>h</bold>, Spatial mapping of selected cell types identified by label transfer from scRNA-seq to spatial-ATAC-seq. <bold>i</bold>, The spatial location of pixels containing a single nucleus. <bold>j</bold>, Fluorescence images of selected pixels containing a single nucleus. <bold>k</bold>, Heat map of the gene scores of selected pixels containing a single nucleus.&#xA0;A list of abbreviation definitions can be found in Supplementary Table <xref rid="MOESM4" ref-type="media">2</xref>.</p></caption><graphic xlink:href="41586_2022_5094_Fig3_HTML" id="d32e1306"/></fig></p>
      <p id="Par15">To further investigate the performance of our technology across species, we next used spatial-ATAC-seq on adult archival human coronal brain section, including the hippocampus and choroid plexus (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9a</xref>). We were able to identify six clusters that were differentially distributed across the tissue section (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9b</xref>). To refine and validate their identities, we performed further integration with a scATAC-seq dataset<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, which revealed enriched chromatin accessibility within specific gene regions for neurons (<italic>vGLUT1</italic>, <italic>VGAT</italic>, cluster 1), oligodendrocytes (<italic>MAG</italic>, cluster 2), astrocytes (<italic>GFAP</italic>, cluster 4) and microglia (<italic>IBA1</italic>, cluster 6) (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9c,d</xref>). Spatial mapping of the identified clusters correlated well with their expected tissue localization, with the granule cell layer mainly consisting of neurons (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9b,c</xref>). These results together confirmed the ability of spatial-ATAC-seq to spatially resolve different cellular populations within human brain tissue on the basis of their chromatin accessibility patterns.</p>
    </sec>
    <sec id="Sec6">
      <title>Spatial mapping of human tonsils</title>
      <p id="Par16">To further demonstrate the ability to profile spatial chromatin accessibility in different species and tissue types, we applied spatial-ATAC-seq to human tonsil tissue. Unsupervised clustering revealed distinct spatial features with the germinal centres (GC) identified mainly in cluster 1 (Fig. <xref rid="Fig4" ref-type="fig">4a&#x2013;c</xref> and Extended Data Fig. <xref rid="Fig14" ref-type="fig">10a</xref>). We next examined the spatial patterns of specific marker genes to distinguish cell types (FDR&#x2009;&lt;&#x2009;0.05, log2[FC]&#x2009;&#x2265;&#x2009;0.1) (Fig. <xref rid="Fig4" ref-type="fig">4d</xref> and Supplementary Fig. <xref rid="MOESM1" ref-type="media">10</xref>) and compared these data with the distribution of protein expression in tonsils (Supplementary Fig. <xref rid="MOESM1" ref-type="media">11</xref>). For B-cell-related genes, the accessibility of <italic>CD10</italic>, a marker for mature GC B cells<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, was enriched in the GC regions. <italic>CD27</italic>, a marker for memory B cells<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, was active in the GC and the extrafollicular regions. <italic>CD38</italic>, which marks activated B cells<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, was found to be enriched in the GC. <italic>CXCR4</italic>, which is expressed in the centroblasts in the GC dark zone<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>, unexpectedly showed high accessibility in only non-GC cells. This discordance between epigenetic state and protein expression may suggest epigenetic priming of pre-GC B cells before entering the GC. It could also be due to the presence of CXCR4<sup>+</sup> T cells supporting extrafollicular B cell responses in the setting of inflammation<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. <italic>PAX5</italic>, a transcription factor for follicular and memory B cells<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, was enriched in the GC but was also observed in the extrafollicular zones in which the memory B cells migrated to. <italic>BHLHE40</italic>, a transcription factor that can bind to the major regulatory regions of the IgH locus, was observed to be highly enriched in the extrafollicular region but completely depleted in the GC, suggesting a potential role in the regulation of class-switch recombination in the pre-GC state<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. This supports a model of epigenetic control for class-switch recombination that occurs before the formation of the GC response. For T cell-related genes, <italic>CD3</italic> corresponded to T cell zones<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> and was also found to be active in the GC. It is known that trafficking of follicular helper T cells (T<sub>FH</sub>) into the GC requires downregulation of CCR7 and upregulation of CXCR5&#xA0;(ref.&#xA0;<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>). We observed significantly reduced <italic>CCR7</italic> accessibility in the GC and strong enrichment outside the GC, indicating that this T<sub>FH</sub> function is indeed epigenetically regulated. <italic>CXCR5</italic> accessibility was extensively detected in the GC but was also observed outside the GC, indicating a possible early epigenetic priming of T<sub>FH</sub> cells before GC entry for B cell help. The accessibility of <italic>BCL6</italic>, a T<sub>FH</sub> master transcription factor<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, was strongly enriched in the GC as expected. <italic>FOXP3</italic>, a master transcription factor for follicular regulatory T cells<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, is mainly in the extrafollicular zone but at low frequency according to human protein atlas data (Supplementary Fig. <xref rid="MOESM1" ref-type="media">11</xref>). Interestingly, it showed extensive open locus accessibility, suggesting extensive epigenetic priming of pre-GC T cells to potentially develop follicular regulatory T cell function as needed to balance GC activity. <italic>CD25</italic>, a surface marker for regulatory T cells<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, was active in both the GC and the extrafollicular zone. For non-lymphoid cells, <italic>CD11B</italic>, a macrophage marker<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, was inactive in the GC, in contrast to <italic>CD11A</italic>, which was more active in GC lymphocytes. <italic>CD103</italic> was enriched in GC follicular dendritic cells. <italic>CD144</italic>, which encodes vascular endothelial cadherin (VE-cadherin)<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, corresponded to endothelial microvasculature near to the crypt or between follicles. <italic>CD32</italic>, a surface receptor that is involved in phagocytosis and clearing of immune complexes<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, and <italic>CD55</italic>, a complement decay-accelerating factor, were both active in the same region such that the cells that are not supposed to be cleared can be protected against phagocytosis by blocking the formation of the membrane attack complex<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. We also examined cell-type-specific transcription factor regulators within each cluster and our data revealed that KLF-family transcription factors were highly enriched in non-GC cells, consistent with a previous study<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> (FDR&#x2009;&lt;&#x2009;0.05, log<sub>2</sub>[FC]&#x2009;&#x2265;&#x2009;0.1) (Supplementary Fig. <xref rid="MOESM1" ref-type="media">12</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Spatial chromatin accessibility mapping of a human tonsil with a 20&#x2009;&#xB5;m pixel size.</title><p><bold>a</bold>, H&amp;E image of a human tonsil from an adjacent tissue section and a region of interest for spatial chromatin accessibility mapping. Scale bar, 1&#x2009;mm. <bold>b</bold>, Unsupervised clustering analysis and spatial distribution of each cluster. For better visualization, we scaled the size of the pixels. <bold>c</bold>, Anatomical annotation of major tonsillar regions. <bold>d</bold>, Spatial mapping of the gene scores for selected genes. <bold>e</bold>, Integration of scRNA-seq data<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and spatial-ATAC-seq data. Unsupervised clustering of the combined data was coloured by different cell types. <bold>f</bold>, Spatial mapping of selected cell types identified by label transferring from scRNA-seq to spatial-ATAC-seq data. Scale bar, 500&#x2009;&#xB5;m. <bold>g</bold>, Pseudotemporal reconstruction from the developmental process from naive B cells to GC B cells plotted in space. <bold>h</bold>, Dynamics of the gene scores of selected genes along the pseudotime shown in <bold>g</bold>. <bold>i</bold>, Dynamics of the chromatin accessibility of individual regulatory elements along pseudotime (highlighted in grey boxes). Fine-mapped autoimmune-associated GWAS variants and high-resolution individual single-nucleotide polymorphism loci localizing to accessible chromatin are shown. Scale bar, 25&#x2009;kb.</p></caption><graphic xlink:href="41586_2022_5094_Fig4_HTML" id="d32e1562"/></fig></p>
      <p id="Par17">To map cell types onto each cluster, we integrated spatial-ATAC-seq data with scRNA-seq and scATAC-seq datasets<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> (Fig. <xref rid="Fig4" ref-type="fig">4e</xref> and Extended Data Fig. <xref rid="Fig14" ref-type="fig">10b</xref>). After label transfer from scRNA-seq, we found that cells from cluster 0 were widely distributed in the non-GC region, whereas cells from cluster 4 were enriched in GC (Fig. <xref rid="Fig4" ref-type="fig">4e,f</xref> and Extended Data Fig. <xref rid="Fig14" ref-type="fig">10c</xref>). We also identified a small region with cells enriched from cluster 13 (Fig. <xref rid="Fig4" ref-type="fig">4f</xref> and Extended Data Fig. <xref rid="Fig14" ref-type="fig">10c</xref>). To define the cell identities for scRNA-seq clusters, we examined the marker genes for each cluster and found that cluster 0 comprised naive B cells, cluster 4 corresponded to GC B cells and cluster 13 was macrophages (Extended Data Fig. <xref rid="Fig14" ref-type="fig">10d</xref>), in agreement with the tissue histology (Fig. <xref rid="Fig4" ref-type="fig">4f</xref>).</p>
      <p id="Par18">Lymphocyte activation, maturation and differentiation are regulated by the gene networks under the control of transcription factors<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. To understand the dynamic regulation process, we implemented a pseudotemporal reconstruction of B cell activation to the GC reaction (Fig. <xref rid="Fig4" ref-type="fig">4g&#x2013;i</xref>). Meanwhile, the projection of each pixel&#x2019;s pseudotime onto spatial coordinates revealed spatially distinct regions in this dynamic process. Interestingly, we found that the enriched macrophage population colocalized with inactivated B cells, consistent with the fact that B cells are activated through acquiring antigens from antigen-presenting macrophages before GC entry or formation<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> (Fig. <xref rid="Fig4" ref-type="fig">4g</xref>). Moreover, pseudotemporal ordering of B cell activation revealed dynamic expression and chromatin activity before commitment to the GC state (Fig. <xref rid="Fig4" ref-type="fig">4h</xref>), including an early activity of <italic>BCL2</italic> and reduced accessibility within GC B cells as compared to naive populations, suggesting that this antiapoptotic molecule may be actively repressed to ensure that GC B cells are eliminated by apoptosis if they are not selected and rescued by survival signals. By contrast, <italic>LMO2</italic> exhibited increased accessibility at the target sites within GC B cells (Extended Data Fig. <xref rid="Fig14" ref-type="fig">10e</xref>), consistent with the previous finding that <italic>LMO2</italic> is specifically upregulated in the GC<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. We also identified putative target genes of fine-mapped autoimmune genome-wide association study (GWAS) genetic variants, and revealed GC-specific regulatory potential, including at loci of major GC regulators such as <italic>BCL6</italic> (Fig. <xref rid="Fig4" ref-type="fig">4i</xref>).</p>
    </sec>
    <sec id="Sec7" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par19">We developed spatial-ATAC-seq for spatially resolved profiling of chromatin accessibility in intact tissue sections with spatial information retained at the cellular level (20&#x2009;&#x3BC;m pixel size). Single-cell chromatin accessibility can also be derived without tissue dissociation by identifying pixels containing only one nucleus using immunofluorescence imaging. Spatial-ATAC-seq was applied to mouse embryos (E11 and E13) to delineate the epigenetic landscape of organogenesis; we identified all major tissue types with a distinct chromatin accessibility state, and revealed the spatiotemporal changes in development. Mapping the accessible genome in the mouse and human brain revealed the intricate arealization of brain region. We also used spatial-ATAC-seq to map the epigenetic state of different immune cells in human tonsils and revealed the dynamics of B cell activation to GC reaction and putative target genes of fine-mapped autoimmune GWAS genetic variants. Compared with spatial-CUT&amp;Tag for the targeted profiling of histone modifications<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, spatial-ATAC-seq provided a genome-wide chromatin accessibility landscape, for which it is challenging to obtain a high signal-to-noise ratio, especially in fresh frozen tissue sections.</p>
      <p id="Par20">The areas for further development include the following. First, the number of mapping pixels could be further increased by increasing the number of barcodes (for example, 100&#x2009;&#xD7;&#x2009;100) or using serpentine microfluidic channels for tissue array. Second, different from single-cell technologies, the pixels in spatial-ATAC-seq may contain partial nuclei or multiple nuclei and could lead to cell mixtures that may comprise multiple cell types, complicating data interpretation. This challenge could be addressed by using cell-type deconvolution approaches or seamless integration with high-resolution tissue images, that is, multicolour immunofluorescence images, to identify the cells in each pixel. We observed that a significant number of pixels (20&#x2009;&#x3BC;m) contained single nuclei, which can give rise to spatially defined scATAC-seq data. Third, integration with other spatial omics measurements such as transcriptomics and proteomics, can provide a comprehensive picture of cell types and cell states. We may combine reagents for DBiT-seq<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and spatial-ATAC-seq in the same microfluidic barcoding step to achieve spatial multi-omics profiling, which should work in theory but does require further optimization for tissue fixation and reaction conditions to make these assays compatible. Finally, spatial-ATAC-seq is yet to be further extended to tissue samples from human patients with a disease to realize its full potential in clinical research. We anticipate that spatial-ATAC-seq will add a new dimension to spatial biology, enabling the profiling of regulatory elements in a spatially resolved manner, which cannot be achieved by spatial transcriptomics or proteomics. Spatial-ATAC-seq may transform multiple biomedical research fields including developmental biology, neuroscience, immunology, oncology and clinical pathology, therefore empowering scientific discovery and translational medicine in human health and disease.</p>
    </sec>
    <sec id="Sec8" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec9">
        <title>Juvenile mouse brain and sample preparation</title>
        <p id="Par21">Experimental procedures on juvenile (P21) mice were conducted in accordance with the European directive 2010/63/EU, local Swedish directive L150/SJVFS/2019:9, Saknr L150 and the Karolinska Institutet complementary guidelines for procurement and use of laboratory animals, Dnr 1937/03-640. The procedures described here were approved by Stockholms Norra Djurf&#xF6;rs&#xF6;ksetiska n&#xE4;mnd, the local committee for ethical experiments on laboratory animals in Sweden, 1995/2019 and 7029/2020.</p>
        <p id="Par22">The mouse line <italic>Sox10:cre-RCE:LoxP</italic> (eGFP), on a C57BL/6xCD1 mixed genetic background, was used for experiments on P21 mice. It was generated by crossing <italic>Sox10:cre</italic> animals<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> (Jackson Laboratory, 025807) on a C57BL/6j genetic background with <italic>RCE:loxP</italic> (enhanced green fluorescent protein (eGFP)) animals<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> (Jackson Laboratory, 32037-JAX) on a C57BL/6xCD1 mixed genetic background. Breeding of female mice with a hemizygous <italic>cre</italic> allele with male mice lacking the <italic>cre</italic> allele (while the reporter allele was kept in hemizygosity or homozygosity in both female and male mice) resulted in labelling of the oligodendrocyte lineage with eGFP. Mice, free of common viral pathogens, ectoparasites, endoparasites and mouse bacterial pathogens, were housed to a maximum of five mice per cage in individually ventilated cages (IVC Sealsafe GM500, Tecniplast). The cages were equipped with hardwood bedding (TAPVEI), nesting material, shredded paper, gnawing sticks and a cardboard box shelter (Scanbur). Mice received regular chew diet and water using a water bottle that was changed weekly. Cages were changed every other week in a laminar air-flow cabinet. General housing parameters, such as relative humidity, temperature and ventilation, were used according to the European convention for the protection of vertebrate animals used for experimental and other scientific purposes treaty ETS 123. Specifically, consistent relative air humidity and temperature were set to 50% and 22&#x2009;&#xB0;C, and the air quality was controlled with the use of stand-alone air handling units supplemented with a HEPA filter. Husbandry parameters were monitored using the ScanClime (Scanbur) units. The following light&#x2013;dark cycle was used: dawn, 6:00&#x2013;7:00; daylight, 7:00&#x2013;18:00; dusk, 18:00&#x2013;19:00; night, 19:00&#x2013;6:00.</p>
      </sec>
      <sec id="Sec10">
        <title>Post-mortem human brain and sample preparation</title>
        <p id="Par23">One human hippocampus sample was obtained from the Brain Collection of the New York State Psychiatric Institute (NYSPI) and Columbia University<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. This brain sample was a fresh frozen unfixed specimen. All procedures of brain collection and autopsy were conducted with Institutional Review Board approval and informed consent from the next of kin. The participant selected was free of neuropsychiatric illness on the basis of our validated psychological autopsy interview of the next of kin<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, died of sudden death (industrial accident) with short agonal state (that can affect brain oxygenation if prolonged), had short post-mortem interval (6.5&#x2009;h), clear neuropathological exam, negative brain toxicology for psychoactive drugs, medication and alcohol, and good RNA quality (RNA integrity number 8.50).</p>
        <p id="Par24">The anterior hippocampus was dissected from a 2-cm-thick coronal block of the right hemisphere, and sectioned at a thickness of 10&#x2009;&#x3BC;m using a cryostat (Leica 3050S). Each of the serial sections of the dentate gyrus region (around 1&#x2009;cm&#x2009;&#xD7;&#x2009;1&#x2009;cm) were placed onto an ultraclean glass slide (Electron Microscopy Sciences, 63478-AS). We took one slide for sequencing and performed H&amp;E and Nissl staining on two adjacent slides. All of the samples were stored at &#x2212;80&#x2009;&#xB0;C before use.</p>
      </sec>
      <sec id="Sec11">
        <title>Fabrication and assembly of the microfluidic device</title>
        <p id="Par25">The moulds for microfluidic devices were fabricated in the cleanroom using standard photolithography. We followed the manufacturer&#x2019;s guidelines to spin-coat SU-8-negative photoresist (SU-2010, SU-2025, Microchem) onto a silicon wafer (C04004, WaferPro). The feature heights of the 50-&#xB5;m-wide and 20-&#xB5;m-wide microfluidic channel device were about 50&#x2009;&#xB5;m and 23&#x2009;&#xB5;m, respectively. During exposure to ultraviolet light, chrome photomasks (Front Range Photomasks) were used. Soft lithography was used for the fabrication of polydimethylsiloxane (PDMS) microfluidic devices. We mixed base and curing agent at a 10:1 ratio and added it over the SU-8 masters. The PDMS was cured (at 65&#x2009;&#xB0;C for 2&#x2009;h) after degassing in a vacuum (30&#x2009;min). After solidification, the PDMS slab was cut out. The outlet and inlet holes were punched for further use. We have published a protocol in terms of device fabrication and operation<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>.</p>
      </sec>
      <sec id="Sec12">
        <title>Preparation of tissue slides</title>
        <p id="Par26">Mouse C57 Embryo Sagittal Frozen Sections (MF-104-11-C57) and Human Tonsil Frozen Sections (HF-707) were purchased from Zyagen. Tissues were snap-frozen in optimal cutting temperature compounds, sectioned (thickness of 7&#x2013;10&#x2009;&#xB5;m) and put at the centre of poly-<sc>l</sc>-lysine-covered glass slides (63478-AS, Electron Microscopy Sciences).</p>
      </sec>
      <sec id="Sec13">
        <title>H&amp;E staining</title>
        <p id="Par27">The frozen slide was warmed at room temperature for 10&#x2009;min and fixed with 1&#x2009;ml 4% formaldehyde (10&#x2009;min). After being washed once with 1&#xD7; DPBS, the slide was quickly dipped in water and dried with air. Isopropanol (500&#x2009;&#x3BC;l) was then added to the slide and incubated for 1&#x2009;min before being removed. After completely dry in the air, the tissue section was stained with 1&#x2009;ml haematoxylin (Sigma-Aldrich) for 7&#x2009;min and cleaned in deionized water. The slide was then incubated in 1&#x2009;ml bluing reagent (0.3% acid alcohol, Sigma-Aldrich) for 2&#x2009;min and rinsed in deionized water. Finally, the tissue slide was stained with 1&#x2009;ml eosin (Sigma-Aldrich) for 2&#x2009;min and cleaned in deionized water.</p>
      </sec>
      <sec id="Sec14">
        <title>Preparation of the transposome</title>
        <p id="Par28">Unloaded Tn5 transposase (C01070010) was purchased from Diagenode, and the transposome was assembled according to the manufacturer&#x2019;s guidelines. The oligos used for transposome assembly were as follows: Tn5MErev, 5&#x2032;-/5Phos/CTGTCTCTTATACACATCT-3&#x2032;; Tn5ME-A, 5&#x2032;-/5Phos/CATCGGCGTACGACTAGATGTGTATAAGAGACAG-3&#x2032;; Tn5ME-B, 5&#x2032;-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3&#x2032;.</p>
      </sec>
      <sec id="Sec15">
        <title>DNA oligos, DNA barcode sequences and other key reagents</title>
        <p id="Par29">Lists of the DNA oligos that were used for sequencing library construction and PCR (Supplementary Table <xref rid="MOESM5" ref-type="media">3</xref>), DNA barcode sequences (Supplementary Table <xref rid="MOESM5" ref-type="media">3</xref>) and all other key reagents (Supplementary Table <xref rid="MOESM6" ref-type="media">4</xref>) are provided.</p>
      </sec>
      <sec id="Sec16">
        <title>Spatial-ATAC-seq profiling</title>
        <p id="Par30">As we proceeded to develop spatial-ATAC-seq, we went through several versions of chemistry to optimize the protocol to achieve a high yield and a high signal-to-noise ratio for the mapping of tissue sections (Supplementary Fig. <xref rid="MOESM1" ref-type="media">2a</xref>). First, a set of 50 DNA oligomers containing both barcode A and adapter were introduced in microchannels to a tissue section for in situ transposition, but the efficiency was low due in part to limited amounts of Tn5 DNA in the microchannels. To address this issue, we conducted bulk transposition followed by two ligation steps to introduce spatial barcodes A and B. We also optimized the fixation condition by reducing the formaldehyde concentration from 4% in chemistry V1 to 0.2%. Furthermore, we tested the sensitivity of different Tn5 transposase enzymes (Diagenode (C01070010) versus Lucigen (TNP92110)).</p>
        <p id="Par31">In the optimized spatial-ATAC-seq protocol, the frozen slide was warmed at room temperature for 10&#x2009;min. The tissue was then fixed with formaldehyde (0.2% for 5&#x2009;min) and quenched with glycine (1.25&#x2009;M for 5&#x2009;min) at room temperature. After fixation, the tissue was washed twice with 1&#x2009;ml 1&#xD7; DPBS and cleaned in deionized water. The tissue section was then permeabilized with 500&#x2009;&#xB5;l lysis buffer (10&#x2009;mM Tris-HCl, pH&#x2009;7.4, 10&#x2009;mM NaCl, 3&#x2009;mM MgCl<sub>2</sub>, 0.01% Tween-20, 0.01% NP-40, 0.001% digitonin, 1%&#x2009;BSA) for 15&#x2009;min and was washed with 500&#x2009;&#xB5;l wash buffer(10&#x2009;mM Tris-HCl pH&#x2009;7.4, 10&#x2009;mM NaCl, 3&#x2009;mM MgCl<sub>2</sub>, 1%&#x2009;BSA, 0.1% Tween-20) for 5&#x2009;min. Then, 100&#x2009;&#xB5;l transposition mix (50&#x2009;&#xB5;l 2&#xD7; tagmentation buffer, 33&#x2009;&#xB5;l 1&#xD7; DPBS, 1&#x2009;&#xB5;l 10% Tween-20, 1&#x2009;&#xB5;l 1% digitonin, 5&#x2009;&#xB5;l transposome, 10&#x2009;&#xB5;l nuclease-free H<sub>2</sub>O) was added followed by incubation at 37&#x2009;&#xB0;C for 30&#x2009;min. After removing the transposition mix, 500&#x2009;&#xB5;l 40&#x2009;mM EDTA was added for incubation at room temperature for 5&#x2009;min to stop transposition. Finally, the EDTA was removed, and the tissue section was washed with 500&#x2009;&#xB5;l 1&#xD7; NEBuffer 3.1 for 5&#x2009;min.</p>
        <p id="Par32">For barcode A in situ ligation, the first PDMS slab was used to cover the region of interest, the bright-field image was taken using a &#xD7;10 objective (Thermo Fisher Scientific, EVOS FL Auto microscope (AMAFD1000), EVOS FL Auto Software (REV 32044)) for further alignment. The tissue slide and PDMS device were then clamped with an acrylic clamp. First, DNA barcode A was annealed with ligation linker 1: 10&#x2009;&#x3BC;l of each DNA barcode A (100&#x2009;&#x3BC;M), 10&#x2009;&#x3BC;l of ligation linker (100&#x2009;&#x3BC;M) and 20&#x2009;&#x3BC;l of 2&#xD7; annealing buffer (20&#x2009;mM Tris, pH&#x2009;7.5&#x2013;8.0, 100&#x2009;mM NaCl, 2&#x2009;mM EDTA) were added together and mixed well. Then, 5&#x2009;&#x3BC;l ligation reaction solution (50 tubes) was prepared by adding 2&#x2009;&#x3BC;l of ligation mix (72.4&#x2009;&#x3BC;l of RNase-free water, 27&#x2009;&#x3BC;l of T4 DNA ligase buffer, 11&#x2009;&#x3BC;l T4 DNA ligase, 5.4&#x2009;&#x3BC;l of 5% Triton X-100), 2&#x2009;&#x3BC;l of 1&#xD7; NEBuffer 3.1 and 1&#x2009;&#x3BC;l of each annealed DNA barcode A (A1&#x2013;A50, 25&#x2009;&#x3BC;M) and loaded into each of the 50 channels under a vacuum. The chip was kept in a wet box for incubation (37&#x2009;&#xB0;C, 30&#x2009;min). After flowing through 1&#xD7; NEBuffer 3.1 for washing (5&#x2009;min), the clamp and PDMS were removed. The slide was quickly dipped in water and dried with air.</p>
        <p id="Par33">For barcode B in situ ligation, the second PDMS slab with channels perpendicular to the first PDMS was attached to the dried slide carefully. A bright-field image was taken and the acrylic clamp was used to press the PDMS against the tissue. The annealing of DNA barcode B with ligation linker 2 was performed the same as described above for the annealing of DNA barcode A and ligation linker 1. The preparation and addition of the ligation reaction solution for DNA barcode B (B1&#x2013;B50, 25&#x2009;&#x3BC;M) were also the same as described for DNA barcode A (A1&#x2013;A50, 25&#x2009;&#x3BC;M). The chip was kept in a wet box for incubation (37&#x2009;&#xB0;C for 30&#x2009;min). After flowing through 1&#xD7; DPBS for washing (5&#x2009;min), the clamp and PDMS were removed, the tissue section was dipped in water and dried with air. The final bright-field image of the tissue was taken.</p>
        <p id="Par34">For tissue digestion, the region of interest of the tissue was covered with a square PDMS well gasket, and 100&#x2009;&#x3BC;l reverse cross-linking solution (50&#x2009;mM Tris-HCl, pH&#x2009;8.0, 1&#x2009;mM EDTA, 1%&#x2009;SDS, 200&#x2009;mM NaCl, 0.4&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> proteinase K) was loaded into it. The lysis was conducted in a wet box (58&#x2009;&#xB0;C, 2&#x2009;h). The final tissue lysate was collected into a 200&#x2009;&#x3BC;l PCR tube for incubation with rotation (65&#x2009;&#xB0;C, overnight).</p>
        <p id="Par35">For library construction, the lysate was first purified using the Zymo DNA Clean &amp; Concentrator-5 kit and eluted into 20&#x2009;&#x3BC;l of DNA elution buffer, followed by mixing with the PCR solution (2.5&#x2009;&#xB5;l 25&#x2009;&#xB5;M new P5 PCR primer, 2.5&#x2009;&#xB5;l 25&#x2009;&#xB5;M Ad2 primer, 25&#x2009;&#xB5;l 2&#xD7; NEBNext Master Mix). Then, PCR was performed using the following program: 72&#x2009;&#xB0;C for 5&#x2009;min; 98&#x2009;&#xB0;C for 30&#x2009;s; and then cycled 5 times at 98&#x2009;&#xB0;C for 10&#x2009;s, 63&#x2009;&#xB0;C for 10&#x2009;s and 72&#x2009;&#xB0;C for 1&#x2009;min. To determine additional cycles, 5&#x2009;&#xB5;l of the pre-amplified mixture was first mixed with the qPCR solution (0.5&#x2009;&#xB5;l 25&#x2009;&#xB5;M new P5 PCR primer, 0.5&#x2009;&#xB5;l 25&#x2009;&#xB5;M Ad2 primer, 0.24&#x2009;&#xB5;l 25&#xD7; SYBR Green, 5&#x2009;&#xB5;l 2&#xD7; NEBNext Master Mix, 3.76&#x2009;&#xB5;l nuclease-free H<sub>2</sub>O). Then, the qPCR reaction was performed under the following conditions: 98&#x2009;&#xB0;C for 30&#x2009;s; and then 20 cycles of 98&#x2009;&#xB0;C for 10&#x2009;s, 63&#x2009;&#xB0;C for 10&#x2009;s and 72&#x2009;&#xB0;C for 1&#x2009;min. Finally, the remaining 45&#x2009;&#xB5;l of the pre-amplified DNA was amplified by running the required number of additional cycles of PCR (the cycles needed to reach 1/3 of the saturated signal in qPCR).</p>
        <p id="Par36">To remove PCR primer residues, the final PCR product was purified using 1&#xD7; Ampure XP beads (45&#x2009;&#xB5;l) according to the standard protocol and eluted into 20&#x2009;&#xB5;l nuclease-free H<sub>2</sub>O. Before sequencing, an Agilent Bioanalyzer High Sensitivity Chip was used to quantify the concentration and size distribution of the library. Next-generation sequencing was performed using the Illumina HiSeq 4000 or NovaSeq 6000 sequencer (paired-end 150&#x2009;bp mode with custom read 1 primer).</p>
      </sec>
      <sec id="Sec17">
        <title>Data preprocessing</title>
        <p id="Par37">Two constant linker sequences (linker 1 and linker 2) were used to filter read 1, and the filtered sequences were transformed to Cell Ranger ATAC format (10x Genomics). The genome sequences were included in the new read 1, barcodes A and barcodes B were included in the new read 2. The resulting fastq files were aligned to the mouse reference (mm10) or human reference (GRCh38) genome, filtered to remove duplicates and counted using Cell Ranger ATAC v.1.2. The BED-like fragments files were generated for downstream analysis. The fragments file contains fragments of information on the genome and tissue location (barcode A &#xD7; barcode B). A preprocessing pipeline we developed using Snakemake workflow management system (v5.28.0) is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/dyxmvp/Spatial_ATAC-seq">https://github.com/dyxmvp/Spatial_ATAC-seq</ext-link>).</p>
      </sec>
      <sec id="Sec18">
        <title>Data visualization</title>
        <p id="Par38">We first identified pixels on tissue samples by manual selection from microscopy images using Adobe Illustrator (v.25.4.3) (<ext-link ext-link-type="uri" xlink:href="https://github.com/rongfan8/DBiT-seq">https://github.com/rongfan8/DBiT-seq</ext-link>), and a custom Python script was used to generate metadata files that were compatible with the Seurat workflow for spatial datasets.</p>
        <p id="Par39">The fragment file was read into ArchR as a tile matrix with a genome binning size of 5&#x2009;kb, and pixels that were not on the tissue were removed on the basis of the metadata file generated in the previous step. Data normalization and dimensionality reduction was conducted using iterative latent semantic indexing (iterations&#x2009;=&#x2009;2, resolution&#x2009;=&#x2009;0.2, varFeatures&#x2009;=&#x2009;25000, dimsToUse&#x2009;=&#x2009;1:30, n.start&#x2009;=&#x2009;10), followed by graph clustering and UMAP embedding (nNeighbors&#x2009;=&#x2009;30, metric&#x2009;=&#x2009;cosine, minDist&#x2009;=&#x2009;0.5)<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>.</p>
        <p id="Par40">The Gene Score model in ArchR was used to generate the gene accessibility score. A gene score matrix was generated for downstream analysis. The getMarkerFeatures and getMarkers function in ArchR (testMethod&#x2009;=&#x2009;&#x201C;wilcoxon&#x201D;, cutOff&#x2009;=&#x2009;&#x201C;FDR&#x2009;&lt;&#x2009;=&#x2009;0.05&#x201D;) was used to identify the marker regions/genes for each cluster, and the marker genes were discussed in the manuscript because they were identified as one of the top differential genes between clusters, and they were also known in the literature. Gene-score imputation was implemented with addImputeWeights for data visualization. The enrichGO function in the clusterProfiler package was used for GO enrichment analysis (qvalueCutoff&#x2009;=&#x2009;0.05)<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. For spatial data visualization, results obtained in ArchR were loaded into Seurat v.3.2.3 to map the data back to the tissue section<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. For better visualization, we scaled the size of the pixels using the &#x2018;pt.size.factor&#x2019; parameter in the Seurat package (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8c</xref>).</p>
        <p id="Par41">Genome browser tracks were plotted using the plotBrowserTrack function in ArchR. Spatial-ATAC-seq data were normalized to the recommended and default value (normMethod&#x2009;=&#x2009;&#x201C;ReadsInTSS&#x201D;), which simultaneously normalizes tracks based on sequencing depth and sample data quality. Blue-coloured genes are on the minus strand and red-coloured genes are on the plus strand. The loops are the links between a peak and a gene, and the colour shows the Pearson correlation between peak accessibility and gene expression. Peaks were called with macs2 using addReproduciblePeakSet function in ArchR.</p>
        <p id="Par42">To project bulk ATAC-seq data, we downloaded raw sequencing data aligned to the mm10 genome (BAM files) from ENCODE. After counting the reads in 5&#x2009;kb tiled genomes using the getCounts function in chromVAR<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>, the ENCODE ATAC-seq data were subsampled in pseudo single cells (<italic>n</italic> = 250) and were projected onto spatial-ATAC UMAPs using the projectBulkATAC function in ArchR.</p>
        <p id="Par43">Cell type identification and pseudo-scRNA-seq profiles were added through integration with scRNA-seq reference data<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The FindTransferAnchors function (Seurat v.3.2 package) was used to align pixels from spatial-ATAC-seq with cells from scRNA-seq by comparing the spatial-ATAC-seq gene score matrix with the scRNA-seq gene expression matrix. The GeneIntegrationMatrix function in ArchR was used to add cell identities and pseudo-scRNA-seq profiles.</p>
        <p id="Par44">Pseudobulk group coverages based on cluster identities were generated using the addGroupCoverages function and used for peak calling with macs2 using the addReproduciblePeakSet function in ArchR. To compute per-cell motif activity, chromVAR<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> was run with addDeviationsMatrix using the cisbp motif set after a background peak set was generated using addBgdPeaks. Cell-type-specific marker peaks were identified using the getMarkerFeatures (bias&#x2009;=&#x2009;c(&#x201C;TSSEnrichment&#x201D;, &#x201C;log10(nFrags)&#x201D;, testMethod&#x2009;=&#x2009;&#x201C;wilcoxon&#x201D;) and getMarkers (cutOff = &#x201C;FDR&#x2009;&lt;&#x2009;=&#x2009;0.05 &amp; Log2FC&#x2009;&gt;&#x2009;=&#x2009;0.1&#x201D;) functions.</p>
        <p id="Par45">Pseudotemporal reconstruction was implemented by trajectory analysis using ArchR. We used the cell-type definitions from label transfer as described above. A trajectory backbone was first created in the form of an ordered vector of cell group labels. We then used the addTrajectory function to create a trajectory, and added the pseudotime to Seurat spatial object to map the data back to the tissue section. Dynamics for selected gene score along the pseudotime were plotted with the plotTrajectory function using the default values.</p>
        <p id="Par46">Correlation analysis was conducted by calculating the Pearson correlation coefficient in R. <italic>P</italic> values were calculated using the cor.test function and were adjusted for multiple comparisons using the Benjamini&#x2013;Hochberg method<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>.</p>
      </sec>
      <sec id="Sec19">
        <title>Reporting summary</title>
        <p id="Par47">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
      </sec>
    </sec>
    <sec id="Sec20" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par48">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-05094-1.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_5094_MOESM1_ESM.pdf"><label>Supplementary Information</label><caption><p>Supplementary Figs. 1&#x2013;12, statistics and reproducibility, the legends for Supplementary Tables 1&#x2013;5 and Supplementary References.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_5094_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_5094_MOESM3_ESM.xlsx"><label>Supplementary Table 1</label><caption><p>A list of marker genes.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_5094_MOESM4_ESM.xlsx"><label>Supplementary Table 2</label><caption><p>A list of cell type annotations in mouse brain.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41586_2022_5094_MOESM5_ESM.xlsx"><label>Supplementary Table 3</label><caption><p>A list of DNA oligos used for PCR and preparation of sequencing library and DNA barcode sequences.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41586_2022_5094_MOESM6_ESM.xlsx"><label>Supplementary Table 4</label><caption><p>A list of chemicals and reagents.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41586_2022_5094_MOESM7_ESM.xlsx"><label>Supplementary Table 5</label><caption><p>Published data for data quality comparison and integrative data analysis.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41586_2022_5094_MOESM8_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec21">
          <title>Extended data figures and tables</title>
          <p id="Par51">
<fig id="Fig5"><label>Extended Data Fig. 1</label><caption><title>Chemistry workflow of spatial-ATAC-seq.</title><p>A tissue section on a standard aminated glass slide was lightly fixed with formaldehyde. Then, Tn5 transposition was performed at 37&#x2009;&#xB0;C, and the adapters containing ligation linker 1 were inserted to the cleaved genomic DNA at transposase accessible sites. Afterwards, a set of DNA barcode A solutions were introduced by microchannel-guided flow delivery to perform in situ ligation reaction for appending a distinct spatial barcode Ai (i&#x2009;=&#x2009;1&#x2013;50) and ligation linker 2. Then, a second set of barcodes Bj (j&#x2009;=&#x2009;1-50) were introduced using another set of microfluidic channels perpendicularly to those in the first flow barcoding step, which were subsequently ligated at the intersections, resulting in a mosaic of tissue pixels, each containing a distinct combination of barcodes Ai and Bj (i&#x2009;=&#x2009;1&#x2013;50, j&#x2009;=&#x2009;1&#x2013;50). After DNA fragments were collected by reversing cross-linking, the library construction was completed during PCR amplification.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig5_ESM" id="d32e2027"/></fig>
</p>
          <p id="Par52">
<fig id="Fig6"><label>Extended Data Fig. 2</label><caption><title>Further analysis of spatial chromatin accessibility mapping of E13 mouse embryo and validation with ENCODE reference data.</title><p><bold>a</bold>, H&amp;E image from an adjacent tissue section and a region of interest for spatial chromatin accessibility mapping (50&#x2009;&#xB5;m pixel size). <bold>b</bold>, Unsupervised clustering analysis and spatial distribution of each cluster. For better visualization, we scaled the size of the pixels. <bold>c</bold>, Genome browser tracks of selected marker genes in different clusters. <bold>d</bold>, UMAP embedding of unsupervised clustering analysis for spatial-ATAC-seq. Cluster identities and colouring of clusters are consistent with (<bold>b</bold>). <bold>e</bold>, LSI projection of ENCODE bulk ATAC-seq data from diverse cell types of the E13.5 mouse embryo dataset onto the spatial ATAC-seq embedding. <bold>f</bold>, UMAP embedding of unsupervised clustering analysis for ENCODE bulk ATAC-seq data from diverse cell types of the E13.5 mouse embryo dataset. <bold>g</bold>, LSI projection of spatial-ATAC-seq data onto ENCODE bulk ATAC-seq embedding. <bold>h</bold>, Spatial mapping of gene scores for selected marker genes in different clusters.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig6_ESM" id="d32e2068"/></fig>
</p>
          <p id="Par53">
<fig id="Fig7"><label>Extended Data Fig. 3</label><caption><title>Motif enrichment analysis of the E13 mouse embryo data.</title><p><bold>a</bold>, Heatmap of spatial-ATAC-seq marker peaks across all clusters identified with bias-matched differential testing. <bold>b</bold>, Annotation of marker peaks across clusters. <bold>c</bold>, Heatmap of motif hypergeometric enrichment-adjusted P values within the marker peaks of each cluster. <bold>d</bold>, Spatial mapping of selected TF motif deviation scores. <bold>e</bold>, GREAT enrichment analysis of marker peaks across clusters.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig7_ESM" id="d32e2096"/></fig>
</p>
          <p id="Par54">
<fig id="Fig8"><label>Extended Data Fig. 4</label><caption><title>Spatial chromatin accessibility mapping of E11 mouse embryo and spatiotemporal analysis (50 &#xB5;m pixel size).</title><p><bold>a</bold>, Unsupervised clustering analysis and spatial distribution of each cluster. Overlay with the tissue image reveals that the spatial chromatin accessibility clusters precisely match the anatomic regions. For better visualization, we scaled the size of the pixels. <bold>b</bold>, UMAP embedding of unsupervised clustering analysis for chromatin accessibility. Cluster identities and colouring of clusters are consistent with (<bold>a</bold>). <bold>c</bold>, Spatial mapping of gene scores for selected marker genes in different clusters and the chromatin accessibility at select genes are highly tissue specific. <bold>d</bold>, Integration of scRNA-seq from E11.5 mouse embryos<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and spatial ATAC-seq data. Unsupervised clustering of the combined data was coloured by different cell types. <bold>e</bold>, Anatomic annotation of major tissue regions based on the H&amp;E image. <bold>f</bold>, Spatial mapping of selected cell types identified by label transferring from scRNA-seq to spatial ATAC-seq data. <bold>g</bold>, Pseudotemporal reconstruction from the developmental process from radial glia to excitatory neurons plotted in space. <bold>h</bold>, Spatial mapping of gene scores for <italic>Notch1</italic>. <bold>i</bold>, dynamics for selected gene score along the pseudo-time shown in (<bold>g</bold>). <bold>j</bold>, Pseudo-time heatmap of TF motifs changes from radial glia to excitatory neurons.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig8_ESM" id="d32e2154"/></fig>
</p>
          <p id="Par55">
<fig id="Fig9"><label>Extended Data Fig. 5</label><caption><title>Further analysis of spatial chromatin accessibility mapping of E11 mouse embryo (50 &#xB5;m pixel size) and validation with the ENCODE reference data.</title><p><bold>a</bold>, H&amp;E image from an adjacent tissue section and a region of interest for spatial chromatin accessibility mapping. <bold>b</bold>, Unsupervised clustering analysis and spatial distribution of each cluster. For better visualization, we scaled the size of the pixels. <bold>c</bold>, Genome browser tracks of selected marker genes in different clusters. <bold>d</bold>, UMAP embedding of unsupervised clustering analysis for spatial ATAC-seq. Cluster identities and colouring of clusters are consistent with (<bold>b</bold>). <bold>e</bold>, LSI projection of ENCODE bulk ATAC-seq data from diverse cell types of the E11.5 mouse embryo dataset onto the spatial-ATAC-seq embedding. <bold>f</bold>, UMAP embedding of unsupervised clustering analysis for ENCODE bulk ATAC-seq data from diverse cell types of the E11.5 mouse embryo dataset. <bold>g</bold>, LSI projection of spatial ATAC-seq data onto ENCODE bulk ATAC-seq embedding.&#xA0;<bold>h</bold>, Spatial mapping of gene scores for selected marker genes in different clusters.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig9_ESM" id="d32e2195"/></fig>
</p>
          <p id="Par56">
<fig id="Fig10"><label>Extended Data Fig. 6</label><caption><title>Motif enrichment analysis in E11 mouse embryo.</title><p><bold>a</bold>, Heatmap of spatial ATAC-seq marker peaks across all clusters identified with bias-matched differential testing. <bold>b</bold>, Annotation of marker peaks across clusters. <bold>c, d</bold>, Spatial mapping of selected TF motif deviation scores. <bold>e</bold>, GREAT enrichment analysis of marker peaks across clusters.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig10_ESM" id="d32e2220"/></fig>
</p>
          <p id="Par57">
<fig id="Fig11"><label>Extended Data Fig. 7</label><caption><title>Spatial chromatin accessibility mapping of E11 mouse embryo and spatiotemporal analysis (20 &#xB5;m pixel size).</title><p><bold>a</bold>, Unsupervised clustering analysis and spatial distribution of each cluster. Overlay with the tissue image reveals that the spatial chromatin accessibility clusters precisely match the anatomic regions. For better visualization, we scaled the size of the pixels. <bold>b</bold>, UMAP embedding of unsupervised clustering analysis for chromatin accessibility. Cluster identities and colouring of clusters are consistent with (<bold>a</bold>). <bold>c</bold>, Spatial mapping of notochord cells identified by label transferring from scRNA-seq (E11.5 mouse embryos<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>) to spatial ATAC-seq data. <bold>d</bold>, Spatial mapping of gene scores for selected marker genes in different clusters and the chromatin accessibility at select genes are highly tissue specific.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig11_ESM" id="d32e2252"/></fig>
</p>
          <p id="Par58">
<fig id="Fig12"><label>Extended Data Fig. 8</label><caption><title>Integrative analysis of spatial-ATAC-seq and scRNA-seq for P21 mouse brain.</title><p><bold>a</bold>, Integration of scRNA-seq from mouse brains<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and spatial-ATAC-seq data. <bold>b</bold>, Spatial mapping of cell types identified by label transfer from scRNA-seq<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> to spatial-ATAC-seq. <bold>c</bold>, Spatial distribution of each cluster in the mouse brain with real (left) and enlarged (right) pixel size. <bold>d</bold>, Fraction of cell types in each spatial-ATAC-seq cluster.&#xA0;A list of abbreviation definitions can be found in Supplementary Table <xref rid="MOESM4" ref-type="media">2</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig12_ESM" id="d32e2289"/></fig>
</p>
          <p id="Par59">
<fig id="Fig13"><label>Extended Data Fig. 9</label><caption><title>Spatial chromatin accessibility mapping of human hippocampus.</title><p><bold>a</bold>, Nissl-stained tissue section adjacent to the one used for spatial chromatin accessibility mapping and region of interest for spatial-ATAC-seq (50&#x2009;&#xB5;m pixel size). <bold>b</bold>, Unsupervised clustering analysis and spatial distribution of each cluster. For better visualization, we scaled the size of the pixels. <bold>c</bold>, Integration of scATAC-seq<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> from human hippocampus and spatial-ATAC-seq. Colouring of spatial-ATAC-seq is consistent with (<bold>b</bold>). <bold>d</bold>, Co-embedding spatial-ATAC-seq and scATAC-seq datasets, coloured by gene score for the annotated lineage-defining gene<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig13_ESM" id="d32e2326"/></fig>
</p>
          <p id="Par60">
<fig id="Fig14"><label>Extended Data Fig. 10</label><caption><title>Further analysis of spatial chromatin accessibility mapping of human tonsil.</title><p><bold>a</bold>, UMAP of tonsillar spatial-ATAC-seq data. <bold>b</bold>, Integration of scATAC-seq<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> from human tonsils and spatial-ATAC-seq. <bold>c</bold>, UMAP of tonsillar immune scRNA-seq reference data<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. <bold>d</bold>, Heatmap comparing key marker gene expression across selected immune cell types. <bold>e</bold>, Pseudo-time heatmap of TF motifs changes from Na&#xEF;ve B cells to GC B cells.</p></caption><graphic position="anchor" xlink:href="41586_2022_5094_Fig14_ESM" id="d32e2363"/></fig>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-05094-1.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-05094-1.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank the staff at the Yale Center for Research Computing for guidance and use of the research computing infrastructure; T. Jimenez-Beristain in the G.C.-B laboratory for writing laboratory animal ethics permits and for assistance with animal experiments;&#xA0;T. Wu, T. Li and R. Hen at Columbia University for scientific discussions and suggestions; and C. Sissoko and A. N. Santiago at Columbia University for help with anatomical annotation of the human hippocampus slices. The moulds for microfluidic devices were fabricated at the Yale SEAS cleanroom and the Yale West Campus Cleanroom. Next-generation sequencing was conducted at the Yale Stem Cell Center Genomics Core Facility, which was supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation. Services provided by the Genomics Core of Yale Cooperative Center of Excellence in Hematology (U54DK106857) were used. This research was supported by Packard Fellowship for Science and Engineering (to R.F.), Stand-Up-to-Cancer (SU2C) Convergence 2.0 Award (to R.F.) and Yale Stem Cell Center Chen Innovation Award (to R.F.). It was also supported in part by grants from the US National Institutes of Health (NIH) (U54AG076043 to R.F., S.H., J.E.C. and M.L.X.; UG3CA257393, R01CA245313 and RF1MH128876, U01CA260507 to R.F.; UH3TR002151 to K.W.L.). Y.L. was supported by the Society for ImmunoTherapy of Cancer (SITC) Fellowship. Work in G.C.-B.&#x2019;s research group was supported by the Swedish Research Council (grant 2019-01360), the European Union (Horizon 2020 Research and Innovation Programme/European Research Council Consolidator Grant EPIScOPE, grant agreement number 681893), the Swedish Cancer Society (Cancerfonden; 190394 Pj), the Knut and Alice Wallenberg Foundation (grants 2019-0107 and 2019-0089), the Swedish Society for Medical Research (SSMF, grant JUB2019), the G&#xF6;ran Gustafsson Foundation for Research in Natural Sciences and Medicine, the Ming Wai Lau Centre for Reparative Medicine and the Karolinska Institutet.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>investigation: Y.D., D.Z., P.K. and Y.X.; Data analysis: Y.D., M. Bartosovic, D.Z., P.K., G.C.-B. and R.F.; Resources: G.S., X.Q., K.W.L., G.B.R., A.J.D., J.J.M. and M. Boldrini; S.M., M.L.X., S.H. and J.E.C. provided advice and input; Original draft: Y.D., D.Z. and R.F. All of the authors reviewed, edited and approved the manuscript.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="FPar1">
        <title>Peer review information</title>
        <p id="Par49"><italic>Nature</italic> thanks Itai Yanai and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. <xref rid="MOESM8" ref-type="media">Peer reviewer reports</xref> are available.</p>
      </sec>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>Raw and processed data reported in this paper are deposited in the Gene Expression Omnibus (GEO) with accession code <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171943">GSE171943</ext-link>. The resulting fastq files were aligned to the mouse reference genome (mm10) or human reference genome (GRCh38). Published data for data quality comparison and integrative data analysis are available online: flash frozen cortex, hippocampus and ventricular zone from embryonic mouse brain (E18) (<ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/resources/datasets/flash-frozen-cortex-hippocampus-and-ventricular-zone-from-embryonic-mouse-brain-e-18-1-standard-1-2-0">https://www.10xgenomics.com/resources/datasets/flash-frozen-cortex-hippocampus-and-ventricular-zone-from-embryonic-mouse-brain-e-18-1-standard-1-2-0</ext-link>), ENCODE mouse embryo ATAC-seq (11.5&#x2009;days) (<ext-link ext-link-type="uri" xlink:href="https://www.encodeproject.org/search/?type=Experiment&amp;status=released&amp;related_series.@type=OrganismDevelopmentSeries&amp;replicates.library.biosample.organism.scientific_name=Mus+musculus&amp;assay_title=ATAC-seq&amp;life_stage_age=embryonic%2011.5%20days">https://www.encodeproject.org/search/?type=Experiment&amp;status=released&amp;related_series.@type=OrganismDevelopmentSeries&amp;replicates.library.biosample.organism.scientific_name=Mus+musculus&amp;assay_title=ATAC-seq&amp;life_stage_age=embryonic%2011.5%20days</ext-link>), ENCODE mouse embryo ATAC-seq (13.5&#x2009;days) (<ext-link ext-link-type="uri" xlink:href="https://www.encodeproject.org/search/?type=Experiment&amp;status=released&amp;related_series.@type=OrganismDevelopmentSeries&amp;replicates.library.biosample.organism.scientific_name=Mus+musculus&amp;assay_title=ATAC-seq&amp;life_stage_age=embryonic%2013.5%20days">https://www.encodeproject.org/search/?type=Experiment&amp;status=released&amp;related_series.@type=OrganismDevelopmentSeries&amp;replicates.library.biosample.organism.scientific_name=Mus+musculus&amp;assay_title=ATAC-seq&amp;life_stage_age=embryonic%2013.5%20days</ext-link>), Mouse Organogenesis Cell Atlas (MOCA) (<ext-link ext-link-type="uri" xlink:href="https://oncoscape.v3.sttrcancer.org/atlas.gs.washington.edu.mouse.rna/downloads">https://oncoscape.v3.sttrcancer.org/atlas.gs.washington.edu.mouse.rna/downloads</ext-link>), Atlas of Gene Regulatory Elements in Adult mouse Cerebrum (<ext-link ext-link-type="uri" xlink:href="http://catlas.org/mousebrain/#!/downloads">http://catlas.org/mousebrain/#!/downloads</ext-link>), Atlas of the Adolescent Mouse Brain (<ext-link ext-link-type="uri" xlink:href="http://mousebrain.org/adolescent/downloads.html">http://mousebrain.org/adolescent/downloads.html</ext-link>), human hippocampus scATAC-seq data (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147672">GSE147672</ext-link>), human tonsil scATAC-seq data (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165860">GSE165860</ext-link>), human tonsil scRNA-seq data (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165860">GSE165860</ext-link>), and the Allen Developing Mouse Brain Atlas (<ext-link ext-link-type="uri" xlink:href="https://developingmouse.brain-map.org/">https://developingmouse.brain-map.org/</ext-link>). A list of published data for data quality comparison and integrative data analysis is provided in in Supplementary Table <xref rid="MOESM7" ref-type="media">5</xref>.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>Code for sequencing data analysis is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/dyxmvp/Spatial_ATAC-seq">https://github.com/dyxmvp/Spatial_ATAC-seq</ext-link>) and archived at Zenodo (10.5281/zenodo.6565118).</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par50">R.F. and Y.D. are inventors of a patent application related to this work&#xA0;(PCT Patent Application No. PCT/US2021/065669). R.F. is scientific founder and advisor of IsoPlexis, Singleron Biotechnologies and AtlasXomics. The interests of R.F. were reviewed and managed by Yale University Provost&#x2019;s Office in accordance with the University&#x2019;s conflict of interest policies. The other authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perkel</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Starfish enterprise: finding RNA patterns in single cells</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>572</volume>
          <fpage>549</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="pmid">31427807</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S. Y. &amp; Zhuang, X. W. Spatially resolved, highly multiplexed RNA profiling in single cells. <italic>Science</italic><bold>348</bold>, aaa6090 (2015).</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>CL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH+</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>568</volume>
          <fpage>235</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="pmid">30911168</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriques</surname>
              <given-names>SG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>363</volume>
          <fpage>1463</fpage>
          <lpage>1467</lpage>
          <pub-id pub-id-type="pmid">30923225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue</article-title>
          <source>Cell</source>
          <year>2020</year>
          <volume>183</volume>
          <fpage>1665</fpage>
          <lpage>1681</lpage>
          <pub-id pub-id-type="pmid">33188776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corces</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues</article-title>
          <source>Nat. Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>959</fpage>
          <lpage>962</lpage>
          <pub-id pub-id-type="pmid">28846090</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other">Regev, A. et al. The human cell atlas. <italic>eLife</italic><bold>6</bold>, e27041 (2017).</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Brink</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations</article-title>
          <source>Nat. Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>935</fpage>
          <lpage>936</lpage>
          <pub-id pub-id-type="pmid">28960196</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buenrostro</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell chromatin accessibility reveals principles of regulatory variation</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>523</volume>
          <fpage>486</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">26083756</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buenrostro</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Giresi</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Zaba</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Greenleaf</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title>
          <source>Nat. Methods</source>
          <year>2013</year>
          <volume>10</volume>
          <fpage>1213</fpage>
          <lpage>1218</lpage>
          <pub-id pub-id-type="pmid">24097267</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing</article-title>
          <source>Nat. Methods</source>
          <year>2016</year>
          <volume>13</volume>
          <fpage>1013</fpage>
          <lpage>1020</lpage>
          <pub-id pub-id-type="pmid">27749837</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thornton</surname>
              <given-names>CA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatially mapped single-cell chromatin accessibility</article-title>
          <source>Nat. Commun.</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>1274</fpage>
          <pub-id pub-id-type="pmid">33627658</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gorkin</surname>
              <given-names>DU</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An atlas of dynamic chromatin landscapes in mouse fetal development</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>583</volume>
          <fpage>744</fpage>
          <lpage>751</lpage>
          <pub-id pub-id-type="pmid">32728240</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Granja</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis</article-title>
          <source>Nat. Genet.</source>
          <year>2021</year>
          <volume>53</volume>
          <fpage>403</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="pmid">33633365</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stelzer</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The GeneCards suite: from gene data mining to disease genome sequence analyses</article-title>
          <source>Curr. Protoc. Bioinformatics</source>
          <year>2016</year>
          <volume>54</volume>
          <fpage>1.30.31</fpage>
          <lpage>31.30.33</lpage>
          <pub-id pub-id-type="pmid">27322403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xFC;dhof</surname>
              <given-names>TC</given-names>
            </name>
          </person-group>
          <article-title>Calcium control of neurotransmitter release</article-title>
          <source>Cold Spring Harb. Perspect. Biol.</source>
          <year>2012</year>
          <volume>4</volume>
          <fpage>a011353</fpage>
          <pub-id pub-id-type="pmid">22068972</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">Soares, D. S., Homem, C. C. F. &amp; Castro, D. S. Function of proneural genes <italic>Ascl1</italic> and <italic>Asense</italic> in neurogenesis: how similar are they? <italic>Front. Cell Dev. Biol.</italic><bold>10</bold>, 838431 (2022).</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meijer</surname>
              <given-names>DH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2</article-title>
          <source>Nat. Rev. Neurosci.</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>819</fpage>
          <lpage>831</lpage>
          <pub-id pub-id-type="pmid">23165259</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other"><italic>Allen Mouse Brain Atlas</italic> (Allen Institute for Brain Science, 2011); <ext-link ext-link-type="uri" xlink:href="https://mouse.brain-map.org/">https://mouse.brain-map.org/</ext-link></mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The single-cell transcriptional landscape of mammalian organogenesis</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>566</volume>
          <fpage>496</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="pmid">30787437</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kriegstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alvarez-Buylla</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The glial nature of embryonic and adult neural stem cells</article-title>
          <source>Ann. Rev. Neurosci.</source>
          <year>2009</year>
          <volume>32</volume>
          <fpage>149</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">19555289</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xF3;mez-L&#xF3;pez</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells in vitro</article-title>
          <source>Glia</source>
          <year>2011</year>
          <volume>59</volume>
          <fpage>1588</fpage>
          <lpage>1599</lpage>
          <pub-id pub-id-type="pmid">21766338</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular architecture of the mouse nervous system</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>999</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="pmid">30096314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagino-Yamagishi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex</article-title>
          <source>Brain Res.</source>
          <year>1997</year>
          <volume>752</volume>
          <fpage>261</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="pmid">9106466</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugitani</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons</article-title>
          <source>Genes Dev.</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>1760</fpage>
          <lpage>1765</lpage>
          <pub-id pub-id-type="pmid">12130536</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saito</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential NOVA2-mediated splicing in excitatory and inhibitory neurons regulates cortical development and cerebellar function</article-title>
          <source>Neuron</source>
          <year>2019</year>
          <volume>101</volume>
          <fpage>707</fpage>
          <lpage>720</lpage>
          <pub-id pub-id-type="pmid">30638744</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activated Notch1 maintains the phenotype of radial glial cells and promotes their adhesion to laminin by upregulating nidogen</article-title>
          <source>Glia</source>
          <year>2008</year>
          <volume>56</volume>
          <fpage>646</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="pmid">18286610</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epigenetic regulation of neuronal cell specification inferred with single cell &#x201C;Omics&#x201D; data</article-title>
          <source>Comput. Struct. Biotechnol. J.</source>
          <year>2020</year>
          <volume>18</volume>
          <fpage>942</fpage>
          <lpage>952</lpage>
          <pub-id pub-id-type="pmid">32368329</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>YE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An atlas of gene regulatory elements in adult mouse cerebrum</article-title>
          <source>Nature</source>
          <year>2021</year>
          <volume>598</volume>
          <fpage>129</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">34616068</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial-CUT&amp;Tag: spatially resolved chromatin modification profiling at the cellular level</article-title>
          <source>Science</source>
          <year>2022</year>
          <volume>375</volume>
          <fpage>681</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="pmid">35143307</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corces</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer&#x2019;s and Parkinson&#x2019;s diseases</article-title>
          <source>Nat. Genet.</source>
          <year>2020</year>
          <volume>52</volume>
          <fpage>1158</fpage>
          <lpage>1168</lpage>
          <pub-id pub-id-type="pmid">33106633</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cook</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas</article-title>
          <source>Mod. Pathol.</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>879</fpage>
          <lpage>885</lpage>
          <pub-id pub-id-type="pmid">13679451</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agematsu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hokibara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nagumo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Komiyama</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>CD27: a memory B-cell marker</article-title>
          <source>Immunol. Today</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>204</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">10782048</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pittner</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Shanafelt</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Jelinek</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation</article-title>
          <source>Leukemia</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>2264</fpage>
          <lpage>2272</lpage>
          <pub-id pub-id-type="pmid">16208411</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Victora</surname>
              <given-names>GD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <fpage>2240</fpage>
          <lpage>2248</lpage>
          <pub-id pub-id-type="pmid">22740445</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caron</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Le Gallou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lamy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tarte</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fest</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells</article-title>
          <source>J. Immunol.</source>
          <year>2009</year>
          <volume>182</volume>
          <fpage>7595</fpage>
          <lpage>7602</lpage>
          <pub-id pub-id-type="pmid">19494283</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elsner</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Baumgarth</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection</article-title>
          <source>J. Virol.</source>
          <year>2012</year>
          <volume>86</volume>
          <fpage>7146</fpage>
          <lpage>7157</lpage>
          <pub-id pub-id-type="pmid">22532671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cattoretti</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance</article-title>
          <source>J. Immunol.</source>
          <year>2006</year>
          <volume>177</volume>
          <fpage>6930</fpage>
          <lpage>6939</lpage>
          <pub-id pub-id-type="pmid">17082608</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>King</surname>
              <given-names>HW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics</article-title>
          <source>Sci. Immunol.</source>
          <year>2021</year>
          <volume>6</volume>
          <fpage>eabe6291</fpage>
          <pub-id pub-id-type="pmid">33579751</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalies</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Blessenohl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nietsch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Westermann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>T cell zones of lymphoid organs constitutively express Th1 cytokine mRNA: specific changes during the early phase of an immune response</article-title>
          <source>J. Immunol.</source>
          <year>2006</year>
          <volume>176</volume>
          <fpage>741</fpage>
          <lpage>749</lpage>
          <pub-id pub-id-type="pmid">16393957</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="other">Law, H., Venturi, V., Kelleher, A. &amp; Munier, C. M. Tfh cells in health and immunity: potential targets for systems biology approaches to vaccination. <italic>Int. J. Mol. Sci.</italic><bold>21</bold>, 8524 (2020).</mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Nurieva</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional regulation of follicular T-helper (Tfh) cells</article-title>
          <source>Immunol. Rev.</source>
          <year>2013</year>
          <volume>252</volume>
          <fpage>139</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">23405901</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program</article-title>
          <source>J. Exp. Med.</source>
          <year>2019</year>
          <volume>216</volume>
          <fpage>605</fpage>
          <lpage>620</lpage>
          <pub-id pub-id-type="pmid">30705058</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santegoets</surname>
              <given-names>SJAM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry</article-title>
          <source>Cancer Immunol. Immunother.</source>
          <year>2015</year>
          <volume>64</volume>
          <fpage>1271</fpage>
          <lpage>1286</lpage>
          <pub-id pub-id-type="pmid">26122357</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlereth</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Kremers</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schr&#xF6;dl</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cursiefen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heindl</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Characterization of antigen-presenting macrophages and dendritic cells in the healthy human sclera</article-title>
          <source>Invest. Ophthalmol. Vis. Sci.</source>
          <year>2016</year>
          <volume>57</volume>
          <fpage>4878</fpage>
          <lpage>4885</lpage>
          <pub-id pub-id-type="pmid">27654414</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hart</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Dransfield</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Immune complexes bind preferentially to Fc&#x3B3;RIIA (CD32) on apoptotic neutrophils, leading to augmented phagocytosis by macrophages and release of proinflammatory cytokines</article-title>
          <source>J. Immunol.</source>
          <year>2004</year>
          <volume>172</volume>
          <fpage>1882</fpage>
          <lpage>1887</lpage>
          <pub-id pub-id-type="pmid">14734773</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dho</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>LK</given-names>
            </name>
          </person-group>
          <article-title>Beyond the role of CD55 as a complement component</article-title>
          <source>Immune Netw.</source>
          <year>2018</year>
          <volume>18</volume>
          <fpage>e11</fpage>
          <pub-id pub-id-type="pmid">29503741</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>King Hamish</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrated single-cell transcriptomics and epigenomics reveals strong germinal center-associated etiology of autoimmune risk loci</article-title>
          <source>Sci. Immunol.</source>
          <year>2021</year>
          <volume>6</volume>
          <fpage>eabh3768</fpage>
          <pub-id pub-id-type="pmid">34623901</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. <italic>Nat. Biotechnol.</italic><bold>40</bold>, 661&#x2013;671 (2022).</mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cubedo</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>119</volume>
          <fpage>5478</fpage>
          <lpage>5491</lpage>
          <pub-id pub-id-type="pmid">22517897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuoka</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neural crest origins of the neck and shoulder</article-title>
          <source>Nature</source>
          <year>2005</year>
          <volume>436</volume>
          <fpage>347</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="pmid">16034409</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <mixed-citation publication-type="other">Sousa, V. H., Miyoshi, G., Hjerling-Leffler, J., Karayannis, T. &amp; Fishell, G. Characterization of Nkx6-2-derived neocortical interneuron lineages. <italic>Cereb. Cortex</italic><bold>19</bold> (Suppl. 1), i1&#x2013;i10 (2009).</mixed-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosoklija</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Duma</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dwork</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Psychiatric brain collection in Macedonia: general lessons for scientific collaboration among countries of differing wealth</article-title>
          <source>Pril. (Makedon. Akad. Nauk. Umet. Odd. Med. Nauki)</source>
          <year>2013</year>
          <volume>34</volume>
          <fpage>95</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">23917747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelly</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis</article-title>
          <source>Acta Psychiatr. Scand.</source>
          <year>1996</year>
          <volume>94</volume>
          <fpage>337</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="pmid">9124080</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial multi-omics sequencing for fixed tissue via DBiT-seq</article-title>
          <source>STAR Protoc.</source>
          <year>2021</year>
          <volume>2</volume>
          <fpage>100532</fpage>
          <pub-id pub-id-type="pmid">34027489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L-G</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Q-Y</given-names>
            </name>
          </person-group>
          <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>
          <source>Omics</source>
          <year>2012</year>
          <volume>16</volume>
          <fpage>284</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">22455463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schep</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Buenrostro</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Greenleaf</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data</article-title>
          <source>Nat. Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>975</fpage>
          <lpage>978</lpage>
          <pub-id pub-id-type="pmid">28825706</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>
          <source>J. R. Stat. Soc. B</source>
          <year>1995</year>
          <volume>57</volume>
          <fpage>289</fpage>
          <lpage>300</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35585235</article-id>
      <article-id pub-id-type="pmc">9159944</article-id>
      <article-id pub-id-type="publisher-id">4730</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-04730-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>MCM complexes are barriers that restrict cohesin-mediated loop extrusion</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7975-2245</contrib-id>
          <name>
            <surname>Dequeker</surname>
            <given-names>Bart J. H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0110-3709</contrib-id>
          <name>
            <surname>Scherr</surname>
            <given-names>Matthias J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5496-0638</contrib-id>
          <name>
            <surname>Brand&#xE3;o</surname>
            <given-names>Hugo B.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4408-6577</contrib-id>
          <name>
            <surname>Gassler</surname>
            <given-names>Johanna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Powell</surname>
            <given-names>Sean</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaspar</surname>
            <given-names>Imre</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Flyamer</surname>
            <given-names>Ilya M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5250-3556</contrib-id>
          <name>
            <surname>Lalic</surname>
            <given-names>Aleksandar</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Wen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9478-3928</contrib-id>
          <name>
            <surname>Stocsits</surname>
            <given-names>Roman</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4945-6415</contrib-id>
          <name>
            <surname>Davidson</surname>
            <given-names>Iain F.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2820-3195</contrib-id>
          <name>
            <surname>Peters</surname>
            <given-names>Jan-Michael</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1279-7841</contrib-id>
          <name>
            <surname>Duderstadt</surname>
            <given-names>Karl E.</given-names>
          </name>
          <address>
            <email>duderstadt@biochem.mpg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0785-5410</contrib-id>
          <name>
            <surname>Mirny</surname>
            <given-names>Leonid A.</given-names>
          </name>
          <address>
            <email>leonid@mit.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6564-7484</contrib-id>
          <name>
            <surname>Tachibana</surname>
            <given-names>Kiku&#xEB;</given-names>
          </name>
          <address>
            <email>tachibana@biochem.mpg.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.473822.8</institution-id><institution-id institution-id-type="ISNI">0000 0005 0375 3232</institution-id><institution>Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), </institution><institution>Vienna BioCenter (VBC), </institution></institution-wrap>Vienna, Austria </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.418615.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0491 845X</institution-id><institution>Structure and Dynamics of Molecular Machines, </institution><institution>Max Planck Institute of Biochemistry (MPIB), </institution></institution-wrap>Martinsried, Germany </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Harvard Program in Biophysics, </institution><institution>Harvard University, </institution></institution-wrap>Cambridge, MA USA </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.418615.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0491 845X</institution-id><institution>Department of Totipotency, </institution><institution>Max Planck Institute of Biochemistry (MPIB), </institution></institution-wrap>Martinsried, Germany </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine (IGMM), </institution><institution>University of Edinburgh, </institution></institution-wrap>Edinburgh, UK </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.473822.8</institution-id><institution-id institution-id-type="ISNI">0000 0005 0375 3232</institution-id><institution>Research Institute of Molecular Pathology (IMP), </institution><institution>Vienna BioCenter (VBC), </institution></institution-wrap>Vienna, Austria </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.6936.a</institution-id><institution-id institution-id-type="ISNI">0000000123222966</institution-id><institution>Department of Physics, </institution><institution>Technical University of Munich, </institution></institution-wrap>Garching, Germany </aff>
        <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution>Department of Physics, </institution><institution>Massachusetts Institute of Technology (MIT), </institution></institution-wrap>Cambridge, MA USA </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.185669.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3954</institution-id><institution>Present Address: Illumina Inc., </institution></institution-wrap>San Diego, CA USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>5</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>5</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>606</volume>
      <issue>7912</issue>
      <fpage>197</fpage>
      <lpage>203</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>10</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>4</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Eukaryotic genomes are compacted into loops and topologically associating domains (TADs)<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref></sup>, which contribute to transcription, recombination and genomic stability<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Cohesin extrudes DNA into loops that are thought to lengthen until CTCF boundaries are encountered<sup><xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR12">12</xref></sup>. Little is known about whether loop extrusion is impeded by DNA-bound machines. Here we show that the minichromosome maintenance (MCM) complex is a barrier that restricts loop extrusion in G1 phase. Single-nucleus Hi-C (high-resolution chromosome conformation capture) of mouse zygotes reveals that MCM loading reduces CTCF-anchored loops and decreases TAD boundary insulation, which suggests that loop extrusion is impeded before reaching CTCF. This effect extends to HCT116 cells, in which MCMs affect the number of CTCF-anchored loops and gene expression. Simulations suggest that MCMs are abundant, randomly positioned and partially permeable barriers. Single-molecule imaging shows that MCMs are physical barriers that frequently constrain cohesin translocation in vitro. Notably, chimeric yeast MCMs that contain a cohesin-interaction motif from human MCM3 induce cohesin pausing, indicating that MCMs are &#x2018;active&#x2019; barriers with binding sites. These findings raise the possibility that cohesin can arrive by loop extrusion at MCMs, which determine the genomic sites at which sister chromatid cohesion is established. On the basis of in vivo, in silico and in vitro data, we conclude that distinct loop extrusion barriers shape the three-dimensional genome.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Single-nucleus Hi-C of embryos, polymer simulations and single-molecule imaging collectively reveal that MCM&#xA0;complexes influence genome folding and gene expression by impeding DNA loop extrusion.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Chromosomes</kwd>
        <kwd>Nuclear organization</kwd>
        <kwd>Computational biology and bioinformatics</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">Eukaryotic genomes are folded into loops that are generated by structural maintenance of chromosomes (SMC) proteins, including cohesin and condensin complexes (reviewed previously<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>). Structures that emerge through loop extrusion are detected by Hi-C experiments. The extrusion process is hypothesized to form progressively larger loops until cohesin encounters a barrier and/or is released by Wapl (refs. <sup><xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR11">11</xref></sup>). The predominant barrier to loop extrusion in vertebrates is CTCF (ref. <sup><xref ref-type="bibr" rid="CR12">12</xref></sup>), which has an instructive role in establishing extrusion-mediated structures that are visible in Hi-C<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. However, the loop extrusion machinery encounters other obstacles on chromatin, such as nucleosomes and other protein complexes. Although RNA polymerases are moving barriers for condensin translocation in bacteria<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and affect cohesin translocation in eukaryotes<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>, it remains unknown how SMCs can extrude loops on &#x2018;busy&#x2019; eukaryotic chromosomes that are bound by a myriad of proteins. Whether other DNA-bound proteins can influence three-dimensional genome architecture in eukaryotes is not known, and could be critical for understanding their function.</p>
      <p id="Par4">The minichromosome maintenance (MCM) complex is an abundant macromolecular machine that is essential for DNA replication in eukaryotes and archaea<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. MCM2&#x2013;MCM7 complexes (hereafter MCM) are loaded at replication origins by the origin recognition complex (ORC), Cdc6 and Cdt1 to form the pre-replication complex during mitosis and G1 phase<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. The head-to-head double MCM hexamer topologically entraps double-stranded DNA and is catalytically inactive as a helicase until the initiation of DNA replication<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Notably, 10&#x2013;100-fold more MCMs are loaded onto chromatin than are needed for S-phase progression. This is referred to as the &#x2018;MCM paradox&#x2019;<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. One hypothesis to explain this phenomenon is that surplus complexes mark dormant origins that fire under conditions such as DNA damage checkpoint activation<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Surplus MCMs have been shown to protect against DNA breaks by reducing replication fork speed<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Whether they have any functional consequences in G1 phase remains unclear. Given the abundance of MCMs, their long residence time on chromatin<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> (more than 6&#x2009;h) and their comparable size<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> (13&#x2009;nm) to the FtsK helicase (12.5&#x2009;nm) (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1</xref>) that can push cohesin on DNA in vitro<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, we asked whether MCMs are obstacles to cohesin-mediated loop extrusion and in this way influence genome architecture.</p>
    </sec>
    <sec id="Sec2">
      <title>MCMs impede CTCF-anchored loops</title>
      <p id="Par5">To test this hypothesis, we used the oocyte-to-zygote transition to investigate whether MCM loss affects loop extrusion. Oocytes are female germ cells that divide meiotically and, after fertilization, generate one-cell embryos (zygotes). These contain maternal and paternal pronuclei, the chromatin of which is organized into cohesin-dependent loops and TADs<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>. Although zygotes are limited by paucity of material, they offer advantages for: (1) studying MCM loading on newly assembled paternal chromatin; (2) deciphering haplotype-resolved chromatin organization; (3) manipulating the assembly of the pre-replication complex without interfering with cell-cycle progression, as there is no DNA replication between meiosis I and II; and (4) disentangling direct from indirect effects because of transcriptional inactivity<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p>
      <p id="Par6">To generate zygotes that are deficient in chromatin-bound MCMs, we interfered with the Cdt1-mediated loading pathway. Cdt1 deposits MCMs onto chromatin, and this reaction is inhibited by geminin, a target of the anaphase-promoting complex/cyclosome (APC/C)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2a</xref>). Mutation of geminin&#x2019;s destruction box generates a non-degradable version (geminin(L26A)) that inhibits the Cdt1-mediated loading of MCMs in G1 phase<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2a</xref>). To achieve this, mouse oocytes were microinjected with mRNA encoding an injection marker GFP with or without geminin(L26A) (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). Metaphase II eggs were fertilized in vitro and zygotes were analysed in G1 phase (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2c</xref>). Geminin(L26A) expression did not grossly affect the abundance of Scc1 and CTCF (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2e, f</xref>). By contrast, few or no chromatin-bound MCMs were detected and EdU was not incorporated in zygotes expressing geminin(L26A) (referred to as &#x2018;MCM loss&#x2019;) (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>, Extended Data Fig. <xref rid="Fig6" ref-type="fig">2b, d</xref>), demonstrating the efficient inhibition of MCM loading.<fig id="Fig1"><label>Fig. 1</label><caption><title>Chromatin-bound MCMs impede loop and TAD formation in G1-phase zygotes.</title><p><bold>a</bold>, Germinal vesicle (GV)-stage oocytes were injected with geminin(L26A) mRNA and metaphase II eggs were fertilized in vitro. Maternal and paternal pronuclei were extracted for snHi-C. <bold>b</bold>, Representative images of immunofluorescence staining of chromatin-bound MCM2 in wild-type (WT) and MCM-loss G1-phase zygotes. DNA is stained with DAPI. Scale bars, 10&#x2009;&#xB5;m. <bold>c</bold>, Comparison of contacts detected in snHi-C versus bulk Hi-C. Contact probability curves, <italic>P</italic><sub>c</sub>(<italic>s</italic>), provide insights into chromatin compaction. <bold>d</bold>, Average loops and TADs for wild-type and MCM-loss chromatin in G1 phase. The data shown are based on <italic>n</italic> (WT, maternal)&#x2009;=&#x2009;13, <italic>n</italic> (WT, paternal)&#x2009;=&#x2009;16, <italic>n</italic> (MCM&#xA0;loss, maternal)&#x2009;=&#x2009;16, <italic>n</italic> (MCM&#xA0;loss, paternal)&#x2009;=&#x2009;15, from 4 independent experiments using 4&#x2013;6 females&#xA0;for each experiment. Heat maps were normalized to an equal number of <italic>cis</italic> contacts. <bold>e</bold>, <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves for wild-type and MCM-loss conditions. <bold>f</bold>, Insulation scores at TAD borders.</p></caption><graphic xlink:href="41586_2022_4730_Fig1_HTML" id="d32e663"/></fig></p>
      <p id="Par7">Using this approach, we generated MCM-loss and control zygotes, isolated maternal and paternal pronuclei in G1 phase and performed single-nucleus Hi-C (snHi-C) (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). The sparsity of snHi-C data precluded de novo calling of loops (referred to as &#x2018;peaks&#x2019;), which represent contacts between CTCF-bound loci. Instead, we used 12,000 loop coordinates from mouse embryonic fibroblast Hi-C data that report on cohesin-dependent contacts in zygotes<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). Notably, MCM loss resulted in an increase in aggregate peaks and aggregate TADs (referred to as &#x2018;peaks&#x2019; and &#x2018;TADs&#x2019;) in maternal chromatin and an even stronger increase in paternal chromatin (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3a&#x2013;c</xref>), which will be focused on hereafter. The increase in peak strengths after MCM loss could reflect higher CTCF occupancy, but this could not explain the barrier effect seen in vitro (see Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). Alternatively, it could reflect increased access of cohesin to CTCF sites, owing to changes in either loop extrusion (potentially caused by barrier loss) or transcription. There were few transcriptomic differences between control and MCM-loss zygotes (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4a, b</xref>). We conclude that MCMs hinder the formation of CTCF-anchored loops and TADs largely independently of changes in gene expression.</p>
      <p id="Par8">To find out whether cohesin is responsible for the increase in snHi-C peak strength caused by MCM loss, we used a conditional genetic knockout approach based on Cre recombinase under control of the <italic>Zp3</italic> promoter to delete floxed alleles of the cohesin subunit <italic>Scc1</italic> in oocytes<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. We expressed geminin(L26A) in <italic>Scc1</italic><sup><italic>&#x394;/&#x394;</italic></sup> oocytes isolated from <italic>Scc1</italic><sup><italic>fl/fl</italic></sup>
<italic>(Tg)Zp3</italic>-Cre females and generated maternal <italic>Scc1</italic> knockout zygotes (<italic>Scc1</italic><sup><italic>&#x394;(m)/+(p)</italic></sup>) (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4c</xref>). Loops and TADs were undetectable in <italic>Scc1</italic><sup><italic>&#x394;(m)/+(p)</italic></sup> zygotes, as reported previously<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, and remained undetectable if MCM loading was prevented (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4d</xref>). We conclude that MCMs interfere with cohesin-dependent chromatin structures.</p>
      <p id="Par9">To determine how MCMs affect chromatin organization, we examined the contact probability <italic>P</italic><sub>c</sub>(<italic>s</italic>) as a function of genomic distance (<italic>s</italic>) (Fig. <xref rid="Fig1" ref-type="fig">1e</xref>, Extended Data Fig. <xref rid="Fig7" ref-type="fig">3d, e</xref>). The position of the &#x2018;shoulder&#x2019; on the <italic>P</italic><sub>c</sub>(<italic>s</italic>) curve is informative of the mean size of extruded loops<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> (Extended Data Fig. <xref rid="Fig7" ref-type="fig">3f</xref>). Of note, MCM loss has little effect on the <italic>P</italic><sub>c</sub>(<italic>s</italic>) curve below 1&#x2009;Mb (Fig. <xref rid="Fig1" ref-type="fig">1e</xref>); this is reminiscent of CTCF loss<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, and suggests that the mean size of extruded loops is largely unaffected. However, the effect of CTCF loss on &#x2018;peaks&#x2019; is opposite to that of MCM loss. We reasoned that if MCMs impede formation of CTCF-mediated structures, then MCM loss should lead to increased CTCF peaks and increased insulation of TAD boundaries, as observed (Fig. <xref rid="Fig1" ref-type="fig">1f</xref>). These effects on chromatin organization are consistent with a mechanism in which MCMs impede loop extrusion by altering loop positioning without considerably changing their sizes.</p>
      <p id="Par10">We tested whether CTCF and MCM together determine the strengths of peaks and TAD boundary insulation. We expressed geminin(L26A) in CTCF-knockdown oocytes isolated from <italic>(Tg)Zp3-CTCFdsRNA</italic> females and generated maternal CTCF-knockdown zygotes<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>, Extended Data Fig. <xref rid="Fig9" ref-type="fig">5a</xref>). CTCF knockdown without or with MCM perturbation resulted in a loss of loops and TADs (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>, Extended Data Fig. <xref rid="Fig9" ref-type="fig">5b</xref>); this shows that CTCF is essential for these structures in zygotes. Knockdown of CTCF caused a weakening of TAD boundary insulation and did not grossly change <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves below 1&#x2009;Mb (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, Extended Data Fig. <xref rid="Fig9" ref-type="fig">5c&#x2013;e</xref>). The lack of TAD organization after knockdown of CTCF, irrespective of MCMs, suggests that MCMs have no instructive function for establishing position-specific boundaries. This is consistent with MCMs being largely located in different positions in different cells<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.<fig id="Fig2"><label>Fig. 2</label><caption><title>MCMs impede CTCF-anchored loops and function independently of Wapl.</title><p><bold>a</bold>, CTCF-knockdown oocytes from <italic>(Tg)Zp3-dsCTCF</italic> females were injected with geminin(L26A) mRNA and eggs were fertilized to generate zygotes for snHi-C analysis in G1 phase. <bold>b</bold>, Average loops and TADs for wild-type, CTCF-knockdown and CTCF-knockdown&#x2009;+&#x2009;MCM loss for paternal chromatin in G1. Data are based on <italic>n</italic> (WT, paternal)&#x2009;=&#x2009;12, <italic>n</italic> (CTCF&#xA0;knockdown, paternal)&#x2009;=&#x2009;8 and <italic>n</italic>(CTCF&#xA0;knockdown +&#x2009;MCM loss, paternal)&#x2009;=&#x2009;8 nuclei, from 4 independent experiments using 4&#x2013;6 females for each genotype. Heat maps were normalized to an equal number of <italic>cis</italic> contacts. <bold>c</bold>, Insulation scores at TAD borders for paternal chromatin. <bold>d</bold>, <italic>Wapl</italic><sup><italic>&#x394;/&#x394;</italic></sup> oocytes from <italic>Wapl</italic><sup><italic>fl/fl</italic></sup> (<italic>Tg</italic>)<italic>Zp3</italic>-Cre&#xA0;females were injected with geminin(L26A) mRNA and eggs were fertilized to generate zygotes for snHi-C analysis in G1 phase. <bold>e</bold>, Average loops and TADs for control (wild type), <italic>Wapl</italic><sup><italic>&#x394;</italic></sup> and <italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#x2009;+&#x2009;MCM loss for paternal chromatin in G1. Data shown are based on <italic>n</italic> (WT, paternal)&#x2009;=&#x2009;20, <italic>n</italic> (<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>, paternal)&#x2009;=&#x2009;11, <italic>n</italic> (<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#x2009;+&#x2009;MCM loss, paternal)&#x2009;=&#x2009;9 nuclei, from 4 independent experiments using 4&#x2013;6 females for each genotype. Control samples are wild type (this study) pooled with <italic>Wapl</italic><sup><italic>fl</italic></sup> samples (published previously<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>). Heat maps were normalized to an equal number of <italic>cis</italic> contacts. <bold>f</bold>, Insulation scores at TAD borders for paternal chromatin.</p></caption><graphic xlink:href="41586_2022_4730_Fig2_HTML" id="d32e954"/></fig></p>
      <p id="Par11">We considered an alternative possibility that MCMs affect loops by functioning with Wapl in releasing cohesin from chromatin. This is based on the similar effects on Hi-C peak and TAD strengths after <italic>Wapl</italic> knockout and MCM loss<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup> (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>). If Wapl and MCMs function together, then their co-depletion would be expected to resemble individual depletions. If they function independently, then co-depletion could have synergistic effects. To distinguish between these, we expressed geminin(L26A) in <italic>Wapl</italic><sup><italic>&#x394;/&#x394;</italic></sup> oocytes isolated from <italic>Wapl</italic><sup><italic>fl/fl</italic></sup>
<italic>(Tg)Zp3</italic>-Cre females and generated maternal <italic>Wapl</italic> knockout zygotes<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> (<italic>Wapl</italic><sup><italic>&#x394;(m)/+(p)</italic></sup>) (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>). Combined MCM loss and <italic>Wapl</italic> knockout strongly increased peak and TAD strengths over the individual conditions (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>, Extended Data Fig. <xref rid="Fig10" ref-type="fig">6a&#x2013;d</xref>), suggesting that they function through separate mechanisms. The combined loss increased TAD boundary insulation, suggesting that MCMs restrict loop extrusion also when cohesin residence time is increased (Fig. <xref rid="Fig2" ref-type="fig">2f</xref>, Extended Data Fig. <xref rid="Fig10" ref-type="fig">6b</xref>).</p>
    </sec>
    <sec id="Sec3">
      <title>MCMs are semi-permeable barriers</title>
      <p id="Par12">We introduced MCMs as randomly located permeable extrusion barriers into polymer models of loop extrusion (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). Polymer simulations identified parameters, including the permeability of MCMs, such that the peak strengths and <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves of paternal chromatin can be quantitatively reproduced (Fig. <xref rid="Fig3" ref-type="fig">3b, d</xref>, Extended Data Fig. <xref rid="Fig10" ref-type="fig">6e&#x2013;h</xref>, <xref rid="MOESM1" ref-type="media">Supplementary Figs. 2&#x2013;5</xref>). In the model, cohesin extrudes loops and is stopped at CTCF sites (around 50% of encounters)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> and MCMs (around 20% of encounters, for an estimated density of 1 MCM per 75&#x2009;kb) (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). If MCM density is lower in zygotes, then blocking will occur more frequently (more than 20%) (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). The predicted semi-permeability of MCMs could explain how CTCF-anchored loops are generated in the presence of MCMs in G1 phase.<fig id="Fig3"><label>Fig. 3</label><caption><title>Simulation model of MCMs as a random barrier to cohesin loop extrusion.</title><p><bold>a</bold>, A quantitative model for loop extrusion by cohesin and interactions with CTCF and MCMs. Cohesin (yellow) extrudes loops. On encountering barriers such as CTCF sites (green triangles), MCMs (red hexagons) or other cohesins, extrusion can be blocked. Cohesins may bypass some CTCFs and MCMs, but not others; the choice to bypass an MCM or CTCF site is stochastic and varies in time. <bold>b</bold>&#x2013;<bold>d</bold>, For paternal chromatin simulations, we assume that CTCF stalls cohesin around 45% of the time, as measured in mouse embryonic stem cells<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, and that MCMs stall cohesin 20% of the time. <bold>b</bold>, Peak strengths for simulated paternal chromatin under various perturbations for TADs of 300&#x2009;kb average length. <bold>c</bold>, Matrix of peak strengths in the wild type, showing a linear trade-off between MCM density and its ability to pause cohesin. AU, arbitrary units. <bold>d</bold>, The simulated contact probability decay curve <italic>P</italic><sub>c</sub>(<italic>s</italic>) for the MCM-loss condition is well matched with experimental data. <bold>e</bold>, Model summarizing the finding that chromatin-bound MCMs can function as barriers for loop extrusion in G1 phase.</p></caption><graphic xlink:href="41586_2022_4730_Fig3_HTML" id="d32e1100"/></fig></p>
      <p id="Par13">Our model provides a rationale for the seemingly contradictory ability of MCM to reduce CTCF&#x2013;CTCF peak strength without strongly affecting the mean size of extruded loops. A peak emerges if cohesin extrudes all chromatin between a pair of CTCFs into loops. A random barrier prevents cohesin from extruding all chromatin between CTCFs, leaving an unextruded gap<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>). The effect of random barriers on the average loop size is, however, marginal (less than 15%) if barriers are sufficiently permeable or sparse (one per TAD of around 300&#x2009;kb). This is an unexpected effect of random barriers on features of chromosome organization.</p>
    </sec>
    <sec id="Sec4">
      <title>MCMs affect transcription and loops</title>
      <p id="Par14">As these findings were obtained in zygotes, we tested whether MCMs also impede loop extrusion in somatic cells. To directly degrade MCMs, we treated G1-synchronized HCT116 cells carrying auxin-inducible degron MCM2-mAID alleles with dimethyl sulfoxide (DMSO) or auxin<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> (Extended Data Figs. <xref rid="Fig11" ref-type="fig">7a&#x2013;g</xref>, <xref rid="Fig12" ref-type="fig">8a&#x2013;f</xref>). Treatment with auxin reduced chromatin-bound MCM2 and MCM4 without grossly affecting the abundance of CTCF and cohesin (Extended Data Figs. <xref rid="Fig11" ref-type="fig">7c</xref>, <xref rid="Fig12" ref-type="fig">8c</xref>). Acute MCM degradation resulted in the differential expression of 229 genes (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8l, m</xref>), which is comparable to the effects of acute CTCF degradation<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Hi-C data showed a moderate increase in aggregate peak strengths in MCM-depleted versus control cells (Extended Data Fig. <xref rid="Fig11" ref-type="fig">7d, e</xref>). To confirm this result using another method, we performed Micro-C and found that MCM depletion results in a moderate but genome-wide and significant (<italic>P</italic>&#x2009;=&#x2009;1.87&#x2009;&#xD7;&#x2009;10<sup>&#x2212;70</sup>) increase in the peak strength (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8d, g&#x2013;i</xref>). Notably, de novo peak calling identified a greater number of loops in MCM-depleted cells, consistent with loop extrusion reaching CTCF sites more frequently (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8j, k</xref>). The effects show the same directionality but are much more subtle than in zygotes and cannot be explained solely by RNA polymerase in somatic cells (Extended Data Fig. <xref rid="Fig12" ref-type="fig">8n, o</xref>). On the basis of the consistent increases in loop strengths and numbers after MCM degradation, we conclude that MCMs impede the formation of CTCF-anchored loops in somatic cells.</p>
    </sec>
    <sec id="Sec5">
      <title>MCMs block cohesin translocation</title>
      <p id="Par15">The most parsimonious interpretation of the effects of MCM loss on genome architecture is that MCMs interfere with loop extrusion by forming randomly located barriers. To directly test this, we established an MCM &#x2018;roadblock assay&#x2019; for passive translocation of cohesin using total internal reflection fluorescence microscopy that detects real-time cohesin&#x2013;MCM interactions at the single-molecule level. Origin licensing was reconstituted from purified components in a stepwise manner on origin-containing DNA molecules<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). Loading of yeast MCM and double-hexamer formation&#x2014;a hallmark of proper origin licensing&#x2014;was observed in the presence of ORC, Cdc6 and Cdt1 (ref. <sup><xref ref-type="bibr" rid="CR41">41</xref></sup>) (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9a</xref>). Cohesin was introduced in low-salt conditions, followed by a high-salt wash to select for fully loaded MCMs<sup><xref ref-type="bibr" rid="CR41">41</xref>&#x2013;<xref ref-type="bibr" rid="CR43">43</xref></sup>. To mimic intracellular conditions, experiments were imaged in physiological salt conditions, promoting cohesin translocation on fast timescales<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9b</xref>, <xref rid="MOESM6" ref-type="media">Supplementary Video 1</xref>). The cohesin diffusion coefficient remained unchanged in the presence of MCMs (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9c</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>MCMs are barriers for cohesin translocation in vitro.</title><p><bold>a</bold>, Principle of a single-molecule cohesin translocation assay on licensed DNA. MCM is loaded onto DNA by the licensing factors ORC, Cdc6 and Cdt1, followed by cohesin. A high-salt wash removes licensing factors and intermediates from DNA. Cohesin translocation is visualized at physiological salt conditions (0.15&#x2009;M NaCl) without free protein and buffer flow. <bold>b</bold>, <bold>c</bold>, Representative kymographs of translocating cohesin on licensed DNA. Origin-bound MCM (<bold>b</bold>) and MCM<sup>Mcm3-YDF</sup> (<bold>c</bold>) are efficient barriers for cohesin translocation. <bold>d</bold>, Probability of translocating cohesin bypassing the origin in the absence or in the presence of MCM or MCM<sup>Mcm3-YDF</sup>, calculated from 74, 162 or 79 molecules with 12,175, 15,348 or 9,455 visualized encounters, respectively. <bold>e</bold>, Cohesin translocation pauses at MCM in a YDF-disordered-region-dependent manner. Fraction of cohesin pausing of the total observation time in the absence or in the presence of MCM or MCM<sup>Mcm3-YDF</sup>. Data in <bold>d</bold>, <bold>e</bold> are depicted as mean within a 95% confidence interval (generated by bootstrapping). <italic>P</italic> values were determined by Kruskal&#x2013;Wallis test followed by Dunn&#x2019;s post-hoc test.</p></caption><graphic xlink:href="41586_2022_4730_Fig4_HTML" id="d32e1248"/></fig></p>
      <p id="Par16">Direct visualization of cohesin encounters with MCMs revealed constrained cohesin translocation with a fourfold reduction in origin passage (Fig. <xref rid="Fig4" ref-type="fig">4b, d</xref>, Extended Data Fig. <xref rid="Fig13" ref-type="fig">9d&#x2013;g</xref>, Supplementary Videos&#xA0;<xref rid="MOESM7" ref-type="media">2</xref>, <xref rid="MOESM8" ref-type="media">3</xref>). Similar results were obtained at higher salt concentrations (Extended Data Figs. <xref rid="Fig13" ref-type="fig">9c</xref>, <xref rid="Fig14" ref-type="fig">10a&#x2013;f</xref>, Supplementary Videos&#xA0;<xref rid="MOESM9" ref-type="media">4</xref>&#x2013;<xref rid="MOESM11" ref-type="media">6</xref>). A subpopulation of cohesin molecules were unable to pass origins even once during the 220-s imaging window (67/162; Fig. <xref rid="Fig4" ref-type="fig">4b</xref>, Extended Data Fig. <xref rid="Fig13" ref-type="fig">9d</xref>). By contrast, origin passage&#xA0;was unimpeded in the absence of MCMs (72/74; Extended Data Fig. <xref rid="Fig13" ref-type="fig">9b</xref>). The observed permeability of MCMs is lower than that predicted by simulations, which could be a result of different conditions from loop extrusion in vivo. It will be important in future studies to test whether MCMs halt loop extrusion, which requires a combined assay that has thus far not been established owing to&#xA0;different reaction conditions in vitro. We conclude that MCMs are physical barriers to cohesin translocation and may occasionally be bypassed.</p>
      <p id="Par17">Finally, we tested whether mammalian MCMs are stronger barriers&#xA0;than yeast MCMs to cohesin translocation. Unlike yeast Mcm3, human MCM3 contains a 19-amino-acid disordered region containing a YDF motif that is sufficient to bind STAG2&#x2013;SCC1 cohesin in vitro<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. The same motif mediates an interaction between CTCF and STAG2&#x2013;SCC1 (ref. <sup><xref ref-type="bibr" rid="CR44">44</xref></sup>). As there is no established human origin licensing assay, we modified the yeast assay to load a chimeric MCM complex containing a &#x2018;humanized&#x2019; MCM3 subunit (MCM-YDF). We found that cohesin bypasses MCM-YDF slightly less frequently compared to MCM, suggesting that its barrier strength is comparable to that of yeast MCMs (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). Notably, we observed frequent pausing of cohesin upon encountering MCM-YDF (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>, Extended Data Fig. <xref rid="Fig13" ref-type="fig">9h, i</xref>), with pauses accounting for 43% of the total observation time on average (Fig. <xref rid="Fig4" ref-type="fig">4e</xref>). These pauses were much less frequent (6.4%) in the presence of MCMs lacking YDF, which suggests that pausing reflects a molecular docking of cohesin to the YDF region.</p>
    </sec>
    <sec id="Sec6" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par18">We have identified MCM complexes as barriers for loop extrusion on the basis of in vivo, in silico and in vitro data. MCMs are members of a new class of randomly positioned and cell-cycle-phase-specific barriers that impede the formation of CTCF-anchored loops and TADs. A key question is which features determine whether a protein impedes loop extrusion. Nanoparticles larger than the diameter of SMC complexes can be bypassed by extruding SMC complexes<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, suggesting that size is not the sole determinant. Unlike those permeable roadblocks, MCMs have two distinguishing features that can promote barrier function. MCMs bind DNA in a topological manner. Although the mechanism of bypassing obstacles is not known, it is conceivable that a topological engagement of proteins around DNA could interfere with cohesin binding to DNA to &#x2018;swing over&#x2019; a protein<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Consistent with this, cohesin that topologically entraps sister chromatids restricts loop extrusion mediated by other cohesin complexes in oocytes<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. In addition, the YDF disordered region alters the outcome of cohesin&#x2013;MCM collisions from blocking to pausing, which suggests that MCMs are active chemical barriers with binding sites rather than passive physical barriers.</p>
      <p id="Par19">The finding that MCMs are barriers to loop extrusion provides a different perspective on the body of knowledge on MCMs and cohesin loading. MCMs recruit cohesin to pre-replication complexes in <italic>Xenopus</italic> extracts<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup> and promote cohesin loading during DNA replication in human cells<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. These studies proposed that MCMs have a role in loading cohesin; that is, capturing cohesin from nucleoplasm and converting it from a freely diffusive into a DNA-bound state. Our work raises the possibility that cohesin could arrive at an MCM site by loop extrusion, where it is either blocked, passes by or pauses. Extruding cohesin pausing at MCMs could potentially be converted into a topologically binding complex that establishes cohesion after passage of the DNA replication fork (Extended Data Fig. <xref rid="Fig14" ref-type="fig">10g</xref>). A similar conversion of DNA binding mode has recently been proposed at CTCF sites<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Our idea distinguishes cohesin loading by MCMs from the arrival of cohesin at MCM sites by loop extrusion.</p>
      <p id="Par20">Given the evolutionary conservation of MCMs, it is possible that replicative helicases might be ancestral barriers in species that lack CTCF-anchored loops, such as <italic>Drosophila</italic>, in which the establishment of TADs during embryonic development coincides with a switch in replication origin usage<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Finally, our data suggest that the &#x2018;MCM paradox&#x2019; has consequences for chromatin organization and gene expression, which might have relevance for human pathologies such as Meier&#x2013;Gorlin syndrome that are linked to mutations in the MCM loading pathway<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>.</p>
    </sec>
    <sec id="Sec7" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec8">
        <title>Animals</title>
        <p id="Par21">The mice used in this work were bred and maintained in agreement with the authorizing committee according to the Austrian Animal Welfare law and the guidelines of the International Guiding Principles for Biomedical Research Involving Animals (CIOMS, the Council for International Organizations of Medical Sciences). Mice were housed in individually ventilated cages under a 14-h light&#x2013;10-h dark cycle at an ambient temperature of 22&#x2009;&#xB0;C&#x2009;&#xB1;&#x2009;1&#x2009;&#xB0;C and humidity of 55%&#x2009;&#xB1;&#x2009;5% with continuous access to food and water. Mice were housed in groups (maximum four males per cage and maximum five females per cage). All mice were bred in the IMBA animal facility. Wild-type, <italic>Scc1</italic><sup><italic>fl/fl</italic></sup> and <italic>Scc1</italic><sup><italic>Myc/+</italic></sup> mice were bred on a mixed background (B6, 129, Sv). <italic>Wapl</italic><sup><italic>fl/fl</italic></sup> and <italic>Zp3-dsCTCF</italic> mice were bred on a primarily C57BL/6J background. <italic>Zp3-dsCTCF</italic> mice were maintained by breeding <italic>Zp3-dsCTCF</italic> males with C57BL/6J females. Experimental <italic>Scc1</italic><sup><italic>fl/fl</italic></sup> and <italic>Wapl</italic><sup><italic>fl/fl</italic></sup> mice were obtained by mating of homozygous floxed females with homozygous floxed males carrying <italic>Tg(Zp3Cre)</italic><sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Experimental <italic>Scc1</italic><sup><italic>Myc/+</italic></sup> mice were obtained by intercrossing heterozygous <italic>Scc1</italic><sup><italic>Myc/+</italic></sup> mice. Experimental <italic>Zp3-dsCTCF</italic> mice were maintained by breeding <italic>Zp3-dsCTCF</italic> males with C57BL/6J females.</p>
      </sec>
      <sec id="Sec9">
        <title>Collection and in vitro culture of mouse oocytes</title>
        <p id="Par22">Ovaries were dissected from sexually mature female mice, which were euthanized by cervical dislocation. Fully grown germinal vesicle (GV) oocytes from 2&#x2013;5-month-old females were isolated by physical disaggregation of ovaries with hypodermic needles. GV oocytes were cultured in M2 medium supplemented with 0.2&#x2009;mM of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, Sigma-Aldrich) at 37&#x2009;&#xB0;C. Mature oocytes were selected according to appearance (size, central nucleus, smooth zona pellucida) and cultured in M16 medium supplemented with IBMX in an incubator at 37&#x2009;&#xB0;C and 5% CO<sub>2</sub>. Oocytes were cultivated in approximately 40-&#xB5;l drops covered with paraffin oil (NidOil).</p>
      </sec>
      <sec id="Sec10">
        <title>Microinjection</title>
        <p id="Par23">GV oocytes were microinjected with in-vitro-transcribed mRNA dissolved in RNAse-free water (mMessage mMachine T3 kit, Ambion). The following mRNA concentrations were injected: 2.3&#x2009;pmol hGeminin(L26A) and 0.2&#x2009;pmol GFP. Microinjection was performed in approximately 20-&#xB5;l drops of M2 (0.2&#x2009;mM IBMX) covered with mineral oil (Sigma-Aldrich) using a Pneumatic PicoPump (World Precision Instruments) and hydraulic micromanipulator (Narishige) mounted onto a Zeiss Axiovert 200 microscope equipped with a 10&#xD7;/0.3 EC plan-neofluar and 40&#xD7;/0.6 LD Apochromat objective. Injected oocytes were cultured for 2&#x2009;h and then released from IBMX inhibition by washing in M16 to resume meiosis.</p>
      </sec>
      <sec id="Sec11">
        <title>In vitro maturation and in vitro fertilization</title>
        <p id="Par24">Oocyte collection and culturing was performed as described above but M2 and M16 media were supplemented with 20% FBS (Gibco) and 6&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> fetuin (Sigma-Aldrich). After microinjection and IBMX release as described above, GV oocytes were subsequently incubated at 37&#x2009;&#xB0;C and in low-oxygen conditions (5% CO<sub>2</sub>, 5% O<sub>2</sub>, 90% N<sub>2</sub>) to initiate in vitro maturation to metaphase II (MII) eggs. Next, MII eggs were in vitro fertilized 10.5&#x2013;12&#x2009;h after release of IBMX. Sperm was isolated from the cauda epididymis and vas deferens of stud males (2&#x2013;5 months old) and capacitated in fertilization medium (Cook Austria GmbH) in a tilted cell culture dish for at least 30&#x2009;min before incubation with MII eggs. For in vitro fertilization of wild-type, <italic>Scc1</italic><sup><italic>fl/fl</italic></sup> (<italic>Tg</italic>)<italic>Zp3</italic>-Cre and <italic>Zp3-dsCTCF</italic> oocytes, sperm was obtained from B6CBAF1 males, whereas sperm of C57BL/6J males was used for in vitro fertilization of&#xA0;<italic>Wapl</italic><sup><italic>fl/fl</italic></sup> (<italic>Tg</italic>)<italic>Zp3</italic>-Cre&#xA0;oocytes. Zygotes were scored by the formation of visible pronuclei at 5&#x2009;h after fertilization.</p>
      </sec>
      <sec id="Sec12">
        <title>In situ fixation, immunofluorescence staining and imaging</title>
        <p id="Par25">Zygotes were pulsed with 1&#x2009;mM 5-ethynyl-2&#x2032;-deoxyuridine (EdU) (Invitrogen) before in situ fixation to check the time frame of G1 phase. To check for DNA replication, zygotes were fixed in G2 after continuous incubation in the presence of EdU. Oocytes and zygotes were stripped from their zona pellucida by using acidic Tyrode&#x2019;s solution (Sigma-Aldrich) before in situ fixation in 4% paraformaldehyde (PFA) (in phosphate-buffered saline (PBS)) for 30&#x2009;min at room temperature, followed by permeabilization in 0.2% Triton X-100 in PBS (PBSTX) for 30&#x2009;min at room temperature. EdU-pulsed cells were processed according to the manual of the Click-iT EdU Alexa Fluor 647 imaging kit (Invitrogen). Blocking was performed using 10% goat serum (Dako) in PBSTX for 1&#x2009;h at room temperature or at 4&#x2009;&#xB0;C overnight. Cells were incubated with primary antibodies for 2.5&#x2009;h at room temperature or at 4&#x2009;&#xB0;C overnight. The following primary antibodies were used: anti-MCM2 (1:500; BD Transduction Laboratories, 610701), anti-CTCF (1:250, Peters Laboratory, A992), anti-MYC (1:500, Millipore, 05-724). After washing in blocking solution three times for at least 20&#x2009;min, cells were incubated with goat anti-mouse Alexa Fluor 488 (1:500, Invitrogen, A11029), donkey anti-rabbit Alexa Fluor 568 (1:500, Invitrogen, A10042) or goat anti-mouse Alexa Fluor 647 (1:500, Invitrogen, A-21235) secondary antibodies for 1&#x2009;h at room temperature. The excess of secondary antibody was removed by washing three times in 0.2% PBSTX for at least 20&#x2009;min, which was followed by a short PBS wash and submerging for 20&#x2009;min in Vectashield with DAPI (Vector Labs). Cells were mounted in Vectashield with DAPI using imaging spacers (Sigma-Aldrich) to preserve three-dimensional integrity. Detection of chromatin-bound MCM2 required pre-extraction before fixation and was performed as described previously<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. In short, the zona pellucida was not removed and zygotes were incubated in ice-cold extraction buffer (50&#x2009;mM NaCl, 3&#x2009;mM MgCl<sub>2</sub>, 300&#x2009;mM sucrose, 25&#x2009;mM HEPES, 0.5% Triton X-100) for 7&#x2009;min on ice, followed by three short washes in ice-cold extraction buffer without Triton X-100. In situ fixation and immunofluorescence was performed as described above. To avoid zona pellucida collapse, cells were submerged in increasing Vectashield concentrations before final mounting. Image acquisition was performed on a Zeiss LSM780 or LSM880 confocal microscope using a plan-apochromat 63&#xD7;/1.4 oil immersion objective. Image analysis was performed in Fiji/ImageJ. Mean intensity was measured within a defined nuclear area of each zygote. To measure nuclear signal over background, images were first deconvoluted by Huygens Professional (SVI) followed by segmentation into nuclei and surrounding cytoplasm using a custom ImageJ macro.</p>
      </sec>
      <sec id="Sec13">
        <title>Cell culture and synchronization</title>
        <p id="Par26">HCT116 cells were cultured as previously described<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. In brief, cells were cultured in McCoy&#x2019;s 5A medium (Thermo Fisher Scientific) supplemented with 10% FBS (Gibco), 2&#x2009;mM <sc>l</sc>-glutamine (Invitrogen) and 10% penicillin&#x2013;streptomycin solution (Sigma-Aldrich). Cells were grown in an incubator at 37&#x2009;&#xB0;C with 5% CO<sub>2</sub>. MCM2&#x2013;mAID degradation was induced by addition of 500&#x2009;&#xB5;M 3-indoleacetic acid (Sigma-Aldrich) for 6&#x2009;h. To synchronize cells in G1 for Hi-C analysis, a 2&#x2009;mM thymidine arrest was followed by release into fresh medium for 6&#x2009;h. Subsequently, nocodazole was added for 5&#x2009;h, followed by shake-off of prometaphase cells and release in fresh medium for 4&#x2009;h. Cells were fixed for Hi-C, microscopy and fluorescence-activated cell sorting (FACS). Cell-cycle profiling was performed using propidium iodide staining. For G1 FACS, cells were synchronized with a double-thymidine arrest&#x2013;release followed by release into fresh medium for 12&#x2009;h. Four hours before sorting, Hoechst 33342 (Sigma) was added to the medium at a concentration of 0.2&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup>. For the triptolide (Trp) experiment, 4&#x2009;h before sorting, triptolide (Sigma) at 1&#x2009;&#xB5;M was added. Live-cell sorting was performed with the BD FACS Aria II flow cytometry instrument. The following gating strategy was used: gating for cells with SSC-A versus FSC-A, excluding doublets with FSC-H versus FSC-A, selecting Hoechst 33342-stained cells with HOECHST-W versus HOECHST-A gating and Count versus HOECHST-A to select to select the G1 population. To avoid S-phase cell contamination, only cells in the left part of the G1 peak were collected (red dashed box in Extended Data Fig. <xref rid="Fig12" ref-type="fig">8</xref>) (see&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Fig. 6</xref> for the gating strategy).</p>
      </sec>
      <sec id="Sec14">
        <title>Chromatin fractionation and protein detection</title>
        <p id="Par27">Fractionation was performed as previous described<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. In brief, cells were extracted in a buffer consisting of 20&#x2009;mM Tris&#x2013;HCl (pH 7.5), 100&#x2009;mM NaCl, 5&#x2009;mM MgCl, 2&#x2009;mM NaF, 10% glycerol, 0.2% NP40, 20&#x2009;mM &#x3B2;-glycerophosphate, 0.5&#x2009;mM DTT and protease inhibitor cocktail (Complete EDTA-free, Roche). Chromatin pellets and supernatant were separated and collected by centrifugation at 1,700<italic>g</italic> for 5&#x2009;min. The chromatin pellets were washed three times with the same buffer. Protein concentration was measured using a Bradford assay. Proteins were separated through SDS&#x2013;PAGE on a Bolt 4&#x2013;12% Bis-Tris Plus Gel (Invitrogen) and transferred to a nitrocellulose membrane. After overnight blocking with 5% skimmed milk in TBS-T at 4&#x2009;&#xB0;C, the membrane was incubated with primary antibodies for 2.5&#x2009;h at room temperature. The following antibodies were used: anti-MCM2 (1:5,000; BD Transduction Laboratories, 610701), anti-MCM4 (1:5,000; Abcam, ab4459), anti-H3 (1:2,000; Cell Signaling, 97155), anti-GAPDH(1:2,500; Millipore, MAB374), anti-CTCF (1:1,000, Peters Laboratory, A992), anti-PCNA (1:500, Santa Cruz, PC10), anti-SCC1 (1:1,000, Millipore, 05-908) and anti-Pol II 8WG16 (1:500, Santa Cruz, sc-56767). Goat anti-mouse immunoglobulins&#x2013;HRP (1:500, Dako, P0447) and goat anti-rabbit immunoglobulins&#x2013;HRP (1:500, Dako, P0448) secondary antibodies were used to detect primary antibodies. Detection was performed using Immobilon Forte Western HRP Substrate (Merck) with a ChemiDoc imaging system (Bio-Rad).</p>
      </sec>
      <sec id="Sec15">
        <title>snHi-C</title>
        <p id="Par28">snHi-C was carried out as previously described<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. Pronuclei of wild-type, <italic>Scc1</italic><sup><italic>&#x394;/&#x394;</italic></sup>, <italic>Wapl</italic><sup><italic>&#x394;/&#x394;</italic></sup> and <italic>Zp3-dsCTCF</italic> zygotes were fixed around 1.5&#x2009;h after visualization of pronuclei (corresponding to 6&#x2013;6.5&#x2009;h after fertilization) and therefore are expected to be in G1 phase of the cell cycle. No blinding or randomization was used for handling of the cells. In brief, isolated pronuclei were fixed in 2% PFA for 15&#x2009;min, transferred to microwell plates (Sigma, M0815) and then lysed on ice in lysis buffer (10&#x2009;mM Tris-HCl pH 8.0, 10&#x2009;mM NaCl, 0.5% (v/v) NP-40 substitute (Sigma), 1% (v/v) Triton X-100 (Sigma), 1&#xD7; Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific)) for at least 30&#x2009;min. After a brief PBS wash, the pronuclei were incubated in 1&#xD7; NEB3 buffer (New England Biolabs) with 0.6% SDS at 37&#x2009;&#xB0;C for 2&#x2009;h with shaking in a humidified atmosphere. The pronuclei were then washed once in 1&#xD7; DpnII buffer (New England Biolabs) with 1&#xD7; bovine serum albumin (BSA) (New England Biolabs) and further digested overnight with 5&#x2009;U DpnII (New England Biolabs) at 37&#x2009;&#xB0;C in a humidified atmosphere. After a brief PBS wash and a wash through 1&#xD7; ligation buffer (Thermo Fisher Scientific), the pronuclei were then ligated with 5&#x2009;U T4 ligase (Thermo Fisher Scientific) at 16&#x2009;&#xB0;C for 4.5&#x2009;h with rotation (50&#x2009;rpm), followed by 30&#x2009;min ligation at room temperature. Next, whole-genome amplification was performed using the illustra GenomiPhi V2 DNA amplification kit (GE Healthcare). In brief, the pronuclei were transferred to 0.2-ml PCR tubes in 3&#x2009;&#xB5;l sample buffer covered with mineral oil (Sigma-Aldrich) and were de-cross-linked at 65&#x2009;&#xB0;C overnight. Then, the pronuclei were lysed by adding 1.5&#x2009;&#xB5;l lysis solution (600&#x2009;mM KOH, 10&#x2009;mM EDTA, 100&#x2009;mM DTT) and incubated for 10 min at 30&#x2009;&#xB0;C, followed by neutralization with the addition of 1.5&#x2009;&#xB5;l neutralization solution (4 vol 1&#x2009;M Tris HCl, pH 8.0; 1 vol 3&#x2009;M HCl). Whole-genome amplification was carried out by addition of 4&#x2009;&#xB5;l sample buffer, 9&#x2009;&#xB5;l reaction buffer and 1&#x2009;&#xB5;l enzyme mixture and incubation at 30&#x2009;&#xB0;C for 4&#x2009;h followed by heat activation at 65&#x2009;&#xB0;C for 10&#x2009;min. High-molecular-weight DNA was purified using AMPure XP beads (Beckman Coulter, 1.8:1.0 beads:DNA ratio) and 1&#x2009;&#xB5;g DNA was sonicated to approximately 300&#x2013;1,300-bp fragments using the E220 Focused-Ultrasonicator (Covaris). The sonicated DNA was purified with a PCR purification kit (Qiagen) and used to prepare Illumina libraries with the NEB Next Ultra Library Prep kit (Illumina). Libraries were sequenced on the HiSeq 2500 v4 with 125-bp paired-end reads (at the VBCF NGS unit) or on the NextSeq high-output lane with 75-bp paired-end reads (at the MPIB NGS core facility).</p>
      </sec>
      <sec id="Sec16">
        <title>snHi-C data analysis</title>
        <p id="Par29">snHi-C data were processed and analysed similarly to a previous report<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> and as previously described in<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. In brief, the reads of each sample were mapped to the mm9 genome with bwa and processed by the pairtools framework (<ext-link ext-link-type="uri" xlink:href="https://pairtools.readthedocs.io/en/latest/">https://pairtools.readthedocs.io/en/latest/</ext-link>) into pairs files. These data were subsequently converted into COOL files by the cooler package and used a container for Hi-C contact maps.</p>
        <p id="Par30">Loops were analysed by summing up snHi-C contact frequencies for loop coordinates of over 12,000 loops identified using the Hi-C data from wild-type mouse embryonic fibroblasts published previously<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.We removed the effect of distance dependence by averaging 20&#x2009;&#xD7;&#x2009;20 matrices surrounding the loops and dividing the final result by similarly averaged control matrices. Control matrices were obtained by averaging 20&#x2009;&#xD7;&#x2009;20 matrices centred on the locations of randomly shifted positions of known loops (shifts ranged from 100 to 1,100&#x2009;kb with 100 shifts for each loop). For display and visual consistency with the loop strength quantification, we set the backgrounds levels of interaction to 1. The background is defined as the top left 6&#x2009;&#xD7;&#x2009;6 and the bottom right 6&#x2009;&#xD7;&#x2009;6 submatrices. To quantify the loop strength, the average signal in the middle 6&#x2009;&#xD7;&#x2009;6 submatrix is divided by the average signal in the top left and bottom right (at the same distance from the main diagonal) 6&#x2009;&#xD7;&#x2009;6 submatrices. Weighted statistics were calculated using the weights package in R (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=weights">https://CRAN.R-project.org/package=weights</ext-link>).</p>
        <p id="Par31">For average TAD analysis, we used published TAD coordinates for the CH12-LX mouse cell line<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. We averaged Hi-C maps of all TADs and their neighbouring regions, chosen to be of the same length as the TAD, after rescaling each TAD to a 90&#x2009;&#xD7;&#x2009;90 matrix. For visualization, the contact probability of these matrices was rescaled to follow a shallow power law with distance (&#x2212;0.25 scaling). TAD strength was quantified using contact probability normalized snHi-C data. In Python notation, if <italic>M</italic> is the 90&#x2009;&#xD7;&#x2009;90 TAD numpy array (where numpy is np) and <italic>L</italic>&#x2009;=&#x2009;90 is the length of the matrix, then TAD_strength&#x2009;=&#x2009;box1/box2, where box1&#x2009;=&#x2009;0.5 * np.sum(M[0:L//3, L//3:2*L//3]) + 0.5 * np.sum(M[L//3:2*L// 3,2*L//3:L]); and box2&#x2009;=&#x2009;np.sum(M[L//3:2*L//3,L//3:2*L//3]).</p>
        <p id="Par32">To calculate the insulation score, we computed the sum of read counts within a sliding 40-kb-by-40-kb diamond. The diamond was positioned such that the &#x2018;tip&#x2019; touched the main axis of the snHi-C map corresponding to a &#x2018;self-interaction&#x2019;. As snHi-C maps are not iteratively corrected, we normalized all insulation profiles by the score of the minimum insulation and then subtracted 1. This way, the insulation/domain boundary is at 0 and has a minimum of 0.</p>
        <p id="Par33">Contact probability <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves were computed from 10-kb binned snHi-C data. We divided the linear genomic separations into logarithmic bins with a factor of 1.3. Data within these log-spaced bins (at distance, <italic>s</italic>) were averaged to produce the value of <italic>P</italic><sub>c</sub>(<italic>s</italic>). Both <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves and their log-space slopes are shown following a Gaussian smoothing (using the scipy.ndimage.filters.gaussian_smoothing1d function with radius 0.8). Both the <italic>y</italic> axis (that is, log(<italic>P</italic><sub>c</sub>(<italic>s</italic>)) and the <italic>x</italic> axis (that is, log[<italic>s</italic>]) were smoothed. The average loop size was determined by studying the derivative of the <italic>P</italic><sub>c</sub>(<italic>s</italic>) curve in log&#x2013;log space; that is, the slope of log(<italic>P</italic><sub>c</sub>(<italic>s</italic>)). The location of the maximum of the derivative curve (that is, the position of the smallest slope) closely matches the average length of extruded loops.</p>
      </sec>
      <sec id="Sec17">
        <title>Hi-C library preparation and sequencing</title>
        <p id="Par34">Hi-C was performed largely as described previously<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> with minor modifications. In brief, around 5&#x2009;&#xD7;&#x2009;10<sup>6</sup> HCT116 cells were cross-linked in 1% formaldehyde for 10 min at room temperature, snap-frozen and stored at &#x2212;80&#x2009;&#xB0;C. After permeabilization in lysis buffer (0.2% Igepal, 10 mM Tris-HCl pH 8.0, 10&#x2009;mM NaCl, 1&#xD7; Halt Protease inhibitor cocktail) nuclei were isolated in 0.3% SDS in NEBuffer 3 at 62&#x2009;&#xB0;C for 10&#x2009;min. SDS was quenched with 1% Triton X-100 at 37&#x2009;&#xB0;C for 1&#x2009;h, then the nuclei were pelleted and resuspended in 250&#x2009;&#x3BC;l DpnII buffer with 600&#x2009;U DpnII (New England Biolabs) at 37&#x2009;&#xB0;C. After overnight digestion, 200&#x2009;U DpnII was added followed by 2&#x2009;h more incubation. Then, nuclei were spun down and resuspended in fill-in mix (biotin-14-dATP (Thermo Fisher Scientific), dCTP, dGTP and dTTP (Thermo Fisher Scientific), Klenow Polymerase (NEB), 1&#xD7; NEB 2 buffer) for 1.5&#x2009;h at 37&#x2009;&#xB0;C with rotation. After ligation at room temperature for 4&#x2009;h with T4 ligase (NEB), the nuclei were pelleted, resuspended in 200&#x2009;&#xB5;l H<sub>2</sub>O and digested with proteinase K for 30&#x2009;min at 55&#x2009;&#xB0;C in the presence of 1% SDS. NaCl was added to a final concentration of 1.85&#x2009;M before cross-links were reversed at 65&#x2009;&#xB0;C overnight. After ethanol precipitation and a 70%&#x2013;80% ethanol wash, DNA was resuspended in 10&#x2009;mM Tris EDTA, transferred to a Covaris microtube (Covaris) and sheared to approximately 300&#x2013;1,300-bp fragments on the E220 Focused-Ultrasonicator (Covaris). DNA was then bound to Dynabeads MyOne Streptavidin C1 beads (Thermo Fisher Scientific) for biotin pull-down. Beads were resuspended in H<sub>2</sub>O used for library preparation with the NEBNext Ultra II Library Prep kit for Illumina (NEB). Beads were then washed four times using Tween wash buffer (5&#x2009;mM Tris-HCl, 1&#x2009;M NaCl, 0.5&#x2009;mM EDTA, 0.05% Tween20) and DNA was eluted using 95% formamide, 10&#x2009;mM EDTA at 65&#x2009;&#xB0;C for 2&#x2009;min. After precipitation, DNA was washed with 70&#x2013;80% ethanol and resuspended in H<sub>2</sub>O. The finished libraries were sequenced on the NovaSeq 6000 system (Illumina) with 100-bp paired-end reads (at the VBCF NGS unit) or on the NextSeq high-output lane (Illumina) with 75-bp paired-end reads (at the MPIB NGS core facility).</p>
      </sec>
      <sec id="Sec18">
        <title>Micro-C library preparation and sequencing</title>
        <p id="Par35">The Micro-C libraries were prepared using the Dovetail Micro-C Kit following the manufacturer&#x2019;s protocol. In brief, the chromatin was fixed with disuccinimidyl glutarate (DSG) and formaldehyde in the nucleus. The cross-linked chromatin was then digested in situ using micrococcal nuclease (MNase). After digestion, the cells were lysed with SDS to extract the chromatin fragments and the chromatin fragments were bound to chromatin capture beads. Next, the chromatin ends were repaired and ligated to a biotinylated bridge adapter followed by proximity ligation of adapter-containing ends. After proximity ligation, the cross-links were reversed, the associated proteins were degraded and the purified DNA was converted into a sequencing library using Illumina-compatible adaptors. Biotinylated molecules were pulled down on streptavidin beads before PCR amplification. The library was sequenced on the NextSeq high-output lane (Illumina) with 75-bp paired-end reads (at the MPIB NGS core facility).</p>
      </sec>
      <sec id="Sec19">
        <title>Hi-C and Micro-C data analysis</title>
        <p id="Par36">Hi-C and Micro-C data processing was performed using distiller&#x2014;a nextflow-based pipeline (<ext-link ext-link-type="uri" xlink:href="https://github.com/open2c/distiller-nf">https://github.com/open2c/distiller-nf</ext-link>)<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Reads were mapped to the hg38 reference genome with default settings except dedup/max_mismatch_bp=0. Multiresolution cooler files<sup><xref ref-type="bibr" rid="CR56">56</xref></sup> generated by distiller were used for visualization in HiGlass<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> and in the downstream analyses.</p>
        <p id="Par37">For downstream analysis, we used quaich (<ext-link ext-link-type="uri" xlink:href="https://github.com/open2c/quaich">https://github.com/open2c/quaich</ext-link>), a new snakemake pipeline for Hi-C postprocessing. It uses cooltools (<ext-link ext-link-type="uri" xlink:href="https://github.com/open2c/cooltools">https://github.com/open2c/cooltools</ext-link>)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, chromosight<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and coolpup.py<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> to perform compartment and insulation analysis, peak annotation and pileups, respectively. The config file we used is available here: <ext-link ext-link-type="uri" xlink:href="https://gist.github.com/Phlya/5c2d0688610ebc5236d5aa7d0fd58adb">https://gist.github.com/Phlya/5c2d0688610ebc5236d5aa7d0fd58adb</ext-link>.</p>
        <p id="Par38">We annotated peaks of enriched contact frequency in untreated HCT116 cells from a previous report<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> using chromosight at 5&#x2009;kb resolution with default parameters. Then we used this annotation to quantify the strength of Hi-C peaks in our datasets using pileups at 5&#x2009;kb resolution. Similarly, valleys of insulation score at 10&#x2009;kb resolution with a window of 500&#x2009;kb (and prominence over 0.1) were identified in the same published dataset and filtered to remove those that don&#x2019;t disappear after cohesin depletion (or don&#x2019;t become at least fivefold weaker) to identify cohesin-dependent domain boundaries. These were used to quantify changes in insulation in our datasets. Neighbouring insulation valleys were joined together to form TADs; regions longer than 1.5&#x2009;Mb were ignored. TAD coordinates were used for rescaled pileup analysis<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> to quantify their strength in our datasets. De novo peaks were called using Mustache<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>.</p>
        <p id="Par39">To investigate whether the increase in loop strength occurs genome wide, we split all loop calls into 1&#x2009;Mb bins, using the coordinate of the centre of the loops. Then for each bin, we created pileups normalized to the global chromosome arm-wide expected level of interactions, using coolpuppy at 5&#x2009;kb resolution with 100&#x2009;kb flanks. In addition, each pileup (105&#x2009;&#xD7;&#x2009;105&#x2009;kb) was normalized to the mean value of the top left and bottom right 3&#x2009;&#xD7;&#x2009;3 pixels, to remove variability in local background between different regions of the genome. Then the mean of the central 3&#x2009;&#xD7;&#x2009;3 square of the pileup was used as the measure of normalized loop strength for this bin. Having done this for both MCM2-depleted and control cells, we plotted the result as a histogram of log<sub>2</sub> ratio between the two, to investigate whether the overall distribution of scores is shifted between the two conditions.</p>
      </sec>
      <sec id="Sec20">
        <title>RNA sequencing (RNA-seq) of G1 zygotes</title>
        <p id="Par40">For each replicate, a pool of 10 G1 zygotes were lysed, total RNA was extracted and cDNA was synthesized using the SMART-Seq v4 Ultra Low Input RNA Kit (Takara Bio Europe). Sequencing libraries were prepared with the Nextera XT DNA Library Preparation Kit for Illumina. Libraries were sequenced on the HiSeq 2500 v4 (Illumina) with 50-bp single-end reads at the VBCF NGS unit.</p>
      </sec>
      <sec id="Sec21">
        <title>RNA-seq of tissue culture cells</title>
        <p id="Par41">Total RNA from HCT116 cells was isolated using a lysis step based on guanidine thiocyanate (adapted from a previous study<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> and using magnetic beads (GE Healthcare, 65152105050450). mRNA sequencing libraries were prepared from 1&#x2009;&#xB5;g total RNA using NEBNext Poly(A) mRNA Magnetic Isolation Module (E7490) and NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (E7760). Paired-end sequencing was performed on Illumina NextSeq 500 (2&#x2009;&#xD7;&#x2009;43-bp reads). A total of six samples were multiplexed and sequenced on a NextSeq 500/550 High Output Kit v2.5 (75 Cycles) at the MPIB NGS core facility. BCL raw data were converted to FASTQ data and demultiplexed by bcl2fastq.</p>
      </sec>
      <sec id="Sec22">
        <title>RNA-seq analysis</title>
        <p id="Par42">FASTQ files from sequencing mouse G1 zygotes or the human HCT116 cell line were pseudoaligned to the mm10 or hg38 releases of the <italic>Mus musculus</italic> or <italic>Homo sapiens</italic> genomes, respectively, using Kallisto with 100 bootstraps<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. The resulting abundance measures were analysed in R to generate PCA plots<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> (factoextra) and a heat map of the correlation matrix (heatmap.2)<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. To find differentially expressed transcripts we used the Wald test for Sleuth model (sleuth) in R. Gene ontology (GO) term enrichment of molecular functions of up- and downregulated genes were carried out using ShinyGO (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.sdstate.edu/go/">http://bioinformatics.sdstate.edu/go/</ext-link>).</p>
        <p id="Par43">The changes in the chromatin contact frequencies that occurred upon MCM depletion around the TSS of differentially expressed (DE), non-differentially expressed (non-DE) and non-expressed genes were analysed&#xA0;by aggregating the number of contacts as determined in Micro-C experiments with 5&#x2009;kb resolution. The number of contacts was normalized with LOESS using HICcompare in R, and ensemble analysis of the four expression categories (upregulated, <italic>n</italic>&#x2009;=&#x2009;164; downregulated, <italic>n</italic>&#x2009;=&#x2009;65; non-DE, <italic>n</italic>&#x2009;=&#x2009;916; non-expressed, <italic>n</italic>&#x2009;=&#x2009;1,000) was carried out in distance bins of 0&#x2013;5&#x2009;kb, 5&#x2013;25&#x2009;kb, 25&#x2013;250&#x2009;kb, 250&#x2013;1,000&#x2009;kb and over 1,000&#x2009;kb up- and downstream of the TSS. The mean change of contact frequencies in each bin for every category was calculated by averaging the auxin versus DMSO treatment ratios of the normalized sum of contacts. All of the mean contact frequency changes were tested against the non-DE TSS control using the non-parametric Kruskal&#x2013;Wallis test followed by pairwise Wilcoxon (Mann&#x2013;Whitney <italic>U</italic>) test.</p>
        <p id="Par44">All plots were compiled with ggplot2 in R.</p>
      </sec>
      <sec id="Sec23">
        <title>Protein expression and purification</title>
        <sec id="Sec24">
          <title>Cohesin</title>
          <p id="Par45">Human recombinant cohesin<sup>STAG1, SCC1-Halo</sup> was purified and fluorescently labelled with Janelia Fluor 549 HaloTag (Promega) as previously described<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p>
        </sec>
        <sec id="Sec25">
          <title>ORC and Cdc6</title>
          <p id="Par46"><italic>Saccharomyces cerevisiae</italic> recombinant ORC and Cdc6 were purified as previously described<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>.</p>
        </sec>
        <sec id="Sec26">
          <title>SFP synthase</title>
          <p id="Par47">SFP synthase was purified essentially as previously described<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>.</p>
        </sec>
        <sec id="Sec27">
          <title>Cdt1&#x2013;MCM and Cdt1&#x2013;MCM<sup>Mcm3-YDF</sup></title>
          <p id="Par48">To generate fluorescently labelled <italic>S. cerevisiae</italic> recombinant Cdt1&#x2013;MCM, the <italic>S. cerevisiae</italic> strain ySA4 was generated. In brief, a ybbR and 3&#xD7;Flag tag were fused to the N and C terminus of Mcm6, respectively, generating Cdt1&#x2013;MCM<sup>ybbR-Mcm6</sup>. The chimeric MCM complex containing a humanized Mcm3 subunit (Cdt1&#x2013;MCM<sup>Mcm3-YDF, ybbR-Mcm6</sup>) was expressed in strain yMS1, which was generated by further modification of ySA4. For this, the corresponding region in <italic>S. cerevisiae</italic> Mcm3 was replaced by the 19-amino-acid disordered region that contains a YDF motif present in human MCM3<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, using CRISPR&#x2013;Cas9-based genome editing essentially as previously described<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. To target <italic>S. cerevisiae</italic> Mcm3, the following guide sequence was used: 5&#x2032;-TATAATGTCACCGCTTCCTG-3&#x2032;. The homologous repair template (synthesized by Eurofins Genomics) encoding the 19-amino-acid disordered region containing the YDF motif (underlined) was: 5&#x2032;-ACTCCAAGAAGGTCAACGGCATCTTCCGTTAATGCCACGCCATCGTCAGCACGCAGAATATTACGTTTTCAAGATGACGAACAGAACGCTGGTGAAGAC<underline>GATGGGGATTCATACGACCCCTATGACTTCAGTGACACAGAGGAGGAAATGCCTCAA</underline>AGGCTTCAACTGGGGTTGAGAGTGTCTCCAAGACGTAGAGAACATCTTCACGCACCTGAGGAAGGTTCGTCGGGACCTCTTACCGAGGTCGGTACTCCA-3&#x2032;. Notably, this strategy allowed the modification of all Mcm3 alleles (confirmed by sequencing) and thus ensured the complete absence of wild-type Mcm3 in the subsequent preparation. Strain yMS1 grew comparably to the parental strain ySA4, confirming that the YDF motif did not alter the MCM function.</p>
          <p id="Par49">Cells were grown in 6&#x2009;l YP medium supplemented with 2% (v/v) raffinose at 30&#x2009;&#xB0;C. At an optical density at 600&#x2009;nm (OD<sub>600&#x2009;nm</sub>) of 1.2, cells were arrested at G1 by adding &#x3B1;-factor to a final concentration of 150&#x2009;ng&#x2009;ml<sup>&#x2212;1</sup> for 3&#x2009;h. Subsequently, protein expression was induced by the addition of 2 % (v/v) galactose. After 4&#x2009;h, cells were collected and washed once with cold MilliQ water + 0.3&#x2009;mM PMSF and once with buffer A (100&#x2009;mM HEPES-KOH, pH 7.6, 0.8&#x2009;M sorbitol, 10&#x2009;mM Mg(OAc)<sub>2</sub>, 0.75&#x2009;M potassium glutamate (KGlu)). Finally, cells were resuspended in 1 packed cell volume of buffer A + 1&#x2009;mM DTT supplemented with a protease inhibitor cocktail (2&#x2009;&#xB5;M pepstatin, 2&#x2009;&#xB5;M leupeptin, 1&#x2009;mM PMSF,1&#x2009;mM benzamidine, 1&#x2009;&#xB5;g&#x2009;ml<sup>&#x2212;1</sup> aprotinin) and frozen dropwise in liquid N<sub>2</sub>. Frozen cells were lysed in a freezer mill (SPEX) and lysed cell powder was resuspended in 1 packed cell volume buffer B (45&#x2009;mM HEPES-KOH, pH 7.6, 0.02 % (v/v) Nonidet P40 Substitute, 5&#x2009;mM Mg(OAc)<sub>2</sub>, 10 % (v/v) glycerol, 1&#x2009;mM ATP, 1&#x2009;mM DTT) + 300&#x2009;mM KGlu. All subsequent purification steps were performed at 4&#x2009;&#xB0;C unless stated otherwise. The lysate was cleared by ultracentrifugation at 235,000<italic>g</italic> for 60&#x2009;min. Soluble lysate was incubated with 0.5&#x2009;ml bed volume (BV) Anti-Flag M2 affinity gel (Sigma) equilibrated with buffer B + 300&#x2009;mM KGlu for 3&#x2009;h. The resin was washed twice with 20 BV buffer B + 300&#x2009;mM KGlu and twice with 20 BV buffer B + 100&#x2009;mM KGlu. Protein was eluted with buffer B + 100&#x2009;mM KGlu + 0.5&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> 3&#xD7;Flag peptide.</p>
          <p id="Par50">For site-specific labelling, Cdt1-MCM<sup>ybbR-Mcm6</sup> or Cdt1-MCM<sup>Mcm3-YDF, ybbR-Mcm6</sup> was incubated with SFP-Synthase and LD655-CoA (Lumidyne Technologies) at a 1:3:6 molar ratio for 2&#x2009;h at 30&#x2009;&#xB0;C in buffer B + 100&#x2009;mM KGlu, 10&#x2009;mM MgCl<sub>2</sub>. Labelled protein was further purified on a Superdex 200 increase 10/300 gel filtration column (GE Healthcare) equilibrated in buffer B + 100&#x2009;mM potassium acetate (KOAc). Protein-containing fractions were pooled, concentrated with a MWCO 50000 Amicon Ultra Centrifugal Filter unit (Merck) and stored in aliquots at &#x2212;80&#x2009;&#xB0;C. The labelling efficiency was estimated to be around 90% from the extinction coefficients of Cdt1-MCM and LD655.</p>
        </sec>
      </sec>
      <sec id="Sec28">
        <title>Single-molecule imaging</title>
        <p id="Par51">Single-molecule assays were performed using an RM21 micromirror TIRF microscope (Mad City Labs) built in a similar manner to that previously described<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> with an Apo N TIRF 60&#xD7; oil-immersion TIRF objective (NA 1.49, Olympus). Janelia Fluor 532 and LD655 were excited with a 532&#x2009;nm and 637&#x2009;nm laser (OBIS 532&#x2009;nm LS 120&#x2009;mW and OBIS 637&#x2009;nm LX 100&#x2009;mW, Coherent), respectively at a frame rate of around 6&#x2009;fps. Residual scattered light from excitation was removed with a ZET532/640m emission filter (Chroma). Emission light was split at 635&#x2009;nm (T635lpxr, Chroma) and recorded as dual-view with an iXon Ultra 888 EMCCD camera (Andor). All microscope parts were controlled using Micromanager v1.4 (ref. <sup><xref ref-type="bibr" rid="CR71">71</xref></sup>) and custom Beanshell scripts.</p>
      </sec>
      <sec id="Sec29">
        <title>Preparation of PEG&#x2013;biotin microscope slides</title>
        <p id="Par52">Glass coverslips (22 &#xD7; 22&#x2009;mm, Marienfeld) were cleaned in a plasma cleaner (Zepto, Diener Electronic) and subsequently incubated in 2% (v/v) 3-aminopropyltriethoxysilane (Roth) in acetone for 5&#x2009;min. Silanized coverslips were washed with ddH<sub>2</sub>O, dried and incubated at 110&#x2009;&#xB0;C for 30&#x2009;min. Slides were covered with a fresh solution of 0.1&#x2009;M NaHCO<sub>3</sub> containing 0.4% (w/v) biotin&#x2013;PEG-SC-5000 and 15% (w/v) mPEG-SC-5000 (Laysan Bio) and incubated overnight. Functionalized slides were washed with ddH<sub>2</sub>O, dried and incubated again overnight in a fresh biotin&#x2013;PEG/mPEG solution. Slides were finally washed, dried and stored under vacuum.</p>
      </sec>
      <sec id="Sec30">
        <title>DNA substrate for single-molecule imaging</title>
        <p id="Par53">To generate pMSuperCos-ARS1, first, a 21&#x2009;kb genomic DNA fragment of bacteriophage lambda (NEB) was flanked by a unique XbaI (position 0) and NotI restriction site on either end and cloned into a pSuperCos1 backbone (Stratagene). Second, the yeast origin ARS1 was inserted at a BamHI site around position 5.3&#x2009;kb within the 21&#x2009;kb genomic DNA fragment.</p>
        <p id="Par54">To produce the DNA substrate for single-molecule imaging, pMSuperCos-ARS1 was isolated from DH5&#x3B1; using a Plasmid Maxi Kit (Qiagen). One hundred micrograms of plasmid was digested with 100&#x2009;U NotI-HF and XbaI (NEB) for 7&#x2009;h at 37&#x2009;&#xB0;C. The resulting 21,202&#x2009;bp ARS1-DNA fragment was separated from the SuperCos1 backbone on a 10&#x2013;40 % sucrose gradient. DNA handles were prepared by annealing oligonucleotides MS_200/201 MS202/203 (see&#xA0;<xref rid="MOESM5" ref-type="media">Supplementary Table 2</xref> for oligonucleotide sequences) in equimolar amounts in 30&#x2009;mM HEPES, pH 7.5, 100&#x2009;mM KOAc by heating to 95&#x2009;&#xB0;C for 5&#x2009;min and cooling to 4&#x2009;&#xB0;C at &#x2212;1&#x2009;&#xB0;C per min. Annealed handles were mixed with the purified 21&#x2009;kb ARS1-DNA at a molar ratio of 15:1 and ligated with T4 DNA Ligase in 1&#xD7; T4 ligase buffer (both NEB) at 16&#x2009;&#xB0;C overnight. Free handles were removed on a Sephacryl S-1000 SF Tricorn 10/300 gel filtration column (GE Healthcare) equilibrated in 10&#x2009;mM Tris, pH 8, 300&#x2009;mM NaCl, 1&#x2009;mM EDTA. Peak fractions were pooled, ethanol precipitated and reconstituted in TE buffer. Final DNA was stored in aliquots at &#x2212;80&#x2009;&#xB0;C. Note that the final linear DNA is functionalized with biotin at a NotI site and an 18-bp single-stranded DNA overhang at an XbaI site that is used for orientation specific doubly tethering.</p>
        <sec id="Sec31">
          <title>Flow cell preparation</title>
          <p id="Par55">A functionalized PEG&#x2013;biotin slide was incubated with blocking buffer (20&#x2009;mM Tris-HCl, pH 7.5, 50&#x2009;mM NaCl, 2&#x2009;mM EDTA, 0.2&#x2009;mg&#x2009;ml&#x2212;1 BSA, 0.025 % (v/v) Tween20) + 0.2&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> streptavidin (Sigma) for 30&#x2009;min. A flow cell was assembled by placing a polydimethylsiloxane block on top to generate a 0.5&#x2009;mm wide and 0.1&#x2009;mm high flow channel and a polyethylene tube (inner diameter 0.58&#x2009;mm) was inserted at either end.</p>
          <p id="Par56">DNA was introduced to the flow cell at 5&#x2009;pM in blocking buffer and incubated for 15&#x2009;min in the absence of buffer flow to allow binding to the slide surface. To doubly tether DNA, the flow lane was flushed with 100&#x2009;&#xB5;M oligonucleotide MS_204 (see&#xA0;<xref rid="MOESM5" ref-type="media">Supplementary Table 2</xref> for oligonucleotide sequences) in blocking buffer at 100&#x2009;&#xB5;l per min.</p>
        </sec>
      </sec>
      <sec id="Sec32">
        <title>Single-molecule sliding assay</title>
        <p id="Par57">Helicase loading was achieved by introducing 0.25&#x2009;nM ORC, 4&#x2009;nM Cdc6 and 10&#x2009;nM Cdt1&#x2013;MCM<sup>ybbR-LD655-Mcm6</sup> or Cdt1&#x2013;MCM<sup>Mcm3-YDF, ybbR-LD655-Mcm6</sup> in licensing buffer (30&#x2009;mM HEPES-KOH, pH 7.6, 8&#x2009;mM Mg(OAc)<sub>2</sub>, 0.1&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> BSA, 0.05 % (v/v) Tween20) + 200&#x2009;mM KOAc, 5&#x2009;mM DTT, 3&#x2009;mM ATP to a prepared flow cell and incubating for 25&#x2009;min. Cohesin loading and sliding was essentially performed as previously described<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Cohesin<sup>STAG1, SCC1-Halo-JF546</sup> (0.7&#x2009;nM) was incubated with licensed DNA in cohesin binding buffer (35&#x2009;mM Tris, pH 7.5, 25&#x2009;mM NaCl, 25&#x2009;mM KCl, 1&#x2009;mM MgCl<sub>2</sub>, 10% (v/v) glycerol, 0.1&#x2009;mg&#x2009;ml<sup>&#x2212;1</sup> BSA, 0.003 (v/v) Tween20, 1&#x2009;mM DTT, 0.2&#x2009;mM ATP) for 10&#x2009;min. To remove free protein, DNA-bound licensing factors and MCM loading intermediates, the flow cell was washed with licensing buffer + 500&#x2009;mM NaCl, 1&#x2009;mM DTT, 0.6&#x2009;mM ATP supplemented with an oxygen scavenging system (1&#x2009;mM Trolox, 2.5&#x2009;mM PCA, 0.21&#x2009;U&#x2009;ml<sup>&#x2212;1</sup> PCD (all Sigma))<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Imaging was either started directly (high-salt condition) or after lowering the salt concentration to 150&#x2009;mM NaCl (physiological salt condition) in an otherwise identical buffer to that described for the high-salt condition. DNA was post-stained with 50&#x2009;nM SYTOX Orange (Thermo Fisher Scientific) in the same buffer that was used during imaging.</p>
      </sec>
      <sec id="Sec33">
        <title>Single-molecule data analysis</title>
        <p id="Par58">Single-molecule data were analysed in Fiji using the Molecule Archive Suite (Mars) plug-in (<ext-link ext-link-type="uri" xlink:href="https://github.com/duderstadt-lab/">https://github.com/duderstadt-lab/</ext-link>)<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> and custom Python scripts. In brief, all doubly tethered DNA molecules containing cohesin were chosen for analysis. Cohesin and MCM were tracked individually and merged with DNA to determine their position on the same DNA molecule. Pauses during cohesin translocation were determined by fitting cohesin trajectories (position on DNA versus time) with the kinetic change point algorithm<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> with the following settings: confidence value 0.6; global sigma 300 base pairs (bps)/s. Subsequently, resulting segments with rates lower than 200&#x2009;bps per s, standard deviations of less than 30 bps per s and length greater than 1&#x2009;s were classified as pause segments. If two adjacent segments were classified as pauses and the end and start position on DNA of the first and second pause segment, respectively, were within 1&#x2009;kb, these segments were merged to one pause segment. The fraction of cohesin pausing reported was determined by calculating the cumulative time of all pause segments divided by the total observation time. These pauses were excluded when calculating cohesin&#x2013;MCM passing probabilities and diffusion coefficients (see below).</p>
        <p id="Par59">The probability of cohesin passing MCM was addressed as follows: Frames in which cohesin colocalized with MCM (median position) within less than thresh1 were classified as encounter. Upon an encounter, if cohesin passed MCM in the consecutive frame by at least thresh2, the encounter was determined as successful bypassing. All remaining frames (distance&#x2009;&gt;&#x2009;thresh1 to MCM) were further evaluated for MCM passing as described above, and in addition counted as an encounter with successful bypassing. DNA molecules with cohesin only were analysed the same way using the theoretical ARS1 position on DNA. All frames within the cohesin trajectory that were part of a translocation pause were excluded from this analysis and instead classified as one encounter with failed bypassing. To account for different resolution at different extensions, two dynamic thresholds, thresh1 and thresh2, were set to 1.5&#x2009;kb and 0.5&#x2009;kb at the mean DNA extension of all DNA molecules and adjusted for the individual length of the DNA molecule (Extended Data Fig. <xref rid="Fig13" ref-type="fig">9g</xref>).</p>
        <p id="Par60">MCM photobleaching steps were defined as abrupt drops in fluorescence intensity and detected using the kinetic change point algorithm<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>.</p>
        <p id="Par61">Diffusion coefficients (<italic>D</italic>) were calculated with:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D=\frac{ &lt; x{ &gt; }^{2}}{2t},$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>&lt;</mml:mo><mml:mi>x</mml:mi><mml:msup><mml:mrow><mml:mo>&gt;</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41586_2022_4730_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par62">in which &lt;<italic>x</italic>&gt;<sup>2</sup> is the mean square displacement in kb<sup>2</sup> and <italic>t</italic> is the time in s.</p>
        <p id="Par63">All kymographs were generated using Fiji. For this, individual DNA ends were fitted with subpixel localization and the kymograph was generated along the connecting line. Individual DNA molecules doubly tethered with different extension to the slide surface and as a consequence, kymographs differ in pixel heights. These length differences were accounted for throughout all of the analysis steps described above.</p>
      </sec>
      <sec id="Sec34">
        <title>Loop extrusion simulations and contact map generation</title>
        <sec id="Sec35">
          <title>Simulations overview</title>
          <p id="Par64">We introduced MCMs into polymer models of loop extrusion<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>), as randomly located extrusion barriers. Both CTCF and MCM barriers stall cohesin with some probability (CTCF 50%; ref. <sup><xref ref-type="bibr" rid="CR38">38</xref></sup>) but allow bypassing, consistent with single-molecule experiments (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). By sweep parameters (processivity and linear density of cohesin, and density and permeability of MCM;&#xA0;Supplementary Figs. 2&#x2013;5), we found a narrow range of values for each condition such that the peak strengths and paternal <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves can be simultaneously reproduced (Fig. <xref rid="Fig3" ref-type="fig">3b, d</xref>,&#xA0;Extended Data Fig. 6e&#x2013;h,&#xA0;Supplementary Figs. 2&#x2013;5). The simulations suggest that in&#xA0;wild-type&#xA0;conditions, cohesins extrude 110&#x2013;130-kb loops and have a density of around 1 per 300&#x2009;kb. MCM permeability was essential to achieve the increase in peak strength without strongly affecting the average loop size after MCM loss; in this regime, there is a linear trade-off between the MCM density and permeability (Fig. <xref rid="Fig3" ref-type="fig">3c</xref>). Using MCM densities (one per 30&#x2013;150&#x2009;kb) experimentally measured in other cell types (see below), cohesins should bypass MCMs in around 60&#x2013;90% of encounters.</p>
        </sec>
        <sec id="Sec36">
          <title>Time steps and lattice set-up</title>
          <p id="Par65">We use a fixed-time-step Monte Carlo algorithm as in previous work<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. We define the chromosome as a lattice of <italic>L</italic>&#x2009;=&#x2009;10,000 sites, in which each lattice site corresponds to 2&#x2009;kb of DNA. Loop extruding factors (LEFs) are represented as two motor subunits, which move bidirectionally away from one another one lattice site at a time. When LEFs encounter one another, we assume that they cannot bypass each other as is typical for cohesin simulations<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. The ends of the chromosome (that is, the first and last lattice sites) are considered boundaries to LEF translocation; this way, LEFs cannot &#x2018;walk off&#x2019; the chromosome.</p>
        </sec>
        <sec id="Sec37">
          <title>CTCF and MCM boundary elements</title>
          <p id="Par66">To simulate TADs, we specify that every 150th lattice site is a CTCF site. In this way, our simulated 20&#x2009;Mb chromosome segment is composed of 66 TADs each of size 300&#x2009;kb. CTCF sites may stall the translocation of a LEF subunit with a probability of 0.45. This stalling probability is chosen within the experimental estimates of 15%&#x2013;50% fractional occupancy of CTCF sites via ChIP&#x2013;seq and microscopy<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. For simulations mimicking the &#x2018;control&#x2019; and &#x2018;Wapl&#x2019; depletion conditions (that is, where MCM is present on the genome), we also add random extrusion barriers to our lattice to mimic the presence of MCMs. For our parameter sweep, we add 33, 66, 132, 264, 528 barriers (that is, representing MCMs) randomly dispersed in the 20&#x2009;Mb chromosome segment; this corresponds to a density of 1 MCM complex per 600&#x2009;kb, 300&#x2009;kb, 150&#x2009;kb, 75&#x2009;kb, 37.5&#x2009;kb, respectively. The MCM barriers are fixed in place for the duration of a simulation. Like the CTCFs, the MCM barriers can also stall LEF translocation. A randomly translocating LEF subunit will be stalled at an MCM site with a probability of 0.0001, 0.05, 0.2, 0.4 or 0.8 (meaning that LEFs can bypass between around 20&#x2013;100% of MCM sites). For both CTCF and MCM lattice sites, &#x2018;stalling&#x2019; a LEF subunit is a permanent event that prevents further movement of that subunit. Stalling events are only resolved after dissociation of the LEF from the lattice. For simulations in which there is &#x2018;MCM loss&#x2019;, we set the total number of random MCM barriers to zero but keep the CTCF lattice sites the same. All results presented in this paper are from an average over 25 different random distributions of MCMs (that is, 25 simulation runs were performed for each condition).</p>
        </sec>
        <sec id="Sec38">
          <title>LEF separations and processivity</title>
          <p id="Par67">For our simulations of&#xA0;&#x2018;control&#x2019; and &#x2018;MCM-loss&#x2019; conditions, the default LEF processivity was 90&#x2009;kb, and the default LEF separation was 300&#x2009;kb. For our simulations of the &#x2018;<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#x2019; and &#x2018;<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#x2009;+&#x2009;MCM loss&#x2019; conditions, the LEF processivity was 130&#x2009;kb, and the separations were 180&#x2009;kb. The approximately 50% increase in density after Wapl depletion is supported by quantitative immunofluorescence data indicating there is a modest enrichment of cohesin after removal of Wapl<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
        </sec>
        <sec id="Sec39">
          <title>Association and dissociation rates</title>
          <p id="Par68">All simulations are performed with fixed numbers of extruders. The dissociation rate is ultimately tied to the &#x2018;processivity&#x2019; of the LEF, which is the average distance in kb (or lattice sites) that the LEF travels before dissociating. We allow LEFs to randomly associate to at any lattice position after a dissociation event.</p>
        </sec>
        <sec id="Sec40">
          <title>Loop extrusion equilibration steps</title>
          <p id="Par69">We compute 10,000 initialization steps for each simulation before creating any contact maps. This ensures that the loop statistics have reached a steady-state. Subsequent loop configurations were sampled every 100 simulation steps to generate contact maps. We sampled from at least 2,500 different LEF configurations (that is, 100 configurations from 25 different simulations) to generate contact probability decay curves and perform aggregate peak analysis (see below).</p>
        </sec>
        <sec id="Sec41">
          <title>Contact maps</title>
          <p id="Par70">We generated contact maps semi-analytically, which uses a Gaussian approximation to calculate contact probability maps directly from the positions of LEFs. This approach was developed previously<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and used to simulate bacterial Hi-C maps. We note that as the density of cohesins is sufficiently low in the zygotes (that is, the processivity and separation ratio is close to or less than 1), and as the contact probability scaling exponent up to 10&#x2009;Mb is close to &#x2212;1.5 in the absence of cohesins<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, we are justified in using the Gaussian approximation to generate contact maps. To generate the <italic>P</italic><sub>c</sub>(<italic>s</italic>) curves, we use at least 9,000,000 random samples of the contact probability; these samples were taken from varying genomic positions and relative separations within the simulated 20&#x2009;Mb of chromosome and averaged using logarithmically spaced bins (factor of 1.3). To generate the equivalent of the aggregate peak analysis for contact enrichments at CTCF sites, we used at least 144,000,000 random samples of the contact probability from a 100&#x2009;kb by 100&#x2009;kb window centred on the CTCF sites. These 144,000,000 samples were distributed evenly between 64 TADs (there are 66 TADs, but we excluded the 2 TADs closest to the chromosome ends) and at least 2,500 LEF conformations. Control matrices for normalization were obtained as described above, but using a shifted window shifted by 150&#x2009;kb from the TAD boundaries. Aggregate peak analysis plots are shown coarse-grained to 20&#x2009;&#xD7;&#x2009;20 bins.</p>
        </sec>
        <sec id="Sec42">
          <title>Comparing simulated and experimental data</title>
          <p id="Par71">The criteria for comparing the experimental data and the simulated data were two-fold. First, we computed from snHi-C the corner peak strength above background; this was usually a number between 1 and 3 depending on the condition. Second, we computed the <italic>P</italic>(<italic>s</italic>) curves from experiments genome wide. However, we knew from previous studies<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, that the effect of cohesin on <italic>P</italic>(<italic>s</italic>) typically only extends up to around 1&#x2009;Mb under normal conditions. Moreover, above 1&#x2009;Mb, the semi-analytical approach to generating contact maps becomes less reliable as non-equilibrium effects, chain topology, and chain swelling may start to have a role in the <italic>P</italic>(<italic>s</italic>) curve, which are not accounted for in our model<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Below 30&#x2009;kb, Hi-C data have been shown to contain artefacts and can vary significantly between different protocols. Thus, we restricted our comparisons to the range 30&#x2009;kb&#x2013;1&#x2009;Mb.</p>
          <p id="Par72">The criteria then for evaluating the goodness of a simulation, were to (1) obtain quantitative values for the corner peak strengths as close as possible to the experiments, preserving the correct relative ordering between various conditions (for example, in paternal zygotes, the corner peak strength from weakest to highest was: wild type, Wapl depletion, MCM depletion, MCM&#x2009;+&#x2009;Wapl depletion). We directly scored the goodness of the simulation by minimizing the absolute error between the simulated and experimental corner peak strengths. (2) Simultaneously, we evaluated the absolute values and shapes of the <italic>P</italic>(<italic>s</italic>) curves between 30&#x2009;kb&#x2013;1&#x2009;Mb. The goodness of <italic>P</italic>(<italic>s</italic>) fit was evaluated by visual agreement. Therefore, we used a combined approach to evaluate the match between experiments and simulations, in which the dot strength and <italic>P</italic>(<italic>s</italic>) curves were evaluated together.</p>
        </sec>
        <sec id="Sec43">
          <title>Estimation of chromatin-bound MCM density in mammalian cells</title>
          <p id="Par73">Using mass-spectrometry analysis, the copy number of each MCM subunit is estimated at around 670,000 in HeLa cells<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>, and quantitative immunoblotting shows that in late G1 phase around 45% of MCM2 is bound to chromatin<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. This leads to the estimate that around 301,500 MCMs are bound to the chromatin in late G1. Knowing that MCMs form double hexamers on chromatin and that the average genome size of HeLa cells is around 7.9&#x2009;&#xD7;&#x2009;10<sup>9</sup> (ref. <sup><xref ref-type="bibr" rid="CR79">79</xref></sup>), we estimate a density of 1 MCM double hexamer every approximately 52&#x2009;kb (7.9&#x2009;&#xD7;&#x2009;10<sup>9</sup>/(301,500/2)) (assuming a random distribution of MCMs).</p>
        </sec>
      </sec>
      <sec id="Sec44">
        <title>Reporting summary</title>
        <p id="Par74">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this paper.</p>
      </sec>
    </sec>
    <sec id="Sec45" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par75">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-04730-0.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_4730_MOESM1_ESM.pdf"><label>Supplementary Information</label><caption><p>This file contains Supplementary Figures 1-6.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_4730_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_4730_MOESM3_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_4730_MOESM4_ESM.xlsx"><label>Supplementary Table 1</label><caption><p>Read statistics of Hi-C and micro-C replicates.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41586_2022_4730_MOESM5_ESM.xlsx"><label>Supplementary Table 2</label><caption><p>Oligonucleotide sequences used for the DNA substrate for single-molecule imaging.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41586_2022_4730_MOESM6_ESM.mov"><label>Supplementary Video 1</label><caption><p>Video showing translocating cohesin (green) on doubly tethered DNA (blue) in the absence of MCM at 0.15&#x2009;M NaCl (corresponds to kymograph in Extended Data Fig. 9b).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41586_2022_4730_MOESM7_ESM.mov"><label>Supplementary Video 2</label><caption><p>Video showing origin-bound MCM (magenta) as an efficient barrier for cohesin translocation (green) on doubly tethered DNA (blue) at 0.15&#x2009;M NaCl (corresponds to kymograph in Fig. 4b).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41586_2022_4730_MOESM8_ESM.mov"><label>Supplementary Video 3</label><caption><p>Video showing translocating cohesin (green) on doubly tethered DNA (blue) that occasionally can bypass origin-bound MCM (magenta) at 0.15 M NaCl (corresponds to kymograph in Extended Data Fig. 9e).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41586_2022_4730_MOESM9_ESM.mov"><label>Supplementary Video 4</label><caption><p>Video showing translocating cohesin (green) on doubly tethered DNA (blue) in the absence of MCM at 0.5 M NaCl (corresponds to kymograph in Extended Data Fig. 10b).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41586_2022_4730_MOESM10_ESM.mov"><label>Supplementary Video 5</label><caption><p>Video showing origin-bound MCM (magenta) as an efficient barrier for cohesin translocation (green) on doubly tethered DNA (blue) at 0.5 M NaCl (corresponds to kymograph in Extended Data Fig. 10c, left).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="41586_2022_4730_MOESM11_ESM.mov"><label>Supplementary Video 6</label><caption><p>Video showing translocating cohesin (green) on doubly tethered DNA (blue) that occasionally can bypass origin-bound MCM (magenta) at 0.5 M NaCl (corresponds to kymograph in Extended Data Fig. 10d, left).</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec46">
          <title>Extended data figures and tables</title>
          <p id="Par78">
<fig id="Fig5"><label>Extended Data Fig. 1</label><caption><title>Dimensions of cohesin compared to the estimated size of the MCM2&#x2013;7 complex and the FtsK roadblock.</title><p>Size comparison between a schematic representation of the ring-shaped heterotrimeric cohesin (SMC1-SMC3-SCC1) with the MCM2&#x2013;7 double hexamer and the FtsK monohexamer. The size estimation of MCM2&#x2013;7 and FtsK was based on their crystal structure. PDB accessions codes for each protein are shown in parentheses.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig5_ESM" id="d32e2491"/></fig>
</p>
          <p id="Par79">
<fig id="Fig6"><label>Extended Data Fig. 2</label><caption><title>Prevention of MCM loading in G1-synchronized zygotes.</title><p><bold>a</bold>, Expression of geminin(L26A), a non-degradable variant of geminin, prevents the recruitment of MCMs to chromatin in G1 phase by inhibiting the Cdt1-mediated loading pathway. <bold>b</bold>, Quantification of mean chromatin-bound MCM2 intensity in maternal and paternal pronuclei from wild type (WT, n&#x2009;=&#x2009;7) and MCM-loading inhibited (MCM loss, n&#x2009;=&#x2009;7) G1-phase zygotes from 1 experiment using 4 females. Representative image is shown in Fig. <xref rid="Fig1" ref-type="fig">1b</xref>. <bold>c</bold>, 5-ethynyl-2&#x2032;-deoxyuridine (EdU)-cultured zygotes collected at 6.5h post-fertilization do not incorporate EdU (0/12) and therefore have not yet entered S phase. Zygotes without EdU in the medium (no EdU) also don&#xB4;t incorporate EdU (0/6), while zygotes fixed at 12h post-fertilization show EdU-incorporation (7/7). Quantification of EdU intensity as signal over background shown for both maternal and paternal pronuclei from G1/no Edu (n&#x2009;=&#x2009;6), G1/EdU (n&#x2009;=&#x2009;12) and S/EdU (n&#x2009;=&#x2009;7) zygotes examined in 1 experiment using 6 females. <bold>d</bold>, Immunofluorescence analysis of WT (n&#x2009;=&#x2009;9) and MCM loss (n&#x2009;=&#x2009;11) zygotes from 1 experiment using 6 females that were cultured in continuous presence of EdU and collected at 14h post-fertilization (G2&#xA0;phase). Top, representative image. Bottom, quantification of EdU signal over background in maternal and paternal pronuclei. <bold>e</bold>, <bold>f</bold>, Immunofluorescence analysis of chromatin-bound CTCF (<bold>e</bold>) and SCC1-MYC (<bold>f</bold>) in WT (n&#x2009;=&#x2009;7 for CTCF, n&#x2009;=&#x2009;5 for SCC1-MYC) and MCM loss (n&#x2009;=&#x2009;8 for CTCF, n&#x2009;=&#x2009;7 for SCC1-MYC) G1-phase zygotes from 1 experiment for each staining using 5 females each. Left, representative image. Right, Quantification of CTCF and SCC1-MYC intensity as signal over background in maternal and paternal pronuclei. <italic>P</italic> values were determined by two-sided unpaired <italic>t</italic>-test (<bold>b</bold>, <bold>c</bold>, <bold>e</bold>, <bold>f</bold>) or by two-sided Mann-Whitney <italic>U</italic> test (<bold>d</bold>). Quantifications in panels b-f are depicted as mean &#xB1; s.d.; *, sperm head. <bold>&#x2020;</bold>, degraded polar body. DNA is stained with DAPI. Scale bars, 10&#x2009;&#xB5;m.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig6_ESM" id="d32e2560"/></fig>
</p>
          <p id="Par80">
<fig id="Fig7"><label>Extended Data Fig. 3</label><caption><title>MCMs impede loops in G1 zygotes while having little effect on the <italic>P</italic><sub>c</sub>(<italic>s</italic>) curve in the range of cohesin-dependent contacts up to 1&#x2009;Mb.</title><p><bold>a</bold>, Peak strength of individual samples for wild type (WT) and MCM-loading inhibited (MCM loss) conditions, shown for maternal and paternal pronuclei. Size of the bullets corresponds to the number of cis 1kb+ contacts per sample (weights). Data are based on n(WT, maternal)&#x2009;=&#x2009;13, n(WT, paternal)&#x2009;=&#x2009;16, n(MCM&#xA0;loss, maternal)&#x2009;=&#x2009;16, n(MCM&#xA0;loss, paternal)&#x2009;=&#x2009;15, from 4 independent experiments using 4-6 females for each experiment (same samples as in Fig. <xref rid="Fig1" ref-type="fig">1d</xref>). Data presented as weighted mean &#xB1; s.d.; <italic>P</italic> values were calculated using weighted statistics (Methods). <bold>b</bold>, Aggregate peak analysis for intermediate (100-250kb) and long loops (&gt;250kb) in WT and MCM loss conditions for maternal and paternal pronuclei. Data are based on the same samples as in (<bold>a</bold>) and Fig. <xref rid="Fig1" ref-type="fig">1d</xref>. <bold>c</bold>, Aggregate peak analysis for WT and MCM loss conditions from a subset of 4, 8 and 12 samples, shown for maternal and paternal pronuclei. <bold>d</bold>, Contact probability P<sub>c</sub>(s) curve as a function of genomic distance (s). Cohesin is directly involved in shaping the P<sub>c</sub>(s) in the range up to 1&#x2009;Mb. The contact frequency in this region is decreased after cohesin depletion (<italic>Scc1</italic><sup><italic>&#x394;</italic></sup>) and is increased after enrichment of chromatin-bound cohesin (<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>). <bold>e</bold>, Contact probability P<sub>c</sub>(s) curves from individual maternal and paternal pronuclei with average P<sub>c</sub>(s) (same as in Fig. <xref rid="Fig1" ref-type="fig">1e</xref>) in bold overlaid. <bold>f</bold>, Slopes of the P<sub>c</sub>(s) curves (depicted in Fig. <xref rid="Fig1" ref-type="fig">1e</xref>) as an indication for the average size of cohesin-extruded loops in WT and MCM loss conditions.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig7_ESM" id="d32e2647"/></fig>
</p>
          <p id="Par81">
<fig id="Fig8"><label>Extended Data Fig. 4</label><caption><title>MCMs impede cohesin-dependent loops and TADs largely independently of transcriptional changes.</title><p><bold>a</bold>, Principal component analysis (PCA) of the transcriptomes of G1 wild type (G1_WT), G1 MCM-loading inhibited (G1_MCM loss) and G2 wild type (G2_WT) zygotes. <bold>b</bold>, Volcano plot showing statistical significance &#x2013;log<sub>10</sub> (FDR) versus fold change (log<sub>2</sub> fold change) for RNA-Seq data between WT and MCM loss conditions in G1 zygotes. Numbers indicate the number of transcripts significantly up- (right) or downregulated (left) after MCM loss at FDR&#x2009;=&#x2009;0.1. Dashed vertical lines indicate &#x2212;0.585 and +0.585 log<sub>2</sub> fold change in expression (1.5-fold decrease and increase in expression), respectively. <bold>c</bold>, <italic>Scc1</italic><sup><italic>&#x394;/&#x394;</italic></sup> oocytes from <italic>Scc1</italic><sup><italic>fl/fl</italic></sup>
<italic>(Tg)Zp3</italic>-Cre females were injected with geminin(L26A) mRNA and eggs were fertilized to generate maternal knockout <italic>Scc1</italic><sup><italic>&#x394;(m)/+(p)</italic></sup> zygotes for snHi-C analysis in G1 phase. Because most proteins are provided by the oocyte and the G1-phase zygote is practically transcriptionally inactive, these maternal knockout zygotes are depleted for Scc1<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. <bold>d</bold>, Aggregate peak and TAD analysis for <italic>Scc1</italic><sup><italic>fl</italic></sup> (WT), <italic>Scc1</italic><sup><italic>&#x394;</italic></sup> and <italic>Scc1</italic><sup><italic>&#x394;</italic></sup>&#xA0;+&#xA0;MCM loss. Maternal and paternal data are shown pooled together. Data are based on n(<italic>Scc1</italic><sup><italic>fl</italic></sup>)&#x2009;=&#x2009;26, n(<italic>Scc1</italic><sup><italic>&#x394;</italic></sup>)&#x2009;=&#x2009;42, and n(<italic>Scc1</italic><sup><italic>&#x394;</italic></sup>&#xA0;+&#xA0;MCM loss)&#x2009;=&#x2009;10 nuclei. Heat maps were normalized to an equal number of <italic>cis</italic> contacts. Control (<italic>Scc1</italic><sup><italic>fl</italic></sup>) samples and 38 Scc1-depleted samples (<italic>Scc1</italic><sup><italic>&#x394;</italic></sup>) were previously published<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig8_ESM" id="d32e2765"/></fig>
</p>
          <p id="Par82">
<fig id="Fig9"><label>Extended Data Fig. 5</label><caption><title>CTCF is required for loop and TAD formation in G1 zygotes.</title><p><bold>a</bold>, Immunofluorescence analysis of CTCF in wild type (n&#x2009;=&#x2009;5) and CTCF-depleted (n&#x2009;=&#x2009;12) surrounded nucleolus (SN) oocytes from 1 experiment using 2 females for each genotype. Left, representative images, DNA is stained with DAPI. Scale bars: 20&#x2009;&#xB5;m. Right, Quantification of CTCF intensity as signal over background. Data are presented as mean &#xB1; s.d.; <italic>P</italic> value was determined by two-sided unpaired <italic>t</italic>-test. <bold>b</bold>, Aggregate peak and TAD analysis for wild type (WT), CTCF-depleted (CTCF knockdown) and CTCF-depleted combined with prevention of MCM loading (CTCF knockdown&#xA0;+&#xA0;MCM loss)&#xA0;maternal chromatin in G1 zygotes. Data shown are based on n(WT, maternal)&#x2009;=&#x2009;12, n(CTCF knockdown, maternal)&#x2009;=&#x2009;12, n(CTCF knockdown&#xA0;+&#xA0;MCM loss, maternal)&#x2009;=&#x2009;10 nuclei, from 4 independent experiments using 4-6 females for each genotype. Heat maps were normalized to an equal number of <italic>cis</italic> contacts. <bold>c</bold>, Insulation scores at TAD borders for maternal nuclei. <bold>d</bold>, Average contact probability P<sub>c</sub>(s) curves for WT and CTCF knockdown conditions, shown separately for maternal and paternal nuclei. <bold>e</bold>, P<sub>c</sub>(s) curves for individual samples (maternal and paternal pronuclei) with average P<sub>c</sub>(s) (same as in <bold>d</bold>) in bold overlaid.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig9_ESM" id="d32e2815"/></fig>
</p>
          <p id="Par83">
<fig id="Fig10"><label>Extended Data Fig. 6</label><caption><title>MCM restricts loop and TAD formation in maternal chromatin independently of Wapl-mediated cohesin release.</title><p><bold>a</bold>, Aggregate peak and TAD analysis for control (WT), <italic>Wapl</italic><sup><italic>&#x394;</italic></sup> and <italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#xA0;+&#xA0;MCM loss for maternal chromatin in G1 zygotes. Data shown are based on n(WT, maternal)&#x2009;=&#x2009;17, n(<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>, maternal)&#x2009;=&#x2009;10, n(<italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#xA0;+&#xA0;MCM loss, maternal)&#x2009;=&#x2009;10, from 4 independent experiments using 4-6 females for each genotype. Control samples are WT (this study) pooled with <italic>Wapl</italic><sup><italic>fl</italic></sup> samples (published in<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>). <bold>b</bold>, Insulation scores at TAD borders for maternal nuclei. <bold>c</bold>, Average contact probability P<sub>c</sub>(s) curves for control (WT), <italic>Wapl</italic><sup><italic>&#x394;</italic></sup> and <italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#xA0;+&#xA0;MCM loss, shown separately for maternal and paternal nuclei. <bold>d</bold>, P<sub>c</sub>(s) curves for individual samples (maternal and paternal pronuclei) with average P<sub>c</sub>(s) (same as in panel c) in bold overlaid. <bold>e</bold>, Matrix of peak strengths, generated by polymer simulations, showing a linear trade-off between the MCM density and its ability to pause cohesins in <italic>Wapl</italic><sup><italic>&#x394;</italic></sup>. <bold>f</bold>&#x2013;<bold>g</bold>, Simulated contact probability decay curve P<sub>c</sub>(s) for WT (<bold>f</bold>), <italic>Wapl</italic><sup><italic>&#x394;</italic></sup> (<bold>g</bold>) and <italic>Wapl</italic><sup><italic>&#x394;</italic></sup>&#xA0;+&#xA0;MCM loss (<bold>h</bold>). The simulated P<sub>c</sub>(s) curve is well matched with the experimental data.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig10_ESM" id="d32e2942"/></fig>
</p>
          <p id="Par84">
<fig id="Fig11"><label>Extended Data Fig. 7</label><caption><title>Moderate increase in aggregate peak strength after acute depletion of MCM in HCT116 cells using Hi-C.</title><p><bold>a</bold>, Schematic for G1 synchronization of HCT116 MCM2-mAID cells. <bold>b</bold>, Cell cycle profiles of asynchronous and G1-synchronized (Control/MCM depletion) HCT116 MCM2-mAID cells. <bold>c</bold>, Immunoblotting analysis of whole-cell lysate (W), supernatant (S) and chromatin (C) fraction for MCM2, MCM4, GAPDH and H3 from G1-synchronized HCT116 MCM2-mAID cells treated with DMSO (Control) or auxin (MCM depletion). GAPDH and H3 are used as loading controls for supernatant and chromatin fraction, respectively. Uncropped blots are displayed in&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Fig. 1</xref>. This experiment was repeated independently three more times with similar results. <bold>d</bold>, Hi-C contact matrices for control and MCM depletion conditions for the region 112,5-117,6 Mb on chromosome 12 at 10&#x2009;kb resolution. Increased corner peaks are denoted with an arrow. CTCF sites are depicted above the contact matrices. <bold>e</bold>, Average of total contact frequency for loops and TADs in aggregate peak and TAD analysis for control and MCM-depleted cells. <bold>f</bold>, Contact probability P<sub>c</sub>(s) curves for control and MCM depletion conditions. <bold>g</bold>, Insulation scores at TAD borders for control and MCM-depleted cells. Read statistics for Hi-C replicates can be found in&#xA0;<xref rid="MOESM4" ref-type="media">Supplementary Table 1</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig11_ESM" id="d32e2986"/></fig>
</p>
          <p id="Par85">
<fig id="Fig12"><label>Extended Data Fig. 8</label><caption><title>Micro-C reveals a genome-wide increase in peak strength and in de novo loop number after acute depletion of MCM2 in HCT116 cells.</title><p><bold>a</bold>, Schematic for G1 synchronization of HCT116 MCM2-mAID cells before G1 FACs sorting. <bold>b</bold>, FACS-analysis of synchronized HCT116 MCM2-mAID cells. Only cells in the left part of the G1 peak were sorted and collected for Micro-C and RNA-seq to avoid contamination of S-phase cells (red dashed box). <bold>c</bold>,&#xA0;Immunoblotting analysis of whole-cell lysate (W), supernatant (S) and chromatin fraction (C) for MCM2, MCM4, CTCF, SCC1, PCNA, GAPDH and H3 from asynchronous and G1-sorted HCT116 MCM2-mAID cells treated with DMSO (Control) or auxin (MCM depletion). GAPDH and H3 are used as loading controls for the supernatant and chromatin fraction, respectively. Uncropped blots are displayed in&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Fig. 1</xref>. This experiment was repeated independently one more time with similar results. <bold>d</bold>, Micro-C contact matrices for the region 57 - 58.5 Mb on chromosome 15 at 10&#x2009;kb resolution in control vs MCM-depleted cells. <bold>e</bold>, P<sub>c</sub>(s) curves for control and MCM depletion conditions. <bold>f</bold>, Insulation scores at TAD borders for control and MCM-depleted cells. <bold>g</bold>, Average of the total contact frequency of loops in an aggregate peak analysis for two independent Micro-C replicates (middle and lower panel) and pooled dataset (upper panel) in control and MCM-depleted cells. <bold>h</bold>, Peak strengths for control and MCM-depleted cells over a range of genomic distances. <bold>i</bold>, Histogram showing the distribution of log<sub>2</sub> ratio of peak strengths in MCM-depleted and control cells within 1&#x2009;Mb bins across the whole genome, normalized to global and local background of interactions. Higher values indicate increase of peak strength after MCM depletion. Mean of the distribution is highly significantly different from 0 (one sample <italic>t</italic>-test), <italic>P</italic>&#x2009;=&#x2009;1.87&#x2009;&#xD7;&#x2009;10<sup>&#x2212;70</sup>. <bold>j</bold>, de novo called loops using Mustache over a range of genomic distances in control and MCM-depleted cells. <bold>k</bold>, Number of de novo loops (called with Mustache) in independent Hi-C and Micro-C experiments. All replicates were downsampled to 300 million total contacts. <bold>l</bold>, Volcano plot showing statistical significance &#x2013;log<sub>10</sub> (FDR) versus fold change (log<sub>2</sub> fold change) for RNA-seq data between MCM2-mAID expressing HCT116 cells treated with DMSO (Control) or auxin (MCM depletion). Numbers indicate the number of transcripts significantly up- (right) or downregulated (left) after MCM depletion at FDR&#x2009;=&#x2009;0.1. Dashed vertical lines indicate &#x2212;0.585 and +0.585 log<sub>2</sub> fold change in expression (1.5-fold decrease and increase in expression), respectively. RNA-seq libraries were generated in triplicate (independent replicates). <bold>m</bold>, Correlation between gene expression changes and relative change in chromatin contact frequencies around the transcriptional start sites (TSSs) after MCM loss. All mean contact frequency changes were tested against the non-DE TSS control using the non-parametric Kruskal-Wallis test followed by pairwise Wilcoxon (Mann-Whitney <italic>U</italic>) test. <bold>n</bold>, Immunoblotting analysis of whole-cell lysate (W), supernatant (S) and chromatin fraction (C) from asynchronous and G1-sorted HCT116 MCM2-mAID cells treated with triptolide (chromatin-bound RNA PolII degradation) and either DMSO (Control) or auxin (MCM depletion). H3 is used as loading control for the chromatin fraction. Uncropped blots are displayed in&#xA0;<xref rid="MOESM1" ref-type="media">Supplementary Fig. 1</xref>. This experiment was repeated independently one more time with similar results. <bold>o</bold>, Peak strengths for control, MCM-depleted, triptolide-treated (DMSO/trp) and triptolide-treated/MCM-depleted (MCM depletion/trp) cells over a range of genomic distances. Notes: Micro-C datasets (control/MCM depletion) are pooled replicates from two biologically independent Micro-C experiments, unless otherwise stated. Read statistics for Hi-C and Micro-C replicates can be found in&#xA0;<xref rid="MOESM4" ref-type="media">Supplementary Table 1</xref>.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig12_ESM" id="d32e3084"/></fig>
</p>
          <p id="Par86">
<fig id="Fig13"><label>Extended Data Fig. 9</label><caption><title>Translocating cohesin can bypass MCM with reduced efficiency.</title><p><bold>a</bold>, MCM loads as double-hexamers at origins. Time traces of origin-bound MCM fluorescence intensity (purple) show two-step bleaching but less frequent also one and multi-step (black, fits by kinetic change point analysis) <bold>b</bold>, Representative kymograph of translocating cohesin in the absence of MCM at the origin. <bold>c</bold>, MCM does not alter observed cohesin translocation velocity. Box plots of cohesin diffusion coefficients in the absence (green) or presence (blue) of MCM at 150 or 500&#x2009;mM NaCl. The centre line displays median, box edges show quartiles 1&#x2013;3, and whiskers span quartiles 1&#x2013;3&#x2009;&#xB1;&#x2009;1.5&#x2009;&#xD7;&#x2009;interquartile range. <italic>P</italic> values were determined by two-sided Mann-Whitney <italic>U</italic> test. <bold>d</bold>, <bold>e</bold>, Representative kymographs of translocating cohesin in the presence of MCM at the origin. MCM is a&#xA0;strong barrier for cohesin translocation (<bold>d</bold>) with MCM passage observed infrequently (<bold>e</bold>) during a 220&#x2009;s interval. <bold>f</bold>, Multiple loaded MCMs do not increase the barrier strength for cohesin translocation. Photobleaching analysis confirm loaded MCM double-hexamers as main species. Data are depicted as mean within a 95 % confidence interval (generated by bootstrapping). <italic>P</italic> values were determined by Kruskal-Wallis test. <bold>g</bold>, Length distribution of doubly tethered DNA in pixels (px). The line represents a Gaussian fit. <bold>h</bold>, Cohesin translocation pauses at origins bound by MCM. Distribution of cohesin pause (green) and corresponding MCM (blue) positions on DNA. <bold>i</bold>, Representative kymographs of translocating cohesin showing frequent pausing after encountering MCM<sup>Mcm3-YDF</sup> at the origin. All data displayed (except in <bold>e</bold> and where specified in <bold>c</bold>) were imaged under physiological salt conditions (0.15&#x2009;M NaCl).</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig13_ESM" id="d32e3150"/></fig>
</p>
          <p id="Par87">
<fig id="Fig14"><label>Extended Data Fig. 10</label><caption><title>MCM is a barrier for cohesin translocation at a high salt concentration.</title><p><bold>a</bold>, Schematic principle of a single-molecule cohesin translocation assay on licensed DNA. MCM is loaded onto DNA in the&#xA0;presence of the licensing factors ORC and Cdc6, followed by cohesin as described in Fig. <xref rid="Fig4" ref-type="fig">4a</xref>. Subsequently, cohesin translocation is visualized at high salt concentration (0.5&#x2009;M NaCl) in the&#xA0;absence of free protein and buffer flow. <bold>b</bold>&#x2013;<bold>d</bold>, Representative kymographs of translocating cohesin on DNA in the absence (<bold>b</bold>) or presence of MCM at the origin (<bold>c</bold>, <bold>d</bold>). Origin-bound MCM is a strong barrier to cohesin translocation (<bold>c</bold>) with passage events occurring infrequently (<bold>d</bold>) during a 220&#x2009;s observation interval. <bold>e</bold>, MCM is a barrier for cohesin translocation at high salt concentration. Probability of translocating cohesin bypassing the origin in the absence or presence of MCM calculated from 40 or 64 molecules with 7802 or 9829 visualized encounters, respectively. <bold>f</bold>, Multiple loaded MCMs do not increase the barrier strength for cohesin translocation. Data in <bold>e</bold>, <bold>f</bold> are depicted as mean within a 95 % confidence interval (generated by bootstrapping). <italic>P values</italic> were determined by Kruskal-Wallis followed by Dunn&#x2019;s post-hoc test. All data displayed were imaged in the presence of 0.5&#x2009;M NaCl. <bold>g</bold>, Model showing that pausing of extruding cohesin at MCMs could promote sister-chromatid cohesion.</p></caption><graphic position="anchor" xlink:href="41586_2022_4730_Fig14_ESM" id="d32e3210"/></fig>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Bart J. H. Dequeker, Matthias J. Scherr</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-04730-0.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-04730-0.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank M. S. Bartolomei for the <italic>(Tg)Zp3-dsCTCF</italic> mouse strain; M.&#xA0;T. Kanemaki for the <italic>MCM2-mAID</italic> HCT116 cell line; the D.&#xA0;Remus laboratory for generating the ySA4 MCM strain that was used in vitro single-molecule assays; Z. Lygerou for sharing the geminin(L26A)-GFP plasmid; U. Cramer and R. Hornberger for technical assistance in generating the MCM3&#x2013;YDF yeast strains; and H. C. Theu&#xDF;l and J. R. Wojciechowski for reviving <italic>(Tg)Zp3-dsCTCF</italic> embryos. Illumina sequencing was performed at the VBCF NGS unit and the MPIB NGS core facility (<ext-link ext-link-type="uri" xlink:href="http://www.vbcf.ac.at">http://www.vbcf.ac.at</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.biochem.mpg.de/7076201/NGS">https://www.biochem.mpg.de/7076201/NGS</ext-link>). B.J.H.D. is funded by the PhD program (DK) Chromosome Dynamics (W1238-B20), supported by the Austrian Science Fund (FWF). L.A.M. and H.B.B. acknowledge support from the National Institutes of Health Common Fund 4D Nucleome Program (DK107980) and the Human Frontier Science Program (HFSP RGP0057/2018). I.M.F. is supported by a Medical Research Council UK University Unit grant (MC_UU_00007/2). Research in the K.E.D. laboratory is supported by the European Research Council (ERC; ERC-StG-804098 ReplisomeBypass), the German Research Foundation (DFG, SFB863-111166240) and the Max Planck Society. Research in the J.-M.P. laboratory is supported by Boehringer Ingelheim, the Austrian Research Promotion Agency (Headquarter grant FFG-878286), the ERC (grant agreement no. 693949 and 101020558), HFSP (RGP0057/2018) and the Vienna Science and Technology Fund (grant LS19-029). Research in the K.T. laboratory is supported by the ERC (ERC-CoG-818556 TotipotentZygotChrom), HFSP (RGP0057/2018), the Herzfelder Foundation and FWF (P30613-B21), the Austrian Academy of Sciences and the Max Planck Society.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>K.T. conceived the project. B.J.H.D. supervised by K.T. performed snHi-C, Hi-C, Micro-C, RNA-seq and imaging experiments. H.B.B. developed and performed snHi-C data analysis and polymer simulations with L.A.M. M.J.S. supervised by K.E.D. performed single-molecule imaging and analysis. J.G. performed snHi-C and imaging experiments. S.P. performed snHi-C data analysis and RNA-seq analysis. I.G. performed RNA-seq analysis&#xA0;and contributed to imaging analysis.&#xA0;A.L. performed Micro-C experiments. J.G., S.P., I.G. and A.L. were supervised by K.T.&#xA0;I.M.F. performed Hi-C and Micro-C analysis. I.F.D. purified recombinant cohesin<sup>STAG1, SCC1-Halo</sup>.&#xA0;W.T. contributed to development of cell lines and R.S. to bioinformatic analyses. I.F.D.,&#xA0;W.T. and&#xA0;R.S. were supervised by J.-M.P. B.J.H.D., H.B.B., M.J.S., I.M.F. and I.G. prepared the figures. B.J.H.D., H.B.B., M.J.S., I.G., K.E.D., L.A.M. and K.T. wrote the manuscript with input from all authors.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="FPar1">
        <title>Peer review information</title>
        <p id="Par76"><italic>Nature</italic> thanks the anonymous reviewers for their contribution to the peer review of this work.&#xA0;<xref rid="MOESM3" ref-type="media">Peer reviewer reports</xref> are available.</p>
      </sec>
    </notes>
    <notes notes-type="funding-information">
      <title>Funding</title>
      <p>Open access funding provided by Max Planck Society.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>All sequencing data in support of the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under the series accession numbers <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196497">GSE196497</ext-link> (snHi-C and RNA-seq) and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155971">GSE155971</ext-link> (Hi-C and Micro-C). The single-molecule video datasets supporting the findings in this study have been deposited at Zenodo with the following: 10.5281/zenodo.5911106 (high-salt experiments), 10.5281/zenodo.5911210 (physiological salt experiments) and 10.5281/zenodo.5911284 (YDF experiments). All data are also available from the authors upon request.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>The snHi-C and single-molecule processing scripts are deposited at Zenodo under 10.5281/zenodo.5906351 and 10.5281/zenodo.5911644, respectively. The simulation codes are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/mirnylab/MCMs-as-random-barriers-to-loop-extrusion-paper">https://github.com/mirnylab/MCMs-as-random-barriers-to-loop-extrusion-paper</ext-link>.</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par77">The authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nora</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial partitioning of the regulatory landscape of the X-inactivation centre</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <fpage>381</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11049</pub-id>
          <pub-id pub-id-type="pmid">22495304</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixon</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Topological domains in mammalian genomes identified by analysis of chromatin interactions</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <fpage>376</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11082</pub-id>
          <pub-id pub-id-type="pmid">22495300</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>SSP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>1665</fpage>
          <lpage>1680</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.021</pub-id>
          <pub-id pub-id-type="pmid">25497547</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cuartero</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation</article-title>
          <source>Nat. Immunol.</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>932</fpage>
          <lpage>941</lpage>
          <pub-id pub-id-type="doi">10.1038/s41590-018-0184-1</pub-id>
          <pub-id pub-id-type="pmid">30127433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The fundamental role of chromatin loop extrusion in physiological V(D)J recombination</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>573</volume>
          <fpage>600</fpage>
          <lpage>604</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1547-y</pub-id>
          <pub-id pub-id-type="pmid">31511698</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davidson</surname>
              <given-names>IF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DNA loop extrusion by human cohesin</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>366</volume>
          <fpage>1338</fpage>
          <lpage>1345</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaz3418</pub-id>
          <pub-id pub-id-type="pmid">31753851</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Finkelstein</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Human cohesin compacts DNA by loop extrusion</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>366</volume>
          <fpage>1345</fpage>
          <lpage>1349</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaz4475</pub-id>
          <pub-id pub-id-type="pmid">31780627</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golfier</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Quail</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Brugu&#xE9;s</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cohesin and condensin extrude DNA loops in a cell cycle-dependent manner</article-title>
          <source>eLife</source>
          <year>2020</year>
          <volume>9</volume>
          <fpage>e53885</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.53885</pub-id>
          <pub-id pub-id-type="pmid">32396063</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alipour</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Marko</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Self-organization of domain structures by DNA-loop-extruding enzymes</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>11202</fpage>
          <lpage>11212</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gks925</pub-id>
          <pub-id pub-id-type="pmid">23074191</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanborn</surname>
              <given-names>AL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2015</year>
          <volume>112</volume>
          <fpage>E6456</fpage>
          <lpage>E6465</lpage>
          <pub-id pub-id-type="pmid">26499245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fudenberg</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Formation of chromosomal domains by loop extrusion</article-title>
          <source>Cell Rep.</source>
          <year>2016</year>
          <volume>15</volume>
          <fpage>2038</fpage>
          <lpage>2049</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.085</pub-id>
          <pub-id pub-id-type="pmid">27210764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hansen</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>CTCF as a boundary factor for cohesin-mediated loop extrusion: evidence for a multi-step mechanism</article-title>
          <source>Nucleus</source>
          <year>2020</year>
          <volume>11</volume>
          <fpage>132</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="doi">10.1080/19491034.2020.1782024</pub-id>
          <pub-id pub-id-type="pmid">32631111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davidson</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>J-M</given-names>
            </name>
          </person-group>
          <article-title>Genome folding through loop extrusion by SMC complexes</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <year>2021</year>
          <volume>22</volume>
          <fpage>445</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="doi">10.1038/s41580-021-00349-7</pub-id>
          <pub-id pub-id-type="pmid">33767413</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nora</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted degradation of CTCF decouples local insulation of chromosome domains from genomic compartmentalization</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>169</volume>
          <fpage>930</fpage>
          <lpage>944</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.05.004</pub-id>
          <pub-id pub-id-type="pmid">28525758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#xE3;o</surname>
              <given-names>HB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RNA polymerases as moving barriers to condensin loop extrusion</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2019</year>
          <volume>116</volume>
          <fpage>20489</fpage>
          <lpage>20499</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1907009116</pub-id>
          <pub-id pub-id-type="pmid">31548377</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinz</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcription elongation can affect genome 3D structure</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>1522</fpage>
          <lpage>1536</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.047</pub-id>
          <pub-id pub-id-type="pmid">30146161</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Busslinger</surname>
              <given-names>GA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin is positioned in mammalian genomes by transcription, CTCF and Wapl</article-title>
          <source>Nature</source>
          <year>2017</year>
          <volume>460</volume>
          <fpage>410</fpage>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deegan</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Diffley</surname>
              <given-names>JFX</given-names>
            </name>
          </person-group>
          <article-title>MCM: one ring to rule them all</article-title>
          <source>Curr. Opin. Struct. Biol.</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>145</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="doi">10.1016/j.sbi.2016.01.014</pub-id>
          <pub-id pub-id-type="pmid">26866665</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyrien</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>How MCM loading and spreading specify eukaryotic DNA replication initiation sites</article-title>
          <source>F1000Res.</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>2063</fpage>
          <pub-id pub-id-type="doi">10.12688/f1000research.9008.1</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Diffley</surname>
              <given-names>JFX</given-names>
            </name>
          </person-group>
          <article-title>Eukaryotic DNA replication control: lock and load, then fire</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <year>2009</year>
          <volume>21</volume>
          <fpage>771</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2009.08.002</pub-id>
          <pub-id pub-id-type="pmid">19767190</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pradhan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Narayan</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>MCM paradox: abundance of eukaryotic replicative helicases and genomic integrity</article-title>
          <source>Mol. Biol. Int.</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>574850</fpage>
          <pub-id pub-id-type="doi">10.1155/2014/574850</pub-id>
          <pub-id pub-id-type="pmid">25386362</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ibarra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwob</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>M&#xE9;ndez</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2008</year>
          <volume>105</volume>
          <fpage>8956</fpage>
          <lpage>8961</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0803978105</pub-id>
          <pub-id pub-id-type="pmid">18579778</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sedlackova</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Equilibrium between nascent and parental MCM proteins protects replicating genomes</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>587</volume>
          <fpage>297</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-020-2842-3</pub-id>
          <pub-id pub-id-type="pmid">33087936</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuipers</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Highly stable loading of Mcm proteins onto chromatin in living cells requires replication to unload</article-title>
          <source>J. Cell Biol.</source>
          <year>2011</year>
          <volume>192</volume>
          <fpage>29</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.201007111</pub-id>
          <pub-id pub-id-type="pmid">21220507</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structure of the eukaryotic MCM complex at 3.8 &#xC5;</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>524</volume>
          <fpage>186</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="doi">10.1038/nature14685</pub-id>
          <pub-id pub-id-type="pmid">26222030</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stigler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>&#xC7;amdere</surname>
              <given-names>G&#xD6;</given-names>
            </name>
            <name>
              <surname>Koshland</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Single-molecule imaging reveals a collapsed conformational state for DNA-bound cohesin</article-title>
          <source>Cell Rep.</source>
          <year>2016</year>
          <volume>15</volume>
          <fpage>988</fpage>
          <lpage>998</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.003</pub-id>
          <pub-id pub-id-type="pmid">27117417</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gassler</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A mechanism of cohesin-dependent loop extrusion organizes zygotic genome architecture</article-title>
          <source>EMBO J.</source>
          <year>2017</year>
          <volume>36</volume>
          <fpage>3600</fpage>
          <lpage>3618</lpage>
          <pub-id pub-id-type="doi">10.15252/embj.201798083</pub-id>
          <pub-id pub-id-type="pmid">29217590</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flyamer</surname>
              <given-names>IM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-nucleus Hi-C reveals unique chromatin reorganization at oocyte-to-zygote transition</article-title>
          <source>Nature</source>
          <year>2017</year>
          <volume>544</volume>
          <fpage>110</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1038/nature21711</pub-id>
          <pub-id pub-id-type="pmid">28355183</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aoki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Worrad</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo</article-title>
          <source>Dev. Biol.</source>
          <year>1997</year>
          <volume>181</volume>
          <fpage>296</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="doi">10.1006/dbio.1996.8466</pub-id>
          <pub-id pub-id-type="pmid">9013938</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGarry</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Kirschner</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Geminin, an inhibitor of DNA replication, is degraded during mitosis</article-title>
          <source>Cell</source>
          <year>1998</year>
          <volume>93</volume>
          <fpage>1043</fpage>
          <lpage>1053</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81209-X</pub-id>
          <pub-id pub-id-type="pmid">9635433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wohlschlegel</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inhibition of eukaryotic DNA replication by geminin binding to Cdt1</article-title>
          <source>Science</source>
          <year>2000</year>
          <volume>290</volume>
          <fpage>2309</fpage>
          <lpage>2312</lpage>
          <pub-id pub-id-type="doi">10.1126/science.290.5500.2309</pub-id>
          <pub-id pub-id-type="pmid">11125146</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>MCC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Wapl releases Scc1-cohesin and regulates chromosome structure and segregation in mouse oocytes</article-title>
          <source>J. Cell Biol.</source>
          <year>2020</year>
          <volume>219</volume>
          <fpage>e201906100</fpage>
          <pub-id pub-id-type="doi">10.1083/jcb.201906100</pub-id>
          <pub-id pub-id-type="pmid">32328639</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ladst&#xE4;tter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tachibana-Konwalski</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A surveillance mechanism ensures repair of DNA lesions during zygotic reprogramming</article-title>
          <source>Cell</source>
          <year>2016</year>
          <volume>167</volume>
          <fpage>1774</fpage>
          <lpage>1787</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2016.11.009</pub-id>
          <pub-id pub-id-type="pmid">27916276</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wutz</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteins</article-title>
          <source>EMBO J.</source>
          <year>2017</year>
          <volume>36</volume>
          <fpage>3573</fpage>
          <lpage>3599</lpage>
          <pub-id pub-id-type="doi">10.15252/embj.201798004</pub-id>
          <pub-id pub-id-type="pmid">29217591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wan</surname>
              <given-names>L-B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development</article-title>
          <source>Development</source>
          <year>2008</year>
          <volume>135</volume>
          <fpage>2729</fpage>
          <lpage>2738</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.024539</pub-id>
          <pub-id pub-id-type="pmid">18614575</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide mapping of human DNA replication by optical replication mapping supports a stochastic model of eukaryotic replication</article-title>
          <source>Mol. Cell</source>
          <year>2021</year>
          <volume>81</volume>
          <fpage>2975</fpage>
          <lpage>2988</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2021.05.024</pub-id>
          <pub-id pub-id-type="pmid">34157308</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haarhuis</surname>
              <given-names>JHI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The cohesin release factor WAPL restricts chromatin loop extension</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>169</volume>
          <fpage>693</fpage>
          <lpage>707</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.04.013</pub-id>
          <pub-id pub-id-type="pmid">28475897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hansen</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Pustova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cattoglio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tjian</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Darzacq</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>CTCF and cohesin regulate chromatin loop stability with distinct dynamics</article-title>
          <source>eLife</source>
          <year>2017</year>
          <volume>6</volume>
          <fpage>2848</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.25776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banigan</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>van den Berg</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Brand&#xE3;o</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Marko</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Mirny</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Chromosome organization by one-sided and two-sided loop extrusion</article-title>
          <source>eLife</source>
          <year>2020</year>
          <volume>9</volume>
          <fpage>e53558</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.53558</pub-id>
          <pub-id pub-id-type="pmid">32250245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Natsume</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute inactivation of the replicative helicase in human cells triggers MCM8-9-dependent DNA synthesis</article-title>
          <source>Genes Dev.</source>
          <year>2017</year>
          <volume>31</volume>
          <fpage>816</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="doi">10.1101/gad.297663.117</pub-id>
          <pub-id pub-id-type="pmid">28487407</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remus</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Concerted loading of MCM2&#x2013;7 double hexamers around DNA during DNA replication origin licensing</article-title>
          <source>Cell</source>
          <year>2009</year>
          <volume>139</volume>
          <fpage>719</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2009.10.015</pub-id>
          <pub-id pub-id-type="pmid">19896182</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evrin</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A double-hexameric MCM2&#x2013;7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>20240</fpage>
          <lpage>20245</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0911500106</pub-id>
          <pub-id pub-id-type="pmid">19910535</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="other">Scherr, M. J., Abd Wahab, S., Remus, D. &amp; Duderstadt, K. E. Mobile origin-licensing factors confer resistance to conflicts with RNA polymerase. <italic>Cell Rep.</italic><bold>38</bold>, 110531 (2022).</mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The structural basis for cohesin&#x2013;CTCF-anchored loops</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>578</volume>
          <fpage>472</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1910-z</pub-id>
          <pub-id pub-id-type="pmid">31905366</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <mixed-citation publication-type="other">Pradhan, B. et al. SMC complexes can traverse physical roadblocks bigger than their ring size. Preprint at <italic>bioRxiv</italic>10.1101/2021.07.15.452501 (2021).</mixed-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauer</surname>
              <given-names>BW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin mediates DNA loop extrusion by a &#x201C;swing and clamp&#x201D; mechanism</article-title>
          <source>Cell</source>
          <year>2021</year>
          <volume>184</volume>
          <fpage>5448</fpage>
          <lpage>5464</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2021.09.016</pub-id>
          <pub-id pub-id-type="pmid">34624221</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chatzidaki</surname>
              <given-names>EE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ovulation suppression protects against chromosomal abnormalities in mouse eggs at advanced maternal age</article-title>
          <source>Curr. Biol.</source>
          <year>2021</year>
          <volume>31</volume>
          <fpage>4038</fpage>
          <lpage>4051</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cub.2021.06.076</pub-id>
          <pub-id pub-id-type="pmid">34314679</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Yiu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Gygi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Recruitment of <italic>Xenopus</italic> Scc2 and cohesin to chromatin requires the pre-replication complex</article-title>
          <source>Nat. Cell Biol.</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>991</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="doi">10.1038/ncb1177</pub-id>
          <pub-id pub-id-type="pmid">15448702</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillespie</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Scc2 couples replication licensing to sister chromatid cohesion in <italic>Xenopus</italic> egg extracts</article-title>
          <source>Curr. Biol.</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>1598</fpage>
          <lpage>1603</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cub.2004.07.053</pub-id>
          <pub-id pub-id-type="pmid">15341749</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kanchwala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Xing</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>MCM2&#x2013;7-dependent cohesin loading during S phase promotes sister-chromatid cohesion</article-title>
          <source>eLife</source>
          <year>2018</year>
          <volume>7</volume>
          <fpage>9906</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.33920</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <mixed-citation publication-type="other">Liu, Y. &amp; Dekker, J. Biochemically distinct cohesin complexes mediate positioned loops between CTCF sites and dynamic loops within chromatin domains. Preprint at <italic>bioRxiv</italic>10.1101/2021.08.24.457555 (2021).</mixed-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hug</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Grimaldi</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Kruse</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vaquerizas</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Chromatin architecture emerges during zygotic genome activation independent of transcription</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>169</volume>
          <fpage>216</fpage>
          <lpage>2289</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.03.024</pub-id>
          <pub-id pub-id-type="pmid">28388407</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Munnik</surname>
              <given-names>SA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Meier&#x2013;Gorlin syndrome genotype&#x2013;phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosis</article-title>
          <source>Eur. J. Hum. Genet.</source>
          <year>2012</year>
          <volume>20</volume>
          <fpage>598</fpage>
          <lpage>606</lpage>
          <pub-id pub-id-type="doi">10.1038/ejhg.2011.269</pub-id>
          <pub-id pub-id-type="pmid">22333897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewandoski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wassarman</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title><italic>Zp3-cre</italic>, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line</article-title>
          <source>Curr. Biol.</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>148</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-9822(06)00059-5</pub-id>
          <pub-id pub-id-type="pmid">9016703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <mixed-citation publication-type="other">Goloborodko, A. et al. mirnylab/distiller-nf: v0.3.3 10.5281/zenodo.3350937 (Zenodo, 2019).</mixed-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdennur</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mirny</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Cooler: scalable storage for Hi-C data and other genomically labeled arrays</article-title>
          <source>Bioinformatics</source>
          <year>2020</year>
          <volume>36</volume>
          <fpage>311</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btz540</pub-id>
          <pub-id pub-id-type="pmid">31290943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerpedjiev</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>HiGlass: web-based visual exploration and analysis of genome interaction maps</article-title>
          <source>Genome Biol.</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>125</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-018-1486-1</pub-id>
          <pub-id pub-id-type="pmid">30143029</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <mixed-citation publication-type="other">Venev, S. et al. mirnylab/cooltools: v0.3.2 10.5281/zenodo.3787004 (Zenodo, 2020).</mixed-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matthey-Doret</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Computer vision for pattern detection in chromosome contact maps</article-title>
          <source>Nat. Commun.</source>
          <year>2020</year>
          <volume>11</volume>
          <fpage>5795</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-020-19562-7</pub-id>
          <pub-id pub-id-type="pmid">33199682</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flyamer</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Illingworth</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Bickmore</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>Coolpup.py: versatile pile-up analysis of Hi-C data</article-title>
          <source>Bioinformatics</source>
          <year>2020</year>
          <volume>36</volume>
          <fpage>2980</fpage>
          <lpage>2985</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa073</pub-id>
          <pub-id pub-id-type="pmid">32003791</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>SSP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cohesin loss eliminates all loop domains</article-title>
          <source>Cell</source>
          <year>2017</year>
          <volume>171</volume>
          <fpage>305</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2017.09.026</pub-id>
          <pub-id pub-id-type="pmid">28985562</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roayaei Ardakany</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gezer</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Lonardi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ay</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Mustache: multi-scale detection of chromatin loops from Hi-C and Micro-C maps using scale-space representation</article-title>
          <source>Genome Biol.</source>
          <year>2020</year>
          <volume>21</volume>
          <fpage>256</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-020-02167-0</pub-id>
          <pub-id pub-id-type="pmid">32998764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boom</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rapid and simple method for purification of nucleic acids</article-title>
          <source>J. Clin. Microbiol.</source>
          <year>1990</year>
          <volume>28</volume>
          <fpage>495</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="doi">10.1128/jcm.28.3.495-503.1990</pub-id>
          <pub-id pub-id-type="pmid">1691208</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bray</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Melsted</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pachter</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Near-optimal probabilistic RNA-seq quantification</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2016</year>
          <volume>34</volume>
          <fpage>525</fpage>
          <lpage>527</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.3519</pub-id>
          <pub-id pub-id-type="pmid">27043002</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L&#xEA;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Josse</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Husson</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>FactoMineR: an R package for multivariate analysis</article-title>
          <source>J. Stat. Soft.</source>
          <year>2008</year>
          <volume>25</volume>
          <fpage>1</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.18637/jss.v025.i01</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <mixed-citation publication-type="other">Warnes, G. R. et al. gplots: various R programming tools for plotting data. R version 3.0. 1 <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=gplots">https://CRAN.R-project.org/package=gplots</ext-link> (2016).</mixed-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frigola</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Remus</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mehanna</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Diffley</surname>
              <given-names>JFX</given-names>
            </name>
          </person-group>
          <article-title>ATPase-dependent quality control of DNA replication origin licensing</article-title>
          <source>Nature</source>
          <year>2013</year>
          <volume>495</volume>
          <fpage>339</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="doi">10.1038/nature11920</pub-id>
          <pub-id pub-id-type="pmid">23474987</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Golan</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Site-specific protein labeling by Sfp phosphopantetheinyl transferase</article-title>
          <source>Nat. Protoc.</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>280</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2006.43</pub-id>
          <pub-id pub-id-type="pmid">17406245</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laughery</surname>
              <given-names>MF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New vectors for simple and streamlined CRISPR&#x2013;Cas9 genome editing in <italic>Saccharomyces cerevisiae</italic>: vectors for simple CRISPR&#x2013;Cas9 genome editing in yeast</article-title>
          <source>Yeast</source>
          <year>2015</year>
          <volume>32</volume>
          <fpage>711</fpage>
          <lpage>720</lpage>
          <pub-id pub-id-type="doi">10.1002/yea.3098</pub-id>
          <pub-id pub-id-type="pmid">26305040</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Design and construction of a multiwavelength, micromirror total internal reflectance fluorescence microscope</article-title>
          <source>Nat. Protoc.</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>2317</fpage>
          <lpage>2328</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2014.155</pub-id>
          <pub-id pub-id-type="pmid">25188633</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edelstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amodaj</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hoover</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vale</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stuurman</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Computer control of microscopes using &#xB5;Manager</article-title>
          <source>Curr. Protoc. Mol. Biol.</source>
          <year>2010</year>
          <volume>92</volume>
          <fpage>14.20.1</fpage>
          <lpage>14.20.17</lpage>
          <pub-id pub-id-type="doi">10.1002/0471142727.mb1420s92</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davidson</surname>
              <given-names>IF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rapid movement and transcriptional re-localization of human cohesin on DNA</article-title>
          <source>EMBO J.</source>
          <year>2016</year>
          <volume>35</volume>
          <fpage>2671</fpage>
          <lpage>2685</lpage>
          <pub-id pub-id-type="doi">10.15252/embj.201695402</pub-id>
          <pub-id pub-id-type="pmid">27799150</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aitken</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Puglisi</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>An oxygen scavenging system for improvement of dye stability in single-molecule fluorescence experiments</article-title>
          <source>Biophys. J.</source>
          <year>2008</year>
          <volume>94</volume>
          <fpage>1826</fpage>
          <lpage>1835</lpage>
          <pub-id pub-id-type="doi">10.1529/biophysj.107.117689</pub-id>
          <pub-id pub-id-type="pmid">17921203</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <mixed-citation publication-type="other">Huisjes, N. M. et al. Mars, a molecule archive suite for reproducible analysis and reporting of single molecule properties from bioimages. Preprint at <italic>bioRxiv</italic>10.1101/2021.11.26.470105 (2021).</mixed-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>van Oijen</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Duderstadt</surname>
              <given-names>KE</given-names>
            </name>
          </person-group>
          <article-title>Detection of kinetic change points in piece-wise linear single molecule motion</article-title>
          <source>J. Chem. Phys.</source>
          <year>2018</year>
          <volume>148</volume>
          <fpage>123317</fpage>
          <pub-id pub-id-type="doi">10.1063/1.5009387</pub-id>
          <pub-id pub-id-type="pmid">29604840</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banigan</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Mirny</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Loop extrusion: theory meets single-molecule experiments</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <year>2020</year>
          <volume>64</volume>
          <fpage>124</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2020.04.011</pub-id>
          <pub-id pub-id-type="pmid">32534241</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kulak</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Pichler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Paron</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nagaraj</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells</article-title>
          <source>Nat. Meth.</source>
          <year>2014</year>
          <volume>11</volume>
          <fpage>319</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.2834</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimitrova</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Todorov</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Melendy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Mcm2, but not Rpa, is a component of the mammalian early G1-phase prereplication complex</article-title>
          <source>J. Cell Biol.</source>
          <year>1999</year>
          <volume>146</volume>
          <fpage>709</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.146.4.709</pub-id>
          <pub-id pub-id-type="pmid">10459007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landry</surname>
              <given-names>JJM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The genomic and transcriptomic landscape of a HeLa cell line</article-title>
          <source>G3</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>1213</fpage>
          <lpage>1224</lpage>
          <pub-id pub-id-type="doi">10.1534/g3.113.005777</pub-id>
          <pub-id pub-id-type="pmid">23550136</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35140405</article-id>
      <article-id pub-id-type="pmc">8971130</article-id>
      <article-id pub-id-type="publisher-id">4410</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-022-04410-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Early prediction of preeclampsia in pregnancy with cell-free RNA</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8953-4057</contrib-id>
          <name>
            <surname>Moufarrej</surname>
            <given-names>Mira N.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0418-5260</contrib-id>
          <name>
            <surname>Vorperian</surname>
            <given-names>Sevahn K.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1205-6936</contrib-id>
          <name>
            <surname>Wong</surname>
            <given-names>Ronald J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campos</surname>
            <given-names>Ana A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Quaintance</surname>
            <given-names>Cecele C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sit</surname>
            <given-names>Rene V.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>Michelle</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Detweiler</surname>
            <given-names>Angela M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mekonen</surname>
            <given-names>Honey</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7141-5420</contrib-id>
          <name>
            <surname>Neff</surname>
            <given-names>Norma F.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baruch-Gravett</surname>
            <given-names>Courtney</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0570-0308</contrib-id>
          <name>
            <surname>Litch</surname>
            <given-names>James A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Druzin</surname>
            <given-names>Maurice L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1136-2907</contrib-id>
          <name>
            <surname>Winn</surname>
            <given-names>Virginia D.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shaw</surname>
            <given-names>Gary M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stevenson</surname>
            <given-names>David K.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1613-0809</contrib-id>
          <name>
            <surname>Quake</surname>
            <given-names>Stephen R.</given-names>
          </name>
          <address>
            <email>steve@quake-lab.org</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Bioengineering, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>ChEM-H and Department of Chemical Engineering, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Pediatrics, </institution><institution>Stanford University School of Medicine, </institution></institution-wrap>Stanford, CA USA </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.499295.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 9234 0175</institution-id><institution>Chan Zuckerberg Biohub, </institution></institution-wrap>San Francisco, CA USA </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.507550.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 8512 7499</institution-id><institution>Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), </institution></institution-wrap>Lynnwood, WA USA </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Obstetrics and Gynecology, </institution><institution>Stanford University School of Medicine, </institution></institution-wrap>Stanford, CA USA </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution>Department of Applied Physics, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>2</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>9</day>
        <month>2</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2022</year>
      </pub-date>
      <volume>602</volume>
      <issue>7898</issue>
      <fpage>689</fpage>
      <lpage>694</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>1</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Liquid biopsies that measure circulating cell-free RNA (cfRNA) offer an opportunity to study the development of pregnancy-related complications in a non-invasive manner and to bridge gaps in clinical care<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref></sup>. Here we used 404 blood samples from 199 pregnant mothers to identify and validate cfRNA transcriptomic changes that are associated with preeclampsia, a multi-organ syndrome that is the second largest cause of maternal death globally<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. We find that changes in cfRNA gene expression between normotensive and preeclamptic mothers are marked and stable early in gestation, well before the onset of symptoms. These changes are enriched for genes specific to neuromuscular, endothelial and immune cell types and tissues that reflect key aspects of preeclampsia physiology<sup><xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref></sup>, suggest new hypotheses for disease progression and correlate with maternal organ health. This enabled the identification and independent validation of a panel of 18 genes that when measured between 5 and 16 weeks of gestation can form the basis of a liquid biopsy test that would identify mothers at risk of preeclampsia long before clinical symptoms manifest themselves. Tests based on these observations could help predict and manage who is at risk for preeclampsia&#x2014;an important objective for obstetric care<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Analyses of circulating cell-free RNA (cfRNA) in blood samples from pregnant mothers identify changes in gene expression that could be used in liquid biopsy tests to identify and monitor individuals who are at risk of preeclampsia.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Gene expression profiling</kwd>
        <kwd>Machine learning</kwd>
        <kwd>Predictive medicine</kwd>
        <kwd>Predictive markers</kwd>
        <kwd>Personalized medicine</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s), under exclusive licence to Springer Nature Limited 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Main</title>
      <p id="Par3">Advances in obstetrics and neonatology have substantially mitigated many of the adverse pregnancy outcomes related to preterm birth and preeclampsia<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Nonetheless, the standard of care implemented today focuses on how to treat a mother and child once a complication has been diagnosed, which proves both insufficient and costly<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>: Preeclampsia and related hypertensive disorders cause 14% of maternal deaths each year globally, second only to haemorrhage<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, and cost nearly US$2&#x2009;billion in care in the first year following delivery<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Worse, three out of five maternal deaths in the USA are preventable and often associated with a missed or delayed diagnosis<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Such outcomes highlight the need for tools that would aid in identifying which mothers are at risk for preeclampsia before clinical presentation<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>.</p>
      <p id="Par4">Formally defined as new-onset hypertension with proteinuria or other organ damage (for example, renal,&#xA0;liver or brain) occurring after 20 weeks of gestation<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, preeclampsia can clinically manifest anytime thereafter, including into the post-partum period<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. So far, no recommended test exists that can predict the future onset of preeclampsia early in pregnancy<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Liquid biopsies that measure plasma cfRNA suggest a means to achieve this<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>; there have been promising results both in the confirmation of preeclampsia at clinical diagnosis<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup> and earlier in pregnancy<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. The prediction of preeclampsia early in gestation, before symptoms present, could guide the prophylactic use of potential therapeutic agents<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> such as low-dose aspirin<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p>
      <p id="Par5">Preeclampsia is specific to humans<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and a few non-human primates<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, and consequently, elucidating its pathogenesis has proven challenging. Broadly, it is accepted that preeclampsia occurs in two stages&#x2014;abnormal placentation early in pregnancy followed by systemic endothelial dysfunction<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. Preeclampsia can present with a diversity of symptoms and efforts to subclassify the disease on the basis of the timing of onset<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> have had mixed success<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. Separate efforts have focused on subtyping preeclampsia molecularly using placental gene expression and histology<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. As cfRNA is derived from many tissues in the body<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>, liquid biopsies present a potential means to indirectly observe pathogenesis in real time and to identify physiological changes associated with preeclampsia for proposed subtypes.</p>
      <p id="Par6">Here we report that cfRNA transcriptomic changes can distinguish between normotensive and preeclampsia pregnancies throughout the course of pregnancy, irrespective of preeclampsia subtype. The majority of these cfRNA changes are most marked early in pregnancy&#x2014;well before the onset of symptoms. Neuromuscular, endothelial and immune cell types and tissues contribute to these cfRNA changes, consistent with important aspects of the pathogenesis of preeclampsia and also suggesting new approaches to stratify the disease. These observations enabled us to identify and independently validate a panel of 18 genes that when measured between 5 and 16 weeks of gestation form a predictive signature of preeclampsia risk. cfRNA measurements also reflect the multifactorial nature of preeclampsia and provide a means to monitor maternal organ health in a non-invasive manner. Together, these results show that cfRNA measurements can form the basis for clinically relevant tests that would predict preeclampsia months before presentation, manage who is at risk for specific organ damage and help to characterize the pathogenesis of preeclampsia in real time.</p>
      <sec id="Sec2">
        <title>Clinical study design</title>
        <p id="Par7">To identify changes associated with preeclampsia well before traditional diagnosis, we designed a prospective study and recruited pregnant mothers at their first clinical visit to Stanford&#x2019;s Lucile Packard Children&#x2019;s Hospital. For each participant, we analysed cfRNA for samples collected before or at 12 weeks, between 13 and 20 weeks, at or after 23 weeks of gestation and post-partum. We then split this larger group into discovery (<italic>n</italic>&#x2009;=&#x2009;73, (49 normotensive, 24 with preeclampsia)) and validation 1 (<italic>n</italic>&#x2009;=&#x2009;39, (32 normotensive, 7 with preeclampsia)) cohorts. We also obtained samples from an independent cohort of 87 mothers (validation 2); these samples were collected at several separate institutions before 16 weeks of gestation (61 normotensive, 26 with preeclampsia) (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Comparing sample, maternal and pregnancy characteristics for normotensive and preeclampsia groups across cohorts.</title><p><bold>a</bold>, Matched sample collection time both across gestation (left) and after delivery (right). <bold>b</bold>, Maternal characteristics (<italic>P</italic>&#x2009;=&#x2009;0.02 comparing BMI in the discovery cohort). <bold>c</bold>, Matched gestational age at preeclampsia onset regardless of preeclampsia symptom severity. <bold>d</bold>, Gestational age at delivery (<italic>P</italic>&#x2009;=&#x2009;6&#x2009;&#xD7;&#x2009;10<sup>&#x2212;7</sup>, 0.04, 8&#x2009;&#xD7;&#x2009;10<sup>&#x2212;9</sup>) for the discovery (<italic>n</italic>&#x2009;=&#x2009;49 normotensive [37, 36, 39, 30]; <italic>n</italic>&#x2009;=&#x2009;24 with preeclampsia [13, 17, 20, 17]), validation 1 (<italic>n</italic>&#x2009;=&#x2009;32 normotensive [19, 27, 19, 19]; <italic>n</italic>&#x2009;=&#x2009;7 with preeclampsia [3, 8, 6, 5]) and validation 2 (<italic>n</italic>&#x2009;=&#x2009;61 normotensive [61]; 26 with preeclampsia [28]) cohorts. Square brackets indicate the sample number per collection group. For <bold>a</bold>, statistics were calculated by sample group. For <bold>b</bold>&#x2013;<bold>d</bold>, statistics were calculated by cohort group (NS&#x2009;=&#x2009;not significant, *<italic>P</italic>&#x2009;&lt;&#x2009;0.05, **<italic>P</italic>&#x2009;&#x2264;&#x2009;10<sup>&#x2212;7</sup>; two-sided (<bold>a</bold>&#x2013;<bold>c</bold>) and one-sided (<bold>d</bold>) Mann&#x2013;Whitney rank test).</p></caption><graphic xlink:href="41586_2022_4410_Fig1_HTML" id="d32e684"/></fig></p>
        <p id="Par8">All cohorts included individuals of diverse racial and ethnic backgrounds in approximately matched proportions across normotensive and preeclampsia groups (Extended Data Table <xref rid="Tab1" ref-type="table">1</xref>). A pregnancy was considered to be normotensive if it was both uncomplicated and went to full-term (37 or more weeks), or as preeclampsia with or without severe features on the basis of current guidelines (see&#xA0;<xref rid="Sec9" ref-type="sec">Methods</xref>). For mothers who developed preeclampsia, all antenatal blood samples were collected before diagnosis. Our final analysis included a subset of those samples that passed predefined quality metrics (Extended Data Fig. <xref rid="Fig5" ref-type="fig">1</xref>, Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>, Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="Sec9" ref-type="sec">Methods</xref>).</p>
        <p id="Par9">Across gestational time points in all cohorts, we found no significant difference in sampling time between preeclampsia and normotensive groups (<italic>P</italic>&#x2009;&#x2265;&#x2009;0.26, 0.11, 0.46) (values are reported as discovery, validation 1, validation 2; two-sided Mann&#x2013;Whitney rank test unless otherwise specified). Known risk factors for preeclampsia, such as pre-pregnancy maternal body mass index (BMI), maternal age and gravidity followed expected trends. BMI was significantly different between preeclampsia and normotensive groups in the discovery cohort alone (<italic>P</italic>&#x2009;=&#x2009;0.02, 0.45, not&#xA0;available), whereas maternal age and gravidity were not (<italic>P</italic>&#x2009;&#x2265;&#x2009;0.29, 0.16, 0.2) (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>, Extended Data Table <xref rid="Tab1" ref-type="table">1</xref>). In validation 2, history of preterm birth and mode of delivery were significantly different between normotensive and preeclampsia groups. Other demographic factors such as race, ethnicity and nulliparity differed across cohorts but not between case groups within each cohort (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05, two-sided chi-squared test for categorical or ANOVA for continuous variables with Bonferroni correction; Extended Data Table <xref rid="Tab1" ref-type="table">1</xref>, Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>).</p>
        <p id="Par10">In mothers who later developed preeclampsia, we observed no significant difference (<italic>P</italic>&#x2009;=&#x2009;0.14, 1.0, 0.4) in gestational age at onset between those who did not experience severe symptoms (<italic>n</italic>&#x2009;=&#x2009;11, 4, 3*) and those who did experience severe symptoms (<italic>n</italic>&#x2009;=&#x2009;13, 3, 13*) (*denotes incomplete data for the specified cohort) (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). Furthermore, 21 mothers who developed preeclampsia also delivered preterm (<italic>n</italic>&#x2009;=&#x2009;9, 1, 11) as compared with no mothers in the normotensive group; this was reflected by significantly different gestational ages at delivery (<italic>P</italic>&#x2009;=&#x2009;10<sup>&#x2212;7</sup>, 0.04, 10<sup>&#x2212;9</sup>; one-sided Mann-Whitney rank&#xA0;test) (Fig. <xref rid="Fig1" ref-type="fig">1d</xref>) and lower fetal weight at delivery (Extended Data Table <xref rid="Tab1" ref-type="table">1</xref>), which is consistent with epidemiological evidence that preeclampsia increases the risk of spontaneous or indicated preterm delivery<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>.</p>
      </sec>
      <sec id="Sec3">
        <title>Identifying preeclampsia-related cfRNA changes</title>
        <p id="Par11">A total of 544 differentially expressed genes (DEGs) were altered across gestation and post-partum between mothers who later developed preeclampsia with or without severe features and normotensive mothers who did not experience complications (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05; see&#xA0;<xref rid="Sec9" ref-type="sec">Methods</xref>). Most DEGs were annotated as protein-coding and a small fraction (43; 8%) were other types, including 11 mitochondrial transfer RNAs, 6 long non-coding RNAs, 8 pseudogenes and 1 small nucleolar RNA (snoRNA). These changes in gene expression occurred most notably before 20 weeks of gestation, as indicated by a clear bimodal distribution with two peaks centred around a log<sub>2</sub>-transformed fold change (log&#xFEFF;<sub>2</sub>(FC)) of +0.8 and &#x2212;0.6 (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). Changes in gene expression were also most stable before 20 weeks of gestation, at which point over 50% of genes had a coefficient of variation (CV)&#x2009;&lt;&#x2009;1 as compared to 31% of genes at or after 23 weeks of gestation and 36% at post-partum (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2a</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Before 20 weeks of gestation, cfRNA measurements segregate preeclampsia and normotensive samples and are enriched for neuromuscular, endothelial and immune cell types and tissues.</title><p><bold>a</bold>, Distribution of log&#xFEFF;<sub>2</sub>(FC) for DEGs (<italic>n</italic>&#x2009;=&#x2009;544) with dashed lines at log&#xFEFF;<sub>2</sub>(FC)&#x2009;=&#x2009;&#xB1;1. <bold>b</bold>, Before 20 weeks of gestation, a subset of DEGs can separate &#xFEFF;preeclampsia (PE) and normotensive samples despite differences in symptom severity, preeclampsia onset subtype and gestational age (GA) at delivery. <italic>HIST2H2BE</italic> is also known as <italic>H2BC21</italic>.&#xA0;See Supplementary Table <xref rid="MOESM3" ref-type="media">3</xref> for more information&#xA0;on genes included in heatmaps. <bold>c</bold>, Comparison of log&#xFEFF;<sub>2</sub>(FC) for DEGs between the discovery and the validation 2 cohorts reveals strong agreement. <bold>d</bold>, DEGs for preeclampsia as compared to normotensive samples can be described as either increased (orange) or decreased (dark blue) in preeclampsia over gestation. Points indicate median per trend and shaded region indicates 95% CI. <bold>e</bold>, Approximately 13% of DEGs are tissue- or cell-type-specific when compared with the Human Protein Atlas (HPA) and an augmented Tabula Sapiens (TSP+) atlas.</p></caption><graphic xlink:href="41586_2022_4410_Fig2_HTML" id="d32e843"/></fig></p>
        <p id="Par12">We then asked whether a subset of genes approximately proportional in number to the total sample number (<italic>n</italic>&#x2009;=&#x2009;49, 49, 57, 46 for 12 weeks or less, 13&#x2013;20 weeks, 23 weeks or more of gestation, and post-partum, respectively) was sufficient to segregate preeclampsia (<italic>n</italic>&#x2009;=&#x2009;13, 16, 20, 17) and normotensive (<italic>n</italic>&#x2009;=&#x2009;36, 33, 37, 29) samples across gestation. We found that 24&#x2013;32 genes were sufficient to separate preeclampsia and normotensive samples across gestation and at post-partum with good specificity (86% [75&#x2013;93%], 79% [66&#x2013;88%], 97% [90&#x2013;100%] and 90% [78&#x2013;96%]) and sensitivity (85% [64&#x2013;95%], 88% [69&#x2013;96%], 65% [47&#x2013;80%] and 71% [51&#x2013;86%]) (values in square brackets are 90% confidence intervals (CI); Fig. <xref rid="Fig2" ref-type="fig">2b</xref>, Extended Data Fig. <xref rid="Fig6" ref-type="fig">2b</xref>). See also Extended Data Fig. <xref rid="Fig7" ref-type="fig">3</xref>, Supplementary Table <xref rid="MOESM3" ref-type="media">3</xref>.</p>
        <p id="Par13">Nearly all 544 DEG changes showed strong agreement in both validation cohorts as compared to the discovery cohort across gestation but not post-partum. Specifically, more than 82% and 92% of genes across gestation had the same log&#xFEFF;<sub>2</sub>(FC) sign, with a Spearman correlation of at least 0.67 and 0.71 for validation 1 and validation 2 respectively (<italic>P</italic>&#x2009;&lt;&#x2009;10<sup>&#x2212;15</sup>; two-sided <italic>t</italic>-test) as compared with 60% and 0.35 post-partum (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>, Extended Data Fig. <xref rid="Fig6" ref-type="fig">2c</xref>). Finally, we asked whether symptom severity correlated with &#xFEFF;log<sub>2</sub>(FC) magnitude for these 544 DEGs common to both preeclampsia subtypes. We found that on average, symptom severity did not influence &#xFEFF;log<sub>2</sub>(FC) magnitude as reflected by a slope of nearly one across gestation (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2e</xref>).</p>
      </sec>
      <sec id="Sec4">
        <title>cfRNA changes reflect preeclampsia pathophysiology</title>
        <p id="Par14">The 544 identified DEGs could be well categorized into two longitudinal trends (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>, Extended Data Fig. <xref rid="Fig8" ref-type="fig">4a, c</xref>). Resembling a V shape, the first trend (group 1) described the longitudinal behaviour of 216 genes (40%), for which measured levels were reduced in preeclampsia samples (&#x2212;1.3&#xD7; to &#x2212;1.5&#xD7;) across gestation with a minimum between 13 and 20 weeks. Peaking in early gestation before 20 weeks (1.75&#xD7;), the second trend (group 2) described the behaviour of 328 genes (60%) that had significantly increased levels in preeclampsia samples before 20 weeks and to a lesser extent after 23 weeks of gestation (1.3&#xD7;). For group 1 but not group 2, gene changes were far less evident post-partum and trended towards no difference between preeclampsia and normotensive, which may reflect a placental contribution. DEGs were also enriched for genes previously implicated in preeclampsia<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> broadly (30 gene overlap, <italic>P</italic>&#x2009;=&#x2009;0.006; one-sided hypergeometric test) and more specifically through placental biopsies<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup> (two of nine previously identified genes overlap, <italic>PIK3CB</italic>, <italic>TAP1</italic>) (Extended Data Table <xref rid="Tab2" ref-type="table">2</xref>).</p>
        <p id="Par15">Approximately 13% of DEGs were tissue- or cell-type-specific (Fig. <xref rid="Fig2" ref-type="fig">2e</xref>). Genes that were decreased in preeclampsia across gestation (group 1) were broadly enriched for the immune system, whereas those genes increased in preeclampsia across gestation (group 2) were enriched for nervous, muscular, endothelial and immune contributions as reflected by cell type and pathway enrichment (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05; one-sided hypergeometric test with multiple hypothesis correction, see&#xA0;<xref rid="Sec9" ref-type="sec">Methods</xref>) (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2e</xref>, Extended Data Table <xref rid="Tab2" ref-type="table">2</xref>, <xref rid="MOESM4" ref-type="media">Supplementary Table 4</xref>). Consistent with the known pathogenesis of preeclampsia, we identified a strong endothelial-linked signal underscored by contributions from capillary aerocytes (<italic>P</italic>&#x2009;=&#x2009;0.03), an endothelial cell type specific to the lungs<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, platelets (<italic>P</italic>&#x2009;=&#x2009;10<sup>&#x2212;33</sup>) and several platelet-related pathways like platelet degranulation (<italic>P</italic>&#x2009;=&#x2009;10<sup>&#x2212;9</sup>) and platelet activation, signalling and aggregation (<italic>P</italic>&#x2009;=&#x2009;10<sup>&#x2212;8</sup>) among others. We also identified a small, borderline-significant placental contribution (<italic>P</italic>&#x2009;=&#x2009;0.16) from two genes (<italic>IGF2</italic>, <italic>TGM2</italic>) in group 1 with established roles in trophoblast development<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
        <p id="Par16">We found increased nervous and muscular contributions for preeclampsia as emphasized by contributions from excitatory neurons (<italic>P</italic>&#x2009;=&#x2009;0.02), oligodendrocytes (<italic>P</italic>&#x2009;=&#x2009;0.005) and smooth muscle (<italic>P</italic>&#x2009;=&#x2009;0.0003), and terms like muscle contraction&#xFEFF;&#xA0;(<italic>P</italic>&#xA0;= 0.02) and dilated cardiomyopathy (<italic>P</italic>&#x2009;=&#x2009;0.01). The immune system also contributes to both increased (for example, mesenchymal stem cells, total peripheral blood mononuclear cells) and decreased (granulocytes, T cells) changes across gestation. Genes in both groups were enriched for signalling pathways (that is, secretion by cell, integrin-mediated signalling pathway, regulation of I&#x3BA;B kinase, NF-&#x3BA;B signalling). Group 2 was also enriched for cellular compartments such as the cell periphery, cell junctions and extracellular space, consistent with reports that preeclampsia may be associated with signalling from the fetoplacental complex<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p>
      </sec>
      <sec id="Sec5">
        <title>Risk prediction early in gestation</title>
        <p id="Par17">As gene expression changes associated with preeclampsia pathogenesis across gestation were readily detected irrespective of symptom severity, we sought to build a classifier that could identify mothers at risk of preeclampsia at or before 16 weeks of gestation (Extended Data Fig. <xref rid="Fig6" ref-type="fig">2e</xref>, Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>). We trained a logistic regression model on the discovery cohort (<italic>n</italic>&#x2009;=&#x2009;61 normotensive, 24 with preeclampsia). After training, the final model performed well, with a near-perfect area under the receiver operating characteristic curve (AUROC) (0.99 [0.99&#x2013;0.99]), good specificity (85% [77&#x2013;91%]) and perfect sensitivity (100% [92&#x2013;100%]) (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>, Extended Data Table <xref rid="Tab3" ref-type="table">3</xref>). We then tested this model on validation 1 (<italic>n</italic>&#x2009;=&#x2009;35 normotensive, 8 preeclampsia) and two other independent cohorts, which were collected at separate institutions: validation 2 (<italic>n</italic>&#x2009;=&#x2009;61 normotensive, 28 preeclampsia) and the cohort used by Del Vecchio and colleagues<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> (<italic>n</italic>&#x2009;=&#x2009;8 normotensive, 5 with preeclampsia, 7 with gestational diabetes, 2 with chronic hypertension). Across these cohorts, the final model once again performed well, with consistent AUROC&#xFEFF; (0.71 [0.70&#x2013;0.72], 0.72 [0.71&#x2013;0.72], 0.74 [0.73&#x2013;0.75]), sensitivity (75% [46&#x2013;92%], 56% [42&#x2013;72%], 60% [26&#x2013;87%]) and specificity (56% [43&#x2013;70%], 69% [59&#x2013;78%], 100% [89&#x2013;100%]) (all reported as validation 1, validation 2, Del Vecchio, value [90% CI]) (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>, Extended Data Table <xref rid="Tab3" ref-type="table">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>A subset of cfRNA changes can predict risk of preeclampsia early in gestation.</title><p><bold>a</bold>, Classifier performance as quantified by receiver operator characteristic curve (ROC) for samples collected in early gestation between 5 and 16 weeks, with AUROC and corresponding 90% CI noted per cohort. <bold>b</bold>, Prediction of preeclampsia incorporates cfRNA levels for 18 genes for which normalized centred log<sub>2</sub>(FC) trends hold across the discovery (<italic>n</italic>&#x2009;=&#x2009;61 normotensive, 24 preeclampsia), validation 1 (<italic>n</italic>&#x2009;=&#x2009;35 normotensive, 8 preeclampsia), validation 2 (<italic>n</italic>&#x2009;=&#x2009;61 normotensive, 28 preeclampsia) and Del Vecchio (<italic>n</italic>&#x2009;=&#x2009;17 normotensive or other complication, 5 preeclampsia) cohorts as confirmed using univariate analysis (*<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05, **<italic>P</italic>&#x2009;&#x2264;&#x2009;0.01, ***<italic>P</italic>&#x2009;&#x2264;&#x2009;0.005; one-sided Mann&#x2013;Whitney rank test with Benjamini&#x2013;Hochberg correction). See Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref> for exact <italic>P</italic> values. For box plots, centre line, box limits, whiskers and outliers represent the median, upper and lower quartiles, 1.5&#xD7; interquartile range and any outliers outside that distribution, respectively. Plot limits are &#x2212;8 to 4 to better visualize the main distribution. log<sub>2</sub>(CPM), log<sub>2</sub>-transformed counts per million reads.</p></caption><graphic xlink:href="41586_2022_4410_Fig3_HTML" id="d32e1113"/></fig></p>
        <p id="Par18">Misclassified individuals did not predominantly belong to one racial or ethnic group; rather, the fraction of misclassified individuals for each race and ethnicity matched the cohort distribution as a whole. Notably, this holds true even for a group not included in the discovery cohort (American Indian or Alaskan Native) which made up 23% of both case and control for the validation 2 cohort. For false negatives in validation 2 and Del Vecchio, we find a shift to later gestational ages at collection (13.5&#x2009;&#xB1;&#x2009;2, 12.5&#x2009;&#xB1;&#x2009;2 weeks) as compared to preeclampsia samples that were correctly classified (12&#x2009;&#xB1;&#x2009;2, 12&#x2009;&#xB1;&#x2009;0 weeks; mean&#x2009;&#xB1;&#x2009;s.d. for validation 2, Del Vecchio) (Extended Data Fig. <xref rid="Fig9" ref-type="fig">5a</xref>). This suggests that in practice, there may an optimal collection window to reduce false negatives. Indeed, if we only consider samples before 14 weeks of gestation, we observe a 9% and a 15% increase in sensitivity, with corresponding AUROC values of 0.73 and 0.90 for validation 2 and Del Vecchio, respectively. There were no false positives from the Del Vecchio cohort, suggesting that the model can distinguish between preeclampsia and other risks like chronic hypertension or gestational diabetes. The model also proved well-calibrated, estimating a slightly increased probability of preeclampsia for gestational diabetes (0.15&#x2009;&#xB1;&#x2009;0.08) and chronic hypertension (0.18&#x2009;&#xB1;&#x2009;0.13)&#x2014;known preeclampsia risk factors<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>&#x2014;as compared to the estimate for normotensive samples (0.1&#x2009;&#xB1;&#x2009;0.08) (mean&#x2009;&#xB1;&#x2009;s.d., Extended Data Fig. <xref rid="Fig9" ref-type="fig">5b</xref>). These increased probabilities for other risk factors affected the AUROC&#xFEFF; of the test (0.74 [0.73&#x2013;0.75] as compared to 0.8 [0.79&#x2013;0.81] for only preeclampsia versus normotensive samples, Extended Data Table <xref rid="Tab3" ref-type="table">3</xref>) (all reported as value [90% CI]).</p>
        <p id="Par19">Finally, we inspected the 18 genes (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>, Extended Data Table <xref rid="Tab4" ref-type="table">4</xref>) used by the model to yield probability estimates. Eight genes were annotated in the Human Protein Atlas (HPA, v.19)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> as enhanced or enriched in the placenta (<italic>TENT5A</italic> (also known as <italic>FAM46A</italic>) and <italic>MYLIP</italic>), neuromuscular (<italic>CAMK2G</italic>, <italic>NDUFV3</italic>, <italic>PI4KA</italic> and <italic>PRTFDC1</italic>) and immune system (<italic>RNF149</italic> and <italic>TRIM21</italic>). Univariate analysis further confirmed that nine of the gene trends (that is, decreased or increased gene levels in preeclampsia) observed in the discovery dataset are upheld in validation 2 (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05; one-sided Mann&#x2013;Whitney rank test with Benjamini&#x2013;Hochberg correction) (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>, Supplementary Table <xref rid="MOESM1" ref-type="media">5</xref>). We also found that most models trained using a subset of the 18 initial genes can predict future preeclampsia onset with varying performance. Notably, performance improved across all metrics (sensitivity, specificity and AUROC) as we increased the number of genes included for model training (Supplementary Table <xref rid="MOESM1" ref-type="media">6</xref>, Extended Data Fig. <xref rid="Fig9" ref-type="fig">5c</xref>).</p>
      </sec>
      <sec id="Sec6">
        <title>Preeclampsia as a multifactorial disease</title>
        <p id="Par20">By comparing mothers who later developed preeclampsia with or without severe symptoms, we identified 503 DEGs (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05). As there were no significant differences in symptom severity as related to the timing of preeclampsia onset (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>), we believe that our observations contrasting preeclampsia with and without severe symptoms are not obscured by differences in preeclampsia-onset type. DEGs could be well categorized into four longitudinal trends (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>, Extended Data Fig. <xref rid="Fig8" ref-type="fig">4b, d</xref>). Two groups (groups 1 and 3) described the temporal behaviour of 217 genes (44%), for which measured levels were either consistently increased (group 1) or reduced (group 3) in preeclampsia with as compared to without severe symptoms (&#xB1;1.8&#xD7;) across gestation and trended towards no change post-partum. By contrast, groups 2 and 4 (286 genes, 56%) changed signs in mid-gestation, beginning as slightly increased (group 2, 1.2&#xD7;) or decreased (group 4, &#x2212;1.2&#xD7;) in severe preeclampsia and then moving to decreased (group 2, &#x2212;1.4&#xD7;) or unchanged (Group 4, 1&#xD7;) at 23 weeks or more of gestation.<fig id="Fig4"><label>Fig. 4</label><caption><title>cfRNA measurements reflect the multifactorial nature and pathogenesis of preeclampsia over pregnancy before diagnosis.</title><p><bold>a</bold>, DEGs for preeclampsia with as compared to without severe features (<italic>n</italic>&#x2009;=&#x2009;503) can be described by four longitudinal trends. <bold>b</bold>, Comparison of organ and cell-type changes over gestation for eight organ systems reflects the multifactorial nature of preeclampsia and provides a possible means to comprehensively monitor maternal organ health. Points indicate median per sample group and shaded region indicates 95% CI in <bold>a</bold> and 75% CI in <bold>b</bold>. LSECs, liver sinusoidal endothelial cells; NK cells, natural killer cells.</p></caption><graphic xlink:href="41586_2022_4410_Fig4_HTML" id="d32e1229"/></fig></p>
        <p id="Par21">Analysis of the enriched cell types and tissues of origin for each of these groups revealed that increased gene differences in severe preeclampsia were driven by contributions from endothelial cells and the adaptive immune system (bone marrow). By contrast, genes that changed signs over gestation were enriched for innate immune cell types (for example, granulocytes and neutrophils for group 2, thymus for group 4) (Extended Data Table <xref rid="Tab5" ref-type="table">5</xref>). Quantifying the total cfRNA signal confirmed an increased bone marrow signal for only severe preeclampsia across gestation and a decreased granulocyte signal for only preeclampsia without severe features at 12 weeks or less of gestation (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). Functional enrichment analysis further revealed pathways specific to genes that were only decreased for severe preeclampsia in early gestation (group 4); for example, axon guidance, nervous development and metabolism of RNA (<italic>P</italic>&#x2009;&lt;&#x2009;0.05; one-sided hypergeometric test with multiple hypothesis correction; see&#xA0;<xref rid="Sec9" ref-type="sec">Methods</xref>).</p>
      </sec>
      <sec id="Sec7">
        <title>cfRNA reflects maternal organ health</title>
        <p id="Par22">We then investigated the possibility of monitoring organ health in a non-invasive&#xFEFF;&#xA0;manner. We focused on eight organ systems (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>) relevant to preeclampsia presentation with consequences such as proteinuria, impaired liver function, renal insufficiency and epilepsy. We found substantial shifts in total contributions for all systems. We observed an increased astrocyte signal before 20 weeks of gestation and decreased oligodendrocytes and excitatory neurons at 23 or more weeks of gestation for all preeclampsia relative to normotensive (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). Although placental contributions increased over pregnancy with a peak in late gestation as expected, placental tissue and syncytiotrophoblast contributions were reduced for preeclampsia pregnancies before 20 weeks of gestation. Finally, we observed a decreased signal in hepatocyte, kidney, endothelial cell and smooth muscle signatures across gestation and an increased platelet signal before 12 weeks of gestation for preeclampsia. These tissue- and cell-type-specific changes are consistent both with common preeclampsia pathogenesis and with the specific, prominent diagnoses in our cohort (for example, thrombocytopenia, proteinuria, impaired liver function and renal insufficiency).</p>
      </sec>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par23">Our findings provide molecular evidence that supports the present physiological understanding of preeclampsia pathogenesis: early abnormal placentation and systemic endothelial dysfunction<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Early in gestation, we observe a reduced placental signal for preeclampsia, regardless of onset type or symptom severity. Concurrently, platelets and endothelial cells drive changes in cfRNA in preeclampsia samples regardless of symptom severity&#xA0;as compared to normotensive samples and between individuals with preeclampsia with and without severe symptoms, especially before 20 weeks of gestation. Increases in cell-type-specific cfRNA may occur&#xFEFF; in part&#xA0;through signalling and secretion by cells, as underscored by functional enrichment analysis. The innate and adaptive immune system also heavily contribute to cfRNA changes in preeclampsia, with marked shifts related to bone marrow, T cells, B cells, granulocytes and neutrophils&#x2014;consistent with previous studies on the maternal&#x2013;placental interface and preeclampsia&#xFEFF;<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR36">36</xref>&#x2013;<xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>.</p>
      <p id="Par24">Given the diversity of clinical presentations in preeclampsia, we propose a non-invasive means of monitoring a mother&#x2019;s risk of specific organ damage. The cfRNA changes that we characterized here reflect dysfunction in at least five organ systems (brain, liver, kidney, muscle and bone marrow), and can in some cases further distinguish between preeclampsia with and without severe symptoms. As a molecular lens into maternal health, liquid biopsies present an opportunity both as a research and clinical tool to learn about the pathogenesis of a human disease in humans and as a predictor of maternal health. Here we have shown proof of principle that cfRNA measurements can form the basis for a robust liquid biopsy test, which predicts preeclampsia very early in gestation. If validated in controlled clinical studies of suitably large, racially and ethnically diverse populations, such tests could help to discover and manage individuals who are at risk for preeclampsia, complementing recent efforts based on clinical and laboratory data<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. We have also shown here that cfRNA measurements reflect who is at risk for specific organ damage. Together, these results form the basis for a series of clinical tests that can be used to help to characterize and stratify the pathogenesis of preeclampsia in real time, and thereby&#xA0;to meet key objectives for obstetric care.</p>
    </sec>
    <sec id="Sec9" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec10">
        <title>Clinical study design</title>
        <p id="Par25">The discovery and validation 1 cohorts were collected as part of a longitudinal, prospective study. We enrolled pregnant mothers (aged 18 years or older) receiving routine antenatal care on or before 12 weeks of gestation at Lucile Packard Children&#x2019;s Hospital at Stanford University, following study review and approval by the Institutional Review Board (IRB) at Stanford University (21956). All individuals signed informed consent before enrolment. Whole-blood samples for plasma isolation were then collected at three distinct time points during their pregnancy course and once (or twice for two individuals) post-&#xFEFF;partum.&#xA0;To split the&#xA0;larger Stanford cohort into Discovery and Validation 1, we first allocated samples using sequencing batches of which there were three. We allocated the sequencing batch with the most preeclampsia&#xA0;samples to Discovery to ensure sufficient statistical power and the second most preeclampsia&#xA0;samples to Validation 1. Sequencing batches themselves contained randomly allocated samples based on the individual&#xA0;such that all samples from the same individual&#xA0;were in the same batch. For the final sequencing batch, we randomly allocated individuals to either Discovery or Validation 1 such that all samples from 1 individual&#xA0;were part of the same group (either Discovery or Validation 1) and we maintained at least a 1&#x2013;2 case to control ratio in both groups.</p>
        <p id="Par26">The validation 2 cohort was collected as part of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) Pregnancy Biorepository at Yakima Valley Memorial Hospital, Swedish Medical Center and the University of Washington Medical Center under review and approval by Advarra IRB (CR00195799). Samples were processed and sequenced at Stanford under the same IRB as above (21956). All individuals signed informed consent before enrolment. Whole-blood samples for plasma isolation were collected at a single time point (or two time points in the case of two individuals with preeclampsia) before or at 16 weeks of gestation.</p>
        <p id="Par27">For all three cohorts&#xFEFF;, we chose a case to control ratio of approximately 1&#x2013;2 to increase statistical power. We also ensured that case and control groups were matched for race and ethnicity, and&#xA0;that all included individuals did not have chronic hypertension or gestational diabetes. No other matching or exclusion criterion were used; we performed no further sample selection prior to sample processing.&#xA0;Mothers were defined as having preeclampsia on the basis of current American College of Obstetrics and Gynecology (ACOG) guidelines (see below). Mothers were defined as controls if they had uncomplicated term pregnancies and either normal spontaneous vaginal or caesarean deliveries. For mothers who developed preeclampsia, all antenatal samples included in this study were collected before clinical diagnosis.</p>
        <p id="Par28">We processed samples from 88 individuals (60 normotensive, 28 with preeclampsia) in the discovery cohort, 43 individuals (34 normotensive, 9 with preeclampsia) in the validation 1 cohort and 87 individuals (61 normotensive, 26 with preeclampsia) in the validation 2 cohort. For some cohorts, only a subset of these individuals was included in the final analysis after filtering samples on the basis of pre-defined quality metrics (see &#x2018;Sample quality filtering&#x2019;, Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>, Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>)</p>
        <p id="Par29">We tested for within-cohort (normotensive versus preeclampsia) and across-cohort differences in demographic variables using a two-sided chi-squared test and ANOVA for categorical and continuous variables. respectively. We then applied Bonferroni correction and reported any differences as significant if &#xFEFF;adjusted <italic>P</italic>&#x2009;&#x2264;&#x2009;0.05.&#xA0;Investigators were blinded during data collection as pregnancy outcomes were not known yet. Investigators were not blinded during data analysis as analysis methods required knowledge of outcome (that is, supervised learning).</p>
      </sec>
      <sec id="Sec11">
        <title>Definition of preeclampsia</title>
        <p id="Par30">Preeclampsia was defined per the ACOG guidelines<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> on the basis of two diagnostic criteria: (1) new-onset hypertension developing on or after 20 weeks of gestation; and (2) new-onset proteinuria or in its absence, thrombocytopenia, impaired liver function, renal insufficiency, pulmonary oedema or cerebral or visual disturbances.</p>
        <p id="Par31">New-onset hypertension was defined when the systolic and/or diastolic blood were at least 140 or 90&#x2009;mmHg, respectively, on at least two separate occasions between four hours and one week apart. Proteinuria was defined when either 300&#x2009;mg protein was present within a 24-h urine collection or an individual urine sample contained a protein/creatinine ratio of 0.3&#x2009;mg&#x2009;dl<sup>&#x2212;1</sup>, or if these were not available, a random urine specimen had more than 1&#x2009;mg protein as measured by dipstick. Thrombocytopenia, impaired liver function and renal insufficiency were defined as a platelet count of less than 100,000 per &#xB5;l, liver transaminase levels two or more times higher than normal and serum creatinine level of higher than 1.1&#x2009;mg&#x2009;dl<sup>&#x2212;1</sup>, respectively.</p>
        <p id="Par32">Symptoms were defined as severe per the ACOG guidelines. Specifically, preeclampsia was defined as severe if any of the following symptoms were present and diagnosed as described above: new-onset hypertension with systolic and/or diastolic blood pressure of at least 160 and/or 110&#x2009;mmHg, respectively, thrombocytopenia, impaired liver function, renal insufficiency, pulmonary oedema, new-onset headache unresponsive to medication and unaccounted for otherwise or visual disturbances.</p>
        <p id="Par33">Finally, a pregnant mother was considered to have early-onset preeclampsia if onset occurred before 34 weeks of gestation and late onset thereafter.</p>
      </sec>
      <sec id="Sec12">
        <title>Sample preparation</title>
        <sec id="Sec13">
          <title>Plasma processing</title>
          <p id="Par34">At Lucile Packard Children&#x2019;s Hospital, blood samples were collected in either EDTA-coated (368661, Becton-Dickinson) or Streck cfRNA BCT (218976, Streck) tubes at &#x2264;12, 13&#x2013;20 and &#x2265;23 weeks of gestation, and post-partum for each participant. Within 30&#x2009;min, tubes were then centrifuged at 1,600<italic>g</italic> for 30&#x2009;min at room temperature. Plasma was transferred to 2-ml microfuge tubes and centrifuged at 13,000<italic>g</italic> for another 10&#x2009;min in a microfuge. One-millilitre aliquots were then transferred to 2-ml Sarstedt screw cap microtubes (50809242, Thermo Fisher Scientific) and stored at &#x2212;80&#x2009;&#xB0;C until analysis.</p>
          <p id="Par35">At GAPPS, blood samples were collected in EDTA-coated tubes at &#x2264;16 weeks of gestation from a network of collection sites. Per standard operating procedure, tubes were then centrifuged within 2&#x2009;h of collection at 2,500 rpm for 10&#x2009;min at room temperature in a swinging bucket rotor. Plasma was transferred to 2-ml cryovials in at most 1-ml aliquots and stored at &#x2212;80&#x2009;&#xB0;C until analysis. Sample volume was also recorded.</p>
        </sec>
        <sec id="Sec14">
          <title>cfRNA isolation</title>
          <p id="Par36">In 96-sample batches, cfRNA from 1-ml plasma samples was extracted in a semi-automated manner using the Opentrons 1.0 system and Norgen Plasma/Serum Circulating and Exosomal RNA Purification 96-Well Kit (Slurry Format) (29500, Norgen). Samples were subsequently treated with Baseline-ZERO DNAse (DB0715K, Lucigen) for 20&#x2009;min at 37&#x2009;&#xB0;C. DNAse-treated cfRNA was then cleaned and concentrated into 12&#x2009;&#xB5;l using Zymo RNA Clean and Concentrator-96 kits (R1080).</p>
          <p id="Par37">After cfRNA extraction from plasma samples, isolated RNA concentrations were estimated for a randomly selected 11 samples per batch using the Bioanalyzer RNA 6000 Pico Kit (5067-1513, Agilent) per the manufacturer&#x2019;s instructions.</p>
        </sec>
        <sec id="Sec15">
          <title>Sequencing library preparation</title>
          <p id="Par38">cfRNA sequencing libraries were prepared with the SMARTer Stranded Total RNAseq Kit v2 - Pico Input Mammalian Components (634419, Takara) from 4&#x2009;&#xB5;l of eluted cfRNA according to the manufacturer&#x2019;s instructions. Samples were barcoded using the SMARTer RNA Unique Dual Index Kit &#x2013; 96U Set A (634452, Takara), and then pooled in an equimolar manner and sequenced on Illumina&#x2019;s NovaSeq platform (2&#x2009;&#xD7;&#x2009;75 bp) to a mean depth of 54, 33 and 38&#x2009;million reads per sample for discovery, validation 1, and validation 2 cohorts, respectively. Some samples (12, 61 and 0 for discovery, validation 1 and validation 2 cohorts) were not sequenced owing to failed library preparation.</p>
        </sec>
      </sec>
      <sec id="Sec16">
        <title>Bioinformatic processing</title>
        <p id="Par39">For each sample, raw sequencing reads were trimmed using Trimmomatic (v.0.36) and then mapped to the human reference genome (hg38) with STAR (v.2.7.3a). Duplicate reads were then removed by GATK&#x2019;s (v.4.1.1) MarkDuplicates tool. Finally, mapped reads were sorted and quantified using htseq-count (v.0.11.1) generating a counts table (genes &#xD7; samples). Read statistics were estimated using FastQC (v.0.11.8).</p>
        <p id="Par40">Across samples, the bioinformatic pipeline was managed using Snakemake (v.5.8.1). Read and tool performance statistics were aggregated across samples and steps using MultiQC (v.1.7). After sample quality and gene filtering, all gene counts were adjusted to log<sub>2</sub>-transformed counts per million reads (CPM) with trimmed mean of M values (TMM) normalization<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>.</p>
      </sec>
      <sec id="Sec17">
        <title>Sample quality filtering</title>
        <p id="Par41">For every sequenced sample, we estimated three quality parameters as previously described<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>. To estimate RNA degradation in each sample, we first counted the number of reads per exon and then annotated each exon with its corresponding gene ID and exon number using htseq-count. Using these annotations, we measured the frequency of genes for which all reads mapped exclusively to the 3&#x2032;-most exon as compared to the total number of genes detected. RNA degradation for a given sample can then be approximated as the fraction of genes in which all reads mapped to the 3&#x2032;-most exon. To estimate the number of reads that mapped to genes, we summed counts for all genes per sample using the counts table generated from bioinformatic processing above. To estimate DNA contamination, we quantified the ratio of reads that mapped to intronic as compared to exonic regions of the genome.</p>
        <p id="Par42">After measuring these metrics across nearly 700 samples, we empirically estimated RNA degradation and DNA contamination&#x2019;s 95th percentile bound. We considered any given sample an outlier, low-quality sample if its value for at least one of these metrics was greater than or equal to the 95th percentile bound or if no reads were assigned to genes.</p>
        <p id="Par43">Once values for each metric were estimated across the entire dataset, we visualized: (1) whether low-quality samples clustered separately using hierarchical clustering (average linkage, Euclidean distance metric); and (2) whether sample quality drove variance in gene measurements using principal component analysis (PCA). These analyses were performed in Python (v.3.6) using Scikit-learn for PCA (v.0.23.2), Scipy for hierarchical clustering (v.1.5.1) and nheatmap for heat map and clustering visualization (v.0.1.4).</p>
        <p id="Par44">After confirming sample quality, 404 samples from 199 mothers (142 normotensive, 57 with preeclampsia) were included in the final analysis (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>). Specifically, 209, 106 and 89 samples from 73, 39 and 87 participants (49, 32 and 61 normotensive; 24, 7 and 26 with preeclampsia) were included in discovery, validation 1 and validation 2, respectively.</p>
      </sec>
      <sec id="Sec18">
        <title>Gene filtering</title>
        <p id="Par45">We performed filtering to identify well-detected genes across the entire cohort. Specifically, we used a basic cut-off that required a given gene be detected at a level of at least 0.5&#x2009;CPM in at least 75% of discovery samples after removing outlier samples. Following this step, we retain 7,160 genes for differential expression analysis.</p>
      </sec>
      <sec id="Sec19">
        <title>Differential expression analysis</title>
        <p id="Par46">Differential expression analysis was performed in R using Limma (v.3.38.3). To identify gene changes associated with preeclampsia across gestation and post-partum, we used a mixed-effects model. We performed differential expression analysis using two design matrices: (1) examine the interaction between time to preeclampsia onset or delivery for normotensive and preeclampsia symptoms (that is, preeclampsia with or without severe symptoms); and (2) examine the interaction between time to preeclampsia onset or delivery for normotensive and preeclampsia broadly. In both design matrices, we included time to preeclampsia onset or delivery for normotensive (continuous variable), whether a sample was collected post-partum (binary variable), the interaction between time and preeclampsia symptoms for (1) or preeclampsia for (2), the interaction between whether a sample is post-partum and preeclampsia symptoms for (1) and preeclampsia for (2), and 7&#x2013;8 confounding factors.</p>
        <p id="Par47">In (1), we defined preeclampsia symptoms categorially using three levels&#x2014;normotensive, preeclampsia without severe symptoms, preeclampsia with severe symptoms. In (2), we defined whether a sample was preeclampsia using a binary, indicator variable (0&#x2009;=&#x2009;normotensive, 1&#x2009;=&#x2009;preeclampsia). The 7&#x2013;8 confounding variables included were maternal race (categorical variable), maternal ethnicity (binary variable), fetal sex (binary variable), maternal pre-pregnancy BMI group (categorical variable), maternal age (continuous variable, only included in design 1), and sequencing batch (categorical variable). We defined time to preeclampsia onset or delivery as the difference between gestational age at onset or delivery and gestational age at sample collection. We defined BMI group as follows: obese (BMI&#x2009;&#x2265;&#x2009;30), overweight (25&#x2009;&#x2264;&#x2009;BMI&#x2009;&lt;&#x2009;30), healthy (18.5&#x2009;&#x2264;&#x2009;BMI&#x2009;&lt;&#x2009;25), underweight (BMI&#x2009;&lt;&#x2009;18.5). We chose to model time to preeclampsia onset or delivery as a continuous variable, specifically a natural cubic spline with four degrees of freedom to account for the range across which samples were collected (one to three months per collection period). We also blocked for participant identity (categorical variable), modelling it as a random effect to account for auto-correlation between samples from the same person.</p>
        <p id="Par48">Per the Limma-Voom guide, to account for sample auto-correlation over time, we ran the function voomWithQualityWeights twice. We first ran it without any blocking on participant identity, and used this base estimation to approximate sample auto-correlation on the basis of participant identity using the function duplicateCorrelation. After estimating correlation, voomWithQualityWeights was run again, this time blocking for participant identity and including the estimated auto-correlation level. A linear model was then fit for each gene using lmFit and differential expression statistics were approximated using Empirical Bayes (eBayes) methods. For comparing preeclampsia with versus without severe symptoms, we contrasted the relevant coefficients (makeContrasts) and then applied Empirical Bayes as opposed to directly after lmFit.</p>
        <p id="Par49">DEGs were then identified using the relevant design matrix coefficients with Benjamini&#x2013;Hochberg multiple hypothesis correction at a significance level of 0.05. For design 1, we identified DEGs related to three comparisons: preeclampsia without severe symptoms versus normotensive (1,759 DEGs); severe preeclampsia versus normotensive (1,198 DEGs); and preeclampsia with versus without severe symptoms (503 DEGs). We find 544 genes in common for preeclampsia without and with severe symptoms versus normotensive. These 544 DEGs are examined in Fig. <xref rid="Fig2" ref-type="fig">2</xref> and the related main text. For design 2, we identified DEGs related to preeclampsia versus normotensive alone (330 DEGs), which we used as the initial gene set for building a logistic regression model (see Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>). Finally, we removed the effect of sequencing batch on estimated logCPM values with TMM normalization for the discovery cohort using the limma-voom function, removeBatchEffect.</p>
      </sec>
      <sec id="Sec20">
        <title>log<sub>2</sub>-transformed fold change and CV estimation</title>
        <p id="Par50">We define log<sub>2</sub>-transformed fold-change (&#xFEFF;log<sub>2</sub>(FC)) as the difference between the median gene level (logCPM; see &#x2018;Bioinformatic processing&#x2019;) between preeclampsia and normotensive samples for a given sample collection period (that is, &#x2264;12, 13&#x2013;20 and &#x2265;23 weeks of gestation, or post-partum). In the case in which a given person had multiple samples included into a specific collection period, we only used the values associated with the first collected sample to avoid artificially reducing within-group (preeclampsia or normotensive) variance due to auto-correlation among samples from the same person.</p>
        <p id="Par51">We then quantified the relative dispersion around the estimated log&#xFEFF;<sub>2</sub>(FC) for each gene using an approximation for CV. Specifically, we consider CV to be the ratio between an error bound, &#x2202;, and the estimated log&#xFEFF;<sub>2</sub>(FC). We defined the error bound, &#x2202;, as the one-sided error bound associated with the lower (or upper in the case of negative &#xFEFF;log<sub>2</sub>(FC) values) 95% CI as estimated by bootstrapping. This definition of &#x2202; as a one-sided bound that approaches 0 (equivalent to no FC) allowed us to explore how confident we could be in an estimated &#xFEFF;log<sub>2</sub>(FC). For instance, a CV&#x2009;=&#x2009;1 would indicate that at the boundary of proposed values, the log&#xFEFF;<sub>2</sub>(FC) for a given gene becomes effectively 0. Similarly, a CV&#x2009;&gt;&#x2009;1 would indicate even less confidence in a proposed average &#xFEFF;log<sub>2</sub>(FC) and indicate that at the boundary, the estimated &#xFEFF;log<sub>2</sub>(FC) changes signs (that is, a negative &#xFEFF;log<sub>2</sub>(FC) becomes a positive one or vice versa).</p>
      </sec>
      <sec id="Sec21">
        <title>Hierarchical clustering analysis</title>
        <p id="Par52">For each sample collection period, hierarchical clustering was performed using DEGs with an |&#xFEFF;log<sub>2</sub>(FC)|&#x2009;&#x2265;&#x2009;1 and CV&#x2009;&lt;&#x2009;0.5 or 0.4 in the case of the 13&#x2013;20 weeks of gestation time point so that the number of genes used did not exceed the number of samples. For each gene that passed these thresholds, we calculated a <italic>z</italic>-score across all samples (at most 1 per individual, the earliest collected sample in a given group) in each sample collection period using the function StandardScaler in Scikit-learn (v.0.23.2), Average linkage hierarchical clustering with a Euclidean distance metric was then performed for both rows (gene <italic>z</italic>-scores) and columns (samples in same collection group) for a given matrix in Python using Scipy (v.1.5.1). Clustering and corresponding heat maps were visualized using nheatmap (v.0.1.4).</p>
      </sec>
      <sec id="Sec22">
        <title>Longitudinal dynamics analysis</title>
        <p id="Par53">To group gene changes by longitudinal behaviour, we performed <italic>k</italic>-means clustering on a matrix in which each row was a DEG and each column was the estimated &#xFEFF;log<sub>2</sub>(FC) for a given sample collection period (<italic>N</italic> genes &#xD7; 4 time points). We measured the sum of squared distances for every &#x2018;<italic>k</italic>&#x2019; between 1 and 16 (4<sup>2</sup>), in which 16 represents the maximum possible <italic>k</italic> (4 time points with 2 possibilities each, &#xFEFF;log<sub>2</sub>(FC)&#x2009;&gt;&#x2009;0 or &#xFEFF;log<sub>2</sub>(FC)&#x2009;&lt;&#x2009;0). We then identified the optimal <italic>k</italic> clusters by using the well-established elbow method to identify the smallest &#x2018;<italic>k</italic>&#x2019; that best explained the data, visually described as the elbow (or knee) of a convex plot like that for the sum of squared distances versus <italic>k</italic> (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4a, c</xref>). To do so, we either visually inspected and identified the elbow (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>) or used the function KneeLocator as implemented in the package Kneed (v.0.7.0) (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>). We used visual inspection for Fig. <xref rid="Fig2" ref-type="fig">2d</xref> as we observed that given two <italic>k</italic>-values (for example, <italic>k</italic>&#x2009;=&#x2009;2, 3) with a similar sum of squared distances, KneeLocator would choose the larger value, whereas we preferred a simpler model. Having identified the optimal number of clusters, <italic>k</italic>, we labelled every DEG with its assigned cluster and visualized average behaviour (median) and the 95% CI (bootstrapped using 1,000 iterations) per cluster using Seaborn line plot (v.0.10.0).</p>
        <p id="Par54">To confirm that the identified patterns were not spurious (that is, an artifact of the <italic>k</italic>-means clustering algorithm), we permuted the data columns (&#xFEFF;log<sub>2</sub>(FC) per time point) for each gene thereby scrambling any time-related structure while preserving its overall distribution. We then visualized the result using Seaborn line plot as described above. After permutation, we observed no longitudinal patterns, which were instead replaced by nearly flat, uninformative trends (Extended Data Fig. <xref rid="Fig8" ref-type="fig">4b, d</xref>).</p>
      </sec>
      <sec id="Sec23">
        <title>Correlation analysis</title>
        <p id="Par55">To verify DEGs identified in the discovery cohort, we compared &#xFEFF;log<sub>2</sub>(FC) values for the discovery cohort as compared to both validation 1 and validation 2 cohorts. We calculated the percentage of genes for which the &#xFEFF;log<sub>2</sub>(FC) had the same sign across cohorts (that is, both positive or both negative) and the Spearman correlation using the function scipy.stats.spearmanr. We did not calculate log&#xFEFF;<sub>2</sub>(FC) values for DEGs at &#x2264;12 weeks of gestation in validation 1 because of small sample numbers (3 preeclampsia samples before 12 weeks).</p>
        <p id="Par56">We also sought to compare whether symptom severity (without or with severe preeclampsia) correlated with &#xFEFF;log<sub>2</sub>(FC) magnitude for 544 DEGs identified as common to all preeclampsia in design 1. To do so, we calculated the slope of a best-fit line in which <italic>x</italic> and <italic>y</italic> were defined as &#xFEFF;log<sub>2</sub>(FC) values for preeclampsia without (<italic>x</italic>) and with (<italic>y</italic>) severe features versus normotensive. We would expect a slope&#x2009;&gt;&#x2009;1 and&#x2009;&lt;&#x2009;1 if log&#xFEFF;<sub>2</sub>(FC) magnitudes for preeclampsia with as compared to without severe symptoms were larger or smaller on average, respectively. Similarly, a slope&#x2009;=&#x2009;1 would reflect that symptom severity did not correlate with &#xFEFF;log<sub>2</sub>(FC) magnitude for the 544 DEGs tested.</p>
        <p id="Par57">Finally, to confirm that the identified correlations were significant, we permuted the data columns (log&#xFEFF;<sub>2</sub>(FC) per cohort) for each gene, thereby scrambling any structure while preserving its overall distribution. We then calculated the same statistics. After permutation, we observe about 50&#x2013;55% log&#xFEFF;<sub>2</sub>(FC) agreement, as expected at random, a Spearman correlation of 0 and a slope of 0.</p>
      </sec>
      <sec id="Sec24">
        <title>Defining cell-type- and tissue-specific gene profiles</title>
        <p id="Par58">Cell-type gene profiles were identified as previously described<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and briefly summarized below. We also briefly describe an adapted, similar method to derive tissue gene profiles.</p>
        <p id="Par59">On the tissue level, for genes and tissues (and some blood and immune cell types) measured in the HPA (v.19)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, we calculated a Gini coefficient per gene as a measure of tissue specificity. As a measure of inequality, Gini coefficient values closer to 1 represent genes that are tissue-specific. We defined a given gene <italic>Y</italic> as specific to tissue <italic>X</italic> included in the HPA if Gini(<italic>Y</italic>)&#x2009;&#x2265;&#x2009;0.6 and max expression for <italic>Y</italic> is in tissue <italic>X</italic>. The aforementioned method can identify genes that are expressed in several tissues (for example, group-enriched) as opposed to only one. Specifically, it is possible to have a gene <italic>Y</italic> where Gini(<italic>Y</italic>)&#x2009;&#x2265;&#x2009;0.6 and the gene is expressed in more than 1 tissue (for example, enrichment in placenta and muscle). To this end, when tracking a single cell type or tissue&#x2019;s trajectory over gestation (for example, Fig. <xref rid="Fig4" ref-type="fig">4b</xref>), where the specificity of a given gene profile is especially important, we imposed a further constraint to ensure that any gene signal only reflects the named tissue (for example, any gene named placenta-specific is specific to the placenta alone). Specifically, we required that genes be annotated by HPA as &#x2018;Tissue-enriched&#x2019; or &#x2018;Tissue-enhanced&#x2019; and term this reference &#x2018;HPA strict&#x2019;.</p>
        <p id="Par60">On the cell-type level, we identified cell-type-specific gene profiles using both Tabula Sapiens v.1.0 (TSP) and individual cell atlases. We used individual cell atlases to identify gene profiles for cell types from missing tissues in TSP (for example, placenta, brain) or tissues that are known to be important in preeclampsia with additional annotations in individual single-cell atlases (for example, liver, kidney). First, for genes and cell types measured in TSP, we defined a given gene <italic>Y</italic> as specific to cell type <italic>X</italic> included in TSP if Gini(<italic>Y</italic>)&#x2009;&#x2265;&#x2009;0.8 and max mean expression for <italic>Y</italic> is in cell type <italic>X</italic>. We&#xFEFF; combined subtype&#xA0;annotations for neutrophil and endothelial cells into single parent&#xA0;categories called &#x2018;neutrophil&#x2019;&#xA0;and &#x2018;endothelial cell&#x2019;&#xA0;respectively; as&#xA0;subtype annotations&#xA0;were based on manifold clustering, it was unclear whether they were truly distinct enough to be distinguished at a whole-body level for our purposes. Next, for genes and cell types described in individual tissue single-cell atlases, we required that a gene be differentially expressed in the specific single-cell atlases and tissue-specific per the HPA (Gini&#x2009;&#x2265;&#x2009;0.6). The following single-cell atlases were used for each organ: (1) placenta<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>; (2) liver<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>; (3) kidney<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>; (4) heart<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>; and (5) brain<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p>
        <p id="Par61">We then created an augmented reference, which we term TSP+. For TSP+, we took the union of TSP and individual atlas gene annotations. A small number of genes had conflicting double annotations in TSP as compared to at most one individual tissue single-cell atlas. In these rare instances, which most often occurred for genes related to cell types missing in TSP (for example, placental or brain cell types), we used the individual single-cell atlas label.</p>
      </sec>
      <sec id="Sec25">
        <title>Determining cell type and tissue of origin</title>
        <p id="Par62">We determined whether a given cell type or tissue was enriched in preeclampsia by comparing preeclampsia DEGs with cell-type and tissue gene profiles using a one-sided hypergeometric test. For every tissue (HPA) or cell type (TSP+) with at least two DEGs specific to it, we performed the following. First, we defined a hypergeometric distribution (scipy.stats.hypergeom, (v.1.5.1)) with the following parameters, where category refers to tissue when using HPA and cell type when using TSP+: <italic>M</italic>&#x2009;=&#x2009;number of genes specific to any category; <italic>n</italic>&#x2009;=&#x2009;number of genes specific to this category; <italic>N</italic>&#x2009;=&#x2009;number of DEGs in this <italic>k</italic>-means longitudinal cluster specific to this category. Next, we estimated a <italic>P</italic> value using the survival function (1&#x2009;&#x2212;&#x2009;cumulative distribution function (CDF)) for the specified distribution. Specifically, a <italic>P</italic> value is defined as the cumulative probability, <italic>P</italic>(<italic>X</italic>&#x2009;&gt;&#x2009;(<italic>n_</italic>DEGs_specific_to_this_category&#x2009;&#x2212;&#x2009;1)), that the distribution takes a value greater than the number of DEGs specific to this category &#x2212; 1. Finally, once we estimated a <italic>P</italic> value for every cell type (TSP+) or tissue (HPA) identified in each DEG <italic>k</italic>-means longitudinal cluster, we adjusted for multiple hypotheses using Benjamini&#x2013;Hochberg with a significance threshold of 0.05.</p>
      </sec>
      <sec id="Sec26">
        <title>Defining relative signature score per cell type or tissue</title>
        <p id="Par63">We define a signature score as the sum of logCPM values over all genes in a given tissue or cell-type gene profile<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. We required that a cell-type or tissue gene profile have at least five specified genes to be considered for signature scoring in cfRNA. Genes were defined as specific to a given tissue on the basis of the reference HPA strict, and to a given cell type on the basis of the reference TSP+ (see &#x2018;Defining cell-type- and tissue-specific gene profiles&#x2019; for details).</p>
        <p id="Par64">To account for our previous observation that baseline cfRNA levels vary between individuals&#x2014;the consequence of biological and technical (for example, sample processing) factors, we chose to calculate relative as opposed to absolute signature scores. For each individual whose post-partum sample passed sample quality control (QC) (see &#x2018;Sample quality filtering&#x2019; for details), we estimated a relative signature score, which was defined as the difference between the signature score at a given gestational time point and the post-partum sample. For both the discovery cohort and the validation 1 cohort, 49 normotensive individuals and 24 individuals with preeclampsia had a post-partum sample that survived sample QC. After normalization, all samples at post-partum had a similar baseline (0). We note that one can define a relative signature score based on any sampled time point for a given person. We chose the post-partum sample because we were interested in tracking maternal organ health over gestation.</p>
        <p id="Par65">Finally, we scaled (that is, <italic>z</italic>-score) the relative signature scores for a given cell type or tissue by dividing by the interquartile range, a robust alternative to standard deviation, using the sklearn.preprocessing class, RobustScaler. This accounted for differing gene profile lengths and gene expression levels, and allowed us to compare both different cell-type and tissue contributions and case groups per cell type or tissue.</p>
        <p id="Par66">Having defined a relative signature score per cell type and tissue, we visualized average behaviour (median) and the 75% CI, a non-parametric estimation of standard deviation, (bootstrapped relative signature score per case group and time point using 1,000 iterations) using Seaborn line plot (v.0.10.0).</p>
      </sec>
      <sec id="Sec27">
        <title>Functional enrichment analysis</title>
        <p id="Par67">Functional enrichment analysis was performed using the tool GProfiler (v.1.0.0) for the following data sources: Gene Ontology: biological processes and cellular compartments (GO:BP, GO:CC, released 1 May 2021, 2021-05-01), Reactome (REAC, released 7 May 2021, 2021-05-07) and Kyoto Encyclopedia of Genes and Genomes (KEGG&#xA0;FTP, released 3 May 2021, 2021-05-03). To identify GO terms, we excluded electronic GO annotations (IEA) and used a custom background of only the 7,160 genes that were included in the differential expression analysis. We then performed the recommended multiple hypothesis correction (g:SCS) with an experiment-wide significance threshold of <italic>a</italic>&#x2009;=&#x2009;0.05 (ref. <sup><xref ref-type="bibr" rid="CR50">50</xref></sup>).</p>
      </sec>
      <sec id="Sec28">
        <title>Logistic regression feature selection and training</title>
        <p id="Par68">To build a robust classifier that can identify mothers at risk of preeclampsia at or before 16 weeks of gestation, we first pre-selected features using the set of 330 DEGs when contrasting preeclampsia versus normotensive (see design 2 in &#x2018;Differential expression analysis&#x2019; and Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>) as a starting point.</p>
        <p id="Par69">We normalized gene measurements using a series of steps. First, to correct for batch effect, in which we define batch as a set of samples processed at the same time by a distinct group (for example, discovery cohort&#x2009;=&#x2009;batch, Del Vecchio cohort&#x2009;=&#x2009;batch), we centred the data by subtracting the median logCPM per gene for a given cohort. Next, we scaled gene values for each cohort using its corresponding interquartile range in the discovery cohort. Finally, to account for sampling differences across samples, we used an approach similar to when analysing quantitative PCR with reverse transcription (RT&#x2013;qPCR) data, and normalized data using multiple internal control (that is, housekeeping) genes. On a per-sample basis, we subtracted the median, normalized logCPM value (centred and scaled) for all internal control genes, which we define as 66 genes for which the measured value did not change across preeclampsia versus normotensive comparisons (all genes with adjusted <italic>P</italic>&#x2009;&gt;&#x2009;0.99 for preeclampsia versus normotensive; design 2). When calculating the median value for all internal control genes, we excluded any 0 logCPM values as these are likely to have been the consequence of technical dropout.</p>
        <p id="Par70">Model training then used the discovery cohort alone split into 80% for hyperparameter tuning and 20% for model selection and consisted of two stages&#x2014;further feature pre-selection based on two metrics followed by the construction of a logistic regression model with an elastic net penalty. Using a split discovery cohort for training mitigated overfitting even though all discovery samples were used for differential expression, which defined the initial feature set.</p>
        <p id="Par71">For feature pre-selection, we calculated logFC values using the 80% discovery split for all 330 genes for preeclampsia versus normotensive. We focused on 2 practical metrics measured across the 80% split of discovery samples collected on or before 16 weeks of gestation: gene change size (|&#xFEFF;log<sub>2</sub>(FC)|) and gene change stability (CV). All model hyperparameters were then tuned using AUROC as the outcome metric and fivefold cross validation. Next, we selected the best model including tuned feature pre-selection cut-offs again using AUROC. Specifically, we calculated an AUROC score for both the 80% and the 20% discovery splits separately, and the selected model achieved the best score on both splits.</p>
        <p id="Par72">Finally, we tuned the probability threshold, <italic>P</italic>, at which a sample is labelled as at risk of preeclampsia if <italic>P</italic>(PE)&#x2009;&#x2265;&#x2009;<italic>P</italic> using the entire discovery cohort. To do so, we constructed a receiver operator characteristic curve (ROC) and calculated the false positive rate (FPR) and true positive rate (TPR) at different thresholds, <italic>P_i</italic>. We identified the threshold, <italic>P_i</italic>, at which FPR&#x2009;=&#x2009;10%, and round to the nearest 5 (for example, 0.37 would become 0.35). This yielded a tuned threshold of <italic>P</italic>&#x2009;=&#x2009;0.35. All classifications as negative or positive were then made based on this threshold.</p>
        <p id="Par73">To understand the importance of each gene feature, we trained a separate logistic regression model for a subset of all possible feature subsets (307 combinations out of a total of 262,143 for 1&#x2013;17 genes). No feature pre-selection was performed for this sub-analysis. All model hyperparameters were tuned as previously described. We defined a gene subset as weakly predictive if the model yielded an AUROC&#x2009;&gt;&#x2009;0.5 on the test set (validation 2).</p>
        <p id="Par74">In all cases, performance metrics were assessed as described below (see next section) and used Scikit-learn (v.0.23.2).</p>
      </sec>
      <sec id="Sec29">
        <title>Performance metric analysis</title>
        <p id="Par75">Model performance was assessed using several statistics including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and AUROC. Given a 2&#x2009;&#xD7;&#x2009;2 confusion matrix in which rows 1and 2 represent true negatives and positives and columns 1 and 2 represent negative and positive predictions, respectively, we can define the values in row 1, column 1 as true negatives (TN), row 1, column 2 as false positives (FP), row 2, column 1 as false negatives (FN), and row 2, column 2 as true positives (TP). We can then define the following proportions: (1) sensitivity&#x2009;=&#x2009;TP/(TP&#x2009;+&#x2009;FN); (2) specificity&#x2009;=&#x2009;TN/(TN&#x2009;+&#x2009;FP); (3) PPV&#x2009;=&#x2009;TP/(TP&#x2009;+&#x2009;FP); (4) NPV&#x2009;=&#x2009;TN/(TN&#x2009;+&#x2009;FN). For each proportion, we calculated 90% CIs using Jeffrey&#x2019;s interval<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> and the function, proportion_confint, from statsmodels.stats.proportion. We also approximated AUC and its corresponding 90% CI using the Scikit-learn function, roc_auc_score, and the binormal approximation, respectively.</p>
      </sec>
      <sec id="Sec30">
        <title>Statistical analyses</title>
        <p id="Par76">All <italic>P</italic> values reported herein were calculated using the non-parametric Mann&#x2013;Whitney rank test unless otherwise stated. One-sided tests were performed where required based on the hypothesis tested.</p>
      </sec>
      <sec id="Sec31">
        <title>Reporting summary</title>
        <p id="Par77">Further information on research design is available in the&#xA0;<xref rid="MOESM2" ref-type="media">Nature Research Reporting Summary</xref> linked to this paper.</p>
      </sec>
    </sec>
    <sec id="Sec32" sec-type="materials|methods">
      <title>Online content</title>
      <p id="Par78">Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41586-022-04410-z.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41586_2022_4410_MOESM1_ESM.pdf"><label>Supplementary Information</label><caption><p>This file contains Supplementary Notes 1 and 2; Supplementary Tables 1, 2, 5 and 6 and legends for Supplementary Tables 3 and 4.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41586_2022_4410_MOESM2_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41586_2022_4410_MOESM3_ESM.xlsx"><label>Supplementary Table 3</label><caption><p>See Supplementary Information file for description.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41586_2022_4410_MOESM4_ESM.xlsx"><label>Supplementary Table 4</label><caption><p>See Supplementary Information file for description.</p></caption></media></supplementary-material>
</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec33">
          <title>Extended data figures and tables</title>
          <p id="Par81">
<fig id="Fig5"><label>Extended Data Fig. 1</label><caption><title>Samples with outlier values for at least one QC metric cluster separately from most non-outlier samples.</title><p><bold>a</bold>&#x2013;<bold>c</bold>, For discovery (<bold>a</bold>), validation 1 (<bold>b</bold>), and validation 2 (<bold>c</bold>), hierarchical clustering (left) and PCA (right) reveals that most outlier samples cluster with negative control (NC) samples and separately from non-outlier samples. <bold>d</bold>, <bold>e</bold>, Visualization of other QC metrics like the amount of cfRNA extracted (<bold>d</bold>) and the percent of reads that align uniquely to the human genome (<bold>e</bold>) (n&#x2009;=&#x2009;209, 106, 89 samples for discovery, validation 1, and validation 2, respectively). For PCA in <bold>a</bold>&#x2013;<bold>c</bold>, sample outliers and poorly detected genes drive PCA and serve as leverage points. The top two principal components are visualized when performed using all samples and all genes (leftmost PCA) or only samples that pass QC metrics (middle PCA) reveals that certain samples can act as leverage points. Once sample outliers and lowly detected genes are removed from the cfRNA gene matrix (rightmost PCA), the top two principal components reflect natural variance in the data and are no longer driven by a few leverage points. For box plots, centre line, box limits, whiskers and outliers represent the median, upper and lower quartiles, 1.5&#xD7; interquartile range and any outliers outside that distribution, respectively.</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Fig5_ESM" id="d32e1961"/></fig>
</p>
          <p id="Par82">
<fig id="Fig6"><label>Extended Data Fig. 2</label><caption><title>Across gestation before diagnosis, changes in the cfRNA transcriptome segregate preeclampsia and normotensive samples and reflect known preeclampsia biology.</title><p><bold>a</bold>, Distribution of CVs with dashed line at CV&#x2009;=&#x2009;1 for all DEGs (n&#x2009;=&#x2009;544) between preeclampsia as compared to normotensive samples across gestation. <bold>b</bold>, At &#x2265;23 weeks of gestation and post-partum, a subset of DEGs can separate preeclampsia (n&#x2009;=&#x2009;20, 17) and normotensive (n&#x2009;=&#x2009;37, 29) samples despite differences in symptom severity, preeclampsia onset subtype, and GA at delivery. <bold>c</bold>, Comparison of log&#xFEFF;<sub>2</sub>(FC) for DEGs for preeclampsia as compared to normotensive between discovery and validation 1 reveals good agreement across gestation but not post-partum. <bold>d</bold>, The genes in each longitudinal trend group reflect known preeclampsia aetiology as highlighted across four databases (GO biological processes, KEGG, the reactome, and GO cellular compartment). Some preeclampsia associated terms are emphasized in bold, coloured text that corresponds to group colour from Fig. <xref rid="Fig2" ref-type="fig">2d</xref> (Dark blue and orange indicate decreased and increased in preeclampsia versus normotensive, respectively) (p&#x2009;&#x2264;&#x2009;0.05; one-sided hypergeometric test with multiple hypothesis correction, see&#xA0;<xref rid="Sec9" ref-type="sec">Methods</xref>). <bold>e</bold>, Comparison of &#xFEFF;log<sub>2</sub>(FC) for DEGs for preeclampsia without severe features versus normotensive and preeclampsia with severe features versus normotensive in the discovery cohort reveals good agreement along the y=x axis with a slope of 0.93, 1.03, 0.77, and 0.86 at &#x2264;12 weeks, 13&#x2013;20, &#x2265;23 weeks, and post-partum, respectively.</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Fig6_ESM" id="d32e2002"/></fig>
</p>
          <p id="Par83">
<fig id="Fig7"><label>Extended Data Fig. 3</label><caption><title>Across gestation and before diagnosis, changes in the cfRNA transcriptome identified at one time point can moderately segregate preeclampsia and normotensive samples at other time points.</title><p>DEGs with |&#xFEFF;log<sub>2</sub>(FC)|&#x2009;&#x2265;&#x2009;1 and CV&#x2009;&lt;&#x2009;0.5 or 0.4 for the 13&#x2013;20 week time point were identified at each time point across gestation. Each row visualizes how well a specific DEG subset from a given sample collection period can separate preeclampsia (n&#x2009;=&#x2009;13, 16, 20, 17) and normotensive (n&#x2009;=&#x2009;36, 33, 37, 29) samples in all other collection periods (&#x2264;12, 13&#x2013;20, &#x2265;23 weeks of gestation and post-partum respectively). The number of genes identified per sample collection period is highlighted along the main diagonal.</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Fig7_ESM" id="d32e2019"/></fig>
</p>
          <p id="Par84">
<fig id="Fig8"><label>Extended Data Fig. 4</label><caption><title><italic>k</italic>-means clustering reveals meaningful longitudinal patterns.</title><p><bold>a</bold>, <bold>c</bold>, The chosen <italic>k</italic> clusters (dashed line) comparing a performance metric, the sum of squared distances, and values of <italic>k</italic> for clustering of DEGs for preeclampsia versus normotensive related to Fig. <xref rid="Fig2" ref-type="fig">2d</xref> (<bold>a</bold>) and DEGs for preeclampsia with versus without severe features related to Fig. <xref rid="Fig4" ref-type="fig">4a</xref> (<bold>c</bold>). <bold>b</bold>, <bold>d</bold>, Following permutation of the data matrix prior to <italic>k</italic>-means clustering, longitudinal changes over gestation are replaced by 2 flat lines for clustering of &#xFEFF;log<sub>2</sub>(FC) for preeclampsia versus normotensive (<bold>b</bold>) and 4 uninformative lines for clustering of &#xFEFF;log<sub>2</sub>(FC) for preeclampsia with versus without severe features (<bold>d</bold>). For <bold>b</bold>, <bold>d</bold>, points indicate median per trend and shaded region indicates 95% CI.</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Fig8_ESM" id="d32e2087"/></fig>
</p>
          <p id="Par85">
<fig id="Fig9"><label>Extended Data Fig. 5</label><caption><title>Examining the logistic regression model used to predict risk of preeclampsia early in gestation.</title><p><bold>a</bold>, Comparison of gestational age at sample collection (weeks) for incorrectly predicted (yellow) or correctly predicted (green) samples across normotensive and preeclampsia groups in the discovery, validation 1, validation 2 and Del Vecchio cohorts shows that incorrectly predicted preeclampsia samples (false negatives) are collected at later gestational ages. <bold>b</bold>, Estimated probability of preeclampsia as outputted by logistic regression for both preeclampsia and normotensive samples shows that the model is well-calibrated across most predictions. Dashed line at 0.35 indicates classifier cut-off where <italic>P</italic>(PE)&#x2009;&#x2265;&#x2009;0.35 constitutes a sample predicted as preeclampsia. <bold>c</bold>, Logistic regression models trained on subsets of 1&#x2013;18 genes of the initial 18 genes can moderately predict future preeclampsia onset in the validation 2 cohort with improving performance as subset size increases and as characterized by PPV, NPV, sensitivity, specificity and AUROC (left to right).</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Fig9_ESM" id="d32e2112"/></fig>
</p>
          <p id="Par86">
<table-wrap id="Tab1"><label>Extended Data Table 1</label><caption><p>Participant, pregnancy and preeclampsia characteristics across both discovery and validation cohorts</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Tab1_ESM" id="d32e2124"><caption><p>Participant, pregnancy and preeclampsia characteristics across both discovery and validation cohorts</p></caption></graphic><table-wrap-foot><p>Maternal age and BMI, gestational age (GA) at delivery, fetal weight and GA at preeclampsia onset are reported as mean&#x2009;&#xB1;&#x2009;s.d. All other values are reported as percentages with the corresponding count in parentheses. Small for GA (SGA) was defined as an infant with a birthweight below the 10th centile for their GA at delivery. Pre-pregnancy BMI was not available for individuals in the validation 2 cohort. See Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref> for exact <italic>P</italic> values. AI/AN, American Indians and Alaska Natives.</p><p>*<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05, two-sided chi-squared (categorical) or ANOVA (continuous) test comparing all cohorts with Bonferroni correction.</p><p>&#x2020;<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05, two-sided chi-squared (categorical) or ANOVA (continuous) test comparing preeclampsia and normotensive within each cohort with Bonferroni correction.</p><p>&#x2021; denotes that missing values were omitted from reported values for a given feature.</p></table-wrap-foot></table-wrap>
</p>
          <p id="Par87">
<table-wrap id="Tab2"><label>Extended Data Table 2</label><caption><p>Tissue, cell types, and genes previously implicated in preeclampsia enriched in 544 DEGs identified when comparing preeclampsia with or without severe features and normotensive pregnancies</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Tab2_ESM" id="d32e2161"><caption><p>Tissue, cell types, and genes previously implicated in preeclampsia enriched in 544 DEGs identified when comparing preeclampsia with or without severe features and normotensive pregnancies</p></caption></graphic><table-wrap-foot><p>For every significantly enriched tissue or cell type (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05; one-sided hypergeometric test with Benjamini&#x2013;Hochberg correction), assigned <italic>k</italic>-means cluster (Fig. <xref rid="Fig2" ref-type="fig">2d</xref>), reference and adjusted <italic>P</italic> values are reported from left to right. The rightmost column lists the gene names for all DEGs that were labelled as specific to a given cell type or tissue. The last row lists gene set enrichment with dbPEC, a preeclampsia-specific database of genes.</p></table-wrap-foot></table-wrap>
</p>
          <p id="Par88">
<table-wrap id="Tab3"><label>Extended Data Table 3&#xFEFF;</label><caption><p>Preeclampsia prediction performance metrics for samples collected early in gestation (5&#x2013;16 weeks)</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Tab3_ESM" id="d32e2192"><caption><p>Preeclampsia prediction performance metrics for samples collected early in gestation (5&#x2013;16 weeks)</p></caption></graphic><table-wrap-foot><p>Control and case sample numbers are reported as the total sample number and, in parentheses, the number of samples misclassified. All other statistics including sensitivity specificity, PPV, NPV and AUROC are reported as the estimated percentage followed by the 90% CI in square brackets. In Del Vecchio<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, the control group is defined as samples from any pregnant mother who did not develop preeclampsia, including those with other underlying or pregnancy-related complications such as chronic hypertension or gestational diabetes, respectively. In Del Vecchio<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, the control group is defined as samples strictly from normotensive pregnant mothers who did not experience complications.</p></table-wrap-foot></table-wrap>
</p>
          <p id="Par89">
<table-wrap id="Tab4"><label>Extended Data Table 4</label><caption><p>Preeclampsia prediction relies on the cfRNA levels of 18 genes</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Tab4_ESM" id="d32e2219"><caption><p>Preeclampsia prediction relies on the cfRNA levels of 18 genes</p></caption></graphic><table-wrap-foot><p>For every gene, symbol, ENSEMBL ID, full name, odds ratio (OR) based on the logistic regression coefficient and, if available, a subset of GO biological processes and molecular functions (if available) are reported from left to right.</p></table-wrap-foot></table-wrap>
</p>
          <p id="Par90">
<table-wrap id="Tab5"><label>Extended Data Table 5</label><caption><p>Tissue and cell types enriched in 503 DEGs identified when comparing preeclampsia with as compared to without severe features</p></caption><graphic position="anchor" xlink:href="41586_2022_4410_Tab5_ESM" id="d32e2238"><caption><p>Tissue and cell types enriched in 503 DEGs identified when comparing preeclampsia with as compared to without severe features</p></caption></graphic><table-wrap-foot><p>For every significantly enriched tissue or cell type (<italic>P</italic>&#x2009;&#x2264;&#x2009;0.05; one-sided hypergeometric test with Benjamini&#x2013;Hochberg correction), assigned <italic>k</italic>-means cluster (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>), reference and adjusted <italic>P</italic> values are reported from left to right. The rightmost column lists the gene names for all DEGs that were labelled as specific to a given cell type or tissue.</p></table-wrap-foot></table-wrap>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Extended data</title>
      <p>is available for this paper at 10.1038/s41586-022-04410-z.</p>
    </sec>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41586-022-04410-z.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank N. Aghaeepour and I. Maric for discussions and data analysis suggestions; the many researchers and clinicians affiliated with the March of Dimes Prematurity Research Center at Stanford University for feedback after oral presentations; the Hess Research Fund&#xA0;for financial support; and the participants in this study for their contribution. This research was conducted using specimens and data collected and stored on behalf of the GAPPS repository. The schematics in Fig. <xref rid="Fig4" ref-type="fig">4b</xref> were created with BioRender. This work was supported by the Chan Zuckerberg Biohub, GAPPS and the March of Dimes Foundation. M.N.M. is supported by the Stanford Bio-X Bowes Fellowship; S.K.V. is supported by a NSF Graduate Research Fellowship (grant no. DGE 1656518), the Benchmark Stanford Graduate Fellowship, and the Stanford ChEM-H Chemistry Biology Interface (CBI) training program; and V.D.W. is supported by the H&amp;H Evergreen Fund.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>M.N.M., G.M.S., D.K.S. and S.R.Q. conceptualized and designed the study. M.L.D., V.D.W., G.M.S. and D.K.S. designed the cohort study at Lucile Packard Children&#x2019;s Hospital. R.J.W., A.A.C. and C.C.Q. collected and processed whole-blood samples and corresponding sample and participant metadata. C.B.-G. and J.A.L. oversaw whole-blood sample and corresponding sample and participant metadata collection at GAPPS. M.N.M. developed experimental protocols for cfRNA extraction and data generation and processed all samples from cfRNA extraction up to and including library generation for RNA sequencing. R.V.S., M.T., A.M.D., H.M. and N.F.N. developed and executed experimental protocols for RNA sequencing and computational protocols for raw sequencing data transfer. S.K.V. developed computational methods to define genes as cell-type- and tissue-specific in the context of the whole body. M.N.M. and S.K.V. designed the analyses to characterize tissue and cell-type contributions. M.N.M. conceptualized and developed computational analyses, analysed the data and wrote the initial manuscript draft in collaboration with S.R.Q. All authors contributed to writing and editing the manuscript.</p>
    </notes>
    <notes notes-type="peer-review">
      <title>Peer review</title>
      <sec id="d32e1867">
        <title>Peer review information</title>
        <p id="Par79"><italic>Nature</italic> thanks the anonymous reviewers for their contribution to the peer review of this work.</p>
      </sec>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>Raw and processed sequencing data (BioProject PRJNA792450)&#xA0;are available through the Sequence Read Archive (SRA, SRP352519) and the Gene Expression Omnibus (GEO, GSE192902), respectively. Data were mapped using the human reference genome (hg38) and annotated using ENSEMBL v.82. We used publicly available data from the HPA (v.19; <ext-link ext-link-type="uri" xlink:href="https://v19.proteinatlas.org/">https://v19.proteinatlas.org/</ext-link>); TSP (v.1.0; <ext-link ext-link-type="uri" xlink:href="https://tabula-sapiens-portal.ds.czbiohub.org/">https://tabula-sapiens-portal.ds.czbiohub.org/</ext-link>); Gene Ontology: biological processes and cellular compartments (GO:BP, GO:CC, released 1 May 2021, 2021-05-01); Reactome (REAC, released 7 May 2021, 2021-05-07); Kyoto Encyclopedia of Genes and Genomes (KEGG, released 3 May 2021, 2021-05-03); and several previous publications<sup><xref ref-type="bibr" rid="CR44">44</xref>&#x2013;<xref ref-type="bibr" rid="CR49">49</xref></sup>.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>All computational analyses were performed using Python 3.6 or R 3.5, and are available on Github at <ext-link ext-link-type="uri" xlink:href="https://github.com/miramou/pe_cfrna">https://github.com/miramou/pe_cfrna</ext-link>.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par80">M.N.M., S.K.V., G.M.S., D.K.S. and S.R.Q. are inventors on a patent application submitted by the Chan Zuckerberg Biohub and Stanford University that covers non-invasive early prediction of preeclampsia and monitoring maternal organ health over pregnancy&#xA0;(USPTO application number&#xA0;63/159,400 filed on 10 March 2021 and&#xA0;63/276,467 filed on 5 November 2021). S.R.Q. is a founder, consultant and shareholder of Mirvie. M.N.M. is also a shareholder of Mirvie.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blencowe</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Born too soon: the global epidemiology of 15 million preterm births</article-title>
          <source>Reprod. Health</source>
          <year>2013</year>
          <volume>10</volume>
          <fpage>S2</fpage>
          <pub-id pub-id-type="pmid">24625129</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevens</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Short-term costs of preeclampsia to the United States health care system</article-title>
          <source>Am. J. Obstet. Gynecol.</source>
          <year>2017</year>
          <volume>217</volume>
          <fpage>237</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">28708975</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Trends in fetal and infant survival following preeclampsia</article-title>
          <source>JAMA</source>
          <year>2006</year>
          <volume>296</volume>
          <fpage>1357</fpage>
          <lpage>1362</lpage>
          <pub-id pub-id-type="pmid">16985227</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beam</surname>
              <given-names>AL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Estimates of healthcare spending for preterm and low-birthweight infants in a commercially insured population: 2008&#x2013;2016</article-title>
          <source>J. Perinatol.</source>
          <year>2020</year>
          <volume>40</volume>
          <fpage>1091</fpage>
          <lpage>1099</lpage>
          <pub-id pub-id-type="pmid">32103158</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Say</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global causes of maternal death: a WHO systematic analysis</article-title>
          <source>Lancet Glob. Health</source>
          <year>2014</year>
          <volume>2</volume>
          <fpage>e323</fpage>
          <lpage>e333</lpage>
          <pub-id pub-id-type="pmid">25103301</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phipps</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Thadhani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Benzing</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Karumanchi</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Pre-eclampsia: pathogenesis, novel diagnostics and therapies</article-title>
          <source>Nat. Rev. Nephrol.</source>
          <year>2019</year>
          <volume>15</volume>
          <fpage>275</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">30792480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pennington</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Schlitt</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Schust</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Preeclampsia: multiple approaches for a multifactorial disease</article-title>
          <source>Dis. Model. Mech.</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>9</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">22228789</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steegers</surname>
              <given-names>EAP</given-names>
            </name>
            <name>
              <surname>von Dadelszen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Duvekot</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Pijnenborg</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Pre-eclampsia</article-title>
          <source>Lancet</source>
          <year>2010</year>
          <volume>376</volume>
          <fpage>631</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="pmid">20598363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burton</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Redman</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Moffett</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Pre-eclampsia: pathophysiology and clinical implications</article-title>
          <source>BMJ</source>
          <year>2019</year>
          <volume>366</volume>
          <fpage>l2381</fpage>
          <pub-id pub-id-type="pmid">31307997</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCarthy</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Chappell</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Prospective biomarkers in preterm preeclampsia: a review</article-title>
          <source>Pregnancy Hypertens.</source>
          <year>2018</year>
          <volume>14</volume>
          <fpage>72</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">30527122</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henderson</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Vesco</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Senger</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Redmond</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US preventive services task force</article-title>
          <source>JAMA</source>
          <year>2021</year>
          <volume>326</volume>
          <fpage>1192</fpage>
          <lpage>1206</lpage>
          <pub-id pub-id-type="pmid">34581730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Behrman, R. E. &amp; Butler, A. S. in <italic>Preterm Birth: Causes, Consequences, and Prevention</italic> (eds Berhman, R. E. &amp; Butler, A. S.) Ch. 12 (National Academic Press, 2007).</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petersen</surname>
              <given-names>EE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vital signs: pregnancy-related deaths, United States, 2011&#x2013;2015, and strategies for prevention, 13 states, 2013&#x2013;2017</article-title>
          <source>MMWR Morb. Mortal. Wkly Rep.</source>
          <year>2019</year>
          <volume>68</volume>
          <fpage>423</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">31071074</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>The American College of Obstetricians and Gynecologists.</collab>
          </person-group>
          <article-title>Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists&#x2019; Task Force on Hypertension in Pregnancy</article-title>
          <source>Obstet. Gynecol.</source>
          <year>2013</year>
          <volume>122</volume>
          <fpage>1122</fpage>
          <lpage>1131</lpage>
          <pub-id pub-id-type="pmid">24150027</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goel</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period</article-title>
          <source>Circulation</source>
          <year>2015</year>
          <volume>132</volume>
          <fpage>1726</fpage>
          <lpage>1733</lpage>
          <pub-id pub-id-type="pmid">26416810</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitehead</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Measuring circulating placental RNAs to non-invasively assess the placental transcriptome and to predict pregnancy complications</article-title>
          <source>Prenat. Diagn.</source>
          <year>2016</year>
          <volume>36</volume>
          <fpage>997</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">27711965</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munchel</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia</article-title>
          <source>Sci. Transl. Med.</source>
          <year>2020</year>
          <volume>12</volume>
          <fpage>eaaz0131</fpage>
          <pub-id pub-id-type="pmid">32611681</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsang</surname>
              <given-names>JCH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2017</year>
          <volume>114</volume>
          <fpage>E7786</fpage>
          <lpage>E7795</lpage>
          <pub-id pub-id-type="pmid">28830992</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Vecchio</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cell-free DNA methylation and transcriptomic signature prediction of pregnancies with adverse outcomes</article-title>
          <source>Epigenetics</source>
          <year>2021</year>
          <volume>16</volume>
          <fpage>642</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="pmid">33045922</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Dadelszen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Magee</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Subclassification of preeclampsia</article-title>
          <source>Hypertens. Pregnancy</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>143</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">12908998</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raymond</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>A critical review of early-onset and late-onset preeclampsia</article-title>
          <source>Obstet. Gynecol. Surv.</source>
          <year>2011</year>
          <volume>66</volume>
          <fpage>497</fpage>
          <lpage>506</lpage>
          <pub-id pub-id-type="pmid">22018452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaiworapongsa</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa</article-title>
          <source>J. Perinat. Med.</source>
          <year>2013</year>
          <volume>41</volume>
          <fpage>485</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="pmid">23793063</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leavey</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia</article-title>
          <source>Hypertension</source>
          <year>2016</year>
          <volume>68</volume>
          <fpage>137</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">27160201</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benton</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Leavey</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grynspan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Bainbridge</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology</article-title>
          <source>Am. J. Obstet. Gynecol.</source>
          <year>2018</year>
          <volume>219</volume>
          <fpage>604.e1</fpage>
          <lpage>604.e25</lpage>
          <pub-id pub-id-type="pmid">30278173</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koh</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Noninvasive in vivo monitoring of tissue-specific global gene expression in humans</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2014</year>
          <volume>111</volume>
          <fpage>7361</fpage>
          <lpage>7366</lpage>
          <pub-id pub-id-type="pmid">24799715</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">Vorperian, S. K., Moufarrej, M. N., Tabula Sapiens Consortium &amp; Quake, S. R. Cell types of origin in the cell free transcriptome in human health and disease. Preprint at <italic>bioRxiv</italic>10.1101/2021.05.05.441859 (2021).</mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>The American College of Obstetricians and Gynecologists.</collab>
          </person-group>
          <article-title>Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222</article-title>
          <source>Obstet. Gynecol.</source>
          <year>2020</year>
          <volume>135</volume>
          <fpage>e237</fpage>
          <lpage>e260</lpage>
          <pub-id pub-id-type="pmid">32443079</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uzun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Triche</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Schuster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dewan</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Padbury</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>dbPEC: a comprehensive literature-based database for preeclampsia related genes and phenotypes</article-title>
          <source>Database</source>
          <year>2016</year>
          <volume>2016</volume>
          <fpage>baw006</fpage>
          <pub-id pub-id-type="pmid">26946289</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillich</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Capillary cell-type specialization in the alveolus</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>586</volume>
          <fpage>785</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="pmid">33057196</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Crocker</surname>
              <given-names>IP</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Aplin</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Westwood</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>IGF2 actions on trophoblast in human placenta are regulated by the insulin-like growth factor 2 receptor, which can function as both a signaling and clearance receptor</article-title>
          <source>Biol. Reprod.</source>
          <year>2011</year>
          <volume>84</volume>
          <fpage>440</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">20980691</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>CJP</given-names>
            </name>
            <name>
              <surname>Aplin</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>A role for tissue transglutaminase in stabilization of membrane-cytoskeletal particles shed from the human placenta</article-title>
          <source>Biol. Reprod.</source>
          <year>2007</year>
          <volume>77</volume>
          <fpage>648</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="pmid">17625111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arck</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Hecher</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Fetomaternal immune cross-talk and its consequences for maternal and offspring&#x2019;s health</article-title>
          <source>Nat. Med.</source>
          <year>2013</year>
          <volume>19</volume>
          <fpage>548</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="pmid">23652115</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weissgerber</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Mudd</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Preeclampsia and diabetes</article-title>
          <source>Curr. Diab. Rep.</source>
          <year>2015</year>
          <volume>15</volume>
          <fpage>9</fpage>
          <pub-id pub-id-type="pmid">25644816</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sibai</surname>
              <given-names>BM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension</article-title>
          <source>Am. J. Obstet. Gynecol.</source>
          <year>2011</year>
          <volume>204</volume>
          <fpage>345.e1</fpage>
          <lpage>345.e6</lpage>
          <pub-id pub-id-type="pmid">21354549</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uhlen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A genome-wide transcriptomic analysis of protein-coding genes in human blood cells</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>366</volume>
          <fpage>eaax9198</fpage>
          <pub-id pub-id-type="pmid">31857451</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential dynamics of the maternal immune system in healthy pregnancy and preeclampsia</article-title>
          <source>Front. Immunol.</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>1305</fpage>
          <pub-id pub-id-type="pmid">31263463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ander</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Coyne</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Immune responses at the maternal&#x2013;fetal interface</article-title>
          <source>Sci. Immunol.</source>
          <year>2019</year>
          <volume>4</volume>
          <fpage>eaat6114</fpage>
          <pub-id pub-id-type="pmid">30635356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szarka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rig&#xF3;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>L&#xE1;z&#xE1;r</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Beko</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Molvarec</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array</article-title>
          <source>BMC Immunol.</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>59</fpage>
          <pub-id pub-id-type="pmid">21126355</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="other">Ibarra, A. et al. Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing. <italic>Nat. Commun.</italic><bold>11</bold>, 400 (2020).</mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mari&#x107;</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Early prediction of preeclampsia via machine learning</article-title>
          <source>Am. J. Obstet. Gynecol MFM</source>
          <year>2020</year>
          <volume>2</volume>
          <fpage>100100</fpage>
          <pub-id pub-id-type="pmid">33345966</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Oshlack</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A scaling normalization method for differential expression analysis of RNA-seq data</article-title>
          <source>Genome Biol.</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>R25</fpage>
          <pub-id pub-id-type="pmid">20196867</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="other">Pan, W. <italic>Development of Diagnostic Methods Using Cell-free Nucleic Acids</italic> (Stanford University, 2016).</mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moufarrej</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Quake</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Investigating pregnancy and its complications using circulating cell-free RNA in women&#x2019;s blood during gestation</article-title>
          <source>Front. Pediatr.</source>
          <year>2020</year>
          <volume>8</volume>
          <fpage>605219</fpage>
          <pub-id pub-id-type="pmid">33381480</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell reconstruction of the early maternal&#x2013;fetal interface in humans</article-title>
          <source>Nature</source>
          <year>2018</year>
          <volume>563</volume>
          <fpage>347</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="pmid">30429548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suryawanshi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A single-cell survey of the human first-trimester placenta and decidua</article-title>
          <source>Sci. Adv.</source>
          <year>2018</year>
          <volume>4</volume>
          <fpage>eaau4788</fpage>
          <pub-id pub-id-type="pmid">30402542</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aizarani</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A human liver cell atlas reveals heterogeneity and epithelial progenitors</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>572</volume>
          <fpage>199</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">31292543</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>BJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatiotemporal immune zonation of the human kidney</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>365</volume>
          <fpage>1461</fpage>
          <lpage>1466</lpage>
          <pub-id pub-id-type="pmid">31604275</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Litvi&#x148;ukov&#xE1;</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cells of the adult human heart</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>588</volume>
          <fpage>466</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="pmid">32971526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mathys</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>570</volume>
          <fpage>332</fpage>
          <lpage>337</lpage>
          <pub-id pub-id-type="pmid">31042697</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raudvere</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2019</year>
          <volume>47</volume>
          <fpage>W191</fpage>
          <lpage>W198</lpage>
          <pub-id pub-id-type="pmid">31066453</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>DasGupta</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Interval estimation for a binomial proportion</article-title>
          <source>Stat. Sci.</source>
          <year>2001</year>
          <volume>16</volume>
          <fpage>101</fpage>
          <lpage>133</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
